<SEC-DOCUMENT>0001628280-19-002315.txt : 20190301
<SEC-HEADER>0001628280-19-002315.hdr.sgml : 20190301
<ACCEPTANCE-DATETIME>20190228191917
ACCESSION NUMBER:		0001628280-19-002315
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20181231
FILED AS OF DATE:		20190301
DATE AS OF CHANGE:		20190228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CROSS COUNTRY HEALTHCARE INC
		CENTRAL INDEX KEY:			0001141103
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				134066229
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-33169
		FILM NUMBER:		19646054

	BUSINESS ADDRESS:	
		STREET 1:		5201 CONGRESS AVENUE
		STREET 2:		SUITE 100B
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		8003472264

	MAIL ADDRESS:	
		STREET 1:		5201 CONGRESS AVENUE
		STREET 2:		SUITE 100B
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROSS COUNTRY INC
		DATE OF NAME CHANGE:	20010521
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ccrn20181231-10k.htm
<DESCRIPTION>10-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sEBB08BDC67E6570AA7A546496DAD922D"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #666666;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">__________________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM 10-K</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:682px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:61px;"></td><td style="width:621px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Fiscal Year Ended December&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">or</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:682px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:61px;"></td><td style="width:621px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the transition period from</font><font style="font-family:inherit;font-size:10pt;">&#32;__________ </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">to</font><font style="font-family:inherit;font-size:10pt;">&#32;__________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commission file number 0-33169</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="cchcoverlogo.jpg" alt="cchcoverlogo.jpg" style="height:98px;width:282px;"></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">Cross Country Healthcare,&#160;Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13-4066229</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or other jurisdiction of incorporation or organization)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(I.R.S. Employer Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5201 Congress Avenue, Suite 100B</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Boca Raton, Florida 33487</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of principal executive offices, zip code)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code: </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(561)&#160;998-2232</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section&#160;12(b) of the Act:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title of each class</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common Stock, par value $0.0001 per share</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The NASDAQ Stock Market</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section&#160;12(g) of the act: None</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act. Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;No </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation&#160;S-K (&#167; 229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form&#160;10-K or any amendment to this Form&#160;10-K.&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule&#160;12b-2 of the Exchange Act: Large&#160;accelerated filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Accelerated&#160;filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font><font style="font-family:inherit;font-size:10pt;">&#32;Non-accelerated&#160;filer&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;Smaller reporting company </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the Registrant is a shell company (as defined by Rule&#160;12b-2 of the Act).&#160;&#160;Yes&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#32;No&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#254;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate market value of the voting stock held by non-affiliates of the Registrant, based on the closing price of Common Stock on June 30, 2018 of </font><font style="font-family:inherit;font-size:10pt;">$11.25</font><font style="font-family:inherit;font-size:10pt;">&#32;as reported on the NASDAQ National Market, was </font><font style="font-family:inherit;font-size:10pt;">$395,272,643</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">This calculation does not reflect a determination that persons are affiliated for any other purpose.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of February 22, 2019, </font><font style="font-family:inherit;font-size:10pt;">36,139,876</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock, $0.0001 par value per share, were outstanding.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Portions of the Registrant&#8217;s definitive proxy statement, for the 2019 Annual Meeting of Stockholders, which statement will be filed pursuant to Regulation&#160;14A not later than 120&#160;days after the end of the fiscal year covered by this Report, are incorporated by reference into Part&#160;III hereof.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #666666;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="sFF0379E0F63553AB9896168D4C720BAE"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">TABLE OF CONTENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:82%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;" href="#sFC827A27894D5D77903D6DE8BDBC1C23"><font style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;">PART I</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s2FAE2EEC93095A1D8B07BBB9E1A193D3"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 1.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s2FAE2EEC93095A1D8B07BBB9E1A193D3"><font style="font-family:inherit;font-size:10pt;color:#000000;">Business</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s2FAE2EEC93095A1D8B07BBB9E1A193D3">1</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s38C776A4906F58888CE6D7E3B14E5CEF"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 1A.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s38C776A4906F58888CE6D7E3B14E5CEF"><font style="font-family:inherit;font-size:10pt;color:#000000;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s38C776A4906F58888CE6D7E3B14E5CEF">8</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sF00F845B5D12543A94A93E8D31C28D5E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 1B.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sF00F845B5D12543A94A93E8D31C28D5E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Unresolved Staff Comments</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sF00F845B5D12543A94A93E8D31C28D5E">16</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s348C44FB596E5BA791907824CAD6A8D4"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 2.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s348C44FB596E5BA791907824CAD6A8D4"><font style="font-family:inherit;font-size:10pt;color:#000000;">Properties</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s348C44FB596E5BA791907824CAD6A8D4">16</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0D7BF069E3555B928CC3A3B7DD94B0BE"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 3.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0D7BF069E3555B928CC3A3B7DD94B0BE"><font style="font-family:inherit;font-size:10pt;color:#000000;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0D7BF069E3555B928CC3A3B7DD94B0BE">16</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s94CFE2F5215C57B2A438FEB51B2EB95E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 4.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s94CFE2F5215C57B2A438FEB51B2EB95E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Mine Safety Disclosures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s94CFE2F5215C57B2A438FEB51B2EB95E">16</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;" href="#sFC827A27894D5D77903D6DE8BDBC1C23"><font style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;">PART I</font></a><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0454071486855AA89F470839AE35D2B3"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 5.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0454071486855AA89F470839AE35D2B3"><font style="font-family:inherit;font-size:10pt;color:#000000;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0454071486855AA89F470839AE35D2B3">16</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sD365469D4A725B148455ABD5337CA252"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 6.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sD365469D4A725B148455ABD5337CA252"><font style="font-family:inherit;font-size:10pt;color:#000000;">Selected Financial Data</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sD365469D4A725B148455ABD5337CA252">17</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sB893F10910C853DEB788F1197338109D"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 7.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sB893F10910C853DEB788F1197338109D"><font style="font-family:inherit;font-size:10pt;color:#000000;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sB893F10910C853DEB788F1197338109D">19</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s4265BF305EB0517BAD02FE1EA1015391"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 7A.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s4265BF305EB0517BAD02FE1EA1015391"><font style="font-family:inherit;font-size:10pt;color:#000000;">Quantitative and Qualitative Disclosures about Market Risk</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s4265BF305EB0517BAD02FE1EA1015391">36</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s22BA672A9ED85CD9B750BBE4739F15BB"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 8.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s22BA672A9ED85CD9B750BBE4739F15BB"><font style="font-family:inherit;font-size:10pt;color:#000000;">Financial Statements and Supplementary Data</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s22BA672A9ED85CD9B750BBE4739F15BB">37</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s5779B362541F51838CDE28B3DF8CA276"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 9.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s5779B362541F51838CDE28B3DF8CA276"><font style="font-family:inherit;font-size:10pt;color:#000000;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s5779B362541F51838CDE28B3DF8CA276">37</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s289CFB892DCD55E69C032A091668114C"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 9A.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s289CFB892DCD55E69C032A091668114C"><font style="font-family:inherit;font-size:10pt;color:#000000;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s289CFB892DCD55E69C032A091668114C">37</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s909F667440055A8781052A3032E99416"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 9B.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s909F667440055A8781052A3032E99416"><font style="font-family:inherit;font-size:10pt;color:#000000;">Other Information</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s48E4482DE119573494B40BAAD2327967">40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;" href="#s909F667440055A8781052A3032E99416"><font style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;">PART III</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sC524D20EFE9D513B9513CBB39FF5B5DC"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 10.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sC524D20EFE9D513B9513CBB39FF5B5DC"><font style="font-family:inherit;font-size:10pt;color:#000000;">Directors, Executive Officers and Corporate Governance</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sC524D20EFE9D513B9513CBB39FF5B5DC">40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s7DEC8DB6B50551889118AD41A5C1A75E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 11.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s7DEC8DB6B50551889118AD41A5C1A75E"><font style="font-family:inherit;font-size:10pt;color:#000000;">Executive Compensation</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s7DEC8DB6B50551889118AD41A5C1A75E">40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8C5D8B3CFB37535C8891CF14D5251552"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 12.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8C5D8B3CFB37535C8891CF14D5251552"><font style="font-family:inherit;font-size:10pt;color:#000000;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8C5D8B3CFB37535C8891CF14D5251552">40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0F4E921044675103BA765D4CC2A45671"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 13.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0F4E921044675103BA765D4CC2A45671"><font style="font-family:inherit;font-size:10pt;color:#000000;">Certain Relationships and Related Transactions, and Director Independence</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s0F4E921044675103BA765D4CC2A45671">40</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8D80F94FCD1C56E8B2DE93F6594F4810"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 14.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8D80F94FCD1C56E8B2DE93F6594F4810"><font style="font-family:inherit;font-size:10pt;color:#000000;">Principal Accountant Fees and Services</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s8D80F94FCD1C56E8B2DE93F6594F4810">40</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;" href="#sA2AC4C3D6A99590898209E4E78CC678E"><font style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;">PART IV</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s40FCAD5DD5A15A07A40D1575A295E935"><font style="font-family:inherit;font-size:10pt;color:#000000;">Item 15.</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s40FCAD5DD5A15A07A40D1575A295E935"><font style="font-family:inherit;font-size:10pt;color:#000000;">Exhibits, Financial Statement Schedules</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#s40FCAD5DD5A15A07A40D1575A295E935">41</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Item 16.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#scc66d8076f6a4f5eb748c248c1eff1d1"><font style="font-family:inherit;font-size:10pt;color:#000000;">Form 10-K Summary</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#scc66d8076f6a4f5eb748c248c1eff1d1">47</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;" href="#s1A493F1A0A845CF1B49E882404D18350"><font style="font-family:inherit;font-size:10pt;font-weight:bold;color:#000000;">SIGNATURES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#000000;" href="#sD09787B80A835FEE8ED99E999DE1EBF0">47</a></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All references to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or &#8220;Cross Country&#8221; in this Report on Form&#160;10-K means Cross Country Healthcare, Inc., its subsidiaries and affiliates.</font></div><div><br></div><hr style="page-break-after:always"><div><a name="sF77E2595C4CD503AA558B02F17BD4963"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to historical information, this Form&#160;10-K contains statements relating to our future results (including certain projections and business trends) that are &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and are subject to the &#8220;safe harbor&#8221; created by those sections. Words such as &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;suggests&#8221;, &#8220;appears&#8221;, &#8220;seeks&#8221;, &#8220;will&#8221; and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in the section entitled &#8220;Item 1A - Risk Factors.&#8221; Readers should also carefully review the &#8220;Risk Factors&#8221; section contained in other documents we file from time to time with the Securities and Exchange Commission, including the Quarterly Reports on Form&#160;10-Q to be filed by us in fiscal year 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management&#8217;s opinions only as of the date of this filing. There can be no assurance that (i)&#160;we have correctly measured or identified all of the factors affecting our business or the extent of these factors&#8217; likely impact; (ii)&#160;the available information with respect to these factors on which such analysis is based is complete or accurate; (iii)&#160;such analysis is correct; or (iv)&#160;our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sFC827A27894D5D77903D6DE8BDBC1C23"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART I</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s2FAE2EEC93095A1D8B07BBB9E1A193D3"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.             Business.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Overview of Our Company</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a national leader in providing healthcare staffing, recruiting and value-added workforce solutions. Through a full suite of innovative workforce solutions and a national presence including 73 office locations throughout the United States (U.S.), we are able to meet the unique and dynamic needs of our clients. By utilizing our various solutions, clients are able to better plan their personnel needs, outsource recruitment processes, strategically flex their workforce, access quality healthcare personnel, and provide continuity of care for improved patient outcomes.  </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our solutions are geared towards assisting our clients in maintaining high quality outcomes by addressing their healthcare workforce needs.  We are increasingly being called upon by our clients to provide more creative and strategic talent sourcing strategies with respect to nurses, doctors, allied healthcare professionals, and healthcare executives, all on a temporary and permanent basis. Over the past several years, our workforce solutions have evolved into a total talent management relationship as our clients continue to focus on improving labor management to address complex financial, compliance, and other challenges in the healthcare industry.  As part of this evolution of our services, we continue to consider the following:  (1) solving the immediate and future needs of our customers and healthcare professionals; (2) enhancing our network of healthcare professionals and deepening our relationship with them; (3) expanding our service offerings to reduce sensitivity to economic cycles; (4) expanding our expertise with various healthcare solutions in various geographic areas of the U.S. and (5) continuing to diversify our client base to enhance our long-term business prospects.  Today, our workforce solutions include:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Managed Service Programs (MSPs).</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;The market has continued to shift towards a centralized model for managing contingent labor for both clinical and non-clinical needs. We have been a market leader in this area since launching our first MSP in 2003, an account we continue to serve today. Over the past 15 years, we have grown our relationships and today service more than 70 clients across more than 900 facilities, with estimated spend under management of approximately $400 million annually. The benefits to our clients not only include reduced costs and increased visibility into their needs and usage, but they gain access and insight from our industry expertise on a broad range of topics. In 2017, we acquired Advantage RN, LLC (Advantage) to supplement the number of nurses we place at our MSP clients, increase our capture rate at those accounts, and reduce the number of positions we outsource to subcontractors. In addition, Advantage provides a vehicle for us to cross-sell our MSP solutions to Advantage's clients and increase our footprint in the Midwest where Advantage is located. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Optimal Workforce Solutions (OWS).  </font><font style="font-family:inherit;font-size:10pt;">The acquisition of Medical Staffing Network in 2014 provided us with a platform to provide outsourced services to large hospital systems to more efficiently manage certain professionals.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Education Healthcare Staffing Services.  </font><font style="font-family:inherit;font-size:10pt;">In 2015, we acquired an education healthcare staffing company, Mediscan, which further diversified our customer base to staff speech language pathologists, physical therapists, and other healthcare workers in schools (public, charter and private) as mandated by the government. This business serves to reduce our sensitivity to economic cycles.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recruitment Process Outsourcing (RPO).</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;In 2016, we acquired an RPO business, US Resources Healthcare, which allows us to deliver financial and operating efficiencies to our customers through labor optimization services while enhancing the quality of care. In 2018, we acquired American Personnel, Inc. (AP Staffing) which also provides RPO services in addition to other strategic solutions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Internal Resource Pool Consulting &amp; Development (IRP).   </font><font style="font-family:inherit;font-size:10pt;">We strategically partner with our clients to set up, administer and manage an IRP or to optimize an existing IRP to create efficiencies for our clients by balancing their workforce mix to meet their current needs.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Electronic Medical Record Transition Staffing (EMR).  </font><font style="font-family:inherit;font-size:10pt;">As healthcare facilities continue to enhance and optimize their electronic medical record technology, we provide a staffing plan and an organized volume of quality healthcare professionals during the process so that our clients may continue to deliver quality care.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consulting Services.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;In 2018, we acquired AP Staffing located in Boston.  In addition to providing temporary and permanent staffing solutions and MSP solutions, AP Staffing acts as a consultative partner with clients to perform, among other things, talent acquisition assessments, the development of requests for proposals, the management of vendor selection processes, and employer branding strategies.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Through a combination of our national reach and industry leading local presence in key markets, we are able to place clinical and non-clinical professionals across a diverse customer base. We believe that our branches provide a unique value proposition to both large and small clients alike as we are able to offer them a high-touch, consultative based approach to understanding the market on both a national and local level. Our acquisition of Medical Staffing Network in 2014 expanded our local presence throughout the U.S. and provided a larger geographic footprint of 55 offices to provide per diem and local contract staffing and support MSP clients in those areas. In August 2018, Staffing Industry Analysts reported that Cross Country Healthcare was the largest per diem staffing company in the U.S. The acquisitions of Allied Health Group in 2013, Medical Staffing Network in 2014, Mediscan in 2015, Advantage in 2017, and American Personnel, Inc. (AP Staffing) in 2018 have expanded our recruiting capabilities and supply of nursing and allied professionals who desire to be engaged on a travel, per diem and/or permanent basis throughout the course of their careers.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We started centralizing our back office, including technology, human resource, finance, and risk management resources in 2013, and we continue to centralize these functions in order to streamline processes and create efficiencies in pursuit of growth and profitability. In an effort to further optimize our processes, from 2014 to 2016 we replaced the front office operating systems of our branch operations, our physician staffing business and our executive and physician search business. In 2018, we began a project to replace the front-end operating system of our travel nurse business to improve our candidate experience and be more efficient. As part of our growth strategy, we are also embracing the way content, messaging and communication generally are being consumed differently and we are continuing to make investments in social media, mobile applications and other technology which we believe will continue enhancing our recruiting capabilities and the experience of our healthcare professionals. These marketing and technology strategies to retain talent more efficiently should serve to give us more leverage in the business and make the company more user-friendly for our corporate employees, our healthcare professionals and our clients.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe our strategy will allow us to expand our current business and capture rate at our MSP clients, increase the number and types of new customers we serve, grow the supply and types of specialties of our healthcare professionals, improve our operating leverage through growth and cost containment, and strengthen and broaden our market presence. This will require us to focus on (i) expanding our workforce solutions offerings to deepen our relationships with current customers and to attract new customers; (ii) expanding our local branch network to grow our local market presence and our MSP business; (iii) further diversifying our customer base into the public and charter school market; (iii) continuing to diversify and deepen our customer base in the local ambulatory care and retail market, which provides more balance between our large volume-based customers and our small local customers; (iv) better positioning ourselves to take additional market share in our MSP business; (v) accessing more candidates; and (vi) continuing to modernize our technologies and processes to optimize our relationships with our healthcare professionals and clients.   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To successfully execute our business strategy, we will rely on our experienced and focused executive and operational teams.  Our executive team has extensive experience in the staffing and healthcare industries. We also foster a culture of performance, talented leadership and collegiality that promotes the achievement of both company and personal goals. In 2018, Cross Country Staffing</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;was recognized as Best of Staffing. Advantage RN, Cross Country Allied, Cross Country TravCorps, Medical Doctor Associates, Medical Staffing Network, MedStaff, PharmStaff all received 2018 Talent ClearlyRated Best of Staffing Awards.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide our services on a national level or through any one of our 66 local branches throughout the United States or through a combination of both. We service a variety of clients, including public and private acute care hospitals, public and charter schools, outpatient clinics, ambulatory care facilities, single and multi-specialty physician practices, rehabilitation facilities, urgent care centers, correctional facilities, government facilities, retailers, and many other healthcare providers. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business consists of three business segments: (i) Nurse and Allied Staffing; (ii)&#160;Physician Staffing; and (iii) Other Human Capital Management Services. Fees for our services are paid directly by our clients and in certain instances by vendor managers, and as a result, we have no direct exposure to Medicare or Medicaid reimbursements. For additional financial information concerning our business segments, see Note 17 - Segment Data to the consolidated financial statements.  Through our business segments, we provide our healthcare clients with a wide range of workforce solutions as described above and staffing services as set forth below. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nursing and Allied Staffing. </font><font style="font-family:inherit;font-size:10pt;">The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing.  We provide flexible workforce solutions to the healthcare and school markets through diversified offerings designed to meet the special needs of each client, including: MSP, OWS, Educational Healthcare Services, RPO, IRP, EMR and consulting services.  We market our services to hospitals and other customers through our Cross Country Staffing</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">, MSN, Allied Health Group, Advantage, Mediscan, AP Staffing, and DirectEd brands. We also market our services to healthcare professionals using a multi-brand strategy to segment the market and maximize our outreach to healthcare professionals.  Our Nurse and Allied Staffing revenue and contribution income is set forth in Note 17 - Segment Data to the consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A majority of our revenue is generated from staffing registered nurses on long-term contract assignments (typically 13 weeks in length) at hospitals and health systems using various brands. Additionally, we offer a short-term staffing solution of registered nurses, licensed practical nurses, certified nurse assistants, advanced practitioners, pharmacists, and more than 100 specialties of allied professionals on local per diem and short-term assignments in a variety of clinical and non-clinical settings through our national network of local branch offices. We also provide travel allied professionals on long-term contract assignments to hospitals, public and charter schools, and skilled nursing facilities under the Cross Country Staffing, Mediscan, and DirectEd brands.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician Staffing. </font><font style="font-family:inherit;font-size:10pt;">We provide physicians in many specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) under our MDA brand as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. We recruit these professionals nationally and place them on assignments varying in length from several days up to one year. Our Physician Staffing revenue and contribution income is set forth in Note 17 - Segment Data to the consolidated financial statements.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human Capital Management Services. </font><font style="font-family:inherit;font-size:10pt;">We provide retained and contingent search services for physicians, healthcare executives, nurses, advanced practice, and allied health professionals. The revenue and contribution income of our Other Human Capital Management Services Segment is set forth in Note 17 - Segment Data to the consolidated financial statements.  Our Cejka Search</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;brand recruits healthcare talent for organizations nationwide through a team of&#160;experienced professionals, advanced use of recruitment technology, and commitment to service excellence. Serving clients nationwide, Cejka completes hundreds of search assignments annually for organizations, including, but not limited to, physician group practices, hospitals and health systems, academic medical centers, accountable care organizations, managed care, and other healthcare organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Business Model</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The recruitment and retention of a sufficient number of qualified healthcare professionals to work temporary assignments on our behalf is critical to the success of our business. Healthcare professionals choose temporary assignments for a variety of reasons that include seeking flexible work opportunities, exploring diverse practice settings, building skills and experience by working at prestigious healthcare facilities, avoiding the demands and political environment of working as permanent staff, working through life and career transitions, and as a means of access into a permanent staff position.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:53px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:29px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Healthcare Professionals</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">Within our Nurse and Allied segment, we operate differentiated brands to recruit nurses and allied professionals. We believe our multi-brand recruiting model helps us reach a larger volume and a more diverse group of candidates to fill open positions at our clients throughout the United States in various clinical and non-clinical settings and in many different geographic areas. Our company is well positioned, as nurses and allied professionals routinely seek a wide range of diverse assignments in attractive locations, with competitive compensation and benefit packages, scheduling options, as well as a high level of service. In addition, we believe nurses and allied professionals are confident we will have new assignments for them as they complete their current assignment. Our competitive benefits generally include professional liability insurance, a 401(k) plan, health insurance, reimbursed travel, per diem allowances, and housing. Each of our nurse and allied healthcare professionals is employed by us and is typically paid hourly wages and any other benefits they are entitled to receive during the assignment period.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recruiters are an essential element of our Nurse and Allied Staffing business, and are responsible for establishing and maintaining key relationships with candidates for the duration of their assignments with us. Recruiters match the supply of qualified candidates in our databases with the demand for open orders posted by our clients. While we rely on word-of-mouth for referrals to access candidates, we also market our brands on the Internet, including extensive utilization of social media, which has become an increasingly important component of our recruitment efforts. We maintain a number of websites to allow potential applicants to obtain information about our brands and assignment opportunities, as well as to apply online.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MDA recruits and contracts with physicians and advanced practice professionals to provide medical services for its healthcare customers.&#160;Each physician or advanced practice professional is an independent contractor and enters into an agreement with MDA to provide medical services at a particular healthcare facility or physician practice group based on terms and conditions specified by that customer. Physicians and advanced practice professionals are engaged to provide medical services for a healthcare customer ranging from a few days up to a year.&#160;We believe physicians are attracted to us because we offer a wide variety of assignments, competitive fees, medical malpractice insurance, and a high level of service to them. MDA relies on word-of-mouth referrals, but also markets it brands on the Internet and through extensive social media campaigns.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales and Marketing</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">We market our Nurse and Allied Staffing services to our hospitals, healthcare facilities, schools, and other clients using our Cross Country Staffing, Medical Staffing Network&#8482;, Advantage, Allied Health Group, Mediscan, AP Staffing, and DirectEd brands. Cross Country Staffing typically contracts with our nurse and allied healthcare clients on behalf of itself and our other brands. Mediscan contracts with its hospitals, public schools, and charter schools under the Mediscan and DirectEd brands. Our traditional staffing includes temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses and allied staffing, and physicians. We provide flexible workforce solutions to the healthcare and school markets through diversified offerings meeting the special needs of each client. Orders for open positions and other services are entered into our various databases and are available to recruiters. Account managers, who develop relationships with our clients to understand their specific settings and culture, submit candidate profiles to clients, and confirm offers and placements with them.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MDA markets its Physician Staffing operations to hospitals and other healthcare facilities throughout the U.S.  Our recruiters use our extensive database of physicians and their expertise in their given specialties to contact physicians to schedule short and long-term engagements at healthcare customers. MDA operates a multi-site business model with employees at several locations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cejka markets its retained and contingent search services to healthcare clients primarily through industry professional organizations, direct marketing, its website, and by word-of-mouth.</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Credentialing and Quality Management.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">We screen all of our candidates prior to placement through our credentialing departments.  Our credentialing processes are designed to ensure that our professionals have the requisite skillsets required by our customers, as well as the aptitude to meet the day-to-day requirements and challenges they would typically encounter on assignments where they are placed. The credentialing of our nurse and allied healthcare professionals is designed to align with the guidelines of The Joint Commission, a national accrediting body, to ensure quality care.  Our Cross Country University division, accredited by the American Nurse Credentialing Center, provides training, assessment, and professional development to further ensure the quality of the personnel we place on assignment.</font><font style="font-family:inherit;font-size:10pt;color:#1f497d;">&#32;</font><font style="font-family:inherit;font-size:10pt;">Our physician credentialing entity, Credent, is also certified by the National Committee for Quality Assurance (NCQA). </font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Payment for Services. </font><font style="font-family:inherit;font-size:10pt;">We negotiate payment for services with our clients based on market conditions and needs. We generally bill our nurse and allied employees at an hourly rate which includes all employer costs, including payroll, withholding taxes, benefits, professional liability insurance, meals and incidentals, and other requirements, as well as any travel and housing arrangements, where applicable. Our shared service center processes hours worked by field employees in the time and attendance systems, which in turn generate the billable transactions to our clients. Hours worked by independent contractor physicians are reported to our MDA office. For our physician and executive search business, Cejka typically bills its clients a candidate acquisition fee and is reimbursed for certain marketing expenses.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operations. </font><font style="font-family:inherit;font-size:10pt;">Our Nurse and Allied and Physician Staffing businesses are operated through a relatively centralized business model servicing all assignment needs of our healthcare professional employees, physicians, and client healthcare facilities primarily through operation centers located in Boca Raton, Florida; Newtown Square, Pennsylvania; West Chester, Ohio; Woodland Hills, California; and Berkeley Lake, Georgia. In addition to the key sales and recruitment activities, certain of these centers also perform support activities such as coordinating housing, payroll processing, benefits administration, billing and collections, travel reimbursement processing, customer service, and risk management. Cejka Search primarily operates its business from its headquarters located in Creve Coeur, Missouri. This business operates relatively independently, other than certain ancillary services that are provided from our Boca Raton, Florida headquarters, such as payroll, legal, and information systems support. On December 31, 2018, we had 73 office locations. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Information Systems. </font><font style="font-family:inherit;font-size:10pt;">Various information systems are utilized to run our customer relationship management, recruitment, and placement functions based on our different brands. Some of these sophisticated applications are proprietary and are hosted in Tier 1 hosting facilities while other systems are Software as a Service (SaaS) based and hosted by our vendor partners. Our systems maintain detailed information about our client required skillsets and status which assist us in enabling fulfillment and assignment renewals. Our databases contain an extensive pool of existing and potential customers and all related recruitment and sales activity. Our financial and human resource systems are managed on leading enterprise resource planning software suites that manage certain aspects of accounts payable, accounts receivable, general ledger, billing, and human capital management. All of our systems are managed by our onshore and offshore Information Technology team.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Risk Management, Insurance, and Benefits.</font><font style="font-family:inherit;font-size:10pt;">&#32;We have developed a risk management program that requires prompt notification of incidents by clients, clinicians, and independent contractors, educational training to our employees, loss analysis, and prompt reporting procedures to reduce our risk of exposure. While we cannot predict the future, we continuously review facts and incidents associated with professional liability and workers&#8217; compensation claims in order to identify trends and reduce our risk of loss in the future where possible. We consider assessments provided by our clients and we work with clinicians and experts from our insurance carriers to determine employment eligibility and potential exposure. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide workers&#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for our eligible employed temporary professionals. We record our estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using our loss history as well as industry statistics. In determining our reserves, we include reserves for estimated claims incurred but not reported. We also estimate on a quarterly basis the healthcare claims that have occurred but have not been reported based on our historical claim submission patterns. The ultimate cost of workers&#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved for such claims.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains a number of insurance policies including general liability, workers&#8217; compensation, fidelity, employment practices liability, fiduciary, directors and officers, cyber, property, and professional liability policies. These policies provide coverage subject to their terms, conditions, limits of liability, and deductibles, for certain liabilities that may arise from our operations. There can be no assurance that any of the above policies will be adequate for our needs, or that we will maintain all such policies in the future.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Geographic Markets and Client Base</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, 2017 and 2016, all of our revenue was generated in the United States, and all of our long-lived assets were located in the United States and India.  On a company-wide basis, we have approximately 7,500 active contracts with healthcare clients, and we provide our staffing services and workforce solutions in all 50 states. During 2018, the largest percentage of our revenue was concentrated in New York, Florida, and California. We provide services to public and private acute care hospitals, public and charter schools, outpatient clinics, ambulatory care facilities, single and multi-specialty physician practices, </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">rehabilitation facilities, urgent care centers, correctional facilities, government facilities, retailers, and many other healthcare providers. In 2018, 2017, and 2016 no client accounted for more than 5% of our revenue.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Our Industry</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We compete in the U.S. temporary healthcare staffing and workforce solutions markets. Staffing Industry Analysts September 2018 report estimates the healthcare staffing markets in which we operate had an aggregate market size of $16.8 billion in 2018 of which $5.3 billion was travel nursing, $3.5 billion was per diem nursing, $4.0 billion was allied health and $4.0 billion was locum tenens and advanced practitioners. The demand for our services is impacted by many factors, however, we believe the most significant are the following:  </font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Industry Demand Drivers</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Economic Backdrop. </font><font style="font-family:inherit;font-size:10pt;">The U.S. economy had a strong year in 2018, and according to the U.S. Bureau of Labor Statistics the job market showed continued signs of continued growth with unemployment at 3.9% as of December 2018. The strong U.S. economy has led to solid job growth, which we expect will result in more individuals receiving healthcare from their employers - thus supporting the demand for healthcare services. A growing U.S. economy coupled with a low unemployment rate typically results in an increase in demand for our services  </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increased Need for Healthcare and Special Education Services in Schools. </font><font style="font-family:inherit;font-size:10pt;">The Individuals with Disabilities Education Act (IDEA), enacted in 1975, mandates that children and youth ages 3-21 with disabilities be provided a free and appropriate public school education. According to the U.S. Department of Education, National Center for Education Statistic Report titled &#8220;The Condition of Education" (April 2018), the number of children and youth ages 3-21 receiving special education services was 6.7 million, or about 13% of traditional public and charter school enrollment. The IDEA requires that these children and young adults receive care from speech language pathologists, physical therapists, occupational therapists, nurses and other healthcare professionals while at school. Based on the foregoing, we believe the demand for consulting and healthcare staffing services for public schools and charter schools will continue to be strong for agencies that can provide consulting services, healthcare personnel, technical assistance on policies, implementation, and training related to children and youth with special needs in school settings.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Creation of Healthcare Jobs Outpacing Other Industries and Occupations. </font><font style="font-family:inherit;font-size:10pt;">Healthcare represented 14% of all jobs created in 2018 (HealthleadersMedia.com, January 4, 2019). According to the Bureau of Labor Statistics, overall, employment is expected to grow 7.4%, far outpaced by employment in the healthcare industry (18%) and among healthcare occupations (18%) (Staffing Industry Analysts, December 14, 2017). This projected 18% growth varies, however, among three categories that make up the healthcare industry: (i) ambulatory healthcare services; (ii) nursing and residential care; and (iii) hospitals. Employment for ambulatory healthcare services is projected to grow 31%; nursing and residential care is projected to grow 13%, and hospital employment is projected to grow 6.8%. We expect the creation of additional jobs in the healthcare market will increase demand for our services as our temporary staff are typically hired to replace healthcare workers taking vacation and leaves of absence.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Outpatient/Ambulatory Settings Services Outpace Inpatient Services.</font><font style="font-family:inherit;font-size:10pt;">&#32;According to the U.S. Census Bureau, the ambulatory healthcare services sector added 37,800 jobs in December 2018, while hospitals added 7,400 jobs in the same. We believe certain government initiatives previously taken, such as Medicare reimbursement incentives for reduced readmissions, have had a direct correlation to the shift from inpatient services to outpatient/ambulatory settings and job growth in that area. We believe this growth will have a positive impact on demand for healthcare staffing services in outpatient/ambulatory settings.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Hospitals Seeking Efficiencies Through Various Workforce Solutions. </font><font style="font-family:inherit;font-size:10pt;">Hospitals continue to face pressure to keep costs down. In addition, the national shift away from volume-based pricing to value-based pricing has continued. We believe these dynamics continue to put pressure on hospitals to find innovative solutions in order to better manage their workforce, which accounts for a large portion of their expenses. As a result, we believe healthcare facilities and providers will continue to utilize workforce solutions, such as MSP, RPO, IRP, and other talent management tools to help them solve these problems and maintain their quality of care. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Macro Drivers of Demand</font><font style="font-family:inherit;font-size:10pt;">. The Affordable Care Act (ACA) increased the number of insured patients over the past few years, especially in states that expanded Medicaid.&#160;It has been reported that the effect of the ACA on healthcare utilization has been that 20 million people gained health insurance coverage. However, the elimination of the individual mandate and other efforts by the current administration may negatively impact the number of individuals with health insurance coverage. In addition, two other long-term macro drivers of our business, a growing and aging U.S. population, should continue to drive demand for our services. According to the U.S. Census Bureau, the number of </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">persons aged 65 and over is expected to increase to 98 million in 2060, which is important because the utilization of healthcare services is generally higher among older people.  </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Supply of Nurses. </font><font style="font-family:inherit;font-size:10pt;">The Georgetown University Center on Education and the Workforce (CEW) predicts a shortage of 192,620 nurses in 2020, which differs from the surplus of nurses predicted for 2025 by the Health Resources and Services Administration (HRSA) National Center for Health Workforce Analysis (Georgetown University Center on Education and the Workforce (CEW), Forecasts of Nursing Demand 2015). However, with healthcare now representing almost 20% of the U.S. economy, the aging of the U.S. population, and the expanded healthcare coverage under the ACA, both the CEW and HRSA agree that demand for healthcare services and healthcare workers will continue to grow. In addition, by 2030 it is expected that almost a million nurses will retire and leave the workforce taking with them the years of knowledge and experience they have accumulated (Modern Healthcare, Nursing Shortage In Perspective, January 1, 2018). There is also an imbalance of RNs at the state level where many states are projected to experience a smaller growth in RN supply relative to their state-specific demand, resulting in a geographical shortage of RNs by 2025. A shortfall of registered nurses in particular specialties is also expected over the next ten years (Georgetown University CEW, Forecasts of Nursing Demand 2015). We believe these geographic and specialty related shortages should have a positive effect on demand for our services as temporary nurse staffing orders typically increase when nurse vacancy rates rise.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician Shortage.</font><font style="font-family:inherit;font-size:10pt;">&#32;According to the Association of American Medical Colleges (AAMC), the United States is expected to face a shortage of physicians over the next decade. The projections show a shortage ranging between 61,700 and 94,700 in 2025 as demand for physicians continues to outpace supply, according to AAMC, with a significant shortage showing among many surgical specialties. In addition, according to the Association of American Medical Colleges (AAMC), 44.1% of physicians in the U.S. is age 55 or older and nearing retirement and, while the number of applicants to U.S. medical schools is increasing, it is not expected to keep pace with expected future demand. This is a significant factor in the demand for locum tenens services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Industry Competition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The workforce solutions and healthcare staffing industries are highly competitive. We compete on a national, regional, and local basis in both industries for healthcare clients and healthcare professionals. We are one of the largest providers in the U.S. of workforce solutions in the healthcare industry and nurse and allied healthcare staffing. In both of these industries, we compete with a few national competitors together with numerous smaller, regional, and local companies, particularly in the per diem business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The principal competitive factors in attracting, retaining, and expanding business with healthcare clients nationally include: (i) understanding the client&#8217;s work environment; (ii) offering a comprehensive suite of services to assist the client in assessing its personnel needs and partnering with clients to design various customizable alternative solutions; (iii) the timely filling of clients' needs; (iv) price; (v) customer service; (vi) quality assurance and screening capabilities; (vii) risk management policies; (viii) insurance coverage; and (ix) general industry reputation.&#160;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe we benefit competitively from the breadth and expertise of value-added workforce solutions that we offer. We also have the ability to meet a national shift towards a more integrated delivery of healthcare through our extensive branch network which allows us to assist hospitals and health systems turning to</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">lower-cost, more accessible alternatives, such as outpatient or ambulatory care centers. By offering travel, per diem, and permanent placement of a variety of healthcare professionals, we are able to offer many different types of personnel to hospitals and health systems at their main campuses and their ambulatory and outpatient facilities. In addition, our joint venture with a large health system's staffing subsidiary provides us with a unique insight into the challenges facing many of our hospital clients generally and this provides us with the opportunity to better serve all of our clients by designing and implementing workforce solutions to meet their needs.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The principal competitive factors in attracting qualified healthcare professionals for temporary employment include: (i) a large national pool of desirable assignments; (ii) pay and benefits; (iii) speed of placements; (iv) customer service; (v) quality of accommodations; and (vi) overall industry reputation. We focus on retaining healthcare professionals by providing high-quality customer service, long-term benefits (to employees), and medical malpractice insurance.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From a candidate attraction standpoint, we have an extensive client base with hospitals and healthcare facilities, and other healthcare providers, throughout the U.S. As a result, we have a diverse choice of assignments for our healthcare professionals to choose from. Healthcare professionals apply with us through our differentiated nursing, locum tenens, and allied healthcare recruitment brands. Our local branch network also provides us access to local healthcare professionals who are uniquely qualified to provide care in ambulatory and outpatient settings. We believe our access to such a large and diverse group of healthcare professionals makes us more attractive to healthcare institutions and facilities seeking healthcare staffing and workforce solutions in the current dynamic marketplace.  </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe we are one of only two large full-service healthcare staffing providers with a national footprint; one of the top five providers of physician staffing services in the U.S.; and one of the top providers of retained and contingent physician and healthcare executive search services in the healthcare marketplace. Some of our competitors in the workforce solutions, healthcare staffing, and search businesses include: AMN Healthcare Services, Inc., CHG Healthcare Services, Maxim Healthcare, Jackson Healthcare, Aya Healthcare, HealthTrust Workforce Solutions, and Witt Kiefer.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Certifications</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The staffing businesses of our Cross Country Staffing, Medical Staffing Network, Mediscan, Advantage, and AP Staffing brands are certified by The Joint Commission under its Health Care Staffing Services Certification Program. In addition, Credent Verification and Licensing Services, a subsidiary of MDA, is certified by the NCQA.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Regulations</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business is subject to regulation by numerous governmental authorities in the jurisdictions in which we operate. Complex federal and state laws and regulations govern, among other things, the licensure of professionals, the payment of our employees (e.g., wage and hour laws, employment taxes and income tax withholdings, etc.), and the operations of our business generally. We conduct business primarily in the U.S. and are subject to federal and state laws and regulations applicable to our business, which may be amended from time to time. Future federal and state legislation or interpretations thereof may require us to change our business practices. Compliance with all of these applicable rules and regulations require a significant amount of resources. We endeavor to be in compliance with all such rules and regulations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employees</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December&#160;31, 2018, we had approximately 1,750 corporate employees. During 2018, we employed an average of 7,154 full-time equivalent field employees in Nurse and Allied Staffing which does not include our Physician Staffing independent contractors, all of whom are not employees. During 2018, we became subject to a collective bargaining agreement covering approximately 450 of our employees at OWS, LLC with Local 1199 of the Service Employees International Union.&#160;We consider our relationship with employees to be good.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Additional Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial reports and filings with the Securities and Exchange Commission (SEC), including this Annual Report on Form&#160;10-K, are available free of charge as soon as reasonably practicable after filing such material with, or furnishing it to, the SEC, on or through our corporate website at </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">www.crosscountryhealthcare.com</font><font style="font-family:inherit;font-size:10pt;">.&#160;The information found on our website is not part of this Annual Report on Form 10-K or any other report we file with or furnish to the SEC.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s38C776A4906F58888CE6D7E3B14E5CEF"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1A.        Risk Factors. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The following risk factors could materially and adversely affect our future operating results and could cause actual results to differ materially from those predicted in the forward-looking statements we make about our business. Our risks are identified primarily through dialogue with our leaders, including a formal Enterprise Risk assessment, industry trends, our experience, and consideration of the current external market and financial environment. These risk factors are considered in our overall strategy and execution of operations. Factors we currently consider immaterial and factors we currently do not know may also materially adversely affect our business or our consolidated results, financial condition, or cash flows. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Decreases in demand by our clients may adversely affect the profitability of our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Among other things, changes in the economy, a decrease or stagnation in the general level of in-patient admissions or out-patient services at our clients&#8217; facilities, uncertainty regarding or changes to federal healthcare law and the willingness of our hospital, healthcare facilities and physician group clients to develop their own temporary staffing pools and increase the productivity of their permanent staff may, individually or in the aggregate, significantly affect demand for our temporary healthcare staffing services and may hamper our ability to attract, develop and retain clients. When a hospital&#8217;s admissions increase, temporary employees or other healthcare professionals are often added before full-time employees are hired. As admissions decrease, clients typically reduce their use of temporary employees or other healthcare professionals before undertaking layoffs of their permanent employees. In addition, if hospitals continue to consolidate in an effort to enhance their market positions, improve operational efficiency, and create organizations capable of managing population health, demand for our services could decrease. Decreases in demand for our services may also affect our ability to provide attractive assignments to our healthcare professionals.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our clients may terminate or not renew their contracts with us.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our arrangements with hospitals, healthcare facilities and physician group clients are generally terminable upon 30 to 90 days&#8217; notice. We may have fixed costs, including housing costs, associated with terminated arrangements that we will be obligated to pay post-termination, thus negatively impacting our profitability. In addition, the loss of one or more of our large clients could materially affect our profitability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may be unable to recruit enough quality healthcare professionals to meet our clients&#8217; demands.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We rely significantly on our ability to attract, develop and retain healthcare professionals who possess the skills, experience and, as required, licensure necessary to meet the specified requirements of our healthcare clients. We compete for healthcare staffing personnel with other temporary healthcare staffing companies as well as actual and potential clients such as healthcare facilities and physician groups, some of which seek to fill positions with either permanent or temporary employees. We rely on word-of-mouth referrals, as well as social media to attract qualified healthcare professionals. If our social media strategy is not successful, our ability to attract qualified healthcare professionals could be negatively impacted.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, with a shortage of certain qualified nurses and physicians in many areas of the United States, competition for these professionals remains intense. Our ability to recruit and retain healthcare professionals depends on our ability to, among other things, offer assignments that are attractive to healthcare professionals and offer them competitive wages and benefits or payments, as applicable. Our competitors might increase hourly wages or the value of benefits to induce healthcare professionals to take assignments with them. If we do not raise wages or increase the value of benefits in response to such increases by our competitors, we could face difficulties attracting and retaining qualified healthcare professionals. If we raise wages or increase benefits in response to our competitors&#8217; increases and are unable to pass such cost increases on to our clients, our margins could decline. At this time, we still do not have enough nurses, allied professionals and physicians to meet all of our clients&#8217; demands for these staffing services. This shortage of healthcare professionals generally and the competition for their services may limit our ability to increase the number of healthcare professionals that we successfully recruit, decreasing our ability to grow our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If our healthcare facility clients increase the use of intermediaries it could impact our profitability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We continue to see an increase in the use of intermediaries by our clients. These intermediaries typically enter into contracts with our clients and then subcontract with us and other agencies to provide staffing services, thus interfering to some extent in our relationship with our clients. Each of these intermediaries charges an administrative fee. In instances where we do not win new MSP opportunities or where other vendors win this MSP or VMS business with our current customers, the number of professionals we have on assignment at those&#160;clients&#160;could decrease. If we are unable to negotiate hourly rates with intermediaries for the services we provide at these&#160;clients&#160;which are sufficient to cover administrative fees charged by those intermediaries, it could impact our profitability. If those intermediaries become insolvent or fail to pay us for our services, it could impact our&#160;bad debt expense&#160;and thus our overall profitability. We also provide comprehensive MSP and other workforce solutions directly&#160;to certain of our clients. While such contracts typically improve our market share at these facilities, they could result in less diversification of our customer base, increased liability, and reduced margins.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our costs of providing services may rise faster than we are able to adjust our bill rates and pay rates and, as a result, our margins could decline.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Costs of providing our services could change more quickly than we are able to renegotiate bill rates in our active contracts and pay rates with our thousands of healthcare professionals. For example, we offer housing subsidies to our healthcare professionals or provide actual housing to our healthcare professionals. At any given time, we have over a thousand apartments on lease throughout the U.S. because we provide housing for certain of our healthcare professionals when they are on an assignment with us. The cost of subsidizing housing or renting apartments and furniture for these healthcare professionals may increase faster than we are able to renegotiate our rates with our customers, and this may have a negative impact on our profitability. In addition, an increase in other incremental costs beyond our control, such as insurance could negatively affect our financial results. The costs related to obtaining and maintaining professional and general liability insurance, health insurance and workers&#8217; compensation insurance for healthcare providers has generally been increasing. This could have an adverse impact on our financial condition unless we are able to pass these costs through to our clients or renegotiate pay rates with our healthcare providers.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our labor costs could be adversely affected by a shortage of experienced healthcare professionals and labor union activity.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our operations are dependent on our ability to recruit and staff quality healthcare professionals. We compete with other healthcare staffing companies in recruiting and retaining qualified personnel. We may be required to enhance wages and benefits to our employees, which could negatively impact our profitability. Labor union activity is another factor that could </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">adversely affect our labor costs or otherwise adversely impact us. To the extent a significant portion of our employee base unionizes, our labor costs could increase significantly.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If our labor costs increase, we may not be able to raise rates to offset these increased costs. Because a significant percentage of our revenues consists of fixed, prospective payments, our ability to pass along increased labor costs is constrained. In the event we are not entirely effective at recruiting and retaining qualified management, nurses and other medical support personnel, or in controlling labor costs, this could have an adverse effect on our results of operations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may face challenges competing in the marketplace if we are unable to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, and client needs.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patient delivery settings continue to evolve, giving rise to alternative modes of healthcare delivery, such as retail medicine, telemedicine and home health. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our success is dependent upon our ability to develop innovative workforce solutions and quickly adapt to changing marketplace conditions and client needs, including making modifications to our technologies and evolving our technology platform that may differentiate our services and abilities from those of our competitors. The markets in which we compete are highly competitive and our competitors may respond more quickly to new or emerging client needs and marketplace conditions. The development of new service lines and business models requires us to be at the forefront of emerging trends in the healthcare industry. We may face challenges competing in the marketplace if we are unable to quickly adapt our business model and successfully implement innovative services to address these changes. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may face difficulties integrating our acquisitions into our operations and our acquisitions may be unsuccessful, involve significant cash expenditures or expose us to unforeseen liabilities.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We continually evaluate opportunities to acquire companies that would complement or enhance our business. These acquisition opportunities involve numerous risks, including potential loss of key employees or clients of acquired companies; difficulties integrating acquired personnel and distinct cultures into our business; difficulties integrating acquired companies into our operating, financial planning and financial reporting systems; diversion of management attention from existing operations; and assumptions of liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for their failure to comply with healthcare and tax regulations.  These acquisitions may also involve significant cash expenditures, debt incurrence and integration expenses that could have a material adverse effect on our financial condition and results of operations. Any acquisition may ultimately have a negative impact on our business and financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If applicable government regulations change, we may face increased costs that reduce our revenue and profitability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The temporary healthcare staffing industry is regulated in many states. For example, in some states, firms such as our nurse staffing companies must be registered to establish and advertise as a nurse-staffing agency or must qualify for an exemption from registration in those states. If we were to lose any required state licenses, we could be required to cease operating in those states. The introduction of new regulatory provisions could also substantially raise the costs associated with hiring temporary employees. For example, some states could impose sales taxes or increase sales tax rates on temporary healthcare staffing services. These increased costs may not be able to be passed on to clients. In addition, if government regulations were implemented that limited the amount we could charge for our services, our profitability could be adversely affected. We continuously monitor changes in regulations and legislation for potential impacts on our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">The healthcare industry is highly regulated. Any material changes in the political, economic or regulatory environment that affect the purchasing policies, practices and operations of healthcare organizations, or that lead to consolidation in the healthcare industry, could reduce the funds available to purchase our services or otherwise require us to modify our offerings.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide our services to hospitals and health systems which pay us directly. Accordingly, Medicare, Medicaid and insurance reimbursement policy changes generally do not directly impact us. However, indirectly, our business, financial condition and results of operations depend upon conditions affecting the healthcare industry generally and hospitals and health systems particularly. The healthcare industry is highly regulated by federal and state authorities and is subject to changing political, economic and regulatory influences.&#160;Factors such as changes in reimbursement policies for healthcare expenses, consolidation in the healthcare industry, regulation, litigation and general economic conditions could affect the purchasing practices, operations and the financial health of our customers which could have a negative impact on our business.&#160;In addition, insurance companies and managed care organizations seek to control costs by requiring healthcare providers, such as hospitals, to discount their services in exchange for exclusive or preferred participation in their benefit plans. While not affecting us directly, future federal and state legislation or evolving commercial reimbursement trends may further reduce or change conditions for our clients&#8217; reimbursement. Such limitations on reimbursement could reduce our clients&#8217; cash flows, hampering the pricing we can charge clients and their ability to pay us. Reimbursement changes in government programs, particularly Medicare and </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medicaid, can and do indirectly affect the demand and the prices paid for our services.&#160;The impact of any other legislation to repeal or amend or replace the ACA is uncertain and could adversely affect our business and financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We operate our business in a regulated industry and modifications, inaccurate interpretations or violations of any applicable statutory or regulatory requirements may result in material costs or penalties as well as litigation and could reduce our revenue and earnings per share.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our industry is subject to many complex federal, state, local and international laws and regulations related to, among other things, the licensure of professionals, the payment of our field employees (e.g., wage and hour laws, employment taxes and income tax withholdings, etc.) and the operations of our business generally (e.g., federal, state and local tax laws). If we do not comply with the laws and regulations that are applicable to our business, we could incur civil and/or criminal penalties as well as litigation or be subject to equitable remedies.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are subject to litigation, which could result in substantial judgment or settlement costs; significant legal actions could subject us to substantial uninsured liabilities.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are party to various litigation, claims, investigations, and other proceedings. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. We evaluate these litigation claims and legal proceedings to assess the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates, if any, we establish reserves and/or disclose the relevant litigation claims or legal proceedings, as appropriate. These assessments are performed at least quarterly and are based on the information available to management at the time and involve a significant amount of management judgment. Based on the new information considered in our reviews, we adjust our loss contingency accruals and our disclosures. We may not have sufficient insurance to cover these risks. Actual outcomes or losses may differ materially from those estimated by our current assessments which would impact our profitability. Adverse developments in existing litigation claims or legal proceedings involving our Company or new claims could require us to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect our financial results.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In recent years, healthcare providers have become subject to an increasing number of legal actions alleging malpractice, vicarious liability, violation of certain consumer protection acts, negligent hiring, negligent credentialing, product liability or related legal theories. We may be subject to liability in such cases even if our Company's contribution to the alleged injury was minimal or related to one of our subcontractors or its employees. Many of these actions involve large claims and significant defense costs. In addition, we may be subject to claims related to torts or crimes committed by our corporate employees or healthcare professionals that we place on assignment. In most instances, we are required to indemnify clients against some or all of these risks. A failure of any of our corporate employees or healthcare professional to observe our policies and guidelines, relevant client policies and guidelines or applicable federal, state or local laws, rules and regulations could result in negative publicity, payment of fines or other damages.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To protect ourselves from the cost of these types of claims, we maintain professional malpractice liability insurance, employment practices liability insurance, and general liability insurance coverage with terms and in amounts with deductibles that we believe are appropriate for our operations. We are partially self-insured for our workers' compensation coverage, health insurance coverage, and professional liability coverage for our locum tenens providers. If we become subject to substantial uninsured workers' compensation, medical coverage or medical malpractice liabilities, whether directly or indirectly, our financial results may be adversely affected. In addition, our insurance coverage may not cover all claims against us or continue to be available to us at a reasonable cost. If we are unable to pay our self-insured retention portion or maintain adequate insurance coverage, we may be exposed to substantial liabilities.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If provisions in our corporate documents and Delaware law delay or prevent a change in control, we may be unable to consummate a transaction that our stockholders consider favorable.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our certificate of incorporation and by-laws may discourage, delay or prevent a merger or acquisition involving us that our stockholders may consider favorable. For example, our certificate of incorporation authorizes our Board of Directors to issue up to 10,000,000 shares of &#8220;blank check&#8221; preferred stock. Without stockholder approval, the Board of Directors has the authority to attach special rights, including voting and dividend rights, to this preferred stock. With these rights, preferred stockholders could make it more difficult for a third party to acquire us. Delaware law may also discourage, delay or prevent someone from acquiring or merging with us.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Market disruptions may adversely affect our operating results and financial condition</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Economic conditions and volatility in the financial markets may have an adverse impact on the availability of credit to us and to our customers and businesses generally. To the extent that disruption in the financial markets occurs, it has the potential to </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">materially affect our and our customers&#8217; ability to tap into debt and/or equity markets to continue ongoing operations, have access to cash and/or pay debts as they come due. These events could negatively impact our results of operations and financial conditions. Although we monitor our credit risks to specific clients that we believe may present credit concerns, default risk or lack of access to liquidity may result from events or circumstances that are difficult to detect or foresee. Conditions in the credit markets and the economy generally could adversely impact our business and limit or prohibit us from refinancing our credit agreements on terms favorable to us or at all when they become due.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock issuable under our stock incentive plans are presently in effect and sales of this stock could cause our stock price to decline.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have registered 6,100,000 shares of common stock for issuance under our 2014 Omnibus Incentive Plan, and 4,398,001 shares of common stock for our predecessor 1999 stock option plan, all of which have been registered. Shares of restricted stock outstanding as of February&#160;22, 2019 were 428,131. In addition, a target of 203,496 performance stock award grants were outstanding as of February 22, 2019. Fully vested stock appreciation rights of 51,500 were issued and outstanding as of February 22, 2019.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:10pt;">See Note 14 - Stockholders' Equity to our consolidated financial statements. Vested restricted stock and issuance of common stock related to our awards as well as common stock issued upon exercise of stock options, and stock appreciation rights under these benefit plans, is eligible for resale in the public market without restriction. We cannot predict what effect, if any, market sales of shares held by any stockholder or the availability of these shares for future sale will have on the market price of our common stock.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are dependent on the proper functioning of our information systems and applications hosted by our vendors.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are dependent on the proper functioning of our information systems in operating our business, including those applications hosted by our vendors. Critical information systems used in daily operations identify and match staffing resources and client assignments and perform billing and accounts receivable functions. Additionally, we rely on our information systems in managing our accounting and financial reporting. These systems are subject to certain risks, including technological obsolescence. We are currently evaluating the technology platforms of our businesses. If our proprietary systems of Software as a Service applications fail or are otherwise unable to function in a manner that properly supports our business operations, or if these systems require significant costs to repair, maintain or further develop or update, we could experience business interruptions or delays that could materially and adversely affect our business and financial results.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, our information systems are protected through a secure hosting facility and additional backup remote processing capabilities also exist in the event our primary systems fail or are not accessible. However, the business is still vulnerable to fire, storm, flood, power loss, telecommunications failures, physical or software break-ins and similar events which may prevent personnel from gaining access to systems necessary to perform their tasks in an automated fashion. In the event that critical information systems fail or are otherwise unavailable, these functions would have to be accomplished manually, which could impact our ability to, among other things, maintain billing and clinical records reliably, to bill for services efficiently and to maintain our accounting and financial reporting accurately.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are dependent on third parties for the execution of certain critical functions.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have outsourced certain critical applications or business processes to external providers, including but not limited to background screenings of our employees. We exercise care in the selection and oversight of these providers. However, the failure or inability to perform on the part of one or more of these critical suppliers could cause significant disruptions and increased costs to our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our collection, use, and retention of personal information and personal health information create risks that may harm our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of our business model, we collect, transmit and retain personal information of our employees and contract professionals and their dependents, including, without limitation, full names, social security numbers, addresses, birth dates, and payroll-related information. We use commercially available information security technologies to protect such information in digital format and have security and business controls to limit access to such information. In addition, we periodically perform penetration tests and respond to those findings. However, employees or third parties may be able to circumvent these measures and acquire or misuse such information, resulting in breaches of privacy, and errors in the storage, use or transmission of such information. Privacy breaches may require notification and other remedies, which can be costly, and which may have other serious adverse consequences for our business, including regulatory penalties and fines, claims for breach of contract, claims for damages, adverse publicity, reduced demand for our services by clients and/or healthcare professional candidates, harm to our reputation, and regulatory oversight by state or federal agencies. The possession and use of personal information and data in conducting our business subjects us to legislative and regulatory burdens. We may be required to incur significant expenses to comply with mandatory privacy and security standards and protocols imposed by law, regulation, industry standards, or contractual obligations.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cyber security risks and cyber incidents could adversely affect our business and disrupt operations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cyber incidents can result from deliberate attacks or unintentional events. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The result of these incidents could include, but are not limited to, disrupted operations, misstated financial data, liability for stolen assets or information, increased cyber security protection costs, litigation and reputational damage adversely affecting customer or investor confidence.&#160;We have implemented systems and processes to focus on identification, prevention, mitigation and resolution. However, these measures cannot provide absolute security, and our systems may be vulnerable to cyber-security breaches such as viruses, hacking, and similar disruptions from unauthorized intrusions. In addition, we rely on third party service providers to perform certain services, such as payroll and tax services. Any failure of our systems or third party systems may compromise our sensitive information and/or personally identifiable information of our employees. While we have secured cyber insurance to potentially cover certain risks associated with cyber incidents, there can be no assurance the insurance will be sufficient to cover any such liability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Losses caused by natural disasters, such as hurricanes and fires, could cause us to suffer material financial losses.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Catastrophes can be caused by various events, including, but not limited to, hurricanes, fires, and other severe weather. The incidence and severity of catastrophes are inherently unpredictable. With our headquarters and shared services located in South Florida, we are more vulnerable to possible disruptions from hurricanes and the impacts resulting therefrom, such as tornadoes, flooding, fuel shortages, and disruption of internet, and telecommunications services. The extent of losses from a catastrophe is a function of both the total amount of insured exposure and the severity of the event. We do not maintain business interruption insurance for these events. We could suffer material financial losses as a result of disruptions from hurricanes, fires, and other catastrophes.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We have a level of indebtedness which may have an adverse effect on our business or limit our ability to take advantage of business, strategic or financing opportunities.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As indicated below, we have and will continue to have a significant amount of indebtedness relative to our equity. The following table sets forth our total principal amount of debt and stockholders&#8217; equity.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:80%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt at par</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Cross Country Healthcare, Inc. stockholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217,528</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our level of indebtedness increases the possibility that we may be unable to generate cash sufficient to pay the principal, interest or other amounts due on our indebtedness. Subject to certain restrictions under our existing indebtedness, we and our subsidiaries may also incur significant additional indebtedness in the future, some of which may be secured debt. This may have the effect of increasing our total leverage. As a consequence of our indebtedness; (1)&#160;demands on our cash resources may increase; (2)&#160;we are subject to restrictive covenants that limit our financial and operating flexibility. Our ability to generate profitability and maintain cash flow from operations could impact our compliance with these covenants; and (3)&#160;we may choose to institute self-imposed limits on our indebtedness based on certain considerations including market interest rates, our relative leverage and our strategic plans. For example, as a result of our level of indebtedness and the uncertainties arising in the credit markets and the U.S. economy:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may be more vulnerable to general adverse economic and industry conditions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may have to pay higher interest rates upon refinancing or on our variable rate indebtedness if interest rates rise, thereby reducing our cash flows;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may find it more difficult to obtain additional financing to fund future working capital, capital expenditures, acquisitions, and other general corporate requirements that would be in our long-term interests;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may be required to dedicate a substantial portion of our cash flow from operations to the payment of principal and interest on our debt, reducing the available cash flow to fund other investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may have limited flexibility in planning for, or reacting to, changes in our business or in the industry;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may have a competitive disadvantage relative to other companies in our industry that are less leveraged; and</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:12px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">-</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">we may be required to sell debt or equity securities or sell some of our core assets, possibly on unfavorable terms, in order to meet payment obligations.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These constraints could have a material adverse effect on our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We could fail to generate sufficient cash to fund our liquidity needs and/or fail to satisfy the financial and other restrictive covenants to which we are subject under our existing indebtedness.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently have sufficient liquidity to operate our business in the normal course.&#160;If, however, we were to make an acquisition or enter into a similar type of transaction, our liquidity needs may exceed our current capacity. In addition, our existing credit facilities currently contain financial covenants that require us to operate above a minimum fixed charge coverage ratio and below a consolidated leverage ratio. Deterioration in our operating results could result in our inability to comply with these covenants and would result in a default under our credit facility.&#160;If an event of default exists, our lenders could call the indebtedness and we may be unable to renegotiate or secure other financing.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are subject to business risks associated with international operations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have international operations in India where our Cross Country Infotech, Pvt Ltd. (Infotech) subsidiary is located. Infotech provides in-house information systems development and support services as well as some back-office processing services. We have limited experience in supporting our services outside of North America.&#160;Operations in certain markets are subject to risks inherent in international business activities, including: fluctuations in currency exchange rates; changes in regulations; varying economic and political conditions; overlapping or differing tax structures; and regulations (pertaining to, among other things,&#160;compensation and benefits, vacation, and the termination of employment).&#160;Our inability to effectively manage our international operations or our violation of a regulation could result in increased costs and adversely affect our results of operations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Due to inherent limitations, there can be no assurance that our system of disclosure and internal controls and procedures will be successful in preventing all errors and fraud, or in making all material information known in a timely manner to management.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and internal controls will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the acts of an individual, by collusion of two or more people, or by management override of the control.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations, misstatements due to error or fraud may occur and not be detected.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment in the value of our goodwill, trade names, or other intangible assets could negatively impact our net income and earnings per share.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are required to test goodwill and intangible assets with indefinite lives (such as trade names) annually, to determine if impairment has occurred. Long-lived assets and other identifiable intangible assets are also reviewed for impairment whenever events or changes in circumstances indicate that amounts may not be recoverable. If the testing performed indicates that impairment has occurred, we are required to record a non-cash impairment charge for the difference between the carrying amount of the goodwill or other intangible assets and the implied fair value of the goodwill or the fair value of the indefinite-lived intangible asset in the period the determination is made. The testing of goodwill and other intangible assets for impairment requires us to make significant estimates about our future performance and cash flows, as well as other assumptions. These estimates can be affected by numerous factors, including changes in economic, industry or market conditions, changes in business operations, changes in competition or changes in our stock price and market capitalization. Changes in these factors, or changes in actual performance compared with estimates of our future performance, could affect the fair value of goodwill, trade names, or other intangible assets, which may result in an impairment charge. We cannot accurately predict the amount and timing of any impairment of assets. Should the value of goodwill or other intangible assets become impaired, there could be an adverse effect on us. At December&#160;31, 2018, goodwill, trade names not subject to amortization, and other intangible assets represented 41% of our total assets. In 2018, 2017, and 2016, we recorded impairment charges of $22.4 million, $14.4 million, and $24.3 million, respectively.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We could suffer adverse tax and other financial consequences if taxing authorities do not agree with our tax positions, if there are further legislative tax changes, or if we are unable to utilize our net operating losses.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are periodically subject to a number of tax examinations by taxing authorities in the states and countries where we do business. We also have significant deferred tax assets related to our net operating losses (NOLs) in U.S. federal and state taxing jurisdictions, which, generally, for U.S. federal and state tax purposes, carry forward for up to twenty years. Tax years generally remain subject to examination until three years after NOLs are used or expire. We expect that we will continue to be subject to tax examinations in the future. We recognize tax benefits of uncertain tax positions when we believe the positions are more likely than not of being sustained upon a challenge by the relevant tax authority. We believe our judgments in this area are reasonable and correct, but there is no guarantee that we will be successful if challenged by a taxing authority. If there are tax benefits, including, but not limited to, the use of NOLs, expense reimbursements, or other tax attributes, that are challenged successfully by a taxing authority, we may be required to pay additional taxes, interest, and penalties, or we may seek to enter into settlements with the taxing authorities, which could require significant payments or otherwise have a material adverse effect on our business, results of operations, and financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, U.S. federal, state and local, as well as international, tax laws and regulations are extremely complex and subject to varying interpretations. Most recently, on December 22, 2017, the President signed the 2017 Tax Act into law. In the long-term, we anticipate that we will have an overall benefit from the reduction in the tax rate slightly offset by potential deductions disallowed under the current law. Although we are not aware of any provision in the 2017 Tax Act or any other pending tax legislation that would have a material adverse impact on our financial performance, the ultimate impact of the 2017 Tax Act may differ from our current assessment due to changes in interpretations and assumptions made by us as well as the issuance of any further regulations or guidance regarding the U.S. federal income tax code. At this time, it is unclear how many U.S. states will incorporate these federal law changes, or portions thereof, into their tax codes. There can be no assurance that the 2017 Tax Act or any other legislative changes will not negatively impact our operating results, financial condition, and future business operations. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we may be limited in our ability to utilize our NOLs to offset future taxable income and thereby reduce our otherwise payable income taxes. Our ability to utilize our NOLs is also dependent, in part, upon us having sufficient future earnings to utilize our NOLs before they expire. If market conditions change materially and we determine that we will be unable to generate sufficient taxable income in the future to utilize our NOLs, we could be required to record an additional valuation allowance. We review the valuation allowances for our NOLs periodically and make adjustments from time to time, which can result in an increase or decrease to the net deferred tax asset related to our NOLs. If we are unable to use our NOLs or use of our NOLs is limited, we may have to make significant payments or reduce our deferred tax assets, which could have a material adverse effect on our business, results of operations and financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If certain of our healthcare professionals are reclassified from independent contractors to employees our profitability could be materially adversely impacted.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal or state taxing authorities could re-classify our locum tenens physicians, CRNAs and other independent contractors as employees, despite both the general industry standard to treat them as independent contractors and many state laws prohibiting non-physician owned companies from employing physicians (e.g., the &#8220;corporate practice of medicine&#8221;). If they were re-classified as employees, we would be subject to, among other things, employment and payroll-related tax claims, as well as any applicable penalties and interest. Any such reclassification would have a material adverse impact on our business model for that business segment and would negatively impact our profitability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If the method for paying locum tenens physicians changes, it could negatively impact our profitability.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Medicare Access and CHIP Reauthorization Act of 2015 creates a new framework for rewarding physicians for providing higher quality care by establishing two tracks of payment: a merit-based incentive payment system, and Advanced Alternative Payment Models. If hospitals change the method for paying locum tenens physicians to meet their performance goals or other criteria for Medicaid or Medicare reimbursements, the profitability of our business could be adversely impacted.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our financial results could be adversely impacted by the loss of key management.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe the successful execution of our business strategy and our ability to build upon significant recent investments and acquisitions depends on the continued employment of key members of our senior management team. If we were to lose any key personnel, we may not be able to find an appropriate replacement on a timely basis and our results of operations could be negatively affected. Further, the loss of a significant number of employees or our inability to hire a sufficient number of qualified employees could have a material adverse effect on our business.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><a name="sF00F845B5D12543A94A93E8D31C28D5E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1B.        Unresolved Staff Comments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s348C44FB596E5BA791907824CAD6A8D4"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.           Properties.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not own any real property. Our principal leases as of February&#160;1, 2019 are listed below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:29%;"></td><td style="width:1%;"></td><td style="width:34%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Function</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Square</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Feet</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Lease Expiration</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing administration and general office use</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2025</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate headquarters</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,154</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 30, 2025</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Berkeley Lake, Georgia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing office</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 31, 2024</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Creve Coeur, Missouri</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician and Executive search headquarters</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,051</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 31, 2024</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s0D7BF069E3555B928CC3A3B7DD94B0BE"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 3.           Legal Proceedings.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, we are involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of our business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. We establish reserves when available information indicates that a loss is probable and an amount, or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve a significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in our reviews, we adjust our loss contingency accruals and our disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by our current assessments including available insurance recoveries, which would impact our profitability. Adverse developments in existing litigation claims or legal proceedings involving our Company or new claims could require us to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect our financial results. With regard to the outstanding contingencies as of December 31, 2018, we believe the outcome of these matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s94CFE2F5215C57B2A438FEB51B2EB95E"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 4.           Mine Safety Disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not applicable.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sE45EC664BC1F5BCAA7AD5A03A6262374"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART II</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s0454071486855AA89F470839AE35D2B3"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 5.           Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;Securities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our common stock currently trades under the symbol &#8220;CCRN&#8221; on the NASDAQ Global Select Market (NASDAQ). Our common stock commenced trading on the NASDAQ National Market under the symbol &#8220;CCRN&#8221; on October&#160;25, 2001. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The graph below compares the Company to the cumulative 5-year total return of holders of the Company's common stock with the cumulative total returns of the NASDAQ Composite index and the Dow Jones U.S. Business Training &amp; Employment Agencies index. The graph assumes that the value of the investment in the Company's common stock and in each of the indexes (including reinvestment of dividends) was $100 on December 31, 2013 and tracks it through December 31, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><img src="a2018graph.jpg" alt="a2018graph.jpg" style="height:495px;width:682px;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The stock price performance included in this graph is not necessarily indicative of future stock price performance.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of February 22, 2019, there were 126 stockholders of record of our common stock. In addition, there were 4,089 beneficial owners of our common stock held by brokers or other institutions on behalf of stockholders.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have never paid or declared cash dividends on our common stock. Covenants in our credit agreement limit our ability to repurchase our common stock and declare and pay cash dividends on our common stock. On February&#160;28, 2008, our Board of Directors authorized our most recent stock repurchase program whereby we may purchase up to 1.5&#160;million of our common shares, subject to the terms of our current credit agreement. The shares may be repurchased from time-to-time in the open market and the repurchase program may be discontinued at any time at our discretion. During the year ended December 31, 2018, the Company repurchased and retired 432,439 shares of its Common Stock at an average market price of $11.54 per share. At December 31, 2018, we had 510,004 shares of common stock left remaining to repurchase under this authorization, subject to the limitations of our credit agreement as described in Note 14 - Stockholders' Equity to our consolidated financial statements.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sD365469D4A725B148455ABD5337CA252"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 6.           Selected Financial Data.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The selected consolidated financial data as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;are derived from the audited consolidated financial statements of Cross Country Healthcare, Inc., included elsewhere in this Report. The selected consolidated financial data as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">&#32;and for the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31,</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">&#32;are derived from the consolidated financial statements of Cross Country Healthcare, Inc., that have been audited but not included in this Report on Form 10-K.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following selected financial data should be read in conjunction with the consolidated financial statements and related notes of Cross Country Healthcare, Inc., &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and other financial information included elsewhere in this report.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consolidated Statements of Operations Data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">816,484</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">865,048</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">833,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">767,421</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">617,825</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Loss) income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,565</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,468</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,717</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,802</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,731</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,954</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,534</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(31,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Per Share Data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.48</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.07</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.02</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Common Shares Outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,657</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,018</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,132</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,514</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,190</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Operating Data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,019</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,630</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,453</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,995</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">427,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">467,687</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">388,378</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">365,595</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">324,502</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt at par</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83,876</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">64,523</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">63,094</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,702</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">218,198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">237,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">141,344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">130,332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash provided by (used in) operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,997</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45,508</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,145</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,235</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,072</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following items impact the comparability and presentation of our consolidated data:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income for the years ended December&#160;31, 2018, 2017, 2016, 2015, and 2014, respectively, includes amounts attributable to noncontrolling interest of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.2</font><font style="font-family:inherit;font-size:10pt;">&#32;million. See Note 1 - Organization and Basis of Presentation to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We acquired AP Staffing effective December 1, 2018, all of the assets of Advantage effective July 1, 2017, all of the membership interests of Mediscan on October 30, 2015, and substantially all of the assets and certain liabilities of MSN on June 30, 2014. The results of these acquisition's operations have been included in our consolidated statements of operations since their respective effective dates of acquisition. For the years ended December&#160;31, 2018, 2017, 2016, 2015, and 2014, we recognized </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of acquisition and integration costs, respectively. See Note 4 - Acquisitions to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, 2017, and 2016 include </font><font style="font-family:inherit;font-size:10pt;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;">, less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of acquisition-related contingent consideration expense primarily due to valuation and accretion adjustments related to the contingent consideration liabilities of the USR and Mediscan acquisitions. See Note 4 - Acquisitions and Note 10 - Fair Value Measurements to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We incurred restructuring costs in the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, 2015, and 2014, for </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Restructuring costs relate to discrete cost savings initiatives in each year, and senior management employee severance pay in 2014.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-tax non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$22.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$14.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$24.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$10.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, were incurred in the years ended December&#160;31, 2018, 2017, 2016, 2015, and 2014. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The years ended December 31, 2017 and 2016 include the impact of a gain on derivative liability of </font><font style="font-family:inherit;font-size:10pt;">$1.6</font><font style="font-family:inherit;font-size:10pt;">&#32;million and </font><font style="font-family:inherit;font-size:10pt;">$5.8 million</font><font style="font-family:inherit;font-size:10pt;">, while the years ended December&#160;31, 2015 and 2014 include the impact of a loss on derivative liability of </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$16.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The derivative liability related to the Convertible Notes issued in conjunction with the acquisition of MSN, which were paid in full on March 17, 2017. See Note 9 - Derivatives to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We incurred a loss on sale of business of </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(an after-tax gain of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">), in the year ended December 31, 2015, related to the sale of our education seminars business, Cross Country Education, LLC on August 31, 2015.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The years ended December 31, 2018, 2017, and 2016, include a loss on early extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$5.0</font><font style="font-family:inherit;font-size:10pt;">&#32;million, and </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to optional prepayments on our Amended Term Loan in 2018, extinguishment fees, and the write-off of unamortized loan fees and net debt discount and issuance costs related to prior credit agreements. See Note 8 - Debt to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit for the years ended December 31, 2018 and 2017 included benefits of $6.0 million and $12.1 million, respectively, related to the non-cash impairment charges. The income tax benefit for the year ended December 31, 2017 was primarily the result of reducing federal and certain state valuation allowances on our deferred tax assets totaling </font><font style="font-family:inherit;font-size:10pt;">$45.4 million</font><font style="font-family:inherit;font-size:10pt;">, offset by an </font><font style="font-family:inherit;font-size:10pt;">$8.0</font><font style="font-family:inherit;font-size:10pt;">&#32;million reduction in our net</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;">&#32;</font><font style="font-family:inherit;font-size:10pt;">deferred tax assets (relating to the impact from the 2017 Tax Act signed into legislation on December 22, 2017). For the year ended December 31, 2018, we completed our 2017 federal and state income tax returns and recorded a discrete tax benefit associated with adjusting our net deferred tax asset. The valuation allowance was maintained and reflected in the years ended December 31, 2014 through December 31, 2016. </font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sB893F10910C853DEB788F1197338109D"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.&#160;          Management's Discussion and Analysis of Financial Condition and Results of Operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with Item 1. Business, Item 6. Selected Financial Data, Item 1A. Risk Factors, Forward-Looking Statements and Item 15. Consolidated Financial Statements and the accompanying notes and other data, all of which appear elsewhere in this Annual Report on Form&#160;10-K.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Business Overview</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We provide healthcare staffing, recruiting and workforce solutions to our customers through a network of 73 office locations throughout the U.S. Our services include placing clinicians on travel and per diem assignments, local short-term contracts, and permanent positions. In addition, we offer flexible workforce management solutions to our customers including: MSP, education healthcare, RPO, and other outsourcing and value-added services as described in Item 1. Business. In addition, we provide both retained and contingent placement services for healthcare executives, physicians, and other healthcare professionals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manage and segment our business based on the nature of our services we offer to our customers. As a result, in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, we report three business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; For the year ended December 31, 2018, Nurse and Allied Staffing represented approximately </font><font style="font-family:inherit;font-size:10pt;">88%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our total revenue. Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Substantially all of the results of the Advantage and AP Staffing acquisitions have been aggregated with our Nurse and Allied Staffing business segment. See Note 4 - Acquisitions to our consolidated financial statements.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; For the year ended December 31, 2018, Physician Staffing represented approximately 10% of our total revenue. Physician Staffing provides physicians in many specialties, as well as CRNAs, NPs, and PAs under our Medical Doctor Associates (MDA) brand as independent contractors on temporary assignments throughout the U.S.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#9679;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services</font><font style="font-family:inherit;font-size:10pt;">&#32;&#8211; For the year ended December 31, 2018, Other Human Capital Management Services (OHCMS) represented approximately 2% of our total revenue. OHCMS is comprised of retained and contingent search services for physicians, healthcare executives, and other healthcare professionals within the U.S.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Summary of Operations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, revenue from services decreased 5.6% to $</font><font style="font-family:inherit;font-size:10pt;">816.5 million</font><font style="font-family:inherit;font-size:10pt;">, with declines in both our Nurse and Allied Staffing and our Physician Staffing reporting segments. The year-over-year decrease in Nurse and Allied Staffing was primarily due to volume declines in travel nurse and branch operations, partly offset by the impact of the acquisition of Advantage in July 2017. The decrease in Physician Staffing was primarily due to a decrease in volume of days filled. We continued to manage our selling, general, and administrative expenses as we remain committed to improving operating leverage and overall profitability. As part of our cost savings and efficiency initiatives, we incurred $2.8 million in restructuring charges during the year ended December 31, 2018. Net loss attributable to common shareholders was </font><font style="font-family:inherit;font-size:10pt;">$17.0 million</font><font style="font-family:inherit;font-size:10pt;">, or $0.48 per diluted share and was impacted by pre-tax non-cash impairment charges of $22.4 million related to Physician Staffing ($16.4 million after taxes).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the year ended December 31, 2018, we generated cash flow from operating activities of $21.0 million, and pursuant to the current authorized share repurchase program, repurchased and retired 432,439 shares of Common Stock for $5.0 million, at an average market price of $11.54 per share. See Note 14 - Stockholders' Equity to our consolidated financial statements.  As of December 31, 2018, we had </font><font style="font-family:inherit;font-size:10pt;">$16.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of cash and cash equivalents and a principal balance of $83.9 million outstanding on our Term Loan. During the year ended December 31, 2018, we repaid $16.1 million on our Term Loan, including $10.0 million of optional prepayments. There were no borrowings drawn on our revolving credit facility, with $20.6 million of letters of credit outstanding as of December 31, 2018. Our ability to draw down on the revolving credit facility would be subject to continued compliance with our financial covenants, which may require us to, among other things, make additional optional principal debt prepayments. See Note 8 - Debt to our consolidated financial statements. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Results of Operations, Segment Results, and Liquidity and Capital Resources sections that follow for further information.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We evaluate our financial condition by tracking operating metrics and financial results specific to each of our segments. Key operating metrics include hours worked, days filled, number of FTEs, revenue per FTE, and revenue per day filled. Other operating metrics include number of open orders, candidate applications, contract bookings, length of assignment, bill and pay rates, and renewal and fill rates, number of active searches, and number of placements. These operating metrics are representative of trends that assist management in evaluating business performance. Due to the timing of our business process and other factors, certain of these operating metrics may not necessarily correlate to the reported GAAP results for the periods presented. Some of the segment financial results analyzed include revenue, operating expenses, and contribution income. In addition, we monitor cash flow as well as operating and leverage ratios to help us assess our liquidity needs.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:44%;"></td><td style="width:56%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Segment</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Measurement</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse and Allied Staffing </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue per FTE by the number of days worked in the respective periods.  Nurse and Allied Staffing revenue also includes revenue from the permanent placement of nurses.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician Staffing</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Days filled is calculated by dividing the total hours invoiced during</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the period, including an estimate for the impact of accrued revenue,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">by 8 hours. Prior periods have been recalculated to include the</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">impact of the accrued revenue.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue per day filled is calculated by dividing revenue as reported</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">by days filled for the period presented. Prior periods have been</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">recalculated to include the impact of the accrued revenue and days.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Results of Operations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes, for the periods indicated, selected consolidated statements of operations data expressed as a&#160;percentage of revenue. Our historical results of operations are not necessarily indicative of future operating results.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:50%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Comparison of Results for the Year Ended December&#160;31, 2018 compared to the Year Ended December&#160;31, 2017</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Dollars in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606,921</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">636,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29,541</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,204</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,828</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">376</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,606</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,513</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NM</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,732</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,067</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24,628</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(209.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,440</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,581</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(263</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(169.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22,496</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(523.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,023</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,519</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(140.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(55</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54,464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(145.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NM - not meaningful</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue from services</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$48.6 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">5.6%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$816.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$865.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The </font><font style="font-family:inherit;font-size:10pt;">decrease</font><font style="font-family:inherit;font-size:10pt;">&#32;was due primarily to volume declines in our Nurse and Allied and Physician Staffing segments. See further discussion in Segment Results.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Direct operating expenses</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses are comprised primarily of field employee compensation and independent contractor expenses, housing expenses, travel expenses, and related insurance expenses. Direct operating expenses </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$29.5 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">4.6%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$606.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$636.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. As a percentage of total revenue, direct operating expenses increased to 74.3% compared to 73.6% in the prior year period, primarily due to lower bill-pay spread, primarily in our travel nurse operations, coupled with an increase in healthcare costs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Selling, general, and administrative expenses</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">3.8%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$180.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, as compared to </font><font style="font-family:inherit;font-size:10pt;">$187.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily reflecting the cost savings and efficiency initiatives completed over the year, partly offset by higher professional service fees, such as legal and consulting. As a percentage of total revenue, selling, general, and administrative expenses were 22.1% and 21.7% for the year ended December 31, 2018 and December 31, 2017, respectively.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Depreciation and amortization expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization expense</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;">in the year ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;increased to </font><font style="font-family:inherit;font-size:10pt;">$11.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as compared to </font><font style="font-family:inherit;font-size:10pt;">$10.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily due to the additional amortization of other intangible assets related to the Advantage acquisition. As a&#160;percentage of revenue, depreciation and amortization expense was </font><font style="font-family:inherit;font-size:10pt;">1.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">1.2%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition-related contingent consideration</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration includes accretion and valuation adjustments on our contingent consideration liabilities for the Mediscan and USR acquisitions, and totaled $2.6 million and less than $0.1 million for the years ended December 31, 2018 and 2017, respectively. Both years included the reversal of an earnout liability which was determined would not be achieved, USR in 2018 and Mediscan in 2017. See Note 10 - Fair Value Measurements to our consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition and integration costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">During the years ended</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and 2017, we incurred acquisition and integration costs of</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">and</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">&#32;</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, respectively. The 2018 costs included integration costs related to the Advantage acquisition, and transaction-related costs related to the AP Staffing acquisition, while the 2017 costs related to the Advantage acquisition.</font><font style="font-family:inherit;font-size:10pt;">&#32;See Note 4 - Acquisitions to our consolidated financial statements. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs include severance, exit costs, and other costs including write-offs related to abandoned locations incurred as part of separate and discrete cost savings initiatives. We recorded restructuring costs of </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment charges </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2018 and 2017, we recorded non-cash impairment charges of $22.4 million and $14.4 million, respectively, relating to the Physician Staffing reporting unit. We reduced our long-range forecast for the Physician Staffing business segment in the fourth quarter of both years. The lower than expected revenue was driven by lower booking volumes, partly due to the loss of customers. In addition, margins of the reporting unit were negatively impacted from investments in the business. As a result, we recorded non-cash impairment charges of $5.2 million and $8.7 million, respectively, related to trade names and $17.2 million and $5.7 million, respectively, related to goodwill. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest expense</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:10pt;">totaled </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The increase was due primarily to the incremental debt resulting from the acquisition of Advantage, coupled with a higher effective interest rate. The effective interest rate on our borrowings increased to 5.1% for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to 4.6% for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gain on derivative liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We incurred a gain on derivative liability of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the change in the fair value of embedded features of our Convertible Notes from the end of the prior quarter through the payoff date, primarily resulting from a decrease in our share price. There were no such charges incurred for the year ended December 31, 2018. See Note 8 - Debt and Note 9 - Derivatives to our consolidated financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Loss on early extinguishment of debt</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt was not material for the year ended December 31, 2018 and relates to the optional prepayments of $5.0 million each made on our Amended Term Loan in the third and fourth quarters of 2018. Loss on early extinguishment of debt of $5.0 million for the year ended December 31, 2017 relates to the early repayment of our Convertible Notes. See Note 8 - Debt to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">I</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">ncome tax benefit </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit totaled </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$34.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.&#160;The effective tax rate was 13.6% and negative 802.2%, including the impact of discrete items, for the years ended December 31, 2018 and 2017, respectively. The effective tax rate in 2018 was impacted by the non-deductibility of certain per diem expenses, the officers' compensation limitation, and international and state income taxes. Further, during the fourth quarter of 2018 the Company completed its 2017 federal and state income tax returns and recorded a discrete tax benefit associated with adjusting its net deferred tax asset. The effective tax rate in 2017 was impacted by the reversal of valuation allowances, partially offset by the changes in estimated deferred tax assets resulting from the 2017 Tax Act. On December 22, 2017, the 2017 Tax Act was signed into legislation which, among other changes, reduced the corporate federal income tax rate from 35% to 21%, effective for our year ended December 31, 2018. Because a change in tax law is accounted for in the period of enactment, we recorded income tax expense of $8.0 million, primarily due to a remeasurement of deferred tax assets and liabilities. See Note 13 - Income Taxes to our consolidated financial statements for further information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Comparison of Results for the Year Ended December&#160;31, 2017 compared to the Year Ended December&#160;31, 2016</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Increase (Decrease)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Dollars in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">636,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">611,802</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,660</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,615</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,828</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,235</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">992</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(770</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(94.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,897</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NM</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,955</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,564</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,805</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,224</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">216.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,315</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(724.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,071</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">764</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">525</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,546</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NM - not meaningful</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue from services</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services increased $31.5 million, or 3.8%, to $865.0 million for the year ended December 31, 2017, as compared to $833.5 million for the year ended December 31, 2016. The increase was entirely from Nurse and Allied Staffing primarily due to the Advantage acquisition, and partially offset by lower revenue from Physician Staffing and OHCMS. See further discussion in Segment Results.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Direct operating expenses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses are comprised primarily of field employee compensation and independent contractor expenses, housing expenses, travel expenses, and field insurance expenses. Direct operating expenses increased $24.7 million, or 4.0%, to $636.5 million for the year ended December 31, 2017, as compared to $611.8 million for the year ended December 31, 2016, entirely due to the Advantage acquisition. As a percentage of total revenue, direct operating expenses increased to 73.6% compared to 73.4% in the prior year period.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Selling, general, and administrative expenses</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses increased $7.6 million, or 4.2%, to $187.4 million for the year ended December 31, 2017, as compared to $179.8 million for the year ended December 31, 2016, partly due to the impact of the acquisition of Advantage. Excluding the impact of Advantage, the increase was primarily due to investments in revenue-producing headcount, higher marketing costs for candidate attraction, and higher compensation and benefit costs. As a percentage of total revenue, selling, general, and administrative expenses were 21.7% and 21.5% for the year ended December 31, 2017 and December 31, 2016, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Depreciation and amortization expense</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization expense in the year ended December 31, 2017 increased to $10.2 million as compared to $9.2 million for the year ended December 31, 2016, partly due to the additional amortization of other intangible assets of Advantage. As a percentage of revenue, depreciation and amortization expense was 1.2% for the year ended December 31, 2017 and 1.1% for the year ended December 31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition-related contingent consideration</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration totaled less than $0.1 million for the year ended December 31, 2017, related to the accretion on earnouts, partly offset by the reversal of an earnout liability related to Mediscan which was determined would not be achieved, as compared to $0.8 million for the year ended December 31, 2016, primarily related to accretion of the Mediscan earnouts. In the fourth quarter of 2017, we also recognized a decrease in the fair value of the USR earnout liability of $1.3 million, driven by the decrease in the projected USR 2018 and 2019 revenue and EBITDA amounts, offset by a $1.2 million increase in the projected fair value of Mediscan's DirectEd earnout liability, as a result of an increase in their projected 2018 and 2019 gross profit amounts. See Note 10 - Fair Value Measurements to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition and integration costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the years ended December 31, 2017 and 2016, we incurred acquisition and integration costs of $2.0 million and $0.1 million, respectively. The 2017 costs consisted primarily of transaction, advisory, and legal fees related to the acquisition of Advantage. See Note 4 - Acquisitions to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs include severance and exit costs incurred as part of separate and discrete cost savings initiatives. We recorded restructuring costs of $1.0 million for the year ended December 31, 2017 and $0.8 million for the year ended December 31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment charges</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, we recorded non-cash impairment charges of $14.4 million relating to the Physician Staffing reporting unit. We reduced our long-range forecast for the Physician Staffing business segment in the fourth quarter of 2017. The lower than expected revenue was driven by lower booking volumes, partly due to the loss of customers. In addition, margins of the reporting unit were negatively impacted from continued investments in the business. As a result, we recorded non-cash impairment charges of $8.7 million related to trade names and $5.7 million related to goodwill.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second quarter of 2016, we recorded non-cash impairment charges of $24.3 million relating to the Physician Staffing reporting unit. Based on its under-performance to plan through the six months ended June 30, 2016, we revised our growth assumptions for the Physician Staffing reporting unit which triggered our evaluation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest expense</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense totaled $4.2 million for the year ended December 31, 2017 and $6.1 million for the year ended December 31, 2016. The decrease was due to a lower effective interest rate partially offset by higher average borrowings. The effective interest rate on our borrowings decreased to 4.6% for the year ended December 31, 2017 compared to 8.4% for the year ended December 31, 2016, primarily due to the payoff of our $25.0 million 8% fixed rate Convertible Notes on March 17, 2017. See Note 8 - Debt to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gain on derivative liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability of $1.6 million and $5.8 million for the years ended December 31, 2017 and December 31, 2016, respectively, related to the change in the fair value of embedded features of our Convertible Notes. The gains in both periods primarily resulted from decreases in our share price from the end of the respective prior years through the 2017 payoff date and through December 31, 2016. The gain in 2016 was partially offset by a reduction in credit risk. See Note 8 - Debt and Note 9 - Derivatives to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Loss on early extinguishment of debt</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt of $5.0 million for the year ended December 31, 2017 relates to the write-off of original issue discount and debt issuance costs of $4.4 million and a pre-payment fee of $0.6 million due to the early settlement of our Convertible Notes. Loss on early extinguishment of debt was $1.6 million for the year ended December 31, 2016 and related to the write-off of unamortized net debt discount and issuance costs, including a redemption premium of $0.6 million, related to our Second Lien Term Loan. See Note 8 - Debt to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">I</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">ncome tax benefit</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit from continuing operations totaled $34.5 million for the year ended December 31, 2017, compared to $4.2 million for the year ended December 31, 2016. The effective tax rate was negative 802.2% and negative 92.1%, including the impact of discrete items, for the years ended December 31, 2017 and 2016, respectively. The effective tax rate in 2017 was impacted by the reversal of valuation allowances, partially offset by the changes in estimated deferred tax assets resulting from the 2017 Tax Act. The effective tax rate in 2016 is different than the statutory rates primarily due to the impact from amortization of indefinite-lived intangible assets for tax purposes and the partial non-deductibility of certain per diem expenses and international and state minimum taxes. See Note 13 - Income Taxes to our consolidated financial statements for further information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Segment Results</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a reconciliation to (loss) income from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,267</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721,486</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,610</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98,283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income (loss):</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,365</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,614</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,992</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,589</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 17 - Segment Data.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain statistical data for our business segments for the periods indicated are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Nurse and Allied Staffing statistical data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">FTEs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,154</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,397</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(243</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Average Nurse and Allied Staffing revenue per FTE per day </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">276</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Physician Staffing statistical data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Days filled </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,039</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,122</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue per day filled </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,552</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percent</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Change</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Nurse and Allied Staffing statistical data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">FTEs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,397</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,953</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Average Nurse and Allied Staffing revenue per FTE per day </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">281</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">284</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Physician Staffing statistical data:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Days filled </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61,584</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,423</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue per day filled </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See definition of Business Measurements under the Operating Metrics section of our Management's Discussion and Analysis.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Comparison - Year Ended December&#160;31, 2018 compared to the Year Ended December&#160;31, 2017</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nurse and Allied Staffing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from the Nurse and Allied Staffing business segment </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$38.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">5.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$720.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, from </font><font style="font-family:inherit;font-size:10pt;">$758.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The year-over-year decrease was primarily due to volume declines across both travel nurse and local staffing, partly offset by the impact of the July 2017 acquisition of Advantage. Excluding the impact of the Advantage acquisition, revenue declined 9.3%. The lower revenue in travel nurse and local staffing was partly offset by increases in travel allied and education healthcare staffing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Nurse and Allied Staffing for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;or </font><font style="font-family:inherit;font-size:10pt;">9.8%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$66.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from </font><font style="font-family:inherit;font-size:10pt;">$73.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. As a&#160;percentage of segment revenue, contribution income margin decreased to </font><font style="font-family:inherit;font-size:10pt;">9.2%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;from </font><font style="font-family:inherit;font-size:10pt;">9.7%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily due to lower travel nurse volumes, and to a lesser extent, lower travel nurse bill rates.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average number of Nurse and Allied Staffing FTEs on contract during the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;decreased 3.3% from the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Average Nurse and Allied Staffing revenue per FTE per day&#160;</font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;approximately </font><font style="font-family:inherit;font-size:10pt;">1.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, reflecting lower average bill rates, primarily in our travel nurse operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Physician Staffing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Physician Staffing </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$11.3 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">12.1%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$82.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$93.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily due to a decrease in volume of days filled. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Physician Staffing for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;or </font><font style="font-family:inherit;font-size:10pt;">9.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. As a&#160;percentage of segment revenue, contribution income was </font><font style="font-family:inherit;font-size:10pt;">5.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">5.6%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The margin improvement was primarily due to lower selling, general and administrative costs, partly offset by a lower gross profit margin.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing days filled </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">11.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">53,039</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">60,161</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Revenue per day filled was $1,552 for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and $1,556 for the year ended December 31, 2017, due to a shift in mix between advanced practice and physician staffing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Human Capital Management Services</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from OHCMS for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">5.4%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$13.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from </font><font style="font-family:inherit;font-size:10pt;">$13.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily due to growth in executive searches, partially offset by lower physician searches.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from OHCMS for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, increased by $1.0 million, or </font><font style="font-family:inherit;font-size:10pt;">267.5%</font><font style="font-family:inherit;font-size:10pt;">, to </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">, compared to a loss of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The year-over-year improvement was due to lower selling, general and administrative expenses, partly offset by a lower gross profit margin.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unallocated corporate overhead</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in unallocated corporate overhead is corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives) and public company expenses. Unallocated corporate overhead increased to $44.6 million for the year ended December&#160;31, 2018, from $39.2 million for the year ended December&#160;31, 2017, primarily due to higher professional service fees, such as legal and consulting, partly offset by the impact of cost savings and efficiency initiatives. As a&#160;percentage of consolidated revenue, unallocated corporate overhead was </font><font style="font-family:inherit;font-size:10pt;">5.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">4.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Comparison - Year Ended December&#160;31, 2017 compared to the Year Ended December&#160;31, 2016</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nurse and Allied Staffing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from the Nurse and Allied Staffing business segment increased $36.8 million, or 5.1% to $758.3 million for the year ended December 31, 2017, from $721.5 million for the year ended December 31, 2016. The year-over-year increase was entirely due the impact of the Advantage acquisition. Excluding the impact of the Advantage acquisition, revenue declined 1.3%, primarily due to the impact of higher average bill rates partly related to specific project revenue in the prior year and lower premium rate business in 2017, partially offset by growth in our education healthcare staffing operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Nurse and Allied Staffing for the year ended December 31, 2017, increased $1.6 million or 2.3%, to $73.6 million from $72.0 million in year ended December 31, 2016. As a percentage of segment revenue, contribution income margin decreased to 9.7% for the year ended December 31, 2017 from 10.0% for the year ended December 31, 2016, primarily due to higher compensation packages for our field staff that were in place in the early part of the year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The average number of Nurse and Allied Staffing FTEs on contract during the year ended December 31, 2017 increased 6.4% over the year ended December 31, 2016, in part due to the impact of the acquisition of Advantage. Average Nurse and Allied Staffing revenue per FTE per day decreased approximately 1.1% in the year ended December 31, 2017 compared to the year ended December 31, 2016, primarily due to less premium rate business in 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Physician Staffing</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from Physician Staffing decreased $4.7 million, or 4.8% to $93.6 million for the year ended December 31, 2017, compared to $98.3 million for the year ended December 31, 2016, primarily due to a decrease in volume of days filled.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income from Physician Staffing for the year ended December 31, 2017, decreased $3.0 million or 36.4% to $5.3 million compared to $8.3 million in the year ended December 31, 2016. As a percentage of segment revenue, contribution income was 5.6% for the year ended December 31, 2017 and 8.4% for the year ended December 31, 2016. The margins were negatively impacted from continued investments in the business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Metrics</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing days filled decreased 2.3% to 60,161 in the year ended December 31, 2017, compared to 61,584 in the year ended December 31, 2016, primarily due to a decline in physician specialties, partly offset by an increase in advanced practices. Part of the volume decline in physician specialties is due to a reduction in orders from government customers. Revenue per day filled was $1,556 and $1,596 for the years ended December 31, 2017 and 2016, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Human Capital Management Services</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from OHCMS for the year ended December 31, 2017, decreased $0.6 million, or 4.3%, to $13.2 million from $13.8 million in the year ended December 31, 2016, primarily due to a decrease in executive searches and placements, partially offset by higher physician searches.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution loss from OHCMS for the year ended December 31, 2017, decreased by $0.1 million, or 33.3%, to $0.4 million, compared to $0.5 million for the year ended December 31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unallocated corporate overhead</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead was $39.2 million for the year ended December 31, 2017, compared to $38.4 million for the year ended December 31, 2016, primarily due to an increase in compensation and benefits. As a percentage of consolidated revenue, unallocated corporate overhead was 4.5% for the year ended December 31, 2017, and 4.6% for the year ended December 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Transactions with Related Parties</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 16 - Related Party Transactions to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Liquidity and Capital Resources</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had </font><font style="font-family:inherit;font-size:10pt;">$16.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash and cash equivalents, and $83.9 million of Term Loan outstanding, at par. Working capital decreased by </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$109.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared to </font><font style="font-family:inherit;font-size:10pt;">$114.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Our net days' sales outstanding (DSO), which excludes amounts owed to subcontractors, increased 4 days to 62 days as of December 31, 2018, compared to 58 days as of December 31, 2017. The increase was due to clients' slow paying, predominantly among a few large customers and, to a lesser extent, clients' seeking extended payment terms.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our operating cash flow constitutes our primary source of liquidity, and historically, has been sufficient to fund our working capital, capital expenditures, internal business expansion, and debt service, including our commitments as described in the Commitments table which follows. We expect to meet our future needs for working capital, capital expenditures, internal business expansion, and debt service from a combination of cash on hand, operating cash flows, and funds available through the revolving loan portion of our Amended and Restated Credit Agreement. See debt discussion which follows. In the third quarter of 2018, we launched a new initiative to replace our legacy system supporting our travel nurse staffing operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon current projections, we will not satisfy the required leverage ratio under our Credit Agreement as of March 31, 2019. As a result, a debt prepayment of between $10 million and $12 million would be required to remain in compliance. We believe such prepayment will be sufficient to maintain compliance with the leverage ratio covenant and meet our obligations for the next twelve months. In the event actual results differ significantly from current projections, we may be required to make additional debt prepayments. Further, we may be able to amend our Credit Agreement, and as a result, would not be required to make any debt prepayments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Flow Comparisons</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Year Ended </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Compared to Year Ended </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities during the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$21.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">$45.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;during the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, primarily due to lower collections and timing of payments. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities during the year ended December 31, 2018 was </font><font style="font-family:inherit;font-size:10pt;">$6.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">$91.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The lower cash used in the year ended December 31, 2018 is due to less cash used for acquisitions. During the year ended December 31, 2018, we used $1.9 million, net of cash acquired, for the AP Staffing acquisition compared to a use of $86.0 million to acquire Advantage in July 2017. See Note 4 - Acquisitions to our consolidated financial statements. In both years, cash used also includes capital expenditures and acquisition-related settlements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in financing activities during the year ended December 31, 2018 was $23.8 million, compared to net cash provided by financing activities of $50.8 million during the year ended December 31, 2017. During the year ended December 31, 2018, we repaid $16.1 million on our Term Loan, including $10.0 million of optional prepayments, and paid $0.3 million in debt issuance costs in connection with the First Amendment to our Amended and Restated Credit Facility. We also repurchased and retired shares of our Common Stock for $5.0 million, and used cash to pay $0.9 million for shares withheld for taxes, $1.2 million for noncontrolling shareholder payments, and $0.3 million of contingent consideration. During the year ended December 31, 2017, in the first quarter, we paid off our Convertible Notes with a partial cash payment of $5.0 million and extinguishment fees of $0.6 million. We also funded the acquisition of Advantage using our Senior Credit Facility and subsequently refinanced, resulting in net borrowings of $68.5 million on the Senior Credit Facility ($62.0 million in Term Loans and $6.5 million on the Revolving Credit Facility which was subsequently repaid) and debt issuance costs of $0.9 </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">million. In addition, we used cash to repay $1.5 million on our Term Loan, pay $1.8 million for shares withheld for taxes, $1.2 million for noncontrolling shareholder payments, and $0.3 million of contingent consideration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Year Ended December&#160;31, 2017 Compared to Year Ended December&#160;31, 2016</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities during the year ended December 31, 2017 was $45.5 million compared to $30.1 million during the year ended December 31, 2016, primarily due to higher collections partly offset by the timing of payments for the year ended December 31, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing activities used a net of $91.4 million in the year ended December 31, 2017 compared to $9.8 million in the year ended December 31, 2016. Net cash used in the year ended December 31, 2017 was for the Advantage acquisition and for capital expenditures, of which $2.9 million was reimbursed from our landlord for tenant improvements and is reflected in operating activities. Net cash used in investing activities in the year ended December 31, 2016 included $6.5 million for capital expenditures, $1.9 million for the acquisition of USR, and $1.9 million of other acquisition-related settlements, which was partially offset by the receipt of $0.5 million related to proceeds from the sale of CCE. See Note 3 - Acquisitions and Note 4 - Disposal to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities during the year ended December 31, 2017 was $50.8 million, compared to $2.2 million net cash used during the year ended December 31, 2016. During the year ended December 31, 2017, in the first quarter, we paid off our Convertible Notes with a partial cash payment of $5.0 million and extinguishment fees of $0.6 million. We also funded the acquisition of Advantage using our Senior Credit Facility and subsequently refinanced, resulting in net borrowings of $68.5 million on the Senior Credit Facility ($62.0 million in Term Loans and $6.5 million on the Revolving Credit Facility which was subsequently repaid) and debt issuance costs of $0.9 million. In addition, we used cash to repay $1.5 million on our Term Loan, pay $1.8 million for shares withheld for taxes, $1.2 million for noncontrolling shareholder payments, and $0.3 million of contingent consideration. During the year ended December 31, 2016, we entered into the 2016 Senior Credit Facility which provided us with $40.0 million of borrowings under the Term Loan Facility. Part of the proceeds from the borrowings were used to prepay our $30.0 million Second Lien Term Loan including a prepayment penalty of $0.6 million and $1.2 million of debt issuance costs. During the year ended December 31, 2016, we also repaid a net of $8.0 million on our senior secured asset-based credit facility and $0.5 million on our term loan facility, and used cash to pay $0.9 million for shares withheld for taxes, $0.7 million for noncontrolling shareholder payments, and $0.2 million of contingent consideration.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As more fully described in Note 8 - Debt to our consolidated financial statements, our Amended and Restated Credit Agreement, entered into on August 1, 2017, provides us with a $215.0 million committed facility, including a term loan of $100.0 million (Amended Term Loan) and a $115.0 million revolving credit facility (Amended Revolving Credit Facility) (together with the Amended Term Loan, the Amended Credit Facilities). As of December 31, 2018, the Applicable Margin, as defined in the Amended and Restated Credit Agreement, was 2.50% for Eurodollar Loans and LIBOR Index Rate Loans and 1.50% for Base Rate Loans. As of December 31, 2018, we had $83.9 million principal balance on the Amended Term Loan and $20.6 million in letters of credit outstanding.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2018, we entered into an amendment to our Amended and Restated Credit Agreement that increased the maximum Consolidated Total Leverage Ratio covenant by 0.50:1.00 through September 30, 2019, and by 0.25:1.00 for the period ended December 31, 2019, modified the definition of Consolidated EBITDA to allow for the exclusion of charges related to an initiative to replace our front-end system supporting our legacy travel nurse operations, and also provided for a less restrictive pro forma Consolidated Total Leverage Ratio threshold for restricted payments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, we paid in full our fixed rate 8% Convertible Notes. The Convertible Notes had an aggregate principal amount of $25.0 million, and were convertible into shares of our Common Stock, at a conversion price of $7.10 per share. As a result of the early repayment, we recognized $5.0 million as loss on early extinguishment of debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At inception of the notes, and at the time of the payoff, the conversion price of $7.10 was below the market price. The initial agreement allowed us to force conversion of the Notes only after three years, beginning July 1, 2017, and if the VWAP exceeded 125% of the Conversion Price for 20 days of a 30 day trading period (the threshold was $8.88, which we were well above). As such, we and the Noteholders agreed to an early settlement at fair value based on the stock price. In connection with </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the repayment, we issued to the Noteholders an aggregate of 3,175,584 shares of Common Stock and cash in the aggregate amount of $5.6 million.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 8 - Debt to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stockholders' Equity</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 14 - Stockholders' Equity to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Commitments and Off-Balance Sheet Arrangements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2018, we do not have any off-balance sheet arrangements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reflects our contractual obligations and other commitments as of December&#160;31, 2018: </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:0px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Thereafter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="27" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited, amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan (a)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,990</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on debt (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,722</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,339</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,073</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,726</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,584</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration (c)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,811</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,531</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating lease obligations (d)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,595</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,407</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,857</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,700</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,893</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,004</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,562</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,431</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,700</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,893</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under our Amended Term Loan, we are required to comply with certain financial covenants. Our inability to comply with the required covenants or other provisions could result in default under our amended credit facilities. In the event of any such default and our inability to obtain a waiver of the default, all amounts outstanding under the Amended Credit Facilities could be declared immediately due and payable. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we are in compliance with the financial covenants and other covenants contained in the Amended and Restated Credit Agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on debt represents payments due through maturity for our Term Loan, calculated using the December 31, 2018 applicable LIBOR and margin rate totaling 5.0% on approximately 45% of the Term Loan balance, and a fixed interest rate of 5.1% on the other approximately 55% of the Term Loan balance, taking into account the interest rate swap. See Note 9 - Derivatives.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration represents the estimated payments due to the sellers related to the Mediscan acquisition, including accretion. See Note 4 - Acquisitions to our consolidated financial statements. We have included the payments in the table based on our best estimates of the amounts and dates when the contingencies may be resolved.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents future minimum lease payments associated with operating lease agreements with original terms of more than one year. </font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 12 - Commitments and Contingencies to our consolidated financial statements.</font></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the above disclosed contractual obligations, we have accrued uncertain tax positions, pursuant to the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, of </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at December&#160;31, 2018. Based on the uncertainties associated with the settlement of these items, we are unable to make reasonably reliable estimates of the period of potential settlements, if any, with the taxing authorities.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Estimates </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have identified the following critical accounting policies that affect the more significant judgments and estimates used in the preparation of our consolidated financial statements. The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. We evaluate our estimates on an on-going basis, including those related to asset impairment, accruals for self-insurance, allowance for doubtful accounts and sales allowances, taxes and other contingencies, and litigation. We state our accounting policies in the notes to the audited consolidated financial statements for the year ended December&#160;31, 2018, contained herein. These estimates are based on information that is currently available to us and on various assumptions that we believe to be reasonable under the circumstances. Actual results could vary from those estimates under different assumptions or&#160;conditions.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill, trade names, and other intangible assets</font><font style="font-family:inherit;font-size:10pt;color:#ff0000;font-style:italic;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business acquisitions typically result in the recording of goodwill, trade names, and other intangible assets, and the recorded values of those assets may become impaired in the future. The determination of the value of such intangible assets requires management to make estimates and assumptions that affect our consolidated financial statements. For intangible assets purchased in a business combination, the estimated fair values of the assets received are used to establish their recorded values. As more fully described in Note 2 - Summary of Significant Accounting Policies, we assess the impairment of goodwill of our reporting units and indefinite-lived intangible assets annually, or more often if events or changes in circumstances indicate that the carrying value may not be recoverable. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. Significant judgments are required to estimate the fair value of reporting units including estimating future cash flows, and determining appropriate discount rates, growth rates, company control premium, and other assumptions. Changes in these estimates and assumptions could materially affect the determination of fair value for each reporting unit.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 5 - Goodwill, Trade Names, and Other Intangible Assets, where impairment testing in 2018, 2017, and 2016 is more fully described. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There can be no assurance that the estimates and assumptions made for purposes of the annual goodwill impairment test will prove to be accurate predictions of the future. Although management believes the assumptions and estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the reported financial results.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we are required to test the recoverability of long-lived assets, including identifiable intangible assets with definite lives, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In testing for potential impairment, if the carrying value of the asset group exceeds the expected undiscounted cash flows, we must then determine the amount by which the fair value of those assets exceeds the carrying value and determine the amount of impairment, if any.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Risk and Uncertainties</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The calculation of fair value used in these impairment assessments included a number of estimates and assumptions that required significant judgments, including projections of future income and cash flows, the identification of appropriate market multiples and the choice of an appropriate discount rate. See Note 10 - Fair Value Measurements. Changes in these assumptions could materially affect the determination of fair value for each reporting unit. Specifically, further deterioration of demand for our services, further deterioration of labor market conditions, reduction of our stock price for an extended period, or other factors as described in Item 1.A. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Risk Factors</font><font style="font-family:inherit;font-size:10pt;">, may affect our determination of fair value of each reporting unit. This evaluation can also be triggered by various indicators of impairment which could cause the estimated discounted cash flows to be less than the carrying amount of net assets.&#160;If we are required to record an impairment charge in the future, it could have an adverse impact on our results of operations. Under the current credit agreement an impairment charge will not have an impact on our liquidity. As of December&#160;31, 2018, we had total goodwill, intangible assets not subject to amortization, and other intangible assets of $176.6 million or 41.4% of our total assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Health, workers' compensation, and professional liability expense</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain accruals for our health, workers&#8217; compensation, and professional liability claims that are partially self-insured and are classified as accrued compensation and benefits on our consolidated balance sheets. We determine the adequacy of these accruals by periodically evaluating our historical experience and trends related to health, workers&#8217; compensation, and professional liability claims and payments, based on actuarial models, as well as industry experience and trends. If such models indicate that our accruals are overstated or understated, we will adjust accruals as appropriate. Healthcare insurance accruals have fluctuated with increases or decreases in the average number of temporary healthcare professionals on assignment as well as actual company experience and increases in national healthcare costs. As of December&#160;31, 2018 and 2017, we had </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and $5.1&#160;million accrued, respectively, for incurred but not reported health insurance claims. Corporate and field employees are covered through a partially self-insured health plan. Workers&#8217; compensation insurance accruals can fluctuate over time due to the number of employees and inflation, as well as additional exposures arising from the current policy year. As </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of December&#160;31, 2018, and 2017, we had $11.9&#160;million and $11.4 million accrued for case reserves and for incurred but not reported workers&#8217; compensation claims, net of insurance receivables, respectively. The accrual for workers&#8217; compensation is based on an actuarial model which is prepared or reviewed by an independent actuary semi-annually. As of December&#160;31, 2018, and 2017, we had $7.3 million and $6.4&#160;million accrued, respectively, for case reserves and for incurred but not reported professional liability claims, net of insurance receivables. The accrual for professional liability is based on actuarial models which are prepared by an independent actuary semi-annually.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue from our services when control of the promised services are transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for the service. We have concluded that transfer of control of our staffing services, which represents the majority of our revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the nature, amount, timing and uncertainty of revenue and cash flows from which we generate revenue.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Temporary Staffing Revenue</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by our field staff. We recognize the majority of our revenue at the contractual amount we have the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of 15 to 60 days. Accounts receivable includes estimated revenue for employees&#8217; and independent contractors&#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, our estimate of amounts that had been worked but had not been billed totaled $44.1 million and $41.8 million, respectively, and are included in accounts receivable on the consolidated balance sheets.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Service Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We offer other optional services to our customers that are transferred over time including: MSPs providing agency services (as further described below in Gross versus Net Policies), RPO, other outsourcing services, and retained search services, which is less than 5% of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For our RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. We do not, in the ordinary course of business, offer warranties or refunds.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Gross Versus Net Policies</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We record revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also entered into certain contracts with acute care facilities to provide comprehensive MSP solutions. Under these contract arrangements, we use our nurses primarily, along with those of third party subcontractors, to fulfill customer orders. If a subcontractor is used, we invoice our customer for these services, but revenue is recorded at the time of billing, net of any related subcontractor liability. The resulting net revenue represents the administrative fee charged by us for our MSP services.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from our Physician Staffing business is recognized on a gross basis as we believe we are the principal in the arrangements.</font></div></td></tr></table><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allowances</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments, which results in a provision for bad debt expense. We determine the adequacy of this allowance by continually evaluating individual customer receivables, considering the customer&#8217;s financial condition, credit history and current economic conditions. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. We write-off specific accounts based on an ongoing review of collectability as well as our past experience with the customer. In addition, we maintain a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances. As of December&#160;31, 2018, our total allowances were $3.7 million.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingent liabilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to various litigation, claims, investigations, and other proceedings that arise in the ordinary course of our business. These proceedings typically relate to professional liability, tax, payroll, contract, competitor disputes, and employment-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding our employment practices. Our healthcare facility clients may also become subject to claims, governmental inquiries and investigations, and legal actions to which we may become a party relating to services provided by our professionals. We record a liability when available information indicates that a loss is probable and an amount, or range of loss can be reasonably estimated. Significant judgment is required to determine both the probability of loss and the estimated amount. At least quarterly, we review our accrual and or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or new information. However, losses ultimately incurred could materially differ from amounts accrued. See Note 12 - Commitments and Contingencies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We account for income taxes in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and other loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. As of December 31, 2018, we have deferred tax assets related to certain federal, state, and foreign net operating loss carryforwards of $20.6 million. The carryforwards will expire as follows: federal between 2032 and 2037, state between 2019 and 2038, and foreign between 2019 and 2023. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2018 and 2017, we had valuation allowances on our deferred tax assets of $1.2 million and $1.1 million, respectively. For the year ended December 31, 2017, we reduced the valuation allowance recorded by $45.4 million (comprised of $15.7 million related to U.S. net operating losses, $4.4 million related to state net operating losses, and $25.3 million related to other net deferred tax assets) predominantly on the basis of management&#8217;s reassessment of deferred tax assets that are more likely than not to be realized. The valuation allowance on a portion of state net operating losses not more likely than not realizable was not released due to the respective expiration periods and specific state taxable income projections. See Note 13 - Income Taxes to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, we evaluate factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. We consider all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. We consider cumulative losses in recent years as well as the impact of one-time events in assessing our pre-tax earnings. Assumptions regarding future taxable income require significant judgment. Our assumptions are consistent with estimates and plans used to manage our business, which includes restructuring and other initiatives.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that actual results differ from these estimates, or we adjust these estimates in future periods for current trends or changes in our estimating assumptions, we may modify the level of the valuation allowance which could materially impact our business, financial condition and results of operations.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2018 and 2017, we had valuation allowances on our deferred tax assets of $1.2 million and $1.1 million, respectively. For the year ended December 31, 2017, we reduced the valuation allowance recorded by $45.4 million (comprised of $15.7 million related to U.S. net operating losses, $4.4 million related to state net operating losses, and $25.3 million related to other net deferred tax assets) predominantly on the basis of management&#8217;s reassessment of deferred tax assets that are more </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">likely than not to be realized. The valuation allowance on a portion of state net operating losses not more likely than not realizable was not released due to the respective expiration periods and specific state taxable income projections.  As of December 31, 2018, management determined that there was sufficient positive evidence to conclude that it was more likely than not that our net deferred tax assets were realizable with the exception of a portion of state net operating losses. See Note 13 - Income Taxes to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to income taxes in the U.S. and certain foreign jurisdictions. Significant judgment is required in determining our consolidated provision for income taxes and recording the related deferred tax assets and liabilities. In the ordinary course of our business there are many transactions and calculations where the ultimate tax determination is uncertain. Accruals for unrecognized tax benefits are provided for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC. An unrecognized tax benefit represents the difference between the recognition of benefits related to exposure items for income tax reporting purposes and financial reporting purposes. The current portion of the unrecognized tax benefit is classified as a component of other current liabilities, and the non-current portion is included within other long-term liabilities on the consolidated balance sheets. As of December 31, 2018, total unrecognized tax benefits recorded was $5.4 million. We reserve for interest and penalties on exposure items, if applicable, which is recorded as a component of the overall income tax provision. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are regularly under audit by tax authorities. Although the outcome of tax audits is always uncertain, we believe that we have appropriate support for the positions taken on our tax returns and that our annual tax provision includes amounts sufficient to pay any assessments. Nonetheless, the amounts ultimately paid, if any, upon resolution of the issues raised by the taxing authorities may differ materially from the amounts accrued for each year.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 2 - Summary of Significant Accounting Policies to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Seasonality</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The number of healthcare professionals on assignment with us is subject to seasonal fluctuations which may impact our quarterly revenue and earnings. Hospital patient census and staffing needs of our hospital and healthcare facilities fluctuate, which impact our number of orders for a particular period. Many of our hospital and healthcare facility clients are located in areas that experience seasonal fluctuations in population during the winter and summer months. These facilities adjust their staffing levels to accommodate the change in this seasonal demand and many of these facilities utilize temporary healthcare professionals to satisfy these seasonal staffing needs. Likewise, the number of nurse and allied professionals on assignment may fluctuate due to the seasonal preferences for destinations of our temporary nurse and allied professionals. In addition, we expect our Physician Staffing business to experience higher demand in the summer months as physicians take vacations. We also expect our education and school business to experience lower demand in the summer months when public and charter schools are closed. This historical seasonality of revenue and earnings may vary due to a variety of factors and the results of any one quarter are not necessarily indicative of the results to be expected for any other quarter or for any year. In addition, typically, our first quarter results are negatively impacted by the reset of payroll taxes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inflation </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We do not believe that inflation had a significant impact on our results of operations for the periods presented. On an ongoing basis, we seek to ensure that billing rates reflect increases in costs due to inflation. In addition, we attempt to minimize any residual impact on our operating results by controlling operating costs.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4265BF305EB0517BAD02FE1EA1015391"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7A.        Quantitative and Qualitative Disclosures about Market Risk.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are exposed to the risk of fluctuation in interest rates relating to our outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, we entered into an interest rate swap agreement which effectively fixed the interest rate on 50% of the amortizing balance of our term debt, exclusive of the credit spread on the debt. We have determined that the interest rate swap qualifies as a cash flow hedge in accordance with Accounting Standards Codification (ASC) 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">. See Note 2 - Summary of Significant Accounting Policies and Note 9 - Derivative to our consolidated financial statements. Excluding the impact of our interest rate swap agreements, a 1% change in interest rates on variable rate debt would have resulted in interest expense fluctuating approximately $1.0&#160;million, $0.7 million, and $0.4 million for the years ended December 31, 2018, 2017, and 2016. Considering the effect of our interest rate swap agreement in a 1% change in interest rates on our variable rate debt would have resulted in interest expense fluctuating approximately $0.6&#160;million for the year ended December 31, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have minor exposure to the impact of foreign currency fluctuations. Approximately 1% of selling, general and administrative expenses are related to certain software development and information technology support provided by our employees in Pune, India. Changes in foreign currency exchange rates impact translations of foreign denominated assets and liabilities into U.S. dollars and future earnings and cash flows from transactions denominated in different currencies. We have not entered into any foreign currency hedges.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our international operations transact business in their functional currency. As a result, fluctuations in the value of foreign currencies against the U.S. dollar have an impact on reported results. Expenses denominated in foreign currencies are translated into U.S. dollars at monthly average exchange rates prevailing during the period. Consequently, as the value of the U.S. dollar changes relative to the currencies of our non-U.S. markets, our reported results vary.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fluctuations in exchange rates also impact the U.S. dollar amount of stockholders&#8217; equity. The assets and liabilities of our non-U.S. subsidiaries are translated into U.S. dollars at the exchange rate in effect at the end of a reporting period. The resulting translation adjustments are recorded in stockholders&#8217; equity, as a component of accumulated other comprehensive loss, included in other stockholders&#8217; equity on our consolidated balance sheets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s22BA672A9ED85CD9B750BBE4739F15BB"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.</font><font style="font-family:inherit;font-size:10pt;">&#160;         </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;Financial Statements and Supplementary Data.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Item 15 &#8211; Exhibits, Financial Statement Schedules of Part IV of this Report.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s5779B362541F51838CDE28B3DF8CA276"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.           Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s289CFB892DCD55E69C032A091668114C"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9A.</font><font style="font-family:inherit;font-size:10pt;">&#160;      </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;Controls and Procedures.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act of 1934, as amended, is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in Internal Control Over Financial Reporting</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were no changes in our internal controls over financial reporting during 2018 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management&#8217;s Report on Internal Control Over Financial Reporting</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2018. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission, or COSO, in the Internal Control-Integrated Framework (2013 framework).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on its evaluation, management concluded that, as of December 31, 2018, our internal control over financial reporting is effective based on the specific criteria.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Attestation Report of Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our independent registered public accounting firm has issued an attestation report on our internal control over financial reporting. This report appears on page 38.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the Stockholders and the Board of Directors of </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on Internal Control over Financial Reporting</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have audited the internal control over financial reporting of Cross</font><font style="font-family:inherit;font-size:10pt;color:#131313;">&#32;Country Healthcare, Inc.</font><font style="font-family:inherit;font-size:10pt;">&#32;and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2018, based on criteria established in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2018, based on criteria established in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by COSO.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) the consolidated financial statements as of and for the year ended December 31, 2018, of the Company and our report dated February 28, 2019 expressed an unqualified opinion on those financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Management's Report on Internal Control over Financial Reporting</font><font style="font-family:inherit;font-size:10pt;">. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:69%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ DELOITTE &amp; TOUCHE LLP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></div><hr style="page-break-after:always"><div><a name="s48E4482DE119573494B40BAAD2327967"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9B.&#160;       Other Information.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s909F667440055A8781052A3032E99416"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART III</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sC524D20EFE9D513B9513CBB39FF5B5DC"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 10.         Directors, Executive Officers and Corporate Governance.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to directors, executive officers and corporate governance is included in our Proxy Statement for the 2019 Annual Meeting of Stockholders (Proxy Statement) to be filed pursuant to Regulation&#160;14A with the SEC and such information is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s7DEC8DB6B50551889118AD41A5C1A75E"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 11.         Executive Compensation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to executive compensation is included in our Proxy Statement to be filed with the SEC and such information is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s8C5D8B3CFB37535C8891CF14D5251552"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 12.&#160;        Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to beneficial ownership of our common stock is included in our Proxy Statement to be filed with the SEC and such information is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to equity compensation plans as of December&#160;31, 2018, see table below:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:50%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Plan&#160;Category</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of securities to</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">be issued upon exercise</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">of outstanding options,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">warrants and rights (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-average</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">exercise price of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">outstanding options,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">warrants and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">rights (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of securities</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">remaining available for</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">future issuance under</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">equity compensation</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">plans (excluding</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">securities reflected in</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">column (a)) (c) </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity compensation plans approved&#160;by</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160; security holders</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,306,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity compensation plans not&#160;approved by</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;security holders</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">N/A</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,306,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;">&#160;For Performance Stock Awards issued under the 2014 Omnibus Incentive Plan, we consider the expected number of shares that may be issued under the award to be outstanding. When the number of Performance Stock Awards have been determined, we true up the actual number of shares that were awarded and return any unawarded shares into shares available for issuance. See Note 14 - Stockholders' Equity to our consolidated financial statements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0F4E921044675103BA765D4CC2A45671"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 13.         Certain Relationships and Related Transactions, and Director Independence.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to certain relationships and related transactions, and director independence is included in our Proxy Statement to be filed with the SEC and such information is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s8D80F94FCD1C56E8B2DE93F6594F4810"></a></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 14.&#160;        Principal Accountant Fees and Services.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to the fees and services of our principal accountant is included in our Proxy Statement to be filed with the SEC and such information is incorporated herein by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></div><hr style="page-break-after:always"><div><a name="sA2AC4C3D6A99590898209E4E78CC678E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART IV</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s40FCAD5DD5A15A07A40D1575A295E935"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 15.&#160;        Exhibits, Financial Statement Schedules.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:91%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;padding-left:67px;text-indent:-66px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)        Documents filed as part of the report.</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Report of Independent Registered Public Accounting Firm</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Balance Sheets as of December&#160;31, 2018 and 2017</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Operations for the Years Ended December&#160;31, 2018, 2017, and 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Comprehensive Income for the Years Ended December&#160;31, 2018, 2017,</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160; and 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Stockholders&#8217; Equity for the Years Ended December&#160;31, 2018, 2017, and 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 2018, 2017, and 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Notes to Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Statements Schedule</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedule II &#8211; Valuation and Qualifying Accounts for the Years Ended December&#160;31, 2018, 2017, and 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibits</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></div><hr style="page-break-after:always"><div><a name="sE95C900A0D25592EA8CE7470B4BA5109"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000091205701530091/a2057156zex-3_1.txt"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Certificate of Incorporation of the Registrant (Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1/A, Commission File No. 333-64914, and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018002702/ccrn20171231-10kex3x2.htm"><font style="font-family:inherit;font-size:10pt;">Certificate of Correction to Amended and Restated Certificate of Incorporation of the Registrant (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018010300/ccrn20180630-10qex3x1.htm"><font style="font-family:inherit;font-size:10pt;">Amended and Restated By-laws of the Registrant&#160;(Previously filed as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2018 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000091205701536175/a2061600zex-4_1.txt"><font style="font-family:inherit;font-size:10pt;">Form&#160;of specimen common stock certificate&#160;(Previously filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1/A, Commission File No. 333-64914, and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514003563/ccrn20140630-10qex41rsaform.htm"><font style="font-family:inherit;font-size:10pt;">2014 Omnibus Incentive Plan - Restricted Stock Agreement Form (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended June 30, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514003563/ccrn20140630-10qex42psaform.htm"><font style="font-family:inherit;font-size:10pt;">2014 Omnibus Incentive Plan - Performance Share and Restricted Stock Agreement Form (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended June 30, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514002739/exhibit104063014.htm"><font style="font-family:inherit;font-size:10pt;">Registration Rights Agreement, dated June 30, 2014, by and among Cross Country Healthcare, Inc. and the noteholders party thereto (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated July 2, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752313001523/a50595935ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement, dated as of March 20, 2013, between William J. Grubbs and the Registrant (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated March 22, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000104746903010584/a2106509zex-10_19.htm"><font style="font-family:inherit;font-size:10pt;">Cross Country, Inc. Deferred Compensation Plan (Previously filed as an exhibit to the Company&#8217;s Form 10-K for the year ended December 31, 2002, and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000111650207000527/cejkalease1043.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement between Cornerstone Opportunity Ventures, LLC and Cejka Search, Inc., dated February 2, 2007 (Previously filed as an exhibit to the Company&#8217;s Form 10-K for the year ended December 31, 2006 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000111650207000527/exhibit1045.htm"><font style="font-family:inherit;font-size:10pt;">Second Amendment to Lease Agreement by and between Meridian Commercial Properties Limited Partnership and Cross Country Healthcare, Inc., dated February 17, 2007 (Previously filed as an exhibit to the Company&#8217;s Form 10-K for the year ended December 31, 2006 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000111650208001825/exhibit105.htm"><font style="font-family:inherit;font-size:10pt;">First Amendment to Lease Agreement dated as of September 1, 2007, by and between Cornerstone Opportunity Ventures, LLC and Cejka Search, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2008 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.6 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000111650207000972/exhibit102.htm"><font style="font-family:inherit;font-size:10pt;">Form of Non-Employee Directors&#8217; Restricted Stock Agreement under Cross Country Healthcare, Inc. 2007 Stock Incentive Plan (Previously filed as an exhibit to the Company&#8217;s 8-K dated May 15, 2007 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000119312507218382/dex101.htm"><font style="font-family:inherit;font-size:10pt;">Form of Stock Appreciation Rights Agreement under Cross Country Healthcare, Inc. 2007 Stock Incentive Plan (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated October 15, 2007 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448810002373/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement, dated July 1, 2010, between Goldberg Brothers Real Estate LLC and MCVT, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended June 30, 2010 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530513001944/exhibit101.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement, dated July 18, 2013, between Peachtree II and III, LLC and MDA Holdings, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended June 30, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.10 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000095013010001422/dex101.htm"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Executive Severance Plan of Cross Country Healthcare, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated May 28, 2010 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.11</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448813000135/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Loan and Security Agreement, dated January 9, 2013, by and among Cross Country Healthcare, Inc. and certain of its subsidiaries, as Borrowers, the Lenders referenced therein, and Bank of America, N.A., as Agent (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated January 11, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.12</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514002739/exhibit101063014.htm"><font style="font-family:inherit;font-size:10pt;">Consent, Waiver and Third Amendment, dated as of June 30, 2014, to Loan and Security Agreement dated January 9, 2013, by and among Cross Country Healthcare, Inc. and certain of its subsidiaries, as Borrowers, the Lenders referenced therein, and Bank of America, N.A., as Agent (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated July 2, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.13</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448813000435/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Stock Purchase Agreement, dated February 2, 2013, by and among ICON Clinical Research, Inc. and ICON Clinical Research UK Limited, as Buyers, and Cross Country Healthcare, Inc., Local Staff, LLC and Cross Country Healthcare UK Holdco Ltd., as Sellers (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated February 5, 2013 and incorporated by reference herein.)</font></a></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX (CONTINUED)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.14</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752313005678/a50761154ex1_01.htm"><font style="font-family:inherit;font-size:10pt;">Asset Purchase Agreement, dated December 2, 2013, between Local Staff, LLC, as Buyer, Cross Country Healthcare, Inc., as Parent and On Assignment Staffing Services, Inc., Assignment Ready, Inc., and On Assignment, Inc., collectively as Seller (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated December 3, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.15 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514001083/exhibit1037.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement, dated March 3, 2014, between William J. Burns and Cross Country Healthcare, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 10-K for the year ended December 31, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.16</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514002462/assetpurchaseagreement.htm"><font style="font-family:inherit;font-size:10pt;">Asset Purchase Agreement, dated June 2, 2014, by and among Cross Country Healthcare, Inc., as Purchaser, and MSN Holdco, LLC, MSN Holding Company Inc., Medical Staffing Network Healthcare, LLC and Optimal Workforce Solutions, LLC, as Seller (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated June 3, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.17</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514002739/exhibit102063014.htm"><font style="font-family:inherit;font-size:10pt;">Second Lien Loan and Security Agreement, dated June 30, 2014, by and among Cross Country Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors, and BSP Agency, LLC, as agent (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated July 2, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.18</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514002739/exhibit103063014.htm"><font style="font-family:inherit;font-size:10pt;">Convertible Note Purchase Agreement, dated as of June 30, 2014, by and among Cross Country Healthcare, Inc. and certain of its domestic subsidiaries and Benefit Street Partners SMA LM L.P., PECM Strategic Funding L.P. and Providence Debt Fund III L.P. and other noteholders defined therein (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated July 2, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.19</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514004846/ccrn20140930-10qex10x1four.htm"><font style="font-family:inherit;font-size:10pt;">Fourth Amendment, dated as of October 20, 2014, to Loan and Security Agreement dated January 9, 2013, by and among Cross Country Healthcare, Inc. and certain of its subsidiaries, as Borrowers, the Lenders referenced therein, and Bank of America, N.A., as Agent (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.20 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000144530514001083/exhibit1038.htm"><font style="font-family:inherit;font-size:10pt;">Transition Agreement, dated March 3, 2014, between Emil Hensel and the Registrant (Previously filed as an exhibit to the Company&#8217;s Form 10-K for the year ended December 31, 2013 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.21</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/a901lease.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement, dated November 22, 1999, by and between Fairfax Boca 92, L.P. and Medical Staffing Network, Inc. (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.22</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment1.htm"><font style="font-family:inherit;font-size:10pt;">First Amendment to Lease Agreement by and between Fairfax Boca 92 L.P. and Medical Staffing Network, Inc., dated July 31, 2001 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.23</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment2.htm"><font style="font-family:inherit;font-size:10pt;">Second Amendment to Lease Agreement by and between Fairfax Boca 92 L.P. and Medical Staffing Network, Inc., dated March 20, 2002 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.24</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment3.htm"><font style="font-family:inherit;font-size:10pt;">Third Amendment to Lease Agreement by and between Fairfax Boca 92 L.P. and Medical Staffing Network, Inc., dated May 14, 2002 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment4.htm"><font style="font-family:inherit;font-size:10pt;">Fourth Amendment to Lease Agreement by and between Fairfax Boca 92 L.P. and Medical Staffing Network, Inc., dated December 13, 2002 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.26</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment5.htm"><font style="font-family:inherit;font-size:10pt;">Fifth Amendment to Lease Agreement by and between Fairfax Boca 92 L.P. and Medical Staffing Network, Inc., dated February 11, 2003 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.27</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment6.htm"><font style="font-family:inherit;font-size:10pt;">Sixth Amendment to Lease Agreement by and between Teachers Insurance and Annuity Association of America and Medical Staffing Network, LLC, dated January 3, 2011 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.28</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment7.htm"><font style="font-family:inherit;font-size:10pt;">Seventh Amendment to Lease Agreement by and between Teachers Insurance and Annuity Association of America and Medical Staffing Network, LLC, dated March 1, 2011 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828015001592/amendment8.htm"><font style="font-family:inherit;font-size:10pt;">Eighth Amendment to Lease Agreement by and between Teachers Insurance and Annuity Association of America,  and Medical Staffing Network, LLC, dated November 22, 2011 (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2014 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.30</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315002448/a51147331ex101.htm"><font style="font-family:inherit;font-size:10pt;">Second Amendment to Second Lien Loan and Security Agreement, dated July 22, 2015, by and among Cross Country Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors, the lenders party thereto, and BSP Agency, LLC, as agent (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated July 23, 2015 and incorporated by reference herein.)</font></a></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX (CONTINUED)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.31</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315002608/a51151557ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Agreement and Plan of Merger, dated as of July 27, 2015, by and among Cross Country Education, LLC, Cross Country Healthcare, Inc., CC Education, LLC and PES, Inc. (Previously filed as an exhibit to the Company's Form 8-K dated July 30, 2015 and incorporated by reference herein)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.32</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448815004495/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Fourth Amendment to Lease Agreement by and between Granite Meridian LLC and Cross Country Healthcare, Inc., dated September 29, 2015 (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated October 2, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.33</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448815004495/ccrn_ex102.htm"><font style="font-family:inherit;font-size:10pt;">Ninth Amendment to Lease Agreement by and between Mainstreet CV North 40, LLC and Cross Country Healthcare, Inc., dated September 29, 2015 (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated October 2, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.34</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000135448815004495/ccrn_ex103.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement by and between Mainstreet CV North 40, LLC and Cross Country Healthcare, Inc., dated September 29, 2015 (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated October 2, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.35</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003338/a51204669ex1_1.htm"><font style="font-family:inherit;font-size:10pt;">Stock Purchase Agreement, dated October 19, 2015, by and among Cross Country Healthcare, Inc. and Dennis Ducham, Emily Serebryany, Emily Serebryany Trust dated 4/16/14, Val Serebryany, and Val Serebryany Family Trust dated 2/18/14 (Previously filed as an exhibit to the Company's Form 8-K dated October 20, 2015 and incorporated by reference herein)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.36</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Asset Purchase Agreement between Mediscan, Inc. and Direct Ed Solutions, Inc. and Mihal Spiegel, dated August 19, 2014 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.37 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_2.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement between Cross Country Healthcare, Inc. and Dennis Ducham, dated October 30, 2015 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.38 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_3.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement between Cross Country Healthcare, Inc. and Val Serebryany, dated October 30, 2015 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.39 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_4.htm"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Agreement between Cross Country Healthcare, Inc. and New Mediscan Diagnostic Services, Inc., dated October 30, 2015 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.40</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_5.htm"><font style="font-family:inherit;font-size:10pt;">Lease Agreement between Golden Egg, LLC and Mediscan Staffing Services, dba Mediscan Diagnostics, Mediscan Therapy Inc., Direct Ed Solutions, and Direct Ed Specialized Services, dated August 4, 2015 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.41</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752315003645/a51213647ex10_6.htm"><font style="font-family:inherit;font-size:10pt;">First Amendment to Lease Agreement between Golden Egg, LLC and Mediscan Diagnostic Services, Mediscan Nursing Staffing, Direct Ed Solutions, and Direct Ed Specialized Services, dated October 30, 2015 (Previously filed as an exhibit to the Company's Form 8-K dated November 3, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.42</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828016012724/exhibit1043.htm"><font style="font-family:inherit;font-size:10pt;">Third Amendment to Lease Agreement between RNSI City Place Owner, LLC and Cejka Search, Inc., dated December 2, 2015 (Previously filed as an exhibit to the Company's Form 10-KA for the year ended December 31, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.43 #</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828016012617/ccrn20151231-10kex10x44.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement, dated as of March 9, 2016, between William J. Grubbs and the Registrant (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2015 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000165495416000542/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Credit Agreement, dated June 22, 2016, by and among Cross Country Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors, the Lenders referenced therein, and Suntrust Bank, as agent (previously filed as an exhibit to the Company's Form 8-K dated June 22, 2016 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.45</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828016020835/ccrn2016-09x30x10qex10x1.htm"><font style="font-family:inherit;font-size:10pt;">Tenth Amendment to Lease agreement between Mainstreet CV North 40, LLC and Cross Country Healthcare, Inc., dated September 19, 2016 (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2016 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.46</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828016020835/ccrn2016-09x30x10qex10x2.htm"><font style="font-family:inherit;font-size:10pt;">Amendment to Lease agreement between Mainstreet CV North 40, LLC and Cross Country Healthcare, Inc., dated September 19, 2016 (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2016 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.47</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828016020835/ccrn2016-09x30x10qex10x3.htm"><font style="font-family:inherit;font-size:10pt;">Amendment No. 2, dated October 31, 2016 to Convertible Note Purchase Agreement, dated June 30, 2014,among Cross Country Healthcare, Inc., the Guarantor subsidiaries of the Company named therein, and theNoteholders named therein (Previously filed as an exhibit to the Company&#8217;s Form 10-Q for the quarter ended September 30, 2016 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.48</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828017002153/ccrn20161231-10kex10x49.htm"><font style="font-family:inherit;font-size:10pt;">Amendment No. 3, dated December 27, 2016 to Convertible Note Purchase Agreement, dated June 30, 2014,among Cross Country Healthcare, Inc., the Guarantor subsidiaries of the Company named therein, and theNoteholders named therein (Previously filed as an exhibit to the Company's Form 10-K for the year ended December 31, 2016 and incorporated by reference herein.)</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX (CONTINUED)</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.49</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000165495417005530/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Asset Purchase Agreement, dated June 13, 2017, among Cross Country Healthcare, Inc., as Buyer,Advantage RN, LLC, Advantage On Call, LLC, Advantage Locums, LLC, and Advantage RN LocalStaffing, the Seller Parties, and Seller Representative (Previously filed as an exhibit to the Company's Form8-K dated June 13, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.50</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752317001917/a51584424ex10_2.htm"><font style="font-family:inherit;font-size:10pt;">Incremental Term Loan Agreement, dated July 1, 2017 to Credit Agreement, dated June 22, 2016, by andamong Cross Country Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors,Suntrust Bank, as lender, and Suntrust Bank, as agent (Previously filed as an exhibit to the Company's Form8-K dated July 6, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.51</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752317001917/a51584424ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Second Amendment to Credit Agreement, dated July 5, 2017 to Credit Agreement, dated June 22, 2016, byand among Cross Country Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors,the Lenders referenced therein, and Suntrust Bank, as agent (Previously filed as an exhibit to the Company'sForm 8-K dated July 6, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.52</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000165495417006891/ccrn_ex101.htm"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Credit Agreement, dated August 1, 2017 to Credit Agreement, by and among CrossCountry Healthcare, Inc., as borrower, certain of its domestic subsidiaries, as guarantors, the Lendersreferenced therein, SunTrust Bank, as Administrative Agent, Swingline Lender and an issuing bank; BMOHarris Bank, N.A. as Syndication Agent; and Bank United N.A. and Fifth Third Bank as Co-DocumentationAgents (Previously filed as an exhibit to the Company's Form 8-K dated August 2, 2017 and incorporated byreference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.53</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828017010809/ccrn2017-09x30x10qex10x1.htm"><font style="font-family:inherit;font-size:10pt;">Fourth Amendment to Lease Agreement between RNSI City Place Owner, LLC and Cejka Search, Inc.,dated May 31, 2017 (Previously filed as an exhibit to the Company's Form 10-Q for the quarter ended September 30, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.54 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000114420418003854/tv484120_ex10-1.htm"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Employment Agreement, dated January 28, 2018, between William J. Burns and Cross Country Healthcare, Inc. (Previously filed as an exhibit to the Company&#8217;s Form 8-K dated January 26, 2018 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.55 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018002702/ccrn20171231-10kex10x55.htm"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. Executive Nonqualified Excess Plan Adoption Agreement (Previously filed as an exhibit to the Company's Form 10-K dated December 31, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.56</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018002702/ccrn20171231-10kex10x56.htm"><font style="font-family:inherit;font-size:10pt;">ISDA Master Agreement between Wells Fargo Bank, N.A. and Cross Country Healthcare, Inc. dated as of February 14 2018 (with Schedule to the Master Agreement) (Previously filed as an exhibit to the Company's Form 10-K dated December 31, 2017 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.57</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018013356/ccrn20180930-10qex10x1.htm"><font style="font-family:inherit;font-size:10pt;">First Amendment to Amended and Restated Credit Agreement, dated October 30, 2018, by and among Cross Country Healthcare, Inc. as borrower, certain of its domestic subsidiaries as guarantors, the Lenders referenced therein, and SunTrust Bank, as agent (Previously filed as an exhibit to the Company's Form 10-Q for the quarter ended September 30, 2018 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.58 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000114420418048862/tv502647_ex10-1.htm"><font style="font-family:inherit;font-size:10pt;">Amendment to Employment Agreement, dated September 10, 2018, by and between Cross Country Healthcare, Inc. and William J. Grubbs (Previously filed as an exhibit to the Company's Form 8-K dated September 10, 2018 and incorporated by reference herein)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.59 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752319000077/a51926439ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Employment Agreement between Cross Country Healthcare, Inc. and Kevin C. Clark, dated January 16, 2019 (Previously filed as an exhibit to the Company's Form 8-K dated January 16, 2019 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.60 #</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000115752319000203/a51933754ex10_1.htm"><font style="font-family:inherit;font-size:10pt;">Amendment and Restatement to Employment Agreement, dated January 31, 2019, by and between Cross Country Healthcare, Inc. and William J. Burns (Previously filed as an exhibit to the Company's Form 8-K dated January 31, 2019 and incorporated by reference herein)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1141103/000162828018005923/ccrn2018-03x31x10qex14x1.htm"><font style="font-family:inherit;font-size:10pt;">Code of Ethics, revised February 2, 2016 (Previously filed as an exhibit to the Company's Form 10-Q for the quarter ended March 31, 2018 and incorporated by reference herein.)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*21.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex21x1.htm"><font style="font-family:inherit;font-size:10pt;">List of subsidiaries of the Registrant</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*23.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex23x1.htm"><font style="font-family:inherit;font-size:10pt;">Consent of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*31.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex31x1.htm"><font style="font-family:inherit;font-size:10pt;">Certification Pursuant to Rule&#160;13a-14(a)/15d-14(a) and pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 by Kevin C. Clark, President, Chief Executive Officer (Principal Executive Officer)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*31.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex31x2.htm"><font style="font-family:inherit;font-size:10pt;">Certification Pursuant to Rule&#160;13a-14(a)/15d-14(a) and pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXHIBIT INDEX (CONTINUED)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*32.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex32x1.htm"><font style="font-family:inherit;font-size:10pt;">Certification Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, by Kevin C. Clark, President, Chief Executive Officer (Principal Executive Officer)</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*32.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ccrn20181231-10kex32x2.htm"><font style="font-family:inherit;font-size:10pt;">Certification Pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</font></a></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:11%;"></td><td style="width:4%;"></td><td style="width:85%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.INS</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Instance Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.SCH</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Schema Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.DEF</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.LAB</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.CAL</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**101.PRE</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PRE XBRL Taxonomy Extension Presentation Linkbase Document</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">#&#160;          Represents a management contract or compensatory plan or arrangement</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Furnished herewith</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></div><hr style="page-break-after:always"><div><a name="scc66d8076f6a4f5eb748c248c1eff1d1"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 16.           Form 10-K Summary.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not applicable.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sD09787B80A835FEE8ED99E999DE1EBF0"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:47%;"></td><td style="width:6%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin C. Clark</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name: Kevin C. Clark</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title: President, Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal Executive Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: February&#160;28, 2019</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons in the capacities indicated and on the dates indicated:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Signature</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Title</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Date</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin C. Clark</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief Executive Officer</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kevin C. Clark</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Executive Officer)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President &amp; Chief Financial Officer </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Accounting and Financial Officer)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ W. Larry Cash</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">W. Larry Cash</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Thomas C. Dircks</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thomas C. Dircks</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Gale Fitzgerald</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gale Fitzgerald</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Darrell S. Freeman, Sr.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Darrell S. Freeman, Sr.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Richard M. Mastaler</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Richard M. Mastaler</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Mark Perlberg</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mark Perlberg</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Joseph A. Trunfio</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Director</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Joseph A. Trunfio</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></div><hr style="page-break-after:always"><div><a name="s1A493F1A0A845CF1B49E882404D18350"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:94%;"></td><td style="width:6%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cross Country Healthcare, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s34B9DAB6D4BA589CA18160AA38A3DC42"><font style="font-family:inherit;font-size:10pt;">Report of Independent Registered Public Accounting Firm</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s34B9DAB6D4BA589CA18160AA38A3DC42">F- 2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0C2F3B3D6BB057169F0AF62C353DC2FE"><font style="font-family:inherit;font-size:10pt;">Consolidated Balance Sheets as of December&#160;31, 2018 and 2017</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s0C2F3B3D6BB057169F0AF62C353DC2FE">F- 3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sDA23978B34D8550283170BC771CBE685"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Operations for the Years Ended December&#160;31, 2018, 2017, and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sDA23978B34D8550283170BC771CBE685">F- 4</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2C5D780A142B512F9645D34397217012"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Comprehensive (Loss) Income for the Years Ended December&#160;31, 2018, 2017, and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s2C5D780A142B512F9645D34397217012">F- 5</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sBF8851AC29145729816AA98A40BE7A9A"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Stockholders&#8217; Equity for the Years Ended December&#160;31, 2018, 2017, and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sBF8851AC29145729816AA98A40BE7A9A">F- 6</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sCA0F6574F28B535B8B4C5886FBE3B9AE"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 2018, 2017, and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sCA0F6574F28B535B8B4C5886FBE3B9AE">F- 7</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s42BB411B574A57D7B26A64FA62942F0A"><font style="font-family:inherit;font-size:10pt;">Notes to Consolidated Financial Statements</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s42BB411B574A57D7B26A64FA62942F0A">F- 8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statement Schedule</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sEAEB79AD829759D3B100335EBB82B8AF"><font style="font-family:inherit;font-size:10pt;">Schedule II &#8211; Valuation and Qualifying Accounts for the Years Ended December&#160;31, 2018, 2017, and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sEAEB79AD829759D3B100335EBB82B8AF">II- 1</a></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Schedules not filed herewith are either not applicable, the information is not material or the information is set forth in the consolidated financial statements or notes thereto.</font></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 1</font></div></div><hr style="page-break-after:always"><div><a name="s34B9DAB6D4BA589CA18160AA38A3DC42"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the Stockholders and the Board of Directors of </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on the Financial Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have audited the accompanying consolidated balance sheets of Cross Country Healthcare, Inc. and subsidiaries (the "Company") as of December 31, 2018 and 2017, the related consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2018, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2018 and 2017, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2018, in conformity with accounting principles generally accepted in the United States of America. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2018, based on criteria established in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 28, 2019, expressed an unqualified opinion on the Company's internal control over financial reporting.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:69%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ DELOITTE &amp; TOUCHE LLP</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 28, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have served as the Company's auditor since 2015.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 2</font></div></div><hr style="page-break-after:always"><div><a name="s0C2F3B3D6BB057169F0AF62C353DC2FE"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(amounts in thousands, except for share data)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable, net of allowances of $3,705 in 2018 and $3,688 in 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">166,128</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">173,603</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Insurance recovery receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,186</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,497</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,364</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">963</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">194,905</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">208,887</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,086</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">101,060</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">117,589</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,402</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,976</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-current deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,219</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,076</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,228</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">427,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">467,687</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">43,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,332</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,271</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,075</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,845</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,386</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94,588</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77,944</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">92,259</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term accrued claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,757</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,409</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,088</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,767</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,276</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">208,805</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">229,968</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Commitments and contingencies</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stockholders' equity:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160; Common stock&#8212;$0.0001 par value; 100,000,000 shares authorized; 35,625,692 and 35,838,108 shares issued and outstanding at December&#160;31, 2018 and 2017, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">303,048</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">305,362</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,462</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated deficit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(84,062</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(67,111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Cross Country Healthcare, Inc. stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">217,528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">237,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">670</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">630</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">218,198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">237,719</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities and stockholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">427,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">467,687</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 3</font></div></div><hr style="page-break-after:always"><div><a name="sDA23978B34D8550283170BC771CBE685"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(amounts in thousands, except per share data)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Direct operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606,921</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">636,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">611,802</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general, and administrative expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,230</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bad debt expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,204</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,828</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">829,364</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">853,300</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">827,353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other expenses (income):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,214</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,805</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,969</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,568</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(418</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(155</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(230</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,195</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,545</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">764</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.01</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,132</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,246</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 4</font></div></div><hr style="page-break-after:always"><div><a name="s2C5D780A142B512F9645D34397217012"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(amounts in thousands)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,731</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive (loss) income, before income tax:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized foreign currency translation (loss) gain</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized loss on interest rate contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(420</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification adjustment to interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(387</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Taxes on other comprehensive (loss) income:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit related to foreign currency translation adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit related to unrealized loss on interest rate contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(107</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense related to reclassification adjustment to interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive (loss) income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(297</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,014</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,877</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,697</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Net income attributable to noncontrolling interest in subsidiary</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive (loss) income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,588</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,933</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 5</font></div></div><hr style="page-break-after:always"><div><a name="sBF8851AC29145729816AA98A40BE7A9A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(amounts in thousands)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27"></td></tr><tr><td style="width:25%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Common Stock</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Additional<br>Paid-In Capital</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accumulated Other Total<br>Comprehensive Loss, net</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Accumulated Deficit) Retained Earnings</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Noncontrolling Interest in Subsidiary</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Stockholders&#8217; Equity</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dollars</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances at December&#160;31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31,952</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">254,108</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,207</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(112,056</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">496</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">141,344</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of share options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vesting of restricted stock and performance stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">284</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(917</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(917</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(34</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distribution to noncontrolling shareholder</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">764</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,731</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances at December&#160;31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">256,570</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(104,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">151,802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of share options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vesting of restricted stock and performance stock awards</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">282</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,774</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,774</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shares issued for Convertible Notes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,176</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45,951</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45,952</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cumulative-effect adjustment - share-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">535</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(535</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distribution to noncontrolling shareholder</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,218</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,218</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,513</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,802</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances at December&#160;31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,838</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">305,362</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,166</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(67,111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">630</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">237,719</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Exercise of share options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vesting of restricted stock and performance stock awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">199</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock repurchase and retirement</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(432</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustment, net of taxes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net change in hedging transaction, net of taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(175</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(175</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distribution to noncontrolling shareholder</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,234</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,717</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balances at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35,626</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">303,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,462</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(84,062</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">670</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">218,198</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 6</font></div></div><hr style="page-break-after:always"><div><a name="sCA0F6574F28B535B8B4C5886FBE3B9AE"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(amounts in thousands)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from operating activities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,717</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38,802</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,731</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,780</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of debt discount and debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">448</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">651</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,728</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for allowances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,974</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,705</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,034</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deferred income tax benefit </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(33,812</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,581</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,805</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Impairment charges</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,423</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,356</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on early extinguishment of debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,969</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,568</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other non-cash costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,231</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">775</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Changes in operating assets and liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,820</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,708</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,781</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid expenses and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,816</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,882</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,095</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,275</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,370</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">847</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(143</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,997</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">45,508</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30,145</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,930</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(85,977</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,900</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-related settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,858</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Purchases of property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,597</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,111</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,522</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(91,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash flows from financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Proceeds from Term Loans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Principal payments on Term Loans</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16,124</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(30,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible Note cash payment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Borrowings on revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">39,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Repayments on revolving credit facility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(67,800</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(901</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Extinguishment fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(578</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(641</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock repurchase and retirement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,335</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,841</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net cash (used in) provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,767</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of exchange rate changes on cash</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,518</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,907</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,177</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents at beginning of year</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,537</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,630</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash and cash equivalents at end of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20,630</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Supplemental disclosure of cash flow information:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,340</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,893</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income taxes paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,773</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 7</font></div></div><hr style="page-break-after:always"><div><a name="s42BB411B574A57D7B26A64FA62942F0A"></a></div><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sD34C35033AFD5B1587865453E3C7AE1A"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization and Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Business </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. (the Company) was incorporated in Delaware on July 29, 1999 as a business providing travel nurse and allied health staffing services. As of December 31, 2018, the Company is a leading national provider of nurse and allied staffing, recruiting, and value-added workforce solution services, multi-specialty locum tenens (temporary physician staffing) services, as well as a provider of other human capital management services focused on healthcare.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its direct and indirect wholly-owned subsidiaries. The consolidated financial statements include all assets, liabilities, revenue, and expenses of Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), which is controlled by the Company but not wholly owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation. See consolidated balance sheets and consolidated statements of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity and Operations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon current projections, the Company will not satisfy the required leverage ratio under its Credit Agreement as of March 31, 2019. As a result, a debt prepayment of between $10 million and $12 million would be required to remain in compliance. The Company believes such prepayment will be sufficient to maintain compliance with the leverage ratio covenant and meet its obligations for the next twelve months. In the event actual results differ significantly from current projections, the Company may be required to make additional debt prepayments. Further, the Company may be able to amend its Credit Agreement, and as a result, would not be required to make any debt prepayments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sE01B9A23D5E5524A98FD00F2E0F892D1"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles (U.S. GAAP), requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation, and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) fair value of interest rate swap agreement; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers all investments with original maturities of three months or less to be cash and cash equivalents. The Company invests its excess cash in highly rated overnight funds and other highly rated liquid accounts. The Company is exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions, and diversifying its counterparties. The Company does not currently anticipate nonperformance by any of its significant counterparties.</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Interest income on cash and cash equivalents of </font><font style="font-family:inherit;font-size:9.75pt;">$0.4 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;for the year ended December 31, 2018, and </font><font style="font-family:inherit;font-size:9.75pt;">$0.1 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;for the years ended December 31, 2017 and 2016, is included in other income, net, on the Company&#8217;s consolidated statements of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Accounts receivable potentially subject the Company to concentrations of credit risk. The Company&#8217;s customers are primarily healthcare providers, and accounts receivable represent amounts due from them. The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables resulting from the inability of its customers to make required payments, which results in a provision for bad debt expense. The adequacy of this allowance is determined by continually evaluating individual customer receivables, considering the customer's financial condition, credit history, and current economic conditions. The Company writes off specific</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">accounts based on an ongoing review of collectability as well as past experience with the customer. </font><font style="font-family:inherit;font-size:10pt;">In addition, the Company maintains a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:9.75pt;">15</font><font style="font-family:inherit;font-size:9.75pt;">&#32;to </font><font style="font-family:inherit;font-size:9.75pt;">60</font><font style="font-family:inherit;font-size:9.75pt;">&#32;days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's business activity is with hospitals located throughout the United States. No single customer accounted for more than 10% of the Company&#8217;s accounts receivable balance as of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, or revenue for the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Prepaid Rent and Deposits</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company leases apartments for eligible field employees under short-term agreements (typically </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;">&#32;to </font><font style="font-family:inherit;font-size:9.75pt;">six</font><font style="font-family:inherit;font-size:9.75pt;">&#32;months), which generally coincide with each employee&#8217;s staffing contract. Costs relating to these leases are included in direct operating expenses on the accompanying consolidated statements of operations. As a condition of these agreements, the Company may place security deposits on the leased apartments. Deposits on field employees&#8217; apartments related to these short-term agreements are included in other current assets on the accompanying consolidated balance sheets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property and Equipment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;">&#32;to </font><font style="font-family:inherit;font-size:9.75pt;">seven</font><font style="font-family:inherit;font-size:9.75pt;">&#32;years. Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the individual lease. On an annual basis, the Company reviews its property and equipment listings and disposes of assets that are no longer in use. </font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Certain software development costs have been capitalized in accordance with the provisions of the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other/Internal-Use Software</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). Such costs include charges for consulting services and costs for Company personnel associated with programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is ready for use and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;">&#32;to </font><font style="font-family:inherit;font-size:9.75pt;">five</font><font style="font-family:inherit;font-size:9.75pt;">&#32;years.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company applies accounting in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the FASB ASC when it acquires control over a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded as acquisition and integration costs; noncontrolling interests, if any, are reflected at fair value at the acquisition date; restructuring costs associated with a business combination are expensed; contingent consideration is measured at fair value at the acquisition date, with changes in the fair value after the acquisition date affecting earnings; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the consolidated statements of operations of the combined entity beginning on the date of acquisition. See Note 4 - Acquisitions.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill, Trade Names, and Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable intangible assets of businesses acquired. Other identifiable intangible assets with definite lives are being amortized using the straight-line method over their estimated useful lives which range from </font><font style="font-family:inherit;font-size:9.75pt;">1</font><font style="font-family:inherit;font-size:9.75pt;">&#32;to </font><font style="font-family:inherit;font-size:9.75pt;">16</font><font style="font-family:inherit;font-size:9.75pt;">&#32;years. Goodwill and certain intangible assets with indefinite lives are not amortized. Instead, in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the FASB ASC, these assets are reviewed for impairment annually at the beginning of the fourth quarter, and whenever circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">When reviewed, the Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, as a basis for determining whether it is necessary to perform the quantitative testing. If it is determined that a quantitative test is necessary or more efficient than a qualitative approach, the Company generally measures the fair value of its reporting units using a combination of income and market approaches.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">For the periods prior to the fourth quarter of 2017, the performance of the quantitative impairment test involved a two-step process. The first step required the Company to determine the fair value of each of its reporting units and compare it to the reporting unit&#8217;s carrying amount. If the reporting unit's fair value was less than its carrying amount, the Company was required to perform a second step to calculate the implied value of goodwill. The implied value was then compared to its carrying amount to calculate the impairment charge, if any. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Beginning in the fourth quarter of 2017, for its annual review on October, 1, 2017, the Company early adopted the provisions of Accounting Standards Update (ASU) 2017-04, </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. </font><font style="font-family:inherit;font-size:9.75pt;">Under ASU 2017-04, the second step of the quantitative assessment is eliminated, and, if the reporting unit&#8217;s carrying value exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value not to exceed the total amount of goodwill allocated to that reporting unit. Additionally, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss is considered, if applicable.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company determines its reporting units by identifying its operating segments and any component businesses and aggregates the components businesses if they have similar economic characteristics. The Company had the following reporting units that it reviewed for impairment: 1) Nurse and Allied Staffing; 2) Physician Staffing; and 3) Search.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. However, fair values that could be realized in an actual transaction may have differed from those used to evaluate the potential impairment of goodwill.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Long-lived assets and identifiable intangible assets with definite lives are evaluated for impairment in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Property, Plant, and Equipment</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the FASB ASC. In accordance with this Topic, long-lived assets and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Recoverability of long-lived assets is measured by a comparison of the carrying amount of the asset group to the future undiscounted net cash flow that is expected to be generated by those assets. If such assets are considered to be impaired, the impairment charge recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Any related impairment losses are recognized in earnings and included in the caption impairment charges on the consolidated statements of operations. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Debt Discount and Debt Issuance Costs </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Stated discounts on proceeds, and other fees reimbursed to lender, as well as the initial value of any embedded derivative features of the Convertible Notes and Term Loans, as defined in Note 8 - Debt, are treated as a discount associated with the respective debt instrument and presented in the balance sheet as an offset to the carrying amount of the debt. Discounts are amortized to interest expense using the effective interest rate method, or a method that approximates the effective interest rate method, over the expected life of the debt.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Convertible Notes and the Term Loans were capitalized and are presented in the balance sheet as a direct deduction from the carrying amount of the debt liability. Deferred costs are amortized using the effective </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">interest method. Deferred costs related to the Convertible Notes were written off in connection with the repayment of such Convertible Notes. See Note 8 - Debt. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Company&#8217;s Revolving Credit Facilities, as defined in Note 8 - Debt, have been capitalized and included in other assets on the consolidated balance sheets, and amortized using the straight line method over the term of the related credit agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to interest rate risk due to its outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, the Company has entered into an interest rate swap agreement to effectively convert a portion of its variable interest payments to a fixed rate. The principal objective of the interest rate swap is to eliminate or reduce the variability of the cash flows in those interest payments associated with the Company&#8217;s long-term debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company has determined that the interest rate swap qualifies as a cash flow hedge in accordance with ASC 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">. As the critical terms of the hedging instrument and the hedged forecasted transaction are the same, the Company has concluded that changes in the cash flows attributable to the risk being hedged are expected to completely offset at inception and on an ongoing basis. Changes in the fair value of an interest rate swap agreement designated as a cash flow hedge are recorded as a component of accumulated other comprehensive income (loss), net of deferred taxes, within stockholders&#8217; equity and are amortized to interest expense over the term of the related debt as the interest payments are made. Interest rate swap payments are included in net cash provided by operating activities on the Company&#8217;s consolidated statement of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with entering into the interest rate swap agreement, the Company early adopted ASU 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative and Hedging (Topic 815) </font><font style="font-family:inherit;font-size:10pt;">to simplify the application of hedge accounting. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates embedded conversion features within its convertible debt in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value. Changes in the fair value of these derivatives during each reporting period were reported in other expenses (income) on the consolidated statements of operations. The fair value at inception had been recorded as debt discount and was being amortized to interest expense over the term of the note using the effective interest method. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sales and Other State Non-income Tax Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company accrues sales and other state non-income tax liabilities based on the Company&#8217;s best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company&#8217;s business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Insurance Claims</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company provides workers&#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for eligible employees. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using the Company&#8217;s loss history as well as industry statistics. The healthcare insurance accrual is for estimated claims that have occurred but have not been reported and is based on the Company&#8217;s historical claim submission patterns. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported as well as unfavorable claims development.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Other Expenses/Insurance Costs</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the FASB ASC previously issued authoritative accounting guidance in the area of insurance contracts and related activity thereto. This topic concluded that, under circumstances such as in the Company&#8217;s insured professional liability and workers' compensation policies, since a right of legal offset does not exist due to the fact that there are three parties to an incurred claim, the insured, the insurer, and the claimant, the related liability to the claimant should be classified separately on a gross basis with a separate related receivable from the insurer recognized as being due from insurance carriers. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Accordingly, the Company&#8217;s consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">&#32;reflect the related short-term liabilities in accrued compensation and benefits and the related</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">long-term liabilities as long-term accrued claims, and the short-term receivable portion as insurance recovery receivable and the long-term portion as non-current insurance recovery receivable. See Note 7 - Balance Sheet Details. The ultimate cost of workers&#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved by the Company for those claims.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Workers&#8217; compensation benefits are provided under a partially self-insured plan. The Company has letters of credit to guarantee payments of claims. At </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the Company had outstanding approximately </font><font style="font-family:inherit;font-size:9.75pt;">$18.8 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">$19.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, respectively, of standby letters of credit as collateral to secure the self-insured portion of this plan.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has occurrence-based primary professional liability policies that provide the Company and each working professional in its nurse and allied healthcare business with coverage. Effective January 1, 2016, the Company has a claims-made professional liability policy for its physicians and advanced practitioners, with a </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;self-insured retention per claim. Prior to January 1, 2016, the Company had an occurrence-based professional liability policy for its independent contractor physicians and advanced practitioners which was insured by a wholly-owned subsidiary, Jamestown Indemnity, Ltd., a wholly-owned Cayman Island captive company (the Captive), until its voluntary liquidation in the third quarter of 2015. Beginning in March 2015, the Company's Physician subsidiary self-insured </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;for each of its professional liability claims. Under the terms of the Captive&#8217;s reinsurance policy there was a requirement to guarantee the payment of claims to its insured party&#8217;s primary medical malpractice insurance carrier via a letter of credit. As a result of the Captive's liquidation, the letter of credit was reduced. As of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the value of the letter of credit was </font><font style="font-family:inherit;font-size:9.75pt;">$1.8 million</font><font style="font-family:inherit;font-size:9.75pt;">&#32;and </font><font style="font-family:inherit;font-size:9.75pt;">$2.0</font><font style="font-family:inherit;font-size:9.75pt;">&#32;million, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Subject to certain limitations, the Company also has umbrella liability coverage for its working nurses and allied healthcare professionals. While this umbrella coverage does not extend to professional liability claims against its independent contractor physicians and advanced practitioners, it does cover claims brought against all of the Company&#8217;s subsidiaries for non-patient general liability.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2018, the Company adopted ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2014-09 introduces a new five-step revenue recognition model in which an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. See Note 3 - Revenue Recognition for additional accounting policy and related disclosures. The Company elected to adopt the standard using a modified retrospective method, which only impacts contracts not completed as of December 31, 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from the Company&#8217;s services is recognized when control of the promised services are transferred to the Company&#8217;s customers, in an amount that reflects the consideration it expects to receive in exchange for the service. The Company has concluded that transfer of control of its staffing services, which represents the majority of its revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the nature, amount, timing, and uncertainty of revenue and cash flows from which the Company generates revenue.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Temporary Staffing Revenue</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by the Company&#8217;s field staff. The Company recognizes the majority of its revenue at the contractual amount the Company has the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;">&#32;days. Accounts receivable includes estimated revenue for employees&#8217; and independent contractors&#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, the Company's estimate of amounts that had been worked but had not been billed totaled </font><font style="font-family:inherit;font-size:10pt;">$44.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$41.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and are included in accounts receivable on the consolidated balance sheets.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Service Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers other optional services to its customers that are transferred over time including: managed service programs (MSP) providing agency services (as further described below in Gross versus Net Policies), recruitment process outsourcing (RPO), other outsourcing services, and retained search services, which is less than </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;">&#32;of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. The Company does not, in the ordinary course of business, offer warranties or refunds.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Gross Versus Net Policies</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Managed Service Programs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has certain contracts with healthcare facilities to provide comprehensive services through its MSPs. Under these contractual arrangements, the customer&#8217;s orders are filled with either one of the Company's healthcare professionals or a third party's healthcare professionals (subcontractors).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When its healthcare professional is staffed, the Company determined that it acts as a principal in the arrangement, as it is considered the employer of record. Accordingly, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Alternatively, the Company determined that it acts as an agent in the arrangement when a subcontracted healthcare professional is staffed, as the Company does not control the services before they are transferred to the customer. Accordingly, revenue is reported on a net basis on the consolidated statements of operations. The customer is invoiced for the hours worked by the subcontracted healthcare professional multiplied by the hourly bill rate. A subcontractor liability, which is recognized as a reduction of revenue, is established in accrued expenses for the invoiced amount, net of an administrative fee, and is generally payable after the Company has received payment from its customer. The Company&#8217;s administrative fee is calculated as a percentage of the customer&#8217;s invoice and is recognized over time as the services are rendered by the subcontracted healthcare professional. The Company does not collect or recognize an upfront placement fee.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Physician Staffing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Physician Staffing business has contracts with its healthcare customers to provide temporary staffing services. The Company uses independent contractors for these services. The Company determined that it acts as a principal in these arrangements and, therefore, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 3 - Revenue Recognition for the Company's revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract Costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All contract fulfillment costs are expensed as incurred to direct operating expenses. With respect to FASB ASC 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, there were no contract assets or material contract liabilities as of December 31, 2018 and 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Practical Expedients and Exemptions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s contracts that have an original duration of one year or less, the Company uses the practical expedients and has elected to recognize any incremental costs of obtaining these contracts as expensed when incurred. Further, the Company </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">does not disclose the value of unsatisfied performance obligations for: (i) contracts with an original expected length of one year or less, and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has, from time to time, granted stock options, stock appreciation rights, performance-based stock awards, and restricted stock for a fixed number of common shares to employees. In accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Compensation-Stock-Compensation</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Topic of the FASB ASC, companies may choose from alternative valuation models. The Company used the Black-Scholes method of valuing its options and stock appreciation rights. The Company has elected to recognize compensation expense on a straight-line basis over the requisite service period of the entire award. The Company values its restricted stock awards and the fair value of its performance-based stock awards by reference to its stock price on the date of grant.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company granted performance-based stock awards to certain key personnel pursuant to its 2014 Omnibus Incentive Plan, amended and restated on May 23, 2017 (2017 Plan) as described in Note 14 - Stockholders' Equity. Pursuant to the plan, the number of target shares that vest are determined based on the level of attainment of the targets.&#160;If a minimum level of performance is attained for the awards, restricted stock is issued based on the level of attainment. The Company recognizes performance-based restricted stock as compensation expense based on the most likely probability of attaining the prescribed performance and over the requisite service period beginning at its grant date and through the date the restricted stock vests.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Compensation expense related to share-based payments is included in selling, general and administrative expenses in the consolidated statements of operations, and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$3.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$4.1</font><font style="font-family:inherit;font-size:9.75pt;">&#32;million, and </font><font style="font-family:inherit;font-size:9.75pt;">$3.4</font><font style="font-family:inherit;font-size:9.75pt;">&#32;million, during the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively. See Note 14 </font><font style="font-family:inherit;font-size:10pt;">-</font><font style="font-family:inherit;font-size:9.75pt;">&#32;Stockholders&#8217; Equity.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s advertising expense consists primarily of online advertising, internet direct marketing, print media, and promotional material. Advertising costs are expensed as incurred and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$6.7 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$7.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">$10.2</font><font style="font-family:inherit;font-size:9.75pt;">&#32;million, for the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring Costs</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring costs on the consolidated statements of operations include on-going benefit costs for its employees, exit costs, and other costs including write-offs related to abandoned locations.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Reconciliations of the beginning and ending total restructuring liability balances are presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:27%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">338</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Charged to restructuring costs (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(1,131</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(235</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(760</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(336</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(282</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(255</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) The restructuring costs on the consolidated statements of operations include direct write-offs of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to abandoned locations, as well as other costs of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Rent</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred rent consists of free rent, rent escalation, tenant improvement allowances, and other incentives received from landlords related to the operating leases for our facilities. Rent escalation represents the difference between actual operating lease payments due and straight-line rent expense, which we record over the term of the lease. The excess is recorded as a deferred credit in the early periods of the lease, when cash payments are generally lower than straight-line rent expense, and is reduced in the later periods of the lease when payments begin to exceed the straight-line expense. Tenant allowances from landlords for tenant improvements are generally comprised of cash received from the landlord or paid on our behalf as part of the negotiated terms of the lease. These tenant improvement allowances and other leasehold incentives are recorded when realizable as deferred rent and are amortized as a reduction of periodic rent expense, over the term of the applicable lease. See Note 12 - Commitments and Contingencies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for income taxes under the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes in its financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. The Company considers all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. It considers cumulative losses in recent years as well as the impact of one-time events in assessing its pre-tax earnings. Assumptions regarding future taxable income require significant judgment. The Company's assumptions are consistent with estimates and plans used to manage its business, which includes restructuring and other initiatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that actual results differ from these estimates, or the Company adjusts these estimates in future periods for current trends or changes in its estimating assumptions, it may modify the level of the valuation allowance which could materially impact its business, financial condition and results of operations. The Company will continue to assess the realizability of its deferred tax assets. See Note 13 - Income Taxes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total comprehensive income (loss) includes net income or loss, foreign currency translation adjustments, and net change in derivative transactions, net of any related deferred taxes. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying consolidated balance sheets and was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at December 31, 2018 and </font><font style="font-family:inherit;font-size:10pt;">$1.2</font><font style="font-family:inherit;font-size:10pt;">&#32;million at December&#160;31, 2017. The cumulative impact of net changes in derivative instruments included in other comprehensive loss in the consolidated balance sheets was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at December 31, 2018. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax impact related to components of other comprehensive income for the period ended December 31, 2018 is reflected on the consolidated statements of comprehensive income. During the period ended December 31, 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of income tax expense was included in the consolidated statements of operations due to the impact of a change in federal tax rate on the deferred tax asset related to foreign currency cumulative translation. See Note 13 - Income Taxes. There was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;income tax impact related to foreign currency translation adjustments for the period ended December&#160;31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company complies with the provisions of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, which defines fair value, establishes a framework for measuring fair value under U.S. GAAP, and expands disclosures about fair value measurements. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s financial assets and liabilities required to be measured on a recurring basis were its deferred compensation liability, its interest rate swap agreements, and its contingent consideration liabilities. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the requirements of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, basic earnings per share is computed by dividing net income available to common shareholders (numerator) by the weighted average number of vested unrestricted common shares outstanding during the period (denominator). Diluted earnings per share gives effect to all dilutive potential common shares outstanding during the period including stock appreciation rights and options and unvested restricted stock, as calculated utilizing the treasury stock method, and Convertible Notes using the if-converted method prior to their payment in full in the first quarter of 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted for all entities, including adoption in an interim period. The Company is currently in the process of evaluating the potential impact the adoption of this standard may have and expects to adopt this standard in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, and should be applied either prospectively or retrospectively depending on the nature of the disclosure. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company is currently in the process of evaluating this standard and expects to adopt the full provisions in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the FASB issued ASU No. 2017-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception</font><font style="font-family:inherit;font-size:10pt;">. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and should be applied retrospectively to outstanding financial instruments with a down round feature by means of either a cumulative-effect adjustment or for each prior reporting period presented. Early adoption is permitted for all entities, including adoption in an interim period. The Company </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2. Summary of Significant Accounting Policies (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">expects to adopt this standard in its first quarter of 2019, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. The FASB has issued several other subsequent updates including the following: 1) ASU No. 2018-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases</font><font style="font-family:inherit;font-size:10pt;">, which includes sixteen separate narrow-scope amendments to clarify the codification and to correct unintended application of guidance; and 2) ASU No. 2018-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842): Targeted Improvements</font><font style="font-family:inherit;font-size:10pt;">, which provides entities with relief from the costs of implementing certain aspects of the new leasing standard by allowing them to elect not to recast the comparative periods presented when transitioning to ASC 842. The new lease standard, and the subsequent ASUs that modified Topic 842, are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the adoption of the new standard, as of December 31, 2018, the Company had </font><font style="font-family:inherit;font-size:10pt;">$34.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of undiscounted future lease payments, primarily related to real estate, that is expected to be included in its initial measurement of its lease liabilities and corresponding right of use asset, and </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of accrued rent that is expected to be reclassified from liability accounts to reduce its beginning right of use asset balance.&#160;The Company does not expect the adoption of ASU 2016-02 to have a material impact on its consolidated statements of operations and statements of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><a name="s98bbf41d1e564154b26fac7f868310c4"></a></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has determined that its revenues are generated from temporary staffing services and other services, as disaggregated in the following table. See Note 2 - Summary of Significant Accounting Policies.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:34%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the year ended December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse<br>And Allied<br>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician<br>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human<br>Capital<br>Management<br>Services Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary Staffing Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782,414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,867</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,326</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,070</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sA7FEEC702EC15B83B77F65C4BC66CF49"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">American Personnel, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2018, the Company completed the acquisition of American Personnel, Inc. (AP Staffing) for a total purchase price of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, subject to a net working capital adjustment. Based in Boston, AP Staffing offers a range of talent management solutions to its healthcare clients primarily in Massachusetts, including permanent placement, consultative staffing solutions, and traditional staffing.   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assigned a total of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to definite life intangible assets with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years. The remaining excess purchase price over the fair value of net assets acquired of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was recorded as goodwill, which is not deductible for tax purposes since this was a stock acquisition. Associated acquisition-related costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and have been included in acquisition and integration costs on the Company's consolidated statement of operations for the year ended December 31, 2018.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, using the acquisition method of accounting. AP Staffing's results of operations are included in the consolidated statements of operations from December 1, 2018 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Acquisitions (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advantage RN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective July 1, 2017, the Company acquired all of the assets of Advantage RN, LLC and its subsidiaries (collectively, Advantage) for cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$86.6 million</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired. The total purchase price of </font><font style="font-family:inherit;font-size:10pt;">$88.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was subject to a net working capital reduction of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at the closing and an additional </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was received during the third quarter of 2017 as the final adjustment for net working capital. Additionally, </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price was deferred as of the closing and is due the seller within </font><font style="font-family:inherit;font-size:10pt;">20 months</font><font style="font-family:inherit;font-size:10pt;">, less any COBRA and healthcare payments incurred by the Company on behalf of the seller. As of December 31, 2018, approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;has been paid for claims and the remaining </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;liability is included in other current liabilities on the Company&#8217;s balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in the amount paid at closing were two escrow accounts, the first was </font><font style="font-family:inherit;font-size:10pt;">$14.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;which related to tax liabilities and the second was </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;which was to cover any post-close liabilities. On July 28, 2017, </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the tax liabilities was released from escrow, leaving a balance of </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">. In the first quarter of 2019, </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the post-close liabilities was released from escrow, leaving a balance of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to cover pending post-close liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company financed the purchase using </font><font style="font-family:inherit;font-size:10pt;">$19.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in available cash and </font><font style="font-family:inherit;font-size:10pt;">$66.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in borrowing under its Credit Facility, including a </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;incremental term loan, which was subsequently refinanced on August 1, 2017. See Note 8 - Debt for further information. The transaction was treated as a purchase of assets for income tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advantage is primarily a travel nurse staffing company that deploys many of its nurses through MSPs and Vendor Management Systems, and Advantage maintains direct relationships with many hospitals throughout the United States. This was a strategic acquisition to help the Company fill its recent MSP contract wins and for revenue growth.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, using the acquisition method of accounting. As such, the amounts of revenue and contribution income included in the Company's consolidated income statement from the acquisition date to the period ended December 31, 2017 were </font><font style="font-family:inherit;font-size:10pt;">$47.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The acquisition results have been substantially aggregated with the Company's Nurse and Allied Staffing business segment. See Note 17 - Segment Data.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is the estimated fair value of the purchase price for Advantage on July 1, 2017:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net working capital adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price was allocated to the assets acquired and the liabilities assumed based on the estimated fair value at the date of acquisition. The Company used a third-party appraiser to assist with the determination of the fair value and estimated useful lives of certain acquired assets and liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Acquisitions (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is an estimate of the fair value of the assets acquired and liabilities assumed on July 1, 2017.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,396</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">392</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,900</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assigned the following values to other identifiable intangible assets: </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to trade names with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years, </font><font style="font-family:inherit;font-size:10pt;">$13.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to customer relationships with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years, </font><font style="font-family:inherit;font-size:10pt;">$11.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to a database, consisting of healthcare professionals, with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years, and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to non-compete agreements with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;">&#32;years, for a total of </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in definite life intangible assets with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining excess purchase price over the fair value of net assets acquired of </font><font style="font-family:inherit;font-size:10pt;">$43.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was recorded as goodwill, which is deductible for tax purposes. Associated acquisition-related costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and have been included in acquisition and integration costs on the Company's consolidated statements of operations for the year ended December 31, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pro Forma Financial Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma financial information approximates the consolidated results of operations of the Company as if the Advantage acquisition had occurred as of January 1, 2016, after giving effect to certain adjustments, including additional interest expense on the amount the Company borrowed on the date of the transaction, the amortization of acquired intangible assets, and the elimination of certain expenses that will not be recurring in post-acquisition periods, net of an estimated income tax impact. These adjustments include removing transaction-related expenses of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the year ended December 31, 2017. These results are not necessarily indicative of future results as they do not include incremental investments in support functions, elimination of costs for integration or operating synergies, or an estimate of any impact on interest expense resulting from the operating cash flow of the acquired businesses, among other adjustments that could be made in the future but are not factually supportable on the date of the transaction. </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Acquisitions (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.83040935672514%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(unaudited, amounts in thousands except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">916,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934,904</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,255</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">US Resources Healthcare</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">, with a maximum of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for 2017, </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for 2018, and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for 2019, based on attainment of specific performance criteria achieved in each of those years. In the fourth quarter of 2017, the Company recognized a decrease in the fair value of the liability of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;included as acquisition-related contingent consideration on its consolidated statements of operations. The adjustment was driven by the decrease in the projected USR 2018 and 2019 revenue and EBITDA amounts. The earnout for 2017 was not achieved. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets and Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mediscan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash (</font><font style="font-family:inherit;font-size:10pt;">$28.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;plus working capital estimate) and </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in shares (or </font><font style="font-family:inherit;font-size:10pt;">349,871</font><font style="font-family:inherit;font-size:10pt;">&#32;shares) of the Company's Common Stock, and a net working capital adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.3</font><font style="font-family:inherit;font-size:10pt;">&#32;million was settled in the first quarter of 2016. Additionally, an amount of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price that was held in escrow to cover any post-closing liabilities, was released to the sellers on May 3, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement also specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;">, with </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and, as of September 30, 2017, the Company</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">determined that the second year earnout would not be achieved for 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per year and 2019 is uncapped. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the remaining obligations was estimated at </font><font style="font-family:inherit;font-size:10pt;">$7.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and is included in other current liabilities and contingent consideration on the consolidated balance sheets. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4. Acquisitions (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Medical Staffing Network</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was deferred and due to the seller </font><font style="font-family:inherit;font-size:10pt;">21 months</font><font style="font-family:inherit;font-size:10pt;">&#32;from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period. The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sC81CE25DFC395B28A9F3C8A327AB041B"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5. Goodwill, Trade Names, and Other Intangible Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br>Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br>Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br>Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br>Carrying<br>Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,909</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,758</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,524</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,912</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,612</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,183</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">878</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,487</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,068</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,092</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,976</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,584</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,678</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, fully amortized intangible assets, along with the related accumulated amortization, were removed from the table above. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:82%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,535</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,131</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,677</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,628</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5. Goodwill, Trade Names, and Other Intangible Assets (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment are as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:37%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Allied Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate goodwill acquired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">347,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">410,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,375</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(283,107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,141</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,030</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,589</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes to aggregate goodwill in 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charge</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Aggregate goodwill acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,835</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,060</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired from the acquisition of AP Staffing. See Note 4 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2018 and 2017 Impairment Charges</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company performed its annual quantitative impairment test of goodwill and other indefinite-lived intangible assets as of October 1, 2018 and 2017. Upon completion of the impairment testing for both years, it was determined that the estimated fair value of the Physician Staffing reporting unit&#8217;s trade name was less than its carrying amount resulting in impairment. For its goodwill impairment testing, with the exception of its Physician Staffing reporting unit, the estimated fair value of its reporting units exceeded their respective carrying values. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projections of revenue, operating costs, and expected cash flows of each reporting unit are inputs into the quantitative testing for goodwill and intangible assets. The Company reduced its long-term revenue forecast for the Physician Staffing business segment in the fourth quarter of 2018 and 2017. The lower than expected revenue was driven by lower booking volumes, partly due to the loss of customers. In addition, margins of the reporting unit were negatively impacted from continued investments in the business. As a result, during the fourth quarter of 2018 and 2017 the Company recorded non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to its trade name and </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to goodwill during the fourth quarter. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the impairment testing as of October 1, 2018, the Company reassessed the Physician Staffing brand's indefinite-life classification and determined it had characteristics that indicated a definite-life assignment was more appropriate. Effective October 1, 2018, the trade name, with a carrying value of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;after impairment charges, that was previously assigned an indefinite life was assigned a finite life of </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;years. During the three months ended December 31, 2018, the amortization expense related to this trade name was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 22</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5. Goodwill, Trade Names, and Other Intangible Assets (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Impairment Charges</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company performed its annual impairment test as of October 1, 2016. Upon completion of the impairment testing, the Company determined that no impairment of goodwill, trade names, or other intangible assets was warranted.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During an evaluation of goodwill, trade names, and other intangible assets at June 30, 2016, the Company determined that indicators were present in the Physician Staffing reporting unit which would suggest the fair value of the reporting unit may have declined below its carrying value. The Physician Staffing reporting unit was under-performing relative to management&#8217;s expectations. The lower than expected revenue was driven by lower booking volumes partly due to the loss of customers, and margins were negatively impacted from continued investments in the business all through the first half of 2016. The Company considered these factors to be impairment indicators that warranted impairment testing of goodwill, trade names, and other intangible assets. The interim impairment testing resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the interim impairment testing was performed which resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the Company recorded a non-cash impairment charge totaling </font><font style="font-family:inherit;font-size:10pt;">$24.3 million</font><font style="font-family:inherit;font-size:10pt;">: </font><font style="font-family:inherit;font-size:10pt;">$17.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to goodwill, </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to trade names, and </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to customer relationships.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Quantitative Methods and Assumptions</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Trade Names</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Relief From Royalty methodology was utilized to value the Physician Staffing trade names using projected cash flows of an estimated royalty fee. The royalty rate was determined by a blended rate using the Market Royalty Rate Method and the Apportionment of Profit Method. </font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The discounted cash flows serve as the primary basis for the income approach and are based on the Company&#8217;s discrete financial forecast of revenue, gross profit margins, operating costs and cash flows. The forecast considers historical and estimated future results, general economic and market conditions, as well as the impact of planned business and operational strategies. For its 2018 testing, the assumptions used in the income approach included discount rates of </font><font style="font-family:inherit;font-size:10pt;">12.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">15.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;and a terminal value growth rate of </font><font style="font-family:inherit;font-size:10pt;">1.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">3.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;for cash flows beyond the discrete forecast period of </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">&#32;years. Assumptions used in the market approach testing included valuation multiples based on an analysis of multiples for comparable public companies. The Company utilized total enterprise value/Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiples ranging from </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">10.5</font><font style="font-family:inherit;font-size:10pt;">. The concluded fair value was based on a weighting of </font><font style="font-family:inherit;font-size:10pt;">75%</font><font style="font-family:inherit;font-size:10pt;">&#32;applied to the income approach and </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">&#32;to the market approach for its Physician Staffing and Search reporting units and a </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">&#32;weighting was applied to the components of each approach to estimate the total fair value of goodwill for its Nurse and Allied Staffing reporting unit. This weighting was an estimate by management and was developed based on the specific characteristics, risks and uncertainties of the reporting units. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Customer Relationships</font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Multi-Period Excess Earnings Method (MPEEM) methodology was utilized for valuing the Physician Staffing customer relationships in its interim impairment testing for the second quarter of 2016. The MPEEM estimates the fair value based on the present value of the allocated future economic benefits. The inputs include the projected revenue and associated expenses from the customers, an estimated attrition rate, and a discount rate of </font><font style="font-family:inherit;font-size:10pt;">13.5%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although management believes that the Company's current estimates and assumptions are reasonable and supportable, there can be no assurance that the estimates and assumptions made for purposes of the impairment testing will prove to be accurate predictions of future performance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 23</font></div></div><hr style="page-break-after:always"><div><a name="s89301335CBC35249B2DAEF32EBEACD55"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6. Property and Equipment</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's property and equipment consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:53%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,651</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,933</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Office equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,966</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,680</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,104</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,764</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,476</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,678</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,628</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,086</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 2 &#8211; Summary of Significant Accounting Policies.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 24</font></div></div><hr style="page-break-after:always"><div><a name="s2300228069845AA3AD5B1CF883E19F18"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7. Balance Sheet Details</font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery receivable:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,623</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,891</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,497</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,280</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,093</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current security deposits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,095</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current income tax receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">935</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">985</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and benefits:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries and payroll taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bonuses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,476</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,067</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,786</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,683</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for healthcare benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for vacation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,332</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term accrued claims:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,997</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,160</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,597</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,299</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,039</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term unrecognized tax benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,767</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 25</font></div></div><hr style="page-break-after:always"><div><a name="s22D7D842DC4B502EB66D790B2876AD28"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8. Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's long-term debt consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,235</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,641</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Amended and Restated Senior Credit Facility</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 1, 2017, the Company entered into an Amendment and Restatement of its Credit Agreement dated June 22, 2016 (Amended and Restated Credit Agreement), to refinance and increase the current aggregate committed size of the facility to </font><font style="font-family:inherit;font-size:10pt;">$215.0 million</font><font style="font-family:inherit;font-size:10pt;">, including a term loan of </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(Amended Term Loan) and a </font><font style="font-family:inherit;font-size:10pt;">$115.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;revolving credit facility (Amended Revolving Credit Facility) (together with the Amended Term Loan, the Amended Credit Facilities). The Amended Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for the issuance of standby letters of credit. The proceeds of </font><font style="font-family:inherit;font-size:10pt;">$106.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from this refinancing included </font><font style="font-family:inherit;font-size:10pt;">$6.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the new revolving credit facility and were used to repay borrowings under the Company&#8217;s 2016 Senior Credit Facilities (defined below), as well as to pay related interest, fees, and expenses of the transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to increasing the size of the facilities, the maturity date was extended to August 1, 2022. The Amended and Restated Credit Agreement also includes an accordion feature permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Amended Revolving Credit Facility or establish one or more additional term loans in an aggregate amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;with optional additional commitments from existing lenders or new commitments from additional lenders. Other terms and pricing are substantially similar to the 2016 Credit Agreement (defined below).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Amended Term Loan are payable in quarterly installments, which commenced January 2, 2018, provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. In addition to its scheduled payments, in both the third and fourth quarters of 2018, the Company made optional prepayments of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;each as permitted by the Amended and Restated Credit Agreement. The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving written notice (or telephonic notice promptly confirmed in writing). The Company is required to prepay the Amended Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:76%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,671</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,990</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8. Debt (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Amended and Restated Credit Agreement, the Company pays interest on: (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time; (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time; and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time. The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.9317738791423%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:33%;"></td><td style="width:20%;"></td><td style="width:18%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 1.50:1.00 </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.00:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.50:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Amended Term Loan and Amended Revolving Credit Facility bore interest at a rate equal to One Month LIBOR plus </font><font style="font-family:inherit;font-size:10pt;">2.50%</font><font style="font-family:inherit;font-size:10pt;">. The interest rate is subject to an increase of </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;if an event of default exists under the Amended and Restated Credit Agreement. The Company is required to pay a commitment fee on the average daily unused portion of the Amended Revolving Credit Facility, based on the Applicable Margin which is </font><font style="font-family:inherit;font-size:10pt;">0.35%</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. During the three months ended March 31, 2018, the Company entered into an interest rate swap to reduce its exposure to fluctuations in the interest rates associated with its debt, which was effective April 2, 2018. See Note 9 - Derivatives.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains customary representations, warranties, and affirmative covenants. The Amended and Restated Credit Agreement also contains customary negative covenants, subject to some exceptions, on: (i) indebtedness and preferred equity; (ii) liens; (iii) fundamental changes; (iv) investments; (v) restricted payments; and (vi) sale of assets and certain other restrictive agreements. The Amended and Restated Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&#8217;s business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement also includes </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;financial covenants: (i) a maximum Consolidated Total Leverage ratio (as defined therein); and (ii) a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of </font><font style="font-family:inherit;font-size:10pt;">1.50</font><font style="font-family:inherit;font-size:10pt;">:1.00. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2018, the Company entered into a First Amendment (First Amendment) to its Amended and Restated Credit Agreement that, among other administrative and clarifying changes, modified the following: (1) the definition utilized in its financial covenants of Consolidated EBITDA to allow for exclusion of charges related to the Company&#8217;s initiative to replace its front-end system supporting its legacy travel nurse operations, subject to a basket of addbacks, of which the basket dollar amount was also increased; (2) increased the maximum Consolidated Total Leverage Ratio to </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;">:1.00 from </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the periods of September 30, 2018 through June 30, 2019, to </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;">:1:00 from </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the period ended September 30, 2019, to </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1.00 from </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the period ended December 31, 2019, and maintained </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the periods thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (3) increased the pro forma Consolidated Total Leverage Ratio threshold for allowing restricted payments. In connection with the First Amendment, the Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in fees to its lenders, of which a portion has been included in other noncurrent assets as deferred issuance costs related to the revolving credit facility and a portion has been treated as a deduction to long-term debt related to its Term Loan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 27</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8. Debt (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing description of the amendment is qualified in its entirety by reference to the full terms and provisions of the Amended and Restated Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The obligations under the Amended and Restated Credit Agreement are guaranteed by all of the Company&#8217;s domestic wholly-owned subsidiaries and are secured by a first-priority security interest in the Collateral (as defined therein).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has </font><font style="font-family:inherit;font-size:10pt;">$20.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;letters of credit outstanding, which relate to the Company&#8217;s workers&#8217; compensation and professional liability insurance policies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Senior Credit Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 22, 2016, the Company entered into a senior credit agreement (2016 Credit Agreement), which provided for an initial term loan of </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(Term Loan) and a revolving credit facility of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(Revolving Credit Facility) (together with the Term Loan, the 2016 Senior Credit Facilities) both of which would have matured on June 22, 2021. The Revolving Credit Facility included a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0</font><font style="font-family:inherit;font-size:10pt;">&#32;million sublimit for the issuance of standby letters of credit. Proceeds of the Senior Credit Facilities were used primarily to refinance the Company&#8217;s prior senior secured asset-based credit facility and </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;Second Lien Term Loan and to pay related transaction fees and expenses, including a redemption premium of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">. The repayment of the Second Lien Term Loan was treated as extinguishment of debt and, as a result, the Company recognized a loss on extinguishment of debt of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the second quarter of 2016, related to the write-off of unamortized net debt discount and issuance costs as well as transaction fees and expenses.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 5, 2017, the Company entered into a Second Amendment to its 2016 Credit Agreement primarily to allow for the acquisition of Advantage including a reset of the Applicable Margin to Level III, based on the incremental borrowings and consistent with the prior pricing grid (or </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;for Eurodollar Loans and LIBOR Index Rate Loans, </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;for Base Rate Loans and a </font><font style="font-family:inherit;font-size:10pt;">0.30%</font><font style="font-family:inherit;font-size:10pt;">&#32;commitment fee). Also, on July 5, 2017, the Company entered into an Incremental Term Loan Agreement for </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;with SunTrust as Lender and Administrative Agent to pay for part of the consideration of the acquisition of Advantage. The Incremental Term Loan maturity date was June 22, 2021 and was prepayable at any time without penalty.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Incremental Term Loan were payable in quarterly installments, commencing September 30, 2017, with each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) for the first eight installments equal to </font><font style="font-family:inherit;font-size:10pt;">1.875%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the principal amount of the Incremental Term Loan for the remaining installments; provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. As of July 5, 2017 the Applicable Margin for Eurodollar Loans and LIBOR Index Rate Loans was </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;and the Applicable Margin for Base Rate Loans was </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Convertible Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014.  Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of convertible notes (the Convertible Notes). On March 17, 2017, the Company paid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;">, and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(of which </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is included in repayment of debt and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is presented as extinguishment fees, both within financing activities on the consolidated statements of cash flows). Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;after the </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;cash payment) and derivative liability (</font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">), the Company recognized a non-cash charge of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as loss on early extinguishment and a non-cash addition to additional paid-in capital of </font><font style="font-family:inherit;font-size:10pt;">$46.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the fair value of the shares, which is not presented on the consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Common Stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$7.10</font><font style="font-family:inherit;font-size:10pt;">&#32;per share, or </font><font style="font-family:inherit;font-size:10pt;">3,521,126</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock. After </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;years from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 28</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8. Debt (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of its Common Stock exceeded </font><font style="font-family:inherit;font-size:10pt;">125%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the then conversion price for </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;">&#32;days of a </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">&#32;day trading period (Forced Conversion date). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes bore interest at a rate of </font><font style="font-family:inherit;font-size:10pt;">8.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sE8EDF0B845965227A920F7C26FB3BB68"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9. Derivatives</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Swap</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2018, the Company entered into an interest rate swap agreement, with an effective date of April 2, 2018 and termination date of August 1, 2022. No initial investments were made to enter into the agreement. The interest rate swap agreement requires the Company to pay a fixed rate to the respective counterparty of </font><font style="font-family:inherit;font-size:10pt;">2.627%</font><font style="font-family:inherit;font-size:10pt;">&#32;per annum on an amortizing notional amount beginning at </font><font style="font-family:inherit;font-size:10pt;">$48.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(corresponding with the initial term loan payment schedule), and to receive from the respective counterparty, interest payments based on the applicable notional amounts and 1 month USD LIBOR, with no exchanges of notional amounts. At initiation, the interest rate swap effectively fixed the interest rate on </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the amortizing balance of the Company&#8217;s term debt, exclusive of the credit spread on the debt. As of December 31, 2018, the interest rate swap is treated as a cash flow hedge and its fair value of a </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;liability is included in current and noncurrent liabilities on the consolidated balance sheets. See Note 2 - Summary of Significant Accounting Policies and Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes Derivative Liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the derivative liability was primarily determined by fluctuations in the Company's stock price. In addition, changes in the Company's credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain that was presented on the Company's consolidated statements of operations as gain on derivative liability in 2017 and 2016 related to its Convertible Notes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sA3CF3E6DCFD4525DA2094676E61FF3E1"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10. Fair Value Measurements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 1</font><font style="font-family:inherit;font-size:10pt;">&#8212;Quoted prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 2</font><font style="font-family:inherit;font-size:10pt;">&#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 3</font><font style="font-family:inherit;font-size:10pt;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10. Fair Value Measurements (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Items Measured at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, interest rate swap agreement included in other current and noncurrent liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred compensation</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&#8217;s deferred compensation liabilities are measured using publicly available indices that define the liability amounts, as per the plan documents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest rate swap agreement</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 2 inputs to value its interest rate swap agreement. See Note 8 - Debt and Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible notes derivative liability</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent consideration liabilities</font><font style="font-family:inherit;font-size:10pt;">&#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. The long-term portion of these liabilities has been included in contingent consideration, and the short-term portion is included in other current liabilities on the consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. Both of the Mediscan contingent consideration liabilities have been measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. In the third quarter of 2017, the Company determined that one of the contingent consideration earnouts related to the Mediscan acquisition would not be achieved for 2017 and, as a result, the entire earnout was reversed. The contingent consideration related to the Company's acquisition of USR was recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 30</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10. Fair Value Measurements (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The opening balances of contingent consideration and Convertible Notes derivative liabilities are reconciled to the closing balances for fair value measurements of these liabilities categorized within Level 3 of the fair value hierarchy as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:54%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments/Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation loss for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,698</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Items Measured at Fair Value on a Non-recurring Basis</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During an evaluation of goodwill, trade names, and other intangible assets during the years ended December 31, 2018, 2017, and 2016, the carrying value of goodwill, trade names, and other intangible assets in the Physician Staffing reporting unit exceeded their fair values. As a result, the Company recorded impairment charges that incorporates fair value measurements based on Level 3 inputs. For further discussion on measuring the Company's non-financial assets, specifically goodwill, trade names, and customer relationships, see Note 5 - Goodwill, Trade Names, and Other Intangible Assets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Fair Value Disclosures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments not measured or recorded at fair value in the accompanying consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and short and long-term debt. The estimated fair value of accounts receivable, accounts payable, and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company&#8217;s debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,179</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,134</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company is exposed to credit risk associated with these investments, as the cash balances typically exceed the current Federal </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 31</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10. Fair Value Measurements (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deposit Insurance Corporation (FDIC) limit of $250,000. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&#8217;s historical collection experience. The Company writes off specific&#160;accounts based on an ongoing review of collectability as well as past experience with the customer. The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;">&#32;days from the date of invoice and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sA8325D120B7A5E6081087D93C0BD2D88"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11. Employee Benefit Plans</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains a voluntary defined contribution 401(k) profit-sharing plan covering all eligible employees as defined in the plan documents. The plan provides for a discretionary matching contribution, which is equal to a&#160;percentage of each eligible contributing participant&#8217;s elective deferral, which the Company, at its sole discretion, determines from year to year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contributions by the Company, net of forfeitures, under this plan amounted to </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Eligible employees who elect to participate in the plan are generally vested in any existing matching contribution after three years of service with the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers a non-qualified deferred compensation program to certain key employees whereby they may defer a portion of annual compensation for payment upon retirement. The program is unfunded for tax purposes and for purposes of Title I of the Employee Retirement Income Security Act of 1974. The liability for the deferred compensation is included in other long-term liabilities on the consolidated balance sheets and amounted to </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6553FA7DE781564B910DFB18C4B7F295"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12. Commitments and Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Commitments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Leases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has entered into non-cancelable operating lease agreements for the rental of office space and equipment. Certain of these leases include options to renew as well as rent escalation clauses and in certain cases, incentives from the landlord for rent-free months and premises reductions, and allowances for tenant improvements. The rent escalations and incentives have been reflected in the table below. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, associated with these agreements with terms of one year or more are as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:81%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,857</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,893</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating lease expense included in selling, general, and administrative expenses was approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$9.4 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$8.4</font><font style="font-family:inherit;font-size:10pt;">&#32;million for the years ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 32</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12. Commitments and Contingencies (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales and Other State Non-income Tax Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Non-income tax expense is included in selling, general and administrative expenses on its consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, on its consolidated balance sheets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Proceedings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount, or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve a significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments including available insurance recoveries, which would impact its profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require it to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect its financial results. With regard to the outstanding contingencies as of December 31, 2018, the Company believes the outcome of these matters will not have a material adverse effect on its business, financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 33</font></div></div><hr style="page-break-after:always"><div><a name="s816AAB6814C35E68978D381CDC15AB78"></a></div><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13. Income Taxes </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of the Company's (loss) income before income taxes are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,826</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,309</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,236</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The components of the Company&#8217;s income tax benefit are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(273</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">587</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(689</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,136</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,137</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,245</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,114</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,812</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,322</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 34</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13. Income Taxes (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:69%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Tax Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued other and prepaid expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">607</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">624</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating&#160;loss carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,717</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,718</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,952</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,729</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,512</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">189</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,415</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,661</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,585</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred Tax Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax on unrepatriated earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,571</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,471</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,655</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,114</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the 2017 Tax Act was signed into legislation which, among other changes, reduced the corporate federal income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">&#32;effective for the Company's year ended December 31, 2018. The Company recorded income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;">, primarily due to a re-measurement of its deferred tax assets and liabilities in the fourth quarter of 2017. The impact of the Global Intangible Low-Taxed Income provision, the transition tax on the deemed repatriation of deferred foreign income, and any future tax impact associated with basis differences on foreign subsidiaries were immaterial. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Securities and Exchange Commission (SEC) staff issued Staff Accounting Bulletin No. 118 (SAB 118), which provided guidance on accounting for the tax effects of the 2017 Tax Act. SAB 118 provided a measurement period that should not extend beyond one year from the enactment date for companies to complete the accounting required under the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC. In accordance with SAB 118, the Company provided a provisional amount with regard to certain foreign tax provisions in 2017. In 2018, the Company revised its estimate with regard to the 2017 Tax Act and recorded </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of tax expense.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2016, the Company determined that it could not sustain a conclusion that it was more likely than not that it would realize any of its deferred tax assets resulting from recent losses, the difficulty of forecasting future taxable income, and other factors, and as a result, the Company had a valuation allowance on its deferred tax assets, exclusive of indefinite-lived intangible deferred tax liabilities.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the year ended December 31, 2017, predominantly on the basis of a reassessment of the amount of its deferred tax assets that are more likely than not to be realized, the Company reduced its valuation allowance by </font><font style="font-family:inherit;font-size:10pt;">$45.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(comprised of </font><font style="font-family:inherit;font-size:10pt;">$15.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to U.S. net operating losses, </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to state net operating losses, and </font><font style="font-family:inherit;font-size:10pt;">$25.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to other </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 35</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13. Income Taxes (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">net deferred tax assets). The valuation allowance on a portion of state net operating losses not more likely than not realizable was not released after analysis of respective expiration periods and specific state taxable income projections.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2018, the Company continues to maintain a valuation allowance of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;on a portion of state net operating losses not more likely than not realizable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$185.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$166.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of federal, state, and foreign net operating loss carryforwards. The carryforwards will expire as follows: federal between </font><font style="font-family:inherit;font-size:10pt;">2032</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2037</font><font style="font-family:inherit;font-size:10pt;">, state between </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2038</font><font style="font-family:inherit;font-size:10pt;">, and foreign between </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2023</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation of income tax computed at the U.S. federal statutory rate to income tax&#160;benefit is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax at U.S. statutory rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,506</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,591</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(543</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(252</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(455</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(260</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible items (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,676</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uncertain tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,629</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,090</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Return to provision</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,011</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(831</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Includes non-deductible meals and incidentals, miscellaneous non-deductible items, and beginning in 2018, non-deductible stock-based compensation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax years 2008 and 2010 through 2017 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax. During 2018, the Company accrued </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of India tax on earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">. India withholding taxes on a dividend of India earnings are not affected by the calculation of U.S. taxes due and continue to be accrued. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,071</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to the current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reductions based on settlements of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Tax Act federal tax rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 36</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13. Income Taxes (continued)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term unrecognized tax benefits are included in other current liabilities on the consolidated balance sheets and were </font><font style="font-family:inherit;font-size:10pt;">$0.1</font><font style="font-family:inherit;font-size:10pt;">&#32;million as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016. Long-term unrecognized tax benefits are included in other long-term liabilities on the consolidated balance sheets and were </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, respectively. See Note 7 - Balance Sheet Details. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, the Company had unrecognized tax benefits, which would affect the effective tax rate if recognized, of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$4.9</font><font style="font-family:inherit;font-size:10pt;">&#32;million, respectively. During </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross increases of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to its current year unrecognized tax benefits, related to federal and state tax positions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. During the year ended December 31, 2017, the Company recognized a decrease in interest and penalties of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, related to statute expirations. The Company has accrued </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.2</font><font style="font-family:inherit;font-size:10pt;">&#32;million, and </font><font style="font-family:inherit;font-size:10pt;">$0.5</font><font style="font-family:inherit;font-size:10pt;">&#32;million for the payment of interest and penalties at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, respectively.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="sE71EF6B815D95D22B390DAFD8F93496D"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14. Stockholders&#8217; Equity</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Repurchase Programs</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under an authorized share repurchase program, during the year ended December 31, 2018, the Company repurchased and retired </font><font style="font-family:inherit;font-size:10pt;">432,439</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of its Common Stock for </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">, at an average market price of </font><font style="font-family:inherit;font-size:10pt;">$11.54</font><font style="font-family:inherit;font-size:10pt;">&#32;per share. During the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not repurchase any shares of its Common Stock under this program. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has </font><font style="font-family:inherit;font-size:10pt;">510,004</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of Common Stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Amended and Restated Credit Agreement. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shares Issued</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, the Company issued </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;">&#32;shares to its prior Convertible Notes noteholders. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Payments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2014 Omnibus Incentive Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's 2014 Omnibus Incentive Plan (2014 Plan) provides for the issuance of stock options, stock appreciation rights, restricted stock, performance shares, and performance-based cash awards that may be granted with the intent to comply with the &#8220;performance-based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code, and other stock-based awards, all as defined by the 2014 Plan, to eligible employees, consultants and non-employee Directors. On May 23, 2017, the Company's shareholders approved an amendment and restatement of its 2014 Plan (2017 Plan) which, among others, included the following modifications: (i) a </font><font style="font-family:inherit;font-size:10pt;">2,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;share increase of the aggregate share reserve to </font><font style="font-family:inherit;font-size:10pt;">6,100,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares, (2) extension of the 2014 Plan until May 23, 2027, and (3) re-approval of the Section 162(m) performance goals so that certain incentive awards granted to certain executive officers of the Company may qualify as exempt performance-based compensation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the 2017 Plan, the Compensation Committee of the Company&#8217;s Board of Directors (the Committee), has the discretion to determine the terms of the awards at the time of the grant provided, however, that in the case of stock options and stock appreciation rights (share options): 1) the exercise price per share of the award is not less than </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;(or, in the case of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">&#32;or more stockholders, the exercise price of the incentive stock options (ISOs) granted may not be less than </font><font style="font-family:inherit;font-size:10pt;">110%</font><font style="font-family:inherit;font-size:10pt;">) of the fair market value of the common stock at the time of the grant; and 2) the term of the award will be no more than </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;">&#32;years after the date the option is granted (or, shall not exceed </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">&#32;years, in the case of a </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">&#32;or more stockholder). In the case of restricted stock, the purchase price may be zero to the extent permitted by applicable law.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards granted under the Company&#8217;s 2017 Plan entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. The shares vest ratably over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;year period ending on the anniversary date of the grant, and vesting is subject to the employee's continuing employment. There is no partial vesting and any unvested portion is forfeited. Pursuant to the 2017 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 37</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14. Stockholders' Equity (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:45%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br>Average<br>Grant Date<br>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br>Average<br>Grant Date<br>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515,601</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391,108</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.96</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,328</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.11</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(219,881</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.18</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,062</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589,120</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">365,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 31, 2018 and 2017, the Company awarded performance stock awards totaling </font><font style="font-family:inherit;font-size:10pt;">238,328</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">181,067</font><font style="font-family:inherit;font-size:10pt;">, respectively. If the minimum level of performance is attained for the </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and 2017 awards, restricted stock will be issued with a vesting date of March 31, 2021 and 2020, respectively. The level of attainment will be certified within 30 days of the vest date. During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;">&#32;level of attainment for the 2016 performance-based share awards, resulting in the issuance of </font><font style="font-family:inherit;font-size:10pt;">66,692</font><font style="font-family:inherit;font-size:10pt;">&#32;performance shares that vested on December 31, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;pre-tax of total unrecognized compensation cost related to non-vested restricted stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.45 years</font><font style="font-family:inherit;font-size:10pt;">. The fair value of shares vested was approximately </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.7</font><font style="font-family:inherit;font-size:10pt;">&#32;million, and </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$0.3</font><font style="font-family:inherit;font-size:10pt;">&#32;million pre-tax of total unrecognized compensation cost related to performance stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.87 years</font><font style="font-family:inherit;font-size:10pt;">, the remaining service period. The fair value of shares vested was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the years ended December&#160;31, 2018, 2017, and 2016, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not issue stock options or stock appreciation rights. The following table represents information about stock options and stock appreciation rights exercised in each year. </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total intrinsic value of options exercised</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stock appreciation rights can only be settled with stock or cash, at the discretion of the Committee. The stock appreciation rights vest </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">&#32;per year over a </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">&#32;year period and expire after </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;">&#32;years. The Company&#8217;s policy is to issue new shares from its authorized but unissued balance of common stock outstanding or shares of common stock reacquired by the Company if stock appreciation rights are settled with stock.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded compensation expense for stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Due to the adoption of the 2014 Plan (previously titled the 2007 Stock Incentive Plan), no further grants have been issued under the Company&#8217;s 1999 Plans referred to below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 38</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14. Stockholders' Equity (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1999 Stock Option Plan and Equity Participation Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December&#160;16, 1999, the Company&#8217;s Board of Directors approved the 1999 Stock Option Plan and Equity Participation Plan (collectively, the 1999 Plans), which was amended and restated on October&#160;25, 2001 and provided for the issuance of ISOs and non-qualified stock options to eligible employees and non-employee directors for the purchase of up to </font><font style="font-family:inherit;font-size:10pt;">4,398,001</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company&#8217;s activities with respect to all of its share option plans (issued under the 2014 Plan and the 1999 Plan) for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:38%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Option Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br>Average<br>Exercise<br>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-<br>Average<br>Remaining<br>Contractual<br>Life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate<br>Intrinsic<br>Value (amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding, January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited/expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding and exercisable, December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.35-$5.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">51,500</font><font style="font-family:inherit;font-size:10pt;">&#32;share options outstanding, all of which were vested at a weighted average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$4.87</font><font style="font-family:inherit;font-size:10pt;">, intrinsic value of </font><font style="font-family:inherit;font-size:10pt;">$0.1</font><font style="font-family:inherit;font-size:10pt;">&#32;million, and a weighted average contractual life of </font><font style="font-family:inherit;font-size:10pt;">1.02</font><font style="font-family:inherit;font-size:10pt;">&#32;years. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 39</font></div></div><hr style="page-break-after:always"><div><a name="sD9D4593DF7935E4F941ABBBB24AAEA3E"></a></div><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">15. Earnings Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:62%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,383</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,626</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,246</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.01</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years 2018, 2017, and 2016, no tax benefits were assumed in the weighted average share calculation due to the Company's net operating loss position.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the securities that could potentially dilute net income per share attributable to common shareholders in the future that were not included in the computation of diluted net income per share attributable to common shareholders because to do so would have been anti-dilutive for the periods presented.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:57%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sA80C6F6236A95CEA8C27B07BFFFBEBD5"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16. Related Party Transactions</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides services to hospitals which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Accounts receivable due from these hospitals at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;were less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the acquisition of MSN, the Company acquired a </font><font style="font-family:inherit;font-size:10pt;">68%</font><font style="font-family:inherit;font-size:10pt;">&#32;ownership interest in Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), a joint venture between the Company and a hospital system. The Company generated revenue providing staffing services to the hospital system of </font><font style="font-family:inherit;font-size:10pt;">$19.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in 2018, 2017, and 2016, respectively. At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and 2017, the Company had a receivable balance of </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a payable balance of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at both periods.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 40</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16. Related Party Transactions (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in 2018, </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in 2017, and 2016 for rent for these premises. In the fourth quarter of 2018, the Company vacated the premises.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s0139E3A283F05D97AF2ED4DE30B028BB"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17. Segment Data</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC, the Company reports </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing - </font><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the United States. Substantially all of the results of the Advantage and AP Staffing acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 4 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing -</font><font style="font-family:inherit;font-size:10pt;">&#32;Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services -</font><font style="font-family:inherit;font-size:10pt;">&#32;Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives, and other healthcare professionals within the United States.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation and amortization, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, applicant tracking system costs, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">&#32;Topic of the FASB ASC. The Company&#8217;s management does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 41</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17. Segment Data (continued)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,610</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98,283</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,365</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,614</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,992</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,589</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges (b)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;padding-left:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been centralizing administrative functions to gain efficiencies, which have been recorded in unallocated corporate overhead, which includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:37px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:13px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 42</font></div></div><hr style="page-break-after:always"><div><a name="sE15E2A6C289E5C2896A074118877AC50"></a></div><div><div style="line-height:120%;text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DECEMBER&#160;31, 2018</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18. Quarterly Financial Data (Unaudited)</font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables contain selected unaudited statements of operations information for each quarter of 2018 and 2017. The following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:57%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">210,288</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">204,572</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,717</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,907</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,920</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,824</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(118</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,343</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,642</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,539</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Diluted (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:57%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">207,573</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">209,313</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228,488</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219,674</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56,528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,480</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,718</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,220</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,044</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,256</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.78</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Excludes depreciation and amortization.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(b) The sum of the quarterly per share amounts may not equal amounts reported for year-to-date due to the effects of rounding                       and changes in the number of weighted average shares outstanding used in the calculation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following items are the most significant items that impact the comparability and presentation of our consolidated data:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018 and 2017, the Company recorded non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$22.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$14.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the goodwill and trade names of Physician Staffing. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company settled its Convertible Notes and recognized a loss on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 8 - Debt.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2018, the Company acquired AP Staffing and on July 1, 2017, the Company acquired all of the assets of Advantage. The acquisitions have been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">using the acquisition method. The results of the acquisitions' operations have been included in the consolidated statements of operations from their dates of acquisition. See Note 4 - Acquisitions. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, the Company benefited from a </font><font style="font-family:inherit;font-size:10pt;text-transform:default;">$43.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;reversal of valuation allowance on its net deferred tax assets, offset by additional income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the remeasurement of its deferred tax assets as a result of the 2017 Tax Act. See Note 13 - Income Taxes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded changes in the fair value of Convertible Notes derivative liability, recording a gain in the first quarter of 2017 of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 9 - Derivatives.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">F- 43</font></div></div><hr style="page-break-after:always"><div><a name="sEAEB79AD829759D3B100335EBB82B8AF"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Schedule II</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">VALUATION AND QUALIFYING ACCOUNTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOR THE YEARS ENDED DECEMBER&#160;31, 2018, 2017, AND 2016</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at<br>Beginning<br>of Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Charged to Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Write-Offs, net of recoveries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other<br>Changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at<br>End<br>of Period</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Allowances for Accounts Receivable</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,974</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,245</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,705</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,262</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,688</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,045</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,034</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Valuation Allowance for Deferred Tax Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,076</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">113</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,189</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(43,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55,336</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,894</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,454</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uncollectible accounts written off, net of recoveries.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Release of valuation allowances on the Company&#8217;s deferred tax assets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance on deferred tax asset related to share-based compensation.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:61px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:61px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">II- 1</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>ccrn20181231-10kex21x1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5C819AB523F75917A3A64FD6A0CBB3F7"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;21.1</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIST OF SUBSIDIARIES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:66%;"></td><td style="width:3%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsidiary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Place of Incorporation</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advantage RN, LLC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advantage RN Local Staffing, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Personnel, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Massachusetts</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assignment America, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cejka Search, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credent Verification and Licensing Services, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Holdco (Cyprus) Limited </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cyprus</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Infotech, Pvt. Ltd.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">India</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Staffing, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Support Services, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intelistaf of Oklahoma LLC*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Local Staff, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MDA Holdings, Inc.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Doctor Associates, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mediscan Diagnostic Services, LLC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">California</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mediscan Nursing Services, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">California</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New Mediscan II, LLC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">California</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">OWS, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Travel Staff, LLC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;&#160;&#160;&#160; Majority-owned joint venture&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ccrn20181231-10kex23x1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sC8322F30DF1052B9989CB9D2640B9B0E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;23.1</font></div><div style="line-height:120%;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consent to the incorporation by reference in Registration Statement Nos. 333-145484, 333-188519, 333-196639, and 333-218557 on Form S-8 of our reports dated February 28, 2019, relating to the consolidated financial statements of Cross Country Healthcare, Inc. and subsidiaries, and the effectiveness of Cross Country Healthcare, Inc. and subsidiaries' internal control over financial reporting, appearing in this Annual Report on Form 10-K of Cross Country Healthcare, Inc. for the year ended December 31, 2018.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;</font><font style="font-family:inherit;font-size:11pt;">DELOITTE &amp; TOUCHE LLP</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boca Raton, Florida</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;28, 2019</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ccrn20181231-10kex31x1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sDD43799E2A58522E97F6675D722DDDE2"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Kevin C. Clark, certify that:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this annual report on Form&#160;10-K of Cross Country Healthcare, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;28, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin C. Clark</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kevin C. Clark</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief&#160;Executive Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal&#160;Executive&#160;Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ccrn20181231-10kex31x2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s0C901E831E535D24A2DDA054C10C33DB"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, William J. Burns, certify that:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this annual report on Form&#160;10-K of Cross Country Healthcare, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">d.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:inherit;font-size:10pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;28, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President, Chief&#160;Financial Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Accounting and Financial Officer)</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ccrn20181231-10kex32x1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5AD55FA14DBA51428499D0978D776C25"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the accompanying Annual Report on Form&#160;10-K of Cross Country Healthcare, Inc. (the Company) for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, (the "Periodic Report"), I, Kevin C. Clark, President and Chief Executive Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;28, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Kevin C. Clark</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kevin C. Clark</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President, Chief&#160;Executive Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal&#160;Executive&#160;Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>ccrn20181231-10kex32x2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s34E2F92906665D47BD0F4A8F0C26EAA2"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.2</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the accompanying Annual Report on Form&#160;10-K of Cross Country Healthcare, Inc. (the "Company") for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, (the "Periodic Report"), I, William J. Burns, Chief Financial Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:21%;"></td><td style="width:73%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;28, 2019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ William J. Burns</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">William J. Burns</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President, Chief&#160;Financial Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Accounting and Financial Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>ccrn-20181231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:723c43457d4846709a9f754a817d9c4a,x:86250b34e0ac4218bb46e3f1bb34dd4f-->
<xbrli:xbrl xmlns:acec="http://fasb.org/dis/acec/2018-01-31" xmlns:ap="http://fasb.org/dis/ap/2018-01-31" xmlns:aro="http://fasb.org/dis/aro/2018-01-31" xmlns:bc="http://fasb.org/dis/bc/2018-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2018-01-31" xmlns:cce="http://fasb.org/dis/cce/2018-01-31" xmlns:ccrn="http://www.crosscountryhealthcare.com/20181231" xmlns:codification-part="http://fasb.org/codification-part/2018-01-31" xmlns:com="http://fasb.org/stm/com/2018-01-31" xmlns:con="http://fasb.org/dis/con/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2018-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2018-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2018-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2018-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2018-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2017-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2017-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2017-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2017-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2018-01-31" xmlns:debt="http://fasb.org/dis/debt/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2018-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2018-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2018-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:diha="http://fasb.org/dis/diha/2018-01-31" xmlns:disops="http://fasb.org/dis/disops/2018-01-31" xmlns:dr="http://fasb.org/dis/dr/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2018-01-31" xmlns:ei="http://fasb.org/dis/ei/2018-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2018-01-31" xmlns:eps="http://fasb.org/dis/eps/2018-01-31" xmlns:equity="http://fasb.org/dis/equity/2018-01-31" xmlns:ero="http://fasb.org/dis/ero/2018-01-31" xmlns:eui="http://fasb.org/dis/eui/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2018-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2018-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2018-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2018-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2018-01-31" xmlns:foct="http://fasb.org/dis/foct/2018-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2018-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2018-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2018-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2018-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2018-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2018-01-31" xmlns:guar="http://fasb.org/dis/guar/2018-01-31" xmlns:hco="http://fasb.org/dis/hco/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2018-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2018-01-31" xmlns:ides="http://fasb.org/dis/ides/2018-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2018-01-31" xmlns:inv="http://fasb.org/dis/inv/2018-01-31" xmlns:invco="http://fasb.org/dis/invco/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2018-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:lea="http://fasb.org/dis/lea/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:ni="http://fasb.org/dis/ni/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:nt="http://fasb.org/dis/nt/2018-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2018-01-31" xmlns:oi="http://fasb.org/dis/oi/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2018-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2018-01-31" xmlns:pay="http://fasb.org/dis/pay/2018-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2018-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2018-01-31" xmlns:rd="http://fasb.org/dis/rd/2018-01-31" xmlns:re="http://fasb.org/dis/re/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:regop="http://fasb.org/dis/regop/2018-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2018-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2018-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2018-01-31" xmlns:ru="http://fasb.org/dis/ru/2018-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2018-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2018-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2018-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2018-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2018-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2018-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2018-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2018-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2018-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2018-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2018-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2018-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2018-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2018-01-31" xmlns:se="http://fasb.org/dis/se/2018-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2018-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2018-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2018-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2018-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2018-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2018-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2018-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2018-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2018-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2018-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2018-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2018-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2018-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2018-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:soc="http://fasb.org/stm/soc/2018-01-31" xmlns:soi="http://fasb.org/stm/soi/2018-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2018-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2018-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2018-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2018-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2018-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2018-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2018-01-31" xmlns:spc="http://fasb.org/stm/spc/2018-01-31" xmlns:sr="http://fasb.org/dis/sr/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:srt-all="http://fasb.org/srt-all/2018-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2018-01-31" xmlns:srt-std="http://fasb.org/srt-std/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:te="http://fasb.org/dis/te/2018-01-31" xmlns:tin-part="http://fasb.org/tin-part/2018-01-31" xmlns:ts="http://fasb.org/dis/ts/2018-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2018-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2018-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2018-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="ccrn-20181231.xsd" xlink:type="simple" />
	<xbrli:context id="FD2018Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q1Feb22">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-02-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">ccrn:MDAHoldingsIncMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">ccrn:ClaimsBasedLiabilityInsuranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">ccrn:MDAHoldingsIncMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">ccrn:ClaimsBasedLiabilityInsuranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q3YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">ccrn:ClaimsBasedLiabilityInsuranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ccrn:CostOptimizationProjectMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q3YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4March2015Dec2018_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">ccrn:MDAHoldingsIncMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">ccrn:OccurrenceBasedProfessionalLiabilityInsuranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-03-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_ccrn_BusinessCombinationConsiderationTransferredAxis_ccrn_NetWorkingCapitalAdjustmentsMember_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:BusinessCombinationConsiderationTransferredAxis">ccrn:NetWorkingCapitalAdjustmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_ccrn_BusinessCombinationConsiderationTransferredAxis_ccrn_PurchasePriceMember_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:BusinessCombinationConsiderationTransferredAxis">ccrn:PurchasePriceMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:USResourcesHealthcareLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:DeferredConsiderationTransferredMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July28_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-28</xbrli:startDate>
			<xbrli:endDate>2017-07-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AmericanPersonnelInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2019Q1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1May3_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-05-03</xbrli:startDate>
			<xbrli:endDate>2017-05-03</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:USResourcesHealthcareLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:USResourcesHealthcareLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q4JulyDec_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:DeferredConsiderationTransferredMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:USResourcesHealthcareLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AmericanPersonnelInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-12-01</xbrli:startDate>
			<xbrli:endDate>2018-12-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-10-30</xbrli:startDate>
			<xbrli:endDate>2015-10-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2014Q2Jun30_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:DeferredConsiderationTransferredMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-06-30</xbrli:startDate>
			<xbrli:endDate>2014-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2019Q1QTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2April1_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-04-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3QTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AssumedAdditionalContingentPurchasePriceLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q1QTD_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_NonrecurringAdjustmentAxis_us-gaap_AcquisitionRelatedCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3July28_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AcquisitionRelatedContingentConsiderationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:USResourcesHealthcareLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AcquisitionRelatedContingentConsiderationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q1Mar31_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MedicalStaffingNetworkMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-07-01</xbrli:startDate>
			<xbrli:endDate>2016-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AdvantageRNLLCMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:DeferredConsiderationTransferredMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:AmericanPersonnelInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AssumedAdditionalContingentPurchasePriceLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:AssumedAdditionalContingentPurchasePriceLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:MediscanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">ccrn:PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2June30_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-30</xbrli:startDate>
			<xbrli:endDate>2016-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Oct1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-10-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2June30_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-30</xbrli:startDate>
			<xbrli:endDate>2016-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2June30_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-30</xbrli:startDate>
			<xbrli:endDate>2016-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ValuationTechniqueAxis_ccrn_IncomeandMarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ccrn:IncomeandMarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_SearchReportingUnitMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:SearchReportingUnitMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_SearchReportingUnitMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:SearchReportingUnitMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A8ConvertibleNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_SecondLienTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SubordinatedDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:SecondLienTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-05</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_EachFiscalQuarterEndingThereafterMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:EachFiscalQuarterEndingThereafterMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q3QTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:FirstAmendmentAmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuartersEndingSeptember302018throughJune302019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-17</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2014Q2_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-08-01</xbrli:startDate>
			<xbrli:endDate>2017-08-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Oct30_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:FirstAmendmentAmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-30</xbrli:startDate>
			<xbrli:endDate>2018-10-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingDecember312019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:FirstAmendmentAmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuarterEndingDecember312019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FirstEightInstallmentsMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FirstEightInstallmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuartersEndingSeptember302018throughJune302019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_RemainingInstallmentsMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:RemainingInstallmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2June22">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-22</xbrli:startDate>
			<xbrli:endDate>2016-06-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingSeptember302019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuarterEndingSeptember302019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-06-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:ConvertibleNoteDerivativeLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-17</xbrli:startDate>
			<xbrli:endDate>2017-03-17</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingDecember312019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuarterEndingDecember312019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3Aug1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingSeptember302019Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:FirstAmendmentAmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:FiscalQuarterEndingSeptember302019Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q2QTD_us-gaap_DebtInstrumentAxis_ccrn_SecondLienTermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:SecondLienTermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-04-01</xbrli:startDate>
			<xbrli:endDate>2016-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3Aug1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-08-01</xbrli:startDate>
			<xbrli:endDate>2017-08-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:IncrementalTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-05</xbrli:startDate>
			<xbrli:endDate>2017-07-05</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_EachFiscalQuarterEndingThereafterMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:FirstAmendmentAmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">ccrn:EachFiscalQuarterEndingThereafterMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">ccrn:LetterofCreditFeeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm5Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm4Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ccrn:DebtCovenantTermsAxis">ccrn:CovenantTerm2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:ContingentConsiderationLiabilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_NetOperatingLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ccrn:NetOperatingLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_NetOperatingLossesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ccrn:NetOperatingLossesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_OtherNetDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">ccrn:OtherNetDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q2May23_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-23</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_StockAppreciationRightsSARSMember_us-gaap_PlanNameAxis_ccrn_IncentiveCompensationPlan2007Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:IncentiveCompensationPlan2007Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember_us-gaap_TitleOfIndividualAxis_ccrn_TenPercentOrMoreStockholdersMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ccrn:TenPercentOrMoreStockholdersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1March31_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-03-31</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1March31_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-31</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2011Q4oct25_us-gaap_PlanNameAxis_ccrn_StockOptionAndEquityParticipationPlan1999Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:StockOptionAndEquityParticipationPlan1999Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2001-10-25</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q2May23_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-05-23</xbrli:startDate>
			<xbrli:endDate>2017-05-23</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember_us-gaap_TitleOfIndividualAxis_ccrn_TenPercentOrMoreStockholdersMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">ccrn:TenPercentOrMoreStockholdersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeTwoMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ccrn:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeThreeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ccrn:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeFiveMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ccrn:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeOneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ccrn:ExercisePriceRangeOneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeFourMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ccrn:ExercisePriceRangeFourMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ConvertibleNotesandSharebasedPaymentAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ConvertibleNotesandSharebasedPaymentAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ConvertibleNotesandSharebasedPaymentAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:OtherHumanCapitalManagementServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-04-01</xbrli:startDate>
			<xbrli:endDate>2018-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-10-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-04-01</xbrli:startDate>
			<xbrli:endDate>2017-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-01</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-01-01</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="day">
		<xbrli:measure>ccrn:day</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="instrument">
		<xbrli:measure>ccrn:instrument</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="d">
		<xbrli:measure>utreg:D</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="financial_covenant">
		<xbrli:measure>ccrn:financial_covenant</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="segment">
		<xbrli:measure>ccrn:segment</xbrli:measure>
	</xbrli:unit>
	<ccrn:BusinessCombinationConsiderationDeferredPeriod contextRef="D2014Q2Jun30_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember" id="Fact-43FAF20B8949E8B7C761A9ED1275AD75">P21M</ccrn:BusinessCombinationConsiderationDeferredPeriod>
	<ccrn:BusinessCombinationConsiderationDeferredPeriod contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember" id="Fact-76E8FA9439DE0417C4DDA9ED1210F5D1">P20M</ccrn:BusinessCombinationConsiderationDeferredPeriod>
	<ccrn:BusinessCombinationConsiderationTransferredCashConsiderationNegotiated contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-726A9C88B7559CCE6EB5A9ED126C14A8" unitRef="usd">28000000</ccrn:BusinessCombinationConsiderationTransferredCashConsiderationNegotiated>
	<ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-EBEA2A74368D624474ECA9ED1269F88F" unitRef="usd">600000</ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment>
	<ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment contextRef="FD2016Q1QTD_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-2FB70A7C287B248B15D8A9ED126C97F3" unitRef="usd">0</ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment>
	<ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement contextRef="FD2017Q3QTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-F4CAAE3AEAEFD87B29CAA9ED12723FFE" unitRef="usd">800000</ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement>
	<ccrn:BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-0F06A5B30810EFC1B086A9ED11F96BE6" unitRef="usd">19900000</ccrn:BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand>
	<ccrn:BusinessCombinationContingentConsiderationArrangementsExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-E57C39ABC1CC963F79C4A9ED124FC1E1" unitRef="usd">814000</ccrn:BusinessCombinationContingentConsiderationArrangementsExpense>
	<ccrn:BusinessCombinationContingentConsiderationArrangementsExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-348403B68484B2F640E8A9ED124EB7AD" unitRef="usd">44000</ccrn:BusinessCombinationContingentConsiderationArrangementsExpense>
	<ccrn:BusinessCombinationContingentConsiderationArrangementsExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0DC47A4D6FE80975E594A9ED122C2EA1" unitRef="usd">2557000</ccrn:BusinessCombinationContingentConsiderationArrangementsExpense>
	<ccrn:BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities contextRef="FI2019Q1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="-5" id="Fact-2913CC12DB242FA220CCBF413F77C2C1" unitRef="usd">500000</ccrn:BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities>
	<ccrn:BusinessCombinationEscrowDepositRelatedToTaxLiabilities contextRef="I2017Q3July28_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-70164F6BA78730A19610A9ED126A405F" unitRef="usd">7200000</ccrn:BusinessCombinationEscrowDepositRelatedToTaxLiabilities>
	<ccrn:BusinessCombinationEscrowDepositRelease contextRef="D2017Q1May3_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-823A3EC2115868DC92C7A9ED1274A68F" unitRef="usd">5000000</ccrn:BusinessCombinationEscrowDepositRelease>
	<ccrn:BusinessCombinationEscrowDepositRelease contextRef="D2017Q3July28_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-73F8FB8B623589867B3FA9ED1254E8EB" unitRef="usd">7300000</ccrn:BusinessCombinationEscrowDepositRelease>
	<ccrn:BusinessCombinationEscrowDepositRelease contextRef="FD2019Q1QTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="-5" id="Fact-27FEE14D7AD3AB8FE6A5BF416E10B0C5" unitRef="usd">7000000</ccrn:BusinessCombinationEscrowDepositRelease>
	<ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-6420B2222906E1713FC2A9ED127B258A" unitRef="usd">1685000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-1C6BDDF7483AB2580774A9ED1258B68C" unitRef="number">1.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-89AE11CF472A046419B5A9ED11D3B1DC" unitRef="number">2.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-8C52C2D0FAF021B2EFCEA9ED1241C823" unitRef="number">1.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-07DFDF0B894A9252FE8DA9ED11F11D33" unitRef="number">2.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-B1F74ADA330E3BE8B573A9ED123C8A95" unitRef="number">2.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-46F3D77BC38484D9FCC1A9ED124DF66C" unitRef="number">3.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-E5F3F021FECAE6965939A9ED123BCE26" unitRef="number">2.50</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ConsolidatedNetLeverageRatio contextRef="FI2018Q4_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-012D5A919CF37FEE9E76A9ED1233E82B" unitRef="number">3.00</ccrn:ConsolidatedNetLeverageRatio>
	<ccrn:ContractualTerm contextRef="FD2018Q3YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_srt_RangeAxis_srt_MaximumMember" id="Fact-6C09743E1BB3705B1A67C002FE7F597A">P60D</ccrn:ContractualTerm>
	<ccrn:ContractualTerm contextRef="FD2018Q3YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_srt_RangeAxis_srt_MinimumMember" id="Fact-EB83B73947BC4C8C1304C002CF6BEE39">P15D</ccrn:ContractualTerm>
	<ccrn:ContractualTerm contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-606994133FCBE7E98484A9ED1247D986">P60D</ccrn:ContractualTerm>
	<ccrn:ContractualTerm contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-758705C90C0166C9DDA9A9ED1246C32D">P15D</ccrn:ContractualTerm>
	<ccrn:DebtCovenantConsolidatedFixedChargeCoverageRatio contextRef="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-F57FBF47F70A2BD98645A9ED124F021A" unitRef="number">1.50</ccrn:DebtCovenantConsolidatedFixedChargeCoverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_EachFiscalQuarterEndingThereafterMember" decimals="INF" id="Fact-65B380676632BDB19D15BF83BFC850BE" unitRef="number">3.00</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingDecember312019Member" decimals="INF" id="Fact-523DDBC27B5D1A8FD04BBF83E1E60DDE" unitRef="number">3.00</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingSeptember302019Member" decimals="INF" id="Fact-91A81195F25C1737BB8DBF83A335CC46" unitRef="number">3.00</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct29_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" decimals="INF" id="Fact-E8989800E897EA4EE5B5BF8358E550BE" unitRef="number">3.25</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_EachFiscalQuarterEndingThereafterMember" decimals="INF" id="Fact-1B7B781425B7E2FC3E0D34C5CC688842" unitRef="number">3.00</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingDecember312019Member" decimals="INF" id="Fact-9CE281F5230484C5008CBF840D05DAB4" unitRef="number">3.25</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuarterEndingSeptember302019Member" decimals="INF" id="Fact-DC99069BBEAA35DF2CD0BF8383C19DC2" unitRef="number">3.50</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtCovenantConsolidatedTotalLeverageRatio contextRef="I2018Q4Oct30_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" decimals="INF" id="Fact-15B5A8B3A4CB27DC6369BF833AC70A36" unitRef="number">3.75</ccrn:DebtCovenantConsolidatedTotalLeverageRatio>
	<ccrn:DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" id="Fact-7DA3ABE58425431D151AA9ED1276F52C">P3Y</ccrn:DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate>
	<ccrn:DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-D92B52711961C32F6C7DA9ED123BE1EE" unitRef="number">0.0200</ccrn:DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault>
	<ccrn:DebtInstrumentPeriodicPaymentPercentageOfPrincipal contextRef="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_FirstEightInstallmentsMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="5" id="Fact-DFDF4BA456F8CCE48AC7A9ED125B2254" unitRef="number">0.01875</ccrn:DebtInstrumentPeriodicPaymentPercentageOfPrincipal>
	<ccrn:DebtInstrumentPeriodicPaymentPercentageOfPrincipal contextRef="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_DebtInstrumentRedemptionPeriodAxis_ccrn_RemainingInstallmentsMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="3" id="Fact-92C34AD5F6BEC7D62A13A9ED126B8052" unitRef="number">0.025</ccrn:DebtInstrumentPeriodicPaymentPercentageOfPrincipal>
	<ccrn:DebtInstrumentPrepaymentPenalty contextRef="D2016Q2June22" decimals="-5" id="Fact-D38D8D90A057ABBB9D28A9ED11D218AF" unitRef="usd">600000</ccrn:DebtInstrumentPrepaymentPenalty>
	<ccrn:DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses contextRef="FI2017Q4" decimals="-3" id="Fact-893A5EA6954458A163E7A9ED11CF04A5" unitRef="usd">2955000</ccrn:DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses>
	<ccrn:DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses contextRef="FI2018Q4" decimals="-3" id="Fact-7924DB741681AD47CA22A9ED121633FC" unitRef="usd">2734000</ccrn:DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses>
	<ccrn:DeferredTaxAssetsLiabilities contextRef="FI2017Q4" decimals="-3" id="Fact-4579F8C058185922741BA9ED11D7CF5F" unitRef="usd">20114000</ccrn:DeferredTaxAssetsLiabilities>
	<ccrn:DeferredTaxAssetsLiabilities contextRef="FI2018Q4" decimals="-3" id="Fact-500F789E0AC8318CF4A1A9ED122DB395" unitRef="usd">23655000</ccrn:DeferredTaxAssetsLiabilities>
	<ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount contextRef="FD2016Q4YTD" decimals="-3" id="Fact-5F548429CC72E4EC9C83BFF74B350E08" unitRef="usd">0</ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount>
	<ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C247FE72FCBE91FC8B07BFF74B0AF7F0" unitRef="usd">0</ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount>
	<ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount contextRef="FD2018Q4YTD" decimals="-3" id="Fact-552A3855E99CC447AEFABFF74AFB4D5E" unitRef="usd">458000</ccrn:EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount>
	<ccrn:FairValueInputsForecastPeriod contextRef="FD2018Q4YTD_us-gaap_ValuationTechniqueAxis_ccrn_IncomeandMarketApproachValuationTechniqueMember" id="Fact-404C67A5FBD05A3E36C5A9ED125C5C41">P10Y</ccrn:FairValueInputsForecastPeriod>
	<ccrn:FairValueInputsRatioofTotalEnterpriseValuebyEBITDA contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember" decimals="INF" id="Fact-89A0C632D37E45073F61A9ED126C127A" unitRef="number">10.5</ccrn:FairValueInputsRatioofTotalEnterpriseValuebyEBITDA>
	<ccrn:FairValueInputsRatioofTotalEnterpriseValuebyEBITDA contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember" decimals="INF" id="Fact-8DD548949EDDAB05018EA9ED11FFF793" unitRef="number">3.0</ccrn:FairValueInputsRatioofTotalEnterpriseValuebyEBITDA>
	<ccrn:FairValueInputsTerminalValueGrowthRate contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="3" id="Fact-BE658A0109FD7819B9D8A9ED1254C83B" unitRef="number">0.030</ccrn:FairValueInputsTerminalValueGrowthRate>
	<ccrn:FairValueInputsTerminalValueGrowthRate contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="3" id="Fact-B919B7DA2AF07360C14EBF5DD31491FE" unitRef="number">0.010</ccrn:FairValueInputsTerminalValueGrowthRate>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="2" id="Fact-20B281D4CDA2ABECDE7CA9ED126ADB8A" unitRef="number">0.50</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember" decimals="2" id="Fact-9C771D0DC65A39C26B01A9ED12184C89" unitRef="number">0.50</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="2" id="Fact-045B35220CBFC4311379A9ED11D60220" unitRef="number">0.75</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember" decimals="2" id="Fact-2816FB5AA713ED4994CFA9ED126C05C0" unitRef="number">0.25</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_SearchReportingUnitMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="2" id="Fact-34187F540D63CF907EB1A9ED12096AD8" unitRef="number">0.75</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueInputsWeightingApplied contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_SearchReportingUnitMember_us-gaap_ValuationTechniqueAxis_us-gaap_MarketApproachValuationTechniqueMember" decimals="2" id="Fact-D6F3E44D353685B835B5A9ED120EC50A" unitRef="number">0.25</ccrn:FairValueInputsWeightingApplied>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-0909CADDD225F00E0888A9ED1218E354" unitRef="usd">967000</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-B27FA6C27B0612EB5ED8A9ED121A9710" unitRef="usd">0</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-21E611F3C9198070A1B8A9ED1228D0B3" unitRef="usd">903000</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-A358CEF0B071623F75EBA9ED122CD712" unitRef="usd">0</ccrn:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense>
	<ccrn:GoodwillImpairmentTestMeasurementInput contextRef="FI2016Q2_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="INF" id="Fact-E4CB716467F399D9389FA9ED11D79B12" unitRef="number">0.135</ccrn:GoodwillImpairmentTestMeasurementInput>
	<ccrn:GoodwillImpairmentTestMeasurementInput contextRef="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="INF" id="Fact-449D0BC0C826B83342A9A9ED1256B31D" unitRef="number">0.150</ccrn:GoodwillImpairmentTestMeasurementInput>
	<ccrn:GoodwillImpairmentTestMeasurementInput contextRef="FI2018Q4_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_us-gaap_IncomeApproachValuationTechniqueMember" decimals="INF" id="Fact-18C1E26A67C504BF066DA9ED11D5EF05" unitRef="number">0.12</ccrn:GoodwillImpairmentTestMeasurementInput>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-30ED5C4F7486DF89F535A9ED11EBB46A" unitRef="usd">9889000</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-FF358737A60AC558CEE3A9ED11E2B0D4" unitRef="usd">0</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-74DBA828B09C2BA5B498A9ED11E65BA7" unitRef="usd">9889000</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-A55E0029F94833664C8FA9ED12806ED0" unitRef="usd">0</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-BD27B4EC882F0CA08F49A9ED11D853FA" unitRef="usd">9889000</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-6ABEC2B4790B183D2836A9ED11E8A0E4" unitRef="usd">0</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-42C50B4DC210334A373EA9ED11FA4771" unitRef="usd">9889000</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:GoodwillWriteOffRelatedToSaleOfBusiness contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-D8D6A8E5B60C451C616AA9ED11F3F84C" unitRef="usd">0</ccrn:GoodwillWriteOffRelatedToSaleOfBusiness>
	<ccrn:InsuranceRecoveryForWorkersCompensationCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-5844A592D03578B0F69CA9ED121BF88E" unitRef="usd">1623000</ccrn:InsuranceRecoveryForWorkersCompensationCurrent>
	<ccrn:InsuranceRecoveryForWorkersCompensationCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-DB897E3169FBC23EF81BA9ED121EF1F9" unitRef="usd">2295000</ccrn:InsuranceRecoveryForWorkersCompensationCurrent>
	<ccrn:InsuranceRecoveryForWorkersCompensationNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-1C94E17C7EA0A4500CADA9ED12542E79" unitRef="usd">6093000</ccrn:InsuranceRecoveryForWorkersCompensationNoncurrent>
	<ccrn:InsuranceRecoveryForWorkersCompensationNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-C8F72E4A642BF3B66105A9ED1225CD9D" unitRef="usd">5280000</ccrn:InsuranceRecoveryForWorkersCompensationNoncurrent>
	<ccrn:JointVenturePercentOwnership contextRef="FI2018Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="2" id="Fact-6B78A7CA998B63F7F6ECA9ED11F2411A" unitRef="number">0.68</ccrn:JointVenturePercentOwnership>
	<ccrn:LeaseExpirationPeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-F6FCD7F39D20F2D84E433060AF93D28A">P6M</ccrn:LeaseExpirationPeriod>
	<ccrn:LeaseExpirationPeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-69DEE446043217D1CE5A306088BAF512">P3M</ccrn:LeaseExpirationPeriod>
	<ccrn:LineOfCreditFacilityAdditionalCapacity contextRef="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="INF" id="Fact-FA24675969C22BDB4665BF814032AF0C" unitRef="usd">50000000.0</ccrn:LineOfCreditFacilityAdditionalCapacity>
	<ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-8B6C6CE13B6FBF974144A9ED12318A17" unitRef="usd">15000000.0</ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans>
	<ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans contextRef="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-6A4808DE84502D18195EBF80E8144695" unitRef="usd">15000000.0</ccrn:LineOfCreditFacilitySubFacilityForSwinglineLoans>
	<ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-902F30C95973D674333AA9ED12644752" unitRef="usd">35000000.0</ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit>
	<ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit contextRef="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-79EE0F1A31B9AA81C14FBF8113C13A19" unitRef="usd">35000000.0</ccrn:LineOfCreditFacilitySubLimitForLettersOfCredit>
	<ccrn:MalpracticeInsurancePolicySelfInsuredRetentionPerClaim contextRef="FI2018Q4_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember" decimals="-5" id="Fact-E8C8C694AB78D44C1A83A9ED124A35F1" unitRef="usd">500000</ccrn:MalpracticeInsurancePolicySelfInsuredRetentionPerClaim>
	<ccrn:NumberofFinancialCovenants contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-C8A1EC8A4A3B7515A7D3A9ED124FB550" unitRef="financial_covenant">2</ccrn:NumberofFinancialCovenants>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3C973002D75B50ADEE21A9ED123C2456" unitRef="usd">79722000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-16D12AE6C340EBC19F52A9ED11F95E40" unitRef="usd">71992000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-FC81DE405BFD40E75DC0A9ED12471122" unitRef="usd">-535000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-5C2A3035505F08CF328AA9ED124C63E0" unitRef="usd">8265000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2017Q4YTD" decimals="-3" id="Fact-AFE3EC2F2B9FC2F93FEBA9ED1249FCF5" unitRef="usd">78513000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-2654381EBCAED3D8B3DBA9ED12493683" unitRef="usd">73614000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-350EC0A41518AB98D30DA9ED123A947F" unitRef="usd">-357000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-D7A519212FC88FDC6719A9ED124CD6EF" unitRef="usd">5256000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CDAABEC7DA5F4DE05764A9ED122C275A" unitRef="usd">71718000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-EEA90F66C71FD03F1F2DA9ED124B6814" unitRef="usd">66365000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-6AFDB0F4D34C310B7175A9ED123962CC" unitRef="usd">598000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-C77076A2EED5BC364D54A9ED11FA45F6" unitRef="usd">4755000</ccrn:OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses>
	<ccrn:OtherLiabilitiesMiscellaneousNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E574C8FB42C363105369A9ED121AD267" unitRef="usd">344000</ccrn:OtherLiabilitiesMiscellaneousNoncurrent>
	<ccrn:OtherLiabilitiesMiscellaneousNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-F34E2680CFF5E73CFD66A9ED1265E8AF" unitRef="usd">318000</ccrn:OtherLiabilitiesMiscellaneousNoncurrent>
	<ccrn:OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan contextRef="FI2017Q4" decimals="-5" id="Fact-CC2FB35C9C261AAA9AFCA9ED12378139" unitRef="usd">19600000</ccrn:OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan>
	<ccrn:OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan contextRef="FI2018Q4" decimals="-5" id="Fact-8FAFCCA266C3990CAAD0BF0AB66EF13D" unitRef="usd">18800000</ccrn:OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan>
	<ccrn:PaymentForDebtPrepayment contextRef="FD2018Q3QTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-5" id="Fact-9240C8EA602A2D196D20BF8175D13A99" unitRef="usd">5000000</ccrn:PaymentForDebtPrepayment>
	<ccrn:PaymentForDebtPrepayment contextRef="FD2018Q4QTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-5" id="Fact-3677EABE9804DEBA326134BD00E5855C" unitRef="usd">5000000</ccrn:PaymentForDebtPrepayment>
	<ccrn:PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-5DC8B1C0F3E22AC527CEA9ED11F5B22D" unitRef="usd">5600000</ccrn:PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt>
	<ccrn:PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-623F529183E8CA16B346A9ED124EFE24" unitRef="usd">7500000</ccrn:PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities>
	<ccrn:PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-A1A461674B13754ACAD6A9ED12728D72" unitRef="usd">14500000</ccrn:PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities>
	<ccrn:ProvisionforDoubtfulAccountsandOtherAllowances contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BB1D2D70628CA7932568A9ED11FB0519" unitRef="usd">4034000</ccrn:ProvisionforDoubtfulAccountsandOtherAllowances>
	<ccrn:ProvisionforDoubtfulAccountsandOtherAllowances contextRef="FD2017Q4YTD" decimals="-3" id="Fact-05B1933235DF44580EF1A9ED11E00F0F" unitRef="usd">4705000</ccrn:ProvisionforDoubtfulAccountsandOtherAllowances>
	<ccrn:ProvisionforDoubtfulAccountsandOtherAllowances contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CECC9DD0601C9488401FA9ED11F2AC21" unitRef="usd">5974000</ccrn:ProvisionforDoubtfulAccountsandOtherAllowances>
	<ccrn:RepatriationOfForeignEarningsAmount contextRef="FD2018Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" decimals="-5" id="Fact-4810FC899968576204CAA9ED125E26F6" unitRef="usd">500000</ccrn:RepatriationOfForeignEarningsAmount>
	<ccrn:RestructuringChargesWriteOffRelatedToAbandonment contextRef="FD2018Q4YTD_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-5" id="Fact-50BCC55ED37D13D19359BF17287A44F7" unitRef="usd">400000</ccrn:RestructuringChargesWriteOffRelatedToAbandonment>
	<ccrn:SegmentReportingUnallocatedCorporateExpenses contextRef="FD2016Q4YTD" decimals="-3" id="Fact-98B62719B495F60A4C26A9ED124ADAC1" unitRef="usd">38400000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
	<ccrn:SegmentReportingUnallocatedCorporateExpenses contextRef="FD2017Q4YTD" decimals="-3" id="Fact-49580FCA9F52049D08FBA9ED12457EF0" unitRef="usd">39190000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
	<ccrn:SegmentReportingUnallocatedCorporateExpenses contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E1BF250FBEAE91B81575A9ED1200E0DA" unitRef="usd">44589000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
	<ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" id="Fact-A8ADD1B224FC701721B4A9ED12296C08">P10Y</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod>
	<ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember_us-gaap_TitleOfIndividualAxis_ccrn_TenPercentOrMoreStockholdersMember" id="Fact-37521D45C9C5252CD559A9ED11ECE876">P5Y</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod>
	<ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_StockAppreciationRightsSARSMember_us-gaap_PlanNameAxis_ccrn_IncentiveCompensationPlan2007Member" id="Fact-795F7C530FC8344C9041A9ED1261AE5C">P7Y</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod>
	<ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_StockAppreciationRightsSARSMember_us-gaap_PlanNameAxis_ccrn_IncentiveCompensationPlan2007Member" decimals="INF" id="Fact-F7F7C27ACDDC19F3B01DA9ED11F118C1" unitRef="number">0.25</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested>
	<ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage contextRef="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="2" id="Fact-41EFCA6D8595761A982DA9ED12383D0E" unitRef="number">0.48</ccrn:SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage>
	<ccrn:StockRepurchasedDuringPeriodPricePerShare contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-110AB19171308E508C17BFD652350F2D" unitRef="usdPerShare">11.54</ccrn:StockRepurchasedDuringPeriodPricePerShare>
	<ccrn:TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-FBA694A21EECCC24517BA9ED123D780E" unitRef="usd">200000</ccrn:TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense>
	<ccrn:TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense contextRef="FD2018Q4YTD" decimals="-5" id="Fact-36EE0A3152AD756553B7BFF1BEF31E45" unitRef="usd">100000</ccrn:TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense>
	<ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-1484AE6F59DE13C9415FA9ED1281940E">P60D</ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided>
	<ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-247DD9CF8762A1CAC191A9ED12100671">P15D</ccrn:ThresholdPeriodPastDueforPaymentofServicesProvided>
	<ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CFBA0A2DEBD7DB166A88A9ED1280D95A" unitRef="usd">0</ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions>
	<ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C34CC6BBF0E8A01B71C1A9ED11DBDE20" unitRef="usd">-220000</ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions>
	<ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C10C2EE2A674014E5A30A9ED11CE9D1E" unitRef="usd">0</ccrn:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions>
	<ccrn:UnrecognizedTaxBenefitsPeriodGrossIncreases contextRef="FD2018Q4YTD" decimals="-5" id="Fact-B346DC8496B0DBF5F4F2A9ED12549551" unitRef="usd">1600000</ccrn:UnrecognizedTaxBenefitsPeriodGrossIncreases>
	<ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6465B1D8930ABA756108A9ED11D513FC" unitRef="usd">0</ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange>
	<ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange contextRef="FD2017Q4YTD" decimals="-3" id="Fact-55ECC1BC3157030CDDCCA9ED125BC6DC" unitRef="usd">1859000</ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange>
	<ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A711B8E9EB23BEC2D456A9ED11D2A6D5" unitRef="usd">0</ccrn:UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange>
	<dei:AmendmentFlag contextRef="FD2018Q4YTD" id="Fact-AA641BCBDEDE1DE51239A9ED1220ABA9">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2018Q4YTD" id="Fact-57FE6D565EE144117585A9ED12246328">--12-31</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2018Q4YTD" id="Fact-BE43980E7A18D6E6F7DEA9ED1220ADF0">FY</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2018Q4YTD" id="Fact-4C598EE319213732BD9AA9ED1226F41E">2018</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2018Q4YTD" id="Fact-B685EE40AC1482D15B92A9ED122374F8">2018-12-31</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2018Q4YTD" id="Fact-F3556689E311AF2E705AA9ED12231D69">10-K</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2018Q4YTD" id="Fact-E434C89F6FB2120665D8A9ED1221E7D8">0001141103</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2019Q1Feb22" decimals="INF" id="Fact-826A4D42B828CA179148A9ED12237BFD" unitRef="shares">36139876</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityCurrentReportingStatus contextRef="FD2018Q4YTD" id="Fact-4FD6B6CA718C3C7AF45CA9ED12245A52">Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityEmergingGrowthCompany contextRef="FD2018Q4YTD" id="Fact-C515C6F95D54DD7346D2AA017338A762">false</dei:EntityEmergingGrowthCompany>
	<dei:EntityFilerCategory contextRef="FD2018Q4YTD" id="Fact-3205EE51434746590E3BA9ED12232118">Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityPublicFloat contextRef="FI2018Q2" decimals="0" id="Fact-87C9847D89E1BD30C83DA9ED122348C4" unitRef="usd">395272643</dei:EntityPublicFloat>
	<dei:EntityRegistrantName contextRef="FD2018Q4YTD" id="Fact-D3716F9AB15897C9DA3BA9ED122334D6">CROSS COUNTRY HEALTHCARE INC</dei:EntityRegistrantName>
	<dei:EntityShellCompany contextRef="FD2018Q4YTD" id="Fact-E1E035528A504F6DC7A8AA01D5E146F1">false</dei:EntityShellCompany>
	<dei:EntitySmallBusiness contextRef="FD2018Q4YTD" id="Fact-22C28BD2CD4849BC8D24AA01727FA684">false</dei:EntitySmallBusiness>
	<dei:EntityVoluntaryFilers contextRef="FD2018Q4YTD" id="Fact-0BEECB8454D4C35DA52FA9ED12240C61">No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef="FD2018Q4YTD" id="Fact-B6338DDA0D07FE55E51FA9ED1222DC3B">No</dei:EntityWellKnownSeasonedIssuer>
	<dei:TradingSymbol contextRef="FD2018Q4YTD" id="Fact-42A6A27759DEBE42AF06A9ED122172EE">CCRN</dei:TradingSymbol>
	<invest:DerivativeNotionalAmount contextRef="FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" decimals="-5" id="Fact-62F9BEF74430692C7F49BF97477EB3D3" unitRef="usd">48800000</invest:DerivativeNotionalAmount>
	<us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C9A1EB2E20CDB0264AB5A9ED1265B9DD" unitRef="usd">50597000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
	<us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-B245B66E0DBA0CF66EBFA9ED127B1EE7" unitRef="usd">43744000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-15626FD3C31ABA349D5DA9ED12755E2D" unitRef="usd">173603000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-12B7622EB9C6301CFEA8A9ED125E4867" unitRef="usd">166128000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableRelatedParties contextRef="FI2017Q4" decimals="-5" id="Fact-3F9A2F847795761DBB20A9ED11F85453" unitRef="usd">400000</us-gaap:AccountsReceivableRelatedParties>
	<us-gaap:AccountsReceivableRelatedParties contextRef="FI2018Q4" decimals="-5" id="Fact-0339BAD363B083218114BFC5AC15FBD8" unitRef="usd">100000</us-gaap:AccountsReceivableRelatedParties>
	<us-gaap:AccruedBonusesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C1002920DA066840FEDEA9ED123624FB" unitRef="usd">2067000</us-gaap:AccruedBonusesCurrent>
	<us-gaap:AccruedBonusesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-8B5B3C30746489A7BE81A9ED125C9DAD" unitRef="usd">1476000</us-gaap:AccruedBonusesCurrent>
	<us-gaap:AccruedRentCurrentAndNoncurrent contextRef="FI2018Q4_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201602Member" decimals="-5" id="Fact-812D13D48300832B678C3100F99C23A5" unitRef="usd">-7200000</us-gaap:AccruedRentCurrentAndNoncurrent>
	<us-gaap:AccruedSalariesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-866D0D5451DB9A1A1676A9ED12786A25" unitRef="usd">16342000</us-gaap:AccruedSalariesCurrent>
	<us-gaap:AccruedSalariesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-084AC58098313593358FA9ED1228EBB1" unitRef="usd">15884000</us-gaap:AccruedSalariesCurrent>
	<us-gaap:AccruedVacationCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-4519BCC2EB49EC9401A6A9ED1250796C" unitRef="usd">2117000</us-gaap:AccruedVacationCurrent>
	<us-gaap:AccruedVacationCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-7DB1D2533DBF8997C2D3A9ED12469C6C" unitRef="usd">1574000</us-gaap:AccruedVacationCurrent>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2017Q4" decimals="-3" id="Fact-91AEC768B3B458E60C33A9ED120603B2" unitRef="usd">30678000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2018Q4" decimals="-3" id="Fact-AC08BB1C762913865097A9ED120B46FF" unitRef="usd">33476000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2017Q4" decimals="-5" id="Fact-02303F1471733D16AEAAA9ED1235F201" unitRef="usd">-1200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2018Q4" decimals="-5" id="Fact-51A0A22554E78E36A784BF17F4E134CB" unitRef="usd">-1300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q4" decimals="-3" id="Fact-FDFFC0B2EC76BE432102A9ED1260A43A" unitRef="usd">-1166000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2018Q4" decimals="-3" id="Fact-4C078218A4D50AA14459A9ED126EF053" unitRef="usd">-1462000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" id="Fact-FBBCA1323638F4D21DB6A9ED11DF4A4F">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" id="Fact-4B4DF6925DC6DC0A9CFDA9ED11DBA24F">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" id="Fact-334AF760D7F5012BDB57A9ED12170C07">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" id="Fact-D45BCB9A2E5F74567093A9ED12507396">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" id="Fact-A8D11F7A18129E1C206BA9ED1279B38B">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2018Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member" id="Fact-AC204D3E547F332B756FE5E8659DC8A2">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2017Q4" decimals="-3" id="Fact-F43691B5F34B1146A8C3A9ED1261D479" unitRef="usd">305362000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2018Q4" decimals="-3" id="Fact-A1AD4928D88180EB6816A9ED125FF041" unitRef="usd">303048000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2016Q4YTD" decimals="-3" id="Fact-01431BB9915853E6F923A9ED12222B59" unitRef="usd">3379000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-FE96DED858B7FC9B35DFA9ED121C455A" unitRef="usd">3379000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E8CB148E339D351BFC63A9ED1219716E" unitRef="usd">4080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-A850DAD903743E248ECAA9ED12261AF9" unitRef="usd">4080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2018Q4YTD" decimals="-3" id="Fact-ADDA543D301764D338CCA9ED12271978" unitRef="usd">3575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-7E442C91272D919D8F1EA9ED120BF53F" unitRef="usd">3575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdvertisingExpense contextRef="FD2016Q4YTD" decimals="-5" id="Fact-915C3488D96180623CABA9ED12473904" unitRef="usd">10200000</us-gaap:AdvertisingExpense>
	<us-gaap:AdvertisingExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-72A43170C8A58333D924A9ED12493594" unitRef="usd">7600000</us-gaap:AdvertisingExpense>
	<us-gaap:AdvertisingExpense contextRef="FD2018Q4YTD" decimals="-5" id="Fact-698F0E75B3CD9F9371F1BF1472DA9219" unitRef="usd">6700000</us-gaap:AdvertisingExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD" decimals="-5" id="Fact-B7E076C395CEEB5E5679A9ED123B5D3D" unitRef="usd">3400000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-1A4394FCFFD5221F0902A9ED123A116D" unitRef="usd">4100000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD" decimals="-5" id="Fact-231119674A7C39171707BF1422FEC7AC" unitRef="usd">3600000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-3C8F749537C586704127A9ED127FB170" unitRef="usd">3688000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-8A3A2C860657BAE28BFDA9ED12809261" unitRef="usd">3705000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AmortizationOfFinancingCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-FC2086F3D6C7599E3944A9ED11DC897A" unitRef="usd">1728000</us-gaap:AmortizationOfFinancingCosts>
	<us-gaap:AmortizationOfFinancingCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-75CB325270A11C2C42BFA9ED11E2AC31" unitRef="usd">651000</us-gaap:AmortizationOfFinancingCosts>
	<us-gaap:AmortizationOfFinancingCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-DC0CD3B1E9EFAD97165BA9ED11DBB3C5" unitRef="usd">448000</us-gaap:AmortizationOfFinancingCosts>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q4QTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-5477C83583BDCEB7EF97FE546D3D3B6C" unitRef="usd">100000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2016Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" decimals="-3" id="Fact-DAF4E36DF6011FF4B790A9ED1267883F" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2017Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" decimals="-3" id="Fact-2AAF64C276D9518D213BA9ED126D3227" unitRef="shares">118000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q4YTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" decimals="-3" id="Fact-23E63769E656FA435603A9ED126171B2" unitRef="shares">373000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax contextRef="FI2018Q4" decimals="-5" id="Fact-66F854E3A4C9D1DD0AF3BF1E0FB704C9" unitRef="usd">-200000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
	<us-gaap:AssetImpairmentCharges contextRef="D2016Q2June30_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-D6D31E525ABA2A47985DA9ED1276D8BE" unitRef="usd">24300000</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A3268FCD2E8B56EBB12BA9ED124A6E83" unitRef="usd">24311000</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2017Q4QTD" decimals="-5" id="Fact-365AA05DDF4179B8BCE8BFB50C4AC7E4" unitRef="usd">14400000</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A69C8C4B69A64B1967ECA9ED1234C5DC" unitRef="usd">14356000</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2018Q4QTD" decimals="-5" id="Fact-9F12CD5284904BF5153AA9ED11D2AAF4" unitRef="usd">22400000</us-gaap:AssetImpairmentCharges>
	<us-gaap:AssetImpairmentCharges contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E61EF69FF2609297A38FA9ED12322C60" unitRef="usd">22423000</us-gaap:AssetImpairmentCharges>
	<us-gaap:Assets contextRef="FI2017Q4" decimals="-3" id="Fact-10189D814A073C1C00E5A9ED127085F9" unitRef="usd">467687000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q4" decimals="-3" id="Fact-3485B2F6CC7A2A006E3EA9ED1265BAAC" unitRef="usd">427003000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-232CAF0D614A1A18B2DEA9ED126B2D6D" unitRef="usd">208887000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-BBD486F31500768FF59CA9ED127A7BCC" unitRef="usd">194905000</us-gaap:AssetsCurrent>
	<us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="INF" id="Fact-A28757EE1A1AFECA8D2FA9ED1272EB08" unitRef="shares">349871</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="FD2016Q4YTD" decimals="2" id="Fact-F74768014C69E82DA24FA9ED12213865" unitRef="usdPerShare">0.35</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="FD2017Q4YTD" decimals="2" id="Fact-F3A703E1548B46CC331FA9ED12317128" unitRef="usdPerShare">1.16</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="FD2016Q4YTD" decimals="2" id="Fact-728C9FAD6D4B6A2E9C1CA9ED12218B88" unitRef="usdPerShare">0.25</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="FD2017Q4YTD" decimals="2" id="Fact-B5302A0EBDF80193B3DEA9ED1225AA81" unitRef="usdPerShare">1.09</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
	<us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-19C92EBBA97E10A0AFFDA9ED11FEFF25" unitRef="usd">43600000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
	<us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A8FA834BB9C6B681189AA9ED121AF2AF" unitRef="usd">11391000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
	<us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0A35652288CC51961AF4A9ED12151E18" unitRef="usd">40255000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
	<us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7C77C062B1E2BA47F629A9ED1227830F" unitRef="usd">934904000</us-gaap:BusinessAcquisitionsProFormaRevenue>
	<us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="FD2017Q4YTD" decimals="-3" id="Fact-F1C9E6810F528FFF04B5A9ED1224FC68" unitRef="usd">916149000</us-gaap:BusinessAcquisitionsProFormaRevenue>
	<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1388856592D0E91FFD8BA9ED1251BC45" unitRef="usd">78000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
	<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-ADFC5FF5DAED303F3D1BA9ED12452AF6" unitRef="usd">1975000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
	<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="FD2017Q4YTD_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-43DB44132D341FBA373DA9ED126EB56D" unitRef="usd">2000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
	<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D75528F9691F57710B04A9ED1235FB99" unitRef="usd">491000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
	<us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="FD2018Q4YTD_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member" decimals="-5" id="Fact-EE3FE96795A2FEA2EAA3E5E8ED115798" unitRef="usd">200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2017Q3July1_ccrn_BusinessCombinationConsiderationTransferredAxis_ccrn_NetWorkingCapitalAdjustmentsMember_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-8381DCBBBA0885A301ABA9ED11D33E96" unitRef="usd">-1438000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2017Q3July1_ccrn_BusinessCombinationConsiderationTransferredAxis_ccrn_PurchasePriceMember_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-9B694CE57EEA6E17AD4EA9ED11D31D03" unitRef="usd">88000000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2017Q3July1_ccrn_BusinessCombinationConsiderationTransferredAxis_ccrn_PurchasePriceMember_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-BBCFB0869D96EC9798A0A9ED11D42548" unitRef="usd">88000000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2018Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member" decimals="-5" id="Fact-9DA93181E24182E0AB91E5E6C45D9619" unitRef="usd">2000000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-87BD94A9107675295795A9ED126831ED" unitRef="usd">4700000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="D2016Q1Mar31_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" decimals="-5" id="Fact-29D183899DD625F6BAB3A9ED11FF487A" unitRef="usd">-400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="D2017Q4JulyDec_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-054CC2A13E92BE3DF535A9ED1221BB33" unitRef="usd">-500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2017Q4QTD_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AcquisitionRelatedContingentConsiderationMember" decimals="-5" id="Fact-2288BB67256F40871A10A9ED126D044E" unitRef="usd">-1300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="FI2016Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-4EC8424BC0DFA4C70EF5BF53B62DB7F3" unitRef="usd">300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="FI2017Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-74622D09C9E71C69E164A9ED1246DB33" unitRef="usd">300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-63F500C2E9F9B0527675A9ED1271DCA0" unitRef="usd">300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-D04B6CD00C4C41E05B04A9ED126EB428" unitRef="usd">7000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" decimals="-5" id="Fact-E5E5965FD9FCB36585A0A9ED12537C9A" unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2015Q4Oct30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" decimals="-5" id="Fact-10374B274F770FB8ADCCA9ED1234B8C9" unitRef="usd">3500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember" decimals="-5" id="Fact-2DC1FE363B433459AE70A9ED11EA001F" unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" decimals="-5" id="Fact-84907A6D830A0FCEA862A9ED126C0CF7" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" decimals="-5" id="Fact-2889CB04DA59CCFC6BBBA9ED12732AA7" unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="I2016Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_USResourcesHealthcareLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" decimals="-5" id="Fact-F41B3A68A1C7C2C58785A9ED11E12CFC" unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2014Q2_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember" decimals="-5" id="Fact-ED2B6A60029A5C1F6673A9ED121F8509" unitRef="usd">2500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-3" id="Fact-7D41F3590F319A4CE9A5A9ED1214245E" unitRef="usd">5368000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-302FF3451A66609E12D4A9ED1204F870" unitRef="usd">100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" decimals="-5" id="Fact-96C569B495D40D78A894A9ED1275D97D" unitRef="usd">7700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-3" id="Fact-EF9DA471B8506085928FA9ED1212147E" unitRef="usd">7689000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2016Q2April1_us-gaap_BusinessAcquisitionAxis_ccrn_MedicalStaffingNetworkMember" decimals="-5" id="Fact-23D8A467CADD737F75B0A9ED126FC489" unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_ContingentConsiderationByTypeAxis_ccrn_DeferredConsiderationTransferredMember" decimals="-5" id="Fact-4BDE608E49693D3C62A4A9ED1274FE53" unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-D523117232320D9FA8B8A9ED127AFC4F" unitRef="usd">5088000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-C7AC5421B928912AAEE2A9ED127A477E" unitRef="usd">7409000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual contextRef="D2017Q4JulyDec_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-63DA6B3F1EBCCA40503FA9ED11D0591D" unitRef="usd">3800000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
	<us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="D2017Q4JulyDec_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-99DB4A2314D7AB780F6FA9ED12579D86" unitRef="usd">47000000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-599F756B68CB6DDCEB4AA9ED1279874F" unitRef="usd">91450000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-92C0F56D3C7179E2287EA9ED1277B7C7" unitRef="usd">2833000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-45E6CB9EAED835E9418FA9ED1277F55E" unitRef="usd">392000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-A862B570BDC5ADB2762DA9ED12769F21" unitRef="usd">14396000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-439D8E8C25DFDA800535A9ED127AA655" unitRef="usd">368000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-2694ECC29EFD89E1027AA9ED127A38B5" unitRef="usd">2000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-E2253D2187F924CA5DDBA9ED127861FF" unitRef="usd">29900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-87AF3A20888D6546B08EA9ED1276D84F" unitRef="usd">2055000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-33F57B861A23012F4A4FA9ED1279ACEE" unitRef="usd">89395000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-BA81B836AC0BF6E5EB94A9ED1278E4FB" unitRef="usd">333000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
	<us-gaap:CashAcquiredFromAcquisition contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-8759AF2E0F986794D5C8A9ED11D42777" unitRef="usd">2833000</us-gaap:CashAcquiredFromAcquisition>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2015Q4" decimals="-3" id="Fact-4BE07A49B74843106958A9ED11F91E85" unitRef="usd">2453000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q4" decimals="-3" id="Fact-B0C5E4065061DE6D962CA9ED11F3D6E9" unitRef="usd">20630000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q4" decimals="-3" id="Fact-265F3F05E51F769CFC24A9ED1263671C" unitRef="usd">25537000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q4" decimals="-3" id="Fact-CC5B714EEF32582E9C03A9ED12727AFA" unitRef="usd">16019000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2016Q4YTD" decimals="-3" id="Fact-47CFA808DDF290038382A9ED11F0E72E" unitRef="usd">18177000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2017Q4YTD" decimals="-3" id="Fact-CC5E4EA3C424B014B2F0A9ED11D2A2C5" unitRef="usd">4907000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2018Q4YTD" decimals="-3" id="Fact-66D38BC31FDEBCBFDDCDA9ED11E45DD9" unitRef="usd">-9518000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CommitmentsAndContingencies contextRef="FI2017Q4" id="Fact-4A3C8BEB5215E7552963A9ED127378FE" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommitmentsAndContingencies contextRef="FI2018Q4" id="Fact-211EBEA497BB3719E068A9ED127982BA" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="I2017Q2May23_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-F469545CCE2FAE182F8AA9ED1233100C" unitRef="shares">6100000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2017Q4" decimals="INF" id="Fact-54D7435A5F62F83F388BA9ED127D192D" unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2018Q4" decimals="INF" id="Fact-05B63DBE700AD0785DE3A9ED127DC593" unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-E48A4AE826FD7E7BD6F3A9ED125DF102" unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2017Q4" decimals="INF" id="Fact-5E1DFA3A0E9C7E585234A9ED127C7553" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2018Q4" decimals="INF" id="Fact-9E7A58276A81E354319DA9ED127F588A" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="FI2017Q4" decimals="INF" id="Fact-A3F8C3D8F11ACD8089EEA9ED127E8F80" unitRef="shares">35838108</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="FI2018Q4" decimals="INF" id="Fact-F077BC30ABCC1E6F43D6A9ED127D8D70" unitRef="shares">35625692</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2017Q4" decimals="INF" id="Fact-16EDD2BDB760C5AC149AA9ED127D7658" unitRef="shares">35838108</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2018Q4" decimals="INF" id="Fact-84214241A36918B4C274A9ED11CE8F19" unitRef="shares">35625692</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockValue contextRef="FI2017Q4" decimals="-3" id="Fact-6C58FD6AF0C365BD3376A9ED1274F6B9" unitRef="usd">4000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2018Q4" decimals="-3" id="Fact-2A7F424F30F67DE94246A9ED127ADD75" unitRef="usd">4000</us-gaap:CommonStockValue>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-8639A5F8B944B3E15ADBA9ED1207459B" unitRef="usd">7933000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C52898AFE2EEC38D4641A9ED120A1AC6" unitRef="usd">37588000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-803513363291C8F2530CA9ED1205EEDE" unitRef="usd">-17248000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2016Q4YTD" decimals="-3" id="Fact-29A5D7FBEF36981F4205A9ED120CFEAB" unitRef="usd">8697000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2017Q4YTD" decimals="-3" id="Fact-CF7B721AECBDA37E475CA9ED12083962" unitRef="usd">38877000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="FD2018Q4YTD" decimals="-3" id="Fact-6DFF82E7C64EACD6868BA9ED120AF6B5" unitRef="usd">-16014000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2016Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" decimals="INF" id="Fact-8108069ADBB893909175C0053ACB0360" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2017Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" decimals="INF" id="Fact-8F2BC1880897436153C1C005376EAD2E" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:ConcentrationRiskPercentage1 contextRef="FD2018Q4YTD_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_ProductConcentrationRiskMember" decimals="INF" id="Fact-4413F7122EA791CDE219C0032D14E138" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
	<us-gaap:CostsAndExpenses contextRef="FD2016Q4YTD" decimals="-3" id="Fact-DAAA469BFE557126D7C0A9ED1230A970" unitRef="usd">827353000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C1BF48A037385C54F19CA9ED124DE883" unitRef="usd">853300000</us-gaap:CostsAndExpenses>
	<us-gaap:CostsAndExpenses contextRef="FD2018Q4YTD" decimals="-3" id="Fact-063E2CEB1612AC940F69A9ED1243FF11" unitRef="usd">829364000</us-gaap:CostsAndExpenses>
	<us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-3E2ACE789AF73DBEEA3CBEECD5B17B48" unitRef="usd">535000</us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1>
	<us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-498C0342F266C9DDEBFEBEECD5A1A5B7" unitRef="usd">-535000</us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F7792BE67B10FB37E2DAA9ED11FD3115" unitRef="usd">227000</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-601D05663030F1EEDF34A9ED122D8C3A" unitRef="usd">-555000</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-AE0A733265ACB00D9069A9ED123C81AE" unitRef="usd">43000</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-30304C59BD769D4E204BA9ED1200C421" unitRef="usd">322000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-02E3164A5292985DE3FAA9ED11E8A10D" unitRef="usd">139000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-42917E9FE944E0C4B651A9ED1233A58C" unitRef="usd">269000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BDC7B5F89918818E170DA9ED123A2EB6" unitRef="usd">1136000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8450CBB7D112854092D4A9ED12306789" unitRef="usd">-689000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-39F0944A7C737D26281AA9ED11F0426E" unitRef="usd">932000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-B96776FEB2F68AF429DCA9ED122C2333" unitRef="usd">587000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-33B556703ED62F5F54ECA9ED12383946" unitRef="usd">-273000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B2EE02A25169BD4ABF31A9ED11F131EF" unitRef="usd">620000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-61D4DBFD5E5A439EBA0DA9ED11CE54E0" unitRef="usd">46000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
	<us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="D2017Q1Marc17_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-56D5E60D3CF0B0281A85A9ED125EC3D1" unitRef="shares">3175584</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
	<us-gaap:DebtConversionOriginalDebtAmount1 contextRef="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_A8ConvertibleNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-C9A11361C3735253EBEBA9ED126CA244" unitRef="usd">20000000</us-gaap:DebtConversionOriginalDebtAmount1>
	<us-gaap:DebtConversionOriginalDebtAmount1 contextRef="D2017Q1Marc17_us-gaap_DebtInstrumentAxis_ccrn_ConvertibleNoteDerivativeLiabilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-1F6E661C8945C1A20F66A9ED12759BD6" unitRef="usd">26000000</us-gaap:DebtConversionOriginalDebtAmount1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-82BBB6CF141ED9ACCC5FA9ED124AA7CC" unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-870FCDE5A64BC35B23E5A9ED1265447A" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-874255914F77EB08C32334C767E3A10F" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-2280057674F7B8492AB8A9ED127C1E9C" unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-07D1A0316CDCD49C1545A9ED127CF6A7" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="D2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-721C17F11E5D90CD682B34C8E86EBDB6" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="4" id="Fact-90F662232C54B93D763434C00AC1D801" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-21C8AF92824B4C59EBABA9ED11E041B3" unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="4" id="Fact-80D9EFEB15163CC8C87DA9ED123AE007" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="4" id="Fact-63B5B7B9F71FAD7AE82634C008D0FC36" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="4" id="Fact-2C994D62BD4F606FF04534C00EE8BDED" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-1D3073E6B12F737A64F4A9ED124FB5A3" unitRef="number">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="4" id="Fact-73D9E837A75C04042202A9ED11E3D84F" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="4" id="Fact-BCBBFBC3F08950B8014E34C00CB4836F" unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="4" id="Fact-7913F56E7822C1A3B1A334C0132AACE7" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-2B03D30B21DFC50AAABDA9ED123CD228" unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="4" id="Fact-9EE1D2925ECAB3D28FA4A9ED122F74DE" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="4" id="Fact-7F917FD3882E9DB5CF4E34C011172D13" unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="4" id="Fact-0D3090A95C81264CEE4134C016EF7F18" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-6EC078E4A87026F39791A9ED11E327A8" unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="4" id="Fact-A7286D4040E892B5A904A9ED11F24953" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="4" id="Fact-A271F6120031901AD6FD34C0151F5D66" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_ccrn_LetterofCreditFeeMember" decimals="4" id="Fact-5165E0C4B71090C2BCAA34C01AD53A93" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-B994F8CA13AC62C0AA60A9ED11E729AB" unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="4" id="Fact-4E9C166562A5318B21F4A9ED11E213AB" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="4" id="Fact-F682D1E795C46A3CC1E934C0191F2A2C" unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q4YTD_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_VariableRateAxis_us-gaap_LondonInterbankOfferedRateLIBORMember" decimals="INF" id="Fact-5702888242D358988B7AA9ED1281748A" unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-551BCDE74F71851F15C5A9ED123066E1" unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-CC094A0DD5608ABE0669A9ED122FD8A1" unitRef="usd">83876000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-5B7729471ECF09BB4CB1A9ED125A890C" unitRef="usdPerShare">7.10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
	<us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-96C13EDE3894C9D9A42CA9ED11D14AE8" unitRef="instrument">3521126</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
	<us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-2E09E4FCD0B170559981A9ED127F7031" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
	<us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-A5DB1AF792D570270815A9ED125A9F88" unitRef="number">1.25</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
	<us-gaap:DebtInstrumentConvertibleThresholdTradingDays contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-58BAF3DCF7164071F920A9ED11E12E8F" unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
	<us-gaap:DebtInstrumentFaceAmount contextRef="FI2014Q2_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-4194962D1A22375C72E6A9ED126355C3" unitRef="usd">25000000.0</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-FDF0CBC63B4A90DA9707BF806D280431" unitRef="usd">215000000.0</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="INF" id="Fact-A4809C30331D24BDA8DABF805E51F9CB" unitRef="usd">100000000.0</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2017Q3July5_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="INF" id="Fact-758BFD1DDB5B0C02B263A9ED11FC669F" unitRef="usd">40000000.0</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-24DB60D542D3CF16EB93A9ED122ADE0D" unitRef="usd">100500000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-63EAACEF8EB91D41566DA9ED11DBEBC2" unitRef="usd">81800000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-798F9AA2E5E5AF4E27E7A9ED122F7302" unitRef="number">0.0361</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-E966C36283B9830AB52DA9ED127E3A30" unitRef="number">0.0480</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2017Q1March17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-B8C484B0ABB3232B4955A9ED126FDA1E" unitRef="number">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-EA57E57894C214AC4EB8BFA5AEE4FFDD" unitRef="usd">1500000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
	<us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-80FCE8AD92349FEC7465A9ED1270A278" unitRef="usd">1467000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
	<us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-34AD37DF5C0FD4D4530AA9ED122E7A72" unitRef="usd">1725000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
	<us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="FI2018Q4" decimals="-5" id="Fact-06F9081AE831F45FD09BA9ED12587FD7" unitRef="usd">1700000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
	<us-gaap:DeferredCompensationPlanAssets contextRef="FI2017Q4" decimals="-3" id="Fact-C867353D685A0DCAB599BF794145318D" unitRef="usd">0</us-gaap:DeferredCompensationPlanAssets>
	<us-gaap:DeferredCompensationPlanAssets contextRef="FI2018Q4" decimals="-3" id="Fact-1386895B81237DFD1504BF79413C0163" unitRef="usd">433000</us-gaap:DeferredCompensationPlanAssets>
	<us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-D5CC37445B2F89147AD4A9ED11F61BBC" unitRef="usd">-4114000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C6581BEB2E9B09386D3AA9ED12349709" unitRef="usd">-23245000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F49AA35E909F32F65944A9ED12348F07" unitRef="usd">-2137000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredFinanceCostsNet contextRef="FI2017Q4" decimals="-3" id="Fact-81793438A696C105498EA9ED1234A975" unitRef="usd">866000</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:DeferredFinanceCostsNet contextRef="FI2017Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-76B9140121CF727AE535A9ED1232D7FF" unitRef="usd">866000</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:DeferredFinanceCostsNet contextRef="FI2018Q4" decimals="-3" id="Fact-A8C2331052510EA49256A9ED122E285F" unitRef="usd">697000</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:DeferredFinanceCostsNet contextRef="FI2018Q4_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-F61DF81252242E2A218DA9ED1231674F" unitRef="usd">697000</us-gaap:DeferredFinanceCostsNet>
	<us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="FI2017Q4" decimals="-3" id="Fact-957598E62915A3CCDD71A9ED12188FA1" unitRef="usd">985000</us-gaap:DeferredFinanceCostsNoncurrentNet>
	<us-gaap:DeferredFinanceCostsNoncurrentNet contextRef="FI2018Q4" decimals="-3" id="Fact-3C6AA18C1DFE4215B845A9ED12701964" unitRef="usd">935000</us-gaap:DeferredFinanceCostsNoncurrentNet>
	<us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-E920AE1A984D9FF3B3E3A9ED122D8467" unitRef="usd">-342000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
	<us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-CAB6DEDABEAB01DFC39EA9ED1230CCE2" unitRef="usd">117000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
	<us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D18DB65B7E8BAB8EC8E2A9ED12307B54" unitRef="usd">4000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CF350FEE4938E6251667A9ED1202A371" unitRef="usd">-5322000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-12A4F484FC64CC522A7FA9ED11FD1143" unitRef="usd">-33812000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-DAD4E07AA0F1918BBBE1A9ED11E53737" unitRef="usd">-3410000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxLiabilities contextRef="FI2017Q4" decimals="-3" id="Fact-5D3AC47785FF7182ECDCA9ED122C33AE" unitRef="usd">10471000</us-gaap:DeferredIncomeTaxLiabilities>
	<us-gaap:DeferredIncomeTaxLiabilities contextRef="FI2018Q4" decimals="-3" id="Fact-328A46AB532B0D1428DCA9ED1217F561" unitRef="usd">11571000</us-gaap:DeferredIncomeTaxLiabilities>
	<us-gaap:DeferredRentCreditNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E63A3BF1DFEE138BFF74A9ED126D3C56" unitRef="usd">6875000</us-gaap:DeferredRentCreditNoncurrent>
	<us-gaap:DeferredRentCreditNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-D9A4DD68A130B8D6500BA9ED127BF7B5" unitRef="usd">6039000</us-gaap:DeferredRentCreditNoncurrent>
	<us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BE6E3AFB8F7076C4BBD7A9ED1217E2CE" unitRef="usd">-866000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-23C976E5C4500C2B774FA9ED1243A800" unitRef="usd">-10684000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-50B745417CBE9762FAD1A9ED121CF076" unitRef="usd">-1277000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
	<us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="FI2017Q4" decimals="-3" id="Fact-BDD8179B7C5B882684CFA9ED1212B3F8" unitRef="usd">7776000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
	<us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="FI2018Q4" decimals="-3" id="Fact-7C966BF4496F1F66A906A9ED1213DB0D" unitRef="usd">11300000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
	<us-gaap:DeferredTaxAssetsGross contextRef="FI2017Q4" decimals="-3" id="Fact-55394D49C6EF8E2AE639A9ED11D00909" unitRef="usd">31661000</us-gaap:DeferredTaxAssetsGross>
	<us-gaap:DeferredTaxAssetsGross contextRef="FI2018Q4" decimals="-3" id="Fact-A2A2DAF92493BB1D31B0A9ED12329513" unitRef="usd">36415000</us-gaap:DeferredTaxAssetsGross>
	<us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-AD8EA6FE5BA4A239DFADA9ED12755F4C" unitRef="usd">20219000</us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent>
	<us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-1A0FB1516DF218213320A9ED126D8705" unitRef="usd">23750000</us-gaap:DeferredTaxAssetsLiabilitiesNetNoncurrent>
	<us-gaap:DeferredTaxAssetsNet contextRef="FI2017Q4" decimals="-3" id="Fact-08D217DC00F80A530853A9ED122F83CB" unitRef="usd">30585000</us-gaap:DeferredTaxAssetsNet>
	<us-gaap:DeferredTaxAssetsNet contextRef="FI2018Q4" decimals="-3" id="Fact-24E8EB509534A39A3076A9ED122695B4" unitRef="usd">35226000</us-gaap:DeferredTaxAssetsNet>
	<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="FI2017Q4" decimals="-3" id="Fact-AB7A133F7C6301AB9CF7A9ED122B7798" unitRef="usd">14718000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
	<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="FI2018Q4" decimals="-3" id="Fact-1B747938EE89D6FB838CA9ED12183D3B" unitRef="usd">15717000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
	<us-gaap:DeferredTaxAssetsOther contextRef="FI2017Q4" decimals="-3" id="Fact-7D2233F11CB2A5EDB86CA9ED121D5889" unitRef="usd">444000</us-gaap:DeferredTaxAssetsOther>
	<us-gaap:DeferredTaxAssetsOther contextRef="FI2018Q4" decimals="-3" id="Fact-5E9F28EFF83D0C95F68AA9ED1228F4F0" unitRef="usd">542000</us-gaap:DeferredTaxAssetsOther>
	<us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="FI2017Q4" decimals="-3" id="Fact-4BAFB6EFC66CE028B52EA9ED121E74EC" unitRef="usd">189000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
	<us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="FI2018Q4" decimals="-3" id="Fact-0FAF03D9A7B31B676080A9ED127FA3DC" unitRef="usd">188000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits contextRef="FI2017Q4" decimals="-3" id="Fact-5AB8114FFCFC53452D66A9ED122E0471" unitRef="usd">2512000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits contextRef="FI2018Q4" decimals="-3" id="Fact-ED691A0F6B5CFD4087CFA9ED1212B79A" unitRef="usd">2729000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="FI2017Q4" decimals="-3" id="Fact-51DC2ECED3959BC17D85A9ED1211B0D2" unitRef="usd">1709000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="FI2018Q4" decimals="-3" id="Fact-F2476D7C1AA773CA8878A9ED12146388" unitRef="usd">1952000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="FI2017Q4" decimals="-3" id="Fact-FBE25B3A9D8A0FD0A04EA9ED1213B1F0" unitRef="usd">734000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="FI2018Q4" decimals="-3" id="Fact-8DAB3FEC6875F63A2F3DA9ED1215B816" unitRef="usd">646000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="FI2017Q4" decimals="-3" id="Fact-AC6A2BBAC40B303291A3A9ED12158E15" unitRef="usd">624000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="FI2018Q4" decimals="-3" id="Fact-8FE11A5F389A776A91CBA9ED12125147" unitRef="usd">607000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="FI2017Q4" decimals="-3" id="Fact-39724E7FA666E9F1753DA9ED1214FA4A" unitRef="usd">1076000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="FI2018Q4" decimals="-3" id="Fact-F8A08D0D5A95F16B2BDEA9ED11DDA774" unitRef="usd">1189000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" decimals="-5" id="Fact-3DEB965DF041D9477502A9ED125D532B" unitRef="usd">1200000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="FI2017Q4" decimals="-3" id="Fact-1325CD28D8565A24CA02A9ED121BC731" unitRef="usd">9964000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
	<us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="FI2018Q4" decimals="-3" id="Fact-1CB344F60988DFFDD1C5A9ED1215DB3C" unitRef="usd">11136000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-6ACB97E68C213653A59AA9ED12547599" unitRef="usd">105000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-85C3712A4F8FD9A5A234A9ED12629C84" unitRef="usd">95000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="FI2017Q4" decimals="-3" id="Fact-DC6F30C56EF334C56EF6A9ED12134FA4" unitRef="usd">41000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
	<us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="FI2018Q4" decimals="-3" id="Fact-DCCD71967FEF9C98829BA9ED121C5616" unitRef="usd">52000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
	<us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="FI2017Q4" decimals="-3" id="Fact-C797D41555FB3CBF1903A9ED121DB6D4" unitRef="usd">466000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
	<us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="FI2018Q4" decimals="-3" id="Fact-05F3DFD99FE335FE9934A9ED1214B443" unitRef="usd">383000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
	<us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" decimals="-5" id="Fact-EF0AE412BC3FDEEB27B1A9ED125BCB6D" unitRef="usd">100000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="FD2016Q4YTD" decimals="-5" id="Fact-E9ED9F43F502F06B6EC8A9ED122930C5" unitRef="usd">800000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="FD2017Q4YTD" decimals="-5" id="Fact-57EF308992072F9A3EE6A9ED128011E5" unitRef="usd">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="FD2018Q4YTD" decimals="-5" id="Fact-D63E75570F9E24E1DBBFBFA5E22555C9" unitRef="usd">800000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
	<us-gaap:DepositsAssetsNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-4547F7E0C5D50BF3AD5EA9ED12621BCD" unitRef="usd">1095000</us-gaap:DepositsAssetsNoncurrent>
	<us-gaap:DepositsAssetsNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-6561E4FA23FFC6FF01FBA9ED1219EDAF" unitRef="usd">982000</us-gaap:DepositsAssetsNoncurrent>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6B1CCBE792FE724FFB38A9ED1249CA9E" unitRef="usd">9182000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2017Q4YTD" decimals="-3" id="Fact-11DB3F98B2E6A2270CD2A9ED12489575" unitRef="usd">10174000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DepreciationDepletionAndAmortization contextRef="FD2018Q4YTD" decimals="-3" id="Fact-9B6631FB6839DC5EDBF7A9ED12449676" unitRef="usd">11780000</us-gaap:DepreciationDepletionAndAmortization>
	<us-gaap:DerivativeFixedInterestRate contextRef="FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" decimals="INF" id="Fact-A09DFE562D2FE74A1653BF97201EADAF" unitRef="number">0.02627</us-gaap:DerivativeFixedInterestRate>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2016Q4YTD" decimals="-3" id="Fact-84C24E98AB559348124EA9ED124AD0D1" unitRef="usd">5805000</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2017Q1QTD" decimals="-5" id="Fact-5E2157789ED2B0FF4FACA9ED128049CD" unitRef="usd">1600000</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-13FE1936FEC13826AF0FA9ED12453C42" unitRef="usd">1581000</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeGainLossOnDerivativeNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-AAF4D9F362859403EE72A9ED1255F002" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
	<us-gaap:DerivativeLiabilities contextRef="FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-3" id="Fact-6F8AD0EB08ED2D3F4365A9ED121D2B78" unitRef="usd">0</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember" decimals="-5" id="Fact-40F45C4B371C397F1B2EBF979B6747EE" unitRef="usd">200000</us-gaap:DerivativeLiabilities>
	<us-gaap:DerivativeLiabilities contextRef="FI2018Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-3" id="Fact-5F2C6B6B1F76180DC1F5A9ED1219489A" unitRef="usd">234000</us-gaap:DerivativeLiabilities>
	<us-gaap:DirectOperatingCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7CD46AC22C4476C1DB64A9ED122DA126" unitRef="usd">611802000</us-gaap:DirectOperatingCosts>
	<us-gaap:DirectOperatingCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-262D0310782A464803D6A9ED12458EDF" unitRef="usd">636462000</us-gaap:DirectOperatingCosts>
	<us-gaap:DirectOperatingCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-721A10C65DBC62953E01A9ED1231C7B7" unitRef="usd">606921000</us-gaap:DirectOperatingCosts>
	<us-gaap:DueFromJointVenturesCurrent contextRef="FI2017Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-6E5CEB6E8E7D74139C99A9ED11F76DDE" unitRef="usd">800000</us-gaap:DueFromJointVenturesCurrent>
	<us-gaap:DueFromJointVenturesCurrent contextRef="FI2018Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-5F7587B92E86DEDF2229BFC892C96F09" unitRef="usd">2800000</us-gaap:DueFromJointVenturesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="FI2017Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-3E2037C954956D98BD3DBFCC5ED33FD5" unitRef="usd">300000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:DueToRelatedPartiesCurrent contextRef="FI2018Q4_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-5153AEF7035ECC991FCCA9ED11EE9041" unitRef="usd">300000</us-gaap:DueToRelatedPartiesCurrent>
	<us-gaap:EarningsPerShareBasic contextRef="FD2016Q4YTD" decimals="2" id="Fact-18401C89DEBE696B6463A9ED122B497E" unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q1QTD" decimals="2" id="Fact-C02DEA99275A6DC99151A9ED127AA150" unitRef="usdPerShare">-0.06</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q2QTD" decimals="2" id="Fact-9AABC331BD07BCBCC0B2A9ED12093CF7" unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q3QTD" decimals="2" id="Fact-40D7494B2EA8CB51F7E1A9ED1266815E" unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q4QTD" decimals="2" id="Fact-52A4F876075365D2A438A9ED12067781" unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q4YTD" decimals="2" id="Fact-B000CAE49FFFABE6388FA9ED122D32F2" unitRef="usdPerShare">1.07</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q1QTD" decimals="2" id="Fact-98D9E0F7D97641EB59DCA9ED11FA3BD6" unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q2QTD" decimals="2" id="Fact-6B013B59D629AF32F729A9ED11F49BAE" unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q3QTD" decimals="2" id="Fact-801DF05BEC74E8EF6EF3A9ED11DCDEEA" unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q4QTD" decimals="2" id="Fact-6E6817FD54F6FA44E6DCA9ED11D53842" unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q4YTD" decimals="2" id="Fact-5B4CD66ADC6223A3E601A9ED1250EF2E" unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2016Q4YTD" decimals="2" id="Fact-B4BE92B51F3C24B5D635A9ED122AAA30" unitRef="usdPerShare">0.15</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q1QTD" decimals="2" id="Fact-CB8FB17E1C21C3F98F0BA9ED126BD631" unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q2QTD" decimals="2" id="Fact-C3B2A4B76F4A53892595A9ED1204C13F" unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q3QTD" decimals="2" id="Fact-5DE150C45FC4B253B37DA9ED12753BFC" unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q4QTD" decimals="2" id="Fact-D14C23A4EC5EB5EE9735A9ED120105E4" unitRef="usdPerShare">0.77</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q4YTD" decimals="2" id="Fact-5CBEC25A748A6E605DD8A9ED1249279E" unitRef="usdPerShare">1.01</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q1QTD" decimals="2" id="Fact-CACDE22B695A9C884D04A9ED127E59BC" unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q2QTD" decimals="2" id="Fact-2BAF06A844EA3874B419A9ED11E0E07F" unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q3QTD" decimals="2" id="Fact-229813AA4FA22F8A76AAA9ED12779B5E" unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q4QTD" decimals="2" id="Fact-E42A8A627A401F9C4A60A9ED11F1CD46" unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q4YTD" decimals="2" id="Fact-529988A9A5916FB314B5A9ED124991B5" unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2016Q4YTD" decimals="-3" id="Fact-B2297ECF6D770018C923A9ED11E6F846" unitRef="usd">-24000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C5B587C27649D92A00E0A9ED11D04C47" unitRef="usd">23000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2018Q4YTD" decimals="-3" id="Fact-32BCD989385156703782A9ED11EFDC57" unitRef="usd">-70000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-CEBB769475F992529558A9ED1268CAE4" unitRef="usd">34271000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-6AA69F5327F96B2A38D0A9ED126997F1" unitRef="usd">33332000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" id="Fact-C739984F0FA42F77095EA9ED12668B6A">P1Y10M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" id="Fact-F0DFB35D4AFAF06697B8A9ED1265662A">P1Y5M13D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-9A034077E9FAF548A63CA9ED126557B5" unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="-5" id="Fact-508DDE5CD796C282ACE4A9ED123FF91F" unitRef="usd">3800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember" decimals="-3" id="Fact-0EE10BECFC1EAD2C4996A9ED121D1F64" unitRef="usd">1467000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByLiabilityClassAxis_ccrn_DeferredCompensationMember" decimals="-3" id="Fact-E4173A36B031702DA4BAA9ED120F6CC0" unitRef="usd">1725000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-5CB17443B5CEC023625BA9ED121B4E4B" unitRef="usd">922000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-A0875633456E59670C73A9ED1227B8D5" unitRef="usd">1581000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-2F53B14AE635E2CA499DA9ED122925D3" unitRef="usd">-1698000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-47232B6657E9FC4BB870A9ED12122489" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-C81E7C3007BA6FE8296DA9ED122B27E9" unitRef="usd">280000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2017Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-69F6D7BAA60E25A4A6B1A9ED11D94C44" unitRef="usd">25951000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-F4ABBCDB189426D49E8AA9ED12142EBD" unitRef="usd">280000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements contextRef="FD2018Q4YTD_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-7AC0DA0958EA235F4864A9ED12156434" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-32D2E6E10DB14BA3AC3CA9ED1228C971" unitRef="usd">5603000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2016Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-95117C5C378F9E129228A9ED11FAD27F" unitRef="usd">27532000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-9DA5C96EDD85A10A79ABA9ED12557A6D" unitRef="usd">5368000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-C040D6AC7605835230E2A9ED1214922B" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByLiabilityClassAxis_ccrn_ContingentConsiderationLiabilityMember" decimals="-3" id="Fact-2BE5BFF19C7342EC34F2A9ED123D19CB" unitRef="usd">7689000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4_us-gaap_FairValueByLiabilityClassAxis_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" decimals="-3" id="Fact-D1BABF0117D71255BC2AA9ED11FF69DF" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="D2018Q4Oct1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" id="Fact-0327CA18AAEEEF8F8893FE57934ED344">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-70561866BD1F266B8FABA9ED12380084">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-954916D6B8738021F1B9A9ED1241EE72">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4" decimals="-3" id="Fact-78946AFE63C51F6DE0DAA9ED12389A86" unitRef="usd">49092000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-B6FE8B6690BDB04FB617A9ED121E7521" unitRef="usd">25912000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-FE4B9E3FBC32976BDBD2A9ED1278AD47" unitRef="usd">18702000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-735E761A803913B3C698A9ED122B47A7" unitRef="usd">3600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-7491A7AA66146B2309B6A9ED122AC206" unitRef="usd">878000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4" decimals="-3" id="Fact-6E132A1F24AF8920B157A9ED123EFDB4" unitRef="usd">34305000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-D94483F34F3946FD5C2AA9ED11F1264F" unitRef="usd">23296000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-C5B8F3E700F74FF75EC1A9ED124CF995" unitRef="usd">9216000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-D6F674D16B37AA1D2F0AA9ED1230A9A4" unitRef="usd">97000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-45293BABA6DEE65B83DCA9ED12365999" unitRef="usd">1696000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="FI2018Q4" decimals="-3" id="Fact-C1962F143A3E240B9E00A9ED11D3204C" unitRef="usd">19628000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="FI2018Q4" decimals="-3" id="Fact-EF13467A72B24C5158DFA9ED11F41BCB" unitRef="usd">7535000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2018Q4" decimals="-3" id="Fact-23F08EA1E013AD28CA9FA9ED11DCC09C" unitRef="usd">6677000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2018Q4" decimals="-3" id="Fact-FE5DA041F3C03C351AD3A9ED121F32D8" unitRef="usd">6780000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2018Q4" decimals="-3" id="Fact-B4800F768FA6B100673FA9ED120560D3" unitRef="usd">7131000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2018Q4" decimals="-3" id="Fact-F1CC3321B7D1446660C3A9ED11D9C2FC" unitRef="usd">7431000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4" decimals="-3" id="Fact-5FE3F07ADDBFA022E536A9ED120CC497" unitRef="usd">110068000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-6A618DD7DBCE845A9355A9ED122C5953" unitRef="usd">55524000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-3E8BA1807F601232C723A9ED11E0EEAB" unitRef="usd">42909000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-24D38A5EB584074F29C3A9ED123D5257" unitRef="usd">3919000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-154D449608D0B5781A79A9ED1249C0B1" unitRef="usd">7716000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4" decimals="-3" id="Fact-D0D59FDC53071199CC5FA9ED1217DA06" unitRef="usd">89487000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-96F2239364C18723B98AA9ED12218D6F" unitRef="usd">49758000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-7E5C13DFB12ED05082E7A9ED123990F6" unitRef="usd">30530000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-CC707DAF3DD4F14CABAFA9ED12429A38" unitRef="usd">320000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-42E2245C89926D343202A9ED11DB16C2" unitRef="usd">8879000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4" decimals="-3" id="Fact-D23F0723D4E16E64EB1CA9ED12681D45" unitRef="usd">60976000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-AB35E3A76F707EB7D713A9ED123BBAF5" unitRef="usd">29612000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-8CB659A37C20B8839F27A9ED11E1C533" unitRef="usd">24207000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-3A98BE84399BCAC3C42BA9ED1240F5F6" unitRef="usd">319000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-8E490F530BCEEC8ED0BEA9ED12396057" unitRef="usd">6838000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4" decimals="-3" id="Fact-43E306342FDC8860B9DFA9ED127C5BDF" unitRef="usd">55182000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-F6DC10BC688A2E9F4B28A9ED121D32C1" unitRef="usd">26462000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-3" id="Fact-DF3C8366945A44A69CADA9ED11D81BD9" unitRef="usd">21314000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-3" id="Fact-F463FC49AE15350F0BD9A9ED11FF0265" unitRef="usd">223000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-3" id="Fact-522F4E920E37955798E5A9ED12339DD0" unitRef="usd">7183000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="I2018Q4Oct1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-04B06D2AD3A8E77306F8FE538D79FEF7" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-8A468665B48F3BD8ADAAA9ED120FBC4B" unitRef="usd">29900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-5" id="Fact-788484022C514C2ACF49A9ED11D1EADB" unitRef="usd">13800000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DatabasesMember" decimals="-5" id="Fact-3E16B6BC1D4FB1ECC95AA9ED11D967C4" unitRef="usd">11300000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-5" id="Fact-CC47DAE931A45BD8AFE3A9ED123E45C4" unitRef="usd">300000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-9780591F9AF3089A8F2CA9ED1217E22A" unitRef="usd">4500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="D2018Q4Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member" decimals="-5" id="Fact-942B4AAC1D1A78EAE41BE5E7CCDA20F0" unitRef="usd">400000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-E5708E9AC37255F7E456A9ED1272C8E9" unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2016Q2QTD_us-gaap_DebtInstrumentAxis_ccrn_SecondLienTermLoanMember" decimals="-5" id="Fact-0A0D77B47695D332310BA9ED12663066" unitRef="usd">-1600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F9C2A2E72180CC9A1A07A9ED122C3A0A" unitRef="usd">-1568000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-9BB0C97CAD8EC44677CABFBB5FDD4196" unitRef="usd">5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C5B0B1EB3B35DE02AE6DA9ED123272EF" unitRef="usd">-4969000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-3EE4828C97B519B9EE34A9ED1252C45C" unitRef="usd">-79000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:Goodwill contextRef="FI2017Q4" decimals="-3" id="Fact-890363CA5CC6E6AB27F9A9ED1264A04C" unitRef="usd">117589000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-6426970C14FB120DCE02A9ED11F02C23" unitRef="usd">117589000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-69EFD05C1C99A3B12D4EA9ED11EEF6A8" unitRef="usd">88141000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-8B97BE3F4372FA220FACA9ED11D5A79A" unitRef="usd">9418000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-04F0C608DD0BC5E366DDA9ED11EAF9C7" unitRef="usd">20030000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4" decimals="-3" id="Fact-62943B6480B79B7CFF6AA9ED125F0FCD" unitRef="usd">101060000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-F36D218BB20A03767565A9ED11E95E00" unitRef="usd">101060000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-9FCFDF9B5C243E9F5424A9ED11EBF9B2" unitRef="usd">88835000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-5CA9092AA977ACD18EB8A9ED11D44A67" unitRef="usd">9418000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-4EC4B11995AAF91B7A5BA9ED11E53907" unitRef="usd">2807000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-3807FBAF2F0FED8F4854A9ED12783AE7" unitRef="usd">43596000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2018Q1Dec1_us-gaap_BusinessAcquisitionAxis_ccrn_AmericanPersonnelInc.Member" decimals="-5" id="Fact-3FB25EBBACDEA7A4C40AE5E89AEF5841" unitRef="usd">700000</us-gaap:Goodwill>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-3C878C0C8B9900C1D965A9ED11D977A9" unitRef="usd">694000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-4A26AE23A67036B3C649A9ED11E4187E" unitRef="usd">694000</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-DFF301E9A1D01D90C849A9ED11F595DB" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillAcquiredDuringPeriod contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-5A73577912B839381AA8A9ED11EC7D9C" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
	<us-gaap:GoodwillGross contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-BFFAA0D2D5701883A59DA9ED11F8BB8D" unitRef="usd">410585000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-D1F2A156709C939ED7E4A9ED11E20EF1" unitRef="usd">347873000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-A1A2530A754FEA0F3148A9ED11DD885E" unitRef="usd">19307000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-2F0EBF71C70DB4C81BEAA9ED11ED2CAE" unitRef="usd">43405000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-659539D4EC1D7D47AC92A9ED11DE47BF" unitRef="usd">411279000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-24F0B51B0DB9F088F89FA9ED11FC4C41" unitRef="usd">348567000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-AE897ABAFCB0EA8DB75AA9ED11EEF597" unitRef="usd">19307000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillGross contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-07E7D424D5ADB3003BAFA9ED11FDDCE9" unitRef="usd">43405000</us-gaap:GoodwillGross>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-1E487B8340072F0C9163A9ED11D61B65" unitRef="usd">283107000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-F339A1440E3339433294A9ED11D70F30" unitRef="usd">259732000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-35A41F08F5232F4BE75DA9ED11E4B0D3" unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2017Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-F0D24659A8521BBDC6ABA9ED11F59E28" unitRef="usd">23375000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-4EBB49012ABCB75E2448A9ED11EE9F40" unitRef="usd">300330000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-27C7458EDD1B643AAE0BA9ED11F2B2B2" unitRef="usd">259732000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-FC3F63078FD8FE3756E7A9ED11E6AC56" unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="FI2018Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-F33F17C62E662282491EA9ED11DAC9A4" unitRef="usd">40598000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="D2016Q2June30_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-3FE2A377C11A5E942A6DA9ED127B0B8A" unitRef="usd">17700000</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2017Q4QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-D338BC0B08D34344E3E0A9ED11D1CF41" unitRef="usd">5700000</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2018Q4QTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-F5D4DF013AC081182D68BF5CA024EDBF" unitRef="usd">17200000</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" decimals="-3" id="Fact-53B39753FCC3B71A4E68A9ED11F18081" unitRef="usd">17223000</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-4C9146EDEFA2751903A3A9ED11DA4840" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-8868A7AC1B275ABE3639A9ED11E95FB5" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillImpairmentLoss contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-933AEE6E7D02FC956628A9ED11E7E838" unitRef="usd">17223000</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GrossProfit contextRef="FD2017Q1QTD" decimals="-3" id="Fact-AF633E446A194DF0ECB5A9ED1278CD12" unitRef="usd">53275000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q2QTD" decimals="-3" id="Fact-CC406A44DF9EED843E64A9ED127E21FD" unitRef="usd">56528000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q3QTD" decimals="-3" id="Fact-649D2A52B4AC9D259CDCA9ED120A5953" unitRef="usd">60480000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q4QTD" decimals="-3" id="Fact-4C44A8D4AA00124A9797A9ED126C5C0F" unitRef="usd">58303000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q1QTD" decimals="-3" id="Fact-11A5BCFA01EDC708D7B6A9ED127C2FB3" unitRef="usd">53753000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q2QTD" decimals="-3" id="Fact-48EA4F2D2D192597460BA9ED1273C72C" unitRef="usd">53689000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q3QTD" decimals="-3" id="Fact-FC1DB1E0B002F95F5853A9ED11E4D559" unitRef="usd">51562000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q4QTD" decimals="-3" id="Fact-86DAB7366998F21A062AA9ED11F3F99A" unitRef="usd">50559000</us-gaap:GrossProfit>
	<us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="D2016Q2June30_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-E2CC3DB86F13EAC23E9BA9ED11D59107" unitRef="usd">6000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
	<us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="D2016Q2June30_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-7688C50C7B542BF4A017A9ED1274EB91" unitRef="usd">600000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
	<us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="FD2017Q4QTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-9432B50A87D622B3E237A9ED11DCDA4A" unitRef="usd">8700000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
	<us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="FD2018Q4QTD_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-5" id="Fact-D26A13A49338E0C23AC0BF5C5FF5950C" unitRef="usd">5200000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
	<us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="FD2016Q4YTD" decimals="-3" id="Fact-ABD71285BF7F66B17E51A9ED12331154" unitRef="usd">764000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
	<us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="FD2017Q4YTD" decimals="-3" id="Fact-166E3365D4CA4E2A31C7A9ED122A4B7F" unitRef="usd">1289000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
	<us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0C3B5CF6EC47BF1A6158A9ED1246402C" unitRef="usd">1234000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0BA783691F65630EFC24A9ED123D29F6" unitRef="usd">3309000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0EA460920F5B34D0FBB9A9ED12587514" unitRef="usd">3826000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2018Q4YTD" decimals="-3" id="Fact-95C6879925B69167B461A9ED123E410B" unitRef="usd">-18619000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2016Q4YTD" decimals="-3" id="Fact-B8CE79F1722EABB1DB57A9ED125A2EDB" unitRef="usd">1236000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2017Q4YTD" decimals="-3" id="Fact-932C215CA01463279D9FA9ED125DEEEC" unitRef="usd">475000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2018Q4YTD" decimals="-3" id="Fact-88D993EE93FB764A8A77A9ED123D3584" unitRef="usd">424000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2016Q4YTD" decimals="-3" id="Fact-D49E594C78E9FFEB44F2A9ED122FBAC0" unitRef="usd">4545000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B809A115731DEED6238AA9ED12346956" unitRef="usd">4301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A68B29021561BECAB5CBA9ED124392F4" unitRef="usd">-18195000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-14232F108C21B0D90B5EBFE41B5CBEA7" unitRef="usd">200000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7803D2E06DE588EDED57A9ED12503600" unitRef="usd">-4186000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B2E6FDB2DAE8430AA98CA9ED124DB224" unitRef="usd">-34501000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A963CD331174FEBC6B88A9ED1253C45D" unitRef="usd">-2478000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2016Q4YTD" decimals="-3" id="Fact-51C7BE5BA5EC8533193BA9ED11DFA7D9" unitRef="usd">-8379000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A8821A41C0962B0F964EA9ED11E52978" unitRef="usd">-45354000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F0F75429F944E6A517B6A9ED11E6B52D" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3352C809DB78C998614EA9ED11E75920" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2017Q4QTD" decimals="-5" id="Fact-68B6CA39F660278B4484BFE65340C233" unitRef="usd">8000000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B33F50D62C216BF9F718A9ED11E4532A" unitRef="usd">8011000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F4460D41611EE9D7BBAFA9ED11D88CC7" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CE623FEAB0AFEB08CE71A9ED11ED5CEB" unitRef="usd">-5000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="FD2017Q4YTD" decimals="-3" id="Fact-5B678C696531294D2634A9ED11DE88C5" unitRef="usd">175000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="FD2018Q4YTD" decimals="-3" id="Fact-880C75869FF65EF5A02CA9ED11E9B5FF" unitRef="usd">180000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F89AAF3D41B4D483E02CA9ED11DCA0F9" unitRef="usd">1591000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2017Q4YTD" decimals="-3" id="Fact-09820773DFDFBD6CC675A9ED11D73DC5" unitRef="usd">1506000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2018Q4YTD" decimals="-3" id="Fact-FBF1B88EA69B06DFD828A9ED11E52842" unitRef="usd">-3821000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-11C3461D2736A269B4F1A9ED11EA360E" unitRef="usd">260000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
	<us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8BF78FD8FF335AFA7017A9ED11DA3404" unitRef="usd">455000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
	<us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-9750A6FDFF976F0C4153A9ED11E326CC" unitRef="usd">252000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3E1EB3846604E1DF13C8A9ED11E308FC" unitRef="usd">1546000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E0409C4E6AC86233F8D6A9ED11E8E51D" unitRef="usd">2676000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CC9BB2BAEEC4A881989BA9ED11E097DC" unitRef="usd">625000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6145832C315323876571A9ED11E3A7FF" unitRef="usd">-113000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2017Q4YTD" decimals="-3" id="Fact-968C217BF5BFEAFF1176A9ED11E450AC" unitRef="usd">-831000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CA40A12DAA0E85AA604FA9ED11D870BA" unitRef="usd">162000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2016Q4YTD" decimals="-3" id="Fact-37CED9B1FD286BB2D6B4A9ED11CFD3A3" unitRef="usd">344000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2017Q4YTD" decimals="-3" id="Fact-88242A4312259D0273EEA9ED11DA1594" unitRef="usd">-1374000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2018Q4YTD" decimals="-3" id="Fact-FE4A2AF00C2B3457F3AAA9ED11EA4270" unitRef="usd">-543000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7D1F3F7DDB216D5587DEA9ED11DBFED8" unitRef="usd">1090000</us-gaap:IncomeTaxReconciliationTaxContingencies>
	<us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D6D2942C7C20D1C4FFBCA9ED11EF6F5C" unitRef="usd">1145000</us-gaap:IncomeTaxReconciliationTaxContingencies>
	<us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4916BE332593E9D03BCBA9ED11CFE5A5" unitRef="usd">1629000</us-gaap:IncomeTaxReconciliationTaxContingencies>
	<us-gaap:IncomeTaxesPaid contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BE0B00F57D4634E9B721A9ED12539C27" unitRef="usd">1773000</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid contextRef="FD2017Q4YTD" decimals="-3" id="Fact-934DF3B1D51C06E16FDCA9ED12128F3B" unitRef="usd">697000</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesPaid contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E2A6D515CB7E219EB5CDA9ED11F2450B" unitRef="usd">1043000</us-gaap:IncomeTaxesPaid>
	<us-gaap:IncomeTaxesReceivableNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-6016C07905CBFDEA924FA9ED12629B49" unitRef="usd">1044000</us-gaap:IncomeTaxesReceivableNoncurrent>
	<us-gaap:IncomeTaxesReceivableNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-B4F3F4D87187F7E09569A9ED126175ED" unitRef="usd">522000</us-gaap:IncomeTaxesReceivableNoncurrent>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7524A66FBE3216E31B7DA9ED11DED406" unitRef="usd">20370000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-614C9ECFEB590F708E17A9ED12002676" unitRef="usd">-9275000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-47678185E33F316B4D0DA9ED11E7E91D" unitRef="usd">-7095000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3A8610F30424BE671648A9ED11D02FA6" unitRef="usd">30781000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2017Q4YTD" decimals="-3" id="Fact-4B14535FEF706CD9825CA9ED1200A0DA" unitRef="usd">-9708000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1BD899FE9CF5A475AD98A9ED12528860" unitRef="usd">-2820000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0BAED1B9A3D56BC56FABA9ED11ED7104" unitRef="usd">1882000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
	<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="FD2017Q4YTD" decimals="-3" id="Fact-04C88EEAB5A1DDBD4891A9ED11F86548" unitRef="usd">-1816000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
	<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="FD2018Q4YTD" decimals="-3" id="Fact-9272F8286281D2B8340EA9ED11D297AE" unitRef="usd">2514000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
	<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1D83ACBE329044BF747EA9ED11D3CAC8" unitRef="usd">-143000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
	<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-063FEA30E1211D6A68F1A9ED11D70DE1" unitRef="usd">847000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
	<us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C717ACAFA98C8D3992A4A9ED11D71326" unitRef="usd">-597000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0210FB67439CC2D299C6A9ED11FC5601" unitRef="shares">3521000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FCB0F79105E6CAFAEC6BA9ED1267E698" unitRef="shares">723000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-715E42DF31F9F57584D7A9ED1200A922" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0082E546F50A7EC1D611BFD11618DCA0" unitRef="shares">593000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2017Q4YTD" decimals="-3" id="Fact-6B5842E2E478839CC7C4A9ED126FFF0A" unitRef="shares">425000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2018Q4YTD" decimals="-3" id="Fact-882DCD35E467F290094CBFD116237011" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IndefiniteLivedTradeNames contextRef="FI2017Q4" decimals="-3" id="Fact-343B8BF95D3ED6C30C79A9ED1268B607" unitRef="usd">26702000</us-gaap:IndefiniteLivedTradeNames>
	<us-gaap:IndefiniteLivedTradeNames contextRef="FI2018Q4" decimals="-3" id="Fact-E7CECE8D0F17BF166D1EA9ED126993D3" unitRef="usd">20402000</us-gaap:IndefiniteLivedTradeNames>
	<us-gaap:InsuranceReceivableForMalpracticeCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E8610ADD2E7F4D12B90FA9ED12432692" unitRef="usd">1874000</us-gaap:InsuranceReceivableForMalpracticeCurrent>
	<us-gaap:InsuranceReceivableForMalpracticeCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-E2861805D06AA87DA870A9ED120B792C" unitRef="usd">1891000</us-gaap:InsuranceReceivableForMalpracticeCurrent>
	<us-gaap:InsuranceReceivableForMalpracticeNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-93B91FF93B1582AE7D65A9ED12273986" unitRef="usd">10011000</us-gaap:InsuranceReceivableForMalpracticeNoncurrent>
	<us-gaap:InsuranceReceivableForMalpracticeNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-F0E985249D6DC0C846C9A9ED12401B7B" unitRef="usd">9924000</us-gaap:InsuranceReceivableForMalpracticeNoncurrent>
	<us-gaap:InsuranceSettlementsReceivableCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E96310723EF839909B98A9ED126D2C7A" unitRef="usd">3497000</us-gaap:InsuranceSettlementsReceivableCurrent>
	<us-gaap:InsuranceSettlementsReceivableCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-52688106A49476C24912A9ED12633382" unitRef="usd">4186000</us-gaap:InsuranceSettlementsReceivableCurrent>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2017Q4" decimals="-3" id="Fact-1583A071733C757E8DE8A9ED11E5E8A7" unitRef="usd">87678000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2018Q4" decimals="-3" id="Fact-3B653952FE93CD2154B5A9ED12661006" unitRef="usd">75584000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-4710A7A7DA99E1E1C82BA9ED12506087" unitRef="usd">6106000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-CAAAFE4C7BC6BE69F66AA9ED1247C37B" unitRef="usd">4214000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1466B165D18C3BE9D4E1A9ED1231DC00" unitRef="usd">5654000</us-gaap:InterestExpense>
	<us-gaap:InterestIncomeOther contextRef="FD2016Q4YTD" decimals="-5" id="Fact-1FBDB3791D9E32C10851305E7DB216B7" unitRef="usd">100000</us-gaap:InterestIncomeOther>
	<us-gaap:InterestIncomeOther contextRef="FD2017Q4YTD" decimals="-5" id="Fact-D05A723DF85607E078C8305DFC4E77FE" unitRef="usd">100000</us-gaap:InterestIncomeOther>
	<us-gaap:InterestIncomeOther contextRef="FD2018Q4YTD" decimals="-5" id="Fact-C99DF836CAFC7B329BDF305DEA3A44A4" unitRef="usd">400000</us-gaap:InterestIncomeOther>
	<us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6A26D88F9FB614CD288EBFD0E0056A46" unitRef="usd">3383000</us-gaap:InterestOnConvertibleDebtNetOfTax>
	<us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-39422C3F041CB6D0556BA9ED126A2B95" unitRef="usd">694000</us-gaap:InterestOnConvertibleDebtNetOfTax>
	<us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-EA766EDA939363888825A9ED11F02E36" unitRef="usd">0</us-gaap:InterestOnConvertibleDebtNetOfTax>
	<us-gaap:InterestPaidNet contextRef="FD2016Q4YTD" decimals="-3" id="Fact-955A74F483C70C323E5DA9ED11FF9EE7" unitRef="usd">3893000</us-gaap:InterestPaidNet>
	<us-gaap:InterestPaidNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A7E35A080A95A4289F8DA9ED11E96989" unitRef="usd">3408000</us-gaap:InterestPaidNet>
	<us-gaap:InterestPaidNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-BC04EAFB9A7C2FEBCDC8A9ED11F6EE1E" unitRef="usd">6340000</us-gaap:InterestPaidNet>
	<us-gaap:LettersOfCreditOutstandingAmount contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="-5" id="Fact-427A183770AADC6625A5A9ED12560C13" unitRef="usd">20600000</us-gaap:LettersOfCreditOutstandingAmount>
	<us-gaap:Liabilities contextRef="FI2017Q4" decimals="-3" id="Fact-707E534E0541ABD0F93DA9ED127BDA4F" unitRef="usd">229968000</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="FI2018Q4" decimals="-3" id="Fact-B0D918094D88B0444C68A9ED12603739" unitRef="usd">208805000</us-gaap:Liabilities>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2017Q4" decimals="-3" id="Fact-D53F8727A62351360856A9ED126F279F" unitRef="usd">467687000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2018Q4" decimals="-3" id="Fact-789142D31918CD84672FA9ED12710E25" unitRef="usd">427003000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C1FB25722E64A2FEC154A9ED126292C3" unitRef="usd">94588000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-11896032706FF466958EA9ED127D1481" unitRef="usd">85386000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="FI2017Q4" decimals="-3" id="Fact-746E398231F4C2C9F682A9ED12701970" unitRef="usd">28757000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
	<us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="FI2018Q4" decimals="-3" id="Fact-587F77334BBA8A645D33A9ED1267C9A7" unitRef="usd">29299000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
	<us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E29C0F1491B154C40A4BA9ED1241D1AA" unitRef="usd">485000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
	<us-gaap:LiabilityForUncertainTaxPositionsNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-50BA2BDFA74C662E176FA9ED121B48E7" unitRef="usd">590000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="D2017Q3July5_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-02F1E9F4030304A124BAA9ED12645F53" unitRef="number">0.003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm1Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-750948CCF028B5E061D5A9ED11E9B521" unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm2Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-493D8D6B5008C2D68253A9ED11CE9F09" unitRef="number">0.003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm3Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-7B16E6078E26F9E313D7A9ED126A22B6" unitRef="number">0.003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm4Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-BCA2E7CF86442DA186BDA9ED124EBA62" unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="FD2018Q4YTD_ccrn_DebtCovenantTermsAxis_ccrn_CovenantTerm5Member_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-3FD42898E3A2C2FFDCF1A9ED1237D0FE" unitRef="number">0.004</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2June22_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="INF" id="Fact-115CE23B2213A2694ADEA9ED125D0922" unitRef="usd">100000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-56145FFA3FEE7525480FA9ED1253B5A2" unitRef="usd">40000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2June22_us-gaap_DebtInstrumentAxis_ccrn_SecondLienTermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SubordinatedDebtMember" decimals="INF" id="Fact-5341EAB7E1E437DE4DD0A9ED125C190A" unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2017Q3Aug1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-2F953FA5684E1204EF70BF80A224AF12" unitRef="usd">115000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="FD2018Q4YTD_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="INF" id="Fact-BBC33EC77317460A2E2DA9ED11D884E5" unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
	<us-gaap:LongTermDebt contextRef="FI2017Q4" decimals="-3" id="Fact-E9F0AC90711C61496D4FA9ED124605EB" unitRef="usd">93125000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-8401C129F8D4F5D16EB4A9ED121399A1" unitRef="usd">99134000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2018Q4" decimals="-3" id="Fact-593FDE2B644E1DA5FBEEA9ED12399B42" unitRef="usd">78641000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-3" id="Fact-BB8DDFCE9BC5C6C2ADA0A9ED121BBD9C" unitRef="usd">83179000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-BA3B4B17AA9EA9E5503CA9ED120CB924" unitRef="usd">83876000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-8D49820DA487BC820623A9ED12792EA6" unitRef="usd">6875000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-892D2F9CB2EDCA4126C2A9ED1274C117" unitRef="usd">5235000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-81A65663C5F5A47F60A6A9ED120E5988" unitRef="usd">5235000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-C6BE1FF1FDC357362B9AA9ED1211C30E" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-3B68DEE744B89E9921F3A9ED1210CC8C" unitRef="usd">65990000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-9BCAEEA92AABC91403C9A9ED1211120C" unitRef="usd">6980000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="FI2018Q4_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="-3" id="Fact-42FECD3EF9DE6985D6DBA9ED1212F3CE" unitRef="usd">5671000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-B83A1FFDB5855F1D8866A9ED12639757" unitRef="usd">92259000</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-386ECDCBD1885F60100BA9ED125EC049" unitRef="usd">77944000</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_ccrn_TermLoanMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorDebtObligationsMember" decimals="INF" id="Fact-6E2E6D34586613757CC8BF97750691A1" unitRef="number">0.5</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
	<us-gaap:MalpracticeInsuranceMaximumCoveragePerIncident contextRef="D2018Q4March2015Dec2018_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember" decimals="INF" id="Fact-96386FF4E981653606CDA9ED124EB5D7" unitRef="usd">500000.0</us-gaap:MalpracticeInsuranceMaximumCoveragePerIncident>
	<us-gaap:MalpracticeLossContingencyAccrualUndiscountedCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-6D06D03D44CA0731FBC3A9ED1257A2B4" unitRef="usd">2683000</us-gaap:MalpracticeLossContingencyAccrualUndiscountedCurrent>
	<us-gaap:MalpracticeLossContingencyAccrualUndiscountedCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-5D34563FF8A6A885D228A9ED1267F18A" unitRef="usd">2786000</us-gaap:MalpracticeLossContingencyAccrualUndiscountedCurrent>
	<us-gaap:MalpracticeLossContingencyAccrualUndiscountedNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-866E08C7AF45295F12C9A9ED1254A22B" unitRef="usd">15597000</us-gaap:MalpracticeLossContingencyAccrualUndiscountedNoncurrent>
	<us-gaap:MalpracticeLossContingencyAccrualUndiscountedNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-AF33E9C3BCA2F235C1B6A9ED125A9DB0" unitRef="usd">16302000</us-gaap:MalpracticeLossContingencyAccrualUndiscountedNoncurrent>
	<us-gaap:MalpracticeLossContingencyLettersOfCreditAndSuretyBonds contextRef="FI2017Q4_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember" decimals="-5" id="Fact-FAD79DB736D56BE9DF27A9ED123F6364" unitRef="usd">2000000</us-gaap:MalpracticeLossContingencyLettersOfCreditAndSuretyBonds>
	<us-gaap:MalpracticeLossContingencyLettersOfCreditAndSuretyBonds contextRef="FI2018Q4_dei_LegalEntityAxis_ccrn_MDAHoldingsIncMember_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_ccrn_ClaimsBasedLiabilityInsuranceMember" decimals="-5" id="Fact-553D04567883CD9411EEBF10D8728F64" unitRef="usd">1800000</us-gaap:MalpracticeLossContingencyLettersOfCreditAndSuretyBonds>
	<us-gaap:MinorityInterest contextRef="FI2017Q4" decimals="-3" id="Fact-A160593074E82E6D04E0A9ED1277281A" unitRef="usd">630000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterest contextRef="FI2018Q4" decimals="-3" id="Fact-52DDCC47EC877CF428DAA9ED12628CD7" unitRef="usd">670000</us-gaap:MinorityInterest>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2016Q4YTD" decimals="-3" id="Fact-B7F9705B9EB087FFE902A9ED122209C5" unitRef="usd">701000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-E1737085020FB0B25E13A9ED121F65C4" unitRef="usd">701000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2017Q4YTD" decimals="-3" id="Fact-4710B0F2754D3D650B18A9ED12226B7D" unitRef="usd">1218000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-52908F0AA9B10DBA35DDA9ED120D4D96" unitRef="usd">1218000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2018Q4YTD" decimals="-3" id="Fact-108396C4BDFB8891F1A4A9ED121C764F" unitRef="usd">1194000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-C3EFE3BE1241D096C331A9ED12195E39" unitRef="usd">1194000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-4E1C4B221B8AB7BC06B5A9ED11F69765" unitRef="usd">-2164000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FAF7506DE7FACD113469A9ED1251B44E" unitRef="usd">50756000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E27D9AA85594EFE31D17A9ED11FA8AD6" unitRef="usd">-23767000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-374BE1A9A5387CA1209FA9ED1208FA0A" unitRef="usd">-9780000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1E2257459B766F4C568EA9ED11FDD305" unitRef="usd">-91380000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-351A597B1ACB82ECA445A9ED11EA130C" unitRef="usd">-6678000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-60E64CDB701B48FDBFA9A9ED120451A1" unitRef="usd">30145000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-30BC5C2780FFA8490F86A9ED11DFA37A" unitRef="usd">45508000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0FC4F40A2F096684ECB5A9ED1252AA64" unitRef="usd">20997000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-32A46F555C6072336876A9ED122E0386" unitRef="usd">7967000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q1QTD" decimals="-3" id="Fact-EC98A50593C8D17C187FA9ED12054366" unitRef="usd">-2010000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q2QTD" decimals="-3" id="Fact-3D8AC0BDFD26BD3D5AFEA9ED125C9033" unitRef="usd">4850000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q3QTD" decimals="-3" id="Fact-4B9EB11F6B9D6EC71C08A9ED1268434A" unitRef="usd">6723000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q4QTD" decimals="-3" id="Fact-FA0E280583C7F7C08908A9ED11D11872" unitRef="usd">27950000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D47B14C5B3EC28AD4708A9ED124C1F03" unitRef="usd">37513000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1QTD" decimals="-3" id="Fact-340F9B8F59E332B56BB7A9ED11DDABE3" unitRef="usd">1642000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q2QTD" decimals="-3" id="Fact-3E338C5BCA882341CFBCA9ED11DF806E" unitRef="usd">1539000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q3QTD" decimals="-3" id="Fact-70A3A4DEE11AC203A6D0A9ED11CF3ACB" unitRef="usd">-441000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q4QTD" decimals="-3" id="Fact-E5E5A874ADB33820AD3AA9ED11D670F9" unitRef="usd">-19691000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q4YTD" decimals="-3" id="Fact-657B66414F0AA8B6777EA9ED122EF364" unitRef="usd">-16951000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2016Q4YTD" decimals="-3" id="Fact-29EFC3BAC55B1B211179A9ED120C2A15" unitRef="usd">764000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B9824DE3B69E5E78CA61A9ED12066FFC" unitRef="usd">1289000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="FD2018Q4YTD" decimals="-3" id="Fact-8448665439189C433051A9ED12087228" unitRef="usd">1234000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="FD2016Q4YTD" decimals="-3" id="Fact-56608BD79DE2511C8519A9ED126EA6F0" unitRef="usd">7967000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="FD2017Q4YTD" decimals="-3" id="Fact-9954DFBA88B832F2F203A9ED126FF03F" unitRef="usd">37513000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F2495F96389C3595050BA9ED12645F53" unitRef="usd">-16951000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="FD2016Q4YTD" decimals="-3" id="Fact-FF157740E26C104D83E9A9ED12022F79" unitRef="usd">5545000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1800088607A77EB18255A9ED127459F8" unitRef="usd">36626000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
	<us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="FD2018Q4YTD" decimals="-3" id="Fact-32E71D14594B6BD16D4EA9ED1260AA26" unitRef="usd">-16951000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
	<us-gaap:NumberOfOperatingSegments contextRef="FD2018Q4YTD" decimals="INF" id="Fact-17CF8043083F167263AAA9ED11F50C46" unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
	<us-gaap:OperatingIncomeLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3BFDDBD7D3B452A63F6AA9ED1253CD63" unitRef="usd">6184000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-564AAB3C514BDF06259EA9ED12322D52" unitRef="usd">11748000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q4YTD" decimals="-3" id="Fact-952E2E573EF8E9F22F8FA9ED124D07EC" unitRef="usd">-12880000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="FI2018Q4" decimals="-3" id="Fact-52F2FC9E2C7662D59FEAA9ED11F9D09F" unitRef="usd">34595000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="FI2018Q4" decimals="-5" id="Fact-55D743CE9F1ABE536F5E30FD4D97612E" unitRef="usd">34600000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-A2B298195BDB933764A1A9ED11FEFB62" unitRef="usd">7451000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="FI2018Q4" decimals="-3" id="Fact-A3527350EEC8DC4E2AA7A9ED11FB9380" unitRef="usd">4700000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="FI2018Q4" decimals="-3" id="Fact-9AEB6153F74D9BD63B2CA9ED120306C2" unitRef="usd">4857000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="FI2018Q4" decimals="-3" id="Fact-3A38BA361521335A5F01A9ED1201A566" unitRef="usd">5407000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="FI2018Q4" decimals="-3" id="Fact-1A9166EB13B558F4146FA9ED11F7306D" unitRef="usd">6287000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter contextRef="FI2018Q4" decimals="-3" id="Fact-874ECECD38E90418A7F8A9ED11FDDA49" unitRef="usd">5893000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
	<us-gaap:OperatingLeasesRentExpenseNet contextRef="FD2016Q4YTD" decimals="-5" id="Fact-515043156CEB6CCD8024A9ED125BC8A2" unitRef="usd">8400000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesRentExpenseNet contextRef="FD2017Q4YTD" decimals="-5" id="Fact-B046236613E80AB12E46A9ED1254CA5C" unitRef="usd">9400000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLeasesRentExpenseNet contextRef="FD2018Q4YTD" decimals="-5" id="Fact-E78864D3D27EFDA45CD2BFA73668D3B0" unitRef="usd">9300000</us-gaap:OperatingLeasesRentExpenseNet>
	<us-gaap:OperatingLossCarryforwards contextRef="FI2017Q4" decimals="-5" id="Fact-AB807585EE9A369981D3A9ED12283B27" unitRef="usd">166100000</us-gaap:OperatingLossCarryforwards>
	<us-gaap:OperatingLossCarryforwards contextRef="FI2018Q4" decimals="-5" id="Fact-CE6F8E6507CD4BBD1817BFE301A499BF" unitRef="usd">185100000</us-gaap:OperatingLossCarryforwards>
	<us-gaap:OtherAssetsCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-07C97540F2DC0EEC4E73A9ED1270A31F" unitRef="usd">963000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-9FFF95204EFF5C2A3D3FA9ED126D6209" unitRef="usd">2364000</us-gaap:OtherAssetsCurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-53C03452AB32EA84D43FA9ED1268F4AA" unitRef="usd">19228000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-CF645DFAF15118C8E8C5A9ED12763006" unitRef="usd">18076000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="FD2016Q4YTD" decimals="-3" id="Fact-E34E74A81C6C4C377830A9ED12086447" unitRef="usd">-34000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="FD2017Q4YTD" decimals="-3" id="Fact-23A787B58753CDD48B8DA9ED120CF518" unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent contextRef="FD2018Q4YTD" decimals="-3" id="Fact-6600FB70CD518AA6FDFDA9ED12048B0B" unitRef="usd">-153000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-2E8FB8EE3BFB4B8468F2A9ED12494CEB" unitRef="usd">-34000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-3B30043B48E69AC20A1BA9ED1204845C" unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F25D2A4B7C5660BD0216A9ED124FB23E" unitRef="usd">-387000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-481970F02108D0F4EAE2BEF010043115" unitRef="usd">-175000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
	<us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-585B1F4A1A7391316B0CBEF0100B6B42" unitRef="usd">-175000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-461837240643F84E8350AA0DE6B691E5" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-61B09464CD907A8FEA11AA0DE56C4794" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-51A57A832A2666C2F07EAA0DE43919E6" unitRef="usd">-420000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A51FF53CD257F77CAB51AA0D3283BF2E" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A15A078E4AE55B4CB913AA0D313CCC0C" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F1D5342C6833E3C593B6AA0D3092B734" unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-990DA929CD3E821F282DA9ED1206DA46" unitRef="usd">-34000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-B5FEFB612847BE986276A9ED1225AE51" unitRef="usd">-34000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1E476DFA17AF3AE617C2A9ED1222F67B" unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-16FB65A49DDC10FE988DA9ED121D91FF" unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E5C6BB4FD42D625528F0A9ED121E6AB1" unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-D9C771D8E664F582EDA2A9ED121BA3C0" unitRef="usd">-121000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BBDEFF2E83950FE2899CA9ED12060943" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-747D4B89CE2B1115849EA9ED124B1240" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E3C91D7C911F5289D423A9ED124E3C42" unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7F0B8B40476827CB8549A9ED120DAA8A" unitRef="usd">-34000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q4YTD" decimals="-3" id="Fact-EF55505223C4FC6E7E23A9ED1206E972" unitRef="usd">75000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CE875374AF895CEFDCCDA9ED120A4B9A" unitRef="usd">-297000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-00E85AC4A22B7907B4B5AA0DE9F56D32" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0ACBAADA1359463C318EAA0DE8AC39B7" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-6D82E16D239F954CED03AA0DE776761C" unitRef="usd">-186000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-5998DBFDFCB9BD7BF761AA0D343388CF" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-947C214B3E435D3ACA4BAA0D33919FD6" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-63634B7611EFF3223238AA0D32F9E087" unitRef="usd">-48000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax>
	<us-gaap:OtherComprehensiveIncomeLossTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1A4256B73A1B635807DAAA0D369F4629" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
	<us-gaap:OtherComprehensiveIncomeLossTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8857457E3D01DE3197F1AA0D35A5FED4" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
	<us-gaap:OtherComprehensiveIncomeLossTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-5C142C23FDB2D0E36D0CAA0D3489EC0A" unitRef="usd">-90000</us-gaap:OtherComprehensiveIncomeLossTax>
	<us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BA72D895094463792F63A9ED1236D21F" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
	<us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-CEFA8141D5F356F2287BA9ED125857E8" unitRef="usd">5105000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
	<us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-DD0BE1B64A09F1742B56A9ED12645CC2" unitRef="usd">5158000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-848A4156BE1C7A3C03EEA9ED126B3B20" unitRef="usd">2845000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-46E4B007ED09FA84B206A9ED12715630" unitRef="usd">3075000</us-gaap:OtherLiabilitiesCurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-3C43CFE199022261923FA9ED1271E886" unitRef="usd">9276000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-EA8ADE811EB8DE3FF641A9ED1269BE2A" unitRef="usd">8767000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-28F952187D95D57C030EA9ED11F98C33" unitRef="usd">-775000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-BF5BC551AE75CBF2DF50A9ED1252C718" unitRef="usd">-68000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0F851D4D7E1FFBEB2488A9ED11D37CA3" unitRef="usd">-3231000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-386AC2A9897297A7D36AA9ED124CADDA" unitRef="usd">230000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1C7F2DDD258CFFCAD317A9ED124BC4A5" unitRef="usd">155000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C1EABA4463E73ABFF73FA9ED124EC806" unitRef="usd">418000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:PaymentsForProceedsFromPreviousAcquisition contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3EC8B9F5A1417AFD566CA9ED11F5D302" unitRef="usd">1858000</us-gaap:PaymentsForProceedsFromPreviousAcquisition>
	<us-gaap:PaymentsForProceedsFromPreviousAcquisition contextRef="FD2017Q4YTD" decimals="-3" id="Fact-4FD3BF54DD29E3555C9CA9ED11FFE26B" unitRef="usd">292000</us-gaap:PaymentsForProceedsFromPreviousAcquisition>
	<us-gaap:PaymentsForProceedsFromPreviousAcquisition contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1E06E931538F3126471DA9ED11E7AD3D" unitRef="usd">151000</us-gaap:PaymentsForProceedsFromPreviousAcquisition>
	<us-gaap:PaymentsForRent contextRef="FD2016Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember" decimals="-5" id="Fact-ADA8EECE6760A877D791A9ED12317ECA" unitRef="usd">400000</us-gaap:PaymentsForRent>
	<us-gaap:PaymentsForRent contextRef="FD2017Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember" decimals="-5" id="Fact-C70EB2FD6465C711BFFDA9ED11F21014" unitRef="usd">400000</us-gaap:PaymentsForRent>
	<us-gaap:PaymentsForRent contextRef="FD2018Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember" decimals="-5" id="Fact-835DBAE8FF3C36033F5EBFC47B6AA551" unitRef="usd">300000</us-gaap:PaymentsForRent>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2016Q4YTD" decimals="-3" id="Fact-D341535463905D02FE7CBEE6D9166724" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FB5A24FC8494DEBD76A6BEE6D654A1CA" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2018Q4YTD" decimals="-3" id="Fact-73B73C10F9A76021F8EDBEE6D5030459" unitRef="usd">5000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRestructuring contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-347213B5E97161003735A9ED1257754D" unitRef="usd">255000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-06FBB61997A351398FA1A9ED1260392D" unitRef="usd">282000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-25FAC90D43DAE8F18F9DA9ED125DF67C" unitRef="usd">336000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-86CD1CEDDBB376FF3027A9ED1257E283" unitRef="usd">760000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-B170C1404B4198DC32C9A9ED125DAB35" unitRef="usd">235000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-C2E959F4951A42B552D4A9ED1255EE4A" unitRef="usd">1131000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-BE7A8DFA1C27491F992BA9ED11D4F460" unitRef="usd">600000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-90F74E958439543AC9A8A9ED11F22216" unitRef="usd">641000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-37B42DB17CC14B30EE50A9ED11D47D50" unitRef="usd">578000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F320C414C0FA0207EFDFA9ED120D9641" unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="D2018Q4Oct30_us-gaap_DebtInstrumentAxis_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember" decimals="-5" id="Fact-C07F7526F4F96B4387BCBF82F80BEF46" unitRef="usd">300000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-233CDA8F0C8D1152084FA9ED11F06B93" unitRef="usd">1182000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-899539E4AFA36C3607AEA9ED11F38C67" unitRef="usd">901000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-14E68C0E0C200139A941A9ED11D887C7" unitRef="usd">308000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2015Q4Oct30-30_us-gaap_BusinessAcquisitionAxis_ccrn_MediscanMember" decimals="-5" id="Fact-3918D2EF94B225501788A9ED126C24F0" unitRef="usd">29900000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-0B7F3FDD678BE94BB107A9ED11D4128E" unitRef="usd">89395000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-5" id="Fact-46D6BDCFDBD0E6E7BEA9A9ED12569A72" unitRef="usd">86600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="D2017Q3July1_us-gaap_BusinessAcquisitionAxis_ccrn_AdvantageRNLLCMember" decimals="-3" id="Fact-831DD19C9FC8118F6637A9ED11D5505D" unitRef="usd">86562000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2016Q4YTD" decimals="-3" id="Fact-84BFAF78A1AE60C23C13A9ED11FC01AA" unitRef="usd">1900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2017Q4YTD" decimals="-3" id="Fact-EA286501A1DEF7F75483A9ED11FE5A58" unitRef="usd">85977000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2018Q4YTD" decimals="-3" id="Fact-5D3987065E427AEB64A9A9ED1203F59B" unitRef="usd">1930000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1AA4B70BFA187861B1B5A9ED11E3427E" unitRef="usd">6522000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2017Q4YTD" decimals="-3" id="Fact-09CAA4F8A00FBCF2CC9BA9ED11E6C4FA" unitRef="usd">5111000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B361ED94DF35513ADE11A9ED11F48355" unitRef="usd">4597000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-E9524B5B332A6AC71228A9ED12733D96" unitRef="usd">5287000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-99FCDE871840696646CFA9ED126A1429" unitRef="usd">6208000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="FD2016Q4YTD" decimals="-3" id="Fact-084C7D739EC914416A92A9ED11D65508" unitRef="usd">500000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
	<us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1F3AA604ACF3E59A9727A9ED11D5EFA7" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
	<us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="FD2018Q4YTD" decimals="-3" id="Fact-56F3E40AE57697CB1E35A9ED11E33295" unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2017Q3Aug1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-5" id="Fact-7DB29716AF83BE2818E6BF86B695B50C" unitRef="usd">6500000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2017Q3Aug1_us-gaap_DebtInstrumentAxis_ccrn_AmendedAndRestatedCreditAgreementMember" decimals="-5" id="Fact-44131DFADDF0B29D3EF2BF86225CF105" unitRef="usd">106500000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2017Q3July1_us-gaap_DebtInstrumentAxis_ccrn_CreditAgreementMember" decimals="-5" id="Fact-06A080BC0DF60689E836A9ED120F3C53" unitRef="usd">66900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2017Q3July1_us-gaap_DebtInstrumentAxis_ccrn_IncrementalTermLoanMember_us-gaap_LongtermDebtTypeAxis_ccrn_TermLoanMember" decimals="-5" id="Fact-C0A52378599A218BC6E2A9ED11DE0251" unitRef="usd">40000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CDDF687F81C1AB2D9434A9ED11EE0E31" unitRef="usd">40000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0A1AB5A77EEDCF65DB4BA9ED11DA59C7" unitRef="usd">62000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D6E1FB0E9FD4C170CC50A9ED11E894FF" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromLinesOfCredit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-99316FEC61F7B6D3C324A9ED11EB733B" unitRef="usd">59800000</us-gaap:ProceedsFromLinesOfCredit>
	<us-gaap:ProceedsFromLinesOfCredit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-316433C1F758AB27532EA9ED120AC785" unitRef="usd">39000000</us-gaap:ProceedsFromLinesOfCredit>
	<us-gaap:ProceedsFromLinesOfCredit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D63F10193D5816821C08A9ED11D98E85" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-94513FA5F84F24D9B8A0A9ED11EEF4F9" unitRef="usd">-1841000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-01D59E9C8DFAD5E4AC29A9ED11E82F19" unitRef="usd">-3265000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C0375F7CECD10A015206A9ED11ECB13C" unitRef="usd">-2335000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProfitLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-3FE99A708906D504558DA9ED12285A62" unitRef="usd">8731000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-65500A049053366217D0A9ED120736BD" unitRef="usd">764000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-4C332864F42D30F006B0A9ED122756E3" unitRef="usd">7967000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q1QTD" decimals="-3" id="Fact-74EA40A1CB6CB0BE4098A9ED1201FC01" unitRef="usd">-1718000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q2QTD" decimals="-3" id="Fact-8F64ABFE1854D1C3DFB8A9ED127998D7" unitRef="usd">5220000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q3QTD" decimals="-3" id="Fact-541E4D94330085AA479EA9ED125EADB3" unitRef="usd">7044000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q4QTD" decimals="-3" id="Fact-22C3BC17F1A6CBDA601EA9ED1277A36B" unitRef="usd">28256000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-02855FE9DEC789E7984FA9ED1247BCBB" unitRef="usd">38802000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q4YTD_us-gaap_NonrecurringAdjustmentAxis_us-gaap_AcquisitionRelatedCostsMember" decimals="-5" id="Fact-DCB5C17FE01633C66DC1A9ED1273B4F7" unitRef="usd">2000000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-B1AB2C107DB6B5B2B913A9ED1205D3A8" unitRef="usd">1289000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-15FF5047AC3961FCCF5DA9ED120F6DC8" unitRef="usd">37513000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q1QTD" decimals="-3" id="Fact-0D235DE646F8B31F06A3A9ED11ED62FE" unitRef="usd">1920000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q2QTD" decimals="-3" id="Fact-E06E22CA8FFED95AC65AA9ED11E1CA77" unitRef="usd">1824000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q3QTD" decimals="-3" id="Fact-B2C8843BBDC6126CC788A9ED11E1026F" unitRef="usd">-118000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q4QTD" decimals="-3" id="Fact-4D49D80733B9B97F2892A9ED11E381BD" unitRef="usd">-19343000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q4YTD" decimals="-3" id="Fact-01478A0ACAB9FB79F8E3A9ED124428CE" unitRef="usd">-15717000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-CD9FA1B4342C67BFB1CAA9ED122608DF" unitRef="usd">1234000</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-94D92C7733E751BB4539A9ED12209361" unitRef="usd">-16951000</us-gaap:ProfitLoss>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4" decimals="-3" id="Fact-6EB7A1F480C95CB92B04A9ED1213FD63" unitRef="usd">44764000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" decimals="-3" id="Fact-E7F55BE103C3142337A2A9ED1216161A" unitRef="usd">6432000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" decimals="-3" id="Fact-EE6B8639C155A874EAC0A9ED120736CD" unitRef="usd">4680000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" decimals="-3" id="Fact-3334F2EDD8CC17DF6E13A9ED121D9C3C" unitRef="usd">7340000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember" decimals="-3" id="Fact-F04E3239500DDC36A128A9ED1210C268" unitRef="usd">1379000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" decimals="-3" id="Fact-3C0FC14F2B90E0C2C498A9ED121061B5" unitRef="usd">24933000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4" decimals="-3" id="Fact-BFC14A97997BD1BA4123A9ED1210339C" unitRef="usd">47104000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" decimals="-3" id="Fact-A6311048E76C1EC47FB1A9ED120FDCD6" unitRef="usd">6257000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" decimals="-3" id="Fact-256EC5B9CACAE236D884A9ED12133053" unitRef="usd">4966000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" decimals="-3" id="Fact-618B803AA0412FAB1549A9ED12073DBE" unitRef="usd">7716000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember" decimals="-3" id="Fact-7D7D45D3A9A8A80222ACA9ED120DEFAF" unitRef="usd">1514000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" decimals="-3" id="Fact-4D5C213D8BB9297C1C1AA9ED121BAC76" unitRef="usd">26651000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2017Q4" decimals="-3" id="Fact-C6F334836429B13E50D2A9ED1266031A" unitRef="usd">14086000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2018Q4" decimals="-3" id="Fact-B36257315C1FA8AD72A3A9ED12615398" unitRef="usd">13628000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-AE3282903B41E75896C3A9ED123FC07F">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" id="Fact-08CE9418C127ADDB951CA9ED127224EC">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" id="Fact-F9E3B0C1D8AA7611570DA9ED126ED781">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember" id="Fact-9D742D021645C1994E31A9ED1270CDB7">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact-11F28173C1EEE4391913A9ED12746FF7">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareDevelopmentMember" id="Fact-69776172B7006C686AA7A9ED1240EA67">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-51519D9F17F18CCF8625A9ED124C2E99">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" id="Fact-FED7A8E67AD3D1F71F36A9ED1273A72D">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" id="Fact-601F5A81F0C0F6609D1EA9ED126CB0CB">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_OfficeEquipmentMember" id="Fact-8640F87135318CE635E5A9ED1272C786">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact-3138E663C498BB802258A9ED12768CB6">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareDevelopmentMember" id="Fact-E060906574AA7A67EFDFA9ED12382D1A">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C77C899248B184174E1BA9ED124B6D47" unitRef="usd">593000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-5F8E7C2F70C59212AEDDA9ED1250CDA7" unitRef="usd">1828000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-79ACAD2489968934AE34A9ED12301387" unitRef="usd">2204000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F0F531989363E0DCDFD9A9ED120774FB" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A114A86E371405DE7CF2A9ED12031B78" unitRef="usd">5000000</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-BDC4D66F6D40B4D54B40A9ED11DB89E9" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfLinesOfCredit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-2D94F19193E8355A3FE2A9ED11D6B4B8" unitRef="usd">67800000</us-gaap:RepaymentsOfLinesOfCredit>
	<us-gaap:RepaymentsOfLinesOfCredit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-7A83AFAAE2ACAFB27A2EA9ED11FE117A" unitRef="usd">39000000</us-gaap:RepaymentsOfLinesOfCredit>
	<us-gaap:RepaymentsOfLinesOfCredit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-316BFF31AA2FE19424E0A9ED11F8524F" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="D2017Q1Marc17_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="-5" id="Fact-9247D228018C2C7ADBF0A9ED11DE2A85" unitRef="usd">5000000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-D064009E1CFEA2E2510AA9ED11EF6AAB" unitRef="usd">30500000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C8CC73CCDA6E0B56D85EA9ED11EB0280" unitRef="usd">1500000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A29CBABCF1B0E1DD7C07A9ED11CFA807" unitRef="usd">16124000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RestructuringCharges contextRef="FD2016Q4YTD" decimals="-3" id="Fact-718F41FCAFF19BC4B223A9ED12529DFC" unitRef="usd">753000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-9ED427ED2D498ECCC78CA9ED12589497" unitRef="usd">190000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-0DB67DF7680613ECC941A9ED1257A633" unitRef="usd">563000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD" decimals="-3" id="Fact-10E93A7F88709057370FA9ED12292BBA" unitRef="usd">1026000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-603404A917AEC9042836A9ED12593C1C" unitRef="usd">504000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-AF6B5799766DDDD2AC16A9ED125F2D58" unitRef="usd">522000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1932DE0D114B8F2561F0A9ED12337B73" unitRef="usd">2758000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-BBC2747AF8FE8E4FDD21A9ED125C1ECB" unitRef="usd">184000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-5F268154C005CDF53A52A9ED125934A3" unitRef="usd">1600000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-5" id="Fact-C6110D71F1A13A024678306B54427861" unitRef="usd">500000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringReserve contextRef="FI2015Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-B7FB38E3FFDA98F361A3A9ED125A9F49" unitRef="usd">338000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2015Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-B52D53F0FA38EC790C82A9ED125B4CCF" unitRef="usd">44000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-948A0949A86C28B3E3E1A9ED1259D1D9" unitRef="usd">273000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-E3FEC2CAB761E0BEAECCA9ED125D5DD8" unitRef="usd">325000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-3908A5D12AF805CEBC08A9ED12585301" unitRef="usd">441000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-7F6231733C99631F80C6A9ED125AF5E3" unitRef="usd">87000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ccrn_ExitCostsMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-03FB466C35BFF262B4F4A9ED125BB73D" unitRef="usd">390000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember_us-gaap_RestructuringPlanAxis_ccrn_CostOptimizationProjectMember" decimals="-3" id="Fact-AB56650B3C5341C678D5A9ED1260DDA5" unitRef="usd">556000</us-gaap:RestructuringReserve>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2017Q4" decimals="-3" id="Fact-88AB41FF4C2181B854A3A9ED126ECE93" unitRef="usd">-67111000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2018Q4" decimals="-3" id="Fact-89BAEF45E853E249FF82A9ED1267C77A" unitRef="usd">-84062000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4768C439016D4C5FC34EBF351DD1361F" unitRef="usd">816484000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember" decimals="-3" id="Fact-5299D5F75D570F41B69DBF3513385712" unitRef="usd">34070000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-6649C82A65284524BFEEBF3505CEDDCC" unitRef="usd">14867000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-07377EAE7C02EB27B894BF350CCE4CD4" unitRef="usd">13877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_OtherServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-158D187B1DF6E642C454BF3508E3CA2A" unitRef="usd">5326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember" decimals="-3" id="Fact-ED99CF16198BF71DC567BF3504985527" unitRef="usd">782414000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-712F84E8FCBDAF3B741EBF34F76C06ED" unitRef="usd">705435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-E49A24869F8DA322759CBF35010ED932" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ccrn_TemporaryStaffingServicesMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-50E1D93178F4F4C35E53BF34FCB089D1" unitRef="usd">76979000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-12393DF55D69294D811FBF35144F24E6" unitRef="usd">720302000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-7E967BE6E319A56A919BBF351BFA1698" unitRef="usd">13877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="FD2018Q4YTD_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-5660C9A8B1889E90B421BF3517C47AC5" unitRef="usd">82305000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2016Q4YTD" decimals="-5" id="Fact-BBCD87080901F3527D87A9ED11F98F3C" unitRef="usd">5000000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2016Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-C1B18F2C983AC1830570A9ED11F9D69E" unitRef="usd">12600000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2017Q4YTD" decimals="-5" id="Fact-230C698885801F5C41DDA9ED11F684D1" unitRef="usd">4900000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2017Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-9E3C22A7744AD97B596EA9ED11F615DA" unitRef="usd">17900000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2018Q4YTD" decimals="-5" id="Fact-CB1954F338AB5443F643BFC556CE8E36" unitRef="usd">100000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:RevenueFromRelatedParties contextRef="FD2018Q4YTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_CorporateJointVentureMember" decimals="-5" id="Fact-8D17BAC17344D2222B2EBFC7C532BE92" unitRef="usd">19400000</us-gaap:RevenueFromRelatedParties>
	<us-gaap:Revenues contextRef="FD2016Q4YTD" decimals="-3" id="Fact-237D99CCCF044F022025A9ED12536443" unitRef="usd">833537000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-A2D7362279001E3F58B3A9ED12481C89" unitRef="usd">721486000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-48C29C6B8B72E7AC36C1A9ED124A852C" unitRef="usd">13768000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-4C39AD22FDB992E88E51A9ED123B4665" unitRef="usd">98283000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD" decimals="-3" id="Fact-CAD5718BF3AA1B24BCF9A9ED1275B72F" unitRef="usd">207573000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q2QTD" decimals="-3" id="Fact-F698A2375D031DE6BF08A9ED1271E16B" unitRef="usd">209313000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q3QTD" decimals="-3" id="Fact-68A0ED18A0D366FC65C1A9ED1265D51D" unitRef="usd">228488000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4QTD" decimals="-3" id="Fact-2B5FCBF5F5BB2B95EE4FA9ED127434A1" unitRef="usd">219674000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0B2216CF136AADD00D3AA9ED1247DF14" unitRef="usd">865048000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-6022E6B5A20E5BAB1986A9ED12532D42" unitRef="usd">758267000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-927ABA97C932B1D66DF3A9ED12466F5F" unitRef="usd">13171000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-5F8E77202AD405A58BACA9ED1245C83D" unitRef="usd">93610000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD" decimals="-3" id="Fact-E87AC64C11BB285C35F2A9ED11DCCDE1" unitRef="usd">210288000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q2QTD" decimals="-3" id="Fact-16E438A562BCD9FAE4C1A9ED11E7A4B4" unitRef="usd">204572000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q3QTD" decimals="-3" id="Fact-DC6A601EE181CA48E474A9ED127081FE" unitRef="usd">200717000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4QTD" decimals="-3" id="Fact-A95CBDD83C04880859F2A9ED11F6813D" unitRef="usd">200907000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD" decimals="-3" id="Fact-69F308C68DC23E19B2C3A9ED122981E9" unitRef="usd">816484000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_NurseAndAlliedStaffingMember" decimals="-3" id="Fact-B4B499E4EE638EBFB344A9ED12409CBC" unitRef="usd">720302000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_OtherHumanCapitalManagementServicesMember" decimals="-3" id="Fact-A4AA8756E7639624E9ABA9ED12377EF1" unitRef="usd">13877000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_ccrn_PhysicianStaffingMember" decimals="-3" id="Fact-313253A6346CEF6DAC4BA9ED12409809" unitRef="usd">82305000</us-gaap:Revenues>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6D7A4D4092E64522E0AEA9ED12427653" unitRef="usd">179820000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-9D58E50A0C9AA0395DA3A9ED1235F3D7" unitRef="usd">187435000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A812C315C742F788F3C5A9ED12299A48" unitRef="usd">180230000</us-gaap:SellingGeneralAndAdministrativeExpense>
	<us-gaap:ShareBasedCompensation contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BB61ECAE5E2DB76FBA17A9ED11DFA8E7" unitRef="usd">3379000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C993B431175F1BF29AFAA9ED11F4ABE0" unitRef="usd">4080000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q4YTD" decimals="-3" id="Fact-335474B43DC1CA258ADEA9ED1200C657" unitRef="usd">3575000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" id="Fact-F342B3460A325CB22D6BA9ED11F98260">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_StockAppreciationRightsSARSMember_us-gaap_PlanNameAxis_ccrn_IncentiveCompensationPlan2007Member" id="Fact-F4195D42CEB0361783BEA9ED11F322E6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-B804280C91F59453AB7EA9ED11FBF615" unitRef="shares">64062</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-780C5FAF0FDD72DB1331A9ED122ED898" unitRef="shares">97708</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-0EF944E8BD49EA0B4CCEA9ED123EA3E4" unitRef="usdPerShare">13.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-72B3A17CA5F8CAA66B23A9ED11F88B61" unitRef="usdPerShare">13.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-81E958BBA257CBB8E129A9ED1236D7E6" unitRef="shares">238328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-0898D5796AE2E85B03BCA9ED120096B3" unitRef="shares">391108</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-E16F21A640FAC3F0B7EEA9ED1238FC70" unitRef="usdPerShare">11.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-E59547F3C61271DCEF1BA9ED121798C0" unitRef="usdPerShare">10.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-3D6D53BACF7EC09A686DA9ED11FFDE3D" unitRef="shares">257575</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-183C40A62C7B1723692BA9ED12693910" unitRef="shares">515601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-52988300EE11B3A0942AA9ED12416C18" unitRef="shares">365149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-C619402FBBC7A2F6BF3AA9ED11EB3A41" unitRef="shares">589120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-DE0230FA79E2B73BCDC1A9ED12001B95" unitRef="usdPerShare">13.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-37F55774B2178BD3204DA9ED11F715CD" unitRef="usdPerShare">13.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-8D946F7DAE8E45E6F936A9ED121705C9" unitRef="usdPerShare">12.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-A022FB2CDBC3D64EEC17A9ED11F8DD80" unitRef="usdPerShare">12.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-DFB54B53369D5A2076E7A9ED123EEF08" unitRef="shares">66692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="INF" id="Fact-80478C1CA0646FCBEC29A9ED12367540" unitRef="shares">219881</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-0ADFB1D3224FA4528519A9ED11F4C0C3" unitRef="usd">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="-5" id="Fact-E76DC1A1910375C0FFD6A9ED11F52179" unitRef="usd">4300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-E348BEECA393F1804AB2A9ED12352941" unitRef="usd">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="-5" id="Fact-17B66240D7D68D47C202A9ED11FA5979" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-C7DC1A92B3CCF2CBC2B5BFD7F6305F0B" unitRef="usd">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="-5" id="Fact-0EE8DEA692AC34CC21D4BFD7A40CAD62" unitRef="usd">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-736ADB3BE76E4CA056D3A9ED12624260" unitRef="usdPerShare">11.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" decimals="2" id="Fact-D40736F8DBD72FFF6CEDA9ED121610A3" unitRef="usdPerShare">12.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="D2017Q2May23_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-B089A2F45D7A9E6C6881A9ED11EBE2BB" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="I2011Q4oct25_us-gaap_PlanNameAxis_ccrn_StockOptionAndEquityParticipationPlan1999Member" decimals="INF" id="Fact-7E06B75E348AA3C714B1A9ED12595284" unitRef="shares">4398001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2016Q4YTD" decimals="-3" id="Fact-28C934EFDE5DC64A6C31A9ED1231FEF5" unitRef="usd">1323000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8C6C8BB4824CC4B668D9A9ED123D7DD5" unitRef="usd">516000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2018Q4YTD" decimals="-3" id="Fact-98F1B463FC9F286E3712A9ED12430066" unitRef="usd">234000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-594A6F78F2370EFA6F2FA9ED11F2F197" unitRef="usdPerShare">7.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="FD2018Q4YTD" decimals="INF" id="Fact-D4C530C02498251BC05EA9ED11F2289F" unitRef="shares">2500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="FD2018Q4YTD" decimals="INF" id="Fact-2CB6C5FC32B0E295E7E7A9ED11F60946" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="FI2018Q4" decimals="-3" id="Fact-21CF0C61770ECE2F0705A9ED11FC2BDF" unitRef="usd">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2017Q4" decimals="INF" id="Fact-1466073F76F01ED20690A9ED11F60D4B" unitRef="shares">94500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q4" decimals="INF" id="Fact-6441C43D6E95E3B7C848A9ED11FCC979" unitRef="shares">51500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2017Q4" decimals="2" id="Fact-B61349DA32524B70D460A9ED11F882E4" unitRef="usdPerShare">5.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q4" decimals="2" id="Fact-F1AA4FA2C5CA942ABA82A9ED11F4555A" unitRef="usdPerShare">4.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice contextRef="FI2018Q4" decimals="2" id="Fact-C61BAF6695ED6C576C00A9ED122F71EB" unitRef="usdPerShare">4.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="FI2018Q4" decimals="-5" id="Fact-B8D4FEC0EF288A1CAC8FA9ED125F9570" unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="D2017Q1March31_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-FBE47C116948561EDB60E5DFB4BB0787" unitRef="shares">181067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="D2018Q1March31_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-95BB01E12CF4A6F18DB4E5DFB6601AB2" unitRef="shares">238328</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="FD2017Q1QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-4BC3131591AE79F6190BA9ED126016FE" unitRef="shares">66692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-5EA1BB96500B093D3270A9ED1201896F" unitRef="usdPerShare">5.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-5DC3C9438AD0FE4A7FF8A9ED11FD5B93" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeFiveMember" decimals="INF" id="Fact-82A35264200B9D4F0310A9ED11FECBEE" unitRef="usdPerShare">4.35</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeOneMember" decimals="INF" id="Fact-73AEBC02555EF5BF2D7FA9ED120710E3" unitRef="usdPerShare">4.16</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeThreeMember" decimals="INF" id="Fact-EBEECD2BDAED6C5E63CAA9ED126E8BC9" unitRef="usdPerShare">4.16</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeFiveMember" decimals="INF" id="Fact-1D7FC8B5CB1D9F69E765A9ED11F3AE8F" unitRef="usdPerShare">5.21</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeFourMember" decimals="INF" id="Fact-0C7BD48B1F7B0595489CA9ED1203FE50" unitRef="usdPerShare">7.44</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeOneMember" decimals="INF" id="Fact-B5D3C7E08421784B8D10A9ED11FFDF2F" unitRef="usdPerShare">7.44</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeThreeMember" decimals="INF" id="Fact-99E0BCA937242A381CE3A9ED12027BC2" unitRef="usdPerShare">7.44</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="FD2018Q4YTD_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_ccrn_ExercisePriceRangeTwoMember" decimals="2" id="Fact-CB57E00D44785D612C7FBFE0CD26267D" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2018Q4YTD" id="Fact-3B0F6BBC2CCA2BE7412DA9ED11E7C94C">P1Y6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="FD2018Q4YTD" id="Fact-C2D9CBC91467597BF43BA9ED11EDDDED">P1Y0M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember" decimals="INF" id="Fact-9F4A2BABD10B4A3D82C2A9ED11F395EF" unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_ccrn_OmnibusPlanMember_us-gaap_TitleOfIndividualAxis_ccrn_TenPercentOrMoreStockholdersMember" decimals="INF" id="Fact-118C608C855E75A9FD99A9ED11EEECA0" unitRef="number">1.1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
	<us-gaap:SharesOutstanding contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-A18C6F0C2AC8B9FD29ACA9ED120B1668" unitRef="shares">31952000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-C949C0EB4A6AB696E4C5A9ED120DE711" unitRef="shares">32339000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-17409F21792261911F98A9ED1205704E" unitRef="shares">35838000</us-gaap:SharesOutstanding>
	<us-gaap:SharesOutstanding contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-9560A2C0DA15CAD7D2B7A9ED121F079A" unitRef="shares">35626000</us-gaap:SharesOutstanding>
	<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-A88F3EB6152278F20BB3BEEC4D7BE194" unitRef="shares">3176000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-B9973BDC29E2AA1196D3A9ED12075602" unitRef="shares">284000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-D9A576B1E4D971876802A9ED1221ECB7" unitRef="shares">282000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-761A070C742DAD8BD214A9ED120E71AC" unitRef="shares">199000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-7A2A42E05AC484E6A551A9ED121CC8C5" unitRef="shares">103000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-CEE768F51A08D6980A9CA9ED12200079" unitRef="shares">41000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2018Q4YTD" decimals="INF" id="Fact-85759C267B667F96EEACA9ED11FB05BF" unitRef="shares">40500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-615B3EEA17E583C162ABA9ED121CCAE6" unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2017Q4YTD" decimals="-3" id="Fact-29650693B657E7A1F23CBEEC63B756B6" unitRef="usd">45952000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-B5F8F90D3140318926B7BEEC63B37E7F" unitRef="usd">45951000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-523B87C451A5E2A1EFB8BEEC63BBA3A6" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CF9A1B25697FE21B1A85A9ED120B3DBE" unitRef="usd">-917000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-7DB707302AB827B073FAA9ED121A312B" unitRef="usd">-917000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D35CF992927329213A56A9ED121B665D" unitRef="usd">-1774000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-C75C802F4CA6844569CFA9ED121E7022" unitRef="usd">-1774000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2018Q4YTD" decimals="-3" id="Fact-348495BFE366D9AAF1A4A9ED12254C1D" unitRef="usd">-889000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-2C8A71D4F657D81DF66AA9ED1202C5B0" unitRef="usd">-889000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="FI2018Q4" decimals="INF" id="Fact-B768CEF215F93DD94D29A9ED1267ED0D" unitRef="shares">510004</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="FD2016Q4YTD" decimals="INF" id="Fact-0F10F4DDD77785C8ECDFA9ED1203E03C" unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="FD2017Q4YTD" decimals="INF" id="Fact-017A5240EF294BCC6D4EA9ED12018672" unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-9E6C976C056DA5CB8D15BEF36970369B" unitRef="shares">432000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-981D396B7A0AAA61B26DBFD61DC39781" unitRef="shares">432439</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B89E1D8FC82FCF0EF7CDBEF357319FE8" unitRef="usd">5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-939579419764930A1BEBBEF35719D146" unitRef="usd">5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-5" id="Fact-3637AF3CDFD063B7D548BFD636F3780A" unitRef="usd">5000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4" decimals="-3" id="Fact-09B587D63AA9CC4294E2A9ED1273AC7D" unitRef="usd">237089000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4" decimals="-3" id="Fact-74E2A481F2C301E3E259A9ED126478C1" unitRef="usd">217528000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4" decimals="-3" id="Fact-57BA0C419F6323642E3BA9ED121877DE" unitRef="usd">141344000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-960CB2C24D33A0E0EC03A9ED1209180A" unitRef="usd">-1207000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-F22DBC2E1444AA013D37A9ED12244E87" unitRef="usd">254108000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-26D345D1E85987F97BF3A9ED12175A87" unitRef="usd">3000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-ECF5EB9CAF234C0D9E7FA9ED121EB3F9" unitRef="usd">496000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-EBC84338F95661A97BE3A9ED1223C679" unitRef="usd">-112056000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4" decimals="-3" id="Fact-DF04B0594C1CF76BE3A9A9ED12208429" unitRef="usd">151802000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-9DD094FEC549508438ADA9ED12091C27" unitRef="usd">-1241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-FDE4352DBC75A021A2ABA9ED120DC07C" unitRef="usd">256570000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-4368867D2DF6E73F1A77A9ED121A2BD3" unitRef="usd">3000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-A903E4FD61D604207CCFA9ED120AE7B3" unitRef="usd">559000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-7317B562D287C267A278A9ED12278A4F" unitRef="usd">-104089000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4" decimals="-3" id="Fact-4AB38A66BB26DEC8BECBA9ED127B48B7" unitRef="usd">237719000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-6660B93EDBCC2B14C755A9ED12020903" unitRef="usd">-1166000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-104D6E842EA3ED37DC03A9ED12226948" unitRef="usd">305362000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-0C5F350F1B9B6F08439EA9ED120EF579" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-B2DDCDAA4033622CDDFDA9ED12200479" unitRef="usd">630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-3F8BE8A568AAF7690805A9ED120EF5E8" unitRef="usd">-67111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4" decimals="-3" id="Fact-2211F775A7D74447B279A9ED12776FDA" unitRef="usd">218198000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-4E67213B543A0915AE01A9ED121A2705" unitRef="usd">-1462000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-BB93456763028EA29666A9ED120E6DD4" unitRef="usd">303048000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-E513BE7393844E484474A9ED1224B73B" unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" decimals="-3" id="Fact-ED40C098F7081BA3C6F8A9ED1208C8BE" unitRef="usd">670000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-6C51BA7B717548735421A9ED1203D0F1" unitRef="usd">-84062000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:UnbilledContractsReceivable contextRef="FI2017Q4" decimals="-5" id="Fact-BFEC7D383DA139EEB588C0035F50417B" unitRef="usd">41800000</us-gaap:UnbilledContractsReceivable>
	<us-gaap:UnbilledContractsReceivable contextRef="FI2018Q4" decimals="-5" id="Fact-58D732222F7CF12B27CEC00360B1368B" unitRef="usd">44100000</us-gaap:UnbilledContractsReceivable>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2015Q4" decimals="-3" id="Fact-09043F3F32D1A9A66C3EA9ED11DC005C" unitRef="usd">4071000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2016Q4" decimals="-3" id="Fact-BCB1EEAF4D94BAEF957CA9ED125E42E0" unitRef="usd">5180000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2016Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" decimals="-5" id="Fact-9A34F4F4B4B6C8072ECB315979F2847D" unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2016Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember" decimals="-5" id="Fact-4E79E275338DC0AA3EB1A9ED125F1F66" unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q4" decimals="-3" id="Fact-1D0E58E9E31BB47D8A9BA9ED12583288" unitRef="usd">3807000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" decimals="-5" id="Fact-AA4C2DBB2DE252A0555A315979EC1F27" unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember" decimals="-5" id="Fact-72A1C21DF7E2387C6753A9ED12565501" unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2018Q4" decimals="-3" id="Fact-C558E88A7108D0042A56A9ED11CFC7C9" unitRef="usd">5412000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherCurrentLiabilitiesMember" decimals="-5" id="Fact-08316315F71CAE52C394A9ED125A78C6" unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember" decimals="-5" id="Fact-EAAB2A6F07E46E7A4E3ABFE4D9EAE0D8" unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0D1B6A4B02C9F9C7006FA9ED12626A78" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-336AFD7F6AF7D1DAC4BEA9ED1265FEAA" unitRef="usd">439000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0B0F015B29C0A4E79924A9ED11D4ECE6" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2016Q4" decimals="-5" id="Fact-622F165E7F562D1208C9A9ED125C4403" unitRef="usd">500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2017Q4" decimals="-5" id="Fact-DF17F1A70A7260399EFAA9ED12158BEC" unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2018Q4" decimals="-5" id="Fact-D1FDAFCDBB687D59E2BABFE3C573DF9A" unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-774951280A20190B674FA9ED12563D1E" unitRef="usd">1054000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-AF6B7BC8D8B07C0CAB9AA9ED11D9432F" unitRef="usd">1145000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-FC92CAED11D4B54D535FA9ED11D62629" unitRef="usd">1401000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A5F731FFCEC847015C02A9ED11D04051" unitRef="usd">55000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E0C2FFE5E0F0ACEB0C77A9ED125ABA3E" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A8664ED38A8163B0A56FA9ED127E8DAA" unitRef="usd">204000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2016Q4" decimals="-5" id="Fact-E43D05D67C122EFA13C9A9ED12354657" unitRef="usd">4900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2017Q4" decimals="-5" id="Fact-3C0D4EE197B9667BA48BA9ED12562B3E" unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="FI2018Q4" decimals="-5" id="Fact-B38E9BA8BA29C73A9AD0BFE47C2AD663" unitRef="usd">5600000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
	<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="FD2017Q4QTD" decimals="-5" id="Fact-3904841FCDFCB8123002A9ED11D46316" unitRef="usd">-43300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
	<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="FD2017Q4YTD" decimals="-5" id="Fact-B7BFD38E690057A1A967A9ED121658F7" unitRef="usd">-45400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
	<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="FD2017Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_NetOperatingLossesMember" decimals="-5" id="Fact-A5DC8F6D77E229E24C2EA9ED12637149" unitRef="usd">-15700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
	<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="FD2017Q4YTD_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_NetOperatingLossesMember" decimals="-5" id="Fact-6A65E698F2613D45B47FA9ED125D934B" unitRef="usd">-4400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
	<us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="FD2017Q4YTD_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_ccrn_OtherNetDeferredTaxAssetsMember" decimals="-5" id="Fact-1F33BBC98C5466F6758DA9ED124E4A39" unitRef="usd">-25300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-32BC4A4A7CDDF58FDB0CA9ED120C586C" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-42B8092650CF5D9D0F6CA9ED11F8597F" unitRef="usd">12000</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-1BF24F1835FDD80DB76CA9ED12009E06" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-5535EDBE65F581976E68A9ED120D2702" unitRef="usd">962000</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-7CF553AB079AB444EEABA9ED1212E080" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesAdjustments contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-8EF41C281F8FA1F54A2BA9ED12074A83" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-F22FDFBC72C4F4759F7FA9ED120810DD" unitRef="usd">4045000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-92B7FC4E53A207ECA6D7A9ED1209D3E5" unitRef="usd">55336000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-A0DC8D3BE8E5699528FCA9ED120405D3" unitRef="usd">3245000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-E121680A3C48BC0990F9A9ED1201EB5E" unitRef="usd">46454000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-39FB32B95B73A51AE49BA9ED1202B139" unitRef="usd">3688000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-9782D185D1607117D0C4A9ED11FEBB03" unitRef="usd">1076000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-0AAC0D890B53F0A76E9CA9ED12114D76" unitRef="usd">3705000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-274502A07835E6885CEAA9ED120F3538" unitRef="usd">1189000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-E028B994E312487DC357A9ED120F6798" unitRef="usd">4034000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-DE0AE2133A366A2C0147A9ED11EDE4C0" unitRef="usd">-8894000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-02BC89A0E44921967050A9ED120D570A" unitRef="usd">4705000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-45DA13ABA53B24C6CBCAA9ED1257D587" unitRef="usd">-3007000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-1E196C1C876F609EA057A9ED12050013" unitRef="usd">5974000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-39A8003EB422646F5E45A9ED1202DA3F" unitRef="usd">113000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-ED3C17A74F01E82FB391A9ED120BFD91" unitRef="usd">4834000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-F7E4AAAA8B02155F3AB4A9ED120A070E" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-38FEB4ADB36A336DBD54A9ED1207C1AC" unitRef="usd">4262000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-B8863D574F91F8559163A9ED12567367" unitRef="usd">43333000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_AllowanceForCreditLossMember" decimals="-3" id="Fact-7382456ECC220160F3D2A9ED120AE943" unitRef="usd">5957000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-459617ED31AD2781E34FA9ED1209C5E5" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2016Q4YTD" decimals="-3" id="Fact-198B0758B229F8C90468A9ED122F106D" unitRef="shares">36246000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q4YTD" decimals="-3" id="Fact-30D94D4C1233B35897DFA9ED124C5A8A" unitRef="shares">36166000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A27E3AADE570BCFED7DEA9ED124445DA" unitRef="shares">35657000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2016Q4YTD" decimals="-3" id="Fact-828024461937BFDAD17AA9ED124FE2A9" unitRef="shares">32132000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q4YTD" decimals="-3" id="Fact-567EE1837B30667F6C3AA9ED122DD37B" unitRef="shares">35018000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2018Q4YTD" decimals="-3" id="Fact-DB72968F1F3288604E6FA9ED1236D2FD" unitRef="shares">35657000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WorkersCompensationLiabilityCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-41934EDCA557C6AA97C3A9ED125158DA" unitRef="usd">5957000</us-gaap:WorkersCompensationLiabilityCurrent>
	<us-gaap:WorkersCompensationLiabilityCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-AEB97E4C80AF43871B20A9ED125B9E8D" unitRef="usd">6454000</us-gaap:WorkersCompensationLiabilityCurrent>
	<us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-13CB812E3FE8D1A7A099A9ED11EFCAD3" unitRef="usd">13160000</us-gaap:WorkersCompensationLiabilityNoncurrent>
	<us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-5BA3D60A00F7F8025C96A9ED121D0FCC" unitRef="usd">12997000</us-gaap:WorkersCompensationLiabilityNoncurrent>
	<ccrn:IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock contextRef="FD2018Q4YTD" id="Fact-B33DCE00FF53FBADA6C9A9ED11ECBC65">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table represents information about stock options and stock appreciation rights exercised in each year. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Total intrinsic value of options exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;516&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,323&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ccrn:IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock>
	<ccrn:PrepaidRentAndDepositsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-1A6C97939C60D0A5A7F1A9ED12426AB6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Prepaid Rent and Deposits&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company leases apartments for eligible field employees under short-term agreements (typically &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; months), which generally coincide with each employee&amp;#8217;s staffing contract. Costs relating to these leases are included in direct operating expenses on the accompanying consolidated statements of operations. As a condition of these agreements, the Company may place security deposits on the leased apartments. Deposits on field employees&amp;#8217; apartments related to these short-term agreements are included in other current assets on the accompanying consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</ccrn:PrepaidRentAndDepositsPolicyTextBlock>
	<ccrn:SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-A43B43ACEDF1BE67FC5CA9ED12403D0A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Sales and Other State Non-income Tax Liabilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company accrues sales and other state non-income tax liabilities based on the Company&amp;#8217;s best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company&amp;#8217;s business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</ccrn:SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock>
	<srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="FD2018Q4YTD" id="Fact-5128503A5103BFC7FBFDA9ED1281EA08">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery receivable:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for workers&amp;#8217; compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,295&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,623&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for professional liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,891&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,874&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,497&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other non-current assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,093&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,924&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,011&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current security deposits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;982&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,095&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current income tax receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;433&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net debt issuance costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;935&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;985&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,228&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued compensation and benefits:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Salaries and payroll taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,884&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Bonuses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,454&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,957&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,786&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,683&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for healthcare benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,105&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for vacation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,574&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,117&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,332&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,271&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term accrued claims:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,997&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,299&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,757&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other long-term liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current deferred tax liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;95&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;105&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred rent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,039&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,875&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term unrecognized tax benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;590&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;318&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,767&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
	<srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-CC044E76BAC41BBF60AFA9ED1210A9BA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Schedule II&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;CROSS COUNTRY HEALTHCARE, INC.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;FOR THE YEARS ENDED DECEMBER&amp;#160;31, 2018, 2017, AND 2016&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:30%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:4%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:3%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:4%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:4%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Balance at&lt;br clear="none"/&gt;Beginning&lt;br clear="none"/&gt;of Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Charged to Operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Write-Offs, net of recoveries&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Other&lt;br clear="none"/&gt;Changes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Balance at&lt;br clear="none"/&gt;End&lt;br clear="none"/&gt;of Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;"&gt;Allowances for Accounts Receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;3,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;5,974&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(5,957&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;3,705&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;3,245&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;4,705&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(4,262&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;3,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;4,045&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;4,034&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(4,834&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;3,245&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;"&gt;Valuation Allowance for Deferred Tax Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;113&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;46,454&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(3,007&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(43,333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;962&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(c)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Year Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;55,336&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(8,894&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;46,454&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Uncollectible accounts written off, net of recoveries.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Release of valuation allowances on the Company&amp;#8217;s deferred tax assets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(c)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation allowance on deferred tax asset related to share-based compensation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
	<us-gaap:AdvertisingCostsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-6F542B81C567509421BCA9ED123B2225">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Advertising&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company&amp;#8217;s advertising expense consists primarily of online advertising, internet direct marketing, print media, and promotional material. Advertising costs are expensed as incurred and totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$6.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$7.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$10.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
	<us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="FD2018Q4YTD" id="Fact-E2B734D6C2150EDD0D6EA9ED126B6552">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following unaudited pro forma financial information approximates the consolidated results of operations of the Company as if the Advantage acquisition had occurred as of January 1, 2016, after giving effect to certain adjustments, including additional interest expense on the amount the Company borrowed on the date of the transaction, the amortization of acquired intangible assets, and the elimination of certain expenses that will not be recurring in post-acquisition periods, net of an estimated income tax impact. These adjustments include removing transaction-related expenses of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the year ended December 31, 2017. These results are not necessarily indicative of future results as they do not include incremental investments in support functions, elimination of costs for integration or operating synergies, or an estimate of any impact on interest expense resulting from the operating cash flow of the acquired businesses, among other adjustments that could be made in the future but are not factually supportable on the date of the transaction. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.83040935672514%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(unaudited, amounts in thousands except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;916,149&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;934,904&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income per common share attributable to common shareholders - basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income per common share attributable to common shareholders - diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.09&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
	<us-gaap:BusinessCombinationDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-35664A58B0C6CB5F186DA9ED126A9CE6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Acquisitions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;American Personnel, Inc.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 1, 2018, the Company completed the acquisition of American Personnel, Inc. (AP Staffing) for a total purchase price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, subject to a net working capital adjustment. Based in Boston, AP Staffing offers a range of talent management solutions to its healthcare clients primarily in Massachusetts, including permanent placement, consultative staffing solutions, and traditional staffing.   &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company assigned a total of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to definite life intangible assets with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. The remaining excess purchase price over the fair value of net assets acquired of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was recorded as goodwill, which is not deductible for tax purposes since this was a stock acquisition. Associated acquisition-related costs incurred were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and have been included in acquisition and integration costs on the Company's consolidated statement of operations for the year ended December 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The acquisition was deemed immaterial and has been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, using the acquisition method of accounting. AP Staffing's results of operations are included in the consolidated statements of operations from December 1, 2018 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Advantage RN&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effective July 1, 2017, the Company acquired all of the assets of Advantage RN, LLC and its subsidiaries (collectively, Advantage) for cash consideration of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$86.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, net of cash acquired. The total purchase price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$88.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was subject to a net working capital reduction of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at the closing and an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was received during the third quarter of 2017 as the final adjustment for net working capital. Additionally, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the purchase price was deferred as of the closing and is due the seller within &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, less any COBRA and healthcare payments incurred by the Company on behalf of the seller. As of December 31, 2018, approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; has been paid for claims and the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; liability is included in other current liabilities on the Company&amp;#8217;s balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Included in the amount paid at closing were two escrow accounts, the first was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; which related to tax liabilities and the second was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; which was to cover any post-close liabilities. On July 28, 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the tax liabilities was released from escrow, leaving a balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. In the first quarter of 2019, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the post-close liabilities was released from escrow, leaving a balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to cover pending post-close liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company financed the purchase using &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$19.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in available cash and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$66.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in borrowing under its Credit Facility, including a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; incremental term loan, which was subsequently refinanced on August 1, 2017. See Note 8 - Debt for further information. The transaction was treated as a purchase of assets for income tax purposes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Advantage is primarily a travel nurse staffing company that deploys many of its nurses through MSPs and Vendor Management Systems, and Advantage maintains direct relationships with many hospitals throughout the United States. This was a strategic acquisition to help the Company fill its recent MSP contract wins and for revenue growth.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The acquisition has been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC, using the acquisition method of accounting. As such, the amounts of revenue and contribution income included in the Company's consolidated income statement from the acquisition date to the period ended December 31, 2017 were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$47.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. The acquisition results have been substantially aggregated with the Company's Nurse and Allied Staffing business segment. See Note 17 - Segment Data.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following is the estimated fair value of the purchase price for Advantage on July 1, 2017:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net working capital adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,438&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,562&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,833&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The purchase price was allocated to the assets acquired and the liabilities assumed based on the estimated fair value at the date of acquisition. The Company used a third-party appraiser to assist with the determination of the fair value and estimated useful lives of certain acquired assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table is an estimate of the fair value of the assets acquired and liabilities assumed on July 1, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,833&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,396&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,596&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,900&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91,450&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable and accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company assigned the following values to other identifiable intangible assets: &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to trade names with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to customer relationships with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$11.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to a database, consisting of healthcare professionals, with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to non-compete agreements with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, for a total of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$29.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in definite life intangible assets with a weighted average estimated useful life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The remaining excess purchase price over the fair value of net assets acquired of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$43.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was recorded as goodwill, which is deductible for tax purposes. Associated acquisition-related costs incurred were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and have been included in acquisition and integration costs on the Company's consolidated statements of operations for the year ended December 31, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Pro Forma Financial Information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following unaudited pro forma financial information approximates the consolidated results of operations of the Company as if the Advantage acquisition had occurred as of January 1, 2016, after giving effect to certain adjustments, including additional interest expense on the amount the Company borrowed on the date of the transaction, the amortization of acquired intangible assets, and the elimination of certain expenses that will not be recurring in post-acquisition periods, net of an estimated income tax impact. These adjustments include removing transaction-related expenses of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the year ended December 31, 2017. These results are not necessarily indicative of future results as they do not include incremental investments in support functions, elimination of costs for integration or operating synergies, or an estimate of any impact on interest expense resulting from the operating cash flow of the acquired businesses, among other adjustments that could be made in the future but are not factually supportable on the date of the transaction. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.83040935672514%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(unaudited, amounts in thousands except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;916,149&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;934,904&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income per common share attributable to common shareholders - basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.16&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Net income per common share attributable to common shareholders - diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.09&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;US Resources Healthcare&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The agreement specified that the sellers were eligible to receive additional purchase price consideration of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, with a maximum of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for 2018, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for 2019, based on attainment of specific performance criteria achieved in each of those years. In the fourth quarter of 2017, the Company recognized a decrease in the fair value of the liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; included as acquisition-related contingent consideration on its consolidated statements of operations. The adjustment was driven by the decrease in the projected USR 2018 and 2019 revenue and EBITDA amounts. The earnout for 2017 was not achieved. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The acquisition was deemed immaterial and has been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets and Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Mediscan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$29.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$28.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; plus working capital estimate) and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in shares (or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,871&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares) of the Company's Common Stock, and a net working capital adjustment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million was settled in the first quarter of 2016. Additionally, an amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the purchase price that was held in escrow to cover any post-closing liabilities, was released to the sellers on May 3, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The agreement also specified that the sellers were eligible to receive additional purchase price consideration of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, with &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and, as of September 30, 2017, the Company&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;determined that the second year earnout would not be achieved for 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per year and 2019 is uncapped. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the fair value of the remaining obligations was estimated at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and is included in other current liabilities and contingent consideration on the consolidated balance sheets. See Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Medical Staffing Network&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was deferred and due to the seller &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period. The Company incurred &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
	<us-gaap:BusinessCombinationsPolicy contextRef="FD2018Q4YTD" id="Fact-E4B33B7F61A91FEEA531A9ED123A072D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Business Combinations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company applies accounting in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Business Combinations&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC when it acquires control over a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded as acquisition and integration costs; noncontrolling interests, if any, are reflected at fair value at the acquisition date; restructuring costs associated with a business combination are expensed; contingent consideration is measured at fair value at the acquisition date, with changes in the fair value after the acquisition date affecting earnings; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the consolidated statements of operations of the combined entity beginning on the date of acquisition. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-7AD04F7CAC66A4BBC5D0A9ED1237B191">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company considers all investments with original maturities of three months or less to be cash and cash equivalents. The Company invests its excess cash in highly rated overnight funds and other highly rated liquid accounts. The Company is exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions, and diversifying its counterparties. The Company does not currently anticipate nonperformance by any of its significant counterparties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Interest income on cash and cash equivalents of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for the year ended December 31, 2018, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for the years ended December 31, 2017 and 2016, is included in other income, net, on the Company&amp;#8217;s consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-E4F932722A00CEF8A560A9ED12514FFF">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Commitments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Operating Leases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has entered into non-cancelable operating lease agreements for the rental of office space and equipment. Certain of these leases include options to renew as well as rent escalation clauses and in certain cases, incentives from the landlord for rent-free months and premises reductions, and allowances for tenant improvements. The rent escalations and incentives have been reflected in the table below. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Future minimum lease payments, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, associated with these agreements with terms of one year or more are as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,451&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,407&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,857&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,700&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,893&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,595&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total operating lease expense included in selling, general, and administrative expenses was approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million for the years ending &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Sales and Other State Non-income Tax Liabilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Non-income tax expense is included in selling, general and administrative expenses on its consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, on its consolidated balance sheets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Legal Proceedings&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount, or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve a significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments including available insurance recoveries, which would impact its profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require it to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect its financial results. With regard to the outstanding contingencies as of December 31, 2018, the Company believes the outcome of these matters will not have a material adverse effect on its business, financial condition, results of operations or cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-3DEFF0137BD23117775EA9ED123706DA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total comprehensive income (loss) includes net income or loss, foreign currency translation adjustments, and net change in derivative transactions, net of any related deferred taxes. Certain of the Company&amp;#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Foreign Currency Matters&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying consolidated balance sheets and was an unrealized loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at December 31, 2018 and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million at December&amp;#160;31, 2017. The cumulative impact of net changes in derivative instruments included in other comprehensive loss in the consolidated balance sheets was an unrealized loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at December 31, 2018. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The income tax impact related to components of other comprehensive income for the period ended December 31, 2018 is reflected on the consolidated statements of comprehensive income. During the period ended December 31, 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of income tax expense was included in the consolidated statements of operations due to the impact of a change in federal tax rate on the deferred tax asset related to foreign currency cumulative translation. See Note 13 - Income Taxes. There was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; income tax impact related to foreign currency translation adjustments for the period ended December&amp;#160;31, 2016.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
	<us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-1308A92B895ABA97AE46A9ED1235E10D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Restructuring Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring costs on the consolidated statements of operations include on-going benefit costs for its employees, exit costs, and other costs including write-offs related to abandoned locations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-B62048D1489CCFE01CB9A9ED11CF3CE5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's long-term debt consists of the following:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,876&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(6,875&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,641&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,125&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Amended and Restated Senior Credit Facility&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On August 1, 2017, the Company entered into an Amendment and Restatement of its Credit Agreement dated June 22, 2016 (Amended and Restated Credit Agreement), to refinance and increase the current aggregate committed size of the facility to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$215.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, including a term loan of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$100.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Amended Term Loan) and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$115.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; revolving credit facility (Amended Revolving Credit Facility) (together with the Amended Term Loan, the Amended Credit Facilities). The Amended Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$35.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; sublimit for the issuance of standby letters of credit. The proceeds of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$106.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from this refinancing included &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the new revolving credit facility and were used to repay borrowings under the Company&amp;#8217;s 2016 Senior Credit Facilities (defined below), as well as to pay related interest, fees, and expenses of the transaction.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In addition to increasing the size of the facilities, the maturity date was extended to August 1, 2022. The Amended and Restated Credit Agreement also includes an accordion feature permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Amended Revolving Credit Facility or establish one or more additional term loans in an aggregate amount not to exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$50.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with optional additional commitments from existing lenders or new commitments from additional lenders. Other terms and pricing are substantially similar to the 2016 Credit Agreement (defined below).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Borrowings under the Amended Term Loan are payable in quarterly installments, which commenced January 2, 2018, provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. In addition to its scheduled payments, in both the third and fourth quarters of 2018, the Company made optional prepayments of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; each as permitted by the Amended and Restated Credit Agreement. The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving written notice (or telephonic notice promptly confirmed in writing). The Company is required to prepay the Amended Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the aggregate scheduled maturities of debt are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Through Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,671&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,980&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;65,990&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,876&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Subject to the Amended and Restated Credit Agreement, the Company pays interest on: (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time; (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time; and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time. The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.9317738791423%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Level&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Consolidated Net Leverage Ratio&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Base Rate Loans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Commitment Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;I&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less than 1.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;II&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 1.50:1.00 &lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;but less than 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;III&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;but less than 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;IV&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;but less than 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;V&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.40%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Amended Term Loan and Amended Revolving Credit Facility bore interest at a rate equal to One Month LIBOR plus &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The interest rate is subject to an increase of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; if an event of default exists under the Amended and Restated Credit Agreement. The Company is required to pay a commitment fee on the average daily unused portion of the Amended Revolving Credit Facility, based on the Applicable Margin which is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. During the three months ended March 31, 2018, the Company entered into an interest rate swap to reduce its exposure to fluctuations in the interest rates associated with its debt, which was effective April 2, 2018. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Amended and Restated Credit Agreement contains customary representations, warranties, and affirmative covenants. The Amended and Restated Credit Agreement also contains customary negative covenants, subject to some exceptions, on: (i) indebtedness and preferred equity; (ii) liens; (iii) fundamental changes; (iv) investments; (v) restricted payments; and (vi) sale of assets and certain other restrictive agreements. The Amended and Restated Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&amp;#8217;s business.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Amended and Restated Credit Agreement also includes &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; financial covenants: (i) a maximum Consolidated Total Leverage ratio (as defined therein); and (ii) a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 30, 2018, the Company entered into a First Amendment (First Amendment) to its Amended and Restated Credit Agreement that, among other administrative and clarifying changes, modified the following: (1) the definition utilized in its financial covenants of Consolidated EBITDA to allow for exclusion of charges related to the Company&amp;#8217;s initiative to replace its front-end system supporting its legacy travel nurse operations, subject to a basket of addbacks, of which the basket dollar amount was also increased; (2) increased the maximum Consolidated Total Leverage Ratio to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.75&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.25&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1:00 for the periods of September 30, 2018 through June 30, 2019, to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1:00 from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 for the period ended September 30, 2019, to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.25&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1:00 for the period ended December 31, 2019, and maintained &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1:00 for the periods thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (3) increased the pro forma Consolidated Total Leverage Ratio threshold for allowing restricted payments. In connection with the First Amendment, the Company paid &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in fees to its lenders, of which a portion has been included in other noncurrent assets as deferred issuance costs related to the revolving credit facility and a portion has been treated as a deduction to long-term debt related to its Term Loan.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The foregoing description of the amendment is qualified in its entirety by reference to the full terms and provisions of the Amended and Restated Credit Agreement.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The obligations under the Amended and Restated Credit Agreement are guaranteed by all of the Company&amp;#8217;s domestic wholly-owned subsidiaries and are secured by a first-priority security interest in the Collateral (as defined therein).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company has &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; letters of credit outstanding, which relate to the Company&amp;#8217;s workers&amp;#8217; compensation and professional liability insurance policies.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2016 Senior Credit Facilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On June 22, 2016, the Company entered into a senior credit agreement (2016 Credit Agreement), which provided for an initial term loan of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Term Loan) and a revolving credit facility of up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$100.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (Revolving Credit Facility) (together with the Term Loan, the 2016 Senior Credit Facilities) both of which would have matured on June 22, 2021. The Revolving Credit Facility included a subfacility for swingline loans up to an amount not to exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$35.0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million sublimit for the issuance of standby letters of credit. Proceeds of the Senior Credit Facilities were used primarily to refinance the Company&amp;#8217;s prior senior secured asset-based credit facility and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$30.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Second Lien Term Loan and to pay related transaction fees and expenses, including a redemption premium of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The repayment of the Second Lien Term Loan was treated as extinguishment of debt and, as a result, the Company recognized a loss on extinguishment of debt of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the second quarter of 2016, related to the write-off of unamortized net debt discount and issuance costs as well as transaction fees and expenses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On July 5, 2017, the Company entered into a Second Amendment to its 2016 Credit Agreement primarily to allow for the acquisition of Advantage including a reset of the Applicable Margin to Level III, based on the incremental borrowings and consistent with the prior pricing grid (or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for Eurodollar Loans and LIBOR Index Rate Loans, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for Base Rate Loans and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; commitment fee). Also, on July 5, 2017, the Company entered into an Incremental Term Loan Agreement for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with SunTrust as Lender and Administrative Agent to pay for part of the consideration of the acquisition of Advantage. The Incremental Term Loan maturity date was June 22, 2021 and was prepayable at any time without penalty.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Borrowings under the Incremental Term Loan were payable in quarterly installments, commencing September 30, 2017, with each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) for the first eight installments equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.875%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the principal amount of the Incremental Term Loan for the remaining installments; provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. As of July 5, 2017 the Applicable Margin for Eurodollar Loans and LIBOR Index Rate Loans was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and the Applicable Margin for Base Rate Loans was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014.  Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of convertible notes (the Convertible Notes). On March 17, 2017, the Company paid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,175,584&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock, par value &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.0001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and cash in the aggregate amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (of which &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is included in repayment of debt and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is presented as extinguishment fees, both within financing activities on the consolidated statements of cash flows). Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; after the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; cash payment) and derivative liability (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$26.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;), the Company recognized a non-cash charge of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as loss on early extinguishment and a non-cash addition to additional paid-in capital of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$46.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the fair value of the shares, which is not presented on the consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Common Stock at a conversion price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share, or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521,126&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock. After &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share of its Common Stock exceeded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;125%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the then conversion price for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days of a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; day trading period (Forced Conversion date). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Convertible Notes bore interest at a rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DebtPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-9C32C6F762F9761E4E1EA9ED123818AC">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Debt Discount and Debt Issuance Costs &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Stated discounts on proceeds, and other fees reimbursed to lender, as well as the initial value of any embedded derivative features of the Convertible Notes and Term Loans, as defined in Note 8 - Debt, are treated as a discount associated with the respective debt instrument and presented in the balance sheet as an offset to the carrying amount of the debt. Discounts are amortized to interest expense using the effective interest rate method, or a method that approximates the effective interest rate method, over the expected life of the debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred costs related to the issuance of the Convertible Notes and the Term Loans were capitalized and are presented in the balance sheet as a direct deduction from the carrying amount of the debt liability. Deferred costs are amortized using the effective interest method. Deferred costs related to the Convertible Notes were written off in connection with the repayment of such Convertible Notes. See Note 8 - Debt. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred costs related to the issuance of the Company&amp;#8217;s Revolving Credit Facilities, as defined in Note 8 - Debt, have been capitalized and included in other assets on the consolidated balance sheets, and amortized using the straight line method over the term of the related credit agreement.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
	<us-gaap:DerivativesAndFairValueTextBlock contextRef="FD2018Q4YTD" id="Fact-94347CD621F186891990A9ED1212E2B9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivatives&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Interest Rate Swap&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In March 2018, the Company entered into an interest rate swap agreement, with an effective date of April 2, 2018 and termination date of August 1, 2022. No initial investments were made to enter into the agreement. The interest rate swap agreement requires the Company to pay a fixed rate to the respective counterparty of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.627%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per annum on an amortizing notional amount beginning at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$48.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (corresponding with the initial term loan payment schedule), and to receive from the respective counterparty, interest payments based on the applicable notional amounts and 1 month USD LIBOR, with no exchanges of notional amounts. At initiation, the interest rate swap effectively fixed the interest rate on &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the amortizing balance of the Company&amp;#8217;s term debt, exclusive of the credit spread on the debt. As of December 31, 2018, the interest rate swap is treated as a cash flow hedge and its fair value of a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; liability is included in current and noncurrent liabilities on the consolidated balance sheets. See Note 2 - Summary of Significant Accounting Policies and Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Convertible Notes Derivative Liability&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Accounting for Derivative Financial Instruments and Hedging Activities &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of the derivative liability was primarily determined by fluctuations in the Company's stock price. In addition, changes in the Company's credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain that was presented on the Company's consolidated statements of operations as gain on derivative liability in 2017 and 2016 related to its Convertible Notes.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
	<us-gaap:DerivativesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-C7043A1E3EE5C89A78E5A9ED12349697">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Derivative Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is exposed to interest rate risk due to its outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, the Company has entered into an interest rate swap agreement to effectively convert a portion of its variable interest payments to a fixed rate. The principal objective of the interest rate swap is to eliminate or reduce the variability of the cash flows in those interest payments associated with the Company&amp;#8217;s long-term debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company has determined that the interest rate swap qualifies as a cash flow hedge in accordance with ASC 815, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. As the critical terms of the hedging instrument and the hedged forecasted transaction are the same, the Company has concluded that changes in the cash flows attributable to the risk being hedged are expected to completely offset at inception and on an ongoing basis. Changes in the fair value of an interest rate swap agreement designated as a cash flow hedge are recorded as a component of accumulated other comprehensive income (loss), net of deferred taxes, within stockholders&amp;#8217; equity and are amortized to interest expense over the term of the related debt as the interest payments are made. Interest rate swap payments are included in net cash provided by operating activities on the Company&amp;#8217;s consolidated statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In conjunction with entering into the interest rate swap agreement, the Company early adopted ASU 2017-12, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivative and Hedging (Topic 815) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;to simplify the application of hedge accounting. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates embedded conversion features within its convertible debt in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value. Changes in the fair value of these derivatives during each reporting period were reported in other expenses (income) on the consolidated statements of operations. The fair value at inception had been recorded as debt discount and was being amortized to interest expense over the term of the note using the effective interest method. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
	<us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="FD2018Q4YTD" id="Fact-34A75E6218126C2CBF40BF337D37981B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has determined that its revenues are generated from temporary staffing services and other services, as disaggregated in the following table. See Note 2 - Summary of Significant Accounting Policies.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;For the year ended December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Nurse&lt;br clear="none"/&gt;And Allied&lt;br clear="none"/&gt;Staffing Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Physician&lt;br clear="none"/&gt;Staffing Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Human&lt;br clear="none"/&gt;Capital&lt;br clear="none"/&gt;Management&lt;br clear="none"/&gt;Services Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Temporary Staffing Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;705,435&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;76,979&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;782,414&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,867&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,326&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,070&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;720,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;816,484&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-94BBE3B72F34D63F960BA9ED12488C7A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Earnings Per Share&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with the requirements of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Earnings Per Share&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, basic earnings per share is computed by dividing net income available to common shareholders (numerator) by the weighted average number of vested unrestricted common shares outstanding during the period (denominator). Diluted earnings per share gives effect to all dilutive potential common shares outstanding during the period including stock appreciation rights and options and unvested restricted stock, as calculated utilizing the treasury stock method, and Convertible Notes using the if-converted method prior to their payment in full in the first quarter of 2017.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2018Q4YTD" id="Fact-E974DEA924BEEACE4A21A9ED11FD294F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,513&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest on Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gain on derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,805&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,626&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,657&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effective of diluted shares:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;425&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;593&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,657&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,166&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,246&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.07&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.15&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the years 2018, 2017, and 2016, no tax benefits were assumed in the weighted average share calculation due to the Company's net operating loss position.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table represents the securities that could potentially dilute net income per share attributable to common shareholders in the future that were not included in the computation of diluted net income per share attributable to common shareholders because to do so would have been anti-dilutive for the periods presented.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;373&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="FD2018Q4YTD" id="Fact-1A45C15AA31DED78519DA9ED120D0CD1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The carrying amounts and estimated fair value of the Company&amp;#8217;s significant financial instruments that were not measured at fair value are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,179&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;81,800&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;99,134&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="FD2018Q4YTD" id="Fact-025AA978D379C08D04CCA9ED121605D1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Quoted prices in active markets for identical assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Level 3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Items Measured at Fair Value on a Recurring Basis&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, interest rate swap agreement included in other current and noncurrent liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Deferred compensation&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&amp;#8217;s deferred compensation liabilities are measured using publicly available indices that define the liability amounts, as per the plan documents.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Interest rate swap agreement&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;The Company utilized Level 2 inputs to value its interest rate swap agreement. See Note 8 - Debt and Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Convertible notes derivative liability&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. The long-term portion of these liabilities has been included in contingent consideration, and the short-term portion is included in other current liabilities on the consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. Both of the Mediscan contingent consideration liabilities have been measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. In the third quarter of 2017, the Company determined that one of the contingent consideration earnouts related to the Mediscan acquisition would not be achieved for 2017 and, as a result, the entire earnout was reversed. The contingent consideration related to the Company's acquisition of USR was recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows summarizes the estimated fair value of the Company&amp;#8217;s financial assets and liabilities measured on a recurring basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The opening balances of contingent consideration and Convertible Notes derivative liabilities are reconciled to the closing balances for fair value measurements of these liabilities categorized within Level 3 of the fair value hierarchy as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivative Liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payments/Settlements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation gain for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(922&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;903&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation loss for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,698&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Items Measured at Fair Value on a Non-recurring Basis&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During an evaluation of goodwill, trade names, and other intangible assets during the years ended December 31, 2018, 2017, and 2016, the carrying value of goodwill, trade names, and other intangible assets in the Physician Staffing reporting unit exceeded their fair values. As a result, the Company recorded impairment charges that incorporates fair value measurements based on Level 3 inputs. For further discussion on measuring the Company's non-financial assets, specifically goodwill, trade names, and customer relationships, see Note 5 - Goodwill, Trade Names, and Other Intangible Assets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Other Fair Value Disclosures&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Financial instruments not measured or recorded at fair value in the accompanying consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and short and long-term debt. The estimated fair value of accounts receivable, accounts payable, and&amp;#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company&amp;#8217;s debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The carrying amounts and estimated fair value of the Company&amp;#8217;s significant financial instruments that were not measured at fair value are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair&lt;br clear="none"/&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,179&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;81,800&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;99,134&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Concentration of Risk&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company is exposed to credit risk associated with these investments, as the cash balances typically exceed the current Federal Deposit Insurance Corporation (FDIC) limit of $250,000. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&amp;#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&amp;#8217;s historical collection experience. The Company writes off specific&amp;#160;accounts based on an ongoing review of collectability as well as past experience with the customer. The Company&amp;#8217;s contract terms typically require payment between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days from the date of invoice and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="FD2018Q4YTD" id="Fact-7A7E57823D07DD4C3C49A9ED1212376E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The opening balances of contingent consideration and Convertible Notes derivative liabilities are reconciled to the closing balances for fair value measurements of these liabilities categorized within Level 3 of the fair value hierarchy as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:54%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivative Liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,532&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payments/Settlements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation gain for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(922&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accretion expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;903&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation loss for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,698&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
	<us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-EF650333ACCF33390AC5A9ED1236EF85">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company complies with the provisions of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, which defines fair value, establishes a framework for measuring fair value under U.S. GAAP, and expands disclosures about fair value measurements. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company&amp;#8217;s financial assets and liabilities required to be measured on a recurring basis were its deferred compensation liability, its interest rate swap agreements, and its contingent consideration liabilities. See Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-A5CC7A595B3C2C1D840AA9ED11D28E83">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company had the following acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;br clear="none"/&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;br clear="none"/&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Databases&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30,530&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,909&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,702&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,207&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,758&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,296&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,524&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-compete agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;320&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;97&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,919&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;319&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,879&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,696&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,716&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;878&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;110,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60,976&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,702&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75,584&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;87,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In 2018, fully amortized intangible assets, along with the related accumulated amortization, were removed from the table above. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, estimated annual amortization expense is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:82%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,431&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,131&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,780&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,677&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,628&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The changes in the carrying amount of goodwill by segment are as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:37%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Nurse and&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Physician&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Human&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Capital&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Management&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Services&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Balances as of December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Aggregate goodwill acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;347,873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,307&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;410,585&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accumulated impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(259,732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(283,107&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill, net of impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,141&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,030&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;117,589&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Changes to aggregate goodwill in 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill acquired (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impairment charge&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Balances as of December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Aggregate goodwill acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;348,567&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,307&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;411,279&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Accumulated impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(259,732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(40,598&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(300,330&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill, net of impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101,060&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill acquired from the acquisition of AP Staffing. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2018 and 2017 Impairment Charges&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company performed its annual quantitative impairment test of goodwill and other indefinite-lived intangible assets as of October 1, 2018 and 2017. Upon completion of the impairment testing for both years, it was determined that the estimated fair value of the Physician Staffing reporting unit&amp;#8217;s trade name was less than its carrying amount resulting in impairment. For its goodwill impairment testing, with the exception of its Physician Staffing reporting unit, the estimated fair value of its reporting units exceeded their respective carrying values. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Projections of revenue, operating costs, and expected cash flows of each reporting unit are inputs into the quantitative testing for goodwill and intangible assets. The Company reduced its long-term revenue forecast for the Physician Staffing business segment in the fourth quarter of 2018 and 2017. The lower than expected revenue was driven by lower booking volumes, partly due to the loss of customers. In addition, margins of the reporting unit were negatively impacted from continued investments in the business. As a result, during the fourth quarter of 2018 and 2017 the Company recorded non-cash impairment charges of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, related to its trade name and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$17.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, related to goodwill during the fourth quarter. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the impairment testing as of October 1, 2018, the Company reassessed the Physician Staffing brand's indefinite-life classification and determined it had characteristics that indicated a definite-life assignment was more appropriate. Effective October 1, 2018, the trade name, with a carrying value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; after impairment charges, that was previously assigned an indefinite life was assigned a finite life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. During the three months ended December 31, 2018, the amortization expense related to this trade name was approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2016 Impairment Charges&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company performed its annual impairment test as of October 1, 2016. Upon completion of the impairment testing, the Company determined that no impairment of goodwill, trade names, or other intangible assets was warranted.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During an evaluation of goodwill, trade names, and other intangible assets at June 30, 2016, the Company determined that indicators were present in the Physician Staffing reporting unit which would suggest the fair value of the reporting unit may have declined below its carrying value. The Physician Staffing reporting unit was under-performing relative to management&amp;#8217;s expectations. The lower than expected revenue was driven by lower booking volumes partly due to the loss of customers, and margins were negatively impacted from continued investments in the business all through the first half of 2016. The Company considered these factors to be impairment indicators that warranted impairment testing of goodwill, trade names, and other intangible assets. The interim impairment testing resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the interim impairment testing was performed which resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the Company recorded a non-cash impairment charge totaling &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$24.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$17.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to goodwill, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to trade names, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to customer relationships.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Quantitative Methods and Assumptions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Trade Names&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Relief From Royalty methodology was utilized to value the Physician Staffing trade names using projected cash flows of an estimated royalty fee. The royalty rate was determined by a blended rate using the Market Royalty Rate Method and the Apportionment of Profit Method. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The discounted cash flows serve as the primary basis for the income approach and are based on the Company&amp;#8217;s discrete financial forecast of revenue, gross profit margins, operating costs and cash flows. The forecast considers historical and estimated future results, general economic and market conditions, as well as the impact of planned business and operational strategies. For its 2018 testing, the assumptions used in the income approach included discount rates of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a terminal value growth rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for cash flows beyond the discrete forecast period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ten&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. Assumptions used in the market approach testing included valuation multiples based on an analysis of multiples for comparable public companies. The Company utilized total enterprise value/Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiples ranging from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The concluded fair value was based on a weighting of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; applied to the income approach and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to the market approach for its Physician Staffing and Search reporting units and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; weighting was applied to the components of each approach to estimate the total fair value of goodwill for its Nurse and Allied Staffing reporting unit. This weighting was an estimate by management and was developed based on the specific characteristics, risks and uncertainties of the reporting units. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Customer Relationships&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Multi-Period Excess Earnings Method (MPEEM) methodology was utilized for valuing the Physician Staffing customer relationships in its interim impairment testing for the second quarter of 2016. The MPEEM estimates the fair value based on the present value of the allocated future economic benefits. The inputs include the projected revenue and associated expenses from the customers, an estimated attrition rate, and a discount rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Although management believes that the Company's current estimates and assumptions are reasonable and supportable, there can be no assurance that the estimates and assumptions made for purposes of the impairment testing will prove to be accurate predictions of future performance.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="FD2018Q4YTD" id="Fact-30602D84FDC0B08B229BA9ED123C9D91">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill, Trade Names, and Other Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable intangible assets of businesses acquired. Other identifiable intangible assets with definite lives are being amortized using the straight-line method over their estimated useful lives which range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;16&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years. Goodwill and certain intangible assets with indefinite lives are not amortized. Instead, in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC, these assets are reviewed for impairment annually at the beginning of the fourth quarter, and whenever circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;When reviewed, the Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, as a basis for determining whether it is necessary to perform the quantitative testing. If it is determined that a quantitative test is necessary or more efficient than a qualitative approach, the Company generally measures the fair value of its reporting units using a combination of income and market approaches.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;For the periods prior to the fourth quarter of 2017, the performance of the quantitative impairment test involved a two-step process. The first step required the Company to determine the fair value of each of its reporting units and compare it to the reporting unit&amp;#8217;s carrying amount. If the reporting unit's fair value was less than its carrying amount, the Company was required to perform a second step to calculate the implied value of goodwill. The implied value was then compared to its carrying amount to calculate the impairment charge, if any. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Beginning in the fourth quarter of 2017, for its annual review on October, 1, 2017, the Company early adopted the provisions of Accounting Standards Update (ASU) 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Under ASU 2017-04, the second step of the quantitative assessment is eliminated, and, if the reporting unit&amp;#8217;s carrying value exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value not to exceed the total amount of goodwill allocated to that reporting unit. Additionally, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss is considered, if applicable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company determines its reporting units by identifying its operating segments and any component businesses and aggregates the components businesses if they have similar economic characteristics. The Company had the following reporting units that it reviewed for impairment: 1) Nurse and Allied Staffing; 2) Physician Staffing; and 3) Search.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. However, fair values that could be realized in an actual transaction may have differed from those used to evaluate the potential impairment of goodwill.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Long-lived assets and identifiable intangible assets with definite lives are evaluated for impairment in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Property, Plant, and Equipment&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC. In accordance with this Topic, long-lived assets and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Recoverability of long-lived assets is measured by a comparison of the carrying amount of the asset group to the future undiscounted net cash flow that is expected to be generated by those assets. If such assets are considered to be impaired, the impairment charge recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Any related impairment losses are recognized in earnings and included in the caption impairment charges on the consolidated statements of operations. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-5D22A52FBD981DD5DB4CA9ED1253C382">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;he components of the Company's (loss) income before income taxes are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(18,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,826&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,309&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;424&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;475&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,236&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(Loss) income before income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(18,195&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,301&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;The components of the Company&amp;#8217;s income tax benefit are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;227&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;587&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;269&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;932&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,137&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,245&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,114&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;117&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,410&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33,812&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,478&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(34,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Significant components of the Company&amp;#8217;s deferred tax assets and liabilities are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred Tax Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued other and prepaid expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,955&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for doubtful accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,776&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net operating&amp;#160;loss carryforwards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,717&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,952&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,709&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,729&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,512&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;646&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Credit carryforwards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;188&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;542&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;444&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross deferred tax assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,415&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,661&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Valuation allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,226&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30,585&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Deferred Tax Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(52&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Indefinite intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,964&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Tax on unrepatriated earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,571&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,471&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net deferred taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,655&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,114&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 22, 2017, the 2017 Tax Act was signed into legislation which, among other changes, reduced the corporate federal income tax rate from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; effective for the Company's year ended December 31, 2018. The Company recorded income tax expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, primarily due to a re-measurement of its deferred tax assets and liabilities in the fourth quarter of 2017. The impact of the Global Intangible Low-Taxed Income provision, the transition tax on the deemed repatriation of deferred foreign income, and any future tax impact associated with basis differences on foreign subsidiaries were immaterial. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In December 2017, the Securities and Exchange Commission (SEC) staff issued Staff Accounting Bulletin No. 118 (SAB 118), which provided guidance on accounting for the tax effects of the 2017 Tax Act. SAB 118 provided a measurement period that should not extend beyond one year from the enactment date for companies to complete the accounting required under the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC. In accordance with SAB 118, the Company provided a provisional amount with regard to certain foreign tax provisions in 2017. In 2018, the Company revised its estimate with regard to the 2017 Tax Act and recorded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of tax expense.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of December 31, 2016, the Company determined that it could not sustain a conclusion that it was more likely than not that it would realize any of its deferred tax assets resulting from recent losses, the difficulty of forecasting future taxable income, and other factors, and as a result, the Company had a valuation allowance on its deferred tax assets, exclusive of indefinite-lived intangible deferred tax liabilities.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the year ended December 31, 2017, predominantly on the basis of a reassessment of the amount of its deferred tax assets that are more likely than not to be realized, the Company reduced its valuation allowance by &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$45.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (comprised of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to U.S. net operating losses, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to state net operating losses, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to other net deferred tax assets). The valuation allowance on a portion of state net operating losses not more likely than not realizable was not released after analysis of respective expiration periods and specific state taxable income projections.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of December 31, 2018, the Company continues to maintain a valuation allowance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; on a portion of state net operating losses not more likely than not realizable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, the Company had approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$185.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$166.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of federal, state, and foreign net operating loss carryforwards. The carryforwards will expire as follows: federal between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2032&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2037&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, state between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2038&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and foreign between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The reconciliation of income tax computed at the U.S. federal statutory rate to income tax&amp;#160;benefit is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Tax at U.S. statutory rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,821&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,506&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State taxes, net of federal benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(543&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,374&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Noncontrolling interest&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(252&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(455&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(260&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-deductible items (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;625&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,676&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,546&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign tax expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation allowances&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(45,354&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Uncertain tax positions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,629&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,145&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,090&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Return to provision&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(458&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal rate change&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,011&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(831&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(113&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,478&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(34,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) Includes non-deductible meals and incidentals, miscellaneous non-deductible items, and beginning in 2018, non-deductible stock-based compensation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The tax years 2008 and 2010 through 2017 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax. During 2018, the Company accrued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of India tax on earnings of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. India withholding taxes on a dividend of India earnings are not affected by the calculation of U.S. taxes due and continue to be accrued. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at January 1 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,071&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additions based on tax positions related to the current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,401&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,145&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,054&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additions based on tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;204&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Reductions based on settlements of tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(439&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017 Tax Act federal tax rate change&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,859&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December&amp;#160;31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Short-term unrecognized tax benefits are included in other current liabilities on the consolidated balance sheets and were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and 2016. Long-term unrecognized tax benefits are included in other long-term liabilities on the consolidated balance sheets and were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and 2016, respectively. See Note 7 - Balance Sheet Details. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and 2016, the Company had unrecognized tax benefits, which would affect the effective tax rate if recognized, of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.9&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million, respectively. During &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had gross increases of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to its current year unrecognized tax benefits, related to federal and state tax positions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. During the year ended December 31, 2017, the Company recognized a decrease in interest and penalties of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, related to statute expirations. The Company has accrued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million for the payment of interest and penalties at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and 2016, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-30B17194BC42BB919A45A9ED1249E626">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company accounts for income taxes under the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes in its financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. The Company considers all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. It considers cumulative losses in recent years as well as the impact of one-time events in assessing its pre-tax earnings. Assumptions regarding future taxable income require significant judgment. The Company's assumptions are consistent with estimates and plans used to manage its business, which includes restructuring and other initiatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the event that actual results differ from these estimates, or the Company adjusts these estimates in future periods for current trends or changes in its estimating assumptions, it may modify the level of the valuation allowance which could materially impact its business, financial condition and results of operations. The Company will continue to assess the realizability of its deferred tax assets. See Note 13 - Income Taxes.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:LesseeLeasesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-C5096CFF0821B9484B80A9ED123EBCB9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Deferred Rent&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred rent consists of free rent, rent escalation, tenant improvement allowances, and other incentives received from landlords related to the operating leases for our facilities. Rent escalation represents the difference between actual operating lease payments due and straight-line rent expense, which we record over the term of the lease. The excess is recorded as a deferred credit in the early periods of the lease, when cash payments are generally lower than straight-line rent expense, and is reduced in the later periods of the lease when payments begin to exceed the straight-line expense. Tenant allowances from landlords for tenant improvements are generally comprised of cash received from the landlord or paid on our behalf as part of the negotiated terms of the lease. These tenant improvement allowances and other leasehold incentives are recorded when realizable as deferred rent and are amortized as a reduction of periodic rent expense, over the term of the applicable lease. See Note 12 - Commitments and Contingencies.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
	<us-gaap:LiabilityReserveEstimatePolicy contextRef="FD2018Q4YTD" id="Fact-3ECC09A53B6BD7764D70A9ED124D3A32">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Insurance Claims&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company provides workers&amp;#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for eligible employees. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using the Company&amp;#8217;s loss history as well as industry statistics. The healthcare insurance accrual is for estimated claims that have occurred but have not been reported and is based on the Company&amp;#8217;s historical claim submission patterns. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported as well as unfavorable claims development.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Other Expenses/Insurance Costs&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC previously issued authoritative accounting guidance in the area of insurance contracts and related activity thereto. This topic concluded that, under circumstances such as in the Company&amp;#8217;s insured professional liability and workers' compensation policies, since a right of legal offset does not exist due to the fact that there are three parties to an incurred claim, the insured, the insurer, and the claimant, the related liability to the claimant should be classified separately on a gross basis with a separate related receivable from the insurer recognized as being due from insurance carriers. Accordingly, the Company&amp;#8217;s consolidated balance sheets as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; reflect the related short-term liabilities in accrued compensation and benefits and the related&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;long-term liabilities as long-term accrued claims, and the short-term receivable portion as insurance recovery receivable and the long-term portion as non-current insurance recovery receivable. See Note 7 - Balance Sheet Details. The ultimate cost of workers&amp;#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved by the Company for those claims.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Workers&amp;#8217; compensation benefits are provided under a partially self-insured plan. The Company has letters of credit to guarantee payments of claims. At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, the Company had outstanding approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$18.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$19.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively, of standby letters of credit as collateral to secure the self-insured portion of this plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company has occurrence-based primary professional liability policies that provide the Company and each working professional in its nurse and allied healthcare business with coverage. Effective January 1, 2016, the Company has a claims-made professional liability policy for its physicians and advanced practitioners, with a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; self-insured retention per claim. Prior to January 1, 2016, the Company had an occurrence-based professional liability policy for its independent contractor physicians and advanced practitioners which was insured by a wholly-owned subsidiary, Jamestown Indemnity, Ltd., a wholly-owned Cayman Island captive company (the Captive), until its voluntary liquidation in the third quarter of 2015. Beginning in March 2015, the Company's Physician subsidiary self-insured &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for each of its professional liability claims. Under the terms of the Captive&amp;#8217;s reinsurance policy there was a requirement to guarantee the payment of claims to its insured party&amp;#8217;s primary medical malpractice insurance carrier via a letter of credit. As a result of the Captive's liquidation, the letter of credit was reduced. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, the value of the letter of credit was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$1.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$2.0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, respectively. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Subject to certain limitations, the Company also has umbrella liability coverage for its working nurses and allied healthcare professionals. While this umbrella coverage does not extend to professional liability claims against its independent contractor physicians and advanced practitioners, it does cover claims brought against all of the Company&amp;#8217;s subsidiaries for non-patient general liability.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LiabilityReserveEstimatePolicy>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-EB382544D48F38210032A9ED1245912E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted for all entities, including adoption in an interim period. The Company is currently in the process of evaluating the potential impact the adoption of this standard may have and expects to adopt this standard in its first quarter of 2020.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-13, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, and should be applied either prospectively or retrospectively depending on the nature of the disclosure. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company is currently in the process of evaluating this standard and expects to adopt the full provisions in its first quarter of 2020.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In July 2017, the FASB issued ASU No. 2017-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#8217;s own stock. The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and should be applied retrospectively to outstanding financial instruments with a down round feature by means of either a cumulative-effect adjustment or for each prior reporting period presented. Early adoption is permitted for all entities, including adoption in an interim period. The Company expects to adopt this standard in its first quarter of 2019, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. The FASB has issued several other subsequent updates including the following: 1) ASU No. 2018-10, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Codification Improvements to Topic 842, Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes sixteen separate narrow-scope amendments to clarify the codification and to correct unintended application of guidance; and 2) ASU No. 2018-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842): Targeted Improvements&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which provides entities with relief from the costs of implementing certain aspects of the new leasing standard by allowing them to elect not to recast the comparative periods presented when transitioning to ASC 842. The new lease standard, and the subsequent ASUs that modified Topic 842, are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;With respect to the adoption of the new standard, as of December 31, 2018, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$34.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of undiscounted future lease payments, primarily related to real estate, that is expected to be included in its initial measurement of its lease liabilities and corresponding right of use asset, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of accrued rent that is expected to be reclassified from liability accounts to reduce its beginning right of use asset balance.&amp;#160;The Company does not expect the adoption of ASU 2016-02 to have a material impact on its consolidated statements of operations and statements of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-809CF36568093DFEDFE4A9ED12257EF6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Organization and Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Nature of Business &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cross Country Healthcare, Inc. (the Company) was incorporated in Delaware on July 29, 1999 as a business providing travel nurse and allied health staffing services. As of December 31, 2018, the Company is a leading national provider of nurse and allied staffing, recruiting, and value-added workforce solution services, multi-specialty locum tenens (temporary physician staffing) services, as well as a provider of other human capital management services focused on healthcare.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of the Company and its direct and indirect wholly-owned subsidiaries. The consolidated financial statements include all assets, liabilities, revenue, and expenses of Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), which is controlled by the Company but not wholly owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation. See consolidated balance sheets and consolidated statements of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Liquidity and Operations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Based upon current projections, the Company will not satisfy the required leverage ratio under its Credit Agreement as of March 31, 2019. As a result, a debt prepayment of between $10 million and $12 million would be required to remain in compliance. The Company believes such prepayment will be sufficient to maintain compliance with the leverage ratio covenant and meet its obligations for the next twelve months. In the event actual results differ significantly from current projections, the Company may be required to make additional debt prepayments. Further, the Company may be able to amend its Credit Agreement, and as a result, would not be required to make any debt prepayments.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
	<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-492CE428D9EB305CC124A9ED1205C2F6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Employee Benefit Plans&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company maintains a voluntary defined contribution 401(k) profit-sharing plan covering all eligible employees as defined in the plan documents. The plan provides for a discretionary matching contribution, which is equal to a&amp;#160;percentage of each eligible contributing participant&amp;#8217;s elective deferral, which the Company, at its sole discretion, determines from year to year.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contributions by the Company, net of forfeitures, under this plan amounted to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Eligible employees who elect to participate in the plan are generally vested in any existing matching contribution after three years of service with the Company.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company offers a non-qualified deferred compensation program to certain key employees whereby they may defer a portion of annual compensation for payment upon retirement. The program is unfunded for tax purposes and for purposes of Title I of the Employee Retirement Income Security Act of 1974. The liability for the deferred compensation is included in other long-term liabilities on the consolidated balance sheets and amounted to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-D7E89AA8C1503F9DCCCBA9ED1258E9F1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's property and equipment consists of the following:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Useful Lives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3-5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,257&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,432&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3-5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,651&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,933&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5-7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,514&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5-7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,966&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,680&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,716&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,340&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,104&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,764&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(30,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,628&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,086&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 2 &amp;#8211; Summary of Significant Accounting Policies.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-C784A2BEB321D086C9ECA9ED12467FC7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Property and Equipment&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;seven&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years. Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the individual lease. On an annual basis, the Company reviews its property and equipment listings and disposes of assets that are no longer in use. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Certain software development costs have been capitalized in accordance with the provisions of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other/Internal-Use Software&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). Such costs include charges for consulting services and costs for Company personnel associated with programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is ready for use and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="FD2018Q4YTD" id="Fact-A26EB0B176D6EE9A7929A9ED12774A20">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's property and equipment consists of the following:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Useful Lives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3-5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,257&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,432&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3-5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,651&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,933&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Office equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5-7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,514&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5-7 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,966&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,680&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,716&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,340&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,104&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,764&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(30,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,628&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,086&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 2 &amp;#8211; Summary of Significant Accounting Policies.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<us-gaap:QuarterlyFinancialInformationTextBlock contextRef="FD2018Q4YTD" id="Fact-083D66C0E4F881D4CD0AA9ED11CE7F62">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables contain selected unaudited statements of operations information for each quarter of 2018 and 2017. The following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;First&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Second&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Third&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Fourth&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;210,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;204,572&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;200,717&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;200,907&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Gross profit (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,753&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;51,562&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;50,559&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Consolidated net (loss) income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(19,343&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,642&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,539&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(19,691&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) per share attributable to common shareholders - Basic (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) per share attributable to common shareholders - Diluted (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;First&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Second&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Third&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Fourth&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;207,573&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;209,313&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;228,488&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;219,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Gross profit (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;56,528&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;60,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;58,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Consolidated net (loss) income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(1,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;5,220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;7,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;28,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;4,850&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;6,723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;27,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.14&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.77&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) Excludes depreciation and amortization.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(b) The sum of the quarterly per share amounts may not equal amounts reported for year-to-date due to the effects of rounding                       and changes in the number of weighted average shares outstanding used in the calculation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following items are the most significant items that impact the comparability and presentation of our consolidated data:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the fourth quarter of 2018 and 2017, the Company recorded non-cash impairment charges of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$22.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, related to the goodwill and trade names of Physician Staffing. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the first quarter of 2017, the Company settled its Convertible Notes and recognized a loss on extinguishment of debt of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 1, 2018, the Company acquired AP Staffing and on July 1, 2017, the Company acquired all of the assets of Advantage. The acquisitions have been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;using the acquisition method. The results of the acquisitions' operations have been included in the consolidated statements of operations from their dates of acquisition. See Note 4 - Acquisitions. &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the fourth quarter of 2017, the Company benefited from a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;text-transform:default;"&gt;$43.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reversal of valuation allowance on its net deferred tax assets, offset by additional income tax expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the remeasurement of its deferred tax assets as a result of the 2017 Tax Act. See Note 13 - Income Taxes.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recorded changes in the fair value of Convertible Notes derivative liability, recording a gain in the first quarter of 2017 of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
	<us-gaap:ReceivablesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-C94906EAECABD2293E6DA9ED124B2718">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Accounts receivable potentially subject the Company to concentrations of credit risk. The Company&amp;#8217;s customers are primarily healthcare providers, and accounts receivable represent amounts due from them. The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&amp;#8217;s estimate of uncollectible receivables resulting from the inability of its customers to make required payments, which results in a provision for bad debt expense. The adequacy of this allowance is determined by continually evaluating individual customer receivables, considering the customer's financial condition, credit history, and current economic conditions. The Company writes off specific&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;accounts based on an ongoing review of collectability as well as past experience with the customer. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In addition, the Company maintains a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company&amp;#8217;s contract terms typically require payment between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's business activity is with hospitals located throughout the United States.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
	<us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="FD2018Q4YTD" id="Fact-373B073C1F97BFBAD534A9ED1206AFD6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;720,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;758,267&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;721,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,610&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;98,283&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,171&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,768&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;816,484&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;865,048&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;833,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contribution income:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;66,365&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;73,614&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,992&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,755&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,265&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;598&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(357&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,513&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,722&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unallocated corporate overhead (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,589&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,190&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,780&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,174&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition and integration costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;491&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition-related contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,557&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;814&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,758&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,026&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;753&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impairment charges (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,423&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,356&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,311&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(Loss) income from operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(12,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,748&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:37px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:36px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:12px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has been centralizing administrative functions to gain efficiencies, which have been recorded in unallocated corporate overhead, which includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:37px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:13px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
	<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-F5E0FF291C86D0F26194A9ED11F8D3AD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Related Party Transactions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company provides services to hospitals which are affiliated with certain members of the Company&amp;#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Accounts receivable due from these hospitals at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; were less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the acquisition of MSN, the Company acquired a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; ownership interest in Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), a joint venture between the Company and a hospital system. The Company generated revenue providing staffing services to the hospital system of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$19.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$17.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in 2018, 2017, and 2016, respectively. At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and 2017, the Company had a receivable balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, and a payable balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at both periods.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in 2018, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in 2017, and 2016 for rent for these premises. In the fourth quarter of 2018, the Company vacated the premises.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
	<us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="FD2018Q4YTD" id="Fact-EFC935E3547F6A44B79BBF333CBF3931">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has determined that its revenues are generated from temporary staffing services and other services, as disaggregated in the following table. See Note 2 - Summary of Significant Accounting Policies.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;For the year ended December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Nurse&lt;br clear="none"/&gt;And Allied&lt;br clear="none"/&gt;Staffing Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Physician&lt;br clear="none"/&gt;Staffing Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Human&lt;br clear="none"/&gt;Capital&lt;br clear="none"/&gt;Management&lt;br clear="none"/&gt;Services Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Temporary Staffing Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;705,435&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;76,979&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;782,414&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,867&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,326&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,070&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;720,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;816,484&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
	<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-54621EEC493D809F56E9A9ED124547F6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revenue Recognition &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the first quarter of 2018, the Company adopted ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. ASU 2014-09 introduces a new five-step revenue recognition model in which an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. See Note 3 - Revenue Recognition for additional accounting policy and related disclosures. The Company elected to adopt the standard using a modified retrospective method, which only impacts contracts not completed as of December 31, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue from the Company&amp;#8217;s services is recognized when control of the promised services are transferred to the Company&amp;#8217;s customers, in an amount that reflects the consideration it expects to receive in exchange for the service. The Company has concluded that transfer of control of its staffing services, which represents the majority of its revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following is a description of the nature, amount, timing, and uncertainty of revenue and cash flows from which the Company generates revenue.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Temporary Staffing Revenue&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by the Company&amp;#8217;s field staff. The Company recognizes the majority of its revenue at the contractual amount the Company has the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days. Accounts receivable includes estimated revenue for employees&amp;#8217; and independent contractors&amp;#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, the Company's estimate of amounts that had been worked but had not been billed totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$44.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$41.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, and are included in accounts receivable on the consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Service Revenue&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company offers other optional services to its customers that are transferred over time including: managed service programs (MSP) providing agency services (as further described below in Gross versus Net Policies), recruitment process outsourcing (RPO), other outsourcing services, and retained search services, which is less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the Company&amp;#8217;s RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. The Company does not, in the ordinary course of business, offer warranties or refunds.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Gross Versus Net Policies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company records revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Managed Service Programs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has certain contracts with healthcare facilities to provide comprehensive services through its MSPs. Under these contractual arrangements, the customer&amp;#8217;s orders are filled with either one of the Company's healthcare professionals or a third party's healthcare professionals (subcontractors).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;When its healthcare professional is staffed, the Company determined that it acts as a principal in the arrangement, as it is considered the employer of record. Accordingly, revenue is reported on a gross basis on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Alternatively, the Company determined that it acts as an agent in the arrangement when a subcontracted healthcare professional is staffed, as the Company does not control the services before they are transferred to the customer. Accordingly, revenue is reported on a net basis on the consolidated statements of operations. The customer is invoiced for the hours worked by the subcontracted healthcare professional multiplied by the hourly bill rate. A subcontractor liability, which is recognized as a reduction of revenue, is established in accrued expenses for the invoiced amount, net of an administrative fee, and is generally payable after the Company has received payment from its customer. The Company&amp;#8217;s administrative fee is calculated as a percentage of the customer&amp;#8217;s invoice and is recognized over time as the services are rendered by the subcontracted healthcare professional. The Company does not collect or recognize an upfront placement fee.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Physician Staffing business has contracts with its healthcare customers to provide temporary staffing services. The Company uses independent contractors for these services. The Company determined that it acts as a principal in these arrangements and, therefore, revenue is reported on a gross basis on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 3 - Revenue Recognition for the Company's revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenue.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contract Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;All contract fulfillment costs are expensed as incurred to direct operating expenses. With respect to FASB ASC 606, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there were no contract assets or material contract liabilities as of December 31, 2018 and 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Practical Expedients and Exemptions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the Company&amp;#8217;s contracts that have an original duration of one year or less, the Company uses the practical expedients and has elected to recognize any incremental costs of obtaining these contracts as expensed when incurred. Further, the Company does not disclose the value of unsatisfied performance obligations for: (i) contracts with an original expected length of one year or less, and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
	<us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="FD2018Q4YTD" id="Fact-C97B38EEE669AB680C5CA9ED11FA1F71">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table represents the securities that could potentially dilute net income per share attributable to common shareholders in the future that were not included in the computation of diluted net income per share attributable to common shareholders because to do so would have been anti-dilutive for the periods presented.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;373&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
	<us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="FD2018Q4YTD" id="Fact-9EC68530D0D63143647AA9ED12686EAE">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following is the estimated fair value of the purchase price for Advantage on July 1, 2017:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net working capital adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,438&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,562&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,833&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
	<us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="FD2018Q4YTD" id="Fact-15B6E158D6CA5045CC58A9ED1260B357">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of the Company&amp;#8217;s income tax benefit are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(555&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;227&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;587&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;269&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;932&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,137&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,245&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,114&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;117&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,410&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33,812&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,322&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,478&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(34,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
	<us-gaap:ScheduleOfDebtTableTextBlock contextRef="FD2018Q4YTD" id="Fact-BD26181BD0AD368DF219A9ED11E68FF7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's long-term debt consists of the following:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Principal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,876&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(6,875&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,641&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(697&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,125&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(866&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Subject to the Amended and Restated Credit Agreement, the Company pays interest on: (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time; (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time; and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time. The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.9317738791423%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="5" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Level&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Consolidated Net Leverage Ratio&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Base Rate Loans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Commitment Fee&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;I&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less than 1.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;II&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 1.50:1.00 &lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;but less than 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.00%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;III&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 2.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;but less than 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.30%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;IV&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 2.50:1.00&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;but less than 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;V&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Greater than or equal to 3.00:1.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.75%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.40%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
	<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="FD2018Q4YTD" id="Fact-4A728B3CAF4D94F356F5A9ED1258D5A3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Significant components of the Company&amp;#8217;s deferred tax assets and liabilities are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred Tax Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued other and prepaid expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,955&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for doubtful accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;624&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,776&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net operating&amp;#160;loss carryforwards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,717&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,952&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,709&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,729&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,512&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;646&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Credit carryforwards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;188&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;542&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;444&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross deferred tax assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,415&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,661&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Valuation allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,226&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30,585&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Deferred Tax Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(52&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Indefinite intangibles&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,964&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Tax on unrepatriated earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,571&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,471&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net deferred taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,655&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,114&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="FD2018Q4YTD" id="Fact-1E0AC5A88293A57773D3A9ED11F48C9C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:62%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Numerator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,513&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,967&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest on Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gain on derivative liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,581&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,805&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(16,951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,626&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Denominator:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,657&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;32,132&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effective of diluted shares:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share-based awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;425&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;593&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,521&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common shares - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35,657&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,166&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,246&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.07&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.15&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="FD2018Q4YTD" id="Fact-8F203BC93B1C9EDD6BC7A9ED125FAB85">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The reconciliation of income tax computed at the U.S. federal statutory rate to income tax&amp;#160;benefit is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Tax at U.S. statutory rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,821&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,506&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State taxes, net of federal benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(543&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,374&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Noncontrolling interest&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(252&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(455&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(260&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-deductible items (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;625&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,676&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,546&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign tax expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation allowances&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(45,354&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,379&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Uncertain tax positions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,629&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,145&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,090&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Return to provision&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(458&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal rate change&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,011&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(831&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(113&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,478&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(34,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) Includes non-deductible meals and incidentals, miscellaneous non-deductible items, and beginning in 2018, non-deductible stock-based compensation.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2018Q4YTD" id="Fact-1B199AA48316C8CCD175A9ED11D53D50">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table which follows summarizes the estimated fair value of the Company&amp;#8217;s financial assets and liabilities measured on a recurring basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Financial Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="FD2018Q4YTD" id="Fact-AFB0075FB7BCC73508F5A9ED124205DD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Future minimum lease payments, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, associated with these agreements with terms of one year or more are as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,451&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,407&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,857&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,700&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,893&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,595&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
	<us-gaap:ScheduleOfGoodwillTextBlock contextRef="FD2018Q4YTD" id="Fact-76927AD32BE4EDDC4A4DA9ED11D6FB7B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The changes in the carrying amount of goodwill by segment are as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:37%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Nurse and&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Physician&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Human&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Capital&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Management&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Services&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Balances as of December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Aggregate goodwill acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;347,873&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,307&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;410,585&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accumulated impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(259,732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(283,107&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill, net of impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,141&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,030&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;117,589&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Changes to aggregate goodwill in 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill acquired (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;694&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impairment charge&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Balances as of December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Aggregate goodwill acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;348,567&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,405&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,307&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;411,279&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,889&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Accumulated impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(259,732&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(40,598&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(300,330&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill, net of impairment loss&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,835&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101,060&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:61px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:37px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill acquired from the acquisition of AP Staffing. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
	<us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="FD2018Q4YTD" id="Fact-983ACA335AD4FBFA0E28A9ED12572EB2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of the Company's (loss) income before income taxes are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(18,619&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,826&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,309&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;424&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;475&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,236&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(Loss) income before income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(18,195&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,301&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
	<us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="FD2018Q4YTD" id="Fact-47CFECAE53D4ACF00632A9ED11D22418">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company had the following acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:21%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;br clear="none"/&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Gross&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated&lt;br clear="none"/&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net&lt;br clear="none"/&gt;Carrying&lt;br clear="none"/&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="23" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Databases&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30,530&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21,314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,909&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,702&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,207&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,758&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23,296&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,524&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,612&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-compete agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;320&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;97&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,919&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;319&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,879&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,696&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,716&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;878&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;110,068&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,092&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60,976&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20,402&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,702&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75,584&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;87,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
	<us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="FD2018Q4YTD" id="Fact-DA880CB6F9272DA434A6A9ED1271F9CA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the aggregate scheduled maturities of debt are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:76%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Through Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,671&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,980&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;65,990&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,876&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
	<us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="FD2018Q4YTD" id="Fact-FBC234EE7935DD2AEBE3A9ED11E3AC6A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables contain selected unaudited statements of operations information for each quarter of 2018 and 2017. The following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;First&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Second&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Third&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Fourth&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;210,288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;204,572&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;200,717&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;200,907&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Gross profit (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,753&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;51,562&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;50,559&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Consolidated net (loss) income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(19,343&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,642&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;1,539&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(19,691&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) per share attributable to common shareholders - Basic (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net income (loss) per share attributable to common shareholders - Diluted (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;First&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Second&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Third&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;Fourth&lt;br clear="none"/&gt;Quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Revenue from services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;207,573&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;209,313&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;228,488&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;219,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Gross profit (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;53,275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;56,528&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;60,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;58,303&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Consolidated net (loss) income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(1,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;5,220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;7,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;28,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income attributable to common shareholders&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(2,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;4,850&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;6,723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;27,950&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income per share attributable to common shareholders - Basic (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.14&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;Net (loss) income per share attributable to common shareholders - Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;0.77&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) Excludes depreciation and amortization.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(b) The sum of the quarterly per share amounts may not equal amounts reported for year-to-date due to the effects of rounding                       and changes in the number of weighted average shares outstanding used in the calculation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following items are the most significant items that impact the comparability and presentation of our consolidated data:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the fourth quarter of 2018 and 2017, the Company recorded non-cash impairment charges of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$22.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, related to the goodwill and trade names of Physician Staffing. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the first quarter of 2017, the Company settled its Convertible Notes and recognized a loss on extinguishment of debt of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 1, 2018, the Company acquired AP Staffing and on July 1, 2017, the Company acquired all of the assets of Advantage. The acquisitions have been accounted for in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Business Combinations &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Topic of the FASB ASC&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;using the acquisition method. The results of the acquisitions' operations have been included in the consolidated statements of operations from their dates of acquisition. See Note 4 - Acquisitions. &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the fourth quarter of 2017, the Company benefited from a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;text-transform:default;"&gt;$43.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reversal of valuation allowance on its net deferred tax assets, offset by additional income tax expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the remeasurement of its deferred tax assets as a result of the 2017 Tax Act. See Note 13 - Income Taxes.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:60px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:36px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recorded changes in the fair value of Convertible Notes derivative liability, recording a gain in the first quarter of 2017 of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
	<us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="FD2018Q4YTD" id="Fact-46A22D95E31D4202802DA9ED1268CF2E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table is an estimate of the fair value of the assets acquired and liabilities assumed on July 1, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,833&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,396&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;333&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,596&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,900&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91,450&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable and accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;368&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued employee compensation and benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other current liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total liabilities assumed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,055&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net assets acquired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
	<us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="FD2018Q4YTD" id="Fact-058DF8B28B5442EC3FC8A9ED1245AF2F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Reconciliations of the beginning and ending total restructuring liability balances are presented below:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:27%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;Year Ended December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Balance at beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;325&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;338&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;"&gt;Charged to restructuring costs (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;1,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;504&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;190&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(1,131&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(336&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;"&gt;Balance at end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;556&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;390&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;325&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) The restructuring costs on the consolidated statements of operations include direct write-offs of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to abandoned locations, as well as other costs of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="FD2018Q4YTD" id="Fact-BB89456E2AD650BF0210A9ED12676C9E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the Company&amp;#8217;s activities with respect to all of its share option plans (issued under the 2014 Plan and the 1999 Plan) for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Option Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Exercise&lt;br clear="none"/&gt;Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted-&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Remaining&lt;br clear="none"/&gt;Contractual&lt;br clear="none"/&gt;Life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Aggregate&lt;br clear="none"/&gt;Intrinsic&lt;br clear="none"/&gt;Value (amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share options outstanding, January 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;94,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.16-$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(40,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.16-$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.46&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited/expired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share options outstanding and exercisable, December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;51,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.35-$5.21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.02&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
	<us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="FD2018Q4YTD" id="Fact-89A68BDB686CA72A77C6A9ED11F733AC">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Restricted Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Performance Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of&lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Target &lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, January&amp;#160;1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;515,601&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.03&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;257,575&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.49&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;391,108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.96&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;238,328&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(219,881&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.64&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(66,692&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.63&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(97,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(64,062&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.03&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;589,120&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;365,149&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
	<us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="FD2018Q4YTD" id="Fact-32D42A45D59F63A5967EA9ED1260BC17">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at January 1 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,071&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additions based on tax positions related to the current year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,401&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,145&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,054&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additions based on tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;204&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Reductions based on settlements of tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(439&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017 Tax Act federal tax rate change&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,859&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(220&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at December&amp;#160;31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,807&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,180&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
	<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="FD2018Q4YTD" id="Fact-C1E1DD0C27C71521FDFDA9ED11D70C4D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, estimated annual amortization expense is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:82%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Years Ending December&amp;#160;31:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,431&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,131&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,780&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,677&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,628&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
	<us-gaap:SegmentReportingDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-76B7F51961FF0D8375F8A9ED1200DAD9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Segment Data&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Segment Reporting&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, the Company reports &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; business segments &amp;#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Nurse and Allied Staffing - &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the United States. Substantially all of the results of the Advantage and AP Staffing acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Physician Staffing -&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Human Capital Management Services -&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives, and other healthcare professionals within the United States.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation and amortization, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, applicant tracking system costs, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Segment Reporting&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC. The Company&amp;#8217;s management does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&amp;#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;720,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;758,267&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;721,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,610&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;98,283&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,877&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,171&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,768&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;816,484&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;865,048&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;833,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contribution income:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Nurse and Allied Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;66,365&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;73,614&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,992&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,755&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,265&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other Human Capital Management Services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;598&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(357&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(535&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,718&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,513&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;79,722&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unallocated corporate overhead (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,589&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,190&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,780&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,174&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,182&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition and integration costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;491&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition-related contingent consideration&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,557&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;814&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,758&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,026&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;753&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impairment charges (b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,423&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,356&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,311&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(Loss) income from operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(12,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,748&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;_______________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:37px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:36px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:12px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has been centralizing administrative functions to gain efficiencies, which have been recorded in unallocated corporate overhead, which includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:37px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:13px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(b)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
	<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="FD2018Q4YTD" id="Fact-A7AA66F7278199EC55E6A9ED123A7F77">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Share-Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company has, from time to time, granted stock options, stock appreciation rights, performance-based stock awards, and restricted stock for a fixed number of common shares to employees. In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Compensation-Stock-Compensation&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC, companies may choose from alternative valuation models. The Company used the Black-Scholes method of valuing its options and stock appreciation rights. The Company has elected to recognize compensation expense on a straight-line basis over the requisite service period of the entire award. The Company values its restricted stock awards and the fair value of its performance-based stock awards by reference to its stock price on the date of grant.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company granted performance-based stock awards to certain key personnel pursuant to its 2014 Omnibus Incentive Plan, amended and restated on May 23, 2017 (2017 Plan) as described in Note 14 - Stockholders' Equity. Pursuant to the plan, the number of target shares that vest are determined based on the level of attainment of the targets.&amp;#160;If a minimum level of performance is attained for the awards, restricted stock is issued based on the level of attainment. The Company recognizes performance-based restricted stock as compensation expense based on the most likely probability of attaining the prescribed performance and over the requisite service period beginning at its grant date and through the date the restricted stock vests.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Compensation expense related to share-based payments is included in selling, general and administrative expenses in the consolidated statements of operations, and totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$3.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$4.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$3.4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively. See Note 14 &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Stockholders&amp;#8217; Equity.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
	<us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="FD2018Q4YTD" id="Fact-EFBDE893367014B1B5AFA9ED125FD955">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stockholders&amp;#8217; Equity&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Stock Repurchase Programs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under an authorized share repurchase program, during the year ended December 31, 2018, the Company repurchased and retired &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;432,439&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of its Common Stock for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, at an average market price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$11.54&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share. During the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company did not repurchase any shares of its Common Stock under this program. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company has &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;510,004&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of Common Stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Amended and Restated Credit Agreement. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Shares Issued&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 17, 2017, the Company issued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,175,584&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares to its prior Convertible Notes noteholders. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Share-Based Payments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2014 Omnibus Incentive Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's 2014 Omnibus Incentive Plan (2014 Plan) provides for the issuance of stock options, stock appreciation rights, restricted stock, performance shares, and performance-based cash awards that may be granted with the intent to comply with the &amp;#8220;performance-based compensation&amp;#8221; exception under Section 162(m) of the Internal Revenue Code, and other stock-based awards, all as defined by the 2014 Plan, to eligible employees, consultants and non-employee Directors. On May 23, 2017, the Company's shareholders approved an amendment and restatement of its 2014 Plan (2017 Plan) which, among others, included the following modifications: (i) a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; share increase of the aggregate share reserve to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,100,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares, (2) extension of the 2014 Plan until May 23, 2027, and (3) re-approval of the Section 162(m) performance goals so that certain incentive awards granted to certain executive officers of the Company may qualify as exempt performance-based compensation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under the 2017 Plan, the Compensation Committee of the Company&amp;#8217;s Board of Directors (the Committee), has the discretion to determine the terms of the awards at the time of the grant provided, however, that in the case of stock options and stock appreciation rights (share options): 1) the exercise price per share of the award is not less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (or, in the case of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; or more stockholders, the exercise price of the incentive stock options (ISOs) granted may not be less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;110%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;) of the fair market value of the common stock at the time of the grant; and 2) the term of the award will be no more than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years after the date the option is granted (or, shall not exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, in the case of a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; or more stockholder). In the case of restricted stock, the purchase price may be zero to the extent permitted by applicable law.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restricted stock awards granted under the Company&amp;#8217;s 2017 Plan entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&amp;#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&amp;#8217;s stock on the date of grant. The shares vest ratably over a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year period ending on the anniversary date of the grant, and vesting is subject to the employee's continuing employment. There is no partial vesting and any unvested portion is forfeited. Pursuant to the 2017 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Restricted Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Performance Stock Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of&lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Target &lt;br clear="none"/&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Grant Date&lt;br clear="none"/&gt;Fair Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, January&amp;#160;1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;515,601&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.03&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;257,575&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.49&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;391,108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.96&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;238,328&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(219,881&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.64&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(66,692&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.63&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(97,708&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(64,062&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.03&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unvested restricted stock awards, December&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;589,120&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;365,149&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 31, 2018 and 2017, the Company awarded performance stock awards totaling &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;238,328&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;181,067&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. If the minimum level of performance is attained for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and 2017 awards, restricted stock will be issued with a vesting date of March 31, 2021 and 2020, respectively. The level of attainment will be certified within 30 days of the vest date. During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; level of attainment for the 2016 performance-based share awards, resulting in the issuance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;66,692&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; performance shares that vested on December 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; pre-tax of total unrecognized compensation cost related to non-vested restricted stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.45 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The fair value of shares vested was approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.7&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million pre-tax of total unrecognized compensation cost related to performance stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.87 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the remaining service period. The fair value of shares vested was approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the years ended December&amp;#160;31, 2018, 2017, and 2016, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company did not issue stock options or stock appreciation rights. The following table represents information about stock options and stock appreciation rights exercised in each year. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Total intrinsic value of options exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;516&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,323&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The stock appreciation rights can only be settled with stock or cash, at the discretion of the Committee. The stock appreciation rights vest &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per year over a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year period and expire after &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. The Company&amp;#8217;s policy is to issue new shares from its authorized but unissued balance of common stock outstanding or shares of common stock reacquired by the Company if stock appreciation rights are settled with stock.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recorded compensation expense for stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Due to the adoption of the 2014 Plan (previously titled the 2007 Stock Incentive Plan), no further grants have been issued under the Company&amp;#8217;s 1999 Plans referred to below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;1999 Stock Option Plan and Equity Participation Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December&amp;#160;16, 1999, the Company&amp;#8217;s Board of Directors approved the 1999 Stock Option Plan and Equity Participation Plan (collectively, the 1999 Plans), which was amended and restated on October&amp;#160;25, 2001 and provided for the issuance of ISOs and non-qualified stock options to eligible employees and non-employee directors for the purchase of up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,398,001&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the Company&amp;#8217;s activities with respect to all of its share option plans (issued under the 2014 Plan and the 1999 Plan) for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Number of Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Option Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Exercise&lt;br clear="none"/&gt;Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Weighted-&lt;br clear="none"/&gt;Average&lt;br clear="none"/&gt;Remaining&lt;br clear="none"/&gt;Contractual&lt;br clear="none"/&gt;Life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Aggregate&lt;br clear="none"/&gt;Intrinsic&lt;br clear="none"/&gt;Value (amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share options outstanding, January 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;94,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.16-$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(40,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.16-$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.46&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited/expired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Share options outstanding and exercisable, December 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;51,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.35-$5.21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.02&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;127&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;51,500&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; share options outstanding, all of which were vested at a weighted average exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.87&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, intrinsic value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million, and a weighted average contractual life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.02&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="FD2018Q4YTD" id="Fact-F447F7D228329ED017F0A9ED123AE589">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Summary of Significant Accounting Policies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles (U.S. GAAP), requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&amp;#8217; compensation, and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) fair value of interest rate swap agreement; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company considers all investments with original maturities of three months or less to be cash and cash equivalents. The Company invests its excess cash in highly rated overnight funds and other highly rated liquid accounts. The Company is exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions, and diversifying its counterparties. The Company does not currently anticipate nonperformance by any of its significant counterparties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Interest income on cash and cash equivalents of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for the year ended December 31, 2018, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for the years ended December 31, 2017 and 2016, is included in other income, net, on the Company&amp;#8217;s consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Accounts receivable potentially subject the Company to concentrations of credit risk. The Company&amp;#8217;s customers are primarily healthcare providers, and accounts receivable represent amounts due from them. The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&amp;#8217;s estimate of uncollectible receivables resulting from the inability of its customers to make required payments, which results in a provision for bad debt expense. The adequacy of this allowance is determined by continually evaluating individual customer receivables, considering the customer's financial condition, credit history, and current economic conditions. The Company writes off specific&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;accounts based on an ongoing review of collectability as well as past experience with the customer. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In addition, the Company maintains a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company&amp;#8217;s contract terms typically require payment between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's business activity is with hospitals located throughout the United States. No single customer accounted for more than 10% of the Company&amp;#8217;s accounts receivable balance as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, or revenue for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Prepaid Rent and Deposits&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company leases apartments for eligible field employees under short-term agreements (typically &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; months), which generally coincide with each employee&amp;#8217;s staffing contract. Costs relating to these leases are included in direct operating expenses on the accompanying consolidated statements of operations. As a condition of these agreements, the Company may place security deposits on the leased apartments. Deposits on field employees&amp;#8217; apartments related to these short-term agreements are included in other current assets on the accompanying consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Property and Equipment&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;seven&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years. Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the individual lease. On an annual basis, the Company reviews its property and equipment listings and disposes of assets that are no longer in use. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Certain software development costs have been capitalized in accordance with the provisions of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other/Internal-Use Software&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). Such costs include charges for consulting services and costs for Company personnel associated with programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is ready for use and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Business Combinations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company applies accounting in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Business Combinations&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC when it acquires control over a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded as acquisition and integration costs; noncontrolling interests, if any, are reflected at fair value at the acquisition date; restructuring costs associated with a business combination are expensed; contingent consideration is measured at fair value at the acquisition date, with changes in the fair value after the acquisition date affecting earnings; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the consolidated statements of operations of the combined entity beginning on the date of acquisition. See Note 4 - Acquisitions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill, Trade Names, and Other Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable intangible assets of businesses acquired. Other identifiable intangible assets with definite lives are being amortized using the straight-line method over their estimated useful lives which range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;16&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; years. Goodwill and certain intangible assets with indefinite lives are not amortized. Instead, in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC, these assets are reviewed for impairment annually at the beginning of the fourth quarter, and whenever circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;When reviewed, the Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, as a basis for determining whether it is necessary to perform the quantitative testing. If it is determined that a quantitative test is necessary or more efficient than a qualitative approach, the Company generally measures the fair value of its reporting units using a combination of income and market approaches.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;For the periods prior to the fourth quarter of 2017, the performance of the quantitative impairment test involved a two-step process. The first step required the Company to determine the fair value of each of its reporting units and compare it to the reporting unit&amp;#8217;s carrying amount. If the reporting unit's fair value was less than its carrying amount, the Company was required to perform a second step to calculate the implied value of goodwill. The implied value was then compared to its carrying amount to calculate the impairment charge, if any. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Beginning in the fourth quarter of 2017, for its annual review on October, 1, 2017, the Company early adopted the provisions of Accounting Standards Update (ASU) 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Under ASU 2017-04, the second step of the quantitative assessment is eliminated, and, if the reporting unit&amp;#8217;s carrying value exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value not to exceed the total amount of goodwill allocated to that reporting unit. Additionally, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss is considered, if applicable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company determines its reporting units by identifying its operating segments and any component businesses and aggregates the components businesses if they have similar economic characteristics. The Company had the following reporting units that it reviewed for impairment: 1) Nurse and Allied Staffing; 2) Physician Staffing; and 3) Search.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. However, fair values that could be realized in an actual transaction may have differed from those used to evaluate the potential impairment of goodwill.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Long-lived assets and identifiable intangible assets with definite lives are evaluated for impairment in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Property, Plant, and Equipment&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC. In accordance with this Topic, long-lived assets and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Recoverability of long-lived assets is measured by a comparison of the carrying amount of the asset group to the future undiscounted net cash flow that is expected to be generated by those assets. If such assets are considered to be impaired, the impairment charge recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Any related impairment losses are recognized in earnings and included in the caption impairment charges on the consolidated statements of operations. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Debt Discount and Debt Issuance Costs &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Stated discounts on proceeds, and other fees reimbursed to lender, as well as the initial value of any embedded derivative features of the Convertible Notes and Term Loans, as defined in Note 8 - Debt, are treated as a discount associated with the respective debt instrument and presented in the balance sheet as an offset to the carrying amount of the debt. Discounts are amortized to interest expense using the effective interest rate method, or a method that approximates the effective interest rate method, over the expected life of the debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred costs related to the issuance of the Convertible Notes and the Term Loans were capitalized and are presented in the balance sheet as a direct deduction from the carrying amount of the debt liability. Deferred costs are amortized using the effective interest method. Deferred costs related to the Convertible Notes were written off in connection with the repayment of such Convertible Notes. See Note 8 - Debt. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred costs related to the issuance of the Company&amp;#8217;s Revolving Credit Facilities, as defined in Note 8 - Debt, have been capitalized and included in other assets on the consolidated balance sheets, and amortized using the straight line method over the term of the related credit agreement.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Derivative Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is exposed to interest rate risk due to its outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, the Company has entered into an interest rate swap agreement to effectively convert a portion of its variable interest payments to a fixed rate. The principal objective of the interest rate swap is to eliminate or reduce the variability of the cash flows in those interest payments associated with the Company&amp;#8217;s long-term debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company has determined that the interest rate swap qualifies as a cash flow hedge in accordance with ASC 815, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. As the critical terms of the hedging instrument and the hedged forecasted transaction are the same, the Company has concluded that changes in the cash flows attributable to the risk being hedged are expected to completely offset at inception and on an ongoing basis. Changes in the fair value of an interest rate swap agreement designated as a cash flow hedge are recorded as a component of accumulated other comprehensive income (loss), net of deferred taxes, within stockholders&amp;#8217; equity and are amortized to interest expense over the term of the related debt as the interest payments are made. Interest rate swap payments are included in net cash provided by operating activities on the Company&amp;#8217;s consolidated statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In conjunction with entering into the interest rate swap agreement, the Company early adopted ASU 2017-12, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivative and Hedging (Topic 815) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;to simplify the application of hedge accounting. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates embedded conversion features within its convertible debt in accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value. Changes in the fair value of these derivatives during each reporting period were reported in other expenses (income) on the consolidated statements of operations. The fair value at inception had been recorded as debt discount and was being amortized to interest expense over the term of the note using the effective interest method. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Sales and Other State Non-income Tax Liabilities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company accrues sales and other state non-income tax liabilities based on the Company&amp;#8217;s best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company&amp;#8217;s business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Insurance Claims&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company provides workers&amp;#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for eligible employees. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using the Company&amp;#8217;s loss history as well as industry statistics. The healthcare insurance accrual is for estimated claims that have occurred but have not been reported and is based on the Company&amp;#8217;s historical claim submission patterns. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported as well as unfavorable claims development.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Other Expenses/Insurance Costs&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC previously issued authoritative accounting guidance in the area of insurance contracts and related activity thereto. This topic concluded that, under circumstances such as in the Company&amp;#8217;s insured professional liability and workers' compensation policies, since a right of legal offset does not exist due to the fact that there are three parties to an incurred claim, the insured, the insurer, and the claimant, the related liability to the claimant should be classified separately on a gross basis with a separate related receivable from the insurer recognized as being due from insurance carriers. Accordingly, the Company&amp;#8217;s consolidated balance sheets as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; reflect the related short-term liabilities in accrued compensation and benefits and the related&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;long-term liabilities as long-term accrued claims, and the short-term receivable portion as insurance recovery receivable and the long-term portion as non-current insurance recovery receivable. See Note 7 - Balance Sheet Details. The ultimate cost of workers&amp;#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved by the Company for those claims.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Workers&amp;#8217; compensation benefits are provided under a partially self-insured plan. The Company has letters of credit to guarantee payments of claims. At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, the Company had outstanding approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$18.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$19.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively, of standby letters of credit as collateral to secure the self-insured portion of this plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company has occurrence-based primary professional liability policies that provide the Company and each working professional in its nurse and allied healthcare business with coverage. Effective January 1, 2016, the Company has a claims-made professional liability policy for its physicians and advanced practitioners, with a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; self-insured retention per claim. Prior to January 1, 2016, the Company had an occurrence-based professional liability policy for its independent contractor physicians and advanced practitioners which was insured by a wholly-owned subsidiary, Jamestown Indemnity, Ltd., a wholly-owned Cayman Island captive company (the Captive), until its voluntary liquidation in the third quarter of 2015. Beginning in March 2015, the Company's Physician subsidiary self-insured &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; for each of its professional liability claims. Under the terms of the Captive&amp;#8217;s reinsurance policy there was a requirement to guarantee the payment of claims to its insured party&amp;#8217;s primary medical malpractice insurance carrier via a letter of credit. As a result of the Captive's liquidation, the letter of credit was reduced. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, the value of the letter of credit was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$1.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$2.0&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, respectively. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Subject to certain limitations, the Company also has umbrella liability coverage for its working nurses and allied healthcare professionals. While this umbrella coverage does not extend to professional liability claims against its independent contractor physicians and advanced practitioners, it does cover claims brought against all of the Company&amp;#8217;s subsidiaries for non-patient general liability.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revenue Recognition &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the first quarter of 2018, the Company adopted ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. ASU 2014-09 introduces a new five-step revenue recognition model in which an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. See Note 3 - Revenue Recognition for additional accounting policy and related disclosures. The Company elected to adopt the standard using a modified retrospective method, which only impacts contracts not completed as of December 31, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue from the Company&amp;#8217;s services is recognized when control of the promised services are transferred to the Company&amp;#8217;s customers, in an amount that reflects the consideration it expects to receive in exchange for the service. The Company has concluded that transfer of control of its staffing services, which represents the majority of its revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following is a description of the nature, amount, timing, and uncertainty of revenue and cash flows from which the Company generates revenue.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Temporary Staffing Revenue&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by the Company&amp;#8217;s field staff. The Company recognizes the majority of its revenue at the contractual amount the Company has the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days. Accounts receivable includes estimated revenue for employees&amp;#8217; and independent contractors&amp;#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, the Company's estimate of amounts that had been worked but had not been billed totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$44.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$41.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, and are included in accounts receivable on the consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Other Service Revenue&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company offers other optional services to its customers that are transferred over time including: managed service programs (MSP) providing agency services (as further described below in Gross versus Net Policies), recruitment process outsourcing (RPO), other outsourcing services, and retained search services, which is less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the Company&amp;#8217;s RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. The Company does not, in the ordinary course of business, offer warranties or refunds.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Gross Versus Net Policies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company records revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Managed Service Programs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has certain contracts with healthcare facilities to provide comprehensive services through its MSPs. Under these contractual arrangements, the customer&amp;#8217;s orders are filled with either one of the Company's healthcare professionals or a third party's healthcare professionals (subcontractors).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;When its healthcare professional is staffed, the Company determined that it acts as a principal in the arrangement, as it is considered the employer of record. Accordingly, revenue is reported on a gross basis on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Alternatively, the Company determined that it acts as an agent in the arrangement when a subcontracted healthcare professional is staffed, as the Company does not control the services before they are transferred to the customer. Accordingly, revenue is reported on a net basis on the consolidated statements of operations. The customer is invoiced for the hours worked by the subcontracted healthcare professional multiplied by the hourly bill rate. A subcontractor liability, which is recognized as a reduction of revenue, is established in accrued expenses for the invoiced amount, net of an administrative fee, and is generally payable after the Company has received payment from its customer. The Company&amp;#8217;s administrative fee is calculated as a percentage of the customer&amp;#8217;s invoice and is recognized over time as the services are rendered by the subcontracted healthcare professional. The Company does not collect or recognize an upfront placement fee.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Physician Staffing&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Physician Staffing business has contracts with its healthcare customers to provide temporary staffing services. The Company uses independent contractors for these services. The Company determined that it acts as a principal in these arrangements and, therefore, revenue is reported on a gross basis on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;See Note 3 - Revenue Recognition for the Company's revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenue.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Contract Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;All contract fulfillment costs are expensed as incurred to direct operating expenses. With respect to FASB ASC 606, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there were no contract assets or material contract liabilities as of December 31, 2018 and 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Practical Expedients and Exemptions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the Company&amp;#8217;s contracts that have an original duration of one year or less, the Company uses the practical expedients and has elected to recognize any incremental costs of obtaining these contracts as expensed when incurred. Further, the Company does not disclose the value of unsatisfied performance obligations for: (i) contracts with an original expected length of one year or less, and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Share-Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company has, from time to time, granted stock options, stock appreciation rights, performance-based stock awards, and restricted stock for a fixed number of common shares to employees. In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-style:italic;"&gt;Compensation-Stock-Compensation&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Topic of the FASB ASC, companies may choose from alternative valuation models. The Company used the Black-Scholes method of valuing its options and stock appreciation rights. The Company has elected to recognize compensation expense on a straight-line basis over the requisite service period of the entire award. The Company values its restricted stock awards and the fair value of its performance-based stock awards by reference to its stock price on the date of grant.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company granted performance-based stock awards to certain key personnel pursuant to its 2014 Omnibus Incentive Plan, amended and restated on May 23, 2017 (2017 Plan) as described in Note 14 - Stockholders' Equity. Pursuant to the plan, the number of target shares that vest are determined based on the level of attainment of the targets.&amp;#160;If a minimum level of performance is attained for the awards, restricted stock is issued based on the level of attainment. The Company recognizes performance-based restricted stock as compensation expense based on the most likely probability of attaining the prescribed performance and over the requisite service period beginning at its grant date and through the date the restricted stock vests.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Compensation expense related to share-based payments is included in selling, general and administrative expenses in the consolidated statements of operations, and totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$3.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$4.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$3.4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively. See Note 14 &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; Stockholders&amp;#8217; Equity.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Advertising&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company&amp;#8217;s advertising expense consists primarily of online advertising, internet direct marketing, print media, and promotional material. Advertising costs are expensed as incurred and totaled &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$6.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$7.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$10.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt; million, for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Restructuring Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring costs on the consolidated statements of operations include on-going benefit costs for its employees, exit costs, and other costs including write-offs related to abandoned locations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Reconciliations of the beginning and ending total restructuring liability balances are presented below:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:27%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;Year Ended December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;font-weight:bold;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;On-Going Benefit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;"&gt;Exit Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Balance at beginning of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;325&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;44&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;338&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;"&gt;Charged to restructuring costs (a)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;1,600&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;504&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;190&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(1,131&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(336&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(282&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;(255&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;"&gt;Balance at end of period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;556&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;390&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;87&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;441&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;325&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;273&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;________________&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(a) The restructuring costs on the consolidated statements of operations include direct write-offs of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to abandoned locations, as well as other costs of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Deferred Rent&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;Deferred rent consists of free rent, rent escalation, tenant improvement allowances, and other incentives received from landlords related to the operating leases for our facilities. Rent escalation represents the difference between actual operating lease payments due and straight-line rent expense, which we record over the term of the lease. The excess is recorded as a deferred credit in the early periods of the lease, when cash payments are generally lower than straight-line rent expense, and is reduced in the later periods of the lease when payments begin to exceed the straight-line expense. Tenant allowances from landlords for tenant improvements are generally comprised of cash received from the landlord or paid on our behalf as part of the negotiated terms of the lease. These tenant improvement allowances and other leasehold incentives are recorded when realizable as deferred rent and are amortized as a reduction of periodic rent expense, over the term of the applicable lease. See Note 12 - Commitments and Contingencies.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company accounts for income taxes under the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes in its financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. The Company considers all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. It considers cumulative losses in recent years as well as the impact of one-time events in assessing its pre-tax earnings. Assumptions regarding future taxable income require significant judgment. The Company's assumptions are consistent with estimates and plans used to manage its business, which includes restructuring and other initiatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the event that actual results differ from these estimates, or the Company adjusts these estimates in future periods for current trends or changes in its estimating assumptions, it may modify the level of the valuation allowance which could materially impact its business, financial condition and results of operations. The Company will continue to assess the realizability of its deferred tax assets. See Note 13 - Income Taxes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total comprehensive income (loss) includes net income or loss, foreign currency translation adjustments, and net change in derivative transactions, net of any related deferred taxes. Certain of the Company&amp;#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Foreign Currency Matters&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying consolidated balance sheets and was an unrealized loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at December 31, 2018 and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million at December&amp;#160;31, 2017. The cumulative impact of net changes in derivative instruments included in other comprehensive loss in the consolidated balance sheets was an unrealized loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at December 31, 2018. See Note 9 - Derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The income tax impact related to components of other comprehensive income for the period ended December 31, 2018 is reflected on the consolidated statements of comprehensive income. During the period ended December 31, 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of income tax expense was included in the consolidated statements of operations due to the impact of a change in federal tax rate on the deferred tax asset related to foreign currency cumulative translation. See Note 13 - Income Taxes. There was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; income tax impact related to foreign currency translation adjustments for the period ended December&amp;#160;31, 2016.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company complies with the provisions of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, which defines fair value, establishes a framework for measuring fair value under U.S. GAAP, and expands disclosures about fair value measurements. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company&amp;#8217;s financial assets and liabilities required to be measured on a recurring basis were its deferred compensation liability, its interest rate swap agreements, and its contingent consideration liabilities. See Note 10 - Fair Value Measurements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Earnings Per Share&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with the requirements of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Earnings Per Share&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Topic of the FASB ASC, basic earnings per share is computed by dividing net income available to common shareholders (numerator) by the weighted average number of vested unrestricted common shares outstanding during the period (denominator). Diluted earnings per share gives effect to all dilutive potential common shares outstanding during the period including stock appreciation rights and options and unvested restricted stock, as calculated utilizing the treasury stock method, and Convertible Notes using the if-converted method prior to their payment in full in the first quarter of 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted for all entities, including adoption in an interim period. The Company is currently in the process of evaluating the potential impact the adoption of this standard may have and expects to adopt this standard in its first quarter of 2020.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2018, the FASB issued ASU No. 2018-13, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurement&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, and should be applied either prospectively or retrospectively depending on the nature of the disclosure. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company is currently in the process of evaluating this standard and expects to adopt the full provisions in its first quarter of 2020.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In July 2017, the FASB issued ASU No. 2017-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#8217;s own stock. The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and should be applied retrospectively to outstanding financial instruments with a down round feature by means of either a cumulative-effect adjustment or for each prior reporting period presented. Early adoption is permitted for all entities, including adoption in an interim period. The Company expects to adopt this standard in its first quarter of 2019, and does not expect this guidance to have a material impact on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. The FASB has issued several other subsequent updates including the following: 1) ASU No. 2018-10, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Codification Improvements to Topic 842, Leases&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes sixteen separate narrow-scope amendments to clarify the codification and to correct unintended application of guidance; and 2) ASU No. 2018-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842): Targeted Improvements&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which provides entities with relief from the costs of implementing certain aspects of the new leasing standard by allowing them to elect not to recast the comparative periods presented when transitioning to ASC 842. The new lease standard, and the subsequent ASUs that modified Topic 842, are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;With respect to the adoption of the new standard, as of December 31, 2018, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$34.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of undiscounted future lease payments, primarily related to real estate, that is expected to be included in its initial measurement of its lease liabilities and corresponding right of use asset, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of accrued rent that is expected to be reclassified from liability accounts to reduce its beginning right of use asset balance.&amp;#160;The Company does not expect the adoption of ASU 2016-02 to have a material impact on its consolidated statements of operations and statements of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="FD2018Q4YTD" id="Fact-9EE87AA82B7F0B629454A9ED12803C32">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;(amounts in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery receivable:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for workers&amp;#8217; compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,295&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,623&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for professional liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,891&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,874&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,186&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,497&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other non-current assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,280&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,093&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Insurance recovery for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,924&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,011&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current security deposits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;982&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,095&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current income tax receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;433&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net debt issuance costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;935&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;985&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,076&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,228&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued compensation and benefits:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Salaries and payroll taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,884&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,342&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Bonuses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,454&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,957&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,786&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,683&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for healthcare benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,105&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for vacation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,574&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,117&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,332&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,271&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term accrued claims:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for workers&amp;#8217; compensation claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,997&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,160&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrual for professional liability claims&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;29,299&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,757&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other long-term liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-current deferred tax liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;95&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;105&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,725&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred rent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,039&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,875&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term unrecognized tax benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;590&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;318&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,767&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
	<us-gaap:UseOfEstimates contextRef="FD2018Q4YTD" id="Fact-77D7B5ECF118FDC5CD6DA9ED124B7A06">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9.75pt;"&gt;&lt;font style="font-family:inherit;font-size:9.75pt;"&gt;The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles (U.S. GAAP), requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&amp;#8217; compensation, and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) fair value of interest rate swap agreement; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>ccrn-20181231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crosscountryhealthcare.com/20181231" xmlns:ccrn="http://www.crosscountryhealthcare.com/20181231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20181231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20181231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20181231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20181231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="Acquisitions" roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions">
        <link:definition>2103100 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails">
        <link:definition>2403406 - Disclosure - Acquisitions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdvantageRnDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails">
        <link:definition>2403403 - Disclosure - Acquisitions - Advantage RN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAmericanPersonnelIncDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails">
        <link:definition>2403402 - Disclosure - Acquisitions - American Personnel, Inc. (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>2403405 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsFairValueOfPurchasePriceDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails">
        <link:definition>2403404 - Disclosure - Acquisitions - Fair Value of Purchase Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2403408 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaDetails" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails">
        <link:definition>2403407 - Disclosure - Acquisitions - Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsTables">
        <link:definition>2303301 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails">
        <link:definition>2107100 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsDetails" roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails">
        <link:definition>2407402 - Disclosure - Balance Sheet Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables">
        <link:definition>2307301 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies">
        <link:definition>2112100 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails">
        <link:definition>2412402 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails">
        <link:definition>2412403 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesTables" roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables">
        <link:definition>2312301 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1005000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations">
        <link:definition>1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity">
        <link:definition>1004000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.crosscountryhealthcare.com/role/Debt">
        <link:definition>2108100 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2016SeniorCreditFacilitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails">
        <link:definition>2408406 - Disclosure - Debt - 2016 Senior Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails">
        <link:definition>2408403 - Disclosure - Debt - Amendment And Restatement Of Senior Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConsolidatedNetLeverageRatioDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails">
        <link:definition>2408405 - Disclosure - Debt - Consolidated Net Leverage Ratio (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDebtMaturitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails">
        <link:definition>2408404 - Disclosure - Debt - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtLongTermDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails">
        <link:definition>2408402 - Disclosure - Debt - Long- Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails">
        <link:definition>2408407 - Disclosure - Debt - Private Placement of Convertible Notes Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.crosscountryhealthcare.com/role/DebtTables">
        <link:definition>2308301 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.crosscountryhealthcare.com/role/Derivatives">
        <link:definition>2109100 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>2409401 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare">
        <link:definition>2139100 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAntidilutiveSecuritiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails">
        <link:definition>2439403 - Disclosure - Earnings Per Share - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails">
        <link:definition>2439402 - Disclosure - Earnings Per Share - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables">
        <link:definition>2339301 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans">
        <link:definition>2111100 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails">
        <link:definition>2411401 - Disclosure - Employee Benefit Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements">
        <link:definition>2110100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>2410402 - Disclosure - Fair Value Measurements - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails">
        <link:definition>2410404 - Disclosure - Fair Value Measurements - Financial Instruments that were not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2410405 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details">
        <link:definition>2410403 - Disclosure - Fair Value Measurements - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables">
        <link:definition>2310301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssets" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets">
        <link:definition>2105100 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails">
        <link:definition>2405402 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Acquired Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails">
        <link:definition>2405404 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails">
        <link:definition>2405403 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Estimated Annual Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2405405 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTradeNamesAndOtherIntangibleAssetsTables" roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables">
        <link:definition>2305301 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes">
        <link:definition>2113100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails">
        <link:definition>2413402 - Disclosure - Income Taxes - Components of Income (Loss) Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails">
        <link:definition>2413403 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2413405 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails">
        <link:definition>2413407 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails">
        <link:definition>2413406 - Disclosure - Income Taxes - Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>2413404 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables">
        <link:definition>2313301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationAndBasisOfPresentation" roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation">
        <link:definition>2101100 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipment" roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment">
        <link:definition>2106100 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentDetails" roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails">
        <link:definition>2406402 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyAndEquipmentTables" roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables">
        <link:definition>2306301 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnaudited" roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited">
        <link:definition>2144100 - Disclosure - Quarterly Financial Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedDetails" roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails">
        <link:definition>2444402 - Disclosure - Quarterly Financial Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyFinancialDataUnauditedTables" roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables">
        <link:definition>2344301 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions">
        <link:definition>2141100 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2441401 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognition">
        <link:definition>2103100 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationOfRevenueDetails" roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails">
        <link:definition>2403402 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables">
        <link:definition>2303301 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccounts" roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts">
        <link:definition>2145100 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
        <link:definition>2445401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentData" roleURI="http://www.crosscountryhealthcare.com/role/SegmentData">
        <link:definition>2143100 - Disclosure - Segment Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails">
        <link:definition>2443402 - Disclosure - Segment Data - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataOperatingSegmentsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails">
        <link:definition>2443403 - Disclosure - Segment Data - Operating Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentDataTables" roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables">
        <link:definition>2343301 - Disclosure - Segment Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity">
        <link:definition>2133100 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails">
        <link:definition>2433406 - Disclosure - Stockholders' Equity - 1999 Stock Option Plan and Equity Participation Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity2014OmnibusIncentivePlanDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails">
        <link:definition>2433403 - Disclosure - Stockholders' Equity - 2014 Omnibus Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2433402 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails">
        <link:definition>2433405 - Disclosure - Stockholders' Equity - Stock Options and Stock Appreciation Rights Granted and Exercised (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails">
        <link:definition>2433407 - Disclosure - Stockholders' Equity - Summary of Company's Share Option Plans Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails">
        <link:definition>2433404 - Disclosure - Stockholders' Equity - Summary of Restricted Stock Award Activity and Performance Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables">
        <link:definition>2333301 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies">
        <link:definition>2102100 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails">
        <link:definition>2402406 - Disclosure - Summary of Significant Accounting Policies - ASU Adoption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2402403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails">
        <link:definition>2402405 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Restructuring Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>2402404 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2302302 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ccrn_A8ConvertibleNotesMember" name="A8ConvertibleNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AcquisitionRelatedContingentConsiderationMember" name="AcquisitionRelatedContingentConsiderationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AdvantageRNLLCMember" name="AdvantageRNLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AmendedAndRestatedCreditAgreementMember" name="AmendedAndRestatedCreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AmericanPersonnelInc.Member" name="AmericanPersonnelInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" name="AssumedAdditionalContingentPurchasePriceLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationDeferredPeriod" name="BusinessCombinationConsiderationDeferredPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_BusinessCombinationConsiderationTransferredAxis" name="BusinessCombinationConsiderationTransferredAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" name="BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_BusinessCombinationConsiderationTransferredDomain" name="BusinessCombinationConsiderationTransferredDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" name="BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement" name="BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand" name="BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" name="BusinessCombinationContingentConsiderationArrangementsExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities" name="BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities" name="BusinessCombinationEscrowDepositRelatedToTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_BusinessCombinationEscrowDepositRelease" name="BusinessCombinationEscrowDepositRelease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_ClaimsBasedLiabilityInsuranceMember" name="ClaimsBasedLiabilityInsuranceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ConsolidatedNetLeverageRatio" name="ConsolidatedNetLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_ContingentConsiderationLiabilityMember" name="ContingentConsiderationLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ContractualTerm" name="ContractualTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ConvertibleNoteDerivativeLiabilityMember" name="ConvertibleNoteDerivativeLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" name="ConvertibleNotesandSharebasedPaymentAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CostOptimizationProjectMember" name="CostOptimizationProjectMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm1Member" name="CovenantTerm1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm2Member" name="CovenantTerm2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm3Member" name="CovenantTerm3Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm4Member" name="CovenantTerm4Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CovenantTerm5Member" name="CovenantTerm5Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" name="DebtCovenantConsolidatedFixedChargeCoverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant" />
  <xsd:element id="ccrn_DebtCovenantConsolidatedTotalLeverageRatio" name="DebtCovenantConsolidatedTotalLeverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_DebtCovenantTermsAxis" name="DebtCovenantTermsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DebtCovenantTermsDomain" name="DebtCovenantTermsDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" name="DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" name="DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal" name="DebtInstrumentPeriodicPaymentPercentageOfPrincipal" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DebtInstrumentPrepaymentPenalty" name="DebtInstrumentPrepaymentPenalty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DeferredCompensationMember" name="DeferredCompensationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_DeferredConsiderationTransferredMember" name="DeferredConsiderationTransferredMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses" name="DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_DeferredTaxAssetsLiabilities" name="DeferredTaxAssetsLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_DocumentDocumentandEntityInformationAbstract" name="DocumentDocumentandEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_EachFiscalQuarterEndingThereafterMember" name="EachFiscalQuarterEndingThereafterMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount" name="EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ExitCostsMember" name="ExitCostsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueInputsForecastPeriod" name="FairValueInputsForecastPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA" name="FairValueInputsRatioofTotalEnterpriseValuebyEBITDA" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueInputsTerminalValueGrowthRate" name="FairValueInputsTerminalValueGrowthRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueInputsWeightingApplied" name="FairValueInputsWeightingApplied" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember" name="FirstAmendmentAmendedAndRestatedCreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FirstEightInstallmentsMember" name="FirstEightInstallmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiscalQuarterEndingDecember312019Member" name="FiscalQuarterEndingDecember312019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiscalQuarterEndingSeptember302019Member" name="FiscalQuarterEndingSeptember302019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" name="FiscalQuartersEndingSeptember302018throughJune302019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems" name="GoodwillAndIntangibleAssetsDisclosureLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_GoodwillAndIntangibleAssetsDisclosureTable" name="GoodwillAndIntangibleAssetsDisclosureTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_GoodwillImpairmentTestMeasurementInput" name="GoodwillImpairmentTestMeasurementInput" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant" />
  <xsd:element id="ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" name="GoodwillWriteOffRelatedToSaleOfBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_IncentiveCompensationPlan2007Member" name="IncentiveCompensationPlan2007Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_IncomeandMarketApproachValuationTechniqueMember" name="IncomeandMarketApproachValuationTechniqueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_IncrementalTermLoanMember" name="IncrementalTermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_InsuranceRecoveryForWorkersCompensationCurrent" name="InsuranceRecoveryForWorkersCompensationCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent" name="InsuranceRecoveryForWorkersCompensationNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock" name="IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_JointVenturePercentOwnership" name="JointVenturePercentOwnership" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LeaseExpirationPeriod" name="LeaseExpirationPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_LetterofCreditFeeMember" name="LetterofCreditFeeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_LineOfCreditFacilityAdditionalCapacity" name="LineOfCreditFacilityAdditionalCapacity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" name="LineOfCreditFacilitySubFacilityForSwinglineLoans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" name="LineOfCreditFacilitySubLimitForLettersOfCredit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_MDAHoldingsIncMember" name="MDAHoldingsIncMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim" name="MalpracticeInsurancePolicySelfInsuredRetentionPerClaim" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_MedicalStaffingNetworkMember" name="MedicalStaffingNetworkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_MediscanMember" name="MediscanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_NetOperatingLossesMember" name="NetOperatingLossesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_NetWorkingCapitalAdjustmentsMember" name="NetWorkingCapitalAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_NumberofFinancialCovenants" name="NumberofFinancialCovenants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_NurseAndAlliedStaffingMember" name="NurseAndAlliedStaffingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember" name="OccurrenceBasedProfessionalLiabilityInsuranceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OmnibusPlanMember" name="OmnibusPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" name="OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OtherComprehensiveIncomeLossTax1Abstract" name="OtherComprehensiveIncomeLossTax1Abstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OtherHumanCapitalManagementServicesMember" name="OtherHumanCapitalManagementServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_OtherLiabilitiesMiscellaneousNoncurrent" name="OtherLiabilitiesMiscellaneousNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ccrn_OtherNetDeferredTaxAssetsMember" name="OtherNetDeferredTaxAssetsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_OtherServicesMember" name="OtherServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan" name="OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ccrn_PaymentForDebtPrepayment" name="PaymentForDebtPrepayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" name="PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities" name="PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities" name="PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PhysicianStaffingMember" name="PhysicianStaffingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" name="PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_PrepaidRentAndDepositsPolicyTextBlock" name="PrepaidRentAndDepositsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" name="ProvisionforDoubtfulAccountsandOtherAllowances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_PurchasePriceMember" name="PurchasePriceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_RemainingInstallmentsMember" name="RemainingInstallmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_RepatriationOfForeignEarningsAmount" name="RepatriationOfForeignEarningsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_RestructuringChargesWriteOffRelatedToAbandonment" name="RestructuringChargesWriteOffRelatedToAbandonment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock" name="SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" name="ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_SearchReportingUnitMember" name="SearchReportingUnitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_SecondLienTermLoanMember" name="SecondLienTermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SegmentReportingUnallocatedCorporateExpenses" name="SegmentReportingUnallocatedCorporateExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" name="SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_SignificantAccountingPoliciesLineItems" name="SignificantAccountingPoliciesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_SignificantAccountingPoliciesTable" name="SignificantAccountingPoliciesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_StockOptionAndEquityParticipationPlan1999Member" name="StockOptionAndEquityParticipationPlan1999Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_StockRepurchasedDuringPeriodPricePerShare" name="StockRepurchasedDuringPeriodPricePerShare" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" name="TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_TemporaryStaffingServicesMember" name="TemporaryStaffingServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_TenPercentOrMoreStockholdersMember" name="TenPercentOrMoreStockholdersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_TermLoanMember" name="TermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" name="ThresholdPeriodPastDueforPaymentofServicesProvided" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ccrn_USResourcesHealthcareLLCMember" name="USResourcesHealthcareLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions" name="UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases" name="UnrecognizedTaxBenefitsPeriodGrossIncreases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange" name="UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>ccrn-20181231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20181231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdvantageRnDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAmericanPersonnelIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsProFormaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:href="ccrn-20181231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20181231.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:href="ccrn-20181231.xsd#Debt2016SeniorCreditFacilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:href="ccrn-20181231.xsd#DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20181231.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20181231.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20181231.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20181231.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20181231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:href="ccrn-20181231.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20181231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20181231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20181231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20181231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20181231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:href="ccrn-20181231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20181231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:href="ccrn-20181231.xsd#PropertyAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:href="ccrn-20181231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ccrn-20181231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:href="ccrn-20181231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20181231.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#SegmentDataAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:href="ccrn-20181231.xsd#SegmentDataOperatingSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20181231.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20181231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20181231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fbe331bf-e36a-7435-2eec-e3249b6c0997" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6ded97a0-4720-80e2-4a5a-a9ed2e63d29a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6ded97a0-4720-80e2-4a5a-a9ed2e63d29a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5f09315-a75f-c740-ae16-e748d175d387" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cc1d8741-0bf1-0f1b-dbad-6859add56d00" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5f09315-a75f-c740-ae16-e748d175d387" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1184f71b-eb96-34a8-7c86-c43ab50947af" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_395f9bb0-2492-f247-ce6b-39e67453292c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8ce68675-8129-3ab4-cbd9-33127f150e28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_787094fe-6809-3d48-32a0-016251d35e96" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_787094fe-6809-3d48-32a0-016251d35e96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_090d08a1-b8fd-3634-47b8-7dcb68699de1" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_090d08a1-b8fd-3634-47b8-7dcb68699de1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_588b212f-0609-2b89-932f-cbe7e57377ff" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2fb474b5-5859-9678-205e-8aa88ca40daa" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_588b212f-0609-2b89-932f-cbe7e57377ff" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_cccd0209-1cd8-b603-e355-33e3ccd4e542" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_cccd0209-1cd8-b603-e355-33e3ccd4e542" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ba68d7-f289-318f-e37f-e4831b34f534" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_78ba68d7-f289-318f-e37f-e4831b34f534" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_faba374e-094a-8c9f-6fd7-a9ed2e6c3243" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_faba374e-094a-8c9f-6fd7-a9ed2e6c3243" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeNoncurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_a0bb984c-dc59-df8c-fa54-131365351328" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_a0bb984c-dc59-df8c-fa54-131365351328" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_61ff83b4-33a0-68aa-a4ad-7dbd9b595dbf" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_61ff83b4-33a0-68aa-a4ad-7dbd9b595dbf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_c6c339a6-89e4-d758-b70f-cdf3b0c067b7" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_c6c339a6-89e4-d758-b70f-cdf3b0c067b7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_525352e9-6825-e86e-ba35-0288cb63eff9" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_525352e9-6825-e86e-ba35-0288cb63eff9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_fa5260eb-4b1c-e22f-06c9-c0ec68b6fbe9" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_fa5260eb-4b1c-e22f-06c9-c0ec68b6fbe9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0e9cc685-b5db-2672-c796-f60383eb4f21" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_4e2061a7-35ad-0a46-8473-528ab1451973" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0e9cc685-b5db-2672-c796-f60383eb4f21" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_4e2061a7-35ad-0a46-8473-528ab1451973" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_31a2f4a8-c799-64a8-3bb7-f08046a02098" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0e9cc685-b5db-2672-c796-f60383eb4f21" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_31a2f4a8-c799-64a8-3bb7-f08046a02098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_5bf5de9d-0910-f3f9-d348-0687d2fc48d3" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationCurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_daf0781c-bb11-6a1f-45ed-a9ed2e3bdbfd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent_5bf5de9d-0910-f3f9-d348-0687d2fc48d3" xlink:to="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_daf0781c-bb11-6a1f-45ed-a9ed2e3bdbfd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeCurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_bd95d6c1-1589-172d-433b-8ef24988771a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent_5bf5de9d-0910-f3f9-d348-0687d2fc48d3" xlink:to="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_bd95d6c1-1589-172d-433b-8ef24988771a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_a6800cd8-5421-aa7f-a4dc-501c17b7ce00" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_AccruedSalariesCurrent_a6800cd8-5421-aa7f-a4dc-501c17b7ce00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent_853bd7d0-a1a5-045b-6078-0f9a7e4e9e80" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_AccruedBonusesCurrent_853bd7d0-a1a5-045b-6078-0f9a7e4e9e80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_02a8ebeb-e95e-e53b-f69a-befaea1261f6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_02a8ebeb-e95e-e53b-f69a-befaea1261f6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_de27263b-a98d-f670-4fa8-a1549c395ddb" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_de27263b-a98d-f670-4fa8-a1549c395ddb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_1782d9d9-eac7-eccb-0eb7-96728a940982" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_1782d9d9-eac7-eccb-0eb7-96728a940982" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_b8f4ceb9-0776-826c-20ff-62f5117a67ea" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:to="loc_us-gaap_AccruedVacationCurrent_b8f4ceb9-0776-826c-20ff-62f5117a67ea" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_6b1efbc2-e859-9fbd-c572-2f4147498390" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_6b1efbc2-e859-9fbd-c572-2f4147498390" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ceda5c9b-a770-d73b-0b09-a6aa89bb6fa3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ceda5c9b-a770-d73b-0b09-a6aa89bb6fa3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_2c8b0baf-771b-c301-80d6-9e2df7367293" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_2c8b0baf-771b-c301-80d6-9e2df7367293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_cf3ef1c3-1c9a-2919-ed18-e1de3345a129" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_cf3ef1c3-1c9a-2919-ed18-e1de3345a129" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherLiabilitiesMiscellaneousNoncurrent" xlink:label="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_fcdd75ba-913a-d145-4047-a9ed2d8fe871" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:to="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_fcdd75ba-913a-d145-4047-a9ed2d8fe871" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f67237f3-7c78-8a5c-b7b3-17f1eb0b017a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f67237f3-7c78-8a5c-b7b3-17f1eb0b017a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_ccaff3fc-3d87-e58a-0083-69dda0c10f9d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_ccaff3fc-3d87-e58a-0083-69dda0c10f9d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_39e76369-4fdc-9d5f-860a-45d0795e5fb0" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_39e76369-4fdc-9d5f-860a-45d0795e5fb0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_fe404cae-7fcc-3489-844f-4d90e9776180" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_fe404cae-7fcc-3489-844f-4d90e9776180" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_5b651b24-1278-4eab-c840-7002c6d68546" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_5b651b24-1278-4eab-c840-7002c6d68546" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_36c616b1-40de-90d4-3c05-7e224ce1169a" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_36c616b1-40de-90d4-3c05-7e224ce1169a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_b69fa2fe-d7f6-024f-39fb-29cad0c95853" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_b69fa2fe-d7f6-024f-39fb-29cad0c95853" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_5bf5de9d-0910-f3f9-d348-0687d2fc48d3" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_5bf5de9d-0910-f3f9-d348-0687d2fc48d3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_79aabdc0-b963-1fd1-4e81-8c0801b1ebca" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_OtherAssetsCurrent_79aabdc0-b963-1fd1-4e81-8c0801b1ebca" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_13b299fc-2905-287d-c0a3-c0d0732afa25" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_13b299fc-2905-287d-c0a3-c0d0732afa25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_5ee94de1-09b5-a281-d50f-420352002a69" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_5ee94de1-09b5-a281-d50f-420352002a69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b291daf5-0cfd-3790-a28c-03051d26add4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b291daf5-0cfd-3790-a28c-03051d26add4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4bcdb937-432e-7a7e-23c2-a441d7b89da5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4bcdb937-432e-7a7e-23c2-a441d7b89da5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0e9cc685-b5db-2672-c796-f60383eb4f21" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_0e9cc685-b5db-2672-c796-f60383eb4f21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f0c68f4f-7ec1-d447-8ba7-0f2766abbe67" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f0c68f4f-7ec1-d447-8ba7-0f2766abbe67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0c0480e-e6f5-c4df-ce25-1ffa4a8c827a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0c0480e-e6f5-c4df-ce25-1ffa4a8c827a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0c0480e-e6f5-c4df-ce25-1ffa4a8c827a" xlink:to="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_df284507-8ac7-eed1-41db-05e81b70be6d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_df284507-8ac7-eed1-41db-05e81b70be6d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_a9feabf5-0bf0-3efe-740e-f5e41a4b3194" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e0c0480e-e6f5-c4df-ce25-1ffa4a8c827a" xlink:to="loc_us-gaap_MinorityInterest_a9feabf5-0bf0-3efe-740e-f5e41a4b3194" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_b412c390-dfec-d4c8-f13e-036e3b49278c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_b412c390-dfec-d4c8-f13e-036e3b49278c" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_562caa58-8708-94e2-1130-147a1e3677b6" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_562caa58-8708-94e2-1130-147a1e3677b6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f29e1615-69a8-32d6-e81b-bb176e7348de" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f29e1615-69a8-32d6-e81b-bb176e7348de" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11620bd8-431c-98f6-ac51-02db9613dc06" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11620bd8-431c-98f6-ac51-02db9613dc06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d54a644c-3d3c-bcc1-da30-2f136651f90f" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d54a644c-3d3c-bcc1-da30-2f136651f90f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91c354d1-d18f-051e-80cb-f13c01058b9d" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91c354d1-d18f-051e-80cb-f13c01058b9d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a039d388-4db8-a076-4618-28899f6ce801" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a039d388-4db8-a076-4618-28899f6ce801" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_174c69cb-dbdb-715b-90aa-41fc0a26f1d6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_174c69cb-dbdb-715b-90aa-41fc0a26f1d6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_80abba07-181c-6ed2-349d-9d7dfc078eab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_c6c53bbe-5f31-2d14-a074-d8879c03f713" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_c6c53bbe-5f31-2d14-a074-d8879c03f713" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_60ab1096-bf53-5d61-76bd-431fe857fc03" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_60ab1096-bf53-5d61-76bd-431fe857fc03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_e6ae60bb-8599-bf4e-5698-2181a00d140c" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_e6ae60bb-8599-bf4e-5698-2181a00d140c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_bd5d5ca5-7d41-2f41-654a-b2433f675680" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_bd5d5ca5-7d41-2f41-654a-b2433f675680" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_35daa78b-69b1-a085-04d1-e403e60f5923" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_35daa78b-69b1-a085-04d1-e403e60f5923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_204acd11-57b2-232a-d32d-d0824032cd6a" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_204acd11-57b2-232a-d32d-d0824032cd6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_38e7f3e2-9d1a-8772-e4aa-fb2cb7d8adc0" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_38e7f3e2-9d1a-8772-e4aa-fb2cb7d8adc0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e0089888-8677-d95e-95e6-00fe630f2dcb" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e0089888-8677-d95e-95e6-00fe630f2dcb" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0e67d263-6e0f-cbd4-f553-6c8cebeb68d8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0e67d263-6e0f-cbd4-f553-6c8cebeb68d8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0e67d263-6e0f-cbd4-f553-6c8cebeb68d8" xlink:to="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0e67d263-6e0f-cbd4-f553-6c8cebeb68d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_fd048371-7ae9-878a-d401-982ff73ca2e8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_fd048371-7ae9-878a-d401-982ff73ca2e8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_881dbe64-5e76-8c22-9cd1-d14b0b92fc4a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_fd048371-7ae9-878a-d401-982ff73ca2e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_881dbe64-5e76-8c22-9cd1-d14b0b92fc4a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_48affc1d-1d93-b02c-d36f-6fb2e4d5af12" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_fd048371-7ae9-878a-d401-982ff73ca2e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_48affc1d-1d93-b02c-d36f-6fb2e4d5af12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_1c93c32b-23fc-bcad-b679-cb6bba0f6868" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_fd048371-7ae9-878a-d401-982ff73ca2e8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_1c93c32b-23fc-bcad-b679-cb6bba0f6868" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_aa6d7695-3c9c-a820-1c3c-0e977db4a781" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_aa6d7695-3c9c-a820-1c3c-0e977db4a781" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_02b50397-d00f-df78-1387-e4ae5dc85e2d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_aa6d7695-3c9c-a820-1c3c-0e977db4a781" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_02b50397-d00f-df78-1387-e4ae5dc85e2d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_266030a6-b86a-832d-2d48-e25abdbffbb6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_aa6d7695-3c9c-a820-1c3c-0e977db4a781" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_266030a6-b86a-832d-2d48-e25abdbffbb6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_1948ccab-4749-82d7-db1f-ee6556da2242" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_aa6d7695-3c9c-a820-1c3c-0e977db4a781" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_1948ccab-4749-82d7-db1f-ee6556da2242" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f5ae002e-8316-7bc0-1b41-6cd171b53db3" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf605d39-9067-2f07-a6b5-7dfa6481009e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f5ae002e-8316-7bc0-1b41-6cd171b53db3" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_435f940b-a471-4122-5132-a245458f6913" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_Revenues_435f940b-a471-4122-5132-a245458f6913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectOperatingCosts" xlink:label="loc_us-gaap_DirectOperatingCosts_3d73b61b-6f03-c339-8d5f-8989baf48d9d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_DirectOperatingCosts_3d73b61b-6f03-c339-8d5f-8989baf48d9d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4f09b019-1798-ea9c-e343-c24acb96b019" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4f09b019-1798-ea9c-e343-c24acb96b019" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_e04ca6ce-4142-8baf-2785-53947ccd390b" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_RestructuringCharges_e04ca6ce-4142-8baf-2785-53947ccd390b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_ef4048fd-02eb-1853-b528-147a1d6f532e" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_ef4048fd-02eb-1853-b528-147a1d6f532e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f29e1615-69a8-32d6-e81b-bb176e7348de" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f29e1615-69a8-32d6-e81b-bb176e7348de" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11620bd8-431c-98f6-ac51-02db9613dc06" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11620bd8-431c-98f6-ac51-02db9613dc06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8aa68cfb-2df7-9a23-d1ed-4fe33385b4a2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_b75c6c71-aebe-7dff-540e-3742b447fc67" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_b75c6c71-aebe-7dff-540e-3742b447fc67" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5cb3949c-1d57-8f66-f002-a3389de7aec0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5cb3949c-1d57-8f66-f002-a3389de7aec0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_89018c92-f86f-28e7-853c-438f4a34e1f6" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_89018c92-f86f-28e7-853c-438f4a34e1f6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_b1147f3a-70ce-fba6-8f57-147a1e47289d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_b1147f3a-70ce-fba6-8f57-147a1e47289d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_204acd11-57b2-232a-d32d-d0824032cd6a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_b1147f3a-70ce-fba6-8f57-147a1e47289d" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_204acd11-57b2-232a-d32d-d0824032cd6a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e52bef3f-d63a-d129-8b6a-48192f5d97b3" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e52bef3f-d63a-d129-8b6a-48192f5d97b3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d81633a3-dcc9-02ed-c932-69afb6c98911" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_d81633a3-dcc9-02ed-c932-69afb6c98911" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_13b299fc-2905-287d-c0a3-c0d0732afa25" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_13b299fc-2905-287d-c0a3-c0d0732afa25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7a49df76-38f6-6baa-87dd-2e9a7efd8303" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7a49df76-38f6-6baa-87dd-2e9a7efd8303" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c9279b6a-f262-f140-7696-5ec40778343f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c9279b6a-f262-f140-7696-5ec40778343f" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d652bfd-fc92-51b1-30d6-b90c4a94f960" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d652bfd-fc92-51b1-30d6-b90c4a94f960" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0e7343bd-e798-afc0-7fcc-ed296ae9f91c" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0e7343bd-e798-afc0-7fcc-ed296ae9f91c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_650e6c8f-1409-4de1-126f-784909f82e64" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_650e6c8f-1409-4de1-126f-784909f82e64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10aa09ac-60b4-bd88-6c3b-c85b3f0fbf0a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10aa09ac-60b4-bd88-6c3b-c85b3f0fbf0a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_840ca4a2-1542-fad2-992c-40136594b396" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_840ca4a2-1542-fad2-992c-40136594b396" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_fe317df7-0725-5da2-f5a6-e3735697b6a6" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_fe317df7-0725-5da2-f5a6-e3735697b6a6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_dccbbcdf-3af2-54ab-0e51-b4372916415d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_dccbbcdf-3af2-54ab-0e51-b4372916415d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e9804aa2-0190-55cd-01a9-85d659cee6b2" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e9804aa2-0190-55cd-01a9-85d659cee6b2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_3ede50f4-da6a-3a1f-1cc5-ed56405717a3" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_3ede50f4-da6a-3a1f-1cc5-ed56405717a3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount" xlink:label="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_CE920876EDDD5A2CEE3ABFF83B8B1279" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_CE920876EDDD5A2CEE3ABFF83B8B1279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsLiabilities" xlink:label="loc_ccrn_DeferredTaxAssetsLiabilities_86aca1fb-d4e0-954d-dc38-a9ed2df38618" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_476b367a-1ad6-eb34-c01b-595b754b8aa8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_DeferredTaxAssetsLiabilities_86aca1fb-d4e0-954d-dc38-a9ed2df38618" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_476b367a-1ad6-eb34-c01b-595b754b8aa8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_476b367a-1ad6-eb34-c01b-595b754b8aa8" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses" xlink:label="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_26db04ee-b3fc-6d09-a785-a9ed2e8da481" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_26db04ee-b3fc-6d09-a785-a9ed2e8da481" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_4de6ab71-5584-b102-1689-14f04c2474ba" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_4de6ab71-5584-b102-1689-14f04c2474ba" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_7f86d0ad-9065-5c14-f7d0-2ff3cc4df692" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_7f86d0ad-9065-5c14-f7d0-2ff3cc4df692" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_877d9548-0a6d-f5af-1e31-5b1edfc4107e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_877d9548-0a6d-f5af-1e31-5b1edfc4107e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a38b9623-d40d-b02c-d37f-d84fb6a4eac7" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a38b9623-d40d-b02c-d37f-d84fb6a4eac7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0cc13c2f-6b23-b741-4f28-07325c7e7169" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0cc13c2f-6b23-b741-4f28-07325c7e7169" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_059ea1c5-ba15-6d4b-3fb5-5fbf937cf251" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_059ea1c5-ba15-6d4b-3fb5-5fbf937cf251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_ad6a47d1-5f32-71bb-5f8d-bd838e70624c" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_ad6a47d1-5f32-71bb-5f8d-bd838e70624c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_476b367a-1ad6-eb34-c01b-595b754b8aa8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_DeferredTaxAssetsLiabilities_86aca1fb-d4e0-954d-dc38-a9ed2df38618" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_42b61cde-44f6-df44-52b0-1b84b1e28a47" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_42b61cde-44f6-df44-52b0-1b84b1e28a47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_7fd38a24-2a25-2514-4676-a830887282eb" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_7fd38a24-2a25-2514-4676-a830887282eb" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_afb6ecef-1355-6c7b-b1bc-147a1ddb8b11" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_afb6ecef-1355-6c7b-b1bc-147a1ddb8b11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4f09b019-1798-ea9c-e343-c24acb96b019" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_4f09b019-1798-ea9c-e343-c24acb96b019" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_e04ca6ce-4142-8baf-2785-53947ccd390b" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_RestructuringCharges_e04ca6ce-4142-8baf-2785-53947ccd390b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_AssetImpairmentCharges_45c69f9e-da88-288e-46e4-172c1cc97df8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_969e248c-184f-61eb-0421-147a1e0e5661" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_969e248c-184f-61eb-0421-147a1e0e5661" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_ef4048fd-02eb-1853-b528-147a1d6f532e" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_ef4048fd-02eb-1853-b528-147a1d6f532e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>ccrn-20181231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20181231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdvantageRnDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAmericanPersonnelIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsProFormaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:href="ccrn-20181231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20181231.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:href="ccrn-20181231.xsd#Debt2016SeniorCreditFacilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:href="ccrn-20181231.xsd#DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20181231.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20181231.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20181231.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20181231.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20181231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:href="ccrn-20181231.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20181231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20181231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20181231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20181231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20181231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:href="ccrn-20181231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20181231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:href="ccrn-20181231.xsd#PropertyAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:href="ccrn-20181231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ccrn-20181231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:href="ccrn-20181231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20181231.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#SegmentDataAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:href="ccrn-20181231.xsd#SegmentDataOperatingSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20181231.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20181231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20181231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_98033A2791EF6E3ADC1FBF4CB624F56A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_TradeNamesMember_98033A2791EF6E3ADC1FBF4CB624F56A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_52C6DF43B6E9E800922FBF4CB6798F82" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_CustomerRelationshipsMember_52C6DF43B6E9E800922FBF4CB6798F82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_C0AF3F27A8647F2EC0FDBF4CB6A90708" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_DatabasesMember_C0AF3F27A8647F2EC0FDBF4CB6A90708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_65CE2977C624BB92BA3CBF4CB6DBC063" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_65CE2977C624BB92BA3CBF4CB6DBC063" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:to="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_04D738361E34DABD6BCFBF4CB523A572" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_04D738361E34DABD6BCFBF4CB523A572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_772D71061F4ACC9FB6B9BF4CB54BDA84" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_772D71061F4ACC9FB6B9BF4CB54BDA84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A29495BFBEDC349F5D8EBF4CB598968A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A29495BFBEDC349F5D8EBF4CB598968A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:to="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredAxis" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PurchasePriceMember" xlink:label="loc_ccrn_PurchasePriceMember_E1BE8023D26DA2A893AD34B4208C4888" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:to="loc_ccrn_PurchasePriceMember_E1BE8023D26DA2A893AD34B4208C4888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_4064A3E8F09CBA16C8A134B4208DF658" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:to="loc_ccrn_TermLoanMember_4064A3E8F09CBA16C8A134B4208DF658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_B2665F2D47A9A357323734B4208E663C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:to="loc_ccrn_CreditAgreementMember_B2665F2D47A9A357323734B4208E663C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncrementalTermLoanMember" xlink:label="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:to="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredConsiderationTransferredMember" xlink:label="loc_ccrn_DeferredConsiderationTransferredMember_0A8E0F558D5805D09F6E34B4208F3A5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:to="loc_ccrn_DeferredConsiderationTransferredMember_0A8E0F558D5805D09F6E34B4208F3A5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_4200AFFA026EEEF54A5934B4208F1E08" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:to="loc_ccrn_AdvantageRNLLCMember_4200AFFA026EEEF54A5934B4208F1E08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C531D85FC5D97BD118A934B42090C07B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C531D85FC5D97BD118A934B42090C07B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_0D688BC9572F4FF682CA34B42090029B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_0D688BC9572F4FF682CA34B42090029B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F8260FDF0D54FA58AA9034B42091145C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F8260FDF0D54FA58AA9034B42091145C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E93C9DA17CF874852CE034B420915D2D" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E93C9DA17CF874852CE034B420915D2D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_BF31697AF8017C5ABD4734B420925D1E" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_BF31697AF8017C5ABD4734B420925D1E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_B07160D0643776ED731534B42092F65A" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_B07160D0643776ED731534B42092F65A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmericanPersonnelInc.Member" xlink:label="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:to="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_2BE8A33F6B8DECB5181BBFBE3B92705F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:to="loc_ccrn_AdvantageRNLLCMember_2BE8A33F6B8DECB5181BBFBE3B92705F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_BBF930876FBAD5136EA2BFBE3B945F76" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_Goodwill_BBF930876FBAD5136EA2BFBE3B945F76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredAxis" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PurchasePriceMember" xlink:label="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:to="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetWorkingCapitalAdjustmentsMember" xlink:label="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:to="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_24165490F0125A1611C2A9ED5E7B60CE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:to="loc_ccrn_AdvantageRNLLCMember_24165490F0125A1611C2A9ED5E7B60CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A42D703C77AC19481CCEA9ED5E7B4703" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A42D703C77AC19481CCEA9ED5E7B4703" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AcquisitionRelatedContingentConsiderationMember" xlink:label="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredConsiderationTransferredMember" xlink:label="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_USResourcesHealthcareLLCMember" xlink:label="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_05DF8CB5526DA6169EACBFBE3B7C54F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_ProfitLoss_05DF8CB5526DA6169EACBFBE3B7C54F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:to="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:to="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:to="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1" xlink:label="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:to="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:to="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_B3CD59884969A3E0B28C34B41FC7D357" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:to="loc_ccrn_CovenantTerm3Member_B3CD59884969A3E0B28C34B41FC7D357" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:to="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:to="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6234F93F8C0CEE0362F634B41FC89B60" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6234F93F8C0CEE0362F634B41FC89B60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_4954951A1E3F32D5AC0334B41FC9FA28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_4954951A1E3F32D5AC0334B41FC9FA28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubordinatedDebtMember" xlink:label="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_A9C4BCBF3244FE513A3634B41FC93C06" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_ccrn_TermLoanMember_A9C4BCBF3244FE513A3634B41FC93C06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_ED9A4A6632F4EBEB34ED34B41FCA8D17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_CreditAgreementMember_ED9A4A6632F4EBEB34ED34B41FCA8D17" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SecondLienTermLoanMember" xlink:label="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncrementalTermLoanMember" xlink:label="loc_ccrn_IncrementalTermLoanMember_5BEE32B3B3CC559A836734B41FCBF7BD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_IncrementalTermLoanMember_5BEE32B3B3CC559A836734B41FCBF7BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:to="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:to="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_16EF7FA93A8E0675453734C7B4A92552" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_16EF7FA93A8E0675453734C7B4A92552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_B01861F3CE276AE5398634B41FCBCF01" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_BaseRateMember_B01861F3CE276AE5398634B41FCBCF01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstEightInstallmentsMember" xlink:label="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:to="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RemainingInstallmentsMember" xlink:label="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:to="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AA71F9B3D75590C57BCD34B41FCDE9A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AA71F9B3D75590C57BCD34B41FCDE9A7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_1874CEEADEC36421A9E834B41FCD622B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_1874CEEADEC36421A9E834B41FCD622B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_51F14C9C8FB597FCB57634B41FCDABE4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_51F14C9C8FB597FCB57634B41FCDABE4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPrepaymentPenalty" xlink:label="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_D0B822A851408225CD9B34B41FCD1C7D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_D0B822A851408225CD9B34B41FCD1C7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_354AA50453EC5C3E769734B41FCEAA5D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_354AA50453EC5C3E769734B41FCEAA5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_C277D1BAFAE7DE2C411334B41FCEF6B4" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_C277D1BAFAE7DE2C411334B41FCEF6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_FD2839CAAD55C64FF63734B41FCE2167" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_FD2839CAAD55C64FF63734B41FCE2167" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal" xlink:label="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:to="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:to="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:to="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:to="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:to="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:to="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:to="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:to="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingSeptember302019Member" xlink:label="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingDecember312019Member" xlink:label="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:to="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:to="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_54773BD17617FB033DE135089A23465C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:to="loc_srt_MaximumMember_54773BD17617FB033DE135089A23465C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_62018AE7BE1954A4CA3B35089A23E870" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:to="loc_srt_MinimumMember_62018AE7BE1954A4CA3B35089A23E870" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6C99C3B202F3A0EB255535089A2398AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6C99C3B202F3A0EB255535089A2398AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentForDebtPrepayment" xlink:label="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedTotalLeverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851_default" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:to="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:to="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3C3F49562104C4C5914334B41FD7D49C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:to="loc_srt_MinimumMember_3C3F49562104C4C5914334B41FD7D49C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_3EAC73BA64893CC132C734B41FD7815B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:to="loc_srt_MaximumMember_3EAC73BA64893CC132C734B41FD7815B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:to="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:to="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:to="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_703A92BB932C706C803534B41FD9591D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_703A92BB932C706C803534B41FD9591D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:to="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_92AB4821727C5EE46718E5D9F8EB9678" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_92AB4821727C5EE46718E5D9F8EB9678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:to="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_B67EE41204140476741AE5D9F8EB5E2C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:to="loc_ccrn_TermLoanMember_B67EE41204140476741AE5D9F8EB5E2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:to="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:to="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:to="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_AB79BB405BA23E20343CA9ED5B9EC5D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:to="loc_us-gaap_CommonStockMember_AB79BB405BA23E20343CA9ED5B9EC5D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:to="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_875CDE585FCCB5C74267A9ED5BA11824" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_875CDE585FCCB5C74267A9ED5BA11824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_4BDD0A1D9746A12E804D30FF0D5658C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:to="loc_ccrn_TermLoanMember_4BDD0A1D9746A12E804D30FF0D5658C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_B2FF82EFE5A61834B07F30FF0D577790" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:to="loc_us-gaap_InterestRateSwapMember_B2FF82EFE5A61834B07F30FF0D577790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_861DC3F984AB14CDFD7631032A4001B6" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_DerivativeLiabilities_861DC3F984AB14CDFD7631032A4001B6" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" xlink:label="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:to="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:to="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:to="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_E3537D1487D0D6F2C18DBF9D19A5BD45" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:to="loc_ccrn_TermLoanMember_E3537D1487D0D6F2C18DBF9D19A5BD45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4B266DF977D6C5D45A9DBF9D19A6B164" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4B266DF977D6C5D45A9DBF9D19A6B164" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:to="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:to="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:to="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8F9232E9FF5E92707B61A9ED5DAC8374" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:to="loc_srt_MinimumMember_8F9232E9FF5E92707B61A9ED5DAC8374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_A9A3C0EA77DB0787DC70A9ED5DACC656" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:to="loc_srt_MaximumMember_A9A3C0EA77DB0787DC70A9ED5DACC656" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:to="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:to="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:to="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:to="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_70A8990AFBC24FFBE2B830ACE37C6ED3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:to="loc_us-gaap_OperatingSegmentsMember_70A8990AFBC24FFBE2B830ACE37C6ED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:to="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:to="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_B16BB003BFDEECBC1F5130ACE37C7475" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_B16BB003BFDEECBC1F5130ACE37C7475" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_2AFE11D5387B9753C67230ACE37DE0D1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_PhysicianStaffingMember_2AFE11D5387B9753C67230ACE37DE0D1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_28025D8F37EA79A9F8C630ACE37DE81B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_28025D8F37EA79A9F8C630ACE37DE81B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:to="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" xlink:label="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureTable" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:to="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:to="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:to="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_15B60C39029200048CBCFE5447879122" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:to="loc_srt_MinimumMember_15B60C39029200048CBCFE5447879122" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_E4E98EC444C5ADA14CC0FE544788B140" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:to="loc_srt_MaximumMember_E4E98EC444C5ADA14CC0FE544788B140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncomeandMarketApproachValuationTechniqueMember" xlink:label="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_C73411E770062F541D50FE56CEC82C79" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:to="loc_us-gaap_TradeNamesMember_C73411E770062F541D50FE56CEC82C79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_94196A0584FB39F80B74FE544789959B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:to="loc_us-gaap_CustomerRelationshipsMember_94196A0584FB39F80B74FE544789959B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:to="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:to="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_43125113B0C054C899A1FE54478A1018" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_PhysicianStaffingMember_43125113B0C054C899A1FE54478A1018" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SearchReportingUnitMember" xlink:label="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_EF04C13D872553946EF8FE54478B7D30" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_EF04C13D872553946EF8FE54478B7D30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_CEAE649E8D53E682A012FE5793166658" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_CEAE649E8D53E682A012FE5793166658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_E914D3F6D3488B21ABDEFE54478C6602" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_AssetImpairmentCharges_E914D3F6D3488B21ABDEFE54478C6602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillImpairmentTestMeasurementInput" xlink:label="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsTerminalValueGrowthRate" xlink:label="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsForecastPeriod" xlink:label="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA" xlink:label="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsWeightingApplied" xlink:label="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetOperatingLossesMember" xlink:label="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:to="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherNetDeferredTaxAssetsMember" xlink:label="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:to="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RepatriationOfForeignEarningsAmount" xlink:label="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:to="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:to="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_B58F2A3E7281FA83FD9DA9ED5CEB3CA2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:to="loc_srt_MinimumMember_B58F2A3E7281FA83FD9DA9ED5CEB3CA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_353534A6C71ED9A3C709A9ED5CEBECA0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:to="loc_srt_MaximumMember_353534A6C71ED9A3C709A9ED5CEBECA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_210B74BC859C59486F7B360098A441AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:to="loc_us-gaap_ConvertibleDebtMember_210B74BC859C59486F7B360098A441AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_EC17EAAC6223A53CE263360098A4E076" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_AssetImpairmentCharges_EC17EAAC6223A53CE263360098A4E076" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2E92845EB1F5CC488930360098A4A2BC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2E92845EB1F5CC488930360098A4A2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_C2F8AEA9ACE22670EDCC360098A56E77" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_C2F8AEA9ACE22670EDCC360098A56E77" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:to="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:to="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:to="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:to="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:to="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:to="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_FCF79F8736B03786C179BF32C8666D5B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_FCF79F8736B03786C179BF32C8666D5B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_E8858B748FB99DF82E63BF32C8671281" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_E8858B748FB99DF82E63BF32C8671281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:to="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:to="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TemporaryStaffingServicesMember" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_72729A42632BB883CCE8BF32C8683002" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_72729A42632BB883CCE8BF32C8683002" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherServicesMember" xlink:label="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:to="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:to="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:to="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:to="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:to="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:to="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ADBF0BB5247C9EC44F7B305E99327192" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ADBF0BB5247C9EC44F7B305E99327192" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_C4C059BE424D6CE569CF305E9932CF7B" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_C4C059BE424D6CE569CF305E9932CF7B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_85255984B397EBF27850305E99320226" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_85255984B397EBF27850305E99320226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_A923DF94A74DEA37D2A6305E9932B32C" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_RestructuringCharges_A923DF94A74DEA37D2A6305E9932B32C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_A29DD3EFF90C4D3121AA305E9932A4AE" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_AssetImpairmentCharges_A29DD3EFF90C4D3121AA305E9932A4AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_642E75689027AF5446E7305E99337BD3" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_OperatingIncomeLoss_642E75689027AF5446E7305E99337BD3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:to="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:to="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:to="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockOptionAndEquityParticipationPlan1999Member" xlink:label="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:to="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_E20414E89A354B22D86C34B41F2D0F74" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_RestrictedStockMember_E20414E89A354B22D86C34B41F2D0F74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_8034EE6F74CE82359A5234B41F2D5E4B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_PerformanceSharesMember_8034EE6F74CE82359A5234B41F2D5E4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TenPercentOrMoreStockholdersMember" xlink:label="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:to="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:to="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:to="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_CBA83B128B70F7ED1C5F34B41F2F1308" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:to="loc_srt_MinimumMember_CBA83B128B70F7ED1C5F34B41F2F1308" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F31FDC7F45801FB0124734B41F2FB7D0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:to="loc_srt_MaximumMember_F31FDC7F45801FB0124734B41F2FB7D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:to="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:to="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:to="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncentiveCompensationPlan2007Member" xlink:label="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:to="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:to="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:to="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A5914CDB8C91C9DB8D93BFBE36A82E3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:to="loc_us-gaap_CommonStockMember_A5914CDB8C91C9DB8D93BFBE36A82E3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockRepurchasedDuringPeriodPricePerShare" xlink:label="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeOneMember" xlink:label="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeTwoMember" xlink:label="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeThreeMember" xlink:label="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFourMember" xlink:label="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFiveMember" xlink:label="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:to="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:to="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:to="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesLineItems" xlink:label="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesTable" xlink:label="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:to="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:to="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_286685576908DF88327934B420B582E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:to="loc_srt_MinimumMember_286685576908DF88327934B420B582E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5A8188549C12DD35ED3434B420B62718" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:to="loc_srt_MaximumMember_5A8188549C12DD35ED3434B420B62718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember" xlink:label="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:to="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ClaimsBasedLiabilityInsuranceMember" xlink:label="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:to="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:to="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:to="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MDAHoldingsIncMember" xlink:label="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:to="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContractualTerm" xlink:label="loc_ccrn_ContractualTerm_06895CA4689DAF82AA3D34B420B915C8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_ContractualTerm_06895CA4689DAF82AA3D34B420B915C8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LeaseExpirationPeriod" xlink:label="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan" xlink:label="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim" xlink:label="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds" xlink:label="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_2F99D124D526BF3B3F6F34BC10C2FC43" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_2F99D124D526BF3B3F6F34BC10C2FC43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:to="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:to="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CostOptimizationProjectMember" xlink:label="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:to="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExitCostsMember" xlink:label="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RestructuringChargesWriteOffRelatedToAbandonment" xlink:label="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:to="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:to="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:to="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:to="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:to="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:to="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TemporaryStaffingServicesMember" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:to="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContractualTerm" xlink:label="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>ccrn-20181231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="lab_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6_label_en-US" xlink:label="lab_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:to="lab_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508_terseLabel_en-US" xlink:label="lab_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508_label_en-US" xlink:label="lab_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:to="lab_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991_label_en-US" xlink:label="lab_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:to="lab_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A_label_en-US" xlink:label="lab_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:to="lab_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:to="lab_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:to="lab_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="arc" />
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430_terseLabel_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary Staffing Services</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430_label_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430_documentation_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TemporaryStaffingServicesMember" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:to="lab_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:to="lab_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:to="lab_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:type="arc" />
    <link:label id="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC_terseLabel_en-US" xlink:label="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract terms</link:label>
    <link:label id="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC_label_en-US" xlink:label="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Term</link:label>
    <link:label id="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC_documentation_en-US" xlink:label="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of time the payments are typically required to be made from the date services are provided.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContractualTerm" xlink:label="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:to="lab_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled contracts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:to="lab_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowances for Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:to="lab_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowance for Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charged to Operations</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Write-Offs, net of recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Changes</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at End of Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:to="lab_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:type="arc" />
    <link:label id="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC_terseLabel_en-US" xlink:label="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Rent and Deposits</link:label>
    <link:label id="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC_label_en-US" xlink:label="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Rent And Deposits Policy [Text Block]</link:label>
    <link:label id="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC_documentation_en-US" xlink:label="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for prepaid rent and deposits on field employees' apartments related to short-term agreements.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PrepaidRentAndDepositsPolicyTextBlock" xlink:label="loc_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:to="lab_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:to="lab_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Trade Names, and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Discount and Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:to="lab_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:type="arc" />
    <link:label id="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079_terseLabel_en-US" xlink:label="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and Other State Non-income Tax Liabilities</link:label>
    <link:label id="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079_label_en-US" xlink:label="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales And Other State Non Income Tax Liabilities Policy [Text Block]</link:label>
    <link:label id="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079_documentation_en-US" xlink:label="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for sales and other state non-income tax liabilities.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock" xlink:label="loc_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:to="lab_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Claims</link:label>
    <link:label id="lab_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64_label_en-US" xlink:label="lab_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Reserve Estimate, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityReserveEstimatePolicy" xlink:label="loc_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:to="lab_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Rent</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:to="lab_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:to="lab_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:to="lab_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="arc" />
    <link:label id="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041_terseLabel_en-US" xlink:label="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost Optimization Project</link:label>
    <link:label id="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041_label_en-US" xlink:label="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Optimization Project [Member]</link:label>
    <link:label id="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041_documentation_en-US" xlink:label="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Optimization Project [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CostOptimizationProjectMember" xlink:label="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:to="lab_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">On-Going Benefit Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:to="lab_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="arc" />
    <link:label id="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691_terseLabel_en-US" xlink:label="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exit Costs</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691_label_en-US" xlink:label="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691_documentation_en-US" xlink:label="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExitCostsMember" xlink:label="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:to="lab_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:to="lab_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="lab_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:to="lab_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735_netLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Charged to restructuring costs (a)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:to="lab_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:to="lab_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:to="lab_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:type="arc" />
    <link:label id="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4_terseLabel_en-US" xlink:label="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct write offs related to abandoned locations</link:label>
    <link:label id="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4_label_en-US" xlink:label="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Write Off Related To Abandonment</link:label>
    <link:label id="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4_documentation_en-US" xlink:label="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Write Off Related To Abandonment</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RestructuringChargesWriteOffRelatedToAbandonment" xlink:label="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:to="lab_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Consolidated net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:to="lab_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:type="arc" />
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A_verboseLabel_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for allowances</link:label>
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A_label_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts and Other Allowances</link:label>
    <link:label id="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A_documentation_en-US" xlink:label="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts and Other Allowances</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:to="lab_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:to="lab_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:to="lab_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other non-cash costs</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Previous Acquisition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:to="lab_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Term Loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Principal payments on Term Loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Convertible Note cash payment</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Extinguishment fees</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:to="lab_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:to="lab_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated net (loss) income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:to="lab_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, before income tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized foreign currency translation (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss on interest rate contracts</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reclassification adjustment to interest expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, before income tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD_terseLabel_en-US" xlink:label="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax1 [Abstract]</link:label>
    <link:label id="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD_label_en-US" xlink:label="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax1 [Abstract]</link:label>
    <link:label id="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD_documentation_en-US" xlink:label="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax1 [Abstract]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherComprehensiveIncomeLossTax1Abstract" xlink:label="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:to="lab_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit related to foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit related to unrealized loss on interest rate contracts</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense related to reclassification adjustment to interest expense</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Taxes on other comprehensive (loss) income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: Net income attributable to noncontrolling interest in subsidiary</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (loss) income attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restricted Stock Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:type="arc" />
    <link:label id="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E_terseLabel_en-US" xlink:label="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options and Stock Appreciation Rights Granted and Exercised</link:label>
    <link:label id="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E_label_en-US" xlink:label="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intrinsic Value Of Options Exercised And Weighted Average Grant Date Fair Value Of Stock Options Granted Table [Text Block]</link:label>
    <link:label id="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E_documentation_en-US" xlink:label="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the total intrinsic value of options exercised and the weighted average grant date fair value of options granted during the period.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock" xlink:label="loc_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:to="lab_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Share Option Plans Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax at U.S. statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:to="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-deductible items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowances</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:type="arc" />
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1_negatedTerseLabel_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1_label_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision, Amount</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1_documentation_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision, Amount</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount" xlink:label="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:to="lab_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal rate change</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="arc" />
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A_terseLabel_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Purchase Liabilities</link:label>
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A_label_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:label id="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A_documentation_en-US" xlink:label="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Consideration Liability [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:to="lab_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B_label_en-US" xlink:label="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments, Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:to="lab_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments/Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE_terseLabel_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accretion expense</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE_label_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</link:label>
    <link:label id="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE_documentation_en-US" xlink:label="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:to="lab_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation gain (loss) for the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:to="lab_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Information on Operating Segments and Reconciliation to Income From Operations</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="lab_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:to="lab_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="arc" />
    <link:label id="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7_terseLabel_en-US" xlink:label="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Operating Losses</link:label>
    <link:label id="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7_label_en-US" xlink:label="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Losses [Member]</link:label>
    <link:label id="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7_documentation_en-US" xlink:label="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Operating Losses [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetOperatingLossesMember" xlink:label="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:to="lab_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270_terseLabel_en-US" xlink:label="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Net Deferred Tax Assets</link:label>
    <link:label id="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270_label_en-US" xlink:label="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Net Deferred Tax Assets [Member]</link:label>
    <link:label id="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270_documentation_en-US" xlink:label="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Net Deferred Tax Assets [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherNetDeferredTaxAssetsMember" xlink:label="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:to="lab_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="arc" />
    <link:label id="lab_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:to="lab_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">India</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:to="lab_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69_netLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Provision income tax expense related to deferred tax asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="arc" />
    <link:label id="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412_terseLabel_en-US" xlink:label="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense related to deferred tax asset</link:label>
    <link:label id="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412_label_en-US" xlink:label="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense</link:label>
    <link:label id="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412_documentation_en-US" xlink:label="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:to="lab_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42_negatedLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reduction in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1_netLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal, state and foreign net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:to="lab_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred liabilities on undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="arc" />
    <link:label id="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891_terseLabel_en-US" xlink:label="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repatriated amount of foreign earnings</link:label>
    <link:label id="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891_label_en-US" xlink:label="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repatriation Of Foreign Earnings Amount</link:label>
    <link:label id="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891_documentation_en-US" xlink:label="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repatriated amount of foreign earnings.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RepatriationOfForeignEarningsAmount" xlink:label="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:to="lab_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, which would affect the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="arc" />
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77_terseLabel_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross increases in current year unrecognized tax</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77_label_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits Period Gross Increases</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77_documentation_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The gross amount of increases in unrecognized tax benefits related to federal and state tax issues.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:to="lab_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in recognized interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefit accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2017 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2018</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2018 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2018 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2019</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2019 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2019 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="arc" />
    <link:label id="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E_terseLabel_en-US" xlink:label="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-Related Contingent Consideration</link:label>
    <link:label id="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E_label_en-US" xlink:label="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition-Related Contingent Consideration [Member]</link:label>
    <link:label id="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E_documentation_en-US" xlink:label="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition-Related Contingent Consideration [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AcquisitionRelatedContingentConsiderationMember" xlink:label="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:to="lab_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="arc" />
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94_terseLabel_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities</link:label>
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94_label_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities [Member]</link:label>
    <link:label id="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94_documentation_en-US" xlink:label="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assumed Additional Contingent Purchase Price Liabilities [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:to="lab_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="arc" />
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958_terseLabel_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958_label_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member]</link:label>
    <link:label id="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958_documentation_en-US" xlink:label="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Earnout, Attainment of Specific Performance Criteria in 2016 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:to="lab_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="arc" />
    <link:label id="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7_terseLabel_en-US" xlink:label="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Consideration Transferred</link:label>
    <link:label id="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7_label_en-US" xlink:label="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Consideration Transferred [Member]</link:label>
    <link:label id="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7_documentation_en-US" xlink:label="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Consideration Transferred [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredConsiderationTransferredMember" xlink:label="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:to="lab_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="arc" />
    <link:label id="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F_terseLabel_en-US" xlink:label="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Resources Healthcare, LLC</link:label>
    <link:label id="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F_label_en-US" xlink:label="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Resources Healthcare, LLC [Member]</link:label>
    <link:label id="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F_documentation_en-US" xlink:label="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">US Resources Healthcare, LLC [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_USResourcesHealthcareLLCMember" xlink:label="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:to="lab_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="arc" />
    <link:label id="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C_terseLabel_en-US" xlink:label="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mediscan</link:label>
    <link:label id="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C_label_en-US" xlink:label="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mediscan [Member]</link:label>
    <link:label id="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C_documentation_en-US" xlink:label="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mediscan [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:to="lab_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="arc" />
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E_terseLabel_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Staffing Network</link:label>
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E_label_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Staffing Network [Member]</link:label>
    <link:label id="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E_documentation_en-US" xlink:label="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Staffing Network [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:to="lab_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, range of outcomes, high</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Release of remaining contingent liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash purchase price paid at closing</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955_verboseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration plus working capital estimate</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Consideration Negotiated</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Cash Consideration Negotiated</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net working capital adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Release of escrow to seller</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE_label_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Release</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Release</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:to="lab_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of deferred consideration</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Deferred, Period</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Deferred, Period</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:to="lab_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly Financial Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:type="arc" />
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B_terseLabel_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B_label_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B_documentation_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:to="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Databases</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E_label_en-US" xlink:label="lab_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:to="lab_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:to="lab_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:to="lab_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:to="lab_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="arc" />
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25_label_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Trade Names</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets not subject to amortization, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of restructuring costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:to="lab_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="arc" />
    <link:label id="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9_terseLabel_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9_label_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9_documentation_en-US" xlink:label="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:to="lab_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:to="lab_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7_label_en-US" xlink:label="lab_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:to="lab_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="lab_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:to="lab_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Total Comprehensive Loss, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Accumulated Deficit) Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:to="lab_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest in Subsidiary</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:to="lab_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:to="lab_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:to="lab_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting of restricted stock and performance stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting of restricted stock and performance stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued for Convertible Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued for Convertible Notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative-effect adjustment - share-based compensation</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect on Retained Earnings, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1" xlink:label="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:to="lab_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in hedging transaction, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Distribution to noncontrolling shareholder</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:to="lab_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:to="lab_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at January 1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reductions based on settlements of tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:type="arc" />
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F_negatedLabel_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">2017 Tax Act federal tax rate change</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F_label_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting From Federal Tax Rate Change</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F_documentation_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting From Federal Tax Rate Change</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:to="lab_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:type="arc" />
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4_terseLabel_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4_label_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increases (Decreases) Resulting From Other Deductions</link:label>
    <link:label id="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4_documentation_en-US" xlink:label="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The gross amount of increases ( decreases) in unrecognized tax benefits resulting from other items.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:to="lab_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at December 31</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:type="arc" />
    <link:label id="lab_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9_label_en-US" xlink:label="lab_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Documentand Entity Information [Abstract]</link:label>
    <link:label id="lab_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9_documentation_en-US" xlink:label="lab_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document Documentand Entity Information [Abstract]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DocumentDocumentandEntityInformationAbstract" xlink:label="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="lab_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0_terseLabel_en-US" xlink:label="lab_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0_label_en-US" xlink:label="lab_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:to="lab_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A_label_en-US" xlink:label="lab_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:to="lab_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:to="lab_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:to="lab_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:to="lab_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C_label_en-US" xlink:label="lab_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:to="lab_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3_label_en-US" xlink:label="lab_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:to="lab_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:to="lab_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:to="lab_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:type="arc" />
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16_label_en-US" xlink:label="lab_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:to="lab_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:to="lab_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:to="lab_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:to="lab_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:type="arc" />
    <link:label id="lab_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:to="lab_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112_label_en-US" xlink:label="lab_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:to="lab_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:type="arc" />
    <link:label id="lab_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628_label_en-US" xlink:label="lab_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:to="lab_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="lab_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from services</link:label>
    <link:label id="lab_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE_label_en-US" xlink:label="lab_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:to="lab_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="lab_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:type="arc" />
    <link:label id="lab_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5_terseLabel_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct operating expenses</link:label>
    <link:label id="lab_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5_label_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Direct Operating Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectOperatingCosts" xlink:label="loc_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:to="lab_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related contingent consideration</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B_label_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expense</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Expense</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:to="lab_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Acquisition and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:to="lab_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:to="lab_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">(Loss) income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:to="lab_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expenses (income):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A_label_en-US" xlink:label="lab_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:to="lab_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain on derivative liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Consolidated net (loss) income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:to="lab_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: Net income attributable to noncontrolling interest in subsidiary</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:to="lab_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Basic (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:to="lab_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income per share attributable to common shareholders - Diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:to="lab_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding&#8212;basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding&#8212;diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:to="lab_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="lab_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:to="lab_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="arc" />
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223_terseLabel_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">8% Convertible Notes</link:label>
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223_label_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">8% Convertible Notes [Member]</link:label>
    <link:label id="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223_documentation_en-US" xlink:label="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">8% Convertible Notes [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:to="lab_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability</link:label>
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02_label_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02_documentation_en-US" xlink:label="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Note Derivative Liability [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:to="lab_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:to="lab_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="lab_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="arc" />
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83_totalLabel_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Payment of debt and extinguishment fees</link:label>
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83_label_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</link:label>
    <link:label id="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83_documentation_en-US" xlink:label="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:to="lab_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6_verboseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extinguishment fees</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Original debt amount in debt conversion</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash write off related to settlement of convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt conversion price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, number of equity instruments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, convertible, threshold period following issuance date (in years)</link:label>
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34_label_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible,Threshold Period Following Issuance Date</link:label>
    <link:label id="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible,Threshold Period Following Issuance Date</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:to="lab_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible, threshold consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:to="lab_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="arc" />
    <link:label id="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3_terseLabel_en-US" xlink:label="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based awards</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3_label_en-US" xlink:label="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes and Share-based Payment Awards [Member]</link:label>
    <link:label id="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3_documentation_en-US" xlink:label="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes and Share-based Payment Awards [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" xlink:label="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:to="lab_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:to="lab_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:to="lab_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Stock Awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:to="lab_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, ending balance (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, beginning balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested restricted stock awards, ending balance (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:type="arc" />
    <link:label id="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60_terseLabel_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60_label_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60_documentation_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesTable" xlink:label="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="lab_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:to="lab_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Type and Tier Identifier [Axis]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Type and Tier Identifier [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:to="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257_terseLabel_en-US" xlink:label="lab_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type and Tier Identifier [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257_label_en-US" xlink:label="lab_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type and Tier Identifier [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:to="lab_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="arc" />
    <link:label id="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820_terseLabel_en-US" xlink:label="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Occurrence-Based Professional Liability Insurance</link:label>
    <link:label id="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820_label_en-US" xlink:label="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Occurrence Based Professional Liability Insurance [Member]</link:label>
    <link:label id="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820_documentation_en-US" xlink:label="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Occurrence-Based Professional Liability Insurance [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember" xlink:label="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:to="lab_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="arc" />
    <link:label id="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C_terseLabel_en-US" xlink:label="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Claims-Based Liability Insurance</link:label>
    <link:label id="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C_label_en-US" xlink:label="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Claims-Based Liability Insurance [Member]</link:label>
    <link:label id="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C_documentation_en-US" xlink:label="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Claims-Based Liability Insurance [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ClaimsBasedLiabilityInsuranceMember" xlink:label="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:to="lab_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="arc" />
    <link:label id="lab_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5_label_en-US" xlink:label="lab_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:to="lab_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="arc" />
    <link:label id="lab_dei_EntityDomain_187A12FEA649C08C059734B420B8083E_terseLabel_en-US" xlink:label="lab_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_187A12FEA649C08C059734B420B8083E_label_en-US" xlink:label="lab_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:to="lab_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="arc" />
    <link:label id="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6_terseLabel_en-US" xlink:label="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MDA Holdings Inc</link:label>
    <link:label id="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6_label_en-US" xlink:label="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">M D A Holdings Inc [Member]</link:label>
    <link:label id="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6_documentation_en-US" xlink:label="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">MDA Holdings Inc [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MDAHoldingsIncMember" xlink:label="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:to="lab_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="arc" />
    <link:label id="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5_terseLabel_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5_label_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5_documentation_en-US" xlink:label="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesLineItems" xlink:label="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="lab_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:to="lab_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="arc" />
    <link:label id="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A_terseLabel_en-US" xlink:label="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short term leases period</link:label>
    <link:label id="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A_label_en-US" xlink:label="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Expiration Period</link:label>
    <link:label id="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A_documentation_en-US" xlink:label="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Apartments lease period for field employees under short-term agreements.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LeaseExpirationPeriod" xlink:label="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:to="lab_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life of assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets- useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="arc" />
    <link:label id="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684_terseLabel_en-US" xlink:label="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding standby letters of credit as collateral</link:label>
    <link:label id="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684_label_en-US" xlink:label="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Letters Of Credit, Collateral to Guarantee Payments Under Self Insured Plan</link:label>
    <link:label id="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684_documentation_en-US" xlink:label="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of standby letters of credit issued as collateral to guarantee payments of workers compensation claims.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan" xlink:label="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:to="lab_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="arc" />
    <link:label id="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6_terseLabel_en-US" xlink:label="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Self insured retention per claim</link:label>
    <link:label id="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6_label_en-US" xlink:label="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Malpractice Insurance, Policy, Self Insured Retention Per Claim</link:label>
    <link:label id="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6_documentation_en-US" xlink:label="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Malpractice Insurance, Policy, Self Insured Retention Per Claim</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim" xlink:label="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:to="lab_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Coverage for professional liability claims</link:label>
    <link:label id="lab_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2_label_en-US" xlink:label="lab_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Malpractice Insurance, Maximum Coverage Per Incident</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:to="lab_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="arc" />
    <link:label id="lab_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of credit for malpractice claims</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Malpractice Loss Contingency, Letters of Credit and Surety Bonds</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds" xlink:label="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:to="lab_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:to="lab_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cumulative impact of currency fluctuations</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="arc" />
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net change in derivative instruments</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit) related to items of other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:to="lab_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:to="lab_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="arc" />
    <link:label id="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276_terseLabel_en-US" xlink:label="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan, net</link:label>
    <link:label id="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276_label_en-US" xlink:label="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276_documentation_en-US" xlink:label="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:to="lab_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:to="lab_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="arc" />
    <link:label id="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36_terseLabel_en-US" xlink:label="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended And Restated Credit Agreement</link:label>
    <link:label id="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36_label_en-US" xlink:label="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended And Restated Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36_documentation_en-US" xlink:label="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended And Restated Credit Agreement [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:to="lab_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="arc" />
    <link:label id="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D_terseLabel_en-US" xlink:label="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Amendment, Amended And Restated Credit Agreement</link:label>
    <link:label id="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D_label_en-US" xlink:label="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Amendment, Amended And Restated Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D_documentation_en-US" xlink:label="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Amendment, Amended And Restated Credit Agreement [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:to="lab_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:to="lab_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:to="lab_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="arc" />
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA_terseLabel_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2018 through June 30, 2019</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA_label_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2018 through June 30, 2019 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA_documentation_en-US" xlink:label="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Quarters Ending September 30, 2018 through June 30, 2019  [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:to="lab_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="arc" />
    <link:label id="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293_terseLabel_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending September 30, 2019</link:label>
    <link:label id="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293_label_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending September 30, 2019 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293_documentation_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending September 30, 2019 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingSeptember302019Member" xlink:label="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:to="lab_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="arc" />
    <link:label id="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924_terseLabel_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending December 31, 2019</link:label>
    <link:label id="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924_label_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending December 31, 2019 [Member]</link:label>
    <link:label id="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924_documentation_en-US" xlink:label="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Quarter Ending December 31, 2019 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingDecember312019Member" xlink:label="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:to="lab_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="arc" />
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4_terseLabel_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter</link:label>
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4_label_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter [Member]</link:label>
    <link:label id="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4_documentation_en-US" xlink:label="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Each Fiscal Quarter Ending Thereafter [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:to="lab_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="arc" />
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sub facility for swingline loans</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Sub Facility For Swingline Loans</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Sub Facility For Swingline Loans</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:to="lab_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="arc" />
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit, subfacility for standby letters of credit</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility Sub Limit For Letters Of Credit</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of credit, subfacility for standby letters of credit.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:to="lab_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="arc" />
    <link:label id="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional capacity</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Additional Capacity</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Additional Capacity</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:to="lab_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="arc" />
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE_terseLabel_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for debt prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE_label_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE_documentation_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentForDebtPrepayment" xlink:label="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:to="lab_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate increase (decrease) (percent)</link:label>
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2_label_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</link:label>
    <link:label id="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:to="lab_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quarterly commitment fee on the average daily unused portion (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="arc" />
    <link:label id="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF_terseLabel_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financial covenants</link:label>
    <link:label id="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF_label_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Financial Covenants</link:label>
    <link:label id="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF_documentation_en-US" xlink:label="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Financial Covenants</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:to="lab_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated fixed charge coverage ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1_label_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Consolidated Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Consolidated Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:to="lab_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated total leverage ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF_label_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Consolidated Total Leverage Ratio</link:label>
    <link:label id="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">calculated as total Indebtedness, as defined divided by Adjusted EBITDA as defined</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedTotalLeverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:to="lab_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="arc" />
    <link:label id="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91_terseLabel_en-US" xlink:label="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">American Personnel, Inc.</link:label>
    <link:label id="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91_label_en-US" xlink:label="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">American Personnel, Inc. [Member]</link:label>
    <link:label id="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91_documentation_en-US" xlink:label="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">American Personnel, Inc. [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmericanPersonnelInc.Member" xlink:label="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:to="lab_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average useful life of assets acquired</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23_label_en-US" xlink:label="lab_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:to="lab_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Acquisition related costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="arc" />
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775_terseLabel_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery for workers&#8217; compensation</link:label>
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775_label_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Recovery For Workers Compensation Current</link:label>
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775_documentation_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The current portion of the amount receivable from insurance for recovery for workers compensation.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationCurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:to="lab_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:type="arc" />
    <link:label id="lab_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery for professional liability</link:label>
    <link:label id="lab_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E_label_en-US" xlink:label="lab_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Receivable for Malpractice, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeCurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:to="lab_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B_totalLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Settlements Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:type="arc" />
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472_terseLabel_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery for workers&#8217; compensation claims</link:label>
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472_label_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Recovery For Workers Compensation Noncurrent</link:label>
    <link:label id="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472_documentation_en-US" xlink:label="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The long term portion of the amount receivable from insurance for recovery for workers compensation.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:to="lab_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:type="arc" />
    <link:label id="lab_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery for professional liability claims</link:label>
    <link:label id="lab_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2_label_en-US" xlink:label="lab_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Receivable for Malpractice, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeNoncurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:to="lab_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current security deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation assets</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:to="lab_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salaries and payroll taxes</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:to="lab_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bonuses</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:to="lab_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for workers&#8217; compensation claims</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:type="arc" />
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for professional liability claims</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117_terseLabel_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for healthcare benefits</link:label>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117_label_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:to="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for vacation</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:to="lab_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:type="arc" />
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for workers&#8217; compensation claims</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:to="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:type="arc" />
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrual for professional liability claims</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Long-term accrued claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:to="lab_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6_terseLabel_en-US" xlink:label="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6_label_en-US" xlink:label="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6_documentation_en-US" xlink:label="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Liabilities, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherLiabilitiesMiscellaneousNoncurrent" xlink:label="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:to="lab_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:to="lab_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:to="lab_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:to="lab_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="lab_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="arc" />
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568_terseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nurse and Allied Staffing Segment</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568_label_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nurse And Allied Staffing [Member]</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568_documentation_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nurse and allied staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:to="lab_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="arc" />
    <link:label id="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A_terseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Physician Staffing Segment</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A_label_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Physician Staffing [Member]</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A_documentation_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Physician staffing [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:to="lab_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF_terseLabel_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Human Capital Management Services Segment</link:label>
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF_label_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Human Capital Management Services [Member]</link:label>
    <link:label id="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF_documentation_en-US" xlink:label="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other human capital management services [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:to="lab_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:to="lab_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="arc" />
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577_terseLabel_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contribution income</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577_label_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss) Before Depreciation Amortization Acquisition and Integration Cost Contingent Consideration Restructuring Costs Impairment Charges And Corporate Expenses</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577_documentation_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Income (Loss) Before Depreciation Amortization Acquisition and Integration Cost Contingent Consideration Restructuring Costs Impairment Charges And Corporate Expenses</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:to="lab_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="arc" />
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC_terseLabel_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unallocated corporate overhead</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC_label_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC_documentation_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:to="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA_label_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Debt Obligations [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:to="lab_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:to="lab_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="arc" />
    <link:label id="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6_terseLabel_en-US" xlink:label="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advantage RN, LLC</link:label>
    <link:label id="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6_label_en-US" xlink:label="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advantage RN, LLC [Member]</link:label>
    <link:label id="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6_documentation_en-US" xlink:label="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advantage RN, LLC [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:to="lab_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill expected to be deductible</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="arc" />
    <link:label id="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F_terseLabel_en-US" xlink:label="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range One</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F_label_en-US" xlink:label="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F_documentation_en-US" xlink:label="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeOneMember" xlink:label="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:to="lab_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="arc" />
    <link:label id="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B_terseLabel_en-US" xlink:label="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B_label_en-US" xlink:label="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B_documentation_en-US" xlink:label="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeTwoMember" xlink:label="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:to="lab_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="arc" />
    <link:label id="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8_terseLabel_en-US" xlink:label="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range Three</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8_label_en-US" xlink:label="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8_documentation_en-US" xlink:label="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeThreeMember" xlink:label="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:to="lab_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="arc" />
    <link:label id="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608_terseLabel_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range Four</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608_label_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608_documentation_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFourMember" xlink:label="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:to="lab_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="arc" />
    <link:label id="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E_terseLabel_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range Five</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E_label_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:label id="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E_documentation_en-US" xlink:label="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFiveMember" xlink:label="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:to="lab_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at end of year (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price, Lower Limit (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price, Upper Limit (usd pre share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at beginning of year, weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised, weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired, weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at end of year, weighted average exercise price (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at end of year, weighted-average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of business acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pro forma information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate scheduled maturities of debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:type="arc" />
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3_terseLabel_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Table]</link:label>
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3_label_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill And Intangible Assets Disclosure [Table]</link:label>
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3_documentation_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Table]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureTable" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:to="lab_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:to="lab_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade Names</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:to="lab_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:to="lab_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="lab_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Approach Valuation Technique</link:label>
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51_label_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation, Income Approach [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:to="lab_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="arc" />
    <link:label id="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8_terseLabel_en-US" xlink:label="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income and Market Approach Valuation Technique</link:label>
    <link:label id="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8_label_en-US" xlink:label="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income and Market Approach Valuation Technique [Member]</link:label>
    <link:label id="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8_documentation_en-US" xlink:label="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income and Market Approach Valuation Technique [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncomeandMarketApproachValuationTechniqueMember" xlink:label="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:to="lab_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1_terseLabel_en-US" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Approach Valuation Technique</link:label>
    <link:label id="lab_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1_label_en-US" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation, Market Approach [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:to="lab_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="arc" />
    <link:label id="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D_terseLabel_en-US" xlink:label="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Search Reporting Unit [Member]</link:label>
    <link:label id="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D_label_en-US" xlink:label="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Search Reporting Unit [Member]</link:label>
    <link:label id="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D_documentation_en-US" xlink:label="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Search Reporting Unit [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SearchReportingUnitMember" xlink:label="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:to="lab_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="arc" />
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817_terseLabel_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Line Items]</link:label>
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817_label_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill And Intangible Assets Disclosure [Line Items]</link:label>
    <link:label id="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817_documentation_en-US" xlink:label="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Line Items]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="lab_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangibles indefinite lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangibles finite lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="arc" />
    <link:label id="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360_terseLabel_en-US" xlink:label="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate percentage</link:label>
    <link:label id="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360_label_en-US" xlink:label="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Test, Measurement Input</link:label>
    <link:label id="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360_documentation_en-US" xlink:label="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Test, Measurement Input</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillImpairmentTestMeasurementInput" xlink:label="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:to="lab_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3_terseLabel_en-US" xlink:label="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Terminal value growth rate percentage</link:label>
    <link:label id="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3_label_en-US" xlink:label="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Terminal Value Growth Rate</link:label>
    <link:label id="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3_documentation_en-US" xlink:label="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Terminal Value Growth Rate</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsTerminalValueGrowthRate" xlink:label="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:to="lab_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0_terseLabel_en-US" xlink:label="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecast period</link:label>
    <link:label id="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0_label_en-US" xlink:label="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Forecast Period</link:label>
    <link:label id="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0_documentation_en-US" xlink:label="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Forecast Period</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsForecastPeriod" xlink:label="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:to="lab_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001_terseLabel_en-US" xlink:label="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ratio of total enterprise value by EBITDA</link:label>
    <link:label id="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001_label_en-US" xlink:label="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Ratio of Total Enterprise Value by EBITDA</link:label>
    <link:label id="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001_documentation_en-US" xlink:label="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Ratio of Total Enterprise Value by EBITDA</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA" xlink:label="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:to="lab_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="arc" />
    <link:label id="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE_terseLabel_en-US" xlink:label="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted applied percentage</link:label>
    <link:label id="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE_label_en-US" xlink:label="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Weighting Applied</link:label>
    <link:label id="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE_documentation_en-US" xlink:label="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Weighting Applied</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsWeightingApplied" xlink:label="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:to="lab_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C_label_en-US" xlink:label="lab_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:to="lab_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:to="lab_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per share attributable to common shareholders - Basic (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:to="lab_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) per share attributable to common shareholders - Diluted (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:to="lab_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49_negatedNetLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense related to deferred tax asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609_label_en-US" xlink:label="lab_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="lab_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:to="lab_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="lab_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:to="lab_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="arc" />
    <link:label id="lab_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5_terseLabel_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5_label_en-US" xlink:label="lab_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:to="lab_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt fixed interest rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:to="lab_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Axis]</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Axis]</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Axis]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredAxis" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Domain]</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred [Domain]</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Business Combination, Consideration Transferred [Axis]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="arc" />
    <link:label id="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424_terseLabel_en-US" xlink:label="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424_label_en-US" xlink:label="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Price [Member]</link:label>
    <link:label id="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424_documentation_en-US" xlink:label="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Price [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PurchasePriceMember" xlink:label="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:to="lab_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="arc" />
    <link:label id="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE_terseLabel_en-US" xlink:label="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Working Capital Adjustments</link:label>
    <link:label id="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE_label_en-US" xlink:label="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Working Capital Adjustments [Member]</link:label>
    <link:label id="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE_documentation_en-US" xlink:label="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Working Capital Adjustments [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetWorkingCapitalAdjustmentsMember" xlink:label="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:to="lab_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from services</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share attributable to common shareholders - Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share attributable to common shareholders - Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:to="lab_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:to="lab_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:to="lab_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Trade Names, and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:to="lab_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC_netLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC_netLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="arc" />
    <link:label id="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990_terseLabel_en-US" xlink:label="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase and retirement (in dollars per share)</link:label>
    <link:label id="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990_label_en-US" xlink:label="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Price Per Share</link:label>
    <link:label id="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990_documentation_en-US" xlink:label="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Price Per Share</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockRepurchasedDuringPeriodPricePerShare" xlink:label="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:to="lab_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock left remaining to repurchase under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares converted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="arc" />
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:type="arc" />
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED_terseLabel_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Threshold period, past due for payment of services provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED_label_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Threshold Period, Past Due for Payment of Services Provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED_documentation_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Threshold Period, Past Due for Payment of Services Provided</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:to="lab_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="lab_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199_label_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Axis]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:to="lab_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851_terseLabel_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Domain]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851_label_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant Terms [Domain]</link:label>
    <link:label id="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851_documentation_en-US" xlink:label="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Debt Covenant Terms [Axis]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="lab_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 1</link:label>
    <link:label id="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C_label_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 1 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 1 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:to="lab_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 2</link:label>
    <link:label id="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003_label_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 2 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 2 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:to="lab_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 3</link:label>
    <link:label id="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78_label_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 3 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 3 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:to="lab_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 4</link:label>
    <link:label id="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F_label_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 4 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 4 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:to="lab_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="arc" />
    <link:label id="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4_terseLabel_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Covenant Term 5</link:label>
    <link:label id="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4_label_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Covenant Term 5 [Member]</link:label>
    <link:label id="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4_documentation_en-US" xlink:label="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Covenant Term 5 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:to="lab_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="arc" />
    <link:label id="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29_terseLabel_en-US" xlink:label="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29_label_en-US" xlink:label="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29_documentation_en-US" xlink:label="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:to="lab_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="arc" />
    <link:label id="lab_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eurodollar Loans</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7_label_en-US" xlink:label="lab_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:to="lab_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297_verboseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LIBOR Index Rate Loans</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="arc" />
    <link:label id="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C_terseLabel_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee</link:label>
    <link:label id="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C_label_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee [Member]</link:label>
    <link:label id="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C_documentation_en-US" xlink:label="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Letter of Credit Fee [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:to="lab_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate Loans</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992_label_en-US" xlink:label="lab_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:to="lab_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:type="arc" />
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61_terseLabel_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61_label_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:label id="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61_documentation_en-US" xlink:label="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consolidated Net Leverage Ratio</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:to="lab_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="lab_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="lab_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowances of $3,705 in 2018 and $3,688 in 2017</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:type="arc" />
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:to="lab_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:to="lab_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1_label_en-US" xlink:label="lab_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:to="lab_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:to="lab_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:to="lab_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term accrued claims</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8_label_en-US" xlink:label="lab_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:to="lab_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:to="lab_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="lab_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock&#8212;$0.0001 par value; 100,000,000 shares authorized; 35,625,692 and 35,838,108 shares issued and outstanding at December 31, 2018 and 2017, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:to="lab_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cross Country Healthcare, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:to="lab_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interest in subsidiary</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:to="lab_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78_terseLabel_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78_label_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:to="lab_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8_label_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93_label_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:to="lab_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="arc" />
    <link:label id="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D_terseLabel_en-US" xlink:label="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incremental Term Loan</link:label>
    <link:label id="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D_label_en-US" xlink:label="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D_documentation_en-US" xlink:label="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incremental Term Loan [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncrementalTermLoanMember" xlink:label="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:to="lab_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement from working capital adjustment settled</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment, Reimbursement</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment, Reimbursement</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="arc" />
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2_terseLabel_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Escrow payment related to tax liabilities</link:label>
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2_label_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Escrow, Portion Related To Tax Liabilities</link:label>
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2_documentation_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Escrow, Portion Related To Tax Liabilities</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:to="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="arc" />
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB_terseLabel_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Escrow payment related to post-close liabilities</link:label>
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB_label_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Escrow, Portion Related To Post-Close Liabilities</link:label>
    <link:label id="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB_documentation_en-US" xlink:label="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments To Acquire Businesses, Escrow, Portion Related To Post-Close Liabilities</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:to="lab_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Escrow deposit related to tax liabilities</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905_label_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Related To Tax Liabilities</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Related To Tax Liabilities</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:to="lab_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Escrow deposit related to post close liabilities</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D_label_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Related To Post Close Liabilities</link:label>
    <link:label id="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Escrow Deposit Related To Post Close Liabilities</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:to="lab_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration transferred, available cash</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Funded With Cash On Hand</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Funded With Cash On Hand</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income since acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17_terseLabel_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subordinated Debt</link:label>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17_label_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subordinated Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubordinatedDebtMember" xlink:label="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:to="lab_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="arc" />
    <link:label id="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098_terseLabel_en-US" xlink:label="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Second Lien Term Loan, net</link:label>
    <link:label id="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098_label_en-US" xlink:label="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Second Lien Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098_documentation_en-US" xlink:label="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Second Lien Term Loan [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SecondLienTermLoanMember" xlink:label="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:to="lab_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="arc" />
    <link:label id="lab_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E_verboseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Eurodollar</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:to="lab_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="arc" />
    <link:label id="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F_terseLabel_en-US" xlink:label="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Eight Installments</link:label>
    <link:label id="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F_label_en-US" xlink:label="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Eight Installments [Member]</link:label>
    <link:label id="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F_documentation_en-US" xlink:label="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Eight Installments [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstEightInstallmentsMember" xlink:label="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:to="lab_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="arc" />
    <link:label id="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3_terseLabel_en-US" xlink:label="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining Installments</link:label>
    <link:label id="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3_label_en-US" xlink:label="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining Installments [Member]</link:label>
    <link:label id="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3_documentation_en-US" xlink:label="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Remaining Installments [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RemainingInstallmentsMember" xlink:label="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:to="lab_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment penalty</link:label>
    <link:label id="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B_label_en-US" xlink:label="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Prepayment Penalty</link:label>
    <link:label id="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Prepayment Penalty</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPrepaymentPenalty" xlink:label="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:to="lab_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="arc" />
    <link:label id="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic payment, percentage of principal</link:label>
    <link:label id="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2_label_en-US" xlink:label="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Percentage Of Principal</link:label>
    <link:label id="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Percentage Of Principal</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal" xlink:label="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:to="lab_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="arc" />
    <link:label id="lab_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E_terseLabel_en-US" xlink:label="lab_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E_label_en-US" xlink:label="lab_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:to="lab_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="arc" />
    <link:label id="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B_terseLabel_en-US" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:label id="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B_label_en-US" xlink:label="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Relationship to Entity [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:to="lab_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="arc" />
    <link:label id="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC_terseLabel_en-US" xlink:label="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ten Percent Or More Stockholders</link:label>
    <link:label id="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC_label_en-US" xlink:label="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ten Percent Or More Stockholders [Member]</link:label>
    <link:label id="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC_documentation_en-US" xlink:label="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ten Percent Or More Stockholders [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TenPercentOrMoreStockholdersMember" xlink:label="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:to="lab_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:to="lab_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:to="lab_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="arc" />
    <link:label id="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5_terseLabel_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Omnibus Plan</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5_label_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5_documentation_en-US" xlink:label="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:to="lab_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="arc" />
    <link:label id="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD_terseLabel_en-US" xlink:label="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2007 Stock Incentive Plan</link:label>
    <link:label id="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD_label_en-US" xlink:label="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incentive Compensation Plan 2007 [Member]</link:label>
    <link:label id="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD_documentation_en-US" xlink:label="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Incentive Compensation Plan 2007 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncentiveCompensationPlan2007Member" xlink:label="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:to="lab_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price percentage of the fair market value of common stock</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="arc" />
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock expiration period</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expiration Period</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award options expiration period.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="arc" />
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89_terseLabel_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of performance attained</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89_label_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</link:label>
    <link:label id="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89_documentation_en-US" xlink:label="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:to="lab_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pretax of total unrecognized compensation cost related to non-vested restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pretax total unrecognized compensation cost related to share options- period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="arc" />
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock vesting percentage per year</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Shares Vested</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award stock award and option vesting rate per year.</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:to="lab_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill balances</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="lab_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_92197561222413669B8230ACE37DB333_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, net of impairment loss, beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:to="lab_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="arc" />
    <link:label id="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94_negatedPeriodStartLabel_en-US" xlink:label="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Sale of business, beginning of period</link:label>
    <link:label id="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94_label_en-US" xlink:label="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Write Off Related To Sale Of Business</link:label>
    <link:label id="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94_documentation_en-US" xlink:label="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill, Write Off Related To Sale Of Business</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" xlink:label="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:to="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Accumulated impairment loss, beginning of period</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Aggregate goodwill acquired, beginning of period</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB_label_en-US" xlink:label="lab_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:to="lab_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairment charge</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Aggregate goodwill acquired, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:to="lab_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:type="arc" />
    <link:label id="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8_negatedPeriodEndLabel_en-US" xlink:label="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Sale of business, end of period</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" xlink:label="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:to="lab_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Accumulated impairment loss, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, net of impairment loss, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:to="lab_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:type="arc" />
    <link:label id="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7_terseLabel_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other and prepaid expenses</link:label>
    <link:label id="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7_label_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Accrued Other Liabilities and Prepaid Expenses</link:label>
    <link:label id="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7_documentation_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Accrued Other Liabilities and Prepaid Expenses</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses" xlink:label="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:to="lab_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional liability claims</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers&#8217; compensation claims</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:to="lab_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Indefinite intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax on unrepatriated earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:type="arc" />
    <link:label id="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D_totalLabel_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred taxes</link:label>
    <link:label id="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D_label_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities)</link:label>
    <link:label id="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D_documentation_en-US" xlink:label="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets (Liabilities)</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsLiabilities" xlink:label="loc_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:to="lab_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:to="lab_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:to="lab_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="arc" />
    <link:label id="lab_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:to="lab_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:to="lab_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Account receivable due from related parties</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="arc" />
    <link:label id="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA_terseLabel_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent ownership in joint venture unit</link:label>
    <link:label id="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA_label_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Joint Venture, Percent Ownership</link:label>
    <link:label id="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA_documentation_en-US" xlink:label="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Joint Venture, Percent Ownership</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:to="lab_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable balance with joint venture</link:label>
    <link:label id="lab_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0_label_en-US" xlink:label="lab_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due from Joint Ventures, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:to="lab_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due to joint venture</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:to="lab_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="arc" />
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued employee compensation and benefits</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Employee Liabilities</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Employee Liabilities</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company contribution net of forfeitures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="arc" />
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:to="lab_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:to="lab_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="arc" />
    <link:label id="lab_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8_verboseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Physician Staffing Segment</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:to="lab_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="arc" />
    <link:label id="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4_terseLabel_en-US" xlink:label="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Services</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4_label_en-US" xlink:label="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Services [Member]</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4_documentation_en-US" xlink:label="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Services [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherServicesMember" xlink:label="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:to="lab_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders - Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Gain on derivative liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income attributable to common shareholders - Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares - Basic (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective of diluted shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based awards (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares - Diluted (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:to="lab_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:to="lab_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net of accumulated depreciation and amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:to="lab_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASU 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Undiscounted future lease payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="arc" />
    <link:label id="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0_terseLabel_en-US" xlink:label="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 1999 Plan</link:label>
    <link:label id="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0_label_en-US" xlink:label="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Option And Equity Participation Plan 1999 [Member]</link:label>
    <link:label id="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0_documentation_en-US" xlink:label="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Option and Equity Participation Plan 1999 [Member]</link:label>
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockOptionAndEquityParticipationPlan1999Member" xlink:label="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:to="lab_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate number of common stock shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options outstanding (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares options outstanding vested or expected to vest -weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares options outstanding vested or expected to vest ,intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares options outstanding vested or expected to vest -weighted average contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>ccrn-20181231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:href="ccrn-20181231.xsd#Acquisitions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAdvantageRnDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAmericanPersonnelIncDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:href="ccrn-20181231.xsd#AcquisitionsProFormaDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:href="ccrn-20181231.xsd#AcquisitionsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:href="ccrn-20181231.xsd#BalanceSheetDetailsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:href="ccrn-20181231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ccrn-20181231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ccrn-20181231.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt" xlink:href="ccrn-20181231.xsd#Debt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:href="ccrn-20181231.xsd#Debt2016SeniorCreditFacilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:href="ccrn-20181231.xsd#DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:href="ccrn-20181231.xsd#DebtConsolidatedNetLeverageRatioDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:href="ccrn-20181231.xsd#DebtDebtMaturitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:href="ccrn-20181231.xsd#DebtLongTermDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:href="ccrn-20181231.xsd#DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:href="ccrn-20181231.xsd#DebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:href="ccrn-20181231.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:href="ccrn-20181231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:href="ccrn-20181231.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:href="ccrn-20181231.xsd#EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:href="ccrn-20181231.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:href="ccrn-20181231.xsd#EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:href="ccrn-20181231.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:href="ccrn-20181231.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:href="ccrn-20181231.xsd#GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:href="ccrn-20181231.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:href="ccrn-20181231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:href="ccrn-20181231.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:href="ccrn-20181231.xsd#PropertyAndEquipment" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:href="ccrn-20181231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:href="ccrn-20181231.xsd#QuarterlyFinancialDataUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:href="ccrn-20181231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:href="ccrn-20181231.xsd#RevenueRecognition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:href="ccrn-20181231.xsd#RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:href="ccrn-20181231.xsd#RevenueRecognitionTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ccrn-20181231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:href="ccrn-20181231.xsd#SegmentData" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:href="ccrn-20181231.xsd#SegmentDataAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:href="ccrn-20181231.xsd#SegmentDataOperatingSegmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:href="ccrn-20181231.xsd#SegmentDataTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:href="ccrn-20181231.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:href="ccrn-20181231.xsd#StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:href="ccrn-20181231.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ccrn-20181231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_EB6E7F1F32C2D1F10635A9ED5C2A60E8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_EB6E7F1F32C2D1F10635A9ED5C2A60E8" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1C4155473DECBECA28EBA9ED5C2AC8EF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8057477D74A1458CE488BF4CB1C49B32" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8057477D74A1458CE488BF4CB1C49B32" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_A10846144C032C1B46BEBF4CB5BBAA34" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_98033A2791EF6E3ADC1FBF4CB624F56A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_TradeNamesMember_98033A2791EF6E3ADC1FBF4CB624F56A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_52C6DF43B6E9E800922FBF4CB6798F82" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_CustomerRelationshipsMember_52C6DF43B6E9E800922FBF4CB6798F82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_C0AF3F27A8647F2EC0FDBF4CB6A90708" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_DatabasesMember_C0AF3F27A8647F2EC0FDBF4CB6A90708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_65CE2977C624BB92BA3CBF4CB6DBC063" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_954285784A439F012DEEBF4CB5BC1012" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_65CE2977C624BB92BA3CBF4CB6DBC063" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_E6C2086AB443FB086C5BBF4CB4D92513" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60C52325F75AA8A1F880BF4CB4D90A56" xlink:to="loc_ccrn_AdvantageRNLLCMember_5F7C15BDE04D95917D84BF4CB64CB8F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A2A325CB751F8EE6BC5BF4CB4D81F45" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_04D738361E34DABD6BCFBF4CB523A572" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_04D738361E34DABD6BCFBF4CB523A572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_772D71061F4ACC9FB6B9BF4CB54BDA84" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_772D71061F4ACC9FB6B9BF4CB54BDA84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_B01AEA20B86DFBFED8BCBF4CB577B45F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A29495BFBEDC349F5D8EBF4CB598968A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BE80B000CF2CEEF1EAC3BF4CB4EAF90B" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A29495BFBEDC349F5D8EBF4CB598968A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_A7E3178EB64809E0239134B4208A0D6B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_A7E3178EB64809E0239134B4208A0D6B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_572633B3C3DC79895AF234B4208BEF78" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_FF38162ECF9626EC91D334B4208B42C8" xlink:to="loc_us-gaap_ScenarioForecastMember_2EDD888EFF8F438FEC9B34B4208BDA93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredAxis" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_EC94ECC0DC95A06B077034B4208C526D" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PurchasePriceMember" xlink:label="loc_ccrn_PurchasePriceMember_E1BE8023D26DA2A893AD34B4208C4888" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_E975752F6B78393C017734B4208C547F" xlink:to="loc_ccrn_PurchasePriceMember_E1BE8023D26DA2A893AD34B4208C4888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DAE897B02A5B82945E9E34B4208D97D2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_4064A3E8F09CBA16C8A134B4208DF658" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B896199EDEC42C5D6CF934B4208DB2FB" xlink:to="loc_ccrn_TermLoanMember_4064A3E8F09CBA16C8A134B4208DF658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0AA77FEAAF4ADC8767EB34B4208DD17F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_B2665F2D47A9A357323734B4208E663C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:to="loc_ccrn_CreditAgreementMember_B2665F2D47A9A357323734B4208E663C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncrementalTermLoanMember" xlink:label="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1F1DFD2BB6EDFFBFC59534B4208DA219" xlink:to="loc_ccrn_IncrementalTermLoanMember_5D732647A67F25D4F5D334B4208EA80D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_F813172483DAC818B7AA34B4208E772E" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredConsiderationTransferredMember" xlink:label="loc_ccrn_DeferredConsiderationTransferredMember_0A8E0F558D5805D09F6E34B4208F3A5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_13A97599F3B7A5D7663534B4208E121C" xlink:to="loc_ccrn_DeferredConsiderationTransferredMember_0A8E0F558D5805D09F6E34B4208F3A5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7B73DEB3179A1C5D4F0B34B4208F545A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_4200AFFA026EEEF54A5934B4208F1E08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_F78B1009DE985C35081034B4208FCB55" xlink:to="loc_ccrn_AdvantageRNLLCMember_4200AFFA026EEEF54A5934B4208F1E08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_CC5D3125E6A828C5D8CA34B4208A8DC1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3304B05D2F66C88BFE4C34B42090E0EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C531D85FC5D97BD118A934B42090C07B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_C531D85FC5D97BD118A934B42090C07B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_0D688BC9572F4FF682CA34B42090029B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_0D688BC9572F4FF682CA34B42090029B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement_1F0A205309D127EF3C3334B42090127E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_AE9C87B6705C7110009034B42091E125" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F8260FDF0D54FA58AA9034B42091145C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_F8260FDF0D54FA58AA9034B42091145C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E93C9DA17CF874852CE034B420915D2D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_E93C9DA17CF874852CE034B420915D2D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities_68C40DEC0ACB707D6DE734B42091C3D2" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities_99AC0C24EEF27CD9F4FE34B42091BBBB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_BF31697AF8017C5ABD4734B420925D1E" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_BF31697AF8017C5ABD4734B420925D1E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities_19A53AA5B00D213E3CAA34B42092F905" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities_DD401BC8F79C22A5D23634CE3734D10D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand_B2F4C094850F05146EEB34B42092EF79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_B07160D0643776ED731534B42092F65A" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_B07160D0643776ED731534B42092F65A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_A7CE8F511CE66652D91534B42092FF1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0741427A0DB0F330E8334B420903698" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_C0189729625C5484719A34B42092E1B9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_AE49FBC6D2C81DFCF9F8E5E747E388CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AE49FBC6D2C81DFCF9F8E5E747E388CE" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_B203680127C4675D1E66E5E749C7E06D" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmericanPersonnelInc.Member" xlink:label="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70AF38E7E866E91A2E3FE5E749CDB388" xlink:to="loc_ccrn_AmericanPersonnelInc.Member_DAF932C6E8B91388B210E5E98D318F91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_C28D031ABA6CE11300CDE5E749C69B5E" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_59025F71EEB6BC030AEAE5E749F71D91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_7B299299ACDD2FD35FDEE5E7CCBCC194" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_194180D2FB4AC20ECBCEE5E86559A49B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_Goodwill_4DB2846AE25B9B1EDF91E5E89AA7AC23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C73FB5E3E1C40124274BE5E749D27BB9" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_A3CC6A8ABA4D4FC07EB2E5E8ECD30355" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_18ABBCD4E93F12AA9004BFBE3B911D15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_18ABBCD4E93F12AA9004BFBE3B911D15" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32E6A5650C04B0BF5386BFBE3B915BBD" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_2BE8A33F6B8DECB5181BBFBE3B92705F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_526576B87C12A77C5180BFBE3B92418C" xlink:to="loc_ccrn_AdvantageRNLLCMember_2BE8A33F6B8DECB5181BBFBE3B92705F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EE133F3A58F7EF2E1099BFBE3B910117" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3131C8D6935F0C093747BFBE3B9269FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_EA7924D41522574C802DBFBE3B93C19F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_C0C745F440ADA4D8797ABFBE3B93E7F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_45F364E66B55CBA20885BFBE3B932021" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_BBF930876FBAD5136EA2BFBE3B945F76" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_Goodwill_BBF930876FBAD5136EA2BFBE3B945F76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5204339C059BC5AE8240BFBE3B9446A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_CB6FBACE7206D8A1A5D2BFBE3B9417D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_ED213EE3227917BF9E55BFBE3B940325" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities_6D8BA6DF14DBEC84CFA8BFBE3B94431F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_41825B9B560F48372171BFBE3B9441EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_60D42328CD26428721A1BFBE3B95EF7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F490C4C14C3ADFFD3C52BFBE3B92D87F" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_54ADEEE43338B3C72665BFBE3B950F0C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_A6C21CF9EB97DEEDA1DDA9ED5E78799B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_A6C21CF9EB97DEEDA1DDA9ED5E78799B" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredAxis" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredDomain" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredAxis_322102DFE877BF8F70A1A9ED5E798577" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PurchasePriceMember" xlink:label="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:to="loc_ccrn_PurchasePriceMember_D8301C9413F6DA71AD82A9ED5E7A0424" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetWorkingCapitalAdjustmentsMember" xlink:label="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredDomain_1BA43BA11E88A3388894A9ED5E794F13" xlink:to="loc_ccrn_NetWorkingCapitalAdjustmentsMember_E836F591F2C4B42C0F2DA9ED5E7A08FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C7E9D5B2F3DA70C6E76BA9ED5E7ACCCF" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AdvantageRNLLCMember" xlink:label="loc_ccrn_AdvantageRNLLCMember_24165490F0125A1611C2A9ED5E7B60CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3D37CCC9966F5D889DC7A9ED5E7AF328" xlink:to="loc_ccrn_AdvantageRNLLCMember_24165490F0125A1611C2A9ED5E7B60CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1E59213A15D300604893A9ED5E79489B" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A42D703C77AC19481CCEA9ED5E7B4703" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_A42D703C77AC19481CCEA9ED5E7B4703" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_BDF647E58B1BB2C24D25A9ED5E7BEB98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_D55AA4E1B5C6E7E2D7EBA9ED5E7BBB18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_F0D0D4A53630151E12E3A9ED5E7BF947" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_24D0903E2241F3E54DFBA9ED5E7C4877" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AC79C7749AD1E6CA08FDBEE588BDEB3C" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_91E89963D08192363871BEE588C0BFDF" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member_E9C323A5A984D0C0E6C7BEE588C1E942" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member_7F298EC95FF63571EFE5BEE588C2E709" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member_E2A17DCD4353186F338FBEE588C230D0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AcquisitionRelatedContingentConsiderationMember" xlink:label="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_AcquisitionRelatedContingentConsiderationMember_37D27E759968189D8014BEE588C26E0E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember" xlink:label="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember_AAF14D2A94CB631160F0BEE588C27C94" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member" xlink:label="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member_0C5C15B199AD9AF50837BEE588C2A958" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredConsiderationTransferredMember" xlink:label="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_FBA3CDBE14164BD6131EBEE588C1917C" xlink:to="loc_ccrn_DeferredConsiderationTransferredMember_A11F3DA9DAE7295977B6BEE588C2E2A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_864BC18FE6E9FA27E536BEE588C3BCBC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_USResourcesHealthcareLLCMember" xlink:label="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_USResourcesHealthcareLLCMember_DC872554C6403207939EBEE588C3518F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MediscanMember" xlink:label="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_MediscanMember_35314FF5986B6F9A9A64BEE588C36C3C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MedicalStaffingNetworkMember" xlink:label="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_A5D73A7D0D18D2C78204BEE588C3B607" xlink:to="loc_ccrn_MedicalStaffingNetworkMember_8D7502F3B84E3825BF85BEE588C4067E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_D5F8199ED68B6F55B2E3BEE588BDF778" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_B5476C48314B729FFA20BEE588C40BA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_8C404857783DB1737470BEE588C5ACA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_C130262D5DDD05D8192ABEE588C5865A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated_521392C8EF1C1935C720BEE588C54955" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_EE639390E20C52BCF635BEE588C52087" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ABC1FAE00F08CDEC295DBEE588C6DFCE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_406DC90B10BDFFD5AF85BEE588C6A4D3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationEscrowDepositRelease" xlink:label="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationEscrowDepositRelease_A278E965A3084EA8F7E3BEE588C614DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_520F16F0FC281DC704AFBEE588C5FD01" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationConsiderationDeferredPeriod" xlink:label="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_BF978E92F4C1C3DEBFB7BEE588C4B408" xlink:to="loc_ccrn_BusinessCombinationConsiderationDeferredPeriod_084D69BE869966E6B0DEBEE588C8026B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2C2016F0CA52314FA12FBFBE3B7A0DCC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2C2016F0CA52314FA12FBFBE3B7A0DCC" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_C211932A33BE412E1BCFBFBE3B7A4C93" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_7B91C16519F65CA48E61BFBE3B7B249C" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_51FF1E3194014951A910BFBE3B7B27DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTable_56EC5EEEABF4D47BC11DBFBE3B7A99FC" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_05DF8CB5526DA6169EACBFBE3B7C54F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_ProfitLoss_05DF8CB5526DA6169EACBFBE3B7C54F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_E7BFD14F2E2D40526B57BFBE3B7C3806" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_D641D3A4183781332786BFBE3B7C6481" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_0217CEA895C6969B1E2CBFBE3B7C76ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems_5AECA9ADEB4A7EA0961CBFBE3B7B3422" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_A07007C159C89C5A8249BFBE3B7CB94F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_AA9FA61C17C0E0897AD7A9ED5BE598A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AA9FA61C17C0E0897AD7A9ED5BE598A8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_C1FD197559BA72137C6FA9ED5BE5F39E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AA9FA61C17C0E0897AD7A9ED5BE598A8" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_C78D51DBDD6BE81B42C2A9ED5BE5313F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_AA9FA61C17C0E0897AD7A9ED5BE598A8" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_E981DEA32B4666D117E7A9ED5BE579CE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8A74CFCD2E5EA2592724A9ED5D565B2C" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_60A557119DE571742BD1A9ED5D56A151" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationCurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_ccrn_InsuranceRecoveryForWorkersCompensationCurrent_CE86A7AC69DC31D0904CE5D9F9204775" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeCurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_InsuranceReceivableForMalpracticeCurrent_1EEB393F5C5C8C42A611E5D9F9214E5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_D5A8B0BFAE0B3C1A310AE5D9F921B55B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent" xlink:label="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent_BB890731B49ECFD40F3CE5D9F9216472" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceReceivableForMalpracticeNoncurrent" xlink:label="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_InsuranceReceivableForMalpracticeNoncurrent_E461C8F8467675C67ED7E5D9F92115F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_966E03235897757D1009E5D9F921A489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_DBBFAF68F57D53E43627E5D9F922B3C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_9281DE4EA259BDFA3249E5D9F9224A90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_D8322945FB92DAD6F31AE5D9F922AB46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17F4528716B509DBEBDBE5D9F92294D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_AccruedSalariesCurrent_18759B616337C1A2BA93E5D9F9220589" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_AccruedBonusesCurrent_3C213674A6DA2FA7FE8DE5D9F922AA4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_4A47682E59A7C9191031E5D9F923950E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent_3F2B66CDE9F4EFDF9DE1E5D9F9231D22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_13D0B2E8C503A980CD70E5D9F9239117" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_AccruedVacationCurrent_28167ADF5537701E8A92E5D9F923FB53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7281093A11A0B4404A1AE5D9F9238D44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_33B0A48154F34FBABA1FE5D9F9237029" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent_E793AC22DA9B311F0DE5E5D9F924B9B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_538D829B16D2AC97E84CE5D9F9249B6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_A6F7119B9D6299D19B12E5E4D54CEB57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_493406A972975E9E72C5E5D9F924C043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_218FA2221B9EBED680D0E5D9F924E0D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_A5EC9E6D73C61A56E36DE5D9F9245DA0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherLiabilitiesMiscellaneousNoncurrent" xlink:label="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_ccrn_OtherLiabilitiesMiscellaneousNoncurrent_F998963C3B09CA0D26DAE5D9F9243CB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_081DB5BE58C5143F59B3E5D9F9206AC8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_864DC4C4C0CB116CE7A9E5D9F92508E9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B5E0D56F503892EC8B17A9ED5E69754D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B5E0D56F503892EC8B17A9ED5E69754D" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_B825CC7244F5CB3A4680A9ED5E690479" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_47EBF3BA792D9FBAABDEA9ED5BED68E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_47EBF3BA792D9FBAABDEA9ED5BED68E7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_FD1920B6F1744B4D1258A9ED5BEDAC2D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_96AFABB41A011398EFB4BF9D19542A67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9C28FFAB3DF65EFF320DBF9D195599DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_9F665753321740A56C50BF9D19550BDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_D759397CE1B9E1B09B49BF9D195516B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_8391298B3AD76AE0AFBCBF9D1955CE6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_D642237B5741C2FB12D5BF9D195B3968" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_344C00A3014F6B73FB76BF9D1954EAFB" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_9D16D964C2A2BF6533A9BF9D195BF395" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_AD39C2BF95281DD38677BF9D194519C9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_AD39C2BF95281DD38677BF9D194519C9" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_4C11F341226FBC5FBB11BF9D1945C660" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75E7FE5F382DF0A96B22A9ED5CA6E779" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_4A8258E5A795096393E2A9ED5CA6447E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_B266D28F8B67F9C31729E5D9FA944571" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B266D28F8B67F9C31729E5D9FA944571" xlink:to="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_BF32FF41F9B6471020F8E5D9FA958487" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4B5B5D516C8E66681C02E5D9FA95F1EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3E97913AE13720136590E5D9FA96FA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_3A2DFD1DFE092FA8801CE5D9FA967EBA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_OtherAssetsCurrent_25DC222A6994EAE2B0C4E5D9FA96FEDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_BD781ABFCBE0EF3AE914E5D9FA954D59" xlink:to="loc_us-gaap_AssetsCurrent_403CF8A5CCD14917EE53E5D9FA9726BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_DABCEC6968360BFDDD7DE5D9FA970D66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_3BECDA7375ED6C3337ADE5D9FA97015D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_Goodwill_3BECDA7375ED6C3337ADE5D9FA97015D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_15D97D169D9BD8E24BE9E5D9FA971C72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_18F654441DE49B2444ECE5D9FA9747BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent_33010CE1849F3A4B7DCBE5D9FA979119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_52F17E99E28A43B9BBB1E5D9FA983C8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_A0625EB5011BF26975DAE5D9FA95C2B8" xlink:to="loc_us-gaap_Assets_447004E1BC32DEFF588FE5D9FA9871E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B266D28F8B67F9C31729E5D9FA944571" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00D980896C97B99C8C5BE5D9FA98BDCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_917FB2D608A700ABE6C4E5D9FA994158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="loc_us-gaap_LongTermDebtCurrent_E8AD7ABD63344E123B20E5D9FA993652" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_51DB446790C168C55913E5D9FA99333B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_AC31CFC28090401727FDE5D9FA982FD8" xlink:to="loc_us-gaap_LiabilitiesCurrent_F552B9753035ACF59B0DE5D9FA9910DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_D6ABFD1D63FEABF2C04CE5D9FA9ADE22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_09DFAD4AEE06465C5C40E5D9FA9AFA40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_D8F98C72E2B08B0933B7E5D9FA9A2B7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_A9613B83A689315F8F49E5D9FA9A5F02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_Liabilities_5A9E9DD4F4D560B80B19E5D9FA9AEFC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_CommitmentsAndContingencies_954908D9C21B8C3E46E2E5D9FA9B99FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_CommonStockValue_4E74E66D261BEA5CDD13E5D9FA9BA0A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_340C3930F114F95DB8A0E5D9FA9BF93B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_99DB5E7DCEC1C15C618CE5D9FA9B20A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_C364BA7C0A9016E55243E5D9FA9C0A93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_StockholdersEquity_B3F438BFBC2DB8091BCEE5D9FA9C8C0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_MinorityInterest_FB9308FB7A88CE231A82E5D9FA9CAAFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_157E934B0572D573BB2CE5D9FA9BAB94" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_77525D6CB9C94A341661E5D9FA9C1DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1BC2A6610E19ACF576A9E5D9FA98657C" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2CFFCB5613E876F76571E5D9FA9C958A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_90A48C5CF40EBCB2FA33A9ED5BD41D7A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_50081B53F60FD4207D90A9ED5BD5BF0C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_50081B53F60FD4207D90A9ED5BD5BF0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_CC789BFDE7663DE6D4D2A9ED5BD51195" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="loc_us-gaap_CommonStockSharesIssued_ED55155176C35CE78348A9ED5BD5BDF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_DBAB2A715D1F007C68ADA9ED5BD481EC" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3CA73A783B9D4DE6D34FA9ED5BD565ED" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:to="loc_us-gaap_ProfitLoss_54F9ED24D3AC12DF250026A350C8F301" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9714109CD6A3FDB8E64326A350C91458" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_486A7D1DCB6DC4E7860926A350C91EA8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ProvisionforDoubtfulAccountsandOtherAllowances" xlink:label="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances_967863AD9AB44753DF2026A350CAFF3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1F1E675D289E84D4308A26A350CA1974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_D08B95F8F010E56C6C5B26A350CAC03C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_AssetImpairmentCharges_C2C7CE3A06643D9A7DFA26A350CA0971" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9BD25B3A0CCD699B1F3626A350CA0F59" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_ShareBasedCompensation_D34CAAC17D164EAFA59D26A350CB41DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_D3F1749E09B29C49A86E26A350CB4DBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7F459D0145603AC0F21926A350C9B69B" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3075FFEF7C3E558876EA26A350CB423A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1BF5C261A2937F0145F126A350CB6323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_39DCBFCDB7D908AC3C5226A350CC071F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4F48C1787E5B1BE0CB4626A350CBCCA0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_8DA2834B16971FA816E626A350CCED6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_A100FFA1328CF204B20826A350C6AB7F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73389A6C83BC4D62FB1226A350CC2856" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_43AE7A3894C064BE53AD26A350CC99D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_B5F5B23DE47D43D8DD7726A350CDCB33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromPreviousAcquisition" xlink:label="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="loc_us-gaap_PaymentsForProceedsFromPreviousAcquisition_CC4CACB6BDF3C892417726A350CD337E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_A48A0BF7937B0CCE662826A350CD838C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2EFC9294D19700ADA0D526A350CC4E5C" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_D3D6A842200710D4E78D26A350CDDE5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0EC8E9337EDA942B9E3126A350CE9E38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_003A1EE584CE6B1E7E8326A350CEE024" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_9441FFFD10B79A61857426A350CE7C80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_90EE9D46867B043D836226A350CEB1FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_CE229E3DDC9D9063F68E26A350CFC57B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_C75D6B6A5881DCC4AEB326A350CF1312" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_6EB76DC5B90B892B2EF826A350CF8244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_746B1616F08BF9B450B526A350CF222B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_020E0367E3E75DD1B74726A350CF4BBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2F6732324C91C8B4ACA826A350CE53B0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_256477458FC5CE5725C726A350CF6C96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_41CC26FB0A826BDA451126A350D0496D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_D8E5E03F85E829605CF026A350D019A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00FE4E799975E06A1ADC26A350D068BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6E77A5A966EC587866EB26A350D08FCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_CD1C545D3554069A87D526A350C41507" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:to="loc_us-gaap_InterestPaidNet_B5EBCCADFD19F993400D26A35304738F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_01C48CECB48BFB12700926A350D01CAD" xlink:to="loc_us-gaap_IncomeTaxesPaid_1DE980691B5C378B1B8826A350D1781B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_ProfitLoss_F68FE7884FAE7765EA7EE5D9FA6E9D91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_C960A2CC67BE432BCA03E5D9FA6F6EE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax_5FE5DB635CD113C46A37E5D9FA6FECEE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax_9848BA3C498AC41DE140E5D9FA6F2472" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_509B0E8FBEEA3D1B9F11E5D9FA6E108E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_010EE73B6BAB9860E1B3E5D9FA6F0BE5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherComprehensiveIncomeLossTax1Abstract" xlink:label="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_160C1EDF9E048B7E6B0BE5D9FA70BCA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_20A5ED6A126EADA4F072E5D9FA707C0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax_33A1E4A76C1BDD5DA4E9E5D9FA70B0B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_OtherComprehensiveIncomeLossTax1Abstract_7B1AA7ECC982EF46E077E5D9FA7085FD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_8B01171EBCDB8A1A01E7E5D9FA71D116" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_008129C3AAFEDB74A7D9E5D9FA71B20E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_051AE058293558FD2F75E5D9FA719B0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_09C5AD9E60A2C4361A1DE5D9FA71F19F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_124C27863B0919FD53ADE5D9FA6EE7B0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_4214AFF28E957169B9D7E5D9FA71AA51" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_Revenues_B2E8C16710923FD2BE44BFBE3C6330BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DirectOperatingCosts" xlink:label="loc_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_DirectOperatingCosts_BCCCA08DFC4FCF1FD2BBBFBE3C6577D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_05ADFFFE147DE002226DBFBE3C6642FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5AA80271BB112E6AFD61BFBE3C6606FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_79D170733E5CBD15375FBFBE3C67AEC9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_79D170733E5CBD15375FBFBE3C67AEC9" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_95E03820529902C355F9BFBE3C67969B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0BAC74EBF19EB065423ABFBE3C676BBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_RestructuringCharges_22FFEE17959B0D938ED1BFBE3C67633F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_B50A86A89AA281070667BFBE3C6889BE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_AssetImpairmentCharges_B50A86A89AA281070667BFBE3C6889BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1E51B5DFAA072396C793BFBE3C642130" xlink:to="loc_us-gaap_CostsAndExpenses_3A8386A95139FF4111BBBFBE3C68EA36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_OperatingIncomeLoss_FB7E0E653D0D5850BB11BFBE3C69692F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:to="loc_us-gaap_InterestExpense_8D5AD527BAF10423DFFABFBE3C6EA81A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_A10B16C37B422976EFC8BFBE3C6FBEA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18F2782AD60AA28E672BBFBE3C6FAAB2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18F2782AD60AA28E672BBFBE3C6FAAB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_7781B1A9C78797E6865BBFBE3C6C8B3F" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_049DAA5C8A181F1CC6DDBFBE3C70216D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FEE3583077544954CD30BFBE3C710679" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_FEE3583077544954CD30BFBE3C710679" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7B9B2CCA6F74402F5A63BFBE3C719082" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_ProfitLoss_03EE7DB82BBD29B4163ABFBE3C71FB1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_E606844422807EF64A24BFBE3C724402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_NetIncomeLoss_B53FA7A330665F78DBB6BFBE3C72830E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_EarningsPerShareBasic_01D475D0BEBB3D8D544CBFBE3C729BB6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_EarningsPerShareDiluted_F24FAE5A3DDDB86FB12EBFBE3C72191D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18D8B3CCA29914EFBC05BFBE3C743AA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_C8EE44465EC094335B0EBFBE3C63C503" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5A01F30F882F3141AD6BBFBE3C75BA3B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_16B4A90999527B54E10EE5D9FA5FDA25" xlink:to="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B511AD4C84090061D217E5D9FA601009" xlink:to="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_CommonStockMember_7AD9F6142737ADDD26A4E5D9FA611BC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2F4D9C6EBC4ABA6C2C24E5D9FA6178E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5F15285FC95A921C4712E5D9FA617133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_RetainedEarningsMember_D2404E6B82A93A2C8E6EE5D9FA615431" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40869F255C86416D1330E5D9FA602754" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6D64EA26598CCA84DF08E5D9FA62142B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8AFCD9E87EAA4AE30348E5D9FA6097F7" xlink:to="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_FD7F5054A622E5AFA316E5D9FA62626F" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_SharesOutstanding_1B5763F72A0F527C9DCAE5D9FA6375DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2B4251BAA196B40427A9E5D9FA6341B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_D76CF6022744573C8C0BE5D9FA63EACC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8A5B4337F0E10E592590E5D9FA63D507" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4630D3302BE23A713779E5D9FA63E705" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_A876D0B04EAF99C45F45E5D9FA6456D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_80268626FB5CD9C202CEE5D9FA64D9A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_EC8C0F41D79F7358AD23E5D9FA647B25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_495E86D6546756183D75E5D9FA647918" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_0337388AF69D190CBA58E5D9FA6448F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1" xlink:label="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1_34D36C43448F38F1D660E5D9FA6465BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4E129E3F0A27618CC9D3E5D9FA6563C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_F7B23FAA5FA2A2918952E5D9FA65E598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1390E54C83517354048BE5D9FA656024" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_ProfitLoss_3D47A66512C2CCF74567E5D9FA65A8E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_SharesOutstanding_51737EFCD616CB661FAEE5D9FA65275F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_E7EEC88D41C923FF72A1E5D9FA62D2C1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_668CF09AE000808BD9D0E5D9FA657651" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1155485C5D076CEF2FE2A9ED5D321ABB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1155485C5D076CEF2FE2A9ED5D321ABB" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_80B16ECD1994DF311636A9ED5D33722E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_782032DE5928F4A7727D34B41FC691A4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_782032DE5928F4A7727D34B41FC691A4" xlink:to="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsAxis_D0719DF1BFFEF93331F934B41FC73E53" xlink:to="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_B3CD59884969A3E0B28C34B41FC7D357" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_5E09FC0436BDD560A6C434B41FC7C894" xlink:to="loc_ccrn_CovenantTerm3Member_B3CD59884969A3E0B28C34B41FC7D357" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_EFA3944E4BFCCF57375C34B41FC8419E" xlink:to="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6234F93F8C0CEE0362F634B41FC89B60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_156165786810D0E8682634B41FC820BA" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6234F93F8C0CEE0362F634B41FC89B60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0EB1E4BFFD03E329526B34B41FC9C4D0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_4954951A1E3F32D5AC0334B41FC9FA28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_4954951A1E3F32D5AC0334B41FC9FA28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SubordinatedDebtMember" xlink:label="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_us-gaap_SubordinatedDebtMember_96025F84B14750ED77A934B41FC93A17" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_A9C4BCBF3244FE513A3634B41FC93C06" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7FC9BE518D6A04371E0334B41FC95B89" xlink:to="loc_ccrn_TermLoanMember_A9C4BCBF3244FE513A3634B41FC93C06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_39CBD225D808BE832F9934B41FCA1AEB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_ED9A4A6632F4EBEB34ED34B41FCA8D17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_CreditAgreementMember_ED9A4A6632F4EBEB34ED34B41FCA8D17" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SecondLienTermLoanMember" xlink:label="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_SecondLienTermLoanMember_F805D847E0503F69D11834B41FCA6098" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncrementalTermLoanMember" xlink:label="loc_ccrn_IncrementalTermLoanMember_5BEE32B3B3CC559A836734B41FCBF7BD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_86125404C8959C391E9234B41FCAC3D6" xlink:to="loc_ccrn_IncrementalTermLoanMember_5BEE32B3B3CC559A836734B41FCBF7BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_92EFBED7D610F965D4F334B41FCB04BF" xlink:to="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_EurodollarMember_414BE44022303CB3065B34B41FCB269E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_16EF7FA93A8E0675453734C7B4A92552" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_16EF7FA93A8E0675453734C7B4A92552" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_B01861F3CE276AE5398634B41FCBCF01" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_90005BF1D1A77D7B62D334B41FCBE222" xlink:to="loc_us-gaap_BaseRateMember_B01861F3CE276AE5398634B41FCBCF01" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B1F3B4FB7BB2AE7B850734B41FCC5094" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstEightInstallmentsMember" xlink:label="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:to="loc_ccrn_FirstEightInstallmentsMember_4A0EC82DF68BCD9F9F0D34B41FCC283F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RemainingInstallmentsMember" xlink:label="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2610401DB1EA6567608134B41FCCB721" xlink:to="loc_ccrn_RemainingInstallmentsMember_98CA9BD7BC0B83388ADD34B41FCC3EA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_E6E002C2410CF69CBC7B34B41FC7EFBC" xlink:to="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AA71F9B3D75590C57BCD34B41FCDE9A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_AA71F9B3D75590C57BCD34B41FCDE9A7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_1874CEEADEC36421A9E834B41FCD622B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_1874CEEADEC36421A9E834B41FCD622B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_51F14C9C8FB597FCB57634B41FCDABE4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_51F14C9C8FB597FCB57634B41FCDABE4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPrepaymentPenalty" xlink:label="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_DebtInstrumentPrepaymentPenalty_E6B52F88358F39062F4034B41FCD8A9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_D0B822A851408225CD9B34B41FCD1C7D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_D0B822A851408225CD9B34B41FCD1C7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_354AA50453EC5C3E769734B41FCEAA5D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_354AA50453EC5C3E769734B41FCEAA5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_C277D1BAFAE7DE2C411334B41FCEF6B4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_C277D1BAFAE7DE2C411334B41FCEF6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_FD2839CAAD55C64FF63734B41FCE2167" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_FD2839CAAD55C64FF63734B41FCE2167" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal" xlink:label="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_C42BAEE910F8A8C80EFB34B41FCD198C" xlink:to="loc_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal_21222DBF65825AD446D934CA8E6E17D2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_C057EA75778E3977BEB035089A1B754F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_C057EA75778E3977BEB035089A1B754F" xlink:to="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_D3D7AAC236B4DAA3480D35089A1C9829" xlink:to="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_45E1D2A4067B0218A77C35089A1DF9CC" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_BE1200CEF42D8764F74C35089A1D058D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D837A62F2659C50BE0EA35089A1DBAA9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:to="loc_ccrn_TermLoanMember_0BCBB1B943FBE1D938AE35089A1E6276" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79968B3D6978B704B3D035089A1D05BD" xlink:to="loc_us-gaap_LineOfCreditMember_3AB2C3E357687B20EF0A35089A1E4348" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_88AAB2C209F30F6F032335089A1F6E28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_AmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:to="loc_ccrn_AmendedAndRestatedCreditAgreementMember_EED31CA2E094F15977A235089A1F7A36" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember" xlink:label="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5C835C614CEC9FB7723735089A1F09C8" xlink:to="loc_ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember_BC220341A79A01221CA935089A20BC1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_F82885AFA5BE0CB7115535089A2059E9" xlink:to="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_BCB196A2E8E718BD4D9135089A20B33A" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_AE5B55A0292BA3045E3435089A21A444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_B0B423DF13FE78C0C70135089A2165F3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member" xlink:label="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member_F4D51E3398C2B6D3C09B35089A2124FA" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingSeptember302019Member" xlink:label="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuarterEndingSeptember302019Member_95DE328DC5CF4565214435089A227293" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiscalQuarterEndingDecember312019Member" xlink:label="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_FiscalQuarterEndingDecember312019Member_9FB098F7FE0FC4F44DE635089A228924" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EachFiscalQuarterEndingThereafterMember" xlink:label="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_FF5CFBCAD7E0BF8689EA35089A216D13" xlink:to="loc_ccrn_EachFiscalQuarterEndingThereafterMember_BAC2BAF7926BA0880ADB35089A22EFE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_B30E679F1103568D03A935089A225EE1" xlink:to="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_54773BD17617FB033DE135089A23465C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:to="loc_srt_MaximumMember_54773BD17617FB033DE135089A23465C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_62018AE7BE1954A4CA3B35089A23E870" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2D8954F7CD039552883B35089A22E5E0" xlink:to="loc_srt_MinimumMember_62018AE7BE1954A4CA3B35089A23E870" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1E4A2C25EA4EA998D04835089A1C1119" xlink:to="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6C99C3B202F3A0EB255535089A2398AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6C99C3B202F3A0EB255535089A2398AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DAD6E37C11719FD6D6D935089A249E84" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans" xlink:label="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans_FCB58A3D558AD70BC0E835089A24D472" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit" xlink:label="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit_9085848EE517B81E8B3935089A24FAB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1C3236DEB278A27E4E3F35089A246EE3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LineOfCreditFacilityAdditionalCapacity" xlink:label="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_LineOfCreditFacilityAdditionalCapacity_F6BBA4DFFE4F4DB18D3E35089A248AB0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentForDebtPrepayment" xlink:label="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_PaymentForDebtPrepayment_FC7F1B054DDAE68CCFE735089A25EEFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8F304FF6A591A580A73235089A25E4B1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault" xlink:label="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault_4A741529F571D72D909135089A25CDD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_20E0E5F42F60A8372E2835089A255833" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NumberofFinancialCovenants" xlink:label="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_NumberofFinancialCovenants_3154F9CD8F85BB640C8135089A25A7FF" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio_37DBEE0C7421AD64EE5F35089A252FC1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantConsolidatedTotalLeverageRatio" xlink:label="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_ccrn_DebtCovenantConsolidatedTotalLeverageRatio_286FAAEB145F7417AEC335089A261BFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_945E7317013984965E9135089A26D24E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_D0E90AC3C6EFB7D2475635089A239D14" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_518027FBF8BA3C8E27DD35089A26DE7A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_729D5B85E9E9757A2E3334B41FD42DE0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_729D5B85E9E9757A2E3334B41FD42DE0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsAxis" xlink:label="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtCovenantTermsDomain" xlink:label="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsAxis_7FED8203A6F466B37DBC34B41FD55199" xlink:to="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm1Member" xlink:label="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm1Member_6B3DE6E357DA3E47FC2E34B41FD5FF3C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm2Member" xlink:label="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm2Member_FCDBFDDB6937180BBCB334B41FD6B003" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm3Member" xlink:label="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm3Member_2093561EE8BA8E7B3C4C34B41FD6DD78" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm4Member" xlink:label="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm4Member_57F6F9414F5477E26CCF34B41FD6936F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CovenantTerm5Member" xlink:label="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DebtCovenantTermsDomain_3ECE0738BE6CBD1C517D34B41FD5E851" xlink:to="loc_ccrn_CovenantTerm5Member_D18EEB05451D0EF2820734B41FD612F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_014C0050DB649D60E03534B41FD61912" xlink:to="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_3C3F49562104C4C5914334B41FD7D49C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:to="loc_srt_MinimumMember_3C3F49562104C4C5914334B41FD7D49C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_3EAC73BA64893CC132C734B41FD7815B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1393378B0FB0FCF4AF5334B41FD7523C" xlink:to="loc_srt_MaximumMember_3EAC73BA64893CC132C734B41FD7815B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7A0D879A4C14DAE2F8D634B41FD702E6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CreditAgreementMember" xlink:label="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0673BAF8CFD3D23F171634B41FD71210" xlink:to="loc_ccrn_CreditAgreementMember_07D11B685695D72CBC7834B41FD85B29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8E1ACF15EE3F1B0BC15834B41FD88417" xlink:to="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_EurodollarMember_651B6FC076740015C8BA34B41FD84BF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_F7609CCAF1D76A5A21A234B41FD92297" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LetterofCreditFeeMember" xlink:label="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_ccrn_LetterofCreditFeeMember_22EBA246D7B381C98F7734C08920659C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_BB14B28A25BC1710A3D534B41FD844D2" xlink:to="loc_us-gaap_BaseRateMember_281217F7EB268F0B39E434B41FD91992" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_07C4FE4251E43D99732E34B41FD51C20" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConsolidatedNetLeverageRatio" xlink:label="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_ccrn_ConsolidatedNetLeverageRatio_FA7DA87EBF4A2EEA426034B41FD9DF61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_703A92BB932C706C803534B41FD9591D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_703A92BB932C706C803534B41FD9591D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_5E2C6D4BC59175FB6E4734B41FD9685B" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_5C6CB03453C942C4340334B41FDA534D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1E61824D4EB0C74B4000BEE58830BBD4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1E61824D4EB0C74B4000BEE58830BBD4" xlink:to="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_F9885255F700D105F28EBEE588305313" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_DC1A2AA334726FE62A6EBEE588318E57" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_D4C83C623C16C14FCA70BEE58831F8AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_F7F44CF0733D3C0058E0BEE588302DAF" xlink:to="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_048A66C0097C4DD3DF19BEE588316F98" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1B759D6828E7A547128BBEE588324E98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_943D5513AE60D8269CD6BEE5883280F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2DE22C00020AA0A2F37CBEE58832F394" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_F9C65F004FDCB567CEB4BEE588321C11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_D40788997D865F8011FBBEE588325066" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_C309DC447ED2256CD5D7BEE58831899D" xlink:to="loc_us-gaap_LongTermDebt_BE41C736F517EF474359BEE58833CD56" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3082A70C90C74E41BFDBE5D9F8E9F3B9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3082A70C90C74E41BFDBE5D9F8E9F3B9" xlink:to="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_C9233D4778EEEACDAED5E5D9F8EA4770" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_92AB4821727C5EE46718E5D9F8EB9678" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4C01413B79930FE412BFE5D9F8EA0FC0" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_92AB4821727C5EE46718E5D9F8EB9678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:to="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_01B44DE0C81728C18C8DE5D9F8EB56B0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_B67EE41204140476741AE5D9F8EB5E2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8D66B09269AEB8FAC106E5D9F8EBE267" xlink:to="loc_ccrn_TermLoanMember_B67EE41204140476741AE5D9F8EB5E2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_471F8EFB8A778CF709F2E5D9F8EA4CB2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_67CFEECBEE1C6165D883E5D9F8EC58DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_LongTermDebtCurrent_0FA6D8305702AE808B5AE5D9F8F1021B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_LongTermDebt_9486E11D3ACECAC26833E5D9F8F184B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8C8ADA051E36220C3501E5D9F8F1D2FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_312D6E6EEA51F07DC6D4E5D9F8EB444A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_D65841CA60BC5127F894E5D9F8F20791" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93811C4F82F97427AFCBA9ED5B9CDD7D" xlink:to="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_F9E45A01A9B26BF81F2FA9ED5B9D57CB" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_A8ConvertibleNotesMember" xlink:label="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:to="loc_ccrn_A8ConvertibleNotesMember_CF8D7654F4041C995EFCA9ED5B9DB223" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNoteDerivativeLiabilityMember" xlink:label="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61BC730A1640108E196DA9ED5B9DD8D5" xlink:to="loc_ccrn_ConvertibleNoteDerivativeLiabilityMember_33526F454745027D5A93A9ED5B9E5F02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_F8D5DE3AF5FE9D70FD70A9ED5B9E959E" xlink:to="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_AB79BB405BA23E20343CA9ED5B9EC5D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2D4AECD79D14CE56BD3CA9ED5B9ED6F9" xlink:to="loc_us-gaap_CommonStockMember_AB79BB405BA23E20343CA9ED5B9EC5D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_30999B7E0671F4873098A9ED5B9F4596" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4C09C5B1FFB59D0E1B64A9ED5B9F1230" xlink:to="loc_us-gaap_ConvertibleDebtMember_44A0480E63389491ACEAA9ED5B9F8775" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6590E9CD5075E4798C75A9ED5B9C9462" xlink:to="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_48F9153ACB78290BA4ABA9ED5BA03618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_CBCAAC48C58B62C51F15A9ED5BA02052" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_A6425CE903C88C874183A9ED5BA0DA7D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt" xlink:label="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt_469BEB6AA496485BADA9A9ED5BA04F83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_38557C861537A317483FA9ED5BA126A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_742589BEC529009CD3BFA9ED5BA1B067" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_BACEC9969C6C74988E7BA9ED5BA1F370" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_875CDE585FCCB5C74267A9ED5BA11824" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_875CDE585FCCB5C74267A9ED5BA11824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_A229B74DA33CF742864EA9ED5BA198E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_3A6EBD95649D563106A5A9ED5BA2BA24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_C4544EE21BD4C879758FA9ED5BA2A58B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate" xlink:label="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate_61E04043098953F97D5EA9ED5BA2AD34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_5BE0788F4BF90AB894FAA9ED5BA24AF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3F38AEDB9F383116145DA9ED5BA2E063" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_CBBE9448F509FBFDA8A6A9ED5BA22170" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_FC8ED31A8EA1063A3C9FA9ED5BA0AD75" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_38AB1FC9F2FBF87D5BE9A9ED5BA240A9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_CA7091E4B1742DBF4D92A9ED5D5DA325" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_CA7091E4B1742DBF4D92A9ED5D5DA325" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_B00C1609E0F9A32E1BE6A9ED5D5EE247" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_CA7091E4B1742DBF4D92A9ED5D5DA325" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_EAC2B84C2B9E1A6D8E82A9ED5D5E7CE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_87C5160C1AA036F496C6BF8CAB8D3854" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_87C5160C1AA036F496C6BF8CAB8D3854" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_D443873A85EDB6565A53BF8CAB8EEC96" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_C97BB17D2CA7E7E331A930FF0D5476D6" xlink:to="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_197980AD999B26BA787830FF0D548CC7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SeniorDebtObligationsMember" xlink:label="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18D5BE717D2B8203199B30FF0D554A70" xlink:to="loc_us-gaap_SeniorDebtObligationsMember_81812F40B362C608027630FF0D55FF47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_BF7D9DB510A9552924F330FF0D558A52" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_4BDD0A1D9746A12E804D30FF0D5658C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_A24409DCAE6C32ED08EE30FF0D568E93" xlink:to="loc_ccrn_TermLoanMember_4BDD0A1D9746A12E804D30FF0D5658C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7AF9ACC8DE800158711F30FF0D562155" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_B2FF82EFE5A61834B07F30FF0D577790" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_C71B5BEE03D8F7058E9630FF0D56E65B" xlink:to="loc_us-gaap_InterestRateSwapMember_B2FF82EFE5A61834B07F30FF0D577790" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8381E020EB1A5D26BF8830FF0D54A609" xlink:to="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_D199C82E7C8410B0A99330FF0D574144" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_invest_DerivativeNotionalAmount_794FA9DCBDCFDEF600AD30FF0D586EE5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_A5D28254DD4D6E6D610030FF0D59E140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_861DC3F984AB14CDFD7631032A4001B6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_77F711ABED83D2BC3CB230FF0D57CEFC" xlink:to="loc_us-gaap_DerivativeLiabilities_861DC3F984AB14CDFD7631032A4001B6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DocumentDocumentandEntityInformationAbstract" xlink:label="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_DocumentType_5F554B317F792A1EFB58AA0177A037C0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_AmendmentFlag_7320D732CE764487A421AA0177A0857A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_DocumentPeriodEndDate_23FEFEB4E57119A9FA0EAA0177A0B591" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_DocumentFiscalYearFocus_37382DF9A9D0670A3C35AA0177A1C8E7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_317B4389221FEFA35DF4AA0177A14688" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_TradingSymbol_3FC4FE325A62E48175F3AA0177A15E9C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityRegistrantName_B0E94A00C4CB9FF5F327AA0177A104E3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityCentralIndexKey_85CCC26854BF0C677532AA0177A1610C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_CurrentFiscalYearEndDate_0E0731963A0185411CCAAA0177A24DE4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_790B34D8BC5DA3470A98AA0177A20DD4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityShellCompany_94896569D6FA23831A3CAA01D5CE6A16" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntitySmallBusiness_B1CC4DAC6788E7A2900DAA01797057C4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityEmergingGrowthCompany_761432285945992707E7AA01795A29B4" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityCurrentReportingStatus_05306DFDC16787B00DB4AA0177A21D3B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityVoluntaryFilers_3F6D8DFF3B331FFB3AF3AA0177A22504" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityFilerCategory_65850DBA2CFD7C7EFEEFAA0177A2F112" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_DA221753BF1C10A35D2AAA0177A3FADD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_DocumentDocumentandEntityInformationAbstract_C6ED9EBF73B3218C7FD2AA01779AE0C9" xlink:to="loc_dei_EntityPublicFloat_8452E291EC7934860E24AA0177A33628" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_488B9430F3C8E6F49205A9ED5CC64345" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_488B9430F3C8E6F49205A9ED5CC64345" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_997BC5030E5637E9EEAFA9ED5CC6ACA1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F3739394C5C7C2455FBFBFBE35BF3139" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_CCD0D1240137708647EBBFBE35BF78F2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember" xlink:label="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3F856765AF81B770C8D2BFBE35C06266" xlink:to="loc_ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember_66999F2CB83E78AF52FABFBE35C0B3E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_DA045CFF2760C4A66EEFBFBE35BF027C" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_12D4FBC425A52F9BB9D0BFBE35C052D0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_D9872B061963E1D1A40CBFBE35C10E08" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_AA3CA0D9E29FBD3DB6B5BFBE35C536E3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_AA3CA0D9E29FBD3DB6B5BFBE35C536E3" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_E98C80F72F714B1F71DABFBE35C66C85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_E12F21986FD2C62E15DABFBE35C653DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_CA2BEDCAD344B0F88AD4BFBE35C6FB6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_73652E68FAA4DA473F79BFBE35C6338F" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_CCAE0B33D9347F1596E8BFBE35C7A5CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_AA3CA0D9E29FBD3DB6B5BFBE35C536E3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_A4090DF1BFFD908901ECBFBE35C78161" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_22EAD52F73E4BDB8EC44BFBE35C7FC51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_0959B2B46C1D8BE2E0E8BFBE35C785A5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_E446F6009283EAA41A5EBFBE35C8573E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_8C88E78A8F6F0B718D0EBFBE35C7F956" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A46CC16CDD756DEA06BABFBE35C854FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_8A7A18D05865A74A5208BFBE35C8E83D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_AA3CA0D9E29FBD3DB6B5BFBE35C536E3" xlink:to="loc_us-gaap_EarningsPerShareBasic_8A7A18D05865A74A5208BFBE35C8E83D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_F2F649FB81E46B2DC24DBFBE35C814AE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_AA3CA0D9E29FBD3DB6B5BFBE35C536E3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_F2F649FB81E46B2DC24DBFBE35C814AE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_EFE5834632E200EE1E35A9ED5DD2FCB4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EFE5834632E200EE1E35A9ED5DD2FCB4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_D3F7B67CECBCD7508623A9ED5DD3B9B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EFE5834632E200EE1E35A9ED5DD2FCB4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_159F48708DFEA0675936A9ED5DD3CCF3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96BCBF72D2C276646DFDA9ED5DEBFB2D" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_7E1586FCFD71EDA71527A9ED5DEBDD13" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_B872BC15D3C9BC91BC17BFBE37D1805A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_B872BC15D3C9BC91BC17BFBE37D1805A" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_0E446EF5DDE1ED4DEE30BFBE37D1FC3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_B872BC15D3C9BC91BC17BFBE37D1805A" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_B161CF2D5E7A46F48AEDBFBE37D203F1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_42DAC5DA3D5053D3103EA9ED5BCC22E0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_42DAC5DA3D5053D3103EA9ED5BCC22E0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_76F49F9EF4933F669FEAA9ED5BCCB63E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0F0A9492A9DDA09396DD30FF0D20AD14" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0F0A9492A9DDA09396DD30FF0D20AD14" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5B128A797E4F35309C3830FF0D21A94E" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5FF4B15FC8B8A0E0FCAE30FF0D21ACEF" xlink:to="loc_us-gaap_InterestRateSwapMember_2C751D1DA69F79CF0D4630FF0D21F77F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_F3BD160A23862192972930FF0D222C48" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredCompensationMember" xlink:label="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_F81D6C04264BEE2B370B30FF0D22BCCC" xlink:to="loc_ccrn_DeferredCompensationMember_47EF6889BE795F40E1ED30FF0D2246C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37DC46558FB52DFD1ABB30FF0D23017D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_E2D4B9620C8E56E7B1A230FF0D23339E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_349EEDBF81ED116797C030FF0D23BEB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_AE2460608F023D8A6C6030FF0D235B9B" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_48DF17535EB5A5F1E3C830FF0D24C519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33C3D4AD9810C540418030FF0D20BE1B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9BFD1AE717F207192BA030FF0D240239" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_DerivativeLiabilities_B16F9178458540C8774231040DACC742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_91DD950B3C6F336CBACC30FF0D247204" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29DBC381B301C84E2A2630FF0D259D6A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_FDF4B4C46DD87E8F3D3BBF9D19A42257" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_FDF4B4C46DD87E8F3D3BBF9D19A42257" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_DB9CA78F28B8E78088D5BF9D19A4240C" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TermLoanMember" xlink:label="loc_ccrn_TermLoanMember_E3537D1487D0D6F2C18DBF9D19A5BD45" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34531F4CBD08D9AA9EE6BF9D19A5AC03" xlink:to="loc_ccrn_TermLoanMember_E3537D1487D0D6F2C18DBF9D19A5BD45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_22EA532DEA15D4DBFCC2BF9D19A5F1B0" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4B266DF977D6C5D45A9DBF9D19A6B164" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_520B4B42D386B6BD5F6DBF9D19A6A668" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4B266DF977D6C5D45A9DBF9D19A6B164" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_D34951E7A6FA4189EC4FBF9D19A68B7B" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_94AC285369A86978801DBF9D19ACC798" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_C40FECBD0B61AD7E759CBF9D19AC9E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7FAAFF65F554B4CA55E9BF9D19A68A2C" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_86AAD3C29210EFDAE33FBF9D19AC5007" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_21E65E6F4E48462F5798BF9D19A48B79" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="loc_us-gaap_LongTermDebt_C6623C664FC35E0E8282BF9D19AD26CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_1F71A0C4493945992FD6BF9D19ADCF6C" xlink:to="loc_us-gaap_DebtInstrumentFairValue_15F78ED200BE668E968EBF9D19AD6A91" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_30B8453B5AFB7A2489B1A9ED5DAB52DB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_30B8453B5AFB7A2489B1A9ED5DAB52DB" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:to="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_94D48AABD5A015EE7F04A9ED5DABE744" xlink:to="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8F9232E9FF5E92707B61A9ED5DAC8374" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:to="loc_srt_MinimumMember_8F9232E9FF5E92707B61A9ED5DAC8374" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_A9A3C0EA77DB0787DC70A9ED5DACC656" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2AEA0D6FB96228BE8DD3A9ED5DAC91F8" xlink:to="loc_srt_MaximumMember_A9A3C0EA77DB0787DC70A9ED5DACC656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_39A33E82C2C0FF76E69AA9ED5DAB40EA" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided" xlink:label="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1BF4E5BA132888134194A9ED5DAC9D60" xlink:to="loc_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided_AB93BD18A2E4DFB00512A9ED5DACBFED" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_B2B5A364414B99BC346CBF9D19BDCACC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_B2B5A364414B99BC346CBF9D19BDCACC" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_CDD121C1FAEC53CD47B7BF9D19BD1837" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContingentConsiderationLiabilityMember" xlink:label="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:to="loc_ccrn_ContingentConsiderationLiabilityMember_B5A7CF1D99286B76BA93BF9D19C3161A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember" xlink:label="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_AC5C86E4DA40E5FE3D0DBF9D19C2E08B" xlink:to="loc_us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember_1838A966B95914E8EF82BF9D19C3436B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2F188CF9968B64B06E11BF9D19BD6979" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6393899E1C4839BF5F9BBF9D19C404D1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6958E29D835ED1E7C884BF9D19C4BAE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0B31011B180250B4A8DCBF9D19C4324D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense" xlink:label="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense_1DA7CCEB438FD1C03878BF9D19C55DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_A284D0078E3FBE59F2C2BF9D19C5E64E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2810F2A9005ADCCCF365BF9D19C4CCE9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3FAEFC47B7D89F9CF8A0BF9D19C5E3E6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_AC34143BEFD7AB921870A9ED5CDAF129" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_7C08A5D9C3F5E8E7C0CDA9ED5CDBBAD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BE2D80CFEC32386CF9FAA9ED5CDA18E1" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_57FF7B6330D72E788798A9ED5CDB98EB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25A1BBD6EF2E155EC757A9ED5D48F40D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_25A1BBD6EF2E155EC757A9ED5D48F40D" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5647ECD109DD6C30C690A9ED5D48E9CB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F055F107F85B7D1E51ACA9ED5B877BA0" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_CFFF6713F1186A39D2A5A9ED5B875F4F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DatabasesMember" xlink:label="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_DatabasesMember_1F674203A5A9CC7C6D5FA9ED5B88C69E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3C268BFF24E379CF2967A9ED5B8971EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_77FFF04A30D634E6AB8DA9ED5B8953E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_B9BFBD77ECEB02DCE3B6A9ED5B88C9D7" xlink:to="loc_us-gaap_TradeNamesMember_E235A0A335AF536CA2C6A9ED5B894827" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_549CD1F80CA65252DA35A9ED5B87FD3B" xlink:to="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_B3FA0030BCA8A7D5AA32A9ED5B897392" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1F9A0A467AC30D72CD53A9ED5B8A4FEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B032D05BD0EAB9A3B5A0A9ED5B8A4C14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_22E7FBEABD9104315F30A9ED5B8A8594" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_FA2F8551718088222766A9ED5B89EE25" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_AAEBE805503480440A1CA9ED5B8A5C57" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DB932329689380C5A04130ACE37A0CEC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DB932329689380C5A04130ACE37A0CEC" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_CB363164EB787D0F6E0030ACE37B6756" xlink:to="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_70A8990AFBC24FFBE2B830ACE37C6ED3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_B847FA925715C2F6434030ACE37BE43A" xlink:to="loc_us-gaap_OperatingSegmentsMember_70A8990AFBC24FFBE2B830ACE37C6ED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_131295AC3AFF9815115830ACE37C2290" xlink:to="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_B16BB003BFDEECBC1F5130ACE37C7475" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_B16BB003BFDEECBC1F5130ACE37C7475" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_2AFE11D5387B9753C67230ACE37DE0D1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_PhysicianStaffingMember_2AFE11D5387B9753C67230ACE37DE0D1" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_28025D8F37EA79A9F8C630ACE37DE81B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_AED9B7C8216605AB90CC30ACE37C553C" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_28025D8F37EA79A9F8C630ACE37DE81B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_E6AD3A47D56F1DE1F99730ACE37B31C4" xlink:to="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_40B125BC489E3C13EC3330ACE37D09A5" xlink:to="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_Goodwill_92197561222413669B8230ACE37DB333" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" xlink:label="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_F1B2E7CAF1AB1819FE3830ACE6812C94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8A9F5FEDE693EE098D1630ACE37E4C79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillGross_E129D9FDF76A3903F56930ACE37E58EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5AF1DA530C32903D709730ACE37E8A46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract_AF690B90829F9D03E80B30ACE37E4B04" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3FC172AE2312BEB7E88F30ACE37F8BD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillGross" xlink:label="loc_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillGross_27F62D0346F5AE14A22530ACE37F9C10" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillWriteOffRelatedToSaleOfBusiness" xlink:label="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness_B252AEC898C9F3EF321130AE39EE3CA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_E160D6C9FD76313039FE30ACE37F5FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3D1138149EF408FB382030ACE37DE59D" xlink:to="loc_us-gaap_Goodwill_C418D4E00448B59C651F30ACE37F6C4B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1F4A9A3E30974FE805C7BEE5888D911F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_F43063862C3A2AE85976BEE5888E7B81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_085456417F63FB66962EBEE5888EA4A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_E566CA71395B2F223CF7BEE5888E6A90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2A37CACDE58833A89D85BEE5888EF329" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7AE78828D84500164404BEE5888EED9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_C6A14F28D33B90851550BEE5888EF1D8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_102235734D1828E8A481BEE5888D4B55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_C6A14F28D33B90851550BEE5888EF1D8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9278D28F78FB3BFD7576FE544782AE58" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureTable" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9278D28F78FB3BFD7576FE544782AE58" xlink:to="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_C3F693B3BA9217023DE7FE5447853E3B" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D19F7F2ECB145D10CA2FFE544785F6C0" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_91AB8B2BD69B616F3E94FE5447866A10" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3479D8FBDFA89220C34FFE544786BAD6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_28232624FC3A7318E36FFE54478691FD" xlink:to="loc_us-gaap_TradeNamesMember_A9193B21A588C0531D03FE54478795E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_417747656F626BDE5CBAFE5447875547" xlink:to="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_15B60C39029200048CBCFE5447879122" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:to="loc_srt_MinimumMember_15B60C39029200048CBCFE5447879122" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_E4E98EC444C5ADA14CC0FE544788B140" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55D7DF46768034CE5764FE5447877FD5" xlink:to="loc_srt_MaximumMember_E4E98EC444C5ADA14CC0FE544788B140" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_7C9EF8B0C54075B54798FE5447880519" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_270CE1749F0E27BF0E93FE544788DA51" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncomeandMarketApproachValuationTechniqueMember" xlink:label="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_ccrn_IncomeandMarketApproachValuationTechniqueMember_5BA584BE2A46273F3C50FE54478988F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_0D3D0284D9112858A54FFE544788AAC4" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_CE9622FD66C2E831DEEBFE54478920C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_88BD69294911F1B2E99BFE544789B985" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_C73411E770062F541D50FE56CEC82C79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:to="loc_us-gaap_TradeNamesMember_C73411E770062F541D50FE56CEC82C79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_94196A0584FB39F80B74FE544789959B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_181E00DD881CFEAA0190FE5447892223" xlink:to="loc_us-gaap_CustomerRelationshipsMember_94196A0584FB39F80B74FE544789959B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_42FC4565ED81D9719DB9FE54478AE618" xlink:to="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_43125113B0C054C899A1FE54478A1018" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_PhysicianStaffingMember_43125113B0C054C899A1FE54478A1018" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SearchReportingUnitMember" xlink:label="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_SearchReportingUnitMember_5A13766FC1507D42F3E6FE54478B0E6D" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_EF04C13D872553946EF8FE54478B7D30" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_CCEC0D2BC07BE54AFEA2FE54478A5C9D" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_EF04C13D872553946EF8FE54478B7D30" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems" xlink:label="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureTable_0487FF99ECE815B1B420FE54478493C3" xlink:to="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_B8D62E277066C79E90EAFE54478BB69B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_60AEA0D78209645D20BDFE54478B69C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6CFD1955180171D7952AFE56CE8FC4F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_CEAE649E8D53E682A012FE5793166658" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_CEAE649E8D53E682A012FE5793166658" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_A7D2F12FC62C4C645E7BFE55AAC329F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_E914D3F6D3488B21ABDEFE54478C6602" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_AssetImpairmentCharges_E914D3F6D3488B21ABDEFE54478C6602" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_4107E253B5BE56B9AAEBFE54478CA62B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_GoodwillImpairmentTestMeasurementInput" xlink:label="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_GoodwillImpairmentTestMeasurementInput_0377B3100B2FBC6B54D0FE54478CC360" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsTerminalValueGrowthRate" xlink:label="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsTerminalValueGrowthRate_FF103376D7B267B03AEEFE54478DBBD3" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsForecastPeriod" xlink:label="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsForecastPeriod_BB95DF802E72DD2F43FCFE54478D29A0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA" xlink:label="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA_ACA39544752994547362FE54478D9001" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_FairValueInputsWeightingApplied" xlink:label="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems_7EFE39981B0BA7BFD733FE54478B5817" xlink:to="loc_ccrn_FairValueInputsWeightingApplied_A5F8E25EF2FA43A34E16FE54478DFCDE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29084955150A2F9817B1A9ED5CA34419" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29084955150A2F9817B1A9ED5CA34419" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_C747739C4123CFE44B24A9ED5CA366BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29084955150A2F9817B1A9ED5CA34419" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_F0CF92AE143548BA3D8BA9ED5CA33028" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29084955150A2F9817B1A9ED5CA34419" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6FEB16C52F37BCD450D7A9ED5CA45DFC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_C95D4F0D960D909ABF5CA9ED5ABBCAC8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C95D4F0D960D909ABF5CA9ED5ABBCAC8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_E12909BF9B711B751575A9ED5ABB05BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_601434BDF0AA9559BFFBBFBE37886489" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_601434BDF0AA9559BFFBBFBE37886489" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0EBAC3B02535C2868335BFBE3788B714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_601434BDF0AA9559BFFBBFBE37886489" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7DE488AC08806B4C5BBCBFBE3789BC68" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_601434BDF0AA9559BFFBBFBE37886489" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2C83ACE2AE8CE383E55BBFBE37890D8C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_8EAA3A4B032EF9F57939E5D9F798BE05" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_496BE46D5A549ECCA0AFE5D9F798320A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_9807231BAD034331C08FE5D9F798279A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_C4FD0301F771A341D6BCE5D9F797DDE9" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_24D7D7FF9F3F8792163CE5D9F798CA85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_26B8A51CDB0D9C20A354E5D9F799DBAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_63638D102B437ADEA9A8E5D9F79926B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_0490CF77D64AEAF6EB52E5D9F799DE39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_C93B2650F5E7E6D02744E5D9F799274F" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_E429B1AEB81D94673042E5D9F7990CCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A9F877B85432BC411F5FE5D9F79763EC" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_994BC330637BAE622E65E5D9F79ADFEC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_465849DC3D9B63C69F4C35FFFC1833A9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_465849DC3D9B63C69F4C35FFFC1833A9" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetDomain" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_A518DD9C52F7A5E31B2935FFFC19EC51" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NetOperatingLossesMember" xlink:label="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:to="loc_ccrn_NetOperatingLossesMember_521CA41689988C9936ED35FFFC196CF7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherNetDeferredTaxAssetsMember" xlink:label="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetDomain_32CA6BB8750DDB937F7235FFFC198B87" xlink:to="loc_ccrn_OtherNetDeferredTaxAssetsMember_8EEEDB0EF71C2108DEA335FFFC1AB270" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_78AF7F6394544C7402D235FFFC1AA133" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_CF2032EE8C9011329BC235FFFC1B3BE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_DE923BCB57711102E01E35FFFC1A4054" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_30AB2878C2F2A927F59835FFFC1B7680" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4D0FDFE6D6E184A25DC635FFFC1BF9FC" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_DomesticCountryMember_6986D2C2C47DD871166735FFFC1B0531" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_1F4112BE959BFCA5ADC635FFFC1C95EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_DD616AF27D868117D8C335FFFC1BE795" xlink:to="loc_us-gaap_ForeignCountryMember_43812BC8CD1BEDF9B9E335FFFC1C2879" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_36F1C614E39853B1125E35FFFC188868" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_9D8875AD7790CA96313635FFFF7DCE69" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_4885AC602397E2C5B34735FFFC222412" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_05DFA966D282EDD4E99635FFFC22CC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_EC1EB7C2B8DA39C7DD3135FFFC22C1A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_OperatingLossCarryforwards_15367EEF7968F11A5FD035FFFC22D8B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_01F332021B0DC0AE20C135FFFC235E51" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RepatriationOfForeignEarningsAmount" xlink:label="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_RepatriationOfForeignEarningsAmount_412250370787A6ECAA8835FFFC23B891" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_41AA348AF04108D519C635FFFC237135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_097F219BD1EAB469D1BC35FFFC23DFC6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases_177E05B996DDA04299FD35FFFC236A77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_3CAB4154DE50D66C868535FFFC23FD66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_66D9A6FE8C2A29131DC335FFFC21FF9C" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7CFAFDF2565B7B8DD92535FFFC24EAE3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_C8BBA3E3342B356848F5A9ED5DEE21D7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C8BBA3E3342B356848F5A9ED5DEE21D7" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_A8436CA8F75EA69FA484A9ED5DEF07A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_1C037456825C0720E0F5A9ED5DEFA05D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_CA39C361B31D5A36EDD2A9ED5DEF4539" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_B532353A044593980A73A9ED5DF037DE" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange_F7F35081AF8F22CEF8B9A9ED5DF0789F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions" xlink:label="loc_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions_A4C9C5D5EA5A3B3052B3A9ED5DF017F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2D7D6ABCF0AD36B3915FA9ED5DEEAC41" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8C06F290489003B49B3CA9ED5DF07DAC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F938FA528D5946806B793600995B8546" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_B14947C65FCEDCAA293C3600995C3E62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_CF177E4C117DA8D60BCF3600995C1C76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_DD5664637B434A88830E3600995CEB6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1947F1C33926997525E33600995CD505" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_505E028701440681A6FD3600995CD486" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8A230E761BA3453ACAD83600995D8C86" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount" xlink:label="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount_EC95B1B9B33C92E93C7E3600995DC5A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_E643F90DF0ECA7CFF11D3600995D658A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_299AD350CE1F24A8B0AF3600995DBE99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8C797C9BF8006ADD8DF33600995DF529" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10F1566927A1F111C8AB3600995BA46B" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8C797C9BF8006ADD8DF33600995DF529" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_CA9B061DB2A9828635EEBFBE374F42D4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CA9B061DB2A9828635EEBFBE374F42D4" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses" xlink:label="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses_4AAD7915BDD51509403FBFBE375203B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_CEC6E62ABF21C20563E9BFBE3752E7A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_92AABDAB21DE1621BA5BBFBE3756AD29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_A088654009800024EBD2BFBE37578317" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_25644A00621B1FEF8583BFBE37578323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_34ED140FB2C2AAE4A403BFBE3757E714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_4C32B9B209F4083A7C8DBFBE3758200A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5FC870A0396EC676CE4CBFBE375893E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_582626919D0CEE95DA24BFBE375864A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2DD864E49F0500166E35BFBE37594C23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_650D8F1794B1826D99DDBFBE37597BE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_E822F15D78F87BA42F6EBFBE37507A55" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4D632E319BA5A902EDC7BFBE3759E66D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CA9B061DB2A9828635EEBFBE374F42D4" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_47AD94B651DC13223F88BFBE375A687C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_19D0266C0B9B44A6139DBFBE375AECC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_44530307906999600405BFBE375BBADD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_7ECC21799EB12E5DFD72BFBE375A2E47" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0AF669C52DE3CE1B0613BFBE375BDC58" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_DeferredTaxAssetsLiabilities" xlink:label="loc_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_CA9B061DB2A9828635EEBFBE374F42D4" xlink:to="loc_ccrn_DeferredTaxAssetsLiabilities_23F054424CBAAB82E683BFBE375B585D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_24DBA94A7FAA827D83EEA9ED5E66CA57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_CC79FE49DC74CFE1CF09A9ED5E66C1C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6308078CD5D28BAEE8EBA9ED5E66487B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_B34B6239CD68851D2E49A9ED5E675951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8125999531C6AFC1A6AFA9ED5E667A21" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7B978089426570318491A9ED5E67B714" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7C48D84C48BFD426D8AFA9ED5AA423C5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_D5E751A0F911666B93E1A9ED5AA52996" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipment" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_EF86507F56801A6746ADA9ED5D35D4E5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_EF86507F56801A6746ADA9ED5D35D4E5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_B539C42F7D3A887E5FADA9ED5D35AAE2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_467917165DD98E9BBD81A9ED5CEAB801" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_467917165DD98E9BBD81A9ED5CEAB801" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_69FF39929408DDE5A79DA9ED5CEA5FA3" xlink:to="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_B58F2A3E7281FA83FD9DA9ED5CEB3CA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:to="loc_srt_MinimumMember_B58F2A3E7281FA83FD9DA9ED5CEB3CA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_353534A6C71ED9A3C709A9ED5CEBECA0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0F543D2ABE809C415E04A9ED5CEB6763" xlink:to="loc_srt_MaximumMember_353534A6C71ED9A3C709A9ED5CEBECA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7C977E1B66AEC611CD59A9ED5CECBB31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_ComputerEquipmentMember_D7A1AC32C6C68C3E0709A9ED5CEC5B3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4116DC4D3EEED4B2539CA9ED5CEC997B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_OfficeEquipmentMember_D2023C3888EEE03E710FA9ED5CEC06D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_07C6CC99106B71D94E87A9ED5CED0158" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3A66082B48500F714B56A9ED5CEC375A" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1CCE8432348C883588F8A9ED5CED64DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_216FCEDF1075F93CEB33A9ED5CEA9598" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8B2442A4DAC6D34DC045A9ED5CED4B32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8D162D10E6F909D60FB6A9ED5CEE2DFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_A6D56A2CFF99797A9367A9ED5CEE21AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7E9B6AAE7119A162F61AA9ED5CED001E" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_2A44EBDAAB91EF505460A9ED5CEE9E05" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_D3C97E4A6313D3F3E673A9ED5CF50B0B" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9179498045DE66A08555A9ED5CF6144E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_AC10E3B16F14D3B37BCEA9ED5E8D9D83" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_8D1AF12F19B0AF6C660FA9ED5E8ED296" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_4AF85E21AFD8CF5B1BF6360098A2C8EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_Revenues_4AF85E21AFD8CF5B1BF6360098A2C8EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_GrossProfit_603147C76031E6D2CBCC360098A29B1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_AA409927DA0927D0CF66360098A234CA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_ProfitLoss_AA409927DA0927D0CF66360098A234CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_NetIncomeLoss_AEB686C49453634FCF35360098A24650" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_EarningsPerShareBasic_6BF5BF451068DB833062360098A26732" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_EarningsPerShareDiluted_A40A52C55438C0F4BD95360098A38A89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_D03ED7C8EC439FD4AB58360098A1458C" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D90CFF64EFD6EE33811C360098A36141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_210B74BC859C59486F7B360098A441AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3C81965B169345C5DA85360098A38033" xlink:to="loc_us-gaap_ConvertibleDebtMember_210B74BC859C59486F7B360098A441AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_0E6C0B36658B4247F529360098A38683" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_EC17EAAC6223A53CE263360098A4E076" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_AssetImpairmentCharges_EC17EAAC6223A53CE263360098A4E076" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_CAAFBF255DE2B89BD789360098A47F49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2E92845EB1F5CC488930360098A4A2BC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2E92845EB1F5CC488930360098A4A2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_98581E6B750E62E50E8136011144AA93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_C2F8AEA9ACE22670EDCC360098A56E77" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_22041E9D0B0704FF0801360098A47214" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_C2F8AEA9ACE22670EDCC360098A56E77" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_9E34616DC564AB1F671BA9ED5BD9489A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_9E34616DC564AB1F671BA9ED5BD9489A" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_CF427B1AE1FA905B6FB5A9ED5BD9F3B2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_00715372BF37A6637F83A9ED5BD71956" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_F1503812AF0CD94EB8E5A9ED5BD73D1E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_285B8F7E7D071CE60CF434B41EEFBFBF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_285B8F7E7D071CE60CF434B41EEFBFBF" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0EC1AAD5FA3EDA04499834B41EEFBCDE" xlink:to="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:to="loc_us-gaap_CorporateJointVentureMember_77C28428666F4792DF8734B41EF091E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_75EA13373D190C346D3F34B41EEFD3EF" xlink:to="loc_srt_AffiliatedEntityMember_28EED07B32EF93D7578634B41EF02F34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7E4753C52DF19B5C0C6C34B41EEF45F4" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromRelatedParties" xlink:label="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_RevenueFromRelatedParties_7BCDE1973A47D11148FA34B41EF032DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableRelatedParties" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_D654B8AD14C0EB1A029E34B41EF1E258" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_JointVenturePercentOwnership" xlink:label="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_ccrn_JointVenturePercentOwnership_B471BD3882822EB762D434B41EF1FCEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueFromJointVenturesCurrent" xlink:label="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_DueFromJointVenturesCurrent_3F11E0319169CAFE928634B41EF171C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_70EDF106EE09C58FC21534B41EF1D416" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_66DC8C56DA12A272740C34B41EF024A2" xlink:to="loc_us-gaap_PaymentsForRent_52283F7D1962D0A95DEE34B41EF15BF8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5A35ED831E79E9B2A8C4BF32C75CDDEF" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_DE046995AC1C400F92D4BF32C76277F6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_FBCC2AE111F05B3ADF19BF32C865BCDE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_FBCC2AE111F05B3ADF19BF32C865BCDE" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E8A16B97A8DCA8419B65BF32C8651260" xlink:to="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_FCF79F8736B03786C179BF32C8666D5B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_FCF79F8736B03786C179BF32C8666D5B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_PhysicianStaffingMember_FC47887E660446F3D00FBF32C8674FB8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_E8858B748FB99DF82E63BF32C8671281" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_A3B2229D6E79C394CC3DBF32C866CA0B" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_E8858B748FB99DF82E63BF32C8671281" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1AF92FE9300A68452EC7BF32C867E5BF" xlink:to="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TemporaryStaffingServicesMember" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_72729A42632BB883CCE8BF32C8683002" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_72729A42632BB883CCE8BF32C8683002" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherServicesMember" xlink:label="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_55254EB0A00FE742E527BF32C86716D7" xlink:to="loc_ccrn_OtherServicesMember_59FF82ECEBD82CBA09E4BF32C8689AC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_EF61888D477DD890358CBF32C8657C8C" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_053BC5ED61E1055B3541BF32C8682637" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_735218D73B3945CABBDFBF32C868AC68" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_C90EA0EE60432B56E9F2BF32C7A0190B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_C90EA0EE60432B56E9F2BF32C7A0190B" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_90DCD8463DA3AD66C4AFBF32C7A1D0DB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_369505CE25B825F54ACDA9ED5CF8ED94" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_369505CE25B825F54ACDA9ED5CF8ED94" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_F9C52044A86F6592BB7EA9ED5CF826B7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_0332E4CD504D85CA5A90BFBE35785265" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_D7B155674A4C36723164BFBE35794956" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_039121DCEEC97F9F915ABFBE357AA3F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_FA90B39EA85B31B53C35BFBE357A3474" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_02B40C49EF451F602982BFBE357A9B3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_A2AC308D994925E24FA5BFBE35791DC0" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_62866BE3D7711A9E58BEBFBE357A305F" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E4170606D4E2FBD6234CBFBE357B6F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_B871B2489CE9789BAC6ABFBE357B3C56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_5459009C1CCF8135A517BFBE357BEC52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_104A3072AC80373B3213BFBE357BB10A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_A950CC49740E735A0A8EBFBE357A557D" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_43CC6CD98B105708A136BFBE357C176F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentData" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_4D2026FC88F7F4391D61A9ED5C5FE5B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4D2026FC88F7F4391D61A9ED5C5FE5B1" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_7EB63CB3891B57C29664A9ED5C5F2A0D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_CE24851B2B834BC74DC2BFBE3595562F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CE24851B2B834BC74DC2BFBE3595562F" xlink:to="loc_us-gaap_NumberOfOperatingSegments_83F739EB32ACD446B2B1BFBE359A7515" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_D8B67019053E9AB0836D305E992F6F7D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D8B67019053E9AB0836D305E992F6F7D" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_726EF22DB2F7B9B6AF77305E992F7D7F" xlink:to="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_D627D8CAAD82F1EB6459305E992F44C9" xlink:to="loc_us-gaap_OperatingSegmentsMember_A0ACB6C771B13DBEE5E3305E9930D48A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_C0965E09EC7B057C8F6F305E9930C7C9" xlink:to="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_NurseAndAlliedStaffingMember" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_D6777E8F1D0C303075B7305E99309568" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PhysicianStaffingMember" xlink:label="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_PhysicianStaffingMember_8AE7770AAC4C1869305D305E99312E6A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OtherHumanCapitalManagementServicesMember" xlink:label="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1C9795693EA8F25C6A27305E9930970F" xlink:to="loc_ccrn_OtherHumanCapitalManagementServicesMember_A677670761DD5E5E6BC5305E99316CDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_9DC8C9D58F81AAC2EE8F305E992FCA41" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_Revenues_BE04C07334BC559ADB75305E9931EF32" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses_8E62D7E3BB3D89BC295A305E99318577" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_7915C5F8F9187E889D47305E9932B7EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ADBF0BB5247C9EC44F7B305E99327192" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ADBF0BB5247C9EC44F7B305E99327192" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_C4C059BE424D6CE569CF305E9932CF7B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_C4C059BE424D6CE569CF305E9932CF7B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_BusinessCombinationContingentConsiderationArrangementsExpense" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_85255984B397EBF27850305E99320226" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense_85255984B397EBF27850305E99320226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_A923DF94A74DEA37D2A6305E9932B32C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_RestructuringCharges_A923DF94A74DEA37D2A6305E9932B32C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_A29DD3EFF90C4D3121AA305E9932A4AE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_AssetImpairmentCharges_A29DD3EFF90C4D3121AA305E9932A4AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_642E75689027AF5446E7305E99337BD3" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_FCCEF8674FC5C9471499305E9931C202" xlink:to="loc_us-gaap_OperatingIncomeLoss_642E75689027AF5446E7305E99337BD3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SegmentDataTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6959ECB95A9ADD524A7BA9ED5C5D7BB4" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_E751A80042D2843242D5A9ED5C5DFF44" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_18B72D5D4964913048C5A9ED5B693508" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18B72D5D4964913048C5A9ED5B693508" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_25B77B995D01CD966BBFA9ED5B6AD8F6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_85F479C8B6740B00D6D5A9ED5E19127D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85F479C8B6740B00D6D5A9ED5E19127D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:to="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_F57C6D790706CED9641DA9ED5E1AC5CE" xlink:to="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockOptionAndEquityParticipationPlan1999Member" xlink:label="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_A0DCC2C8BE41185C3CF6A9ED5E1A1010" xlink:to="loc_ccrn_StockOptionAndEquityParticipationPlan1999Member_E18CB98096043DF848C7A9ED5E1B00F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_DAB030A0CE21BF639462A9ED5E1ABE4E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4156BE21ED9A14ECD6D1A9ED5E1BA923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8770020850D9157E14D8A9ED5E1B7314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_C532219631177A8F228CA9ED5E1B8CA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_82DF6DE5F33D84DBBBBEA9ED5E1CCF54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2C4DCB08CD10C3F799E1A9ED5E1B492F" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_C3D76977CE9D20AE09E3A9ED5E1CCBDE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_5DA41B253C4C36C94A7834B41F2B6571" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5DA41B253C4C36C94A7834B41F2B6571" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_28C3C3955A2DEE3DF9F334B41F2C524E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_E20414E89A354B22D86C34B41F2D0F74" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_RestrictedStockMember_E20414E89A354B22D86C34B41F2D0F74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_8034EE6F74CE82359A5234B41F2D5E4B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_PerformanceSharesMember_8034EE6F74CE82359A5234B41F2D5E4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_EC76788A988F4E5F319F34B41F2CB7E4" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_7C16A2AA7740D31A26CE34B41F2DEA34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualAxis_AE5C664DD6A176DE5E7834B41F2D0C8E" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TenPercentOrMoreStockholdersMember" xlink:label="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2DA01D875D73940B3F1234B41F2E685B" xlink:to="loc_ccrn_TenPercentOrMoreStockholdersMember_3D8EC7C50ECEB9AE024D34B41F2EF2EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6341A50C4E0734F8547234B41F2E709B" xlink:to="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_CBA83B128B70F7ED1C5F34B41F2F1308" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:to="loc_srt_MinimumMember_CBA83B128B70F7ED1C5F34B41F2F1308" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_F31FDC7F45801FB0124734B41F2FB7D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_DEF637AF593DA264446A34B41F2FDFFA" xlink:to="loc_srt_MaximumMember_F31FDC7F45801FB0124734B41F2FB7D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_35F0D5EC59FA5165343C34B41F2F4206" xlink:to="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OmnibusPlanMember" xlink:label="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:to="loc_ccrn_OmnibusPlanMember_F846137D0D2F8884874F34B41F3072B5" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IncentiveCompensationPlan2007Member" xlink:label="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_AA6FB2935D1C11F1948D34B41F30891A" xlink:to="loc_ccrn_IncentiveCompensationPlan2007Member_291923C73E88522B0D0734B41F3132AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D256DD746E0F40565C0F34B41F2CF8A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7C7013886738C8B4C5FE34B41F317A35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_67601272A13997372A3734B41F31287A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_A7A400A7818F4D764AD634B41F310480" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod_D7204509CC5A345F3D2734B41F32F349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_249EB594E40507527A9234B41F32A588" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_6E02554E5EA5AB0A56E734B41F32B472" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage" xlink:label="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage_47AEDD1D05BEF751278434B41F328C89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4ABE127EB14236C2106534B41F32700A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_D9AC18C17786695E639734B41F320E18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8C5F796EC1F91CD2F4F734B41F3334FB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1F928E91F57682E9366E34B41F313A8C" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested_AB2D4777DE77CAE28EC734B41F336F6B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_8E058ADD585D626CACCFBFBE36A73437" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8E058ADD585D626CACCFBFBE36A73437" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_13CEDE1E40F622EA0BC2BFBE36A720C8" xlink:to="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A5914CDB8C91C9DB8D93BFBE36A82E3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39C4BC022F6103147890BFBE36A8A4FE" xlink:to="loc_us-gaap_CommonStockMember_A5914CDB8C91C9DB8D93BFBE36A82E3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_C7D2A7803490E5CA42C7BFBE36A7091E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_3748AA4C556B9895F6C8BFD8DDFEDCFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5FEE47ECF103291F01A6BFD8DE30DFEC" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_StockRepurchasedDuringPeriodPricePerShare" xlink:label="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_ccrn_StockRepurchasedDuringPeriodPricePerShare_3B332988E6711ED2F36EBFD8DE75B990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_1FC2D63D50E3807D224CBFBE36BF5AFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80B401DE51FDE402F45DBFBE36BE499A" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2A59FEC6001CF9CF06B4BFBE36C04965" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_FB318EA47F3C62F65DDCA9ED5D30F311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9DC6366E0ED8095C0E32A9ED5D31956C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_94D56003E1C852248324BFBE35E40C00" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_94D56003E1C852248324BFBE35E40C00" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_74F11389245E76EDC197BFBE35E47014" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeOneMember" xlink:label="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeOneMember_918847E362E67199ACE6BFBE35E50B6F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeTwoMember" xlink:label="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeTwoMember_5D649C67BF0C60B8A167BFBE35E5354B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeThreeMember" xlink:label="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeThreeMember_C2506B39901CD3971C0CBFBE35E6C1F8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFourMember" xlink:label="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeFourMember_E6728640E81149AEFB03BFBE35E66608" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExercisePriceRangeFiveMember" xlink:label="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_C3321EB997B3FDB12D9ABFBE35E470E0" xlink:to="loc_ccrn_ExercisePriceRangeFiveMember_148708A0D229CCED6E88BFBE35E6307E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7D41A6D607411C49C8D9BFBE35E45371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8A62D833BEBE5A4E48C8BFBE35E7DEBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0875CA806FFC208F39E4BFBE35E89079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_B9A9CFC5357282BBCB71BFBE35E8D0A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_76CFA3CA7DD4359D0F8CBFBE35E89D9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_A5ABBF80E973402E29D7BFBE35E7F68C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6FA3FE3E05402BE8DF77BFBE35E851B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_C2CEC429099F9E4865F8BFBE35E9EC4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_7266B63DDA61024C3B71BFBE35E91DA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_DDBDCE0CD274EBA707FCBFBE35E9D52F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_352BFF2EC8649B129427BFBE35EA321B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_77C6804B1F36B9273EACBFBE35EA4F31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1B0FFAB326FE5F91D036BFBE35EA27A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_76C1322B4023F2EF44FABFBE35E905A7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CCFBB57186772D34BF3CBFBE35EBC38E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_F0D3405F3EB19CB69FA1BFBE35EB0295" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_C8F0BEBB1C79B5493B89BFBE35E74C02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6B3750EFF44565F87B73BFBE35EB24C9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_65263D300C08EF27EE69A9ED5DE4128F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_65263D300C08EF27EE69A9ED5DE4128F" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:to="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_96CE1B551B47CE6ED0DFA9ED5DE5F4AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:to="loc_us-gaap_RestrictedStockMember_5844F79F88EC270AAB93A9ED5DE636D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_AACA95EBB6219D3A8A22A9ED5DE566D8" xlink:to="loc_us-gaap_PerformanceSharesMember_B26C919157CFCDC62D66A9ED5DE67302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4CA4862955A6F92E8EF1A9ED5DE55C71" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_72112015A5400306CC6AA9ED5DE6C80B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0F709593508C1427F85EA9ED5DE75349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_AB07F136AA29E4ED2026A9ED5DE7E32D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6E39A9917F64B56F3594A9ED5DE7BA73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9AD6B25E214413C9927DA9ED5DE6D0E6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4282981B0DFA697770E5A9ED5DE7A7A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5780056AC1C3D3E1A8FDA9ED5DE6FDCB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98AD3F9BDB793F8EFC79A9ED5DE84C35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06D6E418DDDBDC7EE361A9ED5DE89B57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9EE3AE0050AD305E8479A9ED5DE84210" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_B2D5E0547468616ADC7EA9ED5DE9DE43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1E35562110A332304691A9ED5DE86B3F" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ABAC3D93A645CE9E3D53A9ED5DE95F86" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_23010748CB49C7C9AD21A9ED5BF53FC1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23010748CB49C7C9AD21A9ED5BF53FC1" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_B28D69B33F229B8E320BA9ED5BF54FFB" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock" xlink:label="loc_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23010748CB49C7C9AD21A9ED5BF53FC1" xlink:to="loc_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock_16524C134D7ADF4A346FA9ED5BF6B28E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_23010748CB49C7C9AD21A9ED5BF53FC1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0E40A1DA98E686A82C86A9ED5BF6C476" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_FBA1148D7B2AB39C24AAA9ED5BC91F56" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_FBA1148D7B2AB39C24AAA9ED5BC91F56" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7C75FF1BC8F8A95C08F8A9ED5BCA4673" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2677CE86A6A82CFEC3C134B37F865D1C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2677CE86A6A82CFEC3C134B37F865D1C" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_AA3DC869C40FD4F9C92B34B37F8EA9B8" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_6E70F3E8E4F38F4CCA9E34B37F8E6B84" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_02E219E75F3E54CF313A34B37F8F4E29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_918A707E31C2B8E1790634B37F88FB91" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_B630024E0B6247727AD634B3F13D80E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_3BAD20AAE08A78BEDC9234B37F8F10B3" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_09C7F446FA66A892320234B384822109" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9310BC68BCA7DA2A4D0B34B420B48308" xlink:type="locator" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesTable" xlink:label="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9310BC68BCA7DA2A4D0B34B420B48308" xlink:to="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6A452153AF8722E4349234B420B5607A" xlink:to="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_286685576908DF88327934B420B582E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:to="loc_srt_MinimumMember_286685576908DF88327934B420B582E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5A8188549C12DD35ED3434B420B62718" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8B86779FE0729E89DE4F34B420B587F0" xlink:to="loc_srt_MaximumMember_5A8188549C12DD35ED3434B420B62718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_DFD8D465CE77D4F0ABE534B420B64D72" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6BD31948CA91C0F2715D34B420B6A9C7" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_C239D3E73395CE32A3CB34B420B6E8C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_1137A66F2CD0034FD15B34B420B72795" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember" xlink:label="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:to="loc_ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember_2740AE2284E7B8F33FA434B420B78820" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ClaimsBasedLiabilityInsuranceMember" xlink:label="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_B72E6398C669DB9221BA34B420B79257" xlink:to="loc_ccrn_ClaimsBasedLiabilityInsuranceMember_0F0ED6F244B1E6F9A34C34B420B77C3C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_F7C74D69D01FAD58E25934B420B7EFF5" xlink:to="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MDAHoldingsIncMember" xlink:label="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_187A12FEA649C08C059734B420B8083E" xlink:to="loc_ccrn_MDAHoldingsIncMember_6113411F15A2213DD37134B420B8ACD6" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SignificantAccountingPoliciesLineItems" xlink:label="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesTable_431962AE042155C1927834B420B4FE60" xlink:to="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_InterestIncomeOther_3D197B617D49300ED5AD34B420B8B12A" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContractualTerm" xlink:label="loc_ccrn_ContractualTerm_06895CA4689DAF82AA3D34B420B915C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_ContractualTerm_06895CA4689DAF82AA3D34B420B915C8" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_LeaseExpirationPeriod" xlink:label="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_LeaseExpirationPeriod_D826283C9F4850DF7FB934B420B9231A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_07A99C91231DBFC4871934B420B917D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_332C74CE2B9D37E3712E34B420B91D2C" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan" xlink:label="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan_9FB473537CFB3E8F702734B420B9A684" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim" xlink:label="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim_C316130853887C5F435034B420BA9BD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident" xlink:label="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident_68400E8F534AB7DE97FB34B420BA5ED2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds" xlink:label="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds_94BC25FFF175EC78493734B420BACCEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_02DF2C9D8F34B3F3137534B420BAE23A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AdvertisingExpense_2E00ACF754F01042CD1234B420BA2A2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0BAD779B0206A9506A0734B420BA0489" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_01AA0F6BE8B5EE2A697D34B420BB9801" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense" xlink:label="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_2F99D124D526BF3B3F6F34BC10C2FC43" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense_2F99D124D526BF3B3F6F34BC10C2FC43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_SignificantAccountingPoliciesLineItems_E9CABD0918C9B19C2CFE34B420B8A1C5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_BAB7EB77481759E92E4734B420BB2A85" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_UseOfEstimates_44519B0636959BAB3A35A9ED5DB2343E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_068D37E8BF38590A048AA9ED5DB3E744" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_7541D82BD038D5CEF4D6A9ED5DB36561" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_PrepaidRentAndDepositsPolicyTextBlock" xlink:label="loc_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_ccrn_PrepaidRentAndDepositsPolicyTextBlock_BEFBA52DB9D43F76769AA9ED5DB30EEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_746E7E1877C6D2AC9539A9ED5DB33F47" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_D7A98DA2165015C8F97CA9ED5DB38472" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_EADED270985081C0D31CA9ED5DB4F28A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_DebtPolicyTextBlock_DAFDE0EC80546C786B11A9ED5DB4B22B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_20C17511D03CAAFC75CDA9ED5DB47F7B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock" xlink:label="loc_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock_A5D39FDD6E56798A8974A9ED5DB4D079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilityReserveEstimatePolicy" xlink:label="loc_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_LiabilityReserveEstimatePolicy_29791D55CC75B7156A98A9ED5DB48B64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_F59818C368716D8D05B3A9ED5DB4DE04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_A7911F3B4E5459458997A9ED5DB5A490" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_C42A181B6A16EE2A35FEA9ED5DB56434" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_80B061C405BFB7D9C51AA9ED5DB5A95D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_3999C09171BDEAB2BA0BA9ED5DB5CC2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_88A9D1B6117EEF88DA62A9ED5DB54B6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_05694A1C83AE5B907503A9ED5DB51025" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9EDBDB46CA947A8A4600A9ED5DB6E383" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_601A5138DE294409AF11A9ED5DB6E828" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_29213EDFDD60DCF8DF6DA9ED5DB29956" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_686B70989059C1ED40FEA9ED5DB69011" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7BE1B51EEEE122384B30305DD2536116" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7BE1B51EEEE122384B30305DD2536116" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_D5F6D3FD3D18D880D043305DD254EC85" xlink:to="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_CostOptimizationProjectMember" xlink:label="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_E6079A41EFB813B4D906305DD254895F" xlink:to="loc_ccrn_CostOptimizationProjectMember_9D8999451EDD63B6DBE3305DD255B041" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_CC3B395CC0A802D07B86305DD255F8DC" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_us-gaap_EmployeeSeveranceMember_0F476A8530181C04D535305DD256BAC4" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ExitCostsMember" xlink:label="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_ccrn_ExitCostsMember_A946C0BFF08CA92CF5F6305DD2564691" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2899A06FC3112FE42BA3305DD256BE73" xlink:to="loc_us-gaap_OtherRestructuringMember_FCA320D3D9948D44223C306BC3929DB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E944EA31B820F4A819FD305DD2532DBD" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_RestructuringReserve_9ECC78385F52F57D36A0305DD25742E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/netLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_RestructuringCharges_6BA9FB25FA75EDAC359F305DD2589735" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_PaymentsForRestructuring_53041292F32BA90E9202305DD258189A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_5BAD0C34ACFEB0DAA32C305DD257E68D" xlink:to="loc_us-gaap_RestructuringReserve_6C8B49A4D0D1A735A638305DD25D74F0" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_RestructuringChargesWriteOffRelatedToAbandonment" xlink:label="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1FE38CC502202823DFCB305DD25734BF" xlink:to="loc_ccrn_RestructuringChargesWriteOffRelatedToAbandonment_B01917194CE2FFE3F0BF305DD25DF6E4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_C97CFB2151ED22659934305DD3EDF26A" xlink:to="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_277D1A3F20B06B0D8B58305DD3EEC9B6" xlink:to="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:to="loc_srt_MinimumMember_5565333C08CE793041ED305DD3EE9991" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_C167048AAD0DF849DEE5305DD3EE3508" xlink:to="loc_srt_MaximumMember_5749AEFDDA6C82BA9D78305DD3EFEE5A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7B9EC67C81FBAAFF947F305DD3EFE45B" xlink:to="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_TemporaryStaffingServicesMember" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_06FA3B273E88443F15D9305DD3EF0373" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_FB6FDF30040850BF8783305DD3EF9430" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_59A809B421C2DB1BA96C305DD3F00048" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7C338C052EA33CA4A851305DD3F03909" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_D71511E0CA461FB6EFDB305DD3F09F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5A4A71C07536970865BC305DD3F0C584" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6AB531771396F84D7FCC305DD3F1F805" xlink:to="loc_us-gaap_SalesRevenueNetMember_7A9E444E00C03755E5B3305DD3F1519F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_D85C1FF46CC3D13B9FC5305DD3EEB582" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:type="arc" />
    <link:loc xlink:href="ccrn-20181231.xsd#ccrn_ContractualTerm" xlink:label="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_ccrn_ContractualTerm_998352351515CC185E703069204DAAEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnbilledContractsReceivable" xlink:label="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_us-gaap_UnbilledContractsReceivable_35DE5B1DEDDB7CF87331305DD3F7FBD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_441F96416D000EC31536305DD3F1F42B" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_AB555A1D1E902ADC3E90305DD3F73223" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_CDBC78C396922536D472A9ED5B434CC1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_CDBC78C396922536D472A9ED5B434CC1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5BD0A62501599479F133A9ED5B43F6BB" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>14
<FILENAME>ccrn2018123110ka01.pdf
<DESCRIPTION>10-K
<TEXT>
<PDF>
begin 644 ccrn2018123110ka01.pdf
M)5!$1BTQ+C4*,2 P(&]B:@H\/"]4>7!E("]086=E<PHO2VED<R!;,R P(%(@
M-2 P(%(@-R P(%(@.2 P(%(@,3$@,"!2(#$S(# @4B Q-2 P(%(@,3<@,"!2
M(#$Y(# @4B R,2 P(%(@,C,@,"!2(#(U(# @4B R-R P(%(@,CD@,"!2(#,Q
M(# @4B S,R P(%(@,S4@,"!2(#,W(# @4B S.2 P(%(@-#$@,"!2(#0S(# @
M4B T-2 P(%(@-#<@,"!2(#0Y(# @4B U,2 P(%(@-3,@,"!2(#4U(# @4B U
M-R P(%(@-3D@,"!2(#8Q(# @4B V,R P(%(@-C4@,"!2(#8W(# @4B V.2 P
M(%(@-S$@,"!2(#<S(# @4B W-2 P(%(@-S<@,"!2(#<Y(# @4B X,2 P(%(@
M.#,@,"!2(#@U(# @4B X-R P(%(@.#D@,"!2(#DQ(# @4B Y,R P(%(@.34@
M,"!2(#DW(# @4B Y.2 P(%(@,3 Q(# @4B Q,#,@,"!2(#$P-2 P(%(@,3 W
M(# @4B Q,#D@,"!2(#$Q,2 P(%(@,3$S(# @4B Q,34@,"!2(#$Q-R P(%(@
M,3$Y(# @4B Q,C$@,"!2(#$R,R P(%(@,3(U(# @4B Q,C<@,"!2(#$R.2 P
M(%(@,3,Q(# @4B Q,S,@,"!2(#$S-2 P(%(@,3,W(# @4B Q,SD@,"!2(#$T
M,2 P(%(@,30S(# @4B Q-#4@,"!2(#$T-R P(%(@,30Y(# @4B Q-3$@,"!2
M(#$U,R P(%(@,34U(# @4B Q-3<@,"!2(#$U.2 P(%(@,38Q(# @4B Q-C,@
M,"!2(#$V-2 P(%(@,38W(# @4B Q-CD@,"!2(#$W,2 P(%(@,3<S(# @4B Q
M-S4@,"!2(#$W-R P(%(@,3<Y(# @4B Q.#$@,"!2(#$X,R P(%(@,3@U(# @
M4B Q.#<@,"!2(#$X.2 P(%(@,3DQ(# @4B Q.3,@,"!2(#$Y-2 P(%(@,3DW
M(# @4B Q.3D@,"!2(#(P,2 P(%)="B]#;W5N=" Q,# ^/@IE;F1O8FH*,R P
M(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP
M(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *
M+T-O;G1E;G1S(#0@,"!2/CX*96YD;V)J"C0@,"!O8FH*/#PO3&5N9W1H(#8R
M-3,^/@IS=')E86T*,"XT(# N-" P+C0@4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#DN-2 W-#4N-B!M"C4V,2XU(#<T-2XV
M(&P*<PI"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!4
M8R Q,# @5'H@,"!43" *0E0@+T8R(#$V+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C0S+C,U(#<R,BXY,"!49" H54Y)5$5$(%-4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S(W+CDW(#<R,BXY,"!49" H02D@5&H@150@40IQ(# @," P
M(')G($)4(#,S."XS,R W,C(N.3 @5&0@*%1%4RD@5&H@150@40I"5" O1C(@
M,38N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,S0N,34@-S S+C<P(%1D("A3
M14-54DE42453("D@5&H@150@40IQ(# @," P(')G($)4(#(S-"XR," W,#,N
M-S @5&0@*$%.1"!%6$-(04Y'12!#3TU-25-324].*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-"XT-2 V.3$N-S @5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C,N.3 @-CDQ+C<P(%1D("AA
M<VAI;F=T;VXL($0N0RX@,C U-#DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C8Q+C P(#8W.2XW,"!49" H7U]?7U]?7U]?
M7U]?7U]?7U]?*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8V-RXW,"!49" HH"D@5&H@150@40I"5" O1C(@,38N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-C(N-C4@-C0X+C4P(%1D("A&3U)-
M(#$P+4LI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-C,V+C4P(%1D("B@*2!4:B!%5"!1"B]'4S @9W,*<2 X+CDR
M(# @," Y+C<V(#4S+C P(#8Q,RXW-"!C;0HO23$@1&\@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y.2XP," V,38N-S,@5&0@*$%.3E5!
M3"D@5&H@150@40IQ(# @," P(')G($)4(#$T,2XR,R V,38N-S,@5&0@*"!2
M15!/4BD@5&H@150@40IQ(# @," P(')G($)4(#$W."XS." V,38N-S,@5&0@
M*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#0N.#8@-C$V+C<S(%1D("@@
M4%524U5!3E0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-#$N-C,@-C$V+C<S
M(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0S+CDU(#8Q-BXW,R!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(U,"XT-" V,38N-S,@5&0@
M*$\@4T5#5$E/3B Q,R!/4B Q-5PH9%PI($]&*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S<V+C0W(#8Q-BXW,R!49" H("D@5&H@150@40IQ(# @," P(')G
M($)4(#,W."XW.2 V,38N-S,@5&0@*%1(12!314-54DE42453($580TA!3D=%
M("D@5&H@150@40IQ(# @," P(')G($)4(#4R-2XR,B V,38N-S,@5&0@*$%#
M5"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M.2XP," V,#8N-S,@5&0@*$]&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$R
M+C4R(#8P-BXW,R!49" H(#$Y,S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X
M-"XU,"!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R,#@N.34@-3<R+C4P(%1D("A&;W(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,C0N,S(@-3<R+C4P(%1D("@@=&AE($9I<V-A;" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R-CDN-S<@-3<R+C4P(%1D("A9*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C<U+C@X(#4W,BXU,"!49" H96%R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C@Y+C4X(#4W,BXU,"!49" H($5N9&5D($1E8V5M
M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8U+C4P(#4W,BXU,"!49" H
MH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,P-BXP," U-C N-3 @5&0@** I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S Q+C,U(#4T."XU,"!49" H;W(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-3,V+C4P(%1D("B@*2!4:B!%5"!1"B]'4S @9W,*<2 X+CDQ(# @," Y
M+C<V(#4S+C P(#4Q,RXW-"!C;0HO23(@1&\@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Y.2XP," U,38N-S,@5&0@*%1204Y3251)3TX@
M4D503U(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3DN-3 @-3$V+C<S(%1D
M("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C U+CDY(#4Q-BXW,R!49" H
M(%!54E-504Y4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8R+C<U(#4Q-BXW
M,R!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#(V-2XP-R U,38N-S,@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S$N-38@-3$V+C<S(%1D
M("A/(%-%0U1)3TX@,3,@3U(@,35<*&1<*2!/1BD@5&H@150@40IQ(# @," P
M(')G($)4(#,Y-RXU.2 U,38N-S,@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S.3DN.3$@-3$V+C<S(%1D("A42$4@4T5#55))5$E%4R!%6$-(04Y'
M12D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M.2XP," U,#8N-S,@5&0@*$%#5"D@5&H@150@40IQ(# @," P(')G($)4(#$Q
M.2XY,R U,#8N-S,@5&0@*"!/1BD@5&H@150@40IQ(# @," P(')G($)4(#$S
M-2XY-2 U,#8N-S,@5&0@*" Q.3,T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M.#DN-3 @5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3@S+C4U(#0W-RXU,"!49" H1F]R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3DX+CDR(#0W-RXU,"!49" H('1H92!T<F%N<VET:6]N('!E
M<FEO9"!F<BD@5&H@150@40IQ(# @," P(')G($)4(#(Y.2XR." T-S<N-3 @
M5&0@*&]M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,Q,BXV,2 T-S<N-3 @5&0@*"!?7U]?7U]?7U]?("D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C<N-C$@-#<W+C4P
M(%1D("AT;RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-S4N.30@-#<W+C4P(%1D("@@7U]?7U]?7U]?7RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-C4N-3 @
M5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C,U+C8U(#0U,RXU,"!49" H0V]M;6ES<VEO;B!F:6QE(&YU;6)E<BD@
M5&H@150@40IQ(# @," P(')G($)4(#,T,"XT-R T-3,N-3 @5&0@*" P+3,S
M,38Y*2!4:B!%5"!1"B]'4S @9W,*<2 R,3(N,# @," P(#<T+C P(#(P,"XP
M," S-C(N-3 @8VT*+TDS($1O(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&
M,B Q-BXP,"!49B!%5 IQ(# @," P(')G($)4(#$Y."XY-2 S-#,N,S @5&0@
M*$-R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$W+C,R(#,T,RXS,"!49" H
M;W-S($-O=6YT<GD@2&5A;'1H8V%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S<Q+C8X(#,T,RXS,"!49" H92R@26YC+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,#(N-S @,S,Q+C,P(%1D("A<*$5X
M86-T(&YA;64@;V8@<F5G:7-T<F%N="!A<R!S<&5C:69I960@:6X@:71S(&-H
M87)T97)<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," S,3DN,S @5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,34W+C@P(#(Y.2XU,R!49" H1&5L87=A
M<BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,RXX,2 R.3DN-3,@5&0@*&4I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# Y
M+C@P(#(Y.2XU,R!49" H,3,M-# V-C(R.2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," R.#8N,S<@5&0@*%PH4W1A
M=&4@;W(@;W1H97(@:G5R:7-D:6-T:6]N(&]F(&EN8V]R<&]R871I;VX@;W(@
M;W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3(N-3,@,C@V+C,W(%1D("AG
M86YI>F%T:6]N7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S8Q+C,U(#(X-BXS-R!49" H7"A)+E(N4RX@16UP;&]Y97(@
M261E;G1I9FEC871I;VX@3F\N7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(W
M,"XS,"!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R,S(N.34@,C4X+C,P(%1D("@U,C Q($-O;F=R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C@R+C0Y(#(U."XS,"!49" H97-S("D@5&H@150@
M40IQ(# @," P(')G($)4(#(Y-BXV-B R-3@N,S @5&0@*$$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,#,N,30@,C4X+C,P(%1D("AV96YU92P@4W5I=&4@
M,3 P0BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R-#DN,#4@,C0V+C,P(%1D("A";V-A(%)A=&]N+"!&;&]R:61A(#,S-#@W
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P
M-RXS-2 R,S0N,S @5&0@*%PH061D<F5S<R!O9B!P<FEN8VEP86P@97AE8W5T
M:79E(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0S+C<Y(#(S-"XS,"!4
M9" H9FEC97,L('II<"!C;V1E7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C$P+C,P(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$V.2XU-2 Q.3@N
M,S @5&0@*%)E9VES=')A;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$S
M+C0S(#$Y."XS,"!49" H<R!T96QE<&AO;F4@;G5M8F5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDQ+C,T(#$Y."XS,"!49" H+"!I;F-L=61I;F<@87)E
M82!C;V1E.B I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S<Y+CDR(#$Y."XS,"!49" H7"@U-C%<*: Y.3@M,C(S,BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M.#8N,S @5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3@S+CDU(#$W-"XS,"!49" H4V5C=7)I=&EE<R!R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,R+C,V(#$W-"XS,"!49" H96=I<W1E<BD@
M5&H@150@40IQ(# @," P(')G($)4(#(V,"XU," Q-S0N,S @5&0@*&5D('!U
M<G-U86YT('1O(%-E8W1I;VZ@,3)<*&)<*2!O9B!T:&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# Y+C8W(#$W-"XS,"!49" H06-T.BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-C(N,S @
M5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,30P+C0U(#$T,BXU,R!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#$T-RXP,R Q-#(N-3,@5&0@*&ET;&4@;V8@96%C:"!C;&%S<RD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#$N,3 @,30R
M+C4S(%1D("A.86UE(&]F(&5A8V@@97AC:&%N9V4@;VX@=VAI8V@@<BD@5&H@
M150@40IQ(# @," P(')G($)4(#0X."XV." Q-#(N-3,@5&0@*&5G:7-T97(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,38N.#$@,30R+C4S(%1D("AE9"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X."XX
M-2 Q,CDN,S<@5&0@*$-O;6UO;B!3=&]C:RP@<&%R('9A;'5E("0P+C P,#$@
M<&5R('-H87)E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,W-2XX," Q,CDN,S<@5&0@*%1H92!.05-$05$@4W1O8VL@36%R
M:V5T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,3,N,S @5&0@** I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@P+C U(#$P
M,2XS,"!49" H4V5C=7)I=&EE<R!R96=I<W1E<F5D('!U<G-U86YT('1O(%-E
M8W1I;VZ@,3)<*&=<*2!O9B!T:&4@86-T.B!.;VYE*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#@Y+C,P(%1D("B@
M*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-2 P(&]B:@H\/"]4>7!E("]0
M86=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP
M,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#8@,"!2
M/CX*96YD;V)J"C8@,"!O8FH*/#PO3&5N9W1H(#@V.3,^/@IS=')E86T*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C$P(%1D
M("A);F1I8V%T92!B>2!C:&5C:R!M87)K(&EF('1H92!296=I<W1R86YT(&ES
M(&$@=V5L;"UK;F]W;B!S96%S;VYE9"!I<W-U97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-# N.3 @-S0R+C$P(%1D("@L(&%S(&1E9FEN960@:6X@4G5L
M9: T,#4@;V8@=&AE(%-E8W5R:71I97,@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3 U+C,Q(#<T,BXQ,"!49" H06-T+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,C0N,S@@-S0R+C$P(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3,P+C8P(#<T,BXQ,"!49" H97.@*2!4:B!%5"!1"B]'4S @9W,*<2 X
M+CDQ(# @," Q,"XP.2 U-#$N-#,@-S,Y+CDT(&-M"B])-"!$;R!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U,"XS-" W-#(N,3 @5&0@
M*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-S,P+C$P(%1D("A.;Z I(%1J($54(%$*+T=3,"!G<PIQ(#@N.3(@
M," P(#$P+C Y(#8T+C<R(#<R-RXY-"!C;0HO234@1&\@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3@N,3 @5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-S V+C$P(%1D("A);F1I8V%T92!B>2!C:&5C:R!M87)K(&EF('1H92!296=I
M<W1R86YT(&ES(&YO="!R97%U:7)E9"!T;R!F:6QE(')E<&]R=',@<'5R<W5A
M;G0@=&\@4V5C=&EO;J Q,R!O<B!396-T:6]NH#$U7"AD7"D@;V8@=&AE("D@
M5&H@150@40IQ(# @," P(')G($)4(#4Q-"XS,B W,#8N,3 @5&0@*$%C="X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,S+C,Y(#<P-BXQ,"!49" H62D@
M5&H@150@40IQ(# @," P(')G($)4(#4S.2XV,2 W,#8N,3 @5&0@*&5SH"D@
M5&H@150@40HO1U,P(&=S"G$@."XY,2 P(# @,3 N,#D@-34P+C0T(#<P,RXY
M-"!C;0HO238@1&\@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-3DN,S4@-S V+C$P(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y-"XQ,"!49" H3F^@*2!4:B!%
M5"!1"B]'4S @9W,*<2 X+CDR(# @," Q,"XP.2 V-"XW,B V.3$N.30@8VT*
M+TDW($1O(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C@R+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8W,"XQ,"!49" H26YD:6-A=&4@8GD@8VAE
M8VL@;6%R:R!W:&5T:&5R('1H92!296=I<W1R86YT.B!<*#%<*:!H87,@9FEL
M960@86QL(')E<&]R=',@<F5Q=6ER960@=&\@8F4@9FEL960@8GD@4V5C=&EO
M;J Q,R!O<B Q-5PH9%PI(&]F('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X+C$P(%1D("A396-U<FET
M:65S($5X8VAA;F=E("D@5&H@150@40IQ(# @," P(')G($)4(#$S,RXS,2 V
M-3@N,3 @5&0@*$%C="!O9B Q.3,T(&1U<FEN9R!T:&4@<')E8V5D:6YG(#$R
MH&UO;G1H<R!<*&]R(&9O<B!S=6-H('-H;W)T97(@<&5R:6]D('1H870@=&AE
M(%)E9VES=')A;G0@=V%S(')E<75I<F5D('1O("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-#8N,3 @5&0@*&9I
M;&4@<W5C:"!R97!O<G1S7"DL(&%N9"!<*#)<*:!H87,@8F5E;B!S=6)J96-T
M('1O('-U8V@@9FEL:6YG(')E<75I<F5M96YT<R!F;W(@=&AE('!A<W0@.3"@
M9&%Y<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C@P(#8T-BXQ,"!4
M9" H62D@5&H@150@40IQ(# @," P(')G($)4(#0R,2XP,R V-#8N,3 @5&0@
M*&5SH"D@5&H@150@40HO1U,P(&=S"G$@."XY,B P(# @,3 N,#D@-#,Q+C@V
M(#8T,RXY-"!C;0HO23@@1&\@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-# N-S<@-C0V+C$P(%1D("@@3F^@*2!4:B!%5"!1"B]'4S @
M9W,*<2 X+CDQ(# @," Q,"XP.2 T-3<N.3D@-C0S+CDT(&-M"B]).2!$;R!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8S-"XQ
M,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," V,C(N,3 @5&0@*$EN9&EC871E(&)Y(&-H96-K(&UA<FL@
M=VAE=&AE<B!T:&4@<F5G:7-T<F%N="!H87,@<W5B;6ET=&5D(&5L96-T<F]N
M:6-A;&QY(&%N9"!P;W-T960@;VX@:71S(&-O<G!O<F%T92!W96(@<VET92P@
M:68@86YY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(Q+C$S(#8R,BXQ,"!4
M9" H+"!E=F5R>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-C$P+C$P(%1D("A);G1E<F%C=&EV92!$871A($9I
M;&4@<F5Q=6ER960@=&\@8F4@<W5B;6ET=&5D(&%N9"!P;W-T960@<'5R<W5A
M;G0@=&\@4G5L9: T,#4@;V8@4F5G=6QA=&EO;J!3+50I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,S@N,S0@-C$P+C$P(%1D("@@9'5R:6YG('1H92!P<F5C
M961I;F<@,3(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4Y."XQ,"!49" H;6]N=&AS(%PH;W(@9F]R('-U8V@@
M<VAO<G1E<B!P97)I;V0@=&AA="!T:&4@<F5G:7-T<F%N="!W87,@<F5Q=6ER
M960@=&\@<W5B;6ET(&%N9"!P;W-T('-U8V@@9FEL97-<*2Z@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#,W+C@X(#4Y."XQ,"!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#0T-"XQ," U.3@N,3 @5&0@*&5SH"D@5&H@150@40HO
M1U,P(&=S"G$@."XY,B P(# @,3 N,#D@-#4T+CDS(#4Y-2XY-"!C;0HO23$P
M($1O(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8S+C@T
M(#4Y."XQ,"!49" HH*!.;R I(%1J($54(%$*+T=3,"!G<PIQ(#@N.3$@," P
M(#$P+C Y(#0X,RXU-B U.34N.30@8VT*+TDQ,2!$;R!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X-BXQ,"!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M-S0N,3 @5&0@*$EN9&EC871E(&)Y(&-H96-K(&UA<FL@:68@9&ES8VQO<W5R
M92!O9B!D96QI;G%U96YT(&9I;&5R<R!P=7)S=6%N="!T;R!)=&5M(#0P-2!O
M9B!296=U;&%T:6]NH%,M2R!<**<@,C(Y+C0P-2!O9B!T:&ES(&-H87!T97)<
M*2!I<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-38R+C$P(%1D("AN;W0@8V]N=&%I;F5D(&AE<F5I;BP@86YD
M('=I;&P@;F]T(&)E(&-O;G1A:6YE9"P@=&\@=&AE(&)E<W0@;V8@4F5G:7-T
M<F%N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#$N,#0@-38R+C$P(%1D
M("AS(&MN;W=L961G92P@:6X@9&5F:6YI=&EV92!P<F]X>2!O<B!I;F9O<FUA
M=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-34P+C$P(%1D("AS=&%T96UE;G1S(&EN8V]R<&]R871E9"!B
M>2!R969E<F5N8V4@:6X@4&%R=*!)24D@;V8@=&AI<R!&;W)MH#$P+4L@;W(@
M86YY(&%M96YD;65N="!T;R!T:&ES($9O<FV@,3 M2RZ@*2!4:B!%5"!1"B]'
M4S @9W,*<2 X+CDR(# @," Q,"XP.2 T-S N,3<@-30W+CDT(&-M"B]),3(@
M1&\@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-SDN,#D@
M-34P+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#4S."XQ,"!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,C8N,3 @5&0@*$EN
M9&EC871E(&)Y(&-H96-K(&UA<FL@=VAE=&AE<B!T:&4@4F5G:7-T<F%N="!I
M<R!A(&QA<BD@5&H@150@40IQ(# @," P(')G($)4(#(V-2XU-R U,C8N,3 @
M5&0@*&=E(&%C8V5L97)A=&5D(&9I;&5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S0Q+C(R(#4R-BXQ,"!49" H+"!A;B!A8V-E;&5R871E9"!F:6QE<BD@
M5&H@150@40IQ(# @," P(')G($)4(#0R,2XX-R U,C8N,3 @5&0@*"P@82!N
M;VXM86-C96QE<F%T960@9FEL97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M,34N.#0@-3(V+C$P(%1D("@L(&]R(&$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Q-"XQ,"!49" H<VUA;&QE
M<B!R97!O<G1I;F<@8V]M<&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#$U
M-RXP.2 U,30N,3 @5&0@*"X@4V5E('1H92!D969I;FET:6]N<R!O9B"3;&%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8T+C8V(#4Q-"XQ,"!49" H9V4@
M86-C96QE<F%T960@9FEL97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-# N
M,S$@-3$T+C$P(%1D("@LE""386-C96QE<F%T960@9FEL97*4(&%N9""3<VUA
M;&QE<B!R97!O<G1I;F<@8V]M<&%N>90@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4P,BXQ,"!49" H:6X@4G5L
M9: Q,F(M,B!O9B!T:&4@17AC:&%N9V4@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3<T+C0Q(#4P,BXQ,"!49" H06-T.B!,87(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,#<N.#,@-3 R+C$P(%1D("AG9:!A8V-E;&5R871E9"!F:6QE
M<J I(%1J($54(%$*+T=3,"!G<PIQ(#@N.3$@," P(#$P+C Y(#(X-BXS." T
M.3DN.30@8VT*+TDQ,R!$;R!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Y-2XR.2 U,#(N,3 @5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R.3<N,C0@-3 R+C$P(%1D("A!8V-E;&5R871E9*!F:6QE<J I(%1J
M($54(%$*+T=3,"!G<PIQ(#@N.3(@," P(#$P+C Y(#,V-BXV,R T.3DN.30@
M8VT*+TDQ-"!$;R!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,W-2XU-2 U,#(N,3 @5&0@*"!.;VXM86-C96QE<F%T962@9FEL97*@*2!4
M:B!%5"!1"B]'4S @9W,*<2 X+CDQ(# @," Q,"XP.2 T-C4N,C$@-#DY+CDT
M(&-M"B]),34@1&\@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-S0N,3(@-3 R+C$P(%1D("@@4VUA;&QE<B!R97!O<G1I;F<@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y
M,"XQ,"!49" H8V]M<&%N>2 I(%1J($54(%$*+T=3,"!G<PIQ(#@N.3$@," P
M(#$P+C Y(#@Y+C$V(#0X-RXY-"!C;0HO23$V($1O(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#<X+C$P(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V
M-BXQ,"!49" H268@86X@96UE<BD@5&H@150@40IQ(# @," P(')G($)4(#DP
M+CDP(#0V-BXQ,"!49" H9VEN9R!G<F]W=&@@8V]M<&%N>2D@5&H@150@40IQ
M(# @," P(')G($)4(#$W."XP,B T-C8N,3 @5&0@*"P@:6YD:6-A=&4@8GD@
M8VAE8VL@;6%R:R!I9B!T:&4@<F5G:7-T<F%N="!H87,@96QE8W1E9"!N;W0@
M=&\@=7-E('1H92!E>'1E;F1E9"!T<F%N<VET:6]N('!E<FEO9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#4T
M+C$P(%1D("AF;W(@8V]M<&QY:6YG('=I=&@@86YY(&YE=R!O<B!R979I<V5D
M(&9I;F%N8VEA;"!A8V-O=6YT:6YG('-T86YD87)D<R!P<F]V:61E9"!P=7)S
M=6%N="!T;R!396-T:6]N(#$S7"AA7"D@;V8@=&AE($5X8VAA;F=E("D@5&H@
M150@40IQ(# @," P(')G($)4(#4T,"XT,B T-30N,3 @5&0@*$%C="X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HO1U,P(&=S"G$@-RXW." P(# @
M,3 N,#D@-3 N,# @-#,Y+CDT(&-M"B]),3<@1&\@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,3@N,3 @5&0@*$EN9&EC871E
M(&)Y(&-H96-K(&UA<FL@=VAE=&AE<B!T:&4@4F5G:7-T<F%N="!I<R!A('-H
M96QL(&-O;7!A;GD@7"AA<R!D969I;F5D(&)Y(%)U;&6@,3)B+3(@;V8@=&AE
M("D@5&H@150@40IQ(# @," P(')G($)4(#0T-RXQ," T,3@N,3 @5&0@*$%C
M=%PI+J"@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<R+C P(#0Q."XQ,"!4
M9" H62D@5&H@150@40IQ(# @," P(')G($)4(#0W."XR,B T,3@N,3 @5&0@
M*&5SH"D@5&H@150@40HO1U,P(&=S"G$@."XY,2 P(# @,3 N,#D@-#@Y+C U
M(#0Q-2XY-"!C;0HO23$X($1O(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DW+CDV(#0Q."XQ,"!49" H($YOH"D@5&H@150@40HO1U,P
M(&=S"G$@."XY,B P(# @,3 N,#D@-3$U+C$X(#0Q-2XY-"!C;0HO23$Y($1O
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-# V
M+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#,Y-"XQ,"!49" H5&AE(&%G9W)E9V%T92!M87)K970@
M=F%L=64@;V8@=&AE('9O=&EN9R!S=&]C:R!H96QD(&)Y(&YO;BUA9BD@5&H@
M150@40IQ(# @," P(')G($)4(#(Y.2XQ-R S.30N,3 @5&0@*&9I;&EA=&5S
M(&]F('1H92!296=I<W1R86YT+"!B87-E9"!O;B!T:&4@8VQO<VEN9R!P<FEC
M92!O9B!#;VUM;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#,X,BXQ,"!49" H4W1O8VL@;VX@2G5N92 S,"P@
M,C Q."!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,34V+CDT(#,X,BXQ,"!49" H)#$I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-C8N-3<@,S@R+C$P(%1D("@Q+C(U*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X-"XP-R S.#(N,3 @5&0@*"!A
M<R!R97!O<G1E9"!O;B!T:&4@3D%31$%1($YA=&EO;F%L($UA<FME="P@=V%S
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M.3,N-#8@,S@R+C$P(%1D("@D,SDU+#(W,BPV-#,I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0X+C0V(#,X,BXQ,"!49" H
M+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#4S+C0V(#,X,BXQ,"!49" H5&AI<R!C86QC=6QA=&EO;B!D;V5S(&YO=" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,S<P+C$P(%1D("AR969L96-T(&$@9&5T97)M:6YA=&EO;B!T:&%T('!E
M<G-O;G,@87)E(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$U+C@U(#,W
M,"XQ,"!49" H9FEL:6%T960@9F]R(&%N>2!O=&AE<B!P=7)P;W-E+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M-3@N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S0V+C$P(%1D("A!<R!O9B!&96)R=6%R>2 R,BP@
M,C Q.2P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$U,RXP-" S-#8N,3 @5&0@*#,V+#$S.2PX-S8I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3DX+C T(#,T-BXQ,"!4
M9" H('-H87)E<R!O9B!#;VUM;VX@4W1O8VLL("0P+C P,#$@<&%R('9A;'5E
M('!E<B!S:&%R92P@=V5R92!O=71S=&%N9&EN9RXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S,T+C$P(%1D("B@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y
M,2XT," S,C(N,3 @5&0@*$1/0U5-14Y44R!)3D-/4E!/4D$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,3DN.#,@,S(R+C$P(%1D("A4140@0EDI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-38N-#$@,S(R+C$P(%1D("@@4D5&15)%3D-%
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,Q,"XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," R.3@N,3 @5&0@*%!O<G1I;VYS(&]F('1H
M92!296=I<W1R86YTDBD@5&H@150@40IQ(# @," P(')G($)4(#$U-2XR-R R
M.3@N,3 @5&0@*',@9&5F:6YI=&EV92!P<F]X>2!S=&%T96UE;G0L(&9O<B!T
M:&4@,C Q.2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C(N-#8@,CDX+C$P
M(%1D("A!;FYU86P@365E=&EN9R!O9B!3=&]C:VAO;&1E<G,L('=H:6-H('-T
M871E;65N="!W:6QL(&)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," R.#8N,3 @5&0@*&9I;&5D('!U<G-U86YT
M('1O(%)E9W5L871I;VZ@,31!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@Q
M+C Y(#(X-BXQ,"!49" H(&YO="!L871E<B!T:&%N(#$R,*!D87ES(&%F=&5R
M('1H92!E;F0@;V8@=&AE(&9I<V-A;"!Y96%R(&-O=F5R960@8GD@=&AI<R!2
M97!O<G0L(&%R92!I;F-O<G!O<F%T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(W-"XQ,"!49" H8GD@<F5F
M97)E;F-E(&EN=&\@4&%R=*!)24D@:&5R96]F+BD@5&H@150@40HP+C0@,"XT
M(# N-"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.2XU(#(V,RXV(&T*-38Q+C4@,C8S+C8@; IS"D)4("]&,2 Q,"XP,"!4
M9B!%5 IE;F1S=')E86T*96YD;V)J"C<@,"!O8FH*/#PO5'EP92 O4&%G90HO
M4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]2
M97-O=7)C97,@,B P(%(*+T%N;F]T<R!;/#PO5'EP92 O06YN;W0@+U-U8G1Y
M<&4@+TQI;FL@+U)E8W0@6S4S(#8Y-"XS,3DS,S4Y,S<U(#@U+C,S.#@V-S$X
M-S4@-S S+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6SD@,"!2
M("]865H@," T.3 N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E
M("],:6YK("]296-T(%LU,R V-S4N,34X,C S,3(U(#@Q+C,R-3$Y-3,Q,C4@
M-C@T+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6SD@,"!2("]8
M65H@," T-C8N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],
M:6YK("]296-T(%LQ,3 @-C<U+C$U.#(P,S$R-2 Q-#4N-38Q-3(S-#,W-2 V
M.#0N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;.2 P(%(@+UA9
M6B P(#0V-BXR,R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI
M;FL@+U)E8W0@6S4S(#8U-BXQ-3@R,#,Q,C4@.#@N-30V.#<U(#8V-2XR-5T@
M+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LR,R P(%(@+UA96B P(#,T
M,BXP-R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E
M8W0@6S$Q," V-38N,34X,C S,3(U(#$V,"XR-S@S,C S,3(U(#8V-2XR-5T@
M+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LR,R P(%(@+UA96B P(#,T
M,BXP-R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E
M8W0@6S4S(#8S-RXQ-3@R,#,Q,C4@.#<N.3DU,3$W,3@W-2 V-#8N,C5=("]"
M;W)D97(@6S @," P72 O2" O22 O1&5S="!;,SD@,"!2("]865H@," W.3(N
M,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T
M(%LQ,3 @-C,W+C$U.#(P,S$R-2 R,C,N-CDQ-# V,C4@-C0V+C(U72 O0F]R
M9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S,Y(# @4B O6%E:(# @-SDR+C P
M(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;
M-3,@-C$X+C$U.#(P,S$R-2 X,2XS,C4Q.34S,3(U(#8R-RXR-5T@+T)O<F1E
M<B!;," P(#!=("](("])("]$97-T(%LS.2 P(%(@+UA96B P(#<P-BXR,R!N
M=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q
M," V,3@N,34X,C S,3(U(#$U,"XU-#8X-S4@-C(W+C(U72 O0F]R9&5R(%LP
M(# @,%T@+T@@+TD@+T1E<W0@6S,Y(# @4B O6%E:(# @-S V+C(S(&YU;&Q=
M/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-3,@-3DY
M+C$U.#(P,S$R-2 X,2XS,C4Q.34S,3(U(#8P."XR-5T@+T)O<F1E<B!;," P
M(#!=("](("])("]$97-T(%LS.2 P(%(@+UA96B P(#4T-"XR,R!N=6QL73X^
M/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q," U.3DN
M,34X,C S,3(U(#$X-"XQ-# V,C4@-C X+C(U72 O0F]R9&5R(%LP(# @,%T@
M+T@@+TD@+T1E<W0@6S,Y(# @4B O6%E:(# @-30T+C(S(&YU;&Q=/CX\/"]4
M>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-3,@-3@P+C$U.#(P
M,S$R-2 X,2XS,C4Q.34S,3(U(#4X.2XR-5T@+T)O<F1E<B!;," P(#!=("](
M("])("]$97-T(%LS.2 P(%(@+UA96B P(#,U,BXR,R!N=6QL73X^/#PO5'EP
M92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q," U.# N,34X,C S
M,3(U(#(P."XS,34T,CDV.#<U(#4X.2XR-5T@+T)O<F1E<B!;," P(#!=("](
M("])("]$97-T(%LS.2 P(%(@+UA96B P(#,U,BXR,R!N=6QL73X^/#PO5'EP
M92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S(#4V,2XS,3DS,S4Y
M,S<U(#@U+C,S.#@V-S$X-S4@-3<P+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@
M+TD@+T1E<W0@6SD@,"!2("]865H@," T.3 N,C,@;G5L;%T^/CP\+U1Y<&4@
M+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU,R U-#(N,34X,C S,3(U
M(#@Q+C,R-3$Y-3,Q,C4@-34Q+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@
M+T1E<W0@6S,Y(# @4B O6%E:(# @,C@P+C(S(&YU;&Q=/CX\/"]4>7!E("]!
M;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;,3$P(#4T,BXQ-3@R,#,Q,C4@
M-3$Y+C(W,C0V,#DS-S4@-34Q+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@
M+T1E<W0@6S,Y(# @4B O6%E:(# @,C@P+C(S(&YU;&Q=/CX\/"]4>7!E("]!
M;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;,3$P(#4S,BXQ-3@R,#,Q,C4@
M,30Y+C0S,S4Y,S<U(#4T,2XR-5T@+T)O<F1E<B!;," P(#!=("](("])("]$
M97-T(%LS.2 P(%(@+UA96B P(#(X,"XR,R!N=6QL73X^/#PO5'EP92 O06YN
M;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S(#4Q,RXQ-3@R,#,Q,C4@.#$N
M,S(U,3DU,S$R-2 U,C(N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S
M="!;-#$@,"!2("]865H@," Q.#4N-3 @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T
M("]3=6)T>7!E("],:6YK("]296-T(%LQ,3 @-3$S+C$U.#(P,S$R-2 R,#0N
M.38P.3,W-2 U,C(N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;
M-#$@,"!2("]865H@," Q.#4N-3 @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3
M=6)T>7!E("],:6YK("]296-T(%LU,R T.30N,34X,C S,3(U(#@Q+C,R-3$Y
M-3,Q,C4@-3 S+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S0U
M(# @4B O6%E:(# @-#$X+C W(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B
M='EP92 O3&EN:R O4F5C="!;,3$P(#0Y-"XQ-3@R,#,Q,C4@-#8X+C(Y,3 Q
M-38R-2 U,#,N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;-#4@
M,"!2("]865H@," T,3@N,#<@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T
M>7!E("],:6YK("]296-T(%LU,R T-S4N,34X,C S,3(U(#@X+C4T-C@W-2 T
M.#0N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;.#$@,"!2("]8
M65H@," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],
M:6YK("]296-T(%LQ,3 @-#<U+C$U.#(P,S$R-2 S-#DN,S@Y-C0X-#,W-2 T
M.#0N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;.#$@,"!2("]8
M65H@," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],
M:6YK("]296-T(%LU,R T-38N,34X,C S,3(U(#@Q+C,R-3$Y-3,Q,C4@-#8U
M+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:
M(# @,S0V+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN
M:R O4F5C="!;,3$P(#0U-BXQ-3@R,#,Q,C4@,CDT+CDU,3$W,3@W-2 T-C4N
M,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;.#$@,"!2("]865H@
M," S-#8N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK
M("]296-T(%LU,R T,S<N,34X,C S,3(U(#@Q+C,R-3$Y-3,Q,C4@-#0V+C(U
M72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:(# @
M,C@V+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O
M4F5C="!;,3$P(#0S-RXQ-3@R,#,Q,C4@-#8X+C@Q,S0W-C4V,C4@-#0V+C(U
M72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:(# @
M,C@V+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O
M4F5C="!;-3,@-#$X+C$U.#(P,S$R-2 X."XU-#8X-S4@-#(W+C(U72 O0F]R
M9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:(# @,C,X+C(S
M(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;
M,3$P(#0Q."XQ-3@R,#,Q,C4@,C X+C,Q-30R.38X-S4@-#(W+C(U72 O0F]R
M9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:(# @,C,X+C(S
M(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;
M-3,@,SDY+C$U.#(P,S$R-2 X-RXY.34Q,3<Q.#<U(#0P."XR-5T@+T)O<F1E
M<B!;," P(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#<P-BXR,R!N
M=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q
M," S.3DN,34X,C S,3(U(#$X,RXP,S(R,C8U-C(U(#0P."XR-5T@+T)O<F1E
M<B!;," P(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#<P-BXR,R!N
M=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S
M(#,X,"XS,3DS,S4Y,S<U(#DS+C$R,C W,#,Q,C4@,S@Y+C(U72 O0F]R9&5R
M(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@W(# @4B O6%E:(# @-S V+C(S(&YU
M;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-3,@
M,S8Q+C$U.#(P,S$R-2 X-BXS,C4Q.34S,3(U(#,W,"XR-5T@+T)O<F1E<B!;
M," P(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#8X,BXR,R!N=6QL
M73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q," S
M-C$N,34X,C S,3(U(#,S-RXT.34Q,3<Q.#<U(#,W,"XR-5T@+T)O<F1E<B!;
M," P(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#8X,BXR,R!N=6QL
M73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S(#,T
M,BXQ-3@R,#,Q,C4@.#4N.34T,3 Q-38R-2 S-3$N,C5=("]";W)D97(@6S @
M," P72 O2" O22 O1&5S="!;.#<@,"!2("]865H@," V,3 N,C,@;G5L;%T^
M/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LQ,3 @,S0R
M+C$U.#(P,S$R-2 R,3 N,C4S.3 V,C4@,S4Q+C(U72 O0F]R9&5R(%LP(# @
M,%T@+T@@+TD@+T1E<W0@6S@W(# @4B O6%E:(# @-C$P+C(S(&YU;&Q=/CX\
M/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-3,@,S(S+C$U
M.#(P,S$R-2 X-BXS,C4Q.34S,3(U(#,S,BXR-5T@+T)O<F1E<B!;," P(#!=
M("](("])("]$97-T(%LX-R P(%(@+UA96B P(#4U,"XR,R!N=6QL73X^/#PO
M5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S$Q," S,C,N,34X
M,C S,3(U(#4Q.2XP-#<X-3$U-C(U(#,S,BXR-5T@+T)O<F1E<B!;," P(#!=
M("](("])("]$97-T(%LX-R P(%(@+UA96B P(#4U,"XR,R!N=6QL73X^/#PO
M5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S(#,P-"XQ-3@R
M,#,Q,C4@.#8N,S(U,3DU,S$R-2 S,3,N,C5=("]";W)D97(@6S @," P72 O
M2" O22 O1&5S="!;.#<@,"!2("]865H@," Q.3DN,C,@;G5L;%T^/CP\+U1Y
M<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LQ,3 @,S T+C$U.#(P
M,S$R-2 T,3(N-CDU,S$R-2 S,3,N,C5=("]";W)D97(@6S @," P72 O2" O
M22 O1&5S="!;.#<@,"!2("]865H@," Q.3DN,C,@;G5L;%T^/CP\+U1Y<&4@
M+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU,R R.#4N,34X,C S,3(U
M(#@V+C,R-3$Y-3,Q,C4@,CDT+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@
M+T1E<W0@6S@W(# @4B O6%E:(# @,3,Y+C(S(&YU;&Q=/CX\/"]4>7!E("]!
M;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;,3$P(#(X-2XQ-3@R,#,Q,C4@
M,C8X+C(Y,3 Q-38R-2 R.30N,C5=("]";W)D97(@6S @," P72 O2" O22 O
M1&5S="!;.#<@,"!2("]865H@," Q,SDN,C,@;G5L;%T^/CP\+U1Y<&4@+T%N
M;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU,R R-C4N,S$Y,S,U.3,W-2 Y
M,BXT-S R,30X-#,W-2 R-S0N,C5=("]";W)D97(@6S @," P72 O2" O22 O
M1&5S="!;.#D@,"!2("]865H@," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N
M;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU,R R-#8N,34X,C S,3(U(#@V
M+C,R-3$Y-3,Q,C4@,C4U+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E
M<W0@6S@Y(# @4B O6%E:(# @-S,P+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO
M=" O4W5B='EP92 O3&EN:R O4F5C="!;,3$P(#(T-BXQ-3@R,#,Q,C4@,C<Q
M+C X,SDX-#,W-2 R-34N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S
M="!;.#D@,"!2("]865H@," W,S N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T
M("]3=6)T>7!E("],:6YK("]296-T(%LQ,3 @,C(W+C$U.#(P,S$R-2 Q.38N
M,3 X,SDX-#,W-2 R,S8N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S
M="!;,3 Q(# @4B O6%E:(# @-SDR+C P(&YU;&Q=/CX\/"]4>7!E("]!;FYO
M=" O4W5B='EP92 O3&EN:R O4F5C="!;-3,@,C X+C,Q.3,S-3DS-S4@,3$W
M+C(W-S,T,S<U(#(Q-RXR-5T@+T)O<F1E<B!;," P(#!=("](("])("]$97-T
M(%LQ,#,@,"!2("]865H@," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T
M("]3=6)T>7!E("],:6YK("]296-T(%LU-30@-C<U+C$U.#(P,S$R-2 U-3D@
M-C@T+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6SD@,"!2("]8
M65H@," T-C8N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],
M:6YK("]296-T(%LU-30@-C4V+C$U.#(P,S$R-2 U-3D@-C8U+C(U72 O0F]R
M9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S(S(# @4B O6%E:(# @,S0R+C W
M(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;
M-30Y(#8S-RXQ-3@R,#,Q,C4@-34Y(#8T-BXR-5T@+T)O<F1E<B!;," P(#!=
M("](("])("]$97-T(%LS.2 P(%(@+UA96B P(#<Y,BXP,"!N=6QL73X^/#PO
M5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4T.2 V,3@N,34X
M,C S,3(U(#4U.2 V,C<N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S
M="!;,SD@,"!2("]865H@," W,#8N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T
M("]3=6)T>7!E("],:6YK("]296-T(%LU-#D@-3DY+C$U.#(P,S$R-2 U-3D@
M-C X+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S,Y(# @4B O
M6%E:(# @-30T+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O
M3&EN:R O4F5C="!;-30Y(#4X,"XQ-3@R,#,Q,C4@-34Y(#4X.2XR-5T@+T)O
M<F1E<B!;," P(#!=("](("])("]$97-T(%LS.2 P(%(@+UA96B P(#,U,BXR
M,R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@
M6S4T.2 U,S(N,C4X,C S,3(U(#4U.2 U-#$N,S5=("]";W)D97(@6S @," P
M72 O2" O22 O1&5S="!;,SD@,"!2("]865H@," R.# N,C,@;G5L;%T^/CP\
M+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU-#D@-3$S+C$U
M.#(P,S$R-2 U-3D@-3(R+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E
M<W0@6S0Q(# @4B O6%E:(# @,3@U+C4P(&YU;&Q=/CX\/"]4>7!E("]!;FYO
M=" O4W5B='EP92 O3&EN:R O4F5C="!;-30Y(#0Y-"XQ-3@R,#,Q,C4@-34Y
M(#4P,RXR-5T@+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LT-2 P(%(@
M+UA96B P(#0Q."XP-R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@
M+TQI;FL@+U)E8W0@6S4T.2 T-S4N,34X,C S,3(U(#4U.2 T.#0N,C5=("]"
M;W)D97(@6S @," P72 O2" O22 O1&5S="!;.#$@,"!2("]865H@," W.3(N
M,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T
M(%LU-#D@-#4V+C$U.#(P,S$R-2 U-3D@-#8U+C(U72 O0F]R9&5R(%LP(# @
M,%T@+T@@+TD@+T1E<W0@6S@Q(# @4B O6%E:(# @,S0V+C(S(&YU;&Q=/CX\
M/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-30Y(#0S-RXQ
M-3@R,#,Q,C4@-34Y(#0T-BXR-5T@+T)O<F1E<B!;," P(#!=("](("])("]$
M97-T(%LX,2 P(%(@+UA96B P(#(X-BXR,R!N=6QL73X^/#PO5'EP92 O06YN
M;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4T.2 T,3@N,34X,C S,3(U(#4U
M.2 T,C<N,C5=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;.#$@,"!2
M("]865H@," R,S@N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E
M("],:6YK("]296-T(%LU-#D@,SDY+C$U.#(P,S$R-2 U-3D@-# X+C(U72 O
M0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@W(# @4B O6%E:(# @-SDR
M+C P(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C
M="!;-30Y(#,V,2XQ-3@R,#,Q,C4@-34Y(#,W,"XR-5T@+T)O<F1E<B!;," P
M(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#8X,BXR,R!N=6QL73X^
M/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4T.2 S-#(N
M,34X,C S,3(U(#4U.2 S-3$N,C5=("]";W)D97(@6S @," P72 O2" O22 O
M1&5S="!;.#<@,"!2("]865H@," V,3 N,C,@;G5L;%T^/CP\+U1Y<&4@+T%N
M;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU-#D@,S(S+C$U.#(P,S$R-2 U
M-3D@,S,R+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S@W(# @
M4B O6%E:(# @-34P+C(S(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP
M92 O3&EN:R O4F5C="!;-30Y(#,P-"XQ-3@R,#,Q,C4@-34Y(#,Q,RXR-5T@
M+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LX-R P(%(@+UA96B P(#$Y
M.2XR,R!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E
M8W0@6S4T.2 R.#0N,C4X,C S,3(U(#4U.2 R.3,N,S5=("]";W)D97(@6S @
M," P72 O2" O22 O1&5S="!;.#<@,"!2("]865H@," Q,SDN,C,@;G5L;%T^
M/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU-#D@,C0V
M+C$U.#(P,S$R-2 U-3D@,C4U+C(U72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@
M+T1E<W0@6S@Y(# @4B O6%E:(# @-S,P+C(S(&YU;&Q=/CX\/"]4>7!E("]!
M;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-30Y(#(R-RXQ-3@R,#,Q,C4@
M-34Y(#(S-BXR-5T@+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LQ,#$@
M,"!2("]865H@," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T
M>7!E("],:6YK("]296-T(%LU-#D@,C X+C$U.#(P,S$R-2 U-3D@,C$W+C(U
M72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$P,2 P(%(@+UA96B P
M(#<P-BXR,R!N=6QL73X^70HO4F]T871E(# *+T-O;G1E;G1S(#@@,"!2/CX*
M96YD;V)J"C@@,"!O8FH*/#PO3&5N9W1H(#$V,#(Y/CX*<W1R96%M"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U,BXV-2 W-#(N,C4@5&0@
M*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3@N-3@@-S0R+C(U(%1D("A!
M0DQ%($]&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S Q+C@R(#<T,BXR-2!4
M9" H($-/3E1%3E13*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#<S,"XR-2!49" HH"D@5&H@150@40HP(# @,"!2
M1PHO1U,P(&=S"C(N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,C@N
M-2 W,#4N-S4@;0HU-C(N-2 W,#4N-S4@; IS"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#<Q,"XS,B!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,3 N,# @-S$P+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S-"XW," W,3 N-#@@5&0@*%!A9V4I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XY-2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"C4S(#8Y-"XY,3(U.3<V-38R-2!M"C@U+C,S.#@V-S$X
M-S4@-CDT+CDQ,C4Y-S8U-C(U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#8Y
M-BXT."!49" H4"D@5&H@150@40IQ(# @," P(')G($)4(#4X+C,W(#8Y-BXT
M."!49" H05(I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXT-B V.38N-#@@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" W."XY-2 V.38N-#@@5&0@
M*"!)*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q,3 N,# @-CDV+C,R(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XP," V
M.38N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," P
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S
M(#8W-2XY.#,S.3@T,S<U(&T*.#$N,S(U,3DU,S$R-2 V-S4N.3@S,SDX-#,W
M-2!L"G,*<2 P(# @,"!R9R!"5" U,RXP," V-S<N,S(@5&0@*$ET96T@,2XI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HQ,3 @-C<U+CDX,S,Y.#0S-S4@;0HQ-#4N-38Q-3(S-#,W-2 V-S4N
M.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" Q,3 N,# @-C<W+C,R(%1D
M("A"=7-I;F5S<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q
M(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@
M,"!D"C$@2@HQ(&H*,R!-"C4S(#8U-BXY.#,S.3@T,S<U(&T*.#@N-30V.#<U
M(#8U-BXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#8U."XS
M,B!49" H271E;2 Q02XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @-C4V+CDX,S,Y.#0S-S4@;0HQ-C N
M,C<X,S(P,S$R-2 V-38N.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" Q
M,3 N,# @-C4X+C,R(%1D("A2:7-K($9A8W1O<G,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU,R V,S<N.3@S
M,SDX-#,W-2!M"C@W+CDY-3$Q-S$X-S4@-C,W+CDX,S,Y.#0S-S4@; IS"G$@
M," P(# @<F<@0E0@-3,N,# @-C,Y+C,R(%1D("A)=&5M(#%"+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," P
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q
M," V,S<N.3@S,SDX-#,W-2!M"C(R,RXV.3$T,#8R-2 V,S<N.3@S,SDX-#,W
M-2!L"G,*<2 P(# @,"!R9R!"5" Q,3 N,# @-C,Y+C,R(%1D("A5;G)E<V]L
M=F5D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S0N-3,@-C,Y+C,R
M(%1D("AF($-O;6UE;G1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"
M5" O1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*-3,@-C$X+CDX,S,Y.#0S-S4@;0HX,2XS
M,C4Q.34S,3(U(#8Q."XY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S
M+C P(#8R,"XS,B!49" H271E;2 R+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," V,3@N.3@S,SDX-#,W
M-2!M"C$U,"XU-#8X-S4@-C$X+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@
M0E0@,3$P+C P(#8R,"XS,B!49" H4')O<&5R=&EE<RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'
M4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S(#4Y.2XY
M.#,S.3@T,S<U(&T*.#$N,S(U,3DU,S$R-2 U.3DN.3@S,SDX-#,W-2!L"G,*
M<2 P(# @,"!R9R!"5" U,RXP," V,#$N,S(@5&0@*$ET96T@,RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ
M,3 @-3DY+CDX,S,Y.#0S-S4@;0HQ.#0N,30P-C(U(#4Y.2XY.#,S.3@T,S<U
M(&P*<PIQ(# @," P(')G($)4(#$Q,"XP," V,#$N,S(@5&0@*$QE9V%L(%!R
M;V-E961I;F=S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@
M,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P
M(&0*,2!*"C$@:@HS($T*-3,@-3@P+CDX,S,Y.#0S-S4@;0HX,2XS,C4Q.34S
M,3(U(#4X,"XY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#4X
M,BXS,B!49" H271E;2 T+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," U.# N.3@S,SDX-#,W-2!M"C(P
M."XS,34T,CDV.#<U(#4X,"XY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4
M(#$Q,"XP," U.#(N,S(@5&0@*$UI;F4@4V%F971Y($1I<V-L;W-U<F5S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C(@,3 N,# @5&8@150*
M," P(# @4D<*+T=3,"!G<PHP+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*-3,@-38Q+CDQ,C4Y-S8U-C(U(&T*.#4N,S,X.#8W,3@W-2 U-C$N.3$R
M-3DW-C4V,C4@; IS"G$@," P(# @<F<@0E0@-3,N,# @-38S+C0X(%1D("A0
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N,S<@-38S+C0X(%1D("A!4BD@
M5&H@150@40IQ(# @," P(')G($)4(#<R+C0V(#4V,RXT."!49" H5"D@5&H@
M150@40IQ(# @," P(')G($)4(#<X+CDU(#4V,RXT."!49" H($DI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XY-2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C@U+C,S.#@V-S$X-S4@-38Q+CDQ
M,C4Y-S8U-C(U(&T*.#DN,C,P-#8X-S4@-38Q+CDQ,C4Y-S8U-C(U(&P*<PIQ
M(# @," P(')G($)4(#@U+C,T(#4V,RXT."!49" H22D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;
M72 P(&0*,2!*"C$@:@HS($T*-3,@-30R+CDX,S,Y.#0S-S4@;0HX,2XS,C4Q
M.34S,3(U(#4T,BXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S+C P
M(#4T-"XS,B!49" H271E;2 U+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," U-#(N.3@S,SDX-#,W-2!M
M"C4Q.2XR-S(T-C Y,S<U(#4T,BXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G
M($)4(#$Q,"XP," U-#0N,S(@5&0@*$UA<FME="!F;W(@4F5G:7-T<F%N=)(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3DN-#(@-30T+C,R(%1D("AS($-O
M;6UO;B!%<75I='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S$N-34@-30T
M+C,R(%1D("@L(%)E;&%T960@4W1O8VMH;VQD97(@36%T=&5R<R!A;F0@27-S
M=65R(%!U<F-H87-E<R!O9B!%<75I='D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HQ,3 @-3,R+CDX,S,Y.#0S-S4@;0HQ-#DN-#,S-3DS-S4@
M-3,R+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@,3$P+C P(#4S-"XS
M,B!49" H4V5C=7)I=&EE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S(#4Q,RXY.#,S.3@T,S<U(&T*.#$N
M,S(U,3DU,S$R-2 U,3,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" U
M,RXP," U,34N,S(@5&0@*$ET96T@-BXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @-3$S+CDX,S,Y.#0S
M-S4@;0HR,#0N.38P.3,W-2 U,3,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R
M9R!"5" Q,3 N,# @-3$U+C,R(%1D("A396QE8W1E9"!&:6YA;F-I86P@1&%T
M82D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F
M($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"C4S(#0Y-"XY.#,S.3@T,S<U(&T*.#$N,S(U,3DU,S$R-2 T.30N
M.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" U,RXP," T.38N,S(@5&0@
M*$ET96T@-RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q
M,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HQ,3 @-#DT+CDX,S,Y.#0S-S4@;0HT-C@N,CDQ,#$U
M-C(U(#0Y-"XY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#$Q,"XP," T
M.38N,S(@5&0@*$UA;F%G96UE;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,38T+CDX(#0Y-BXS,B!49" H<R!$:7-C=7-S:6]N(&%N9" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,S0N,34@-#DV+C,R(%1D("A!;F%L>7-I<R!O9B!&
M:6YA;F-I86P@0V]N9&ET:6]N(&%N9"!297-U;'1S(&]F($]P97)A=&EO;G,I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HU,R T-S4N.3@S,SDX-#,W-2!M"C@X+C4T-C@W-2 T-S4N.3@S,SDX
M-#,W-2!L"G,*<2 P(# @,"!R9R!"5" U,RXP," T-S<N,S(@5&0@*$ET96T@
M-T$N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @
M5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*,3$P(#0W-2XY.#,S.3@T,S<U(&T*,S0Y+C,X.38T.#0S-S4@
M-#<U+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@,3$P+C P(#0W-RXS
M,B!49" H475A;G1I=&%T:79E(&%N9"!1=6%L:71A=&EV92!$:7-C;&]S=7)E
M<R!A8F]U="!-87)K970@4FES:RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S(#0U-BXY.#,S.3@T,S<U(&T*
M.#$N,S(U,3DU,S$R-2 T-38N.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"
M5" U,RXP," T-3@N,S(@5&0@*$ET96T@."XI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @-#4V+CDX,S,Y
M.#0S-S4@;0HR.30N.34Q,3<Q.#<U(#0U-BXY.#,S.3@T,S<U(&P*<PIQ(# @
M," P(')G($)4(#$Q,"XP," T-3@N,S(@5&0@*$9I;F%N8VEA;"!3=&%T96UE
M;G1S(&%N9"!3=7!P;&5M96YT87)Y($1A=&$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU,R T,S<N.3@S,SDX
M-#,W-2!M"C@Q+C,R-3$Y-3,Q,C4@-#,W+CDX,S,Y.#0S-S4@; IS"G$@," P
M(# @<F<@0E0@-3,N,# @-#,Y+C,R(%1D("A)=&5M(#DN*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*," P(# @4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*,3$P(#0S
M-RXY.#,S.3@T,S<U(&T*-#8X+C@Q,S0W-C4V,C4@-#,W+CDX,S,Y.#0S-S4@
M; IS"G$@," P(# @<F<@0E0@,3$P+C P(#0S.2XS,B!49" H0VAA;F=E<R!I
M;B!A;F0@1&ES86=R965M96YT<R!W:71H("D@5&H@150@40IQ(# @," P(')G
M($)4(#(U-2XX,2 T,SDN,S(@5&0@*$%C8V]U;G1A;G1S(&]N("D@5&H@150@
M40IQ(# @," P(')G($)4(#,R,"XR-" T,SDN,S(@5&0@*$%C8V]U;G1I;F<@
M86YD($9I;F%N8VEA;"!$:7-C;&]S=7)E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3,@-#$X+CDX,S,Y.#0S
M-S4@;0HX."XU-#8X-S4@-#$X+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@
M0E0@-3,N,# @-#(P+C,R(%1D("A)=&5M(#E!+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," T,3@N.3@S
M,SDX-#,W-2!M"C(P."XS,34T,CDV.#<U(#0Q."XY.#,S.3@T,S<U(&P*<PIQ
M(# @," P(')G($)4(#$Q,"XP," T,C N,S(@5&0@*$-O;G1R;VQS(&%N9"!0
M<F]C961U<F5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@
M,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P
M(&0*,2!*"C$@:@HS($T*-3,@,SDY+CDX,S,Y.#0S-S4@;0HX-RXY.34Q,3<Q
M.#<U(#,Y.2XY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#0P
M,2XS,B!49" H271E;2 Y0BXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @,SDY+CDX,S,Y.#0S-S4@;0HQ
M.#,N,#,R,C(V-38R-2 S.3DN.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"
M5" Q,3 N,# @-# Q+C,R(%1D("A/=&AE<B!);F9O<FUA=&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8R(#$P+C P(%1F($54"C @," P
M(%)'"B]'4S @9W,*,"XY-2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S
M(#,X,"XY,3(U.3<V-38R-2!M"CDS+C$R,C W,#,Q,C4@,S@P+CDQ,C4Y-S8U
M-C(U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#,X,BXT."!49" H4"D@5&H@
M150@40IQ(# @," P(')G($)4(#4X+C,W(#,X,BXT."!49" H05(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" W,BXT-B S.#(N-#@@5&0@*%0I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" W."XY-2 S.#(N-#@@5&0@*"!)24DI(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$Q,"XP," S.#(N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C P(#,X,BXS,B!49" HH"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3,@,S8Q+CDX,S,Y.#0S
M-S4@;0HX-BXS,C4Q.34S,3(U(#,V,2XY.#,S.3@T,S<U(&P*<PIQ(# @," P
M(')G($)4(#4S+C P(#,V,RXS,B!49" H271E;2 Q,"XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @,S8Q
M+CDX,S,Y.#0S-S4@;0HS,S<N-#DU,3$W,3@W-2 S-C$N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,"!R9R!"5" Q,3 N,# @,S8S+C,R(%1D("A$:7)E8W1O<G,L
M($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," P(')G($)4(#(P-2XP-B S
M-C,N,S(@5&0@*&9I8V5R<R!A;F0@0V]R<&]R871E($=O=F5R;F%N8V4I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HU,R S-#(N.3@S,SDX-#,W-2!M"C@U+CDU-#$P,34V,C4@,S0R+CDX,S,Y
M.#0S-S4@; IS"G$@," P(# @<F<@0E0@-3,N,# @,S0T+C,R(%1D("A)=&5M
M(#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" W."XT-2 S-#0N,S(@5&0@*#$N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@
M150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@
M:@HS($T*,3$P(#,T,BXY.#,S.3@T,S<U(&T*,C$P+C(U,SDP-C(U(#,T,BXY
M.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#$Q,"XP," S-#0N,S(@5&0@
M*$5X96-U=&EV92!#;VUP96YS871I;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU,R S,C,N.3@S,SDX-#,W
M-2!M"C@V+C,R-3$Y-3,Q,C4@,S(S+CDX,S,Y.#0S-S4@; IS"G$@," P(# @
M<F<@0E0@-3,N,# @,S(U+C,R(%1D("A)=&5M(#$R+BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'
M4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," S,C,N
M.3@S,SDX-#,W-2!M"C4Q.2XP-#<X-3$U-C(U(#,R,RXY.#,S.3@T,S<U(&P*
M<PIQ(# @," P(')G($)4(#$Q,"XP," S,C4N,S(@5&0@*%-E8W5R:71Y($]W
M;F5R<VAI<"!O9B!#97)T86EN($)E;F5F:6-I86P@3W=N97)S(&%N9"!-86YA
M9V5M96YT(&%N9"!296QA=&5D(%-T;V-K:&]L9&5R<R!-871T97)S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*," P
M(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M-3,@,S T+CDX,S,Y.#0S-S4@;0HX-BXS,C4Q.34S,3(U(#,P-"XY.#,S.3@T
M,S<U(&P*<PIQ(# @," P(')G($)4(#4S+C P(#,P-BXS,B!49" H271E;2 Q
M,RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*
M,2!J"C,@30HQ,3 @,S T+CDX,S,Y.#0S-S4@;0HT,3(N-CDU,S$R-2 S,#0N
M.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" Q,3 N,# @,S V+C,R(%1D
M("A#97)T86EN(%)E;&%T:6]N<VAI<',@86YD(%)E;&%T960@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C0X+C8X(#,P-BXS,B!49" H5"D@5&H@150@40IQ
M(# @," P(')G($)4(#(U-"XT,R S,#8N,S(@5&0@*')A;G-A8W1I;VYS+"!A
M;F0@1&ER96-T;W(@26YD97!E;F1E;F-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3,@,C@U+CDX,S,Y.#0S
M-S4@;0HX-BXS,C4Q.34S,3(U(#(X-2XY.#,S.3@T,S<U(&P*<PIQ(# @," P
M(')G($)4(#4S+C P(#(X-RXS,B!49" H271E;2 Q-"XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HQ,3 @,C@U
M+CDX,S,Y.#0S-S4@;0HR-C@N,CDQ,#$U-C(U(#(X-2XY.#,S.3@T,S<U(&P*
M<PIQ(# @," P(')G($)4(#$Q,"XP," R.#<N,S(@5&0@*%!R:6YC:7!A;" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#@N,#4@,C@W+C,R(%1D("A!8V-O
M=6YT86YT($9E97,@86YD(%-E<G9I8V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3,@,C8U+CDQ,C4Y-S8U
M-C(U(&T*.3(N-#<P,C$T.#0S-S4@,C8U+CDQ,C4Y-S8U-C(U(&P*<PIQ(# @
M," P(')G($)4(#4S+C P(#(V-RXT."!49" H4"D@5&H@150@40IQ(# @," P
M(')G($)4(#4X+C,W(#(V-RXT."!49" H05(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" W,BXT-B R-C<N-#@@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" W."XY-2 R-C<N-#@@5&0@*"!)5BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3$P+C P
M(#(V-RXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S$N,# @,C8W+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HU,R R-#8N.3@S,SDX-#,W-2!M"C@V+C,R-3$Y
M-3,Q,C4@,C0V+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-3,N,# @
M,C0X+C,R(%1D("A)=&5M(#$U+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C$Q," R-#8N.3@S,SDX-#,W-2!M
M"C(W,2XP.#,Y.#0S-S4@,C0V+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@
M0E0@,3$P+C P(#(T."XS,B!49" H17AH:6)I=',L($9I;F%N8VEA;"!3=&%T
M96UE;G0@4V-H961U;&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"
M5" O1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*-3,@,C(W+CDX,S,Y.#0S-S4@;0HX-BXS
M,C4Q.34S,3(U(#(R-RXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4S
M+C P(#(R.2XS,B!49" H271E;2 Q-BXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@
M2@HQ(&H*,R!-"C$Q," R,C<N.3@S,SDX-#,W-2!M"C$Y-BXQ,#@S.3@T,S<U
M(#(R-RXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#$Q,"XP," R,CDN
M,S(@5&0@*$9O<FT@,3 M2R!3=6UM87)Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3,@,C X+CDQ,C4Y-S8U
M-C(U(&T*,3$W+C(W-S,T,S<U(#(P."XY,3(U.3<V-38R-2!L"G,*<2 P(# @
M,"!R9R!"5" U,RXP," R,3 N-#@@5&0@*%-)1TY!*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@.#,N.3,@,C$P+C0X(%1D("A455)%4RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Y-"XR-2!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M.#(N,C4@5&0@*$%L;"!R969E<F5N8V5S('1O()-W92R4()-U<RR4()-O=7(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#0N.# @,3@R+C(U(%1D("@LE"!O
M<B"30W)O<W,@0V]U;G1R>90@:6X@=&AI<R!297!O<G0@;VX@1F]R;: Q,"U+
M(&UE86YS($-R;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@26YC+BP@:71S("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q-S N,C4@5&0@*'-U8G-I9&EA<FEE<R!A;F0@868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,C0N,C0@,3<P+C(U(%1D("AF:6QI871E<RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4U-" V-S4N.3@S,SDX-#,W-2!M
M"C4U.2 V-S4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,"!R9R!"5" U-30N,# @
M-C<W+C,R(%1D("@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O
M1C$@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;
M72 P(&0*,2!*"C$@:@HS($T*-34T(#8U-BXY.#,S.3@T,S<U(&T*-34Y(#8U
M-BXY.#,S.3@T,S<U(&P*<PIQ(# @," P(')G($)4(#4U-"XP," V-3@N,S(@
M5&0@*#@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HU-#D@-C,W+CDX,S,Y.#0S-S4@;0HU-3D@-C,W+CDX,S,Y
M.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#8S.2XS,B!49" H,38I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HU-#D@-C$X+CDX,S,Y.#0S-S4@;0HU-3D@-C$X+CDX,S,Y.#0S-S4@
M; IS"G$@," P(# @<F<@0E0@-30Y+C P(#8R,"XS,B!49" H,38I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU
M-#D@-3DY+CDX,S,Y.#0S-S4@;0HU-3D@-3DY+CDX,S,Y.#0S-S4@; IS"G$@
M," P(# @<F<@0E0@-30Y+C P(#8P,2XS,B!49" H,38I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@-3@P
M+CDX,S,Y.#0S-S4@;0HU-3D@-3@P+CDX,S,Y.#0S-S4@; IS"G$@," P(# @
M<F<@0E0@-30Y+C P(#4X,BXS,B!49" H,38I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@-3,S+C X,S,Y
M.#0S-S4@;0HU-3D@-3,S+C X,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@
M-30Y+C P(#4S-"XT,B!49" H,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@-3$S+CDX,S,Y.#0S-S4@
M;0HU-3D@-3$S+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P
M(#4Q-2XS,B!49" H,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@-#DT+CDX,S,Y.#0S-S4@;0HU-3D@
M-#DT+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#0Y-BXS
M,B!49" H,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q
M,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HU-#D@-#<U+CDX,S,Y.#0S-S4@;0HU-3D@-#<U+CDX
M,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#0W-RXS,B!49" H
M,S<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*
M,2!J"C,@30HU-#D@-#4V+CDX,S,Y.#0S-S4@;0HU-3D@-#4V+CDX,S,Y.#0S
M-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#0U."XS,B!49" H,S<I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HU-#D@-#,W+CDX,S,Y.#0S-S4@;0HU-3D@-#,W+CDX,S,Y.#0S-S4@; IS
M"G$@," P(# @<F<@0E0@-30Y+C P(#0S.2XS,B!49" H,S<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@
M-#$X+CDX,S,Y.#0S-S4@;0HU-3D@-#$X+CDX,S,Y.#0S-S4@; IS"G$@," P
M(# @<F<@0E0@-30Y+C P(#0R,"XS,B!49" H,S<I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@,SDY+CDX
M,S,Y.#0S-S4@;0HU-3D@,SDY+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@
M0E0@-30Y+C P(#0P,2XS,B!49" H-# I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@,S8Q+CDX,S,Y.#0S
M-S4@;0HU-3D@,S8Q+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y
M+C P(#,V,RXS,B!49" H-# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@,S0R+CDX,S,Y.#0S-S4@;0HU
M-3D@,S0R+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#,T
M-"XS,B!49" H-# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HU-#D@,S(S+CDX,S,Y.#0S-S4@;0HU-3D@,S(S
M+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#,R-2XS,B!4
M9" H-# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HU-#D@,S T+CDX,S,Y.#0S-S4@;0HU-3D@,S T+CDX,S,Y
M.#0S-S4@; IS"G$@," P(# @<F<@0E0@-30Y+C P(#,P-BXS,B!49" H-# I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HU-#D@,C@U+C X,S,Y.#0S-S4@;0HU-3D@,C@U+C X,S,Y.#0S-S4@
M; IS"G$@," P(# @<F<@0E0@-30Y+C P(#(X-BXT,B!49" H-# I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU
M-#D@,C0V+CDX,S,Y.#0S-S4@;0HU-3D@,C0V+CDX,S,Y.#0S-S4@; IS"G$@
M," P(# @<F<@0E0@-30Y+C P(#(T."XS,B!49" H-#$I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@,C(W
M+CDX,S,Y.#0S-S4@;0HU-3D@,C(W+CDX,S,Y.#0S-S4@; IS"G$@," P(# @
M<F<@0E0@-30Y+C P(#(R.2XS,B!49" H-#<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU-#D@,C X+CDX,S,Y
M.#0S-S4@;0HU-3D@,C X+CDX,S,Y.#0S-S4@; IS"G$@," P(# @<F<@0E0@
M-30Y+C P(#(Q,"XS,B!49" H-#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"F5N9'-T<F5A;0IE;F1O8FH*.2 P(&]B:@H\/"]4>7!E("]086=E"B]0
M87)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E
M<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$P(# @4CX^"F5N
M9&]B:@HQ," P(&]B:@H\/"],96YG=&@@,3$W-3$^/@IS=')E86T*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S S+C4P(#,Q+C8P(%1D("@Q
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#<T,BXR-2!49" H1F]R=V%R9"U,;V]K:6YG(%-T871E;65N=',I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-S,P+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#<Q."XR-2!49" H26X@861D:71I;VX@=&\@:&ES
M=&]R:6-A;"!I;F9O<FUA=&EO;BP@=&AI<R!&;W)MH#$P+4L@8V]N=&%I;G,@
M<W1A=&5M96YT<R!R96QA=&EN9R!T;R!O=7(@9G5T=7)E(')E<W5L=',@7"AI
M;F-L=61I;F<@8V5R=&%I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S V+C(U(%1D("AP<F]J96-T:6]N<R!A
M;F0@8G5S:6YE<W,@=')E;F1S7"D@=&AA="!A<F4@DV9O<G=A<F0M;&]O:VEN
M9R!S=&%T96UE;G1SE"!W:71H:6X@=&AE(&UE86YI;F<@;V8@4V5C=&EO;J R
M-T$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S0N,#8@-S V+C(U(%1D("@@
M;V8@=&AE(%-E8W5R:71I97,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30S
M+C0Y(#<P-BXR-2!49" H06-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V.30N,C4@5&0@*&]F(#$Y,S,L(&%S
M(&%M96YD960L(&%N9"!396-T:6]NH#(Q12!O9B!T:&4@4V5C=7)I=&EE<R!%
M>&-H86YG92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,30N-C4@-CDT+C(U
M(%1D("A!8W0@;V8@,3DS-"P@87,@86UE;F1E9"!<*'1H92!%>&-H86YG92 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S8N,C8@-CDT+C(U(%1D("A!8W1<
M*2P@86YD(&%R92!S=6)J96-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V.#(N,C4@5&0@*'1O('1H92"3<V%F
M92!H87)B;W*4(&-R96%T960@8GD@=&AO<V4@<V5C=&EO;G,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(S-2XU." V.#(N,C4@5&0@*%<I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R-#0N,C$@-C@R+C(U(%1D("AO<F1S('-U8V@@87,@
MDV5X<&5C='.4+""386YT:6-I<&%T97.4+""3:6YT96YD<Y0L()-P;&%N<Y0L
M()-B96QI979E<Y0L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," V-S N,C4@5&0@*)-E<W1I;6%T97.4+""3<W5G
M9V5S='.4+""387!P96%R<Y0L()-S965K<Y0L()-W:6QLE"!A;F0@=F%R:6%T
M:6]N<R!O9B!S=6-H('=O<F1S(&%N9"!S:6UI;&%R(&5X<')E<W-I;VYS(&%R
M92!I;G1E;F1E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C4X+C(U(%1D("AI9&5N=&EF>2!F;W)W87)D
M+6QO;VMI;F<@<W1A=&5M96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3DX+C8W(#8U."XR-2!49" H5&AE<V4@<W1A=&5M96YT<R!I;G9O;'9E(&MN
M;W=N(&%N9"!U;FMN;W=N(')I<VMS+"!U;F-E<G1A:6YT:65S+"!A;F0@;W1H
M97(@9F%C=&]R<R!T:&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V-#8N,C4@5&0@*&UA>2!C875S92!O=7(@
M86-T=6%L(')E<W5L=',@86YD('!E<F9O<FUA;F-E('1O(&)E(&UA=&5R:6%L
M;'D@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$Q+C,X(#8T-BXR-2!4
M9" H9F5R96YT(&9R;VT@86YY(&9U='5R92!R97-U;'1S(&]R('!E<F9O<FUA
M;F-E(&5X<')E<W-E9"!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-C,T+C(U(%1D("AI;7!L:65D(&)Y('1H
M97-E(&9O<G=A<F0M;&]O:VEN9R!S=&%T96UE;G1S+B!&86-T;W)S('1H870@
M;6EG:'0@8V%U<V4@<W5C:"!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M-C4N-3@@-C,T+C(U(%1D("AF97)E;F-E<R!I;F-L=61E+"!B=70@87)E(&YO
M="!L:6UI=&5D('1O+"!T:&]S92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C(R+C(U(%1D("AD:7-C=7-S960@
M:6X@=&AE('-E8W1I;VX@96YT:71L960@DTET96T@,4$I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,38N,#<@-C(R+C(U(%1D("@@+2!2:7-K($9A8W1O<G,N
ME"!296%D97)S('-H;W5L9"!A;'-O(&-A<F5F=6QL>2!R979I97<@=&AE()-2
M:7-K($9A8W1O<G.4('-E8W1I;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Q,"XR-2!49" H8V]N=&%I;F5D
M(&EN(&]T:&5R(&1O8W5M96YT<R!W92!F:6QE(&9R;VT@=&EM92!T;R!T:6UE
M('=I=&@@=&AE(%-E8W5R:71I97,@86YD($5X8VAA;F=E($-O;6UI<W-I;VXL
M(&EN8VQU9&EN9R!T:&4@475A<G1E<FQY("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,C4@5&0@*%)E<&]R
M=',@;VX@1F]R;: Q,"U1('1O(&)E(&9I;&5D(&)Y('5S(&EN(&9I<V-A;"!Y
M96%R(#(P,3DN*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4W-"XR-2!49" H06QT:&]U9V@@=V4@8F5L:65V92!T
M:&%T('1H97-E('-T871E;65N=',@87)E(&)A<V5D('5P;VX@<F5A<V]N86)L
M92!A<W-U;7!T:6]N<RP@=V4@8V%N;F]T(&=U87)A;G1E92!F=71U<F4@<F5S
M=6QT<R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4V,BXR-2!49" H<F5A9&5R<R!A<F4@8V%U=&EO;F5D
M(&YO="!T;R!P;&%C92!U;F1U92!R96QI86YC92!O;B!T:&5S92!F;W)W87)D
M+6QO;VMI;F<@<W1A=&5M96YT<RP@=VAI8V@@<F5F;&5C="!M86YA9V5M96YT
MDBD@5&H@150@40IQ(# @," P(')G($)4(#4P-RXS,2 U-C(N,C4@5&0@*',@
M;W!I;FEO;G,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4U,"XR-2!49" H;VYL>2!A<R!O9B!T:&4@9&%T92!O
M9B!T:&ES(&9I;&EN9RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@P+C W
M(#4U,"XR-2!49" H5&AE<F4@8V%N(&)E(&YO(&%S<W5R86YC92!T:&%T(%PH
M:5PIH'=E(&AA=F4@8V]R<F5C=&QY(&UE87-U<F5D(&]R(&ED96YT:69I960@
M86QL(&]F('1H92!F86-T;W)S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U,S@N,C4@5&0@*&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3<N-3D@-3,X+C(U(%1D("AF96-T:6YG(&]U<B!B
M=7-I;F5S<R!O<B!T:&4@97AT96YT(&]F('1H97-E(&9A8W1O<G.2*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C4V+C(S(#4S."XR-2!49" H(&QI:V5L>2!I
M;7!A8W0[(%PH:6E<*:!T:&4@879A:6QA8FQE(&EN9F]R;6%T:6]N('=I=&@@
M<F5S<&5C="!T;R!T:&5S92!F86-T;W)S(&]N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,C8N,C4@5&0@*'=H
M:6-H('-U8V@@86YA;'ES:7,@:7,@8F%S960@:7,@8V]M<&QE=&4@;W(@86-C
M=7)A=&4[(%PH:6EI7"F@<W5C:"!A;F%L>7-I<R!I<R!C;W)R96-T.R!O<B!<
M*&EV7"F@;W5R('-T<F%T96=Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4T
M+C4P(#4R-BXR-2!49" H+"!W:&EC:"!I<R!B87-E9"!I;B!P87)T(&]N("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," U,30N,C4@5&0@*'1H:7,@86YA;'ES:7,L('=I;&P@8F4@<W5C8V5S<V9U
M;"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@P+C X(#4Q-"XR-2!49" H
M5&AE($-O;7!A;GD@=6YD97)T86ME<R!N;R!O8FQI9V%T:6]N('1O('5P9&%T
M92!O<B!R979I<V4@9F]R=V%R9"UL;V]K:6YG('-T871E;65N=',N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y
M,"XR-2!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R.#DN.# @-#<X+C(U(%1D("A0*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDU+C$W(#0W."XR-2!49" H05(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#DN,C8@-#<X+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S$U+C<U(#0W."XR-2!49" H($DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#8V+C(U(%1D("B@*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0U
M-"XR-2!49" H271E;2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXT.2 T
M-30N,C4@5&0@*#$N("D@5&H@150@40IQ(# @," P(')G($)4(#@R+C0Y(#0U
M-"XR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#@T+CDY(#0U-"XR
M-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#@W+C0Y(#0U-"XR-2!4
M9" H("D@5&H@150@40IQ(# @," P(')G($)4(#@Y+CDY(#0U-"XR-2!49" H
M("D@5&H@150@40IQ(# @," P(')G($)4(#DR+C0Y(#0U-"XR-2!49" H("D@
M5&H@150@40IQ(# @," P(')G($)4(#DT+CDY(#0U-"XR-2!49" H("D@5&H@
M150@40IQ(# @," P(')G($)4(#DW+C0Y(#0U-"XR-2!49" H("D@5&H@150@
M40IQ(# @," P(')G($)4(#DY+CDY(#0U-"XR-2!49" H("D@5&H@150@40IQ
M(# @," P(')G($)4(#$P,BXT.2 T-30N,C4@5&0@*" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,#0N.3D@-#4T+C(U(%1D("@@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3 W+C0Y(#0U-"XR-2!49" H("D@5&H@150@40IQ(# @," P
M(')G($)4(#$P.2XY.2 T-30N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,3(N-#D@-#4T+C(U(%1D("A"=7-I;F5S<RXI(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#,P+C(U(%1D
M("A/=F5R=FEE=R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,RXU.2 T,S N
M,C4@5&0@*&]F("D@5&H@150@40IQ(# @," P(')G($)4(#$P-"XT,B T,S N
M,C4@5&0@*$]U<BD@5&H@150@40IQ(# @," P(')G($)4(#$R,BXP,B T,S N
M,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C0N-3(@-#,P+C(U
M(%1D("A#;VUP86YY*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#0Q."XR-2!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,#8N,C4@5&0@*$-R
M;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@26YC+B!<*$Y!4T1!43H@0T-23EPI
M(&ES(&$@;F%T:6]N86P@;&5A9&5R(&EN('!R;W9I9&EN9R!H96%L=&AC87)E
M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#<N,C(@-# V+C(U(%1D
M("AF:6YG+"!R96-R=6ET:6YG(&%N9"!V86QU92TI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,SDT+C(U(%1D("AA
M9&1E9"!W;W)K9F]R8V4@<V]L=71I;VYS+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-C N.3 @,SDT+C(U(%1D("A4:')O=6=H(&$@9G5L;"!S=6ET92!O
M9B!I;FYO=F%T:79E('=O<FMF;W)C92!S;VQU=&EO;G,@86YD(&$@;F%T:6]N
M86P@<')E<V5N8V4@:6YC;'5D:6YG(#<S(&]F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3,W+C(Y(#,Y-"XR-2!49" H9FEC92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S@R+C(U(%1D("AL
M;V-A=&EO;G,@=&AR;W5G:&]U="!T:&4@56YI=&5D(%-T871E<R!<*%4N4RY<
M*2P@=V4@87)E(&%B;&4@=&\@;65E="!T:&4@=6YI<75E(&%N9"!D>6YA;6EC
M(&YE961S(&]F(&]U<B!C;&EE;G1S+B!">2!U=&EL:7II;F<@;W5R("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M-S N,C4@5&0@*'9A<FEO=7,@<V]L=71I;VYS+"!C;&EE;G1S(&%R92!A8FQE
M('1O(&)E='1E<B!P;&%N('1H96ER('!E<G-O;FYE;"!N965D<RP@;W5T<V]U
M<F-E(')E8W)U:71M96YT('!R;V-E<W-E<RP@<W1R871E9VEC86QL>2!F;&5X
M('1H96ER("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," S-3@N,C4@5&0@*'=O<FMF;W)C92P@86-C97-S('%U86QI
M='D@:&5A;'1H8V%R92!P97)S;VYN96PL(&%N9"!P<F]V:61E(&-O;G1I;G5I
M='D@;V8@8V%R92!F;W(@:6UP<F]V960@<&%T:65N="!O=71C;VUE<RX@("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S,S@N,C4@5&0@*$]U<B!S;VQU=&EO;G,@87)E(&=E87)E9"!T;W=A<F1S
M(&%S<VES=&EN9R!O=7(@8VQI96YT<R!I;B!M86EN=&%I;FEN9R!H:6=H('%U
M86QI='D@;W5T8V]M97,@8GD@861D<F5S<VEN9R!T:&5I<B!H96%L=&AC87)E
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," S,C8N,C4@5&0@*'=O<FMF;W)C92!N965D<RX@("D@5&H@150@40IQ
M(# @," P(')G($)4(#$R,RXV." S,C8N,C4@5&0@*%<I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,S(N,S$@,S(V+C(U(%1D("AE(&%R92!I;F-R96%S:6YG
M;'D@8F5I;F<@8V%L;&5D('5P;VX@8GD@;W5R(&-L:65N=',@=&\@<')O=FED
M92!M;W)E(&-R96%T:79E(&%N9"!S=')A=&5G:6,@=&%L96YT('-O=7)C:6YG
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," S,30N,C4@5&0@*'-T<F%T96=I97,@=VET:"!R97-P96-T('1O(&YU
M<G-E<RP@9&]C=&]R<RP@86QL:65D(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L
M<RP@86YD(&AE86QT:&-A<F4@97AE8W5T:79E<RP@86QL(&]N(&$@=&5M<&]R
M87)Y(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,S R+C(U(%1D("AP97)M86YE;G0@8F%S:7,N($]V97(@
M=&AE('!A<W0@<V5V97)A;"!Y96%R<RP@;W5R('=O<FMF;W)C92!S;VQU=&EO
M;G,@:&%V92!E=F]L=F5D(&EN=&\@82!T;W1A;"!T86QE;G0@;6%N86=E;65N
M="!R96QA=&EO;G-H:7 @*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#(Y,"XR-2!49" H87,@;W5R(&-L:65N=',@
M8V]N=&EN=64@=&\@9F]C=7,@;VX@:6UP<F]V:6YG(&QA8F]R(&UA;F%G96UE
M;G0@=&\@861D<F5S<R!C;VUP;&5X(&9I;F%N8VEA;"P@8V]M<&QI86YC92P@
M86YD(&]T:&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R-S@N,C4@5&0@*&-H86QL96YG97,@:6X@=&AE(&AE
M86QT:&-A<F4@:6YD=7-T<GDI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.34N
M-#$@,C<X+C(U(%1D("@N(" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#(N
M,S4@,C<X+C(U(%1D("A!<R!P87)T(&]F('1H:7,@979O;'5T:6]N(&]F(&]U
M<B!S97)V:6-E<RP@=V4@8V]N=&EN=64@=&\@8V]N<VED97(@=&AE(&9O;&QO
M=VEN9SH@(%PH,5PI("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," R-C8N,C4@5&0@*'-O;'9I;F<@=&AE(&EM;65D
M:6%T92!A;F0@9G5T=7)E(&YE961S(&]F(&]U<B!C=7-T;VUE<G,@86YD(&AE
M86QT:&-A<F4@<')O9F5S<VEO;F%L<SL@7"@R7"D@96YH86YC:6YG(&]U<B!N
M971W;W)K(&]F(&AE86QT:&-A<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(U-"XR-2!49" H<')O9F5S<VEO
M;F%L<R!A;F0@9&5E<&5N:6YG(&]U<B!R96QA=&EO;G-H:7 @=VET:"!T:&5M
M.R!<*#-<*2!E>'!A;F1I;F<@;W5R('-E<G9I8V4@;V8I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.3 N,# @,C4T+C(U(%1D("AF97)I;F=S('1O(')E9'5C
M92!S96YS:71I=FET>2!T;R!E8V]N;VUI8R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C0R+C(U(%1D("AC>6-L
M97,[(%PH-%PI(&5X<&%N9&EN9R!O=7(@97AP97)T:7-E('=I=&@@=F%R:6]U
M<R!H96%L=&AC87)E('-O;'5T:6]N<R!I;B!V87)I;W5S(&=E;V=R87!H:6,@
M87)E87,@;V8@=&AE(%4N4RX@86YD(%PH-5PI(&-O;G1I;G5I;F<@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(S
M,"XR-2!49" H=&\@9&EV97)S:69Y(&]U<B!C;&EE;G0@8F%S92!T;R!E;FAA
M;F-E(&]U<B!L;VYG+71E<FT@8G5S:6YE<W,@<')O<W!E8W1S+B @*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S0S+CDQ(#(S,"XR-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#,T.2XS,B R,S N,C4@5&0@*&]D87DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C@N,3$@,C,P+C(U(%1D("@L(&]U<B!W;W)K
M9F]R8V4@<V]L=71I;VYS(&EN8VQU9&4Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(Q,"XR-2!49" HE2 I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P
M(#(Q,"XR-2!49" H36%N86=E9"!397)V:6-E(%!R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C X+C0V(#(Q,"XR-2!49" H;V=R86US(%PH35-0<UPI+BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-S8N
M-S@@,C$P+C(U(%1D("@@("D@5&H@150@40IQ(# @," P(')G($)4(#(X,2XV
M," R,3 N,C4@5&0@*%1H92!M87)K970@:&%S(&-O;G1I;G5E9"!T;R!S:&EF
M="!T;W=A<F1S(&$@8V5N=')A;&EZ960@;6]D96P@9F]R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @,3DX+C(U
M(%1D("AM86YA9VEN9R!C;VYT:6YG96YT(&QA8F]R(&9O<B!B;W1H(&-L:6YI
M8V%L(&%N9"!N;VXM8VQI;FEC86P@;F5E9',N("D@5&H@150@40IQ(# @," P
M(')G($)4(#,Y,BXX-" Q.3@N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,#$N-#@@,3DX+C(U(%1D("AE(&AA=F4@8F5E;B!A(&UA<FME="!L
M96%D97(@:6X@=&AI<R!A<F5A("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q,C(N,# @,3@V+C(U(%1D("AS:6YC92!L875N
M8VAI;F<@;W5R(&9I<G-T($U34"D@5&H@150@40IQ(# @," P(')G($)4(#(T
M,2XP-B Q.#8N,C4@5&0@*"!I;B R,# S+"!A;B!A8V-O=6YT('=E(&-O;G1I
M;G5E('1O('-E<G9E('1O9&%Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,P
M+CDQ(#$X-BXR-2!49" H+B!/=F5R('1H92!P87-T(#$U('EE87)S+"!W92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R
M+C P(#$W-"XR-2!49" H:&%V92!G<F]W;B!O=7(@<F5L871I;VYS:&EP<R!A
M;F0@=&]D87D@<V5R=FEC92!M;W)E('1H86X@-S @8VQI96YT<R!A8W)O<W,@
M;6]R92!T:&%N(#DP,"!F86-I;&ET:65S+"!W:71H("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @,38R+C(U(%1D
M("AE<W1I;6%T960@<W!E;F0@=6YD97(@;6%N86=E;65N="!O9B!A<'!R;WAI
M;6%T96QY("0T,# @;6EL;&EO;B!A;FYU86QL>2D@5&H@150@40IQ(# @," P
M(')G($)4(#0R-BXR-R Q-C(N,C4@5&0@*"X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#,Q+C Y(#$V,BXR-2!49" H5&AE(&)E;F5F:71S('1O(&]U<B!C
M;&EE;G1S(&YO=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3(R+C P(#$U,"XR-2!49" H;VYL>2!I;F-L=61E(')E9'5C
M960@8V]S=',@86YD(&EN8W)E87-E9"!V:7-I8FEL:71Y(&EN=&\@=&AE:7(@
M;F5E9',@86YD('5S86=E+"!B=70@=&AE>2!G86EN(&%C8V5S<R!A;F0@:6YS
M:6=H=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(R+C P(#$S."XR-2!49" H9G)O;2!O=7(@:6YD=7-T<GD@97AP97)T
M:7-E(&]N(&$@8G)O860@<F%N9V4@;V8@=&]P:6-S+B!);B R,#$W+"!W92!A
M8W%U:7)E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,CDN,3,@,3,X+C(U
M(%1D("A!9'9A;G1A9V4@4DXL($Q,0R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#$R-BXR-2!49" H7"A!9'9A
M;G1A9V5<*2!T;R!S=7!P;&5M96YT('1H92!N=6UB97(@;V8@;G5R<V5S('=E
M('!L86-E(&%T(&]U<B!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#(N
M.34@,3(V+C(U(%1D("@@8VQI96YT<RP@:6YC<F5A<V4@;W5R(&-A<'1U<F4@
M<F%T92!A=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3(R+C P(#$Q-"XR-2!49" H=&AO<V4@86-C;W5N=',L(&%N9"!R
M961U8V4@=&AE(&YU;6)E<B!O9B!P;W-I=&EO;G,@=V4@;W5T<V]U<F-E('1O
M('-U8F-O;G1R86-T;W)S+B!);B!A9&1I=&EO;BP@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3 V+C W(#$Q-"XR-2!49" H061V86YT86=E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @,3 R
M+C(U(%1D("AP<F]V:61E<R!A('9E:&EC;&4@9F]R('5S('1O(&-R;W-S+7-E
M;&P@;W5R($U34"D@5&H@150@40IQ(# @," P(')G($)4(#,P."XX,B Q,#(N
M,C4@5&0@*"!S;VQU=&EO;G,@=&\@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S4Y+C8W(#$P,BXR-2!49" H061V86YT86=E)W,@8VQI96YT<R!A;F0@:6YC
M<F5A<V4@;W5R(&9O;W1P<FEN="!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#DP+C(U(%1D("AT:&4@36ED
M=V5S="!W:&5R92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,# N-3D@.3 N
M,C4@5&0@*$%D=F%N=&%G92!I<R!L;V-A=&5D+B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-S@N,C4@5&0@*)4@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R
M,BXP," W."XR-2!49" H3W!T:6UA;" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q-3DN.#@@-S@N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-CDN,S(@-S@N,C4@5&0@*&]R:V9O<BD@5&H@150@40IQ(# @," P(')G($)4
M(#$Y-BXY,2 W."XR-2!49" H8V4@4V]L=71I;VYS(%PH3U=37"DN(" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@W+C<U
M(#<X+C(U(%1D("A4:&4@86-Q=6ES:71I;VX@;V8@365D:6-A;"!3=&%F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C(P(#<X+C(U(%1D("AF:6YG($YE
M='=O<FL@:6X@,C Q-"!P<F]V:61E9"!U<R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#8V+C(U(%1D("AW:71H
M(&$@<&QA=&9O<FT@=&\@<')O=FED92!O=71S;W5R8V5D('-E<G9I8V5S('1O
M(&QA<BD@5&H@150@40IQ(# @," P(')G($)4(#,S,2XR," V-BXR-2!49" H
M9V4@:&]S<&ET86P@<WES=&5M<R!T;R!M;W)E(&5F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#4R+C,Y(#8V+C(U(%1D("AF:6-I96YT;'D@;6%N86=E(&-E
M<G1A:6X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$R,BXP," U-"XR-2!49" H<')O9F5S<VEO;F%L<RXI(%1J($54(%$*
M96YD<W1R96%M"F5N9&]B:@HQ,2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E
M;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U
M<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$R(# @4CX^"F5N9&]B
M:@HQ,B P(&]B:@H\/"],96YG=&@@,3,Y.#0^/@IS=')E86T*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S S+C4P(#,Q+C8P(%1D("@R*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P
M(#<T,BXQ,"!49" HE2 I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,3(R+C P(#<T,BXQ,"!49" H161U8V%T:6]N($AE86QT
M:&-A<BD@5&H@150@40IQ(# @," P(')G($)4(#(Q,"XY." W-#(N,3 @5&0@
M*&4@4W1A9F9I;F<@4V5R=FEC97,N(" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,CDV+C@P(#<T,BXQ,"!49" H26X@,C Q
M-2P@=V4@86-Q=6ER960@86X@961U8V%T:6]N(&AE86QT:&-A<F4@<W1A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#0Y-"XX-B W-#(N,3 @5&0@*&9I;F<@
M8V]M<&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#4T.2XT." W-#(N,3 @
M5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$R,BXP," W,S N,3 @5&0@*$UE9&ES8V%N+"!W:&EC:"!F=7)T:&5R
M(&1I=F5R<VEF:65D(&]U<B!C=7-T;VUE<B!B87-E('1O('-T868I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N-3@@-S,P+C$P(%1D("AF('-P965C:"!L
M86YG=6%G92!P871H;VQO9VES=',L('!H>7-I8V%L("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @-S$X+C$P(%1D
M("AT:&5R87!I<W1S+"!A;F0@;W1H97(@:&5A;'1H8V%R92!W;W)K97)S(&EN
M('-C:&]O;',@7"AP=6)L:6,L(&-H87)T97(@86YD('!R:79A=&5<*2!A<R!M
M86YD871E9"!B>2!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$R,BXP," W,#8N,3 @5&0@*&=O=F5R;FUE;G0N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$W-"XU." W,#8N,3 @5&0@*%1H:7,@
M8G5S:6YE<W,@<V5R=F5S('1O(')E9'5C92!O=7(@<V5N<VET:79I='D@=&\@
M96-O;F]M:6,@8WEC;&5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," V.30N,3 @5&0@*)4@*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," V.30N,3 @
M5&0@*%)E8W)U:71M96YT(%!R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@X
M+C<S(#8Y-"XQ,"!49" H;V-E<W,@3W5T<V]U<BD@5&H@150@40IQ(# @," P
M(')G($)4(#(T."XR-R V.30N,3 @5&0@*&-I;F<@7"A24$]<*2XI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDX+C@R(#8Y
M-"XQ,"!49" H("!);B R,#$V+"!W92!A8W%U:7)E9"!A;B!24$\@8G5S:6YE
M<W,L(%53(%)E<V]U<F-E<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3(R+C P(#8X,BXQ,"!49" H2&5A;'1H8V%R92P@
M=VAI8V@@86QL;W=S('5S('1O(&1E;&EV97(@9FEN86YC:6%L(&%N9"!O<&5R
M871I;F<@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.# N,#4@-C@R+C$P
M(%1D("AF:6-I96YC:65S('1O(&]U<B!C=7-T;VUE<G,@=&AR;W5G:"!L86)O
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3(R+C P(#8W,"XQ,"!49" H;W!T:6UI>F%T:6]N('-E<G9I8V5S('=H:6QE
M(&5N:&%N8VEN9R!T:&4@<75A;&ET>2!O9B!C87)E+B!);B R,#$X+"!W92!A
M8W%U:7)E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#$N.#D@-C<P+C$P
M(%1D("A!;65R:6-A;B!097)S;VYN96PL($EN8RX@7"A!4"D@5&H@150@40IQ
M(# @," P(')G($)4(#4V,2XW-R V-S N,3 @5&0@*" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#8U."XQ,"!4
M9" H4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$S-RXY,R V-3@N,3 @
M5&0@*&9I;F=<*2!W:&EC:"!A;'-O('!R;W9I9&5S(%)03R!S97)V:6-E<R!I
M;B!A9&1I=&EO;B!T;R!O=&AE<B!S=')A=&5G:6,@<V]L=71I;VYS+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," V
M-#8N,3 @5&0@*)4@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$R,BXP," V-#8N,3 @5&0@*$EN=&5R;F%L(%)E<V]U<BD@
M5&H@150@40IQ(# @," P(')G($)4(#$X.2XX-R V-#8N,3 @5&0@*&-E(%!O
M;VP@0V]N<W5L=&EN9R F($1E=F5L;W!M96YT(%PH25)07"DN(" @*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-2XQ,R V
M-#8N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#,N-S<@-C0V
M+C$P(%1D("AE('-T<F%T96=I8V%L;'D@<&%R=&YE<B!W:71H(&]U<B!C;&EE
M;G1S('1O('-E=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3(R+C P(#8S-"XQ,"!49" H=7 L(&%D;6EN:7-T97(@86YD
M(&UA;F%G92!A;B!)4E I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3DN,S<@
M-C,T+C$P(%1D("@@;W(@=&\@;W!T:6UI>F4@86X@97AI<W1I;F<@25)0*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C<W(#8S-"XQ,"!49" H('1O(&-R
M96%T92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#0R."XT.2 V,S0N,3 @
M5&0@*&9I8VEE;F-I97,@9F]R(&]U<B!C;&EE;G1S(&)Y("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @-C(R+C$P
M(%1D("AB86QA;F-I;F<@=&AE:7(@=V]R:V9O<F-E(&UI>"!T;R!M965T('1H
M96ER(&-U<G)E;G0@;F5E9',N(" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.#8N,# @-C$P+C$P(%1D("B5("D@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @-C$P
M+C$P(%1D("A%;&5C='(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#<N.3$@
M-C$P+C$P(%1D("AO;FEC($UE9&EC86P@4F5C;W)D("D@5&H@150@40IQ(# @
M," P(')G($)4(#(S."XU-" V,3 N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-#0N-#<@-C$P+C$P(%1D("AR86YS:71I;VX@4W1A9F9I;F<@
M7"A%35)<*2X@("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S-3DN,3D@-C$P+C$P(%1D("A!<R!H96%L=&AC87)E(&9A8VEL
M:71I97,@8V]N=&EN=64@=&\@96YH86YC92!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," U.3@N,3 @5&0@
M*&]P=&EM:7IE('1H96ER(&5L96-T<F]N:6,@;65D:6-A;"!R96-O<F0@=&5C
M:&YO;&]G>2D@5&H@150@40IQ(# @," P(')G($)4(#,R."XR,2 U.3@N,3 @
M5&0@*"P@=V4@<')O=FED92!A('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T,#$N-C$@-3DX+C$P(%1D("AF:6YG('!L86X@86YD(&%N(&]R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#<V+CDV(#4Y."XQ,"!49" H9V%N:7IE9"!V
M;VQU;64@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$R,BXP," U.#8N,3 @5&0@*'%U86QI='D@:&5A;'1H8V%R92!P
M<F]F97-S:6]N86QS(&1U<FEN9R!T:&4@<')O8V5S<R!S;R!T:&%T(&]U<B!C
M;&EE;G1S(&UA>2!C;VYT:6YU92!T;R!D96QI=F5R('%U86QI='D@8V%R92XI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N
M,# @-3<T+C$P(%1D("B5("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q,C(N,# @-3<T+C$P(%1D("A#;VYS=6QT:6YG(%-E
M<G9I8V5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,#@N-C<@-3<T+C$P(%1D("@@($EN(#(P,3@L('=E(&%C<75I<F5D
M("D@5&H@150@40IQ(# @," P(')G($)4(#,P,"XP,R U-S0N,3 @5&0@*$%0
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$R+C0T(#4W-"XQ,"!49" H(%-T
M868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S N.#<@-3<T+C$P(%1D("AF
M:6YG(&QO8V%T960@:6X@0F]S=&]N+B @26X@861D:71I;VX@=&\@<')O=FED
M:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,C(N,# @-38R+C$P(%1D("AT96UP;W)A<GD@86YD('!E<FUA;F5N="!S
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0Q+C0Y(#4V,BXQ,"!49" H
M9FEN9R!S;VQU=&EO;G,@86YD($U34"D@5&H@150@40IQ(# @," P(')G($)4
M(#,S-2XS," U-C(N,3 @5&0@*"!S;VQU=&EO;G,L("D@5&H@150@40IQ(# @
M," P(')G($)4(#,W."XS-R U-C(N,3 @5&0@*$%0*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,SDP+C<X(#4V,BXQ,"!49" H(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,#DN,C$@-38R+C$P(%1D("AF:6YG(&%C=',@87,@82!C
M;VYS=6QT871I=F4@<&%R=&YE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3(R+C P(#4U,"XQ,"!49" H=VET:"!C;&EE
M;G1S('1O('!E<F9O<FTL(&%M;VYG(&]T:&5R('1H:6YG<RP@=&%L96YT(&%C
M<75I<VET:6]N(&%S<V5S<VUE;G1S+"!T:&4@9&5V96QO<&UE;G0@;V8@<F5Q
M=65S=',@9F]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q,C(N,# @-3,X+C$P(%1D("AP<F]P;W-A;',L('1H92!M86YA
M9V5M96YT(&]F('9E;F1O<B!S96QE8W1I;VX@<')O8V5S<V5S+"!A;F0@96UP
M;&]Y97(@8G)A;F1I;F<@<W1R871E9VEE<RXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3$T+C$P(%1D("A4:')O
M=6=H(&$@8V]M8FEN871I;VX@;V8@;W5R(&YA=&EO;F%L(')E86-H(&%N9"!I
M;F1U<W1R>2!L96%D:6YG(&QO8V%L('!R97-E;F-E(&EN(&ME>2!M87)K971S
M+"!W92!A<F4@86)L92!T;R!P;&%C92!C;&EN:6-A;" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3 R+C$P(%1D
M("AA;F0@;F]N+6-L:6YI8V%L('!R;V9E<W-I;VYA;',@86-R;W-S(&$@9&EV
M97)S92!C=7-T;VUE<B!B87-E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M,# N,#$@-3 R+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S X
M+C8U(#4P,BXQ,"!49" H92!B96QI979E('1H870@;W5R(&)R86YC:&5S('!R
M;W9I9&4@82!U;FEQ=64@=F%L=64@<')O<&]S:71I;VX@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y,"XQ,"!4
M9" H=&\@8F]T:"!L87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,"XY,B T
M.3 N,3 @5&0@*&=E(&%N9"!S;6%L;"!C;&EE;G1S(&%L:6ME(&%S('=E(&%R
M92!A8FQE('1O(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<Q+C<X(#0Y
M,"XQ,"!49" H9F5R('1H96T@82!H:6=H+71O=6-H+"!C;VYS=6QT871I=F4@
M8F%S960@87!P<F]A8V@@=&\@=6YD97)S=&%N9&EN9R!T:&4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0W."XQ
M,"!49" H;6%R:V5T(&]N(&)O=&@@82!N871I;VYA;"!A;F0@;&]C86P@;&5V
M96PN($]U<B!A8W%U:7-I=&EO;B!O9B!-961I8V%L(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-#0N-#4@-#<X+C$P(%1D("AF:6YG($YE='=O<FL@
M:6X@,C Q-"!E>'!A;F1E9"!O=7(@;&]C86P@<')E<V5N8V4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V-BXQ
M,"!49" H=&AR;W5G:&]U="!T:&4@52Y3+B!A;F0@<')O=FED960@82!L87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#,N-C@@-#8V+C$P(%1D("AG97(@
M9V5O9W)A<&AI8R!F;V]T<')I;G0@;V8@-34@;V8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,S0N.#0@-#8V+C$P(%1D("AF:6-E<R!T;R!P<F]V:61E('!E
M<B!D:65M(&%N9"!L;V-A;"!C;VYT<F%C="!S=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3(U+C$T(#0V-BXQ,"!49" H9FEN9R!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0U-"XQ
M,"!49" H<W5P<&]R="!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#(N
M,30@-#4T+C$P(%1D("@@8VQI96YT<R!I;B!T:&]S92!A<F5A<RX@26X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C R+CDU(#0U-"XQ,"!49" H075G=7-T
M(#(P,3@L(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S4N,C<@-#4T
M+C$P(%1D("AF:6YG($EN9'5S=')Y("D@5&H@150@40IQ(# @," P(')G($)4
M(#,R.2XQ-B T-30N,3 @5&0@*$%N86QY<W1S(')E<&]R=&5D('1H870@0W)O
M<W,@0V]U;G1R>2!(96%L=&AC87)E('=A<R!T:&4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXQ,"!49" H
M;&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C N,S<@-#0R+C$P(%1D("AG
M97-T('!E<B!D:65M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S$N
M,# @-#0R+C$P(%1D("AF:6YG(&-O;7!A;GD@:6X@=&AE(%4N4RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,S+C@V(#0T,BXQ,"!49" H5&AE(&%C<75I
M<VET:6]N<R!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3(N-#8@-#0R
M+C$P(%1D("A!;&QI960@2&5A;'1H($=R;W5P(&EN(#(P,3,L($UE9&EC86P@
M4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#0X,RXV,R T-#(N,3 @5&0@
M*&9I;F<@3F5T=V]R:R!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-#,P+C$P(%1D("@R,#$T+"!-961I<V-A
M;B!I;B R,#$U+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3$N,3 @-#,P
M+C$P(%1D("A!9'9A;G1A9V4@:6X@,C Q-RP@86YD("D@5&H@150@40IQ(# @
M," P(')G($)4(#(T."XU." T,S N,3 @5&0@*$%M97)I8V%N(%!E<G-O;FYE
M;"P@26YC+B!<*$%0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8X+C0V(#0S
M,"XQ,"!49" H(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#8N.#@@
M-#,P+C$P(%1D("AF:6YG7"D@:6X@,C Q."!H879E(&5X<&%N9&5D(&]U<B!R
M96-R=6ET:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T,3@N,3 @5&0@*&-A<&%B:6QI=&EE<R!A;F0@<W5P
M<&QY(&]F(&YU<G-I;F<@86YD(&%L;&EE9"!P<F]F97-S:6]N86QS('=H;R!D
M97-I<F4@=&\@8F4@96YG86=E9"!O;B!A('1R879E;"P@<&5R(&1I96T@86YD
M+V]R('!E<FUA;F5N=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-# V+C$P(%1D("AB87-I<R!T:')O=6=H;W5T
M('1H92!C;W5R<V4@;V8@=&AE:7(@8V%R965R<RXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,SDT+C$P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,X,BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T
M(#,X,BXQ,"!49" H92!S=&%R=&5D(&-E;G1R86QI>FEN9R!O=7(@8F%C:R!O
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$X.2XW.2 S.#(N,3 @5&0@*&9I
M8V4L(&EN8VQU9&EN9R!T96-H;F]L;V=Y*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDS+C@S(#,X,BXQ,"!49" H+"!H=6UA;B!R97-O=7)C92P@9FEN86YC
M92P@86YD(')I<VL@;6%N86=E;65N="!R97-O=7)C97,@:6X@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W,"XQ
M,"!49" H,C Q,RP@86YD('=E(&-O;G1I;G5E('1O(&-E;G1R86QI>F4@=&AE
M<V4@9G5N8W1I;VYS(&EN(&]R9&5R('1O('-T<F5A;6QI;F4@<')O8V5S<V5S
M(&%N9"!C<F5A=&4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S<N-#4@
M,S<P+C$P(%1D("AF:6-I96YC:65S(&EN('!U<G-U:70@;V8@9W)O=W1H("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S-3@N,3 @5&0@*&%N9"!P<F]F:71A8FEL:71Y*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3$T+C V(#,U."XQ,"!49" H+B!);B!A;B!E9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$T.2XT,2 S-3@N,3 @5&0@*&9O<G0@=&\@9G5R
M=&AE<B!O<'1I;6EZ92!O=7(@<')O8V5S<V5S+"!F<F]M(#(P,30@=&\@,C Q
M-B!W92!R97!L86-E9"!T:&4@9G)O;G0@;V8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-S4N-3(@,S4X+C$P(%1D("AF:6-E(&]P97)A=&EN9R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S0V
M+C$P(%1D("AS>7-T96US(&]F(&]U<B!B<F%N8V@@;W!E<F%T:6]N<RP@;W5R
M('!H>7-I8VEA;B!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4X+C$Q
M(#,T-BXQ,"!49" H9FEN9R!B=7-I;F5S<R!A;F0@;W5R(&5X96-U=&EV92!A
M;F0@<&AY<VEC:6%N('-E87)C:"!B=7-I;F5S<RX@26X@,C Q."P@=V4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#,S-"XQ,"!49" H8F5G86X@82!P<F]J96-T('1O(')E<&QA8V4@=&AE(&9R
M;VYT+65N9"!O<&5R871I;F<@<WES=&5M(&]F(&]U<B!T<F%V96P@;G5R<V4@
M8G5S:6YE<W,@=&\@:6UP<F]V92!O=7(@8V%N9&ED871E(&5X<&5R:65N8V4@
M86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S,C(N,3 @5&0@*&)E(&UO<F4@968I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Y,BXU-R S,C(N,3 @5&0@*&9I8VEE;G0N("D@5&H@150@40IQ
M(# @," P(')G($)4(#$R,BXU-B S,C(N,3 @5&0@*$%S('!A<G0@;V8@;W5R
M(&=R;W=T:"!S=')A=&5G>2D@5&H@150@40IQ(# @," P(')G($)4(#(T,BXW
M,B S,C(N,3 @5&0@*"P@=V4@87)E(&%L<V\@96UB<F%C:6YG('1H92!W87D@
M8V]N=&5N="P@;65S<V%G:6YG(&%N9"!C;VUM=6YI8V%T:6]N("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,3 N
M,3 @5&0@*&=E;F5R86QL>2!A<F4@8F5I;F<@8V]N<W5M960@9&EF*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3@S+C$P(#,Q,"XQ,"!49" H9F5R96YT;'D@
M86YD('=E(&%R92!C;VYT:6YU:6YG('1O(&UA:V4@:6YV97-T;65N=',@:6X@
M<V]C:6%L(&UE9&EA+"!M;V)I;&4@87!P;&EC871I;VYS(&%N9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,CDX
M+C$P(%1D("AO=&AE<B!T96-H;F]L;V=Y('=H:6-H('=E(&)E;&EE=F4@=VEL
M;"!C;VYT:6YU92!E;FAA;F-I;F<@;W5R(')E8W)U:71I;F<@8V%P86)I;&ET
M:65S(&%N9"!T:&4@97AP97)I96YC92!O9B!O=7(@:&5A;'1H8V%R92 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,C@V+C$P(%1D("AP<F]F97-S:6]N86QS+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,#<N-3D@,C@V+C$P(%1D("A4:&5S92!M87)K971I;F<@86YD('1E
M8VAN;VQO9WD@<W1R871E9VEE<R!T;R!R971A:6X@=&%L96YT(&UO<F4@968I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S(N,#,@,C@V+C$P(%1D("AF:6-I
M96YT;'D@<VAO=6QD('-E<G9E('1O(&=I=F4@=7,@;6]R92!L979E<F%G92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,C<T+C$P(%1D("AI;B!T:&4@8G5S:6YE<W,@86YD(&UA:V4@=&AE(&-O
M;7!A;GD@;6]R92!U<V5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0U+C@V
M(#(W-"XQ,"!49" H+69R:65N9&QY(&9O<B!O=7(@8V]R<&]R871E(&5M<&QO
M>65E<RP@;W5R(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!A;F0@;W5R("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," R-C(N,3 @5&0@*&-L:65N=',N(" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C,X+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3@N-C0@,C,X+C$P(%1D("AE(&)E;&EE=F4@
M;W5R('-T<F%T96=Y('=I;&P@86QL;W<@=7,@=&\@97AP86YD(&]U<B!C=7)R
M96YT(&)U<VEN97-S(&%N9"!C87!T=7)E(')A=&4@870@;W5R($U34"D@5&H@
M150@40IQ(# @," P(')G($)4(#0S-RXS,R R,S@N,3 @5&0@*"!C;&EE;G1S
M+"!I;F-R96%S92!T:&4@;G5M8F5R("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,C8N,3 @5&0@*&%N9"!T>7!E
M<R!O9B!N97<@8W5S=&]M97)S('=E('-E<G9E+"!G<F]W('1H92!S=7!P;'D@
M86YD('1Y<&5S(&]F('-P96-I86QT:65S(&]F(&]U<B!H96%L=&AC87)E('!R
M;V9E<W-I;VYA;',L(&EM<')O=F4@;W5R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,30N,3 @5&0@*&]P97)A
M=&EN9R!L979E<F%G92!T:')O=6=H(&=R;W=T:"!A;F0@8V]S="!C;VYT86EN
M;65N="P@86YD('-T<F5N9W1H96X@86YD(&)R;V%D96X@;W5R(&UA<FME="!P
M<F5S96YC92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Y+C8W(#(Q-"XQ
M,"!49" H5&AI<R!W:6QL(')E<75I<F4@=7,@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(P,BXQ,"!49" H=&\@
M9F]C=7,@;VX@7"AI7"D@97AP86YD:6YG(&]U<B!W;W)K9F]R8V4@<V]L=71I
M;VYS(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4Y+C(R(#(P,BXQ,"!4
M9" H9F5R:6YG<R!T;R!D965P96X@;W5R(')E;&%T:6]N<VAI<',@=VET:"!C
M=7)R96YT(&-U<W1O;65R<R!A;F0@=&\@871T<F%C=" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3DP+C$P(%1D
M("AN97<@8W5S=&]M97)S.R!<*&EI7"D@97AP86YD:6YG(&]U<B!L;V-A;"!B
M<F%N8V@@;F5T=V]R:R!T;R!G<F]W(&]U<B!L;V-A;"!M87)K970@<')E<V5N
M8V4@86YD(&]U<B!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C<N.#0@
M,3DP+C$P(%1D("@@8G5S:6YE<W,[(%PH:6EI7"D@9G5R=&AE<B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3<X
M+C$P(%1D("AD:79E<G-I9GEI;F<@;W5R(&-U<W1O;65R(&)A<V4@:6YT;R!T
M:&4@<'5B;&EC(&%N9"!C:&%R=&5R('-C:&]O;"!M87)K970[(%PH:6EI7"D@
M8V]N=&EN=6EN9R!T;R!D:79E<G-I9GD@86YD(&1E97!E;B!O=7(@8W5S=&]M
M97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#$V-BXQ,"!49" H8F%S92!I;B!T:&4@;&]C86P@86UB=6QA=&]R
M>2!C87)E(&%N9"!R971A:6P@;6%R:V5T+"!W:&EC:"!P<F]V:61E<R!M;W)E
M(&)A;&%N8V4@8F5T=V5E;B!O=7(@;&%R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#,Y+C$P(#$V-BXQ,"!49" H9V4@=F]L=6UE+6)A<V5D(&-U<W1O;65R
M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,34T+C$P(%1D("AA;F0@;W5R('-M86QL(&QO8V%L(&-U<W1O;65R
M<SL@7"AI=EPI(&)E='1E<B!P;W-I=&EO;FEN9R!O=7)S96QV97,@=&\@=&%K
M92!A9&1I=&EO;F%L(&UA<FME="!S:&%R92!I;B!O=7(@35-0*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#<V+C(Q(#$U-"XQ,"!49" H(&)U<VEN97-S.R!<
M*'9<*2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,30R+C$P(%1D("AA8V-E<W-I;F<@;6]R92!C86YD:61A=&5S
M.R!A;F0@7"AV:5PI(&-O;G1I;G5I;F<@=&\@;6]D97)N:7IE(&]U<B!T96-H
M;F]L;V=I97,@86YD('!R;V-E<W-E<R!T;R!O<'1I;6EZ92!O=7(@<F5L871I
M;VYS:&EP<R!W:71H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," Q,S N,3 @5&0@*&]U<B!H96%L=&AC87)E('!R
M;V9E<W-I;VYA;',@86YD(&-L:65N=',N(" @*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$P-BXQ,"!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#4U+C0Q(#$P-BXQ,"!49" H;R!S=6-C
M97-S9G5L;'D@97AE8W5T92!O=7(@8G5S:6YE<W,@<W1R871E9WDI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,S N-34@,3 V+C$P(%1D("@L('=E('=I;&P@
M<F5L>2!O;B!O=7(@97AP97)I96YC960@86YD(&9O8W5S960@97AE8W5T:79E
M(&%N9"!O<&5R871I;VYA;"!T96%M<RX@("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Y-"XQ,"!49" H3W5R(&5X
M96-U=&EV92!T96%M(&AA<R!E>'1E;G-I=F4@97AP97)I96YC92!I;B!T:&4@
M<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#(W,2XY-" Y-"XQ,"!49" H
M9FEN9R!A;F0@:&5A;'1H8V%R92!I;F1U<W1R:65S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.30N-S@@.30N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,#,N-#$@.30N,3 @5&0@*&4@86QS;R!F;W-T97(@82!C=6QT
M=7)E(&]F('!E<F9O<FUA;F-E+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @.#(N,3 @5&0@*'1A;&5N=&5D(&QE
M861E<G-H:7 @86YD(&-O;&QE9VEA;&ET>2!T:&%T('!R;VUO=&5S('1H92!A
M8VAI979E;65N="!O9B!B;W1H(&-O;7!A;GD@86YD('!E<G-O;F%L(&=O86QS
M+B!);B R,#$X+"!#<F]S<R!#;W5N=')Y("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,"XQ,"!49" H4W1A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#8U+CDS(#<P+C$P(%1D("AF:6YG*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@-BXU,"!49B!%5 IQ
M(# @," P(')G($)4(#@R+C T(#<T+C8S(%1D("BN*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+CDW(#<P+C$P(%1D("@@
M=V%S(')E8V]G;FEZ960@87,@0F5S="!O9B!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C$Q+C<U(#<P+C$P(%1D("AF:6YG+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,S(N,S$@-S N,3 @5&0@*$%D=F%N=&%G92!23BP@0W)O
M<W,@0V]U;G1R>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3<N,#,@-S N
M,3 @5&0@*$%L;&EE9"P@0W)O<W,@0V]U;G1R>2 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-#<N-# @-S N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-3,N,38@-S N,3 @5&0@*')A=D-O<G!S+"!-961I8V%L($1O8W1O
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-3@N,3 @5&0@*$%S<V]C:6%T97,L($UE9&EC86P@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#$T."XY-B U."XQ,"!49" H9FEN9R!.971W
M;W)K+"!-9613=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0Q+C@R(#4X
M+C$P(%1D("AF+"!0:&%R;5-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.3(N,3@@-3@N,3 @5&0@*&8@86QL(')E8V5I=F5D(#(P,3@@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S8Y+C$Y(#4X+C$P(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S<T+C8P(#4X+C$P(%1D("AA;&5N="!#;&5A<FQY4F%T
M960@0F5S="!O9B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DX+C@S
M(#4X+C$P(%1D("AF:6YG("D@5&H@150@40IQ(# @," P(')G($)4(#4Q-BXX
M." U."XQ,"!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#4R,RXQ.2 U
M."XQ,"!49" H=V%R9',N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3,@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q-" P(%(^/@IE;F1O8FH*,30@,"!O8FH*/#PO3&5N9W1H
M(#$Q,C4W/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,P,RXU," S,2XV,"!49" H,RD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W-#(N,C4@5&0@*%-E<G9I8V5S
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#<Q."XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T
M(#<Q."XR-2!49" H92!P<F]V:61E(&]U<B!S97)V:6-E<R!O;B!A(&YA=&EO
M;F%L(&QE=F5L(&]R('1H<F]U9V@@86YY(&]N92!O9B!O=7(@-C8@;&]C86P@
M8G)A;F-H97,@=&AR;W5G:&]U="!T:&4@56YI=&5D(%-T871E<R!O<B!T:')O
M=6=H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W,#8N,C4@5&0@*&$@8V]M8FEN871I;VX@;V8@8F]T:"X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,30R+C@V(#<P-BXR-2!49" H5RD@5&H@
M150@40IQ(# @," P(')G($)4(#$U,2XT.2 W,#8N,C4@5&0@*&4@<V5R=FEC
M92!A('9A<FEE='D@;V8@8VQI96YT<RP@:6YC;'5D:6YG('!U8FQI8R!A;F0@
M<')I=F%T92!A8W5T92!C87)E(&AO<W!I=&%L<RP@<'5B;&EC(&%N9"!C:&%R
M=&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," V.30N,C4@5&0@*'-C:&]O;',L(&]U='!A=&EE;G0@8VQI;FEC
M<RP@86UB=6QA=&]R>2!C87)E(&9A8VEL:71I97,L('-I;F=L92!A;F0@;75L
M=&DM<W!E8VEA;'1Y('!H>7-I8VEA;B!P<F%C=&EC97,L(')E:&%B:6QI=&%T
M:6]N(&9A8VEL:71I97,L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V.#(N,C4@5&0@*'5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3@N,34@-C@R+C(U(%1D("AG96YT(&-A<F4@8V5N=&5R
M<RP@8V]R<F5C=&EO;F%L(&9A8VEL:71I97,L(&=O=F5R;FUE;G0@9F%C:6QI
M=&EE<RP@<F5T86EL97)S+"!A;F0@;6%N>2!O=&AE<B!H96%L=&AC87)E('!R
M;W9I9&5R<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8V,BXR-2!49" H3W5R(&)U<VEN97-S(&-O;G-I<W1S
M(&]F('1H<F5E(&)U<VEN97-S('-E9VUE;G1S.B!<*&E<*2!.=7)S92!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S U+C4R(#8V,BXR-2!49" H06QL
M:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#@N.34@-C8R+C(U
M(%1D("AF:6YG.R!<*&EI7"F@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T-#(N,S8@-C8R+C(U(%1D("AF:6YG.R!A;F0@7"AI:6E<
M*2!/=&AE<B!(=6UA;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C4P+C(U(%1D("A#87!I=&%L($UA;F%G96UE
M;G0@4V5R=FEC97,N($9E97,@9F]R(&]U<B!S97)V:6-E<R!A<F4@<&%I9"!D
M:7)E8W1L>2!B>2!O=7(@8VQI96YT<R!A;F0@:6X@8V5R=&%I;B!I;G-T86YC
M97,@8GD@=F5N9&]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," V,S@N,C4@5&0@*&UA;F%G97)S+"!A;F0@87,@
M82!R97-U;'0L('=E(&AA=F4@;F\@9&ER96-T(&5X<&]S=7)E('1O($UE9&EC
M87)E(&]R($UE9&EC86ED(')E:6UB=7)S96UE;G1S+B!&;W(@861D:71I;VYA
M;"!F:6YA;F-I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#8R-BXR-2!49" H:6YF;W)M871I;VX@8V]N8V5R
M;FEN9R!O=7(@8G5S:6YE<W,@<V5G;65N=',L('-E92!.;W1E(#$W("T@4V5G
M;65N="!$871A('1O('1H92!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E
M;65N=',N(" I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C N-3,@-C(V+C(U
M(%1D("A4:')O=6=H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," V,30N,C4@5&0@*&]U<B!B=7-I;F5S<R!S96=M
M96YT<RP@=V4@<')O=FED92!O=7(@:&5A;'1H8V%R92!C;&EE;G1S('=I=&@@
M82!W:61E(')A;F=E(&]F('=O<FMF;W)C92!S;VQU=&EO;G,@87,@9&5S8W)I
M8F5D(&%B;W9E(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C R+C(U(%1D("AS=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-C0N,C8@-C R+C(U(%1D("AF:6YG('-E<G9I8V5S(&%S
M('-E="!F;W)T:"!B96QO=RD@5&H@150@40IQ(# @," P(')G($)4(#$X-RXW
M-" V,#(N,C4@5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#8X+C P(#4W."XR-2!49" H7"@Q7"D@*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4W."XR
M-2!49" H3G5R<VEN9R!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30Q
M+C R(#4W."XR-2!49" H06QL:65D(%-T869F:6YG+B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C W+CDW(#4W."XR-2!4
M9" H5&AE($YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C@N
M-SD@-3<X+C(U(%1D("A!;&QI960@4W1A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#,Q,BXR,2 U-S@N,C4@5&0@*&9I;F<@<V5G;65N="!P<F]V:61E<R!W
M;W)K9F]R8V4@<V]L=71I;VYS(&%N9"!T<F%D:71I;VYA;" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-38V+C(U
M(%1D("AS=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 P+C(V(#4V-BXR
M-2!49" H9FEN9RP@:6YC;'5D:6YG('1E;7!O<F%R>2!A;F0@<&5R;6%N96YT
M('!L86-E;65N="!O9B!T<F%V96P@;G5R<V5S(&%N9"!A;&QI960@<')O9F5S
M<VEO;F%L<RP@8G)A;F-H+6)A<V5D(&QO8V%L("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U-30N,C4@5&0@*&YU
M<G-E<RP@86YD(&%L;&EE9"!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3<R+C0V(#4U-"XR-2!49" H9FEN9RX@("D@5&H@150@40IQ(# @," P(')G
M($)4(#$Y-2XX.2 U-30N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R,#0N-3,@-34T+C(U(%1D("AE('!R;W9I9&4@9FQE>&EB;&4@=V]R:V9O
M<F-E('-O;'5T:6]N<R!T;R!T:&4@:&5A;'1H8V%R92!A;F0@<V-H;V]L(&UA
M<FME=',@=&AR;W5G:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#8N,# @-30R+C(U(%1D("AD:79E<G-I9FEE9"!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#$S.2XT,2 U-#(N,C4@5&0@*&9E<FEN
M9W,@9&5S:6=N960@=&\@;65E="!T:&4@<W!E8VEA;"!N965D<R!O9B!E86-H
M(&-L:65N="P@:6YC;'5D:6YG.B!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T,S$N,# @-30R+C(U(%1D("@L($]74RP@161U8V%T:6]N86P@2&5A;'1H
M8V%R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#8N,# @-3,P+C(U(%1D("A397)V:6-E<RP@4E!/+"!)4E I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-C,N-S@@-3,P+C(U(%1D("@L($5-4B!A;F0@
M8V]N<W5L=&EN9R!S97)V:6-E<RX@("D@5&H@150@40IQ(# @," P(')G($)4
M(#(Y,RXU." U,S N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M,#(N,C(@-3,P+C(U(%1D("AE(&UA<FME="!O=7(@<V5R=FEC97,@=&\@:&]S
M<&ET86QS(&%N9"!O=&AE<B!C=7-T;VUE<G,@=&AR;W5G:" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-3$X+C(U
M(%1D("AO=7(@0W)O<W,@0V]U;G1R>2!3=&%F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3<X+C,R(#4Q."XR-2!49" H9FEN9RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*0E0@+T8Q(#8N-3 @5&8@150*<2 P(# @,"!R9R!"5" Q
M.30N-#,@-3(R+C<X(%1D("BN*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$Y.2XS-R U,3@N,C4@5&0@*"P@35-.+" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,S N-#D@-3$X+C(U(%1D("A!;&QI960@
M2&5A;'1H($=R;W5P+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3<N,30@
M-3$X+C(U(%1D("A!9'9A;G1A9V4L($UE9&ES8V%N+" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,#@N-S@@-3$X+C(U(%1D("A!4"D@5&H@150@40IQ(# @
M," P(')G($)4(#0R,2XQ.2 U,3@N,C4@5&0@*"!3=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#,Y+C8R(#4Q."XR-2!49" H9FEN9RP@86YD($1I<F5C
M=$5D(&)R86YD<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30W+C<T(#4Q
M."XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4U-BXS." U,3@N
M,C4@5&0@*&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#4P-BXR-2!49" H86QS;R!M87)K970@;W5R('-E<G9I
M8V5S('1O(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!U<VEN9R!A(&UU;'1I
M+6)R86YD('-T<F%T96=Y('1O('-E9VUE;G0@=&AE(&UA<FME="!A;F0@;6%X
M:6UI>F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#@V+C P(#0Y-"XR-2!49" H;W5R(&]U=')E86-H('1O(&AE86QT:&-A
M<F4@<')O9F5S<VEO;F%L<RX@($]U<B!.=7)S92!A;F0@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S$S+C<P(#0Y-"XR-2!49" H06QL:65D(%-T868I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-3<N,3(@-#DT+C(U(%1D("AF:6YG(')E
M=F5N=64@86YD(&-O;G1R:6)U=&EO;B!I;F-O;64@:7,@<V5T(&9O<G1H("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP
M," T.#(N,C4@5&0@*&EN($YO=&4@,3<@+2!396=M96YT($1A=&$@=&\@=&AE
M(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-#8R+C(U
M(%1D("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3(N-C<@-#8R+C(U(%1D
M("@@;6%J;W)I='D@;V8@;W5R(')E=F5N=64@:7,@9V5N97)A=&5D(&9R;VT@
M<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#(W.2XP.2 T-C(N,C4@5&0@
M*&9I;F<@<F5G:7-T97)E9"!N=7)S97,@;VX@;&]N9RUT97)M(&-O;G1R86-T
M(&%S<VEG;FUE;G1S(%PH='EP:6-A;&QY(#$S("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," T-3 N,C4@5&0@*'=E
M96MS(&EN(&QE;F=T:%PI(&%T(&AO<W!I=&%L<R!A;F0@:&5A;'1H('-Y<W1E
M;7,@=7-I;F<@=F%R:6]U<R!B<F%N9',N("D@5&H@150@40IQ(# @," P(')G
M($)4(#,V-RXV,R T-3 N,C4@5&0@*$%D9&ET:6]N86QL>2D@5&H@150@40IQ
M(# @," P(')G($)4(#0Q-RXU,R T-3 N,C4@5&0@*"P@=V4@;V8I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T-#0N.#0@-#4P+C(U(%1D("AF97(@82!S:&]R
M="UT97)M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C,N-SD@-#4P
M+C(U(%1D("AF:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," T,S@N,C4@5&0@*'-O;'5T:6]N(&]F(')E9VES
M=&5R960@;G5R<V5S+"!L:6-E;G-E9"!P<F%C=&EC86P@;G5R<V5S+"!C97)T
M:69I960@;G5R<V4@87-S:7-T86YT<RP@861V86YC960@<')A8W1I=&EO;F5R
M<RP@<&AA<FUA8VES=',L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," T,C8N,C4@5&0@*&%N9"!M;W)E('1H86X@
M,3 P('-P96-I86QT:65S(&]F(&%L;&EE9"!P<F]F97-S:6]N86QS(&]N(&QO
M8V%L('!E<B!D:65M(&%N9"!S:&]R="UT97)M(&%S<VEG;FUE;G1S(&EN(&$@
M=F%R:65T>2!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#8N,# @-#$T+C(U(%1D("AC;&EN:6-A;"!A;F0@;F]N+6-L
M:6YI8V%L('-E='1I;F=S('1H<F]U9V@@;W5R(&YA=&EO;F%L(&YE='=O<FL@
M;V8@;&]C86P@8G)A;F-H(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# X
M+C(R(#0Q-"XR-2!49" H9FEC97,N("D@5&H@150@40IQ(# @," P(')G($)4
M(#0S,2XY,B T,30N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-# N-38@-#$T+C(U(%1D("AE(&%L<V\@<')O=FED92!T<F%V96P@86QL:65D
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X
M-BXP," T,#(N,C4@5&0@*'!R;V9E<W-I;VYA;',@;VX@;&]N9RUT97)M(&-O
M;G1R86-T(&%S<VEG;FUE;G1S('1O(&AO<W!I=&%L<RP@<'5B;&EC(&%N9"!C
M:&%R=&5R('-C:&]O;',L(&%N9"!S:VEL;&5D(&YU<G-I;F<@9F%C:6QI=&EE
M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.#8N,# @,SDP+C(U(%1D("AU;F1E<B!T:&4@0W)O<W,@0V]U;G1R>2!3=&%F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C R+C0W(#,Y,"XR-2!49" H9FEN
M9RP@365D:7-C86XL(&%N9"!$:7)E8W1%9"!B<F%N9',N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8X+C P(#,W,"XR-2!4
M9" H7"@R7"D@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#,W,"XR-2!49" H4&AY<VEC:6%N(%-T869F:6YG+B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38X
M+C4Q(#,W,"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#$W-RXQ
M-2 S-S N,C4@5&0@*&4@<')O=FED92!P:'ES:6-I86YS(&EN(&UA;GD@<W!E
M8VEA;'1I97,L(&-E<G1I9FEE9"!R96=I<W1E<F5D(&YU<G-E(&%N97-T:&5T
M:7-T<R!<*$-23D%S7"DL(&YU<G-E("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" X-BXP," S-3@N,C4@5&0@*'!R86-T:71I
M;VYE<G,@7"A.4'-<*2P@86YD('!H>7-I8VEA;B!A<W-I<W1A;G1S(%PH4"D@
M5&H@150@40IQ(# @," P(')G($)4(#(W,BXX,R S-3@N,C4@5&0@*$%S7"D@
M=6YD97(@;W5R($U$02D@5&H@150@40IQ(# @," P(')G($)4(#,U,RXV-B S
M-3@N,C4@5&0@*"!B<F%N9"!A<R!I;F1E<&5N9&5N="!C;VYT<F%C=&]R<R!O
M;B!T96UP;W)A<GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#@V+C P(#,T-BXR-2!49" H87-S:6=N;65N=',@=&AR;W5G
M:&]U="!T:&4@56YI=&5D(%-T871E<R!A="!V87)I;W5S(&AE86QT:&-A<F4@
M9F%C:6QI=&EE<RP@<W5C:"!A<R!A8W5T92!A;F0@;F]N+6%C=71E(&-A<F4@
M9F%C:6QI=&EE<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#@V+C P(#,S-"XR-2!49" H;65D:6-A;"!G<F]U<"!P<F%C
M=&EC97,L(&=O=F5R;FUE;G0@9F%C:6QI=&EE<RP@86YD(&UA;F%G960@8V%R
M92!O<BD@5&H@150@40IQ(# @," P(')G($)4(#,U.2XP,R S,S0N,C4@5&0@
M*&=A;FEZ871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#DN,SD@
M,S,T+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$X+C S(#,S
M-"XR-2!49" H92!R96-R=6ET('1H97-E('!R;V9E<W-I;VYA;',@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#,R
M,BXR-2!49" H;F%T:6]N86QL>2!A;F0@<&QA8V4@=&AE;2!O;B!A<W-I9VYM
M96YT<R!V87)Y:6YG(&EN(&QE;F=T:"!F<F]M('-E=F5R86P@9&%Y<R!U<"!T
M;R!O;F4@>65A<BD@5&H@150@40IQ(# @," P(')G($)4(#0U-BXQ." S,C(N
M,C4@5&0@*"X@3W5R(%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3,V+C4U(#,R,BXR-2!49" H9FEN9R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,S$P+C(U(%1D("AR
M979E;G5E(&%N9"!C;VYT<FEB=71I;VX@:6YC;VUE(&ES('-E="!F;W)T:"!I
M;B!.;W1E(#$W("T@4V5G;65N="!$871A('1O('1H92!C;VYS;VQI9&%T960@
M9FEN86YC:6%L('-T871E;65N=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#8X+C P(#(Y,"XR-2!49" H7"@S7"D@*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P
M(#(Y,"XR-2!49" H3W1H97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,3$N
M,S<@,CDP+C(U(%1D("@@2'5M86X@0V%P:71A;"!-86YA9V5M96YT(%-E<G9I
M8V5S+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C@Q+C,U(#(Y,"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#(X.2XY.2 R.3 N,C4@5&0@*&4@<')O=FED92!R971A:6YE9"!A;F0@8V]N
M=&EN9V5N="!S96%R8V@@<V5R=FEC97,@9F]R('!H>7-I8VEA;G,L("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," R
M-S@N,C4@5&0@*&AE86QT:&-A<F4@97AE8W5T:79E<RP@;G5R<V5S+"!A9'9A
M;F-E9"!P<F%C=&EC92P@86YD(&%L;&EE9"!H96%L=&@@<')O9F5S<VEO;F%L
M<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$P+C0P(#(W."XR-2!49" H
M5&AE(')E=F5N=64@86YD(&-O;G1R:6)U=&EO;B!I;F-O;64@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(V-BXR
M-2!49" H;V8@;W5R($]T:&5R($AU;6%N($-A<&ET86P@36%N86=E;65N="!3
M97)V:6-E<R!396=M96YT(&ES('-E="!F;W)T:"!I;B!.;W1E(#$W("T@4V5G
M;65N="!$871A('1O('1H92!C;VYS;VQI9&%T960@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(U-"XR-2!49" H
M9FEN86YC:6%L('-T871E;65N=',N("!/=7(@0V5J:V$@4V5A<F-H*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@-BXU,"!49B!%5 IQ(# @
M," P(')G($)4(#(T-"XR." R-3@N-S@@5&0@**XI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C0Y+C(Q(#(U-"XR-2!49" H
M(&)R86YD(')E8W)U:71S(&AE86QT:&-A<F4@=&%L96YT(&9O<B!O<BD@5&H@
M150@40IQ(# @," P(')G($)4(#0P,"XP-R R-30N,C4@5&0@*&=A;FEZ871I
M;VYS(&YA=&EO;G=I9&4@=&AR;W5G:"!A('1E86T@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(T,BXR-2!49" H
M;V:@97AP97)I96YC960@<')O9F5S<VEO;F%L<RP@861V86YC960@=7-E(&]F
M(')E8W)U:71M96YT('1E8VAN;VQO9WDI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S-C0N-CD@,C0R+C(U(%1D("@L(&%N9"!C;VUM:71M96YT('1O('-E<G9I
M8V4@97AC96QL96YC92X@4V5R=FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,C,P+C(U(%1D("AC;&EE;G1S
M(&YA=&EO;G=I9&4L($-E:FMA(&-O;7!L971E<R!H=6YD<F5D<R!O9B!S96%R
M8V@@87-S:6=N;65N=',@86YN=6%L;'D@9F]R(&]R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#(Q+C4V(#(S,"XR-2!49" H9V%N:7IA=&EO;G,L(&EN8VQU
M9&EN9RP@8G5T(&YO=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#8N,# @,C$X+C(U(%1D("AL:6UI=&5D('1O+"!P:'ES
M:6-I86X@9W)O=7 @<')A8W1I8V5S+"!H;W-P:71A;',@86YD(&AE86QT:"!S
M>7-T96US+"!A8V%D96UI8R!M961I8V%L(&-E;G1E<G,L(&%C8V]U;G1A8FQE
M(&-A<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#@V+C P(#(P-BXR-2!49" H;W(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Y-"XQ-2 R,#8N,C4@5&0@*&=A;FEZ871I;VYS+"!M86YA9V5D(&-A<F4L
M(&%N9"!O=&AE<B!H96%L=&AC87)E(&]R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDV+C8T(#(P-BXR-2!49" H9V%N:7IA=&EO;G,N*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$X,BXR-2!4
M9" H3W5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C<N-C @,3@R+C(U(%1D
M("@@0G5S:6YE<W,@36]D96PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,34X+C(U(%1D("A4:&4@<F5C<G5I=&UE
M;G0@86YD(')E=&5N=&EO;B!O9B!A('-U9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(P,2XT,R Q-3@N,C4@5&0@*&9I8VEE;G0@;G5M8F5R(&]F('%U86QI
M9FEE9"!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@=&\@=V]R:R!T96UP;W)A
M<GD@87-S:6=N;65N=',@;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#$T-BXR-2!49" H;W5R(&)E:&%L9B!I
M<R!C<FET:6-A;"!T;R!T:&4@<W5C8V5S<R!O9B!O=7(@8G5S:6YE<W,N($AE
M86QT:&-A<F4@<')O9F5S<VEO;F%L<R!C:&]O<V4@=&5M<&]R87)Y(&%S<VEG
M;FUE;G1S(&9O<B!A('9A<FEE='D@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$S-"XR-2!49" H<F5A<V]N
M<R!T:&%T(&EN8VQU9&4@<V5E:VEN9R!F;&5X:6)L92!W;W)K(&]P<&]R='5N
M:71I97,L(&5X<&QO<FEN9R!D:79E<G-E('!R86-T:6-E('-E='1I;F=S+"!B
M=6EL9&EN9R!S:VEL;',@86YD(&5X<&5R:65N8V4@8GD@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$R,BXR-2!4
M9" H=V]R:VEN9R!A="!P<F5S=&EG:6]U<R!H96%L=&AC87)E(&9A8VEL:71I
M97,L(&%V;VED:6YG('1H92!D96UA;F1S(&%N9"!P;VQI=&EC86P@96YV:7)O
M;FUE;G0@;V8@=V]R:VEN9R!A<R!P97)M86YE;G0@<W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#4S-BXY," Q,C(N,C4@5&0@*&8L("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,3 N,C4@
M5&0@*'=O<FMI;F<@=&AR;W5G:"!L:69E(&%N9"!C87)E97(@=')A;G-I=&EO
M;G,L(&%N9"!A<R!A(&UE86YS(&]F(&%C8V5S<R!I;G1O(&$@<&5R;6%N96YT
M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3$N,S8@,3$P+C(U(%1D
M("AF('!O<VET:6]N+BD@5&H@150@40IE;F1S=')E86T*96YD;V)J"C$U(# @
M;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @
M," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO
M0V]N=&5N=',@,38@,"!2/CX*96YD;V)J"C$V(# @;V)J"CP\+TQE;F=T:" Q
M,38Q,SX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,#,N-3 @,S$N-C @5&0@*#0I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-S(N,# @-S0R+C(U(%1D("A<*#%<*2 I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3 N,# @
M-S0R+C(U(%1D("A/=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#<N-C @
M-S0R+C(U(%1D("@@2&5A;'1H8V%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,34R+C8X(#<T,BXR-2!49" H92!0<BD@5&H@150@40IQ(# @," P(')G($)4
M(#$V.2XY.2 W-#(N,C4@5&0@*&]F97-S:6]N86QS*2!4:B!%5"!1"D)4("]&
M,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q-2XU-2 W-#(N,C4@5&0@
M*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(R,"XU-2 W-#(N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,CDN-3@@-S0R+C(U(%1D("AI=&AI;B!O=7(@3G5R<V4@86YD("D@5&H@150@
M40IQ(# @," P(')G($)4(#,P.2XP,B W-#(N,C4@5&0@*$%L;&EE9"!S96=M
M96YT+"!W92!O<&5R871E(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#0S
M,2XX-2 W-#(N,C4@5&0@*&9E<F5N=&EA=&5D(&)R86YD<R!T;R!R96-R=6ET
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M,"XP," W,S N,C4@5&0@*&YU<G-E<R!A;F0@86QL:65D('!R;V9E<W-I;VYA
M;',N("D@5&H@150@40IQ(# @," P(')G($)4(#(Q-RXR.2 W,S N,C4@5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C4N.3,@-S,P+C(U(%1D("AE
M(&)E;&EE=F4@;W5R(&UU;'1I+6)R86YD(')E8W)U:71I;F<@;6]D96P@:&5L
M<',@=7,@<F5A8V@@82!L87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S4N
M,3 @-S,P+C(U(%1D("AG97(@=F]L=6UE(&%N9"!A("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," W,3@N,C4@5&0@
M*&UO<F4@9&EV97)S92!G<F]U<"!O9B!C86YD:61A=&5S('1O(&9I;&P@;W!E
M;B!P;W-I=&EO;G,@870@;W5R(&-L:65N=',@=&AR;W5G:&]U="!T:&4@56YI
M=&5D(%-T871E<R!I;B!V87)I;W5S(&-L:6YI8V%L("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," W,#8N,C4@5&0@
M*&%N9"!N;VXM8VQI;FEC86P@<V5T=&EN9W,@86YD(&EN(&UA;GD@9&EF*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C4S+C$R(#<P-BXR-2!49" H9F5R96YT
M(&=E;V=R87!H:6,@87)E87,N($]U<B!C;VUP86YY(&ES('=E;&P@<&]S:71I
M;VYE9"P@87,@;G5R<V5S(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.3 N,# @-CDT+C(U(%1D("AA;&QI960@<')O
M9F5S<VEO;F%L<R!R;W5T:6YE;'D@<V5E:R!A('=I9&4@<F%N9V4@;V8@9&EV
M97)S92!A<W-I9VYM96YT<R!I;B!A='1R86-T:79E(&QO8V%T:6]N<RP@=VET
M:"!C;VUP971I=&EV92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.3 N,# @-C@R+C(U(%1D("AC;VUP96YS871I;VX@86YD
M(&)E;F5F:70@<&%C:V%G97,L('-C:&5D=6QI;F<@;W!T:6]N<RP@87,@=V5L
M;"!A<R!A(&AI9V@@;&5V96P@;V8@<V5R=FEC92X@26X@861D:71I;VXL('=E
M(&)E;&EE=F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#DP+C P(#8W,"XR-2!49" H;G5R<V5S(&%N9"!A;&QI960@<')O
M9F5S<VEO;F%L<R!A<F4@8V]N9FED96YT('=E('=I;&P@:&%V92!N97<@87-S
M:6=N;65N=',@9F]R('1H96T@87,@=&AE>2!C;VUP;&5T92!T:&5I<B!C=7)R
M96YT("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Y,"XP," V-3@N,C4@5&0@*&%S<VEG;FUE;G0N($]U<B!C;VUP971I=&EV
M92!B96YE9FET<R!G96YE<F%L;'D@:6YC;'5D92!P<F]F97-S:6]N86P@;&EA
M8FEL:71Y(&EN<W5R86YC92P@82 T,#%<*&M<*2!P;&%N+"!H96%L=&@@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DP+C P
M(#8T-BXR-2!49" H:6YS=7)A;F-E+"!R96EM8G5R<V5D('1R879E;"P@<&5R
M(&1I96T@86QL;W=A;F-E<RP@86YD(&AO=7-I;F<N($5A8V@@;V8@;W5R(&YU
M<G-E(&%N9"!A;&QI960@:&5A;'1H8V%R92!P<F]F97-S:6]N86QS("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," V
M,S0N,C4@5&0@*&ES(&5M<&QO>65D(&)Y('5S(&%N9"!I<R!T>7!I8V%L;'D@
M<&%I9"!H;W5R;'D@=V%G97,@86YD(&%N>2!O=&AE<B!B96YE9FET<R!T:&5Y
M(&%R92!E;G1I=&QE9"!T;R!R96-E:79E(&1U<FEN9R!T:&4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DP+C P(#8R,BXR
M-2!49" H87-S:6=N;65N="!P97)I;V0N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#DP+C P(#4Y."XR-2!49" H4F5C<G5I
M=&5R<R!A<F4@86X@97-S96YT:6%L(&5L96UE;G0@;V8@;W5R($YU<G-E(&%N
M9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,# N-S4@-3DX+C(U(%1D("A!
M;&QI960@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#,T-"XQ-R U.3@N
M,C4@5&0@*&9I;F<@8G5S:6YE<W,L(&%N9"!A<F4@<F5S<&]N<VEB;&4@9F]R
M(&5S=&%B;&ES:&EN9R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DP+C P(#4X-BXR-2!49" H;6%I;G1A:6YI;F<@
M:V5Y(')E;&%T:6]N<VAI<',@=VET:"!C86YD:61A=&5S(&9O<B!T:&4@9'5R
M871I;VX@;V8@=&AE:7(@87-S:6=N;65N=',@=VET:"!U<RX@4F5C<G5I=&5R
M<R!M871C:"!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#DP+C P(#4W-"XR-2!49" H<W5P<&QY(&]F('%U86QI9FEE
M9"!C86YD:61A=&5S(&EN(&]U<B!D871A8F%S97,@=VET:"!T:&4@9&5M86YD
M(&9O<B!O<&5N(&]R9&5R<R!P;W-T960@8GD@;W5R(&-L:65N=',N("D@5&H@
M150@40IQ(# @," P(')G($)4(#4P,"XR-R U-S0N,C4@5&0@*%=H:6QE('=E
M(')E;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#DP+C P(#4V,BXR-2!49" H;VX@=V]R9"UO9BUM;W5T:"!F;W(@<F5F
M97)R86QS('1O(&%C8V5S<R!C86YD:61A=&5S+"!W92!A;'-O(&UA<FME="!O
M=7(@8G)A;F1S(&]N('1H92!);G1E<FYE="P@:6YC;'5D:6YG(&5X=&5N<VEV
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.3 N,# @-34P+C(U(%1D("AU=&EL:7IA=&EO;B!O9B!S;V-I86P@;65D:6$L
M('=H:6-H(&AA<R!B96-O;64@86X@:6YC<F5A<VEN9VQY(&EM<&]R=&%N="!C
M;VUP;VYE;G0@;V8@;W5R(')E8W)U:71M96YT(&5F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3 Y+CDV(#4U,"XR-2!49" H9F]R=',N("D@5&H@150@40IQ
M(# @," P(')G($)4(#4S,RXQ,2 U-3 N,C4@5&0@*%<I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U-#$N-S4@-34P+C(U(%1D("AE("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," U,S@N,C4@5&0@
M*&UA:6YT86EN(&$@;G5M8F5R(&]F('=E8G-I=&5S('1O(&%L;&]W('!O=&5N
M=&EA;"!A<'!L:6-A;G1S('1O(&]B=&%I;B!I;F9O<FUA=&EO;B!A8F]U="!O
M=7(@8G)A;F1S(&%N9"!A<W-I9VYM96YT("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," U,C8N,C4@5&0@*&]P<&]R
M='5N:71I97,L(&%S('=E;&P@87,@=&\@87!P;'D@;VYL:6YE+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," U,#8N
M,C4@5&0@*$U$02D@5&H@150@40IQ(# @," P(')G($)4(#$Q,BXW." U,#8N
M,C4@5&0@*"!R96-R=6ET<R!A;F0@8V]N=')A8W1S('=I=&@@<&AY<VEC:6%N
M<R!A;F0@861V86YC960@<')A8W1I8V4@<')O9F5S<VEO;F%L<R!T;R!P<F]V
M:61E(&UE9&EC86P@<V5R=FEC97,@9F]R(&ET<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3 N,# @-#DT+C(U(%1D("AH
M96%L=&AC87)E(&-U<W1O;65R<RZ@16%C:"!P:'ES:6-I86X@;W(@861V86YC
M960@<')A8W1I8V4@<')O9F5S<VEO;F%L(&ES(&%N(&EN9&5P96YD96YT(&-O
M;G1R86-T;W(@86YD(&5N=&5R<R!I;G1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y,"XP," T.#(N,C4@5&0@*&%N(&%G
M<F5E;65N="!W:71H($U$02D@5&H@150@40IQ(# @," P(')G($)4(#$X.2XQ
M-" T.#(N,C4@5&0@*"!T;R!P<F]V:61E(&UE9&EC86P@<V5R=FEC97,@870@
M82!P87)T:6-U;&%R(&AE86QT:&-A<F4@9F%C:6QI='D@;W(@<&AY<VEC:6%N
M('!R86-T:6-E(&=R;W5P("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Y,"XP," T-S N,C4@5&0@*&)A<V5D(&]N('1E<FUS
M(&%N9"!C;VYD:71I;VYS('-P96-I9FEE9"!B>2!T:&%T(&-U<W1O;65R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S$X+C(X(#0W,"XR-2!49" H+B!0:'ES
M:6-I86YS(&%N9"!A9'9A;F-E9"!P<F%C=&EC92!P<F]F97-S:6]N86QS(&%R
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.3 N,# @-#4X+C(U(%1D("AE;F=A9V5D('1O('!R;W9I9&4@;65D:6-A;"!S
M97)V:6-E<R!F;W(@82!H96%L=&AC87)E(&-U<W1O;65R(')A;F=I;F<@9G)O
M;2!A(&9E=R!D87ES('5P('1O(&$@>65A<BD@5&H@150@40IQ(# @," P(')G
M($)4(#0X."XT-2 T-3@N,C4@5&0@*"Z@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#DS+C(W(#0U."XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#4P,2XY," T-3@N,C4@5&0@*&4@8F5L:65V92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3 N,# @-#0V+C(U(%1D("AP
M:'ES:6-I86YS(&%R92!A='1R86-T960@=&\@=7,@8F5C875S92!W92!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#(V-"XT-R T-#8N,C4@5&0@*&9E<B!A
M('=I9&4@=F%R:65T>2!O9B!A<W-I9VYM96YT<RP@8V]M<&5T:71I=F4@9F5E
M<RP@;65D:6-A;"!M86QP<F%C=&EC92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.3 N,# @-#,T+C(U(%1D("AI;G-U<F%N
M8V4L(&%N9"!A(&AI9V@@;&5V96P@;V8@<V5R=FEC92!T;R!T:&5M+B!-1$$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN,3$@-#,T+C(U(%1D("@@<F5L
M:65S(&]N('=O<F0M;V8M;6]U=&@@<F5F97)R86QS+"!B=70@86QS;R!M87)K
M971S(&ET(&)R86YD<R!O;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3 N,# @-#(R+C(U(%1D("AT:&4@26YT97)N970@
M86YD('1H<F]U9V@@97AT96YS:79E('-O8VEA;"!M961I82!C86UP86EG;G,N
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8X
M+C P(#0P,BXR-2!49" H7"@R7"D@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@V+C P(#0P,BXR-2!49" H4V%L97,@86YD
M($UA<FME=&EN9RD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-S0N,S0@-# R+C(U(%1D("@N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-SDN,S0@-# R+C(U(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@W+CDX(#0P,BXR-2!49" H92!M
M87)K970@;W5R($YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.#,N-S@@-# R+C(U(%1D("A!;&QI960@4W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#,R-RXR," T,#(N,C4@5&0@*&9I;F<@<V5R=FEC97,@=&\@;W5R
M(&AO<W!I=&%L<RP@:&5A;'1H8V%R92!F86-I;&ET:65S+" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,SDP+C(U
M(%1D("AS8VAO;VQS+"!A;F0@;W1H97(@8VQI96YT<R!U<VEN9R!O=7(@0W)O
M<W,@0V]U;G1R>2!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S V+C X
M(#,Y,"XR-2!49" H9FEN9RP@365D:6-A;"!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S<X+C,X(#,Y,"XR-2!49" H9FEN9R!.971W;W)KF2P@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#0V+C(R(#,Y,"XR-2!49" H061V86YT
M86=E+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.3,N.3D@,SDP+C(U(%1D
M("A!;&QI960@2&5A;'1H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," S-S@N,C4@5&0@*$=R;W5P+"!-961I<V-A
M;BP@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34Y+C@X(#,W."XR-2!49" H
M05 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S(N,CD@,S<X+C(U(%1D("@@
M4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,"XW,B S-S@N,C4@5&0@
M*&9I;F<L(&%N9"!$:7)E8W1%9"!B<F%N9',N($-R;W-S($-O=6YT<GD@4W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#,W-2XU,2 S-S@N,C4@5&0@*&9I
M;F<@='EP:6-A;&QY(&-O;G1R86-T<R!W:71H(&]U<B!N=7)S92!A;F0@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P
M(#,V-BXR-2!49" H86QL:65D(&AE86QT:&-A<F4@8VQI96YT<R!O;B!B96AA
M;&8@;V8@:71S96QF(&%N9"!O=7(@;W1H97(@8G)A;F1S+B!-961I<V-A;B!C
M;VYT<F%C=',@=VET:"!I=',@:&]S<&ET86QS+"!P=6)L:6,@<V-H;V]L<RP@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V
M+C P(#,U-"XR-2!49" H86YD(&-H87)T97(@<V-H;V]L<R!U;F1E<B!T:&4@
M365D:7-C86X@86YD($1I<F5C=$5D(&)R86YD<RX@3W5R('1R861I=&EO;F%L
M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3 N,38@,S4T+C(U(%1D
M("AF:6YG(&EN8VQU9&5S('1E;7!O<F%R>2!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#,T,BXR-2!49" H
M<&5R;6%N96YT('!L86-E;65N="!O9B!T<F%V96P@;G5R<V5S(&%N9"!A;&QI
M960@<')O9F5S<VEO;F%L<RP@8G)A;F-H+6)A<V5D(&QO8V%L(&YU<G-E<R!A
M;F0@86QL:65D('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.3DN-34@
M,S0R+C(U(%1D("AF:6YG+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@V+C P(#,S,"XR-2!49" H<&AY<VEC:6%N
M<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,S+C T(#,S,"XR-2!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#$T,2XV-R S,S N,C4@5&0@*&4@
M<')O=FED92!F;&5X:6)L92!W;W)K9F]R8V4@<V]L=71I;VYS('1O('1H92!H
M96%L=&AC87)E(&%N9"!S8VAO;VP@;6%R:V5T<R!T:')O=6=H(&1I=F5R<VEF
M:65D(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,R+C(Q(#,S,"XR-2!4
M9" H9F5R:6YG<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#8N,# @,S$X+C(U(%1D("AM965T:6YG('1H92!S<&5C:6%L
M(&YE961S(&]F(&5A8V@@8VQI96YT+B!/<F1E<G,@9F]R(&]P96X@<&]S:71I
M;VYS(&%N9"!O=&AE<B!S97)V:6-E<R!A<F4@96YT97)E9"!I;G1O(&]U<B!V
M87)I;W5S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" X-BXP," S,#8N,C4@5&0@*&1A=&%B87-E<R!A;F0@87)E(&%V86EL
M86)L92!T;R!R96-R=6ET97)S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M-#DN-3,@,S V+C(U(%1D("A!8V-O=6YT(&UA;F%G97)S+"!W:&\@9&5V96QO
M<"!R96QA=&EO;G-H:7!S('=I=&@@;W5R(&-L:65N=',@=&\@=6YD97)S=&%N
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.#8N,# @,CDT+C(U(%1D("AT:&5I<B!S<&5C:69I8R!S971T:6YG<R!A;F0@
M8W5L='5R92P@<W5B;6ET(&-A;F1I9&%T92!P<F]F:6QE<R!T;R!C;&EE;G1S
M+"!A;F0@8V]N9FER;2!O9BD@5&H@150@40IQ(# @," P(')G($)4(#0R-RXS
M.2 R.30N,C4@5&0@*&9E<G,@86YD('!L86-E;65N=',@=VET:"!T:&5M+BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP
M," R-S N,C4@5&0@*$U$02D@5&H@150@40IQ(# @," P(')G($)4(#$P."XW
M." R-S N,C4@5&0@*"!M87)K971S(&ET<R!0:'ES:6-I86X@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#(Q-"XW," R-S N,C4@5&0@*&9I;F<@;W!E
M<F%T:6]N<R!T;R!H;W-P:71A;',@86YD(&]T:&5R(&AE86QT:&-A<F4@9F%C
M:6QI=&EE<R!T:')O=6=H;W5T('1H92!5+E,N("!/=7(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(U."XR-2!4
M9" H<F5C<G5I=&5R<R!U<V4@;W5R(&5X=&5N<VEV92!D871A8F%S92!O9B!P
M:'ES:6-I86YS(&%N9"!T:&5I<B!E>'!E<G1I<V4@:6X@=&AE:7(@9VEV96X@
M<W!E8VEA;'1I97,@=&\@8V]N=&%C="!P:'ES:6-I86YS('1O("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," R-#8N
M,C4@5&0@*'-C:&5D=6QE('-H;W)T(&%N9"!L;VYG+71E<FT@96YG86=E;65N
M=',@870@:&5A;'1H8V%R92!C=7-T;VUE<G,N($U$02D@5&H@150@40IQ(# @
M," P(')G($)4(#,X,2XQ.2 R-#8N,C4@5&0@*"!O<&5R871E<R!A(&UU;'1I
M+7-I=&4@8G5S:6YE<W,@;6]D96P@=VET:" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,C,T+C(U(%1D("AE;7!L
M;WEE97,@870@<V5V97)A;"!L;V-A=&EO;G,N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(Q-"XR-2!49" H0V5J
M:V$@;6%R:V5T<R!I=',@<F5T86EN960@86YD(&-O;G1I;F=E;G0@<V5A<F-H
M('-E<G9I8V5S('1O(&AE86QT:&-A<F4@8VQI96YT<R!P<FEM87)I;'D@=&AR
M;W5G:"!I;F1U<W1R>2!P<F]F97-S:6]N86P@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#(P,BXR-2!49" H;W(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-"XQ-2 R,#(N,C4@5&0@*&=A;FEZ
M871I;VYS+"!D:7)E8W0@;6%R:V5T:6YG+"!I=',@=V5B<VET92P@86YD(&)Y
M('=O<F0M;V8M;6]U=&@N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#8X+C P(#$X,BXR-2!49" H7"@S7"D@*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#$X,BXR
M-2!49" H0W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-RXT." Q.#(N,C4@
M5&0@*&5D96YT:6%L:6YG(&%N9"!1=6%L:71Y($UA;F%G96UE;G0N*2!4:B!%
M5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U.2XQ-2 Q
M.#(N,C4@5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C8Q+C8U(#$X,BXR-2!49" H5RD@5&H@150@40IQ(# @," P
M(')G($)4(#(W,"XR.2 Q.#(N,C4@5&0@*&4@<V-R965N(&%L;"!O9B!O=7(@
M8V%N9&ED871E<R!P<FEO<B!T;R!P;&%C96UE;G0@=&AR;W5G:"!O=7(@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P
M(#$W,"XR-2!49" H8W)E9&5N=&EA;&EN9R!D97!A<G1M96YT<RX@($]U<B!C
M<F5D96YT:6%L:6YG('!R;V-E<W-E<R!A<F4@9&5S:6=N960@=&\@96YS=7)E
M('1H870@;W5R('!R;V9E<W-I;VYA;',@:&%V92!T:&4@<F5Q=6ES:71E("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP
M," Q-3@N,C4@5&0@*'-K:6QL<V5T<R!R97%U:7)E9"!B>2!O=7(@8W5S=&]M
M97)S+"!A<R!W96QL(&%S('1H92!A<'1I='5D92!T;R!M965T('1H92!D87DM
M=&\M9&%Y(')E<75I<F5M96YT<R!A;F0@8VAA;&QE;F=E<R!T:&5Y("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," Q
M-#8N,C4@5&0@*'=O=6QD('1Y<&EC86QL>2!E;F-O=6YT97(@;VX@87-S:6=N
M;65N=',@=VAE<F4@=&AE>2!A<F4@<&QA8V5D+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-#DN,#<@,30V+C(U(%1D("A4:&4@8W)E9&5N=&EA;&EN9R!O
M9B!O=7(@;G5R<V4@86YD(&%L;&EE9"!H96%L=&AC87)E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," Q,S0N,C4@
M5&0@*'!R;V9E<W-I;VYA;',@:7,@9&5S:6=N960@=&\@86QI9VX@=VET:"!T
M:&4@9W5I9&5L:6YE<R!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3 N
M-3$@,3,T+C(U(%1D("A4:&4@2F]I;G0@0V]M;6ES<VEO;BP@82!N871I;VYA
M;"!A8V-R961I=&EN9R!B;V1Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$S
M+CDY(#$S-"XR-2!49" H+"!T;R!E;G-U<F4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#$R,BXR-2!49" H<75A
M;&ET>2!C87)E+B @3W5R($-R;W-S($-O=6YT<GD@56YI=F5R<VET>2!D:79I
M<VEO;BP@86-C<F5D:71E9"!B>2!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S<Q+C(R(#$R,BXR-2!49" H06UE<FEC86X@3G5R<V4@0W)E9&5N=&EA
M;&EN9R!#96YT97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C(N-S$@,3(R
M+C(U(%1D("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" X-BXP," Q,3 N,C4@5&0@*'!R;W9I9&5S('1R86EN:6YG+"!A
M<W-E<W-M96YT+"!A;F0@<')O9F5S<VEO;F%L(&1E=F5L;W!M96YT('1O(&9U
M<G1H97(@96YS=7)E('1H92!Q=6%L:71Y(&]F('1H92!P97)S;VYN96P@=V4@
M<&QA8V4@;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#DX+C(U(%1D("AA<W-I9VYM96YT+BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @
M5'H@,"!43" *<2 P+C$R,34V.#8R-S0U,#DX,#,Y(# N,C@V,C<T-3 Y.# S
M.3(Q-34@,"XT.3 Q.38P-S@T,S$S-S(U,R!R9R!"5" Q,S,N-3 @.3@N,C4@
M5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"G$@," P(# @<F<@0E0@,3,V+C P
M(#DX+C(U(%1D("A/=7(@<&AY<VEC:6%N(&-R961E;G1I86QI;F<@96YT:71Y
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<Q+C8Y(#DX+C(U(%1D("@L($-R
M961E;G0L(&ES(&%L<V\@8V5R=&EF:65D(&)Y('1H92!.871I;VYA;"!#;VUM
M:71T964@9F]R(%%U86QI='D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#@V+C P(#@V+C(U(%1D("A!<W-U<F%N8V4@7"A.
M0U%!7"DN("D@5&H@150@40IE;F1S=')E86T*96YD;V)J"C$W(# @;V)J"CP\
M+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N
M,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N
M=',@,3@@,"!2/CX*96YD;V)J"C$X(# @;V)J"CP\+TQE;F=T:" Q,C(Q-3X^
M"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#,N
M-3 @,S$N-C @5&0@*#4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-C@N,# @-S0R+C(U(%1D("A<*#1<*2 I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-S0R+C(U
M(%1D("A087EM96YT(&9O<BD@5&H@150@40IQ(# @," P(')G($)4(#$S."XX
M-B W-#(N,C4@5&0@*"!397)V:6-E<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$X,2XS-" W-#(N,C4@5&0@*%<I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q.#DN.3@@-S0R+C(U(%1D("AE(&YE9V]T
M:6%T92!P87EM96YT(&9O<B!S97)V:6-E<R!W:71H(&]U<B!C;&EE;G1S(&)A
M<V5D(&]N(&UA<FME="!C;VYD:71I;VYS(&%N9"!N965D<RX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-30S+C,P(#<T,BXR-2!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#4U,2XY-" W-#(N,C4@5&0@*&4@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#<S,"XR-2!4
M9" H9V5N97)A;&QY(&)I;&P@;W5R(&YU<G-E(&%N9"!A;&QI960@96UP;&]Y
M965S(&%T(&%N(&AO=7)L>2!R871E('=H:6-H(&EN8VQU9&5S(&%L;"!E;7!L
M;WEE<B!C;W-T<RP@:6YC;'5D:6YG('!A>7)O;&PL("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," W,3@N,C4@5&0@
M*'=I=&AH;VQD:6YG('1A>&5S+"!B96YE9FET<RP@<')O9F5S<VEO;F%L(&QI
M86)I;&ET>2!I;G-U<F%N8V4L(&UE86QS(&%N9"!I;F-I9&5N=&%L<RP@86YD
M(&]T:&5R(')E<75I<F5M96YT<RP@87,@=V5L;"!A<R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-S V+C(U(%1D
M("AA;GD@=')A=F5L(&%N9"!H;W5S:6YG(&%R<F%N9V5M96YT<RP@=VAE<F4@
M87!P;&EC86)L92X@3W5R('-H87)E9"!S97)V:6-E(&-E;G1E<B!P<F]C97-S
M97,@:&]U<G,@=V]R:V5D(&)Y(&9I96QD("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," V.30N,C4@5&0@*&5M<&QO
M>65E<R!I;B!T:&4@=&EM92!A;F0@871T96YD86YC92!S>7-T96US+"!W:&EC
M:"!I;B!T=7)N(&=E;F5R871E('1H92!B:6QL86)L92!T<F%N<V%C=&EO;G,@
M=&\@;W5R(&-L:65N=',N($AO=7)S("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" X-BXP," V.#(N,C4@5&0@*'=O<FME9"!B
M>2!I;F1E<&5N9&5N="!C;VYT<F%C=&]R('!H>7-I8VEA;G,@87)E(')E<&]R
M=&5D('1O(&]U<B!-1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-CDN-3,@
M-C@R+C(U(%1D("@@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.# N,3<@
M-C@R+C(U(%1D("AF:6-E+B!&;W(@;W5R('!H>7-I8VEA;B!A;F0@97AE8W5T
M:79E('-E87)C:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#8N,# @-C<P+C(U(%1D("AB=7-I;F5S<RP@0V5J:V$@='EP
M:6-A;&QY(&)I;&QS(&ET<R!C;&EE;G1S(&$@8V%N9&ED871E(&%C<75I<VET
M:6]N(&9E92!A;F0@:7,@<F5I;6)U<G-E9"!F;W(@8V5R=&%I;B!M87)K971I
M;F<@97AP96YS97,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#8X+C P(#8T-BXR-2!49" H7"@U7"D@*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#8T-BXR-2!4
M9" H3W!E<F%T:6]N<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$S."XW." V-#8N,C4@5&0@*$]U<B!.=7)S92!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DY+C8P(#8T-BXR-2!49" H06QL
M:65D(&%N9"!0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#,P,2XS-2 V-#8N,C4@5&0@*&9I;F<@8G5S:6YE<W-E<R!A<F4@;W!E<F%T
M960@=&AR;W5G:"!A(')E;&%T:79E;'D@8V5N=')A;&EZ960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#8S-"XR
M-2!49" H8G5S:6YE<W,@;6]D96P@<V5R=FEC:6YG(&%L;"!A<W-I9VYM96YT
M(&YE961S(&]F(&]U<B!H96%L=&AC87)E('!R;V9E<W-I;VYA;"!E;7!L;WEE
M97,L('!H>7-I8VEA;G,L(&%N9"!C;&EE;G0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#8R,BXR-2!49" H:&5A
M;'1H8V%R92!F86-I;&ET:65S('!R:6UA<FEL>2!T:')O=6=H(&]P97)A=&EO
M;B!C96YT97)S(&QO8V%T960@:6X@0F]C82!2871O;BP@1FQO<FED83L@3F5W
M=&]W;B!3<75A<F4L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," V,3 N,C4@5&0@*%!E;FYS>6QV86YI83L@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,30T+C0R(#8Q,"XR-2!49" H5RD@5&H@
M150@40IQ(# @," P(')G($)4(#$U,RXP-B V,3 N,C4@5&0@*&5S="!#:&5S
M=&5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DV+C@R(#8Q,"XR-2!49" H
M+"!/:&EO.R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C8N.3$@-C$P+C(U
M(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,U+C4U(#8Q,"XR-2!4
M9" H;V]D;&%N9"!(:6QL<RP@0V%L:69O<FYI83L@86YD($)E<FME;&5Y($QA
M:V4L($=E;W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-# N.#8@-C$P+C(U
M(%1D("AG:6$N($EN(&%D9&ET:6]N('1O('1H92!K97D@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4Y."XR-2!4
M9" H<V%L97,@86YD(')E8W)U:71M96YT(&%C=&EV:71I97,L(&-E<G1A:6X@
M;V8@=&AE<V4@8V5N=&5R<R!A;'-O('!E<F9O<FT@<W5P<&]R="!A8W1I=FET
M:65S('-U8V@@87,@8V]O<F1I;F%T:6YG(&AO=7-I;F<L("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U.#8N,C4@
M5&0@*'!A>7)O;&P@<')O8V5S<VEN9RP@8F5N969I=',@861M:6YI<W1R871I
M;VXL(&)I;&QI;F<@86YD(&-O;&QE8W1I;VYS+"!T<F%V96P@<F5I;6)U<G-E
M;65N="!P<F]C97-S:6YG+"!C=7-T;VUE<B!S97)V:6-E+" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-3<T+C(U
M(%1D("AA;F0@<FES:R!M86YA9V5M96YT+B!#96IK82!396%R8V@@<')I;6%R
M:6QY(&]P97)A=&5S(&ET<R!B=7-I;F5S<R!F<F]M(&ET<R!H96%D<75A<G1E
M<G,@;&]C871E9"!I;B!#<F5V92!#;V5U<BD@5&H@150@40IQ(# @," P(')G
M($)4(#4S-2XT-B U-S0N,C4@5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4V,BXR-2!49" H36ES<V]U
M<FDN("D@5&H@150@40IQ(# @," P(')G($)4(#$R-BXS." U-C(N,C4@5&0@
M*%1H:7,@8G5S:6YE<W,@;W!E<F%T97,@<F5L871I=F5L>2!I;F1E<&5N9&5N
M=&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$U+C$S(#4V,BXR-2!49" H
M+"!O=&AE<B!T:&%N(&-E<G1A:6X@86YC:6QL87)Y('-E<G9I8V5S('1H870@
M87)E('!R;W9I9&5D(&9R;VT@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#@V+C P(#4U,"XR-2!49" H;W5R($)O8V$@4F%T
M;VXL($9L;W)I9&$@:&5A9'%U87)T97)S+"!S=6-H(&%S('!A>7)O;&PL(&QE
M9V%L+"!A;F0@:6YF;W)M871I;VX@<WES=&5M<R!S=7!P;W)T+B!/;B!$96-E
M;6)E<B S,2P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#4S."XR-2!49" H,C Q."P@=V4@:&%D(#<S(&]F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,38R+C<U(#4S."XR-2!49" H9FEC92!L
M;V-A=&EO;G,N("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" V."XP," U,30N,C4@5&0@*%PH-EPI("D@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U,30N,C4@5&0@
M*$EN9F]R;6%T:6]N(%-Y<W1E;7,N("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.# N,3<@-3$T+C(U(%1D("A6*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3@V+C(X(#4Q-"XR-2!49" H87)I;W5S(&EN
M9F]R;6%T:6]N('-Y<W1E;7,@87)E('5T:6QI>F5D('1O(')U;B!O=7(@8W5S
M=&]M97(@<F5L871I;VYS:&EP(&UA;F%G96UE;G0L("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U,#(N,C4@5&0@
M*')E8W)U:71M96YT+"!A;F0@<&QA8V5M96YT(&9U;F-T:6]N<R!B87-E9"!O
M;B!O=7(@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S Q+C@V(#4P,BXR
M-2!49" H9F5R96YT(&)R86YD<RX@4V]M92!O9B!T:&5S92!S;W!H:7-T:6-A
M=&5D(&%P<&QI8V%T:6]N<R!A<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@V+C P(#0Y,"XR-2!49" H<')O<')I971A
M<GD@86YD(&%R92!H;W-T960@:6X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C S+C(X(#0Y,"XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(P
M.2XP,R T.3 N,C4@5&0@*&EE<B Q(&AO<W1I;F<@9F%C:6QI=&EE<R!W:&EL
M92!O=&AE<B!S>7-T96US(&%R92!3;V9T=V%R92!A<R!A(%-E<G9I8V4@7"A3
M86%37"D@8F%S960@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," T-S@N,C4@5&0@*&AO<W1E9"!B>2!O=7(@
M=F5N9&]R('!A<G1N97)S+B!/=7(@<WES=&5M<R!M86EN=&%I;B!D971A:6QE
M9"!I;F9O<FUA=&EO;B!A8F]U="!O=7(@8VQI96YT(')E<75I<F5D('-K:6QL
M<V5T<R!A;F0@<W1A='5S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," T-C8N,C4@5&0@*'=H:6-H(&%S<VES="!U
M<R!I;B!E;F%B;&EN9R!F=6QF:6QL;65N="!A;F0@87-S:6=N;65N="!R96YE
M=V%L<RX@3W5R(&1A=&%B87-E<R!C;VYT86EN(&%N(&5X=&5N<VEV92!P;V]L
M(&]F(&5X:7-T:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," T-30N,C4@5&0@*&%N9"!P;W1E;G1I86P@8W5S
M=&]M97)S(&%N9"!A;&P@<F5L871E9"!R96-R=6ET;65N="!A;F0@<V%L97,@
M86-T:79I='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3DN-#(@-#4T+C(U
M(%1D("@N($]U<B!F:6YA;F-I86P@86YD(&AU;6%N(')E<V]U<F-E('-Y<W1E
M;7,@87)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" X-BXP," T-#(N,C4@5&0@*&UA;F%G960@;VX@;&5A9&EN9R!E;G1E
M<G!R:7-E(')E<V]U<F-E('!L86YN:6YG('-O9G1W87)E('-U:71E<R!T:&%T
M(&UA;F%G92!C97)T86EN(&%S<&5C=',@;V8@86-C;W5N=',@<&%Y86)L92P@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V
M+C P(#0S,"XR-2!49" H86-C;W5N=',@<F5C96EV86)L92P@9V5N97)A;"!L
M961G97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C8N,#<@-#,P+C(U(%1D
M("@L(&)I;&QI;F<L(&%N9"!H=6UA;B!C87!I=&%L(&UA;F%G96UE;G0N("D@
M5&H@150@40IQ(# @," P(')G($)4(#,Y,RXU,R T,S N,C4@5&0@*$%L;"!O
M9B!O=7(@<WES=&5M<R!A<F4@;6%N86=E9"!B>2!O=7(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#0Q."XR-2!4
M9" H;VYS:&]R92!A;F0@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#4N
M,C4@-#$X+C(U(%1D("AF<VAO<F4@26YF;W)M871I;VX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C(R+C@R(#0Q."XR-2!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#(R."XR,R T,3@N,C4@5&0@*&5C:&YO;&]G>2!T96%M+BD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP
M," S.30N,C4@5&0@*%PH-UPI("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X-BXP," S.30N,C4@5&0@*%)I<VL@36%N86=E
M;65N="P@26YS=7)A;F-E+"!A;F0@0F5N969I=',N*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(W,BXT," S.30N,C4@5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S0N-S(@,SDT+C(U(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@S+C,U(#,Y-"XR-2!49" H92!H
M879E(&1E=F5L;W!E9"!A(')I<VL@;6%N86=E;65N="!P<F]G<F%M('1H870@
M<F5Q=6ER97,@<')O;7!T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," S.#(N,C4@5&0@*&YO=&EF:6-A=&EO;B!O
M9B!I;F-I9&5N=',@8GD@8VQI96YT<RP@8VQI;FEC:6%N<RP@86YD(&EN9&5P
M96YD96YT(&-O;G1R86-T;W)S+"!E9'5C871I;VYA;"!T<F%I;FEN9R!T;R!O
M=7(@96UP;&]Y965S+"!L;W-S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X-BXP," S-S N,C4@5&0@*&%N86QY<VES+"!A
M;F0@<')O;7!T(')E<&]R=&EN9R!P<F]C961U<F5S('1O(')E9'5C92!O=7(@
M<FES:R!O9B!E>'!O<W5R92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q
M+C4W(#,W,"XR-2!49" H5VAI;&4@=V4@8V%N;F]T('!R961I8W0@=&AE(&9U
M='5R92P@=V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#,U."XR-2!49" H8V]N=&EN=6]U<VQY(')E=FEE=R!F
M86-T<R!A;F0@:6YC:61E;G1S(&%S<V]C:6%T960@=VET:"!P<F]F97-S:6]N
M86P@;&EA8FEL:71Y(&%N9"!W;W)K97)SDBD@5&H@150@40IQ(# @," P(')G
M($)4(#0T-RXS.2 S-3@N,C4@5&0@*"!C;VUP96YS871I;VX@8VQA:6US(&EN
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X
M-BXP," S-#8N,C4@5&0@*&]R9&5R('1O(&ED96YT:69Y('1R96YD<R!A;F0@
M<F5D=6-E(&]U<B!R:7-K(&]F(&QO<W,@:6X@=&AE(&9U='5R92!W:&5R92!P
M;W-S:6)L92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# T+C8R(#,T-BXR
M-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#0Q,RXR-B S-#8N,C4@
M5&0@*&4@8V]N<VED97(@87-S97-S;65N=',@<')O=FED960@8GD@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#,S
M-"XR-2!49" H;W5R(&-L:65N=',@86YD('=E('=O<FL@=VET:"!C;&EN:6-I
M86YS(&%N9"!E>'!E<G1S(&9R;VT@;W5R(&EN<W5R86YC92!C87)R:65R<R!T
M;R!D971E<FUI;F4@96UP;&]Y;65N="!E;&EG:6)I;&ET>2 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,S(R+C(U
M(%1D("AA;F0@<&]T96YT:6%L(&5X<&]S=7)E+B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,CDX+C(U(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.30N-C0@,CDX+C(U(%1D("AE('!R
M;W9I9&4@=V]R:V5R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN-#(@
M,CDX+C(U(%1D("@@8V]M<&5N<V%T:6]N(&EN<W5R86YC92!C;W9E<F%G92P@
M<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;W9E<F%G92P@86YD(&AE86QT:&-A
M<F4@8F5N969I=',@9F]R(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.#8N,# @,C@V+C(U(%1D("AE;&EG:6)L92!E
M;7!L;WEE9"!T96UP;W)A<GD@<')O9F5S<VEO;F%L<RX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C8Q+C8Q(#(X-BXR-2!49" H5RD@5&H@150@40IQ(# @
M," P(')G($)4(#(W,"XR-" R.#8N,C4@5&0@*&4@<F5C;W)D(&]U<B!E<W1I
M;6%T92!O9B!T:&4@=6QT:6UA=&4@8V]S="!O9BP@86YD(')E<V5R=F5S(&9O
M<BD@5&H@150@40IQ(# @," P(')G($)4(#4Q,RXP." R.#8N,C4@5&0@*"P@
M=V]R:V5R<R<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#(W-"XR-2!49" H8V]M<&5N<V%T:6]N(&%N9"!P<F]F
M97-S:6]N86P@;&EA8FEL:71Y(&)E;F5F:71S(&)A<V5D(&]N(&%C='5A<FEA
M;"!M;V1E;',@<')E<&%R960@;W(@<F5V:65W960@8GD@86X@:6YD97!E;F1E
M;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#@V+C P(#(V,BXR-2!49" H86-T=6%R>2!U<VEN9R!O=7(@;&]S<R!H:7-T
M;W)Y(&%S('=E;&P@87,@:6YD=7-T<GD@<W1A=&ES=&EC<RX@26X@9&5T97)M
M:6YI;F<@;W5R(')E<V5R=F5S+"!W92!I;F-L=61E(')E<V5R=F5S(&9O<B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N
M,# @,C4P+C(U(%1D("AE<W1I;6%T960@8VQA:6US(&EN8W5R<F5D(&)U="!N
M;W0@<F5P;W)T960N("D@5&H@150@40IQ(# @," P(')G($)4(#(U.2XY,R R
M-3 N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C@N-3<@,C4P
M+C(U(%1D("AE(&%L<V\@97-T:6UA=&4@;VX@82!Q=6%R=&5R;'D@8F%S:7,@
M=&AE(&AE86QT:&-A<F4@8VQA:6US('1H870@:&%V92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,C,X+C(U(%1D
M("AO8V-U<G)E9"!B=70@:&%V92!N;W0@8F5E;B!R97!O<G1E9"!B87-E9"!O
M;B!O=7(@:&ES=&]R:6-A;"!C;&%I;2!S=6)M:7-S:6]N('!A='1E<FYS+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S0N-C$@,C,X+C(U(%1D("A4:&4@
M=6QT:6UA=&4@8V]S="!O9B!W;W)K97)SDBD@5&H@150@40IQ(# @," P(')G
M($)4(#4U,BXQ-B R,S@N,C4@5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,C(V+C(U(%1D("AC;VUP96YS
M871I;VXL('!R;V9E<W-I;VYA;"!L:6%B:6QI='DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,C@N,S@@,C(V+C(U(%1D("@L(&%N9"!H96%L=&@@:6YS=7)A
M;F-E(&-L86EM<R!W:6QL(&1E<&5N9"!O;B!A8W1U86P@86UO=6YT<R!I;F-U
M<G)E9"!T;R!S971T;&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@V+C P(#(Q-"XR-2!49" H=&AO<V4@8VQA:6US(&%N
M9"!M87D@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@U+C<Y(#(Q-"XR
M-2!49" H9F5R(&9R;VT@=&AE(&%M;W5N=',@<F5S97)V960@9F]R('-U8V@@
M8VQA:6US+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" X-BXP," Q.30N,C4@5&0@*%1H92!#;VUP86YY(&UA:6YT86EN<R!A
M(&YU;6)E<B!O9B!I;G-U<F%N8V4@<&]L:6-I97,@:6YC;'5D:6YG(&=E;F5R
M86P@;&EA8FEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C<Q(#$Y
M-"XR-2!49" H+"!W;W)K97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#0U
M-"XU,2 Q.30N,C4@5&0@*"!C;VUP96YS871I;VXL(&9I9&5L:71Y*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-30U+C<X(#$Y-"XR-2!49" H+" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,3@R
M+C(U(%1D("AE;7!L;WEM96YT('!R86-T:6-E<R!L:6%B:6QI='DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,#8N.3@@,3@R+C(U(%1D("@L(&9I9'5C:6%R
M>2D@5&H@150@40IQ(# @," P(')G($)4(#(T-RXT,R Q.#(N,C4@5&0@*"P@
M9&ER96-T;W)S(&%N9"!O9BD@5&H@150@40IQ(# @," P(')G($)4(#,Q-2XP
M," Q.#(N,C4@5&0@*&9I8V5R<RP@8WEB97(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-C0N,#$@,3@R+C(U(%1D("@L('!R;W!E<G1Y*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# R+C(T(#$X,BXR-2!49" H+"!A;F0@<')O9F5S<VEO
M;F%L(&QI86)I;&ET>2!P;VQI8VEE<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#$W,"XR-2!49" H5&AE<V4@
M<&]L:6-I97,@<')O=FED92!C;W9E<F%G92!S=6)J96-T('1O('1H96ER('1E
M<FUS+"!C;VYD:71I;VYS+"!L:6UI=',@;V8@;&EA8FEL:71Y*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#$Y+CDY(#$W,"XR-2!49" H+"!A;F0@9&5D=6-T
M:6)L97,L(&9O<B!C97)T86EN("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X-BXP," Q-3@N,C4@5&0@*&QI86)I;&ET:65S
M('1H870@;6%Y(&%R:7-E(&9R;VT@;W5R(&]P97)A=&EO;G,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(V."XU-2 Q-3@N,C4@5&0@*%1H97)E(&-A;B!B
M92!N;R!A<W-U<F%N8V4@=&AA="!A;GD@;V8@=&AE(&%B;W9E('!O;&EC:65S
M('=I;&P@8F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@V+C P(#$T-BXR-2!49" H861E<75A=&4@9F]R(&]U<B!N965D
M<RP@;W(@=&AA="!W92!W:6QL(&UA:6YT86EN(&%L;"!S=6-H('!O;&EC:65S
M(&EN('1H92!F=71U<F4N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,Y."XQ,B Q-#8N,C4@5&0@** I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3(V+C(U(%1D
M("A/=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-RXV," Q,C8N,C4@5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,"XQ," Q,C8N,C4@5&0@*$=E
M;V=R87!H:6,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(R+C4Y(#$R-BXR
M-2!49" H36%R:V5T<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C$N,3D@
M,3(V+C(U(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<Y+C@Q
M(#$R-BXR-2!49" H0VQI96YT("D@5&H@150@40IQ(# @," P(')G($)4(#(P
M."XT,B Q,C8N,C4@5&0@*$)A<V4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3 V+C(U(%1D("A);B R,#$X+" R
M,#$W(&%N9" R,#$V+"!A;&P@;V8@;W5R(')E=F5N=64@=V%S(&=E;F5R871E
M9"!I;B!T:&4@56YI=&5D(%-T871E<RP@86YD(&%L;"!O9B!O=7(@;&]N9RUL
M:79E9"!A<W-E=',@=V5R92!L;V-A=&5D(&EN("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Y-"XR-2!49" H=&AE
M(%5N:71E9"!3=&%T97,@86YD($EN9&EA+B @3VX@82!C;VUP86YY+7=I9&4@
M8F%S:7,L('=E(&AA=F4@87!P<F]X:6UA=&5L>2 W+#4P,"!A8W1I=F4@8V]N
M=')A8W1S('=I=&@@:&5A;'1H8V%R92!C;&EE;G1S+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @.#(N,C4@5&0@
M*&%N9"!W92!P<F]V:61E(&]U<B!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,30T+C(S(#@R+C(U(%1D("AF:6YG('-E<G9I8V5S(&%N9"!W;W)K9F]R
M8V4@<V]L=71I;VYS(&EN(&%L;" U,"!S=&%T97,N($1U<FEN9R R,#$X+"!T
M:&4@;&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0P+C$P(#@R+C(U(%1D
M("AG97-T('!E<F-E;G1A9V4@;V8@;W5R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,"XR-2!49" H<F5V96YU
M92!W87,@8V]N8V5N=')A=&5D(&EN($YE=R I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q.#<N,#<@-S N,C4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q.3,N,CD@-S N,C4@5&0@*&]R:RP@1FQO<FED82P@86YD($-A;&EF;W)N
M:6$N("D@5&H@150@40IQ(# @," P(')G($)4(#,P-RXX," W,"XR-2!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#,Q-BXT-" W,"XR-2!49" H92!P
M<F]V:61E('-E<G9I8V5S('1O('!U8FQI8R!A;F0@<')I=F%T92!A8W5T92!C
M87)E(&AO<W!I=&%L<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#4X+C(U(%1D("AP=6)L:6,@86YD(&-H87)T
M97(@<V-H;V]L<RP@;W5T<&%T:65N="!C;&EN:6-S+"!A;6)U;&%T;W)Y(&-A
M<F4@9F%C:6QI=&EE<RP@<VEN9VQE(&%N9"!M=6QT:2US<&5C:6%L='D@<&AY
M<VEC:6%N('!R86-T:6-E<RP@*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*
M,3D@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O
M>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T
M92 P"B]#;VYT96YT<R R," P(%(^/@IE;F1O8FH*,C @,"!O8FH*/#PO3&5N
M9W1H(#$Q-3DR/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,P,RXU," S,2XV,"!49" H-BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W-#(N,3 @5&0@*')E:&%B
M:6QI=&%T:6]N(&9A8VEL:71I97,L('5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,34S+C,Y(#<T,BXQ,"!49" H9V5N="!C87)E(&-E;G1E<G,L(&-O<G)E
M8W1I;VYA;"!F86-I;&ET:65S+"!G;W9E<FYM96YT(&9A8VEL:71I97,L(')E
M=&%I;&5R<RP@86YD(&UA;GD@;W1H97(@:&5A;'1H8V%R92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S,P+C$P
M(%1D("AP<F]V:61E<G,N($EN(#(P,3@L(#(P,3<L(&%N9" R,#$V(&YO(&-L
M:65N="!A8V-O=6YT960@9F]R(&UO<F4@=&AA;B U)2!O9B!O=7(@<F5V96YU
M92X@("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W,3 N,3 @5&0@*$]U<BD@5&H@150@40IQ(# @," P(')G($)4
M(#8W+C8P(#<Q,"XQ,"!49" H($EN9'5S=')Y*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y."XQ,"!49" HH"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V.#8N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" V
M.#8N,3 @5&0@*&4@8V]M<&5T92!I;B!T:&4@52Y3+B!T96UP;W)A<GD@:&5A
M;'1H8V%R92!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0X+C8V(#8X
M-BXQ,"!49" H9FEN9R!A;F0@=V]R:V9O<F-E('-O;'5T:6]N<R!M87)K971S
M+B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$X+CDY(#8X-BXQ,"!4
M9" H9FEN9R!);F1U<W1R>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S(N
M.#@@-C@V+C$P(%1D("A!;F%L>7-T<R!397!T96UB97(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8W-"XQ,"!4
M9" H,C Q."!R97!O<G0@97-T:6UA=&5S('1H92!H96%L=&AC87)E('-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N,30@-C<T+C$P(%1D("AF:6YG
M(&UA<FME=',@:6X@=VAI8V@@=V4@;W!E<F%T92!H860@86X@86=G<F5G871E
M(&UA<FME="!S:7IE(&]F("0Q-BXX(&)I;&QI;VX@:6X@,C Q." I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C8R
M+C$P(%1D("AO9B!W:&EC:" D-2XS(&)I;&QI;VX@=V%S('1R879E;"!N=7)S
M:6YG+" D,RXU(&)I;&QI;VX@=V%S('!E<B!D:65M(&YU<G-I;F<L("0T+C @
M8FEL;&EO;B!W87,@86QL:65D(&AE86QT:"!A;F0@)#0N,"!B:6QL:6]N('=A
M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-C4P+C$P(%1D("AL;V-U;2!T96YE;G,@86YD(&%D=F%N8V5D('!R
M86-T:71I;VYE<G,N("D@5&H@150@40IQ(# @," P(')G($)4(#(Q-RXU,R V
M-3 N,3 @5&0@*%1H92!D96UA;F0@9F]R(&]U<B!S97)V:6-E<R!I<R!I;7!A
M8W1E9"!B>2!M86YY(&9A8W1O<G,L(&AO=V5V97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T.#8N,C$@-C4P+C$P(%1D("@L('=E(&)E;&EE=F4@=&AE("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,S@N,3 @5&0@*&UO<W0@<VEG;FEF:6-A;G0@87)E('1H92!F;VQL;W=I
M;F<Z(" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#(N,# @-C$T+C$P(%1D("A);F1U<W1R>2!$96UA;F0@1')I=F5R<RD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP
M," U.30N,3 @5&0@*$5C;VYO;6EC($)A8VMD<BD@5&H@150@40IQ(# @," P
M(')G($)4(#$U."XR,2 U.30N,3 @5&0@*&]P+B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<S+C<W(#4Y-"XQ,"!49" H
M5&AE(%4N4RX@96-O;F]M>2!H860@82!S=')O;F<@>65A<B!I;B R,#$X+"!A
M;F0@86-C;W)D:6YG('1O('1H92!5+E,N($)U<F5A=2!O9B!,86)O<B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @
M-3@R+C$P(%1D("A3=&%T:7-T:6-S('1H92!J;V(@;6%R:V5T('-H;W=E9"!C
M;VYT:6YU960@<VEG;G,@;V8@8V]N=&EN=65D(&=R;W=T:"!W:71H('5N96UP
M;&]Y;65N="!A=" S+CDE(&%S(&]F($1E8V5M8F5R("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U-S N,3 @5&0@
M*#(P,3@N("D@5&H@150@40IQ(# @," P(')G($)4(#$P-BXX,B U-S N,3 @
M5&0@*%1H92!S=')O;F<@52Y3+B!E8V]N;VUY(&AA<R!L960@=&\@<V]L:60@
M:F]B(&=R;W=T:"P@=VAI8V@@=V4@97AP96-T('=I;&P@<F5S=6QT(&EN(&UO
M<F4@:6YD:79I9'5A;',@<F5C96EV:6YG("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U-3@N,3 @5&0@*&AE86QT
M:&-A<F4@9G)O;2!T:&5I<B!E;7!L;WEE<G,@+2!T:'5S('-U<'!O<G1I;F<@
M=&AE(&1E;6%N9"!F;W(@:&5A;'1H8V%R92!S97)V:6-E<RX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#(V+C T(#4U."XQ,"!49" H02D@5&H@150@40IQ
M(# @," P(')G($)4(#0S,BXW,2 U-3@N,3 @5&0@*"!G<F]W:6YG(%4N4RX@
M96-O;F]M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.#(N,# @-30V+C$P(%1D("AC;W5P;&5D('=I=&@@82!L;W<@=6YE
M;7!L;WEM96YT(')A=&4@='EP:6-A;&QY(')E<W5L=',@:6X@86X@:6YC<F5A
M<V4@:6X@9&5M86YD(&9O<B!O=7(@<V5R=FEC97,@("D@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U,C8N,3 @5&0@
M*$EN8W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,# N,34@-3(V+C$P(%1D
M("AE87-E9"!.965D(&9O<BD@5&H@150@40IQ(# @," P(')G($)4(#$V,BXW
M,R U,C8N,3 @5&0@*"!(96%L=&AC87(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R,#<N.#$@-3(V+C$P(%1D("AE(&%N9"!3<&5C:6%L($5D=6-A=&EO;B!3
M97)V:6-E<R!I;B!38VAO;VQS+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDX+C,Y(#4R-BXQ,"!49" H5&AE($EN9&EV
M:61U86QS('=I=&@@1&ES86)I;&ET:65S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U,30N,3 @5&0@*$5D=6-A
M=&EO;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C0N-#D@-3$T+C$P(%1D
M("A!8W0@7"A)1$5!7"DL(&5N86-T960@:6X@,3DW-2P@;6%N9&%T97,@=&AA
M="!C:&EL9')E;B!A;F0@>6]U=&@@86=E<R S+3(Q('=I=&@@9&ES86)I;&ET
M:65S(&)E('!R;W9I9&5D(&$@9G)E92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @-3 R+C$P(%1D("AA;F0@87!P
M<F]P<FEA=&4@<'5B;&EC('-C:&]O;"!E9'5C871I;VXN("D@5&H@150@40IQ
M(# @," P(')G($)4(#(T-BXS.2 U,#(N,3 @5&0@*$%C8V]R9&EN9R!T;R!T
M:&4@52Y3+B!$97!A<G1M96YT(&]F($5D=6-A=&EO;BP@3F%T:6]N86P@0V5N
M=&5R(&9O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.#(N,# @-#DP+C$P(%1D("A%9'5C871I;VX@4W1A=&ES=&EC(%)E
M<&]R="!T:71L960@DU1H92!#;VYD:71I;VX@;V8@161U8V%T:6]N(B!<*$%P
M<FEL(#(P,3A<*2P@=&AE(&YU;6)E<B!O9B!C:&EL9')E;B!A;F0@>6]U=&@@
M86=E<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#(N,# @-#<X+C$P(%1D("@S+3(Q(')E8V5I=FEN9R!S<&5C:6%L(&5D
M=6-A=&EO;B!S97)V:6-E<R!W87,@-BXW(&UI;&QI;VXL(&]R(&%B;W5T(#$S
M)2!O9B!T<F%D:71I;VYA;"!P=6)L:6,@86YD(&-H87)T97(@<V-H;V]L("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP
M," T-C8N,3 @5&0@*&5N<F]L;&UE;G0N("D@5&H@150@40IQ(# @," P(')G
M($)4(#$S,"XQ-" T-C8N,3 @5&0@*%1H92!)1$5!*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3<Q+C4R(#0V-BXQ,"!49" H(')E<75I<F5S('1H870@=&AE
M<V4@8VAI;&1R96X@86YD('EO=6YG(&%D=6QT<R!R96-E:79E(&-A<F4@9G)O
M;2!S<&5E8V@@;&%N9W5A9V4@<&%T:&]L;V=I<W1S+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @-#4T+C$P(%1D
M("AP:'ES:6-A;"!T:&5R87!I<W1S+"!O8V-U<&%T:6]N86P@=&AE<F%P:7-T
M<RP@;G5R<V5S(&%N9"!O=&AE<B!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@
M=VAI;&4@870@<V-H;V]L+B!"87-E9"!O;B!T:&4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#0T,BXQ,"!49" H
M9F]R96=O:6YG+"!W92!B96QI979E('1H92!D96UA;F0@9F]R(&-O;G-U;'1I
M;F<@86YD(&AE86QT:&-A<F4@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#,U,RXS." T-#(N,3 @5&0@*&9I;F<@<V5R=FEC97,@9F]R('!U8FQI8R!S
M8VAO;VQS(&%N9"!C:&%R=&5R('-C:&]O;',@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#0S,"XQ,"!49" H=VEL
M;"!C;VYT:6YU92!T;R!B92!S=')O;F<@9F]R(&%G96YC:65S('1H870@8V%N
M('!R;W9I9&4@8V]N<W5L=&EN9R!S97)V:6-E<RP@:&5A;'1H8V%R92!P97)S
M;VYN96PL('1E8VAN:6-A;"!A<W-I<W1A;F-E("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," T,3@N,3 @5&0@*&]N
M('!O;&EC:65S+"!I;7!L96UE;G1A=&EO;BP@86YD('1R86EN:6YG(')E;&%T
M960@=&\@8VAI;&1R96X@86YD('EO=71H('=I=&@@<W!E8VEA;"!N965D<R!I
M;B!S8VAO;VP@<V5T=&EN9W,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#@R+C P(#,Y."XQ,"!49" H0W(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Y,RXT." S.3@N,3 @5&0@*&5A=&EO;B!O9B!(96%L
M=&AC87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S4N-3 @,SDX+C$P(%1D
M("AE($IO8G,@3W5T<&%C:6YG($]T:&5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C<W+C(W(#,Y."XQ,"!49" H($EN9'5S=')I97,@86YD($]C8W5P871I
M;VYS+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# R+C4X(#,Y."XQ,"!49" H2&5A;'1H8V%R92!R97!R97-E;G1E9" Q
M-"4@;V8@86QL(&IO8G,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@R+C P(#,X-BXQ,"!49" H8W)E871E9"!I;B R,#$X
M(%PH2&5A;'1H;&5A9&5R<TUE9&EA+F-O;2P@2F%N=6%R>2 T+" R,#$Y7"DN
M("D@5&H@150@40IQ(# @," P(')G($)4(#,R-BXP." S.#8N,3 @5&0@*$%C
M8V]R9&EN9R!T;R!T:&4@0G5R96%U(&]F($QA8F]R(%-T871I<W1I8W,L(&]V
M97)A;&PL("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" X,BXP," S-S0N,3 @5&0@*&5M<&QO>6UE;G0@:7,@97AP96-T960@
M=&\@9W)O=R W+C0E+"!F87(@;W5T<&%C960@8GD@96UP;&]Y;65N="!I;B!T
M:&4@:&5A;'1H8V%R92!I;F1U<W1R>2!<*#$X)5PI(&%N9"!A;6]N9R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @
M,S8R+C$P(%1D("AH96%L=&AC87)E(&]C8W5P871I;VYS(%PH,3@E7"D@7"A3
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(R+C4Y(#,V,BXQ,"!49" H
M9FEN9R!);F1U<W1R>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S8N-#@@
M,S8R+C$P(%1D("A!;F%L>7-T<RP@1&5C96UB97(@,30L(#(P,3=<*2X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-# S+C(Q(#,V,BXQ,"!49" H5&AI<R!P
M<F]J96-T960@,3@E(&=R;W=T:"!V87)I97,L("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," S-3 N,3 @5&0@*&AO
M=V5V97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,38N,#,@,S4P+C$P(%1D
M("@L(&%M;VYG('1H<F5E(&-A=&5G;W)I97,@=&AA="!M86ME('5P('1H92!H
M96%L=&AC87)E(&EN9'5S=')Y.B!<*&E<*2!A;6)U;&%T;W)Y(&AE86QT:&-A
M<F4@<V5R=FEC97,[(%PH:6E<*2!N=7)S:6YG("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," S,S@N,3 @5&0@*&%N
M9"!R97-I9&5N=&EA;"!C87)E.R!A;F0@7"AI:6E<*2!H;W-P:71A;',N($5M
M<&QO>6UE;G0@9F]R(&%M8G5L871O<GD@:&5A;'1H8V%R92!S97)V:6-E<R!I
M<R!P<F]J96-T960@=&\@9W)O=R S,24[("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," S,C8N,3 @5&0@*&YU<G-I
M;F<@86YD(')E<VED96YT:6%L(&-A<F4@:7,@<')O:F5C=&5D('1O(&=R;W<@
M,3,E+"!A;F0@:&]S<&ET86P@96UP;&]Y;65N="!I<R!P<F]J96-T960@=&\@
M9W)O=R V+C@E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3$N-S$@,S(V
M+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(P+C,U(#,R-BXQ
M,"!49" H92!E>'!E8W0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@R+C P(#,Q-"XQ,"!49" H=&AE(&-R96%T:6]N(&]F
M(&%D9&ET:6]N86P@:F]B<R!I;B!T:&4@:&5A;'1H8V%R92!M87)K970@=VEL
M;"!I;F-R96%S92!D96UA;F0@9F]R(&]U<B!S97)V:6-E<R!A<R!O=7(@=&5M
M<&]R87)Y('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,SDN-#(@,S$T
M+C$P(%1D("AF(&%R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#(N,# @,S R+C$P(%1D("AT>7!I8V%L;'D@:&ER960@
M=&\@<F5P;&%C92!H96%L=&AC87)E('=O<FME<G,@=&%K:6YG('9A8V%T:6]N
M(&%N9"!L96%V97,@;V8@86)S96YC92XI(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @,C@R+C$P(%1D("A/=71P871I
M96YT+T%M8G5L871O<GD@4V5T=&EN9W,@4V5R=FEC97,@3W5T<&%C92!);G!A
M=&EE;G0@4V5R=FEC97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,W."XP.2 R.#(N,3 @5&0@*" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.# N,#0@,C@R+C$P(%1D("A!8V-O<F1I;F<@=&\@=&AE
M(%4N4RX@0V5N<W5S($)U<F5A=2P@=&AE("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," R-S N,3 @5&0@*&%M8G5L
M871O<GD@:&5A;'1H8V%R92!S97)V:6-E<R!S96-T;W(@861D960@,S<L.# P
M(&IO8G,@:6X@1&5C96UB97(@,C Q."P@=VAI;&4@:&]S<&ET86QS(&%D9&5D
M(#<L-# P(&IO8G,@:6X@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X,BXP," R-3@N,3 @5&0@*'-A;64N("D@5&H@
M150@40IQ(# @," P(')G($)4(#$P-RXS-R R-3@N,3 @5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q,38N,# @,C4X+C$P(%1D("AE(&)E;&EE=F4@
M8V5R=&%I;B!G;W9E<FYM96YT(&EN:71I871I=F5S('!R979I;W5S;'D@=&%K
M96XL('-U8V@@87,@365D:6-A<F4@<F5I;6)U<G-E;65N="!I;F-E;G1I=F5S
M(&9O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#(N,# @,C0V+C$P(%1D("AR961U8V5D(')E861M:7-S:6]N<RP@:&%V
M92!H860@82!D:7)E8W0@8V]R<F5L871I;VX@=&\@=&AE('-H:69T(&9R;VT@
M:6YP871I96YT('-E<G9I8V5S('1O(&]U='!A=&EE;G0O86UB=6QA=&]R>2!S
M971T:6YG<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.#(N,# @,C,T+C$P(%1D("AA;F0@:F]B(&=R;W=T:"!I;B!T:&%T
M(&%R96$N("D@5&H@150@40IQ(# @," P(')G($)4(#$Y-"XR.2 R,S0N,3 @
M5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#(N.3(@,C,T+C$P(%1D
M("AE(&)E;&EE=F4@=&AI<R!G<F]W=&@@=VEL;"!H879E(&$@<&]S:71I=F4@
M:6UP86-T(&]N(&1E;6%N9"!F;W(@:&5A;'1H8V%R92!S=&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3$W+CDQ(#(S-"XQ,"!49" H9FEN9R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @,C(R
M+C$P(%1D("AS97)V:6-E<R!I;B!O=71P871I96YT+V%M8G5L871O<GD@<V5T
M=&EN9W,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#@R+C P(#(P,BXQ,"!49" H2&]S<&ET86QS(%-E96MI;F<@169F:6-I
M96YC:65S("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU-" R,#(N,3 @
M5&0@*%1H<BD@5&H@150@40IQ(# @," P(')G($)4(#(R."XP,R R,#(N,3 @
M5&0@*&]U9V@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4Q+C0W(#(P,BXQ
M,"!49" H5BD@5&H@150@40IQ(# @," P(')G($)4(#(U-RXW." R,#(N,3 @
M5&0@*&%R:6]U<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#8N-S<@,C R
M+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDV+C(Q(#(P,BXQ
M,"!49" H;W)K9F]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(S+C@P(#(P
M,BXQ,"!49" H8V4@4V]L=71I;VYS+B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S<Y+C8T(#(P,BXQ,"!49" H2&]S<&ET
M86QS(&-O;G1I;G5E('1O(&9A8V4@<')E<W-U<F4@=&\@:V5E<" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @,3DP
M+C$P(%1D("AC;W-T<R!D;W=N+B!);B!A9&1I=&EO;BP@=&AE(&YA=&EO;F%L
M('-H:69T(&%W87D@9G)O;2!V;VQU;64M8F%S960@<')I8VEN9R!T;R!V86QU
M92UB87-E9"!P<FEC:6YG(&AA<R!C;VYT:6YU960N("D@5&H@150@40IQ(# @
M," P(')G($)4(#4S-BXT,R Q.3 N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U-#4N,#<@,3DP+C$P(%1D("AE("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," Q-S@N,3 @5&0@*&)E
M;&EE=F4@=&AE<V4@9'EN86UI8W,@8V]N=&EN=64@=&\@<'5T('!R97-S=7)E
M(&]N(&AO<W!I=&%L<R!T;R!F:6YD(&EN;F]V871I=F4@<V]L=71I;VYS(&EN
M(&]R9&5R('1O(&)E='1E<B!M86YA9V4@=&AE:7(@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#$V-BXQ,"!49" H
M=V]R:V9O<F-E+"!W:&EC:"!A8V-O=6YT<R!F;W(@82!L87(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,C,N.3@@,38V+C$P(%1D("AG92!P;W)T:6]N(&]F
M('1H96ER(&5X<&5N<V5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,SDN
M-3 @,38V+C$P(%1D("A!<R!A(')E<W5L="P@=V4@8F5L:65V92!H96%L=&AC
M87)E(&9A8VEL:71I97,@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X,BXP," Q-30N,3 @5&0@*'!R;W9I9&5R<R!W
M:6QL(&-O;G1I;G5E('1O('5T:6QI>F4@=V]R:V9O<F-E('-O;'5T:6]N<RP@
M<W5C:"!A<R!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3 N,S @,34T
M+C$P(%1D("@L(%)03RP@25)0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDT
M+C(Q(#$U-"XQ,"!49" H+"!A;F0@;W1H97(@=&%L96YT(&UA;F%G96UE;G0@
M=&]O;',@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#@R+C P(#$T,BXQ,"!49" H:&5L<"!T:&5M('-O;'9E('1H97-E
M('!R;V)L96US(&%N9"!M86EN=&%I;B!T:&5I<B!Q=6%L:71Y(&]F(&-A<F4N
M("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X
M,BXP," Q,C(N,3 @5&0@*$UA8W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,#4N,3,@,3(R+C$P(%1D("AO($1R:79E<G,@;V8@1&5M86YD*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y-"XR.2 Q,C(N
M,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DY+C$P(#$R,BXQ
M,"!49" H5&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(Q-BXV," Q,C(N
M,3 @5&0@*$%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(V+CDW(#$R,BXQ
M,"!49" H9F]R9&%B;&4@0V%R92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.#,N-C$@,3(R+C$P(%1D("A!8W0@7"A!0T%<*2!I;F-R96%S960@=&AE(&YU
M;6)E<B!O9B!I;G-U<F5D('!A=&EE;G1S(&]V97(@=&AE('!A<W0@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#$Q
M,"XQ,"!49" H9F5W('EE87)S+"!E<W!E8VEA;&QY(&EN('-T871E<R!T:&%T
M(&5X<&%N9&5D($UE9&EC86ED+J!)="!H87,@8F5E;B!R97!O<G1E9"!T:&%T
M('1H92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#0R-2XU-R Q,3 N,3 @
M5&0@*&9E8W0@;V8@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#0V."XP
M-2 Q,3 N,3 @5&0@*$%#02D@5&H@150@40IQ(# @," P(')G($)4(#0X."XV
M,2 Q,3 N,3 @5&0@*"!O;B!H96%L=&AC87)E("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," Y."XQ,"!49" H=71I
M;&EZ871I;VX@:&%S(&)E96X@=&AA=" R,"!M:6QL:6]N('!E;W!L92!G86EN
M960@:&5A;'1H(&EN<W5R86YC92!C;W9E<F%G92X@2&]W979E<BD@5&H@150@
M40IQ(# @," P(')G($)4(#0R-RXP,R Y."XQ,"!49" H+"!T:&4@96QI;6EN
M871I;VX@;V8@=&AE(&EN9&EV:61U86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#@V+C$P(%1D("AM86YD871E
M(&%N9"!O=&AE<B!E9BD@5&H@150@40IQ(# @," P(')G($)4(#$V-2XY-2 X
M-BXQ,"!49" H9F]R=',@8GD@=&AE(&-U<G)E;G0@861M:6YI<W1R871I;VX@
M;6%Y(&YE9V%T:79E;'D@:6UP86-T('1H92!N=6UB97(@;V8@:6YD:79I9'5A
M;',@=VET:"!H96%L=&@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@R+C P(#<T+C$P(%1D("AI;G-U<F%N8V4@8V]V97)A
M9V4N($EN(&%D9&ET:6]N+"!T=V\@;W1H97(@;&]N9RUT97)M(&UA8W)O(&1R
M:79E<G,@;V8@;W5R(&)U<VEN97-S+"!A(&=R;W=I;F<@86YD(&%G:6YG(%4N
M4RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#@R+C P(#8R+C$P(%1D("AP;W!U;&%T:6]N+"!S:&]U;&0@8V]N=&EN=64@
M=&\@9')I=F4@9&5M86YD(&9O<B!O=7(@<V5R=FEC97,N("D@5&H@150@40IQ
M(# @," P(')G($)4(#,S,"XP," V,BXQ,"!49" H06-C;W)D:6YG('1O('1H
M92!5+E,N($-E;G-U<R!"=7)E874L('1H92!N=6UB97(@;V8@*2!4:B!%5"!1
M"F5N9'-T<F5A;0IE;F1O8FH*,C$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R
M96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O
M=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R R,B P(%(^/@IE;F1O
M8FH*,C(@,"!O8FH*/#PO3&5N9W1H(#$R,#<U/CX*<W1R96%M"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,RXU," S,2XV,"!49" H-RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP
M," W-#(N,3 @5&0@*'!E<G-O;G,@86=E9" V-2!A;F0@;W9E<B!I<R!E>'!E
M8W1E9"!T;R!I;F-R96%S92!T;R Y."!M:6QL:6]N(&EN(#(P-C L('=H:6-H
M(&ES(&EM<&]R=&%N="!B96-A=7-E('1H92!U=&EL:7IA=&EO;B!O9B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N,# @
M-S,P+C$P(%1D("AH96%L=&AC87)E('-E<G9I8V5S(&ES(&=E;F5R86QL>2!H
M:6=H97(@86UO;F<@;VQD97(@<&5O<&QE+B @*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#<Q,"XQ,"!49" H4W5P
M<&QY(&]F($YU<G-E<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$U.2XX," W,3 N,3 @5&0@*%1H92!'96]R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3DW+C8U(#<Q,"XQ,"!49" H9V5T;W=N(%5N
M:79E<G-I='D@0V5N=&5R(&]N($5D=6-A=&EO;B!A;F0@=&AE("D@5&H@150@
M40IQ(# @," P(')G($)4(#,Y,"XT." W,3 N,3 @5&0@*%<I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.3DN,3(@-S$P+C$P(%1D("AO<FMF;W)C92!<*$-%
M5UPI('!R961I8W1S(&$@<VAO<G1A9V4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#8Y."XQ,"!49" H,3DR
M+#8R,"!N=7)S97,@:6X@,C R,"P@=VAI8V@@9&EF*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C$X+C(P(#8Y."XQ,"!49" H9F5R<R!F<F]M('1H92!S=7)P
M;'5S(&]F(&YU<G-E<R!P<F5D:6-T960@9F]R(#(P,C4@8GD@=&AE($AE86QT
M:"!297-O=7)C97,@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X,BXP," V.#8N,3 @5&0@*%-E<G9I8V5S("D@5&H@
M150@40IQ(# @," P(')G($)4(#$Q-RXX,R V.#8N,3 @5&0@*$%D;6EN:7-T
M<F%T:6]N(%PH2%)305PI($YA=&EO;F%L($-E;G1E<B!F;W(@2&5A;'1H("D@
M5&H@150@40IQ(# @," P(')G($)4(#,R-2XY-" V.#8N,3 @5&0@*%<I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,S0N-3<@-C@V+C$P(%1D("AO<FMF;W)C
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S N,SD@-C@V+C$P(%1D("A!
M;F%L>7-I<R!<*$=E;W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S$N,#,@
M-C@V+C$P(%1D("AG971O=VX@56YI=F5R<VET>2!#96YT97(@;VX@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#8W
M-"XQ,"!49" H161U8V%T:6]N(&%N9"!T:&4@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,34V+C4R(#8W-"XQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G
M($)4(#$V-2XQ-2 V-S0N,3 @5&0@*&]R:V9O<F-E(%PH0T577"DL($9O<F5C
M87-T<R!O9B!.=7)S:6YG($1E;6%N9" R,#$U7"DN($AO=V5V97(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,C(N,3@@-C<T+C$P(%1D("@L('=I=&@@:&5A
M;'1H8V%R92!N;W<@<F5P<F5S96YT:6YG("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," V-C(N,3 @5&0@*&%L;6]S
M=" R,"4@;V8@=&AE(%4N4RX@96-O;F]M>2D@5&H@150@40IQ(# @," P(')G
M($)4(#(Q,RXX,R V-C(N,3 @5&0@*"P@=&AE(&%G:6YG(&]F('1H92!5+E,N
M('!O<'5L871I;VXL(&%N9"!T:&4@97AP86YD960@:&5A;'1H8V%R92!C;W9E
M<F%G92!U;F1E<B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@R+C P(#8U,"XQ,"!49" H04-!+"!B;W1H('1H92!#
M15<I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C4N,30@-C4P+C$P(%1D("@@
M86YD($A24T$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3 N-S$@-C4P+C$P
M(%1D("@@86=R964@=&AA="!D96UA;F0@9F]R(&AE86QT:&-A<F4@<V5R=FEC
M97,@86YD(&AE86QT:&-A<F4@=V]R:V5R<R!W:6QL(&-O;G1I;G5E('1O("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP
M," V,S@N,3 @5&0@*&=R;W<I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#$N
M.3 @-C,X+C$P(%1D("@N($EN(&%D9&ET:6]N+"!B>2 R,#,P(&ET(&ES(&5X
M<&5C=&5D('1H870@86QM;W-T(&$@;6EL;&EO;B!N=7)S97,@=VEL;"!R971I
M<F4@86YD(&QE879E('1H92!W;W)K9F]R8V4@=&%K:6YG('=I=&@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#8R
M-BXQ,"!49" H=&AE;2!T:&4@>65A<G,@;V8@:VYO=VQE9&=E(&%N9"!E>'!E
M<FEE;F-E('1H97D@:&%V92!A8V-U;75L871E9"!<*$UO9&5R;B!(96%L=&AC
M87)E+"!.=7)S:6YG(%-H;W)T86=E($EN("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," V,30N,3 @5&0@*%!E<G-P
M96-T:79E+"!*86YU87)Y(#$L(#(P,3A<*2X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C T+C@T(#8Q-"XQ,"!49" H5&AE<F4@:7,@86QS;R!A;B!I;6)A
M;&%N8V4@;V8@4DYS(&%T('1H92!S=&%T92!L979E;"!W:&5R92!M86YY('-T
M871E<R!A<F4@<')O:F5C=&5D('1O("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" X,BXP," V,#(N,3 @5&0@*&5X<&5R:65N
M8V4@82!S;6%L;&5R(&=R;W=T:"!I;B!23B!S=7!P;'D@<F5L871I=F4@=&\@
M=&AE:7(@<W1A=&4M<W!E8VEF:6,@9&5M86YD+"!R97-U;'1I;F<@:6X@82!G
M96]G<F%P:&EC86P@<VAO<G1A9V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@R+C P(#4Y,"XQ,"!49" H;V8@4DYS(&)Y
M(#(P,C4N("D@5&H@150@40IQ(# @," P(')G($)4(#$U,"XP-B U.3 N,3 @
M5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-38N-S,@-3DP+C$P(%1D
M("@@<VAO<G1F86QL(&]F(')E9VES=&5R960@;G5R<V5S(&EN('!A<G1I8W5L
M87(@<W!E8VEA;'1I97,@:7,@86QS;R!E>'!E8W1E9"!O=F5R('1H92!N97AT
M('1E;B!Y96%R<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#(N,# @-3<X+C$P(%1D("A<*$=E;W(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,#4N,30@-3<X+C$P(%1D("AG971O=VX@56YI=F5R<VET
M>2!#15<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#,N,#D@-3<X+C$P(%1D
M("@L($9O<F5C87-T<R!O9B!.=7)S:6YG($1E;6%N9" R,#$U7"DN("D@5&H@
M150@40IQ(# @," P(')G($)4(#,U."XT-" U-S@N,3 @5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N,#@@-3<X+C$P(%1D("AE(&)E;&EE=F4@
M=&AE<V4@9V5O9W)A<&AI8R!A;F0@<W!E8VEA;'1Y(')E;&%T960@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#4V
M-BXQ,"!49" H<VAO<G1A9V5S('-H;W5L9"!H879E(&$@<&]S:71I=F4@968I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C$N-3$@-38V+C$P(%1D("AF96-T
M(&]N(&1E;6%N9"!F;W(@;W5R('-E<G9I8V5S(&%S('1E;7!O<F%R>2!N=7)S
M92!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0S+C$Y(#4V-BXQ,"!4
M9" H9FEN9R!O<F1E<G,@='EP:6-A;&QY(&EN8W)E87-E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U-30N,3 @
M5&0@*'=H96X@;G5R<V4@=F%C86YC>2!R871E<R!R:7-E+BD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," U,S0N,3 @
M5&0@*%!H>7-I8VEA;B!3:&]R=&%G92XI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,38V+C0U(#4S-"XQ,"!49" H("D@5&H@
M150@40IQ(# @," P(')G($)4(#$V."XT," U,S0N,3 @5&0@*$%C8V]R9&EN
M9R!T;R!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,W+C4U(#4S-"XQ
M,"!49" H07-S;V-I871I;VX@;V8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,CDW+C4T(#4S-"XQ,"!49" H06UE<FEC86X@365D:6-A;"!#;VQL96=E<R!<
M*$%!34-<*2P@=&AE(%5N:71E9"!3=&%T97,@:7,@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#4R,BXQ,"!49" H
M97AP96-T960@=&\@9F%C92!A('-H;W)T86=E(&]F('!H>7-I8VEA;G,@;W9E
M<B!T:&4@;F5X="!D96-A9&4N("D@5&H@150@40IQ(# @," P(')G($)4(#,S
M-2XU.2 U,C(N,3 @5&0@*%1H92!P<F]J96-T:6]N<R!S:&]W(&$@<VAO<G1A
M9V4@<F%N9VEN9R!B971W965N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X,BXP," U,3 N,3 @5&0@*#8Q+#<P,"!A;F0@
M.30L-S P(&EN(#(P,C4@87,@9&5M86YD(&9O<B!P:'ES:6-I86YS(&-O;G1I
M;G5E<R!T;R!O=71P86-E('-U<'!L>2D@5&H@150@40IQ(# @," P(')G($)4
M(#0P-BXS," U,3 N,3 @5&0@*"P@86-C;W)D:6YG('1O("D@5&H@150@40IQ
M(# @," P(')G($)4(#0V,BXY-2 U,3 N,3 @5&0@*$%!34,L('=I=&@@82 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#(N
M,# @-#DX+C$P(%1D("AS:6=N:69I8V%N="!S:&]R=&%G92!S:&]W:6YG(&%M
M;VYG(&UA;GD@<W5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8U+CDV(#0Y
M."XQ,"!49" H9VEC86P@<W!E8VEA;'1I97,N($EN(&%D9&ET:6]N+"!A8V-O
M<F1I;F<@=&\@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#0T.2XU,2 T
M.3@N,3 @5&0@*$%S<V]C:6%T:6]N(&]F("D@5&H@150@40IQ(# @," P(')G
M($)4(#4P.2XU," T.3@N,3 @5&0@*$%M97)I8V%N("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,BXP," T.#8N,3 @5&0@
M*$UE9&EC86P@0V]L;&5G97,@7"A!04U#7"DL(#0T+C$E(&]F('!H>7-I8VEA
M;G,@:6X@=&AE(%4N4RX@:7,@86=E(#4U(&]R(&]L9&5R(&%N9"!N96%R:6YG
M(')E=&ER96UE;G0@86YD+"!W:&EL92!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C P(#0W-"XQ,"!49" H;G5M
M8F5R(&]F(&%P<&QI8V%N=',@=&\@52Y3+B!M961I8V%L('-C:&]O;',@:7,@
M:6YC<F5A<VEN9RP@:70@:7,@;F]T(&5X<&5C=&5D('1O(&ME97 @<&%C92!W
M:71H(&5X<&5C=&5D(&9U='5R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.#(N,# @-#8R+C$P(%1D("AD96UA;F0N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$Q."XT-R T-C(N,3 @5&0@*%1H:7,@
M:7,@82!S:6=N:69I8V%N="!F86-T;W(@:6X@=&AE(&1E;6%N9"!F;W(@;&]C
M=6T@=&5N96YS('-E<G9I8V5S+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," T-#(N,3 @5&0@*$EN9'5S=')Y($-O
M;7!E=&ET:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0Q."XQ,"!49" H5&AE('=O<FMF;W)C92!S;VQU=&EO
M;G,@86YD(&AE86QT:&-A<F4@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#(R-2XP,R T,3@N,3 @5&0@*&9I;F<@:6YD=7-T<FEE<R!A<F4@:&EG:&QY
M(&-O;7!E=&ET:79E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-SDN.#$@
M-#$X+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@X+C0U(#0Q
M."XQ,"!49" H92!C;VUP971E(&]N(&$@;F%T:6]N86PL(')E9VEO;F%L+"!A
M;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0P-BXQ,"!49" H;&]C86P@8F%S:7,@:6X@8F]T:"!I;F1U<W1R
M:65S(&9O<B!H96%L=&AC87)E(&-L:65N=',@86YD(&AE86QT:&-A<F4@<')O
M9F5S<VEO;F%L<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<P+C@S(#0P
M-BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#,W.2XT-B T,#8N
M,3 @5&0@*&4@87)E(&]N92!O9B!T:&4@;&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#4S+CDV(#0P-BXQ,"!49" H9V5S="!P<F]V:61E<G,@:6X@=&AE
M(%4N4RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#,Y-"XQ,"!49" H;V8@=V]R:V9O<F-E('-O;'5T:6]N<R!I
M;B!T:&4@:&5A;'1H8V%R92!I;F1U<W1R>2!A;F0@;G5R<V4@86YD(&%L;&EE
M9"!H96%L=&AC87)E('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N
M-#@@,SDT+C$P(%1D("AF:6YG+B!);B!B;W1H(&]F('1H97-E(&EN9'5S=')I
M97,L('=E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," S.#(N,3 @5&0@*&-O;7!E=&4@=VET:"!A(&9E=R!N871I
M;VYA;"!C;VUP971I=&]R<R!T;V=E=&AE<B!W:71H(&YU;65R;W5S('-M86QL
M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#(N,#(@,S@R+C$P(%1D("@L
M(')E9VEO;F%L+"!A;F0@;&]C86P@8V]M<&%N:65S+"!P87)T:6-U;&%R;'D@
M:6X@=&AE('!E<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S<P+C$P(%1D("AD:65M(&)U<VEN97-S+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M-3 N,3 @5&0@*%1H92!P<FEN8VEP86P@8V]M<&5T:71I=F4@9F%C=&]R<R!I
M;B!A='1R86-T:6YG+"!R971A:6YI;F<L(&%N9"!E>'!A;F1I;F<@8G5S:6YE
M<W,@=VET:"!H96%L=&AC87)E(&-L:65N=',@;F%T:6]N86QL>2!I;F-L=61E
M.B!<*&E<*2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,S,X+C$P(%1D("AU;F1E<G-T86YD:6YG('1H92!C;&EE
M;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30X+C@V(#,S."XQ,"!49" H
M<R!W;W)K(&5N=FER;VYM96YT.R!<*&EI7"D@;V8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-38N.3D@,S,X+C$P(%1D("AF97)I;F<@82!C;VUP<F5H96YS
M:79E('-U:71E(&]F('-E<G9I8V5S('1O(&%S<VES="!T:&4@8VQI96YT(&EN
M(&%S<V5S<VEN9R!I=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#,R-BXQ,"!49" H<&5R<V]N;F5L(&YE961S
M(&%N9"!P87)T;F5R:6YG('=I=&@@8VQI96YT<R!T;R!D97-I9VX@=F%R:6]U
M<R!C=7-T;VUI>F%B;&4@86QT97)N871I=F4@<V]L=71I;VYS.R!<*&EI:5PI
M('1H92!T:6UE;'D@9FEL;&EN9R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S$T+C$P(%1D("AC;&EE;G1S
M)R!N965D<SL@7"AI=EPI('!R:6-E.R!<*'9<*2!C=7-T;VUE<B!S97)V:6-E
M.R!<*'9I7"D@<75A;&ET>2!A<W-U<F%N8V4@86YD('-C<F5E;FEN9R!C87!A
M8FEL:71I97,[(%PH=FEI7"D@<FES:R!M86YA9V5M96YT('!O;&EC:65S.R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,S R+C$P(%1D("A<*'9I:6E<*2!I;G-U<F%N8V4@8V]V97)A9V4[(&%N
M9"!<*&EX7"D@9V5N97)A;"!I;F1U<W1R>2!R97!U=&%T:6]N+J I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C@R
M+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@,C@R+C$P
M(%1D("AE(&)E;&EE=F4@=V4@8F5N969I="!C;VUP971I=&EV96QY(&9R;VT@
M=&AE(&)R96%D=&@@86YD(&5X<&5R=&ES92!O9B!V86QU92UA9&1E9"!W;W)K
M9F]R8V4@<V]L=71I;VYS('1H870@=V4@;V8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,#<N-S,@,C@R+C$P(%1D("AF97(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,3@N,C@@,C@R+C$P(%1D("@N("D@5&H@150@40IQ(# @," P(')G
M($)4(#4R,RXQ," R.#(N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,S$N-S0@,C@R+C$P(%1D("AE(&%L<V\@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(W,"XQ,"!49" H:&%V
M92!T:&4@86)I;&ET>2!T;R!M965T(&$@;F%T:6]N86P@<VAI9G0@=&]W87)D
M<R!A(&UO<F4@:6YT96=R871E9"!D96QI=F5R>2!O9B!H96%L=&AC87)E('1H
M<F]U9V@@;W5R(&5X=&5N<VEV92!B<F%N8V@@;F5T=V]R:R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4X+C$P
M(%1D("AW:&EC:"!A;&QO=W,@=7,@=&\@87-S:7-T(&AO<W!I=&%L<R!A;F0@
M:&5A;'1H('-Y<W1E;7,@='5R;FEN9R!T;RD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,#8N-C4@,C4X+C$P(%1D("@@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P.2XQ
M-2 R-3@N,3 @5&0@*&QO=V5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,Q
M+C<R(#(U."XQ,"!49" H+6-O<W0L(&UO<F4@86-C97-S:6)L92!A;'1E<FYA
M=&EV97,L('-U8V@@87,@;W5T<&%T:65N="!O<B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C0V+C$P(%1D("AA
M;6)U;&%T;W)Y(&-A<F4@8V5N=&5R<RX@0GD@;V8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-S(N.#(@,C0V+C$P(%1D("AF97)I;F<@=')A=F5L+"!P97(@
M9&EE;2P@86YD('!E<FUA;F5N="!P;&%C96UE;G0@;V8@82!V87)I971Y(&]F
M(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<RP@=V4@87)E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,S0N,3 @
M5&0@*&%B;&4@=&\@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-RXU." R
M,S0N,3 @5&0@*&9E<B!M86YY(&1I9BD@5&H@150@40IQ(# @," P(')G($)4
M(#$S-BXX,R R,S0N,3 @5&0@*&9E<F5N="!T>7!E<R!O9B!P97)S;VYN96P@
M=&\@:&]S<&ET86QS(&%N9"!H96%L=&@@<WES=&5M<R!A="!T:&5I<B!M86EN
M(&-A;7!U<V5S(&%N9"!T:&5I<B!A;6)U;&%T;W)Y(&%N9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C(R+C$P
M(%1D("AO=71P871I96YT(&9A8VEL:71I97,N($EN(&%D9&ET:6]N+"!O=7(@
M:F]I;G0@=F5N='5R92!W:71H(&$@;&%R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C@W+C(V(#(R,BXQ,"!49" H9V4@:&5A;'1H('-Y<W1E;2=S('-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S8N,S8@,C(R+C$P(%1D("AF:6YG
M('-U8G-I9&EA<GD@<')O=FED97,@=7,@=VET:"!A('5N:7%U92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C$P
M+C$P(%1D("AI;G-I9VAT(&EN=&\@=&AE(&-H86QL96YG97,@9F%C:6YG(&UA
M;GD@;V8@;W5R(&AO<W!I=&%L(&-L:65N=',@9V5N97)A;&QY(&%N9"!T:&ES
M('!R;W9I9&5S('5S('=I=&@@=&AE(&]P<&]R='5N:71Y('1O(&)E='1E<B!S
M97)V92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,3DX+C$P(%1D("AA;&P@;V8@;W5R(&-L:65N=',@8GD@9&5S
M:6=N:6YG(&%N9"!I;7!L96UE;G1I;F<@=V]R:V9O<F-E('-O;'5T:6]N<R!T
M;R!M965T('1H96ER(&YE961S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," Q-S@N,3 @5&0@*%1H92!P<FEN8VEP
M86P@8V]M<&5T:71I=F4@9F%C=&]R<R!I;B!A='1R86-T:6YG('%U86QI9FEE
M9"!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@9F]R('1E;7!O<F%R>2!E;7!L
M;WEM96YT(&EN8VQU9&4Z(%PH:5PI(&$@;&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-30W+C$S(#$W."XQ,"!49" H9V4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$V-BXQ,"!49" H;F%T
M:6]N86P@<&]O;"!O9B!D97-I<F%B;&4@87-S:6=N;65N=',[(%PH:6E<*2!P
M87D@86YD(&)E;F5F:71S.R!<*&EI:5PI('-P965D(&]F('!L86-E;65N=',[
M(%PH:79<*2!C=7-T;VUE<B!S97)V:6-E.R!<*'9<*2!Q=6%L:71Y(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q-30N,3 @5&0@*&%C8V]M;6]D871I;VYS.R!A;F0@7"AV:5PI(&]V97)A
M;&P@:6YD=7-T<GD@<F5P=71A=&EO;BX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C8W+C@R(#$U-"XQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#(W-BXT-B Q-30N,3 @5&0@*&4@9F]C=7,@;VX@<F5T86EN:6YG(&AE86QT
M:&-A<F4@<')O9F5S<VEO;F%L<R!B>2!P<F]V:61I;F<@:&EG:"UQ=6%L:71Y
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," Q-#(N,3 @5&0@*&-U<W1O;65R('-E<G9I8V4L(&QO;F<M=&5R;2!B
M96YE9FET<R!<*'1O(&5M<&QO>65E<UPI+"!A;F0@;65D:6-A;"!M86QP<F%C
M=&EC92!I;G-U<F%N8V4N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#$R,BXQ,"!49" H1G)O;2!A(&-A;F1I9&%T
M92!A='1R86-T:6]N('-T86YD<&]I;G0L('=E(&AA=F4@86X@97AT96YS:79E
M(&-L:65N="!B87-E('=I=&@@:&]S<&ET86QS(&%N9"!H96%L=&AC87)E(&9A
M8VEL:71I97,L(&%N9"!O=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3$P+C$P(%1D("AH96%L=&AC87)E
M('!R;W9I9&5R<RP@=&AR;W5G:&]U="!T:&4@52Y3+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,3<N,3@@,3$P+C$P(%1D("A!<R!A(')E<W5L="P@=V4@
M:&%V92!A(&1I=F5R<V4@8VAO:6-E(&]F(&%S<VEG;FUE;G1S(&9O<B!O=7(@
M:&5A;'1H8V%R92!P<F]F97-S:6]N86QS("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Y."XQ,"!49" H=&\@8VAO
M;W-E(&9R;VTN($AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!A<'!L>2!W:71H
M('5S('1H<F]U9V@@;W5R(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#,S
M,BXX,2 Y."XQ,"!49" H9F5R96YT:6%T960@;G5R<VEN9RP@;&]C=6T@=&5N
M96YS+"!A;F0@86QL:65D(&AE86QT:&-A<F4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#@V+C$P(%1D("AR96-R
M=6ET;65N="!B<F%N9',N($]U<B!L;V-A;"!B<F%N8V@@;F5T=V]R:R!A;'-O
M('!R;W9I9&5S('5S(&%C8V5S<R!T;R!L;V-A;"!H96%L=&AC87)E('!R;V9E
M<W-I;VYA;',@=VAO(&%R92!U;FEQ=65L>2 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0N,3 @5&0@*'%U86QI
M9FEE9"!T;R!P<F]V:61E(&-A<F4@:6X@86UB=6QA=&]R>2!A;F0@;W5T<&%T
M:65N="!S971T:6YG<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S S+C8T
M(#<T+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$R+C(X(#<T
M+C$P(%1D("AE(&)E;&EE=F4@;W5R(&%C8V5S<R!T;R!S=6-H(&$@;&%R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#0R+C@W(#<T+C$P(%1D("AG92!A;F0@
M9&EV97)S92!G<F]U<"!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-C(N,3 @5&0@*&AE86QT:&-A<F4@<')O
M9F5S<VEO;F%L<R!M86ME<R!U<R!M;W)E(&%T=')A8W1I=F4@=&\@:&5A;'1H
M8V%R92!I;G-T:71U=&EO;G,@86YD(&9A8VEL:71I97,@<V5E:VEN9R!H96%L
M=&AC87)E('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.38N-3D@-C(N
M,3 @5&0@*&9I;F<@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," U,"XQ,"!49" H=V]R:V9O<F-E('-O;'5T
M:6]N<R!I;B!T:&4@8W5R<F5N="!D>6YA;6EC(&UA<FME='!L86-E+B @*2!4
M:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,C,@,"!O8FH*/#PO5'EP92 O4&%G
M90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!=
M"B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R R-" P(%(^
M/@IE;F1O8FH*,C0@,"!O8FH*/#PO3&5N9W1H(#$Q-3<Y/CX*<W1R96%M"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,RXU," S,2XV,"!4
M9" H."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W-#(N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M."XV-" W-#(N,3 @5&0@*&4@8F5L:65V92!W92!A<F4@;VYE(&]F(&]N;'D@
M='=O(&QA<BD@5&H@150@40IQ(# @," P(')G($)4(#(P,2XW,R W-#(N,3 @
M5&0@*&=E(&9U;&PM<V5R=FEC92!H96%L=&AC87)E('-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,3DN-30@-S0R+C$P(%1D("AF:6YG('!R;W9I9&5R
M<R!W:71H(&$@;F%T:6]N86P@9F]O='!R:6YT.R!O;F4@;V8@=&AE('1O<"!F
M:79E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W,S N,3 @5&0@*'!R;W9I9&5R<R!O9B!P:'ES:6-I86X@<W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$U-BXQ." W,S N,3 @5&0@*&9I
M;F<@<V5R=FEC97,@:6X@=&AE(%4N4RX[(&%N9"!O;F4@;V8@=&AE('1O<"!P
M<F]V:61E<G,@;V8@<F5T86EN960@86YD(&-O;G1I;F=E;G0@<&AY<VEC:6%N
M(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S$X+C$P(%1D("AH96%L=&AC87)E(&5X96-U=&EV92!S96%R
M8V@@<V5R=FEC97,@:6X@=&AE(&AE86QT:&-A<F4@;6%R:V5T<&QA8V4N(%-O
M;64@;V8@;W5R(&-O;7!E=&ET;W)S(&EN('1H92!W;W)K9F]R8V4@<V]L=71I
M;VYS+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S V+C$P(%1D("AH96%L=&AC87)E('-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,#<N.#0@-S V+C$P(%1D("AF:6YG+"!A;F0@<V5A
M<F-H(&)U<VEN97-S97,@:6YC;'5D93H@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C4R+C@P(#<P-BXQ,"!49" H04U.($AE86QT:&-A<F4@4V5R=FEC97,L
M($EN8RXL($-(1R!(96%L=&AC87)E(%-E<G9I8V5S+"!-87AI;2 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT
M+C$P(%1D("A(96%L=&AC87)E+"!*86-K<V]N($AE86QT:&-A<F4L("D@5&H@
M150@40IQ(# @," P(')G($)4(#$X,"XR,2 V.30N,3 @5&0@*$$I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.#8N-3$@-CDT+C$P(%1D("AY82!(96%L=&AC
M87)E+"!(96%L=&A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<Y+C$W(#8Y
M-"XQ,"!49" H<G5S=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.38N-#@@
M-CDT+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S U+C$R(#8Y
M-"XQ,"!49" H;W)K9F]R8V4@4V]L=71I;VYS+"!A;F0@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# Q+C T(#8Y-"XQ,"!49" H5RD@5&H@150@40IQ(# @
M," P(')G($)4(#0Q,"XP-R V.30N,3 @5&0@*&ET="!+:65F97(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T-#4N.#D@-CDT+C$P(%1D("@N*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8W-"XQ
M,"!49" H0V5R=&EF:6-A=&EO;G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C4T+C$P(%1D("A4:&4@<W1A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#@R+C,P(#8U-"XQ,"!49" H9FEN9R!B
M=7-I;F5S<V5S(&]F(&]U<B!#<F]S<R!#;W5N=')Y(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R-#@N-S@@-C4T+C$P(%1D("AF:6YG+"!-961I8V%L
M(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C$N,#@@-C4T+C$P(%1D
M("AF:6YG($YE='=O<FLL($UE9&ES8V%N+" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,C,N,#$@-C4T+C$P(%1D("A!9'9A;G1A9V4L(&%N9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T.#<N-S$@-C4T+C$P(%1D("A!4"D@5&H@150@
M40IQ(# @," P(')G($)4(#4P,"XQ,B V-30N,3 @5&0@*"!3=&%F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3$X+C4U(#8U-"XQ,"!49" H9FEN9R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C0R+C$P(%1D("AB<F%N9',@87)E(&-E<G1I9FEE9"!B>2 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-#(N,# @-C0R+C$P(%1D("A4:&4@2F]I;G0@0V]M
M;6ES<VEO;B!U;F1E<B!I=',@2&5A;'1H($-A<F4@4W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#,S."XW-" V-#(N,3 @5&0@*&9I;F<@4V5R=FEC97,@
M0V5R=&EF:6-A=&EO;B!0<F]G<F%M+B!);B!A9&1I=&EO;BP@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8S,"XQ
M,"!49" H0W)E9&5N=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" X,RXY-R V
M,S N,3 @5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,"XP.2 V,S N
M,3 @5&0@*&5R:69I8V%T:6]N(&%N9"!,:6-E;G-I;F<@4V5R=FEC97,L(&$@
M<W5B<VED:6%R>2!O9B!-1$$L(&ES(&-E<G1I9FEE9"!B>2!T:&4@3D-102XI
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C$P+C$P(%1D("A296=U;&%T:6]N<RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3 N,3 @5&0@*$]U<B!B
M=7-I;F5S<R!I<R!S=6)J96-T('1O(')E9W5L871I;VX@8GD@;G5M97)O=7,@
M9V]V97)N;65N=&%L(&%U=&AO<FET:65S(&EN('1H92!J=7)I<V1I8W1I;VYS
M(&EN('=H:6-H('=E(&]P97)A=&4N($-O;7!L97@@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4W."XQ,"!49" H
M9F5D97)A;"!A;F0@<W1A=&4@;&%W<R!A;F0@<F5G=6QA=&EO;G,@9V]V97)N
M+"!A;6]N9R!O=&AE<B!T:&EN9W,L('1H92!L:6-E;G-U<F4@;V8@<')O9F5S
M<VEO;F%L<RP@=&AE('!A>6UE;G0@;V8@;W5R(&5M<&QO>65E<R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-38V
M+C$P(%1D("A<*&4N9RXL('=A9V4@86YD(&AO=7(@;&%W<RP@96UP;&]Y;65N
M="!T87AE<R!A;F0@:6YC;VUE('1A>"!W:71H:&]L9&EN9W,L(&5T8RY<*2P@
M86YD('1H92!O<&5R871I;VYS(&]F(&]U<B!B=7-I;F5S<R!G96YE<F%L;'DI
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U-3$N-S(@-38V+C$P(%1D("@N("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," U-30N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" U
M-30N,3 @5&0@*&4@8V]N9'5C="!B=7-I;F5S<R!P<FEM87)I;'D@:6X@=&AE
M(%4N4RX@86YD(&%R92!S=6)J96-T('1O(&9E9&5R86P@86YD('-T871E(&QA
M=W,@86YD(')E9W5L871I;VYS(&%P<&QI8V%B;&4@=&\@;W5R(&)U<VEN97-S
M+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-30R+C$P(%1D("AW:&EC:"!M87D@8F4@86UE;F1E9"!F<F]M('1I
M;64@=&\@=&EM92X@1G5T=7)E(&9E9&5R86P@86YD('-T871E(&QE9VES;&%T
M:6]N(&]R(&EN=&5R<')E=&%T:6]N<R!T:&5R96]F(&UA>2!R97%U:7)E('5S
M('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,S N,3 @5&0@*&-H86YG92!O=7(@8G5S:6YE<W,@<')A8W1I
M8V5S+B!#;VUP;&EA;F-E('=I=&@@86QL(&]F('1H97-E(&%P<&QI8V%B;&4@
M<G5L97,@86YD(')E9W5L871I;VYS(')E<75I<F4@82!S:6=N:69I8V%N="!A
M;6]U;G0@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4Q."XQ,"!49" H<F5S;W5R8V5S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Y,BXU." U,3@N,3 @5&0@*%<I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,#$N,C(@-3$X+C$P(%1D("AE(&5N9&5A=F]R('1O(&)E
M(&EN(&-O;7!L:6%N8V4@=VET:"!A;&P@<W5C:"!R=6QE<R!A;F0@<F5G=6QA
M=&EO;G,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#0Y."XQ,"!49" H16UP;&]Y965S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0W."XQ,"!49" H
M07,@;V8@1&5C96UB97*@,S$L(#(P,3@L('=E(&AA9"!A<'!R;WAI;6%T96QY
M(#$L-S4P(&-O<G!O<F%T92!E;7!L;WEE97,N($1U<FEN9R R,#$X+"!W92!E
M;7!L;WEE9"!A;B!A=F5R86=E(&]F(#<L,34T("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-C8N,3 @5&0@*&9U
M;&PM=&EM92!E<75I=F%L96YT(&9I96QD(&5M<&QO>65E<R!I;B!.=7)S92!A
M;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4P+C<X(#0V-BXQ,"!49" H
M06QL:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.30N,C @-#8V
M+C$P(%1D("AF:6YG('=H:6-H(&1O97,@;F]T(&EN8VQU9&4@;W5R(%!H>7-I
M8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@P+CDS(#0V-BXQ
M,"!49" H9FEN9R!I;F1E<&5N9&5N=" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#4T+C$P(%1D("AC;VYT<F%C
M=&]R<RP@86QL(&]F('=H;VT@87)E(&YO="!E;7!L;WEE97,N($1U<FEN9R R
M,#$X+"!W92!B96-A;64@<W5B:F5C="!T;R!A(&-O;&QE8W1I=F4@8F%R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#,S+C R(#0U-"XQ,"!49" H9V%I;FEN
M9R!A9W)E96UE;G0@8V]V97)I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXQ,"!49" H87!P<F]X:6UA
M=&5L>2 T-3 @;V8@;W5R(&5M<&QO>65E<R!A="!/5U,L($Q,0R!W:71H($QO
M8V%L(#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,#@N,3@@-#0R+C$P(%1D
M("@Q.3D@;V8@=&AE(%-E<G9I8V4@16UP;&]Y965S($EN=&5R;F%T:6]N86P@
M56YI;VXNH"D@5&H@150@40IQ(# @," P(')G($)4(#4Q-"XP-2 T-#(N,3 @
M5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C(N-CD@-#0R+C$P(%1D
M("AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," T,S N,3 @5&0@*&-O;G-I9&5R(&]U<B!R96QA=&EO;G-H:7 @
M=VET:"!E;7!L;WEE97,@=&\@8F4@9V]O9"XI(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$P+C$P(%1D("A!9&1I
M=&EO;F%L($EN9F]R;6%T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#,Y,"XQ,"!49" H1FEN86YC:6%L(')E
M<&]R=',@86YD(&9I;&EN9W,@=VET:"!T:&4@4V5C=7)I=&EE<R!A;F0@17AC
M:&%N9V4@0V]M;6ES<VEO;B!<*%-%0UPI+"!I;F-L=61I;F<@=&AI<R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T-# N-3 @,SDP+C$P(%1D("A!;FYU86P@
M4F5P;W)T(&]N($9O<FV@,3 M2RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W."XQ,"!49" H87)E(&%V86EL
M86)L92!F<F5E(&]F(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#DN
M,3D@,S<X+C$P(%1D("AG92!A<R!S;V]N(&%S(')E87-O;F%B;'D@<')A8W1I
M8V%B;&4@869T97(@9FEL:6YG('-U8V@@;6%T97)I86P@=VET:"P@;W(@9G5R
M;FES:&EN9R!I="!T;RP@=&AE(%-%0RP@;VX@;W(@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,V-BXQ,"!49" H
M=&AR;W5G:"!O=7(@8V]R<&]R871E('=E8G-I=&4@870@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HQ.#(N-#4V,#4T-C@W-2 S-C0N-S8V.3DR
M,3@W-2!M"C,Q-RXX-C8R,3 Y,S<U(#,V-"XW-C8Y.3(Q.#<U(&P*<PIQ(# @
M," P(')G($)4(#$X,BXT-B S-C8N,3 @5&0@*'=W=RD@5&H@150@40IQ(# @
M," P(')G($)4(#(P,RXT-R S-C8N,3 @5&0@*"YC<F]S<V-O=6YT<GEH96%L
M=&AC87)E+F-O;2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,3<N.#<@,S8V+C$P(%1D("@NH"D@5&H@150@40IQ(# @," P
M(')G($)4(#,R,BXV.2 S-C8N,3 @5&0@*%1H92!I;F9O<FUA=&EO;B!F;W5N
M9"!O;B!O=7(@=V5B<VET92!I<R!N;W0@<&%R="!O9B!T:&ES("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-30N
M,3 @5&0@*$%N;G5A;"!297!O<G0@;VX@1F]R;2 Q,"U+(&]R(&%N>2!O=&AE
M<B!R97!O<G0@=V4@9FEL92!W:71H(&]R(&9U<FYI<V@@=&\@=&AE(%-%0RXI
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,S,P+C$P(%1D("A)=&5M("D@5&H@150@40IQ(# @," P(')G($)4(#<R
M+C0Y(#,S,"XQ,"!49" H,4$N("D@5&H@150@40IQ(# @," P(')G($)4(#@Y
M+C<Q(#,S,"XQ,"!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DR+C(Q
M(#,S,"XQ,"!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DT+C<Q(#,S
M,"XQ,"!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DW+C(Q(#,S,"XQ
M,"!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DY+C<Q(#,S,"XQ,"!4
M9" H("D@5&H@150@40IQ(# @," P(')G($)4(#$P,BXR,2 S,S N,3 @5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#0N-S$@,S,P+C$P(%1D("@@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 W+C(Q(#,S,"XQ,"!49" H4FES
M:R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,CDN,3<@,S,P+C$P(%1D("A&
M86-T;W)S+B I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,S V+C$P(%1D("A4:&4@9F]L;&]W:6YG(')I<VL@9F%C
M=&]R<R!C;W5L9"!M871E<FEA;&QY(&%N9"!A9'9E<G-E;'D@869F96-T(&]U
M<B!F=71U<BD@5&H@150@40IQ(# @," P(')G($)4(#,T,BXS." S,#8N,3 @
M5&0@*&4@;W!E<F%T:6YG('(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.30N
M,C(@,S V+C$P(%1D("AE<W5L=',@86YD(&-O=6QD(&-A=7-E(&%C='5A;"!R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$X+C P(#,P-BXQ,"!49" H97-U
M;'1S('1O("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," R.30N,3 @5&0@*&1I9F9E<B!M871E<FEA;&QY(&9R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3(T+C W(#(Y-"XQ,"!49" H;VT@=&AO
M<V4@<'(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S N.3(@,CDT+C$P(%1D
M("AE9&EC=&5D(&EN('1H92!F;W)W87(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R-30N,34@,CDT+C$P(%1D("AD+6QO;VMI;F<@<W1A=&5M96YT<R!W92!M
M86ME(&%B;W5T(&]U<B!B=7-I;F5S<RX@3W5R(')I<VMS(&%R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3 U+CDX(#(Y-"XQ,"!49" H92!I9&5N=&EF:65D
M("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," R.#(N,3 @5&0@*'!R:6UA<FEL>2!T:'(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#$N-3@@,C@R+C$P(%1D("AO=6=H(&1I86QO9W5E('=I=&@@
M;W5R(&QE861E<G,L(&EN8VQU9&EN9R!A(&9O<FUA;"!%;G1E<G!R:7-E(%)I
M<VL@87-S97-S;65N="P@:6YD=7-T<GD@='(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-C0N-3,@,C@R+C$P(%1D("AE;F1S+"!O=7(@97AP97)I96YC92P@
M*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#(W,"XQ,"!49" H86YD(&-O;G-I9&5R871I;VX@;V8@=&AE(&-U<G(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C8N.#0@,C<P+C$P(%1D("AE;G0@
M97AT97)N86P@;6%R:V5T(&%N9"!F:6YA;F-I86P@96YV:7(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,C(N.#(@,C<P+C$P(%1D("AO;FUE;G0N(%1H97-E
M(')I<VL@9F%C=&]R<R!A<BD@5&H@150@40IQ(# @," P(')G($)4(#0S.2XS
M." R-S N,3 @5&0@*&4@8V]N<VED97(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.# N,SD@,C<P+C$P(%1D("AE9"!I;B!O=7(@;W9E<F%L;" I(%1J($54
M(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4X
M+C$P(%1D("AS=')A=&5G>2!A;F0@97AE8W5T:6]N(&]F(&]P97)A=&EO;G,N
M($9A8W1O<G,@=V4@8W5R<BD@5&H@150@40IQ(# @," P(')G($)4(#(V-2XQ
M-2 R-3@N,3 @5&0@*&5N=&QY(&-O;G-I9&5R(&EM;6%T97)I86P@86YD(&9A
M8W1O<G,@=V4@8W5R<BD@5&H@150@40IQ(# @," P(')G($)4(#0T."XV-2 R
M-3@N,3 @5&0@*&5N=&QY(&1O(&YO="!K;F]W(&UA>2!A;'-O("D@5&H@150@
M40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-#8N
M,3 @5&0@*&UA=&5R:6%L;'D@861V97)S96QY(&%F9F5C="!O=7(@8G5S:6YE
M<W,@;W(@;W5R(&-O;G-O;&ED871E9"!R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDV+C@R(#(T-BXQ,"!49" H97-U;'1S+"!F:6YA;F-I86P@8V]N9&ET
M:6]N+"!O<B!C87-H(&9L;W=S+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C,T+C$P(%1D("B@*2!4:B!%5"!1
M"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R,BXQ
M,"!49" H1&5C<F5A<V5S(&EN(&1E;6%N9"!B>2!O=7(@8VQI96YT<R!M87D@
M861V97)S96QY(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8W+C Q(#(R
M,BXQ,"!49" H9F5C="!T:&4@<')O9FET86)I;&ET>2!O9B!O=7(@8G5S:6YE
M<W,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#(P,BXQ,"!49" H06UO;F<@;W1H97(@=&AI;F=S+"!C:&%N9V5S
M(&EN('1H92!E8V]N;VUY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,P+C<P
M(#(P,BXQ,"!49" H+"!A(&1E8W)E87-E(&]R('-T86=N871I;VX@:6X@=&AE
M(&=E;F5R86P@;&5V96P@;V8@:6XM<&%T:65N="!A9&UI<W-I;VYS(&]R(&]U
M="TI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3DP+C$P(%1D("AP871I96YT('-E<G9I8V5S(&%T(&]U<B!C;&EE
M;G1SDBD@5&H@150@40IQ(# @," P(')G($)4(#$V."XV-B Q.3 N,3 @5&0@
M*"!F86-I;&ET:65S+"!U;F-E<G1A:6YT>2!R96=A<F1I;F<@;W(@8VAA;F=E
M<R!T;R!F961E<F%L(&AE86QT:&-A<F4@;&%W(&%N9"!T:&4@=VEL;&EN9VYE
M<W,@;V8@;W5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," Q-S@N,3 @5&0@*&AO<W!I=&%L+"!H96%L=&AC87)E
M(&9A8VEL:71I97,@86YD('!H>7-I8VEA;B!G<F]U<"!C;&EE;G1S('1O(&1E
M=F5L;W @=&AE:7(@;W=N('1E;7!O<F%R>2!S=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#(R+C(P(#$W."XQ,"!49" H9FEN9R!P;V]L<R!A;F0@:6YC
M<F5A<V4@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," Q-C8N,3 @5&0@*'!R;V1U8W1I=FET>2!O9B!T:&5I
M<B!P97)M86YE;G0@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,BXP
M," Q-C8N,3 @5&0@*&8@;6%Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$T
M+C,Y(#$V-BXQ,"!49" H+"!I;F1I=FED=6%L;'D@;W(@:6X@=&AE(&%G9W)E
M9V%T92P@<VEG;FEF:6-A;G1L>2!A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#0P.2XY.2 Q-C8N,3 @5&0@*&9E8W0@9&5M86YD(&9O<B!O=7(@=&5M<&]R
M87)Y("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," Q-30N,3 @5&0@*&AE86QT:&-A<F4@<W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#$P-RXX-" Q-30N,3 @5&0@*&9I;F<@<V5R=FEC97,@
M86YD(&UA>2!H86UP97(@;W5R(&%B:6QI='D@=&\@871T<F%C="P@9&5V96QO
M<"!A;F0@<F5T86EN(&-L:65N=',N("D@5&H@150@40IQ(# @," P(')G($)4
M(#0R,2XW,2 Q-30N,3 @5&0@*%=H96X@82!H;W-P:71A;)(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T.#DN-#<@,34T+C$P(%1D("AS(&%D;6ES<VEO;G,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#$T,BXQ,"!49" H:6YC<F5A<V4L('1E;7!O<F%R>2!E;7!L;WEE97,@
M;W(@;W1H97(@:&5A;'1H8V%R92!P<F]F97-S:6]N86QS(&%R92!O9G1E;B!A
M9&1E9"!B969O<F4@9G5L;"UT:6UE(&5M<&QO>65E<R!A<F4@:&ER960N("D@
M5&H@150@40IQ(# @," P(')G($)4(#4R,RXY-B Q-#(N,3 @5&0@*$%S("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q,S N,3 @5&0@*&%D;6ES<VEO;G,@9&5C<F5A<V4L(&-L:65N=',@='EP
M:6-A;&QY(')E9'5C92!T:&5I<B!U<V4@;V8@=&5M<&]R87)Y(&5M<&QO>65E
M<R!O<B!O=&AE<B!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@8F5F;W)E("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q,3@N,3 @5&0@*'5N9&5R=&%K:6YG(&QA>6]F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3(P+C8S(#$Q."XQ,"!49" H9G,@;V8@=&AE:7(@<&5R;6%N
M96YT(&5M<&QO>65E<RX@26X@861D:71I;VXL(&EF(&AO<W!I=&%L<R!C;VYT
M:6YU92!T;R!C;VYS;VQI9&%T92!I;B!A;B!E9BD@5&H@150@40IQ(# @," P
M(')G($)4(#0W-"XX," Q,3@N,3 @5&0@*&9O<G0@=&\@96YH86YC92!T:&5I
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3 V+C$P(%1D("AM87)K970@<&]S:71I;VYS+"!I;7!R;W9E(&]P
M97)A=&EO;F%L(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$R+C(X(#$P
M-BXQ,"!49" H9FEC:65N8WDI(%1J($54(%$*<2 P(# @,"!R9R!"5" R-#,N
M.#,@,3 V+C$P(%1D("@L(&%N9"!C<F5A=&4@;W(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,# N,C@@,3 V+C$P(%1D("AG86YI>F%T:6]N<R!C87!A8FQE
M(&]F(&UA;F%G:6YG('!O<'5L871I;VX@:&5A;'1H+"!D96UA;F0@9F]R("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Y-"XQ,"!49" H;W5R('-E<G9I8V5S(&-O=6QD(&1E8W)E87-E+B!$96-R
M96%S97,@:6X@9&5M86YD(&9O<B!O=7(@<V5R=FEC97,@;6%Y(&%L<V\@868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C(N-S0@.30N,3 @5&0@*&9E8W0@
M;W5R(&%B:6QI='D@=&\@<')O=FED92!A='1R86-T:79E(&%S<VEG;FUE;G1S
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," X,BXQ,"!49" H=&\@;W5R(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L
M<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HR-2 P(&]B:@H\/"]4>7!E
M("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y
M,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#(V
M(# @4CX^"F5N9&]B:@HR-B P(&]B:@H\/"],96YG=&@@,3$T.#,^/@IS=')E
M86T*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S S+C4P(#,Q
M+C8P(%1D("@Y*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<T,BXR-2!49" H3W5R(&-L:65N=',@;6%Y('1E<FUI
M;F%T92!O<B!N;W0@<F5N97<@=&AE:7(@8V]N=')A8W1S('=I=&@@=7,N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<R,BXR-2!49" H3W5R(&%R<F%N9V5M96YT<R!W:71H(&AO<W!I=&%L<RP@
M:&5A;'1H8V%R92!F86-I;&ET:65S(&%N9"!P:'ES:6-I86X@9W)O=7 @8VQI
M96YT<R!A<F4@9V5N97)A;&QY('1E<FUI;F%B;&4@=7!O;B S,"!T;R Y,"!D
M87ESDBD@5&H@150@40IQ(# @," P(')G($)4(#4U-BXS,B W,C(N,C4@5&0@
M*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-S$P+C(U(%1D("AN;W1I8V4N("D@5&H@150@40IQ(# @," P(')G
M($)4(#<Y+C(U(#<Q,"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#@W+C@Y(#<Q,"XR-2!49" H92!M87D@:&%V92!F:7AE9"!C;W-T<RP@:6YC
M;'5D:6YG(&AO=7-I;F<@8V]S=',L(&%S<V]C:6%T960@=VET:"!T97)M:6YA
M=&5D(&%R<F%N9V5M96YT<R!T:&%T('=E('=I;&P@8F4@;V)L:6=A=&5D('1O
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V.3@N,C4@5&0@*'!A>2!P;W-T+71E<FUI;F%T:6]N+"!T:'5S(&YE
M9V%T:79E;'D@:6UP86-T:6YG(&]U<B!P<F]F:71A8FEL:71Y*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S V+C@P(#8Y."XR-2!49" H+B!);B!A9&1I=&EO
M;BP@=&AE(&QO<W,@;V8@;VYE(&]R(&UO<F4@;V8@;W5R(&QA<BD@5&H@150@
M40IQ(# @," P(')G($)4(#0Y,2XX-2 V.3@N,C4@5&0@*&=E(&-L:65N=',@
M8V]U;&0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#8X-BXR-2!49" H;6%T97)I86QL>2!A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#$P,"XV,R V.#8N,C4@5&0@*&9E8W0@;W5R('!R;V9I
M=&%B:6QI='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#$N,#8@-C@V+C(U
M(%1D("@N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#8V-BXR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#4X+C$U(#8V-BXR-2!49" H92!M87D@8F4@=6YA8FQE('1O(')E8W)U:70@
M96YO=6=H('%U86QI='D@:&5A;'1H8V%R92!P<F]F97-S:6]N86QS('1O(&UE
M970@;W5R(&-L:65N='.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C,V
M(#8V-BXR-2!49" H(&1E;6%N9',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#8T-BXR-2!49" H5RD@5&H@150@
M40IQ(# @," P(')G($)4(#4X+C8T(#8T-BXR-2!49" H92!R96QY('-I9VYI
M9FEC86YT;'D@;VX@;W5R(&%B:6QI='D@=&\@871T<F%C="P@9&5V96QO<"!A
M;F0@<F5T86EN(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!W:&\@<&]S<V5S
M<R!T:&4@<VMI;&QS+"!E>'!E<FEE;F-E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,S0N,C4@5&0@*&%N9"P@
M87,@<F5Q=6ER960L(&QI8V5N<W5R92!N96-E<W-A<GD@=&\@;65E="!T:&4@
M<W!E8VEF:65D(')E<75I<F5M96YT<R!O9B!O=7(@:&5A;'1H8V%R92!C;&EE
M;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,SDN.3,@-C,T+C(U(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0X+C4W(#8S-"XR-2!49" H
M92!C;VUP971E(&9O<B!H96%L=&AC87)E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,C(N,C4@5&0@*'-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" V-"XR-B V,C(N,C4@5&0@*&9I;F<@
M<&5R<V]N;F5L('=I=&@@;W1H97(@=&5M<&]R87)Y(&AE86QT:&-A<F4@<W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#(V.2XP," V,C(N,C4@5&0@*&9I
M;F<@8V]M<&%N:65S(&%S('=E;&P@87,@86-T=6%L(&%N9"!P;W1E;G1I86P@
M8VQI96YT<R!S=6-H(&%S(&AE86QT:&-A<F4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Q,"XR-2!49" H9F%C
M:6QI=&EE<R!A;F0@<&AY<VEC:6%N(&=R;W5P<RP@<V]M92!O9B!W:&EC:"!S
M965K('1O(&9I;&P@<&]S:71I;VYS('=I=&@@96ET:&5R('!E<FUA;F5N="!O
M<B!T96UP;W)A<GD@96UP;&]Y965S+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,3,N.#<@-C$P+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3(R+C4Q(#8Q,"XR-2!49" H92!R96QY(&]N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,C4@5&0@*'=O
M<F0M;V8M;6]U=&@@<F5F97)R86QS+"!A<R!W96QL(&%S('-O8VEA;"!M961I
M82!T;R!A='1R86-T('%U86QI9FEE9"!H96%L=&AC87)E('!R;V9E<W-I;VYA
M;',N($EF(&]U<B!S;V-I86P@;65D:6$@<W1R871E9WD@:7,@;F]T("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M.#8N,C4@5&0@*'-U8V-E<W-F=6PL(&]U<B!A8FEL:71Y('1O(&%T=')A8W0@
M<75A;&EF:65D(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!C;W5L9"!B92!N
M96=A=&EV96QY(&EM<&%C=&5D+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U-C8N,C4@5&0@*$EN(&%D9&ET:6]N
M+"!W:71H(&$@<VAO<G1A9V4@;V8@8V5R=&%I;B!Q=6%L:69I960@;G5R<V5S
M(&%N9"!P:'ES:6-I86YS(&EN(&UA;GD@87)E87,@;V8@=&AE(%5N:71E9"!3
M=&%T97,L(&-O;7!E=&ET:6]N(&9O<B!T:&5S92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-34T+C(U(%1D("AP
M<F]F97-S:6]N86QS(')E;6%I;G,@:6YT96YS92X@3W5R(&%B:6QI='D@=&\@
M<F5C<G5I="!A;F0@<F5T86EN(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!D
M97!E;F1S(&]N(&]U<B!A8FEL:71Y('1O+"!A;6]N9R!O=&AE<B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-30R
M+C(U(%1D("AT:&EN9W,L(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#<N
M-C @-30R+C(U(%1D("AF97(@87-S:6=N;65N=',@=&AA="!A<F4@871T<F%C
M=&EV92!T;R!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@86YD(&]F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S4X+C<P(#4T,BXR-2!49" H9F5R('1H96T@
M8V]M<&5T:71I=F4@=V%G97,@86YD(&)E;F5F:71S(&]R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,S N,C4@
M5&0@*'!A>6UE;G1S+"!A<R!A<'!L:6-A8FQE+B!/=7(@8V]M<&5T:71O<G,@
M;6EG:'0@:6YC<F5A<V4@:&]U<FQY('=A9V5S(&]R('1H92!V86QU92!O9B!B
M96YE9FET<R!T;R!I;F1U8V4@:&5A;'1H8V%R92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3$X+C(U(%1D("AP
M<F]F97-S:6]N86QS('1O('1A:V4@87-S:6=N;65N=',@=VET:"!T:&5M+B!)
M9B!W92!D;R!N;W0@<F%I<V4@=V%G97,@;W(@:6YC<F5A<V4@=&AE('9A;'5E
M(&]F(&)E;F5F:71S(&EN(')E<W!O;G-E('1O('-U8V@@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4P-BXR-2!4
M9" H:6YC<F5A<V5S(&)Y(&]U<B!C;VUP971I=&]R<RP@=V4@8V]U;&0@9F%C
M92!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S@N-C0@-3 V+C(U(%1D
M("AF:6-U;'1I97,@871T<F%C=&EN9R!A;F0@<F5T86EN:6YG('%U86QI9FEE
M9"!H96%L=&AC87)E('!R;V9E<W-I;VYA;',N($EF('=E(')A:7-E("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M.30N,C4@5&0@*'=A9V5S(&]R(&EN8W)E87-E(&)E;F5F:71S(&EN(')E<W!O
M;G-E('1O(&]U<B!C;VUP971I=&]R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.#$N-#$@-#DT+C(U(%1D("@@:6YC<F5A<V5S(&%N9"!A<F4@=6YA8FQE
M('1O('!A<W,@<W5C:"!C;W-T(&EN8W)E87-E<R!O;B!T;R!O=7(@8VQI96YT
M<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0X,BXR-2!49" H;W5R(&UA<BD@5&H@150@40IQ(# @," P(')G
M($)4(#@Q+C(P(#0X,BXR-2!49" H9VEN<R!C;W5L9"!D96-L:6YE+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-3@N-# @-#@R+C(U(%1D("A!="!T:&ES
M('1I;64L('=E('-T:6QL(&1O(&YO="!H879E(&5N;W5G:"!N=7)S97,L(&%L
M;&EE9"!P<F]F97-S:6]N86QS(&%N9"!P:'ES:6-I86YS('1O(&UE970@86QL
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," T-S N,C4@5&0@*&]U<B!C;&EE;G1SDBD@5&H@150@40IQ(# @
M," P(')G($)4(#DT+C4R(#0W,"XR-2!49" H(&1E;6%N9',@9F]R('1H97-E
M('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#8N-3,@-#<P+C(U(%1D
M("AF:6YG('-E<G9I8V5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-#(N
M,3<@-#<P+C(U(%1D("A4:&ES('-H;W)T86=E(&]F(&AE86QT:&-A<F4@<')O
M9F5S<VEO;F%L<R!G96YE<F%L;'D@86YD('1H92!C;VUP971I=&EO;B!F;W(@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0U."XR-2!49" H=&AE:7(@<V5R=FEC97,@;6%Y(&QI;6ET(&]U<B!A
M8FEL:71Y('1O(&EN8W)E87-E('1H92!N=6UB97(@;V8@:&5A;'1H8V%R92!P
M<F]F97-S:6]N86QS('1H870@=V4@<W5C8V5S<V9U;&QY(')E8W)U:70L(&1E
M8W)E87-I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0T-BXR-2!49" H;W5R(&%B:6QI='D@=&\@9W)O=R!O
M=7(@8G5S:6YE<W,N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#0R-BXR-2!49" H268@;W5R(&AE86QT:&-A<F4@
M9F%C:6QI='D@8VQI96YT<R!I;F-R96%S92!T:&4@=7-E(&]F(&EN=&5R;65D
M:6%R:65S(&ET(&-O=6QD(&EM<&%C="!O=7(@<')O9FET86)I;&ET>2D@5&H@
M150@40IQ(# @," P(')G($)4(#0U,BXY-2 T,C8N,C4@5&0@*"XI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-# V
M+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@-# V+C(U
M(%1D("AE(&-O;G1I;G5E('1O('-E92!A;B!I;F-R96%S92!I;B!T:&4@=7-E
M(&]F(&EN=&5R;65D:6%R:65S(&)Y(&]U<B!C;&EE;G1S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-#4N.#4@-# V+C(U(%1D("A4:&5S92!I;G1E<FUE
M9&EA<FEE<R!T>7!I8V%L;'D@96YT97(@:6YT;R!C;VYT<F%C=',@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Y
M-"XR-2!49" H=VET:"!O=7(@8VQI96YT<R!A;F0@=&AE;B!S=6)C;VYT<F%C
M="!W:71H('5S(&%N9"!O=&AE<B!A9V5N8VEE<R!T;R!P<F]V:61E('-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C8N,3(@,SDT+C(U(%1D("AF:6YG
M('-E<G9I8V5S+"!T:'5S(&EN=&5R9F5R:6YG('1O('-O;64@97AT96YT(&EN
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," S.#(N,C4@5&0@*&]U<B!R96QA=&EO;G-H:7 @=VET:"!O=7(@8VQI
M96YT<RX@16%C:"!O9B!T:&5S92!I;G1E<FUE9&EA<FEE<R!C:&%R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S$U+C@T(#,X,BXR-2!49" H9V5S(&%N(&%D
M;6EN:7-T<F%T:79E(&9E92X@26X@:6YS=&%N8V5S('=H97)E('=E(&1O(&YO
M="!W:6X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#,W,"XR-2!49" H;F5W($U34"D@5&H@150@40IQ(# @," P
M(')G($)4(#@X+C@P(#,W,"XR-2!49" H(&]P<&]R='5N:71I97,@;W(@=VAE
M<F4@;W1H97(@=F5N9&]R<R!W:6X@=&AI<R!-4U I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.34N-C,@,S<P+C(U(%1D("@@;W(@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S X+C<X(#,W,"XR-2!49" H5DU3(&)U<VEN97-S('=I=&@@
M;W5R(&-U<G)E;G0@8W5S=&]M97)S+"!T:&4@;G5M8F5R(&]F("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-3@N
M,C4@5&0@*'!R;V9E<W-I;VYA;',@=V4@:&%V92!O;B!A<W-I9VYM96YT(&%T
M('1H;W-EH&-L:65N='.@8V]U;&0@9&5C<F5A<V4N($EF('=E(&%R92!U;F%B
M;&4@=&\@;F5G;W1I871E(&AO=7)L>2!R871E<R!W:71H("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-#8N,C4@
M5&0@*&EN=&5R;65D:6%R:65S(&9O<B!T:&4@<V5R=FEC97,@=V4@<')O=FED
M92!A="!T:&5S9:!C;&EE;G1SH'=H:6-H(&%R92!S=68I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,S4N-30@,S0V+C(U(%1D("AF:6-I96YT('1O(&-O=F5R
M(&%D;6EN:7-T<F%T:79E(&9E97,@8VAA<BD@5&H@150@40IQ(# @," P(')G
M($)4(#0Y,RXY," S-#8N,C4@5&0@*&=E9"!B>2!T:&]S92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S,T+C(U
M(%1D("AI;G1E<FUE9&EA<FEE<RP@:70@8V]U;&0@:6UP86-T(&]U<B!P<F]F
M:71A8FEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,W+C8S(#,S-"XR
M-2!49" H+B!)9B!T:&]S92!I;G1E<FUE9&EA<FEE<R!B96-O;64@:6YS;VQV
M96YT(&]R(&9A:6P@=&\@<&%Y('5S(&9O<B!O=7(@<V5R=FEC97,L(&ET("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S,C(N,C4@5&0@*&-O=6QD(&EM<&%C="!O=7*@8F%D(&1E8G0@97AP96YS
M9:!A;F0@=&AU<R!O=7(@;W9E<F%L;"!P<F]F:71A8FEL:71Y*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(P+CDT(#,R,BXR-2!49" H+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,C4N-S8@,S(R+C(U(%1D("A7*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S,T+C0P(#,R,BXR-2!49" H92!A;'-O('!R;W9I9&4@
M8V]M<')E:&5N<VEV92!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S4N
M-C<@,S(R+C(U(%1D("@@86YD(&]T:&5R('=O<FMF;W)C92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S$P+C(U
M(%1D("AS;VQU=&EO;G,@9&ER96-T;'F@=&\@8V5R=&%I;B!O9B!O=7(@8VQI
M96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Y+C(R(#,Q,"XR-2!4
M9" H5VAI;&4@<W5C:"!C;VYT<F%C=',@='EP:6-A;&QY(&EM<')O=F4@;W5R
M(&UA<FME="!S:&%R92!A="!T:&5S92!F86-I;&ET:65S+"!T:&5Y("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R
M.3@N,C4@5&0@*&-O=6QD(')E<W5L="!I;B!L97-S(&1I=F5R<VEF:6-A=&EO
M;B!O9B!O=7(@8W5S=&]M97(@8F%S92P@:6YC<F5A<V5D(&QI86)I;&ET>2D@
M5&H@150@40IQ(# @," P(')G($)4(#,T-BXW-R R.3@N,C4@5&0@*"P@86YD
M(')E9'5C960@;6%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$X+C(R(#(Y
M."XR-2!49" H9VEN<RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C<X+C(U(%1D("A/=7(@8V]S=',@;V8@<')O
M=FED:6YG('-E<G9I8V5S(&UA>2!R:7-E(&9A<W1E<B!T:&%N('=E(&%R92!A
M8FQE('1O(&%D:G5S="!O=7(@8FEL;"!R871E<R!A;F0@<&%Y(')A=&5S(&%N
M9"P@87,@82!R97-U;'0L(&]U<B I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C8V+C(U(%1D("AM87)G:6YS(&-O
M=6QD(&1E8VQI;F4N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#(T-BXR-2!49" H0V]S=',@;V8@<')O=FED:6YG
M(&]U<B!S97)V:6-E<R!C;W5L9"!C:&%N9V4@;6]R92!Q=6EC:VQY('1H86X@
M=V4@87)E(&%B;&4@=&\@<F5N96=O=&EA=&4@8FEL;"!R871E<R!I;B!O=7(@
M86-T:79E(&-O;G1R86-T<R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(S-"XR-2!49" H<&%Y(')A=&5S
M('=I=&@@;W5R('1H;W5S86YD<R!O9B!H96%L=&AC87)E('!R;V9E<W-I;VYA
M;',N($9O<B!E>&%M<&QE+"!W92!O9BD@5&H@150@40IQ(# @," P(')G($)4
M(#,U-BXV-R R,S0N,C4@5&0@*&9E<B!H;W5S:6YG('-U8G-I9&EE<R!T;R!O
M=7(@:&5A;'1H8V%R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C(R+C(U(%1D("AP<F]F97-S:6]N86QS(&]R
M('!R;W9I9&4@86-T=6%L(&AO=7-I;F<@=&\@;W5R(&AE86QT:&-A<F4@<')O
M9F5S<VEO;F%L<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,V+C4Y(#(R
M,BXR-2!49" H070@86YY(&=I=F5N('1I;64L('=E(&AA=F4@;W9E<B!A('1H
M;W5S86YD(&%P87)T;65N=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(Q,"XR-2!49" H;VX@;&5A<V4@=&AR
M;W5G:&]U="!T:&4@52Y3+B!B96-A=7-E('=E('!R;W9I9&4@:&]U<VEN9R!F
M;W(@8V5R=&%I;B!O9B!O=7(@:&5A;'1H8V%R92!P<F]F97-S:6]N86QS('=H
M96X@=&AE>2!A<F4@;VX@86X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#$Y."XR-2!49" H87-S:6=N;65N="!W
M:71H('5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S$N-#@@,3DX+C(U
M(%1D("A4:&4@8V]S="!O9B!S=6)S:61I>FEN9R!H;W5S:6YG(&]R(')E;G1I
M;F<@87!A<G1M96YT<R!A;F0@9G5R;FET=7)E(&9O<B!T:&5S92!H96%L=&AC
M87)E('!R;V9E<W-I;VYA;',@;6%Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q.#8N,C4@5&0@*&EN8W)E87-E
M(&9A<W1E<B!T:&%N('=E(&%R92!A8FQE('1O(')E;F5G;W1I871E(&]U<B!R
M871E<R!W:71H(&]U<B!C=7-T;VUE<G,L(&%N9"!T:&ES(&UA>2!H879E(&$@
M;F5G871I=F4@:6UP86-T(&]N(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3<T+C(U(%1D("AP<F]F:71A
M8FEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3<N,3(@,3<T+C(U(%1D
M("@N($EN(&%D9&ET:6]N+"!A;B!I;F-R96%S92!I;B!O=&AE<B!I;F-R96UE
M;G1A;"!C;W-T<R!B97EO;F0@;W5R(&-O;G1R;VPL('-U8V@@87,@:6YS=7)A
M;F-E(&-O=6QD(&YE9V%T:79E;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,S,N-#8@,3<T+C(U(%1D("AF96-T("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-C(N,C4@5&0@*&]U<B!F
M:6YA;F-I86P@<F5S=6QT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,T
M+C(T(#$V,BXR-2!49" H5&AE(&-O<W1S(')E;&%T960@=&\@;V)T86EN:6YG
M(&%N9"!M86EN=&%I;FEN9R!P<F]F97-S:6]N86P@86YD(&=E;F5R86P@;&EA
M8FEL:71Y(&EN<W5R86YC92P@:&5A;'1H("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-3 N,C4@5&0@*&EN<W5R
M86YC92!A;F0@=V]R:V5R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#(N
M-34@,34P+C(U(%1D("@@8V]M<&5N<V%T:6]N(&EN<W5R86YC92!F;W(@:&5A
M;'1H8V%R92!P<F]V:61E<G,@:&%S(&=E;F5R86QL>2!B965N(&EN8W)E87-I
M;F<N("D@5&H@150@40IQ(# @," P(')G($)4(#0V-"XW-" Q-3 N,C4@5&0@
M*%1H:7,@8V]U;&0@:&%V92!A;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3,X+C(U(%1D("AA9'9E<G-E(&EM
M<&%C="!O;B!O=7(@9FEN86YC:6%L(&-O;F1I=&EO;B!U;FQE<W,@=V4@87)E
M(&%B;&4@=&\@<&%S<R!T:&5S92!C;W-T<R!T:')O=6=H('1O(&]U<B!C;&EE
M;G1S(&]R(')E;F5G;W1I871E('!A>2!R871E<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3(V+C(U(%1D("AW
M:71H(&]U<B!H96%L=&AC87)E('!R;W9I9&5R<RXI(%1J($54(%$*0E0@+T8S
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3 V+C(U(%1D("A/
M=7(@;&%B;W(@8V]S=',@8V]U;&0@8F4@861V97)S96QY(&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C R+C S(#$P-BXR-2!49" H9F5C=&5D(&)Y(&$@
M<VAO<G1A9V4@;V8@97AP97)I96YC960@:&5A;'1H8V%R92!P<F]F97-S:6]N
M86QS(&%N9"!L86)O<B!U;FEO;B!A8W1I=FET>2D@5&H@150@40IQ(# @," P
M(')G($)4(#4U,"XX," Q,#8N,C4@5&0@*"XI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @.#8N,C4@5&0@*$]U<B!O
M<&5R871I;VYS(&%R92!D97!E;F1E;G0@;VX@;W5R(&%B:6QI='D@=&\@<F5C
M<G5I="!A;F0@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#(Y-BXY-B X
M-BXR-2!49" H9B!Q=6%L:71Y(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<RX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,T+C(S(#@V+C(U(%1D("A7*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#0R+C@W(#@V+C(U(%1D("AE(&-O;7!E
M=&4@=VET:"!O=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-S0N,C4@5&0@*&AE86QT:&-A<F4@<W1A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#$P-RXX-" W-"XR-2!49" H9FEN9R!C
M;VUP86YI97,@:6X@<F5C<G5I=&EN9R!A;F0@<F5T86EN:6YG('%U86QI9FEE
M9"!P97)S;VYN96PN("D@5&H@150@40IQ(# @," P(')G($)4(#,V,"XP." W
M-"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#,V."XW,B W-"XR
M-2!49" H92!M87D@8F4@<F5Q=6ER960@=&\@96YH86YC92!W86=E<R!A;F0@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8R+C(U(%1D("AB96YE9FET<R!T;R!O=7(@96UP;&]Y965S+"!W:&EC
M:"!C;W5L9"!N96=A=&EV96QY(&EM<&%C="!O=7(@<')O9FET86)I;&ET>2D@
M5&H@150@40IQ(# @," P(')G($)4(#,T-BXT.2 V,BXR-2!49" H+B!,86)O
M<B!U;FEO;B!A8W1I=FET>2!I<R!A;F]T:&5R(&9A8W1O<B!T:&%T(&-O=6QD
M("D@5&H@150@40IE;F1S=')E86T*96YD;V)J"C(W(# @;V)J"CP\+U1Y<&4@
M+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR
M+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,C@@
M,"!2/CX*96YD;V)J"C(X(# @;V)J"CP\+TQE;F=T:" Q,38T-SX^"G-T<F5A
M;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N
M-C @5&0@*#$P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<T,BXQ,"!49" H861V97)S96QY(&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@.3@N-# @-S0R+C$P(%1D("AF96-T(&]U<B!L86)O
M<B!C;W-T<R!O<B!O=&AE<G=I<V4@861V97)S96QY(&EM<&%C="!U<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S$S+C<Q(#<T,BXQ,"!49" H5"D@5&H@
M150@40IQ(# @," P(')G($)4(#,Q.2XQ,B W-#(N,3 @5&0@*&\@=&AE(&5X
M=&5N="!A('-I9VYI9FEC86YT('!O<G1I;VX@;V8@;W5R(&5M<&QO>65E(&)A
M<V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<S,"XQ,"!49" H=6YI;VYI>F5S+"!O=7(@;&%B;W(@8V]S=',@
M8V]U;&0@:6YC<F5A<V4@<VEG;FEF:6-A;G1L>2D@5&H@150@40IQ(# @," P
M(')G($)4(#(V-"XP,2 W,S N,3 @5&0@*"XI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$P+C$P(%1D("A)9B!O
M=7(@;&%B;W(@8V]S=',@:6YC<F5A<V4L('=E(&UA>2!N;W0@8F4@86)L92!T
M;R!R86ES92!R871E<R!T;R!O9BD@5&H@150@40IQ(# @," P(')G($)4(#,Q
M,"XP," W,3 N,3 @5&0@*&9S970@=&AE<V4@:6YC<F5A<V5D(&-O<W1S+B!"
M96-A=7-E(&$@<VEG;FEF:6-A;G0@<&5R8V5N=&%G92!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDX+C$P
M(%1D("AO=7(@<F5V96YU97,@8V]N<VES=',@;V8@9FEX960L('!R;W-P96-T
M:79E('!A>6UE;G1S+"!O=7(@86)I;&ET>2!T;R!P87-S(&%L;VYG(&EN8W)E
M87-E9"!L86)O<B!C;W-T<R!I<R!C;VYS=')A:6YE9"X@26X@=&AE(&5V96YT
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V.#8N,3 @5&0@*'=E(&%R92!N;W0@96YT:7)E;'D@968I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q,S0N-S@@-C@V+C$P(%1D("AF96-T:79E(&%T
M(')E8W)U:71I;F<@86YD(')E=&%I;FEN9R!Q=6%L:69I960@;6%N86=E;65N
M="P@;G5R<V5S(&%N9"!O=&AE<B!M961I8V%L('-U<'!O<G0@<&5R<V]N;F5L
M+"!O<B!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-C<T+C$P(%1D("AC;VYT<F]L;&EN9R!L86)O<B!C;W-T
M<RP@=&AI<R!C;W5L9"!H879E(&%N(&%D=F5R<V4@968I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-C N,#,@-C<T+C$P(%1D("AF96-T(&]N(&]U<B!R97-U
M;'1S(&]F(&]P97)A=&EO;G,N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#8U-"XQ,"!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#4X+C$U(#8U-"XQ,"!49" H92!M87D@9F%C92!C:&%L
M;&5N9V5S(&-O;7!E=&EN9R!I;B!T:&4@;6%R:V5T<&QA8V4@:68@=V4@87)E
M('5N86)L92!T;R!A;G1I8VEP871E(&%N9"!Q=6EC:VQY(')E<W!O;F0@=&\@
M8VAA;F=I;F<@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8T,BXQ,"!49" H;6%R:V5T<&QA8V4@8V]N9&ET:6]N
M<RP@<W5C:"!A<R!A;'1E<FYA=&EV92!M;V1E<R!O9B!H96%L=&AC87)E(&1E
M;&EV97)Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0X+C(Q(#8T,BXQ,"!4
M9" H+"!R96EM8G5R<V5M96YT+"!A;F0@8VQI96YT(&YE961S+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,C(N
M,3 @5&0@*%!A=&EE;G0@9&5L:79E<GD@<V5T=&EN9W,@8V]N=&EN=64@=&\@
M979O;'9E+"!G:79I;F<@<FES92!T;R!A;'1E<FYA=&EV92!M;V1E<R!O9B!H
M96%L=&AC87)E(&1E;&EV97)Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0R
M+C4V(#8R,BXQ,"!49" H+"!S=6-H(&%S(')E=&%I;"!M961I8VEN92P@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8Q,"XQ,"!49" H=&5L96UE9&EC:6YE(&%N9"!H;VUE(&AE86QT:"X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#4Y,"XQ,"!49" H3W5R('-U8V-E<W,@:7,@9&5P96YD96YT('5P;VX@;W5R
M(&%B:6QI='D@=&\@9&5V96QO<"!I;FYO=F%T:79E('=O<FMF;W)C92!S;VQU
M=&EO;G,@86YD('%U:6-K;'D@861A<'0@=&\@8VAA;F=I;F<@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4W."XQ
M,"!49" H;6%R:V5T<&QA8V4@8V]N9&ET:6]N<R!A;F0@8VQI96YT(&YE961S
M+"!I;F-L=61I;F<@;6%K:6YG(&UO9&EF:6-A=&EO;G,@=&\@;W5R('1E8VAN
M;VQO9VEE<R!A;F0@979O;'9I;F<@;W5R('1E8VAN;VQO9WD@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4V-BXQ
M,"!49" H<&QA=&9O<FT@=&AA="!M87D@9&EF*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3,U+C W(#4V-BXQ,"!49" H9F5R96YT:6%T92!O=7(@<V5R=FEC
M97,@86YD(&%B:6QI=&EE<R!F<F]M('1H;W-E(&]F(&]U<B!C;VUP971I=&]R
M<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# Q+C(P(#4V-BXQ,"!49" H
M5&AE(&UA<FME=',@:6X@=VAI8V@@=V4@8V]M<&5T92!A<F4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4U-"XQ
M,"!49" H:&EG:&QY(&-O;7!E=&ET:79E(&%N9"!O=7(@8V]M<&5T:71O<G,@
M;6%Y(')E<W!O;F0@;6]R92!Q=6EC:VQY('1O(&YE=R!O<B!E;65R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S<Y+C<T(#4U-"XQ,"!49" H9VEN9R!C;&EE
M;G0@;F5E9',@86YD(&UA<FME='!L86-E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-#(N,3 @5&0@*&-O;F1I
M=&EO;G,N("D@5&H@150@40IQ(# @," P(')G($)4(#DV+C0X(#4T,BXQ,"!4
M9" H5&AE(&1E=F5L;W!M96YT(&]F(&YE=R!S97)V:6-E(&QI;F5S(&%N9"!B
M=7-I;F5S<R!M;V1E;',@<F5Q=6ER97,@=7,@=&\@8F4@870@=&AE(&9O<F5F
M<F]N="!O9B!E;65R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DW+C Q(#4T
M,BXQ,"!49" H9VEN9R!T<F5N9',@:6X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4S,"XQ,"!49" H=&AE(&AE
M86QT:&-A<F4@:6YD=7-T<GDI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-# N
M-#(@-3,P+C$P(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#$T-2XR
M-" U,S N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3,N.#@@
M-3,P+C$P(%1D("AE(&UA>2!F86-E(&-H86QL96YG97,@8V]M<&5T:6YG(&EN
M('1H92!M87)K971P;&%C92!I9B!W92!A<F4@=6YA8FQE('1O('%U:6-K;'D@
M861A<'0@;W5R(&)U<VEN97-S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U,3@N,3 @5&0@*&UO9&5L(&%N9"!S
M=6-C97-S9G5L;'D@:6UP;&5M96YT(&EN;F]V871I=F4@<V5R=FEC97,@=&\@
M861D<F5S<R!T:&5S92!C:&%N9V5S+B I(%1J($54(%$*0E0@+T8S(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DX+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3@N,34@-#DX+C$P(%1D("AE(&UA>2!F86-E
M(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#$Q-2XT-" T.3@N,3 @5&0@
M*&9I8W5L=&EE<R!I;G1E9W)A=&EN9R!O=7(@86-Q=6ES:71I;VYS(&EN=&\@
M;W5R(&]P97)A=&EO;G,@86YD(&]U<B!A8W%U:7-I=&EO;G,@;6%Y(&)E('5N
M<W5C8V5S<V9U;"P@:6YV;VQV92 I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-#@V+C$P(%1D("AS:6=N:69I8V%N
M="!C87-H(&5X<&5N9&ET=7)E<R!O<B!E>'!O<V4@=7,@=&\@=6YF;W)E<V5E
M;B!L:6%B:6QI=&EE<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-#8V+C$P(%1D("A7*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3@N-C0@-#8V+C$P(%1D("AE(&-O;G1I;G5A;&QY(&5V86QU
M871E(&]P<&]R='5N:71I97,@=&\@86-Q=6ER92!C;VUP86YI97,@=&AA="!W
M;W5L9"!C;VUP;&5M96YT(&]R(&5N:&%N8V4@;W5R(&)U<VEN97-S+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.#DN,3<@-#8V+C$P(%1D("A4:&5S92!A
M8W%U:7-I=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-#4T+C$P(%1D("AO<'!O<G1U;FET:65S(&EN=F]L
M=F4@;G5M97)O=7,@<FES:W,L(&EN8VQU9&EN9R!P;W1E;G1I86P@;&]S<R!O
M9B!K97D@96UP;&]Y965S(&]R(&-L:65N=',@;V8@86-Q=6ER960@8V]M<&%N
M:65S.R!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3@N-C$@-#4T+C$P
M(%1D("AF:6-U;'1I97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#0T,BXQ,"!49" H:6YT96=R871I;F<@86-Q
M=6ER960@<&5R<V]N;F5L(&%N9"!D:7-T:6YC="!C=6QT=7)E<R!I;G1O(&]U
M<B!B=7-I;F5S<SL@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0Q+C$T
M(#0T,BXQ,"!49" H9FEC=6QT:65S(&EN=&5G<F%T:6YG(&%C<75I<F5D(&-O
M;7!A;FEE<R!I;G1O(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-#,P+C$P(%1D("AO<&5R871I;F<L(&9I
M;F%N8VEA;"!P;&%N;FEN9R!A;F0@9FEN86YC:6%L(')E<&]R=&EN9R!S>7-T
M96US.R!D:79E<G-I;VX@;V8@;6%N86=E;65N="!A='1E;G1I;VX@9G)O;2!E
M>&ES=&EN9R!O<&5R871I;VYS.R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Q."XQ,"!49" H87-S=6UP
M=&EO;G,@;V8@;&EA8FEL:71I97,@86YD(&5X<&]S=7)E('1O('5N9F]R97-E
M96X@;&EA8FEL:71I97,@;V8@86-Q=6ER960@8V]M<&%N:65S+"!I;F-L=61I
M;F<@;&EA8FEL:71I97,@9F]R('1H96ER(&9A:6QU<F4@=&\@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0P-BXQ
M,"!49" H8V]M<&QY('=I=&@@:&5A;'1H8V%R92!A;F0@=&%X(')E9W5L871I
M;VYS+B @*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(Y+C<V(#0P-BXQ,"!4
M9" H5&AE<V4@86-Q=6ES:71I;VYS(&UA>2!A;'-O(&EN=F]L=F4@<VEG;FEF
M:6-A;G0@8V%S:"!E>'!E;F1I='5R97,L(&1E8G0@:6YC=7)R96YC92 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,SDT+C$P(%1D("AA;F0@:6YT96=R871I;VX@97AP96YS97,@=&AA="!C;W5L
M9"!H879E(&$@;6%T97)I86P@861V97)S92!E9BD@5&H@150@40IQ(# @," P
M(')G($)4(#(Y-RXW-R S.30N,3 @5&0@*&9E8W0@;VX@;W5R(&9I;F%N8VEA
M;"!C;VYD:71I;VX@86YD(')E<W5L=',@;V8@;W!E<F%T:6]N<RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3(S+C@R(#,Y-"XQ,"!49" H06YY("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M.#(N,3 @5&0@*&%C<75I<VET:6]N(&UA>2!U;'1I;6%T96QY(&AA=F4@82!N
M96=A=&EV92!I;7!A8W0@;VX@;W5R(&)U<VEN97-S(&%N9"!F:6YA;F-I86P@
M8V]N9&ET:6]N+BD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," S-C(N,3 @5&0@*$EF(&%P<&QI8V%B;&4@9V]V97)N
M;65N="!R96=U;&%T:6]N<R!C:&%N9V4L('=E(&UA>2!F86-E(&EN8W)E87-E
M9"!C;W-T<R!T:&%T(')E9'5C92!O=7(@<F5V96YU92!A;F0@<')O9FET86)I
M;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#4R-"XV," S-C(N,3 @5&0@
M*"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,S0R+C$P(%1D("A4:&4@=&5M<&]R87)Y(&AE86QT:&-A<F4@<W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$V.2XT." S-#(N,3 @5&0@*&9I
M;F<@:6YD=7-T<GD@:7,@<F5G=6QA=&5D(&EN(&UA;GD@<W1A=&5S+B!&;W(@
M97AA;7!L92P@:6X@<V]M92!S=&%T97,L(&9I<FUS('-U8V@@87,@;W5R(&YU
M<G-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S,S N,3 @5&0@*'-T868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" V-"XR-B S,S N,3 @5&0@*&9I;F<@8V]M<&%N:65S(&UU<W0@8F4@<F5G
M:7-T97)E9"!T;R!E<W1A8FQI<V@@86YD(&%D=F5R=&ES92!A<R!A(&YU<G-E
M+7-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C0N,C8@,S,P+C$P(%1D
M("AF:6YG(&%G96YC>2!O<B!M=7-T('%U86QI9GD@9F]R(&%N(&5X96UP=&EO
M;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,S$X+C$P(%1D("AF<F]M(')E9VES=')A=&EO;B!I;B!T:&]S92!S
M=&%T97,N($EF('=E('=E<F4@=&\@;&]S92!A;GD@<F5Q=6ER960@<W1A=&4@
M;&EC96YS97,L('=E(&-O=6QD(&)E(')E<75I<F5D('1O(&-E87-E(&]P97)A
M=&EN9R!I;B!T:&]S92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,S V+C$P(%1D("AS=&%T97,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#<W+C T(#,P-BXQ,"!49" H5&AE(&EN=')O9'5C
M=&EO;B!O9B!N97<@<F5G=6QA=&]R>2!P<F]V:7-I;VYS(&-O=6QD(&%L<V\@
M<W5B<W1A;G1I86QL>2!R86ES92!T:&4@8V]S=',@87-S;V-I871E9"!W:71H
M(&AI<FEN9R!T96UP;W)A<GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(Y-"XQ,"!49" H96UP;&]Y965S+B!&
M;W(@97AA;7!L92P@<V]M92!S=&%T97,@8V]U;&0@:6UP;W-E('-A;&5S('1A
M>&5S(&]R(&EN8W)E87-E('-A;&5S('1A>"!R871E<R!O;B!T96UP;W)A<GD@
M:&5A;'1H8V%R92!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(P+C0Y
M(#(Y-"XQ,"!49" H9FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,C@R+C$P(%1D("AS97)V:6-E<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.#<N,#,@,C@R+C$P(%1D("A4:&5S92!I
M;F-R96%S960@8V]S=',@;6%Y(&YO="!B92!A8FQE('1O(&)E('!A<W-E9"!O
M;B!T;R!C;&EE;G1S+B!);B!A9&1I=&EO;BP@:68@9V]V97)N;65N="!R96=U
M;&%T:6]N<R!W97)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," R-S N,3 @5&0@*&EM<&QE;65N=&5D('1H870@
M;&EM:71E9"!T:&4@86UO=6YT('=E(&-O=6QD(&-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-38N,34@,C<P+C$P(%1D("AG92!F;W(@;W5R('-E<G9I
M8V5S+"!O=7(@<')O9FET86)I;&ET>2!C;W5L9"!B92!A9'9E<G-E;'D@868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#8N-#0@,C<P+C$P(%1D("AF96-T
M960N("D@5&H@150@40IQ(# @," P(')G($)4(#4Q-2XV." R-S N,3 @5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C0N,S(@,C<P+C$P(%1D("AE
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," R-3@N,3 @5&0@*&-O;G1I;G5O=7-L>2!M;VYI=&]R(&-H86YG97,@
M:6X@<F5G=6QA=&EO;G,@86YD(&QE9VES;&%T:6]N(&9O<B!P;W1E;G1I86P@
M:6UP86-T<R!O;B!O=7(@8G5S:6YE<W,N*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(S."XQ,"!49" H5&AE(&AE
M86QT:&-A<F4@:6YD=7-T<GD@:7,@:&EG:&QY(')E9W5L871E9"X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,R+C<P(#(S."XQ,"!49" H06YY(&UA=&5R
M:6%L(&-H86YG97,@:6X@=&AE('!O;&ET:6-A;"P@96-O;F]M:6,@;W(@<F5G
M=6QA=&]R>2!E;G9I<F]N;65N="!T:&%T("D@5&H@150@40I"5" O1C,@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,C8N,3 @5&0@*&%F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3@N,34@,C(V+C$P(%1D("AF96-T('1H
M92!P=7)C:&%S:6YG('!O;&EC:65S+"!P<F%C=&EC97,@86YD(&]P97)A=&EO
M;G,@;V8@:&5A;'1H8V%R92!O<F=A;FEZ871I;VYS+"!O<B!T:&%T(&QE860@
M=&\@8V]N<V]L:61A=&EO;B!I;B!T:&4@*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q-"XQ,"!49" H:&5A;'1H
M8V%R92!I;F1U<W1R>2D@5&H@150@40IQ(# @," P(')G($)4(#$R.2XY,B R
M,30N,3 @5&0@*"P@8V]U;&0@<F5D=6-E('1H92!F=6YD<R!A=F%I;&%B;&4@
M=&\@<'5R8VAA<V4@;W5R('-E<G9I8V5S(&]R(&]T:&5R=VES92!R97%U:7)E
M('5S('1O(&UO9&EF>2!O=7(@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(P,BXQ,"!49" H;V8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" U."XQ-2 R,#(N,3 @5&0@*&9E<FEN9W,N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$X
M,BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#$X,BXQ
M,"!49" H92!P<F]V:61E(&]U<B!S97)V:6-E<R!T;R!H;W-P:71A;',@86YD
M(&AE86QT:"!S>7-T96US('=H:6-H('!A>2!U<R!D:7)E8W1L>2D@5&H@150@
M40IQ(# @," P(')G($)4(#,V,"XW," Q.#(N,3 @5&0@*"X@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S8U+C$U(#$X,BXQ,"!49" H06-C;W)D:6YG;'DI
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,30N-#@@,3@R+C$P(%1D("@L($UE
M9&EC87)E+"!-961I8V%I9"!A;F0@:6YS=7)A;F-E("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-S N,3 @5&0@
M*')E:6UB=7)S96UE;G0@<&]L:6-Y(&-H86YG97,@9V5N97)A;&QY(&1O(&YO
M="!D:7)E8W1L>2!I;7!A8W0@=7,N($AO=V5V97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-34N,#8@,3<P+C$P(%1D("@L(&EN9&ER96-T;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.3<N-S,@,3<P+C$P(%1D("@L(&]U<B!B=7-I
M;F5S<RP@9FEN86YC:6%L(&-O;F1I=&EO;B!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U."XQ,"!49" H
M<F5S=6QT<R!O9B!O<&5R871I;VYS(&1E<&5N9"!U<&]N(&-O;F1I=&EO;G,@
M868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,SDN,C(@,34X+C$P(%1D("AF
M96-T:6YG('1H92!H96%L=&AC87)E(&EN9'5S=')Y(&=E;F5R86QL>2!A;F0@
M:&]S<&ET86QS(&%N9"!H96%L=&@@<WES=&5M<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,30V+C$P(%1D("AP
M87)T:6-U;&%R;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-2XT-" Q-#8N
M,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 P+C(V(#$T-BXQ
M,"!49" H5&AE(&AE86QT:&-A<F4@:6YD=7-T<GD@:7,@:&EG:&QY(')E9W5L
M871E9"!B>2!F961E<F%L(&%N9"!S=&%T92!A=71H;W)I=&EE<R!A;F0@:7,@
M<W5B:F5C="!T;R!C:&%N9VEN9R!P;VQI=&EC86PL("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S0N,3 @5&0@
M*&5C;VYO;6EC(&%N9"!R96=U;&%T;W)Y(&EN9FQU96YC97,NH$9A8W1O<G,@
M<W5C:"!A<R!C:&%N9V5S(&EN(')E:6UB=7)S96UE;G0@<&]L:6-I97,@9F]R
M(&AE86QT:&-A<F4@97AP96YS97,L(&-O;G-O;&ED871I;VX@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$R,BXQ
M,"!49" H:6X@=&AE(&AE86QT:&-A<F4@:6YD=7-T<GDI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-3 N-S @,3(R+C$P(%1D("@L(')E9W5L871I;VXL(&QI
M=&EG871I;VX@86YD(&=E;F5R86P@96-O;F]M:6,@8V]N9&ET:6]N<R!C;W5L
M9"!A9BD@5&H@150@40IQ(# @," P(')G($)4(#0P-BXU-B Q,C(N,3 @5&0@
M*&9E8W0@=&AE('!U<F-H87-I;F<@<')A8W1I8V5S+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3$P+C$P(%1D
M("AO<&5R871I;VYS(&%N9"!T:&4@9FEN86YC:6%L(&AE86QT:"!O9B!O=7(@
M8W5S=&]M97)S('=H:6-H(&-O=6QD(&AA=F4@82!N96=A=&EV92!I;7!A8W0@
M;VX@;W5R(&)U<VEN97-S+J!);B!A9&1I=&EO;BP@:6YS=7)A;F-E("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Y
M."XQ,"!49" H8V]M<&%N:65S(&%N9"!M86YA9V5D(&-A<F4@;W(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-S@N,#D@.3@N,3 @5&0@*&=A;FEZ871I;VYS
M('-E96L@=&\@8V]N=')O;"!C;W-T<R!B>2!R97%U:7)I;F<@:&5A;'1H8V%R
M92!P<F]V:61E<G,L('-U8V@@87,@:&]S<&ET86QS+"!T;R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @.#8N,3 @
M5&0@*&1I<V-O=6YT('1H96ER('-E<G9I8V5S(&EN(&5X8VAA;F=E(&9O<B!E
M>&-L=7-I=F4@;W(@<')E9F5R<F5D('!A<G1I8VEP871I;VX@:6X@=&AE:7(@
M8F5N969I="!P;&%N<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,W+C$W
M(#@V+C$P(%1D("A7:&EL92!N;W0@868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.#8N.3<@.#8N,3 @5&0@*&9E8W1I;F<@=7,@9&ER96-T;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U-3@N-3(@.#8N,3 @5&0@*"P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T+C$P
M(%1D("AF=71U<F4@9F5D97)A;"!A;F0@<W1A=&4@;&5G:7-L871I;VX@;W(@
M979O;'9I;F<@8V]M;65R8VEA;"!R96EM8G5R<V5M96YT('1R96YD<R!M87D@
M9G5R=&AE<B!R961U8V4@;W(@8VAA;F=E(&-O;F1I=&EO;G,@9F]R("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M,BXQ,"!49" H;W5R(&-L:65N='.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M.30N-3(@-C(N,3 @5&0@*"!R96EM8G5R<V5M96YT+B!3=6-H(&QI;6ET871I
M;VYS(&]N(')E:6UB=7)S96UE;G0@8V]U;&0@<F5D=6-E(&]U<B!C;&EE;G1S
MDBD@5&H@150@40IQ(# @," P(')G($)4(#0P,RXQ-" V,BXQ,"!49" H(&-A
M<V@@9FQO=W,L(&AA;7!E<FEN9R!T:&4@<')I8VEN9R!W92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3 N,3 @
M5&0@*&-A;B!C:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#,N-# @-3 N
M,3 @5&0@*&=E(&-L:65N=',@86YD('1H96ER(&%B:6QI='D@=&\@<&%Y('5S
M+B!296EM8G5R<V5M96YT(&-H86YG97,@:6X@9V]V97)N;65N="!P<F]G<F%M
M<RP@<&%R=&EC=6QA<FQY($UE9&EC87)E(&%N9" I(%1J($54(%$*96YD<W1R
M96%M"F5N9&]B:@HR.2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P
M(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R
M(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#,P(# @4CX^"F5N9&]B:@HS," P
M(&]B:@H\/"],96YG=&@@,3$P,#8^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S Q+C$U(#,Q+C8P(%1D("@Q*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S U+C<X(#,Q+C8P(%1D("@Q*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T,BXQ,"!4
M9" H365D:6-A:60L(&-A;B!A;F0@9&\@:6YD:7)E8W1L>2!A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$X-BXY.2 W-#(N,3 @5&0@*&9E8W0@=&AE(&1E
M;6%N9"!A;F0@=&AE('!R:6-E<R!P86ED(&9O<B!O=7(@<V5R=FEC97,NH"D@
M5&H@150@40IQ(# @," P(')G($)4(#,Y."XQ,2 W-#(N,3 @5&0@*%1H92!I
M;7!A8W0@;V8@86YY(&]T:&5R(&QE9VES;&%T:6]N('1O("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,S N,3 @
M5&0@*')E<&5A;"!O<B!A;65N9"!O<B!R97!L86-E('1H92 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-S,N,C<@-S,P+C$P(%1D("A!0T$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.3,N.#,@-S,P+C$P(%1D("@@:7,@=6YC97)T86EN
M(&%N9"!C;W5L9"!A9'9E<G-E;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,S4N,C8@-S,P+C$P(%1D("AF96-T(&]U<B!B=7-I;F5S<R!A;F0@9FEN
M86YC:6%L(&-O;F1I=&EO;BXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S$P+C$P(%1D("A7*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3@N,34@-S$P+C$P(%1D("AE(&]P97)A=&4@;W5R(&)U
M<VEN97-S(&EN(&$@<F5G=6QA=&5D(&EN9'5S=')Y(&%N9"!M;V1I9FEC871I
M;VYS+"!I;F%C8W5R871E(&EN=&5R<')E=&%T:6]N<R!O<B!V:6]L871I;VYS
M(&]F(&%N>2!A<'!L:6-A8FQE("D@5&H@150@40I"5" O1C,@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V.3@N,3 @5&0@*'-T871U=&]R>2!O
M<B!R96=U;&%T;W)Y(')E<75I<F5M96YT<R!M87D@<F5S=6QT(&EN(&UA=&5R
M:6%L(&-O<W1S(&]R('!E;F%L=&EE<R!A<R!W96QL(&%S(&QI=&EG871I;VX@
M86YD(&-O=6QD(')E9'5C92!O=7(@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#8X-BXQ,"!49" H<F5V96YU92!A
M;F0@96%R;FEN9W,@<&5R('-H87)E+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-C8N,3 @5&0@*$]U<B!I;F1U
M<W1R>2!I<R!S=6)J96-T('1O(&UA;GD@8V]M<&QE>"!F961E<F%L+"!S=&%T
M92P@;&]C86P@86YD(&EN=&5R;F%T:6]N86P@;&%W<R!A;F0@<F5G=6QA=&EO
M;G,@<F5L871E9"!T;RP@86UO;F<@;W1H97(@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8U-"XQ,"!49" H=&AI
M;F=S+"!T:&4@;&EC96YS=7)E(&]F('!R;V9E<W-I;VYA;',L('1H92!P87EM
M96YT(&]F(&]U<B!F:65L9"!E;7!L;WEE97,@7"AE+F<N+"!W86=E(&%N9"!H
M;W5R(&QA=W,L(&5M<&QO>6UE;G0@=&%X97,@86YD("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-#(N,3 @5&0@
M*&EN8V]M92!T87@@=VET:&AO;&1I;F=S+"!E=&,N7"D@86YD('1H92!O<&5R
M871I;VYS(&]F(&]U<B!B=7-I;F5S<R!G96YE<F%L;'D@7"AE+F<N+"!F961E
M<F%L+"!S=&%T92!A;F0@;&]C86P@=&%X(&QA=W-<*2X@268@=V4@9&\@;F]T
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V,S N,3 @5&0@*&-O;7!L>2!W:71H('1H92!L87=S(&%N9"!R96=U
M;&%T:6]N<R!T:&%T(&%R92!A<'!L:6-A8FQE('1O(&]U<B!B=7-I;F5S<RP@
M=V4@8V]U;&0@:6YC=7(@8VEV:6P@86YD+V]R(&-R:6UI;F%L('!E;F%L=&EE
M<R!A<R!W96QL("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," V,3@N,3 @5&0@*&%S(&QI=&EG871I;VX@;W(@8F4@
M<W5B:F5C="!T;R!E<75I=&%B;&4@<F5M961I97,N*2!4:B!%5"!1"D)4("]&
M,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Y."XQ,"!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C$U(#4Y."XQ,"!49" H92!A
M<F4@<W5B:F5C="!T;R!L:71I9V%T:6]N+"!W:&EC:"!C;W5L9"!R97-U;'0@
M:6X@<W5B<W1A;G1I86P@:G5D9VUE;G0@;W(@<V5T=&QE;65N="!C;W-T<SL@
M<VEG;FEF:6-A;G0@;&5G86P@86-T:6]N<R!C;W5L9" I(%1J($54(%$*0E0@
M+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3@V+C$P(%1D
M("AS=6)J96-T('5S('1O('-U8G-T86YT:6%L('5N:6YS=7)E9"!L:6%B:6QI
M=&EE<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-38V+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3@N-C0@-38V+C$P(%1D("AE(&%R92!P87)T>2!T;R!V87)I;W5S(&QI=&EG
M871I;VXL(&-L86EM<RP@:6YV97-T:6=A=&EO;G,L(&%N9"!O=&AE<B!P<F]C
M965D:6YG<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<Q+C0S(#4V-BXQ
M,"!49" H5&AE<V4@;6%T=&5R<R!P<FEM87)I;'D@<F5L871E('1O(&5M<&QO
M>65E+2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U-30N,3 @5&0@*')E;&%T960@;6%T=&5R<R!T:&%T(&EN8VQU
M9&4@:6YD:79I9'5A;"!A;F0@8V]L;&5C=&EV92!C;&%I;7,L('!R;V9E<W-I
M;VYA;"!L:6%B:6QI='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S4N,S8@
M-34T+C$P(%1D("@L('1A>"P@86YD('!A>7)O;&P@<')A8W1I8V5S+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.#4N-CD@-34T+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#DT+C,S(#4U-"XQ,"!49" H92!E=F%L=6%T
M92!T:&5S92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-30R+C$P(%1D("AL:71I9V%T:6]N(&-L86EM<R!A;F0@
M;&5G86P@<')O8V5E9&EN9W,@=&\@87-S97-S('1H92!L:6ME;&EH;V]D(&]F
M('5N9F%V;W)A8FQE(&]U=&-O;65S(&%N9"!T;R!E<W1I;6%T92P@:68@<&]S
M<VEB;&4L('1H92!A;6]U;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#4S,"XQ,"!49" H;V8@<&]T96YT:6%L
M(&QO<W-E<RX@0F%S960@;VX@=&AE<V4@87-S97-S;65N=',@86YD(&5S=&EM
M871E<RP@:68@86YY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(R+C X(#4S
M,"XQ,"!49" H+"!W92!E<W1A8FQI<V@@<F5S97)V97,@86YD+V]R(&1I<V-L
M;W-E('1H92!R96QE=F%N=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3$X+C$P(%1D("AL:71I9V%T:6]N(&-L
M86EM<R!O<B!L96=A;"!P<F]C965D:6YG<RP@87,@87!P<F]P<FEA=&4N("D@
M5&H@150@40IQ(# @," P(')G($)4(#(V-"XT-R U,3@N,3 @5&0@*%1H97-E
M(&%S<V5S<VUE;G1S(&%R92!P97)F;W)M960@870@;&5A<W0@<75A<G1E<FQY
M(&%N9"!A<F4@8F%S960@;VX@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,#8N,3 @5&0@*&EN9F]R;6%T
M:6]N(&%V86EL86)L92!T;R!M86YA9V5M96YT(&%T('1H92!T:6UE(&%N9"!I
M;G9O;'9E(&$@<VEG;FEF:6-A;G0@86UO=6YT(&]F(&UA;F%G96UE;G0@:G5D
M9VUE;G0N($)A<V5D(&]N('1H92!N97<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y-"XQ,"!49" H:6YF;W)M
M871I;VX@8V]N<VED97)E9"!I;B!O=7(@<F5V:65W<RP@=V4@861J=7-T(&]U
M<B!L;W-S(&-O;G1I;F=E;F-Y(&%C8W)U86QS(&%N9"!O=7(@9&ES8VQO<W5R
M97,N("D@5&H@150@40IQ(# @," P(')G($)4(#0U,"XX,R T.30N,3 @5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3DN-#8@-#DT+C$P(%1D("AE
M(&UA>2!N;W0@:&%V92!S=68I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S0N
M.#$@-#DT+C$P(%1D("AF:6-I96YT("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T.#(N,3 @5&0@*&EN<W5R86YC
M92!T;R!C;W9E<B!T:&5S92!R:7-K<RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3<R+C$Y(#0X,BXQ,"!49" H06-T=6%L(&]U=&-O;65S(&]R(&QO<W-E
M<R!M87D@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$P+C S(#0X,BXQ
M,"!49" H9F5R(&UA=&5R:6%L;'D@9G)O;2!T:&]S92!E<W1I;6%T960@8GD@
M;W5R(&-U<G)E;G0@87-S97-S;65N=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0W,"XQ,"!49" H=VAI8V@@
M=V]U;&0@:6UP86-T(&]U<B!P<F]F:71A8FEL:71Y*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3DW+C$P(#0W,"XQ,"!49" H+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,#$N-34@-#<P+C$P(%1D("A!9'9E<G-E(&1E=F5L;W!M96YT
M<R!I;B!E>&ES=&EN9R!L:71I9V%T:6]N(&-L86EM<R!O<B!L96=A;"!P<F]C
M965D:6YG<R!I;G9O;'9I;F<@;W5R("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-3@N,3 @5&0@*$-O;7!A;GD@
M;W(@;F5W(&-L86EM<R!C;W5L9"!R97%U:7)E('5S('1O(&5S=&%B;&ES:"!O
M<B!I;F-R96%S92!L:71I9V%T:6]N(')E<V5R=F5S(&]R(&5N=&5R(&EN=&\@
M=6YF879O<F%B;&4@<V5T=&QE;65N=',@;W(@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T-BXQ,"!49" H<V%T
M:7-F>2!J=61G;65N=',@9F]R(&UO;F5T87)Y(&1A;6%G97,@9F]R(&%M;W5N
M=',@:6X@97AC97-S(&]F(&-U<G)E;G0@<F5S97)V97,L('=H:6-H(&-O=6QD
M(&%D=F5R<V5L>2!A9BD@5&H@150@40IQ(# @," P(')G($)4(#0X,RXU-R T
M-#8N,3 @5&0@*&9E8W0@;W5R(&9I;F%N8VEA;" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#,T+C$P(%1D("AR
M97-U;'1S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," T,30N,3 @5&0@*$EN(')E8V5N="!Y96%R<RP@:&5A;'1H
M8V%R92!P<F]V:61E<G,@:&%V92!B96-O;64@<W5B:F5C="!T;R!A;B!I;F-R
M96%S:6YG(&YU;6)E<B!O9B!L96=A;"!A8W1I;VYS(&%L;&5G:6YG(&UA;'!R
M86-T:6-E+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-# R+C$P(%1D("AV:6-A<FEO=7,@;&EA8FEL:71Y*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3$Y+C8Q(#0P,BXQ,"!49" H+"!V:6]L
M871I;VX@;V8@8V5R=&%I;B!C;VYS=6UE<B!P<F]T96-T:6]N(&%C=',L(&YE
M9VQI9V5N="!H:7)I;F<L(&YE9VQI9V5N="!C<F5D96YT:6%L:6YG+"!P<F]D
M=6-T(&QI86)I;&ET>2!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,SDP+C$P(%1D("AR96QA=&5D(&QE9V%L
M('1H96]R:65S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S@N,3$@,SDP
M+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30V+C<U(#,Y,"XQ
M,"!49" H92!M87D@8F4@<W5B:F5C="!T;R!L:6%B:6QI='D@:6X@<W5C:"!C
M87-E<R!E=F5N(&EF(&]U<B!#;VUP86YY)W,@8V]N=')I8G5T:6]N('1O('1H
M92!A;&QE9V5D(&EN:G5R>2!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W."XQ,"!49" H;6EN:6UA;"!O
M<B!R96QA=&5D('1O(&]N92!O9B!O=7(@<W5B8V]N=')A8W1O<G,@;W(@:71S
M(&5M<&QO>65E<RX@36%N>2!O9B!T:&5S92!A8W1I;VYS(&EN=F]L=F4@;&%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0T+CDY(#,W."XQ,"!49" H9V4@
M8VQA:6US(&%N9"!S:6=N:69I8V%N=" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S8V+C$P(%1D("AD969E;G-E
M(&-O<W1S+B!);B!A9&1I=&EO;BP@=V4@;6%Y(&)E('-U8FIE8W0@=&\@8VQA
M:6US(')E;&%T960@=&\@=&]R=',@;W(@8W)I;65S(&-O;6UI='1E9"!B>2!O
M=7(@8V]R<&]R871E(&5M<&QO>65E<R!O<B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S4T+C$P(%1D("AH96%L
M=&AC87)E('!R;V9E<W-I;VYA;',@=&AA="!W92!P;&%C92!O;B!A<W-I9VYM
M96YT+B!);B!M;W-T(&EN<W1A;F-E<RP@=V4@87)E(')E<75I<F5D('1O(&EN
M9&5M;FEF>2!C;&EE;G1S(&%G86EN<W0@<V]M92!O<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S0R+C$P(%1D
M("AA;&P@;V8@=&AE<V4@<FES:W,N("D@5&H@150@40IQ(# @," P(')G($)4
M(#$Q.2XW,2 S-#(N,3 @5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,C8N,S@@,S0R+C$P(%1D("@@9F%I;'5R92!O9B!A;GD@;V8@;W5R(&-O<G!O
M<F%T92!E;7!L;WEE97,@;W(@:&5A;'1H8V%R92!P<F]F97-S:6]N86P@=&\@
M;V)S97)V92!O=7(@<&]L:6-I97,@86YD(&=U:61E;&EN97,L("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,S N
M,3 @5&0@*')E;&5V86YT(&-L:65N="!P;VQI8VEE<R!A;F0@9W5I9&5L:6YE
M<R!O<B!A<'!L:6-A8FQE(&9E9&5R86PL('-T871E(&]R(&QO8V%L(&QA=W,L
M(')U;&5S(&%N9"!R96=U;&%T:6]N<R!C;W5L9"!R97-U;'0@:6X@;F5G871I
M=F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#,Q."XQ,"!49" H<'5B;&EC:71Y*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@.#0N.3 @,S$X+C$P(%1D("@L('!A>6UE;G0@;V8@9FEN97,@;W(@
M;W1H97(@9&%M86=E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,CDX+C$P(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-34N-#$@,CDX+C$P(%1D("AO('!R;W1E8W0@;W5R<V5L=F5S
M(&9R;VT@=&AE(&-O<W0@;V8@=&AE<V4@='EP97,@;V8@8VQA:6US+"!W92!M
M86EN=&%I;B!P<F]F97-S:6]N86P@;6%L<')A8W1I8V4@;&EA8FEL:71Y(&EN
M<W5R86YC92P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#(X-BXQ,"!49" H96UP;&]Y;65N="!P<F%C=&EC97,@
M;&EA8FEL:71Y(&EN<W5R86YC92P@86YD(&=E;F5R86P@;&EA8FEL:71Y(&EN
M<W5R86YC92!C;W9E<F%G92!W:71H('1E<FUS(&%N9"!I;B!A;6]U;G1S('=I
M=&@@9&5D=6-T:6)L97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#(W-"XQ,"!49" H=&AA="!W92!B96QI979E
M(&%R92!A<'!R;W!R:6%T92!F;W(@;W5R(&]P97)A=&EO;G,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(U,BXR,R R-S0N,3 @5&0@*%<I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R-C N.#<@,C<T+C$P(%1D("AE(&%R92!P87)T:6%L
M;'D@<V5L9BUI;G-U<F5D(&9O<B!O=7(@=V]R:V5R<R<@8V]M<&5N<V%T:6]N
M(&-O=F5R86=E+"!H96%L=&@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(V,BXQ,"!49" H:6YS=7)A;F-E(&-O
M=F5R86=E+"!A;F0@<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;W9E<F%G92!F
M;W(@;W5R(&QO8W5M('1E;F5N<R!P<F]V:61E<G,N($EF('=E(&)E8V]M92!S
M=6)J96-T('1O('-U8G-T86YT:6%L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-3 N,3 @5&0@*'5N:6YS=7)E
M9"!W;W)K97)S)R!C;VUP96YS871I;VXL(&UE9&EC86P@8V]V97)A9V4@;W(@
M;65D:6-A;"!M86QP<F%C=&EC92!L:6%B:6QI=&EE<RP@=VAE=&AE<B!D:7)E
M8W1L>2!O<B!I;F1I<F5C=&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$T
M+C,Q(#(U,"XQ,"!49" H+"!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(S."XQ,"!49" H9FEN86YC:6%L
M(')E<W5L=',@;6%Y(&)E(&%D=F5R<V5L>2!A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#$Y-BXQ-2 R,S@N,3 @5&0@*&9E8W1E9"X@26X@861D:71I;VXL
M(&]U<B!I;G-U<F%N8V4@8V]V97)A9V4@;6%Y(&YO="!C;W9E<B!A;&P@8VQA
M:6US(&%G86EN<W0@=7,@;W(@8V]N=&EN=64@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R-BXQ,"!49" H=&\@
M8F4@879A:6QA8FQE('1O('5S(&%T(&$@<F5A<V]N86)L92!C;W-T+B!)9B!W
M92!A<F4@=6YA8FQE('1O('!A>2!O=7(@<V5L9BUI;G-U<F5D(')E=&5N=&EO
M;B!P;W)T:6]N(&]R(&UA:6YT86EN(&%D97%U871E("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,30N,3 @5&0@
M*&EN<W5R86YC92!C;W9E<F%G92P@=V4@;6%Y(&)E(&5X<&]S960@=&\@<W5B
M<W1A;G1I86P@;&EA8FEL:71I97,N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Y-"XQ,"!49" H268@<')O=FES
M:6]N<R!I;B!O=7(@8V]R<&]R871E(&1O8W5M96YT<R!A;F0@1&5L87=A<F4@
M;&%W(&1E;&%Y(&]R('!R979E;G0@82!C:&%N9V4@:6X@8V]N=')O;"P@=V4@
M;6%Y(&)E('5N86)L92!T;R I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,3@R+C$P(%1D("AC;VYS=6UM871E(&$@
M=')A;G-A8W1I;VX@=&AA="!O=7(@<W1O8VMH;VQD97)S(&-O;G-I9&5R(&9A
M=F]R86)L92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,38R+C$P(%1D("A/=7(@8V5R=&EF:6-A=&4@;V8@:6YC
M;W)P;W)A=&EO;B!A;F0@8GDM;&%W<R!M87D@9&ES8V]U<F%G92P@9&5L87D@
M;W(@<')E=F5N="!A(&UE<BD@5&H@150@40IQ(# @," P(')G($)4(#,X-BXV
M,R Q-C(N,3 @5&0@*&=E<B!O<B!A8W%U:7-I=&EO;B!I;G9O;'9I;F<@=7,@
M=&AA="!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#$U,"XQ,"!49" H<W1O8VMH;VQD97)S(&UA>2!C;VYS
M:61E<B!F879O<F%B;&4N($9O<B!E>&%M<&QE+"!O=7(@8V5R=&EF:6-A=&4@
M;V8@:6YC;W)P;W)A=&EO;B!A=71H;W)I>F5S(&]U<B!";V%R9"!O9B!$:7)E
M8W1O<G,@=&\@:7-S=64@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#$S."XQ,"!49" H=7 @=&\@,3 L,# P+# P
M,"!S:&%R97,@;V8@DV)L86YK(&-H96-KE"!P<F5F97)R960@<W1O8VLN("D@
M5&H@150@40IQ(# @," P(')G($)4(#(X,RXP-R Q,S@N,3 @5&0@*%<I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R.3(N,3$@,3,X+C$P(%1D("AI=&AO=70@
M<W1O8VMH;VQD97(@87!P<F]V86PL('1H92!";V%R9"!O9B!$:7)E8W1O<G,@
M:&%S('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,3(V+C$P(%1D("AA=71H;W)I='D@=&\@871T86-H('-P
M96-I86P@<FEG:'1S+"!I;F-L=61I;F<@=F]T:6YG(&%N9"!D:79I9&5N9"!R
M:6=H=',L('1O('1H:7,@<')E9F5R<F5D('-T;V-K+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,C8N,3,@,3(V+C$P(%1D("A7*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#,U+C$W(#$R-BXQ,"!49" H:71H('1H97-E(')I9VAT<RP@
M<')E9F5R<F5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," Q,30N,3 @5&0@*'-T;V-K:&]L9&5R<R!C;W5L9"!M
M86ME(&ET(&UO<F4@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DS+CDU
M(#$Q-"XQ,"!49" H9FEC=6QT(&9O<B!A('1H:7)D('!A<G1Y('1O(&%C<75I
M<F4@=7,N($1E;&%W87)E(&QA=R!M87D@86QS;R!D:7-C;W5R86=E+"!D96QA
M>2!O<B!P<F5V96YT("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," Q,#(N,3 @5&0@*'-O;65O;F4@9G)O;2!A8W%U
M:7)I;F<@;W(@;65R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<V+C0U(#$P
M,BXQ,"!49" H9VEN9R!W:71H('5S+BD@5&H@150@40I"5" O1C,@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," X,BXQ,"!49" H36%R:V5T(&1I
M<W)U<'1I;VYS(&UA>2!A9'9E<G-E;'D@868I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q.3DN.#$@.#(N,3 @5&0@*&9E8W0@;W5R(&]P97)A=&EN9R!R97-U
M;'1S(&%N9"!F:6YA;F-I86P@8V]N9&ET:6]N*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXV,B X,BXQ,"!49" H+BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,BXQ,"!49" H16-O;F]M:6,@8V]N9&ET:6]N<R!A;F0@=F]L871I;&ET
M>2!I;B!T:&4@9FEN86YC:6%L(&UA<FME=',@;6%Y(&AA=F4@86X@861V97)S
M92!I;7!A8W0@;VX@=&AE(&%V86EL86)I;&ET>2!O9B!C<F5D:70@=&\@=7,@
M86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,"XQ,"!49" H=&\@;W5R(&-U<W1O;65R<R!A;F0@8G5S:6YE
M<W-E<R!G96YE<F%L;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3<N,S<@
M-3 N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(R+C$Y(#4P
M+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(W+C8P(#4P+C$P
M(%1D("AO('1H92!E>'1E;G0@=&AA="!D:7-R=7!T:6]N(&EN('1H92!F:6YA
M;F-I86P@;6%R:V5T<R!O8V-U<G,L(&ET(&AA<R!T:&4@<&]T96YT:6%L('1O
M("D@5&H@150@40IE;F1S=')E86T*96YD;V)J"C,Q(# @;V)J"CP\+U1Y<&4@
M+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR
M+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,S(@
M,"!2/CX*96YD;V)J"C,R(# @;V)J"CP\+TQE;F=T:" Q,3$P-SX^"G-T<F5A
M;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N
M-C @5&0@*#$R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<T,BXQ,"!49" H;6%T97)I86QL>2!A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$P,"XV,R W-#(N,3 @5&0@*&9E8W0@;W5R(&%N
M9"!O=7(@8W5S=&]M97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#(P.2XX
M-" W-#(N,3 @5&0@*"!A8FEL:71Y('1O('1A<"!I;G1O(&1E8G0@86YD+V]R
M(&5Q=6ET>2!M87)K971S('1O(&-O;G1I;G5E(&]N9V]I;F<@;W!E<F%T:6]N
M<RP@:&%V92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-S,P+C$P(%1D("AA8V-E<W,@=&\@8V%S:"!A;F0O;W(@
M<&%Y(&1E8G1S(&%S('1H97D@8V]M92!D=64N("D@5&H@150@40IQ(# @," P
M(')G($)4(#(U,2XQ-" W,S N,3 @5&0@*%1H97-E(&5V96YT<R!C;W5L9"!N
M96=A=&EV96QY(&EM<&%C="!O=7(@<F5S=6QT<R!O9B!O<&5R871I;VYS(&%N
M9"!F:6YA;F-I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#<Q."XQ,"!49" H8V]N9&ET:6]N<RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.38N,3$@-S$X+C$P(%1D("A!;'1H;W5G:"!W
M92!M;VYI=&]R(&]U<B!C<F5D:70@<FES:W,@=&\@<W!E8VEF:6,@8VQI96YT
M<R!T:&%T('=E(&)E;&EE=F4@;6%Y('!R97-E;G0@8W)E9&ET(&-O;F-E<FYS
M+"!D969A=6QT(')I<VL@;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#<P-BXQ,"!49" H;&%C:R!O9B!A8V-E
M<W,@=&\@;&EQ=6ED:71Y(&UA>2!R97-U;'0@9G)O;2!E=F5N=',@;W(@8VER
M8W5M<W1A;F-E<R!T:&%T(&%R92!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S-C(N,C$@-S V+C$P(%1D("AF:6-U;'0@=&\@9&5T96-T(&]R(&9O<F5S
M964N($-O;F1I=&EO;G,@:6X@=&AE(&-R961I=" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C$P(%1D("AM
M87)K971S(&%N9"!T:&4@96-O;F]M>2!G96YE<F%L;'D@8V]U;&0@861V97)S
M96QY(&EM<&%C="!O=7(@8G5S:6YE<W,@86YD(&QI;6ET(&]R('!R;VAI8FET
M('5S(&9R;VT@<F5F:6YA;F-I;F<@;W5R(&-R961I=" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R+C$P(%1D
M("AA9W)E96UE;G1S(&]N('1E<FUS(&9A=F]R86)L92!T;R!U<R!O<B!A="!A
M;&P@=VAE;B!T:&5Y(&)E8V]M92!D=64N*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8V,BXQ,"!49" H4W1O8VL@
M:7-S=6%B;&4@=6YD97(@;W5R('-T;V-K(&EN8V5N=&EV92!P;&%N<R!A<F4@
M<')E<V5N=&QY(&EN(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$W+C U
M(#8V,BXQ,"!49" H9F5C="!A;F0@<V%L97,@;V8@=&AI<R!S=&]C:R!C;W5L
M9"!C875S92!O=7(@<W1O8VL@<')I8V4@=&\@*2!4:B!%5"!1"D)4("]&,R Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8U,"XQ,"!49" H9&5C
M;&EN92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-C,P+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3@N-C0@-C,P+C$P(%1D("AE(&AA=F4@<F5G:7-T97)E9" V+#$P,"PP,# @
M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!F;W(@:7-S=6%N8V4@=6YD97(@;W5R
M(#(P,30@3VUN:6)U<R!);F-E;G1I=F4@4&QA;BP@86YD(#0L,SDX+# P,2 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C$X+C$P(%1D("AS:&%R97,@;V8@8V]M;6]N('-T;V-K(&9O<B!O=7(@
M<')E9&5C97-S;W(@,3DY.2!S=&]C:R!O<'1I;VX@<&QA;BP@86QL(&]F('=H
M:6-H(&AA=F4@8F5E;B!R96=I<W1E<F5D+B!3:&%R97,@;V8@<F5S=')I8W1E
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-C V+C$P(%1D("AS=&]C:R!O=71S=&%N9&EN9R!A<R!O9B!&96)R
M=6%R>: R,BP@,C Q.2!W97)E(#0R."PQ,S$N($EN(&%D9&ET:6]N+"!A('1A
M<BD@5&H@150@40IQ(# @," P(')G($)4(#,T-2XX-R V,#8N,3 @5&0@*&=E
M="!O9B R,#,L-#DV('!E<F9O<FUA;F-E('-T;V-K(&%W87)D(&=R86YT<R!W
M97)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U.30N,3 @5&0@*&]U='-T86YD:6YG(&%S(&]F($9E8G)U87)Y
M(#(R+" R,#$Y+B!&=6QL>2!V97-T960@<W1O8VL@87!P<F5C:6%T:6]N(')I
M9VAT<R!O9B U,2PU,# @=V5R92!I<W-U960@86YD(&]U='-T86YD:6YG(&%S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U.#(N,3 @5&0@*$9E8G)U87)Y(#(R+" R,#$Y+BD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C8N,3 @-3@R
M+C$P(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$R."XV," U.#(N,3 @5&0@*%-E92!.;W1E(#$T("T@4W1O8VMH
M;VQD97)S)R!%<75I='D@=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@
M<W1A=&5M96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,U+C$U(#4X
M,BXQ,"!49" H5BD@5&H@150@40IQ(# @," P(')G($)4(#0T,2XR-B U.#(N
M,3 @5&0@*&5S=&5D(')E<W1R:6-T960@<W1O8VL@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-S N,3 @
M5&0@*&ES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!R96QA=&5D('1O(&]U<B!A
M=V%R9',@87,@=V5L;"!A<R!C;VUM;VX@<W1O8VL@:7-S=65D('5P;VX@97AE
M<F-I<V4@;V8@<W1O8VL@;W!T:6]N<RP@86YD('-T;V-K("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-3@N,3 @
M5&0@*&%P<')E8VEA=&EO;B!R:6=H=',@=6YD97(@=&AE<V4@8F5N969I="!P
M;&%N<RP@:7,@96QI9VEB;&4@9F]R(')E<V%L92!I;B!T:&4@<'5B;&EC(&UA
M<FME="!W:71H;W5T(')E<W1R:6-T:6]N+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-S0N-CD@-34X+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#@S+C,S(#4U."XQ,"!49" H92!C86YN;W0@<')E9&EC=" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-30V
M+C$P(%1D("AW:&%T(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-SDN-3,@
M-30V+C$P(%1D("AF96-T+"!I9B!A;GDI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,C$N.3$@-30V+C$P(%1D("@L(&UA<FME="!S86QE<R!O9B!S:&%R97,@
M:&5L9"!B>2!A;GD@<W1O8VMH;VQD97(@;W(@=&AE(&%V86EL86)I;&ET>2!O
M9B!T:&5S92!S:&%R97,@9F]R(&9U='5R92!S86QE('=I;&P@:&%V92!O;B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-3,T+C$P(%1D("AT:&4@;6%R:V5T('!R:6-E(&]F(&]U<B!C;VUM;VX@
M<W1O8VLN*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4Q-"XQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4
M(#4X+C$U(#4Q-"XQ,"!49" H92!A<F4@9&5P96YD96YT(&]N('1H92!P<F]P
M97(@9G5N8W1I;VYI;F<@;V8@;W5R(&EN9F]R;6%T:6]N('-Y<W1E;7,@86YD
M(&%P<&QI8V%T:6]N<R!H;W-T960@8GD@;W5R('9E;F1O<G,N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y-"XQ
M,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#0Y-"XQ,"!4
M9" H92!A<F4@9&5P96YD96YT(&]N('1H92!P<F]P97(@9G5N8W1I;VYI;F<@
M;V8@;W5R(&EN9F]R;6%T:6]N('-Y<W1E;7,@:6X@;W!E<F%T:6YG(&]U<B!B
M=7-I;F5S<RP@:6YC;'5D:6YG('1H;W-E(&%P<&QI8V%T:6]N<R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#@R
M+C$P(%1D("AH;W-T960@8GD@;W5R('9E;F1O<G,N($-R:71I8V%L(&EN9F]R
M;6%T:6]N('-Y<W1E;7,@=7-E9"!I;B!D86EL>2!O<&5R871I;VYS(&ED96YT
M:69Y(&%N9"!M871C:"!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0Y
M+C0V(#0X,BXQ,"!49" H9FEN9R!R97-O=7)C97,@86YD(&-L:65N=" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-#<P+C$P(%1D("AA<W-I9VYM96YT<R!A;F0@<&5R9F]R;2!B:6QL:6YG(&%N
M9"!A8V-O=6YT<R!R96-E:79A8FQE(&9U;F-T:6]N<RX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S(Q+C,Q(#0W,"XQ,"!49" H061D:71I;VYA;&QY*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S<Q+C(R(#0W,"XQ,"!49" H+"!W92!R
M96QY(&]N(&]U<B!I;F9O<FUA=&EO;B!S>7-T96US(&EN("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-3@N,3 @
M5&0@*&UA;F%G:6YG(&]U<B!A8V-O=6YT:6YG(&%N9"!F:6YA;F-I86P@<F5P
M;W)T:6YG+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3 N,#,@-#4X+C$P
M(%1D("A4:&5S92!S>7-T96US(&%R92!S=6)J96-T('1O(&-E<G1A:6X@<FES
M:W,L(&EN8VQU9&EN9R!T96-H;F]L;V=I8V%L("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-#8N,3 @5&0@*&]B
M<V]L97-C96YC92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 W+C4W(#0T
M-BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#$Q-BXR,2 T-#8N
M,3 @5&0@*&4@87)E(&-U<G)E;G1L>2!E=F%L=6%T:6YG('1H92!T96-H;F]L
M;V=Y('!L871F;W)M<R!O9B!O=7(@8G5S:6YE<W-E<RX@268@;W5R('!R;W!R
M:65T87)Y('-Y<W1E;7,@;V8@4V]F='=A<F4@87,@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0S-"XQ,"!49" H
M82!397)V:6-E(&%P<&QI8V%T:6]N<R!F86EL(&]R(&%R92!O=&AE<G=I<V4@
M=6YA8FQE('1O(&9U;F-T:6]N(&EN(&$@;6%N;F5R('1H870@<')O<&5R;'D@
M<W5P<&]R=',@;W5R(&)U<VEN97-S(&]P97)A=&EO;G,L(&]R(&EF("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M,C(N,3 @5&0@*'1H97-E('-Y<W1E;7,@<F5Q=6ER92!S:6=N:69I8V%N="!C
M;W-T<R!T;R!R97!A:7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S@N-#0@
M-#(R+C$P(%1D("@L(&UA:6YT86EN(&]R(&9U<G1H97(@9&5V96QO<"!O<B!U
M<&1A=&4L('=E(&-O=6QD(&5X<&5R:65N8V4@8G5S:6YE<W,@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Q,"XQ
M,"!49" H:6YT97)R=7!T:6]N<R!O<B!D96QA>7,@=&AA="!C;W5L9"!M871E
M<FEA;&QY(&%N9"!A9'9E<G-E;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.3,N,#<@-#$P+C$P(%1D("AF96-T(&]U<B!B=7-I;F5S<R!A;F0@9FEN
M86YC:6%L(')E<W5L=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#,Y,"XQ,"!49" H26X@861D:71I;VXL(&]U
M<B!I;F9O<FUA=&EO;B!S>7-T96US(&%R92!P<F]T96-T960@=&AR;W5G:"!A
M('-E8W5R92!H;W-T:6YG(&9A8VEL:71Y(&%N9"!A9&1I=&EO;F%L(&)A8VMU
M<"!R96UO=&4@<')O8V5S<VEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S<X+C$P(%1D("AC87!A8FEL:71I
M97,@86QS;R!E>&ES="!I;B!T:&4@979E;G0@;W5R('!R:6UA<GD@<WES=&5M
M<R!F86EL(&]R(&%R92!N;W0@86-C97-S:6)L92X@2&]W979E<BD@5&H@150@
M40IQ(# @," P(')G($)4(#0P.2XW-B S-S@N,3 @5&0@*"P@=&AE(&)U<VEN
M97-S(&ES('-T:6QL('9U;&YE<F%B;&4@=&\@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,V-BXQ,"!49" H9FER
M92P@<W1O<FTL(&9L;V]D+"!P;W=E<B!L;W-S+"!T96QE8V]M;75N:6-A=&EO
M;G,@9F%I;'5R97,L('!H>7-I8V%L(&]R('-O9G1W87)E(&)R96%K+6EN<R!A
M;F0@<VEM:6QA<B!E=F5N=',@=VAI8V@@;6%Y("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-30N,3 @5&0@*'!R
M979E;G0@<&5R<V]N;F5L(&9R;VT@9V%I;FEN9R!A8V-E<W,@=&\@<WES=&5M
M<R!N96-E<W-A<GD@=&\@<&5R9F]R;2!T:&5I<B!T87-K<R!I;B!A;B!A=71O
M;6%T960@9F%S:&EO;BX@26X@=&AE(&5V96YT('1H870@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,T,BXQ,"!4
M9" H8W)I=&EC86P@:6YF;W)M871I;VX@<WES=&5M<R!F86EL(&]R(&%R92!O
M=&AE<G=I<V4@=6YA=F%I;&%B;&4L('1H97-E(&9U;F-T:6]N<R!W;W5L9"!H
M879E('1O(&)E(&%C8V]M<&QI<VAE9"!M86YU86QL>2D@5&H@150@40IQ(# @
M," P(')G($)4(#4R-2XX-R S-#(N,3 @5&0@*"P@=VAI8V@@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,S,"XQ
M,"!49" H8V]U;&0@:6UP86-T(&]U<B!A8FEL:71Y('1O+"!A;6]N9R!O=&AE
M<B!T:&EN9W,L(&UA:6YT86EN(&)I;&QI;F<@86YD(&-L:6YI8V%L(')E8V]R
M9',@<F5L:6%B;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C N,#D@,S,P
M+C$P(%1D("@L('1O(&)I;&P@9F]R('-E<G9I8V5S(&5F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3 W+C8V(#,S,"XQ,"!49" H9FEC:65N=&QY(&%N9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,S$X+C$P(%1D("AT;R!M86EN=&%I;B!O=7(@86-C;W5N=&EN9R!A;F0@
M9FEN86YC:6%L(')E<&]R=&EN9R!A8V-U<F%T96QY*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,CDS+CDW(#,Q."XQ,"!49" H+BD@5&H@150@40I"5" O1C,@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R.3@N,3 @5&0@*%<I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XQ-2 R.3@N,3 @5&0@*&4@87)E
M(&1E<&5N9&5N="!O;B!T:&ER9"!P87)T:65S(&9O<B!T:&4@97AE8W5T:6]N
M(&]F(&-E<G1A:6X@8W)I=&EC86P@9G5N8W1I;VYS+BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-S@N,3 @5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" R-S@N,3 @5&0@*&4@
M:&%V92!O=71S;W5R8V5D(&-E<G1A:6X@8W)I=&EC86P@87!P;&EC871I;VYS
M(&]R(&)U<VEN97-S('!R;V-E<W-E<R!T;R!E>'1E<FYA;"!P<F]V:61E<G,L
M(&EN8VQU9&EN9R!B=70@;F]T(&QI;6ET960@=&\@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(V-BXQ,"!49" H
M8F%C:V=R;W5N9"!S8W)E96YI;F=S(&]F(&]U<B!E;7!L;WEE97,N("D@5&H@
M150@40IQ(# @," P(')G($)4(#(Q."XV-B R-C8N,3 @5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,C<N,CD@,C8V+C$P(%1D("AE(&5X97)C:7-E
M(&-A<F4@:6X@=&AE('-E;&5C=&EO;B!A;F0@;W9E<G-I9VAT(&]F('1H97-E
M('!R;W9I9&5R<RX@2&]W979E<BD@5&H@150@40IQ(# @," P(')G($)4(#4R
M,2XR,B R-C8N,3 @5&0@*"P@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-30N,3 @5&0@*&9A:6QU<F4@
M;W(@:6YA8FEL:71Y('1O('!E<F9O<FT@;VX@=&AE('!A<G0@;V8@;VYE(&]R
M(&UO<F4@;V8@=&AE<V4@8W)I=&EC86P@<W5P<&QI97)S(&-O=6QD(&-A=7-E
M('-I9VYI9FEC86YT(&1I<W)U<'1I;VYS(&%N9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C0R+C$P(%1D("AI
M;F-R96%S960@8V]S=',@=&\@;W5R(&)U<VEN97-S+BD@5&H@150@40I"5" O
M1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,C(N,3 @5&0@
M*$]U<B!C;VQL96-T:6]N+"!U<V4L(&%N9"!R971E;G1I;VX@;V8@<&5R<V]N
M86P@:6YF;W)M871I;VX@86YD('!E<G-O;F%L(&AE86QT:"!I;F9O<FUA=&EO
M;B!C<F5A=&4@<FES:W,@=&AA="!M87D@:&%R;2!O=7(@*2!4:B!%5"!1"D)4
M("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q,"XQ,"!4
M9" H8G5S:6YE<W,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#$Y,"XQ,"!49" H07,@<&%R="!O9B!O=7(@8G5S
M:6YE<W,@;6]D96PL('=E(&-O;&QE8W0L('1R86YS;6ET(&%N9"!R971A:6X@
M<&5R<V]N86P@:6YF;W)M871I;VX@;V8@;W5R(&5M<&QO>65E<R!A;F0@8V]N
M=')A8W0@<')O9F5S<VEO;F%L<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3<X+C$P(%1D("AA;F0@=&AE:7(@
M9&5P96YD96YT<RP@:6YC;'5D:6YG+"!W:71H;W5T(&QI;6ET871I;VXL(&9U
M;&P@;F%M97,L('-O8VEA;"!S96-U<FET>2!N=6UB97)S+"!A9&1R97-S97,L
M(&)I<G1H(&1A=&5S+"!A;F0@<&%Y<F]L;"TI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,38V+C$P(%1D("AR96QA
M=&5D(&EN9F]R;6%T:6]N+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S$N
M-S,@,38V+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30P+C,W
M(#$V-BXQ,"!49" H92!U<V4@8V]M;65R8VEA;&QY(&%V86EL86)L92!I;F9O
M<FUA=&EO;B!S96-U<FET>2!T96-H;F]L;V=I97,@=&\@<')O=&5C="!S=6-H
M(&EN9F]R;6%T:6]N(&EN(&1I9VET86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U-"XQ,"!49" H9F]R;6%T
M(&%N9"!H879E('-E8W5R:71Y(&%N9"!B=7-I;F5S<R!C;VYT<F]L<R!T;R!L
M:6UI="!A8V-E<W,@=&\@<W5C:"!I;F9O<FUA=&EO;BX@26X@861D:71I;VXL
M('=E('!E<FEO9&EC86QL>2!P97)F;W)M("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-#(N,3 @5&0@*'!E;F5T
M<F%T:6]N('1E<W1S(&%N9"!R97-P;VYD('1O('1H;W-E(&9I;F1I;F=S+B!(
M;W=E=F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<V+C<W(#$T,BXQ,"!4
M9" H+"!E;7!L;WEE97,@;W(@=&AI<F0@<&%R=&EE<R!M87D@8F4@86)L92!T
M;R!C:7)C=6UV96YT('1H97-E(&UE87-U<F5S("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S N,3 @5&0@*&%N
M9"!A8W%U:7)E(&]R(&UI<W5S92!S=6-H(&EN9F]R;6%T:6]N+"!R97-U;'1I
M;F<@:6X@8G)E86-H97,@;V8@<')I=F%C>2D@5&H@150@40IQ(# @," P(')G
M($)4(#,S."XT,R Q,S N,3 @5&0@*"P@86YD(&5R<F]R<R!I;B!T:&4@<W1O
M<F%G92P@=7-E(&]R('1R86YS;6ES<VEO;B!O9B!S=6-H("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,3@N,3 @
M5&0@*&EN9F]R;6%T:6]N+B!0<FEV86-Y(&)R96%C:&5S(&UA>2!R97%U:7)E
M(&YO=&EF:6-A=&EO;B!A;F0@;W1H97(@<F5M961I97,L('=H:6-H(&-A;B!B
M92!C;W-T;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S$N-#0@,3$X+C$P
M(%1D("@L(&%N9"!W:&EC:"!M87D@:&%V92!O=&AE<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3 V+C$P(%1D
M("AS97)I;W5S(&%D=F5R<V4@8V]N<V5Q=65N8V5S(&9O<B!O=7(@8G5S:6YE
M<W,L(&EN8VQU9&EN9R!R96=U;&%T;W)Y('!E;F%L=&EE<R!A;F0@9FEN97,L
M(&-L86EM<R!F;W(@8G)E86-H(&]F(&-O;G1R86-T+"!C;&%I;7,@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#DT
M+C$P(%1D("AF;W(@9&%M86=E<RP@861V97)S92!P=6)L:6-I='DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-S(N,#@@.30N,3 @5&0@*"P@<F5D=6-E9"!D
M96UA;F0@9F]R(&]U<B!S97)V:6-E<R!B>2!C;&EE;G1S(&%N9"]O<B!H96%L
M=&AC87)E('!R;V9E<W-I;VYA;"!C86YD:61A=&5S+"!H87)M('1O("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," X
M,BXQ,"!49" H;W5R(')E<'5T871I;VXL(&%N9"!R96=U;&%T;W)Y(&]V97)S
M:6=H="!B>2!S=&%T92!O<B!F961E<F%L(&%G96YC:65S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,C4N,C<@.#(N,3 @5&0@*%1H92!P;W-S97-S:6]N
M(&%N9"!U<V4@;V8@<&5R<V]N86P@:6YF;W)M871I;VX@86YD(&1A=&$@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<P+C$P(%1D("AI;B!C;VYD=6-T:6YG(&]U<B!B=7-I;F5S<R!S=6)J96-T
M<R!U<R!T;R!L96=I<VQA=&EV92!A;F0@<F5G=6QA=&]R>2!B=7)D96YS+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-38N-#,@-S N,3 @5&0@*%<I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C4N,#<@-S N,3 @5&0@*&4@;6%Y(&)E
M(')E<75I<F5D('1O(&EN8W5R('-I9VYI9FEC86YT(&5X<&5N<V5S("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M."XQ,"!49" H=&\@8V]M<&QY('=I=&@@;6%N9&%T;W)Y('!R:79A8WD@86YD
M('-E8W5R:71Y('-T86YD87)D<R!A;F0@<')O=&]C;VQS(&EM<&]S960@8GD@
M;&%W*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# Q+C0Y(#4X+C$P(%1D("@L
M(')E9W5L871I;VXL(&EN9'5S=')Y('-T86YD87)D<RP@;W(@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V+C$P
M(%1D("AC;VYT<F%C='5A;"!O8FQI9V%T:6]N<RXI(%1J($54(%$*96YD<W1R
M96%M"F5N9&]B:@HS,R P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P
M(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R
M(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#,T(# @4CX^"F5N9&]B:@HS-" P
M(&]B:@H\/"],96YG=&@@,3 U.#(^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P(%1D("@Q,RD@5&H@150@
M40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W-#(N
M,C4@5&0@*$-Y8F5R('-E8W5R:71Y(')I<VMS(&%N9"!C>6)E<B!I;F-I9&5N
M=',@8V]U;&0@861V97)S96QY(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,CDP+C,U(#<T,BXR-2!49" H9F5C="!O=7(@8G5S:6YE<W,@86YD(&1I<W)U
M<'0@;W!E<F%T:6]N<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-S(R+C(U(%1D("A#>6)E<B!I;F-I9&5N=',@
M8V%N(')E<W5L="!F<F]M(&1E;&EB97)A=&4@871T86-K<R!O<B!U;FEN=&5N
M=&EO;F%L(&5V96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0W+C(R
M(#<R,BXR-2!49" H5&AE<V4@:6YC:61E;G1S(&-A;B!I;F-L=61E+"!B=70@
M87)E(&YO="!L:6UI=&5D('1O+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-S$P+C(U(%1D("AG86EN:6YG('5N
M875T:&]R:7IE9"!A8V-E<W,@=&\@9&EG:71A;"!S>7-T96US(&9O<B!P=7)P
M;W-E<R!O9B!M:7-A<'!R;W!R:6%T:6YG(&%S<V5T<R!O<B!S96YS:71I=F4@
M:6YF;W)M871I;VXL(&-O<G)U<'1I;F<@9&%T82P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y."XR-2!49" H
M;W(@8V%U<VEN9R!O<&5R871I;VYA;"!D:7-R=7!T:6]N+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.#8N-S,@-CDX+C(U(%1D("A4:&4@<F5S=6QT(&]F
M('1H97-E(&EN8VED96YT<R!C;W5L9"!I;F-L=61E+"!B=70@87)E(&YO="!L
M:6UI=&5D('1O+"!D:7-R=7!T960@;W!E<F%T:6]N<RP@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8X-BXR-2!4
M9" H;6ES<W1A=&5D(&9I;F%N8VEA;"!D871A+"!L:6%B:6QI='D@9F]R('-T
M;VQE;B!A<W-E=',@;W(@:6YF;W)M871I;VXL(&EN8W)E87-E9"!C>6)E<B!S
M96-U<FET>2!P<F]T96-T:6]N(&-O<W1S+"!L:71I9V%T:6]N(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C<T+C(U(%1D("AR97!U=&%T:6]N86P@9&%M86=E(&%D=F5R<V5L>2!A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#$X,BXR-B V-S0N,C4@5&0@*&9E8W1I
M;F<@8W5S=&]M97(@;W(@:6YV97-T;W(@8V]N9FED96YC92Z@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S0U+CDP(#8W-"XR-2!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#,U-"XU-" V-S0N,C4@5&0@*&4@:&%V92!I;7!L96UE
M;G1E9"!S>7-T96US(&%N9"!P<F]C97-S97,@=&\@9F]C=7,@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8V,BXR
M-2!49" H;VX@:61E;G1I9FEC871I;VXL('!R979E;G1I;VXL(&UI=&EG871I
M;VX@86YD(')E<V]L=71I;VXN($AO=V5V97(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,3 N,S<@-C8R+C(U(%1D("@L('1H97-E(&UE87-U<F5S(&-A;FYO
M="!P<F]V:61E(&%B<V]L=71E('-E8W5R:71Y*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3 W+C$V(#8V,BXR-2!49" H+"!A;F0@;W5R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-3 N,C4@
M5&0@*'-Y<W1E;7,@;6%Y(&)E('9U;&YE<F%B;&4@=&\@8WEB97(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.3(N.#$@-C4P+C(U(%1D("@M<V5C=7)I='D@
M8G)E86-H97,@<W5C:"!A<R!V:7)U<V5S+"!H86-K:6YG+"!A;F0@<VEM:6QA
M<B!D:7-R=7!T:6]N<R!F<F]M('5N875T:&]R:7IE9" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C,X+C(U(%1D
M("AI;G1R=7-I;VYS+B!);B!A9&1I=&EO;BP@=V4@<F5L>2!O;B!T:&ER9"!P
M87)T>2!S97)V:6-E('!R;W9I9&5R<R!T;R!P97)F;W)M(&-E<G1A:6X@<V5R
M=FEC97,L('-U8V@@87,@<&%Y<F]L;"!A;F0@=&%X('-E<G9I8V5S+B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C(V+C(U(%1D("A!;GD@9F%I;'5R92!O9B!O=7(@<WES=&5M<R!O<B!T:&ER
M9"!P87)T>2!S>7-T96US(&UA>2!C;VUP<F]M:7-E(&]U<B!S96YS:71I=F4@
M:6YF;W)M871I;VX@86YD+V]R('!E<G-O;F%L;'D@:61E;G1I9FEA8FQE("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,30N,C4@5&0@*&EN9F]R;6%T:6]N(&]F(&]U<B!E;7!L;WEE97,N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$W,RXY-B V,30N,C4@5&0@*%=H:6QE
M('=E(&AA=F4@<V5C=7)E9"!C>6)E<B!I;G-U<F%N8V4@=&\@<&]T96YT:6%L
M;'D@8V]V97(@8V5R=&%I;B!R:7-K<R!A<W-O8VEA=&5D('=I=&@@8WEB97(@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8P,BXR-2!49" H:6YC:61E;G1S+"!T:&5R92!C86X@8F4@;F\@87-S
M=7)A;F-E('1H92!I;G-U<F%N8V4@=VEL;"!B92!S=68I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R.3,N,S0@-C R+C(U(%1D("AF:6-I96YT('1O(&-O=F5R
M(&%N>2!S=6-H(&QI86)I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#0R
M-"XU.2 V,#(N,C4@5&0@*"XI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3@R+C(U(%1D("A,;W-S97,@8V%U<V5D
M(&)Y(&YA='5R86P@9&ES87-T97)S+"!S=6-H(&%S(&AU<G)I8V%N97,@86YD
M(&9I<F5S+"!C;W5L9"!C875S92!U<R!T;R!S=68I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,#0N,S(@-3@R+C(U(%1D("AF97(@;6%T97)I86P@9FEN86YC
M:6%L(&QO<W-E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-38R+C(U(%1D("A#871A<W1R;W!H97,@8V%N(&)E
M(&-A=7-E9"!B>2!V87)I;W5S(&5V96YT<RP@:6YC;'5D:6YG+"!B=70@;F]T
M(&QI;6ET960@=&\L(&AU<G)I8V%N97,L(&9I<F5S+"!A;F0@;W1H97(@<V5V
M97)E('=E871H97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C(N-C,@-38R
M+C(U(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#4R-RXT-2 U-C(N
M,C4@5&0@*%1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-34P+C(U(%1D("AI;F-I9&5N8V4@86YD('-E=F5R
M:71Y(&]F(&-A=&%S=')O<&AE<R!A<F4@:6YH97)E;G1L>2!U;G!R961I8W1A
M8FQE+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C$N-C4@-34P+C(U(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,P+C8X(#4U,"XR-2!49" H
M:71H(&]U<B!H96%D<75A<G1E<G,@86YD('-H87)E9"!S97)V:6-E<R!L;V-A
M=&5D(&EN(%-O=71H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U,S@N,C4@5&0@*$9L;W)I9&$L('=E(&%R92!M
M;W)E('9U;&YE<F%B;&4@=&\@<&]S<VEB;&4@9&ES<G5P=&EO;G,@9G)O;2!H
M=7)R:6-A;F5S(&%N9"!T:&4@:6UP86-T<R!R97-U;'1I;F<@=&AE<F5F<F]M
M+"!S=6-H(&%S('1O<FYA9&]E<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#4R-BXR-2!49" H9FQO;V1I;F<L
M(&9U96P@<VAO<G1A9V5S+"!A;F0@9&ES<G5P=&EO;B!O9B!I;G1E<FYE="P@
M86YD('1E;&5C;VUM=6YI8V%T:6]N<R!S97)V:6-E<RX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,SDS+C W(#4R-BXR-2!49" H5&AE(&5X=&5N="!O9B!L
M;W-S97,@9G)O;2!A(&-A=&%S=')O<&AE(&ES("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,30N,C4@5&0@*&$@
M9G5N8W1I;VX@;V8@8F]T:"!T:&4@=&]T86P@86UO=6YT(&]F(&EN<W5R960@
M97AP;W-U<F4@86YD('1H92!S979E<FET>2!O9B!T:&4@979E;G0N("D@5&H@
M150@40IQ(# @," P(')G($)4(#,Y,"XU-B U,30N,C4@5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.3DN,3D@-3$T+C(U(%1D("AE(&1O(&YO="!M
M86EN=&%I;B!B=7-I;F5S<R!I;G1E<G)U<'1I;VX@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4P,BXR-2!49" H
M:6YS=7)A;F-E(&9O<B!T:&5S92!E=F5N=',N("D@5&H@150@40IQ(# @," P
M(')G($)4(#$U."XS.2 U,#(N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-C<N,#,@-3 R+C(U(%1D("AE(&-O=6QD('-U9BD@5&H@150@40IQ
M(# @," P(')G($)4(#(Q,"XW,B U,#(N,C4@5&0@*&9E<B!M871E<FEA;"!F
M:6YA;F-I86P@;&]S<V5S(&%S(&$@<F5S=6QT(&]F(&1I<W)U<'1I;VYS(&9R
M;VT@:'5R<FEC86YE<RP@9FER97,L(&%N9"!O=&AE<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DP+C(U(%1D
M("AC871A<W1R;W!H97,N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#0W,"XR-2!49" H5RD@5&H@150@40IQ(# @
M," P(')G($)4(#4X+C$U(#0W,"XR-2!49" H92!H879E(&$@;&5V96P@;V8@
M:6YD96)T961N97-S('=H:6-H(&UA>2!H879E(&%N(&%D=F5R<V4@968I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,#4N-#(@-#<P+C(U(%1D("AF96-T(&]N
M(&]U<B!B=7-I;F5S<R!O<B!L:6UI="!O=7(@86)I;&ET>2!T;R!T86ME(&%D
M=F%N=&%G92!O9B I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-#4X+C(U(%1D("AB=7-I;F5S<RP@<W1R871E9VEC
M(&]R(&9I;F%N8VEN9R!O<'!O<G1U;FET:65S+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,S@N,C4@5&0@*$%S
M(&EN9&EC871E9"!B96QO=RD@5&H@150@40IQ(# @," P(')G($)4(#$R-BXU
M-2 T,S@N,C4@5&0@*"P@=V4@:&%V92!A;F0@=VEL;"!C;VYT:6YU92!T;R!H
M879E(&$@<VEG;FEF:6-A;G0@86UO=6YT(&]F(&EN9&5B=&5D;F5S<R!R96QA
M=&EV92!T;R!O=7(@97%U:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 R
M+C<T(#0S."XR-2!49" H+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#<N
M-38@-#,X+C(U(%1D("A4:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#0R-BXR-2!49" H9F]L;&]W:6YG('1A
M8FQE('-E=',@9F]R=&@@;W5R('1O=&%L('!R:6YC:7!A;"!A;6]U;G0@;V8@
M9&5B="!A;F0@<W1O8VMH;VQD97)SDBD@5&H@150@40IQ(# @," P(')G($)4
M(#,V,"XP,B T,C8N,C4@5&0@*"!E<75I='DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S.#8N.#<@-#(V+C(U(%1D("@N*2!4:B!%5"!1"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#,W,RXW-2 T,3(N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-C(N-3 @,S<S+C<U(#$P,"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0V,BXU(#,Y-2XW-2!M"C4V,BXU(#,Y-2XW-2!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#8R+C4@,S4Y+C<U(&T*-38R+C4@,S4Y+C<U(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-C(N-2 S-3<N
M-S4@;0HU-C(N-2 S-3<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0V,BXU(#,U-RXW-2!M"C4V,BXU
M(#,U-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#8R+C4@,S4Y+C<U(&T*-38R+C4@,S4Y+C<U(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT-C(N-2 S-#0N-S4@;0HU-C(N-2 S-#0N-S4@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0V,BXU
M(#,T,BXW-2!M"C4V,BXU(#,T,BXW-2!L"G,*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,N,# @-# P+C0R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,BXW," T,# N-#(@
M5&0@*$1E8V5M8F5R(#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S+C P(#,X-BXS,B!49" HH"D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,"XP," S.#8N
M,C$@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," S-C,N-#(@5&0@
M*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XW-B S-C,N-#(@5&0@*&]T
M86P@9&5B="!A="!P87(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8U+C P(#,V,RXT,B!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N,34@,S8S+C0R(%1D
M("@X,RPX-S8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,N,# @,S0X+C0R(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N-#$@,S0X+C0R(%1D("AO=&%L($-R;W-S($-O=6YT<GD@2&5A;'1H
M8V%R92P@26YC+B!S=&]C:VAO;&1E<G,G(&5Q=6ET>2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,# @,S0X+C0R(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R-BXQ-2 S-#@N-#(@5&0@*#(Q-RPU,C@I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,Q,BXR-2!49" H3W5R(&QE=F5L(&]F(&EN9&5B=&5D;F5S<R!I;F-R
M96%S97,@=&AE('!O<W-I8FEL:71Y('1H870@=V4@;6%Y(&)E('5N86)L92!T
M;R!G96YE<F%T92!C87-H('-U9BD@5&H@150@40IQ(# @," P(')G($)4(#0R
M-"XT,B S,3(N,C4@5&0@*&9I8VEE;G0@=&\@<&%Y('1H92!P<FEN8VEP86PL
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," S,# N,C4@5&0@*&EN=&5R97-T(&]R(&]T:&5R(&%M;W5N=',@9'5E
M(&]N(&]U<B!I;F1E8G1E9&YE<W,N(%-U8FIE8W0@=&\@8V5R=&%I;B!R97-T
M<FEC=&EO;G,@=6YD97(@;W5R(&5X:7-T:6YG(&EN9&5B=&5D;F5S<RP@=V4@
M86YD(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C@X+C(U(%1D("AS=6)S:61I87)I97,@;6%Y(&%L<V\@
M:6YC=7(@<VEG;FEF:6-A;G0@861D:71I;VYA;"!I;F1E8G1E9&YE<W,@:6X@
M=&AE(&9U='5R92P@<V]M92!O9B!W:&EC:"!M87D@8F4@<V5C=7)E9"!D96)T
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#0N-#(@,C@X+C(U(%1D("A4
M:&ES(&UA>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C<V+C(U(%1D("AH879E('1H92!E9BD@5&H@150@40IQ
M(# @," P(')G($)4(#DS+C8X(#(W-BXR-2!49" H9F5C="!O9B!I;F-R96%S
M:6YG(&]U<B!T;W1A;"!L979E<F%G92X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C0P+C P(#(W-BXR-2!49" H07,@82!C;VYS97%U96YC92!O9B!O=7(@
M:6YD96)T961N97-S.R!<*#%<*:!D96UA;F1S(&]N(&]U<B!C87-H(')E<V]U
M<F-E<R!M87D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#(V-"XR-2!49" H:6YC<F5A<V4[(%PH,EPIH'=E(&%R
M92!S=6)J96-T('1O(')E<W1R:6-T:79E(&-O=F5N86YT<R!T:&%T(&QI;6ET
M(&]U<B!F:6YA;F-I86P@86YD(&]P97)A=&EN9R!F;&5X:6)I;&ET>2D@5&H@
M150@40IQ(# @," P(')G($)4(#0T-2XS,B R-C0N,C4@5&0@*"X@3W5R(&%B
M:6QI='D@=&\@9V5N97)A=&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(U,BXR-2!49" H<')O9FET86)I;&ET
M>2!A;F0@;6%I;G1A:6X@8V%S:"!F;&]W(&9R;VT@;W!E<F%T:6]N<R!C;W5L
M9"!I;7!A8W0@;W5R(&-O;7!L:6%N8V4@=VET:"!T:&5S92!C;W9E;F%N=',[
M(&%N9"!<*#-<*:!W92!M87D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(T,"XR-2!49" H8VAO;W-E('1O(&EN
M<W1I='5T92!S96QF+6EM<&]S960@;&EM:71S(&]N(&]U<B!I;F1E8G1E9&YE
M<W,@8F%S960@;VX@8V5R=&%I;B!C;VYS:61E<F%T:6]N<R!I;F-L=61I;F<@
M;6%R:V5T(&EN=&5R97-T(')A=&5S+"!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R."XR-2!49" H<F5L
M871I=F4@;&5V97)A9V4@86YD(&]U<B!S=')A=&5G:6,@<&QA;G,N($9O<B!E
M>&%M<&QE+"!A<R!A(')E<W5L="!O9B!O=7(@;&5V96P@;V8@:6YD96)T961N
M97-S(&%N9"!T:&4@=6YC97)T86EN=&EE<R!A<FES:6YG(&EN("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,38N
M,C4@5&0@*'1H92!C<F5D:70@;6%R:V5T<R!A;F0@=&AE(%4N4RX@96-O;F]M
M>3HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3DV+C(U(%1D("@M("D@5&H@150@40IQ(# @," P(')G($)4(#4Y
M+C P(#$Y-BXR-2!49" H=V4@;6%Y(&)E(&UO<F4@=G5L;F5R86)L92!T;R!G
M96YE<F%L(&%D=F5R<V4@96-O;F]M:6,@86YD(&EN9'5S=')Y(&-O;F1I=&EO
M;G,[*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#$W-BXR-2!49" H+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M.2XP," Q-S8N,C4@5&0@*'=E(&UA>2!H879E('1O('!A>2!H:6=H97(@:6YT
M97)E<W0@<F%T97,@=7!O;B!R969I;F%N8VEN9R!O<B!O;B!O=7(@=F%R:6%B
M;&4@<F%T92!I;F1E8G1E9&YE<W,@:68@:6YT97)E<W0@<F%T97,@<FES92P@
M=&AE<F5B>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3DN,# @,38T+C(U(%1D("AR961U8VEN9R!O=7(@8V%S:"!F;&]W
M<SLI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,30T+C(U(%1D("@M("D@5&H@150@40IQ(# @," P(')G($)4(#4Y
M+C P(#$T-"XR-2!49" H=V4@;6%Y(&9I;F0@:70@;6]R92!D:68I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-3,N-3(@,30T+C(U(%1D("AF:6-U;'0@=&\@
M;V)T86EN(&%D9&ET:6]N86P@9FEN86YC:6YG('1O(&9U;F0@9G5T=7)E('=O
M<FMI;F<@8V%P:71A;"P@8V%P:71A;"!E>'!E;F1I='5R97,L(&%C<75I<VET
M:6]N<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4Y+C P(#$S,BXR-2!49" H86YD(&]T:&5R(&=E;F5R86P@8V]R<&]R
M871E(')E<75I<F5M96YT<R!T:&%T('=O=6QD(&)E(&EN(&]U<B!L;VYG+71E
M<FT@:6YT97)E<W1S.RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," Q,3(N,C4@5&0@*"T@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3DN,# @,3$R+C(U(%1D("AW92!M87D@8F4@<F5Q=6ER960@
M=&\@9&5D:6-A=&4@82!S=6)S=&%N=&EA;"!P;W)T:6]N(&]F(&]U<B!C87-H
M(&9L;W<@9G)O;2!O<&5R871I;VYS('1O('1H92!P87EM96YT(&]F('!R:6YC
M:7!A;"!A;F0@:6YT97)E<W0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4Y+C P(#$P,"XR-2!49" H;VX@;W5R(&1E8G0L
M(')E9'5C:6YG('1H92!A=F%I;&%B;&4@8V%S:"!F;&]W('1O(&9U;F0@;W1H
M97(@:6YV97-T;65N=',[*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#@P+C(U(%1D("@M("D@5&H@150@40IQ(# @
M," P(')G($)4(#4Y+C P(#@P+C(U(%1D("AW92!M87D@:&%V92!L:6UI=&5D
M(&9L97AI8FEL:71Y(&EN('!L86YN:6YG(&9O<BD@5&H@150@40IQ(# @," P
M(')G($)4(#(T-BXP-B X,"XR-2!49" H+"!O<B!R96%C=&EN9R!T;RP@8VAA
M;F=E<R!I;B!O=7(@8G5S:6YE<W,@;W(@:6X@=&AE(&EN9'5S=')Y.RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M,"XR-2!49" H+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" U.2XP," V,"XR
M-2!49" H=V4@;6%Y(&AA=F4@82!C;VUP971I=&EV92!D:7-A9'9A;G1A9V4@
M<F5L871I=F4@=&\@;W1H97(@8V]M<&%N:65S(&EN(&]U<B!I;F1U<W1R>2!T
M:&%T(&%R92!L97-S(&QE=F5R86=E9#L@86YD*2!4:B!%5"!1"F5N9'-T<F5A
M;0IE;F1O8FH*,S4@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R S-B P(%(^/@IE;F1O8FH*,S8@,"!O
M8FH*/#PO3&5N9W1H(#$P-C@Q/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,30I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C$P
M(%1D("@M("D@5&H@150@40IQ(# @," P(')G($)4(#4Y+C P(#<T,BXQ,"!4
M9" H=V4@;6%Y(&)E(')E<75I<F5D('1O('-E;&P@9&5B="!O<B!E<75I='D@
M<V5C=7)I=&EE<R!O<B!S96QL('-O;64@;V8@;W5R(&-O<F4@87-S971S+"!P
M;W-S:6)L>2!O;B!U;F9A=F]R86)L92!T97)M<RP@:6X@;W)D97(@=&\@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P
M(#<S,"XQ,"!49" H;65E="!P87EM96YT(&]B;&EG871I;VYS+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3 N
M,3 @5&0@*%1H97-E(&-O;G-T<F%I;G1S(&-O=6QD(&AA=F4@82!M871E<FEA
M;"!A9'9E<G-E(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4Q+C$R(#<Q
M,"XQ,"!49" H9F5C="!O;B!O=7(@8G5S:6YE<W,N*2!4:B!%5"!1"D)4("]&
M,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y,"XQ,"!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C$U(#8Y,"XQ,"!49" H92!C
M;W5L9"!F86EL('1O(&=E;F5R871E('-U9BD@5&H@150@40IQ(# @," P(')G
M($)4(#$V-RXV." V.3 N,3 @5&0@*&9I8VEE;G0@8V%S:"!T;R!F=6YD(&]U
M<B!L:7%U:61I='D@;F5E9',@86YD+V]R(&9A:6P@=&\@<V%T:7-F>2!T:&4@
M9FEN86YC:6%L(&%N9"!O=&AE<B!R97-T<FEC=&EV92 I(%1J($54(%$*0E0@
M+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C<X+C$P(%1D
M("AC;W9E;F%N=',@=&\@=VAI8V@@=V4@87)E('-U8FIE8W0@=6YD97(@;W5R
M(&5X:7-T:6YG(&EN9&5B=&5D;F5S<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3@N-C0@-C4X+C$P(%1D("AE(&-U<G)E;G1L
M>2!H879E('-U9BD@5&H@150@40IQ(# @," P(')G($)4(#$S-RXU.2 V-3@N
M,3 @5&0@*&9I8VEE;G0@;&EQ=6ED:71Y('1O(&]P97)A=&4@;W5R(&)U<VEN
M97-S(&EN('1H92!N;W)M86P@8V]U<G-E+J!)9BP@:&]W979E<BD@5&H@150@
M40IQ(# @," P(')G($)4(#0R.2XP-2 V-3@N,3 @5&0@*"P@=V4@=V5R92!T
M;R!M86ME(&%N(&%C<75I<VET:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-#8N,3 @5&0@*&]R(&5N=&5R
M(&EN=&\@82!S:6UI;&%R('1Y<&4@;V8@=')A;G-A8W1I;VXL(&]U<B!L:7%U
M:61I='D@;F5E9',@;6%Y(&5X8V5E9"!O=7(@8W5R<F5N="!C87!A8VET>2D@
M5&H@150@40IQ(# @," P(')G($)4(#0R-"XW-R V-#8N,3 @5&0@*"X@26X@
M861D:71I;VXL(&]U<B!E>&ES=&EN9R!C<F5D:70@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8S-"XQ,"!49" H
M9F%C:6QI=&EE<R!C=7)R96YT;'D@8V]N=&%I;B!F:6YA;F-I86P@8V]V96YA
M;G1S('1H870@<F5Q=6ER92!U<R!T;R!O<&5R871E(&%B;W9E(&$@;6EN:6UU
M;2!F:7AE9"!C:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4T+C$Q(#8S
M-"XQ,"!49" H9V4@8V]V97)A9V4@<F%T:6\@86YD("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,C(N,3 @5&0@
M*&)E;&]W(&$@8V]N<V]L:61A=&5D(&QE=F5R86=E(')A=&EO+B!$971E<FEO
M<F%T:6]N(&EN(&]U<B!O<&5R871I;F<@<F5S=6QT<R!C;W5L9"!R97-U;'0@
M:6X@;W5R(&EN86)I;&ET>2!T;R!C;VUP;'D@=VET:"!T:&5S92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C$P
M+C$P(%1D("AC;W9E;F%N=',@86YD('=O=6QD(')E<W5L="!I;B!A(&1E9F%U
M;'0@=6YD97(@;W5R(&-R961I="!F86-I;&ET>2D@5&H@150@40IQ(# @," P
M(')G($)4(#,P,RXQ-2 V,3 N,3 @5&0@*"Z@268@86X@979E;G0@;V8@9&5F
M875L="!E>&ES=',L(&]U<B!L96YD97)S(&-O=6QD(&-A;&P@=&AE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M.3@N,3 @5&0@*&EN9&5B=&5D;F5S<R!A;F0@=V4@;6%Y(&)E('5N86)L92!T
M;R!R96YE9V]T:6%T92!O<B!S96-U<F4@;W1H97(@9FEN86YC:6YG+BD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M-S@N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XQ-2 U-S@N
M,3 @5&0@*&4@87)E('-U8FIE8W0@=&\@8G5S:6YE<W,@<FES:W,@87-S;V-I
M871E9"!W:71H(&EN=&5R;F%T:6]N86P@;W!E<F%T:6]N<RXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-34X+C$P
M(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@-34X+C$P(%1D
M("AE(&AA=F4@:6YT97)N871I;VYA;"!O<&5R871I;VYS(&EN($EN9&EA('=H
M97)E(&]U<B!#<F]S<R!#;W5N=')Y($EN9F]T96-H+"!0=G0@3'1D+B!<*$EN
M9F]T96-H7"D@<W5B<VED:6%R>2!I<R!L;V-A=&5D+B!);F9O=&5C:" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-30V+C$P(%1D("AP<F]V:61E<R!I;BUH;W5S92!I;F9O<FUA=&EO;B!S>7-T
M96US(&1E=F5L;W!M96YT(&%N9"!S=7!P;W)T('-E<G9I8V5S(&%S('=E;&P@
M87,@<V]M92!B86-K+6]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0Q+C0P
M(#4T-BXQ,"!49" H9FEC92!P<F]C97-S:6YG('-E<G9I8V5S+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U-#$N,3@@-30V+C$P(%1D("A7*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-30Y+C@Q(#4T-BXQ,"!49" H92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3,T+C$P
M(%1D("AH879E(&QI;6ET960@97AP97)I96YC92!I;B!S=7!P;W)T:6YG(&]U
M<B!S97)V:6-E<R!O=71S:61E(&]F($YO<G1H("D@5&H@150@40IQ(# @," P
M(')G($)4(#,R,2XV," U,S0N,3 @5&0@*$%M97)I8V$NH$]P97)A=&EO;G,@
M:6X@8V5R=&%I;B!M87)K971S(&%R92!S=6)J96-T('1O(')I<VMS("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M,C(N,3 @5&0@*&EN:&5R96YT(&EN(&EN=&5R;F%T:6]N86P@8G5S:6YE<W,@
M86-T:79I=&EE<RP@:6YC;'5D:6YG.B!F;'5C='5A=&EO;G,@:6X@8W5R<F5N
M8WD@97AC:&%N9V4@<F%T97,[(&-H86YG97,@:6X@<F5G=6QA=&EO;G,[('9A
M<GEI;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4Q,"XQ,"!49" H96-O;F]M:6,@86YD('!O;&ET:6-A;"!C
M;VYD:71I;VYS.R!O=F5R;&%P<&EN9R!O<B!D:68I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-C(N-30@-3$P+C$P(%1D("AF97)I;F<@=&%X('-T<G5C='5R
M97,[(&%N9"!R96=U;&%T:6]N<R!<*'!E<G1A:6YI;F<@=&\L(&%M;VYG(&]T
M:&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," T.3@N,3 @5&0@*'1H:6YG<RR@8V]M<&5N<V%T:6]N(&%N9"!B
M96YE9FET<RP@=F%C871I;VXL(&%N9"!T:&4@=&5R;6EN871I;VX@;V8@96UP
M;&]Y;65N=%PI+J!/=7(@:6YA8FEL:71Y('1O(&5F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#4Q+C$Q(#0Y."XQ,"!49" H9F5C=&EV96QY(&UA;F%G92!O
M=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0X-BXQ,"!49" H:6YT97)N871I;VYA;"!O<&5R871I;VYS(&]R
M(&]U<B!V:6]L871I;VX@;V8@82!R96=U;&%T:6]N(&-O=6QD(')E<W5L="!I
M;B!I;F-R96%S960@8V]S=',@86YD(&%D=F5R<V5L>2!A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#0V,"XU,B T.#8N,3 @5&0@*&9E8W0@;W5R(')E<W5L
M=',@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#0W-"XQ,"!49" H;W!E<F%T:6]N<RXI(%1J($54(%$*0E0@
M+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#4T+C$P(%1D
M("A$=64@=&\@:6YH97)E;G0@;&EM:71A=&EO;G,L('1H97)E(&-A;B!B92!N
M;R!A<W-U<F%N8V4@=&AA="!O=7(@<WES=&5M(&]F(&1I<V-L;W-U<F4@86YD
M(&EN=&5R;F%L(&-O;G1R;VQS(&%N9"!P<F]C961U<F5S("D@5&H@150@40I"
M5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-#(N,3 @
M5&0@*'=I;&P@8F4@<W5C8V5S<V9U;"!I;B!P<F5V96YT:6YG(&%L;"!E<G)O
M<G,@86YD(&9R875D+"!O<B!I;B!M86MI;F<@86QL(&UA=&5R:6%L(&EN9F]R
M;6%T:6]N(&MN;W=N(&EN(&$@=&EM96QY(&UA;FYE<B!T;R I(%1J($54(%$*
M0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#,P+C$P
M(%1D("AM86YA9V5M96YT+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," T,3 N,3 @5&0@*$]U<B!M86YA9V5M96YT
M+"!I;F-L=61I;F<@;W5R($-H:65F($5X96-U=&EV92!/9BD@5&H@150@40IQ
M(# @," P(')G($)4(#(U-RXX,2 T,3 N,3 @5&0@*&9I8V5R(&%N9"!#:&EE
M9B!&:6YA;F-I86P@3V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S N,S<@
M-#$P+C$P(%1D("AF:6-E<BD@5&H@150@40IQ(# @," P(')G($)4(#,X."XR
M." T,3 N,3 @5&0@*"P@9&]E<R!N;W0@97AP96-T('1H870@;W5R(&1I<V-L
M;W-U<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#,Y."XQ,"!49" H8V]N=')O;',@86YD(&EN=&5R;F%L(&-O
M;G1R;VQS('=I;&P@<')E=F5N="!A;&P@97)R;W)S(&%N9"!A;&P@9G)A=60N
M("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,RXR-2 S.3@N,3 @5&0@*$$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3DN.3(@,SDX+C$P(%1D("@@8V]N
M=')O;"!S>7-T96TL(&YO(&UA='1E<B!H;W<@=V5L;"!D97-I9VYE9"!A;F0@
M;W!E<F%T960L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," S.#8N,3 @5&0@*&-A;B!P<F]V:61E(&]N;'D@<F5A
M<V]N86)L92P@;F]T(&%B<V]L=71E+"!A<W-U<F%N8V4@=&AA="!T:&4@;V)J
M96-T:79E<R!O9B!T:&4@8V]N=')O;"!S>7-T96T@87)E(&UE="X@0F5C875S
M92!O9B!T:&4@:6YH97)E;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#,W-"XQ,"!49" H;&EM:71A=&EO;G,@
M:6X@86QL(&-O;G1R;VP@<WES=&5M<RP@;F\@979A;'5A=&EO;B!O9B!C;VYT
M<F]L<R!C86X@<')O=FED92!A8G-O;'5T92!A<W-U<F%N8V4@=&AA="!A;&P@
M8V]N=')O;"!I<W-U97,@86YD(&EN<W1A;F-E<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S8R+C$P(%1D("AO
M9B!F<F%U9"P@:68@86YY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 Y+C,S
M(#,V,BXQ,"!49" H+"!W:71H:6X@;W5R(&-O;7!A;GD@:&%V92!B965N(&1E
M=&5C=&5D+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S@N,C4@,S8R+C$P
M(%1D("A4:&5S92!I;FAE<F5N="!L:6UI=&%T:6]N<R!I;F-L=61E('1H92!R
M96%L:71I97,@=&AA="!J=61G;65N=',@:6X@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U,"XQ,"!49" H9&5C
M:7-I;VXM;6%K:6YG(&-A;B!B92!F875L='DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-S N,30@,S4P+C$P(%1D("@L(&%N9"!T:&%T(&)R96%K9&]W;G,@
M8V%N(&]C8W5R(&)E8V%U<V4@;V8@82!S:6UP;&4@97)R;W(@;W(@;6ES=&%K
M92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4P+C@W(#,U,"XQ,"!49" H
M061D:71I;VYA;&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 P+C<W(#,U
M,"XQ,"!49" H+"!C;VYT<F]L<R!C86X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,S."XQ,"!49" H8F4@8VER
M8W5M=F5N=&5D(&)Y('1H92!A8W1S(&]F(&%N(&EN9&EV:61U86PL(&)Y(&-O
M;&QU<VEO;B!O9B!T=V\@;W(@;6]R92!P96]P;&4L(&]R(&)Y(&UA;F%G96UE
M;G0@;W9E<G)I9&4@;V8@=&AE(&-O;G1R;VPN*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Q."XQ,"!49" H5&AE
M(&1E<VEG;B!O9B!A;GD@<WES=&5M(&]F(&-O;G1R;VQS(&%L<V\@:7,@8F%S
M960@:6X@<&%R="!U<&]N(&-E<G1A:6X@87-S=6UP=&EO;G,@86)O=70@=&AE
M(&QI:V5L:6AO;V0@;V8@9G5T=7)E(&5V96YT<RP@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,#8N,3 @
M5&0@*'1H97)E(&-A;B!B92!N;R!A<W-U<F%N8V4@=&AA="!A;GD@9&5S:6=N
M('=I;&P@<W5C8V5E9"!I;B!A8VAI979I;F<@:71S('-T871E9"!G;V%L<R!U
M;F1E<B!A;&P@<&]T96YT:6%L(&9U='5R92!C;VYD:71I;VYS.R!O=F5R("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," R.30N,3 @5&0@*'1I;64L(&$@8V]N=')O;"!M87D@8F5C;VUE(&EN861E
M<75A=&4@8F5C875S92!O9B!C:&%N9V5S(&EN(&-O;F1I=&EO;G,L(&]R('1H
M92!D96=R964@;V8@8V]M<&QI86YC92!W:71H('1H92!P;VQI8VEE<R!O<B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,C@R+C$P(%1D("AP<F]C961U<F5S(&UA>2!D971E<FEO<F%T92X@0F5C
M875S92!O9B!T:&4@:6YH97)E;G0@;&EM:71A=&EO;G,L(&UI<W-T871E;65N
M=',@9'5E('1O(&5R<F]R(&]R(&9R875D(&UA>2!O8V-U<B!A;F0@;F]T(&)E
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," R-S N,3 @5&0@*&1E=&5C=&5D+BD@5&H@150@40I"5" O1C,@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-3 N,3 @5&0@*$EM<&%I
M<FUE;G0@:6X@=&AE('9A;'5E(&]F(&]U<B!G;V]D=VEL;"P@=')A9&4@;F%M
M97,L(&]R(&]T:&5R(&EN=&%N9VEB;&4@87-S971S(&-O=6QD(&YE9V%T:79E
M;'D@:6UP86-T(&]U<B!N970@:6YC;VUE(&%N9" I(%1J($54(%$*0E0@+T8S
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C,X+C$P(%1D("AE
M87)N:6YG<R!P97(@<VAA<F4N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(Q."XQ,"!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#4X+C8T(#(Q."XQ,"!49" H92!A<F4@<F5Q=6ER960@
M=&\@=&5S="!G;V]D=VEL;"!A;F0@:6YT86YG:6)L92!A<W-E=',@=VET:"!I
M;F1E9FEN:71E(&QI=F5S(%PH<W5C:"!A<R!T<F%D92!N86UE<UPI(&%N;G5A
M;&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Q+C(P(#(Q."XQ,"!49" H
M+"!T;R!D971E<FUI;F4@:68@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(P-BXQ,"!49" H:6UP86ER;65N="!H
M87,@;V-C=7)R960N($QO;F<M;&EV960@87-S971S(&%N9"!O=&AE<B!I9&5N
M=&EF:6%B;&4@:6YT86YG:6)L92!A<W-E=',@87)E(&%L<V\@<F5V:65W960@
M9F]R(&EM<&%I<FUE;G0@=VAE;F5V97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Y-"XQ,"!49" H979E;G1S
M(&]R(&-H86YG97,@:6X@8VER8W5M<W1A;F-E<R!I;F1I8V%T92!T:&%T(&%M
M;W5N=',@;6%Y(&YO="!B92!R96-O=F5R86)L92X@268@=&AE('1E<W1I;F<@
M<&5R9F]R;65D(&EN9&EC871E<R!T:&%T("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q.#(N,3 @5&0@*&EM<&%I
M<FUE;G0@:&%S(&]C8W5R<F5D+"!W92!A<F4@<F5Q=6ER960@=&\@<F5C;W)D
M(&$@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S8X+C4V(#$X,BXQ,"!49" H9V4@9F]R('1H92!D:68I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,C N,S$@,3@R+C$P(%1D("AF97)E;F-E(&)E
M='=E96X@=&AE(&-A<G)Y:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," Q-S N,3 @5&0@*&%M;W5N="!O9B!T
M:&4@9V]O9'=I;&P@;W(@;W1H97(@:6YT86YG:6)L92!A<W-E=',@86YD('1H
M92!I;7!L:65D(&9A:7(@=F%L=64@;V8@=&AE(&=O;V1W:6QL(&]R('1H92!F
M86ER('9A;'5E(&]F('1H92!I;F1E9FEN:71E+2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-3@N,3 @5&0@*&QI
M=F5D(&EN=&%N9VEB;&4@87-S970@:6X@=&AE('!E<FEO9"!T:&4@9&5T97)M
M:6YA=&EO;B!I<R!M861E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3@N
M,S8@,34X+C$P(%1D("A4:&4@=&5S=&EN9R!O9B!G;V]D=VEL;"!A;F0@;W1H
M97(@:6YT86YG:6)L92!A<W-E=',@9F]R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-#8N,3 @5&0@*&EM<&%I
M<FUE;G0@<F5Q=6ER97,@=7,@=&\@;6%K92!S:6=N:69I8V%N="!E<W1I;6%T
M97,@86)O=70@;W5R(&9U='5R92!P97)F;W)M86YC92!A;F0@8V%S:"!F;&]W
M<RP@87,@=V5L;"!A<R!O=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3,T+C$P(%1D("AA<W-U;7!T:6]N
M<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 T+C(W(#$S-"XQ,"!49" H
M5&AE<V4@97-T:6UA=&5S(&-A;B!B92!A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(P-BXR-B Q,S0N,3 @5&0@*&9E8W1E9"!B>2!N=6UE<F]U<R!F86-T
M;W)S+"!I;F-L=61I;F<@8VAA;F=E<R!I;B!E8V]N;VUI8RP@:6YD=7-T<GD@
M;W(@;6%R:V5T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," Q,C(N,3 @5&0@*&-O;F1I=&EO;G,L(&-H86YG97,@
M:6X@8G5S:6YE<W,@;W!E<F%T:6]N<RP@8VAA;F=E<R!I;B!C;VUP971I=&EO
M;B!O<B!C:&%N9V5S(&EN(&]U<B!S=&]C:R!P<FEC92!A;F0@;6%R:V5T(&-A
M<&ET86QI>F%T:6]N+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,3$P+C$P(%1D("A#:&%N9V5S(&EN('1H97-E
M(&9A8W1O<G,L(&]R(&-H86YG97,@:6X@86-T=6%L('!E<F9O<FUA;F-E(&-O
M;7!A<F5D('=I=&@@97-T:6UA=&5S(&]F(&]U<B!F=71U<F4@<&5R9F]R;6%N
M8V4L(&-O=6QD(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,P+C0V(#$Q
M,"XQ,"!49" H9F5C="!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#DX+C$P(%1D("AF86ER('9A;'5E(&]F
M(&=O;V1W:6QL+"!T<F%D92!N86UE<RP@;W(@;W1H97(@:6YT86YG:6)L92!A
M<W-E=',L('=H:6-H(&UA>2!R97-U;'0@:6X@86X@:6UP86ER;65N="!C:&%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4X+C@V(#DX+C$P(%1D("AG92X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<S+C$R(#DX+C$P(%1D("A7*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#@Q+C<V(#DX+C$P(%1D("AE(&-A;FYO
M="!A8V-U<F%T96QY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," X-BXQ,"!49" H<')E9&EC="!T:&4@86UO=6YT
M(&%N9"!T:6UI;F<@;V8@86YY(&EM<&%I<FUE;G0@;V8@87-S971S+B!3:&]U
M;&0@=&AE('9A;'5E(&]F(&=O;V1W:6QL(&]R(&]T:&5R(&EN=&%N9VEB;&4@
M87-S971S(&)E8V]M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-S0N,3 @5&0@*&EM<&%I<F5D+"!T:&5R92!C
M;W5L9"!B92!A;B!A9'9E<G-E(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C R+C(U(#<T+C$P(%1D("AF96-T(&]N('5S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-#4N-3<@-S0N,3 @5&0@*$%T($1E8V5M8F5RH#,Q+" R,#$X
M+"!G;V]D=VEL;"P@=')A9&4@;F%M97,@;F]T('-U8FIE8W0@=&\@86UO<G1I
M>F%T:6]N+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#8R+C$P(%1D("AO=&AE<B!I;G1A;F=I8FQE(&%S
M<V5T<R!R97!R97-E;G1E9" T,24@;V8@;W5R('1O=&%L(&%S<V5T<RX@26X@
M,C Q."P@,C Q-RP@86YD(#(P,38L('=E(')E8V]R9&5D(&EM<&%I<FUE;G0@
M8VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#4P-BXP-R V,BXQ,"!49" H
M9V5S(&]F("0R,BXT("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U,"XQ,"!49" H;6EL;&EO;BP@)#$T+C0@;6EL
M;&EO;BP@86YD("0R-"XS(&UI;&QI;VXL(')E<W!E8W1I=F5L>2D@5&H@150@
M40IQ(# @," P(')G($)4(#(V-BXR-R U,"XQ,"!49" H+BD@5&H@150@40IE
M;F1S=')E86T*96YD;V)J"C,W(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N
M=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R
M8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,S@@,"!2/CX*96YD;V)J
M"C,X(# @;V)J"CP\+TQE;F=T:" Q,3$V,SX^"G-T<F5A;0I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#$U*2!4
M:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<T,BXR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C$U(#<T
M,BXR-2!49" H92!C;W5L9"!S=68I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,#(N.3<@-S0R+C(U(%1D("AF97(@861V97)S92!T87@@86YD(&]T:&5R(&9I
M;F%N8VEA;"!C;VYS97%U96YC97,@:68@=&%X:6YG(&%U=&AO<FET:65S(&1O
M(&YO="!A9W)E92!W:71H(&]U<B!T87@@<&]S:71I;VYS+"!I9B I(%1J($54
M(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S,P
M+C(U(%1D("AT:&5R92!A<F4@9G5R=&AE<B!L96=I<VQA=&EV92!T87@@8VAA
M;F=E<RP@;W(@:68@=V4@87)E('5N86)L92!T;R!U=&EL:7IE(&]U<B!N970@
M;W!E<F%T:6YG(&QO<W-E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S$P+C(U(%1D("A7*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3@N-C0@-S$P+C(U(%1D("AE(&%R92!P97)I;V1I8V%L
M;'D@<W5B:F5C="!T;R!A(&YU;6)E<B!O9B!T87@@97AA;6EN871I;VYS(&)Y
M('1A>&EN9R!A=71H;W)I=&EE<R!I;B!T:&4@<W1A=&5S(&%N9"!C;W5N=')I
M97,@=VAE<F4@=V4@9&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8Y."XR-2!49" H8G5S:6YE<W,N("D@5&H@
M150@40IQ(# @," P(')G($)4(#@X+C<Q(#8Y."XR-2!49" H5RD@5&H@150@
M40IQ(# @," P(')G($)4(#DW+C,U(#8Y."XR-2!49" H92!A;'-O(&AA=F4@
M<VEG;FEF:6-A;G0@9&5F97)R960@=&%X(&%S<V5T<R!R96QA=&5D('1O(&]U
M<B!N970@;W!E<F%T:6YG(&QO<W-E<R!<*$Y/3'-<*2!I;B!5+E,N(&9E9&5R
M86P@86YD('-T871E('1A>&EN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C@V+C(U(%1D("AJ=7)I<V1I8W1I
M;VYS+"!W:&EC:"P@9V5N97)A;&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3<P+C0S(#8X-BXR-2!49" H+"!F;W(@52Y3+B!F961E<F%L(&%N9"!S=&%T
M92!T87@@<'5R<&]S97,L(&-A<G)Y(&9O<G=A<F0@9F]R('5P('1O('1W96YT
M>2!Y96%R<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@R+CDR(#8X-BXR
M-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#0X."XS,R V.#8N,C4@
M5&0@*&%X('EE87)S(&=E;F5R86QL>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C<T+C(U(%1D("AR96UA:6X@
M<W5B:F5C="!T;R!E>&%M:6YA=&EO;B!U;G1I;"!T:')E92!Y96%R<R!A9G1E
M<B!.3TQS(&%R92!U<V5D(&]R(&5X<&ER92X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S8T+C$U(#8W-"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G
M($)4(#,W,BXW." V-S0N,C4@5&0@*&4@97AP96-T('1H870@=V4@=VEL;"!C
M;VYT:6YU92!T;R!B92!S=6)J96-T('1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-C(N,C4@5&0@*'1A>"!E
M>&%M:6YA=&EO;G,@:6X@=&AE(&9U='5R92X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3<T+C(S(#8V,BXR-2!49" H5RD@5&H@150@40IQ(# @," P(')G
M($)4(#$X,BXX-R V-C(N,C4@5&0@*&4@<F5C;V=N:7IE('1A>"!B96YE9FET
M<R!O9B!U;F-E<G1A:6X@=&%X('!O<VET:6]N<R!W:&5N('=E(&)E;&EE=F4@
M=&AE('!O<VET:6]N<R!A<F4@;6]R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4P+C(U(%1D("AL:6ME;'D@
M=&AA;B!N;W0@;V8@8F5I;F<@<W5S=&%I;F5D('5P;VX@82!C:&%L;&5N9V4@
M8GD@=&AE(')E;&5V86YT('1A>"!A=71H;W)I='DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-C<N.#<@-C4P+C(U(%1D("@N("D@5&H@150@40IQ(# @," P
M(')G($)4(#,W,BXV.2 V-3 N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S.#$N,S,@-C4P+C(U(%1D("AE(&)E;&EE=F4@;W5R(&IU9&=M96YT
M<R!I;B!T:&ES(&%R96$@87)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V,S@N,C4@5&0@*')E87-O;F%B;&4@
M86YD(&-O<G)E8W0L(&)U="!T:&5R92!I<R!N;R!G=6%R86YT964@=&AA="!W
M92!W:6QL(&)E('-U8V-E<W-F=6P@:68@8VAA;&QE;F=E9"!B>2!A('1A>&EN
M9R!A=71H;W)I='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#<N.# @-C,X
M+C(U(%1D("@N($EF('1H97)E(&%R92!T87@@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8R-BXR-2!49" H8F5N
M969I=',L(&EN8VQU9&EN9RP@8G5T(&YO="!L:6UI=&5D('1O+"!T:&4@=7-E
M(&]F($Y/3',L(&5X<&5N<V4@<F5I;6)U<G-E;65N=',L(&]R(&]T:&5R('1A
M>"!A='1R:6)U=&5S+"!T:&%T(&%R92!C:&%L;&5N9V5D("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,30N,C4@
M5&0@*'-U8V-E<W-F=6QL>2!B>2!A('1A>&EN9R!A=71H;W)I='DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.#,N-S8@-C$T+C(U(%1D("@L('=E(&UA>2!B
M92!R97%U:7)E9"!T;R!P87D@861D:71I;VYA;"!T87AE<RP@:6YT97)E<W0L
M(&%N9"!P96YA;'1I97,L(&]R('=E(&UA>2!S965K('1O(&5N=&5R("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M,#(N,C4@5&0@*&EN=&\@<V5T=&QE;65N=',@=VET:"!T:&4@=&%X:6YG(&%U
M=&AO<FET:65S+"!W:&EC:"!C;W5L9"!R97%U:7)E('-I9VYI9FEC86YT('!A
M>6UE;G1S(&]R(&]T:&5R=VES92!H879E(&$@;6%T97)I86P@861V97)S92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-3DP+C(U(%1D("AE9BD@5&H@150@40IQ(# @," P(')G($)4(#4W+C4Y
M(#4Y,"XR-2!49" H9F5C="!O;B!O=7(@8G5S:6YE<W,L(')E<W5L=',@;V8@
M;W!E<F%T:6]N<RP@86YD(&9I;F%N8VEA;"!C;VYD:71I;VXN*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4W,"XR
M-2!49" H26X@861D:71I;VXL(%4N4RX@9F5D97)A;"P@<W1A=&4@86YD(&QO
M8V%L+"!A<R!W96QL(&%S(&EN=&5R;F%T:6]N86PL('1A>"!L87=S(&%N9"!R
M96=U;&%T:6]N<R!A<F4@97AT<F5M96QY(&-O;7!L97@@86YD('-U8FIE8W0@
M=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#4U."XR-2!49" H=F%R>6EN9R!I;G1E<G!R971A=&EO;G,N($UO
M<W0@<F5C96YT;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R,# N-#(@-34X
M+C(U(%1D("@L(&]N($1E8V5M8F5R(#(R+" R,#$W+"!T:&4@4')E<VED96YT
M('-I9VYE9"!T:&4@,C Q-R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C$N
M-3@@-34X+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(V+CDY
M(#4U."XR-2!49" H87@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,X+C,X
M(#4U."XR-2!49" H06-T(&EN=&\@;&%W*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#@W+C$V(#4U."XR-2!49" H+B!);B!T:&4@;&]N9RUT97)M+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-30V+C(U(%1D("AW92!A;G1I8VEP871E('1H870@=V4@=VEL;"!H879E(&%N
M(&]V97)A;&P@8F5N969I="!F<F]M('1H92!R961U8W1I;VX@:6X@=&AE('1A
M>"!R871E('-L:6=H=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(S
M+C@U(#4T-BXR-2!49" H9G-E="!B>2!P;W1E;G1I86P@9&5D=6-T:6]N<R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-3,T+C(U(%1D("AD:7-A;&QO=V5D('5N9&5R('1H92!C=7)R96YT(&QA
M=RD@5&H@150@40IQ(# @," P(')G($)4(#$X,"XT,B U,S0N,C4@5&0@*"X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@T+C@V(#4S-"XR-2!49" H06QT
M:&]U9V@@=V4@87)E(&YO="!A=V%R92!O9B!A;GD@<')O=FES:6]N(&EN('1H
M92 R,#$W("D@5&H@150@40IQ(# @," P(')G($)4(#0Q,2XP,B U,S0N,C4@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,38N-#,@-3,T+C(U(%1D
M("AA>" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C<N.#$@-3,T+C(U(%1D
M("A!8W0@;W(@86YY(&]T:&5R('!E;F1I;F<@=&%X("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,C(N,C4@5&0@
M*&QE9VES;&%T:6]N('1H870@=V]U;&0@:&%V92!A(&UA=&5R:6%L(&%D=F5R
M<V4@:6UP86-T(&]N(&]U<B!F:6YA;F-I86P@<&5R9F]R;6%N8V4L('1H92!U
M;'1I;6%T92!I;7!A8W0@;V8@=&AE(#(P,3<@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3$T+C,X(#4R,BXR-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#4Q.2XW.2 U,C(N,C4@5&0@*&%X("D@5&H@150@40IQ(# @," P(')G
M($)4(#4S,2XQ-R U,C(N,C4@5&0@*$%C=" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3$P+C(U(%1D("AM87D@
M9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.# N-C0@-3$P+C(U(%1D("AF
M97(@9G)O;2!O=7(@8W5R<F5N="!A<W-E<W-M96YT(&1U92!T;R!C:&%N9V5S
M(&EN(&EN=&5R<')E=&%T:6]N<R!A;F0@87-S=6UP=&EO;G,@;6%D92!B>2!U
M<R!A<R!W96QL(&%S('1H92!I<W-U86YC92!O9B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DX+C(U(%1D("AA
M;GD@9G5R=&AE<B!R96=U;&%T:6]N<R!O<B!G=6ED86YC92!R96=A<F1I;F<@
M=&AE(%4N4RX@9F5D97)A;"!I;F-O;64@=&%X(&-O9&4N("D@5&H@150@40IQ
M(# @," P(')G($)4(#,V.2XP-2 T.3@N,C4@5&0@*$%T('1H:7,@=&EM92P@
M:70@:7,@=6YC;&5A<B!H;W<@;6%N>2!5+E,N('-T871E<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#@V+C(U
M(%1D("AW:6QL(&EN8V]R<&]R871E('1H97-E(&9E9&5R86P@;&%W(&-H86YG
M97,L(&]R('!O<G1I;VYS('1H97)E;V8L(&EN=&\@=&AE:7(@=&%X(&-O9&5S
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#0N,34@-#@V+C(U(%1D("A4
M:&5R92!C86X@8F4@;F\@87-S=7)A;F-E('1H870@=&AE(#(P,3<@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-30V+C8W(#0X-BXR-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#4U,BXP." T.#8N,C4@5&0@*&%X("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-S0N
M,C4@5&0@*$%C="!O<B!A;GD@;W1H97(@;&5G:7-L871I=F4@8VAA;F=E<R!W
M:6QL(&YO="!N96=A=&EV96QY(&EM<&%C="!O=7(@;W!E<F%T:6YG(')E<W5L
M=',L(&9I;F%N8VEA;"!C;VYD:71I;VXL(&%N9"!F=71U<F4@8G5S:6YE<W,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0V,BXR-2!49" H;W!E<F%T:6]N<RX@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXR-2!49" H26X@
M861D:71I;VXL('=E(&UA>2!B92!L:6UI=&5D(&EN(&]U<B!A8FEL:71Y('1O
M('5T:6QI>F4@;W5R($Y/3',@=&\@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,C@N,S@@-#0R+C(U(%1D("AF<V5T(&9U='5R92!T87AA8FQE(&EN8V]M
M92!A;F0@=&AE<F5B>2!R961U8V4@;W5R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,S N,C4@5&0@*&]T:&5R
M=VES92!P87EA8FQE(&EN8V]M92!T87AE<RX@3W5R(&%B:6QI='D@=&\@=71I
M;&EZ92!O=7(@3D],<R!I<R!A;'-O(&1E<&5N9&5N="P@:6X@<&%R="P@=7!O
M;B!U<R!H879I;F<@<W5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@Y+C0T
M(#0S,"XR-2!49" H9FEC:65N="!F=71U<F4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Q."XR-2!49" H96%R
M;FEN9W,@=&\@=71I;&EZ92!O=7(@3D],<R!B969O<F4@=&AE>2!E>'!I<F4N
M($EF(&UA<FME="!C;VYD:71I;VYS(&-H86YG92!M871E<FEA;&QY(&%N9"!W
M92!D971E<FUI;F4@=&AA="!W92!W:6QL(&)E("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,#8N,C4@5&0@*'5N
M86)L92!T;R!G96YE<F%T92!S=68I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,S<N.#0@-# V+C(U(%1D("AF:6-I96YT('1A>&%B;&4@:6YC;VUE(&EN('1H
M92!F=71U<F4@=&\@=71I;&EZ92!O=7(@3D],<RP@=V4@8V]U;&0@8F4@<F5Q
M=6ER960@=&\@<F5C;W)D(&%N(&%D9&ET:6]N86P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Y-"XR-2!49" H
M=F%L=6%T:6]N(&%L;&]W86YC92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3,U+C V(#,Y-"XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#$T
M,RXW," S.30N,C4@5&0@*&4@<F5V:65W('1H92!V86QU871I;VX@86QL;W=A
M;F-E<R!F;W(@;W5R($Y/3',@<&5R:6]D:6-A;&QY(&%N9"!M86ME(&%D:G5S
M=&UE;G1S(&9R;VT@=&EM92!T;R!T:6UE+" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S@R+C(U(%1D("AW:&EC
M:"!C86X@<F5S=6QT(&EN(&%N(&EN8W)E87-E(&]R(&1E8W)E87-E('1O('1H
M92!N970@9&5F97)R960@=&%X(&%S<V5T(')E;&%T960@=&\@;W5R($Y/3',N
M($EF('=E(&%R92!U;F%B;&4@=&\@=7-E(&]U<B!.3TQS("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-S N,C4@
M5&0@*&]R('5S92!O9B!O=7(@3D],<R!I<R!L:6UI=&5D+"!W92!M87D@:&%V
M92!T;R!M86ME('-I9VYI9FEC86YT('!A>6UE;G1S(&]R(')E9'5C92!O=7(@
M9&5F97)R960@=&%X(&%S<V5T<RP@=VAI8V@@8V]U;&0@:&%V92!A("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M-3@N,C4@5&0@*&UA=&5R:6%L(&%D=F5R<V4@968I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,C4N.#@@,S4X+C(U(%1D("AF96-T(&]N(&]U<B!B=7-I;F5S
M<RP@<F5S=6QT<R!O9B!O<&5R871I;VYS(&%N9"!F:6YA;F-I86P@8V]N9&ET
M:6]N+BD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S,S@N,C4@5&0@*$EF(&-E<G1A:6X@;V8@;W5R(&AE86QT:&-A
M<F4@<')O9F5S<VEO;F%L<R!A<F4@<F5C;&%S<VEF:65D(&9R;VT@:6YD97!E
M;F1E;G0@8V]N=')A8W1O<G,@=&\@96UP;&]Y965S(&]U<B!P<F]F:71A8FEL
M:71Y(&-O=6QD("D@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," S,C8N,C4@5&0@*&)E(&UA=&5R:6%L;'D@861V97)S
M96QY(&EM<&%C=&5D+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S,#8N,C4@5&0@*$9E9&5R86P@;W(@<W1A=&4@
M=&%X:6YG(&%U=&AO<FET:65S(&-O=6QD(')E+6-L87-S:69Y(&]U<B!L;V-U
M;2!T96YE;G,@<&AY<VEC:6%N<RP@0U).07,@86YD(&]T:&5R(&EN9&5P96YD
M96YT(&-O;G1R86-T;W)S(&%S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," R.30N,C4@5&0@*&5M<&QO>65E<RP@
M9&5S<&ET92!B;W1H('1H92!G96YE<F%L(&EN9'5S=')Y('-T86YD87)D('1O
M('1R96%T('1H96T@87,@:6YD97!E;F1E;G0@8V]N=')A8W1O<G,@86YD(&UA
M;GD@<W1A=&4@;&%W<R!P<F]H:6)I=&EN9R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C@R+C(U(%1D("AN;VXM
M<&AY<VEC:6%N(&]W;F5D(&-O;7!A;FEE<R!F<F]M(&5M<&QO>6EN9R!P:'ES
M:6-I86YS(%PH92YG+BP@=&AE()-C;W)P;W)A=&4@<')A8W1I8V4@;V8@;65D
M:6-I;F647"DN($EF('1H97D@=V5R92!R92TI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C<P+C(U(%1D("AC;&%S
M<VEF:65D(&%S(&5M<&QO>65E<RP@=V4@=V]U;&0@8F4@<W5B:F5C="!T;RP@
M86UO;F<@;W1H97(@=&AI;F=S+"!E;7!L;WEM96YT(&%N9"!P87ER;VQL+7)E
M;&%T960@=&%X(&-L86EM<RP@87,@=V5L;"!A<R!A;GD@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(U."XR-2!4
M9" H87!P;&EC86)L92!P96YA;'1I97,@86YD(&EN=&5R97-T+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.#(N-#4@,C4X+C(U(%1D("A!;GD@<W5C:"!R
M96-L87-S:69I8V%T:6]N('=O=6QD(&AA=F4@82!M871E<FEA;"!A9'9E<G-E
M(&EM<&%C="!O;B!O=7(@8G5S:6YE<W,@;6]D96P@9F]R('1H870@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(T
M-BXR-2!49" H8G5S:6YE<W,@<V5G;65N="!A;F0@=V]U;&0@;F5G871I=F5L
M>2!I;7!A8W0@;W5R('!R;V9I=&%B:6QI='DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#,N-#<@,C0V+C(U(%1D("@N*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R-BXR-2!49" H268@=&AE
M(&UE=&AO9"!F;W(@<&%Y:6YG(&QO8W5M('1E;F5N<R!P:'ES:6-I86YS(&-H
M86YG97,L(&ET(&-O=6QD(&YE9V%T:79E;'D@:6UP86-T(&]U<B!P<F]F:71A
M8FEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8W+C8Y(#(R-BXR-2!4
M9" H+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," R,#8N,C4@5&0@*%1H92!-961I8V%R92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,#<N-S4@,C V+C(U(%1D("A!8V-E<W,@86YD($-(25 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S<N.3(@,C V+C(U(%1D("@@4F5A
M=71H;W)I>F%T:6]N("D@5&H@150@40IQ(# @," P(')G($)4(#(T-BXR-" R
M,#8N,C4@5&0@*$%C="!O9B R,#$U(&-R96%T97,@82!N97<@9G)A;65W;W)K
M(&9O<B!R97=A<F1I;F<@<&AY<VEC:6%N<R!F;W(@<')O=FED:6YG("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M.30N,C4@5&0@*&AI9VAE<B!Q=6%L:71Y(&-A<F4@8GD@97-T86)L:7-H:6YG
M('1W;R!T<F%C:W,@;V8@<&%Y;65N=#H@82!M97)I="UB87-E9"!I;F-E;G1I
M=F4@<&%Y;65N="!S>7-T96TL(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-C8N-34@,3DT+C(U(%1D("A!9'9A;F-E9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U,#DN,#,@,3DT+C(U(%1D("A!;'1E<FYA=&EV92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3@R
M+C(U(%1D("A087EM96YT($UO9&5L<RX@268@:&]S<&ET86QS(&-H86YG92!T
M:&4@;65T:&]D(&9O<B!P87EI;F<@;&]C=6T@=&5N96YS('!H>7-I8VEA;G,@
M=&\@;65E="!T:&5I<B!P97)F;W)M86YC92!G;V%L<R!O<B!O=&AE<B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,3<P+C(U(%1D("AC<FET97)I82!F;W(@365D:6-A:60@;W(@365D:6-A<F4@
M<F5I;6)U<G-E;65N=',L('1H92!P<F]F:71A8FEL:71Y(&]F(&]U<B!B=7-I
M;F5S<R!C;W5L9"!B92!A9'9E<G-E;'D@:6UP86-T960N*2!4:B!%5"!1"D)4
M("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U,"XR-2!4
M9" H3W5R(&9I;F%N8VEA;"!R97-U;'1S(&-O=6QD(&)E(&%D=F5R<V5L>2!I
M;7!A8W1E9"!B>2!T:&4@;&]S<R!O9B!K97D@;6%N86=E;65N="XI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3,P
M+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@,3,P+C(U
M(%1D("AE(&)E;&EE=F4@=&AE('-U8V-E<W-F=6P@97AE8W5T:6]N(&]F(&]U
M<B!B=7-I;F5S<R!S=')A=&5G>2!A;F0@;W5R(&%B:6QI='D@=&\@8G5I;&0@
M=7!O;B!S:6=N:69I8V%N="!R96-E;G0@:6YV97-T;65N=',@86YD("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M,3@N,C4@5&0@*&%C<75I<VET:6]N<R!D97!E;F1S(&]N('1H92!C;VYT:6YU
M960@96UP;&]Y;65N="!O9B!K97D@;65M8F5R<R!O9B!O=7(@<V5N:6]R(&UA
M;F%G96UE;G0@=&5A;2X@268@=V4@=V5R92!T;R!L;W-E(&%N>2!K97D@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#$P-BXR-2!49" H<&5R<V]N;F5L+"!W92!M87D@;F]T(&)E(&%B;&4@=&\@
M9FEN9"!A;B!A<'!R;W!R:6%T92!R97!L86-E;65N="!O;B!A('1I;65L>2!B
M87-I<R!A;F0@;W5R(')E<W5L=',@;V8@;W!E<F%T:6]N<R!C;W5L9"!B92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @.30N,C4@5&0@*&YE9V%T:79E;'D@868I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,#$N-S0@.30N,C4@5&0@*&9E8W1E9"X@1G5R=&AE<BD@5&H@150@
M40IQ(# @," P(')G($)4(#$V,"XR," Y-"XR-2!49" H+"!T:&4@;&]S<R!O
M9B!A('-I9VYI9FEC86YT(&YU;6)E<B!O9B!E;7!L;WEE97,@;W(@;W5R(&EN
M86)I;&ET>2!T;R!H:7)E(&$@<W5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#4Y+C,Y(#DT+C(U(%1D("AF:6-I96YT(&YU;6)E<B!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @.#(N,C4@
M5&0@*'%U86QI9FEE9"!E;7!L;WEE97,@8V]U;&0@:&%V92!A(&UA=&5R:6%L
M(&%D=F5R<V4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C(N,C(@.#(N
M,C4@5&0@*&9E8W0@;VX@;W5R(&)U<VEN97-S+BD@5&H@150@40IE;F1S=')E
M86T*96YD;V)J"C,Y(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @
M4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@
M,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@-# @,"!2/CX*96YD;V)J"C0P(# @
M;V)J"CP\+TQE;F=T:" Q,#0P-SX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#$V*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T,BXR
M-2!49" H271E;2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXT.2 W-#(N
M,C4@5&0@*#%"+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" X.2XQ-B W-#(N
M,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,2XV-B W-#(N,C4@
M5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-"XQ-B W-#(N,C4@5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-BXV-B W-#(N,C4@5&0@*" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Y.2XQ-B W-#(N,C4@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q,#$N-C8@-S0R+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3 T+C$V(#<T,BXR-2!49" H("D@5&H@150@
M40IQ(# @," P(')G($)4(#$P-BXV-B W-#(N,C4@5&0@*%5N<BD@5&H@150@
M40IQ(# @," P(')G($)4(#$R,RXW," W-#(N,C4@5&0@*&5S;VQV960@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,34W+C,Q(#<T,BXR-2!49" H4W1A9F8@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@P+C,V(#<T,BXR-2!49" H0V]M
M;65N=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#<Q."XR-2!49" H3F]N92XI(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C(U(%1D("A)=&5M
M("D@5&H@150@40IQ(# @," P(')G($)4(#<R+C0Y(#8Y-"XR-2!49" H,BX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#(N-#D@-CDT+C(U(%1D("@@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.#0N.3D@-CDT+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#<N-#D@-CDT+C(U(%1D("@@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@.#DN.3D@-CDT+C(U(%1D("@@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@.3(N-#D@-CDT+C(U(%1D("@@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@.30N.3D@-CDT+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@.3<N-#D@-CDT+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@.3DN.3D@-CDT+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 R+C0Y(#8Y-"XR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#$P
M-"XY.2 V.30N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#<N
M-#D@-CDT+C(U(%1D("A0<BD@5&H@150@40IQ(# @," P(')G($)4(#$Q-RXX
M-B V.30N,C4@5&0@*&]P97)T:65S+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-S N,C4@5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U."XV-" V-S N,C4@5&0@*&4@9&\@;F]T(&]W
M;B!A;GD@<F5A;"!P<F]P97)T>2D@5&H@150@40IQ(# @," P(')G($)4(#$X
M,"XW,R V-S N,C4@5&0@*"X@3W5R('!R:6YC:7!A;"!L96%S97,@87,@;V8@
M1F5B<G5A<GF@,2P@,C Q.2!A<F4@;&ES=&5D(&)E;&]W*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#(S+C8R(#8W,"XR-2!49" H+BD@5&H@150@40HP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," V,S4N-S4@
M,34S+C P("TR-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,C S+C4P(#8S-2XW-2 T+C P("TR-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,C W+C4P(#8S-2XW-2 Q-S,N,# @+3(U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.# N-3 @-C,U
M+C<U(#0N,# @+3(U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#0N-3 @-C,U+C<U(#8P+C P("TR-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#0T+C4P(#8S-2XW-2 T+C P("TR-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0X+C4P(#8S
M-2XW-2 Q,30N,# @+3(U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," U.34N-S4@,34S+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,C S+C4P(#4Y-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C W+C4P
M(#4Y-2XW-2 Q-S,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.# N-3 @-3DU+C<U(#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS.#0N-3 @-3DU+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0T
M+C4P(#4Y-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0X+C4P(#4Y-2XW-2 Q,30N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,"XU(#8S-2XW-2!M"C(P,RXU
M(#8S-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,C W+C4@-C,U+C<U(&T*,S@P+C4@-C,U+C<U(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HS.#0N-2 V,S4N-S4@;0HT-#0N-2 V,S4N-S4@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T."XU
M(#8S-2XW-2!M"C4V,BXU(#8S-2XW-2!L"G,*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3 W+C8P(#8T,"XT,R!49" H3&]C871I;VXI(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<T+C,P
M(#8T,"XT,R!49" H1G5N8W1I;VXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDX+C@P(#8U,"XT,R!49" H4W%U87(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T,C0N-S0@-C4P+C0S(%1D("AE*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-"XX," V
M-# N-#,@5&0@*$9E970I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8X+C0U(#8T,"XT,R!49" H3&5A<V4@17AP:7)A=&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,RXP," V,C8N,S(@5&0@*$)O8V$@4F%T;VXL($9L;W)I9&$I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P(#8R-2XT
M,B!49" H3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#(U,RXP
M-" V,C4N-#(@5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDV+C(X(#8R-2XT,B!49" H9FEN9R!A9&UI;FES=')A=&EO;BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3DN,# @
M-C$U+C0R(%1D("AA;F0@9V5N97)A;"!O9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(W-BXQ," V,34N-#(@5&0@*&9I8V4@=7-E*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,"XR-2 V,C8N,S(@5&0@
M*#<P+#0P-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-3$N,# @-C(V+C,R(%1D("A$96-E;6)E<B S,2P@,C R-2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V
M,# N-#(@5&0@*$)O8V$@4F%T;VXL($9L;W)I9&$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P(#8P,"XT,B!49" H
M0V]R<&]R871E(&AE861Q=6%R=&5R<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,# N,C4@-C P+C0R(%1D("@T."PQ-30I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4Q
M+C P(#8P,"XT,B!49" H3F]V96UB97(@,S L(#(P,C4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-3@V+C,R(%1D
M("A"97)K96QE>2!,86ME+"!'96]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3,V+C0X(#4X-BXS,B!49" H9VEA*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(Q,"XP," U.#8N,S(@5&0@*%!H>7-I8VEA
M;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8W+C0P(#4X-BXS,B!4
M9" H9FEN9R!O9BD@5&H@150@40IQ(# @," P(')G($)4(#(Y-"XQ-B U.#8N
M,S(@5&0@*&9I8V4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-# P+C(U(#4X-BXS,B!49" H-#$L-C W*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,2XP," U.#8N,S(@
M5&0@*$]C=&]B97(@,S$L(#(P,C0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @-3<Q+C,R(%1D("A#<F5V92!#;V5U
M<BD@5&H@150@40IQ(# @," P(')G($)4(#$P,RXV,B U-S$N,S(@5&0@*"P@
M36ES<V]U<FDI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$P+C P(#4W,"XT,B!49" H4&AY<VEC:6%N(&%N9"!%>&5C=71I
M=F4@<V5A<F-H*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Q.2XP," U-C N-#(@5&0@*&AE861Q=6%R=&5R<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,C4@-3<Q
M+C,R(%1D("@R-RPP-3$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#4Q+C P(#4W,2XS,B!49" H075G=7-T(#,Q+" R,#(T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U-#0N,C4@5&0@** I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3,R+C(U
M(%1D("A)=&5M(#,N(" @(" @(" @("!,96=A;"!0<BD@5&H@150@40IQ(# @
M," P(')G($)4(#$T-"XR-" U,S(N,C4@5&0@*&]C965D:6YG<RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3 X
M+C(U(%1D("A&<F]M('1I;64@=&\@=&EM92P@=V4@87)E(&EN=F]L=F5D(&EN
M('9A<FEO=7,@;&ET:6=A=&EO;BP@8VQA:6US+"!I;G9E<W1I9V%T:6]N<RP@
M86YD(&]T:&5R('!R;V-E961I;F=S('1H870@87)I<V4@:6X@=&AE(&]R9&EN
M87)Y("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," T.38N,C4@5&0@*&-O=7)S92!O9B!O=7(@8G5S:6YE<W,N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$T,RXY-R T.38N,C4@5&0@*%1H97-E
M(&UA='1E<G,@<')I;6%R:6QY(')E;&%T92!T;R!E;7!L;WEE92UR96QA=&5D
M(&UA='1E<G,@=&AA="!I;F-L=61E(&EN9&EV:61U86P@86YD(&-O;&QE8W1I
M=F4@8VQA:6US+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-#@T+C(U(%1D("AP<F]F97-S:6]N86P@;&EA8FEL
M:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,Q+C@T(#0X-"XR-2!49" H
M+"!T87@L(&%N9"!P87ER;VQL('!R86-T:6-E<RX@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C0R+C$W(#0X-"XR-2!49" H5RD@5&H@150@40IQ(# @," P
M(')G($)4(#(U,"XX,2 T.#0N,C4@5&0@*&4@97-T86)L:7-H(')E<V5R=F5S
M('=H96X@879A:6QA8FQE(&EN9F]R;6%T:6]N(&EN9&EC871E<R!T:&%T(&$@
M;&]S<R!I<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#<R+C(U(%1D("AP<F]B86)L92!A;F0@86X@86UO=6YT
M+"!O<B!R86YG92!O9B!L;W-S(&-A;B!B92!R96%S;VYA8FQY(&5S=&EM871E
M9"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,S+C V(#0W,BXR-2!49" H
M5&AE<V4@87-S97-S;65N=',@87)E('!E<F9O<FUE9"!A="!L96%S="!Q=6%R
M=&5R;'D@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T-C N,C4@5&0@*&%R92!B87-E9"!O;B!T:&4@:6YF
M;W)M871I;VX@879A:6QA8FQE('1O(&UA;F%G96UE;G0@870@=&AE('1I;64@
M86YD(&EN=F]L=F4@82!S:6=N:69I8V%N="!M86YA9V5M96YT(&IU9&=M96YT
M('1O(&1E=&5R;6EN92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-#0X+C(U(%1D("AT:&4@<')O8F%B:6QI='D@
M86YD(&5S=&EM871E9"!A;6]U;G0@;V8@<&]T96YT:6%L(&QO<W-E<RP@:68@
M86YY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S P+CDV(#0T."XR-2!49" H
M+B!"87-E9"!O;B!T:&4@879A:6QA8FQE(&EN9F]R;6%T:6]N(&-O;G-I9&5R
M960@:6X@;W5R(')E=FEE=W,L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," T,S8N,C4@5&0@*'=E(&%D:G5S="!O
M=7(@;&]S<R!C;VYT:6YG96YC>2!A8V-R=6%L<R!A;F0@;W5R(&1I<V-L;W-U
M<F5S(&%S(&UA>2!B92!R97%U:7)E9"X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S<Q+C R(#0S-BXR-2!49" H06-T=6%L(&]U=&-O;65S(&]R(&QO<W-E
M<R!M87D@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 X+C@W(#0S-BXR
M-2!49" H9F5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T,C0N,C4@5&0@*&UA=&5R:6%L;'D@9G)O;2!T:&]S
M92!E<W1I;6%T960@8GD@;W5R(&-U<G)E;G0@87-S97-S;65N=',@:6YC;'5D
M:6YG(&%V86EL86)L92!I;G-U<F%N8V4@<F5C;W9E<FEE<RP@=VAI8V@@=V]U
M;&0@:6UP86-T(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-#$R+C(U(%1D("AP<F]F:71A8FEL:71Y*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.3<N,3(@-#$R+C(U(%1D("@N("D@5&H@
M150@40IQ(# @," P(')G($)4(#$P,2XU-R T,3(N,C4@5&0@*$%D=F5R<V4@
M9&5V96QO<&UE;G1S(&EN(&5X:7-T:6YG(&QI=&EG871I;VX@8VQA:6US(&]R
M(&QE9V%L('!R;V-E961I;F=S(&EN=F]L=FEN9R!O=7(@0V]M<&%N>2!O<B!N
M97<@8VQA:6US("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T,# N,C4@5&0@*&-O=6QD(')E<75I<F4@=7,@=&\@
M97-T86)L:7-H(&]R(&EN8W)E87-E(&QI=&EG871I;VX@<F5S97)V97,@;W(@
M96YT97(@:6YT;R!U;F9A=F]R86)L92!S971T;&5M96YT<R!O<B!S871I<V9Y
M(&IU9&=M96YT<R!F;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#,X."XR-2!49" H;6]N971A<GD@9&%M86=E
M<R!F;W(@86UO=6YT<R!I;B!E>&-E<W,@;V8@8W5R<F5N="!R97-E<G9E<RP@
M=VAI8V@@8V]U;&0@861V97)S96QY(&%F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,SDV+C8T(#,X."XR-2!49" H9F5C="!O=7(@9FEN86YC:6%L(')E<W5L
M=',N("D@5&H@150@40IQ(# @," P(')G($)4(#0Y."XS-B S.#@N,C4@5&0@
M*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#<N-# @,S@X+C(U(%1D("AI
M=&@@<F5G87)D('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S-S8N,C4@5&0@*'1H92!O=71S=&%N9&EN9R!C
M;VYT:6YG96YC:65S(&%S(&]F($1E8V5M8F5R(#,Q+" R,#$X+"!W92!B96QI
M979E('1H92!O=71C;VUE(&]F('1H97-E(&UA='1E<G,@=VEL;"!N;W0@:&%V
M92!A(&UA=&5R:6%L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S-C0N,C4@5&0@*&%D=F5R<V4@968I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Y,"XV,R S-C0N,C4@5&0@*&9E8W0@;VX@;W5R
M(&)U<VEN97-S+"!F:6YA;F-I86P@8V]N9&ET:6]N+"!R97-U;'1S(&]F(&]P
M97)A=&EO;G,@;W(@8V%S:"!F;&]W<RXI(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S0P+C(U(%1D("A)=&5M(#0N
M(" @(" @(" @("!-:6YE(%-A9F5T>2!$:7-C;&]S=7(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,#$N,3D@,S0P+C(U(%1D("AE<RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S$V+C(U(%1D
M("A.;W0@87!P;&EC86)L92XI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C@W+C@U(#(Y,BXR-2!49" H4"D@5&H@150@40IQ
M(# @," P(')G($)4(#(Y,RXR,B R.3(N,C4@5&0@*$%2*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S W+C,Q(#(Y,BXR-2!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#,Q,RXX," R.3(N,C4@5&0@*"!)22D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R.# N,C4@5&0@
M** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,C8X+C(U(%1D("A)=&5M(#4N(" @(" @(" @("!-87)K970@9F]R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34T+C<Y(#(V."XR-2!49" H(%)E
M9VES=')A;G0G<R!#;VUM;VX@17%U:71Y*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C@Q+C<T(#(V."XR-2!49" H+"!296QA=&5D(%-T;V-K:&]L9&5R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S<S+C4P(#(V."XR-2!49" H($UA='1E
M<G,@86YD($ES<W5E<BD@5&H@150@40IQ(# @," P(')G($)4(#0U-BXY,B R
M-C@N,C4@5&0@*"!0=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S4N,S4@
M,C8X+C(U(%1D("AC:&%S97,@;V8@17%U:71Y("D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-38N,C4@5&0@*" @
M(" @(" @(" @(" @(" @(" @(" @4V5C=7)I=&EE<RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C,R+C(U(%1D
M("A/=7(@8V]M;6]N('-T;V-K(&-U<G)E;G1L>2!T<F%D97,@=6YD97(@=&AE
M('-Y;6)O;""30T-23I0@;VX@=&AE($Y!4T1!42!';&]B86P@4V5L96-T($UA
M<FME="!<*$Y!4T1!45PI+B!/=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R,"XR-2!49" H8V]M;6]N('-T
M;V-K(&-O;6UE;F-E9"!T<F%D:6YG(&]N('1H92!.05-$05$@3F%T:6]N86P@
M36%R:V5T('5N9&5R('1H92!S>6UB;VP@DT-#4DZ4(&]N($]C=&]B97*@,C4L
M(#(P,#$N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," Q.38N,C4@5&0@*%1H92!G<F%P:"!B96QO=R!C;VUP87)E
M<R!T:&4@0V]M<&%N>2!T;R!T:&4@8W5M=6QA=&EV92 U+7EE87(@=&]T86P@
M<F5T=7)N(&]F(&AO;&1E<G,@;V8@=&AE($-O;7!A;GDG<R!C;VUM;VX@<W1O
M8VL@=VET:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,3@T+C(U(%1D("AT:&4@8W5M=6QA=&EV92!T;W1A;"!R
M971U<FYS(&]F('1H92!.05-$05$@0V]M<&]S:71E(&EN9&5X(&%N9"!T:&4@
M1&]W($IO;F5S(%4N4RX@0G5S:6YE<W,@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#,X+CDT(#$X-"XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#0T-"XW," Q.#0N,C4@5&0@*')A:6YI;F<@)B!%;7!L;WEM96YT("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M-S(N,C4@5&0@*$%G96YC:65S(&EN9&5X+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,38N-S0@,3<R+C(U(%1D("A4:&4@9W)A<&@@87-S=6UE<R!T:&%T
M('1H92!V86QU92!O9B!T:&4@:6YV97-T;65N="!I;B!T:&4@0V]M<&%N>2=S
M(&-O;6UO;B!S=&]C:R!A;F0@:6X@96%C:"!O9B!T:&4@:6YD97AE<R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,38P+C(U(%1D("A<*&EN8VQU9&EN9R!R96EN=F5S=&UE;G0@;V8@9&EV:61E
M;F1S7"D@=V%S("0Q,# @;VX@1&5C96UB97(@,S$L(#(P,3,@86YD('1R86-K
M<R!I="!T:')O=6=H($1E8V5M8F5R(#,Q+" R,#$X+BD@5&H@150@40IE;F1S
M=')E86T*96YD;V)J"C0Q(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q
M(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S
M(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@-#(@,"!2/CX*96YD;V)J"C0R
M(# @;V)J"CP\+TQE;F=T:" U,S,T/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,3<I(%1J($54
M(%$*+T=3,"!G<PIQ(#4Q,BXP," P(# @,S<Q+C4P(#4P+C P(#,W-RXU-2!C
M;0HO23(P($1O(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-38R+C P(#,W-RXU-2!49" HH"D@5&H@150@40I"5" O1C0@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," S-3,N-34@5&0@*%1H92!S=&]C:R!P
M<FEC92!P97)F;W)M86YC92!I;F-L=61E9"!I;B!T:&ES(&=R87!H(&ES(&YO
M="!N96-E<W-A<FEL>2!I;F1I8V%T:79E(&]F(&9U='5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# P+CDV(#,U,RXU-2!49" H92!S=&]C:R!P<FEC92!P
M97)F;W)M86YC92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S(Y+C4U(%1D("A!<R!O9B!&96)R=6%R>2 R,BP@
M,C Q.2P@=&AE<F4@=V5R92 Q,C8@<W1O8VMH;VQD97)S(&]F(')E8V]R9"!O
M9B!O=7(@8V]M;6]N('-T;V-K+B!);B!A9&1I=&EO;BP@=&AE<F4@=V5R92 T
M+# X.2!B96YE9FEC:6%L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," S,3<N-34@5&0@*&]W;F5R<R!O9B!O=7(@
M8V]M;6]N('-T;V-K(&AE;&0@8GD@8G)O:V5R<R!O<B!O=&AE<B!I;G-T:71U
M=&EO;G,@;VX@8F5H86QF(&]F('-T;V-K:&]L9&5R<RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,CDS+C4U(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@,CDS+C4U(%1D("AE
M(&AA=F4@;F5V97(@<&%I9"!O<B!D96-L87)E9"!C87-H(&1I=FED96YD<R!O
M;B!O=7(@8V]M;6]N('-T;V-K+B!#;W9E;F%N=',@:6X@;W5R(&-R961I="!A
M9W)E96UE;G0@;&EM:70@;W5R(&%B:6QI='D@=&\@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(X,2XU-2!49" H
M<F5P=7)C:&%S92!O=7(@8V]M;6]N('-T;V-K(&%N9"!D96-L87)E(&%N9"!P
M87D@8V%S:"!D:79I9&5N9',@;VX@;W5R(&-O;6UO;B!S=&]C:RX@3VX@1F5B
M<G5A<GF@,C@L(#(P,#@L(&]U<B!";V%R9"!O9B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C8Y+C4U(%1D("A$
M:7)E8W1O<G,@875T:&]R:7IE9"!O=7(@;6]S="!R96-E;G0@<W1O8VL@<F5P
M=7)C:&%S92!P<F]G<F%M('=H97)E8GD@=V4@;6%Y('!U<F-H87-E('5P('1O
M(#$N-:!M:6QL:6]N(&]F(&]U<B!C;VUM;VX@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(U-RXU-2!49" H<VAA
M<F5S+"!S=6)J96-T('1O('1H92!T97)M<R!O9B!O=7(@8W5R<F5N="!C<F5D
M:70@86=R965M96YT+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#DN-S,@
M,C4W+C4U(%1D("A4:&4@<VAA<F5S(&UA>2!B92!R97!U<F-H87-E9"!F<F]M
M('1I;64M=&\M=&EM92!I;B!T:&4@;W!E;B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C0U+C4U(%1D("AM87)K
M970@86YD('1H92!R97!U<F-H87-E('!R;V=R86T@;6%Y(&)E(&1I<V-O;G1I
M;G5E9"!A="!A;GD@=&EM92!A="!O=7(@9&ES8W)E=&EO;BX@1'5R:6YG('1H
M92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C,S+C4U(%1D("@R,#$X
M+"!T:&4@0V]M<&%N>2!R97!U<F-H87-E9"!A;F0@<F5T:7)E9" T,S(L-#,Y
M('-H87)E<R!O9B!I=',@0V]M;6]N(%-T;V-K(&%T(&%N(&%V97)A9V4@;6%R
M:V5T('!R:6-E(&]F("0Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 V+C$V
M(#(S,RXU-2!49" H,2XU-"!P97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R,2XU-2!49" H<VAA<F4N("D@
M5&H@150@40IQ(# @," P(')G($)4(#<U+C4U(#(R,2XU-2!49" H070@1&5C
M96UB97(@,S$L(#(P,3@L('=E(&AA9" U,3 L,# T('-H87)E<R!O9B!C;VUM
M;VX@<W1O8VL@;&5F="!R96UA:6YI;F<@=&\@<F5P=7)C:&%S92!U;F1E<B!T
M:&ES(&%U=&AO<FEZ871I;VXL("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," R,#DN-34@5&0@*'-U8FIE8W0@=&\@
M=&AE(&QI;6ET871I;VYS(&]F(&]U<B!C<F5D:70@86=R965M96YT(&%S(&1E
M<V-R:6)E9"!I;B!.;W1E(#$T("T@4W1O8VMH;VQD97)S)R!%<75I='D@=&\@
M;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Y-RXU-2!49" H<W1A
M=&5M96YT<RZ@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#$W,RXU-2!49" H271E;2 V+B @(" @(" @(" @4V5L
M96-T960@1FEN86YC:6%L($1A=&$N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#$T.2XU-2!49" H5&AE('-E;&5C
M=&5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@9&%T82!A<R!O9B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,T+C Y(#$T
M.2XU-2!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S$R+C8W(#$T.2XU-2!49" H(&%N
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S,R+C$Q(#$T.2XU-2!49" H,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-3(N,3$@,30Y+C4U(%1D("@@86YD(&9O
M<B!T:&4@>65A<G,@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0U,"XT," Q-#DN-34@5&0@*$1E8V5M8F5RH#,Q
M+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4R."XY." Q-#DN-34@5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S,RXY." Q-#DN-34@5&0@*#(P,3<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34S
M+CDX(#$T.2XU-2!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,3,W+C4U(%1D("AA;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8V+CDT(#$S-RXU
M-2!49" H,C Q-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" X-BXY-" Q,S<N-34@5&0@*"!A<F4@9&5R:79E9"!F<F]M('1H
M92!A=61I=&5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!O
M9B!#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L($EN8RXL(&EN8VQU9&5D(&5L
M<V5W:&5R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,3(U+C4U(%1D("AI;B!T:&ES(%)E<&]R="X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3 Y+C(V(#$R-2XU-2!49" H5&AE('-E;&5C
M=&5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@9&%T82!A<R!O9B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDS+C,U(#$R
M-2XU-2!49" H1&5C96UB97*@,S$L(#(P,38I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S<Q+CDS(#$R-2XU-2!49" H+" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<V
M+CDS(#$R-2XU-2!49" H,C Q-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.38N.3,@,3(U+C4U(%1D("@L(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$X+C@W
M(#$R-2XU-2!49" H,C Q-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,S@N.#<@,3(U+C4U(%1D("@@86YD(&9O<B!T:&4@
M>65A<G,@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#$Q,RXU-2!49" H1&5C96UB97(@,S$L*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P-BXP." Q
M,3,N-34@5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3 X+C4X(#$Q,RXU-2!49" H,C Q-2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C@N-3@@,3$S+C4U(%1D
M("@@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q-#@N,#(@,3$S+C4U(%1D("@R,#$T*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$V."XP,B Q,3,N-34@5&0@*"!A
M<F4@9&5R:79E9"!F<F]M('1H92!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T
M871E;65N=',@;V8@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N+"!T
M:&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," Q,#$N-34@5&0@*&AA=F4@8F5E;B!A=61I=&5D(&)U="!N;W0@
M:6YC;'5D960@:6X@=&AI<R!297!O<G0@;VX@1F]R;2 Q,"U++BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," X.2XU
M-2!49" HH* I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-S<N-34@5&0@*%1H92!F;VQL;W=I;F<@<V5L96-T960@
M9FEN86YC:6%L(&1A=&$@<VAO=6QD(&)E(')E860@:6X@8V]N:G5N8W1I;VX@
M=VET:"!T:&4@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N
M9"!R96QA=&5D(&YO=&5S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V-2XU-2!49" H;V8@0W)O<W,@0V]U;G1R
M>2!(96%L=&AC87)E+"!);F,N+""336%N86=E;65N=)(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-#DN,S@@-C4N-34@5&0@*',@1&ES8W5S<VEO;B!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$X+C4U(#8U+C4U(%1D("A!;F%L
M>7-I<R!O9B!&:6YA;F-I86P@0V]N9&ET:6]N(&%N9"!297-U;'1S(&]F($]P
M97)A=&EO;G.4("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," U,RXU-2!49" H86YD(&]T:&5R(&9I;F%N8VEA;"!I
M;F9O<FUA=&EO;B!I;F-L=61E9"!E;'-E=VAE<F4@:6X@=&AI<R!R97!O<G0N
M*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-#,@,"!O8FH*/#PO5'EP92 O
M4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N
M,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R T-" P
M(%(^/@IE;F1O8FH*-#0@,"!O8FH*/#PO3&5N9W1H(#(T.34Q/CX*<W1R96%M
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV
M,"!49" H,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-S0R+C$P(%1D("B@*2!4:B!%5"!1"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#8X-BXV," R-# N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHR.3 N-3 @-C@V+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P
M+C4P(#8X-BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#8X-BXV," U,2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,Y-2XU," V.#8N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y
M.2XU," V.#8N-C @-3$N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @-C@V+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT-30N-3 @-C@V+C8P(#4R+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 V+C4P(#8X-BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P(#8X-BXV," U
M,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#8U-BXV," R-# N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHR.3 N-3 @-C4V+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P+C4P(#8U-BXV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#8U-BXV," U,2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,Y-2XU," V-38N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," V-38N
M-C @-3$N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @-C4V+C8P(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT-30N-3 @-C4V+C8P(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#8U
M-BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P(#8U-BXV," U,BXP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C4P(#8R-BXV," R-# N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @
M-C(V+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P+C4P(#8R-BXV," T+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S0T+C4P(#8R-BXV," U,2XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU
M," V,C8N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," V,C8N-C @-3$N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-3 N-3 @-C(V+C8P(#0N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N
M-3 @-C(V+C8P(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#8R-BXV," T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3$P+C4P(#8R-BXV," U,BXP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C4P(#4Y-BXV," R-# N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @-3DV+C8P(#4P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S0P+C4P(#4Y-BXV," T+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S0T+C4P(#4Y-BXV," U,2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU," U.38N-C @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," U.38N-C @-3$N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-3 N-3 @-3DV+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N-3 @-3DV+C8P
M(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#4Y-BXV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3$P+C4P(#4Y-BXV," U,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4U."XV
M," R-# N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @-34X+C8P(#4P+C P("TR,RXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0P+C4P(#4U."XV," T+C P("TR,RXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#4U
M."XV," U,2XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU," U-3@N-C @-"XP," M,C,N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,Y.2XU," U-3@N-C @-3$N,# @+3(S+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @
M-34X+C8P(#0N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N-3 @-34X+C8P(#4R+C P("TR
M,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 V+C4P(#4U."XV," T+C P("TR,RXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P
M(#4U."XV," U,BXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4R,"XV," R-# N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHR.3 N-3 @-3(P+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P
M+C4P(#4R,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#4R,"XV," U,2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,Y-2XU," U,C N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y
M.2XU," U,C N-C @-3$N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @-3(P+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT-30N-3 @-3(P+C8P(#4R+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 V+C4P(#4R,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P(#4R,"XV," U
M,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0Y,"XV," R-# N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHR.3 N-3 @-#DP+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P+C4P(#0Y,"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#0Y,"XV," U,2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,Y-2XU," T.3 N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," T.3 N
M-C @-3$N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @-#DP+C8P(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT-30N-3 @-#DP+C8P(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#0Y
M,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P(#0Y,"XV," U,BXP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C4P(#0V,"XV," R-# N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @
M-#8P+C8P(#4P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0P+C4P(#0V,"XV," T+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S0T+C4P(#0V,"XV," U,2XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU
M," T-C N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," T-C N-C @-3$N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-3 N-3 @-#8P+C8P(#0N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N
M-3 @-#8P+C8P(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#0V,"XV," T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3$P+C4P(#0V,"XV," U,BXP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C4P(#0S,"XV," R-# N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @-#,P+C8P(#4P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S0P+C4P(#0S,"XV," T+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S0T+C4P(#0S,"XV," U,2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU," T,S N-C @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Y.2XU," T,S N-C @-3$N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-3 N-3 @-#,P+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N-3 @-#,P+C8P
M(#4R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 V+C4P(#0S,"XV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3$P+C4P(#0S,"XV," U,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0P,"XV
M," R-# N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3 N-3 @-# P+C8P(#4P+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0P+C4P(#0P,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#0P
M,"XV," U,2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-2XU," T,# N-C @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,Y.2XU," T,# N-C @-3$N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3 N-3 @
M-# P+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-30N-3 @-# P+C8P(#4R+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 V+C4P(#0P,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P
M(#0P,"XV," U,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(Y,"XU(#<Q
M-BXV(&T*,S0P+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T,"XU(#<Q-BXV(&T*,S0T+C4@
M-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,T-"XU(#<Q-BXV(&T*,SDU+C4@-S$V+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,Y-2XU(#<Q-BXV(&T*,SDY+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y.2XU(#<Q-BXV
M(&T*-#4P+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U,"XU(#<Q-BXV(&T*-#4T+C4@-S$V
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0U-"XU(#<Q-BXV(&T*-3 V+C4@-S$V+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P
M-BXU(#<Q-BXV(&T*-3$P+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4Q,"XU(#<Q-BXV(&T*
M-38R+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C(Y,"XU(#<Q-BXV(&T*,S0P+C4@-S$V+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(Y,"XU(#<P,2XV(&T*,S0P+C4@-S Q+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T-"XU
M(#<Q-BXV(&T*,SDU+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T-"XU(#<P,2XV(&T*,SDU
M+C4@-S Q+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,Y.2XU(#<Q-BXV(&T*-#4P+C4@-S$V+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,Y.2XU(#<P,2XV(&T*-#4P+C4@-S Q+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U-"XU(#<Q
M-BXV(&T*-3 V+C4@-S$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U-"XU(#<P,2XV(&T*-3 V+C4@
M-S Q+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C4Q,"XU(#<Q-BXV(&T*-38R+C4@-S$V+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C4Q,"XU(#<P,2XV(&T*-38R+C4@-S Q+C8@; IS"D)4("]&,B Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S<V+C$U(#<R,2XP-2!49" H62D@5&H@150@
M40IQ(# @," P(')G($)4(#,X,BXQ-2 W,C$N,#4@5&0@*&5A<BD@5&H@150@
M40IQ(# @," P(')G($)4(#,Y-"XP-B W,C$N,#4@5&0@*"!%;F1E9"!$96-E
M;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#0V,BXS.2 W,C$N,#4@5&0@
M** S,2PI(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,#8N,# @-S V+C U(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S8P+C4P(#<P-BXP-2!49" H,C Q-RD@
M5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-2XU
M," W,#8N,#4@5&0@*#(P,38I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-S$N,# @-S V+C U(%1D("@R,#$U*2!4:B!%5"!1
M"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(W+C P(#<P-BXP
M-2!49" H,C Q-"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,S-BXW-2 V.3$N,#4@5&0@*%PH06UO=6YT<R!I;B!T:&]U<V%N
M9',L(&5X8V5P="!P97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-CDN.#4@
M-CDQ+C U(%1D("@@<VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#0X."XY
M-" V.3$N,#4@5&0@*&4@9&%T85PI*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @-C<V+C U(%1D("A#;VYS;VQI9&%T
M960@4W1A=&5M96YT<R!O9B!/<&5R871I;VYS($1A=&$Z*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C8Q+C V(%1D
M("A2979E;G5E(&9R;VT@<V5R=FEC97,I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.3,N,# @-C8Q+C V(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S W+C<U(#8V
M,2XP-B!49" H.#$V+#0X-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,T-RXP," V-C$N,#8@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C(N-S4@-C8Q+C V(%1D
M("@X-C4L,#0X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# R+C P(#8V,2XP-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Q-RXW-2 V-C$N,#8@5&0@*#@S,RPU
M,S<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-3<N,# @-C8Q+C V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#<S+C<U(#8V,2XP-B!49" H-S8W+#0R,2D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q,RXP," V
M-C$N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,CDN-S4@-C8Q+C V(%1D("@V,3<L.#(U*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C0V+C V(%1D
M("A<*$QO<W-<*2!I;F-O;64@9G)O;2!O<&5R871I;VYS*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S Y+C(U(#8T-BXP-B!4
M9" H7"@Q,BPX.# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,S<N,# @-C0V+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-RXR-2 V-#8N,#8@5&0@*#$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S$N-S4@-C0V+C V(%1D("@Q+#<T
M."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0R
M-BXW-2 V-#8N,#8@5&0@*#8L,3@T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#<X+C(U(#8T-BXP-B!49" H,C L-38U*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C(U
M(#8T-BXP-B!49" H7"@Q,"PT-C@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-3DN,# @-C0V+C V(%1D("A<*2D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#8S,2XP
M-B!49" H0V]N<V]L:61A=&5D(&YE="!<*&QO<W-<*2!I;F-O;64I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,#DN,C4@-C,Q
M+C V(%1D("A<*#$U+#<Q-RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,S-RXP," V,S$N,#8@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S8W+C(U(#8S,2XP-B!4
M9" H,S@L.# R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#(V+C<U(#8S,2XP-B!49" H."PW,S$I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#(N-S4@-C,Q+C V(%1D("@T
M+#DU-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S,2XR-2 V,S$N,#8@5&0@*%PH,S$L-3,T*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#8S,2XP-B!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP
M," V,38N.38@5&0@*$YE="!<*&QO<W-<*2!I;F-O;64@871T<FEB=71A8FQE
M('1O(&-O;6UO;B!S:&%R96AO;&1E<G,I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,#DN,C4@-C$V+C V(%1D("A<*#$V+#DU
M,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,S
M-RXP," V,38N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S8W+C(U(#8Q-BXP-B!49" H,S<L-3$S*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(V+C<U(#8Q
M-BXP-B!49" H-RPY-C<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.#(N-S4@-C$V+C V(%1D("@T+#0Q."D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XR-2 V,38N,#8@
M5&0@*%PH,S$L-S@S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-34Y+C P(#8Q-BXP-B!49" H7"DI(%1J($54(%$*0E0@+T8R
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," U.#8N,#4@5&0@*%!E
M<BD@5&H@150@40IQ(# @," P(')G($)4(#8V+C0Q(#4X-BXP-2!49" H(%-H
M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-RXP," U.#8N,#4@5&0@*&4@
M1&%T83HI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," U-S(N-#8@5&0@*$YE="!<*&QO<W-<*2!I;F-O;64@<&5R('-H
M87)E(&%T=')I8G5T86)L92!T;R!C;VUM;VX@<VAA<F5H;VQD97)S*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-38S
M+C0V(%1D("@M($)A<VEC*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,CDS+C P(#4V,RXP-B!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q."XR-2 U-C,N,#8@5&0@
M*%PH,"XT."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,S-RXP," U-C,N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S0W+C P(#4V,RXP-B!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-BXR-2 U
M-C,N,#8@5&0@*#$N,#<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,#(N,# @-38S+C V(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Q+C(U(#4V,RXP-B!49" H
M,"XR-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0U-RXP," U-C,N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.#<N,C4@-38S+C V(%1D("@P+C$T*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3$S+C P(#4V
M,RXP-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4T,"XR-2 U-C,N,#8@5&0@*%PH,2XP,BD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XP," U-C,N,#8@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @-30Y+C0V(%1D("A.970@7"AL;W-S7"D@:6YC;VUE('!E<B!S:&%R
M92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N('-H87)E:&]L9&5R<RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#4T,"XT
M-B!49" H+2!$:6QU=&5D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,CDS+C P(#4T,"XP-B!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q."XR-2 U-# N,#8@5&0@
M*%PH,"XT."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,S-RXP," U-# N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S0W+C P(#4T,"XP-B!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-BXR-2 U
M-# N,#8@5&0@*#$N,#$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,#(N,# @-30P+C V(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Q+C(U(#4T,"XP-B!49" H
M,"XQ-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0U-RXP," U-# N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.#<N,C4@-30P+C V(%1D("@P+C$T*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3$S+C P(#4T
M,"XP-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4T,"XR-2 U-# N,#8@5&0@*%PH,2XP,BD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XP," U-# N,#8@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @-3$P+C U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C$N
M-S4@-3$P+C U(%1D("AE:6=H=&5D("D@5&H@150@40IQ(# @," P(')G($)4
M(#DQ+C4P(#4Q,"XP-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#DW
M+C0R(#4Q,"XP-2!49" H=F5R86=E($-O;6UO;B!3:&%R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3@P+CDY(#4Q,"XP-2!49" H97,@3W5T<W1A;F1I;F<Z
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN
M,# @-#DU+C V(%1D("A"87-I8RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,Q,BXR-2 T.34N,#8@5&0@*#,U+#8U-RD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-RXR-2 T
M.34N,#8@5&0@*#,U+# Q."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0R,BXR-2 T.34N,#8@5&0@*#,R+#$S,BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W."XR-2 T.34N
M,#8@5&0@*#,Q+#4Q-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S-"XR-2 T.34N,#8@5&0@*#,Q+#$Y,"D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0X,"XP-B!4
M9" H1&EL=71E9"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Q,BXR-2 T.# N,#8@5&0@*#,U+#8U-RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-RXR-2 T.# N,#8@5&0@
M*#,V+#$V-BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0R,BXR-2 T.# N,#8@5&0@*#,V+#(T-BD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W."XR-2 T.# N,#8@5&0@*#,R
M+#$V,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S-"XR-2 T.# N,#8@5&0@*#,Q+#$Y,"D@5&H@150@40I"5" O1C(@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#0U,"XP-2!49" H3W1H97(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" W-2XX,R T-3 N,#4@5&0@*"!/<&5R
M871I;F<@1&%T83HI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,RXP," T,S4N,#8@5&0@*$-A<V@@86YD(&-A<V@@97%U:79A
M;&5N=',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" R.3,N,# @-#,U+C V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S$R+C(U(#0S-2XP-B!49" H,38L,#$Y*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S0W+C P
M(#0S-2XP-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V-RXR-2 T,S4N,#8@5&0@*#(U+#4S-RD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXP," T,S4N,#8@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,C(N,C4@-#,U+C V(%1D("@R,"PV,S I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-3<N,# @-#,U+C V(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@R+C<U
M(#0S-2XP-B!49" H,BPT-3,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,3,N,# @-#,U+C V(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,X+C<U(#0S-2XP-B!4
M9" H-"PY.34I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," T,C N,#8@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U."XQ." T,C N,#8@5&0@*&]T86P@87-S971S*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S W+C<U(#0R,"XP-B!49" H
M-#(W+# P,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V,BXW-2 T,C N,#8@5&0@*#0V-RPV.#<I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,3<N-S4@-#(P+C V(%1D("@S
M.#@L,S<X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<S+C<U(#0R,"XP-B!49" H,S8U+#4Y-2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R.2XW-2 T,C N,#8@5&0@*#,R
M-"PU,#(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," T,#4N,#8@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M."XQ." T,#4N,#8@5&0@*&]T86P@9&5B="!A="!P87(I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,3(N,C4@-# U+C V(%1D
M("@X,RPX-S8I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-C(N-S4@-# U+C V(%1D("@Q,# L,# P*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(R+C(U(#0P-2XP-B!49" H
M-C0L-3(S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<X+C(U(#0P-2XP-B!49" H-C,L,#DT*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,T+C(U(#0P-2XP-B!49" H-3@L
M-S R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @,SDP+C V(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N
M,3@@,SDP+C V(%1D("AO=&%L('-T;V-K:&]L9&5R<Y(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,C$N-S<@,SDP+C V(%1D("@@97%U:71Y*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S W+C<U(#,Y,"XP
M-B!49" H,C$X+#$Y."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V,BXW-2 S.3 N,#8@5&0@*#(S-RPW,3DI(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,3<N-S4@,SDP+C V
M(%1D("@Q-3$L.# R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#<S+C<U(#,Y,"XP-B!49" H,30Q+#,T-"D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R.2XW-2 S.3 N,#8@
M5&0@*#$S,"PS,S(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,RXP," S-S4N,#8@5&0@*$YE="!C87-H('!R;W9I9&5D(&)Y
M(%PH=7-E9"!I;EPI(&]P97)A=&EN9R!A8W1I=FET:65S*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S$R+C(U(#,W-2XP-B!4
M9" H,C L.3DW*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S8W+C(U(#,W-2XP-B!49" H-#4L-3 X*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(R+C(U(#,W-2XP-B!49" H
M,S L,30U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<X+C(U(#,W-2XP-B!49" H,3@L,C,U*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C<U(#,W-2XP-B!49" H7"@T
M+# W,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4U.2XP," S-S4N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M-#DN-3 @5&0@*%]?7U]?7U]?7U]?7U]?7RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,C4N-3 @5&0@*%1H92!F
M;VQL;W=I;F<@:71E;7,@:6UP86-T('1H92!C;VUP87)A8FEL:71Y(&%N9"!P
M<F5S96YT871I;VX@;V8@;W5R(&-O;G-O;&ED871E9"!D871A.BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-RXP," S,#$N
M-3 @5&0@*)4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#DU+C P(#,P,2XU,"!49" H0V]N<V]L:61A=&5D(&YE="!<*&QO
M<W-<*2!I;F-O;64@9F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<J S,2P@
M,C Q."P@,C Q-RP@,C Q-BP@,C Q-2P@86YD(#(P,30L(')E<W!E8W1I=F5L
M>2D@5&H@150@40IQ(# @," P(')G($)4(#4T."XV." S,#$N-3 @5&0@*"P@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU
M+C P(#(X.2XU,"!49" H:6YC;'5D97,@86UO=6YT<R!A='1R:6)U=&%B;&4@
M=&\@;F]N8V]N=')O;&QI;F<@:6YT97)E<W0@;V8@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R.2XV-R R.#DN-3 @5&0@
M*"0Q+C(@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S-S@N-38@,C@Y+C4P(%1D("@L("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.#,N-38@,C@Y+C4P(%1D
M("@D,2XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,R+C0V(#(X.2XU,"!49" H+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,W+C0V(#(X.2XU,"!4
M9" H)# N."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0X-BXS-2 R.#DN-3 @5&0@*"P@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,2XS-2 R.#DN-3 @
M5&0@*"0P+C4@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-# N,C0@,C@Y+C4P(%1D("@L(&%N9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @,C<W
M+C4P(%1D("@D,"XR*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Q,BXU," R-S<N-3 @5&0@*"!M:6QL:6]N+B!3964@3F]T
M92 Q("T@3W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-#<@,C<W+C4P
M(%1D("AG86YI>F%T:6]N(&%N9"!"87-I<R!O9B!0<F5S96YT871I;VX@=&\@
M;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S<N,# @,C4S
M+C4P(%1D("B5("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Y-2XP," R-3,N-3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,#,N-C0@,C4S+C4P(%1D("AE(&%C<75I<F5D("D@5&H@150@40IQ
M(# @," P(')G($)4(#$T-BXY-2 R-3,N-3 @5&0@*$%0*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,34Y+C,V(#(U,RXU,"!49" H(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-S<N-SD@,C4S+C4P(%1D("AF:6YG(&5F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C S+CDX(#(U,RXU,"!49" H9F5C=&EV92!$
M96-E;6)E<B Q+" R,#$X+"!A;&P@;V8@=&AE(&%S<V5T<R!O9B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.#8N-#(@,C4S+C4P(%1D("A!9'9A;G1A9V4@
M968I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,SDN.#(@,C4S+C4P(%1D("AF
M96-T:79E($IU;'D@,2P@,C Q-RP@86QL(&]F('1H92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @,C0Q+C4P(%1D
M("AM96UB97)S:&EP(&EN=&5R97-T<R!O9B!-961I<V-A;B!O;B!/8W1O8F5R
M(#,P+" R,#$U+"!A;F0@<W5B<W1A;G1I86QL>2!A;&P@;V8@=&AE(&%S<V5T
M<R!A;F0@8V5R=&%I;B!L:6%B:6QI=&EE<R!O9B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @,C(Y+C4P(%1D("A-
M4TX@;VX@2G5N92 S,"P@,C Q-"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3DR+C,R(#(R.2XU,"!49" H5&AE(')E<W5L=',@;V8@=&AE<V4@86-Q=6ES
M:71I;VXG<R!O<&5R871I;VYS(&AA=F4@8F5E;B!I;F-L=61E9"!I;B!O=7(@
M8V]N<V]L:61A=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Y-2XP," R,3<N-3 @5&0@*'-T871E;65N=',@;V8@;W!E
M<F%T:6]N<R!S:6YC92!T:&5I<B!R97-P96-T:79E(&5F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C@Y+C$Y(#(Q-RXU,"!49" H9F5C=&EV92!D871E<R!O
M9B!A8W%U:7-I=&EO;BX@1F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<J S
M,2P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#DU+C P(#(P-2XU,"!49" H,C Q."P@,C Q-RP@,C Q-BP@,C Q-2P@86YD
M(#(P,30L('=E(')E8V]G;FEZ960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(Y-RXT-B R,#4N-3 @5&0@*"0P+C4@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S-#8N,S4@,C U+C4P(%1D("@L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-3$N,S4@,C U+C4P(%1D("@D,BXP(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# P+C(T(#(P-2XU,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-# U+C(T(#(P-2XU,"!49" H)# N,2!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0U-"XQ-" R,#4N-3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0U.2XQ-" R,#4N-3 @5&0@*"0P+CD@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,#@N,#,@,C U+C4P(%1D("@L(&%N9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Y+CDW(#(P-2XU,"!49" H
M)#@N," I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.34N,# @,3DS+C4P(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,RXX.2 Q.3,N-3 @5&0@*"!O
M9B!A8W%U:7-I=&EO;B!A;F0@:6YT96=R871I;VX@8V]S=',L(')E<W!E8W1I
M=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#,Q.2XP,B Q.3,N-3 @5&0@
M*"X@4V5E($YO=&4@-" M("D@5&H@150@40IQ(# @," P(')G($)4(#,W-2XV
M." Q.3,N-3 @5&0@*$%C<75I<VET:6]N<R!T;R!O=7(@8V]N<V]L:61A=&5D
M(&9I;F%N8VEA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.34N,# @,3@Q+C4P(%1D("AS=&%T96UE;G1S+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-RXP," Q-3<N
M-3 @5&0@*)4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#DU+C P(#$U-RXU,"!49" H5&AE('EE87)S(&5N9&5D("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C,N,#(@
M,34W+C4P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-#$N-C$@,34W+C4P(%1D("@L
M(#(P,3<L(&%N9" R,#$V(&EN8VQU9&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,T,BXY." Q-3<N-3 @5&0@*"0R+C8@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.3$N.#<@,34W+C4P(%1D("@L(&QE<W,@=&AA;B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,T+C Y(#$U-RXU
M,"!49" H)# N,2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0X,BXY." Q-3<N-3 @5&0@*"P@86YD("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,#0N.3(@
M,34W+C4P(%1D("@D,"XX(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-34S+C@Q(#$U-RXU,"!49" H+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @
M,30U+C4P(%1D("AR97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q-#(N-C8@,30U+C4P(%1D("@L(&]F(&%C<75I<VET:6]N+7)E;&%T960@
M8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N(&5X<&5N<V4@<')I;6%R:6QY(&1U
M92!T;R!V86QU871I;VX@86YD(&%C8W)E=&EO;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @,3,S+C4P(%1D("AA
M9&IU<W1M96YT<R!R96QA=&5D('1O('1H92!C;VYT:6YG96YT(&-O;G-I9&5R
M871I;VX@;&EA8FEL:71I97,@;V8@=&AE(%534B!A;F0@365D:7-C86X@86-Q
M=6ES:71I;VYS+B!3964@3F]T92 T("T@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#DU+C P(#$R,2XU,"!49" H06-Q=6ES
M:71I;VYS(&%N9"!.;W1E(#$P("T@1F%I<B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,C,N-CD@,3(Q+C4P(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C(Y+C@P(#$R,2XU,"!49" H86QU92!-96%S=7)E;65N=',@=&\@;W5R
M(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S<N,# @.3<N-3 @
M5&0@*)4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#DU+C P(#DW+C4P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 S+C8T(#DW+C4P(%1D("AE(&EN8W5R<F5D(')E<W1R=6-T=7)I;F<@8V]S
M=',@:6X@=&AE('EE87)S(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.3<N-#8@.3<N-3 @5&0@*$1E8V5M8F5R
MH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,W-BXP-" Y-RXU,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S@Q+C T(#DW+C4P(%1D("@R,#$W
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P
M,2XP-" Y-RXU,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# V+C T(#DW+C4P(%1D("@R,#$V*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R-BXP-" Y-RXU
M,"!49" H+" R,#$U+"!A;F0@,C Q-"P@9F]R("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3(N,30@.3<N-3 @5&0@*"0R
M+C@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#DU+C P(#@U+C4P(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$R,RXX.2 X-2XU,"!49" H+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(X+C@Y
M(#@U+C4P(%1D("@D,2XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3<W+C<X(#@U+C4P(%1D("@L("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#(N-S@@
M.#4N-3 @5&0@*"0P+C@@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R,S$N-C<@.#4N-3 @5&0@*"P@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S-BXV-R X
M-2XU,"!49" H)#$N,R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(X-2XU-R X-2XU,"!49" H+"!A;F0@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P-RXU
M," X-2XU,"!49" H)# N."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,U-BXT," X-2XU,"!49" H+"!R97-P
M96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#DN,#8@.#4N-3 @
M5&0@*"X@4F5S=')U8W1U<FEN9R!C;W-T<R!R96QA=&4@=&\@9&ES8W)E=&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU
M+C P(#<S+C4P(%1D("AC;W-T('-A=FEN9W,@:6YI=&EA=&EV97,@:6X@96%C
M:"!Y96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,U+CDU(#<S+C4P(%1D
M("@L(&%N9"!S96YI;W(@;6%N86=E;65N="!E;7!L;WEE92!S979E<F%N8V4@
M<&%Y(&EN(#(P,30N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-#4@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R T-B P(%(^/@IE;F1O8FH*-#8@,"!O8FH*/#PO3&5N9W1H(#$T
M,C(W/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,P,2XP," S,2XV,"!49" H,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-S<N,# @-S0R+C$P(%1D("B5("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XP," W-#(N
M,3 @5&0@*%!R92UT87@@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,P+C8P(#<T,BXQ,"!49" H9V5S(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3<N
M,C8@-S0R+C$P(%1D("@D,C(N-"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q,2XQ-2 W-#(N,3 @5&0@*"P@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q
M-BXQ-2 W-#(N,3 @5&0@*"0Q-"XT(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<P+C T(#<T,BXQ,"!49" H
M+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S<U+C T(#<T,BXQ,"!49" H)#(T+C,@;6EL;&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C@N.30@-S0R+C$P(%1D
M("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,S,N.30@-S0R+C$P(%1D("@D,BXQ(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@R+C@S(#<T,BXQ,"!4
M9" H+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P-"XW-R W-#(N,3 @5&0@*"0Q,"XP(&UI;&QI;VXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34X+C8V(#<T
M,BXQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.34N,# @-S,P+C$P(%1D("AR97-P96-T:79E;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-#(N-C8@-S,P+C$P(%1D("@L('=E<F4@:6YC
M=7)R960@:6X@=&AE('EE87)S(&5N9&5D($1E8V5M8F5RH#,Q+" R,#$X+" R
M,#$W+" R,#$V+" R,#$U+"!A;F0@,C Q-"X@4V5E($YO=&4@-2 M("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XP," W
M,3@N,3 @5&0@*$=O;V1W:6QL+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,S<N-C @-S$X+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30S
M+C,U(#<Q."XQ,"!49" H<F%D92!.86UE<RP@86YD($]T:&5R($EN=&%N9VEB
M;&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@P+C4S(#<Q."XQ,"!49" H
M07-S971S('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N
M=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#<W+C P(#8Y-"XQ,"!49" HE2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.34N,# @-CDT+C$P(%1D("A4:&4@>65A<G,@
M96YD960@1&5C96UB97(@,S$L(#(P,3<@86YD(#(P,38@:6YC;'5D92!T:&4@
M:6UP86-T(&]F(&$@9V%I;B!O;B!D97)I=F%T:79E(&QI86)I;&ET>2!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DV
M+C@Q(#8Y-"XQ,"!49" H)#$N-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,30N,S$@-CDT+C$P(%1D("@@;6EL;&EO;B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N
M,# @-C@R+C$P(%1D("AA;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$Q,2XY-" V.#(N,3 @5&0@*"0U+C@@;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q
M-C N.#,@-C@R+C$P(%1D("@L('=H:6QE('1H92!Y96%R<R!E;F1E9"!$96-E
M;6)E<J S,2P@,C Q-2!A;F0@,C Q-"!I;F-L=61E('1H92!I;7!A8W0@;V8@
M82!L;W-S(&]N(&1E<FEV871I=F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#DU+C P(#8W,"XQ,"!49" H;&EA8FEL:71Y
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,SDN-#0@-C<P+C$P(%1D("@D.2XY(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@X+C,S(#8W,"XQ,"!4
M9" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C W+C<W(#8W,"XQ,"!49" H)#$V+C<@;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-C$N-C8@-C<P
M+C$P(%1D("@L(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4
M(#,Q-"XS,B V-S N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S$Y+C$T(#8W,"XQ,"!49" H5&AE(&1E<FEV871I=F4@;&EA8FEL:71Y(')E
M;&%T960@=&\@=&AE($-O;G9E<G1I8FQE($YO=&5S("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XP," V-3@N,3 @5&0@
M*&ES<W5E9"!I;B!C;VYJ=6YC=&EO;B!W:71H('1H92!A8W%U:7-I=&EO;B!O
M9B!-4TXL('=H:6-H('=E<F4@<&%I9"!I;B!F=6QL(&]N($UA<F-H(#$W+" R
M,#$W+B!3964@3F]T92 Y("T@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DU+C P(#8T-BXQ,"!49" H1&5R:79A=&EV97,@
M=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S<N,# @
M-C(R+C$P(%1D("B5("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Y-2XP," V,C(N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#,N-C0@-C(R+C$P(%1D("AE(&EN8W5R<F5D(&$@;&]S<R!O
M;B!S86QE(&]F(&)U<VEN97-S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R-3DN.3D@-C(R+C$P(%1D("@D,BXR(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S X+C@X(#8R,BXQ,"!49" H(%PH86X@869T97(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-#0N-S<@-C(R+C$P(%1D("@M=&%X(&=A:6X@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,RXS
M-B V,C(N,3 @5&0@*"0Q+C,@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-#(N,C4@-C(R+C$P(%1D("A<*2P@
M:6X@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DU+C P(#8Q,"XQ,"!49" H1&5C96UB97(@,S$L
M(#(P,34L(')E;&%T960@=&\@=&AE('-A;&4@;V8@;W5R(&5D=6-A=&EO;B!S
M96UI;F%R<R!B=7-I;F5S<RP@0W)O<W,@0V]U;G1R>2!%9'5C871I;VXL($Q,
M0R!O;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.34N,# @-3DX+C$P(%1D("A!=6=U<W0@,S$L(#(P,34N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<W+C P(#4W-"XQ
M,"!49" HE2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.34N,# @-3<T+C$P(%1D("A4:&4@>65A<G,@96YD960@1&5C96UB
M97(@,S$L(#(P,3@L(#(P,3<L(&%N9" R,#$V+"!I;F-L=61E(&$@;&]S<R!O
M;B!E87)L>2!E>'1I;F=U:7-H;65N="!O9B!D96)T(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3$N,# @-3<T+C$P
M(%1D("@D,"XQ("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Y-2XP," U-C(N,3 @5&0@*&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(S+C@Y(#4V,BXQ,"!4
M9" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(X+C@Y(#4V,BXQ,"!49" H)#4N,"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#8N,SD@-38R+C$P(%1D("@@;6EL
M;&EO;BP@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q.3DN-S(@-38R+C$P(%1D("@D,2XV(&UI;&QI;VXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C0X+C8Q(#4V
M,BXQ,"!49" H+"!R97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,#$N,C<@-38R+C$P(%1D("@L(')E;&%T960@=&\@;W!T:6]N86P@<')E
M<&%Y;65N=',@;VX@;W5R("D@5&H@150@40IQ(# @," P(')G($)4(#0V,BXY
M," U-C(N,3 @5&0@*$%M96YD960@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3 T+C$P(#4V,BXQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#4P
M.2XU,2 U-C(N,3 @5&0@*&5R;2!,;V%N(&EN("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XP," U-3 N,3 @5&0@*#(P
M,3@L(&5X=&EN9W5I<VAM96YT(&9E97,L(&%N9"!T:&4@=W)I=&4M;V8I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R-C@N.30@-34P+C$P(%1D("AF(&]F('5N
M86UO<G1I>F5D(&QO86X@9F5E<R!A;F0@;F5T(&1E8G0@9&ES8V]U;G0@86YD
M(&ES<W5A;F-E(&-O<W1S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Y-2XP," U,S@N,3 @5&0@*')E;&%T960@=&\@<')I
M;W(@8W)E9&ET(&%G<F5E;65N=',N(%-E92!.;W1E(#@@+2!$96)T('1O(&]U
M<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<W+C P(#4Q-"XQ
M,"!49" HE2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.34N,# @-3$T+C$P(%1D("A);F-O;64@=&%X(&)E;F5F:70@9F]R
M('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B S,2P@,C Q."!A;F0@,C Q-R!I
M;F-L=61E9"!B96YE9FET<R!O9B D-BXP(&UI;&QI;VX@86YD("0Q,BXQ("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XP
M," U,#(N,3 @5&0@*&UI;&QI;VXL(')E<W!E8W1I=F5L>2D@5&H@150@40IQ
M(# @," P(')G($)4(#$W-BXU-2 U,#(N,3 @5&0@*"P@<F5L871E9"!T;R!T
M:&4@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S0P+C0W(#4P,BXQ,"!49" H9V5S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-3@N-C(@-3 R+C$P(%1D("A4:&4@:6YC;VUE('1A>"!B96YE
M9FET(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.34N,# @-#DP+C$P(%1D("A$96-E;6)E
M<B S,2P@,C Q-R!W87,@<')I;6%R:6QY('1H92!R97-U;'0@;V8@<F5D=6-I
M;F<@9F5D97)A;"!A;F0@8V5R=&%I;B!S=&%T92!V86QU871I;VX@86QL;W=A
M;F-E<R!O;B!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#DU+C P(#0W."XQ,"!49" H9&5F97)R960@=&%X(&%S<V5T
M<R!T;W1A;&EN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C T+C0P(#0W."XQ,"!49" H)#0U+C0@;6EL;&EO;BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S @
M-#<X+C$P(%1D("@L(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<Q+C0U
M(#0W."XQ,"!49" H9G-E="!B>2!A;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S$R+C@R(#0W."XQ,"!49" H)#@N,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S N
M,S(@-#<X+C$P(%1D("@@;6EL;&EO;B!R961U8W1I;VX@:6X@;W5R(&YE="D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@
M,"!48R Q,# @5'H@,"!43" *<2 Q(# @,"!R9R!"5" T-#(N.# @-#<X+C$P
M(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( IQ(# @," P(')G($)4(#0T-2XS
M," T-S@N,3 @5&0@*&1E9F5R<F5D('1A>"!A<W-E=',@7"AR96QA=&EN9R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N
M,# @-#8V+C$P(%1D("AT;R!T:&4@:6UP86-T(&9R;VT@=&AE(#(P,3<@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C X+C8X(#0V-BXQ,"!49" H5"D@5&H@
M150@40IQ(# @," P(')G($)4(#(Q-"XP.2 T-C8N,3 @5&0@*&%X("D@5&H@
M150@40IQ(# @," P(')G($)4(#(R-2XT." T-C8N,3 @5&0@*$%C="!S:6=N
M960@:6YT;R!L96=I<VQA=&EO;B!O;B!$96-E;6)E<B R,BP@,C Q-UPI+B!&
M;W(@=&AE('EE87(@96YD960@1&5C96UB97(@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU+C P(#0U-"XQ,"!49" H,S$L
M(#(P,3@L('=E(&-O;7!L971E9"!O=7(@,C Q-R!F961E<F%L(&%N9"!S=&%T
M92!I;F-O;64@=&%X(')E='5R;G,@86YD(')E8V]R9&5D(&$@9&ES8W)E=&4@
M=&%X(&)E;F5F:70@87-S;V-I871E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.34N,# @-#0R+C$P(%1D("AW:71H(&%D
M:G5S=&EN9R!O=7(@;F5T(&1E9F5R<F5D('1A>"!A<W-E="X@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C4Y+C<W(#0T,BXQ,"!49" H5&AE('9A;'5A=&EO
M;B!A;&QO=V%N8V4@=V%S(&UA:6YT86EN960@86YD(')E9FQE8W1E9"!I;B!T
M:&4@>65A<G,@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#DU+C P(#0S,"XQ,"!49" H1&5C96UB97(@,S$L(#(P
M,30@=&AR;W5G:"!$96-E;6)E<B S,2P@,C Q-BX@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0P-BXQ,"!49" H
M271E;2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXT.2 T,#8N,3 @5&0@
M*#<NH" I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-"XY.2 T,#8N,3 @5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-RXT.2 T,#8N,3 @5&0@*" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" X.2XY.2 T,#8N,3 @5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Y,BXT.2 T,#8N,3 @5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Y-"XY.2 T,#8N,3 @5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Y-RXT.2 T,#8N,3 @5&0@*" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y.2XY.2 T,#8N,3 @5&0@*" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#(N-#D@-# V+C$P(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3 T+CDY(#0P-BXQ,"!49" H("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P-RXT.2 T,#8N,3 @5&0@*$UA;F%G96UE;G0G<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-S(N-S8@-# V+C$P(%1D("A$:7-C=7-S:6]N("D@
M5&H@150@40IQ(# @," P(')G($)4(#(R,"XR-R T,#8N,3 @5&0@*&%N9" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S@N,S0@-# V+C$P(%1D("A!;F%L
M>7-I<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S8N.3<@-# V+C$P(%1D
M("AO9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#<N.# @-# V+C$P(%1D
M("A&:6YA;F-I86P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,P+C,P(#0P
M-BXQ,"!49" H0V]N9&ET:6]N("D@5&H@150@40IQ(# @," P(')G($)4(#,W
M-2XV," T,#8N,3 @5&0@*&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M.30N,C(@-# V+C$P(%1D("A297-U;'1S("D@5&H@150@40IQ(# @," P(')G
M($)4(#0R-RXX,R T,#8N,3 @5&0@*&]F("D@5&H@150@40IQ(# @," P(')G
M($)4(#0S."XV-B T,#8N,3 @5&0@*$]P97)A=&EO;G,N*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,X,BXQ,"!4
M9" H5&AE(&9O;&QO=VEN9R!D:7-C=7-S:6]N(&%N9"!A;F%L>7-I<R!O9B!O
M=7(@9FEN86YC:6%L(&-O;F1I=&EO;B!A;F0@<BD@5&H@150@40IQ(# @," P
M(')G($)4(#,S,"XW-2 S.#(N,3 @5&0@*&5S=6QT<R!O9B!O<&5R871I;VYS
M('-H;W5L9"!B92!R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4V+C(Q(#,X
M,BXQ,"!49" H96%D(&EN(&-O;FIU;F-T:6]N('=I=&@@*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W,"XQ,"!4
M9" H271E;2 Q+B!"=7-I;F5S<RP@271E;2 V+B!396QE8W1E9"!&:6YA;F-I
M86P@1&%T82P@271E;2 Q02X@4FES:R!&86-T;W)S+"!&;W)W87(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-S4N,3(@,S<P+C$P(%1D("AD+4QO;VMI;F<@
M4W1A=&5M96YT<R!A;F0@271E;2 Q-2X@*2!4:B!%5"!1"D)4("]&-" Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U."XQ,"!49" H0V]N<V]L
M:61A=&5D($9I;F%N8VEA;"!3=&%T96UE;G1S(&%N9"!T:&4@86-C;VUP86YY
M:6YG(&YO=&5S(&%N9"!O=&AE<B!D871A+"!A;&P@;V8@=VAI8V@@87!P96%R
M(&5L<V5W:&5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@Y+C,P(#,U."XQ
M,"!49" H92!I;B!T:&ES("D@5&H@150@40IQ(# @," P(')G($)4(#4R,RXR
M." S-3@N,3 @5&0@*$%N;G5A;" I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S0V+C$P(%1D("A297!O<G0@;VX@
M1F]R;: Q,"U++BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*," P(# @
M4D<*+T=3,"!G<PHP+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3 @
M,S(P+C4S-3 U.#4Y,S<U(&T*,3,P+C(W.#,R,#,Q,C4@,S(P+C4S-3 U.#4Y
M,S<U(&P*<PIQ(# @," P(')G($)4(#4P+C P(#,R,BXQ,"!49" H0G5S:6YE
M<W,@3W9E<G9I97<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S$P+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y."XQ,"!49" H5RD@
M5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#(Y."XQ,"!49" H92!P<F]V
M:61E(&AE86QT:&-A<F4@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$U
M-BXT-B R.3@N,3 @5&0@*&9I;F<L(')E8W)U:71I;F<@86YD('=O<FMF;W)C
M92!S;VQU=&EO;G,@=&\@;W5R(&-U<W1O;65R<R!T:')O=6=H(&$@;F5T=V]R
M:R!O9B W,R!O9BD@5&H@150@40IQ(# @," P(')G($)4(#0Y-"XU-" R.3@N
M,3 @5&0@*&9I8V4@;&]C871I;VYS("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R.#8N,3 @5&0@*'1H<F]U9VAO
M=70@=&AE(%4N4RX@3W5R('-E<G9I8V5S(&EN8VQU9&4@<&QA8VEN9R!C;&EN
M:6-I86YS(&]N('1R879E;"!A;F0@<&5R(&1I96T@87-S:6=N;65N=',L(&QO
M8V%L('-H;W)T+71E<FT@8V]N=')A8W1S+"!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(W-"XQ,"!49" H
M<&5R;6%N96YT('!O<VET:6]N<RX@26X@861D:71I;VXL('=E(&]F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C V+C<S(#(W-"XQ,"!49" H9F5R(&9L97AI
M8FQE('=O<FMF;W)C92!M86YA9V5M96YT('-O;'5T:6]N<R!T;R!O=7(@8W5S
M=&]M97)S(&EN8VQU9&EN9SH@35-0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3(P+C(X(#(W-"XQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C8R+C$P(%1D("AE9'5C871I;VX@
M:&5A;'1H8V%R92P@4E!/+"!A;F0@;W1H97(@;W5T<V]U<F-I;F<@86YD('9A
M;'5E+6%D9&5D('-E<G9I8V5S(&%S(&1E<V-R:6)E9"!I;B!)=&5M(#$N($)U
M<VEN97-S+B!);B!A9&1I=&EO;BP@=V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(U,"XQ,"!49" H<')O=FED
M92!B;W1H(')E=&%I;F5D(&%N9"!C;VYT:6YG96YT('!L86-E;65N="!S97)V
M:6-E<R!F;W(@:&5A;'1H8V%R92!E>&5C=71I=F5S+"!P:'ES:6-I86YS+"!A
M;F0@;W1H97(@:&5A;'1H8V%R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C,X+C$P(%1D("AP<F]F97-S:6]N
M86QS+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," R,C8N,3 @5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C$T+C$P(%1D("A7*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3@N-C0@,C$T+C$P(%1D("AE(&UA;F%G92!A;F0@
M<V5G;65N="!O=7(@8G5S:6YE<W,@8F%S960@;VX@=&AE(&YA='5R92!O9B!O
M=7(@<V5R=FEC97,@=V4@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N
M.# @,C$T+C$P(%1D("AF97(@=&\@;W5R(&-U<W1O;65R<RX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#4R+C4P(#(Q-"XQ,"!49" H07,@82!R97-U;'0L
M(&EN(&%C8V]R9&%N8V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#(P,BXQ,"!49" H=VET:"!T:&4@*2!4:B!%
M5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C P(#(P
M,BXQ,"!49" H4V5G;65N="!297!O<G1I;F<@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$V,RXX-R R,#(N,3 @5&0@*%0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN,C@@,C R+C$P(%1D("AO<&EC
M(&]F('1H92!&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Y+C,V(#(P,BXQ
M,"!49" H05-"("D@5&H@150@40IQ(# @," P(')G($)4(#(T,"XW-B R,#(N
M,3 @5&0@*$%30RP@=V4@<F5P;W)T('1H<F5E(&)U<VEN97-S('-E9VUE;G1S
M()8@3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#0U-"XV,2 R
M,#(N,3 @5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#DX+C T(#(P,BXQ,"!49" H9FEN9RP@4&AY<VEC:6%N("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q.3 N,3 @
M5&0@*%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-2XY,R Q.3 N,3 @
M5&0@*&9I;F<L(&%N9"!/=&AE<B!(=6UA;B!#87!I=&%L($UA;F%G96UE;G0@
M4V5R=FEC97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HO1U,P(&=S
M"G$@-BXP," P(# @,3 N,#D@-C@N,# @,38S+CDT(&-M"B]),C$@1&\@40IQ
M(# @," P(')G($)4(#<T+C P(#$V-BXQ,"!49" H("D@5&H@150@40I"5" O
M1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," Q-C8N,3 @5&0@
M*$YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,CDN-S$@,38V
M+C$P(%1D("A!;&QI960@4W1A9F9I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3@W+C(Q(#$V-BXQ,"!49" H()8@1F]R
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!.=7)S92!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# P+C<U(#$V-BXQ,"!49" H06QL
M:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#0N,3<@,38V+C$P
M(%1D("AF:6YG(')E<')E<V5N=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" X-BXP," Q-30N,3 @5&0@*&%P<')O>&EM
M871E;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$T-BXR-B Q-30N,3 @5&0@*#@X)2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C0N-3D@,34T+C$P(%1D("@@;V8@
M;W5R('1O=&%L(')E=F5N=64N($YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3,N-#0@,34T+C$P(%1D("A!;&QI960@4W1A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#,S-BXX-B Q-30N,3 @5&0@*&9I;F<@<')O=FED
M97,@=')A9&ET:6]N86P@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#0U
M,"XR-B Q-30N,3 @5&0@*&9I;F<L(')E8W)U:71I;F<L(&%N9"!V86QU92TI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N
M,# @,30R+C$P(%1D("AA9&1E9"!W;W)K9F]R8V4@<V]L=71I;VYS(&EN8VQU
M9&EN9SH@=&5M<&]R87)Y(&%N9"!P97)M86YE;G0@<&QA8V5M96YT(&]F('1R
M879E;"!A;F0@;&]C86P@8G)A;F-H+6)A<V5D(&YU<G-E(&%N9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,3,P
M+C$P(%1D("AA;&QI960@<')O9F5S<VEO;F%L<RP@35-0*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3@X+C$R(#$S,"XQ,"!49" H('-E<G9I8V5S+"!E9'5C
M871I;VX@:&5A;'1H8V%R92!S97)V:6-E<RP@86YD(&]U='-O=7)C:6YG('-E
M<G9I8V5S+B!3=6)S=&%N=&EA;&QY(&%L;"!O9B!T:&4@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#$Q."XQ,"!4
M9" H<F5S=6QT<R!O9B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,Y
M+C8P(#$Q."XQ,"!49" H061V86YT86=E(&%N9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,#$N.#$@,3$X+C$P(%1D("A!4"D@5&H@150@40IQ(# @," P
M(')G($)4(#(Q-"XR,B Q,3@N,3 @5&0@*"!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C,R+C8U(#$Q."XQ,"!49" H9FEN9R!A8W%U:7-I=&EO;G,@
M:&%V92!B965N(&%G9W)E9V%T960@=VET:"!O=7(@3G5R<V4@86YD("D@5&H@
M150@40IQ(# @," P(')G($)4(#0V.2XU,B Q,3@N,3 @5&0@*$%L;&EE9"!3
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$R+CDT(#$Q."XQ,"!49" H
M9FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#8N,# @,3 V+C$P(%1D("AB=7-I;F5S<R!S96=M96YT+B!3964@3F]T
M92 T("T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$R+C,W(#$P-BXQ,"!4
M9" H06-Q=6ES:71I;VYS('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L
M('-T871E;65N=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HO1U,P
M(&=S"G$@-BXP," P(# @,3 N,#D@-C@N,# @-SDN.30@8VT*+TDR,B!$;R!1
M"G$@," P(# @<F<@0E0@-S0N,# @.#(N,3 @5&0@*" I(%1J($54(%$*0E0@
M+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @.#(N,3 @5&0@
M*%!H>7-I8VEA;B!3=&%F9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q-3DN,#4@.#(N,3 @5&0@*""6($9O<B!T:&4@
M>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q."P@4&AY<VEC:6%N(%-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N,30@.#(N,3 @5&0@*&9I;F<@
M<F5P<F5S96YT960@87!P<F]X:6UA=&5L>2 Q,"4@;V8@;W5R("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," W,"XQ
M,"!49" H=&]T86P@<F5V96YU92X@4&AY<VEC:6%N(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,# N,C,@-S N,3 @5&0@*&9I;F<@<')O=FED97,@
M<&AY<VEC:6%N<R!I;B!M86YY('-P96-I86QT:65S+"!A<R!W96QL(&%S($-2
M3D%S+"!.4',L(&%N9"!0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 S+C0U
M(#<P+C$P(%1D("A!<R!U;F1E<B!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4X+C$P(%1D("A-961I8V%L
M($1O8W1O<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3 N.3@@-3@N,3 @
M5&0@*$%S<V]C:6%T97,@7"A-1$%<*2!B<F%N9"!A<R!I;F1E<&5N9&5N="!C
M;VYT<F%C=&]R<R!O;B!T96UP;W)A<GD@87-S:6=N;65N=',@=&AR;W5G:&]U
M="!T:&4@52Y3+BD@5&H@150@40IE;F1S=')E86T*96YD;V)J"C0W(# @;V)J
M"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V
M,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N
M=&5N=',@-#@@,"!2/CX*96YD;V)J"C0X(# @;V)J"CP\+TQE;F=T:" Q,#,S
M-SX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,#$N,# @,S$N-C @5&0@*#(P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HO1U,P(&=S"G$@-BXP," P(# @,3 N,#D@-C@N,# @-S,Y+CDT(&-M"B])
M,C,@1&\@40IQ(# @," P(')G($)4(#<T+C P(#<T,BXQ,"!49" H("D@5&H@
M150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," W
M-#(N,3 @5&0@*$]T:&5R($AU;6%N($-A<&ET86P@36%N86=E;65N="!397)V
M:6-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R-C0N,S @-S0R+C$P(%1D("@@EB!&;W(@=&AE('EE87(@96YD960@1&5C
M96UB97(@,S$L(#(P,3@L($]T:&5R($AU;6%N($-A<&ET86P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#<S,"XQ
M,"!49" H36%N86=E;65N="!397)V:6-E<R!<*$](0TU37"D@<F5P<F5S96YT
M960@87!P<F]X:6UA=&5L>2 R)2!O9B!O=7(@=&]T86P@<F5V96YU92X@3TA#
M35,@:7,@8V]M<')I<V5D(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" X-BXP," W,3@N,3 @5&0@*')E=&%I;F5D(&%N
M9"!C;VYT:6YG96YT('-E87)C:"!S97)V:6-E<R!F;W(@<&AY<VEC:6%N<RP@
M:&5A;'1H8V%R92!E>&5C=71I=F5S+"!A;F0@;W1H97(@:&5A;'1H8V%R92!P
M<F]F97-S:6]N86QS('=I=&AI;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.#8N,# @-S V+C$P(%1D("AT:&4@52Y3+BD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP
M+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3 @-C@P+C4S-3 U.#4Y
M,S<U(&T*,34S+C,S,# W.#$R-2 V.# N-3,U,#4X-3DS-S4@; IS"G$@," P
M(# @<F<@0E0@-3 N,# @-C@R+C$P(%1D("A3=6UM87)Y(&]F($]P97)A=&EO
M;G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-C4X+C$P(%1D("A&;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R-RXQ.2 V-3@N
M,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(P-2XW." V-3@N,3 @5&0@*"P@<F5V
M96YU92!F<F]M('-E<G9I8V5S(&1E8W)E87-E9" U+C8E('1O("0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@R+C Y(#8U
M."XQ,"!49" H.#$V+C4@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,S4N.3@@-C4X+C$P(%1D("@L('=I=&@@
M9&5C;&EN97,@:6X@8F]T:"!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#8T-BXQ,"!49" H3G5R<V4@86YD
M("D@5&H@150@40IQ(# @," P(')G($)4(#DR+C<W(#8T-BXQ,"!49" H06QL
M:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S8N,3D@-C0V+C$P
M(%1D("AF:6YG(&%N9"!O=7(@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-#0N.#@@-C0V+C$P(%1D("AF:6YG(')E<&]R=&EN9R!S
M96=M96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0T+C8X(#8T-BXQ
M,"!49" H5&AE('EE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-SDN-S0@
M-C0V+C$P(%1D("@M;W9E<BD@5&H@150@40IQ(# @," P(')G($)4(#0P,"XV
M,R V-#8N,3 @5&0@*"UY96%R(&1E8W)E87-E(&EN($YU<G-E(&%N9" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" U,3,N-C,@-C0V+C$P(%1D("A!;&QI960@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8S-"XQ,"!49" H4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#8U
M+CDS(#8S-"XQ,"!49" H9FEN9R!W87,@<')I;6%R:6QY(&1U92!T;R!V;VQU
M;64@9&5C;&EN97,@:6X@=')A=F5L(&YU<G-E(&%N9"!B<F%N8V@@;W!E<F%T
M:6]N<RP@<&%R=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(T+C(U
M(#8S-"XQ,"!49" H9G-E="!B>2!T:&4@:6UP86-T(&]F('1H92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C(R
M+C$P(%1D("AA8W%U:7-I=&EO;B!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,#8N-C8@-C(R+C$P(%1D("A!9'9A;G1A9V4@:6X@2G5L>2 R,#$W+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#8N-S0@-C(R+C$P(%1D("A4:&4@
M9&5C<F5A<V4@:6X@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,CDN,S @-C(R+C$P(%1D("AF:6YG('=A<R!P<FEM87)I;'D@9'5E
M('1O(&$@9&5C<F5A<V4@:6X@=F]L=6UE(&]F(&1A>7,@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Q,"XQ,"!4
M9" H9FEL;&5D+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" W-2XY,B V,3 N
M,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-"XU-B V,3 N,3 @
M5&0@*&4@8V]N=&EN=65D('1O(&UA;F%G92!O=7(@<V5L;&EN9RP@9V5N97)A
M;"P@86YD(&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S(&%S('=E(')E;6%I;B!C
M;VUM:71T960@=&\@:6UP<F]V:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,3 @5&0@*&]P97)A=&EN
M9R!L979E<F%G92!A;F0@;W9E<F%L;"!P<F]F:71A8FEL:71Y*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C(P+CDU(#4Y."XQ,"!49" H+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,C4N-# @-3DX+C$P(%1D("A!<R!P87)T(&]F(&]U
M<B!C;W-T('-A=FEN9W,@86YD(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S4Y+C,U(#4Y."XQ,"!49" H9FEC:65N8WD@:6YI=&EA=&EV97,L('=E(&EN
M8W5R<F5D("0R+C@@;6EL;&EO;B!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3@V+C$P(%1D("AR97-T<G5C
M='5R:6YG(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C N-C(@-3@V
M+C$P(%1D("AG97,@9'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q
M+" R,#$X+B!.970@;&]S<R!A='1R:6)U=&%B;&4@=&\@8V]M;6]N('-H87)E
M:&]L9&5R<R!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4Q,2XS-" U.#8N,3 @5&0@*"0Q-RXP("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-S0N,3 @
M5&0@*&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-S@N.#D@-3<T+C$P(%1D("@L(&]R("0P+C0X('!E<B!D:6QU
M=&5D('-H87)E(&%N9"!W87,@:6UP86-T960@8GD@<')E+71A>"!N;VXM8V%S
M:"!I;7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3 N
M-30@-3<T+C$P(%1D("AG97,@;V8@)#(R+C0@;6EL;&EO;B!R96QA=&5D('1O
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," U-C(N,3 @5&0@*%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3 W+C,Q(#4V,BXQ,"!49" H9FEN9R!<*"0Q-BXT(&UI;&QI
M;VX@869T97(@=&%X97-<*2XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-34P+C$P(%1D("@@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4S."XQ,"!4
M9" H1F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!W92!G
M96YE<F%T960@8V%S:"!F;&]W(&9R;VT@;W!E<F%T:6YG(&%C=&EV:71I97,@
M;V8@)#(Q+C @;6EL;&EO;BP@86YD('!U<G-U86YT('1O('1H92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3(V
M+C$P(%1D("AC=7)R96YT(&%U=&AO<FEZ960@<VAA<F4@<F5P=7)C:&%S92!P
M<F]G<F%M+"!R97!U<F-H87-E9"!A;F0@<F5T:7)E9" T,S(L-#,Y('-H87)E
M<R!O9B!#;VUM;VX@4W1O8VL@9F]R("0U+C @;6EL;&EO;BP@870@86X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#4Q-"XQ,"!49" H879E<F%G92!M87)K970@<')I8V4@;V8@)#$I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-38N-SD@-3$T+C$P(%1D("@Q+C4T('!E<B!S
M:&%R92X@4V5E($YO=&4@,30@+2!3=&]C:VAO;&1E<G,G($5Q=6ET>2!T;R!O
M=7(@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+B @*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3(V+C@T(#4Q-"XQ,"!49" H07,@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#4P,BXQ,"!49" H1&5C96UB97(@,S$L(#(P,3@L('=E(&AA9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38T+C8X(#4P
M,BXQ,"!49" H)#$V+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R,3@N-3<@-3 R+C$P(%1D("@@;V8@8V%S
M:"!A;F0@8V%S:"!E<75I=F%L96YT<R!A;F0@82!P<FEN8VEP86P@8F%L86YC
M92!O9B D.#,N.2!M:6QL:6]N(&]U='-T86YD:6YG(&]N("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T.3 N,3 @
M5&0@*&]U<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-2XV-2 T.3 N,3 @
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,2XP-B T.3 N,3 @5&0@
M*&5R;2!,;V%N+B!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L
M(#(P,3@L('=E(')E<&%I9" D,38N,2!M:6QL:6]N(&]N(&]U<B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,38N,#4@-#DP+C$P(%1D("A4*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#(Q+C0V(#0Y,"XQ,"!49" H97)M($QO86XL(&EN
M8VQU9&EN9R D,3 N,"!M:6QL:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-S@N,3 @5&0@*&]F(&]P=&EO
M;F%L('!R97!A>6UE;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3(N
M,#(@-#<X+C$P(%1D("A4:&5R92!W97)E(&YO(&)O<G)O=VEN9W,@9')A=VX@
M;VX@;W5R(')E=F]L=FEN9R!C<F5D:70@9F%C:6QI='DI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,#DN.#D@-#<X+C$P(%1D("@L('=I=&@@)#(P+C8@;6EL
M;&EO;B!O9B!L971T97)S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," T-C8N,3 @5&0@*&-R961I="!O=71S
M=&%N9&EN9R!A<R!O9B!$96-E;6)E<B S,2P@,C Q."X@3W5R(&%B:6QI='D@
M=&\@9')A=R!D;W=N(&]N('1H92!R979O;'9I;F<@8W)E9&ET(&9A8VEL:71Y
M('=O=6QD(&)E('-U8FIE8W0@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#0U-"XQ,"!49" H8V]N=&EN=65D
M(&-O;7!L:6%N8V4@=VET:"!O=7(@9FEN86YC:6%L(&-O=F5N86YT<RP@=VAI
M8V@@;6%Y(')E<75I<F4@=7,@=&\L(&%M;VYG(&]T:&5R('1H:6YG<RP@;6%K
M92!A9&1I=&EO;F%L(&]P=&EO;F%L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-#(N,3 @5&0@*'!R:6YC:7!A
M;"!D96)T('!R97!A>6UE;G1S+B!3964@3F]T92 X("T@1&5B="!T;R!O=7(@
M8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X+C$P
M(%1D("A3964@4F5S=6QT<R!O9B!/<&5R871I;VYS+"!396=M96YT(%)E<W5L
M=',L(&%N9"!,:7%U:61I='D@86YD($-A<&ET86P@4F5S;W5R8V5S('-E8W1I
M;VYS('1H870@9F]L;&]W(&9O<B!F=7)T:&5R(&EN9F]R;6%T:6]N+BD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+CDU
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3 @,SDR+C4S-3 U.#4Y,S<U
M(&T*,3(Y+C$T,#8R-2 S.3(N-3,U,#4X-3DS-S4@; IS"G$@," P(# @<F<@
M0E0@-3 N,# @,SDT+C$P(%1D("A/<&5R871I;F<@365T<FEC<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-S N
M,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" S-S N,3 @
M5&0@*&4@979A;'5A=&4@;W5R(&9I;F%N8VEA;"!C;VYD:71I;VX@8GD@=')A
M8VMI;F<@;W!E<F%T:6YG(&UE=')I8W,@86YD(&9I;F%N8VEA;"!R97-U;'1S
M('-P96-I9FEC('1O(&5A8V@@;V8@;W5R('-E9VUE;G1S+B!+97D@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U
M."XQ,"!49" H;W!E<F%T:6YG(&UE=')I8W,@:6YC;'5D92!H;W5R<R!W;W)K
M960L(&1A>7,@9FEL;&5D+"!N=6UB97(@;V8@1E1%<RP@<F5V96YU92!P97(@
M1E1%+"!A;F0@<F5V96YU92!P97(@9&%Y(&9I;&QE9"X@3W1H97(@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,T
M-BXQ,"!49" H;W!E<F%T:6YG(&UE=')I8W,@:6YC;'5D92!N=6UB97(@;V8@
M;W!E;B!O<F1E<G,L(&-A;F1I9&%T92!A<'!L:6-A=&EO;G,L(&-O;G1R86-T
M(&)O;VMI;F=S+"!L96YG=&@@;V8@87-S:6=N;65N="P@8FEL;"!A;F0@<&%Y
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," S,S0N,3 @5&0@*')A=&5S+"!A;F0@<F5N97=A;"!A;F0@9FEL;"!R
M871E<RP@;G5M8F5R(&]F(&%C=&EV92!S96%R8VAE<RP@86YD(&YU;6)E<B!O
M9B!P;&%C96UE;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3DN-C<@
M,S,T+C$P(%1D("A4:&5S92!O<&5R871I;F<@;65T<FEC<R!A<F4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,R
M,BXQ,"!49" H<F5P<F5S96YT871I=F4@;V8@=')E;F1S('1H870@87-S:7-T
M(&UA;F%G96UE;G0@:6X@979A;'5A=&EN9R!B=7-I;F5S<R!P97)F;W)M86YC
M92X@1'5E('1O('1H92!T:6UI;F<@;V8@;W5R(&)U<VEN97-S('!R;V-E<W,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,Q,"XQ,"!49" H86YD(&]T:&5R(&9A8W1O<G,L(&-E<G1A:6X@;V8@
M=&AE<V4@;W!E<F%T:6YG(&UE=')I8W,@;6%Y(&YO="!N96-E<W-A<FEL>2!C
M;W)R96QA=&4@=&\@=&AE(')E<&]R=&5D($=!05 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-C4N,#(@,S$P+C$P(%1D("@@<F5S=6QT<R!F;W(@=&AE('!E
M<FEO9',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#(Y."XQ,"!49" H<')E<V5N=&5D+B!3;VUE(&]F('1H92!S
M96=M96YT(&9I;F%N8VEA;"!R97-U;'1S(&%N86QY>F5D(&EN8VQU9&4@<F5V
M96YU92P@;W!E<F%T:6YG(&5X<&5N<V5S+"!A;F0@8V]N=')I8G5T:6]N(&EN
M8V]M92X@26X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#(X-BXQ,"!49" H861D:71I;VXL('=E(&UO;FET;W(@
M8V%S:"!F;&]W(&%S('=E;&P@87,@;W!E<F%T:6YG(&%N9"!L979E<F%G92!R
M871I;W,@=&\@:&5L<"!U<R!A<W-E<W,@;W5R(&QI<75I9&ET>2!N965D<RXI
M(%1J($54(%$*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-3$N-2 R-#@N-C P,# P,# P,# P,#(@;0HR-S<N-2 R
M-#@N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(W-RXU(#(T."XV,# P,# P,# P
M,# P,B!M"C4U.2XU(#(T."XV,# P,# P,# P,# P,B!L"G,*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-30N,# @,C4S+C(X(%1D("A"=7-I
M;F5S<R!396=M96YT*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(X,"XP," R-3,N,C@@5&0@*$)U<VEN97-S($UE87-U<BD@
M5&H@150@40IQ(# @," P(')G($)4(#,U,2XW-R R-3,N,C@@5&0@*&5M96YT
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T
M+C P(#(S.2XS,R!49" H3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P,"XT," R,SDN,S,@5&0@*$%L;&EE9"!3=&%F9FEN9RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.# N,# @,C,Y
M+C$W(%1D("A&5$5S(')E<')E<V5N="!T:&4@879E<F%G92!N=6UB97(@;V8@
M3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#0W."XU-" R,SDN
M,3<@5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(Q
M+C<W(#(S.2XQ-R!49" H9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.# N,# @,C(Y+C$W(%1D("AC;VYT<F%C="!P
M97)S;VYN96P@;VX@82!F=6QL+71I;64@97%U:79A;&5N="!B87-I<RXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@P+C P
M(#(P.2XQ-R!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#(X-BXT." R
M,#DN,3<@5&0@*'9E<F%G92!R979E;G5E('!E<B!&5$4@<&5R(&1A>2!I<R!C
M86QC=6QA=&5D(&)Y(&1I=FED:6YG('1H92D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R.# N,# @,3DY+C$W(%1D("A.=7)S
M92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(R+C<W(#$Y.2XQ-R!4
M9" H06QL:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C8N,3D@
M,3DY+C$W(%1D("AF:6YG(')E=F5N=64@<&5R($9412!B>2!T:&4@;G5M8F5R
M(&]F(&1A>7,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C@P+C P(#$X.2XQ-R!49" H=V]R:V5D(&EN('1H92!R97-P96-T
M:79E('!E<FEO9',N("!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#8P+C(R(#$X.2XQ-R!49" H06QL:65D(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,#,N-C4@,3@Y+C$W(%1D("AF:6YG(')E=F5N=64I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@P+C P
M(#$W.2XQ-R!49" H86QS;R!I;F-L=61E<R!R979E;G5E(&9R;VT@=&AE('!E
M<FUA;F5N="!P;&%C96UE;G0@;V8@;G5R<V5S+BD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-"XP," Q-#4N,S,@5&0@*%!H
M>7-I8VEA;B!3=&%F9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R.# N,# @,30U+C$W(%1D("A$87ES(&9I;&QE9"!I
M<R!C86QC=6QA=&5D(&)Y(&1I=FED:6YG('1H92!T;W1A;"!H;W5R<R!I;G9O
M:6-E9"!D=7)I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@P+C P(#$S-2XQ-R!49" H=&AE('!E<FEO9"P@:6YC;'5D
M:6YG(&%N(&5S=&EM871E(&9O<B!T:&4@:6UP86-T(&]F(&%C8W)U960@<F5V
M96YU92PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C@P+C P(#$R-2XQ-R!49" H8GD@."!H;W5R<RX@4')I;W(@<&5R:6]D
M<R!H879E(&)E96X@<F5C86QC=6QA=&5D('1O(&EN8VQU9&4@=&AE*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X,"XP," Q
M,34N,3<@5&0@*&EM<&%C="!O9B!T:&4@86-C<G5E9"!R979E;G5E+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.# N,# @
M.38N,3<@5&0@*%)E=F5N=64@<&5R(&1A>2!F:6QL960@:7,@8V%L8W5L871E
M9"!B>2!D:79I9&EN9R!R979E;G5E(&%S(')E<&]R=&5D*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X,"XP," X-BXQ-R!4
M9" H8GD@9&%Y<R!F:6QL960@9F]R('1H92!P97)I;V0@<')E<V5N=&5D+B!0
M<FEO<B!P97)I;V1S(&AA=F4@8F5E;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.# N,# @-S8N,3<@5&0@*')E8V%L8W5L
M871E9"!T;R!I;F-L=61E('1H92!I;7!A8W0@;V8@=&AE(&%C8W)U960@<F5V
M96YU92!A;F0@9&%Y<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N
M9'-T<F5A;0IE;F1O8FH*-#D@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT
M(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C
M97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R U," P(%(^/@IE;F1O8FH*
M-3 @,"!O8FH*/#PO3&5N9W1H(#$T-C4X/CX*<W1R96%M"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,C$I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XY
M-2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4P(#<T,"XV.#4P-3@U.3,W
M-2!M"C$T,BXR,C$V-SDV.#<U(#<T,"XV.#4P-3@U.3,W-2!L"G,*<2 P(# @
M,"!R9R!"5" U,"XP," W-#(N,C4@5&0@*%)E<W5L=',@;V8@3W!E<F%T:6]N
M<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," W,S N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S$X+C(U(%1D("A4:&4@9F]L;&]W:6YG
M('1A8FQE('-U;6UA<FEZ97,L(&9O<B!T:&4@<&5R:6]D<R!I;F1I8V%T960L
M('-E;&5C=&5D(&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO
M;G,@9&%T82!E>'!R97-S960@87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#<P-BXR-2!49" H8:!P97)C96YT
M86=E(&]F(')E=F5N=64N($]U<B!H:7-T;W)I8V%L(')E<W5L=',@;V8@;W!E
M<F%T:6]N<R!A<F4@;F]T(&YE8V5S<V%R:6QY(&EN9&EC871I=F4@;V8@9G5T
M=7)E(&]P97)A=&EN9R!R97-U;'1S+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V.30N,C4@5&0@** I(%1J($54
M(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @
M-C4U+C<U(#(V,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,"XU," V-34N-S4@.# N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS.3 N-3 @-C4U+C<U(#0N,# @+3$T+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.30N
M-3 @-C4U+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<T+C4P(#8U-2XW-2 T+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#<X+C4P(#8U-2XW-2 X,"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C4P(#8R-RXW-2 R-C N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N-3 @-C(W+C<U(#@P
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,SDP+C4P(#8R-RXW-2 T+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,SDT+C4P(#8R-RXW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-"XU," V,C<N-S4@
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0W."XU," V,C<N-S4@.# N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,"XU," U.3DN-S4@,C8P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$P+C4P(#4Y.2XW
M-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,Y,"XU," U.3DN-S4@-"XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,Y-"XU," U.3DN-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S0N-3 @-3DY
M+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S@N-3 @-3DY+C<U(#@P+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 N-3 @-3<Q+C<U(#(V,"XP," M,30N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,"XU," U
M-S$N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3 N-3 @-3<Q+C<U(#0N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS.30N-3 @-3<Q+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<T+C4P
M(#4W,2XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<X+C4P(#4W,2XW-2 X,"XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P+C4P(#4T,RXW-2 R-C N,# @+3$T+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N
M-3 @-30S+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,SDP+C4P(#4T,RXW-2 T+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,SDT+C4P(#4T,RXW-2 X,"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W
M-"XU," U-#,N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W."XU," U-#,N-S4@.# N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XU," U,34N-S4@,C8P+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S$P+C4P(#4Q-2XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y,"XU," U,34N-S4@
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Y-"XU," U,34N-S4@.# N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-S0N-3 @-3$U+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S@N-3 @-3$U+C<U
M(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-#@W+C<U(#(V,"XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,Q,"XU," T.#<N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3 N-3 @-#@W
M+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS.30N-3 @-#@W+C<U(#@P+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#<T+C4P(#0X-RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<X+C4P(#0X
M-RXW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0U.2XW-2 R-C N,# @+3$V
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS,3 N-3 @-#4Y+C<U(#@P+C P("TQ-BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,SDP+C4P
M(#0U.2XW-2 T+C P("TQ-BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,SDT+C4P(#0U.2XW-2 X,"XP," M
M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0W-"XU," T-3DN-S4@-"XP," M,38N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W."XU
M," T-3DN-S4@.# N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," T,CDN-S4@,C8P+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S$P+C4P(#0R.2XW-2 X,"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y
M,"XU," T,CDN-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-"XU," T,CDN-S4@.# N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT-S0N-3 @-#(Y+C<U(#0N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-S@N-3 @-#(Y+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @,SDP+C<U(#(V
M,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Q,"XU," S.3 N-S4@.# N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS.3 N-3 @,SDP+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.30N-3 @,SDP+C<U
M(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#<T+C4P(#,Y,"XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#<X+C4P(#,Y,"XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,Q,"XU(#8V.2XW-2!M"C,Y,"XU(#8V.2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,SDP+C4@-C8Y
M+C<U(&T*,SDT+C4@-C8Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.30N-2 V-CDN-S4@;0HT-S0N
M-2 V-CDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0W-"XU(#8V.2XW-2!M"C0W."XU(#8V.2XW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#<X+C4@-C8Y+C<U(&T*-34X+C4@-C8Y+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N
M-2 V-34N-S4@;0HS.3 N-2 V-34N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-"XU(#8U-2XW-2!M
M"C0W-"XU(#8U-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#<X+C4@-C4U+C<U(&T*-34X+C4@-C4U
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS,3 N-2 V-34N-S4@;0HS.3 N-2 V-34N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,Y-"XU(#8U-2XW-2!M"C0W-"XU(#8U-2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<X+C4@-C4U
M+C<U(&T*-34X+C4@-C4U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 U,CDN-S4@;0HS.3 N
M-2 U,CDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,Y-"XU(#4R.2XW-2!M"C0W-"XU(#4R.2XW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#<X+C4@-3(Y+C<U(&T*-34X+C4@-3(Y+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N
M-2 T-3DN-S4@;0HS.3 N-2 T-3DN-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-"XU(#0U.2XW-2!M
M"C0W-"XU(#0U.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#<X+C4@-#4Y+C<U(&T*-34X+C4@-#4Y
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS,3 N-2 T,CDN-S4@;0HS.3 N-2 T,CDN-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,Y-"XU(#0R.2XW-2!M"C0W-"XU(#0R.2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<X+C4@-#(Y
M+C<U(&T*-34X+C4@-#(Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.30N-2 T,CDN-S4@;0HT-S0N
M-2 T,CDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,Q,"XU(#,Y,"XW-2!M"C,Y,"XU(#,Y,"XW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,SDT+C4@,SDP+C<U(&T*-#<T+C4@,SDP+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-S@N
M-2 S.3 N-S4@;0HU-3@N-2 S.3 N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Q,"XU(#,W-RXW-2!M
M"C,Y,"XU(#,W-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S$P+C4@,S<U+C<U(&T*,SDP+C4@,S<U
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS.30N-2 S-S<N-S4@;0HT-S0N-2 S-S<N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,Y-"XU(#,W-2XW-2!M"C0W-"XU(#,W-2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<X+C4@,S<W
M+C<U(&T*-34X+C4@,S<W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-S@N-2 S-S4N-S4@;0HU-3@N
M-2 S-S4N-S4@; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#8W-"XS,B!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-S@N-C @-C<T+C0S(%1D("A9*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@U+C(W(#8W-"XT,R!49" H96%R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,SDX+C4P(#8W-"XT,R!49" H($5N9&5D($1E8V5M
M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<T+C0R(#8W-"XT,R!49" H
MH#,Q+"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," V-C N,S(@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S0P+C P(#8V,"XT,R!49" H,C Q."D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C0N,# @
M-C8P+C0S(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P."XP," V-C N-#,@5&0@*#(P,38I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C0V+C,R
M(%1D("A2979E;G5E(&9R;VT@<V5R=FEC97,I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S4U+C@P(#8T-BXS,B!49" H,3 P
M+C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S<X+C,P(#8T-BXS,B!49" H)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-#,N,34@-C0V+C,R(%1D("@Q,# N,"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N-C4@
M-C0V+C,R(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R-RXQ-2 V-#8N,S(@5&0@*#$P,"XP*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T.2XV-2 V-#8N,S(@
M5&0@*"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3DN,# @-C,R+C,R(%1D("A$:7)E8W0@;W!E<F%T:6YG(&5X<&5N<V5S
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V
M,"XX," V,S(N,S(@5&0@*#<T+C,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#0X+C$U(#8S,BXS,B!49" H-S,N-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S(N,34@
M-C,R+C,R(%1D("@W,RXT*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4Y+C P(#8Q."XS,B!49" H4V5L;&EN9RP@9V5N97)A
M;"P@86YD(&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,"XX," V,3@N,S(@5&0@
M*#(R+C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#0X+C$U(#8Q."XS,B!49" H,C$N-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,S(N,34@-C$X+C,R(%1D("@R,2XU
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y
M+C P(#8P-"XS,B!49" H0F%D(&1E8G0@97AP96YS92D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C4N.# @-C T+C,R(%1D
M("@P+C,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4S+C$U(#8P-"XS,B!49" H,"XR*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S-RXQ-2 V,#0N,S(@5&0@*# N,2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP
M," U.3 N,S(@5&0@*$1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-2XX
M," U.3 N,S(@5&0@*#$N-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-3,N,34@-3DP+C,R(%1D("@Q+C(I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,W+C$U(#4Y,"XS
M,B!49" H,2XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Y+C P(#4W-BXS,B!49" H06-Q=6ES:71I;VX@86YD(&EN=&5G
M<F%T:6]N(&-O<W1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V-2XX," U-S8N,S(@5&0@*# N,2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3,N,34@-3<V+C,R(%1D
M("@P+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,Y+C8U(#4W-BXS,B!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U-C(N,S(@5&0@*$%C<75I<VET
M:6]N+7)E;&%T960@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-2XX," U-C(N
M,S(@5&0@*# N,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-34N-C4@-38R+C,R(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-RXQ-2 U-C(N,S(@5&0@*# N
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M.2XP," U-#@N,S(@5&0@*%)E<W1R=6-T=7)I;F<@8V]S=',I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8U+C@P(#4T."XS
M,B!49" H,"XS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U,RXQ-2 U-#@N,S(@5&0@*# N,2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S<N,34@-30X+C,R(%1D("@P
M+C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3DN,# @-3,T+C,R(%1D("A);7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,C4N,C<@-3,T+C,R(%1D("AG97,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8U+C@P(#4S-"XS,B!4
M9" H,BXX*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0U,RXQ-2 U,S0N,S(@5&0@*#$N-BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,S<N,34@-3,T+C,R(%1D("@R+CDI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N
M,# @-3(P+C,R(%1D("A<*$QO<W-<*2!I;F-O;64@9G)O;2!O<&5R871I;VYS
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V
M,BXT-2 U,C N,S(@5&0@*%PH,2XV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,W."XS," U,C N,S(@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,RXQ-2 U
M,C N,S(@5&0@*#$N-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S<N,34@-3(P+C,R(%1D("@P+C@I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-3 V+C,R(%1D
M("A);G1E<F5S="!E>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,V-2XX," U,#8N,S(@5&0@*# N-RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3,N,34@-3 V
M+C,R(%1D("@P+C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,W+C$U(#4P-BXS,B!49" H,"XW*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0Y,BXS,B!49" H
M1V%I;B!O;B!D97)I=F%T:79E(&QI86)I;&ET>2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C@N,S @-#DR+C,R(%1D("B7
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M.2XX," T.3(N,S<@5&0@*%PH,"XR*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V-2XV-2 T.3(N,S(@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,RXX," T
M.3(N,S<@5&0@*%PH,"XW*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4T.2XV-2 T.3(N,S(@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0W."XS,B!4
M9" H3&]S<R!O;B!E87)L>2!E>'1I;F=U:7-H;65N="!O9B!D96)T*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V."XS," T
M-S@N,S(@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#4S+C$U(#0W."XS,B!49" H,"XV*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-RXQ-2 T-S@N,S(@5&0@
M*# N,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U.2XP," T-C0N,S(@5&0@*$]T:&5R(&EN8V]M92P@;F5T*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXT-2 T-C0N
M,S(@5&0@*%PH,"XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,W."XS," T-C0N,S(@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U-2XV-2 T-C0N,S(@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,Y+C8U(#0V-"XS,B!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,RXP," T-3 N,S(@5&0@*%PH3&]S<UPI(&EN
M8V]M92!B969O<F4@:6YC;VUE('1A>&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXT-2 T-#@N-#(@5&0@*%PH,BXR
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W
M."XS," T-#@N-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0U,RXQ-2 T-#@N-#(@5&0@*# N-2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S<N,34@-#0X
M+C0R(%1D("@P+C8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,N,# @-#,T+C,R(%1D("A);F-O;64@=&%X(&)E;F5F:70I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8R
M+C0U(#0S-"XS,B!49" H7"@P+C,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S<X+C,P(#0S-"XS,B!49" H7"DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0Y+C@P(#0S
M-"XS-R!49" H7"@T+C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8U+C8U(#0S-"XS,B!49" H7"DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,S+C@P(#0S-"XS-R!4
M9" H7"@P+C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-30Y+C8U(#0S-"XS,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-#(P+C,R(%1D("A#;VYS
M;VQI9&%T960@;F5T(%PH;&]S<UPI(&EN8V]M92D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C(N-#4@-#(P+C,R(%1D("A<
M*#$N.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S-S@N,S @-#(P+C,R(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-3,N,34@-#(P+C,R(%1D("@T+C4I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,W+C$U
M(#0R,"XS,B!49" H,2XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4S+C P(#0P-2XT,B!49" H3&5S<SH@3F5T(&EN8V]M
M92!A='1R:6)U=&%B;&4@=&\@;F]N8V]N=')O;&QI;F<@:6YT97)E<W0@:6XI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N
M,# @,SDU+C0R(%1D("AS=6)S:61I87)Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,V-2XX," S.34N-#(@5&0@*# N,BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3,N
M,34@,SDU+C0R(%1D("@P+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,W+C$U(#,Y-2XT,B!49" H,"XQ*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#,X,2XS
M,B!49" H3F5T(%PH;&]S<UPI(&EN8V]M92!A='1R:6)U=&%B;&4@=&\@8V]M
M;6]N('-H87)E:&]L9&5R<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-C(N-#4@,S@Q+C,R(%1D("A<*#(N,2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S@N,S @,S@Q
M+C,R(%1D("A<*24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#4S+C$U(#,X,2XS,B!49" H-"XS*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-2XV-2 S.#$N,S(@5&0@
M*"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,W+C$U(#,X,2XS,B!49" H,2XP*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T.2XV-2 S.#$N,S(@5&0@*"4I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A;0IE;F1O8FH*-3$@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R U,B P(%(^/@IE;F1O8FH*-3(@,"!O8FH*/#PO3&5N9W1H(#(V
M-#DY/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,P,2XP," S,2XV,"!49" H,C(I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C(U(%1D("A#;VUP87)I<V]N
M(&]F(%)E<W5L=',@9F]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38R+C,Q
M(#<T,BXR-2!49" H('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.# N
M,C<@-S0R+C(U(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@V+C,Y
M(#<T,BXR-2!49" H96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C P+C X
M(#<T,BXR-2!49" H($5N9&5D($1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C<V+C P(#<T,BXR-2!49" HH#,Q+" R,#$X(&-O;7!A<BD@5&H@
M150@40IQ(# @," P(')G($)4(#,T."XU.2 W-#(N,C4@5&0@*&5D('1O('1H
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N,S@@-S0R+C(U(%1D("A9
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDS+C0Y(#<T,BXR-2!49" H96%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# W+C$Y(#<T,BXR-2!49" H($5N
M9&5D($1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@S+C$Q(#<T
M,BXR-2!49" HH#,Q+" R,#$W*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#8T."XW-2 R-C N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS,#DN-3 @-C0X+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8Y+C4P(#8T
M."XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S<S+C4P(#8T."XW-2 V,"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S,RXU," V-#@N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-RXU," V
M-#@N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @-C0X+C<U(#0N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,#$N-3 @-C0X+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN-3 @
M-C$X+C<U(#(V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,P.2XU," V,3@N-S4@-C N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-CDN-3 @-C$X+C<U(#0N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S,N
M-3 @-C$X+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,S+C4P(#8Q."XW-2 T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,W+C4P(#8Q."XW-2 V,"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M-RXU," V,3@N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,2XU," V,3@N-S4@-C N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.2XU," U.#@N-S4@,C8P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S Y+C4P(#4X."XW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,V.2XU," U.#@N-S4@
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,W,RXU," U.#@N-S4@-C N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S,N-3 @-3@X+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S<N-3 @-3@X+C<U
M(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#4X."XW-2 T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 Q+C4P(#4X."XW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#4U."XW
M-2 R-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#DN-3 @-34X+C<U(#8P+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S8Y+C4P(#4U."XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<S+C4P(#4U
M."XW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S,RXU," U-3@N-S4@-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S-RXU," U-3@N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @
M-34X+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#$N-3 @-34X+C<U(#8P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DN-3 @-3(X+C<U(#(V,"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,P.2XU
M," U,C@N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-CDN-3 @-3(X+C<U(#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-S,N-3 @-3(X+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,S
M+C4P(#4R."XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,W+C4P(#4R."XW-2 V,"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y-RXU," U,C@N-S4@-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M,2XU," U,C@N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XU," T.3@N-S4@,C8P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S Y+C4P(#0Y."XW-2 V,"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,V.2XU," T.3@N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W,RXU," T.3@N-S4@
M-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S,N-3 @-#DX+C<U(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S<N-3 @-#DX+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#0Y."XW
M-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 Q+C4P(#0Y."XW-2 V,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0Y+C4P(#0V."XW-2 R-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#DN-3 @-#8X
M+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S8Y+C4P(#0V."XW-2 T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S<S+C4P(#0V."XW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S,RXU," T
M-C@N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-RXU," T-C@N-S4@-C N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.3<N-3 @-#8X+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#$N-3 @
M-#8X+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN-3 @-#,X+C<U(#(V,"XP," M
M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,P.2XU," T,S@N-S4@-C N,# @+3$V+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-CDN
M-3 @-#,X+C<U(#0N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S,N-3 @-#,X+C<U(#8P+C P
M("TQ-BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,S+C4P(#0S."XW-2 T+C P("TQ-BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,W
M+C4P(#0S."XW-2 V,"XP," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," T,S@N-S4@-"XP
M," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P,2XU," T,S@N-S4@-C N,# @+3$V+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.2XU," T,#<N-S4@,C8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S Y+C4P(#0P-RXW-2 V
M,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,V.2XU," T,#<N-S4@-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,W,RXU," T,#<N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S,N-3 @-# W+C<U
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S<N-3 @-# W+C<U(#8P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DW+C4P(#0P-RXW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 Q+C4P(#0P-RXW
M-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#,V-RXW-2 R-C N,# @+3(U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS,#DN-3 @,S8W+C<U(#8P+C P("TR-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8Y+C4P(#,V
M-RXW-2 T+C P("TR-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S<S+C4P(#,V-RXW-2 V,"XP," M,C4N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S,RXU," S-C<N-S4@-"XP," M,C4N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-RXU," S
M-C<N-S4@-C N,# @+3(U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @,S8W+C<U(#0N,# @+3(U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,#$N-3 @,S8W+C<U(#8P+C P("TR-2XP,"!R92!F"B]'4S @
M9W,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,S Y+C4@-S T+C<U(&T*,S8Y+C4@-S T+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-CDN
M-2 W,#0N-S4@;0HS-S,N-2 W,#0N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W,RXU(#<P-"XW-2!M
M"C0S,RXU(#<P-"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#,S+C4@-S T+C<U(&T*-#,W+C4@-S T
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,S<N-2 W,#0N-S4@;0HT.3<N-2 W,#0N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0Y-RXU(#<P-"XW-2!M"C4P,2XU(#<P-"XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 Q+C4@-S T
M+C<U(&T*-38Q+C4@-S T+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#$N-2 W,#0N-S4@;0HU-C$N
M-2 W,#0N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,P.2XU(#8V,RXW-2!M"C,V.2XU(#8V,RXW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,S<S+C4@-C8S+C<U(&T*-#,S+C4@-C8S+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#$N
M-2 V-C,N-S4@;0HU-C$N-2 V-C,N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,P.2XU(#8V,RXW-2!M
M"C,V.2XU(#8V,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S<S+C4@-C8S+C<U(&T*-#,S+C4@-C8S
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,S<N-2 V-C,N-S4@;0HT.3<N-2 V-C,N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,P.2XU(#4Q,RXW-2!M"C,V.2XU(#4Q,RXW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<S+C4@-3$S
M+C<U(&T*-#,S+C4@-3$S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S<N-2 U,3,N-S4@;0HT.3<N
M-2 U,3,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C4P,2XU(#4Q,RXW-2!M"C4V,2XU(#4Q,RXW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,S Y+C4@-3$S+C<U(&T*,S8Y+C4@-3$S+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S,N
M-2 U,3,N-S4@;0HT,S,N-2 U,3,N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,P.2XU(#0S."XW-2!M
M"C,V.2XU(#0S."XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S<S+C4@-#,X+C<U(&T*-#,S+C4@-#,X
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,S<N-2 T,S@N-S4@;0HT.3<N-2 T,S@N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C4P,2XU(#0S."XW-2!M"C4V,2XU(#0S."XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S Y+C4@-# W
M+C<U(&T*,S8Y+C4@-# W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S,N-2 T,#<N-S4@;0HT,S,N
M-2 T,#<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0S-RXU(#0P-RXW-2!M"C0Y-RXU(#0P-RXW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-3 Q+C4@-# W+C<U(&T*-38Q+C4@-# W+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,#DN
M-2 S-C<N-S4@;0HS-CDN-2 S-C<N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W,RXU(#,V-RXW-2!M
M"C0S,RXU(#,V-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#,W+C4@,S8W+C<U(&T*-#DW+C4@,S8W
M+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HU,#$N-2 S-C<N-S4@;0HU-C$N-2 S-C<N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,P.2XU(#,T,RXW-2!M"C,V.2XU(#,T,RXW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S Y+C4@,S0Q
M+C<U(&T*,S8Y+C4@,S0Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S,N-2 S-#,N-S4@;0HT,S,N
M-2 S-#,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,W,RXU(#,T,2XW-2!M"C0S,RXU(#,T,2XW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#,W+C4@,S0S+C<U(&T*-#DW+C4@,S0S+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S<N
M-2 S-#$N-S4@;0HT.3<N-2 S-#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P,2XU(#,T,RXW-2!M
M"C4V,2XU(#,T,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-3 Q+C4@,S0Q+C<U(&T*-38Q+C4@,S0Q
M+C<U(&P*<PI"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-SDN
M-C @-S Y+C0S(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@V+C(W
M(#<P.2XT,R!49" H96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDY+C4P
M(#<P.2XT,R!49" H($5N9&5D($1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#<U+C0R(#<P.2XT,R!49" H(#,Q+"D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#DN,# @-CDS+C0S(%1D("A)
M;F-R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8W+C(T(#8Y,RXT,R!49" H
M96%S92D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-#0N-C @-C@S+C0S(%1D("A<*$1E8W(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-C@N,S@@-C@S+C0S(%1D("AE87-E7"DI(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$S+C P(#8Y,RXT,R!49" H
M26YC<BD@5&H@150@40IQ(# @," P(')G($)4(#4S,2XR-" V.3,N-#,@5&0@
M*&5A<V4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 X+C8P(#8X,RXT,R!49" H7"A$96-R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3,R+C,X(#8X,RXT,R!49" H96%S95PI*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R.2XP," V-C@N-#,@5&0@
M*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,SDS+C P(#8V."XT,R!49" H,C Q-RD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-C0N-3 @-C8X+C0S(%1D("@D*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R-BXP
M," V-C@N-#,@5&0@*"4I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" S.3(N-#4@-C4S+C(P(%1D("A<*$1O;&QA<G,@:6X@=&AO
M=7-A;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N,# @-C,X+C0R(%1D("A2979E;G5E(&9R;VT@<V5R=FEC97,I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$R
M+C P(#8S."XT,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,S,N,34@-C,X+C0R(%1D("@X,38L-#@T*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-BXP," V
M,S@N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,SDW+C$U(#8S."XT,B!49" H.#8U+# T."D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-# N,# @-C,X+C0R
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V,BXX," V,S@N-#<@5&0@*%PH-#@L-38T*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,RXV-2 V,S@N-#(@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S,RXT-2 V,S@N-#(@5&0@*%PH-2XV*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4T.2XS," V,S@N-#(@5&0@*%PI)2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XP
M," V,C,N-#(@5&0@*$1I<F5C="!O<&5R871I;F<@97AP96YS97,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,S+C$U(#8R
M,RXT,B!49" H-C V+#DR,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.3<N,34@-C(S+C0R(%1D("@V,S8L-#8R*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,BXX," V
M,C,N-#<@5&0@*%PH,CDL-30Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y,RXV-2 V,C,N-#(@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,RXT-2 V,C,N
M-#(@5&0@*%PH-"XV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4T.2XS," V,C,N-#(@5&0@*%PI)2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XP," V,#@N-#(@5&0@
M*%-E;&QI;F<L(&=E;F5R86PL(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E
M<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,S,N,34@-C X+C0R(%1D("@Q.# L,C,P*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,Y-RXQ-2 V,#@N-#(@5&0@*#$X-RPT
M,S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#8W+C@P(#8P."XT-R!49" H7"@W+#(P-2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.3,N-C4@-C X+C0R(%1D("A<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S,N
M-#4@-C X+C0R(%1D("A<*#,N."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-#DN,S @-C X+C0R(%1D("A<*24I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N,# @-3DS
M+C0R(%1D("A"860@9&5B="!E>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,T,RXQ-2 U.3,N-#(@5&0@*#(L,C T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P
M-RXQ-2 U.3,N-#(@5&0@*#$L.#(X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0W."XV-2 U.3,N-#(@5&0@*#,W-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N.# @
M-3DS+C0R(%1D("@R,"XV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4U,BXV-2 U.3,N-#(@5&0@*"4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N,# @-3<X+C0R(%1D
M("A$97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S@N,34@-3<X+C0R(%1D
M("@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0S+C$U(#4W."XT,B!49" H
M,2PW.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# R+C$U(#4W."XT,B!49" H,3 L,3<T*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,2XQ-2 U-S@N-#(@5&0@*#$L
M-C V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S,2XX," U-S@N-#(@5&0@*#$U+C@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-34R+C8U(#4W."XT,B!49" H)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XP," U
M-C,N-#(@5&0@*$%C<75I<VET:6]N+7)E;&%T960@8V]N=&EN9V5N="!C;VYS
M:61E<F%T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,T,RXQ-2 U-C,N-#(@5&0@*#(L-34W*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q.2XV-2 U-C,N-#(@5&0@
M*#0T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0W,2XQ-2 U-C,N-#(@5&0@*#(L-3$S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4T,2XX-2 U-C,N-#(@5&0@*$Y-*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C P
M(#4T."XT,B!49" H06-Q=6ES:71I;VX@86YD(&EN=&5G<F%T:6]N(&-O<W1S
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,U
M,"XV-2 U-#@N-#(@5&0@*#0Y,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,#<N,34@-30X+C0R(%1D("@Q+#DW-2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N.# @
M-30X+C0W(%1D("A<*#$L-#@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y,RXV-2 U-#@N-#(@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R."XT-2 U-#@N
M-#(@5&0@*%PH-S4N,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U-#DN,S @-30X+C0R(%1D("A<*24I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N,# @-3,S+C0R(%1D
M("A297-T<G5C='5R:6YG(&-O<W1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,T,RXQ-2 U,S,N-#(@5&0@*#(L-S4X*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXQ
M-2 U,S,N-#(@5&0@*#$L,#(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0W,2XQ-2 U,S,N-#(@5&0@*#$L-S,R*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R-BXW-2 U
M,S,N-#(@5&0@*#$V."XX*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4U,BXV-2 U,S,N-#(@5&0@*"4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N,# @-3$X+C0R(%1D
M("A);7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C0N
M,C<@-3$X+C0R(%1D("AG97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S,X+C$U(#4Q."XT,B!49" H,C(L-#(S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXQ-2 U
M,3@N-#(@5&0@*#$T+#,U-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-S$N,34@-3$X+C0R(%1D("@X+# V-RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N.# @-3$X
M+C0R(%1D("@U-BXR*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4U,BXV-2 U,3@N-#(@5&0@*"4I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-3 S+C0R(%1D("A<
M*$QO<W-<*2!I;F-O;64@9G)O;2!O<&5R871I;VYS*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S-"XX," U,#,N-#<@5&0@
M*%PH,3(L.#@P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,V-2XV-2 U,#,N-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXQ-2 U,#,N-#(@5&0@*#$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#<N,34@-3 S+C0R(%1D("@Q+#<T
M."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-C(N.# @-3 S+C0W(%1D("A<*#(T+#8R."D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.3,N-C4@-3 S+C0R(%1D("A<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C,N
M-#4@-3 S+C0R(%1D("A<*#(P.2XV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T.2XS," U,#,N-#(@5&0@*%PI)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XP," T
M.#@N-#(@5&0@*$EN=&5R97-T(&5X<&5N<V4I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S0S+C$U(#0X."XT,B!49" H-2PV
M-30I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-# W+C$U(#0X."XT,B!49" H-"PR,30I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<Q+C$U(#0X."XT,B!49" H,2PT-# I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q
M+C@P(#0X."XT,B!49" H,S0N,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-3(N-C4@-#@X+C0R(%1D("@E*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C P(#0W,RXT
M,B!49" H1V%I;B!O;B!D97)I=F%T:79E(&QI86)I;&ET>2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-34N-C4@-#<S+C0R
M(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0P,RXX," T-S,N-#<@5&0@*%PH,2PU.#$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Y+C8U(#0W,RXT,B!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#<Q+C$U(#0W,RXT,B!49" H,2PU.#$I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(V+C<U(#0W,RXT,B!49" H,3 P+C I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34R
M+C8U(#0W,RXT,B!49" H)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U."XP," T-3@N-#(@5&0@*$QO<W,@;VX@96%R;'D@
M97AT:6YG=6ES:&UE;G0@;V8@9&5B="D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-34N-C4@-#4X+C0R(%1D("@W.2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#<N,34@
M-#4X+C0R(%1D("@T+#DV.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C<N.# @-#4X+C0W(%1D("A<*#0L.#DP*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,RXV-2 T
M-3@N-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R."XT-2 T-3@N-#(@5&0@*%PH.3@N-"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#DN,S @-#4X+C0R
M(%1D("A<*24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3@N,# @-#0S+C0R(%1D("A/=&AE<B!I;F-O;64L(&YE="D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#<N,S @
M-#0S+C0W(%1D("A<*#0Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-C4N-C4@-#0S+C0R(%1D("A<*2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N,S @-#0S+C0W
M(%1D("A<*#$U-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,CDN-C4@-#0S+C0R(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S4N,S @-#0S+C0W(%1D("A<
M*#(V,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.3,N-C4@-#0S+C0R(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,C,N-#4@-#0S+C0R(%1D("A<*#$V.2XW
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T
M.2XS," T-#,N-#(@5&0@*%PI)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXP," T,C<N-#(@5&0@*%PH3&]S<UPI(&EN
M8V]M92!B969O<F4@:6YC;VUE('1A>&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,S-"XX," T,C<N-#<@5&0@*%PH,3@L
M,3DU*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,V-2XV-2 T,C<N-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P-RXQ-2 T,C<N-#(@5&0@*#0L,S Q*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,BXX
M," T,C<N-#<@5&0@*%PH,C(L-#DV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y,RXV-2 T,C<N-#(@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R,RXT-2 T
M,C<N-#(@5&0@*%PH-3(S+C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30Y+C,P(#0R-RXT,B!49" H7"DE*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#0Q,BXT
M,B!49" H26YC;VUE('1A>"!B96YE9FET*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,S.2XX," T,3(N-#<@5&0@*%PH,BPT
M-S@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S8U+C8U(#0Q,BXT,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDX+C@P(#0Q,BXT-R!49" H7"@S-"PU,#$I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Y
M+C8U(#0Q,BXT,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#8V+C$U(#0Q,BXT,B!49" H,S(L,#(S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XX," T
M,3(N-#(@5&0@*#DR+C@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-34R+C8U(#0Q,BXT,B!49" H)2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S.3<N-#(@5&0@
M*$-O;G-O;&ED871E9"!N970@7"AL;W-S7"D@:6YC;VUE*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S-"XX," S.3<N-#<@
M5&0@*%PH,34L-S$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V-2XV-2 S.3<N-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXQ-2 S.3<N-#(@5&0@
M*#,X+#@P,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-C(N.# @,SDW+C0W(%1D("A<*#4T+#4Q.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3,N-C4@,SDW+C0R(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,C,N-#4@,SDW+C0R(%1D("A<*#$T,"XU*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T.2XS," S.3<N-#(@5&0@*%PI
M)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,BXP," S.#(N-#(@5&0@*$QE<W,Z($YE="!I;F-O;64@871T<FEB=71A8FQE
M('1O(&YO;F-O;G1R;VQL:6YG(&EN=&5R97-T(&EN*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#,W,BXT,B!49" H
M<W5B<VED:6%R>2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S-#,N,34@,S<R+C0R(%1D("@Q+#(S-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#<N,34@,S<R+C0R(%1D
M("@Q+#(X.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.# N,S @,S<R+C0W(%1D("A<*#4U*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,RXV-2 S-S(N-#(@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M,RXT-2 S-S(N-#(@5&0@*%PH-"XS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T.2XS," S-S(N-#(@5&0@*%PI)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S
M-#<N-#(@5&0@*$YE="!<*&QO<W-<*2!I;F-O;64@871T<FEB=71A8FQE('1O
M(&-O;6UO;B!S:&%R96AO;&1E<G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S$R+C P(#,T-RXT,B!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S0N.# @,S0W
M+C0W(%1D("A<*#$V+#DU,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-C4N-C4@,S0W+C0R(%1D("A<*2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S8N,# @,S0W+C0R
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0P,BXQ-2 S-#<N-#(@5&0@*#,W+#4Q,RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-# N,# @,S0W+C0R(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V
M,BXX," S-#<N-#<@5&0@*%PH-30L-#8T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y,RXV-2 S-#<N-#(@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R,RXT
M-2 S-#<N-#(@5&0@*%PH,30U+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-30Y+C,P(#,T-RXT,B!49" H7"DE*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S,3DN,C4@5&0@*$Y-("T@;F]T(&UE86YI;F=F
M=6PI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,CDU+C(U(%1D("A2979E;G5E(&9R;VT@<V5R=FEC97,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C@S
M+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#(W,2XR-2!49" H4F5V96YU92!F<F]M('-E<G9I8V5S
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q
M-#0N,3,@,C<Q+C(U(%1D("AD96-R96%S960I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,3@S+C4T(#(W,2XR-2!49" H("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#8N
M,#0@,C<Q+C(U(%1D("@D-#@N-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S.2XY-" R-S$N,C4@5&0@*"P@
M;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(U-2XW-R R-S$N,C4@5&0@*#4N-B4I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C<V+C8P(#(W,2XR-2!49" H+"!T;R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDQ
M+C@X(#(W,2XR-2!49" H)#@Q-BXU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4P+C<W(#(W,2XR-2!49" H
M(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#(X+C(S(#(W,2XR-2!49" H1&5C96UB97*@
M,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 V+C@Q(#(W,2XR-2!49" H+"!A<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4Y+C(U(%1D("AC
M;VUP87)E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3 R+C(P(#(U.2XR-2!49" H)#@V-2XP(&UI;&QI;VXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38Q+C Y
M(#(U.2XR-2!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,X+C4U(#(U.2XR-2!4
M9" H1&5C96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S$W+C$T(#(U.2XR-2!49" H+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,C$N.38@,C4Y+C(U(%1D("A4:&4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T,"XP," R
M-3DN,C4@5&0@*&1E8W)E87-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,W-"XT,B R-3DN,C4@5&0@*"!W87,@9'5E('!R
M:6UA<FEL>2!T;R!V;VQU;64@9&5C;&EN97,@:6X@;W5R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-#<N,C4@
M5&0@*$YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,BXW-R R
M-#<N,C4@5&0@*$%L;&EE9"!A;F0@4&AY<VEC:6%N(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.30N-3(@,C0W+C(U(%1D("AF:6YG('-E9VUE;G1S
M+B!3964@9G5R=&AE<B!D:7-C=7-S:6]N(&EN(%-E9VUE;G0@4F5S=6QT<RXI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,C,U+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#(R,RXR-2!49" H1&ER96-T(&]P97)A=&EN
M9R!E>'!E;G-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R,3$N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3DY+C(U(%1D("A$:7)E
M8W0@;W!E<F%T:6YG(&5X<&5N<V5S(&%R92!C;VUP<FES960@<')I;6%R:6QY
M(&]F(&9I96QD(&5M<&QO>65E(&-O;7!E;G-A=&EO;B!A;F0@:6YD97!E;F1E
M;G0@8V]N=')A8W1O<B!E>'!E;G-E<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$X-RXR-2!49" H:&]U<VEN
M9R!E>'!E;G-E<RP@=')A=F5L(&5X<&5N<V5S+"!A;F0@<F5L871E9"!I;G-U
M<F%N8V4@97AP96YS97,N($1I<F5C="!O<&5R871I;F<@97AP96YS97,@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R-BXU
M,R Q.#<N,C4@5&0@*&1E8W)E87-E9"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-C4N.34@,3@W+C(U(%1D("@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V."XT-2 Q
M.#<N,C4@5&0@*"0R.2XU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(R+C,T(#$X-RXR-2!49" H+"!O<B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,X
M+C$W(#$X-RXR-2!49" H-"XV)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-3DN,# @,3@W+C(U(%1D("@L("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-S4N
M,C4@5&0@*'1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" V,"XR." Q-S4N,C4@5&0@*"0V,#8N.2!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Q.2XQ-R Q
M-S4N,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y-BXV,R Q-S4N,C4@5&0@
M*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(W-2XR,2 Q-S4N,C4@5&0@*"P@87,@8V]M<&%R
M960@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,T,RXR-2 Q-S4N,C4@5&0@*"0V,S8N-2!M:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,BXQ-" Q-S4N
M,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W.2XV," Q-S4N,C4@5&0@*$1E
M8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4U."XQ." Q-S4N,C4@5&0@*"X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$V,RXR-2!4
M9" H07,@82!P97)C96YT86=E(&]F('1O=&%L(')E=F5N=64L(&1I<F5C="!O
M<&5R871I;F<@97AP96YS97,@:6YC<F5A<V5D('1O(#<T+C,E(&-O;7!A<F5D
M('1O(#<S+C8E(&EN('1H92!P<FEO<B!Y96%R('!E<FEO9"P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U,2XR
M-2!49" H<')I;6%R:6QY(&1U92!T;R!L;W=E<B!B:6QL+7!A>2!S<')E860L
M('!R:6UA<FEL>2!I;B!O=7(@=')A=F5L(&YU<G-E(&]P97)A=&EO;G,L(&-O
M=7!L960@=VET:"!A;B!I;F-R96%S92!I;B!H96%L=&AC87)E(&-O<W1S+BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q,SDN,C4@5&0@*" @("D@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," Q,C<N,C4@5&0@*%-E;&QI;F<L(&=E;F5R
M86PL(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E<RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,34N,C4@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3 S+C(U(%1D("A396QL:6YG+"!G96YE<F%L+"!A;F0@861M:6YI
M<W1R871I=F4@97AP96YS97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(S,RXP," Q,#,N,C4@5&0@*&1E8W)E87-E9"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-S(N
M-#(@,3 S+C(U(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(W-"XY,B Q,#,N,C4@5&0@*"0W+C(@;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,C,N
M.#$@,3 S+C(U(%1D("@L(&]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,SDN-C0@,3 S+C(U(%1D("@S+C@E*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,"XT-R Q
M,#,N,C4@5&0@*"P@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,W-2XW-2 Q,#,N,C4@5&0@*"0Q.# N,B!M:6QL:6]N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S
M-"XV-" Q,#,N,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#DQ+C(U
M(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q,C@N-3@@.3$N,C4@5&0@*"P@87,@8V]M
M<&%R960@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$Y-BXV,B Y,2XR-2!49" H)#$X-RXT(&UI;&QI;VXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4U+C4Q(#DQ
M+C(U(%1D("@@9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S(N.3<@.3$N,C4@5&0@*$1E
M8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q,2XU-2 Y,2XR-2!49" H+"!P<FEM87)I;'D@<F5F
M;&5C=&EN9R!T:&4@8V]S="!S879I;F=S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W.2XR-2!49" H86YD(&5F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S0N-3,@-SDN,C4@5&0@*&9I8VEE
M;F-Y(&EN:71I871I=F5S(&-O;7!L971E9"!O=F5R('1H92!Y96%R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C0W+C$Q(#<Y+C(U(%1D("@L('!A<G1L>2!O
M9BD@5&H@150@40IQ(# @," P(')G($)4(#(X-BXP." W.2XR-2!49" H9G-E
M="!B>2!H:6=H97(@<')O9F5S<VEO;F%L('-E<G9I8V4@9F5E<RP@<W5C:"!A
M<R!L96=A;"!A;F0@8V]N<W5L=&EN9RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8W+C(U(%1D("A!<R!A('!E
M<F-E;G1A9V4@;V8@=&]T86P@<F5V96YU92P@<V5L;&EN9RP@9V5N97)A;"P@
M86YD(&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S('=E<F4@,C(N,24@86YD(#(Q
M+C<E(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-34N,C4@5&0@*$1E8V5M8F5R
M(#,Q+" R,#$X(&%N9"!$96-E;6)E<B S,2P@,C Q-RP@<F5S<&5C=&EV96QY
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<Y+C(W(#4U+C(U(%1D("@N*2!4
M:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-3,@,"!O8FH*/#PO5'EP92 O4&%G
M90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!=
M"B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R U-" P(%(^
M/@IE;F1O8FH*-30@,"!O8FH*/#PO3&5N9W1H(#$R,#8Y/CX*<W1R96%M"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!4
M9" H,C,I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S,P+C(U(%1D("A$97!R96-I871I;VX@86YD(&%M;W)T:7IA
M=&EO;B!E>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#<Q."XR-2!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,#8N,C4@5&0@*$1E
M<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N(&5X<&5N<V4I(%1J($54(%$*
M0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C V+C,R(#<P-BXR
M-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,#@N.#(@-S V+C(U(%1D("AI;B!T:&4@>65A<B!E;F1E9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@,2 Q(')G"B]'4S @9W,*,C<Y
M+CDP(#<Q,RXQ." W."XU." M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R
M9R!"5" R-SDN.3 @-S V+C(U(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-3@N-#D@
M-S V+C(U(%1D("@@:6YC<F5A<V5D('1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N-3(@-S V+C(U(%1D("@D,2D@
M5&H@150@40IQ(# @," P(')G($)4(#0R,2XQ-2 W,#8N,C4@5&0@*#$N."!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V-2XP-" W,#8N,C4@5&0@*"!A<R!C;VUP87)E9"!T;R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C4W(#<P
M-BXR-2!49" H)#$P+C(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8Y-"XR-2!49" H;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W."XX.2 V.30N
M,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U-BXS-2 V.30N,C4@5&0@*$1E
M8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(S-"XY-" V.30N,C4@5&0@*"P@<')I;6%R:6QY(&1U
M92!T;R!T:&4@861D:71I;VYA;"!A;6]R=&EZ871I;VX@;V8@;W1H97(@:6YT
M86YG:6)L92!A<W-E=',@<F5L871E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R+C(U(%1D("AT:&4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C0N,3<@-C@R+C(U(%1D("A!9'9A
M;G1A9V4@86-Q=6ES:71I;VXN("D@5&H@150@40IQ(# @," P(')G($)4(#$U
M."XS,2 V.#(N,C4@5&0@*$%S(&&@<&5R8V5N=&%G92!O9B!R979E;G5E+"!D
M97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;B!E>'!E;G-E('=A<R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0V+C<Y
M(#8X,BXR-2!49" H,2XT)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C<N-C(@-C@R+C(U(%1D("@@9F]R('1H92!Y96%R
M(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,2 Q(#$@<F<*
M+T=3,"!G<PHU,"XP," V-S<N,3@@-S@N-3@@+3DN,#D@<F4@9@HO1U,P(&=S
M"G$@," P(# @<F<@0E0@-3 N,# @-C<P+C(U(%1D("A$96-E;6)E<J S,2P@
M,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,C@N-3@@-C<P+C(U(%1D("@@86YD("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#@N,#(@-C<P+C(U(%1D("@Q+C(E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$V
M."XX-2 V-S N,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(T-BXS,2 V-S N
M,C4@5&0@*$1E8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,R-"XY," V-S N,C4@5&0@*"XI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C4X+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#8T-BXR-2!49" H06-Q=6ES:71I;VXM<F5L871E
M9"!C;VYT:6YG96YT(&-O;G-I9&5R871I;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C(R+C(U(%1D("A!8W%U
M:7-I=&EO;BUR96QA=&5D(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B!I;F-L
M=61E<R!A8V-R971I;VX@86YD('9A;'5A=&EO;B!A9&IU<W1M96YT<R!O;B!O
M=7(@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,3 N,C4@5&0@*&QI
M86)I;&ET:65S(&9O<B!T:&4@365D:7-C86X@86YD(%534B!A8W%U:7-I=&EO
M;G,L(&%N9"!T;W1A;&5D("0R+C8@;6EL;&EO;B!A;F0@;&5S<R!T:&%N("0P
M+C$@;6EL;&EO;B!F;W(@=&AE('EE87)S(&5N9&5D("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,C4@5&0@
M*$1E8V5M8F5R(#,Q+" R,#$X(&%N9" R,#$W+"!R97-P96-T:79E;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,C N-C@@-3DX+C(U(%1D("@N($)O=&@@
M>65A<G,@:6YC;'5D960@=&AE(')E=F5R<V%L(&]F(&%N(&5A<FYO=70@;&EA
M8FEL:71Y('=H:6-H('=A<R!D971E<FUI;F5D("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.#8N,C4@5&0@*'=O
M=6QD(&YO="!B92!A8VAI979E9"P@55-2(&EN(#(P,3@@86YD($UE9&ES8V%N
M(&EN(#(P,3<N(%-E92!.;W1E(#$P("T@1F%I<B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-CDN,C$@-3@V+C(U(%1D("A6*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S<U+C,R(#4X-BXR-2!49" H86QU92!-96%S=7)E;65N=',@=&\@
M;W5R(&-O;G-O;&ED871E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C(U(%1D("AF:6YA;F-I86P@<W1A
M=&5M96YT<RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-34P+C(U(%1D("A!8W%U:7-I=&EO;B!A;F0@:6YT96=R
M871I;VX@8V]S=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@,2 Q
M(')G"B]'4S @9W,*-3 N,# @-3,S+C$X(#DU+C4R("TY+C Y(')E(&8*+T=3
M,"!G<PIQ(# @," P(')G($)4(#4P+C P(#4R-BXR-2!49" H1'5R:6YG('1H
M92!Y96%R<R!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@
M,2 Q(')G"B]'4S @9W,*,30U+C4R(#4S,RXQ." W."XU." M.2XP.2!R92!F
M"B]'4S @9W,*<2 P(# @,"!R9R!"5" Q-#4N-3(@-3(V+C(U(%1D("A$96-E
M;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,2 Q
M(#$@<F<*+T=3,"!G<PHR,C0N,3$@-3,S+C$X(#(S-BXX." M.2XP.2!R92!F
M"B]'4S @9W,*<2 P(# @,"!R9R!"5" R,C0N,3$@-3(V+C(U(%1D("@@86YD
M(#(P,3<L('=E(&EN8W5R<F5D(&%C<75I<VET:6]N(&%N9"!I;G1E9W)A=&EO
M;B!C;W-T<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@,2 Q
M(')G"B]'4S @9W,*-#8P+CDY(#4S,RXQ." T."XX.2 M.2XP.2!R92!F"B]'
M4S @9W,*<2 P(# @,"!R9R!"5" T-C N.3D@-3(V+C(U(%1D("@D,"XU(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@,2 Q(')G"B]'
M4S @9W,*-3 Y+C@X(#4S,RXQ." Q.2XT-" M.2XP.2!R92!F"B]'4S @9W,*
M<2 P(# @,"!R9R!"5" U,#DN.#@@-3(V+C(U(%1D("@@86YD("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*,2 Q(#$@<F<*+T=3,"!G<PHU,CDN,S(@
M-3,S+C$X(#(P+C P("TY+C Y(')E(&8*+T=3,"!G<PIQ(# @," P(')G($)4
M(#4R.2XS,B U,C8N,C4@5&0@*"0R+C @*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HQ(#$@,2!R9PHO1U,P(&=S"C4P+C P(#4R,2XQ." R."XX.2 M
M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U,"XP," U,30N,C4@
M5&0@*&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C$@,2 Q
M(')G"B]'4S @9W,*-S@N.#D@-3(Q+C$X(#0V."XT-R M.2XP.2!R92!F"B]'
M4S @9W,*<2 P(# @,"!R9R!"5" W."XX.2 U,30N,C4@5&0@*"P@<F5S<&5C
M=&EV96QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,Q+C4U(#4Q-"XR-2!4
M9" H+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S8N,S<@-3$T+C(U(%1D
M("A4:&4@,C Q."!C;W-T<R!I;F-L=61E9"!I;G1E9W)A=&EO;B!C;W-T<R!R
M96QA=&5D('1O('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3@N.#(@
M-3$T+C(U(%1D("A!9'9A;G1A9V4@86-Q=6ES:71I;VXL(&%N9"!T<F%N<V%C
M=&EO;BUR96QA=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,2 Q
M(#$@<F<*+T=3,"!G<PHU,"XP," U,#DN,3@@-# U+C<U("TY+C Y(')E(&8*
M+T=3,"!G<PIQ(# @," P(')G($)4(#4P+C P(#4P,BXR-2!49" H8V]S=',@
M<F5L871E9"!T;R!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(V+C8U
M(#4P,BXR-2!49" H05 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,SDN,#8@
M-3 R+C(U(%1D("@@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$U-RXT
M.2 U,#(N,C4@5&0@*&9I;F<@86-Q=6ES:71I;VXL('=H:6QE('1H92 R,#$W
M(&-O<W1S(')E;&%T960@=&\@=&AE("D@5&H@150@40IQ(# @," P(')G($)4
M(#,V,RXU-2 U,#(N,C4@5&0@*$%D=F%N=&%G92!A8W%U:7-I=&EO;BXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4U+C<U
M(#4P,BXR-2!49" H(%-E92!.;W1E(#0@+2 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,#DN.3$@-3 R+C(U(%1D("A!8W%U:7-I=&EO;G,@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Y,"XR
M-2!49" H=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT
M<RX@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0V-BXR-2!49" H4F5S=')U8W1U<FEN9R!C;W-T<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-#(N
M,C4@5&0@*%)E<W1R=6-T=7)I;F<@8V]S=',@:6YC;'5D92!S979E<F%N8V4L
M(&5X:70@8V]S=',L(&%N9"!O=&AE<B!C;W-T<R!I;F-L=61I;F<@=W)I=&4M
M;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#,N,#8@-#0R+C(U(%1D("AF
M<R!R96QA=&5D('1O(&%B86YD;VYE9"!L;V-A=&EO;G,@:6YC=7)R960@87,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0S,"XR-2!49" H<&%R="!O9B!S97!A<F%T92!A;F0@9&ES8W)E=&4@
M8V]S="!S879I;F=S(&EN:71I871I=F5S+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-C N,#,@-#,P+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C8X+C8W(#0S,"XR-2!49" H92!R96-O<F1E9"!R97-T<G5C='5R:6YG
M(&-O<W1S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,# N,# @-#,P+C(U(%1D("@D,BXX(&UI;&QI;VXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0X+CDP(#0S
M,"XR-2!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X+C(U(%1D("A$
M96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q,C@N-3@@-#$X+C(U(%1D("@@86YD("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#@N,#(@-#$X
M+C(U(%1D("@D,2XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3DV+CDQ(#0Q."XR-2!49" H(&9O<B!T:&4@
M>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C<T+C,X(#0Q."XR-2!49" H1&5C96UB97*@,S$L(#(P,3<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4R
M+CDV(#0Q."XR-2!49" H+BD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," S.30N,C4@5&0@*$EM<&%I<FUE;G0@8VAA
M<F=E<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,S@R+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W,"XR-2!49" H26X@=&AE(&9O
M=7)T:"!Q=6%R=&5R(&]F(#(P,3@@86YD(#(P,3<L('=E(')E8V]R9&5D(&YO
M;BUC87-H(&EM<&%I<FUE;G0@8VAA<BD@5&H@150@40IQ(# @," P(')G($)4
M(#,V-"XT,R S-S N,C4@5&0@*&=E<R!O9B D,C(N-"!M:6QL:6]N(&%N9" D
M,30N-"!M:6QL:6]N+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,S4X+C(U(%1D("AR97-P96-T:79E;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Y-RXV-B S-3@N,C4@5&0@*"P@<F5L871I
M;F<@=&\@=&AE(%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C$X+C Q(#,U."XR-2!49" H9FEN9R!R97!O<G1I;F<@=6YI="X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,CDV+C$U(#,U."XR-2!49" H5RD@5&H@
M150@40IQ(# @," P(')G($)4(#,P-"XW.2 S-3@N,C4@5&0@*&4@<F5D=6-E
M9"!O=7(@;&]N9RUR86YG92!F;W)E8V%S="!F;W(@=&AE(%!H>7-I8VEA;B!3
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(W+C@V(#,U."XR-2!49" H
M9FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,S0V+C(U(%1D("AB=7-I;F5S<R!S96=M96YT(&EN('1H92!F
M;W5R=&@@<75A<G1E<B!O9B!B;W1H('EE87)S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-C$N.3D@,S0V+C(U(%1D("A4:&4@;&]W97(@=&AA;B!E>'!E
M8W1E9"!R979E;G5E('=A<R!D<FEV96X@8GD@;&]W97(@8F]O:VEN9R!V;VQU
M;65S+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,S,T+C(U(%1D("AP87)T;'D@9'5E('1O('1H92!L;W-S(&]F
M(&-U<W1O;65R<RX@26X@861D:71I;VXL(&UA<BD@5&H@150@40IQ(# @," P
M(')G($)4(#(U-BXQ-R S,S0N,C4@5&0@*&=I;G,@;V8@=&AE(')E<&]R=&EN
M9R!U;FET('=E<F4@;F5G871I=F5L>2!I;7!A8W1E9"!F<F]M(&EN=F5S=&UE
M;G1S(&EN('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S(R+C(U(%1D("AB=7-I;F5S<RX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@.#@N,S0@,S(R+C(U(%1D("A!<R!A(')E<W5L="P@
M=V4@<F5C;W)D960@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,CDQ+CDW(#,R,BXR-2!49" H9V5S(&]F("0U+C(@
M;6EL;&EO;B!A;F0@)#@N-R!M:6QL:6]N+"!R97-P96-T:79E;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T.#@N-3$@,S(R+C(U(%1D("@L(')E;&%T960@
M=&\@=')A9&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#,Q,"XR-2!49" H;F%M97,@86YD("0Q-RXR(&UI;&QI
M;VX@86YD("0U+C<@;6EL;&EO;BP@<F5S<&5C=&EV96QY*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C8Y+C@W(#,Q,"XR-2!49" H+"!R96QA=&5D('1O(&=O
M;V1W:6QL+B I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C@V+C(U(%1D("A);G1E<F5S="!E>'!E;G-E*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(W
M-"XR-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R-C(N,C4@5&0@*$EN=&5R97-T(&5X<&5N<V4I(%1J
M($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3$T+C8Y
M(#(V,BXR-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q,3<N,3D@,C8R+C(U(%1D("AT;W1A;&5D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#8N.3 @,C8R
M+C(U(%1D("@D-2XW(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3DU+C@P(#(V,BXR-2!49" H(&9O<B!T:&4@
M>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C<S+C(V(#(V,BXR-2!49" H1&5C96UB97*@,S$L(#(P,3@I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4Q
M+C@T(#(V,BXR-2!49" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S<Q+C(X(#(V,BXR-2!49" H)#0N,B!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0R,"XQ-R R-C(N,C4@5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y-RXV,R R
M-C(N,C4@5&0@*$1E8V5M8F5RH#,Q+" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4P+C(U(%1D("@R,#$W*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<P+C P
M(#(U,"XR-2!49" H+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" W-"XX,B R
M-3 N,C4@5&0@*%1H92!I;F-R96%S92!W87,@9'5E('!R:6UA<FEL>2!T;R!T
M:&4@:6YC<F5M96YT86P@9&5B="!R97-U;'1I;F<@9G)O;2!T:&4@86-Q=6ES
M:71I;VX@;V8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(X+C T(#(U,"XR
M-2!49" H061V86YT86=E+"!C;W5P;&5D('=I=&@@82 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C,X+C(U(%1D
M("AH:6=H97(@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-2XV,R R,S@N
M,C4@5&0@*&9E8W1I=F4@:6YT97)E<W0@<F%T92X@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,38W+C X(#(S."XR-2!49" H5&AE(&5F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3DR+C<Q(#(S."XR-2!49" H9F5C=&EV92!I;G1E<F5S
M="!R871E(&]N(&]U<B!B;W)R;W=I;F=S(&EN8W)E87-E9"!T;R U+C$E(&9O
M<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DW+C T(#(S."XR-2!49" H1&5C96UB97*@,S$L
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," R,C8N,C4@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-S N,# @,C(V+C(U(%1D("@@8V]M<&%R960@
M=&\@-"XV)2!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R,BXY.2 R,C8N,C4@5&0@*$1E
M8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,P,2XU." R,C8N,C4@5&0@*"XI(%1J($54(%$*0E0@
M+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C R+C(U(%1D
M("A'86EN(&]N(&1E<FEV871I=F4@;&EA8FEL:71Y*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$W."XR-2!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#$W."XR-2!49" H92!I
M;F-U<G)E9"!A(&=A:6X@;VX@9&5R:79A=&EV92!L:6%B:6QI='D@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R-RXT
M-R Q-S@N,C4@5&0@*"0Q+C8@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-S8N,S8@,3<X+C(U(%1D("@@9F]R
M('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-3,N.#(@,3<X+C(U(%1D("A$96-E;6)E<J S,2P@
M,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,S(N-# @,3<X+C(U(%1D("@@<F5L871E9"!T;R!T:&4@8VAA;F=E(&EN
M('1H92!F86ER("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," Q-C8N,C4@5&0@*'9A;'5E(&]F(&5M8F5D9&5D(&9E
M871U<F5S(&]F(&]U<B!#;VYV97)T:6)L92!.;W1E<R!F<F]M('1H92!E;F0@
M;V8@=&AE('!R:6]R('%U87)T97(@=&AR;W5G:"!T:&4@<&%Y;V8I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T-C<N-S,@,38V+C(U(%1D("AF(&1A=&4L('!R
M:6UA<FEL>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,34T+C(U(%1D("AR97-U;'1I;F<@9G)O;2!A(&1E8W)E
M87-E(&EN(&]U<B!S:&%R92!P<FEC92X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C(W+C@P(#$U-"XR-2!49" H5&AE<F4@=V5R92!N;R!S=6-H(&-H87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C4N.3 @,34T+C(U(%1D("AG97,@
M:6YC=7)R960@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X
M+B!3964@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#$T,BXR-2!49" H3F]T92 X("T@1&5B="!A;F0@3F]T92 Y
M("T@1&5R:79A=&EV97,@=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@
M<W1A=&5M96YT<RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,3(R+C(U(%1D("A,;W-S(&]N(&5A<FQY(&5X=&EN
M9W5I<VAM96YT(&]F(&1E8G0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,3 R+C(U(%1D("A,;W-S(&]N(&5A<FQY
M(&5X=&EN9W5I<VAM96YT(&]F(&1E8G0@=V%S(&YO="!M871E<FEA;"!F;W(@
M=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3@@86YD(')E;&%T97,@
M=&\@=&AE(&]P=&EO;F%L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," Y,"XR-2!49" H<')E<&%Y;65N=',@;V8@
M)#4N,"!M:6QL:6]N(&5A8V@@;6%D92!O;B!O=7(@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C,X+C4V(#DP+C(U(%1D("A!;65N9&5D("D@5&H@150@40IQ
M(# @," P(')G($)4(#(W.2XW-B Y,"XR-2!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#(X-2XQ-R Y,"XR-2!49" H97)M($QO86X@:6X@=&AE('1H
M:7)D(&%N9"!F;W5R=&@@<75A<G1E<G,@;V8@,C Q."X@3&]S<R!O;B!E87)L
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-S@N,C4@5&0@*&5X=&EN9W5I<VAM96YT(&]F(&1E8G0@;V8@)#4N
M,"!M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q
M-R!R96QA=&5S('1O('1H92!E87)L>2!R97!A>6UE;G0@;V8@;W5R($-O;G9E
M<G1I8FQE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," V-BXR-2!49" H3F]T97,N(%-E92!.;W1E(#@@+2!$96)T
M('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N*2!4
M:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-34@,"!O8FH*/#PO5'EP92 O4&%G
M90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!=
M"B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R U-B P(%(^
M/@IE;F1O8FH*-38@,"!O8FH*/#PO3&5N9W1H(#(U,#8T/CX*<W1R96%M"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!4
M9" H,C0I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S0R+C$P(%1D("A)*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S+C,S(#<T,BXQ,"!49" H;F-O;64@=&%X
M(&)E;F5F:70@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<S,"XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3@N,3 @5&0@*$EN8V]M
M92!T87@@8F5N969I="!T;W1A;&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-3<N,3@@-S$X+C$P(%1D("@D,BXU(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C V+C W(#<Q."XQ,"!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@S+C4S
M(#<Q."XQ,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8R+C$Q(#<Q."XQ,"!49" H
M+"!C;VUP87)E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#$Y+C,R(#<Q."XQ,"!49" H)#,T+C4@;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S,N
M,C$@-S$X+C$P(%1D("@@9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,#8N,3 @
M5&0@*$1E8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$R."XU." W,#8N,3 @5&0@*"Z@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3,S+C0P(#<P-BXQ,"!49" H5&AE(&5F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,34Y+C T(#<P-BXQ,"!49" H9F5C=&EV
M92!T87@@<F%T92!W87,@,3,N-B4@86YD(&YE9V%T:79E(#@P,BXR)2P@:6YC
M;'5D:6YG('1H92!I;7!A8W0@;V8@9&ES8W)E=&4@:71E;7,L(&9O<B!T:&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8Y-"XQ,"!49" H>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,3@@
M86YD(#(P,3<L(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4
M(#(W,"XV-B V.30N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C<U+C0X(#8Y-"XQ,"!49" H5&AE(&5F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S Q+C$Q(#8Y-"XQ,"!49" H9F5C=&EV92!T87@@<F%T92!I;B R,#$X
M('=A<R!I;7!A8W1E9"!B>2!T:&4@;F]N+61E9'5C=&EB:6QI='D@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8X,BXQ,"!49" H8V5R=&%I;B!P97(@9&EE;2!E>'!E;G-E<RP@=&AE(&]F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@Q+C0S(#8X,BXQ,"!49" H9FEC
M97)S)R!C;VUP96YS871I;VX@;&EM:71A=&EO;BP@86YD(&EN=&5R;F%T:6]N
M86P@86YD('-T871E(&EN8V]M92!T87AE<RX@1G5R=&AE<BD@5&H@150@40IQ
M(# @," P(')G($)4(#4P-"XQ,R V.#(N,3 @5&0@*"P@9'5R:6YG('1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C<P+C$P(%1D("AF;W5R=&@@<75A<G1E<B!O9B R,#$X('1H92!#;VUP
M86YY(&-O;7!L971E9"!I=',@,C Q-R!F961E<F%L(&%N9"!S=&%T92!I;F-O
M;64@=&%X(')E='5R;G,@86YD(')E8V]R9&5D(&$@9&ES8W)E=&4@=&%X(&)E
M;F5F:70@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#8U."XQ,"!49" H87-S;V-I871E9"!W:71H(&%D:G5S=&EN
M9R!I=',@;F5T(&1E9F5R<F5D('1A>"!A<W-E="X@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C4T+C0X(#8U."XQ,"!49" H5&AE(&5F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C@P+C$R(#8U."XQ,"!49" H9F5C=&EV92!T87@@<F%T
M92!I;B R,#$W('=A<R!I;7!A8W1E9"!B>2!T:&4@<F5V97)S86P@;V8@=F%L
M=6%T:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," V-#8N,3 @5&0@*&%L;&]W86YC97,L('!A<G1I86QL>2!O
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$T,RXS.2 V-#8N,3 @5&0@*&9S
M970@8GD@=&AE(&-H86YG97,@:6X@97-T:6UA=&5D(&1E9F5R<F5D('1A>"!A
M<W-E=',@<F5S=6QT:6YG(&9R;VT@=&AE(#(P,3<@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#0V+C$X(#8T-BXQ,"!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#0U,2XU.2 V-#8N,3 @5&0@*&%X("D@5&H@150@40IQ(# @," P
M(')G($)4(#0V,BXY-R V-#8N,3 @5&0@*$%C="X@3VX@1&5C96UB97(@,C(L
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V,S0N,3 @5&0@*#(P,3<L('1H92 R,#$W("D@5&H@150@40IQ(# @
M," P(')G($)4(#$Q,BXP-" V,S0N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,3<N-#4@-C,T+C$P(%1D("AA>" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,C@N.#,@-C,T+C$P(%1D("A!8W0@=V%S('-I9VYE9"!I;G1O
M(&QE9VES;&%T:6]N('=H:6-H+"!A;6]N9R!O=&AE<B!C:&%N9V5S+"!R961U
M8V5D('1H92!C;W)P;W)A=&4@9F5D97)A;"!I;F-O;64@=&%X(')A=&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8R,BXQ,"!49" H9G)O;2 S-24@=&\@,C$E+"!E9BD@5&H@150@40IQ(# @
M," P(')G($)4(#$S,RXY-B V,C(N,3 @5&0@*&9E8W1I=F4@9F]R(&]U<B!Y
M96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+B!"96-A=7-E(&$@8VAA;F=E
M(&EN('1A>"!L87<@:7,@86-C;W5N=&5D(&9O<B!I;B!T:&4@<&5R:6]D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,3 N,3 @5&0@*&]F(&5N86-T;65N="P@=V4@<F5C;W)D960@:6YC;VUE
M('1A>"!E>'!E;G-E(&]F("0X+C @;6EL;&EO;BP@<')I;6%R:6QY(&1U92!T
M;R!A(')E;65A<W5R96UE;G0@;V8@9&5F97)R960@=&%X(&%S<V5T<R!A;F0@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#4Y."XQ,"!49" H;&EA8FEL:71I97,N(%-E92!.;W1E(#$S("T@26YC
M;VUE("D@5&H@150@40IQ(# @," P(')G($)4(#$X,2XW,R U.3@N,3 @5&0@
M*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#<N,30@-3DX+C$P(%1D("AA
M>&5S('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@
M9F]R(&9U<G1H97(@:6YF;W)M871I;VXN*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4W-"XQ,"!49" H0V]M<&%R
M:7-O;B!O9B!297-U;'1S(&9O<BD@5&H@150@40IQ(# @," P(')G($)4(#$V
M,BXS,2 U-S0N,3 @5&0@*"!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3@P+C(W(#4W-"XQ,"!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#$X
M-BXS.2 U-S0N,3 @5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#(P
M,"XP." U-S0N,3 @5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @
M," P(')G($)4(#(W-BXP," U-S0N,3 @5&0@** S,2P@,C Q-R!C;VUP87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#@N-3D@-3<T+C$P(%1D("AE9"!T
M;R!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C,X(#4W-"XQ,"!4
M9" H62D@5&H@150@40IQ(# @," P(')G($)4(#,Y,RXT.2 U-S0N,3 @5&0@
M*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0P-RXQ.2 U-S0N,3 @5&0@
M*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#0X,RXQ
M,2 U-S0N,3 @5&0@** S,2P@,C Q-BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-3 N,3 @5&0@** I(%1J($54
M(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @
M-#8U+C8P(#(V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,"XU," T-C4N-C @-C N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-S N-3 @-#8U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S0N
M-3 @-#8U+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,T+C4P(#0V-2XV," T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,X+C4P(#0V-2XV," V,"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M."XU," T-C4N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,BXU," T-C4N-C @-C N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XU," T,S4N-C @,C8P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S$P+C4P(#0S-2XV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W,"XU," T,S4N-C @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,W-"XU," T,S4N-C @-C N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S0N-3 @-#,U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @-#,U+C8P
M(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DX+C4P(#0S-2XV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 R+C4P(#0S-2XV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0P-2XV
M," R-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N-3 @-# U+C8P(#8P+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S<P+C4P(#0P-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<T+C4P(#0P
M-2XV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-"XU," T,#4N-C @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S."XU," T,#4N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3@N-3 @
M-# U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#(N-3 @-# U+C8P(#8P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 N-3 @,S<U+C8P(#(V,"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,"XU
M," S-S4N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S N-3 @,S<U+C8P(#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-S0N-3 @,S<U+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,T
M+C4P(#,W-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X+C4P(#,W-2XV," V,"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y."XU," S-S4N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M,BXU," S-S4N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," S-#4N-C @,C8P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S$P+C4P(#,T-2XV," V,"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,W,"XU," S-#4N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W-"XU," S-#4N-C @
M-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S0N-3 @,S0U+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S@N-3 @,S0U+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DX+C4P(#,T-2XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 R+C4P(#,T-2XV," V,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4P+C4P(#,Q-2XV," R-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N-3 @,S$U
M+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S<P+C4P(#,Q-2XV," T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S<T+C4P(#,Q-2XV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-"XU," S
M,34N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S."XU," S,34N-C @-C N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.3@N-3 @,S$U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#(N-3 @
M,S$U+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @,C@U+C8P(#(V,"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,Q,"XU," R.#4N-C @-C N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S N
M-3 @,C@U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S0N-3 @,C@U+C8P(#8P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,T+C4P(#(X-2XV," T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X
M+C4P(#(X-2XV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y."XU," R.#4N-C @-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P,BXU," R.#4N-C @-C N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,"XU," R-30N-C @,C8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$P+C4P(#(U-"XV," V
M,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,W,"XU," R-30N-C @-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,W-"XU," R-30N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S0N-3 @,C4T+C8P
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @,C4T+C8P(#8P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DX+C4P(#(U-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 R+C4P(#(U-"XV
M," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#(R-"XV," R-C N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS,3 N-3 @,C(T+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<P+C4P(#(R
M-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S<T+C4P(#(R-"XV," V,"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S-"XU," R,C0N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S."XU," R
M,C0N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3@N-3 @,C(T+C8P(#0N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,#(N-3 @,C(T+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @
M,3@T+C8P(#(V,"XP," M,C4N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,"XU," Q.#0N-C @-C N,# @
M+3(U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-S N-3 @,3@T+C8P(#0N,# @+3(U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S0N
M-3 @,3@T+C8P(#8P+C P("TR-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,T+C4P(#$X-"XV," T+C P
M("TR-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,X+C4P(#$X-"XV," V,"XP," M,C4N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M."XU," Q.#0N-C @-"XP," M,C4N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,BXU," Q.#0N-C @-C N
M,# @+3(U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 U,C$N-B!M"C,W,"XU
M(#4R,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS-S N-2 U,C$N-B!M"C,W-"XU(#4R,2XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-S0N-2 U,C$N-B!M"C0S-"XU(#4R,2XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S0N-2 U,C$N
M-B!M"C0S."XU(#4R,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S@N-2 U,C$N-B!M"C0Y."XU(#4R
M,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT.3@N-2 U,C$N-B!M"C4P,BXU(#4R,2XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU
M,#(N-2 U,C$N-B!M"C4V,BXU(#4R,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N-2 U,C$N-B!M
M"C4V,BXU(#4R,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 T.# N-B!M"C,W,"XU(#0X,"XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS-S0N-2 T.# N-B!M"C0S-"XU(#0X,"XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N
M-2 T.# N-B!M"C4V,BXU(#0X,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 T.# N-B!M"C,W
M,"XU(#0X,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS-S0N-2 T.# N-B!M"C0S-"XU(#0X,"XV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT,S@N-2 T.# N-B!M"C0Y."XU(#0X,"XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 S
M,S N-B!M"C,W,"XU(#,S,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S0N-2 S,S N-B!M"C0S-"XU
M(#,S,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT,S@N-2 S,S N-B!M"C0Y."XU(#,S,"XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HU,#(N-2 S,S N-B!M"C4V,BXU(#,S,"XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3 N-2 S,S N
M-B!M"C,W,"XU(#,S,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S0N-2 S,S N-B!M"C0S-"XU(#,S
M,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS,3 N-2 R-30N-C P,# P,# P,# P,#(@;0HS-S N-2 R
M-30N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W-"XU(#(U-"XV,# P,# P,# P
M,# P,B!M"C0S-"XU(#(U-"XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@
M,C4T+C8P,# P,# P,# P,# R(&T*-#DX+C4@,C4T+C8P,# P,# P,# P,# R
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HU,#(N-2 R-30N-C P,# P,# P,# P,#(@;0HU-C(N-2 R-30N
M-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Q,"XU(#(R-"XV,# P,# P,# P,# P
M,B!M"C,W,"XU(#(R-"XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<T+C4@,C(T
M+C8P,# P,# P,# P,# R(&T*-#,T+C4@,C(T+C8P,# P,# P,# P,# R(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT,S@N-2 R,C0N-C P,# P,# P,# P,#(@;0HT.3@N-2 R,C0N-C P
M,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C4P,BXU(#(R-"XV,# P,# P,# P,# P,B!M
M"C4V,BXU(#(R-"XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$P+C4@,3@T+C8P
M,# P,# P,# P,# R(&T*,S<P+C4@,3@T+C8P,# P,# P,# P,# R(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-S0N-2 Q.#0N-C P,# P,# P,# P,#(@;0HT,S0N-2 Q.#0N-C P,# P
M,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0S."XU(#$X-"XV,# P,# P,# P,# P,B!M"C0Y
M."XU(#$X-"XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 R+C4@,3@T+C8P,# P
M,# P,# P,# R(&T*-38R+C4@,3@T+C8P,# P,# P,# P,# R(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M,3 N-2 Q-C N-C P,# P,# P,# P,#(@;0HS-S N-2 Q-C N-C P,# P,# P
M,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,Q,"XU(#$U."XV,# P,# P,# P,# P,B!M"C,W,"XU
M(#$U."XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<T+C4@,38P+C8P,# P,# P
M,# P,# R(&T*-#,T+C4@,38P+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S0N
M-2 Q-3@N-C P,# P,# P,# P,#(@;0HT,S0N-2 Q-3@N-C P,# P,# P,# P
M,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S."XU(#$V,"XV,# P,# P,# P,# P,B!M"C0Y."XU(#$V
M,"XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@,34X+C8P,# P,# P,# P
M,# R(&T*-#DX+C4@,34X+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N-2 Q
M-C N-C P,# P,# P,# P,#(@;0HU-C(N-2 Q-C N-C P,# P,# P,# P,#(@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C4P,BXU(#$U."XV,# P,# P,# P,# P,B!M"C4V,BXU(#$U."XV
M,# P,# P,# P,# P,B!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S@P+C8P(#4R-BXR."!49" H62D@5&H@150@40IQ(# @," P(')G
M($)4(#,X-RXR-R U,C8N,C@@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G
M($)4(#0P,"XU," U,C8N,C@@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@
M40IQ(# @," P(')G($)4(#0W-BXT,B U,C8N,C@@5&0@*" S,2PI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4P+C P(#4Q
M,"XR."!49" H26YC<BD@5&H@150@40IQ(# @," P(')G($)4(#0V."XR-" U
M,3 N,C@@5&0@*&5A<V4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#0U+C8P(#4P,"XR."!49" H7"A$96-R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#8Y+C,X(#4P,"XR."!49" H96%S95PI*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q-"XP," U
M,3 N,C@@5&0@*$EN8W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S(N,C0@
M-3$P+C(X(%1D("AE87-E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P.2XV," U,# N,C@@5&0@*%PH1&5C<BD@5&H@150@
M40IQ(# @," P(')G($)4(#4S,RXS." U,# N,C@@5&0@*&5A<V5<*2D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S N,# @
M-#@U+C(X(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,Y-"XP," T.#4N,C@@5&0@*#(P,38I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C4P(#0X-2XR
M."!49" H)"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,C<N,# @-#@U+C(X(%1D("@E*2!4:B!%5"!1"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDS+C0U(#0W,"XP-2!49" H7"A$;VQL
M87)S(&EN('1H;W5S86YD<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#0U-2XR-R!49" H4F5V96YU92!F<F]M
M('-E<G9I8V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Q,RXP," T-34N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S,T+C$U(#0U-2XR-R!49" H.#8U
M+# T."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S-S<N,# @-#4U+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y."XQ-2 T-34N,C<@5&0@*#@S,RPU,S<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0Q
M+C P(#0U-2XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C<N,34@-#4U+C(W(%1D("@S,2PU,2D@5&H@150@
M40IQ(# @," P(')G($)4(#0X.2XV-2 T-34N,C<@5&0@*#$I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,W+C@P(#0U-2XR
M-R!49" H,RXX*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4U,RXV-2 T-34N,C<@5&0@*"4I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-#0P+C(W(%1D("A$:7)E
M8W0@;W!E<F%T:6YG(&5X<&5N<V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,S-"XQ-2 T-# N,C<@5&0@*#8S-BPT-C(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDX
M+C$U(#0T,"XR-R!49" H-C$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#@N
M,34@-#0P+C(W(%1D("@Q+#@P,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-C<N,34@-#0P+C(W(%1D("@R-"PV-C I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,W+C@P
M(#0T,"XR-R!49" H-"XP*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4U,RXV-2 T-# N,C<@5&0@*"4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-#(U+C(W(%1D
M("A396QL:6YG+"!G96YE<F%L+"!A;F0@861M:6YI<W1R871I=F4@97AP96YS
M97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S,T+C$U(#0R-2XR-R!49" H,3@W+#0S-2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S.3@N,34@-#(U+C(W(%1D("@Q-SDL
M.#(P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0W,BXQ-2 T,C4N,C<@5&0@*#<L-C$U*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S-RXX," T,C4N,C<@5&0@*#0N,BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3,N
M-C4@-#(U+C(W(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4Y+C P(#0Q,"XR-R!49" H0F%D(&1E8G0@97AP96YS
M92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-#0N,34@-#$P+C(W(%1D("@Q+#@R."D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,34N-C4@-#$P+C(W(%1D("@U.3,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#<R+C$U
M(#0Q,"XR-R!49" H,2PR,S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(W+C<U(#0Q,"XR-R!49" H,C X+C,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34S+C8U(#0Q
M,"XR-R!49" H)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U.2XP," S.34N,C<@5&0@*$1E<')E8VEA=&EO;B!A;F0@86UO
M<G1I>F%T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,S.2XQ-2 S.34N,C<@5&0@*#$P+#$W-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#@N,34@,SDU+C(W(%1D
M("@Y+#$X,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-SDN-C4@,SDU+C(W(%1D("@Y.3(I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,R+C@P(#,Y-2XR-R!49" H,3 N
M."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-3,N-C4@,SDU+C(W(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4Y+C P(#,X,"XR-R!49" H06-Q=6ES:71I;VXM
M<F5L871E9"!C;VYT:6YG96YT(&-O;G-I9&5R871I;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4V+C8U(#,X,"XR-R!4
M9" H-#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#$U+C8U(#,X,"XR-R!49" H.#$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W-BXS," S.# N,S(@5&0@*%PH-S<P
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M-"XV-2 S.# N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R.2XT-2 S.# N,C<@5&0@*%PH.30N-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3 N,S @
M,S@P+C(W(%1D("A<*24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3DN,# @,S8U+C(W(%1D("A!8W%U:7-I=&EO;B!A;F0@
M:6YT96=R871I;VX@8V]S=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S0T+C$U(#,V-2XR-R!49" H,2PY-S4I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(P+C8U(#,V
M-2XR-R!49" H-S@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#<R+C$U(#,V-2XR-R!49" H,2PX.3<I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30R+C@U(#,V-2XR-R!4
M9" H3DTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3DN,# @,S4P+C(W(%1D("A297-T<G5C='5R:6YG(&-O<W1S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T-"XQ-2 S
M-3 N,C<@5&0@*#$L,#(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q-2XV-2 S-3 N,C<@5&0@*#<U,RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-SDN-C4@,S4P+C(W
M(%1D("@R-S,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,R+C@P(#,U,"XR-R!49" H,S8N,RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3,N-C4@,S4P+C(W(%1D("@E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y
M+C P(#,S-2XR-R!49" H26UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3(U+C(W(#,S-2XR-R!49" H9V5S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S.2XQ-2 S,S4N,C<@5&0@
M*#$T+#,U-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,#,N,34@,S,U+C(W(%1D("@R-"PS,2D@5&H@150@40IQ(# @," P
M(')G($)4(#0R-2XV-2 S,S4N,C<@5&0@*#$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#8X+C@P(#,S-2XS,B!49" H7"@Y
M+#DU-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.30N-C4@,S,U+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,CDN-#4@,S,U+C(W(%1D("A<*#0P+CDI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34P
M+C,P(#,S-2XR-R!49" H7"DE*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#,R,"XR-R!49" H26YC;VUE(&9R;VT@
M;W!E<F%T:6]N<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,SDN,34@,S(P+C(W(%1D("@Q*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S0T+C$U(#,R,"XR-R!49" H,2PW-#@I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# X+C$U(#,R,"XR-R!49" H
M-BPQ.#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<R+C$U(#,R,"XR-R!49" H-2PU-C0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,R+C@P(#,R,"XR-R!49" H.3 N
M,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-3,N-C4@,S(P+C(W(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4Y+C P(#,P-2XR-R!49" H26YT97)E<W0@97AP
M96YS92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S-#0N,34@,S U+C(W(%1D("@T+#(Q-"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,#@N,34@,S U+C(W(%1D("@V+#$P
M-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-C@N.# @,S U+C,R(%1D("A<*#$L.#DR*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y-"XV-2 S,#4N,C<@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R.2XT
M-2 S,#4N,C<@5&0@*%PH,S$N,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-3 N,S @,S U+C(W(%1D("A<*24I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @,CDP
M+C(W(%1D("A'86EN(&]N(&1E<FEV871I=F4@;&EA8FEL:71Y*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T,"XX," R.3 N
M,S(@5&0@*%PH,2PU.#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S8V+C8U(#(Y,"XR-R!49" H7"DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# T+C@P(#(Y,"XS,B!4
M9" H7"@U+#@P-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,S N-C4@,CDP+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S(N,34@,CDP+C(W(%1D("@T
M+#(R-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S(N.# @,CDP+C(W(%1D("@W,BXX*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4U,RXV-2 R.3 N,C<@5&0@*"4I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @
M,C<U+C(W(%1D("A,;W-S(&]N(&5A<FQY(&5X=&EN9W5I<VAM96YT(&]F(&1E
M8G0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S0T+C$U(#(W-2XR-R!49" H-"PY-CDI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-# X+C$U(#(W-2XR-R!49" H,2PU-C@I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#<R
M+C$U(#(W-2XR-R!49" H,RPT,#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(W+C<U(#(W-2XR-R!49" H,C$V+CDI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34S+C8U
M(#(W-2XR-R!49" H)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U.2XP," R-3DN,C<@5&0@*$]T:&5R(&EN8V]M92P@;F5T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T
M."XS," R-3DN,S(@5&0@*%PH,34U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,V-BXV-2 R-3DN,C<@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,BXS," R
M-3DN,S(@5&0@*%PH,C,P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0S,"XV-2 R-3DN,C<@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-"XV-2 R-3DN,C<@
M5&0@*#<U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S,BXX," R-3DN,C<@5&0@*#,R+C8I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-34S+C8U(#(U.2XR-R!49" H)2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP
M," R-#0N,C<@5&0@*$EN8V]M92!B969O<F4@:6YC;VUE('1A>&5S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T-"XQ-2 R
M-#0N,C<@5&0@*#0L,S Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0P."XQ-2 R-#0N,C<@5&0@*#0L-30U*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-BXS," R-#0N
M,S(@5&0@*%PH,C0T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y-"XV-2 R-#0N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XT-2 R-#0N,C<@5&0@
M*%PH-2XT*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4U,"XS," R-#0N,C<@5&0@*%PI)2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," R,CDN,C<@5&0@*$EN8V]M
M92!T87@@8F5N969I="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,S4N.# @,C(Y+C,R(%1D("A<*#,T+#4P,2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N-C4@,C(Y
M+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,#0N.# @,C(Y+C,R(%1D("A<*#0L,3@V*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XV-2 R,CDN,C<@
M5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V,RXX," R,CDN,S(@5&0@*%PH,S L,S$U*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y-"XV-2 R,CDN,C<@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R-"XT-2 R,CDN,C<@5&0@*%PH-S(T+C(I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-34P+C,P(#(R.2XR-R!49" H7"DE
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#(Q-"XR-R!49" H0V]N<V]L:61A=&5D(&YE="!I;F-O;64I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,Y+C$U(#(Q
M-"XR-R!49" H,S@L.# R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0P."XQ-2 R,30N,C<@5&0@*#@L-S,Q*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-RXQ-2 R,30N
M,C<@5&0@*#,P+# W,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,C<N-S4@,C$T+C(W(%1D("@S-#0N-"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3,N-C4@,C$T+C(W
M(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#$Y.2XR-R!49" H3&5S<SH@3F5T(&EN8V]M92!A='1R:6)U
M=&%B;&4@=&\@;F]N8V]N=')O;&QI;F<@:6YT97)E<W0@:6XI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,3@Y+C(W
M(%1D("AS=6)S:61I87)Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,T-"XQ-2 Q.#DN,C<@5&0@*#$L,C@Y*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-2XV-2 Q.#DN
M,C<@5&0@*#<V-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-SDN-C4@,3@Y+C(W(%1D("@U,C4I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,R+C@P(#$X.2XR-R!49" H
M-C@N-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-3,N-C4@,3@Y+C(W(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S+C P(#$V-"XR-R!49" H3F5T(&EN8V]M
M92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N('-H87)E:&]L9&5R<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3,N,# @,38T
M+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,S.2XQ-2 Q-C0N,C<@5&0@*#,W+#4Q,RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S<N,# @,38T+C(W(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0P."XQ-2 Q-C0N,C<@5&0@*#<L.38W*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XP," Q-C0N,C<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8W+C$U
M(#$V-"XR-R!49" H,CDL-30V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R-RXW-2 Q-C0N,C<@5&0@*#,W,"XY*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U,RXV-2 Q
M-C0N,C<@5&0@*"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$S-BXQ,"!49" H
M3DT@+2!N;W0@;65A;FEN9V9U;"D@5&H@150@40I"5" O1C,@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," Q,3(N,3 @5&0@*%)E=F5N=64@9G)O
M;2!S97)V:6-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," X."XQ,"!49" H4F5V96YU92!F<F]M('-E<G9I8V5S
M(&EN8W)E87-E9" D,S$N-2!M:6QL:6]N+"!O<B S+C@E+"!T;R D.#8U+C @
M;6EL;&EO;B!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3<L
M(&%S(&-O;7!A<F5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," W-BXQ,"!49" H=&\@)#@S,RXU(&UI;&QI;VX@
M9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R.# N,#,@-S8N,3 @5&0@*%1H92!I;F-R96%S
M92!W87,@96YT:7)E;'D@9G)O;2!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#0Y+C$T(#<V+C$P(%1D("A!;&QI960@4W1A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#0Y,BXU-B W-BXQ,"!49" H9FEN9R!P<FEM87)I
M;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#8T+C$P(%1D("AD=64@=&\@=&AE("D@5&H@150@40IQ(# @," P
M(')G($)4(#DQ+C,X(#8T+C$P(%1D("A!9'9A;G1A9V4@86-Q=6ES:71I;VXL
M(&%N9"!P87)T:6%L;'D@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-#8N
M.3D@-C0N,3 @5&0@*&9S970@8GD@;&]W97(@<F5V96YU92!F<F]M(%!H>7-I
M8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$U+C Y(#8T+C$P
M(%1D("AF:6YG(&%N9"!/2$--4RX@4V5E(&9U<G1H97(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4R+C$P(%1D
M("AD:7-C=7-S:6]N(&EN(%-E9VUE;G0@4F5S=6QT<RXI(%1J($54(%$*96YD
M<W1R96%M"F5N9&]B:@HU-R P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@
M,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E
M<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#4X(# @4CX^"F5N9&]B:@HU
M." P(&]B:@H\/"],96YG=&@@.#$R,#X^"G-T<F5A;0I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#(U*2!4:B!%
M5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<S
M,"XQ,"!49" H1&ER96-T(&]P97)A=&EN9R!E>'!E;G-E<RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,#8N,3 @
M5&0@*$1I<F5C="!O<&5R871I;F<@97AP96YS97,@87)E(&-O;7!R:7-E9"!P
M<FEM87)I;'D@;V8@9FEE;&0@96UP;&]Y964@8V]M<&5N<V%T:6]N(&%N9"!I
M;F1E<&5N9&5N="!C;VYT<F%C=&]R(&5X<&5N<V5S+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C$P(%1D
M("AH;W5S:6YG(&5X<&5N<V5S+"!T<F%V96P@97AP96YS97,L(&%N9"!F:65L
M9"!I;G-U<F%N8V4@97AP96YS97,N($1I<F5C="!O<&5R871I;F<@97AP96YS
M97,@:6YC<F5A<V5D("0R-"XW(&UI;&QI;VXL(&]R(#0N,"4L('1O("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M.#(N,3 @5&0@*"0V,S8N-2!M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$
M96-E;6)E<B S,2P@,C Q-RP@87,@8V]M<&%R960@=&\@)#8Q*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S0W+C8P(#8X,BXQ,"!49" H,2XX(&UI;&QI;VX@
M9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C<P
M+C$P(%1D("AE;G1I<F5L>2!D=64@=&\@=&AE("D@5&H@150@40IQ(# @," P
M(')G($)4(#$R-"XT,B V-S N,3 @5&0@*$%D=F%N=&%G92!A8W%U:7-I=&EO
M;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C4W(#8W,"XQ,"!49" H
M07,@82!P97)C96YT86=E(&]F('1O=&%L(')E=F5N=64L(&1I<F5C="!O<&5R
M871I;F<@97AP96YS97,@:6YC<F5A<V5D('1O(#<S+C8E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-3@N,3 @
M5&0@*&-O;7!A<F5D('1O(#<S+C0E(&EN('1H92!P<FEO<B!Y96%R('!E<FEO
M9"XI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-C,T+C$P(%1D("A396QL:6YG+"!G96YE<F%L+"!A;F0@861M:6YI
M<W1R871I=F4@97AP96YS97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-C$P+C$P(%1D("A396QL:6YG+"!G96YE
M<F%L+"!A;F0@861M:6YI<W1R871I=F4@97AP96YS97,@:6YC<F5A<V5D("0W
M+C8@;6EL;&EO;BP@;W(@-"XR)2P@=&\@)#$X-RXT(&UI;&QI;VX@9F]R('1H
M92!Y96%R(&5N9&5D($1E8V5M8F5R("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,3 @5&0@*#,Q+" R,#$W
M+"!A<R!C;VUP87)E9"!T;R D,3<Y+C@@;6EL;&EO;B!F;W(@=&AE('EE87(@
M96YD960@1&5C96UB97(@,S$L(#(P,38L('!A<G1L>2!D=64@=&\@=&AE(&EM
M<&%C="!O9B!T:&4@86-Q=6ES:71I;VX@;V8@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X-BXQ,"!49" H061V
M86YT86=E+B!%>&-L=61I;F<@=&AE(&EM<&%C="!O9B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q.38N-C,@-3@V+C$P(%1D("A!9'9A;G1A9V4L('1H92!I
M;F-R96%S92!W87,@<')I;6%R:6QY(&1U92!T;R!I;G9E<W1M96YT<R!I;B!R
M979E;G5E+7!R;V1U8VEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C$P(%1D("AH96%D8V]U;G0L(&AI
M9VAE<B!M87)K971I;F<@8V]S=',@9F]R(&-A;F1I9&%T92!A='1R86-T:6]N
M+"!A;F0@:&EG:&5R(&-O;7!E;G-A=&EO;B!A;F0@8F5N969I="!C;W-T<RX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8R+C Y(#4W-"XQ,"!49" H07,@
M82!P97)C96YT86=E(&]F('1O=&%L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-C(N,3 @5&0@*')E=F5N=64L
M('-E;&QI;F<L(&=E;F5R86PL(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E
M<R!W97)E(#(Q+C<E(&%N9" R,2XU)2!F;W(@=&AE('EE87(@96YD960@1&5C
M96UB97(@,S$L(#(P,3<@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U-3 N,3 @5&0@*$1E8V5M8F5R(#,Q
M+" R,#$V+"!R97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M.#$N,C4@-34P+C$P(%1D("@N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#4R-BXQ,"!49" H1&5P<F5C:6%T:6]N
M(&%N9"!A;6]R=&EZ871I;VX@97AP96YS92D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,#(N,3 @5&0@*$1E<')E
M8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N(&5X<&5N<V4@:6X@=&AE('EE87(@
M96YD960@1&5C96UB97(@,S$L(#(P,3<@:6YC<F5A<V5D('1O("0Q,"XR(&UI
M;&QI;VX@87,@8V]M<&%R960@=&\@)#DN,B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DP+C$P(%1D("AM:6QL
M:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-BP@<&%R
M=&QY(&1U92!T;R!T:&4@861D:71I;VYA;"!A;6]R=&EZ871I;VX@;V8@;W1H
M97(@:6YT86YG:6)L92!A<W-E=',@;V8@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3$U+C<P(#0Y,"XQ,"!49" H061V86YT86=E+B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#<X+C$P(%1D
M("A!<R!A('!E<F-E;G1A9V4@;V8@<F5V96YU92P@9&5P<F5C:6%T:6]N(&%N
M9"!A;6]R=&EZ871I;VX@97AP96YS92!W87,@,2XR)2!F;W(@=&AE('EE87(@
M96YD960@1&5C96UB97(@,S$L(#(P,3<@86YD(#$N,24@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V-BXQ,"!4
M9" H9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+BD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M-#(N,3 @5&0@*$%C<75I<VET:6]N+7)E;&%T960@8V]N=&EN9V5N="!C;VYS
M:61E<F%T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0Q."XQ,"!49" H06-Q=6ES:71I;VXM<F5L871E9"!C
M;VYT:6YG96YT(&-O;G-I9&5R871I;VX@=&]T86QE9"!L97-S('1H86X@)# N
M,2!M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q
M-RP@<F5L871E9"!T;R!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#0P-BXQ,"!49" H86-C<F5T:6]N(&]N
M(&5A<FYO=71S+"!P87)T;'D@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-S0N-#D@-# V+C$P(%1D("AF<V5T(&)Y('1H92!R979E<G-A;"!O9B!A;B!E
M87)N;W5T(&QI86)I;&ET>2!R96QA=&5D('1O($UE9&ES8V%N('=H:6-H('=A
M<R!D971E<FUI;F5D('=O=6QD(&YO=" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,SDT+C$P(%1D("AB92!A8VAI
M979E9"P@87,@8V]M<&%R960@=&\@)# N."!M:6QL:6]N(&9O<B!T:&4@>65A
M<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-BP@<')I;6%R:6QY(')E;&%T960@
M=&\@86-C<F5T:6]N(&]F('1H92!-961I<V-A;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S@R+C$P(%1D("AE
M87)N;W5T<RX@26X@=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3<L('=E(&%L
M<V\@<F5C;V=N:7IE9"!A(&1E8W)E87-E(&EN('1H92!F86ER('9A;'5E(&]F
M('1H92!54U(@96%R;F]U="!L:6%B:6QI='D@;V8@)#$N,R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S<P+C$P
M(%1D("AM:6QL:6]N+"!D<FEV96X@8GD@=&AE(&1E8W)E87-E(&EN('1H92!P
M<F]J96-T960@55-2(#(P,3@@86YD(#(P,3D@<F5V96YU92!A;F0@14))5$1!
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$Q+C@U(#,W,"XQ,"!49" H(&%M
M;W5N=',L(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8Q+C,Y(#,W,"XQ
M,"!49" H9G-E="!B>2!A("0Q+C(@;6EL;&EO;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S4X+C$P(%1D("AI
M;F-R96%S92!I;B!T:&4@<')O:F5C=&5D(&9A:7(@=F%L=64@;V8@365D:7-C
M86XG<R!$:7)E8W1%9"!E87)N;W5T(&QI86)I;&ET>2D@5&H@150@40IQ(# @
M," P(')G($)4(#,T.2XY,B S-3@N,3 @5&0@*"P@87,@82!R97-U;'0@;V8@
M86X@:6YC<F5A<V4@:6X@=&AE:7(@<')O:F5C=&5D(#(P,3@@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,T-BXQ
M,"!49" H86YD(#(P,3D@9W)O<W,@<')O9FET(&%M;W5N=',N(%-E92!.;W1E
M(#$P("T@1F%I<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3(N,CD@,S0V
M+C$P(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4X+C0P(#,T-BXQ
M,"!49" H86QU92!-96%S=7)E;65N=',@=&\@;W5R(&-O;G-O;&ED871E9"!F
M:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S(R+C$P(%1D("A!8W%U:7-I=&EO
M;B!A;F0@:6YT96=R871I;VX@8V]S=',I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,CDX+C$P(%1D("A$=7)I;F<@
M=&AE('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$W(&%N9" R,#$V+"!W
M92!I;F-U<G)E9"!A8W%U:7-I=&EO;B!A;F0@:6YT96=R871I;VX@8V]S=',@
M;V8@)#(N,"!M:6QL:6]N(&%N9" D,"XQ("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R.#8N,3 @5&0@*&UI;&QI
M;VXL(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#$S,2XU
M-2 R.#8N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,V+C,W
M(#(X-BXQ,"!49" H5&AE(#(P,3<@8V]S=',@8V]N<VES=&5D('!R:6UA<FEL
M>2!O9B!T<F%N<V%C=&EO;BP@861V:7-O<GDI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-S(N,S0@,C@V+C$P(%1D("@L(&%N9"!L96=A;"!F965S(')E;&%T
M960@=&\@=&AE(&%C<75I<VET:6]N(&]F("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-S0N,3 @5&0@*$%D=F%N
M=&%G92X@4V5E($YO=&4@-" M("D@5&H@150@40IQ(# @," P(')G($)4(#$T
M.2XY-R R-S0N,3 @5&0@*$%C<75I<VET:6]N<R!T;R!O=7(@8V]N<V]L:61A
M=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+BD@5&H@150@40I"5" O1C,@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-3 N,3 @5&0@*%)E<W1R
M=6-T=7)I;F<@8V]S=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C(V+C$P(%1D("A297-T<G5C='5R:6YG(&-O
M<W1S(&EN8VQU9&4@<V5V97)A;F-E(&%N9"!E>&ET(&-O<W1S(&EN8W5R<F5D
M(&%S('!A<G0@;V8@<V5P87)A=&4@86YD(&1I<V-R971E(&-O<W0@<V%V:6YG
M<R!I;FET:6%T:79E<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$V+C@Y
M(#(R-BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4R-2XU,R R
M,C8N,3 @5&0@*&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#(Q-"XQ,"!49" H<F5C;W)D960@<F5S=')U8W1U
M<FEN9R!C;W-T<R!O9B D,2XP(&UI;&QI;VX@9F]R('1H92!Y96%R(&5N9&5D
M($1E8V5M8F5R(#,Q+" R,#$W(&%N9" D,"XX(&UI;&QI;VX@9F]R('1H92!Y
M96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R,#(N,3 @5&0@*$1E8V5M8F5R(#,Q+" R,#$V+BD@
M5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Q-S@N,3 @5&0@*$EM<&%I<FUE;G0@8VAA<F=E<RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-30N,3 @5&0@
M*$EN('1H92!F;W5R=&@@<75A<G1E<B!O9B R,#$W+"!W92!R96-O<F1E9"!N
M;VXM8V%S:"!I;7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,C0N.3D@,34T+C$P(%1D("AG97,@;V8@)#$T+C0@;6EL;&EO;B!R96QA
M=&EN9R!T;R!T:&4@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,C,N,SD@,34T+C$P(%1D("AF:6YG("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-#(N,3 @5&0@*')E
M<&]R=&EN9R!U;FET+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#DN-3,@
M,30R+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$X+C$W(#$T
M,BXQ,"!49" H92!R961U8V5D(&]U<B!L;VYG+7)A;F=E(&9O<F5C87-T(&9O
M<B!T:&4@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M-#$N,C0@,30R+C$P(%1D("AF:6YG(&)U<VEN97-S('-E9VUE;G0@:6X@=&AE
M(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3<N("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S N,3 @5&0@*%1H92!L
M;W=E<B!T:&%N(&5X<&5C=&5D(')E=F5N=64@=V%S(&1R:79E;B!B>2!L;W=E
M<B!B;V]K:6YG('9O;'5M97,L('!A<G1L>2!D=64@=&\@=&AE(&QO<W,@;V8@
M8W5S=&]M97)S+B!);B!A9&1I=&EO;BP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Q."XQ,"!49" H;6%R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-C4N,S<@,3$X+C$P(%1D("AG:6YS(&]F
M('1H92!R97!O<G1I;F<@=6YI="!W97)E(&YE9V%T:79E;'D@:6UP86-T960@
M9G)O;2!C;VYT:6YU960@:6YV97-T;65N=',@:6X@=&AE(&)U<VEN97-S+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3 N,# @,3$X+C$P(%1D("A!<R!A
M(')E<W5L="P@=V4@<F5C;W)D960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#$P-BXQ,"!49" H;F]N+6-A<V@@
M:6UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34T+C(R
M(#$P-BXQ,"!49" H9V5S(&]F("0X+C<@;6EL;&EO;B!R96QA=&5D('1O('1R
M861E(&YA;65S(&%N9" D-2XW(&UI;&QI;VX@<F5L871E9"!T;R!G;V]D=VEL
M;"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @.#(N,3 @5&0@*$EN('1H92!S96-O;F0@<75A<G1E<B!O9B R,#$V
M+"!W92!R96-O<F1E9"!N;VXM8V%S:"!I;7!A:7)M96YT(&-H87(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,C@N,S(@.#(N,3 @5&0@*&=E<R!O9B D,C0N
M,R!M:6QL:6]N(')E;&%T:6YG('1O('1H92!0:'ES:6-I86X@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#4R-BXW,B X,BXQ,"!49" H9FEN9R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-S N,3 @5&0@*')E<&]R=&EN9R!U;FET+B!"87-E9"!O;B!I=',@=6YD97(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#,N-C<@-S N,3 @5&0@*"UP97)F
M;W)M86YC92!T;R!P;&%N('1H<F]U9V@@=&AE('-I>"!M;VYT:',@96YD960@
M2G5N92 S,"P@,C Q-BP@=V4@<F5V:7-E9"!O=7(@9W)O=W1H("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U."XQ
M,"!49" H87-S=6UP=&EO;G,@9F]R('1H92!0:'ES:6-I86X@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#$X."XQ-" U."XQ,"!49" H9FEN9R!R97!O
M<G1I;F<@=6YI="!W:&EC:"!T<FEG9V5R960@;W5R(&5V86QU871I;VXN*2!4
M:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-3D@,"!O8FH*/#PO5'EP92 O4&%G
M90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!=
M"B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R V," P(%(^
M/@IE;F1O8FH*-C @,"!O8FH*/#PO3&5N9W1H(#4V,S<^/@IS=')E86T*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P(%1D
M("@R-BD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W-#(N,C4@5&0@*$EN=&5R97-T(&5X<&5N<V4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$X+C(U
M(%1D("A);G1E<F5S="!E>'!E;G-E('1O=&%L960@)#0N,B!M:6QL:6]N(&9O
M<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-R!A;F0@)#8N,2!M
M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<P
M-BXR-2!49" H,C Q-BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S0N.#(@
M-S V+C(U(%1D("A4:&4@9&5C<F5A<V4@=V%S(&1U92!T;R!A(&QO=V5R(&5F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$T+C@T(#<P-BXR-2!49" H9F5C
M=&EV92!I;G1E<F5S="!R871E('!A<G1I86QL>2!O9BD@5&H@150@40IQ(# @
M," P(')G($)4(#,S-RXY,R W,#8N,C4@5&0@*&9S970@8GD@:&EG:&5R(&%V
M97)A9V4@8F]R<F]W:6YG<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Y
M+C,X(#<P-BXR-2!49" H5&AE(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3 U+C Q(#<P-BXR-2!49" H9F5C=&EV92 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C(U(%1D("AI;G1E
M<F5S="!R871E(&]N(&]U<B!B;W)R;W=I;F=S(&1E8W)E87-E9"!T;R T+C8E
M(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-R!C;VUP87)E
M9"!T;R X+C0E(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R+C(U(%1D("A$
M96-E;6)E<B S,2P@,C Q-BP@<')I;6%R:6QY(&1U92!T;R!T:&4@<&%Y;V8I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S<N.#(@-C@R+C(U(%1D("AF(&]F
M(&]U<B D,C4N,"!M:6QL:6]N(#@E(&9I>&5D(')A=&4@0V]N=F5R=&EB;&4@
M3F]T97,@;VX@36%R8V@@,3<L(#(P,3<N(%-E92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C<P+C(U(%1D("A.
M;W1E(#@@+2!$96)T('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T
M871E;65N=',N*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8T-BXR-2!49" H1V%I;B!O;B!D97)I=F%T:79E(&QI
M86)I;&ET>2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," V,C(N,C4@5&0@*$=A:6X@;VX@9&5R:79A=&EV92!L:6%B
M:6QI='D@;V8@)#$N-B!M:6QL:6]N(&%N9" D-2XX(&UI;&QI;VX@9F]R('1H
M92!Y96%R<R!E;F1E9"!$96-E;6)E<B S,2P@,C Q-R!A;F0@1&5C96UB97(@
M,S$L(#(P,38L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," V,3 N,C4@5&0@*')E<W!E8W1I=F5L>2D@5&H@150@
M40IQ(# @," P(')G($)4(#DW+C8V(#8Q,"XR-2!49" H+"!R96QA=&5D('1O
M('1H92!C:&%N9V4@:6X@=&AE(&9A:7(@=F%L=64@;V8@96UB961D960@9F5A
M='5R97,@;V8@;W5R($-O;G9E<G1I8FQE($YO=&5S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T-#8N-SD@-C$P+C(U(%1D("A4:&4@9V%I;G,@:6X@8F]T
M:"!P97)I;V1S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," U.3@N,C4@5&0@*'!R:6UA<FEL>2!R97-U;'1E9"!F
M<F]M(&1E8W)E87-E<R!I;B!O=7(@<VAA<F4@<')I8V4@9G)O;2!T:&4@96YD
M(&]F('1H92!R97-P96-T:79E('!R:6]R('EE87)S('1H<F]U9V@@=&AE(#(P
M,3<@<&%Y;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3DN.3,@-3DX+C(U
M(%1D("AF(&1A=&4@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," U.#8N,C4@5&0@*'1H<F]U9V@@1&5C96UB
M97(@,S$L(#(P,38N("D@5&H@150@40IQ(# @," P(')G($)4(#$V-RXP,2 U
M.#8N,C4@5&0@*%1H92!G86EN(&EN(#(P,38@=V%S('!A<G1I86QL>2!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#(Y.2XU." U.#8N,C4@5&0@*&9S970@
M8GD@82!R961U8W1I;VX@:6X@8W)E9&ET(')I<VLN(%-E92!.;W1E(#@@+2!$
M96)T(&%N9"!.;W1E(#D@+2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C(U(%1D("A$97)I=F%T:79E<R!T
M;R!O=7(@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+BD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M-3 N,C4@5&0@*$QO<W,@;VX@96%R;'D@97AT:6YG=6ES:&UE;G0@;V8@9&5B
M="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," U,C8N,C4@5&0@*$QO<W,@;VX@96%R;'D@97AT:6YG=6ES:&UE;G0@
M;V8@9&5B="!O9B D-2XP(&UI;&QI;VX@9F]R('1H92!Y96%R(&5N9&5D($1E
M8V5M8F5R(#,Q+" R,#$W(')E;&%T97,@=&\@=&AE('=R:71E+6]F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3 T+CDW(#4R-BXR-2!49" H9B!O9B!O<FEG
M:6YA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-3$T+C(U(%1D("AI<W-U92!D:7-C;W5N="!A;F0@9&5B="!I
M<W-U86YC92!C;W-T<R!O9B D-"XT(&UI;&QI;VX@86YD(&$@<')E+7!A>6UE
M;G0@9F5E(&]F("0P+C8@;6EL;&EO;B!D=64@=&\@=&AE(&5A<FQY('-E='1L
M96UE;G0@;V8@;W5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U,#(N,C4@5&0@*$-O;G9E<G1I8FQE($YO=&5S
M+B!,;W-S(&]N(&5A<FQY(&5X=&EN9W5I<VAM96YT(&]F(&1E8G0@=V%S("0Q
M+C8@;6EL;&EO;B!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P
M,38@86YD(')E;&%T960@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#0Y,"XR-2!49" H=&AE('=R:71E+6]F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.38N-S0@-#DP+C(U(%1D("AF(&]F
M('5N86UO<G1I>F5D(&YE="!D96)T(&1I<V-O=6YT(&%N9"!I<W-U86YC92!C
M;W-T<RP@:6YC;'5D:6YG(&$@<F5D96UP=&EO;B!P<F5M:75M(&]F("0P+C8@
M;6EL;&EO;BP@<F5L871E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-#<X+C(U(%1D("AO=7(@4V5C;VYD
M($QI96X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$X+C0Q(#0W."XR-2!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$R,RXX,B T-S@N,C4@5&0@
M*&5R;2!,;V%N+B!3964@3F]T92 X("T@1&5B="!T;R!O=7(@8V]N<V]L:61A
M=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+BD@5&H@150@40I"5" O1C0@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-30N,C4@5&0@*$DI(%1J
M($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,S,@
M-#4T+C(U(%1D("AN8V]M92!T87@@8F5N969I="D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,S N,C4@5&0@*$EN
M8V]M92!T87@@8F5N969I="!F<F]M(&-O;G1I;G5I;F<@;W!E<F%T:6]N<R!T
M;W1A;&5D("0S-"XU(&UI;&QI;VX@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M
M8F5R(#,Q+" R,#$W+"!C;VUP87)E9"!T;R D-"XR("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,3@N,C4@5&0@
M*&UI;&QI;VX@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,SDN-S8@-#$X+C(U(%1D("A4
M:&4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C4N,SD@-#$X+C(U(%1D
M("AF96-T:79E('1A>"!R871E('=A<R!N96=A=&EV92 X,#(N,B4@86YD(&YE
M9V%T:79E(#DR+C$E+"!I;F-L=61I;F<@=&AE("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,#8N,C4@5&0@*&EM
M<&%C="!O9B!D:7-C<F5T92!I=&5M<RP@9F]R('1H92!Y96%R<R!E;F1E9"!$
M96-E;6)E<B S,2P@,C Q-R!A;F0@,C Q-BP@<F5S<&5C=&EV96QY*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-# P+C,T(#0P-BXR-2!49" H+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,#4N,38@-# V+C(U(%1D("A4:&4@968I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T,S N-SD@-# V+C(U(%1D("AF96-T:79E
M('1A>"!R871E(&EN(#(P,3<@=V%S("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S.30N,C4@5&0@*&EM<&%C=&5D
M(&)Y('1H92!R979E<G-A;"!O9B!V86QU871I;VX@86QL;W=A;F-E<RP@<&%R
M=&EA;&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDT+C0U(#,Y-"XR
M-2!49" H9G-E="!B>2!T:&4@8VAA;F=E<R!I;B!E<W1I;6%T960@9&5F97)R
M960@=&%X(&%S<V5T<R!R97-U;'1I;F<@9G)O;2 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S@R+C(U(%1D("AT
M:&4@,C Q-R I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-RXP-" S.#(N,C4@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,BXT-2 S.#(N,C4@5&0@
M*&%X("D@5&H@150@40IQ(# @," P(')G($)4(#$P,RXX,R S.#(N,C4@5&0@
M*$%C="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(S+C Y(#,X,BXR-2!4
M9" H5&AE(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30X+C<S(#,X,BXR
M-2!49" H9F5C=&EV92!T87@@<F%T92!I;B R,#$V(&ES(&1I9BD@5&H@150@
M40IQ(# @," P(')G($)4(#(V,RXU,2 S.#(N,C4@5&0@*&9E<F5N="!T:&%N
M('1H92!S=&%T=71O<GD@<F%T97,@<')I;6%R:6QY(&1U92!T;R!T:&4@:6UP
M86-T(&9R;VT@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#,W,"XR-2!49" H86UO<G1I>F%T:6]N(&]F(&EN9&5F
M:6YI=&4M;&EV960@:6YT86YG:6)L92!A<W-E=',@9F]R('1A>"!P=7)P;W-E
M<R!A;F0@=&AE('!A<G1I86P@;F]N+61E9'5C=&EB:6QI='D@;V8@8V5R=&%I
M;B!P97(@9&EE;2!E>'!E;G-E<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S4X+C(U(%1D("AA;F0@:6YT97)N
M871I;VYA;"!A;F0@<W1A=&4@;6EN:6UU;2!T87AE<RX@4V5E($YO=&4@,3,@
M+2!);F-O;64@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$T+C$Y(#,U."XR
M-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#,Q.2XV," S-3@N,C4@
M5&0@*&%X97,@=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M
M96YT<R!F;W(@9G5R=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,S0V+C(U(%1D("AI;F9O<FUA=&EO;BXI
M(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HV,2 P(&]B:@H\/"]4>7!E("]0
M86=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP
M,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#8R(# @
M4CX^"F5N9&]B:@HV,B P(&]B:@H\/"],96YG=&@@,C$S-3(^/@IS=')E86T*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P
M(%1D("@R-RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*
M+T=3,"!G<PHP+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3 @-S0P
M+C8X-3 U.#4Y,S<U(&T*,3(P+C(W,S0S-S4@-S0P+C8X-3 U.#4Y,S<U(&P*
M<PIQ(# @," P(')G($)4(#4P+C P(#<T,BXR-2!49" H4V5G;65N="!297-U
M;'1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<Q."XR-2!49" H26YF;W)M871I;VX@;VX@;W!E<F%T:6YG('-E
M9VUE;G1S(&%N9"!A(')E8V]N8VEL:6%T:6]N('1O(%PH;&]S<UPI(&EN8V]M
M92!F<F]M(&]P97)A=&EO;G,@9F]R('1H92!P97)I;V1S(&EN9&EC871E9"!A
M<F4@87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#<P-BXR-2!49" H9F]L;&]W<SHI(%1J($54(%$*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN-3 @-C0X+C<U(#(V
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Q,RXU," V-#@N-S4@.# N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS.3,N-3 @-C0X+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3<N-3 @-C0X+C<U
M(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#<W+C4P(#8T."XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#@Q+C4P(#8T."XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#8R,"XW
M-2 R-C0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3,N-3 @-C(P+C<U(#@P+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,SDS+C4P(#8R,"XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,SDW+C4P(#8R
M,"XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXU," V,C N-S4@-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0X,2XU," V,C N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XU," U
M.3(N-S4@,C8T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$S+C4P(#4Y,BXW-2 X,"XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,Y,RXU," U.3(N-S4@-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-RXU
M," U.3(N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S<N-3 @-3DR+C<U(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.#$N-3 @-3DR+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN
M-3 @-38T+C<U(#(V-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,RXU," U-C0N-S4@.# N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHS.3,N-3 @-38T+C<U(#0N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M.3<N-3 @-38T+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<W+C4P(#4V-"XW-2 T
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#@Q+C4P(#4V-"XW-2 X,"XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y+C4P(#4S-BXW-2 R-C0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3,N-3 @-3,V+C<U
M(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,SDS+C4P(#4S-BXW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,SDW+C4P(#4S-BXW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXU," U,S8N
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0X,2XU," U,S8N-S4@.# N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.2XU," U,#@N-S4@,C8T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$S+C4P(#4P
M."XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y,RXU," U,#@N-S4@-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,Y-RXU," U,#@N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S<N-3 @
M-3 X+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#$N-3 @-3 X+C<U(#@P+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DN-3 @-#@P+C<U(#(V-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,RXU
M," T.# N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3,N-3 @-#@P+C<U(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS.3<N-3 @-#@P+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<W
M+C4P(#0X,"XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@Q+C4P(#0X,"XW-2 X,"XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y+C4P(#0U,BXW-2 R-C0N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M,3,N-3 @-#4R+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,SDS+C4P(#0U,BXW-2 T
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,SDW+C4P(#0U,BXW-2 X,"XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0W-RXU," T-3(N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X,2XU," T-3(N-S4@
M.# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.2XU," T,C0N-S4@,C8T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S$S+C4P(#0R-"XW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Y,RXU," T,C0N
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,Y-RXU," T,C0N-S4@.# N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT-S<N-3 @-#(T+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#$N-3 @-#(T
M+C<U(#@P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN-3 @,SDV+C<U(#(V-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,Q,RXU," S.38N-S4@.# N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3,N-3 @
M,SDV+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3<N-3 @,SDV+C<U(#@P+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#<W+C4P(#,Y-BXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@Q+C4P
M(#,Y-BXW-2 X,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Q,RXU(#8W
M-BXW-2!M"C,Y,RXU(#8W-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,SDS+C4@-C<V+C<U(&T*,SDW
M+C4@-C<V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS.3<N-2 V-S8N-S4@;0HT-S<N-2 V-S8N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0W-RXU(#8W-BXW-2!M"C0X,2XU(#8W-BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@Q
M+C4@-C<V+C<U(&T*-38Q+C4@-C<V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3,N-2 V-C(N-S4@
M;0HS.3,N-2 V-C(N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#8V,BXW-2!M"C0W-RXU(#8V
M,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#@Q+C4@-C8R+C<U(&T*-38Q+C4@-C8R+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS,3,N-2 U.3(N-S4@;0HS.3,N-2 U.3(N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#4Y
M,BXW-2!M"C0W-RXU(#4Y,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@Q+C4@-3DR+C<U(&T*-38Q
M+C4@-3DR+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS,3,N-2 U.3(N-S4@;0HS.3,N-2 U.3(N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,Q,RXU(#4W.2XW-2!M"C,Y,RXU(#4W.2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$S
M+C4@-3<W+C<U(&T*,SDS+C4@-3<W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.3<N-2 U.3(N-S4@
M;0HT-S<N-2 U.3(N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#4W.2XW-2!M"C0W-RXU(#4W
M.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,SDW+C4@-3<W+C<U(&T*-#<W+C4@-3<W+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.#$N-2 U.3(N-S4@;0HU-C$N-2 U.3(N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X,2XU(#4W
M.2XW-2!M"C4V,2XU(#4W.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@Q+C4@-3<W+C<U(&T*-38Q
M+C4@-3<W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.#$N-2 U,#@N-S4@;0HU-C$N-2 U,#@N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,Q,RXU(#4P."XW-2!M"C,Y,RXU(#4P."XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,SDW
M+C4@-3 X+C<U(&T*-#<W+C4@-3 X+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3,N-2 S.38N-S4@
M;0HS.3,N-2 S.38N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#,Y-BXW-2!M"C0W-RXU(#,Y
M-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#@Q+C4@,SDV+C<U(&T*-38Q+C4@,SDV+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS,3,N-2 S.38N-S4@;0HS.3,N-2 S.38N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Q,RXU(#,X
M,RXW-2!M"C,Y,RXU(#,X,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$S+C4@,S@Q+C<U(&T*,SDS
M+C4@,S@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS.3<N-2 S.38N-S4@;0HT-S<N-2 S.38N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,Y-RXU(#,X,RXW-2!M"C0W-RXU(#,X,RXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,SDW
M+C4@,S@Q+C<U(&T*-#<W+C4@,S@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#$N-2 S.38N-S4@
M;0HU-C$N-2 S.38N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X,2XU(#,X,RXW-2!M"C4V,2XU(#,X
M,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#@Q+C4@,S@Q+C<U(&T*-38Q+C4@,S@Q+C<U(&P*<PI"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," V.#$N-#(@
M5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S@Q+C8P(#8X,2XT,R!49" H62D@5&H@150@40IQ(# @," P(')G($)4
M(#,X."XR-R V.#$N-#,@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4
M(#0P,2XU," V.#$N-#,@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#0W-RXT,B V.#$N-#,@5&0@** S,2PI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-C8W+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,T,RXP," V-C<N-#,@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#(W+C P(#8V-RXT,R!49" H,C Q
M-RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,3$N,# @-C8W+C0S(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C P(#8U,RXS,B!49" HH"D@5&H@150@
M40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,2XY-2 V-3,N
M,C @5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," V,SDN,S(@5&0@
M*%)E=F5N=64@9G)O;2!S97)V:6-E<SHI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S$V+C P(#8S.2XS,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,# @
M-C,Y+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0X-"XP," V,SDN,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N,# @-C(U+C,R(%1D("A.
M=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 Q+C T(#8R-2XS
M,B!49" H06QL:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#0N
M,C@@-C(U+C,R(%1D("AF:6YG*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,Q-BXP," V,C4N,S(@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4W+C$U(#8R-2XS
M,B!49" H-S(P+#,P,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,# N,# @-C(U+C,R(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XQ-2 V,C4N,S(@5&0@
M*#<U."PR-C<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#@T+C P(#8R-2XS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,C4N,34@-C(U+C,R(%1D("@W,C$L
M-#@V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4X+C P(#8Q,2XS,B!49" H4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,34N-# @-C$Q+C,R(%1D("AF:6YG*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXQ-2 V,3$N,S(@
M5&0@*#@R+#,P-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-#8N,34@-C$Q+C,R(%1D("@Y,RPV,3 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C$U(#8Q,2XS,B!4
M9" H.3@L,C@S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4X+C P(#4Y-RXS,B!49" H3W1H97(@2'5M86X@0V%P:71A;"!-
M86YA9V5M96YT(%-E<G9I8V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,V,BXQ-2 U.3<N,S(@5&0@*#$S+#@W-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N,34@
M-3DW+C,R(%1D("@Q,RPQ-S$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,P+C$U(#4Y-RXS,B!49" H,3,L-S8X*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#4X
M,RXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,38N,# @-3@S+C,R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,U-RXQ-2 U.#,N,S(@5&0@*#@Q
M-BPT.#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# P+C P(#4X,RXS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-#$N,34@-3@S+C,R(%1D("@X-C4L,#0X
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X
M-"XP," U.#,N,S(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(U+C$U(#4X,RXS,B!49" H.#,S+#4S-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," U
M-34N,S(@5&0@*$-O;G1R:6)U=&EO;B!I;F-O;64@7"AL;W-S7"DZ*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,"XP," U
M-34N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#<T+C P(#4U-2XS,B!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3@N,# @-34U+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X
M+C P(#4T,2XS,B!49" H3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P,2XP-" U-#$N,S(@5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,30T+C(X(#4T,2XS,B!49" H9FEN9RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,38N,# @-30Q+C,R
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V,BXQ-2 U-#$N,S(@5&0@*#8V+#,V-2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,# @-30Q+C,R(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M-BXQ-2 U-#$N,S(@5&0@*#<S+#8Q-"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.#0N,# @-30Q+C,R(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,"XQ-2 U
M-#$N,S(@5&0@*#<Q+#DY,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U."XP," U,C<N,S(@5&0@*%!H>7-I8VEA;B!3=&%F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$U+C0P(#4R-RXS,B!49" H9FEN
M9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-C<N,34@-3(W+C,R(%1D("@T+#<U-2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-3$N,34@-3(W+C,R(%1D("@U+#(U-BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N
M,34@-3(W+C,R(%1D("@X+#(V-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U."XP," U,3,N,S(@5&0@*$]T:&5R($AU;6%N
M($-A<&ET86P@36%N86=E;65N="!397)V:6-E<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S0N-C4@-3$S+C,R(%1D("@U
M.3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#4U+C,P(#4Q,RXS-R!49" H7"@S-3<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<S+C8U(#4Q,RXS,B!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Y+C,P
M(#4Q,RXS-R!49" H7"@U,S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34W+C8U(#4Q,RXS,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-#DY+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V,BXQ-2 T.3DN,S(@5&0@*#<Q+#<Q."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N,34@-#DY+C,R(%1D("@W
M."PU,3,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,P+C$U(#0Y.2XS,B!49" H-SDL-S(R*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#0W,2XS,B!49" H56YA
M;&QO8V%T960@8V]R<&]R871E(&]V97)H96%D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXQ-2 T-S$N,S(@5&0@*#0T
M+#4X.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-#8N,34@-#<Q+C,R(%1D("@S.2PQ.3 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C$U(#0W,2XS,B!49" H,S@L
M-# P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R+C P(#0U-RXS,B!49" H1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I
M;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S8R+C$U(#0U-RXS,B!49" H,2D@5&H@150@40IQ(# @," P(')G($)4(#,V
M-RXQ-2 T-3<N,S(@5&0@*#$L-S@P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0T-BXQ-2 T-3<N,S(@5&0@*#$P+#$W-"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N
M,34@-#4W+C,R(%1D("@Y+#$X,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXP," T-#,N,S(@5&0@*$%C<75I<VET:6]N
M(&%N9"!I;G1E9W)A=&EO;B!C;W-T<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-S0N-C4@-#0S+C,R(%1D("@T.3$I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4Q+C$U
M(#0T,RXS,B!49" H,2PY-S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30W+C8U(#0T,RXS,B!49" H-S@I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-#(Y+C,R
M(%1D("A!8W%U:7-I=&EO;BUR96QA=&5D(&-O;G1I;F=E;G0@8V]N<VED97)A
M=&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S-C<N,34@-#(Y+C,R(%1D("@R+#4U-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-C,N-C4@-#(Y+C,R(%1D("@T-"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#(N
M-C4@-#(Y+C,R(%1D("@X,30I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N,# @-#$U+C,R(%1D("A297-T<G5C='5R:6YG
M(&-O<W1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V-RXQ-2 T,34N,S(@5&0@*#(L-S4X*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,2XQ-2 T,34N,S(@5&0@*#$L
M,#(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4T,BXV-2 T,34N,S(@5&0@*#<U,RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXP," T,#$N,S(@5&0@*$EM<&%I<FUE
M;G0@8VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#$Q."XR-R T,#$N,S(@
M5&0@*&=E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-C(N,34@-# Q+C,R(%1D("@R,BPT,C,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0V+C$U(#0P,2XS,B!49" H
M,30L,S4V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S,"XQ-2 T,#$N,S(@5&0@*#(T+#,Q*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-34R+C8U(#0P,2XS,B!49" H,2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S.#<N,S(@5&0@*%PH3&]S
M<UPI(&EN8V]M92!F<F]M(&]P97)A=&EO;G,I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S$V+C P(#,X-RXS,B!49" H)"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-3@N
M.# @,S@W+C,W(%1D("A<*#$R+#@X,"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S.#DN-C4@,S@W+C,R(%1D("A<*2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,# @
M,S@W+C,R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T-BXQ-2 S.#<N,S(@5&0@*#$I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-3$N,34@,S@W+C,R(%1D("@Q+#<T."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#0N,# @,S@W+C,R(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S-2XQ-2 S.#<N,S(@5&0@*#8L,3@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S-3DN,C4@5&0@*%-E92!.;W1E(#$W("T@4V5G;65N="!$871A+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M,S4N,C4@5&0@*$-E<G1A:6X@<W1A=&ES=&EC86P@9&%T82!F;W(@;W5R(&)U
M<VEN97-S('-E9VUE;G1S(&9O<B!T:&4@<&5R:6]D<R!I;F1I8V%T960@87)E
M(&%S(&9O;&QO=W,Z*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y+C4P(#(X-2XW-2 R,S0N,# @+3$R+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR
M.#,N-3 @,C@U+C<U(#8T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0W+C4P(#(X-2XW-2 Q
M,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,U-RXU," R.#4N-S4@-C4N,# @+3$R+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,C(N-3 @,C@U+C<U(#DN,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S$N-3 @,C@U+C<U
M(#8P+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DQ+C4P(#(X-2XW-2 Q,"XP," M,3(N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4P,2XU," R.#4N-S4@-C N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XU," R-C$N
M-S4@,C,T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,C@S+C4P(#(V,2XW-2 V-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,T-RXU," R-C$N-S4@,3 N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3<N-3 @
M,C8Q+C<U(#8U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(R+C4P(#(V,2XW-2 Y+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#,Q+C4P(#(V,2XW-2 V,"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,2XU
M," R-C$N-S4@,3 N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#$N-3 @,C8Q+C<U(#8P+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#DN-3 @,C,U+C<U(#(S-"XP," M,3(N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(X
M,RXU," R,S4N-S4@-C0N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#<N-3 @,C,U+C<U(#$P
M+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S4W+C4P(#(S-2XW-2 V-2XP," M,3(N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0R,BXU," R,S4N-S4@.2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S,2XU," R,S4N-S4@
M-C N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.3$N-3 @,C,U+C<U(#$P+C P("TQ,BXP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 Q+C4P(#(S-2XW-2 V,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#(Q,2XW
M-2 R,S0N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHR.#,N-3 @,C$Q+C<U(#8T+C P("TQ,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0W+C4P(#(Q,2XW-2 Q,"XP," M,3(N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U-RXU," R
M,3$N-S4@-C4N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C(N-3 @,C$Q+C<U(#DN,# @+3$R
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT,S$N-3 @,C$Q+C<U(#8P+C P("TQ,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DQ+C4P
M(#(Q,2XW-2 Q,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,2XU," R,3$N-S4@-C N,# @
M+3$R+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HR.#,N-2 S,#DN-S4@;0HS-#<N-2 S
M,#DN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,T-RXU(#,P.2XW-2!M"C,U-RXU(#,P.2XW-2!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,S4W+C4@,S Y+C<U(&T*-#(R+C4@,S Y+C<U(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR.#,N-2 R
M.3<N-S4@;0HS-#<N-2 R.3<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U-RXU(#(Y-RXW-2!M"C0R
M,BXU(#(Y-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#,Q+C4@,CDW+C<U(&T*-#DQ+C4@,CDW+C<U
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HU,#$N-2 R.3<N-S4@;0HU-C$N-2 R.3<N-S4@; IS"D)4("]&
M,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S R+C8U(#,Q-"XR,"!49" H
M62D@5&H@150@40IQ(# @," P(')G($)4(#,P."XV-2 S,30N,C @5&0@*&5A
M<BD@5&H@150@40IQ(# @," P(')G($)4(#,R,"XU-B S,30N,C @5&0@*"!%
M;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#,X."XX.2 S
M,30N,C @5&0@*" S,2PI(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,38N,S @,S$T+C(P(%1D("A097(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,CDN-S$@,S$T+C(P(%1D("AC96YT*2!4:B!%5"!1"D)4
M("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S V+C P(#,P,2XQ-2!4
M9" H,C Q."D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,X,"XU," S,#$N,34@5&0@*#(P,3<I(%1J($54(%$*0E0@+T8R(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N,C @,S Q+C$U(%1D("A#:&%N
M9V4I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,38N,C @,S Q+C$U(%1D("A#:&%N9V4I(%1J($54(%$*0E0@+T8R(#DN,# @
M5&8@150*," P(# @4D<*+T=3,"!G<PHP+C@V('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*-3(@,C<U+C<T-C,S-S@Y,#8R-2!M"C(Q,"XR-34X-3DS-S4@
M,C<U+C<T-C,S-S@Y,#8R-2!L"G,*<2 P(# @,"!R9R!"5" U,BXP," R-S<N
M,34@5&0@*$YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,RXW
M-B R-S<N,34@5&0@*$%L;&EE9"!3=&%F9FEN9R!S=&%T:7-T:6-A;"!D871A
M.BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C P(#(V-2XP,2!49" H1E1%<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,R,RXW-2 R-C4N,#$@5&0@*#<L,34T*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDX+C<U(#(V
M-2XP,2!49" H-RPS.3<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-S$N-3 @,C8U+C Q(%1D("A<*#(T,RD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0X."XP," R-C4N,#$@
M5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,V+C(U(#(V-2XP,2!49" H7"@S+C,I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-3 N-3 @,C8U+C Q(%1D("A<*24I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP
M," R-3(N,C$@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XQ-R R
M-3(N,C$@5&0@*'9E<F%G92!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3(R+C@P(#(U,BXR,2!49" H06QL:65D(%-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C$N-S(@,C4R+C(Q(%1D("AF:6YG(')E=F5N=64@
M<&5R($9412!P97(@9&%Y*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C@V+C P(#(U,BXR,2!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,S,"XU," R-3(N,C$@5&0@
M*#(W-BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,V,"XP," R-3(N,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,#4N-3 @,C4R+C(Q(%1D("@R.#$I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,S0N,# @,C4R
M+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#@P+C4P(#(U,BXR,2!49" H7"@U*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#@X+C P(#(U,BXR,2!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N
M,C4@,C4R+C(Q(%1D("A<*#$N."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4U,"XU," R-3(N,C$@5&0@*%PI)2D@5&H@150@
M40I"5" O1C(@.2XP,"!49B!%5 HP(# @,"!21PHO1U,P(&=S"C N.#8@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HU,B R,C4N-S0V,S,W.#DP-C(U(&T*
M,3@R+C<U,#0X.#(X,3(U(#(R-2XW-#8S,S<X.3 V,C4@; IS"G$@," P(# @
M<F<@0E0@-3(N,# @,C(W+C$U(%1D("A0:'ES:6-I86X@4W1A9F9I;F<@<W1A
M=&ES=&EC86P@9&%T83HI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,BXP," R,34N,#$@5&0@*$1A>7,@9FEL;&5D*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S$Y+C(U(#(Q
M-2XP,2!49" H-3,L,#,Y*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDT+C(U(#(Q-2XP,2!49" H-C L,38Q*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8T+C<U(#(Q-2XP
M,2!49" H7"@W+#$R,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0X."XP," R,34N,#$@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C<U(#(Q-2XP,2!49" H
M7"@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,Y+C(U(#(Q-2XP,2!49" H
M,2XX*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-34P+C4P(#(Q-2XP,2!49" H7"DE*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N,# @,C S+C Q(%1D("A2979E;G5E('!E
M<B!D87D@9FEL;&5D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@V+C P(#(P,RXP,2!49" H)"D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,R,RXW-2 R,#,N,#$@5&0@*#$L
M-34R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S8P+C P(#(P,RXP,2!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,Y."XW-2 R,#,N,#$@5&0@*#$L-34V*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#,T+C P(#(P
M,RXP,2!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0X,"XU," R,#,N,#$@5&0@*%PH-"D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0X."XP," R,#,N,#$@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V
M+C(U(#(P,RXP,2!49" H7"@P+C,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-3 N-3 @,C S+C Q(%1D("A<*24I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A;0IE;F1O8FH*-C,@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R V-" P(%(^/@IE;F1O8FH*-C0@,"!O8FH*/#PO3&5N9W1H(#(P
M,S,X/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,P,2XP," S,2XV,"!49" H,C@I(%1J($54(%$*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3$N-3 @-S$R+C4P(#(S,"XP," M,3(N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C(X,2XU," W,3(N-3 @-C0N,# @+3$R+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#4N-3 @
M-S$R+C4P(#$P+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4U+C4P(#<Q,BXU," V-2XP," M
M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0R,"XU," W,3(N-3 @.2XP," M,3(N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R.2XU
M," W,3(N-3 @-C N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#DN-3 @-S$R+C4P(#$P+C P
M("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#DY+C4P(#<Q,BXU," V,"XP," M,3(N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q
M+C4P(#8X."XU," R,S N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.#$N-3 @-C@X+C4P(#8T
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S0U+C4P(#8X."XU," Q,"XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,U-2XU," V.#@N-3 @-C4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C N-3 @-C@X+C4P
M(#DN,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,CDN-3 @-C@X+C4P(#8P+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#@Y+C4P(#8X."XU," Q,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y.2XU," V.#@N
M-3 @-C N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHU,2XU," V-C(N-3 @,C,P+C P("TQ,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,C@Q+C4P(#8V,BXU," V-"XP," M,3(N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,T-2XU," V
M-C(N-3 @,3 N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-34N-3 @-C8R+C4P(#8U+C P("TQ
M,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#(P+C4P(#8V,BXU," Y+C P("TQ,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(Y+C4P
M(#8V,BXU," V,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X.2XU," V-C(N-3 @,3 N,# @
M+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.3DN-3 @-C8R+C4P(#8P+C P("TQ,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$N
M-3 @-C,X+C4P(#(S,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(X,2XU," V,S@N-3 @-C0N
M,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHS-#4N-3 @-C,X+C4P(#$P+C P("TQ,BXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S4U+C4P(#8S."XU," V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R,"XU," V,S@N-3 @
M.2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0R.2XU," V,S@N-3 @-C N,# @+3$R+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.#DN-3 @-C,X+C4P(#$P+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DY+C4P(#8S."XU
M," V,"XP," M,3(N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(X,2XU(#<S-BXU(&T*
M,S0U+C4@-S,V+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,T-2XU(#<S-BXU(&T*,S4U+C4@-S,V+C4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,U-2XU(#<S-BXU(&T*-#(P+C4@-S,V+C4@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(X,2XU
M(#<R-"XU(&T*,S0U+C4@-S(T+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U-2XU(#<R-"XU(&T*-#(P
M+C4@-S(T+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0R.2XU(#<R-"XU(&T*-#@Y+C4@-S(T+C4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0Y.2XU(#<R-"XU(&T*-34Y+C4@-S(T+C4@; IS"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S P+C8U(#<S.2XY,"!49" H62D@5&H@
M150@40IQ(# @," P(')G($)4(#,P-BXV-2 W,SDN.3 @5&0@*&5A<BD@5&H@
M150@40IQ(# @," P(')G($)4(#,Q."XU-B W,SDN.3 @5&0@*"!%;F1E9"!$
M96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#,X-BXX.2 W,SDN.3 @
M5&0@*" S,2PI(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,30N,S @-S,Y+CDP(%1D("A097(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,C<N-S$@-S,Y+CDP(%1D("AC96YT*2!4:B!%5"!1"D)4("]&,B Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S T+C P(#<R-RXY,"!49" H,C Q
M-RD@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W
M."XU," W,C<N.3 @5&0@*#(P,38I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-#0N,C @-S(W+CDP(%1D("A#:&%N9V4I(%1J
M($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,30N,C @
M-S(W+CDP(%1D("A#:&%N9V4I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*
M," P(# @4D<*+T=3,"!G<PHP+C@V('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*-30@-S R+C0Y-C,S-S@Y,#8R-2!M"C(Q,BXR-34X-3DS-S4@-S R+C0Y
M-C,S-S@Y,#8R-2!L"G,*<2 P(# @,"!R9R!"5" U-"XP," W,#,N.3 @5&0@
M*$YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-2XW-B W,#,N
M.3 @5&0@*$%L;&EE9"!3=&%F9FEN9R!S=&%T:7-T:6-A;"!D871A.BD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T+C P(#8Y
M,2XW-B!49" H1E1%<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,R,2XW-2 V.3$N-S8@5&0@*#<L,SDW*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDV+C<U(#8Y,2XW-B!4
M9" H-BPY-3,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-S(N-3 @-CDQ+C<V(%1D("@T-#0I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,S<N,C4@-CDQ+C<V(%1D("@V+C0I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3$N
M-3 @-CDQ+C<V(%1D("@E*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-30N,# @-C<X+CDV(%1D("A!*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-C N,3<@-C<X+CDV(%1D("AV97)A9V4@3G5R<V4@86YD("D@
M5&H@150@40IQ(# @," P(')G($)4(#$R-"XX," V-S@N.38@5&0@*$%L;&EE
M9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38S+C<R(#8W."XY-B!4
M9" H9FEN9R!R979E;G5E('!E<B!&5$4@<&5R(&1A>2D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(X-"XP," V-S@N.38@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,C@N-3 @-C<X+CDV(%1D("@R.#$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-3@N,# @-C<X+CDV(%1D("@D*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-# S+C4P(#8W."XY
M-B!49" H,C@T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#,R+C P(#8W."XY-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W."XU," V-S@N.38@5&0@*%PH,RD@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-BXP
M," V-S@N.38@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,T+C(U(#8W."XY-B!49" H7"@Q+C$I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-#@N-3 @-C<X+CDV
M(%1D("A<*24I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*," P(# @4D<*
M+T=3,"!G<PHP+C@V('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-30@-C4R
M+C0Y-C,S-S@Y,#8R-2!M"C$X-"XW-3 T.#@R.#$R-2 V-3(N-#DV,S,W.#DP
M-C(U(&P*<PIQ(# @," P(')G($)4(#4T+C P(#8U,RXY,"!49" H4&AY<VEC
M:6%N(%-T869F:6YG('-T871I<W1I8V%L(&1A=&$Z*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30N,# @-C0Q+C<V(%1D("A$
M87ES(&9I;&QE9"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Q-RXR-2 V-#$N-S8@5&0@*#8P+#$V,2D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,BXR-2 V-#$N-S8@5&0@
M*#8Q+#4X-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V,BXW-2 V-#$N-S8@5&0@*%PH,2PT,C,I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#8N,# @-C0Q+C<V(%1D("A<
M*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M-"XR-2 V-#$N-S8@5&0@*%PH,BXS*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-30X+C4P(#8T,2XW-B!49" H7"DE*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30N,# @-C(Y
M+C<V(%1D("A2979E;G5E('!E<B!D87D@9FEL;&5D*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C@T+C P(#8R.2XW-B!49" H
M)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,R
M,2XW-2 V,CDN-S8@5&0@*#$L-34V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S4X+C P(#8R.2XW-B!49" H)"D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y-BXW-2 V,CDN
M-S8@5&0@*#$L-3DV*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#,R+C P(#8R.2XW-B!49" H)"D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-"XP," V,CDN-S8@5&0@*%PH
M-# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#8N,# @-C(Y+C<V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S-"XR-2 V,CDN-S8@5&0@*%PH,BXU*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30X+C4P(#8R
M.2XW-B!49" H7"DE*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,#,N,# @5&0@
M*%-E92!D969I;FET:6]N(&]F($)U<VEN97-S($UE87-U<F5M96YT<R!U;F1E
M<B!T:&4@3W!E<F%T:6YG($UE=')I8W,@<V5C=&EO;B!O9B!O=7(@36%N86=E
M;65N="=S($1I<V-U<W-I;VX@86YD("D@5&H@150@40IQ(# @," P(')G($)4
M(#4Q-"XR," V,#,N,# @5&0@*$%N86QY<VES+BD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-SDN,# @5&0@*%-E
M9VUE;G0@0V]M<&%R:7-O;B M("D@5&H@150@40IQ(# @," P(')G($)4(#$T
M.2XY," U-SDN,# @5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-38N
M,#(@-3<Y+C P(%1D("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN
M-S$@-3<Y+C P(%1D("@@16YD960@1&5C96UB97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-#4N-C,@-3<Y+C P(%1D("B@,S$L(#(P,3@@8V]M<&%R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S$X+C(R(#4W.2XP,"!49" H960@=&\@
M=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#,U-RXP,2 U-SDN,# @5&0@
M*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C,N,3(@-3<Y+C P(%1D("AE
M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S8N.#(@-3<Y+C P(%1D("@@
M16YD960@1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3(N-S,@
M-3<Y+C P(%1D("B@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-34U+C P(%1D("A.=7)S92!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.34N,C @-34U+C P(%1D("A!;&QI
M960@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$S."XV,R U-34N,# @
M5&0@*&9I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-30S+C P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4S,2XP,"!49" H4F5V96YU
M92!F<F]M('1H92!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,38V+CDQ(#4S,2XP,"!49" H06QL:65D(%-T868I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,3 N,S,@-3,Q+C P(%1D("AF:6YG(&)U<VEN97-S('-E9VUE
M;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,P,2XQ-B U,S$N,# @5&0@*&1E8W)E87-E9"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-# N-3<@-3,Q+C P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T
M,RXP-R U,S$N,# @5&0@*"0S."XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDV+CDV(#4S,2XP,"!49" H
M+"!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#$R+C<Y(#4S,2XP,"!49" H-2XP)2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,S,N-C(@-3,Q+C P(%1D("@@=&\@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M-BXT," U,S$N,# @5&0@*"0W,C N,R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P-2XR.2 U,S$N,# @5&0@
M*"!F;W(@=&AE('EE87(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#4Q.2XP,"!49" H96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<V+C,X(#4Q.2XP
M,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,34T+CDV(#4Q.2XP,"!49" H+"!F<F]M
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q
M.#$N.3 @-3$Y+C P(%1D("@D-S4X+C,@;6EL;&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-# N-SD@-3$Y+C P(%1D
M("@@9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,3@N,C4@-3$Y+C P(%1D("A$96-E;6)E
M<J S,2P@,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S.38N.#0@-3$Y+C P(%1D("@N("D@5&H@150@40IQ(# @," P
M(')G($)4(#0P,2XV-B U,3DN,# @5&0@*%1H92!Y96%R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#,V+C<Q(#4Q.2XP,"!49" H+6]V97(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-3<N-C$@-3$Y+C P(%1D("@M>65A<B!D96-R96%S
M92!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4P-RXP,"!49" H<')I;6%R:6QY(&1U92!T;R!V;VQU;64@
M9&5C;&EN97,@86-R;W-S(&)O=&@@=')A=F5L(&YU<G-E(&%N9"!L;V-A;"!S
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,U+C Q(#4P-RXP,"!49" H
M9FEN9RP@<&%R=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDP+C Y
M(#4P-RXP,"!49" H9G-E="!B>2!T:&4@:6UP86-T(&]F('1H92!*=6QY(#(P
M,3<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0Y-2XP,"!49" H86-Q=6ES:71I;VX@;V8@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3 V+C8V(#0Y-2XP,"!49" H061V86YT86=E+B!%>&-L
M=61I;F<@=&AE(&EM<&%C="!O9B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C8X+C P(#0Y-2XP,"!49" H061V86YT86=E(&%C<75I<VET:6]N+"!R
M979E;G5E(&1E8VQI;F5D(#DN,R4N("D@5&H@150@40IQ(# @," P(')G($)4
M(#0U."XX-R T.34N,# @5&0@*%1H92!L;W=E<B!R979E;G5E(&EN("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M.#,N,# @5&0@*'1R879E;"!N=7)S92!A;F0@;&]C86P@<W1A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$U,BXU-2 T.#,N,# @5&0@*&9I;F<@=V%S('!A
M<G1L>2!O9BD@5&H@150@40IQ(# @," P(')G($)4(#(R,RXQ.2 T.#,N,# @
M5&0@*&9S970@8GD@:6YC<F5A<V5S(&EN('1R879E;"!A;&QI960@86YD(&5D
M=6-A=&EO;B!H96%L=&AC87)E('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-C@N,3<@-#@S+C P(%1D("AF:6YG+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-3DN,# @5&0@*$-O;G1R
M:6)U=&EO;B!I;F-O;64@9G)O;2!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C P+C(U(#0U.2XP,"!49" H06QL:65D(%-T868I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R-#,N-C@@-#4Y+C P(%1D("AF:6YG(&9O<B!T
M:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S,W+C(U(#0U.2XP,"!49" H1&5C96UB97*@,S$L(#(P
M,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$U+C@S(#0U.2XP,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#(P+C@S(#0U.2XP,"!49" H9&5C<F5A<V5D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V
M,"XR-" T-3DN,# @5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#8R+C<T(#0U.2XP,"!49" H)#<N,B!M:6QL:6]N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q
M,2XV-" T-3DN,# @5&0@*"!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(T+CDW(#0U.2XP,"!49" H.2XX)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#4N.# @
M-#4Y+C P(%1D("@L('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," T-#<N,# @5&0@*"0V-BXT(&UI;&QI;VXI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 S
M+C@Y(#0T-RXP,"!49" H(&9R;VT@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$R."XS,R T-#<N,# @5&0@*"0W,RXV(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3@R+C(R(#0T-RXP,"!49" H(&EN('EE87(@96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(T,2XP." T-#<N
M,# @5&0@*$1E8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,Q.2XV-R T-#<N,# @5&0@*"X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S(T+C$R(#0T-RXP,"!49" H07,@8:!P
M97)C96YT86=E(&]F('-E9VUE;G0@<F5V96YU92P@8V]N=')I8G5T:6]N(&EN
M8V]M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-#,U+C P(%1D("AM87(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" V-2XS-R T,S4N,# @5&0@*&=I;B!D96-R96%S960@=&\@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$S,BXX-" T,S4N
M,# @5&0@*#DN,B4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,34S+C8W(#0S-2XP,"!49" H(&9O<B!T:&4@>65A<B!E;F1E
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C,Q+C$S(#0S-2XP,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S Y+C<Q(#0S-2XP
M,"!49" H(&9R;VT@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,S-"XQ-2 T,S4N,# @5&0@*#DN-R4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4T+CDX(#0S-2XP,"!4
M9" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#,R+C0T(#0S-2XP,"!49" H1&5C96UB
M97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3$Q+C S(#0S-2XP,"!49" H+"!P<FEM87)I;'D@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0R
M,RXP,"!49" H9'5E('1O(&QO=V5R('1R879E;"!N=7)S92!V;VQU;65S+"!A
M;F0@=&\@82!L97-S97(@97AT96YT+"!L;W=E<B!T<F%V96P@;G5R<V4@8FEL
M;"!R871E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#$Q+C P(%1D("B@*2!4:B!%5"!1"D)4("]&-" Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Y.2XP,"!49" H3W!E<F%T
M:6YG($UE=')I8W,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S<U+C P(%1D("A4:&4@879E<F%G92!N=6UB97(@
M;V8@3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#$X."XR." S
M-S4N,# @5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C,Q+C<P(#,W-2XP,"!49" H9FEN9R!&5$5S(&]N(&-O;G1R86-T(&1U<FEN
M9R!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#$Q+C Y(#,W-2XP,"!49" H1&5C96UB97*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#@Y+C8W(#,W-2XP,"!49" H(&1E8W)E87-E9" S+C,E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-C,N
M,# @5&0@*&9R;VT@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$S,BXW-" S-C,N,# @5&0@*$1E
M8V5M8F5RH#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(Q,2XS,B S-C,N,# @5&0@*"X@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C$U+C<W(#,V,RXP,"!49" H02D@5&H@150@40IQ(# @
M," P(')G($)4(#(R,BXR-2 S-C,N,# @5&0@*'9E<F%G92!.=7)S92!A;F0@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDT+C$W(#,V,RXP,"!49" H06QL
M:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S<N-3D@,S8S+C P
M(%1D("AF:6YG(')E=F5N=64@<&5R($9412!P97(@9&%YH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3@N,3 @,S8S+C P
M(%1D("AD96-R96%S960I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DW+C4Q(#,V,RXP,"!49" H(&%P<')O>&EM871E;'D@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,U,2XP,"!49" H,2XX)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" W,"XX,R S-3$N,# @5&0@*"!I;B!T:&4@>65A
M<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,30T+C0Q(#,U,2XP,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C(R+CDY
M(#,U,2XP,"!49" H(&-O;7!A<F5D('1O('1H92!Y96%R(&5N9&5D("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S@N-3 @
M,S4Q+C P(%1D("A$96-E;6)E<J S,2P@,C Q-RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3<N,#@@,S4Q+C P(%1D("@L
M(')E9FQE8W1I;F<@;&]W97(@879E<F%G92!B:6QL(')A=&5S+" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S,Y
M+C P(%1D("AP<FEM87)I;'D@:6X@;W5R('1R879E;"!N=7)S92!O<&5R871I
M;VYS+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S,C<N,# @5&0@*" I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S$U+C P(%1D("A0:'ES:6-I86X@
M4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$P.2XU-2 S,34N,# @5&0@
M*&9I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,S S+C P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y,2XP,"!49" H4F5V96YU92!F
M<F]M(%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38V
M+C<T(#(Y,2XP,"!49" H9FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3@U+C,U(#(Y,2XP,"!49" H9&5C<F5A<V5D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R
M-"XW-B R.3$N,# @5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C(W+C(V(#(Y,2XP,"!49" H)#$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,S8N.#D@,CDQ+C P(%1D("@Q+C,@;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.# N
M-S@@,CDQ+C P(%1D("@L(&]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.38N-C$@,CDQ+C P(%1D("@Q,BXQ)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,C(N-#0@
M,CDQ+C P(%1D("@@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,S-2XR,B R.3$N,# @5&0@*"0X,BXS(&UI;&QI;VXI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@Y
M+C$Q(#(Y,2XP,"!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C4W(#(Y,2XP
M,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-30U+C$V(#(Y,2XP,"!49" H+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,C<Y+C P(%1D("AC;VUP87)E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3 R+C(P(#(W.2XP,"!49" H)#DS+C8@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q-38N,#D@,C<Y+C P(%1D("@@9F]R('1H92!Y96%R(&5N9&5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S,N
M-34@,C<Y+C P(%1D("A$96-E;6)E<J S,2P@,C Q-RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3(N,30@,C<Y+C P(%1D
M("@L('!R:6UA<FEL>2!D=64@=&\@82!D96-R96%S92!I;B!V;VQU;64@;V8@
M9&%Y<R!F:6QL960N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," R-34N,# @5&0@*$-O;G1R:6)U=&EO;B!I;F-O
M;64@9G)O;2!0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#(Q-"XX," R-34N,# @5&0@*&9I;F<@9F]R('1H92!Y96%R(&5N9&5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#@N
M,S<@,C4U+C P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.#8N.34@,C4U+C P(%1D
M("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S.3$N.34@,C4U+C P(%1D("AD96-R96%S960I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Q+C,W(#(U-2XP,"!49" H
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,S,N.#<@,C4U+C P(%1D("@D,"XU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@R+C<V(#(U-2XP,"!49" H
M(&]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.38N,#D@,C4U+C P(%1D("@Y+C4E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Q-BXY,B R-34N,# @5&0@*"!T;R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Y
M+C<P(#(U-2XP,"!49" H)#0N." I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,C0S+C P(%1D("AM:6QL:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C@Y
M(#(T,RXP,"!49" H(&-O;7!A<F5D('1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q,S,N-3D@,C0S+C P(%1D("@D-2XS
M(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3@R+C0Y(#(T,RXP,"!49" H(&EN('1H92!Y96%R(&5N9&5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-38N
M,#8@,C0S+C P(%1D("A$96-E;6)E<J S,2P@,C Q-RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S0N-C4@,C0S+C P(%1D
M("@N("D@5&H@150@40IQ(# @," P(')G($)4(#,S.2XQ," R-#,N,# @5&0@
M*$%S(&&@<&5R8V5N=&%G92!O9B!S96=M96YT(')E=F5N=64L(&-O;G1R:6)U
M=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,C,Q+C P(%1D("AI;F-O;64@=V%S("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y.2XY.2 R,S$N,# @5&0@
M*#4N."4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(P+C@R(#(S,2XP,"!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3DX+C(X
M(#(S,2XP,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<V+C@V(#(S,2XP,"!49" H
M(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,CDV+C,P(#(S,2XP,"!49" H-2XV)2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,3<N,3,@,C,Q+C P(%1D("@@9F]R
M('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.30N-3D@,C,Q+C P(%1D("A$96-E;6)E<J S,2P@
M,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-S,N,3<@,C,Q+C P(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4
M(#0W-RXY.2 R,S$N,# @5&0@*%1H92!M87(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,3$N-#$@,C,Q+C P(%1D("AG:6X@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q.2XP,"!49" H:6UP
M<F]V96UE;G0@=V%S('!R:6UA<FEL>2!D=64@=&\@;&]W97(@<V5L;&EN9RP@
M9V5N97)A;"!A;F0@861M:6YI<W1R871I=F4@8V]S=',L('!A<G1L>2!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#0Q-2XR." R,3DN,# @5&0@*&9S970@
M8GD@82!L;W=E<B!G<F]S<R!P<F]F:70@;6%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-30P+C8R(#(Q.2XP,"!49" H9VEN+BD@5&H@150@40I"5" O1C0@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q.34N,# @5&0@*$]P
M97)A=&EN9R!-971R:6-S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#$W,2XP,"!49" H4&AY<VEC:6%N(%-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#<N,S$@,3<Q+C P(%1D("AF:6YG
M(&1A>7,@9FEL;&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q-S N,S8@,3<Q+C P(%1D("AD96-R96%S960I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C Y+C<W(#$W
M,2XP,"!49" H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R,3(N,C<@,3<Q+C P(%1D("@Q*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C$V+CDP(#$W,2XP,"!49" H,2XX)2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S<N-S,@,3<Q+C P(%1D("@@
M=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(U,"XU,2 Q-S$N,# @5&0@*#4S+# S.2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-S@N,#$@,3<Q+C P(%1D("@@:6X@
M=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,U,2XU.2 Q-S$N,# @5&0@*$1E8V5M8F5RH#,Q+" R
M,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,"XQ-R Q-S$N,# @5&0@*"P@8V]M<&%R960@=&\@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-RXS-R Q-S$N,# @
M5&0@*#8P+#$V,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,30N.#<@,3<Q+C P(%1D("@@:6X@=&AE('EE87(@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U
M.2XP,"!49" H96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#<V+C,X(#$U.2XP,"!49" H1&5C96UB97*@,S$L(#(P
M,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,34T+CDV(#$U.2XP,"!49" H+B!2979E;G5E('!E<B!D87D@9FEL;&5D('=A
M<R D,2PU-3(@9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S8N,C<@,34Y+C P(%1D("A$
M96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-30N.#4@,34Y+C P(%1D("@@86YD("0Q+#4U-B!F
M;W(@=&AE('EE87(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#$T-RXP,"!49" H96YD960@1&5C96UB97(@,S$L
M(#(P,3<L(&1U92!T;R!A('-H:69T(&EN(&UI>"!B971W965N(&%D=F%N8V5D
M('!R86-T:6-E(&%N9"!P:'ES:6-I86X@<W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#0R-"XY-B Q-#<N,# @5&0@*&9I;F<N*2!4:B!%5"!1"D)4("]&
M,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$R,RXP,"!49" H
M3W1H97(@2'5M86X@0V%P:71A;"!-86YA9V5M96YT(%-E<G9I8V5S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#DY
M+C P(%1D("A2979E;G5E(&9R;VT@3TA#35,@9F]R('1H92!Y96%R(&5N9&5D
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,C(N-#4@.3DN,# @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP-" Y.2XP,"!4
M9" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S V+C T(#DY+C P(%1D("AI;F-R96%S960I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0S+C<Y(#DY+C P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T
M-BXR.2 Y.2XP,"!49" H)# N-R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y-2XQ." Y.2XP,"!49" H+"!O
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$Q+C Q(#DY+C P(%1D("@U+C0E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0S,2XX-" Y.2XP,"!49" H+"!T;R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C$R
M(#DY+C P(%1D("@D,3,N.2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P,2XP,2 Y.2XP,"!49" H(&9R;VT@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M-2XT-2 Y.2XP,"!49" H)#$S+C(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#@W+C P(%1D("AM:6QL:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C@Y
M(#@W+C P(%1D("@@:6X@=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U,BXT-R X-RXP,"!49" H
M1&5C96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C,Q+C U(#@W+C P(%1D("@L('!R:6UA<FEL>2!D
M=64@=&\@9W)O=W1H(&EN(&5X96-U=&EV92!S96%R8VAE<RP@<&%R=&EA;&QY
M(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8W+C<T(#@W+C P(%1D("AF
M<V5T(&)Y(&QO=V5R('!H>7-I8VEA;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S4N,# @5&0@*'-E87)C:&5S
M+BD@5&H@150@40IE;F1S=')E86T*96YD;V)J"C8U(# @;V)J"CP\+U1Y<&4@
M+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR
M+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@-C8@
M,"!2/CX*96YD;V)J"C8V(# @;V)J"CP\+TQE;F=T:" Q,#0S,#X^"G-T<F5A
M;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N
M-C @5&0@*#(Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<T,BXQ,"!49" H0V]N=')I8G5T:6]N(&EN8V]M92!F
M<F]M($](0TU3(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<P+C4Q(#<T,BXQ,"!49" H
M1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S0Y+C$P(#<T,BXQ,"!49" H+"!I;F-R96%S960@
M8GD@)#$N,"!M:6QL:6]N+"!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#<Q+C4W(#<T,BXQ,"!49" H,C8W+C4E*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P,BXT
M," W-#(N,3 @5&0@*"P@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4Q-RXV." W-#(N,3 @5&0@*"0P+C8@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<S
M,"XQ,"!49" H;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" W."XX.2 W,S N,3 @5&0@*"P@8V]M<&%R960@=&\@
M82!L;W-S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-S$N.3(@-S,P+C$P(%1D("@D,"XT(&UI;&QI;VXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C(P+C@R(#<S
M,"XQ,"!49" H(&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDX+C(X(#<S,"XQ,"!49" H
M1&5C96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S<V+C@V(#<S,"XQ,"!49" H+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.#$N-C@@-S,P+C$P(%1D("A4:&4@>65A<BD@5&H@
M150@40IQ(# @," P(')G($)4(#0Q-BXW,R W,S N,3 @5&0@*"UO=F5R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#,W+C8S(#<S,"XQ,"!49" H+7EE87(@
M:6UP<F]V96UE;G0@=V%S(&1U92!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$X+C$P(%1D("AL;W=E<B!S
M96QL:6YG+"!G96YE<F%L(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E<RP@
M<&%R=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDP+C4X(#<Q."XQ
M,"!49" H9G-E="!B>2!A(&QO=V5R(&=R;W-S('!R;V9I="!M87(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,34N.3(@-S$X+C$P(%1D("AG:6XN*2!4:B!%
M5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y
M-"XQ,"!49" H56YA;&QO8V%T960@8V]R<&]R871E(&]V97)H96%D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8W
M,"XQ,"!49" H26YC;'5D960@:6X@=6YA;&QO8V%T960@8V]R<&]R871E(&]V
M97)H96%D(&ES(&-O<G!O<F%T92!C;VUP96YS871I;VX@86YD(&)E;F5F:71S
M+"!A;F0@9V5N97)A;"!A;F0@861M:6YI<W1R871I=F4@97AP96YS97,@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8U."XQ,"!49" H:6YC;'5D:6YG(')E;G0@86YD('5T:6QI=&EE<RP@8V]M
M<'5T97(@<W5P<&QI97,@86YD(&5X<&5N<V5S+"!I;G-U<F%N8V4L('!R;V9E
M<W-I;VYA;"!E>'!E;G-E<RP@8V]R<&]R871E+7=I9&4@<')O:F5C=',@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8T-BXQ,"!49" H7"AI;FET:6%T:79E<UPI(&%N9"!P=6)L:6,@8V]M<&%N
M>2!E>'!E;G-E<RX@56YA;&QO8V%T960@8V]R<&]R871E(&]V97)H96%D(&EN
M8W)E87-E9"!T;R D-#0N-B!M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C,T+C$P(%1D("A$96-E;6)E<J S,2P@,C Q."P@9G)O;2 D,SDN,B!M
M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<J S,2P@,C Q-RP@
M<')I;6%R:6QY(&1U92!T;R!H:6=H97(@<')O9F5S<VEO;F%L('-E<G9I8V4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8R,BXQ,"!49" H9F5E<RP@<W5C:"!A<R!L96=A;"!A;F0@8V]N<W5L
M=&EN9RP@<&%R=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(R+C(W
M(#8R,BXQ,"!49" H9G-E="!B>2!T:&4@:6UP86-T(&]F(&-O<W0@<V%V:6YG
M<R!A;F0@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#(N-C @-C(R+C$P
M(%1D("AF:6-I96YC>2!I;FET:6%T:79E<RX@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#8Q+C$Y(#8R,BXQ,"!49" H07,@8:!P97)C96YT86=E(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,3 N,3 @5&0@*&-O;G-O;&ED871E9"!R979E;G5E+"!U;F%L;&]C871E
M9"!C;W)P;W)A=&4@;W9E<FAE860@=V%S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R.#4N-S,@-C$P+C$P(%1D("@U+C4E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P
M-BXU-B V,3 N,3 @5&0@*"!F;W(@=&AE('EE87(@96YD960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X-"XP,B V,3 N
M,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0V,BXV," V,3 N,3 @5&0@*"P@86YD
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#0N-30@-C$P+C$P(%1D("@T+C4E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P-2XS-R V,3 N,3 @5&0@*"!F;W(@=&AE
M('EE87(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4Y."XQ,"!49" H96YD960@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<V+C,X(#4Y."XQ,"!49" H1&5C
M96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,34T+CDV(#4Y."XQ,"!49" H+BD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-S0N,3 @5&0@
M*%-E9VUE;G0@0V]M<&%R:7-O;B M("D@5&H@150@40IQ(# @," P(')G($)4
M(#$T.2XY," U-S0N,3 @5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-38N,#(@-3<T+C$P(%1D("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-CDN-S$@-3<T+C$P(%1D("@@16YD960@1&5C96UB97(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-#4N-C,@-3<T+C$P(%1D("B@,S$L(#(P,3<@8V]M<&%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$X+C(R(#4W-"XQ,"!49" H960@
M=&\@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#,U-RXP,2 U-S0N,3 @
M5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C,N,3(@-3<T+C$P(%1D
M("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S8N.#(@-3<T+C$P(%1D
M("@@16YD960@1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3(N
M-S,@-3<T+C$P(%1D("B@,S$L(#(P,38I(%1J($54(%$*0E0@+T8S(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-34P+C$P(%1D("A.=7)S92 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" W-RXU," U-3 N,3 @5&0@*&%N9" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-2XR," U-3 N,3 @5&0@*$%L;&EE
M9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C(N,30@-34P+C$P(%1D("A3
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,X+C8S(#4U,"XQ,"!49" H
M9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,S@N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-3(V+C$P(%1D("A2979E;G5E(&9R
M;VT@=&AE($YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C8N
M.3$@-3(V+C$P(%1D("A!;&QI960@4W1A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(Q,"XS,R U,C8N,3 @5&0@*&9I;F<@8G5S:6YE<W,@<V5G;65N="!I
M;F-R96%S960@)#,V+C@@;6EL;&EO;BP@;W(@-2XQ)2!T;R D-S4X+C,@;6EL
M;&EO;B!F;W(@=&AE('EE87(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#4Q-"XQ,"!49" H96YD960@1&5C96UB
M97(@,S$L(#(P,3<L(&9R;VT@)#<R,2XU(&UI;&QI;VX@9F]R('1H92!Y96%R
M(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,#$N-C8@-3$T+C$P(%1D("A4:&4@>65A<BD@5&H@150@40IQ(# @
M," P(')G($)4(#0S-BXW,2 U,30N,3 @5&0@*"UO=F5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#4W+C8Q(#4Q-"XQ,"!49" H+7EE87(@:6YC<F5A<V4@
M=V%S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,#(N,3 @5&0@*&5N=&ER96QY(&1U92!T:&4@:6UP86-T(&]F
M('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN-# @-3 R+C$P(%1D
M("A!9'9A;G1A9V4@86-Q=6ES:71I;VXN($5X8VQU9&EN9R!T:&4@:6UP86-T
M(&]F('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S<N,3,@-3 R+C$P
M(%1D("A!9'9A;G1A9V4@86-Q=6ES:71I;VXL(')E=F5N=64@9&5C;&EN960@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0Y,"XQ,"!49" H,2XS)2P@<')I;6%R:6QY(&1U92!T;R!T:&4@:6UP
M86-T(&]F(&AI9VAE<B!A=F5R86=E(&)I;&P@<F%T97,@<&%R=&QY(')E;&%T
M960@=&\@<W!E8VEF:6,@<')O:F5C="!R979E;G5E(&EN('1H92!P<FEO<B!Y
M96%R(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#<X+C$P(%1D("AL;W=E<B!P<F5M:75M(')A=&4@8G5S
M:6YE<W,@:6X@,C Q-RP@<&%R=&EA;&QY(&]F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C0W+C P(#0W."XQ,"!49" H9G-E="!B>2!G<F]W=&@@:6X@;W5R
M(&5D=6-A=&EO;B!H96%L=&AC87)E('-T868I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,S(N-3@@-#<X+C$P(%1D("AF:6YG(&]P97)A=&EO;G,N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V
M-BXQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T-30N,3 @5&0@*$-O;G1R:6)U=&EO;B!I;F-O;64@
M9G)O;2!.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C P+C(U
M(#0U-"XQ,"!49" H06QL:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R-#,N-C@@-#4T+C$P(%1D("AF:6YG(&9O<B!T:&4@>65A<B!E;F1E9"!$
M96-E;6)E<B S,2P@,C Q-RP@:6YC<F5A<V5D("0Q+C8@;6EL;&EO;B!O<B R
M+C,E+"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#0R+C$P(%1D("@D-S,N-B!M:6QL:6]N(&9R;VT@)#<R
M+C @;6EL;&EO;B!I;B!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C0N,3(@-#0R+C$P(%1D("A!<R!A
M('!E<F-E;G1A9V4@;V8@<V5G;65N="!R979E;G5E+"!C;VYT<FEB=71I;VX@
M:6YC;VUE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," T,S N,3 @5&0@*&UA<BD@5&H@150@40IQ(# @," P(')G
M($)4(#8U+C,W(#0S,"XQ,"!49" H9VEN(&1E8W)E87-E9"!T;R Y+C<E(&9O
M<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-R!F<F]M(#$P+C E
M(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-BP@<')I;6%R
M:6QY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," T,3@N,3 @5&0@*&1U92!T;R!H:6=H97(@8V]M<&5N<V%T:6]N
M('!A8VMA9V5S(&9O<B!O=7(@9FEE;&0@<W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#(V-RXU,B T,3@N,3 @5&0@*&8@=&AA="!W97)E(&EN('!L86-E
M(&EN('1H92!E87)L>2!P87)T(&]F('1H92!Y96%R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#4T+C,X(#0Q."XQ,"!49" H+BD@5&H@150@40I"5" O1C0@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S.30N,3 @5&0@*$]P
M97)A=&EN9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,RXV,2 S.30N,3 @
M5&0@*$UE=')I8W,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S<P+C$P(%1D("A4:&4@879E<F%G92!N=6UB97(@
M;V8@3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#$X."XR." S
M-S N,3 @5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C,Q+C<P(#,W,"XQ,"!49" H9FEN9R!&5$5S(&]N(&-O;G1R86-T(&1U<FEN
M9R!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-R!I;F-R96%S960@
M-BXT)2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,S4X+C$P(%1D("AO=F5R('1H92!Y96%R(&5N9&5D($1E8V5M
M8F5R(#,Q+" R,#$V+"!I;B!P87)T(&1U92!T;R!T:&4@:6UP86-T(&]F('1H
M92!A8W%U:7-I=&EO;B!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.38N
M.#,@,S4X+C$P(%1D("A!9'9A;G1A9V4N("D@5&H@150@40IQ(# @," P(')G
M($)4(#0T-"XU.2 S-3@N,3 @5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-3$N,#<@,S4X+C$P(%1D("AV97)A9V4@3G5R<V4@86YD("D@5&H@150@
M40IQ(# @," P(')G($)4(#4R,BXY.2 S-3@N,3 @5&0@*$%L;&EE9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,S0V+C$P(%1D("A3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C4N.3,@
M,S0V+C$P(%1D("AF:6YG(')E=F5N=64@<&5R($9412!P97(@9&%Y(&1E8W)E
M87-E9"!A<'!R;WAI;6%T96QY(#$N,24@:6X@=&AE('EE87(@96YD960@1&5C
M96UB97(@,S$L(#(P,3<@8V]M<&%R960@=&\@=&AE('EE87(@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,S-"XQ
M,"!49" H96YD960@1&5C96UB97(@,S$L(#(P,38L('!R:6UA<FEL>2!D=64@
M=&\@;&5S<R!P<F5M:75M(')A=&4@8G5S:6YE<W,@:6X@,C Q-RXI(%1J($54
M(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S$P
M+C$P(%1D("A0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#$P.2XU-2 S,3 N,3 @5&0@*&9I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,CDX+C$P(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(X
M-BXQ,"!49" H4F5V96YU92!F<F]M(%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,38V+C<T(#(X-BXQ,"!49" H9FEN9R!D96-R96%S
M960@)#0N-R!M:6QL:6]N+"!O<B T+C@E('1O("0Y,RXV(&UI;&QI;VX@9F]R
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$W+" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C<T+C$P
M(%1D("AC;VUP87)E9"!T;R D.3@N,R!M:6QL:6]N(&9O<B!T:&4@>65A<B!E
M;F1E9"!$96-E;6)E<B S,2P@,C Q-BP@<')I;6%R:6QY(&1U92!T;R!A(&1E
M8W)E87-E(&EN('9O;'5M92!O9B!D87ES(&9I;&QE9"XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4P+C$P(%1D
M("A#;VYT<FEB=71I;VX@:6YC;VUE(&9R;VT@4&AY<VEC:6%N(%-T868I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,30N.# @,C4P+C$P(%1D("AF:6YG(&9O
M<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-RP@9&5C<F5A<V5D
M("0S+C @;6EL;&EO;B!O<B S-BXT)2!T;R D-2XS("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,S@N,3 @5&0@
M*&UI;&QI;VX@8V]M<&%R960@=&\@)#@N,R!M:6QL:6]N(&EN('1H92!Y96%R
M(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$V+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,SDN,3 @,C,X+C$P(%1D("A!<R!A('!E<F-E;G1A9V4@;V8@<V5G
M;65N="!R979E;G5E+"!C;VYT<FEB=71I;VX@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R-BXQ,"!49" H:6YC
M;VUE('=A<R U+C8E(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@
M,C Q-R!A;F0@."XT)2!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L
M(#(P,38N("D@5&H@150@40IQ(# @," P(')G($)4(#0W-RXY.2 R,C8N,3 @
M5&0@*%1H92!M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3$N-#$@,C(V
M+C$P(%1D("AG:6YS('=E<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(Q-"XQ,"!49" H;F5G871I=F5L>2!I
M;7!A8W1E9"!F<F]M(&-O;G1I;G5E9"!I;G9E<W1M96YT<R!I;B!T:&4@8G5S
M:6YE<W,N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#$Y,"XQ,"!49" H3W!E<F%T:6YG($UE=')I8W,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,38V
M+C$P(%1D("A0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#$P-RXS,2 Q-C8N,3 @5&0@*&9I;F<@9&%Y<R!F:6QL960@9&5C<F5A<V5D
M(#(N,R4@=&\@-C L,38Q(&EN('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q
M+" R,#$W+"!C;VUP87)E9"!T;R V,2PU.#0@:6X@=&AE('EE87(@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U
M-"XQ,"!49" H96YD960@1&5C96UB97(@,S$L(#(P,38L('!R:6UA<FEL>2!D
M=64@=&\@82!D96-L:6YE(&EN('!H>7-I8VEA;B!S<&5C:6%L=&EE<RP@<&%R
M=&QY(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDV+CDS(#$U-"XQ,"!4
M9" H9G-E="!B>2!A;B!I;F-R96%S92!I;B!A9'9A;F-E9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,30R+C$P
M(%1D("AP<F%C=&EC97,N(%!A<G0@;V8@=&AE('9O;'5M92!D96-L:6YE(&EN
M('!H>7-I8VEA;B!S<&5C:6%L=&EE<R!I<R!D=64@=&\@82!R961U8W1I;VX@
M:6X@;W)D97)S(&9R;VT@9V]V97)N;65N="!C=7-T;VUE<G,N("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S N
M,3 @5&0@*%)E=F5N=64@<&5R(&1A>2!F:6QL960@=V%S("0Q+#4U-B!A;F0@
M)#$L-3DV(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,3<@
M86YD(#(P,38L(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4
M(#0X-RXX,B Q,S N,3 @5&0@*"XI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,3 V+C$P(%1D("A/=&AE<B!(=6UA
M;B!#87!I=&%L($UA;F%G96UE;G0@4V5R=FEC97,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @.#(N,3 @5&0@*%)E
M=F5N=64@9G)O;2!/2$--4R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@
M,S$L(#(P,3<L(&1E8W)E87-E9" D,"XV(&UI;&QI;VXL(&]R(#0N,R4L('1O
M("0Q,RXR(&UI;&QI;VX@9G)O;2 D,3,N." I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S N,3 @5&0@*&UI;&QI
M;VX@:6X@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,38L('!R:6UA
M<FEL>2!D=64@=&\@82!D96-R96%S92!I;B!E>&5C=71I=F4@<V5A<F-H97,@
M86YD('!L86-E;65N=',L('!A<G1I86QL>2!O9BD@5&H@150@40IQ(# @," P
M(')G($)4(#4T-2XQ." W,"XQ,"!49" H9G-E=" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3@N,3 @5&0@*&)Y
M(&AI9VAE<B!P:'ES:6-I86X@<V5A<F-H97,N*2!4:B!%5"!1"F5N9'-T<F5A
M;0IE;F1O8FH*-C<@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R V." P(%(^/@IE;F1O8FH*-C@@,"!O
M8FH*/#PO3&5N9W1H(#$R,S,Y/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,S I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C$P
M(%1D("A#;VYT<FEB=71I;VX@;&]S<R!F<F]M($](0TU3(&9O<B!T:&4@>65A
M<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-RP@9&5C<F5A<V5D(&)Y("0P+C$@
M;6EL;&EO;BP@;W(@,S,N,R4L('1O("0P+C0@;6EL;&EO;BP@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<S,"XQ
M,"!49" H8V]M<&%R960@=&\@)# N-2!M:6QL:6]N(&9O<B!T:&4@>65A<B!E
M;F1E9"!$96-E;6)E<B S,2P@,C Q-BXI(%1J($54(%$*0E0@+T8S(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S V+C$P(%1D("A5;F%L;&]C
M871E9"!C;W)P;W)A=&4@;W9E<FAE860I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R+C$P(%1D("A5;F%L;&]C
M871E9"!C;W)P;W)A=&4@;W9E<FAE860@=V%S("0S.2XR(&UI;&QI;VX@9F]R
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$W+"!C;VUP87)E9"!T
M;R D,S@N-"!M:6QL:6]N(&9O<B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8W,"XQ,"!49" H>65A<B!E
M;F1E9"!$96-E;6)E<B S,2P@,C Q-BP@<')I;6%R:6QY(&1U92!T;R!A;B!I
M;F-R96%S92!I;B!C;VUP96YS871I;VX@86YD(&)E;F5F:71S+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,34N,34@-C<P+C$P(%1D("A!<R!A('!E<F-E
M;G1A9V4@;V8@8V]N<V]L:61A=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-3@N,3 @5&0@*')E=F5N=64L
M('5N86QL;V-A=&5D(&-O<G!O<F%T92!O=F5R:&5A9"!W87,@-"XU)2!F;W(@
M=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3<L(&%N9" T+C8E(&9O
M<B!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-C0V+C$P(%1D("A$96-E;6)E<B S,2P@
M,C Q-BXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"C @," P(%)'"B]'
M4S @9W,*,"XY-2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4P(#8R,"XU
M,S4P-3@U.3,W-2!M"C$Y,RXY-C0X-#,W-2 V,C N-3,U,#4X-3DS-S4@; IS
M"G$@," P(# @<F<@0E0@-3 N,# @-C(R+C$P(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-34N.3,@-C(R+C$P(%1D("AR86YS86-T:6]N<R!W:71H
M(%)E;&%T960@4&%R=&EE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V,3 N,3 @5&0@** I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3DX+C$P(%1D
M("A3964@3F]T92 Q-B M(%)E;&%T960@4&%R='D@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,38S+C8X(#4Y."XQ,"!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#$V.2XT,R U.3@N,3 @5&0@*')A;G-A8W1I;VYS('1O(&]U<B!C
M;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X-BXQ,"!4
M9" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*," P(# @4D<*+T=3
M,"!G<PHP+CDU('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-3 @-3<R+C4S
M-3 U.#4Y,S<U(&T*,3@X+C0U,C$T.#0S-S4@-3<R+C4S-3 U.#4Y,S<U(&P*
M<PIQ(# @," P(')G($)4(#4P+C P(#4W-"XQ,"!49" H3&EQ=6ED:71Y(&%N
M9"!#87!I=&%L(%)E<V]U<BD@5&H@150@40IQ(# @," P(')G($)4(#$W-2XV
M." U-S0N,3 @5&0@*&-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," U-C(N,3 @5&0@** I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-34P+C$P(%1D
M("A!=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-C(N-3 @-34P+C$P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#$N,#@@-34P
M+C$P(%1D("@L('=E(&AA9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3<W+C$X(#4U,"XQ,"!49" H)#$V+C @;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,S$N,#<@-34P+C$P(%1D("@@:6X@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<RP@86YD("0X,RXY(&UI;&QI;VX@;V8@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#,U+C@U(#4U,"XQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#0T,2XR-B U-3 N,3 @5&0@*&5R;2!,;V%N(&]U='-T86YD:6YG+"!A="!P
M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-34N.34@-34P+C$P(%1D("@N
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," U,S@N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV
M-" U,S@N,3 @5&0@*&]R:VEN9R!C87!I=&%L(&1E8W)E87-E9"!B>2 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<P+C@Q
M(#4S."XQ,"!49" H)#0N."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(Q.2XW," U,S@N,3 @5&0@*"!T;R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,R
M+C0X(#4S."XQ,"!49" H)#$P.2XU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDQ+C,W(#4S."XQ,"!49" H
M(&%S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,34N-3,@-3,X+C$P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.30N,3(@
M-3,X+C$P(%1D("@L(&-O;7!A<F5D('1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-3$N,S(@-3,X+C$P(%1D("@D,2D@
M5&H@150@40IQ(# @," P(')G($)4(#0V,"XY-2 U,S@N,3 @5&0@*#$T+C,@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,#DN.#0@-3,X+C$P(%1D("@@87,@;V8@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4R-BXQ,"!49" H
M1&5C96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3(X+C4X(#4R-BXQ,"!49" H+B!/=7(@;F5T(&1A
M>7,G('-A;&5S(&]U='-T86YD:6YG(%PH1%-/7"DL('=H:6-H(&5X8VQU9&5S
M(&%M;W5N=',@;W=E9"!T;R!S=6)C;VYT<F%C=&]R<RP@:6YC<F5A<V5D(#0@
M9&%Y<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-3$T+C$P(%1D("AT;R V,B!D87ES(&%S(&]F($1E8V5M8F5R
M(#,Q+" R,#$X+"!C;VUP87)E9"!T;R U."!D87ES(&%S(&]F($1E8V5M8F5R
M(#,Q+" R,#$W+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#DN-#4@-3$T
M+C$P(%1D("A4:&4@:6YC<F5A<V4@=V%S(&1U92!T;R!C;&EE;G1S)R!S;&]W
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," U,#(N,3 @5&0@*'!A>6EN9RP@<')E9&]M:6YA;G1L>2!A;6]N9R!A
M(&9E=R!L87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#<N-34@-3 R+C$P
M(%1D("AG92!C=7-T;VUE<G,@86YD+"!T;R!A(&QE<W-E<B!E>'1E;G0L(&-L
M:65N=',G('-E96MI;F<@97AT96YD960@<&%Y;65N="!T97)M<RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DP
M+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0W."XQ,"!49" H3W5R(&]P97)A=&EN9R!C87-H(&9L
M;W<@8V]N<W1I='5T97,@;W5R('!R:6UA<GD@<V]U<F-E(&]F(&QI<75I9&ET
M>2D@5&H@150@40IQ(# @," P(')G($)4(#,Q-RXS-" T-S@N,3 @5&0@*"P@
M86YD(&AI<W1O<FEC86QL>2D@5&H@150@40IQ(# @," P(')G($)4(#,X,RXV
M,B T-S@N,3 @5&0@*"P@:&%S(&)E96X@<W5F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#,W+C@W(#0W."XQ,"!49" H9FEC:65N="!T;R!F=6YD(&]U<B!W
M;W)K:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," T-C8N,3 @5&0@*&-A<&ET86PL(&-A<&ET86P@97AP96YD
M:71U<F5S+"!I;G1E<FYA;"!B=7-I;F5S<R!E>'!A;G-I;VXL(&%N9"!D96)T
M('-E<G9I8V4L(&EN8VQU9&EN9R!O=7(@8V]M;6ET;65N=',@87,@9&5S8W)I
M8F5D(&EN('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-#4T+C$P(%1D("A#;VUM:71M96YT<R!T86)L92!W
M:&EC:"!F;VQL;W=S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3(N.#8@
M-#4T+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C Q+C4P(#0U
M-"XQ,"!49" H92!E>'!E8W0@=&\@;65E="!O=7(@9G5T=7)E(&YE961S(&9O
M<B!W;W)K:6YG(&-A<&ET86PL(&-A<&ET86P@97AP96YD:71U<F5S+"!I;G1E
M<FYA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-#0R+C$P(%1D("AB=7-I;F5S<R!E>'!A;G-I;VXL(&%N9"!D
M96)T('-E<G9I8V4@9G)O;2!A(&-O;6)I;F%T:6]N(&]F(&-A<V@@;VX@:&%N
M9"P@;W!E<F%T:6YG(&-A<V@@9FQO=W,L(&%N9"!F=6YD<R!A=F%I;&%B;&4@
M=&AR;W5G:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#,P+C$P(%1D("AT:&4@<F5V;VQV:6YG(&QO86X@<&]R
M=&EO;B!O9B!O=7(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@R+C<U(#0S
M,"XQ,"!49" H06UE;F1E9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@150@
M40IQ(# @," P(')G($)4(#,P-"XY-2 T,S N,3 @5&0@*$%G<F5E;65N="X@
M4V5E(&1E8G0@9&ES8W5S<VEO;B!W:&EC:"!F;VQL;W=S+B!);B!T:&4@=&AI
M<F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#0Q."XQ,"!49" H<75A<G1E<B!O9B R,#$X+"!W92!L875N8VAE
M9"!A(&YE=R!I;FET:6%T:79E('1O(')E<&QA8V4@;W5R(&QE9V%C>2!S>7-T
M96T@<W5P<&]R=&EN9R!O=7(@=')A=F5L(&YU<G-E('-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-S0N-C@@-#$X+C$P(%1D("AF:6YG(&]P97)A=&EO
M;G,N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S.30N,3 @5&0@*$)A<V5D('5P;VX@8W5R<F5N="!P<F]J96-T
M:6]N<RP@=V4@=VEL;"!N;W0@<V%T:7-F>2!T:&4@<F5Q=6ER960@;&5V97)A
M9V4@<F%T:6\@=6YD97(@;W5R($-R961I=" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,S$N-34@,SDT+C$P(%1D("A!9W)E96UE;G0@87,@;V8@36%R8V@@
M,S$L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S.#(N,3 @5&0@*#(P,3DN("D@5&H@150@40IQ(# @," P(')G
M($)4(#<T+C0U(#,X,BXQ,"!49" H07,@82!R97-U;'0L(&$@9&5B="!P<F5P
M87EM96YT(&]F(&)E='=E96X@)#$P(&UI;&QI;VX@86YD("0Q,B!M:6QL:6]N
M('=O=6QD(&)E(')E<75I<F5D('1O(')E;6%I;B!I;B!C;VUP;&EA;F-E+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S8N.3(@,S@R+C$P(%1D("A7*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-30U+C4V(#,X,BXQ,"!49" H92 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,S<P+C$P(%1D("AB96QI979E('-U8V@@<')E<&%Y;65N="!W:6QL(&)E('-U
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,RXY-" S-S N,3 @5&0@*&9I
M8VEE;G0@=&\@;6%I;G1A:6X@8V]M<&QI86YC92!W:71H('1H92!L979E<F%G
M92!R871I;R!C;W9E;F%N="!A;F0@;65E="!O=7(@;V)L:6=A=&EO;G,@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#,U."XQ,"!49" H9F]R('1H92!N97AT('1W96QV92!M;VYT:',N($EN('1H
M92!E=F5N="!A8W1U86P@<F5S=6QT<R!D:68I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-S<N.#$@,S4X+C$P(%1D("AF97(@<VEG;FEF:6-A;G1L>2!F<F]M
M(&-U<G)E;G0@<')O:F5C=&EO;G,L('=E(&UA>2!B92!R97%U:7)E9"!T;R!M
M86ME("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S-#8N,3 @5&0@*&%D9&ET:6]N86P@9&5B="!P<F5P87EM96YT
M<RX@1G5R=&AE<BD@5&H@150@40IQ(# @," P(')G($)4(#$Y-RXS-" S-#8N
M,3 @5&0@*"P@=V4@;6%Y(&)E(&%B;&4@=&\@86UE;F0@;W5R($-R961I=" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#DN-3(@,S0V+C$P(%1D("A!9W)E
M96UE;G0L(&%N9"!A<R!A(')E<W5L="P@=V]U;&0@;F]T(&)E(')E<75I<F5D
M('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S,S0N,3 @5&0@*&UA:V4@86YY(&1E8G0@<')E<&%Y;65N=',N
M*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,Q,"XQ,"!49" H0V%S:"!&;&]W($-O;7!A<FES;VYS*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y."XQ
M,"!49" HH"D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," R.#8N,3 @5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U-"XV-" R.#8N,3 @5&0@*&5A<B!%;F1E9" I(%1J($54(%$*0E0@+T8T
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3@N-3(@,C@V+C$P(%1D("A$
M96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q-S<N,3$@,C@V+C$P(%1D("@@0V]M<&%R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C$R+C R(#(X-BXQ,"!49" H960@=&\@62D@
M5&H@150@40IQ(# @," P(')G($)4(#(S."XX." R.#8N,3 @5&0@*&5A<B!%
M;F1E9" I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C@R+C<V(#(X-BXQ,"!49" H1&5C96UB97*@,S$L(#(P,3<I(%1J($54
M(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8Q+C,U(#(X
M-BXQ,"!49" H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R-S0N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C8R+C$P(%1D("A.970@
M8V%S:"!P<F]V:61E9"!B>2!O<&5R871I;F<@86-T:79I=&EE<R!D=7)I;F<@
M=&AE('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,P-BXP,R R-C(N,3 @5&0@*$1E8V5M8F5RH#,Q+" R
M,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,X-"XV,2 R-C(N,3 @5&0@*"!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P-2XQ-B R-C(N,3 @5&0@*"0R,2XP
M(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#4Y+C U(#(V,BXQ,"!49" H(&-O;7!A<F5D('1O("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3,N-S4@,C8R
M+C$P(%1D("@D-#4N-2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C4P+C$P(%1D("AM:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C@Y(#(U,"XQ
M,"!49" H(&1U<FEN9R!T:&4@>65A<B!E;F1E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<P+C@P(#(U,"XQ,"!49" H
M1&5C96UB97*@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C0Y+C,X(#(U,"XQ,"!49" H+"!P<FEM87)I;'D@
M9'5E('1O(&QO=V5R(&-O;&QE8W1I;VYS(&%N9"!T:6UI;F<@;V8@<&%Y;65N
M=',N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," R,C8N,3 @5&0@*$YE="!C87-H('5S960@:6X@:6YV97-T:6YG
M(&%C=&EV:71I97,@9'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q
M+" R,#$X('=A<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S@T+C8R(#(R-BXQ,"!49" H)#8N-R!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,RXU,B R
M,C8N,3 @5&0@*"!C;VUP87)E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#@X+C(R(#(R-BXQ,"!49" H)#DQ+C0@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-#(N,3$@,C(V+C$P(%1D("@@:6X@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q-"XQ,"!49" H=&AE
M('EE87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Q,"XX," R,30N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$W
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X
M.2XS." R,30N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DT
M+C(P(#(Q-"XQ,"!49" H5&AE(&QO=V5R(&-A<V@@=7-E9"!I;B!T:&4@>65A
M<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q."!I<R!D=64@=&\@;&5S<R!C87-H
M('5S960@9F]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," R,#(N,3 @5&0@*&%C<75I<VET:6]N<RX@1'5R:6YG
M('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!W92!U<V5D("0Q
M+CD@;6EL;&EO;BP@;F5T(&]F(&-A<V@@86-Q=6ER960L(&9O<B!T:&4@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#@P+C0S(#(P,BXQ,"!49" H05 I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.3(N.#4@,C R+C$P(%1D("@@4W1A9BD@
M5&H@150@40IQ(# @," P(')G($)4(#4Q,2XR-R R,#(N,3 @5&0@*&9I;F<@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#$Y,"XQ,"!49" H86-Q=6ES:71I;VX@8V]M<&%R960@=&\@82!U<V4@
M;V8@)#@V+C @;6EL;&EO;B!T;R!A8W%U:7)E("D@5&H@150@40IQ(# @," P
M(')G($)4(#(X,"XR,B Q.3 N,3 @5&0@*$%D=F%N=&%G92!I;B!*=6QY(#(P
M,3<N(%-E92!.;W1E(#0@+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S(N
M,30@,3DP+C$P(%1D("A!8W%U:7-I=&EO;G,@=&\@;W5R(&-O;G-O;&ED871E
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3<X+C$P(%1D("AF:6YA;F-I86P@<W1A=&5M96YT<RX@26X@8F]T
M:"!Y96%R<RP@8V%S:"!U<V5D(&%L<V\@:6YC;'5D97,@8V%P:71A;"!E>'!E
M;F1I='5R97,@86YD(&%C<75I<VET:6]N+7)E;&%T960@<V5T=&QE;65N=',N
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," Q-C8N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,34T+C$P(%1D("A.970@8V%S:"!U<V5D
M(&EN(&9I;F%N8VEN9R!A8W1I=FET:65S(&1U<FEN9R!T:&4@>65A<B!E;F1E
M9"!$96-E;6)E<B S,2P@,C Q."!W87,@)#(S+C@@;6EL;&EO;BP@8V]M<&%R
M960@=&\@;F5T(&-A<V@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#$T,BXQ,"!49" H<')O=FED960@8GD@9FEN
M86YC:6YG(&%C=&EV:71I97,@;V8@)#4P+C@@;6EL;&EO;B!D=7)I;F<@=&AE
M('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3<N($1U<FEN9R!T:&4@>65A
M<B!E;F1E9"!$96-E;6)E<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,3,P+C$P(%1D("@S,2P@,C Q."P@=V4@
M<F5P86ED("0Q-BXQ(&UI;&QI;VX@;VX@;W5R("D@5&H@150@40IQ(# @," P
M(')G($)4(#(Q-BXQ.2 Q,S N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,C$N-C @,3,P+C$P(%1D("AE<FT@3&]A;BP@:6YC;'5D:6YG("0Q
M,"XP(&UI;&QI;VX@;V8@;W!T:6]N86P@<')E<&%Y;65N=',L(&%N9"!P86ED
M("0P+C,@;6EL;&EO;B!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,3$X+C$P(%1D("AD96)T(&ES<W5A;F-E
M(&-O<W1S(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@1FER<W0@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C0P+C4S(#$Q."XQ,"!49" H06UE;F1M96YT('1O
M(&]U<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3@N,#(@,3$X+C$P(%1D
M("A!;65N9&5D(&%N9"!297-T871E9"!#<F5D:70@1F%C:6QI='DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T-S N-C8@,3$X+C$P(%1D("@N("D@5&H@150@
M40IQ(# @," P(')G($)4(#0W-2XT." Q,3@N,3 @5&0@*%<I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T.#0N,3(@,3$X+C$P(%1D("AE(&%L<V\@<F5P=7)C
M:&%S960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#$P-BXQ,"!49" H86YD(')E=&ER960@<VAA<F5S(&]F(&]U
M<B!#;VUM;VX@4W1O8VL@9F]R("0U+C @;6EL;&EO;BP@86YD('5S960@8V%S
M:"!T;R!P87D@)# N.2!M:6QL:6]N(&9O<B!S:&%R97,@=VET:&AE;&0@9F]R
M('1A>&5S+" D,2XR("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," Y-"XQ,"!49" H;6EL;&EO;B!F;W(@;F]N8V]N
M=')O;&QI;F<@<VAA<F5H;VQD97(@<&%Y;65N=',L(&%N9" D,"XS(&UI;&QI
M;VX@;V8@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N+B!$=7)I;F<@=&AE('EE
M87(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#@R+C$P(%1D("A$96-E;6)E<B S,2P@,C Q-RP@:6X@
M=&AE(&9I<G-T('%U87)T97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#4N
M,3 @.#(N,3 @5&0@*"P@=V4@<&%I9"!O9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(U,BXQ,R X,BXQ,"!49" H9B!O=7(@0V]N=F5R=&EB;&4@3F]T97,@
M=VET:"!A('!A<G1I86P@8V%S:"!P87EM96YT(&]F("0U+C @;6EL;&EO;B!A
M;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<P+C$P(%1D("AE>'1I;F=U:7-H;65N="!F965S(&]F("0P+C8@
M;6EL;&EO;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DW+C,P(#<P+C$P
M(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C U+CDT(#<P+C$P(%1D
M("AE(&%L<V\@9G5N9&5D('1H92!A8W%U:7-I=&EO;B!O9B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,S,N,3,@-S N,3 @5&0@*$%D=F%N=&%G92!U<VEN
M9R!O=7(@4V5N:6]R($-R961I="!&86-I;&ET>2!A;F0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X+C$P(%1D
M("AS=6)S97%U96YT;'D@<F5F:6YA;F-E9"P@<F5S=6QT:6YG(&EN(&YE="!B
M;W)R;W=I;F=S(&]F("0V."XU(&UI;&QI;VX@;VX@=&AE(%-E;FEO<B!#<F5D
M:70@1F%C:6QI='D@7"@D-C(N,"!M:6QL:6]N(&EN("D@5&H@150@40IQ(# @
M," P(')G($)4(#4Q-2XX-B U."XQ,"!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#4R,2XR-R U."XQ,"!49" H97)M("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-BXQ,"!49" H3&]A
M;G,@86YD("0V+C4@;6EL;&EO;B!O;B!T:&4@4F5V;VQV:6YG($-R961I="!&
M86-I;&ET>2!W:&EC:"!W87,@<W5B<V5Q=65N=&QY(')E<&%I9%PI(&%N9"!D
M96)T(&ES<W5A;F-E(&-O<W1S(&]F("0P+CD@*2!4:B!%5"!1"F5N9'-T<F5A
M;0IE;F1O8FH*-CD@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R W," P(%(^/@IE;F1O8FH*-S @,"!O
M8FH*/#PO3&5N9W1H(#$P-C4S/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,S$I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C$P
M(%1D("AM:6QL:6]N+B!);B!A9&1I=&EO;BP@=V4@=7-E9"!C87-H('1O(')E
M<&%Y("0Q+C4@;6EL;&EO;B!O;B!O=7(@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S R+C(X(#<T,BXQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#,P-RXV.2 W-#(N,3 @5&0@*&5R;2!,;V%N+"!P87D@)#$N."!M:6QL:6]N
M(&9O<B!S:&%R97,@=VET:&AE;&0@9F]R('1A>&5S+" D,2XR("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,S N
M,3 @5&0@*&UI;&QI;VX@9F]R(&YO;F-O;G1R;VQL:6YG('-H87)E:&]L9&5R
M('!A>6UE;G1S+"!A;F0@)# N,R!M:6QL:6]N(&]F(&-O;G1I;F=E;G0@8V]N
M<VED97)A=&EO;BXI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-S V+C$P(%1D("A9*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-30N-C0@-S V+C$P(%1D("AE87(@16YD960@1&5C96UB97*@,S$L
M(#(P,3<@0V]M<&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$R+C R(#<P
M-BXQ,"!49" H960@=&\@62D@5&H@150@40IQ(# @," P(')G($)4(#(S."XX
M." W,#8N,3 @5&0@*&5A<B!%;F1E9"!$96-E;6)E<J S,2P@,C Q-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M.30N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-C@R+C$P(%1D("A.970@8V%S:"!P<F]V:61E9"!B
M>2!O<&5R871I;F<@86-T:79I=&EE<R!D=7)I;F<@=&AE('EE87(@96YD960@
M1&5C96UB97(@,S$L(#(P,3<@=V%S("0T-2XU(&UI;&QI;VX@8V]M<&%R960@
M=&\@)#,P+C$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8W,"XQ,"!49" H;6EL;&EO;B!D=7)I;F<@=&AE('EE
M87(@96YD960@1&5C96UB97(@,S$L(#(P,38L('!R:6UA<FEL>2!D=64@=&\@
M:&EG:&5R(&-O;&QE8W1I;VYS('!A<G1L>2!O9BD@5&H@150@40IQ(# @," P
M(')G($)4(#0R.2XQ-B V-S N,3 @5&0@*&9S970@8GD@=&AE('1I;6EN9R!O
M9B!P87EM96YT<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-C4X+C$P(%1D("AF;W(@=&AE('EE87(@96YD960@
M1&5C96UB97(@,S$L(#(P,3<N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#8S-"XQ,"!49" H26YV97-T:6YG(&%C
M=&EV:71I97,@=7-E9"!A(&YE="!O9B D.3$N-"!M:6QL:6]N(&EN('1H92!Y
M96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$W(&-O;7!A<F5D('1O("0Y+C@@
M;6EL;&EO;B!I;B!T:&4@>65A<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C(R+C$P(%1D("AE;F1E9"!$96-E
M;6)E<B S,2P@,C Q-BX@3F5T(&-A<V@@=7-E9"!I;B!T:&4@>65A<B!E;F1E
M9"!$96-E;6)E<B S,2P@,C Q-R!W87,@9F]R('1H92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,38N-30@-C(R+C$P(%1D("A!9'9A;G1A9V4@86-Q=6ES
M:71I;VX@86YD(&9O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C$P+C$P(%1D("AC87!I=&%L(&5X<&5N9&ET
M=7)E<RP@;V8@=VAI8V@@)#(N.2!M:6QL:6]N('=A<R!R96EM8G5R<V5D(&9R
M;VT@;W5R(&QA;F1L;W)D(&9O<B!T96YA;G0@:6UP<F]V96UE;G1S(&%N9"!I
M<R!R969L96-T960@:6X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#4Y."XQ,"!49" H;W!E<F%T:6YG(&%C=&EV
M:71I97,N($YE="!C87-H('5S960@:6X@:6YV97-T:6YG(&%C=&EV:71I97,@
M:6X@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,38@:6YC;'5D960@
M)#8N-2!M:6QL:6]N(&9O<B!C87!I=&%L("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.#8N,3 @5&0@*&5X<&5N
M9&ET=7)E<RP@)#$N.2!M:6QL:6]N(&9O<B!T:&4@86-Q=6ES:71I;VX@;V8@
M55-2+"!A;F0@)#$N.2!M:6QL:6]N(&]F(&]T:&5R(&%C<75I<VET:6]N+7)E
M;&%T960@<V5T=&QE;65N=',L('=H:6-H('=A<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C$P(%1D("AP
M87)T:6%L;'D@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,RXY-R U-S0N
M,3 @5&0@*&9S970@8GD@=&AE(')E8V5I<'0@;V8@)# N-2!M:6QL:6]N(')E
M;&%T960@=&\@<')O8V5E9',@9G)O;2!T:&4@<V%L92!O9B!#0T4N(%-E92!.
M;W1E(#,@+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#DN-S @-3<T+C$P
M(%1D("A!8W%U:7-I=&EO;G,@86YD($YO=&4@-" M("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-C(N,3 @5&0@
M*$1I<W!O<V%L('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E
M;65N=',N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4S."XQ,"!49" H3F5T(&-A<V@@<')O=FED960@8GD@9FEN
M86YC:6YG(&%C=&EV:71I97,@9'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M
M8F5R(#,Q+" R,#$W('=A<R D-3 N."!M:6QL:6]N+"!C;VUP87)E9"!T;R D
M,BXR("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,C8N,3 @5&0@*&UI;&QI;VX@;F5T(&-A<V@@=7-E9"!D=7)I
M;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,38N($1U<FEN9R!T
M:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-RP@:6X@=&AE(&9I<G-T
M('%U87)T97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-38N.3,@-3(V+C$P
M(%1D("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," U,30N,3 @5&0@*'=E('!A:60@;V8I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y,BXP,R U,30N,3 @5&0@*&8@;W5R($-O;G9E<G1I8FQE
M($YO=&5S('=I=&@@82!P87)T:6%L(&-A<V@@<&%Y;65N="!O9B D-2XP(&UI
M;&QI;VX@86YD(&5X=&EN9W5I<VAM96YT(&9E97,@;V8@)# N-B!M:6QL:6]N
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,C@N,34@-3$T+C$P(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,V+C<Y(#4Q-"XQ,"!49" H92!A
M;'-O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U,#(N,3 @5&0@*&9U;F1E9"!T:&4@86-Q=6ES:71I;VX@;V8@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34Q+C8U(#4P,BXQ,"!49" H061V
M86YT86=E('5S:6YG(&]U<B!396YI;W(@0W)E9&ET($9A8VEL:71Y(&%N9"!S
M=6)S97%U96YT;'D@<F5F:6YA;F-E9"P@<F5S=6QT:6YG(&EN(&YE="!B;W)R
M;W=I;F=S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," T.3 N,3 @5&0@*&]F("0V."XU(&UI;&QI;VX@;VX@=&AE
M(%-E;FEO<B!#<F5D:70@1F%C:6QI='D@7"@D-C(N,"!M:6QL:6]N(&EN("D@
M5&H@150@40IQ(# @," P(')G($)4(#,P,RXT,2 T.3 N,3 @5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,#@N.#(@-#DP+C$P(%1D("AE<FT@3&]A
M;G,@86YD("0V+C4@;6EL;&EO;B!O;B!T:&4@4F5V;VQV:6YG($-R961I="!&
M86-I;&ET>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#<X+C$P(%1D("AW:&EC:"!W87,@<W5B<V5Q=65N=&QY
M(')E<&%I9%PI(&%N9"!D96)T(&ES<W5A;F-E(&-O<W1S(&]F("0P+CD@;6EL
M;&EO;BX@26X@861D:71I;VXL('=E('5S960@8V%S:"!T;R!R97!A>2 D,2XU
M(&UI;&QI;VX@;VX@;W5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," T-C8N,3 @5&0@*%0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U-2XT,2 T-C8N,3 @5&0@*&5R;2!,;V%N+"!P87D@)#$N
M."!M:6QL:6]N(&9O<B!S:&%R97,@=VET:&AE;&0@9F]R('1A>&5S+" D,2XR
M(&UI;&QI;VX@9F]R(&YO;F-O;G1R;VQL:6YG('-H87)E:&]L9&5R('!A>6UE
M;G1S+"!A;F0@)# N,R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-#4T+C$P(%1D("AM:6QL:6]N(&]F(&-O;G1I
M;F=E;G0@8V]N<VED97)A=&EO;BX@1'5R:6YG('1H92!Y96%R(&5N9&5D($1E
M8V5M8F5R(#,Q+" R,#$V+"!W92!E;G1E<F5D(&EN=&\@=&AE(#(P,38@4V5N
M:6]R($-R961I="!&86-I;&ET>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-#0R+C$P(%1D("AW:&EC:"!P<F]V
M:61E9"!U<R!W:71H("0T,"XP(&UI;&QI;VX@;V8@8F]R<F]W:6YG<R!U;F1E
M<B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S Q+C<S(#0T,BXQ,"!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#,P-RXQ-" T-#(N,3 @5&0@
M*&5R;2!,;V%N($9A8VEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<X
M+C$T(#0T,BXQ,"!49" H+B!087)T(&]F('1H92!P<F]C965D<R!F<F]M('1H
M92!B;W)R;W=I;F=S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," T,S N,3 @5&0@*'=E<F4@=7-E9"!T;R!P<F5P
M87D@;W5R("0S,"XP(&UI;&QI;VX@4V5C;VYD($QI96X@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C4W+C4U(#0S,"XQ,"!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#(V,BXY-B T,S N,3 @5&0@*&5R;2!,;V%N(&EN8VQU9&EN
M9R!A('!R97!A>6UE;G0@<&5N86QT>2!O9B D,"XV(&UI;&QI;VX@86YD("0Q
M+C(@;6EL;&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-#$X+C$P(%1D("AO9B!D96)T(&ES<W5A;F-E(&-O
M<W1S+B!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,38L
M('=E(&%L<V\@<F5P86ED(&$@;F5T(&]F("0X+C @;6EL;&EO;B!O;B!O=7(@
M<V5N:6]R('-E8W5R960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#0P-BXQ,"!49" H87-S970M8F%S960@8W)E
M9&ET(&9A8VEL:71Y(&%N9" D,"XU(&UI;&QI;VX@;VX@;W5R('1E<FT@;&]A
M;B!F86-I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#,Q."XY.2 T,#8N
M,3 @5&0@*"P@86YD('5S960@8V%S:"!T;R!P87D@)# N.2!M:6QL:6]N(&9O
M<B!S:&%R97,@=VET:&AE;&0@9F]R("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S.30N,3 @5&0@*'1A>&5S+" D
M,"XW(&UI;&QI;VX@9F]R(&YO;F-O;G1R;VQL:6YG('-H87)E:&]L9&5R('!A
M>6UE;G1S+"!A;F0@)# N,B!M:6QL:6]N(&]F(&-O;G1I;F=E;G0@8V]N<VED
M97)A=&EO;BXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,S<P+C$P(%1D("A$96)T*2!4:B!%5"!1"D)4("]&-" Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U,"XQ,"!49" H0W(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" V,"XQ.2 S-3 N,3 @5&0@*&5D:70@
M1F%C:6QI=&EE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," S,C8N,3 @5&0@*$%S(&UO<F4@9G5L;'D@9&5S8W)I
M8F5D(&EN($YO=&4@." M($1E8G0@=&\@;W5R(&-O;G-O;&ED871E9"!F:6YA
M;F-I86P@<W1A=&5M96YT<RP@;W5R("D@5&H@150@40IQ(# @," P(')G($)4
M(#,Y-2XT-R S,C8N,3 @5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-R961I
M=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,S$T+C$P(%1D("A!9W)E96UE;G0L(&5N=&5R960@:6YT;R!O;B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C$N,S4@,S$T+C$P(%1D("A!=6=U
M<W0@,2P@,C Q-RP@<')O=FED97,@=7,@=VET:"!A("0R,34N,"!M:6QL:6]N
M(&-O;6UI='1E9"!F86-I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#0S
M-RXV,B S,30N,3 @5&0@*"P@:6YC;'5D:6YG(&$@=&5R;2!L;V%N(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S,#(N,3 @5&0@*"0Q,# N,"!M:6QL:6]N(%PH06UE;F1E9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-34N.3(@,S R+C$P(%1D("A4*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,38Q+C,S(#,P,BXQ,"!49" H97)M($QO86Y<*2!A
M;F0@82 D,2D@5&H@150@40IQ(# @," P(')G($)4(#(S.2XR-B S,#(N,3 @
M5&0@*#$U+C @;6EL;&EO;B!R979O;'9I;F<@8W)E9&ET(&9A8VEL:71Y(%PH
M06UE;F1E9"!2979O;'9I;F<@0W)E9&ET($9A8VEL:71Y7"D@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y,"XQ
M,"!49" H7"AT;V=E=&AE<B!W:71H('1H92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,C,N,#0@,CDP+C$P(%1D("A!;65N9&5D("D@5&H@150@40IQ(# @
M," P(')G($)4(#$V-"XR,R R.3 N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-CDN-C0@,CDP+C$P(%1D("AE<FT@3&]A;BP@=&AE("D@5&H@
M150@40IQ(# @," P(')G($)4(#(R-RXT," R.3 N,3 @5&0@*$%M96YD960@
M0W)E9&ET($9A8VEL:71I97-<*2X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S0P+C<Q(#(Y,"XQ,"!49" H07,@;V8@1&5C96UB97(@,S$L(#(P,3@L('1H
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C(N.3$@,CDP+C$P(%1D("A!
M<'!L:6-A8FQE($UA<BD@5&H@150@40IQ(# @," P(')G($)4(#4R-2XW-B R
M.3 N,3 @5&0@*&=I;BP@87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#(W."XQ,"!49" H9&5F:6YE9"!I;B!T
M:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 V+CDS(#(W."XQ,"!49" H
M06UE;F1E9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@150@40IQ(# @," P
M(')G($)4(#(R.2XQ,B R-S@N,3 @5&0@*$%G<F5E;65N="P@=V%S(#(N-3 E
M(&9O<B!%=7)O9&]L;&%R($QO86YS(&%N9"!,24)/4B!);F1E>"!2871E($QO
M86YS(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C8V+C$P(%1D("@Q+C4P)2!F;W(@0F%S92!2871E($QO
M86YS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C0N,30@,C8V+C$P(%1D
M("A!<R!O9B!$96-E;6)E<B S,2P@,C Q."P@=V4@:&%D("0X,RXY(&UI;&QI
M;VX@<')I;F-I<&%L(&)A;&%N8V4@;VX@=&AE("D@5&H@150@40IQ(# @," P
M(')G($)4(#0U-RXT," R-C8N,3 @5&0@*$%M96YD960@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#DX+C4Y(#(V-BXQ,"!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#4P-"XP," R-C8N,3 @5&0@*&5R;2!,;V%N(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,C4T+C$P(%1D("@D,C N-B!M:6QL:6]N(&EN(&QE='1E<G,@;V8@8W)E9&ET
M(&]U='-T86YD:6YG+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," R,S N,3 @5&0@*$]N($]C=&]B97(@,S L(#(P
M,3@L('=E(&5N=&5R960@:6YT;R!A;B!A;65N9&UE;G0@=&\@;W5R("D@5&H@
M150@40IQ(# @," P(')G($)4(#(Y,"XR,2 R,S N,3 @5&0@*$%M96YD960@
M86YD(%)E<W1A=&5D($-R961I=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M,3(N-#$@,C,P+C$P(%1D("A!9W)E96UE;G0@=&AA="!I;F-R96%S960@=&AE
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," R,3@N,3 @5&0@*&UA>&EM=6T@0V]N<V]L:61A=&5D("D@5&H@150@
M40IQ(# @," P(')G($)4(#$T."XQ-" R,3@N,3 @5&0@*%0I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-3,N-34@,C$X+C$P(%1D("AO=&%L($QE=F5R86=E
M(%)A=&EO(&-O=F5N86YT(&)Y(# N-3 Z,2XP,"!T:')O=6=H(%-E<'1E;6)E
M<B S,"P@,C Q.2P@86YD(&)Y(# N,C4Z,2XP,"!F;W(@=&AE("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,#8N
M,3 @5&0@*'!E<FEO9"!E;F1E9"!$96-E;6)E<B S,2P@,C Q.2P@;6]D:69I
M960@=&AE(&1E9FEN:71I;VX@;V8@0V]N<V]L:61A=&5D($5"251$02D@5&H@
M150@40IQ(# @," P(')G($)4(#,X-"XY,B R,#8N,3 @5&0@*"!T;R!A;&QO
M=R!F;W(@=&AE(&5X8VQU<VEO;B!O9B!C:&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3$Y+CDX(#(P-BXQ,"!49" H9V5S("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q.30N,3 @5&0@*')E
M;&%T960@=&\@86X@:6YI=&EA=&EV92!T;R!R97!L86-E(&]U<B!F<F]N="UE
M;F0@<WES=&5M('-U<'!O<G1I;F<@;W5R(&QE9V%C>2!T<F%V96P@;G5R<V4@
M;W!E<F%T:6]N<RP@86YD(&%L<V\@<')O=FED960@9F]R(&$@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$X,BXQ
M,"!49" H;&5S<R!R97-T<FEC=&EV92!P<F\@9F]R;6$@0V]N<V]L:61A=&5D
M("D@5&H@150@40IQ(# @," P(')G($)4(#(P-RXR." Q.#(N,3 @5&0@*%0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3(N-CD@,3@R+C$P(%1D("AO=&%L
M($QE=F5R86=E(%)A=&EO('1H<F5S:&]L9"!F;W(@<F5S=')I8W1E9"!P87EM
M96YT<RXI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,34X+C$P(%1D("A#;VYV97)T:6)L92!.;W1E<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S<N
M,3 @5&0@*$]N($UA<F-H(#$W+" R,#$W+"!W92!P86ED(&EN(&9U;&P@;W5R
M(&9I>&5D(')A=&4@."4@0V]N=F5R=&EB;&4@3F]T97,N("D@5&H@150@40IQ
M(# @," P(')G($)4(#,T,RXY,B Q,S<N,3 @5&0@*%1H92!#;VYV97)T:6)L
M92!.;W1E<R!H860@86X@86=G<F5G871E('!R:6YC:7!A;" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3(U+C$P
M(%1D("AA;6]U;G0@;V8@)#(U+C @;6EL;&EO;BP@86YD('=E<F4@8V]N=F5R
M=&EB;&4@:6YT;R!S:&%R97,@;V8@;W5R($-O;6UO;B!3=&]C:RP@870@82!C
M;VYV97)S:6]N('!R:6-E(&]F("0W+C$P('!E<B!S:&%R92X@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-30P+C0T(#$R-2XQ,"!49" H07,@82 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3$S
M+C$P(%1D("AR97-U;'0@;V8@=&AE(&5A<FQY(')E<&%Y;65N="P@=V4@<F5C
M;V=N:7IE9" D-2XP(&UI;&QI;VX@87,@;&]S<R!O;B!E87)L>2!E>'1I;F=U
M:7-H;65N="!O9B!D96)T+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," X.2XQ,"!49" H070@:6YC97!T:6]N(&]F
M('1H92!N;W1E<RP@86YD(&%T('1H92!T:6UE(&]F('1H92!P87EO9BD@5&H@
M150@40IQ(# @," P(')G($)4(#(V,RXV-2 X.2XQ,"!49" H9BP@=&AE(&-O
M;G9E<G-I;VX@<')I8V4@;V8@)#<N,3 @=V%S(&)E;&]W('1H92!M87)K970@
M<')I8V4N("D@5&H@150@40IQ(# @," P(')G($)4(#4P-BXQ-B X.2XQ,"!4
M9" H5&AE(&EN:71I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#<W+C$P(%1D("AA9W)E96UE;G0@86QL;W=E
M9"!U<R!T;R!F;W)C92!C;VYV97)S:6]N(&]F('1H92!.;W1E<R!O;FQY(&%F
M=&5R('1H<F5E('EE87)S+"!B96=I;FYI;F<@2G5L>2 Q+" R,#$W+"!A;F0@
M:68@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#0Y-RXQ." W-RXQ,"!4
M9" H5E<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3(N-S,@-S<N,3 @5&0@
M*$%0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(U+C$U(#<W+C$P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8U+C$P(%1D("AE>&-E961E9" Q,C4E(&]F('1H92!#;VYV97)S:6]N
M(%!R:6-E(&9O<B R,"!D87ES(&]F(&$@,S @9&%Y('1R861I;F<@<&5R:6]D
M(%PH=&AE('1H<F5S:&]L9"!W87,@)#@N.#@L('=H:6-H('=E('=E<F4@=V5L
M;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-3,N,3 @5&0@*&%B;W9E7"DN("D@5&H@150@40IQ(# @," P(')G
M($)4(#@Q+C8V(#4S+C$P(%1D("A!<R!S=6-H+"!W92!A;F0@=&AE($YO=&5H
M;VQD97)S(&%G<F5E9"!T;R!A;B!E87)L>2!S971T;&5M96YT(&%T(&9A:7(@
M=F%L=64@8F%S960@;VX@=&AE('-T;V-K('!R:6-E+B!);B!C;VYN96-T:6]N
M('=I=&@@*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*-S$@,"!O8FH*/#PO
M5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP
M," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT
M<R W,B P(%(^/@IE;F1O8FH*-S(@,"!O8FH*/#PO3&5N9W1H(#$X.3<V/CX*
M<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP
M," S,2XV,"!49" H,S(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-S0R+C$P(%1D("AT:&4@<F5P87EM96YT+"!W
M92!I<W-U960@=&\@=&AE($YO=&5H;VQD97)S(&%N(&%G9W)E9V%T92!O9B S
M+#$W-2PU.#0@<VAA<F5S(&]F($-O;6UO;B!3=&]C:R!A;F0@8V%S:"!I;B!T
M:&4@86=G<F5G871E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," W,S N,3 @5&0@*&%M;W5N="!O9B D-2XV(&UI
M;&QI;VXN*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#<P-BXQ,"!49" H4V5E($YO=&4@." M($1E8G0@=&\@;W5R
M(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<RXI(%1J($54(%$*
M0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R+C$P
M(%1D("A3=&]C:VAO;&1E<G,G($5Q=6ET>2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-S N,3 @5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C4X+C$P(%1D("A3964@3F]T92 Q-" M(%-T;V-K:&]L9&5R<R<@17%U:71Y
M('1O(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8T-BXQ,"!49" HH"D@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," V,S0N,3 @5&0@*$-O;6UI=&UE;G1S(&%N9"!/
M9BD@5&H@150@40IQ(# @," P(')G($)4(#$S."XQ-B V,S0N,3 @5&0@*&8M
M0F%L86YC92!3:&5E=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#8N,3(@
M-C,T+C$P(%1D("A!<G)A;F=E;65N=',I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C(R+C$P(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Q
M,"XQ,"!49" H07,@;V8@1&5C96UB97(@,S$L(#(P,3@L('=E(&1O(&YO="!H
M879E(&%N>2!O9BD@5&H@150@40IQ(# @," P(')G($)4(#(T-BXT,R V,3 N
M,3 @5&0@*&8M8F%L86YC92!S:&5E="!A<G)A;F=E;65N=',N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Y."XQ
M,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," U.#8N,3 @5&0@*%1H92!F;VQL;W=I;F<@=&%B;&4@<F5F
M;&5C=',@;W5R(&-O;G1R86-T=6%L(&]B;&EG871I;VYS(&%N9"!O=&AE<B!C
M;VUM:71M96YT<R!A<R!O9B!$96-E;6)E<J S,2P@,C Q.#H@*2!4:B!%5"!1
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4S
M."XV," Q-C4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,34N-3 @-3,X+C8P(#0N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHR,3DN-3 @-3,X+C8P(#0U+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C8T+C4P
M(#4S."XV," T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C8X+C4P(#4S."XV," T-2XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,Q,RXU," U,S@N-C @-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q-RXU
M," U,S@N-C @-#4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-C(N-3 @-3,X+C8P(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-C8N-3 @-3,X+C8P(#0T+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$P
M+C4P(#4S."XV," T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$T+C4P(#4S."XV," T-2XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0U.2XU," U,S@N-C @-"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0V
M,RXU," U,S@N-C @-#,N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#8N-3 @-3,X+C8P(#0N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,3 N-3 @-3,X+C8P(#4R+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 N-3 @-3$P+C8P(#$V-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Q-2XU," U,3 N-C @
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C(Q.2XU," U,3 N-C @-#4N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHR-C0N-3 @-3$P+C8P(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-C@N-3 @-3$P+C8P
M(#0U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S$S+C4P(#4Q,"XV," T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S$W+C4P(#4Q,"XV," T-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,V,BXU," U,3 N
M-C @-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,V-BXU," U,3 N-C @-#0N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,3 N-3 @-3$P+C8P(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,30N-3 @-3$P
M+C8P(#0U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#4Y+C4P(#4Q,"XV," T+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#8S+C4P(#4Q,"XV," T,RXP," M,30N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P-BXU," U
M,3 N-C @-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,"XU," U,3 N-C @-3(N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,"XU," T.#(N-C @,38U+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$U+C4P
M(#0X,BXV," T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$Y+C4P(#0X,BXV," T-2XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C(V-"XU," T.#(N-C @-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(V."XU
M," T.#(N-C @-#4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3,N-3 @-#@R+C8P(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,3<N-3 @-#@R+C8P(#0U+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8R
M+C4P(#0X,BXV," T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8V+C4P(#0X,BXV," T-"XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Q,"XU," T.#(N-C @-"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q
M-"XU," T.#(N-C @-#4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3DN-3 @-#@R+C8P(#0N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT-C,N-3 @-#@R+C8P(#0S+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 V+C4P(#0X,BXV," T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$P+C4P(#0X,BXV," U
M,BXP," M,30N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*,"XU
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P+C4@-34R+C8@;0HR,34N
M-2 U-3(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,C$Y+C4@-34R+C8@;0HR-C0N-2 U-3(N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,C8X+C4@-34R+C8@;0HS,3,N-2 U-3(N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$W+C4@-34R
M+C8@;0HS-C(N-2 U-3(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S8V+C4@-34R+C8@;0HT,3 N-2 U
M-3(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#$T+C4@-34R+C8@;0HT-3DN-2 U-3(N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#8S+C4@-34R+C8@;0HU,#8N-2 U-3(N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$P+C4@-34R+C8@
M;0HU-C(N-2 U-3(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,C$U+C4@-#@R+C8@;0HR,3DN-2 T.#(N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,C$U+C4@-#8Y+C8@;0HR,3DN-2 T-CDN-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$U
M+C4@-#8W+C8@;0HR,3DN-2 T-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$Y+C4@-#@R+C8@;0HR
M-C0N-2 T.#(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,C$Y+C4@-#8Y+C8@;0HR-C0N-2 T-CDN-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,C$Y+C4@-#8W+C8@;0HR-C0N-2 T-C<N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C8X+C4@
M-#@R+C8@;0HS,3,N-2 T.#(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C8X+C4@-#8Y+C8@;0HS,3,N
M-2 T-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,C8X+C4@-#8W+C8@;0HS,3,N-2 T-C<N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,S$W+C4@-#@R+C8@;0HS-C(N-2 T.#(N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$W+C4@-#8Y
M+C8@;0HS-C(N-2 T-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$W+C4@-#8W+C8@;0HS-C(N-2 T
M-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S8V+C4@-#@R+C8@;0HT,3 N-2 T.#(N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S8V+C4@-#8Y+C8@;0HT,3 N-2 T-CDN-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S8V+C4@-#8W+C8@
M;0HT,3 N-2 T-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#$T+C4@-#@R+C8@;0HT-3DN-2 T.#(N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#$T+C4@-#8Y+C8@;0HT-3DN-2 T-CDN-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$T
M+C4@-#8W+C8@;0HT-3DN-2 T-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#8S+C4@-#@R+C8@;0HU
M,#8N-2 T.#(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#8S+C4@-#8Y+C8@;0HU,#8N-2 T-CDN-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#8S+C4@-#8W+C8@;0HU,#8N-2 T-C<N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$P+C4@
M-#@R+C8@;0HU-C(N-2 T.#(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$P+C4@-#8Y+C8@;0HU-C(N
M-2 T-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-3$P+C4@-#8W+C8@;0HU-C(N-2 T-C<N-B!L"G,*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 P+C<P(#4U-RXR
M."!49" H0V]M;6ET;65N=',I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C,P+C4U(#4U-RXR."!49" H5"D@5&H@150@40IQ
M(# @," P(')G($)4(#(S-BXW-B U-3<N,C@@5&0@*&]T86PI(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@P+C4P(#4U-RXR
M."!49" H,C Q.2D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,CDN-3 @-34W+C(X(%1D("@R,#(P*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W."XP," U-3<N,C@@5&0@
M*#(P,C$I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#(V+C4P(#4U-RXR."!49" H,C R,BD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-S0N-3 @-34W+C(X(%1D("@R,#(S
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q
M,RXQ," U-3<N,C@@5&0@*%1H97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M,S0N,3(@-34W+C(X(%1D("AE869T97(I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-30S+C$W(%1D("B@*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q-2XT-2 U
M-#,N,C@@5&0@*%PH56YA=61I=&5D+"!A;6]U;G1S(&EN('1H;W5S86YD<UPI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#4R.2XQ-R!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#4X+C<V
M(#4R.2XQ-R!49" H97)M($QO86X@7"AA7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C(R+C P(#4R.2XQ-R!49" H)"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S,N
M,3 @-3(Y+C$W(%1D("@X,RPX-S8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C<Q+C P(#4R.2XQ-R!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.#<N,34@-3(Y
M+C$W(%1D("@U+#(S-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,C N,# @-3(Y+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S-BXQ-2 U,CDN,3<@5&0@
M*#4L-C<Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V.2XP," U,CDN,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S@T+C$U(#4R.2XQ-R!49" H-BPY.# I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$W
M+C P(#4R.2XQ-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,C@N,3 @-3(Y+C$W(%1D("@V-2PY.3 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C P(#4R
M.2XQ-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.3(N-C4@-3(Y+C$W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q,RXP," U,CDN,3<@5&0@*"0I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30X
M+C8U(#4R.2XQ-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," U,34N,3<@5&0@*$EN=&5R97-T(&]N(&1E
M8G0@7"AB7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C,S+C$P(#4Q-2XQ-R!49" H,3<L-S(R*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X-RXQ-2 U,34N,3<@5&0@
M*#4L,S,Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,S-BXQ-2 U,34N,3<@5&0@*#4L,#<S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X-"XQ-2 U,34N,3<@5&0@*#0L
M-S(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,RXQ-2 U,34N,3<@5&0@*#(L-3@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y,BXV-2 U,34N,3<@5&0@*)<I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30X+C8U
M(#4Q-2XQ-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,RXP," U,#$N,3<@5&0@*$-O;G1I;F=E;G0@8V]N<VED
M97)A=&EO;B!<*&-<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" R,S@N,34@-3 Q+C$W(%1D("@X+#@Q*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C4U+C8U(#4P,2XQ-R!49" H,2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.30N-C4@-3 Q+C$W(%1D
M("@R.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S,V+C$U(#4P,2XQ-R!49" H."PU,S$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,SDV+C8U(#4P,2XQ-R!49" HERD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#4N
M-C4@-3 Q+C$W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y,BXV-2 U,#$N,3<@5&0@*)<I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30X+C8U(#4P,2XQ-R!4
M9" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," T.#<N,3<@5&0@*$]P97)A=&EN9R!L96%S92!O8FQI9V%T:6]N
M<R!<*&1<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,S,N,3 @-#@W+C$W(%1D("@S-"PU.34I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@W+C$U(#0X-RXQ-R!49" H
M-RPT-3$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S,V+C$U(#0X-RXQ-R!49" H-BPR.#<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S@T+C$U(#0X-RXQ-R!49" H-2PT
M,#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#,S+C$U(#0X-RXQ-R!49" H-"PX-3<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#@P+C$P(#0X-RXQ-R!49" H-"PW,# I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V
M+C$U(#0X-RXQ-R!49" H-2PX.3,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @-#<S+C$W(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R,BXP," T-S,N
M,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C(X+C$P(#0W,RXQ-R!49" H,30U+# P-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-S$N,# @-#<S+C$W(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(X,BXQ," T-S,N,3<@5&0@*#$X+#,P-2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,C N,# @-#<S+C$W(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S,2XQ
M," T-S,N,3<@5&0@*#(U+#4V,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-CDN,# @-#<S+C$W(%1D("@D*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W.2XQ," T-S,N
M,3<@5&0@*#$W+#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.38N-C @-#<S
M+C$W(%1D("@Q,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,3<N,# @-#<S+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R."XQ," T-S,N,3<@5&0@*#<S
M+#0S,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-C8N,# @-#<S+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0X,"XQ," T-S,N,3<@5&0@*#0L-S P*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q,RXP
M," T-S,N,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,V+C$U(#0W,RXQ-R!49" H-2PX.3,I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0U-RXQ,"!49" H7U]?7U]?7U]?7U]?7U]?*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T
M-2XQ,"!49" H7"AA7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#8X+C P(#0T-2XQ,"!49" H56YD97(@;W5R("D@5&H@
M150@40IQ(# @," P(')G($)4(#$Q,"XW-R T-#4N,3 @5&0@*$%M96YD960@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34Q+CDV(#0T-2XQ,"!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#$U-RXS." T-#4N,3 @5&0@*&5R;2!,
M;V%N+"!W92!A<F4@<F5Q=6ER960@=&\@8V]M<&QY('=I=&@@8V5R=&%I;B!F
M:6YA;F-I86P@8V]V96YA;G1S+B!/=7(@:6YA8FEL:71Y('1O(&-O;7!L>2!W
M:71H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" V."XP," T,S,N,3 @5&0@*'1H92!R97%U:7)E9"!C;W9E;F%N=',@;W(@
M;W1H97(@<')O=FES:6]N<R!C;W5L9"!R97-U;'0@:6X@9&5F875L="!U;F1E
M<B!O=7(@86UE;F1E9"!C<F5D:70@9F%C:6QI=&EE<RX@26X@=&AE(&5V96YT
M(&]F(&%N>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-C@N,# @-#(Q+C$P(%1D("AS=6-H(&1E9F%U;'0@86YD(&]U<B!I
M;F%B:6QI='D@=&\@;V)T86EN(&$@=V%I=F5R(&]F('1H92!D969A=6QT+"!A
M;&P@86UO=6YT<R!O=71S=&%N9&EN9R!U;F1E<B!T:&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#4W+CDP(#0R,2XQ,"!49" H06UE;F1E9"!#<F5D:70@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8X
M+C P(#0P.2XQ,"!49" H1F%C:6QI=&EE<R!C;W5L9"!B92!D96-L87)E9"!I
M;6UE9&EA=&5L>2!D=64@86YD('!A>6%B;&4N("D@5&H@150@40IQ(# @," P
M(')G($)4(#,P,BXP." T,#DN,3 @5&0@*$%S(&]F("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,C8N-3,@-# Y+C$P(%1D
M("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,#4N,3$@-# Y+C$P(%1D("@L('=E(&%R92!I
M;B!C;VUP;&EA;F-E('=I=&@@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" V."XP," S.3<N,3 @5&0@*&9I;F%N8VEA
M;"!C;W9E;F%N=',@86YD(&]T:&5R(&-O=F5N86YT<R!C;VYT86EN960@:6X@
M=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(Y-BXR-2 S.3<N,3 @5&0@
M*$%M96YD960@86YD(%)E<W1A=&5D($-R961I=" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,3@N-#0@,SDW+C$P(%1D("A!9W)E96UE;G0N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,X-2XQ
M,"!49" H7"AB7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#8X+C P(#,X-2XQ,"!49" H26YT97)E<W0@;VX@9&5B="!R
M97!R97-E;G1S('!A>6UE;G1S(&1U92!T:')O=6=H(&UA='5R:71Y(&9O<B!O
M=7(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,S+C,P(#,X-2XQ,"!49" H
M5"D@5&H@150@40IQ(# @," P(')G($)4(#,S."XW,2 S.#4N,3 @5&0@*&5R
M;2!,;V%N+"!C86QC=6QA=&5D('5S:6YG('1H92!$96-E;6)E<B S,2P@,C Q
M." I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-C@N,# @,S<S+C$P(%1D("AA<'!L:6-A8FQE($Q)0D]2(&%N9"!M87(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-S8N,SD@,S<S+C$P(%1D("AG:6X@<F%T
M92!T;W1A;&EN9R U+C E(&]N(&%P<')O>&EM871E;'D@-#4E(&]F('1H92 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#0N-#D@,S<S+C$P(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S@Y+CDP(#,W,RXQ,"!49" H97)M($QO
M86X@8F%L86YC92P@86YD(&$@9FEX960@:6YT97)E<W0@<F%T92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @,S8Q
M+C$P(%1D("AO9B U+C$E(&]N('1H92!O=&AE<B!A<'!R;WAI;6%T96QY(#4U
M)2!O9B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4X+C@X(#,V,2XQ
M,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(V-"XR.2 S-C$N,3 @
M5&0@*&5R;2!,;V%N(&)A;&%N8V4L('1A:VEN9R!I;G1O(&%C8V]U;G0@=&AE
M(&EN=&5R97-T(')A=&4@<W=A<"X@4V5E($YO=&4@.2 M("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP," S-#DN,3 @
M5&0@*$1E<FEV871I=F5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," S,S<N,3 @5&0@*%PH8UPI("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP," S,S<N
M,3 @5&0@*%1H92!C;VYT:6YG96YT(&-O;G-I9&5R871I;VX@<F5P<F5S96YT
M<R!T:&4@97-T:6UA=&5D('!A>6UE;G1S(&1U92!T;R!T:&4@<V5L;&5R<R!R
M96QA=&5D('1O('1H92!-961I<V-A;B!A8W%U:7-I=&EO;BP@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8X+C P(#,R-2XQ
M,"!49" H:6YC;'5D:6YG(&%C8W)E=&EO;BX@4V5E($YO=&4@-" M("D@5&H@
M150@40IQ(# @," P(')G($)4(#(P,2XU-R S,C4N,3 @5&0@*$%C<75I<VET
M:6]N<R!T;R!O=7(@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3@N,CD@,S(U+C$P(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(V+CDS(#,R-2XQ,"!49" H92!H
M879E(&EN8VQU9&5D('1H92!P87EM96YT<R!I;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @,S$S+C$P(%1D("AT
M:&4@=&%B;&4@8F%S960@;VX@;W5R(&)E<W0@97-T:6UA=&5S(&]F('1H92!A
M;6]U;G1S(&%N9"!D871E<R!W:&5N('1H92!C;VYT:6YG96YC:65S(&UA>2!B
M92!R97-O;'9E9"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,S Q+C$P(%1D("A<*&1<*2 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @,S Q+C$P(%1D
M("A297!R97-E;G1S(&9U='5R92!M:6YI;75M(&QE87-E('!A>6UE;G1S(&%S
M<V]C:6%T960@=VET:"!O<&5R871I;F<@;&5A<V4@86=R965M96YT<R!W:71H
M(&]R:6=I;F%L('1E<FUS(&]F(&UO<F4@=&AA;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @,C@Y+C$P(%1D("AO
M;F4@>65A<BD@5&H@150@40IQ(# @," P(')G($)4(#$P,2XU.2 R.#DN,3 @
M5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#(V-2XQ,"!49" H4V5E($YO=&4@,3(@+2!#;VUM:71M96YT
M<R!A;F0@0V]N=&EN9V5N8VEE<R!T;R!O=7(@8V]N<V]L:61A=&5D(&9I;F%N
M8VEA;"!S=&%T96UE;G1S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," R-#$N,3 @5&0@*$EN(&%D9&ET:6]N('1O
M('1H92!A8F]V92!D:7-C;&]S960@8V]N=')A8W1U86P@;V)L:6=A=&EO;G,L
M('=E(&AA=F4@86-C<G5E9"!U;F-E<G1A:6X@=&%X('!O<VET:6]N<RP@<'5R
M<W5A;G0@=&\@=&AE("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,3 N,34@,C0Q+C$P(%1D("A);F-O;64@*2!4:B!%5"!1
M"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R.2XQ
M,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#4T+C8T(#(R.2XQ,"!4
M9" H87AE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" W,BXT,2 R,CDN,3 @5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" W-"XW,R R,CDN,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" X
M,"XQ-" R,CDN,3 @5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,S N,C(@,C(Y+C$P(%1D("A!4T(@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,34Q+C8S(#(R.2XQ,"!49" H05-#+"!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@V+CDQ(#(R.2XQ
M,"!49" H)#4N-"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(S-2XX," R,CDN,3 @5&0@*"!A="!$96-E;6)E
M<J S,2P@,C Q."X@0F%S960@;VX@=&AE('5N8V5R=&%I;G1I97,@87-S;V-I
M871E9"!W:71H('1H92!S971T;&5M96YT("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,3<N,3 @5&0@*&]F('1H
M97-E(&ET96US+"!W92!A<F4@=6YA8FQE('1O(&UA:V4@<F5A<V]N86)L>2!R
M96QI86)L92!E<W1I;6%T97,@;V8@=&AE('!E<FEO9"!O9B!P;W1E;G1I86P@
M<V5T=&QE;65N=',L(&EF(&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#0Y
M-2XS,2 R,3<N,3 @5&0@*"P@=VET:"!T:&4@=&%X:6YG("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,#4N,3 @
M5&0@*&%U=&AO<FET:65S+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," Q.#$N,3 @5&0@*$-R:71I8V%L("D@5&H@
M150@40IQ(# @," P(')G($)4(#@T+C<Q(#$X,2XQ,"!49" H06-C;W5N=&EN
M9R!0;VQI8VEE<R!A;F0@17-T:6UA=&5S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-CDN,3 @5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,34W+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@,34W
M+C$P(%1D("AE(&AA=F4@:61E;G1I9FEE9"!T:&4@9F]L;&]W:6YG(&-R:71I
M8V%L(&%C8V]U;G1I;F<@<&]L:6-I97,@=&AA="!A9BD@5&H@150@40IQ(# @
M," P(')G($)4(#,Q.2XQ.2 Q-3<N,3 @5&0@*&9E8W0@=&AE(&UO<F4@<VEG
M;FEF:6-A;G0@:G5D9VUE;G1S(&%N9"!E<W1I;6%T97,@=7-E9"!I;B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,30U+C$P(%1D("AT:&4@<')E<&%R871I;VX@;V8@;W5R(&-O;G-O;&ED871E
M9"!F:6YA;F-I86P@<W1A=&5M96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C<V+CDV(#$T-2XQ,"!49" H5&AE('!R97!A<F%T:6]N(&]F(&]U<B!C
M;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3,S+C$P(%1D("AW:71H(&%C8V]U;G1I;F<@<')I;F-I<&QE<R!G
M96YE<F%L;'D@86-C97!T960@:6X@=&AE(%5N:71E9"!3=&%T97,@;V8@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S(W+C$S(#$S,RXQ,"!49" H06UE<FEC
M82!R97%U:7)E<R!U<R!T;R!M86ME(&5S=&EM871E<R!A;F0@:G5D9VUE;G1S
M('1H870@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#$R,2XQ,"!49" H868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U-RXU.2 Q,C$N,3 @5&0@*&9E8W0@;W5R(')E<&]R=&5D(&%M;W5N=',@
M;V8@87-S971S(&%N9"!L:6%B:6QI=&EE<RP@<F5V96YU97,@86YD(&5X<&5N
M<V5S+"!A;F0@<F5L871E9"!D:7-C;&]S=7)E<R!O9B!C;VYT:6YG96YT(&%S
M<V5T<R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#$P.2XQ,"!49" H;&EA8FEL:71I97,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#DR+C T(#$P.2XQ,"!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#$P,"XV-R Q,#DN,3 @5&0@*&4@979A;'5A=&4@;W5R
M(&5S=&EM871E<R!O;B!A;B!O;BUG;VEN9R!B87-I<RP@:6YC;'5D:6YG('1H
M;W-E(')E;&%T960@=&\@87-S970@:6UP86ER;65N="P@86-C<G5A;',@9F]R
M('-E;&8M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#DW+C$P(%1D("AI;G-U<F%N8V4L(&%L;&]W86YC92!F;W(@
M9&]U8G1F=6P@86-C;W5N=',@86YD('-A;&5S(&%L;&]W86YC97,L('1A>&5S
M(&%N9"!O=&AE<B!C;VYT:6YG96YC:65S+"!A;F0@;&ET:6=A=&EO;BX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#DS+C4V(#DW+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3 R+C(P(#DW+C$P(%1D("AE('-T871E(&]U
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @.#4N,3 @5&0@*&%C8V]U;G1I;F<@<&]L:6-I97,@:6X@=&AE(&YO
M=&5S('1O('1H92!A=61I=&5D(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A
M=&5M96YT<R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97*@,S$L(#(P,3@L
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," W,RXQ,"!49" H8V]N=&%I;F5D(&AE<F5I;BX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3(Q+C$X(#<S+C$P(%1D("A4:&5S92!E<W1I;6%T97,@
M87)E(&)A<V5D(&]N(&EN9F]R;6%T:6]N('1H870@:7,@8W5R<F5N=&QY(&%V
M86EL86)L92!T;R!U<R!A;F0@;VX@=F%R:6]U<R!A<W-U;7!T:6]N<R!T:&%T
M('=E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," V,2XQ,"!49" H8F5L:65V92!T;R!B92!R96%S;VYA8FQE('5N
M9&5R('1H92!C:7)C=6US=&%N8V5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R-#DN.3(@-C$N,3 @5&0@*$%C='5A;"!R97-U;'1S(&-O=6QD('9A<GD@
M9G)O;2!T:&]S92!E<W1I;6%T97,@=6YD97(@9&EF*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#<T+C$R(#8Q+C$P(%1D("AF97)E;G0@87-S=6UP=&EO;G,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0Y+C$P(%1D("AO<J!C;VYD:71I;VYS+BD@5&H@150@40IE;F1S=')E
M86T*96YD;V)J"C<S(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @
M4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@
M,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@-S0@,"!2/CX*96YD;V)J"C<T(# @
M;V)J"CP\+TQE;F=T:" Q,#(Q,#X^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#,S*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T,BXQ
M,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," W,S N,3 @5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U."XV-" W,S N,3 @5&0@*&4@8F5L:65V92!T:&%T('1H92!F;VQL;W=I
M;F<@8W)I=&EC86P@86-C;W5N=&EN9R!P;VQI8VEE<R!A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#(X."XS-R W,S N,3 @5&0@*&9E8W0@=&AE(&UO<F4@
M<VEG;FEF:6-A;G0@:G5D9VUE;G1S(&%N9"!E<W1I;6%T97,@=7-E9"!I;B!T
M:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<Q."XQ,"!49" H<')E<&%R871I;VX@;V8@;W5R(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P@<W1A=&5M96YT<SHI(%1J($54(%$*0E0@+T8S(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C$P(%1D("A';V]D
M=VEL;"P@=')A9&4@;F%M97,L(&%N9"!O=&AE<B!I;G1A;F=I8FQE(&%S<V5T
M<RD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @
M5'<@,"!48R Q,# @5'H@,"!43" *<2 Q(# @,"!R9R!"5" R-3<N.# @-CDT
M+C$P(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( IQ(# @," P(')G($)4(#4P
M+C P(#8W,"XQ,"!49" H3W5R(&)U<VEN97-S(&%C<75I<VET:6]N<R!T>7!I
M8V%L;'D@<F5S=6QT(&EN('1H92!R96-O<F1I;F<@;V8@9V]O9'=I;&PL('1R
M861E(&YA;65S+"!A;F0@;W1H97(@:6YT86YG:6)L92!A<W-E=',L(&%N9"!T
M:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#8U."XQ,"!49" H<F5C;W)D960@=F%L=65S(&]F('1H;W-E(&%S
M<V5T<R!M87D@8F5C;VUE(&EM<&%I<F5D(&EN('1H92!F=71U<F4N("D@5&H@
M150@40IQ(# @," P(')G($)4(#,R,"XX,R V-3@N,3 @5&0@*%1H92!D971E
M<FUI;F%T:6]N(&]F('1H92!V86QU92!O9B!S=6-H(&EN=&%N9VEB;&4@87-S
M971S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," V-#8N,3 @5&0@*')E<75I<F5S(&UA;F%G96UE;G0@=&\@;6%K
M92!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS('1H870@868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,#8N-#$@-C0V+C$P(%1D("AF96-T(&]U<B!C;VYS
M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N($9O<B!I;G1A;F=I8FQE
M(&%S<V5T<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-C,T+C$P(%1D("AP=7)C:&%S960@:6X@82!B=7-I;F5S
M<R!C;VUB:6YA=&EO;BP@=&AE(&5S=&EM871E9"!F86ER('9A;'5E<R!O9B!T
M:&4@87-S971S(')E8V5I=F5D(&%R92!U<V5D('1O(&5S=&%B;&ES:"!T:&5I
M<B!R96-O<F1E9"!V86QU97,N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V,C(N,3 @5&0@*$%S(&UO<F4@9G5L
M;'D@9&5S8W)I8F5D(&EN($YO=&4@,B M(%-U;6UA<GD@;V8@4VEG;FEF:6-A
M;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C0V(#8R,BXQ,"!49" H
M06-C;W5N=&EN9R!0;VQI8VEE<RP@=V4@87-S97-S('1H92!I;7!A:7)M96YT
M(&]F(&=O;V1W:6QL(&]F(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C$P+C$P(%1D("AR97!O<G1I;F<@
M=6YI=',@86YD(&EN9&5F:6YI=&4M;&EV960@:6YT86YG:6)L92!A<W-E=',@
M86YN=6%L;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.30N,CD@-C$P+C$P
M(%1D("@L(&]R(&UO<F4@;V9T96X@:68@979E;G1S(&]R(&-H86YG97,@:6X@
M8VER8W5M<W1A;F-E<R!I;F1I8V%T92!T:&%T("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,3 @5&0@*'1H
M92!C87)R>6EN9R!V86QU92!M87D@;F]T(&)E(')E8V]V97)A8FQE+B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-3<T+C$P(%1D("A!<'!L:6-A=&EO;B!O9B!T:&4@9V]O9'=I;&P@:6UP86ER
M;65N="!T97-T(')E<75I<F5S(&IU9&=M96YT+"!I;F-L=61I;F<@=&AE(&ED
M96YT:69I8V%T:6]N(&]F(')E<&]R=&EN9R!U;FET<RP@87-S:6=N;65N="!O
M9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-38R+C$P(%1D("AA<W-E=',@86YD(&QI86)I;&ET:65S('1O(')E
M<&]R=&EN9R!U;FET<RP@87-S:6=N;65N="!O9B!G;V]D=VEL;"!T;R!R97!O
M<G1I;F<@=6YI=',L(&%N9"!D971E<FUI;F%T:6]N(&]F('1H92!F86ER('9A
M;'5E(&]F(&5A8V@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#4U,"XQ,"!49" H<F5P;W)T:6YG('5N:70N(%-I
M9VYI9FEC86YT(&IU9&=M96YT<R!A<F4@<F5Q=6ER960@=&\@97-T:6UA=&4@
M=&AE(&9A:7(@=F%L=64@;V8@<F5P;W)T:6YG('5N:71S(&EN8VQU9&EN9R!E
M<W1I;6%T:6YG(&9U='5R92!C87-H("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,S@N,3 @5&0@*&9L;W=S+"!A
M;F0@9&5T97)M:6YI;F<@87!P<F]P<FEA=&4@9&ES8V]U;G0@<F%T97,L(&=R
M;W=T:"!R871E<RP@8V]M<&%N>2!C;VYT<F]L('!R96UI=6TL(&%N9"!O=&AE
M<B!A<W-U;7!T:6]N<RX@0VAA;F=E<R!I;B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3(V+C$P(%1D("AT:&5S
M92!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS(&-O=6QD(&UA=&5R:6%L;'D@
M868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-38N.3D@-3(V+C$P(%1D("AF
M96-T('1H92!D971E<FUI;F%T:6]N(&]F(&9A:7(@=F%L=64@9F]R(&5A8V@@
M<F5P;W)T:6YG('5N:70N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#4P,BXQ,"!49" H4V5E($YO=&4@-2 M($=O
M;V1W:6QL+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#0N.# @-3 R+C$P
M(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34P+C4V(#4P,BXQ,"!4
M9" H<F%D92!.86UE<RP@86YD($]T:&5R($EN=&%N9VEB;&4@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C@W+C<S(#4P,BXQ,"!49" H07-S971S+"!W:&5R
M92!I;7!A:7)M96YT('1E<W1I;F<@:6X@,C Q."P@,C Q-RP@86YD(#(P,38@
M:7,@;6]R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#DP+C$P(%1D("AF=6QL>2!D97-C<FEB960N("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T
M-S N,3 @5&0@*%1H97)E(&-A;B!B92!N;R!A<W-U<F%N8V4@=&AA="!T:&4@
M97-T:6UA=&5S(&%N9"!A<W-U;7!T:6]N<R!M861E(&9O<B!P=7)P;W-E<R!O
M9B!T:&4@86YN=6%L(&=O;V1W:6QL(&EM<&%I<FUE;G0@=&5S="!W:6QL("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," T-3@N,3 @5&0@*'!R;W9E('1O(&)E(&%C8W5R871E('!R961I8W1I;VYS
M(&]F('1H92!F=71U<F4N("D@5&H@150@40IQ(# @," P(')G($)4(#(S-"XP
M.2 T-3@N,3 @5&0@*$%L=&AO=6=H(&UA;F%G96UE;G0@8F5L:65V97,@=&AE
M(&%S<W5M<'1I;VYS(&%N9"!E<W1I;6%T97,@;6%D92!A<F4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T-BXQ
M,"!49" H<F5A<V]N86)L92!A;F0@87!P<F]P<FEA=&4L(&1I9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$W,RXV-2 T-#8N,3 @5&0@*&9E<F5N="!A<W-U
M;7!T:6]N<R!A;F0@97-T:6UA=&5S(&-O=6QD(&UA=&5R:6%L;'D@:6UP86-T
M('1H92!R97!O<G1E9"!F:6YA;F-I86P@<F5S=6QT<RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#(R+C$P(%1D
M("A);B!A9&1I=&EO;BP@=V4@87)E(')E<75I<F5D('1O('1E<W0@=&AE(')E
M8V]V97)A8FEL:71Y(&]F(&QO;F<M;&EV960@87-S971S+"!I;F-L=61I;F<@
M:61E;G1I9FEA8FQE(&EN=&%N9VEB;&4@87-S971S('=I=&@@9&5F:6YI=&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0Q,"XQ,"!49" H;&EV97,L('=H96YE=F5R(&5V96YT<R!O<B!C:&%N
M9V5S(&EN(&-I<F-U;7-T86YC97,@:6YD:6-A=&4@=&AA="!T:&4@8V%R<GEI
M;F<@86UO=6YT(&UA>2!N;W0@8F4@<F5C;W9E<F%B;&4N($EN('1E<W1I;F<@
M9F]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," S.3@N,3 @5&0@*'!O=&5N=&EA;"!I;7!A:7)M96YT+"!I9B!T
M:&4@8V%R<GEI;F<@=F%L=64@;V8@=&AE(&%S<V5T(&=R;W5P(&5X8V5E9',@
M=&AE(&5X<&5C=&5D('5N9&ES8V]U;G1E9"!C87-H(&9L;W=S+"!W92!M=7-T
M('1H96X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#,X-BXQ,"!49" H9&5T97)M:6YE('1H92!A;6]U;G0@8GD@
M=VAI8V@@=&AE(&9A:7(@=F%L=64@;V8@=&AO<V4@87-S971S(&5X8V5E9',@
M=&AE(&-A<G)Y:6YG('9A;'5E(&%N9"!D971E<FUI;F4@=&AE(&%M;W5N="!O
M9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,S<T+C$P(%1D("AI;7!A:7)M96YT+"!I9B!A;GDI(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,C,N-3 @,S<T+C$P(%1D("@N*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U,"XQ,"!4
M9" H4FES:R!A;F0@56YC97)T86EN=&EE<RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,S@N,3 @5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M,S(V+C$P(%1D("A4:&4@8V%L8W5L871I;VX@;V8@9F%I<B!V86QU92!U<V5D
M(&EN('1H97-E(&EM<&%I<FUE;G0@87-S97-S;65N=',@:6YC;'5D960@82!N
M=6UB97(@;V8@97-T:6UA=&5S(&%N9"!A<W-U;7!T:6]N<R!T:&%T("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S
M,30N,3 @5&0@*')E<75I<F5D('-I9VYI9FEC86YT(&IU9&=M96YT<RP@:6YC
M;'5D:6YG('!R;VIE8W1I;VYS(&]F(&9U='5R92!I;F-O;64@86YD(&-A<V@@
M9FQO=W,L('1H92!I9&5N=&EF:6-A=&EO;B!O9B!A<'!R;W!R:6%T92!M87)K
M970@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#,P,BXQ,"!49" H;75L=&EP;&5S(&%N9"!T:&4@8VAO:6-E(&]F
M(&%N(&%P<')O<')I871E(&1I<V-O=6YT(')A=&4N(%-E92!.;W1E(#$P("T@
M1F%I<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3(N-S@@,S R+C$P(%1D
M("A6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4X+C@Y(#,P,BXQ,"!49" H
M86QU92!-96%S=7)E;65N=',N($-H86YG97,@:6X@=&AE<V4@87-S=6UP=&EO
M;G,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#(Y,"XQ,"!49" H8V]U;&0@;6%T97)I86QL>2!A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$R-2XS-" R.3 N,3 @5&0@*&9E8W0@=&AE(&1E
M=&5R;6EN871I;VX@;V8@9F%I<B!V86QU92!F;W(@96%C:"!R97!O<G1I;F<@
M=6YI="X@4W!E8VEF:6-A;&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# X
M+C<T(#(Y,"XQ,"!49" H+"!F=7)T:&5R(&1E=&5R:6]R871I;VX@;V8@9&5M
M86YD(&9O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C<X+C$P(%1D("AO=7(@<V5R=FEC97,L(&9U<G1H97(@
M9&5T97)I;W)A=&EO;B!O9B!L86)O<B!M87)K970@8V]N9&ET:6]N<RP@<F5D
M=6-T:6]N(&]F(&]U<B!S=&]C:R!P<FEC92!F;W(@86X@97AT96YD960@<&5R
M:6]D+"!O<B!O=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C8V+C$P(%1D("AF86-T;W)S(&%S(&1E<V-R
M:6)E9"!I;B!)=&5M(#$N02X@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$X,BXQ." R-C8N,3 @5&0@*%)I<VL@1F%C=&]R
M<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,S,N,# @,C8V+C$P(%1D("@L(&UA>2!A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(V-2XS,2 R-C8N,3 @5&0@*&9E8W0@;W5R(&1E=&5R;6EN871I;VX@
M;V8@9F%I<B!V86QU92!O9B!E86-H(')E<&]R=&EN9R!U;FET+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T.3DN,C @,C8V+C$P(%1D("A4:&ES(&5V86QU
M871I;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#(U-"XQ,"!49" H8V%N(&%L<V\@8F4@=')I9V=E<F5D(&)Y
M('9A<FEO=7,@:6YD:6-A=&]R<R!O9B!I;7!A:7)M96YT('=H:6-H(&-O=6QD
M(&-A=7-E('1H92!E<W1I;6%T960@9&ES8V]U;G1E9"!C87-H(&9L;W=S('1O
M(&)E(&QE<W,@=&AA;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @,C0R+C$P(%1D("AT:&4@8V%R<GEI;F<@86UO
M=6YT(&]F(&YE="!A<W-E=',NH$EF('=E(&%R92!R97%U:7)E9"!T;R!R96-O
M<F0@86X@:6UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S<V+C8S(#(T,BXQ,"!49" H9V4@:6X@=&AE(&9U='5R92P@:70@8V]U;&0@
M:&%V92!A;B!A9'9E<G-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," R,S N,3 @5&0@*&EM<&%C="!O;B!O=7(@
M<F5S=6QT<R!O9B!O<&5R871I;VYS+B!5;F1E<B!T:&4@8W5R<F5N="!C<F5D
M:70@86=R965M96YT(&%N(&EM<&%I<FUE;G0@8VAA<BD@5&H@150@40IQ(# @
M," P(')G($)4(#0Q-"XQ,R R,S N,3 @5&0@*&=E('=I;&P@;F]T(&AA=F4@
M86X@:6UP86-T(&]N(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,C$X+C$P(%1D("AL:7%U:61I='DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" X,RXR-" R,3@N,3 @5&0@*"X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#<N-CD@,C$X+C$P(%1D("A!<R!O9B!$96-E
M;6)E<J S,2P@,C Q."P@=V4@:&%D('1O=&%L(&=O;V1W:6QL+"!I;G1A;F=I
M8FQE(&%S<V5T<R!N;W0@<W5B:F5C="!T;R!A;6]R=&EZ871I;VXL(&%N9"!O
M=&AE<B!I;G1A;F=I8FQE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," R,#8N,3 @5&0@*&%S<V5T<R!O9B D,3<V
M+C8@;6EL;&EO;B!O<B T,2XT)2!O9B!O=7(@=&]T86P@87-S971S+BD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q
M.#(N,3 @5&0@*$AE86QT:"P@=V]R:V5R<R<@8V]M<&5N<V%T:6]N+"!A;F0@
M<')O9F5S<VEO;F%L(&QI86)I;&ET>2!E>'!E;G-E*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U."XQ,"!49" H
M5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#$U."XQ,"!49" H92!M
M86EN=&%I;B!A8V-R=6%L<R!F;W(@;W5R(&AE86QT:"P@=V]R:V5R<Y(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,S(N-30@,34X+C$P(%1D("@@8V]M<&5N
M<V%T:6]N+"!A;F0@<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;&%I;7,@=&AA
M="!A<F4@<&%R=&EA;&QY('-E;&8M:6YS=7)E9"!A;F0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$T-BXQ,"!4
M9" H87)E(&-L87-S:69I960@87,@86-C<G5E9"!C;VUP96YS871I;VX@86YD
M(&)E;F5F:71S(&]N(&]U<B!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',N
M("D@5&H@150@40IQ(# @," P(')G($)4(#0P,BXQ." Q-#8N,3 @5&0@*%<I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3 N.#(@,30V+C$P(%1D("AE(&1E
M=&5R;6EN92!T:&4@861E<75A8WD@;V8@=&AE<V4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$S-"XQ,"!49" H
M86-C<G5A;',@8GD@<&5R:6]D:6-A;&QY(&5V86QU871I;F<@;W5R(&AI<W1O
M<FEC86P@97AP97)I96YC92!A;F0@=')E;F1S(')E;&%T960@=&\@:&5A;'1H
M+"!W;W)K97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#0T,2XV," Q,S0N
M,3 @5&0@*"!C;VUP96YS871I;VXL(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3(R+C$P(%1D("AP<F]F
M97-S:6]N86P@;&EA8FEL:71Y(&-L86EM<R!A;F0@<&%Y;65N=',L(&)A<V5D
M(&]N(&%C='5A<FEA;"!M;V1E;',L(&%S('=E;&P@87,@:6YD=7-T<GD@97AP
M97)I96YC92!A;F0@=')E;F1S+B!)9B!S=6-H(&UO9&5L<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3$P+C$P
M(%1D("AI;F1I8V%T92!T:&%T(&]U<B!A8V-R=6%L<R!A<F4@;W9E<G-T871E
M9"!O<B!U;F1E<G-T871E9"P@=V4@=VEL;"!A9&IU<W0@86-C<G5A;',@87,@
M87!P<F]P<FEA=&4N($AE86QT:&-A<F4@:6YS=7)A;F-E(&%C8W)U86QS("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," Y."XQ,"!49" H:&%V92!F;'5C='5A=&5D('=I=&@@:6YC<F5A<V5S(&]R
M(&1E8W)E87-E<R!I;B!T:&4@879E<F%G92!N=6UB97(@;V8@=&5M<&]R87)Y
M(&AE86QT:&-A<F4@<')O9F5S<VEO;F%L<R!O;B!A<W-I9VYM96YT(&%S('=E
M;&P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#@V+C$P(%1D("AA<R!A8W1U86P@8V]M<&%N>2!E>'!E<FEE;F-E
M(&%N9"!I;F-R96%S97,@:6X@;F%T:6]N86P@:&5A;'1H8V%R92!C;W-T<RX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0Q+C(V(#@V+C$P(%1D("A!<R!O
M9B!$96-E;6)E<J S,2P@,C Q."!A;F0@,C Q-RP@=V4@:&%D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3DN.#(@.#8N
M,3 @5&0@*"0U+C(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#<T+C$P(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C@Y(#<T+C$P(%1D
M("@@86YD("0U+C&@;6EL;&EO;B!A8V-R=65D+"!R97-P96-T:79E;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,S,N-#<@-S0N,3 @5&0@*"P@9F]R(&EN
M8W5R<F5D(&)U="!N;W0@<F5P;W)T960@:&5A;'1H(&EN<W5R86YC92!C;&%I
M;7,N($-O<G!O<F%T92!A;F0@9FEE;&0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8R+C$P(%1D("AE;7!L;WEE
M97,@87)E(&-O=F5R960@=&AR;W5G:"!A('!A<G1I86QL>2!S96QF+6EN<W5R
M960@:&5A;'1H('!L86XN("D@5&H@150@40IQ(# @," P(')G($)4(#,Q.2XQ
M-B V,BXQ,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#,R-RXX," V
M,BXQ,"!49" H;W)K97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#,U-2XS
M." V,BXQ,"!49" H(&-O;7!E;G-A=&EO;B!I;G-U<F%N8V4@86-C<G5A;',@
M8V%N(&9L=6-T=6%T92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-3 N,3 @5&0@*&]V97(@=&EM92!D=64@=&\@
M=&AE(&YU;6)E<B!O9B!E;7!L;WEE97,@86YD(&EN9FQA=&EO;BP@87,@=V5L
M;"!A<R!A9&1I=&EO;F%L(&5X<&]S=7)E<R!A<FES:6YG(&9R;VT@=&AE(&-U
M<G)E;G0@<&]L:6-Y('EE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#4N
M,3,@-3 N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30Y+C4X
M(#4P+C$P(%1D("A!<R I(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HW-2 P
M(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP
M(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *
M+T-O;G1E;G1S(#<V(# @4CX^"F5N9&]B:@HW-B P(&]B:@H\/"],96YG=&@@
M.#4V-SX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,#$N,# @,S$N-C @5&0@*#,T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T,BXQ,"!49" H;V8@1&5C96UB
M97*@,S$L(#(P,3@L(&%N9" R,#$W+"!W92!H860@)#$I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,C<N,#@@-S0R+C$P(%1D("@Q+CF@;6EL;&EO;B!A;F0@
M)#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,# N,#0@-S0R+C$P(%1D("@Q
M+C0@;6EL;&EO;B!A8V-R=65D(&9O<B!C87-E(')E<V5R=F5S(&%N9"!F;W(@
M:6YC=7)R960@8G5T(&YO=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S,P+C$P(%1D("AR97!O<G1E9"!W;W)K
M97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#$R,"XV,B W,S N,3 @5&0@
M*"!C;VUP96YS871I;VX@8VQA:6US+"!N970@;V8@:6YS=7)A;F-E(')E8V5I
M=F%B;&5S+"!R97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M-S8N,C4@-S,P+C$P(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#,X
M,2XP-R W,S N,3 @5&0@*%1H92!A8V-R=6%L(&9O<B!W;W)K97)SDBD@5&H@
M150@40IQ(# @," P(')G($)4(#0W.2XT-" W,S N,3 @5&0@*"!C;VUP96YS
M871I;VX@:7,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<Q."XQ,"!49" H8F%S960@;VX@86X@86-T=6%R:6%L
M(&UO9&5L('=H:6-H(&ES('!R97!A<F5D(&]R(')E=FEE=V5D(&)Y(&%N(&EN
M9&5P96YD96YT(&%C='5A<GD@<V5M:2UA;FYU86QL>2D@5&H@150@40IQ(# @
M," P(')G($)4(#0U,2XT,B W,3@N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#4U+C@V(#<Q."XQ,"!49" H07,@;V8@1&5C96UB97*@,S$L
M(#(P,3@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," W,#8N,3 @5&0@*&%N9" R,#$W+"!W92!H860@)#<N,R!M
M:6QL:6]N(&%N9" D-BXTH&UI;&QI;VX@86-C<G5E9"P@<F5S<&5C=&EV96QY
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(V+C4P(#<P-BXQ,"!49" H+"!F
M;W(@8V%S92!R97-E<G9E<R!A;F0@9F]R(&EN8W5R<F5D(&)U="!N;W0@<F5P
M;W)T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#8Y-"XQ,"!49" H<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C
M;&%I;7,L(&YE="!O9B!I;G-U<F%N8V4@<F5C96EV86)L97,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(X,BXR-" V.30N,3 @5&0@*%1H92!A8V-R=6%L
M(&9O<B!P<F]F97-S:6]N86P@;&EA8FEL:71Y(&ES(&)A<V5D(&]N(&%C='5A
M<FEA;"!M;V1E;',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#8X,BXQ,"!49" H=VAI8V@@87)E('!R97!A<F5D
M(&)Y(&%N(&EN9&5P96YD96YT(&%C='5A<GD@<V5M:2UA;FYU86QL>2D@5&H@
M150@40IQ(# @," P(')G($)4(#(Y,BXX-B V.#(N,3 @5&0@*"XI(%1J($54
M(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X
M+C$P(%1D("A2979E;G5E(')E8V]G;FET:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8S-"XQ,"!49" H5RD@
M5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#8S-"XQ,"!49" H92!R96-O
M9VYI>F4@<F5V96YU92!F<F]M(&]U<B!S97)V:6-E<R!W:&5N(&-O;G1R;VP@
M;V8@=&AE('!R;VUI<V5D('-E<G9I8V5S(&%R92!T<F%N<V9E<G)E9"!T;R!O
M=7(@8W5S=&]M97)S+"!I;B!A;B!A;6]U;G0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8R,BXQ,"!49" H=&AA
M="!R969L96-T<R!T:&4@8V]N<VED97)A=&EO;B!W92!E>'!E8W0@=&\@<F5C
M96EV92!I;B!E>&-H86YG92!F;W(@=&AE('-E<G9I8V4N("D@5&H@150@40IQ
M(# @," P(')G($)4(#,V-RXT-2 V,C(N,3 @5&0@*%<I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-S8N,#@@-C(R+C$P(%1D("AE(&AA=F4@8V]N8VQU9&5D
M('1H870@=')A;G-F97(@;V8@8V]N=')O;"!O9B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C$P+C$P(%1D("AO
M=7(@<W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#@P+C Y(#8Q,"XQ,"!4
M9" H9FEN9R!S97)V:6-E<RP@=VAI8V@@<F5P<F5S96YT<R!T:&4@;6%J;W)I
M='D@;V8@;W5R(')E=F5N=65S+"!O8V-U<G,@;W9E<B!T:6UE(&%S('1H92!S
M97)V:6-E<R!A<F4@<')O=FED960L('=H:6-H(&ES("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3@N,3 @5&0@
M*&-O;G-I<W1E;G0@=VET:"!R979E;G5E(')E8V]G;FET:6]N('5N9&5R('1H
M92!P<FEO<B!G=6ED86YC92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C$P(%1D("A4:&4@9F]L;&]W:6YG
M(&ES(&$@9&5S8W)I<'1I;VX@;V8@=&AE(&YA='5R92P@86UO=6YT+"!T:6UI
M;F<@86YD('5N8V5R=&%I;G1Y(&]F(')E=F5N=64@86YD(&-A<V@@9FQO=W,@
M9G)O;2!W:&EC:"!W92!G96YE<F%T92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-38R+C$P(%1D("AR979E;G5E
M+BD@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," U,S8N-S @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-"XV
M-" U,S8N-S @5&0@*&5M<&]R87)Y(%-T869F:6YG(%)E=F5N=64I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3$V
M+C<P(%1D("A2979E;G5E(&9R;VT@=&5M<&]R87)Y('-T868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C<N,C@@-3$V+C<P(%1D("AF:6YG(&ES(')E8V]G
M;FEZ960@87,@8V]N=')O;"!O9B!T:&4@<V5R=FEC97,@:7,@=')A;G-F97)R
M960@;W9E<B!T:6UE+"!A;F0@:7,@8F%S960@;VX@:&]U<G,@=V]R:V5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," U,#0N-S @5&0@*&)Y(&]U<B!F:65L9"!S=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3$S+C0Q(#4P-"XW,"!49" H9BX@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3(Q+C4V(#4P-"XW,"!49" H5RD@5&H@150@40IQ(# @," P
M(')G($)4(#$S,"XR," U,#0N-S @5&0@*&4@<F5C;V=N:7IE('1H92!M86IO
M<FET>2!O9B!O=7(@<F5V96YU92!A="!T:&4@8V]N=')A8W1U86P@86UO=6YT
M('=E(&AA=F4@=&AE(')I9VAT('1O(&EN=F]I8V4@9F]R('-E<G9I8V5S("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," T.3(N-S @5&0@*&-O;7!L971E9"!T;R!D871E+B!'96YE<F%L;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-C0N.#8@-#DR+C<P(%1D("@L(&)I;&QI
M;F<@=&\@8W5S=&]M97)S(&]C8W5R<R!W965K;'DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,#@N-C(@-#DR+C<P(%1D("@L(&)I+7=E96ML>2D@5&H@150@
M40IQ(# @," P(')G($)4(#,U,BXY-B T.3(N-S @5&0@*"P@;W(@;6]N=&AL
M>2!A;F0@:7,@86QI9VYE9"!W:71H('1H92!P87EM96YT(&]F("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T.# N
M-S @5&0@*'-E<G9I8V5S('1O('1H92!T96UP;W)A<GD@<W1A9BD@5&H@150@
M40IQ(# @," P(')G($)4(#$V-RXU-2 T.# N-S @5&0@*&8L('=I=&@@<&%Y
M;65N="!T97)M<R!O9B Q-2!T;R V,"!D87ES+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,C8N-S @-#@P+C<P(%1D("A!8V-O=6YT<R!R96-E:79A8FQE
M(&EN8VQU9&5S(&5S=&EM871E9"!R979E;G5E(&9O<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#8X+C<P(%1D
M("AE;7!L;WEE97.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.34N,S4@-#8X
M+C<P(%1D("@@86YD(&EN9&5P96YD96YT(&-O;G1R86-T;W)SDBD@5&H@150@
M40IQ(# @," P(')G($)4(#(Q,RXQ-R T-C@N-S @5&0@*"!T:6UE('=O<FME
M9"!B=70@;F]T('EE="!I;G9O:6-E9"X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S4R+C4Y(#0V."XW,"!49" H070@1&5C96UB97(@,S$L(#(P,3@@86YD
M($1E8V5M8F5R(#,Q+" R,#$W+"!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0U-BXW,"!49" H97-T:6UA
M=&4@;V8@86UO=6YT<R!T:&%T(&AA9"!B965N('=O<FME9"!B=70@:&%D(&YO
M="!B965N(&)I;&QE9"!T;W1A;&5D("0T-"XQ(&UI;&QI;VX@86YD("0T,2XX
M(&UI;&QI;VXL(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4
M(#4R-2XP." T-38N-S @5&0@*"P@86YD(&%R92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#0T+C<P(%1D("AI
M;F-L=61E9"!I;B!A8V-O=6YT<R!R96-E:79A8FQE(&]N('1H92!C;VYS;VQI
M9&%T960@8F%L86YC92!S:&5E=',N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#0Q.2XS,"!49" H3W1H97(@4V5R
M=FEC92!2979E;G5E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#,Y.2XS,"!49" H5RD@5&H@150@40IQ(# @," P
M(')G($)4(#4X+C8T(#,Y.2XS,"!49" H92!O9BD@5&H@150@40IQ(# @," P
M(')G($)4(#<S+C<S(#,Y.2XS,"!49" H9F5R(&]T:&5R(&]P=&EO;F%L('-E
M<G9I8V5S('1O(&]U<B!C=7-T;VUE<G,@=&AA="!A<F4@=')A;G-F97)R960@
M;W9E<B!T:6UE(&EN8VQU9&EN9SH@35-0<R!P<F]V:61I;F<@86=E;F-Y('-E
M<G9I8V5S(%PH87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#,X-RXS,"!49" H9G5R=&AE<B!D97-C<FEB960@
M8F5L;W<@:6X@1W)O<W,@=F5R<W5S($YE="!0;VQI8VEE<UPI+"!24$\L(&]T
M:&5R(&]U='-O=7)C:6YG('-E<G9I8V5S+"!A;F0@<F5T86EN960@<V5A<F-H
M('-E<G9I8V5S+"!W:&EC:"!I<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @,S<U+C,P(%1D("AL97-S('1H86X@
M-24@;V8@:71S(&-O;G-O;&ED871E9"!R979E;G5E(&9O<B!T:&4@>65A<G,@
M96YD960@1&5C96UB97(@,S$L(#(P,3@L(#(P,3<L(&%N9" R,#$V+B!'96YE
M<F%L;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#$N,38@,S<U+C,P(%1D
M("@L(&)I;&QI;F<@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," S-C,N,S @5&0@*'!A>6UE;G0@=&5R;7,@
M9F]R($U34"D@5&H@150@40IQ(# @," P(')G($)4(#$T-2XT-2 S-C,N,S @
M5&0@*"!A9V5N8WD@<V5R=FEC97,@:7,@8V]N<VES=&5N="!W:71H('1E;7!O
M<F%R>2!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0S+C(W(#,V,RXS
M,"!49" H9FEN9R!A<R!T:&4@8W5S=&]M97)S(&%R92!S:6UI;&%R(&]R('1H
M92!S86UE+B!2979E;G5E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," S-3$N,S @5&0@*&9R;VT@=&AE<V4@<V5R
M=FEC97,@87)E(')E8V]G;FEZ960@8F%S960@;VX@=&AE(&-O;G1R86-T=6%L
M(&%M;W5N="!F;W(@<V5R=FEC97,@8V]M<&QE=&5D('1O(&1A=&4@=VAI8V@@
M8F5S="!D97!I8W1S('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,S,Y+C,P(%1D("AT<F%N<V9E<B!O9B!C
M;VYT<F]L(&]F('-E<G9I8V5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," S,34N,S @5&0@*$9O<B!O=7(@4E!/
M+"!O=&AE<B!O=71S;W5R8VEN9RP@86YD(')E=&%I;F5D('-E87)C:"!S97)V
M:6-E<RP@<F5V96YU92!I<R!G96YE<F%L;'D@<F5C;V=N:7IE9"!I;B!T:&4@
M86UO=6YT('1O('=H:6-H('1H92!E;G1I='D@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,P,RXS,"!49" H:&%S
M(&$@<FEG:'0@=&\@:6YV;VEC92!W:&EC:"!C;W)R97-P;VYD<R!D:7)E8W1L
M>2!W:71H('1H92!V86QU92!T;R!T:&4@8W5S=&]M97(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-C<N-#(@,S S+C,P(%1D("@N("D@5&H@150@40IQ(# @
M," P(')G($)4(#,W,BXR-" S,#,N,S @5&0@*%<I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.# N.#<@,S S+C,P(%1D("AE(&1O(&YO="P@:6X@=&AE(&]R
M9&EN87)Y(&-O=7)S92!O9B!B=7-I;F5S<RP@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y,2XS,"!49" H;V8I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XQ-2 R.3$N,S @5&0@*&9E<B!W
M87)R86YT:65S(&]R(')E9G5N9',N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(V-2XY,"!49" H1W(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" V,"XW-" R-C4N.3 @5&0@*&]S<R!6*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#$N,#,@,C8U+CDP(%1D("AE<G-U<R!.970@
M4&]L:6-I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C0U+CDP(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N-C0@,C0U+CDP(%1D("AE(')E8V]R9"!R979E;G5E(&]N(&$@9W)O
M<W,@8F%S:7,@87,@82!P<FEN8VEP86P@;W(@;VX@82!N970@8F%S:7,@87,@
M86X@86=E;G0@9&5P96YD:6YG(&]N('1H92!C;VYT<F%C=&5D(&%R<F%N9V5M
M96YT+"!A<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C,S+CDP(%1D("AF;VQL;W=S.BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP," R,3,N.3 @5&0@
M*)4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#@V+C P(#(Q,RXY,"!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#DT
M+C8T(#(Q,RXY,"!49" H92!H879E(&%L<V\@96YT97)E9"!I;G1O(&-E<G1A
M:6X@8V]N=')A8W1S('=I=&@@86-U=&4@8V%R92!F86-I;&ET:65S('1O('!R
M;W9I9&4@8V]M<')E:&5N<VEV92!-4U I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.#4N-SD@,C$S+CDP(%1D("@@<V]L=71I;VYS+B!5;F1E<B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,C Q
M+CDP(%1D("AT:&5S92!C;VYT<F%C="!A<G)A;F=E;65N=',L('=E('5S92!O
M=7(@;G5R<V5S('!R:6UA<FEL>2D@5&H@150@40IQ(# @," P(')G($)4(#,Q
M,RXP-2 R,#$N.3 @5&0@*"P@86QO;F<@=VET:"!T:&]S92!O9B!T:&ER9"!P
M87)T>2!S=6)C;VYT<F%C=&]R<RP@=&\@9G5L9FEL;" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,3@Y+CDP(%1D
M("AC=7-T;VUE<B!O<F1E<G,N($EF(&$@<W5B8V]N=')A8W1O<B!I<R!U<V5D
M+"!W92!I;G9O:6-E(&]U<B!C=7-T;VUE<B!F;W(@=&AE<V4@<V5R=FEC97,L
M(&)U="!R979E;G5E(&ES(')E8V]R9&5D(&%T('1H92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,3<W+CDP(%1D
M("AT:6UE(&]F(&)I;&QI;F<L(&YE="!O9B!A;GD@<F5L871E9"!S=6)C;VYT
M<F%C=&]R(&QI86)I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#,P-RXW
M.2 Q-S<N.3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$R+C8Q
M(#$W-RXY,"!49" H5&AE(')E<W5L=&EN9R!N970@<F5V96YU92!R97!R97-E
M;G1S('1H92!A9&UI;FES=')A=&EV92!F964@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#$V-2XY,"!49" H8VAA
M<BD@5&H@150@40IQ(# @," P(')G($)4(#$P,RXP,R Q-C4N.3 @5&0@*&=E
M9"!B>2!U<R!F;W(@;W5R($U34"D@5&H@150@40IQ(# @," P(')G($)4(#$Y
M,RXT.2 Q-C4N.3 @5&0@*"!S97)V:6-E<RXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @,30U+CDP(%1D("B5("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP
M," Q-#4N.3 @5&0@*%)E=F5N=64@9G)O;2!O=7(@4&AY<VEC:6%N(%-T868I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N-3<@,30U+CDP(%1D("AF:6YG
M(&)U<VEN97-S(&ES(')E8V]G;FEZ960@;VX@82!G<F]S<R!B87-I<R!A<R!W
M92!B96QI979E('=E(&%R92!T:&4@<')I;F-I<&%L(&EN('1H92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @,3,S
M+CDP(%1D("AA<G)A;F=E;65N=',N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O
M8FH*-S<@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I
M84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O
M=&%T92 P"B]#;VYT96YT<R W." P(%(^/@IE;F1O8FH*-S@@,"!O8FH*/#PO
M3&5N9W1H(#$P-34R/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,P,2XP," S,2XV,"!49" H,S4I(%1J($54(%$*0E0@+T8S
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C(U(%1D("A!
M;&QO=V%N8V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<Q."XR-2!49" H5RD@5&H@150@40IQ(# @," P(')G
M($)4(#4X+C8T(#<Q."XR-2!49" H92!M86EN=&%I;B!A;B!A;&QO=V%N8V4@
M9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&9O<B!E<W1I;6%T960@;&]S<V5S(')E
M<W5L=&EN9R!F<F]M('1H92!I;F%B:6QI='D@;V8@;W5R(&-U<W1O;65R<R!T
M;R!M86ME("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," W,#8N,C4@5&0@*')E<75I<F5D('!A>6UE;G1S+"!W:&EC
M:"!R97-U;'1S(&EN(&$@<')O=FES:6]N(&9O<B!B860@9&5B="!E>'!E;G-E
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S N,#(@-S V+C(U(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,X+C8V(#<P-BXR-2!49" H92!D
M971E<FUI;F4@=&AE(&%D97%U86-Y(&]F('1H:7,@86QL;W=A;F-E(&)Y("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V.30N,C4@5&0@*&-O;G1I;G5A;&QY(&5V86QU871I;F<@:6YD:79I9'5A
M;"!C=7-T;VUE<B!R96-E:79A8FQE<RP@8V]N<VED97)I;F<@=&AE(&-U<W1O
M;65R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<T+C<R(#8Y-"XR-2!49" H
MDBD@5&H@150@40IQ(# @," P(')G($)4(#,W-RXU," V.30N,C4@5&0@*',@
M9FEN86YC:6%L(&-O;F1I=&EO;BP@8W)E9&ET(&AI<W1O<GD@86YD("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V
M.#(N,C4@5&0@*&-U<G)E;G0@96-O;F]M:6,@8V]N9&ET:6]N<RX@268@=&AE
M(&9I;F%N8VEA;"!C;VYD:71I;VX@;V8@;W5R(&-U<W1O;65R<R!W97)E('1O
M(&1E=&5R:6]R871E+"!R97-U;'1I;F<@:6X@86X@:6UP86ER;65N="!O9B!T
M:&5I<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-C<P+C(U(%1D("AA8FEL:71Y('1O(&UA:V4@<&%Y;65N=',L
M(&%D9&ET:6]N86P@86QL;W=A;F-E<R!M87D@8F4@<F5Q=6ER960N("D@5&H@
M150@40IQ(# @," P(')G($)4(#,Q-2XP,2 V-S N,C4@5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,C,N-C4@-C<P+C(U(%1D("AE('=R:71E+6]F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8R+C8R(#8W,"XR-2!49" H9B!S
M<&5C:69I8R!A8V-O=6YT<R!B87-E9"!O;B!A;B!O;F=O:6YG(')E=FEE=R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C4X+C(U(%1D("AO9B!C;VQL96-T86)I;&ET>2!A<R!W96QL(&%S(&]U
M<B!P87-T(&5X<&5R:65N8V4@=VET:"!T:&4@8W5S=&]M97(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,#@N,C4@-C4X+C(U(%1D("@N($EN(&%D9&ET:6]N
M+"!W92!M86EN=&%I;B!A('-A;&5S(&%L;&]W86YC92!F;W(@8W5S=&]M97(@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#8T-BXR-2!49" H9&ES<'5T97,@=VAI8V@@;6%Y(&%R:7-E(&EN('1H
M92!O<F1I;F%R>2!C;W5R<V4L('=H:6-H(&ES(')E8V]R9&5D(&%S(&-O;G1R
M82UR979E;G5E+B!(:7-T;W)I8V%L;'DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-#$N-S(@-C0V+C(U(%1D("@L(&QO<W-E<R!O;B!U;F-O;&QE8W1I8FQE
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V,S0N,C4@5&0@*&%C8V]U;G1S(&%N9"!S86QE<R!A;&QO=V%N8V5S
M(&AA=F4@;F]T(&5X8V5E9&5D(&]U<B!A;&QO=V%N8V5S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,30N,S0@-C,T+C(U(%1D("A!<R!O9B!$96-E;6)E
M<J S,2P@,C Q."P@;W5R('1O=&%L(&%L;&]W86YC97,@=V5R92 D,RXW("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,C(N,C4@5&0@*&UI;&QI;VXN*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Y."XR-2!49" H0V]N=&EN9V5N
M="!L:6%B:6QI=&EE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U-S0N,C4@5&0@*%<I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U."XV-" U-S0N,C4@5&0@*&4@87)E('-U8FIE8W0@=&\@=F%R
M:6]U<R!L:71I9V%T:6]N+"!C;&%I;7,L(&EN=F5S=&EG871I;VYS+"!A;F0@
M;W1H97(@<')O8V5E9&EN9W,@=&AA="!A<FES92!I;B!T:&4@;W)D:6YA<GD@
M8V]U<G-E(&]F(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-38R+C(U(%1D("AB=7-I;F5S<RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#@N-S$@-38R+C(U(%1D("A4:&5S92!P<F]C
M965D:6YG<R!T>7!I8V%L;'D@<F5L871E('1O('!R;V9E<W-I;VYA;"!L:6%B
M:6QI='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C N,C$@-38R+C(U(%1D
M("@L('1A>"P@<&%Y<F]L;"P@8V]N=')A8W0L(&-O;7!E=&ET;W(@9&ES<'5T
M97,L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-34P+C(U(%1D("AE;7!L;WEM96YT+7)E;&%T960@;6%T
M=&5R<R!A;F0@:6YC;'5D92!I;F1I=FED=6%L(&%N9"!C;VQL96-T:79E(&QA
M=W-U:71S+"!A<R!W96QL(&%S(&EN<75I<FEE<R!A;F0@:6YV97-T:6=A=&EO
M;G,@8GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4S."XR-2!49" H9V]V97)N;65N=&%L(&%G96YC:65S(')E
M9V%R9&EN9R!O=7(@96UP;&]Y;65N="!P<F%C=&EC97,N($]U<B!H96%L=&AC
M87)E(&9A8VEL:71Y(&-L:65N=',@;6%Y(&%L<V\@8F5C;VUE('-U8FIE8W0@
M=&\@8VQA:6US+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-3(V+C(U(%1D("AG;W9E<FYM96YT86P@:6YQ=6ER
M:65S(&%N9"!I;G9E<W1I9V%T:6]N<RP@86YD(&QE9V%L(&%C=&EO;G,@=&\@
M=VAI8V@@=V4@;6%Y(&)E8V]M92!A('!A<G1Y(')E;&%T:6YG('1O('-E<G9I
M8V5S('!R;W9I9&5D(&)Y("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," U,30N,C4@5&0@*&]U<B!P<F]F97-S:6]N
M86QS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C,N-#(@-3$T+C(U(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,R+C V(#4Q-"XR-2!49" H
M92!R96-O<F0@82!L:6%B:6QI='D@=VAE;B!A=F%I;&%B;&4@:6YF;W)M871I
M;VX@:6YD:6-A=&5S('1H870@82!L;W-S(&ES('!R;V)A8FQE(&%N9"!A;B!A
M;6]U;G0L(&]R(')A;F=E(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," U,#(N,C4@5&0@*&QO<W,@8V%N(&)E
M(')E87-O;F%B;'D@97-T:6UA=&5D+B!3:6=N:69I8V%N="!J=61G;65N="!I
M<R!R97%U:7)E9"!T;R!D971E<FUI;F4@8F]T:"!T:&4@<')O8F%B:6QI='D@
M;V8@;&]S<R!A;F0@=&AE(&5S=&EM871E9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DP+C(U(%1D("AA;6]U
M;G0N("D@5&H@150@40IQ(# @," P(')G($)4(#@T+C0T(#0Y,"XR-2!49" H
M070@;&5A<W0@<75A<G1E<FQY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34S
M+C(Q(#0Y,"XR-2!49" H+"!W92!R979I97<@;W5R(&%C8W)U86P@86YD(&]R
M(&1I<V-L;W-U<F5S('1O(')E9FQE8W0@=&AE(&EM<&%C="!O9B!N96=O=&EA
M=&EO;G,L('-E='1L96UE;G1S+"!R=6QI;F=S+" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#<X+C(U(%1D("AA
M9'9I8V4@;V8@;&5G86P@8V]U;G-E;"P@;W(@;F5W(&EN9F]R;6%T:6]N+B!(
M;W=E=F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8U+C,V(#0W."XR-2!4
M9" H+"!L;W-S97,@=6QT:6UA=&5L>2!I;F-U<G)E9"!C;W5L9"!M871E<FEA
M;&QY(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#0U-"XR.2 T-S@N,C4@
M5&0@*&9E<B!F<F]M(&%M;W5N=',@86-C<G5E9"X@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0V-BXR-2!49" H
M4V5E($YO=&4@,3(@+2!#;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE<RXI
M(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-#0R+C(U(%1D("A);F-O;64@=&%X97,I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X+C(U(%1D("A7*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@-#$X+C(U(%1D("AE(&%C8V]U
M;G0@9F]R(&EN8V]M92!T87AE<R!I;B!A8V-O<F1A;F-E('=I=&@@=&AE("D@
M5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-C$N
M,#0@-#$X+C(U(%1D("A);F-O;64@5"D@5&H@150@40IQ(# @," P(')G($)4
M(#(Y-RXV,B T,3@N,C4@5&0@*&%X97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,Q-RXX.2 T,3@N,C4@5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,C,N,S @-#$X+C(U(%1D("AO<&EC(&]F
M('1H92!&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<S+C,X(#0Q."XR-2!4
M9" H05-"("D@5&H@150@40IQ(# @," P(')G($)4(#,Y-"XW." T,3@N,C4@
M5&0@*$%30RX@1&5F97)R960@=&%X(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#0P-BXR-2!49" H87)E(')E8V]G;FEZ960@9F]R('1H92!F=71U<F4@
M=&%X(&-O;G-E<75E;F-E<R!A='1R:6)U=&%B;&4@=&\@9&EF*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S W+C<V(#0P-BXR-2!49" H9F5R96YC97,@8F5T
M=V5E;B!F:6YA;F-I86P@<W1A=&5M96YT(&-A<G)Y:6YG(&%M;W5N=',@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#,Y-"XR-2!49" H97AI<W1I;F<@87-S971S(&%N9"!L:6%B:6QI=&EE
M<R!A;F0@=&AE:7(@<F5S<&5C=&EV92!T87@@8F%S97,@86YD(&]P97)A=&EN
M9R!L;W-S(&%N9"!O=&AE<B!L;W-S(&-A<G)Y9F]R=V%R9',N($1E9F5R<F5D
M('1A>"!A<W-E=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#,X,BXR-2!49" H86YD(&QI86)I;&ET:65S(&%R
M92!M96%S=7)E9"!U<VEN9R!E;F%C=&5D('1A>"!R871E<R!E>'!E8W1E9"!T
M;R!A<'!L>2!T;R!T87AA8FQE(&EN8V]M92!I;B!T:&4@>65A<G,@:6X@=VAI
M8V@@=&AO<V4@=&5M<&]R87)Y("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," S-S N,C4@5&0@*&1I9BD@5&H@150@
M40IQ(# @," P(')G($)4(#8P+CDS(#,W,"XR-2!49" H9F5R96YC97,@87)E
M(&5X<&5C=&5D('1O(&)E(')E8V]V97)E9"!O<B!S971T;&5D+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R-30N.3D@,S<P+C(U(%1D("A!<R!O9B!$96-E
M;6)E<B S,2P@,C Q."P@=V4@:&%V92!D969E<G)E9"!T87@@87-S971S(')E
M;&%T960@=&\@8V5R=&%I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,S4X+C(U(%1D("AF961E<F%L+"!S=&%T
M92P@86YD(&9O<F5I9VX@;F5T(&]P97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R
M9',@;V8@)#(P+C8@;6EL;&EO;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S4U+C4V(#,U."XR-2!49" H5&AE(&-A<G)Y9F]R=V%R9',@=VEL;"!E>'!I
M<F4@87,@9F]L;&]W<SH@9F5D97)A;" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S0V+C(U(%1D("AB971W965N
M(#(P,S(@86YD(#(P,S<L('-T871E(&)E='=E96X@,C Q.2!A;F0@,C S."P@
M86YD(&9O<F5I9VX@8F5T=V5E;B R,#$Y(&%N9" R,#(S+B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S(R+C(U
M(%1D("A!<R!O9B!$96-E;6)E<B S,2P@,C Q."!A;F0@,C Q-RP@=V4@:&%D
M('9A;'5A=&EO;B!A;&QO=V%N8V5S(&]N(&]U<B!D969E<G)E9"!T87@@87-S
M971S(&]F("0Q+C(@;6EL;&EO;B!A;F0@)#$N,2!M:6QL:6]N+" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S$P
M+C(U(%1D("AR97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Y
M-RXV-B S,3 N,C4@5&0@*"X@1F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R
M(#,Q+" R,#$W+"!W92!R961U8V5D('1H92!V86QU871I;VX@86QL;W=A;F-E
M(')E8V]R9&5D(&)Y("0T-2XT(&UI;&QI;VX@7"AC;VUP<FES960@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Y
M."XR-2!49" H;V8@)#$U+C<@;6EL;&EO;B!R96QA=&5D('1O(%4N4RX@;F5T
M(&]P97)A=&EN9R!L;W-S97,L("0T+C0@;6EL;&EO;B!R96QA=&5D('1O('-T
M871E(&YE="!O<&5R871I;F<@;&]S<V5S+"!A;F0@)#(U+C,@;6EL;&EO;B!R
M96QA=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," R.#8N,C4@5&0@*'1O(&]T:&5R(&YE="!D969E<G)E9"!T
M87@@87-S971S7"D@<')E9&]M:6YA;G1L>2!O;B!T:&4@8F%S:7,@;V8@;6%N
M86=E;65N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3(N.38@,C@V+C(U
M(%1D("AS(')E87-S97-S;65N="!O9B!D969E<G)E9"!T87@@87-S971S('1H
M870@87)E(&UO<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#(W-"XR-2!49" H;&EK96QY('1H86X@;F]T('1O
M(&)E(')E86QI>F5D+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C@N.34@
M,C<T+C(U(%1D("A4:&4@=F%L=6%T:6]N(&%L;&]W86YC92!O;B!A('!O<G1I
M;VX@;V8@<W1A=&4@;F5T(&]P97)A=&EN9R!L;W-S97,@;F]T(&UO<F4@;&EK
M96QY('1H86X@;F]T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," R-C(N,C4@5&0@*')E86QI>F%B;&4@=V%S(&YO
M="!R96QE87-E9"!D=64@=&\@=&AE(')E<W!E8W1I=F4@97AP:7)A=&EO;B!P
M97)I;V1S(&%N9"!S<&5C:69I8R!S=&%T92!T87AA8FQE(&EN8V]M92!P<F]J
M96-T:6]N<RX@4V5E($YO=&4@,3,@+2 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4P+C(U(%1D("A);F-O;64@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#(N,S @,C4P+C(U(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.#<N-S$@,C4P+C(U(%1D("AA>&5S('1O
M(&]U<B!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(R
M-BXR-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#(R-BXR
M-2!49" H92!M86EN=&%I;B!V86QU871I;VX@86QL;W=A;F-E<R!W:&5N(&ET
M(&ES(&UO<F4@;&EK96QY('1H86X@;F]T('1H870@86QL(&]R(&$@<&]R=&EO
M;B!O9B!A(&1E9F5R<F5D('1A>"!A<W-E="!W:6QL(&YO="!B92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C$T
M+C(U(%1D("AR96%L:7IE9"X@26X@9&5T97)M:6YI;F<@=VAE=&AE<B!A('9A
M;'5A=&EO;B!A;&QO=V%N8V4@:7,@=V%R<F%N=&5D+"!W92!E=F%L=6%T92!F
M86-T;W)S('-U8V@@87,@<')I;W(@96%R;FEN9W,@:&ES=&]R>2D@5&H@150@
M40IQ(# @," P(')G($)4(#4R,RXV,2 R,30N,C4@5&0@*"P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(P,BXR
M-2!49" H97AP96-T960@9G5T=7)E(&5A<FYI;F=S+"!C87)R>6)A8VL@86YD
M(&-A<G)Y9F]R=V%R9"!P97)I;V1S+"!A;F0@=&%X('-T<F%T96=I97,N("D@
M5&H@150@40IQ(# @," P(')G($)4(#,W-2XU," R,#(N,C4@5&0@*%<I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S.#0N,30@,C R+C(U(%1D("AE(&-O;G-I
M9&5R(&%L;"!P;W-I=&EV92!A;F0@;F5G871I=F4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Y,"XR-2!49" H
M979I9&5N8V4@=&\@97-T:6UA=&4@:68@<W5F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,34T+C<X(#$Y,"XR-2!49" H9FEC:65N="!F=71U<F4@=&%X86)L
M92!I;F-O;64@=VEL;"!B92!G96YE<F%T960@=&\@<F5A;&EZ92!T:&4@9&5F
M97)R960@=&%X(&%S<V5T+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S(N
M-S@@,3DP+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@Q+C0R
M(#$Y,"XR-2!49" H92!C;VYS:61E<B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3<X+C(U(%1D("AC=6UU;&%T
M:79E(&QO<W-E<R!I;B!R96-E;G0@>65A<G,@87,@=V5L;"!A<R!T:&4@:6UP
M86-T(&]F(&]N92UT:6UE(&5V96YT<R!I;B!A<W-E<W-I;F<@;W5R('!R92UT
M87@@96%R;FEN9W,N("D@5&H@150@40IQ(# @," P(')G($)4(#0X,2XX,B Q
M-S@N,C4@5&0@*$%S<W5M<'1I;VYS("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-C8N,C4@5&0@*')E9V%R9&EN
M9R!F=71U<F4@=&%X86)L92!I;F-O;64@<F5Q=6ER92!S:6=N:69I8V%N="!J
M=61G;65N="X@3W5R(&%S<W5M<'1I;VYS(&%R92!C;VYS:7-T96YT('=I=&@@
M97-T:6UA=&5S(&%N9"!P;&%N<R!U<V5D('1O("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-30N,C4@5&0@*&UA
M;F%G92!O=7(@8G5S:6YE<W,L('=H:6-H(&EN8VQU9&5S(')E<W1R=6-T=7)I
M;F<@86YD(&]T:&5R(&EN:71I871I=F5S+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S0N,C4@5&0@*$EN('1H
M92!E=F5N="!T:&%T(&%C='5A;"!R97-U;'1S(&1I9BD@5&H@150@40IQ(# @
M," P(')G($)4(#$X,RXQ,2 Q,S0N,C4@5&0@*&9E<B!F<F]M('1H97-E(&5S
M=&EM871E<RP@;W(@=V4@861J=7-T('1H97-E(&5S=&EM871E<R!I;B!F=71U
M<F4@<&5R:6]D<R!F;W(@8W5R<F5N="!T<F5N9',@;W(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$R,BXR-2!4
M9" H8VAA;F=E<R!I;B!O=7(@97-T:6UA=&EN9R!A<W-U;7!T:6]N<RP@=V4@
M;6%Y(&UO9&EF>2!T:&4@;&5V96P@;V8@=&AE('9A;'5A=&EO;B!A;&QO=V%N
M8V4@=VAI8V@@8V]U;&0@;6%T97)I86QL>2!I;7!A8W0@;W5R("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,3 N
M,C4@5&0@*&)U<VEN97-S+"!F:6YA;F-I86P@8V]N9&ET:6]N(&%N9"!R97-U
M;'1S(&]F(&]P97)A=&EO;G,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#DP+C(U(%1D("A!<R!O9B!$96-E;6)E
M<B S,2P@,C Q."!A;F0@,C Q-RP@=V4@:&%D('9A;'5A=&EO;B!A;&QO=V%N
M8V5S(&]N(&]U<B!D969E<G)E9"!T87@@87-S971S(&]F("0Q+C(@;6EL;&EO
M;B!A;F0@)#$N,2!M:6QL:6]N+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-S@N,C4@5&0@*')E<W!E8W1I=F5L
M>2D@5&H@150@40IQ(# @," P(')G($)4(#DW+C8V(#<X+C(U(%1D("@N($9O
M<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q-RP@=V4@<F5D=6-E
M9"!T:&4@=F%L=6%T:6]N(&%L;&]W86YC92!R96-O<F1E9"!B>2 D-#4N-"!M
M:6QL:6]N(%PH8V]M<')I<V5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V-BXR-2!49" H;V8@)#$U+C<@;6EL
M;&EO;B!R96QA=&5D('1O(%4N4RX@;F5T(&]P97)A=&EN9R!L;W-S97,L("0T
M+C0@;6EL;&EO;B!R96QA=&5D('1O('-T871E(&YE="!O<&5R871I;F<@;&]S
M<V5S+"!A;F0@)#(U+C,@;6EL;&EO;B!R96QA=&5D("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-"XR-2!49" H
M=&\@;W1H97(@;F5T(&1E9F5R<F5D('1A>"!A<W-E='-<*2!P<F5D;VUI;F%N
M=&QY(&]N('1H92!B87-I<R!O9B!M86YA9V5M96YTDBD@5&H@150@40IQ(# @
M," P(')G($)4(#,U,BXY-B U-"XR-2!49" H<R!R96%S<V5S<VUE;G0@;V8@
M9&5F97)R960@=&%X(&%S<V5T<R!T:&%T(&%R92!M;W)E("D@5&H@150@40IE
M;F1S=')E86T*96YD;V)J"C<Y(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N
M=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R
M8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@.# @,"!2/CX*96YD;V)J
M"C@P(# @;V)J"CP\+TQE;F=T:" X,3,Y/CX*<W1R96%M"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H,S8I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-S0R+C$P(%1D("AL:6ME;'D@=&AA;B!N;W0@=&\@8F4@<F5A;&EZ960N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$V."XY-2 W-#(N,3 @5&0@*%1H92!V
M86QU871I;VX@86QL;W=A;F-E(&]N(&$@<&]R=&EO;B!O9B!S=&%T92!N970@
M;W!E<F%T:6YG(&QO<W-E<R!N;W0@;6]R92!L:6ME;'D@=&AA;B!N;W0@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<S,"XQ,"!49" H<F5A;&EZ86)L92!W87,@;F]T(')E;&5A<V5D(&1U92!T
M;R!T:&4@<F5S<&5C=&EV92!E>'!I<F%T:6]N('!E<FEO9',@86YD('-P96-I
M9FEC('-T871E('1A>&%B;&4@:6YC;VUE('!R;VIE8W1I;VYS+B @*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3 U+CDS(#<S,"XQ,"!49" H07,@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<Q."XQ,"!49" H1&5C96UB97(@,S$L(#(P,3@L(&UA;F%G96UE;G0@9&5T
M97)M:6YE9"!T:&%T('1H97)E('=A<R!S=68I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#0N-S,@-S$X+C$P(%1D("AF:6-I96YT('!O<VET:79E(&5V:61E
M;F-E('1O(&-O;F-L=61E('1H870@:70@=V%S(&UO<F4@;&EK96QY("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W
M,#8N,3 @5&0@*'1H86X@;F]T('1H870@;W5R(&YE="!D969E<G)E9"!T87@@
M87-S971S('=E<F4@<F5A;&EZ86)L92!W:71H('1H92!E>&-E<'1I;VX@;V8@
M82!P;W)T:6]N(&]F('-T871E(&YE="!O<&5R871I;F<@;&]S<V5S+B!3964@
M3F]T92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-CDT+C$P(%1D("@Q,R M($EN8V]M92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,# N-C,@-CDT+C$P(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3 V+C T(#8Y-"XQ,"!49" H87AE<R!T;R!O=7(@8V]N<V]L
M:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-S0N,3 @5&0@*%<I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" V-S0N,3 @5&0@*&4@87)E
M('-U8FIE8W0@=&\@:6YC;VUE('1A>&5S(&EN('1H92!5+E,N(&%N9"!C97)T
M86EN(&9O<F5I9VX@:G5R:7-D:6-T:6]N<RX@4VEG;FEF:6-A;G0@:G5D9VUE
M;G0@:7,@<F5Q=6ER960@:6X@9&5T97)M:6YI;F<@;W5R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-C(N,3 @
M5&0@*&-O;G-O;&ED871E9"!P<F]V:7-I;VX@9F]R(&EN8V]M92!T87AE<R!A
M;F0@<F5C;W)D:6YG('1H92!R96QA=&5D(&1E9F5R<F5D('1A>"!A<W-E=',@
M86YD(&QI86)I;&ET:65S+B!);B!T:&4@;W)D:6YA<GD@8V]U<G-E(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V-3 N,3 @5&0@*&]U<B!B=7-I;F5S<R!T:&5R92!A<F4@;6%N>2!T<F%N
M<V%C=&EO;G,@86YD(&-A;&-U;&%T:6]N<R!W:&5R92!T:&4@=6QT:6UA=&4@
M=&%X(&1E=&5R;6EN871I;VX@:7,@=6YC97)T86EN+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T.#(N,#@@-C4P+C$P(%1D("A!8V-R=6%L<R!F;W(@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8S."XQ,"!49" H=6YR96-O9VYI>F5D('1A>"!B96YE9FET<R!A<F4@<')O
M=FED960@9F]R(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q-"XX." V,S@N,3 @
M5&0@*$EN8V]M92!4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4Q+C0V(#8S
M."XQ,"!49" H87AE<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S<Q+C<R(#8S."XQ,"!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#,W-RXQ,R V,S@N,3 @5&0@*&]P:6,@;V8@=&AE($8I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T,C<N,C(@-C,X+C$P(%1D("A!4T(@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#0X+C8R(#8S."XQ,"!49" H05-#+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S(N-3(@-C,X+C$P(%1D("A!;B!U
M;G)E8V]G;FEZ960@=&%X("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V,C8N,3 @5&0@*&)E;F5F:70@<F5P<F5S
M96YT<R!T:&4@9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30X+CDU(#8R
M-BXQ,"!49" H9F5R96YC92!B971W965N('1H92!R96-O9VYI=&EO;B!O9B!B
M96YE9FET<R!R96QA=&5D('1O(&5X<&]S=7)E(&ET96US(&9O<B!I;F-O;64@
M=&%X(')E<&]R=&EN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C$T+C$P(%1D("AP=7)P;W-E<R!A;F0@9FEN
M86YC:6%L(')E<&]R=&EN9R!P=7)P;W-E<RX@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C(R+C P(#8Q-"XQ,"!49" H5&AE(&-U<G)E;G0@<&]R=&EO;B!O
M9B!T:&4@=6YR96-O9VYI>F5D('1A>"!B96YE9FET(&ES(&-L87-S:69I960@
M87,@82!C;VUP;VYE;G0@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#8P,BXQ,"!49" H;W1H97(@8W5R<F5N
M="!L:6%B:6QI=&EE<RP@86YD('1H92!N;VXM8W5R<F5N="!P;W)T:6]N(&ES
M(&EN8VQU9&5D('=I=&AI;B!O=&AE<B!L;VYG+71E<FT@;&EA8FEL:71I97,@
M;VX@=&AE(&-O;G-O;&ED871E9"!B86QA;F-E("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U.3 N,3 @5&0@*'-H
M965T<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S@N.#D@-3DP+C$P(%1D
M("A!<R!O9B!$96-E;6)E<B S,2P@,C Q."P@=&]T86P@=6YR96-O9VYI>F5D
M('1A>"!B96YE9FET<R!R96-O<F1E9"!W87,@)#4N-"!M:6QL:6]N+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T,C$N-C8@-3DP+C$P(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#,P+C,P(#4Y,"XQ,"!49" H92!R97-E<G9E
M(&9O<B!I;G1E<F5S="!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#4W."XQ,"!49" H<&5N86QT:65S(&]N
M(&5X<&]S=7)E(&ET96US+"!I9B!A<'!L:6-A8FQE+"!W:&EC:"!I<R!R96-O
M<F1E9"!A<R!A(&-O;7!O;F5N="!O9B!T:&4@;W9E<F%L;"!I;F-O;64@=&%X
M('!R;W9I<VEO;BX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#4U-"XQ,"!49" H5RD@5&H@150@40IQ(# @," P
M(')G($)4(#4X+C8T(#4U-"XQ,"!49" H92!A<F4@<F5G=6QA<FQY('5N9&5R
M(&%U9&ET(&)Y('1A>"!A=71H;W)I=&EE<RX@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C0P+C4R(#4U-"XQ,"!49" H06QT:&]U9V@@=&AE(&]U=&-O;64@
M;V8@=&%X(&%U9&ET<R!I<R!A;'=A>7,@=6YC97)T86EN+"!W92!B96QI979E
M('1H870@=V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4T,BXQ,"!49" H:&%V92!A<'!R;W!R:6%T92!S=7!P
M;W)T(&9O<B!T:&4@<&]S:71I;VYS('1A:V5N(&]N(&]U<B!T87@@<F5T=7)N
M<R!A;F0@=&AA="!O=7(@86YN=6%L('1A>"!P<F]V:7-I;VX@:6YC;'5D97,@
M86UO=6YT<R!S=68I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S4N-30@-30R
M+C$P(%1D("AF:6-I96YT("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," U,S N,3 @5&0@*'1O('!A>2!A;GD@87-S
M97-S;65N=',N($YO;F5T:&5L97-S+"!T:&4@86UO=6YT<R!U;'1I;6%T96QY
M('!A:60L(&EF(&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#,T,"XQ,R U
M,S N,3 @5&0@*"P@=7!O;B!R97-O;'5T:6]N(&]F('1H92!I<W-U97,@<F%I
M<V5D(&)Y('1H92!T87AI;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#4Q."XQ,"!49" H875T:&]R:71I97,@
M;6%Y(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#$R-2XS-B U,3@N,3 @
M5&0@*&9E<B!M871E<FEA;&QY(&9R;VT@=&AE(&%M;W5N=',@86-C<G5E9"!F
M;W(@96%C:"!Y96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0P+C(U(#4Q
M."XQ,"!49" H+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," T.30N,3 @5&0@*%)E8V5N=" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" X,2XS." T.30N,3 @5&0@*$%C8V]U;G1I;F<@4'(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-#,N,3,@-#DT+C$P(%1D("AO;F]U;F-E
M;65N=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#0W,"XQ,"!49" H4V5E($YO=&4@,B M(%-U;6UA<GD@;V8@
M4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C P+C(U(#0W
M,"XQ,"!49" H06-C;W5N=&EN9R!0;VQI8VEE<R!T;R!O=7(@8V]N<V]L:61A
M=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+BD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T-#8N,3 @5&0@*%-E87-O
M;F%L:71Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#0S-"XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,C(N,3 @5&0@*%1H92!N=6UB
M97(@;V8@:&5A;'1H8V%R92!P<F]F97-S:6]N86QS(&]N(&%S<VEG;FUE;G0@
M=VET:"!U<R!I<R!S=6)J96-T('1O('-E87-O;F%L(&9L=6-T=6%T:6]N<R!W
M:&EC:"!M87D@:6UP86-T(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-#$P+C$P(%1D("AQ=6%R=&5R;'D@
M<F5V96YU92!A;F0@96%R;FEN9W,N($AO<W!I=&%L('!A=&EE;G0@8V5N<W5S
M(&%N9"!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S U+C Q(#0Q,"XQ
M,"!49" H9FEN9R!N965D<R!O9B!O=7(@:&]S<&ET86P@86YD(&AE86QT:&-A
M<F4@9F%C:6QI=&EE<R!F;'5C='5A=&4L("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S.3@N,3 @5&0@*'=H:6-H
M(&EM<&%C="!O=7(@;G5M8F5R(&]F(&]R9&5R<R!F;W(@82!P87)T:6-U;&%R
M('!E<FEO9"X@36%N>2!O9B!O=7(@:&]S<&ET86P@86YD(&AE86QT:&-A<F4@
M9F%C:6QI='D@8VQI96YT<R!A<F4@;&]C871E9"!I;B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,S@V+C$P(%1D
M("AA<F5A<R!T:&%T(&5X<&5R:65N8V4@<V5A<V]N86P@9FQU8W1U871I;VYS
M(&EN('!O<'5L871I;VX@9'5R:6YG('1H92!W:6YT97(@86YD('-U;6UE<B!M
M;VYT:',N("D@5&H@150@40IQ(# @," P(')G($)4(#0S-2XR-R S.#8N,3 @
M5&0@*%1H97-E(&9A8VEL:71I97,@861J=7-T('1H96ER("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-S0N,3 @
M5&0@*'-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-"XR-B S-S0N,3 @
M5&0@*&9I;F<@;&5V96QS('1O(&%C8V]M;6]D871E('1H92!C:&%N9V4@:6X@
M=&AI<R!S96%S;VYA;"!D96UA;F0@86YD(&UA;GD@;V8@=&AE<V4@9F%C:6QI
M=&EE<R!U=&EL:7IE('1E;7!O<F%R>2!H96%L=&AC87)E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S-C(N,3 @
M5&0@*'!R;V9E<W-I;VYA;',@=&\@<V%T:7-F>2!T:&5S92!S96%S;VYA;"!S
M=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$W+C@T(#,V,BXQ,"!49" H
M9FEN9R!N965D<RX@3&EK97=I<V4L('1H92!N=6UB97(@;V8@;G5R<V4@86YD
M(&%L;&EE9"!P<F]F97-S:6]N86QS(&]N(&%S<VEG;FUE;G0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,U,"XQ
M,"!49" H;6%Y(&9L=6-T=6%T92!D=64@=&\@=&AE('-E87-O;F%L('!R969E
M<F5N8V5S(&9O<B!D97-T:6YA=&EO;G,@;V8@;W5R('1E;7!O<F%R>2!N=7)S
M92!A;F0@86QL:65D('!R;V9E<W-I;VYA;',N($EN(&%D9&ET:6]N+"!W92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @,S,X+C$P(%1D("AE>'!E8W0@;W5R(%!H>7-I8VEA;B!3=&%F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,34Q+C<T(#,S."XQ,"!49" H9FEN9R!B=7-I
M;F5S<R!T;R!E>'!E<FEE;F-E(&AI9VAE<B!D96UA;F0@:6X@=&AE('-U;6UE
M<B!M;VYT:',@87,@<&AY<VEC:6%N<R!T86ME('9A8V%T:6]N<RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3,S+CDV(#,S."XQ,"!49" H5RD@5&H@150@
M40IQ(# @," P(')G($)4(#4T,BXV," S,S@N,3 @5&0@*&4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,R-BXQ
M,"!49" H86QS;R!E>'!E8W0@;W5R(&5D=6-A=&EO;B!A;F0@<V-H;V]L(&)U
M<VEN97-S('1O(&5X<&5R:65N8V4@;&]W97(@9&5M86YD(&EN('1H92!S=6UM
M97(@;6]N=&AS('=H96X@<'5B;&EC(&%N9"!C:&%R=&5R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S,30N,3 @
M5&0@*'-C:&]O;',@87)E(&-L;W-E9"X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3(W+C4W(#,Q-"XQ,"!49" H5&AI<R!H:7-T;W)I8V%L('-E87-O;F%L
M:71Y(&]F(')E=F5N=64@86YD(&5A<FYI;F=S(&UA>2!V87)Y(&1U92!T;R!A
M('9A<FEE='D@;V8@9F%C=&]R<R!A;F0@=&AE(')E<W5L=',@;V8@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,P
M,BXQ,"!49" H86YY(&]N92!Q=6%R=&5R(&%R92!N;W0@;F5C97-S87)I;'D@
M:6YD:6-A=&EV92!O9B!T:&4@<F5S=6QT<R!T;R!B92!E>'!E8W1E9"!F;W(@
M86YY(&]T:&5R('%U87)T97(@;W(@9F]R(&%N>2!Y96%R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#DQ+C0X(#,P,BXQ,"!49" H+B!);B!A9&1I=&EO;BP@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#(Y,"XQ,"!49" H='EP:6-A;&QY*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@.#0N,S0@,CDP+C$P(%1D("@L(&]U<B!F:7)S="!Q=6%R=&5R(')E<W5L
M=',@87)E(&YE9V%T:79E;'D@:6UP86-T960@8GD@=&AE(')E<V5T(&]F('!A
M>7)O;&P@=&%X97,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#(V-BXQ,"!49" H26YF;&%T:6]N("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-30N
M,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,C0R+C$P(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N-C0@,C0R+C$P(%1D("AE(&1O(&YO="!B96QI979E('1H870@:6YF
M;&%T:6]N(&AA9"!A('-I9VYI9FEC86YT(&EM<&%C="!O;B!O=7(@<F5S=6QT
M<R!O9B!O<&5R871I;VYS(&9O<B!T:&4@<&5R:6]D<R!P<F5S96YT960N($]N
M(&%N(&]N9V]I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#(S,"XQ,"!49" H8F%S:7,L('=E('-E96L@=&\@
M96YS=7)E('1H870@8FEL;&EN9R!R871E<R!R969L96-T(&EN8W)E87-E<R!I
M;B!C;W-T<R!D=64@=&\@:6YF;&%T:6]N+B!);B!A9&1I=&EO;BP@=V4@871T
M96UP="!T;R!M:6YI;6EZ92!A;GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q."XQ,"!49" H<F5S:61U86P@
M:6UP86-T(&]N(&]U<B!O<&5R871I;F<@<F5S=6QT<R!B>2!C;VYT<F]L;&EN
M9R!O<&5R871I;F<@8V]S=',N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*
M.#$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O
M>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T
M92 P"B]#;VYT96YT<R X,B P(%(^/@IE;F1O8FH*.#(@,"!O8FH*/#PO3&5N
M9W1H(#$Q-3(S/CX*<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,P,2XP," S,2XV,"!49" H,S<I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S0R+C(U(%1D("A)=&5M
M("D@5&H@150@40IQ(# @," P(')G($)4(#<R+C0Y(#<T,BXR-2!49" H-T$N
M("D@5&H@150@40IQ(# @," P(')G($)4(#@Y+C<Q(#<T,BXR-2!49" H("D@
M5&H@150@40IQ(# @," P(')G($)4(#DR+C(Q(#<T,BXR-2!49" H("D@5&H@
M150@40IQ(# @," P(')G($)4(#DT+C<Q(#<T,BXR-2!49" H("D@5&H@150@
M40IQ(# @," P(')G($)4(#DW+C(Q(#<T,BXR-2!49" H("D@5&H@150@40IQ
M(# @," P(')G($)4(#DY+C<Q(#<T,BXR-2!49" H("D@5&H@150@40IQ(# @
M," P(')G($)4(#$P,BXR,2 W-#(N,C4@5&0@*" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#0N-S$@-S0R+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3 W+C(Q(#<T,BXR-2!49" H475A;G1I=&%T:79E("D@5&H@150@
M40IQ(# @," P(')G($)4(#$V,RXV," W-#(N,C4@5&0@*&%N9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.#(N,C(@-S0R+C(U(%1D("A1=6%L:71A=&EV
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S(N-3 @-S0R+C(U(%1D("A$
M:7-C;&]S=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S(N,S$@-S0R+C(U
M(%1D("AE<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#,N,30@-S0R+C(U
M(%1D("AA8F]U=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3 N,3 @-S0R
M+C(U(%1D("A-87)K970@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0T+C@P
M(#<T,BXR-2!49" H4FES:RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S$X+C(U(%1D("A);G1E<F5S="!2871E
M(%)I<VLI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-CDT+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3@N-C0@-CDT+C(U(%1D("AE(&%R92!E>'!O<V5D('1O('1H92!R:7-K(&]F
M(&9L=6-T=6%T:6]N(&EN(&EN=&5R97-T(')A=&5S(')E;&%T:6YG('1O(&]U
M<B!O=71S=&%N9&EN9R!S96YI;W(@<V5C=7)E9"!T97)M(&QO86X@96YT97)E
M9"!I;G1O(&]N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," V.#(N,C4@5&0@*$%U9W5S=" Q+" R,#$W('=I=&@@
M82!V87)I86)L92!I;G1E<F5S="!R871E+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,C<N,3@@-C@R+C(U(%1D("A!<R!A(')E<W5L="P@=V4@96YT97)E
M9"!I;G1O(&%N(&EN=&5R97-T(')A=&4@<W=A<"!A9W)E96UE;G0@=VAI8V@@
M968I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#(N,38@-C@R+C(U(%1D("AF
M96-T:79E;'D@9FEX960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8W,"XR-2!49" H=&AE(&EN=&5R97-T(')A
M=&4@;VX@-3 E(&]F('1H92!A;6]R=&EZ:6YG(&)A;&%N8V4@;V8@;W5R('1E
M<FT@9&5B="P@97AC;'5S:79E(&]F('1H92!C<F5D:70@<W!R96%D(&]N('1H
M92!D96)T+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.3 N-#D@-C<P+C(U
M(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DY+C$S(#8W,"XR-2!4
M9" H92!H879E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," V-3@N,C4@5&0@*&1E=&5R;6EN960@=&AA="!T:&4@
M:6YT97)E<W0@<F%T92!S=V%P('%U86QI9FEE<R!A<R!A(&-A<V@@9FQO=R!H
M961G92!I;B!A8V-O<F1A;F-E('=I=&@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-# Q+C@Q(#8U."XR-2!49" H06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D
M:69I8V%T:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,"XP," V-#8N,C4@5&0@*%PH05-#7"D@.#$U+" I(%1J($54
M(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3@N-C$@-C0V
M+C(U(%1D("A$97)I=F%T:79E<R!A;F0@2&5D9VEN9RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3DN,34@-C0V+C(U(%1D
M("@N(%-E92!.;W1E(#(@+2!3=6UM87)Y(&]F(%-I9VYI9FEC86YT("D@5&H@
M150@40IQ(# @," P(')G($)4(#,U-"XT," V-#8N,C4@5&0@*$%C8V]U;G1I
M;F<@4&]L:6-I97,@86YD($YO=&4@.2 M($1E<FEV871I=F4@=&\@;W5R("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V,S0N,C4@5&0@*&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT
M<RX@17AC;'5D:6YG('1H92!I;7!A8W0@;V8@;W5R(&EN=&5R97-T(')A=&4@
M<W=A<"!A9W)E96UE;G1S+"!A(#$E(&-H86YG92!I;B!I;G1E<F5S="!R871E
M<R!O;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-C(R+C(U(%1D("AV87)I86)L92!R871E(&1E8G0@=V]U;&0@
M:&%V92!R97-U;'1E9"!I;B!I;G1E<F5S="!E>'!E;G-E(&9L=6-T=6%T:6YG
M(&%P<')O>&EM871E;'D@)#$N,*!M:6QL:6]N+" D,"XW(&UI;&QI;VXL(&%N
M9" D,"XT(&UI;&QI;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8Q,"XR-2!49" H9F]R('1H92!Y96%R<R!E
M;F1E9"!$96-E;6)E<B S,2P@,C Q."P@,C Q-RP@86YD(#(P,38N($-O;G-I
M9&5R:6YG('1H92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#,U,RXP-R V
M,3 N,C4@5&0@*&9E8W0@;V8@;W5R(&EN=&5R97-T(')A=&4@<W=A<"!A9W)E
M96UE;G0@:6X@82 Q)2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-3DX+C(U(%1D("AC:&%N9V4@:6X@:6YT97)E
M<W0@<F%T97,@;VX@;W5R('9A<FEA8FQE(')A=&4@9&5B="!W;W5L9"!H879E
M(')E<W5L=&5D(&EN(&EN=&5R97-T(&5X<&5N<V4@9FQU8W1U871I;F<@87!P
M<F]X:6UA=&5L>2 D,"XVH&UI;&QI;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X-BXR-2!49" H9F]R('1H
M92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+BD@5&H@150@40I"5" O
M1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-3 N,C4@5&0@
M*$9O<F5I9VX@0W5R<F5N8WD@4FES:RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U,C8N,C4@5&0@*%<I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U."XV-" U,C8N,C4@5&0@*&4@:&%V92!M:6YO
M<B!E>'!O<W5R92!T;R!T:&4@:6UP86-T(&]F(&9O<F5I9VX@8W5R<F5N8WD@
M9FQU8W1U871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S<N.3D@
M-3(V+C(U(%1D("A!<'!R;WAI;6%T96QY(#$E(&]F('-E;&QI;F<L(&=E;F5R
M86P@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," U,30N,C4@5&0@*&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S
M(&%R92!R96QA=&5D('1O(&-E<G1A:6X@<V]F='=A<F4@9&5V96QO<&UE;G0@
M86YD(&EN9F]R;6%T:6]N('1E8VAN;VQO9WD@<W5P<&]R="!P<F]V:61E9"!B
M>2!O=7(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4P,BXR-2!49" H96UP;&]Y965S(&EN(%!U;F4L($EN9&EA
M+B!#:&%N9V5S(&EN(&9O<F5I9VX@8W5R<F5N8WD@97AC:&%N9V4@<F%T97,@
M:6UP86-T('1R86YS;&%T:6]N<R!O9B!F;W)E:6=N(&1E;F]M:6YA=&5D(&%S
M<V5T<R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#0Y,"XR-2!49" H;&EA8FEL:71I97,@:6YT;R!5+E,N
M(&1O;&QA<G,@86YD(&9U='5R92!E87)N:6YG<R!A;F0@8V%S:"!F;&]W<R!F
M<F]M('1R86YS86-T:6]N<R!D96YO;6EN871E9"!I;B!D:68I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-#8N.34@-#DP+C(U(%1D("AF97)E;G0@8W5R<F5N
M8VEE<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$X+C8W(#0Y,"XR-2!4
M9" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4R-RXS,2 T.3 N,C4@5&0@
M*&4@:&%V92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-#<X+C(U(%1D("AN;W0@96YT97)E9"!I;G1O(&%N>2!F
M;W)E:6=N(&-U<G)E;F-Y(&AE9&=E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#4T+C(U(%1D("A/=7(@:6YT
M97)N871I;VYA;"!O<&5R871I;VYS('1R86YS86-T(&)U<VEN97-S(&EN('1H
M96ER(&9U;F-T:6]N86P@8W5R<F5N8WDI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S-#,N-S @-#4T+C(U(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4
M(#,T."XQ-2 T-30N,C4@5&0@*$%S(&$@<F5S=6QT+"!F;'5C='5A=&EO;G,@
M:6X@=&AE('9A;'5E(&]F(&9O<F5I9VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXR-2!49" H8W5R<F5N
M8VEE<R!A9V%I;G-T('1H92!5+E,N(&1O;&QA<B!H879E(&%N(&EM<&%C="!O
M;B!R97!O<G1E9"!R97-U;'1S+B!%>'!E;G-E<R!D96YO;6EN871E9"!I;B!F
M;W)E:6=N(&-U<G)E;F-I97,@87)E('1R86YS;&%T960@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0S,"XR-2!4
M9" H:6YT;R!5+E,N(&1O;&QA<G,@870@;6]N=&AL>2!A=F5R86=E(&5X8VAA
M;F=E(')A=&5S('!R979A:6QI;F<@9'5R:6YG('1H92!P97)I;V0N($-O;G-E
M<75E;G1L>2D@5&H@150@40IQ(# @," P(')G($)4(#0S,"XP." T,S N,C4@
M5&0@*"P@87,@=&AE('9A;'5E(&]F('1H92!5+E,N(&1O;&QA<B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X
M+C(U(%1D("AC:&%N9V5S(')E;&%T:79E('1O('1H92!C=7)R96YC:65S(&]F
M(&]U<B!N;VXM52Y3+B!M87)K971S+"!O=7(@<F5P;W)T960@<F5S=6QT<R!V
M87)Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@U+C W(#0Q."XR-2!49" H
M+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," T,#8N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,SDT+C(U(%1D("A&;'5C='5A=&EO;G,@
M:6X@97AC:&%N9V4@<F%T97,@86QS;R!I;7!A8W0@=&AE(%4N4RX@9&]L;&%R
M(&%M;W5N="!O9B!S=&]C:VAO;&1E<G.2*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S<Y+C0V(#,Y-"XR-2!49" H(&5Q=6ET>2D@5&H@150@40IQ(# @," P
M(')G($)4(#0P-BXS," S.30N,C4@5&0@*"X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#$Q+C$R(#,Y-"XR-2!49" H5&AE(&%S<V5T<R!A;F0@;&EA8FEL
M:71I97,@;V8@;W5R(&YO;BTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @,S@R+C(U(%1D("A5+E,N('-U8G-I9&EA
M<FEE<R!A<F4@=')A;G-L871E9"!I;G1O(%4N4RX@9&]L;&%R<R!A="!T:&4@
M97AC:&%N9V4@<F%T92!I;B!E9BD@5&H@150@40IQ(# @," P(')G($)4(#,T
M-"XQ-R S.#(N,C4@5&0@*&9E8W0@870@=&AE(&5N9"!O9B!A(')E<&]R=&EN
M9R!P97)I;V0N("D@5&H@150@40IQ(# @," P(')G($)4(#0Y,"XS,B S.#(N
M,C4@5&0@*%1H92!R97-U;'1I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W,"XR-2!49" H=')A;G-L871I
M;VX@861J=7-T;65N=',@87)E(')E8V]R9&5D(&EN('-T;V-K:&]L9&5R<Y(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C N-3@@,S<P+C(U(%1D("@@97%U
M:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@W+C0S(#,W,"XR-2!49" H
M+"!A<R!A(&-O;7!O;F5N="!O9B!A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H
M96YS:79E(&QO<W,L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S-3@N,C4@5&0@*&EN8VQU9&5D(&EN(&]T:&5R
M('-T;V-K:&]L9&5R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S,N,SD@
M,S4X+C(U(%1D("@@97%U:71Y(&]N(&]U<B!C;VYS;VQI9&%T960@8F%L86YC
M92!S:&5E=',N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#,R,BXR-2!49" H271E;2 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" W,BXT.2 S,C(N,C4@5&0@*#@N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<Y+CDY(#,R,BXR-2!49" HH" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" X-"XY.2 S,C(N,C4@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" X-RXT.2 S,C(N,C4@5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" X.2XY.2 S,C(N,C4@5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Y,BXT.2 S,C(N,C4@5&0@*" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y-"XY.2 S,C(N,C4@5&0@*" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Y-RXT.2 S,C(N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Y.2XY.2 S,C(N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,#(N-#D@,S(R+C(U(%1D("@@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$P-"XY.2 S,C(N,C4@5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q,#<N-#D@,S(R+C(U(%1D("A&:6YA;F-I86P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34P+C P(#,R,BXR-2!49" H4W1A
M=&5M96YT<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3DN-S$@,S(R+C(U
M(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C,S(#,R,BXR
M-2!49" H4W5P<&QE;65N=&%R>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.#8N,SD@,S(R+C(U(%1D("A$871A+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R.3@N,C4@5&0@*%-E92!)=&5M
M(#$U()8@17AH:6)I=',L($9I;F%N8VEA;"!3=&%T96UE;G0@4V-H961U;&5S
M(&]F(%!A<G0@258I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3$N,38@,CDX
M+C(U(%1D("@@;V8@=&AI<R!297!O<G0N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(X-BXR-2!49" HH"D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R
M-S0N,C4@5&0@*$ET96T@.2X@(" @(" @(" @($-H86YG97,@:6X@86YD($1I
M<V%G<BD@5&H@150@40IQ(# @," P(')G($)4(#(P-"XR." R-S0N,C4@5&0@
M*&5E;65N=',@=VET:" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C(N,#4@
M,C<T+C(U(%1D("A!8V-O=6YT86YT<R!O;B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,S N,SD@,C<T+C(U(%1D("A!8V-O=6YT:6YG(&%N9"!&:6YA;F-I
M86P@1&ES8VQO<W5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@R+C<S(#(W
M-"XR-2!49" H92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,C4P+C(U(%1D("A.;VYE+BD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,C8N,C4@5&0@
M*$ET96T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S(N-#D@,C(V+C(U(%1D
M("@Y02XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.#<N,C$@,C(V+C(U(%1D("B@("D@5&H@150@40IQ(# @," P(')G($)4
M(#DR+C(Q(#(R-BXR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DT
M+C<Q(#(R-BXR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DW+C(Q
M(#(R-BXR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DY+C<Q(#(R
M-BXR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#$P,BXR,2 R,C8N
M,C4@5&0@*" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3 T+C<Q(#(R-BXR-2!49" H("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P-RXR,2 R,C8N,C4@5&0@*$-O;G1R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3,R+C4X(#(R-BXR-2!49" H;VQS("D@5&H@150@40IQ(# @," P
M(')G($)4(#$T-BXW-2 R,C8N,C4@5&0@*&%N9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-C4N,S@@,C(V+C(U(%1D("A0<BD@5&H@150@40IQ(# @," P
M(')G($)4(#$W-2XW-" R,C8N,C4@5&0@*&]C961U<BD@5&H@150@40IQ(# @
M," P(')G($)4(#(P-2XP," R,C8N,C4@5&0@*&5S+BD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,#(N,C4@5&0@
M*$5V86QU871I;VX@;V8@1&ES8VQO<W5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,30Y+C@S(#(P,BXR-2!49" H92!#;VYT<BD@5&H@150@40IQ(# @," P
M(')G($)4(#$X,BXQ-" R,#(N,C4@5&0@*&]L<R!A;F0@4'(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,C4N,S @,C R+C(U(%1D("AO8V5D=7(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R-30N-38@,C R+C(U(%1D("AE<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q-S@N
M,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XV-" Q-S@N,C4@
M5&0@*&4@8V%R<FEE9"!O=70@86X@979A;'5A=&EO;BP@=6YD97(@=&AE('-U
M<&5R=FES:6]N(&%N9"!W:71H('1H92!P87)T:6-I<&%T:6]N(&]F(&]U<B!#
M:&EE9B!%>&5C=71I=F4@3V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C<N
M-#D@,3<X+C(U(%1D("AF:6-E<B!A;F0@0VAI968@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$V-BXR-2!49" H
M1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 P+C X(#$V
M-BXR-2!49" H9FEC97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,3@N,# @
M,38V+C(U(%1D("@L(&]F('1H92!E9BD@5&H@150@40IQ(# @," P(')G($)4
M(#$U-BXQ,R Q-C8N,C4@5&0@*&9E8W1I=F5N97-S(&]F('1H92!D97-I9VX@
M86YD(&]P97)A=&EO;B!O9B!O=7(@(F1I<V-L;W-U<F4@8V]N=')O;',@86YD
M('!R;V-E9'5R97,B(%PH87,@9&5F:6YE9"!I;B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,34T+C(U(%1D("A2
M=6QE<R Q,V$M,35<*&5<*2!A;F0@,35D+3$U7"AE7"D@;V8@=&AE(%-E8W5R
M:71I97,@17AC:&%N9V4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@T+C,W
M(#$U-"XR-2!49" H06-T(&]F(#$Y,S0L(&%S(&%M96YD960L(&]R('1H92!%
M>&-H86YG92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-34N.3@@,34T+C(U
M(%1D("A!8W1<*2P@87,@;V8@=&AE(&5N9"!O9B!T:&4@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$T,BXR-2!4
M9" H<&5R:6]D(&-O=F5R960@8GD@=&AI<R!R97!O<G0N($)A<V5D('5P;VX@
M=&AE(&5V86QU871I;VXL(&]U<B!#:&EE9B!%>&5C=71I=F4@3V8I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-S0N-S(@,30R+C(U(%1D("AF:6-E<B!A;F0@
M0VAI968@1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@W
M+C(X(#$T,BXR-2!49" H9FEC97(@8V]N8VQU9&5D("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,S N,C4@5&0@
M*'1H870@;W5R(&1I<V-L;W-U<F4@8V]N=')O;',@86YD('!R;V-E9'5R97,@
M87)E(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0V+C8Y(#$S,"XR-2!4
M9" H9F5C=&EV92X@1&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@<')O8V5D=7)E
M<R!A<F4@9&5S:6=N960@=&\@96YS=7)E('1H870@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$Q."XR-2!49" H
M:6YF;W)M871I;VX@<F5Q=6ER960@=&\@8F4@9&ES8VQO<V5D(&EN(&]U<B!R
M97!O<G1S(&9I;&5D(&]R('-U8FUI='1E9"!U;F1E<B!T:&4@17AC:&%N9V4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# X+C<Y(#$Q."XR-2!49" H06-T
M(&ES(')E8V]R9&5D+"!P<F]C97-S960L("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," Q,#8N,C4@5&0@*'-U;6UA
M<FEZ960L(&-O;6UU;FEC871E9"!T;R!M86YA9V5M96YT+"!I;F-L=61I;F<@
M=&AE($-H:65F($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," P(')G($)4
M(#,V-"XQ-R Q,#8N,C4@5&0@*&9I8V5R(&%N9"!T:&4@0VAI968@1FEN86YC
M:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DQ+C0T(#$P-BXR-2!4
M9" H9FEC97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#DN,S4@,3 V+C(U
M(%1D("@L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @.30N,C4@5&0@*')E<&]R=&5D('=I=&AI;B!T:&4@
M=&EM92!P97)I;V1S('-P96-I9FEE9"!I;B!T:&4@4V5C=7)I=&EE<R!A;F0@
M17AC:&%N9V4@0V]M;6ES<VEO;I(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M.3@N-3,@.30N,C4@5&0@*',@<G5L97,@86YD(&9O<FUS+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-S$N.34@.30N,C4@5&0@*%1H92!D:7-C;&]S=7)E
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," X,BXR-2!49" H8V]N=')O;',@86YD('!R;V-E9'5R97,@87)E(&1E
M<VEG;F5D('1O(&5N<W5R92!T:&%T(&EN9F]R;6%T:6]N(')E<75I<F5D('1O
M(&)E(&1I<V-L;W-E9"!B>2!U<R!I;B!R97!O<G1S(')E<75I<F5D('5N9&5R
M('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S N,C4@5&0@*$5X8VAA;F=E("D@5&H@150@40IQ(# @," P
M(')G($)4(#DQ+C,W(#<P+C(U(%1D("A!8W0@;V8@,3DS-"P@87,@86UE;F1E
M9"P@:7,@86-C=6UU;&%T960@86YD(&-O;6UU;FEC871E9"!T;R!O=7(@;6%N
M86=E;65N="P@:6YC;'5D:6YG('1H92!#:&EE9B!%>&5C=71I=F4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4X
M+C(U(%1D("A/9BD@5&H@150@40IQ(# @," P(')G($)4(#8P+C,W(#4X+C(U
M(%1D("AF:6-E<B!A;F0@0VAI968@1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3<R+CDR(#4X+C(U(%1D("AF:6-E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#$Y,"XX-" U."XR-2!49" H+"!I;B!O<F1E<B!T;R!A
M;&QO=R!T:6UE;'D@9&5C:7-I;VYS(')E9V%R9&EN9R!A;GD@<F5Q=6ER960@
M9&ES8VQO<W5R92X@*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*.#,@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R X-" P(%(^/@IE;F1O8FH*.#0@,"!O8FH*/#PO3&5N9W1H(#,W
M,3<^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S Q+C P(#,Q+C8P(%1D("@S."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," W-#(N,C4@5&0@*$-H86YG97,@:6X@
M26YT97)N86P@0V]N='(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C(N.#D@
M-S0R+C(U(%1D("AO;"!/=F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DT
M+C8T(#<T,BXR-2!49" H($9I;F%N8VEA;"!297!O<G1I;F<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$X+C(U
M(%1D("A4:&5R92!W97)E(&YO(&-H86YG97,@:6X@;W5R(&EN=&5R;F%L(&-O
M;G1R;VQS(&]V97(@9FEN86YC:6%L(')E<&]R=&EN9R!D=7)I;F<@,C Q."!T
M:&%T(&AA=F4@;6%T97)I86QL>2!A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#0W-BXS,R W,3@N,C4@5&0@*&9E8W1E9"P@;W(@87)E("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,#8N,C4@
M5&0@*')E87-O;F%B;'D@;&EK96QY('1O(&UA=&5R:6%L;'D@868I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.#$N.3D@-S V+C(U(%1D("AF96-T+"!O=7(@
M:6YT97)N86P@8V]N=')O;',@;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG+BD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," V.#(N,C4@5&0@*$UA;F%G96UE;G22*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3 Y+C V(#8X,BXR-2!49" H<R!297!O<G0@;VX@26YT97)N86P@0V]N
M='(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C,N.#<@-C@R+C(U(%1D("AO
M;"!/=F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4U+C8S(#8X,BXR-2!4
M9" H($9I;F%N8VEA;"!297!O<G1I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X+C(U(%1D("A/=7(@;6%N
M86=E;65N="!I<R!R97-P;VYS:6)L92!F;W(@97-T86)L:7-H:6YG(&%N9"!M
M86EN=&%I;FEN9R!A9&5Q=6%T92!I;G1E<FYA;"!C;VYT<F]L(&]V97(@9FEN
M86YC:6%L(')E<&]R=&EN9R!<*&%S(&1E9FEN960@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8T-BXR-2!49" H
M:6X@4G5L92 Q,V$M,35<*&9<*2!U;F1E<B!T:&4@17AC:&%N9V4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C S+C(X(#8T-BXR-2!49" H06-T7"DN($]U
M<B!I;G1E<FYA;"!C;VYT<F]L('-Y<W1E;2!I<R!D97-I9VYE9"!T;R!P<F]V
M:61E(')E87-O;F%B;&4@87-S=7)A;F-E(')E9V%R9&EN9R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C,T+C(U
M(%1D("AT:&4@<F5L:6%B:6QI='D@;V8@9FEN86YC:6%L(')E<&]R=&EN9R!A
M;F0@=&AE('!R97!A<F%T:6]N(&]F(&9I;F%N8VEA;"!S=&%T96UE;G1S(&9O
M<B!E>'1E<FYA;"!P=7)P;W-E<R!I;B!A8V-O<F1A;F-E('=I=&@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8R
M,BXR-2!49" H9V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I
M<&QE<RX@0F5C875S92!O9B!I=',@:6YH97)E;G0@;&EM:71A=&EO;G,L(&EN
M=&5R;F%L(&-O;G1R;VP@;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG(&UA>2!N
M;W0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#8Q,"XR-2!49" H<')E=F5N="!O<B!D971E8W0@;6ES<W1A=&5M
M96YT<RX@4')O:F5C=&EO;G,@;V8@86YY(&5V86QU871I;VX@;V8@968I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,3DN,3@@-C$P+C(U(%1D("AF96-T:79E
M;F5S<R!T;R!F=71U<F4@<&5R:6]D<R!A<F4@<W5B:F5C="!T;R!T:&4@<FES
M:W,@=&AA=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-3DX+C(U(%1D("AC;VYT<F]L<R!M87D@8F5C;VUE(&EN
M861E<75A=&4@8F5C875S92!O9B!C:&%N9V5S(&EN(&-O;F1I=&EO;G,@;W(@
M=&AA="!T:&4@9&5G<F5E(&]F(&-O;7!L:6%N8V4@=VET:"!T:&4@<&]L:6-I
M97,@;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4X-BXR-2!49" H<')O8V5D=7)E<R!M87D@9&5T97)I;W)A
M=&4N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#4V,BXR-2!49" H36%N86=E;65N="!C;VYD=6-T960@86X@979A
M;'5A=&EO;B!O9B!T:&4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S<N
M-3(@-38R+C(U(%1D("AF96-T:79E;F5S<R!O9B!O=7(@:6YT97)N86P@8V]N
M=')O;"!O=F5R(&9I;F%N8VEA;"!R97!O<G1I;F<@87,@;V8@1&5C96UB97(@
M,S$L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," U-3 N,C4@5&0@*#(P,3@N($EN(&UA:VEN9R!T:&ES(&%S<V5S
M<VUE;G0L(&UA;F%G96UE;G0@=7-E9"!T:&4@8W)I=&5R:6$@<V5T(&9O<G1H
M(&)Y('1H92!#;VUM:71T964@;V8@4W!O;G-O<FEN9R!/<BD@5&H@150@40IQ
M(# @," P(')G($)4(#0X,RXV,B U-3 N,C4@5&0@*&=A;FEZ871I;VYS(&]F
M('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-3,X+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-34N-S8@-3,X+C(U(%1D("AR96%D=V%Y($-O;6UI<W-I;VXL(&]R($-/4T\L
M(&EN('1H92!);G1E<FYA;"!#;VYT<F]L+4EN=&5G<F%T960@1G)A;65W;W)K
M(%PH,C Q,R!F<F%M97=O<FM<*2XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-3$T+C(U(%1D("A"87-E9"!O;B!I
M=',@979A;'5A=&EO;BP@;6%N86=E;65N="!C;VYC;'5D960@=&AA="P@87,@
M;V8@1&5C96UB97(@,S$L(#(P,3@L(&]U<B!I;G1E<FYA;"!C;VYT<F]L(&]V
M97(@9FEN86YC:6%L(')E<&]R=&EN9R!I<R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3 R+C(U(%1D("AE9BD@
M5&H@150@40IQ(# @," P(')G($)4(#4W+C4Y(#4P,BXR-2!49" H9F5C=&EV
M92!B87-E9"!O;B!T:&4@<W!E8VEF:6,@8W)I=&5R:6$N*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0W."XR-2!4
M9" H071T97-T871I;VX@4F5P;W)T(&]F($EN9&5P96YD96YT(%)E9VES=&5R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,T+C<Y(#0W."XR-2!49" H960@
M4'5B;&EC("D@5&H@150@40IQ(# @," P(')G($)4(#(W-BXT-R T-S@N,C4@
M5&0@*$%C8V]U;G1I;F<@1FER;2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," T-30N,C4@5&0@*$]U<B!I;F1E<&5N
M9&5N="!R96=I<W1E<F5D('!U8FQI8R!A8V-O=6YT:6YG(&9I<FT@:&%S(&ES
M<W5E9"!A;B!A='1E<W1A=&EO;B!R97!O<G0@;VX@;W5R(&EN=&5R;F%L(&-O
M;G1R;VP@;W9E<B!F:6YA;F-I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXR-2!49" H<F5P;W)T:6YG
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,2XT-R T-#(N,C4@5&0@*%1H
M:7,@<F5P;W)T(&%P<&5A<G,@;VX@<&%G92 S."XI(%1J($54(%$*96YD<W1R
M96%M"F5N9&]B:@HX-2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P
M(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R
M(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#@V(# @4CX^"F5N9&]B:@HX-B P
M(&]B:@H\/"],96YG=&@@.3$T,CX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#,Y*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$S-2XT," W-#(N
M,C4@5&0@*%)%4$]2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<P+C U(#<T
M,BXR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$W-BXU-" W-#(N
M,C4@5&0@*"!/1BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,BXU-2 W-#(N
M,C4@5&0@*"!)3D1%4$5.1$5.5"D@5&H@150@40IQ(# @," P(')G($)4(#(V
M-RXV-B W-#(N,C4@5&0@*"!214=)4U1%4D5$(%!50DQ)0R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-S<N.3<@-S0R+C(U(%1D("A!0T-/54Y424Y'($9)
M4DTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-CDT+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-34N
M-#$@-CDT+C(U(%1D("AO('1H92!3=&]C:VAO;&1E<G,@86YD('1H92!";V%R
M9"!O9B!$:7)E8W1O<G,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#8X,BXR-2!49" H0W)O<W,@0V]U;G1R
M>2!(96%L=&AC87)E+"!);F,N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V-S N,C4@5&0@*$)O8V$@4F%T;VXL
M($9L;W)I9&$I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-C4P+C(U(%1D("A/<&EN:6]N(&]N($EN=&5R;F%L($-O
M;G1R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38S+C0U(#8U,"XR-2!49" H
M;VP@;W9E<BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,BXT,R V-3 N,C4@
M5&0@*"!&:6YA;F-I86P@4F5P;W)T:6YG*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8S,"XR-2!49" H5RD@5&H@
M150@40IQ(# @," P(')G($)4(#4X+C8T(#8S,"XR-2!49" H92!H879E(&%U
M9&ET960@=&AE(&EN=&5R;F%L(&-O;G1R;VP@;W9E<B!F:6YA;F-I86P@<F5P
M;W)T:6YG(&]F($-R;W-S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( IQ(# N,#<T-3 Y
M.# S.3(Q-38X-C,@,"XP-S0U,#DX,#,Y,C$U-C@V,R P+C W-#4P.3@P,SDR
M,34V.#8S(')G($)4(#,R-RXY.2 V,S N,C4@5&0@*"!#;W5N=')Y($AE86QT
M:&-A<F4L($EN8RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*
M+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"G$@," P(# @<F<@0E0@
M-#(Y+C,T(#8S,"XR-2!49" H(&%N9"!S=6)S:61I87)I97,@7"AT:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8Q."XR-2!49" HDT-O;7!A;GF47"D@87,@;V8@1&5C96UB97(@,S$L(#(P
M,3@L(&)A<V5D(&]N(&-R:71E<FEA(&5S=&%B;&ES:&5D(&EN("D@5&H@150@
M40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S0N-C,@-C$X
M+C(U(%1D("A);G1E<FYA;"!#;VYT<BD@5&H@150@40IQ(# @," P(')G($)4
M(#,Y,BXS,2 V,3@N,C4@5&0@*&]L("T@26YT96=R871E9"!&<F%M97=O<FL@
M7"@R,#$S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(X+C0P(#8Q."XR-2!49" H(&ES<W5E9" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C V+C(U(%1D
M("AB>2!T:&4@0V]M;6ET=&5E(&]F(%-P;VYS;W)I;F<@3W(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.3,N-#(@-C V+C(U(%1D("AG86YI>F%T:6]N<R!O
M9B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8V+C@S(#8P-BXR-2!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(W,BXU." V,#8N,C4@5&0@
M*')E861W87D@0V]M;6ES<VEO;B!<*$-/4T]<*2X@26X@;W5R(&]P:6YI;VXL
M('1H92!#;VUP86YY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U.30N,C4@5&0@*&UA:6YT86EN960L(&EN(&%L
M;"!M871E<FEA;"!R97-P96-T<RP@968I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R,#(N,C8@-3DT+C(U(%1D("AF96-T:79E(&EN=&5R;F%L(&-O;G1R;VP@
M;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG(&%S(&]F($1E8V5M8F5R(#,Q+" R
M,#$X+"!B87-E9"!O;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-3@R+C(U(%1D("AC<FET97)I82!E<W1A8FQI
M<VAE9"!I;B I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3,X+C R(#4X,BXR-2!49" H26YT97)N86P@0V]N='(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.34N-S$@-3@R+C(U(%1D("AO;" M($EN=&5G
M<F%T960@1G)A;65W;W)K(%PH,C Q,UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,S,2XW.2 U.#(N,C4@5&0@*"!I<W-U
M960@8GD@0T]33RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-38R+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3@N-C0@-38R+C(U(%1D("AE(&AA=F4@86QS;R!A=61I=&5D+"!I
M;B!A8V-O<F1A;F-E('=I=&@@=&AE('-T86YD87)D<R!O9B!T:&4@4'5B;&EC
M($-O;7!A;GD@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C0T(#4V,BXR
M-2!49" H06-C;W5N=&EN9R!/=F5R<VEG:'0@0F]A<F0@7"A5;FET960@4W1A
M=&5S7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#4U,"XR-2!49" H7"A00T%/0EPI('1H92!C;VYS;VQI9&%T
M960@9FEN86YC:6%L('-T871E;65N=',@87,@;V8@86YD(&9O<B!T:&4@>65A
M<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q."P@;V8@=&AE($-O;7!A;GD@86YD
M(&]U<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-3,X+C(U(%1D("AR97!O<G0@9&%T960@1F5B<G5A<GD@,C@L
M(#(P,3D@97AP<F5S<V5D(&%N('5N<75A;&EF:65D(&]P:6YI;VX@;VX@=&AO
M<V4@9FEN86YC:6%L('-T871E;65N=',N*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Q."XR-2!49" H0F%S:7,@
M9F]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#<N,S(@-3$X+C(U(%1D("@@
M3W!I;FEO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," T.3@N,C4@5&0@*%1H92!#;VUP86YYDBD@5&H@150@40IQ
M(# @," P(')G($)4(#$P.2XW,2 T.3@N,C4@5&0@*',@;6%N86=E;65N="!I
M<R!R97-P;VYS:6)L92!F;W(@;6%I;G1A:6YI;F<@968I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R.3@N.3,@-#DX+C(U(%1D("AF96-T:79E(&EN=&5R;F%L
M(&-O;G1R;VP@;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG(&%N9"!F;W(@:71S
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," T.#8N,C4@5&0@*&%S<V5S<VUE;G0@;V8@=&AE(&5F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3,P+C W(#0X-BXR-2!49" H9F5C=&EV96YE<W,@
M;V8@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I;F%N8VEA;"!R97!O<G1I;F<L
M(&EN8VQU9&5D(&EN('1H92!A8V-O;7!A;GEI;F<@*2!4:B!%5"!1"D)4("]&
M-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,RXX-" T.#8N,C4@5&0@
M*$UA;F%G96UE;G0G<R!297!O<G0@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#0W-"XR-2!49" H;VX@26YT97)N
M86P@0V]N='(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C N,3D@-#<T+C(U
M(%1D("AO;"!O=F5R($9I;F%N8VEA;"!297!O<G1I;F<I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,R+C$Q(#0W-"XR-2!4
M9" H+B!/=7(@<F5S<&]N<VEB:6QI='D@:7,@=&\@97AP<F5S<R!A;B!O<&EN
M:6]N(&]N('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#0W
M-RXY,B T-S0N,C4@5&0@*',@:6YT97)N86P@8V]N=')O;" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#8R+C(U
M(%1D("AO=F5R(&9I;F%N8VEA;"!R97!O<G1I;F<@8F%S960@;VX@;W5R(&%U
M9&ET+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C4N,S(@-#8R+C(U(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,S+CDV(#0V,BXR-2!49" H
M92!A<F4@82!P=6)L:6,@86-C;W5N=&EN9R!F:7)M(')E9VES=&5R960@=VET
M:"!T:&4@4$-!3T(@86YD(&%R92!R97%U:7)E9"!T;R!B92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#4P+C(U
M(%1D("AI;F1E<&5N9&5N="!W:71H(')E<W!E8W0@=&\@=&AE($-O;7!A;GD@
M:6X@86-C;W)D86YC92!W:71H('1H92!5+E,N(&9E9&5R86P@<V5C=7)I=&EE
M<R!L87=S(&%N9"!T:&4@87!P;&EC86)L92!R=6QE<R!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0S."XR
M-2!49" H<F5G=6QA=&EO;G,@;V8@=&AE(%-E8W5R:71I97,@86YD($5X8VAA
M;F=E($-O;6UI<W-I;VX@86YD('1H92!00T%/0BXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X+C(U(%1D("A7
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C0@-#$X+C(U(%1D("AE(&-O
M;F1U8W1E9"!O=7(@875D:70@:6X@86-C;W)D86YC92!W:71H('1H92!S=&%N
M9&%R9',@;V8@=&AE(%!#04]"+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M-#0N,C$@-#$X+C(U(%1D("A4:&]S92!S=&%N9&%R9',@<F5Q=6ER92!T:&%T
M('=E('!L86X@86YD('!E<F9O<FT@=&AE("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T,#8N,C4@5&0@*&%U9&ET
M('1O(&]B=&%I;B!R96%S;VYA8FQE(&%S<W5R86YC92!A8F]U="!W:&5T:&5R
M(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8S+CDP(#0P-BXR-2!49" H
M9F5C=&EV92!I;G1E<FYA;"!C;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R
M=&EN9R!W87,@;6%I;G1A:6YE9"!I;B!A;&P@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Y-"XR-2!49" H;6%T
M97)I86P@<F5S<&5C=',N($]U<B!A=61I="!I;F-L=61E9"!O8G1A:6YI;F<@
M86X@=6YD97)S=&%N9&EN9R!O9B!I;G1E<FYA;"!C;VYT<F]L(&]V97(@9FEN
M86YC:6%L(')E<&]R=&EN9RP@87-S97-S:6YG('1H92!R:7-K("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," S.#(N
M,C4@5&0@*'1H870@82!M871E<FEA;"!W96%K;F5S<R!E>&ES=',L('1E<W1I
M;F<@86YD(&5V86QU871I;F<@=&AE(&1E<VEG;B!A;F0@;W!E<F%T:6YG(&5F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<V+C8V(#,X,BXR-2!49" H9F5C
M=&EV96YE<W,@;V8@:6YT97)N86P@8V]N=')O;"!B87-E9"!O;B!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#,W,"XR-2!49" H87-S97-S960@<FES:RP@86YD('!E<F9O<FUI;F<@<W5C
M:"!O=&AE<B!P<F]C961U<F5S(&%S('=E(&-O;G-I9&5R960@;F5C97-S87)Y
M(&EN('1H92!C:7)C=6US=&%N8V5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-3DN-C@@,S<P+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#8X+C,R(#,W,"XR-2!49" H92!B96QI979E('1H870@;W5R(&%U9&ET("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," S-3@N,C4@5&0@*'!R;W9I9&5S(&$@<F5A<V]N86)L92!B87-I<R!F;W(@
M;W5R(&]P:6YI;VXN("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," S,S@N,C4@5&0@*$1E9FEN:71I;VX@86YD($QI
M;6ET871I;VYS(&]F($EN=&5R;F%L($-O;G1R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C,Y+C4U(#,S."XR-2!49" H;VP@;W9E<BD@5&H@150@40IQ(# @
M," P(')G($)4(#(V."XU,R S,S@N,C4@5&0@*"!&:6YA;F-I86P@4F5P;W)T
M:6YG*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#,Q."XR-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#4V
M+C8W(#,Q."XR-2!49" H(&-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@.3@N-C @,S$X+C(U(%1D("AS(&EN=&5R;F%L(&-O;G1R;VP@;W9E<B!F
M:6YA;F-I86P@<F5P;W)T:6YG(&ES(&$@<')O8V5S<R!D97-I9VYE9"!T;R!P
M<F]V:61E(')E87-O;F%B;&4@87-S=7)A;F-E(')E9V%R9&EN9R!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#,P-BXR-2!49" H<F5L:6%B:6QI='D@;V8@9FEN86YC:6%L(')E<&]R=&EN
M9R!A;F0@=&AE('!R97!A<F%T:6]N(&]F(&9I;F%N8VEA;"!S=&%T96UE;G1S
M(&9O<B!E>'1E<FYA;"!P=7)P;W-E<R!I;B!A8V-O<F1A;F-E('=I=&@@9V5N
M97)A;&QY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," R.30N,C4@5&0@*&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I
M;F-I<&QE<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<W+C<R(#(Y-"XR
M-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#$X-"XS.2 R.30N,C4@
M5&0@*"!C;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#(R-BXS,R R
M.30N,C4@5&0@*',@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I;F%N8VEA;"!R
M97!O<G1I;F<@:6YC;'5D97,@=&AO<V4@<&]L:6-I97,@86YD('!R;V-E9'5R
M97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#(X,BXR-2!49" H=&AA="!<*#%<*2!P97)T86EN('1O('1H92!M
M86EN=&5N86YC92!O9B!R96-O<F1S('1H870L(&EN(')E87-O;F%B;&4@9&5T
M86EL+"!A8V-U<F%T96QY(&%N9"!F86ER;'D@<F5F;&5C="!T:&4@=')A;G-A
M8W1I;VYS(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @,C<P+C(U(%1D("AD:7-P;W-I=&EO;G,@;V8@=&AE
M(&%S<V5T<R!O9B!T:&4@8V]M<&%N>3L@7"@R7"D@<')O=FED92!R96%S;VYA
M8FQE(&%S<W5R86YC92!T:&%T('1R86YS86-T:6]N<R!A<F4@<F5C;W)D960@
M87,@;F5C97-S87)Y('1O('!E<FUI=" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C4X+C(U(%1D("AP<F5P87)A
M=&EO;B!O9B!F:6YA;F-I86P@<W1A=&5M96YT<R!I;B!A8V-O<F1A;F-E('=I
M=&@@9V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<RP@
M86YD('1H870@<F5C96EP=',@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R-#8N,C4@5&0@*&5X<&5N9&ET
M=7)E<R!O9B!T:&4@8V]M<&%N>2!A<F4@8F5I;F<@;6%D92!O;FQY(&EN(&%C
M8V]R9&%N8V4@=VET:"!A=71H;W)I>F%T:6]N<R!O9B!M86YA9V5M96YT(&%N
M9"!D:7)E8W1O<G,@;V8@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," R,S0N,C4@5&0@*&-O;7!A;GD[(&%N
M9"!<*#-<*2!P<F]V:61E(')E87-O;F%B;&4@87-S=7)A;F-E(')E9V%R9&EN
M9R!P<F5V96YT:6]N(&]R('1I;65L>2!D971E8W1I;VX@;V8@=6YA=71H;W)I
M>F5D(&%C<75I<VET:6]N+"!U<V4L(&]R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," R,C(N,C4@5&0@*&1I<W!O
M<VET:6]N(&]F('1H92!C;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4
M(#$V,2XS." R,C(N,C4@5&0@*',@87-S971S('1H870@8V]U;&0@:&%V92!A
M(&UA=&5R:6%L(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S V+CDW(#(R
M,BXR-2!49" H9F5C="!O;B!T:&4@9FEN86YC:6%L('-T871E;65N=',N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#(P,BXR-2!49" H0F5C875S92!O9B!I=',@:6YH97)E;G0@;&EM:71A=&EO
M;G,L(&EN=&5R;F%L(&-O;G1R;VP@;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG
M(&UA>2!N;W0@<')E=F5N="!O<B!D971E8W0@;6ES<W1A=&5M96YT<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3$X+C(P(#(P,BXR-2!49" H06QS;RP@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#$Y,"XR-2!49" H<')O:F5C=&EO;G,@;V8@86YY(&5V86QU871I;VX@
M;V8@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#<N,C<@,3DP+C(U(%1D
M("AF96-T:79E;F5S<R!T;R!F=71U<F4@<&5R:6]D<R!A<F4@<W5B:F5C="!T
M;R!T:&4@<FES:R!T:&%T(&-O;G1R;VQS(&UA>2!B96-O;64@:6YA9&5Q=6%T
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @,3<X+C(U(%1D("AB96-A=7-E(&]F(&-H86YG97,@:6X@8V]N9&ET
M:6]N<RP@;W(@=&AA="!T:&4@9&5G<F5E(&]F(&-O;7!L:6%N8V4@=VET:"!T
M:&4@<&]L:6-I97,@;W(@<')O8V5D=7)E<R!M87D@9&5T97)I;W)A=&4N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P
M(#$T.2XT,B!49" H+W,O($1%3$])5%1%("8@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3(U+CDU(#$T.2XT,B!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#$S,2XX." Q-#DN-#(@5&0@*$]50TA%($Q,4"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," Q,3DN-#(@5&0@
M*$)O8V$@4F%T;VXL($9L;W)I9&$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @,3 T+C0R(%1D("A&96)R=6%R>2 R
M."P@,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*96YD<W1R96%M
M"F5N9&]B:@HX-R P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*
M+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @
M4@HO4F]T871E(# *+T-O;G1E;G1S(#@X(# @4CX^"F5N9&]B:@HX." P(&]B
M:@H\/"],96YG=&@@,38R-S<^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P(%1D("@T,"D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W-#(N,C4@
M5&0@*$ET96T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S(N-#D@-S0R+C(U
M(%1D("@Y0BZ@("D@5&H@150@40IQ(# @," P(')G($)4(#DQ+C8V(#<T,BXR
M-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#DT+C$V(#<T,BXR-2!4
M9" H("D@5&H@150@40IQ(# @," P(')G($)4(#DV+C8V(#<T,BXR-2!49" H
M("D@5&H@150@40IQ(# @," P(')G($)4(#DY+C$V(#<T,BXR-2!49" H("D@
M5&H@150@40IQ(# @," P(')G($)4(#$P,2XV-B W-#(N,C4@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q,#0N,38@-S0R+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3 V+C8V(#<T,BXR-2!49" H3W1H97(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q,S(N,#,@-S0R+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3,T+C4S(#<T,BXR-2!49" H26YF;W)M871I
M;VXN*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<Q."XR-2!49" H3F]N92XI(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C@U+CDP(#8Y-"XR-2!49" H4"D@5&H@
M150@40IQ(# @," P(')G($)4(#(Y,2XR-R V.30N,C4@5&0@*$%2*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S U+C,V(#8Y-"XR-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#,Q,2XX-2 V.30N,C4@5&0@*"!)24DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C@R
M+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8W,"XR-2!49" H271E;2 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" W,BXT.2 V-S N,C4@5&0@*#$P+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" X-RXT.2 V-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" X.2XY.2 V-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Y,BXT.2 V-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y
M-"XY.2 V-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-RXT
M.2 V-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y.2XY.2 V
M-S N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#(N-#D@-C<P
M+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 T+CDY(#8W,"XR
M-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#$P-RXT.2 V-S N,C4@
M5&0@*$1I<BD@5&H@150@40IQ(# @," P(')G($)4(#$R,2XW-2 V-S N,C4@
M5&0@*&5C=&]R<RP@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34R+C(Y(#8W
M,"XR-2!49" H17AE8W5T:79E("D@5&H@150@40IQ(# @," P(')G($)4(#$Y
M-BXT-" V-S N,C4@5&0@*$]F9FEC97)S("D@5&H@150@40IQ(# @," P(')G
M($)4(#(S,RXS-B V-S N,C4@5&0@*&%N9" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-3$N.3D@-C<P+C(U(%1D("A#;W)P;W)A=&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDX+CDR(#8W,"XR-2!49" H1V]V97)N86YC92XI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-C0V+C(U(%1D("A);F9O<FUA=&EO;B!W:71H(')E<W!E8W0@=&\@9&ER96-T
M;W)S+"!E>&5C=71I=F4@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3 N
M-3@@-C0V+C(U(%1D("AF:6-E<G,@86YD(&-O<G!O<F%T92!G;W9E<FYA;F-E
M(&ES(&EN8VQU9&5D(&EN(&]U<B!0<F]X>2!3=&%T96UE;G0@9F]R('1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C,T+C(U(%1D("@R,#$Y("D@5&H@150@40IQ(# @," P(')G($)4(#<Q
M+CDU(#8S-"XR-2!49" H06YN=6%L($UE971I;F<@;V8@4W1O8VMH;VQD97)S
M(%PH4')O>'D@4W1A=&5M96YT7"D@=&\@8F4@9FEL960@<'5R<W5A;G0@=&\@
M4F5G=6QA=&EO;J Q-$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S0N,3$@
M-C,T+C(U(%1D("@@=VET:"!T:&4@4T5#(&%N9"!S=6-H("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V,C(N,C4@
M5&0@*&EN9F]R;6%T:6]N(&ES(&EN8V]R<&]R871E9"!H97)E:6X@8GD@<F5F
M97)E;F-E+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," V,3 N,C4@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3DX+C(U(%1D("A)=&5M("D@
M5&H@150@40IQ(# @," P(')G($)4(#<R+C0Y(#4Y."XR-2!49" H,2D@5&H@
M150@40IQ(# @," P(')G($)4(#<V+CDT(#4Y."XR-2!49" H,2X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#8N.30@-3DX+C(U(%1D("@@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@.#DN-#0@-3DX+C(U(%1D("@@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@.3$N.30@-3DX+C(U(%1D("@@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@.30N-#0@-3DX+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@.38N.30@-3DX+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@.3DN-#0@-3DX+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 Q+CDT(#4Y."XR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#$P
M-"XT-" U.3@N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#8N
M.30@-3DX+C(U(%1D("A%>&5C=71I=F4@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,34Q+C Y(#4Y."XR-2!49" H0V]M<&5N<V%T:6]N+BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-S0N,C4@
M5&0@*$EN9F]R;6%T:6]N('=I=&@@<F5S<&5C="!T;R!E>&5C=71I=F4@8V]M
M<&5N<V%T:6]N(&ES(&EN8VQU9&5D(&EN(&]U<B!0<F]X>2!3=&%T96UE;G0@
M=&\@8F4@9FEL960@=VET:"!T:&4@4T5#(&%N9"!S=6-H("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-C(N,C4@
M5&0@*&EN9F]R;6%T:6]N(&ES(&EN8V]R<&]R871E9"!H97)E:6X@8GD@<F5F
M97)E;F-E+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," U-3 N,C4@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3,X+C(U(%1D("A)=&5M("D@
M5&H@150@40IQ(# @," P(')G($)4(#<R+C0Y(#4S."XR-2!49" H,3(NH" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" X.2XY.2 U,S@N,C4@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Y,BXT.2 U,S@N,C4@5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Y-"XY.2 U,S@N,C4@5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Y-RXT.2 U,S@N,C4@5&0@*" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y.2XY.2 U,S@N,C4@5&0@*" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#(N-#D@-3,X+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3 T+CDY(#4S."XR-2!49" H("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P-RXT.2 U,S@N,C4@5&0@*%-E8W5R:71Y("D@5&H@150@40IQ(# @
M," P(')G($)4(#$T-2XU-" U,S@N,C4@5&0@*$]W;F5R<VAI<" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.34N,C<@-3,X+C(U(%1D("AO9B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,#8N,3 @-3,X+C(U(%1D("A#97)T86EN("D@
M5&H@150@40IQ(# @," P(')G($)4(#(T,2XS-R U,S@N,C4@5&0@*$)E;F5F
M:6-I86P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@V+C X(#4S."XR-2!4
M9" H3W=N97)S("D@5&H@150@40IQ(# @," P(')G($)4(#,R,2XY,2 U,S@N
M,C4@5&0@*&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-# N-3,@-3,X
M+C(U(%1D("A-86YA9V5M96YT("D@5&H@150@40IQ(# @," P(')G($)4(#,Y
M.2XQ,R U,S@N,C4@5&0@*&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M,3<N-S4@-3,X+C(U(%1D("A296QA=&5D("D@5&H@150@40IQ(# @," P(')G
M($)4(#0U,RXP,B U,S@N,C4@5&0@*%-T;V-K:&]L9&5R<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" U,3$N,#@@-3,X+C(U(%1D("A-871T97)S+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U
M,30N,C4@5&0@*$EN9F]R;6%T:6]N('=I=&@@<F5S<&5C="!T;R!B96YE9FEC
M:6%L(&]W;F5R<VAI<"!O9B!O=7(@8V]M;6]N('-T;V-K(&ES(&EN8VQU9&5D
M(&EN(&]U<B!0<F]X>2!3=&%T96UE;G0@=&\@8F4@9FEL960@=VET:"!T:&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#4P,BXR-2!49" H4T5#(&%N9"!S=6-H(&EN9F]R;6%T:6]N(&ES(&EN
M8V]R<&]R871E9"!H97)E:6X@8GD@<F5F97)E;F-E+BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T.3 N,C4@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-#<X+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3DN
M,#0@-#<X+C(U(%1D("AI=&@@<F5S<&5C="!T;R!E<75I='D@8V]M<&5N<V%T
M:6]N('!L86YS(&%S(&]F($1E8V5M8F5RH#,Q+" R,#$X+"!S964@=&%B;&4@
M8F5L;W<Z*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C4P(#,T,"XW-2 R-3(N,# @+3(V+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#(N-3 @
M,S0P+C<U(#@T+C P("TR-BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@V+C4P(#,T,"XW-2 T+C P("TR
M-BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,SDP+C4P(#,T,"XW-2 X-"XP," M,C8N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-"XU
M," S-# N-S4@-"XP," M,C8N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W."XU," S-# N-S4@.#0N,# @
M+3(V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,"XU," R.#@N-S4@,C4R+C P("TQ."XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S R
M+C4P(#(X."XW-2 X-"XP," M,3@N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X-BXU," R.#@N-S4@-"XP
M," M,3@N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,Y,"XU," R.#@N-S4@.#0N,# @+3$X+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-S0N-3 @,C@X+C<U(#0N,# @+3$X+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S@N-3 @,C@X+C<U(#@T
M+C P("TQ."XP,"!R92!F"B]'4S @9W,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S R+C4@,S0P+C<U(&T*,S@V
M+C4@,S0P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS.3 N-2 S-# N-S4@;0HT-S0N-2 S-# N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0W."XU(#,T,"XW-2!M"C4V,BXU(#,T,"XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S R
M+C4@,C@X+C<U(&T*,S@V+C4@,C@X+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.3 N-2 R.#@N-S4@
M;0HT-S0N-2 R.#@N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0W."XU(#(X."XW-2!M"C4V,BXU(#(X
M."XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S R+C4@,C<Q+C<U(&T*,S@V+C4@,C<Q+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS,#(N-2 R-CDN-S4@;0HS.#8N-2 R-CDN-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y,"XU(#(W
M,2XW-2!M"C0W-"XU(#(W,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,SDP+C4@,C8Y+C<U(&T*-#<T
M+C4@,C8Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT-S@N-2 R-S$N-S4@;0HU-C(N-2 R-S$N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0W."XU(#(V.2XW-2!M"C4V,BXU(#(V.2XW-2!L"G,*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,S0U+C0S(%1D("A0
M;&%NH$-A=&5G;W)Y*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,R,"XX-2 T,34N-#,@5&0@*$YU;6)E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#,U-BXR,B T,34N-#,@5&0@*"!O9B I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$X+C4U(#0P-2XT
M,R!49" H<V5C=7)I=&EE<R!T;RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,3(N-34@,SDU+C0S(%1D("AB92!I<W-U960@
M=7!O;B I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S(W+C$U(#,X-2XT,R!49" H97AE<BD@5&H@150@40IQ(# @," P(')G
M($)4(#,T-2XR." S.#4N-#,@5&0@*&-I<V4I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S$S+C(U(#,W-2XT,R!49" H;V8@
M;W5T<W1A;F1I;F<@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,R-RXQ-2 S-C4N-#,@5&0@*&]P=&EO;G,L*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q-2XR," S-34N
M-#,@5&0@*'=A<G)A;G1S(&%N9" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S(T+C0P(#,T-2XT,R!49" H<FEG:'1S(%PH
M85PI*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,Y,RXS-2 S.34N-#,@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M,#(N.# @,SDU+C0S(%1D("AE:6=H=&5D+6%V97)A9V4I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C8U(#,X-2XT,R!4
M9" H97AE<BD@5&H@150@40IQ(# @," P(')G($)4(#0Q-2XW." S.#4N-#,@
M5&0@*&-I<V4@<')I8V4@;V8I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# V+C<P(#,W-2XT,R!49" H;W5T<W1A;F1I;F<@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q
M-2XQ-2 S-C4N-#,@5&0@*&]P=&EO;G,L*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P,RXR," S-34N-#,@5&0@*'=A<G)A
M;G1S(&%N9"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,3(N,3 @,S0U+C0S(%1D("AR:6=H=',@7"AB7"DI(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DV+C@U(#0U-2XT
M,R!49" H3G5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,R+C(R(#0U
M-2XT,R!49" H(&]F("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,# N,# @-#0U+C0S(%1D("AS96-U<FET:65S*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y."XQ," T
M,S4N-#,@5&0@*'(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#(N,S8@-#,U
M+C0S(%1D("AE;6%I;FEN9R I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DS+C(U(#0R-2XT,R!49" H879A:6QA8FQE(&9O
M<BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#<N-S @-#$U+C0S(%1D("AF=71U<BD@5&H@150@40IQ(# @," P(')G($)4
M(#4P.2XW-" T,34N-#,@5&0@*&4@:7-S=6%N8V4@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P-RXS," T,#4N-#,@5&0@
M*'5N9&5R*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P-BXV-2 S.34N-#,@5&0@*&5Q=6ET>2 I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C4U(#,X-2XT,R!49" H
M8V]M<&5N<V%T:6]N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0X-2XQ," S-S4N-#,@5&0@*'!L86YS(%PH97AC;'5D:6YG
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M,"XP," S-C4N-#,@5&0@*'-E8W5R:71I97,@*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y-BXP-2 S-34N-#,@5&0@*'(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,# N,S$@,S4U+C0S(%1D("AE9FQE
M8W1E9"!I;BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.#,N-34@,S0U+C0S(%1D("AC;VQU;6X@7"AA7"E<*2!<*&-<*2 I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"D)4("]&,B V+C4P(%1F($54
M"G$@," P(# @<F<@0E0@-30X+C@Q(#,T.2XY-B!49" H7"@Q7"DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,S,P
M+C,W(%1D("A%<75I='D@8V]M<&5N<V%T:6]N('!L86YS(&%P<')O=F5DH&)Y
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#,R,"XS-R!49" HH* @<V5C=7)I='D@:&]L9&5R<RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-34N,34@,S$Y+C0R
M(%1D("@U,2PU,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,SDS+C P(#,Q.2XT,B!49" H)"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3,N,34@,S$Y+C0R(%1D("@T
M+C@W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4Q."XV-2 S,3DN-#(@5&0@*#(L,S V+# P."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," S,#0N,S<@5&0@*$5Q
M=6ET>2!C;VUP96YS871I;VX@<&QA;G,@;F]TH&%P<')O=F5D(&)Y*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#(Y
M-"XS-R!49" HH*!S96-U<FET>2!H;VQD97)S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,2XS," R.3,N-#(@5&0@*$YO
M;F4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#4T+C,P(#(Y,RXT,B!49" H3B]!*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T,BXS," R.3,N-#(@5&0@*$XO02D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," R
M-S4N-#,@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-"XW-2 R-S4N
M-#,@5&0@*&]T86PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S4U+C$U(#(W-2XT,B!49" H-3$L-3 P*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,RXP," R-S4N-#(@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4S+C$U(#(W-2XT,B!49" H-"XX-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,3@N-C4@,C<U+C0R(%1D("@R+#,P
M-BPP,#@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@-BXU,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#(U,2XW."!49" H7"@Q7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3<N-3@@,C0W+C(U(%1D("B@1F]R("D@5&H@150@
M40IQ(# @," P(')G($)4(#<V+C Y(#(T-RXR-2!49" H4&5R9F]R;6%N8V4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(Y+C(Y(#(T-RXR-2!49" H4W1O
M8VL@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34S+C<S(#(T-RXR-2!49" H
M02D@5&H@150@40IQ(# @," P(')G($)4(#$V,"XP,R R-#<N,C4@5&0@*'=A
M<F1S("D@5&H@150@40IQ(# @," P(')G($)4(#$X-BXP,R R-#<N,C4@5&0@
M*&ES<W5E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3,N,34@,C0W+C(U
M(%1D("AU;F1E<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S@N,#0@,C0W
M+C(U(%1D("AT:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4R+C,X(#(T
M-RXR-2!49" H,C Q-" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S0N-3 @
M,C0W+C(U(%1D("A/;6YI8G5S("D@5&H@150@40IQ(# @," P(')G($)4(#,Q
M,RXR.2 R-#<N,C4@5&0@*$EN8V5N=&EV92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-3(N-C$@,C0W+C(U(%1D("A0;&%N+" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-S4N,#$@,C0W+C(U(%1D("AW92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#@N-SD@,C0W+C(U(%1D("AC;VYS:61E<B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T,C0N-SD@,C0W+C(U(%1D("AT:&4@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#,Y+C$S(#(T-RXR-2!49" H97AP96-T960@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#<V+C<X(#(T-RXR-2!49" H;G5M8F5R
M("D@5&H@150@40IQ(# @," P(')G($)4(#4P.2XT-2 R-#<N,C4@5&0@*&]F
M("D@5&H@150@40IQ(# @," P(')G($)4(#4Q.2XY," R-#<N,C4@5&0@*'-H
M87)E<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#<N,#$@,C0W+C(U(%1D
M("AT:&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,"XP," R,S4N,C4@5&0@*&UA>2 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" V.2XT," R,S4N,C4@5&0@*&)E("D@5&H@150@40IQ(# @," P(')G
M($)4(#@Q+C S(#(S-2XR-2!49" H:7-S=65D("D@5&H@150@40IQ(# @," P
M(')G($)4(#$P."XR,2 R,S4N,C4@5&0@*'5N9&5R("D@5&H@150@40IQ(# @
M," P(')G($)4(#$S,RXQ-R R,S4N,C4@5&0@*'1H92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-#<N-3<@,C,U+C(U(%1D("AA=V%R9" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-S0N,3D@,C,U+C(U(%1D("AT;R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.#0N,34@,C,U+C(U(%1D("AB92 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.34N-S@@,C,U+C(U(%1D("AO=71S=&%N9&EN9RX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0V+CDW(#(S-2XR-2!49" H5VAE
M;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S,N,#0@,C,U+C(U(%1D("AT
M:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@W+C0T(#(S-2XR-2!49" H
M;G5M8F5R("D@5&H@150@40IQ(# @," P(')G($)4(#,R,"XQ-R R,S4N,C4@
M5&0@*&]F("D@5&H@150@40IQ(# @," P(')G($)4(#,S,"XV.2 R,S4N,C4@
M5&0@*%!E<F9O<FUA;F-E("D@5&H@150@40IQ(# @," P(')G($)4(#,X,RXY
M-B R,S4N,C4@5&0@*%-T;V-K("D@5&H@150@40IQ(# @," P(')G($)4(#0P
M."XT-" R,S4N,C4@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,30N
M-S0@,C,U+C(U(%1D("AW87)D<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-# N.#$@,C,U+C(U(%1D("AH879E("D@5&H@150@40IQ(# @," P(')G($)4
M(#0V,2XX." R,S4N,C4@5&0@*&)E96X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#@R+CDT(#(S-2XR-2!49" H9&5T97)M:6YE9"P@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3,R+C8Q(#(S-2XR-2!49" H=V4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-30V+C0U(#(S-2XR-2!49" H=')U92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,C(S+C(U
M(%1D("AU<" I(%1J($54(%$*<2 P(# @,"!R9R!"5" V,BXV." R,C,N,C4@
M5&0@*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" W-RXU." R,C,N,C4@
M5&0@*&%C='5A;" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#0N,3,@,C(S
M+C(U(%1D("AN=6UB97(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,W+C,U
M(#(R,RXR-2!49" H;V8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30X+C,V
M(#(R,RXR-2!49" H<VAA<F5S("D@5&H@150@40IQ(# @," P(')G($)4(#$W
M-BXP,R R,C,N,C4@5&0@*'1H870@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3DS+C<Q(#(R,RXR-2!49" H=V5R92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R,34N.#(@,C(S+C(U(%1D("AA=V%R9&5D("D@5&H@150@40IQ(# @," P
M(')G($)4(#(U,BXS-B R,C,N,C4@5&0@*&%N9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-CDN-#@@,C(S+C(U(%1D("AR971U<FX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDV+C T(#(R,RXR-2!49" H86YY("D@5&H@150@40IQ
M(# @," P(')G($)4(#,Q,RXQ-B R,C,N,C4@5&0@*'5N87=A<F1E9" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-3DN-S @,C(S+C(U(%1D("AS:&%R97,@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C,W(#(R,RXR-2!49" H:6YT
M;R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#4N-C$@,C(S+C(U(%1D("AS
M:&%R97,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,S+C(X(#(R,RXR-2!4
M9" H879A:6QA8FQE("D@5&H@150@40IQ(# @," P(')G($)4(#0W,BXP-2 R
M,C,N,C4@5&0@*&9O<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#8N,SD@
M,C(S+C(U(%1D("AI<W-U86YC92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3(U+C0U(#(R,RXR-2!49" H4V5E("D@5&H@150@40IQ(# @," P(')G($)4
M(#4T,BXU-B R,C,N,C4@5&0@*$YO=&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#(Q,2XR-2!49" H,30@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-C(N-3 @,C$Q+C(U(%1D("@M("D@5&H@
M150@40IQ(# @," P(')G($)4(#8X+C,S(#(Q,2XR-2!49" H4W1O8VMH;VQD
M97)S)R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C0N.#4@,C$Q+C(U(%1D
M("A%<75I='D@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34T+C Q(#(Q,2XR
M-2!49" H=&\@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38T+C(Y(#(Q,2XR
M-2!49" H;W5R("D@5&H@150@40IQ(# @," P(')G($)4(#$X,"XQ,B R,3$N
M,C4@5&0@*&-O;G-O;&ED871E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,S,N,38@,C$Q+C(U(%1D("AF:6YA;F-I86P@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C<P+C8T(#(Q,2XR-2!49" H<W1A=&5M96YT<RXI(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,3@W+C(U
M(%1D("A)=&5M("D@5&H@150@40IQ(# @," P(')G($)4(#<R+C0Y(#$X-RXR
M-2!49" H,3,N("D@5&H@150@40IQ(# @," P(')G($)4(#@W+C0Y(#$X-RXR
M-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#@Y+CDY(#$X-RXR-2!4
M9" H("D@5&H@150@40IQ(# @," P(')G($)4(#DR+C0Y(#$X-RXR-2!49" H
M("D@5&H@150@40IQ(# @," P(')G($)4(#DT+CDY(#$X-RXR-2!49" H("D@
M5&H@150@40IQ(# @," P(')G($)4(#DW+C0Y(#$X-RXR-2!49" H("D@5&H@
M150@40IQ(# @," P(')G($)4(#DY+CDY(#$X-RXR-2!49" H("D@5&H@150@
M40IQ(# @," P(')G($)4(#$P,BXT.2 Q.#<N,C4@5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,#0N.3D@,3@W+C(U(%1D("@@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3 W+C0Y(#$X-RXR-2!49" H0V5R=&%I;B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-#(N-S8@,3@W+C(U(%1D("A296QA=&EO;G-H
M:7!S("D@5&H@150@40IQ(# @," P(')G($)4(#(P,RXP-2 Q.#<N,C4@5&0@
M*&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C$N-C<@,3@W+C(U(%1D
M("A296QA=&5D("D@5&H@150@40IQ(# @," P(')G($)4(#(U-BXW-B Q.#<N
M,C4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C(N-CD@,3@W+C(U
M(%1D("AR86YS86-T:6]N<RP@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$V
M+C4X(#$X-RXR-2!49" H86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,S
M-2XR,2 Q.#<N,C4@5&0@*$1I<BD@5&H@150@40IQ(# @," P(')G($)4(#,T
M.2XT-B Q.#<N,C4@5&0@*&5C=&]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S<P+CDS(#$X-RXR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#,W
M,RXT,R Q.#<N,C4@5&0@*$EN9&5P96YD96YC92XI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @,38S+C(U(%1D("A)
M;F9O<FUA=&EO;B!W:71H(')E<W!E8W0@=&\@8V5R=&%I;B!R96QA=&EO;G-H
M:7!S(&%N9"!R96QA=&5D('1R86YS86-T:6]N<RP@86YD(&1I<F5C=&]R(&EN
M9&5P96YD96YC92!I<R!I;F-L=61E9"!I;B!O=7(@4')O>'D@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$U,2XR
M-2!49" H4W1A=&5M96YT('1O(&)E(&9I;&5D('=I=&@@=&AE(%-%0R!A;F0@
M<W5C:"!I;F9O<FUA=&EO;B!I<R!I;F-O<G!O<F%T960@:&5R96EN(&)Y(')E
M9F5R96YC92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,3,Y+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$R-RXR-2!49" H271E;2 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXT.2 Q,C<N,C4@5&0@*#$T+J @
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#DN.3D@,3(W+C(U(%1D("@@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.3(N-#D@,3(W+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.30N.3D@,3(W+C(U(%1D("@@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@.3<N-#D@,3(W+C(U(%1D("@@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@.3DN.3D@,3(W+C(U(%1D("@@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3 R+C0Y(#$R-RXR-2!49" H("D@5&H@150@40IQ(# @," P
M(')G($)4(#$P-"XY.2 Q,C<N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,#<N-#D@,3(W+C(U(%1D("A0<FEN8VEP86P@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,30X+C@X(#$R-RXR-2!49" H06-C;W5N=&%N=" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,# N.#,@,3(W+C(U(%1D("A&965S("D@
M5&H@150@40IQ(# @," P(')G($)4(#(R,BXR," Q,C<N,C4@5&0@*&%N9" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R-# N.#,@,3(W+C(U(%1D("A397)V
M:6-E<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @,3 S+C(U(%1D("A);F9O<FUA=&EO;B!W:71H(')E<W!E8W0@
M=&\@=&AE(&9E97,@86YD('-E<G9I8V5S(&]F(&]U<B!P<FEN8VEP86P@86-C
M;W5N=&%N="!I<R!I;F-L=61E9"!I;B!O=7(@4')O>'D@4W1A=&5M96YT('1O
M(&)E(&9I;&5D('=I=&@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#DQ+C(U(%1D("AT:&4@4T5#(&%N9"!S=6-H
M(&EN9F]R;6%T:6]N(&ES(&EN8V]R<&]R871E9"!H97)E:6X@8GD@<F5F97)E
M;F-E+BD@5&H@150@40IE;F1S=')E86T*96YD;V)J"C@Y(# @;V)J"CP\+U1Y
M<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @
M-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@
M.3 @,"!2/CX*96YD;V)J"CDP(# @;V)J"CP\+TQE;F=T:" S-3 T/CX*<W1R
M96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S
M,2XV,"!49" H-#$I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@V+C,P(#<T,BXR-2!49" H4"D@5&H@150@40IQ(# @," P
M(')G($)4(#(Y,2XV-R W-#(N,C4@5&0@*$%2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S U+C<V(#<T,BXR-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#,Q,BXR-2 W-#(N,C4@5&0@*"!)5BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,#8N,# @-S,P+C(U(%1D("B@*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<Q."XR-2!49" H271E;2 Q-2Z@(" @(" @("!%>&AI8FET<RP@1FEN86YC
M:6%L(%-T871E;65N="!38VAE9'5L97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4T+C0U(#8X-2XT,B!49" H7"AA7"D@
M(" @(" @($1O8W5M96YT<R!F:6QE9"!A<R!P87)T(&]F('1H92!R97!O<G0N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U
M+C,P(#8V-BXS,B!49" H7"@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DS+C8U(#8V-BXS,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 P+C P(#8V-BXS
M,B!49" H0V]N<V]L:61A=&5D($9I;F%N8VEA;"!3=&%T96UE;G1S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT+C P(#8T
M-RXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q,# N,# @-C0W+C,R(%1D("A297!O<G0@;V8@26YD97!E;F1E
M;G0@4F5G:7-T97)E9"!0=6)L:6,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C8U+C4R(#8T-RXS,B!49" H06-C;W5N=&EN9R!&:7)M*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT+C P(#8R-2XS,B!4
M9" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,# N,# @-C(U+C,R(%1D("A#;VYS;VQI9&%T960@0F%L86YC92!3:&5E
M=',@87,@;V8@1&5C96UB97*@,S$L(#(P,3@@86YD(#(P,3<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.30N,# @-C V+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$P,"XP," V,#8N,S(@5&0@*$-O;G-O;&ED871E9"!3=&%T96UE;G1S
M(&]F($]P97)A=&EO;G,@9F]R('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.#<N-34@-C V+C,R(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,CDT+C Y(#8P-BXS,B!49" H96%R<R!%;F1E9"!$96-E;6)E<J S,2P@,C Q
M."P@,C Q-RP@86YD(#(P,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.30N,# @-3@W+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P,"XP," U.#<N,S(@
M5&0@*$-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F($-O;7!R96AE;G-I=F4@
M26YC;VUE(&9O<B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,X+C<T
M(#4X-RXS,B!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#,T-"XY-B U
M.#<N,S(@5&0@*&5A<G,@16YD960@1&5C96UB97*@,S$L(#(P,3@L(#(P,3<L
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P
M,"XP," U-S<N,S(@5&0@**"@(&%N9" R,#$V*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT+C P(#4U."XS,B!49" HH"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,# N
M,# @-34X+C,R(%1D("A#;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!3=&]C
M:VAO;&1E<G.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8W+C8V(#4U."XS
M,B!49" H($5Q=6ET>2!F;W(@=&AE("D@5&H@150@40IQ(# @," P(')G($)4
M(#,R-RXV-2 U-3@N,S(@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M,S0N,3@@-34X+C,R(%1D("AE87)S($5N9&5D($1E8V5M8F5RH#,Q+" R,#$X
M+" R,#$W+"!A;F0@,C Q-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Y-"XP," U,SDN,S(@5&0@** I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 P+C P(#4S.2XS,B!4
M9" H0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@0V%S:"!&;&]W<R!F;W(@
M=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(Y,"XV,R U,SDN,S(@5&0@
M*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3<N,3<@-3,Y+C,R(%1D("AE
M87)S($5N9&5D($1E8V5M8F5RH#,Q+" R,#$X+" R,#$W+"!A;F0@,C Q-BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-"XP
M," U,C N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,3 P+C P(#4R,"XS,B!49" H3F]T97,@=&\@0V]N<V]L
M:61A=&5D($9I;F%N8VEA;"!3=&%T96UE;G1S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C,P(#4P,2XS,B!49" H7"@R
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DS
M+C8U(#4P,2XS,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3 P+C P(#4P,2XS,B!49" H1FEN86YC:6%L(%-T
M871E;65N=',@4V-H961U;&4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.30N,# @-#@R+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P,"XP," T.#(N,S(@
M5&0@*%-C:&5D=6QE($E)()8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34U
M+C8S(#0X,BXS,B!49" H5BD@5&H@150@40IQ(# @," P(')G($)4(#$V,2XW
M-2 T.#(N,S(@5&0@*&%L=6%T:6]N(&%N9"!1=6%L:69Y:6YG("D@5&H@150@
M40IQ(# @," P(')G($)4(#(U."XV-R T.#(N,S(@5&0@*$%C8V]U;G1S(&9O
M<B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(W+C0U(#0X,BXS,B!4
M9" H62D@5&H@150@40IQ(# @," P(')G($)4(#,S,RXV-R T.#(N,S(@5&0@
M*&5A<G,@16YD960@1&5C96UB97*@,S$L(#(P,3@L(#(P,3<L(&%N9" R,#$V
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U
M+C,P(#0V,RXS,B!49" H7"@S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DS+C8U(#0V,RXS,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 P+C P(#0V,RXS
M,B!49" H17AH:6)I=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N
M9'-T<F5A;0IE;F1O8FH*.3$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT
M(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C
M97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Y,B P(%(^/@IE;F1O8FH*
M.3(@,"!O8FH*/#PO3&5N9W1H(#(Q,#<T/CX*<W1R96%M"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XP," S,2XV,"!49" H-#(I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8W+C,P
M(#<T,BXR-2!49" H15A(24))5"D@5&H@150@40IQ(# @," P(')G($)4(#,P
M.2XY,2 W-#(N,C4@5&0@*"!)3D1%6"D@5&H@150@40HP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,"XU(#<Q-BXW
M-2!M"C@X+C4@-S$V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HY,BXU(#<Q-BXW-2!M"C4V,BXU(#<Q
M-BXW-2!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N
M,# @-S(R+C0X(%1D("A.;RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3$N,# @-S(R+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,BXR-2 W,C(N-#@@
M5&0@*$1E<V-R:7!T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4S+C P(#<P-RXS,B!49" H,RXQ*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P(#<P-RXS,B!4
M9" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S
M"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-S U+CDX,S,Y.#0S-S4@
M;0HU,3DN,S(Q,C@Y,#8R-2 W,#4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," W,#<N,S(@5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-E
M<G1I9FEC871E(&]F($EN8V]R<&]R871I;VX@;V8@=&AE(%)E9VES=')A;G0@
M7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-CDU+CDX,S,Y.#0S-S4@
M;0HU-C$N,S$X,S4Y,S<U(#8Y-2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DU+C P(#8Y-RXS,B!49" H0V]M<&%N>9(I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" Q,S8N-C<@-CDW+C,R(%1D("AS(%)E9VES=')A=&EO;B!3=&%T
M96UE;G0@;VX@1F]R;2!3+3$O02P@0V]M;6ES<VEO;B!&:6QE($YO+B S,S,M
M-C0Y,30L(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-C@U+CDX,S,Y.#0S-S4@;0HQ
M,C4N.#$U-#(Y-C@W-2 V.#4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y-2XP," V.#<N,S(@5&0@*&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!4
M3" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C<T
M+C,R(%1D("@S+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*
M+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8W,BXY.#,S
M.3@T,S<U(&T*-34Q+C@P,3<U-S@Q,C4@-C<R+CDX,S,Y.#0S-S4@; IS"G$@
M," P(#$@<F<@0E0@.34N,# @-C<T+C,R(%1D("A#97)T:69I8V%T92!O9B!#
M;W)R96-T:6]N('1O("D@5&H@150@40IQ(# @," Q(')G($)4(#(P-2XU,B V
M-S0N,S(@5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-E<G1I9FEC871E(&]F
M($EN8V]R<&]R871I;VX@;V8@=&AE(%)E9VES=')A;G0@7"A0<F5V:6]U<VQY
M(&9I;&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-C8R
M+CDX,S,Y.#0S-S4@;0HU-#4N-3,W,3 Y,S<U(#8V,BXY.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DU+C P(#8V-"XS,B!49" H87,@86X@97AH:6)I
M="!T;R!T:&4@0V]M<&%N>2=S($9O<FT@,3 M2R!F;W(@=&AE('EE87(@96YD
M960@1&5C96UB97(@,S$L(#(P,3<@86YD(&EN8V]R<&]R871E9"!B>2!R969E
M<F5N8V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 V-3(N
M.3@S,SDX-#,W-2!M"C$R-2XX,34T,CDV.#<U(#8U,BXY.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DU+C P(#8U-"XS,B!49" H:&5R96EN+EPI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P
M(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," V,S@N,S(@5&0@*#,N,RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," V,S@N,S(@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @
M5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *
M6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8S-BXY.#,S.3@T,S<U(&T*-34Q+C$V
M,C$P.3,W-2 V,S8N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP
M," V,S@N,S(@5&0@*$%M96YD960@86YD(%)E<W1A=&5D($)Y+6QA=W,@;V8@
M=&AE(%)E9VES=')A;G2@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB
M:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M(#$P+5$@9F]R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@-C(V+CDX,S,Y.#0S-S4@;0HS-S@N
M,C X,# W.#$R-2 V,C8N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M-2XP," V,C@N,S(@5&0@*'1H92!Q=6%R=&5R(&5N9&5D($IU;F4@,S L(#(P
M,3@@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P
M(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," V,3(N,S(@5&0@*#0N,2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," V,3(N,S(@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @
M5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *
M6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8Q,"XY.#,S.3@T,S<U(&T*-3(P+C<T
M,C$X-S4@-C$P+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @
M-C$R+C,R(%1D("A&;W)MH&]F('-P96-I;65N(&-O;6UO;B!S=&]C:R!C97)T
M:69I8V%T9:!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T
M:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" T-C(N.3<@-C$R
M+C,R(%1D("AS(%)E9VES=')A=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@
M2@HQ(&H*,R!-"CDU(#8P,"XY.#,S.3@T,S<U(&T*-#DR+C8Y-3,Q,C4@-C P
M+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-C R+C,R(%1D
M("A3=&%T96UE;G0@;VX@1F]R;2!3+3$O02P@0V]M;6ES<VEO;B!&:6QE($YO
M+B S,S,M-C0Y,30L(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE
M<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P
M(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,N,# @-3@U+C,R(%1D("@T+C(@(RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," U.#4N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3
M,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#4X,RXY.#,S.3@T
M,S<U(&T*-34V+C@W,#$Q-S$X-S4@-3@S+CDX,S,Y.#0S-S4@; IS"G$@," P
M(#$@<F<@0E0@.34N,# @-3@U+C,R(%1D("@R,#$T($]M;FEB=7,@26YC96YT
M:79E(%!L86X@+2!297-T<FEC=&5D(%-T;V-K("D@5&H@150@40IQ(# @," Q
M(')G($)4(#(Y,"XR-2 U.#4N,S(@5&0@*$%G<F5E;65N="!&;W)M(%PH4')E
M=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YYDBD@
M5&H@150@40IQ(# @," Q(')G($)4(#4U,"XT." U.#4N,S(@5&0@*',@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U-S,N.3@S,SDX-#,W
M-2!M"C0S.2XU.#DX-#,W-2 U-S,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," U-S4N,S(@5&0@*$9O<FT@,3 M42!F;W(@=&AE('%U87)T
M97(@96YD960@2G5N92 S,"P@,C Q-"!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E
M9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#4U-RXS,B!49" H-"XS
M(",I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.3$N,# @-34W+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U
M-34N.3@S,SDX-#,W-2!M"C4T.2XS,S4Y,S<U(#4U-2XY.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DU+C P(#4U-RXS,B!49" H,C Q-"!/;6YI8G5S
M($EN8V5N=&EV92!0;&%N("T@4&5R9F]R;6%N8V4@4VAA<F4@86YD(%)E<W1R
M:6-T960@4W1O8VL@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S@V+C T(#4U
M-RXS,B!49" H06=R965M96YT($9O<FT@7"A0<F5V:6]U<VQY(&9I;&5D(&%S
M(&%N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-30U+CDX
M,S,Y.#0S-S4@;0HU-#(N.3$U,#,Y,#8R-2 U-#4N.3@S,SDX-#,W-2!L"G,*
M<2 P(# @,2!R9R!"5" Y-2XP," U-#<N,S(@5&0@*&5X:&EB:70@=&\@=&AE
M($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,3DQ+CDS(#4T-RXS
M,B!49" H<R!&;W)M(#$P+5$@9F]R('1H92!Q=6%R=&5R(&5N9&5D($IU;F4@
M,S L(#(P,30@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN
M+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*
M,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,RXP," U,S N,S(@5&0@*#0N-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," U,S N,S(@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP
M(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#4R."XY.#,S.3@T,S<U(&T*
M-3(V+C(Y.#@R.#$R-2 U,C@N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y-2XP," U,S N,S(@5&0@*%)E9VES=')A=&EO;B!2:6=H=',@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,3<T+C0U(#4S,"XS,B!49" H06=R965M96YT
M+"!D871E9"!*=6YE(#,P+" R,#$T+"!B>2!A;F0@86UO;F<@0W)O<W,@0V]U
M;G1R>2!(96%L=&AC87)E+"!);F,N(&%N9"!T:&4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY-2 U,3@N.3@S,SDX-#,W-2!M"C4R-RXY-S@U
M,34V,C4@-3$X+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @
M-3(P+C,R(%1D("AN;W1E:&]L9&5R<R!P87)T>2!T:&5R971O(%PH4')E=FEO
M=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YYDBD@5&H@
M150@40IQ(# @," Q(')G($)4(#,X-BXV," U,C N,S(@5&0@*',@1F]R;2 X
M+4L@9&%T960@2G5L>2 R+" R,#$T(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"CDU(#4P."XY.#,S.3@T,S<U(&T*,C,Q+C S,#(W,S0S
M-S4@-3 X+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-3$P
M+C,R(%1D("AI;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@
M,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,N,# @-#DU+C,R(%1D("@Q,"XQ(",I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3$N,# @-#DU+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4
M=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 T.3,N.3@S,SDX-#,W-2!M"C4T
M-RXV-3$S-C<Q.#<U(#0Y,RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#0Y-2XS,B!49" H16UP;&]Y;65N=" I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" Q-#@N-C$@-#DU+C,R(%1D("A!9W)E96UE;G0L(&1A=&5D(&%S
M(&]F($UA<F-H(#(P+" R,#$S+"!B971W965N("D@5&H@150@40IQ(# @," Q
M(')G($)4(#,T."XP." T.34N,S(@5&0@*%<I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" S-3<N,3(@-#DU+C,R(%1D("AI;&QI86T@2BX@1W)U8F)S(&%N9"!T
M:&4@4F5G:7-T<F%N="!<*%!R979I;W5S;'D@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HY-2 T.#,N.3@S,SDX-#,W-2!M"C4R-RXS-C,R.#$R
M-2 T.#,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," T.#4N
M,S(@5&0@*&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,C,U+C4S(#0X-2XS,B!49" H<R!&;W)M
M(#@M2R!D871E9"!-87)C:" R,BP@,C Q,R!A;F0@:6YC;W)P;W)A=&5D(&)Y
M(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#0V."XS,B!49" H
M,3 N,B C*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#DQ+C P(#0V."XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.34@-#8V+CDX,S,Y.#0S-S4@;0HU-3 N-C8X.30U,S$R-2 T-C8N.3@S,SDX
M-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," T-C@N,S(@5&0@*$-R;W-S
M($-O=6YT<GDI(%1J($54(%$*<2 P(# @,2!R9R!"5" Q-3(N-#$@-#8X+C,R
M(%1D("@L($EN8RX@1&5F97)R960@0V]M<&5N<V%T:6]N(%!L86X@7"A0<F5V
M:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@-#@R+CDP(#0V."XS,B!49" H<R!&;W)M
M(#$P+4L@9F]R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@
M4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@
M-#4V+CDX,S,Y.#0S-S4@;0HS.3(N,S4S-3$U-C(U(#0U-BXY.#,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#0U."XS,B!49" H=&AE('EE87(@
M96YD960@1&5C96UB97(@,S$L(#(P,#(L(&%N9"!I;F-O<G!O<F%T960@8GD@
M<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-#0R+C,R(%1D("@Q
M,"XS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#DQ+C P(#0T,BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@
M4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@
M-#0P+CDX,S,Y.#0S-S4@;0HU-3<N-#4V,#4T-C@W-2 T-# N.3@S,SDX-#,W
M-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," T-#(N,S(@5&0@*$QE87-E("D@
M5&H@150@40IQ(# @," Q(')G($)4(#$R,"XR-B T-#(N,S(@5&0@*$%G<F5E
M;65N="!B971W965N($-O<FYE<G-T;VYE($]P<&]R='5N:71Y("D@5&H@150@
M40IQ(# @," Q(')G($)4(#,P-2XU.2 T-#(N,S(@5&0@*%8I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" S,3$N-S @-#0R+C,R(%1D("AE;G1U<F5S+"!,3$,@
M86YD($-E:FMA(%-E87)C:"P@26YC+BP@9&%T960@1F5B<G5A<GD@,BP@,C P
M-R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#0S,"XY.#,S
M.3@T,S<U(&T*-3$P+C<S,C0R,3@W-2 T,S N.3@S,SDX-#,W-2!L"G,*<2 P
M(# @,2!R9R!"5" Y-2XP," T,S(N,S(@5&0@*%PH4')E=FEO=7-L>2!F:6QE
M9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @
M," Q(')G($)4(#(X-"XQ-" T,S(N,S(@5&0@*',@1F]R;2 Q,"U+(&9O<B!T
M:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C P-B!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 T,C N.3@S,SDX-#,W-2!M"C(S
M,2XP,S R-S,T,S<U(#0R,"XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#0R,BXS,B!49" H:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H
M97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3
M,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#0P-2XS,B!49" H,3 N-"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," T,#4N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3
M,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#0P,RXY.#,S.3@T
M,S<U(&T*-34Y+C,Q-C0P-C(U(#0P,RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q
M(')G($)4(#DU+C P(#0P-2XS,B!49" H4V5C;VYD("D@5&H@150@40IQ(# @
M," Q(')G($)4(#$R-BXS.2 T,#4N,S(@5&0@*$%M96YD;65N="!T;R!,96%S
M92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,3,N.#8@-# U+C,R(%1D("A!
M9W)E96UE;G0@8GD@86YD(&)E='=E96X@365R:61I86X@0V]M;65R8VEA;"!0
M<F]P97)T:65S($QI;6ET960@4&%R=&YE<G-H:7 @86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@,SDS+CDX,S,Y.#0S-S4@;0HU-3<N
M-#$R,3 Y,S<U(#,Y,RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#,Y-2XS,B!49" H0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N
M+"!D871E9"!&96)R=6%R>2 Q-RP@,C P-R!<*%!R979I;W5S;'D@9FEL960@
M87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" U,3,N-3(@,SDU+C,R(%1D("AS($9O<FT@,3 M*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 S.#,N.3@S,SDX-#,W-2!M"C0Q
M,RXW,S4S-3$U-C(U(#,X,RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#,X-2XS,B!49" H2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB
M97(@,S$L(#(P,#8@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R
M96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," S-S(N,S(@5&0@*#$P+C4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3$N,# @,S<R+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 S-S N,#@S,SDX-#,W
M-2!M"C4T,RXW.#0Q-SDV.#<U(#,W,"XP.#,S.3@T,S<U(&P*<PIQ(# @," Q
M(')G($)4(#DU+C P(#,W,2XT,B!49" H1FER<W0@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,3$U+C(Y(#,W,2XT,B!49" H06UE;F1M96YT('1O($QE87-E
M("D@5&H@150@40IQ(# @," Q(')G($)4(#(P,BXW-B S-S$N-#(@5&0@*$%G
M<F5E;65N="!D871E9"!A<R!O9B!397!T96UB97(@,2P@,C P-RP@8GD@86YD
M(&)E='=E96X@0V]R;F5R<W1O;F4@3W!P;W)T=6YI='D@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY-2 S-C N,#@S,SDX-#,W-2!M"C4U,2XU
M-3<V,3<Q.#<U(#,V,"XP.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#,V,2XT,B!49" H5BD@5&H@150@40IQ(# @," Q(')G($)4(#$P,2XQ
M,2 S-C$N-#(@5&0@*&5N='5R97,L($Q,0R!A;F0@0V5J:V$@4V5A<F-H+"!)
M;F,N(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#
M;VUP86YYDBD@5&H@150@40IQ(# @," Q(')G($)4(#0S."XR-2 S-C$N-#(@
M5&0@*',@1F]R;2 Q,"U1(&9O<B!T:&4@<75A<G1E<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *
M6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#,U,"XP.#,S.3@T,S<U(&T*,S4W+C$P
M.3,W-2 S-3 N,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," S
M-3$N-#(@5&0@*&5N9&5D(%-E<'1E;6)E<B S,"P@,C P."!A;F0@:6YC;W)P
M;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @
M5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#,S
M-RXS,B!49" H,3 N-B C*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#DQ+C P(#,S-RXS,B!49" HH"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.34@,S,U+CDX,S,Y.#0S-S4@;0HU-3 N,C4X-S@Y,#8R-2 S
M,S4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," S,S<N,S(@
M5&0@*$9O<FT@;V8@3F]N+45M<&QO>65E($1I<F5C=&]R<Y(I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" R,S,N,SD@,S,W+C,R(%1D("@@4F5S=')I8W1E9"!3
M=&]C:R I(%1J($54(%$*<2 P(# @,2!R9R!"5" S,#,N-C8@,S,W+C,R(%1D
M("A!9W)E96UE;G0@=6YD97(@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!)
M;F,N(#(P,#<@4W1O8VL@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HY-2 S,C4N.3@S,SDX-#,W-2!M"C4S,RXU,34V,C4@,S(U+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @,S(W+C,R(%1D("A);F-E;G1I
M=F4@4&QA;B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T
M:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" S-#0N,3(@,S(W
M+C,R(%1D("AS(#@M2R!D871E9"!-87D@,34L(#(P,#<@86YD(&EN8V]R<&]R
M871E9"!B>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'
M"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#,Q
M-2XY.#,S.3@T,S<U(&T*,38U+C0Y.# T-C@W-2 S,34N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y-2XP," S,3<N,S(@5&0@*')E9F5R96YC92!H
M97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3
M,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#,P,RXS,B!49" H,3 N-R C*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P(#,P
M,RXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO
M1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,S Q+C X,S,Y
M.#0S-S4@;0HU-#0N,#<W,30X-#,W-2 S,#$N,#@S,SDX-#,W-2!L"G,*<2 P
M(# @,2!R9R!"5" Y-2XP," S,#(N-#(@5&0@*$9O<FT@;V8@4W1O8VL@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,34T+C<S(#,P,BXT,B!49" H07!P<F5C
M:6%T:6]N(%)I9VAT<R I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,S<N-3 @
M,S R+C0R(%1D("A!9W)E96UE;G0@=6YD97(@0W)O<W,@0V]U;G1R>2!(96%L
M=&AC87)E+"!);F,N(#(P,#<@4W1O8VL@26YC96YT:79E(%!L86X@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 R.3$N,#@S,SDX-#,W-2!M
M"C4U,2XR-C0V-#@T,S<U(#(Y,2XP.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DU+C P(#(Y,BXT,B!49" H7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N
M(&5X:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,C@T+C$T(#(Y,BXT,B!49" H<R!&;W)M(#@M2R!D871E9"!/8W1O8F5R
M(#$U+" R,# W(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C@Q+C X,S,Y.#0S-S4@
M;0HQ,C4N.#$U-#(Y-C@W-2 R.#$N,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," R.#(N-#(@5&0@*&AE<F5I;BY<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @
M,C8X+C,R(%1D("@Q,"XX*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#DQ+C P(#(V."XS,B!49" HH"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.34@,C8V+CDX,S,Y.#0S-S4@;0HU-#8N-#8T.#0S-S4@,C8V
M+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @,C8X+C,R(%1D
M("A,96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q,C N,C8@,C8X+C,R
M(%1D("A!9W)E96UE;G0L(&1A=&5D($IU;'D@,2P@,C Q,"P@8F5T=V5E;B!'
M;VQD8F5R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S$V+C0R(#(V."XS,B!4
M9" H9R!"<F]T:&5R<R!296%L($5S=&%T92!,3$,@86YD($U#5E0I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" T-S4N,#D@,C8X+C,R(%1D("@L($EN8RX@7"A0
M<F5V:6]U<VQY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@
M4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@
M,C4V+CDX,S,Y.#0S-S4@;0HU-34N-CDS,S4Y,S<U(#(U-BXY.#,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#(U."XS,B!49" H9FEL960@87,@
M86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" R,S4N-3,@,C4X+C,R(%1D("AS($9O<FT@,3 M42!F;W(@=&AE('%U
M87)T97(@96YD960@2G5N92 S,"P@,C Q,"!A;F0@:6YC;W)P;W)A=&5D(&)Y
M(')E9F5R96YC92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU
M(#(T-BXY.#,S.3@T,S<U(&T*,3(U+C@Q-30R.38X-S4@,C0V+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @,C0X+C,R(%1D("AH97)E:6XN
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP
M(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S+C P(#(S,RXS,B!49" H,3 N.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XP," R,S,N,S(@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP
M(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#(S,2XP.#,S.3@T,S<U,# P
M,B!M"C4T,BXY,S0U-S S,3(U(#(S,2XP.#,S.3@T,S<U,# P,B!L"G,*<2 P
M(# @,2!R9R!"5" Y-2XP," R,S(N-#(@5&0@*$QE87-E("D@5&H@150@40IQ
M(# @," Q(')G($)4(#$R,"XR-B R,S(N-#(@5&0@*$%G<F5E;65N="P@9&%T
M960@2G5L>2 Q."P@,C Q,RP@8F5T=V5E;B!096%C:'1R964@24D@86YD($E)
M22P@3$Q#(&%N9"!-1$$I(%1J($54(%$*<2 P(# @,2!R9R!"5" T,S(N,SD@
M,C,R+C0R(%1D("@@2&]L9&EN9W,L($EN8RX@7"A0<F5V:6]U<VQY("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C(Q+C X,S,Y.#0S-S4P
M,# R(&T*-34U+C8Y,S,U.3,W-2 R,C$N,#@S,SDX-#,W-3 P,#(@; IS"G$@
M," P(#$@<F<@0E0@.34N,# @,C(R+C0R(%1D("AF:6QE9"!A<R!A;B!E>&AI
M8FET('1O('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," Q(')G($)4(#(S
M-2XU,R R,C(N-#(@5&0@*',@1F]R;2 Q,"U1(&9O<B!T:&4@<75A<G1E<B!E
M;F1E9"!*=6YE(#,P+" R,#$S(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E
M;F-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C$Q+C X
M,S,Y.#0S-S4P,# R(&T*,3(U+C@Q-30R.38X-S4@,C$Q+C X,S,Y.#0S-S4P
M,# R(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#(Q,BXT,B!49" H:&5R96EN
M+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*
M,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,RXP," Q.3@N,S(@5&0@*#$P+C$P(",I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3$N,# @,3DX+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 Q.38N.3@S,SDX-#,W
M-2!M"C4U-BXU,C@S,C S,3(U(#$Y-BXY.#,S.3@T,S<U(&P*<PIQ(# @," Q
M(')G($)4(#DU+C P(#$Y."XS,B!49" H06UE;F1E9"!A;F0@4F5S=&%T960@
M17AE8W5T:79E(%-E=F5R86YC92!0;&%N(&]F($-R;W-S($-O=6YT<GD@2&5A
M;'1H8V%R92P@26YC+B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I
M=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#$X-BXY.#,S
M.3@T,S<U(&T*-#0U+C<R-S4S.3 V,C4@,3@V+CDX,S,Y.#0S-S4@; IS"G$@
M," P(#$@<F<@0E0@.34N,# @,3@X+C,R(%1D("AT;R!T:&4@0V]M<&%N>9(I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" Q-C$N-C8@,3@X+C,R(%1D("AS($9O
M<FT@."U+(&1A=&5D($UA>2 R."P@,C Q,"!A;F0@:6YC;W)P;W)A=&5D(&)Y
M(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#$W-2XS,B!49" H
M,3 N,2D@5&H@150@40IQ(# @," P(')G($)4(#<P+C4P(#$W-2XS,B!49" H
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M,2XP," Q-S4N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'
M"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#$W
M,RXY.#,S.3@T,S<U(&T*-34U+C8Y,S,U.3,W-2 Q-S,N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y-2XP," Q-S4N,S(@5&0@*$QO86X@86YD(%-E
M8W5R:71Y("D@5&H@150@40IQ(# @," Q(')G($)4(#$W,"XR-B Q-S4N,S(@
M5&0@*$%G<F5E;65N="P@9&%T960@2F%N=6%R>2 Y+" R,#$S+"!B>2!A;F0@
M86UO;F<@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N(&%N9"!C97)T
M86EN(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,38S
M+CDX,S,Y.#0S-S4@;0HU-#0N-3DT-S(V-38R-2 Q-C,N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y-2XP," Q-C4N,S(@5&0@*&ET<R!S=6)S:61I
M87)I97,L(&%S($)O<G)O=V5R<RP@=&AE($QE;F1E<G,@<F5F97)E;F-E9"!T
M:&5R96EN+"!A;F0@0F%N:R!O9B I(%1J($54(%$*<2 P(# @,2!R9R!"5" S
M.30N.3 @,38U+C,R(%1D("A!;65R:6-A+"!.+D$N+"!A<R I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" T-CDN,#4@,38U+C,R(%1D("A!9V5N="!<*%!R979I
M;W5S;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 Q-3,N
M.3@S,SDX-#,W-2!M"C4S,2XY.3(Q.#<U(#$U,RXY.#,S.3@T,S<U(&P*<PIQ
M(# @," Q(')G($)4(#DU+C P(#$U-2XS,B!49" H9FEL960@87,@86X@97AH
M:6)I="!T;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" R
M,S4N-3,@,34U+C,R(%1D("AS($9O<FT@."U+(&1A=&5D($IA;G5A<GD@,2D@
M5&H@150@40IQ(# @," Q(')G($)4(#,T-BXU,B Q-34N,S(@5&0@*#$L(#(P
M,3,@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P
M(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," Q-# N,S(@5&0@*#$P+C$R*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P(#$T,"XS,B!49" HH"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@
M,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@,3,U+C X,S,Y.#0S-S4P,# R(&T*
M-34U+CDS-S4@,3,U+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#$S-BXT,B!49" H0V]N<V5N="P@*2!4:B!%5"!1"G$@," P(#$@
M<F<@0E0@,3,R+C8P(#$S-BXT,B!49" H5RD@5&H@150@40IQ(# @," Q(')G
M($)4(#$T,2XR-" Q,S8N-#(@5&0@*&%I=F5R(&%N9" I(%1J($54(%$*<2 P
M(# @,2!R9R!"5" Q.# N-#@@,3,V+C0R(%1D("A4:&ER9" I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" R,#0N-C0@,3,V+C0R(%1D("A!;65N9&UE;G0L(&1A
M=&5D(&%S(&]F($IU;F4@,S L(#(P,30L('1O($QO86X@86YD(%-E8W5R:71Y
M("D@5&H@150@40IQ(# @," Q(')G($)4(#0U,2XR-B Q,S8N-#(@5&0@*$%G
M<F5E;65N="!D871E9"!*86YU87)Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.34@,3(U+C X,S,Y.#0S-S4P,# R(&T*-30T+C@X-S8Y-3,Q
M,C4@,3(U+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4(#DU+C P
M(#$R-BXT,B!49" H.2P@,C Q,RP@8GD@86YD(&%M;VYG($-R;W-S($-O=6YT
M<GD@2&5A;'1H8V%R92P@26YC+B!A;F0@8V5R=&%I;B!O9B!I=',@<W5B<VED
M:6%R:65S+"!A<R!";W)R;W=E<G,L('1H92!,96YD97)S("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@,3$U+C X,S,Y.#0S-S4P,# R(&T*
M-34R+C,X,C@Q,C4@,3$U+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G
M($)4(#DU+C P(#$Q-BXT,B!49" H<F5F97)E;F-E9"!T:&5R96EN+"!A;F0@
M0F%N:R!O9B I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,C,N,C<@,3$V+C0R
M(%1D("A!;65R:6-A+"!.+D$N+"!A<R I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" R.3<N-#(@,3$V+C0R(%1D("A!9V5N="!<*%!R979I;W5S;'D@9FEL960@
M87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" U,3,N-#D@,3$V+C0R(%1D("AS($9O<FT@."TI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#$P-2XP.#,S.3@T,S<U,# P,B!M
M"C,S,RXU,34V,C4@,3 U+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G
M($)4(#DU+C P(#$P-BXT,B!49" H2R!D871E9"!*=6QY(#(L(#(P,30@86YD
M(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P
M,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,RXP," Y,BXS,B!49" H,3 N,3,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.3$N,# @.3(N,S(@5&0@** I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P
M(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"CDU(#@X+C X,S,Y.#0S-S4P,# R(&T*-3(Y+C U-S8Q
M-S$X-S4@.#@N,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@.34N
M,# @.#DN-#(@5&0@*%-T;V-K(%!U<F-H87-E("D@5&H@150@40IQ(# @," Q
M(')G($)4(#$U."XS,R X.2XT,B!49" H06=R965M96YT+"!D871E9"!&96)R
M=6%R>2 R+" R,#$S+"!B>2!A;F0@86UO;F<@24-/3B!#;&EN:6-A;"!297-E
M87)C:"P@26YC+B!A;F0@24-/3B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"CDU(#<X+C X,S,Y.#0S-S4P,# R(&T*-38P+C4T-C@W-2 W."XP
M.#,S.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," W.2XT,B!4
M9" H0VQI;FEC86P@4F5S96%R8V@@54L@3&EM:71E9"P@87,@0G5Y97)S+"!A
M;F0@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N+"!,;V-A;"!3=&%F
M*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-#4S+C,S(#<Y+C0R(%1D("AF+"!,
M3$,@86YD($-R;W-S($-O=6YT<GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*
M,2!J"C,@30HY-2 V."XP.#,S.3@T,S<U,# P,B!M"C4U,BXQ,3DQ-# V,C4@
M-C@N,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@.34N,# @-CDN
M-#(@5&0@*$AE86QT:&-A<F4@54L@2&]L9&-O($QT9"XL(&%S(%-E;&QE<G,@
M7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A
M;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-#0P+C<U(#8Y+C0R(%1D("AS
M($9O<FT@."U+(&1A=&5D($9E8G)U87)Y("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*
M,2!*"C$@:@HS($T*.34@-3@N,#@S,SDX-#,W-3 P,#(@;0HR.# N-#8X-S4@
M-3@N,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@.34N,# @-3DN
M-#(@5&0@*#4L(#(P,3,@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@
M:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@
M150*96YD<W1R96%M"F5N9&]B:@HY,R P(&]B:@H\/"]4>7!E("]086=E"B]0
M87)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E
M<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#DT(# @4CX^"F5N
M9&]B:@HY-" P(&]B:@H\/"],96YG=&@@,C$W-# ^/@IS=')E86T*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P(%1D("@T
M,RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,S(N,34@-S0R+C(U(%1D("A%6$A)0DE4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C<T+C<V(#<T,BXR-2!49" H($E.1$58(%PH0T].5$E.545$7"DI(%1J
M($54(%$*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 N-2 W,38N-S4@;0HX."XU(#<Q-BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*.3(N
M-2 W,38N-S4@;0HU-C(N-2 W,38N-S4@; IS"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#<R,BXT."!49" H3F\N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P(#<R,BXS
M,B!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,#(N,C4@-S(R+C0X(%1D("A$97-C<FEP=&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," W,#<N,S(@
M5&0@*#$P+C$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#DQ+C P(#<P-RXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *
M," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*.34@-S U+CDX,S,Y.#0S-S4@;0HU,3DN-3@T.38P.3,W-2 W,#4N.3@S
M,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," W,#<N,S(@5&0@*$%S
M<V5T(%!U<F-H87-E("D@5&H@150@40IQ(# @," Q(')G($)4(#$U-RXW-R W
M,#<N,S(@5&0@*$%G<F5E;65N="P@9&%T960@1&5C96UB97(@,BP@,C Q,RP@
M8F5T=V5E;B!,;V-A;"!3=&%F*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S@V
M+CDT(#<P-RXS,B!49" H9BP@3$Q#+"!A<R!"=7EE<BD@5&H@150@40IQ(# @
M," Q(')G($)4(#0U-"XP,B W,#<N,S(@5&0@*"P@0W)O<W,@0V]U;G1R>2 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8Y-2XY.#,S.3@T
M,S<U(&T*-38Q+C(Y,SDT-3,Q,C4@-CDU+CDX,S,Y.#0S-S4@; IS"G$@," P
M(#$@<F<@0E0@.34N,# @-CDW+C,R(%1D("A(96%L=&AC87)E+"!);F,N+"!A
M<R!087)E;G0@86YD($]N("D@5&H@150@40IQ(# @," Q(')G($)4(#(S,RXU
M-2 V.3<N,S(@5&0@*$%S<VEG;FUE;G0@4W1A9BD@5&H@150@40IQ(# @," Q
M(')G($)4(#(Y.2XW-B V.3<N,S(@5&0@*&9I;F<@4V5R=FEC97,L($EN8RXL
M("D@5&H@150@40IQ(# @," Q(')G($)4(#,W-BXY-B V.3<N,S(@5&0@*$%S
M<VEG;FUE;G0@4F5A9'DI(%1J($54(%$*<2 P(# @,2!R9R!"5" T-3(N,30@
M-CDW+C,R(%1D("@L($EN8RXL(&%N9"!/;B I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" U,#@N-3(@-CDW+C,R(%1D("A!<W-I9VYM96YT+" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8X-2XY.#,S.3@T,S<U(&T*-34U
M+CDY-C Y,S<U(#8X-2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#8X-RXS,B!49" H26YC+BP@8V]L;&5C=&EV96QY(&%S(%-E;&QE<B!<
M*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N
M>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" S.3 N,C$@-C@W+C,R(%1D("AS
M($9O<FT@."U+(&1A=&5D($1E8V5M8F5R(#,L(#(P,3,@86YD("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-C<U+CDX,S,Y.#0S-S4@;0HR
M,S$N,#,P,C<S-#,W-2 V-S4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y-2XP," V-S<N,S(@5&0@*&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@
M:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,RXP," V-C,N,S(@5&0@*#$P+C$U(",I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3$N,# @
M-C8S+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R
M"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 V-C$N.3@S
M,SDX-#,W-2!M"C4S-2XQ-#$V,#$U-C(U(#8V,2XY.#,S.3@T,S<U(&P*<PIQ
M(# @," Q(')G($)4(#DU+C P(#8V,RXS,B!49" H16UP;&]Y;65N=" I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" Q-#@N-C$@-C8S+C,R(%1D("A!9W)E96UE
M;G0L(&1A=&5D($UA<F-H(#,L(#(P,30L(&)E='=E96X@*2!4:B!%5"!1"G$@
M," P(#$@<F<@0E0@,S(Q+C0R(#8V,RXS,B!49" H5RD@5&H@150@40IQ(# @
M," Q(')G($)4(#,S,"XT-B V-C,N,S(@5&0@*&EL;&EA;2!*+B!"=7)N<R!A
M;F0@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@-C4Q+CDX,S,Y.#0S-S4@;0HU,3 N
M-S,R-#(Q.#<U(#8U,2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#8U,RXS,B!49" H7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB
M:70@=&\@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C@T
M+C$T(#8U,RXS,B!49" H<R!&;W)M(#$P+4L@9F]R('1H92!Y96%R(&5N9&5D
M($1E8V5M8F5R(#,Q+" R,#$S(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@
M2@HQ(&H*,R!-"CDU(#8T,2XY.#,S.3@T,S<U(&T*,C,Q+C S,#(W,S0S-S4@
M-C0Q+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-C0S+C,R
M(%1D("AI;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!4
M8R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,N,# @-C(Y+C,R(%1D("@Q,"XQ-BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *
M," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*.34@-C(W+CDX,S,Y.#0S-S4@;0HU-#<N,C8P-S0R,3@W-2 V,C<N.3@S
M,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," V,CDN,S(@5&0@*$%S
M<V5T(%!U<F-H87-E("D@5&H@150@40IQ(# @," Q(')G($)4(#$U-RXW-R V
M,CDN,S(@5&0@*$%G<F5E;65N="P@9&%T960@2G5N92 R+" R,#$T+"!B>2!A
M;F0@86UO;F<@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N+"!A<R!0
M=7)C:&%S97(I(%1J($54(%$*<2 P(# @,2!R9R!"5" U,C4N,S(@-C(Y+C,R
M(%1D("@L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU
M(#8Q-RXY.#,S.3@T,S<U(&T*-3(W+C<Y-S@U,34V,C4@-C$W+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-C$Y+C,R(%1D("A-4TX@2&]L
M9&-O+"!,3$,L($U33B!(;VQD:6YG($-O;7!A;GD@26YC+BP@365D:6-A;"!3
M=&%F*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S0Y+C@P(#8Q.2XS,B!49" H
M9FEN9R!.971W;W)K($AE86QT:&-A<F4L($Q,0R!A;F0@3W!T:6UA;" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#8P-RXY.#,S.3@T,S<U
M(&T*-34X+C4V.3,S-3DS-S4@-C W+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.34N,# @-C Y+C,R(%1D("A7*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,3 S+C8T(#8P.2XS,B!49" H;W)K9F]R8V4@4V]L=71I;VYS+"!,3$,L
M(&%S(%-E;&QE<B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T
M;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" T,S(N-#<@
M-C Y+C,R(%1D("AS($9O<FT@."U+(&1A=&5D($IU;F4@,RP@,C Q-" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#4Y-RXY.#,S.3@T,S<U
M(&T*,C0W+CDV.#<U(#4Y-RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#4Y.2XS,B!49" H86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N
M8V4@:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R
M"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,RXP," U.#8N,S(@5&0@*#$P+C$W*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P
M(#4X-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4
M<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-3@T+C X
M,S,Y.#0S-S4@;0HU-38N-30W.#4Q-38R-2 U.#0N,#@S,SDX-#,W-2!L"G,*
M<2 P(# @,2!R9R!"5" Y-2XP," U.#4N-#(@5&0@*%-E8V]N9"!,:65N($QO
M86X@86YD(%-E8W5R:71Y("D@5&H@150@40IQ(# @," Q(')G($)4(#(R,RXP
M,B U.#4N-#(@5&0@*$%G<F5E;65N="P@9&%T960@2G5N92 S,"P@,C Q-"P@
M8GD@86YD(&%M;VYG($-R;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@26YC+BP@
M87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U-S0N,#@S
M,SDX-#,W-2!M"C4V,"XT,3DY,C$X-S4@-3<T+C X,S,Y.#0S-S4@; IS"G$@
M," P(#$@<F<@0E0@.34N,# @-3<U+C0R(%1D("AB;W)R;W=E<BD@5&H@150@
M40IQ(# @," Q(')G($)4(#$S,2XR-2 U-S4N-#(@5&0@*"P@8V5R=&%I;B!O
M9B!I=',@9&]M97-T:6,@<W5B<VED:6%R:65S+"!A<R!G=6%R86YT;W)S+"!A
M;F0@0E-0*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S<Q+CDU(#4W-2XT,B!4
M9" H("D@5&H@150@40IQ(# @," Q(')G($)4(#,W,RXY," U-S4N-#(@5&0@
M*$%G96YC>2D@5&H@150@40IQ(# @," Q(')G($)4(#0P-"XS-2 U-S4N-#(@
M5&0@*"P@3$Q#+"!A<R!A9V5N="!<*%!R979I;W5S;'D@9FEL960@87,@86X@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U-C0N,#@S,SDX
M-#,W-2!M"C0V.2XS-# X,C S,3(U(#4V-"XP.#,S.3@T,S<U(&P*<PIQ(# @
M," Q(')G($)4(#DU+C P(#4V-2XT,B!49" H97AH:6)I="!T;R!T:&4@0V]M
M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q.3$N.3,@-38U+C0R(%1D
M("AS($9O<FT@."U+(&1A=&5D($IU;'D@,BP@,C Q-"!A;F0@:6YC;W)P;W)A
M=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#4U,2XS
M,B!49" H,3 N,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.3$N,# @-34Q+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,
M( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HY-2 U-#DN.3@S,SDX-#,W-2!M"C4T-BXU-3(W,S0S-S4@-30Y+CDX
M,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-34Q+C,R(%1D("A#
M;VYV97)T:6)L92!.;W1E(%!U<F-H87-E("D@5&H@150@40IQ(# @," Q(')G
M($)4(#(P-"XW," U-3$N,S(@5&0@*$%G<F5E;65N="P@9&%T960@87,@;V8@
M2G5N92 S,"P@,C Q-"P@8GD@86YD(&%M;VYG($-R;W-S($-O=6YT<GD@2&5A
M;'1H8V%R92P@26YC+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-
M"CDU(#4S.2XY.#,S.3@T,S<U(&T*-30V+C V-#0U,S$R-2 U,SDN.3@S,SDX
M-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," U-#$N,S(@5&0@*&%N9"!C
M97)T86EN(&]F(&ET<R!D;VUE<W1I8R!S=6)S:61I87)I97,@86YD($)E;F5F
M:70@4W1R965T(%!A<G1N97)S(%--02D@5&H@150@40IQ(# @," Q(')G($)4
M(#,X,RXX,R U-#$N,S(@5&0@*"!,32!,+E I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" T,38N.#D@-30Q+C,R(%1D("@N+"!014--(%-T<F%T96=I8R!&=6YD
M:6YG($PN4"D@5&H@150@40IQ(# @," Q(')G($)4(#4T,2XP-B U-#$N,S(@
M5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U,CDN
M.3@S,SDX-#,W-2!M"C4S-"XS,S4Y,S<U(#4R.2XY.#,S.3@T,S<U(&P*<PIQ
M(# @," Q(')G($)4(#DU+C P(#4S,2XS,B!49" H86YD(%!R;W9I9&5N8V4@
M1&5B="!&=6YD($E)22!,+E I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,CDN
M.3@@-3,Q+C,R(%1D("@N(&%N9"!O=&AE<B!N;W1E:&]L9&5R<R!D969I;F5D
M('1H97)E:6X@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@
M=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-3$Y+CDX
M,S,Y.#0S-S4@;0HT,30N,#<R,C8U-C(U(#4Q.2XY.#,S.3@T,S<U(&P*<PIQ
M(# @," Q(')G($)4(#DU+C P(#4R,2XS,B!49" H0V]M<&%N>9(I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" Q,S8N-C<@-3(Q+C,R(%1D("AS($9O<FT@."U+
M(&1A=&5D($IU;'D@,BP@,C Q-"!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R
M96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#4P."XS,B!49" H,3 N,3DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3$N
M,# @-3 X+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 U,#8N
M.3@S,SDX-#,W-2!M"C4U,RXR,C<U,SDP-C(U(#4P-BXY.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DU+C P(#4P."XS,B!49" H1F]U<G1H("D@5&H@
M150@40IQ(# @," Q(')G($)4(#$R,RXV,B U,#@N,S(@5&0@*$%M96YD;65N
M="P@9&%T960@87,@;V8@3V-T;V)E<B R,"P@,C Q-"P@=&\@3&]A;B!A;F0@
M4V5C=7)I='D@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S@T+C$Q(#4P."XS
M,B!49" H06=R965M96YT(&1A=&5D($IA;G5A<GD@.2P@,C Q,RP@8GD@86YD
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-#DV+CDX,S,Y
M.#0S-S4@;0HU-3<N.#DU-3 W.#$R-2 T.38N.3@S,SDX-#,W-2!L"G,*<2 P
M(# @,2!R9R!"5" Y-2XP," T.3@N,S(@5&0@*&%M;VYG($-R;W-S($-O=6YT
M<GD@2&5A;'1H8V%R92P@26YC+B!A;F0@8V5R=&%I;B!O9B!I=',@<W5B<VED
M:6%R:65S+"!A<R!";W)R;W=E<G,L('1H92!,96YD97)S(')E9F5R96YC960@
M=&AE<F5I;BP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 T
M.#8N.3@S,SDX-#,W-2!M"C4T.2XS-3 U.#4Y,S<U(#0X-BXY.#,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#0X."XS,B!49" H86YD($)A;FL@
M;V8@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,30U+C@S(#0X."XS,B!49" H
M06UE<FEC82P@3BY!+BP@87,@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C$Y
M+CDW(#0X."XS,B!49" H06=E;G0@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N
M(&5X:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@-#,V+C T(#0X."XS,B!49" H<R!&;W)M(#$P+5$@9F]R('1H92!Q=6%R
M=&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-#<V+CDX
M,S,Y.#0S-S4@;0HS-3<N,3 Y,S<U(#0W-BXY.#,S.3@T,S<U(&P*<PIQ(# @
M," Q(')G($)4(#DU+C P(#0W."XS,B!49" H96YD960@4V5P=&5M8F5R(#,P
M+" R,#$T(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @
M5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,N,# @-#8U+C,R(%1D("@Q,"XR," C*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DQ+C P(#0V-2XS,B!4
M9" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S
M"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@-#8S+CDX,S,Y.#0S-S4@
M;0HU-C N-C,Y-C0X-#,W-2 T-C,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," T-C4N,S(@5&0@*%0I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" Q,# N-S8@-#8U+C,R(%1D("AR86YS:71I;VX@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,3,W+C<P(#0V-2XS,B!49" H06=R965M96YT+"!D871E9"!-
M87)C:" S+" R,#$T+"!B971W965N($5M:6P@2&5N<V5L(&%N9"!T:&4@4F5G
M:7-T<F%N="!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I=" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#0U,RXY.#,S.3@T,S<U
M(&T*-3(T+C(X-S$P.3,W-2 T-3,N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," T-34N,S(@5&0@*'1O('1H92!#;VUP86YYDBD@5&H@150@
M40IQ(# @," Q(')G($)4(#$V,2XV-B T-34N,S(@5&0@*',@1F]R;2 Q,"U+
M(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@,C Q,R!A;F0@:6YC
M;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z
M(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P
M(#0T,BXS,B!49" H,3 N,C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3$N,# @-#0R+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4
M>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HY-2 T-# N.3@S,SDX-#,W-2!M"C4U."XP,3<U-S@Q,C4@
M-#0P+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @-#0R+C,R
M(%1D("A,96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q,C N,C8@-#0R
M+C,R(%1D("A!9W)E96UE;G0L(&1A=&5D($YO=F5M8F5R(#(R+" Q.3DY+"!B
M>2!A;F0@8F5T=V5E;B!&86ER9F%X($)O8V$@.3(L($PN4"D@5&H@150@40IQ
M(# @," Q(')G($)4(#0R-BXR.2 T-#(N,S(@5&0@*"X@86YD($UE9&EC86P@
M4W1A9BD@5&H@150@40IQ(# @," Q(')G($)4(#0Y.2XT,B T-#(N,S(@5&0@
M*&9I;F<@3F5T=V]R:RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HY-2 T,S N.3@S,SDX-#,W-2!M"C4R-RXU,C0T,30P-C(U(#0S,"XY.#,S
M.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#0S,BXS,B!49" H26YC
M+B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M
M<&%N>2=S($9O<FT@,3 M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@
M,S$L(#(P,30@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.34@-#(P+CDX,S,Y.#0S-S4@;0HR,S$N,#,P,C<S-#,W-2 T,C N.3@S,SDX
M-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," T,C(N,S(@5&0@*&EN8V]R
M<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P
M(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," T
M,#<N,S(@5&0@*#$P+C(R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 T,#4N
M.3@S,SDX-#,W-2!M"C4T-BXY,C,X,C@Q,C4@-# U+CDX,S,Y.#0S-S4@; IS
M"G$@," P(#$@<F<@0E0@.34N,# @-# W+C,R(%1D("A&:7)S=" I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" Q,34N,CD@-# W+C,R(%1D("A!;65N9&UE;G0@
M=&\@3&5A<V4@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C R+C<V(#0P-RXS
M,B!49" H06=R965M96YT(&)Y(&%N9"!B971W965N($9A:7)F87@@0F]C82 Y
M,B!,+E I(%1J($54(%$*<2 P(# @,2!R9R!"5" S.30N.3,@-# W+C,R(%1D
M("@N(&%N9"!-961I8V%L(%-T868I(%1J($54(%$*<2 P(# @,2!R9R!"5" T
M-C@N,#8@-# W+C,R(%1D("AF:6YG($YE='=O<FLL($EN8RXL("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,SDU+CDX,S,Y.#0S-S4@;0HU
M-3$N,30R-3<X,3(U(#,Y-2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#,Y-RXS,B!49" H9&%T960@2G5L>2 S,2P@,C P,2!<*%!R979I
M;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>2=S($9O
M<FT@,3 M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y
M('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,S@U+CDX,S,Y.#0S-S4@
M;0HR-S N-#8X-S4@,S@U+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@
M.34N,# @,S@W+C,R(%1D("@R,#$T(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F
M97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,S<S+C,R(%1D("@Q,"XR
M,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @
M5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,S<Q+CDX,S,Y.#0S-S4@;0HU
M-3@N,#(R-#8P.3,W-2 S-S$N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y-2XP," S-S,N,S(@5&0@*%-E8V]N9" I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" Q,C8N,SD@,S<S+C,R(%1D("A!;65N9&UE;G0@=&\@3&5A<V4@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,C$S+C@V(#,W,RXS,B!49" H06=R965M
M96YT(&)Y(&%N9"!B971W965N($9A:7)F87@@0F]C82 Y,B!,+E I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" T,#8N,#,@,S<S+C,R(%1D("@N(&%N9"!-961I
M8V%L(%-T868I(%1J($54(%$*<2 P(# @,2!R9R!"5" T-SDN,38@,S<S+C,R
M(%1D("AF:6YG($YE='=O<FLL($EN8RXL("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*
M,2!*"C$@:@HS($T*.34@,S8Q+CDX,S,Y.#0S-S4@;0HU-C N-3<Q,C@Y,#8R
M-2 S-C$N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," S-C,N
M,S(@5&0@*&1A=&5D($UA<F-H(#(P+" R,# R(%PH4')E=FEO=7-L>2!F:6QE
M9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YY)W,@1F]R;2 Q,"U+(&9O
M<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY-2 S-3$N.3@S,SDX-#,W-2!M"C(W,"XT-C@W
M-2 S-3$N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," S-3,N
M,S(@5&0@*#(P,30@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R
M96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," S,S@N,S(@5&0@*#$P+C(T*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P
M,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HY-2 S,S8N,#@S,SDX-#,W-2!M"C4U,"XX,# W.#$R
M-2 S,S8N,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," S,S<N
M-#(@5&0@*%1H:7)D("D@5&H@150@40IQ(# @," Q(')G($)4(#$Q.2XQ-R S
M,S<N-#(@5&0@*$%M96YD;65N="!T;R!,96%S92 I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" R,#8N-C0@,S,W+C0R(%1D("A!9W)E96UE;G0@8GD@86YD(&)E
M='=E96X@1F%I<F9A>"!";V-A(#DR($PN4"D@5&H@150@40IQ(# @," Q(')G
M($)4(#,Y."XX," S,S<N-#(@5&0@*"X@86YD($UE9&EC86P@4W1A9BD@5&H@
M150@40IQ(# @," Q(')G($)4(#0W,2XY,R S,S<N-#(@5&0@*&9I;F<@3F5T
M=V]R:RP@26YC+BP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY
M-2 S,C8N,#@S,SDX-#,W-2!M"C4U,BXX,#(W,S0S-S4@,S(V+C X,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.34N,# @,S(W+C0R(%1D("AD871E9"!-
M87D@,30L(#(P,#(@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@
M=&\@=&AE($-O;7!A;GDG<R!&;W)M(#$P+4L@9F]R('1H92!Y96%R(&5N9&5D
M($1E8V5M8F5R(#,Q+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-
M"CDU(#,Q-BXP.#,S.3@T,S<U(&T*,C<P+C0V.#<U(#,Q-BXP.#,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#,Q-RXT,B!49" H,C Q-"!A;F0@
M:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P
M(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#,P,RXS,B!49" H,3 N,C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU
M(#,P,2XP.#,S.3@T,S<U(&T*-34U+C(U,SDP-C(U(#,P,2XP.#,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#,P,BXT,B!49" H1F]U<G1H("D@
M5&H@150@40IQ(# @," Q(')G($)4(#$R,RXV,B S,#(N-#(@5&0@*$%M96YD
M;65N="!T;R!,96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,3$N,#D@
M,S R+C0R(%1D("A!9W)E96UE;G0@8GD@86YD(&)E='=E96X@1F%I<F9A>"!"
M;V-A(#DR($PN4"D@5&H@150@40IQ(# @," Q(')G($)4(#0P,RXR-B S,#(N
M-#(@5&0@*"X@86YD($UE9&EC86P@4W1A9BD@5&H@150@40IQ(# @," Q(')G
M($)4(#0W-BXS.2 S,#(N-#(@5&0@*&9I;F<@3F5T=V]R:RP@26YC+BP@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 R.3$N,#@S,SDX-#,W
M-2!M"C4V,"XU-38V-# V,C4@,CDQ+C X,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.34N,# @,CDR+C0R(%1D("AD871E9"!$96-E;6)E<B Q,RP@,C P
M,B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M
M<&%N>2=S($9O<FT@,3 M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 R.#$N,#@S,SDX
M-#,W-2!M"C(X-2XT-C@W-2 R.#$N,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R
M9R!"5" Y-2XP," R.#(N-#(@5&0@*#,Q+" R,#$T(&%N9"!I;F-O<G!O<F%T
M960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C8X+C,R
M(%1D("@Q,"XR-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO
M1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C8V+C X,S,Y
M.#0S-S4@;0HU-#@N,#,R,C(V-38R-2 R-C8N,#@S,SDX-#,W-2!L"G,*<2 P
M(# @,2!R9R!"5" Y-2XP," R-C<N-#(@5&0@*$9I9G1H("D@5&H@150@40IQ
M(# @," Q(')G($)4(#$Q-BXT," R-C<N-#(@5&0@*$%M96YD;65N="!T;R!,
M96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,#,N.#<@,C8W+C0R(%1D
M("A!9W)E96UE;G0@8GD@86YD(&)E='=E96X@1F%I<F9A>"!";V-A(#DR($PN
M4"D@5&H@150@40IQ(# @," Q(')G($)4(#,Y-BXP-" R-C<N-#(@5&0@*"X@
M86YD($UE9&EC86P@4W1A9BD@5&H@150@40IQ(# @," Q(')G($)4(#0V.2XQ
M-R R-C<N-#(@5&0@*&9I;F<@3F5T=V]R:RP@26YC+BP@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY-2 R-38N,#@S,SDX-#,W-2!M"C4U-2XR
M,# Q.34S,3(U(#(U-BXP.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#(U-RXT,B!49" H9&%T960@1F5B<G5A<GD@,2D@5&H@150@40IQ(# @
M," Q(')G($)4(#$V,BXS." R-3<N-#(@5&0@*#$L(#(P,#,@7"A0<F5V:6]U
M<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M
M(#$P+4L@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C0V+C X,S,Y.#0S-S4P,# R(&T*
M,C@U+C0V.#<U(#(T-BXP.#,S.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"
M5" Y-2XP," R-#<N-#(@5&0@*#,Q+" R,#$T(&%N9"!I;F-O<G!O<F%T960@
M8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C,S+C,R(%1D
M("@Q,"XR-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P
M(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,C,Q+C X,S,Y.#0S
M-S4P,# R(&T*-30T+C@R-#(Q.#<U(#(S,2XP.#,S.3@T,S<U,# P,B!L"G,*
M<2 P(# @,2!R9R!"5" Y-2XP," R,S(N-#(@5&0@*%-I>'1H("D@5&H@150@
M40IQ(# @," Q(')G($)4(#$Q."XP-R R,S(N-#(@5&0@*$%M96YD;65N="!T
M;R!,96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,#4N-30@,C,R+C0R
M(%1D("A!9W)E96UE;G0@8GD@86YD(&)E='=E96X@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,S$W+C4T(#(S,BXT,B!49" H5"D@5&H@150@40IQ(# @," Q
M(')G($)4(#,R,BXY-2 R,S(N-#(@5&0@*&5A8VAE<G,@26YS=7)A;F-E(&%N
M9" I(%1J($54(%$*<2 P(# @,2!R9R!"5" T,3,N,3@@,C,R+C0R(%1D("A!
M;FYU:71Y("D@5&H@150@40IQ(# @," Q(')G($)4(#0T-RXY,2 R,S(N-#(@
M5&0@*$%S<V]C:6%T:6]N(&]F("D@5&H@150@40IQ(# @," Q(')G($)4(#4P
M-RXY," R,S(N-#(@5&0@*$%M97)I8V$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HY-2 R,C$N,#@S,SDX-#,W-3 P,#(@;0HU-30N,C$X-S4@
M,C(Q+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#(R
M,BXT,B!49" H86YD($UE9&EC86P@4W1A9BD@5&H@150@40IQ(# @," Q(')G
M($)4(#$V,RXQ,R R,C(N-#(@5&0@*&9I;F<@3F5T=V]R:RP@3$Q#+"!D871E
M9"!*86YU87)Y(#,L(#(P,2D@5&H@150@40IQ(# @," Q(')G($)4(#,R."XP
M," R,C(N-#(@5&0@*#$@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB
M:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*
M,2!*"C$@:@HS($T*.34@,C$Q+C X,S,Y.#0S-S4P,# R(&T*-#(W+C V-30R
M.38X-S4@,C$Q+C X,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4(#DU
M+C P(#(Q,BXT,B!49" H,3 M2R!F;W(@=&AE('EE87(@96YD960@1&5C96UB
M97(@,S$L(#(P,30@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@:&5R
M96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," Q.3@N,S(@5&0@*#$P+C(X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P
M,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HY-2 Q.38N,#@S,SDX-#,W-3 P,#(@;0HU-34N.3(R
M.#4Q-38R-2 Q.38N,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@
M.34N,# @,3DW+C0R(%1D("A3979E;G1H("D@5&H@150@40IQ(# @," Q(')G
M($)4(#$R.2XQ-R Q.3<N-#(@5&0@*$%M96YD;65N="!T;R!,96%S92 I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" R,38N-C0@,3DW+C0R(%1D("A!9W)E96UE
M;G0@8GD@86YD(&)E='=E96X@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S(X
M+C8T(#$Y-RXT,B!49" H5"D@5&H@150@40IQ(# @," Q(')G($)4(#,S-"XP
M-2 Q.3<N-#(@5&0@*&5A8VAE<G,@26YS=7)A;F-E(&%N9" I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" T,C0N,C@@,3DW+C0R(%1D("A!;FYU:71Y("D@5&H@
M150@40IQ(# @," Q(')G($)4(#0U.2XP," Q.3<N-#(@5&0@*$%S<V]C:6%T
M:6]N(&]F("D@5&H@150@40IQ(# @," Q(')G($)4(#4Q.2XP," Q.3<N-#(@
M5&0@*$%M97)I8V$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY
M-2 Q.#8N,#@S,SDX-#,W-3 P,#(@;0HU-#DN,C$X-S4@,3@V+C X,S,Y.#0S
M-S4P,# R(&P*<PIQ(# @," Q(')G($)4(#DU+C P(#$X-RXT,B!49" H86YD
M($UE9&EC86P@4W1A9BD@5&H@150@40IQ(# @," Q(')G($)4(#$V,RXQ,R Q
M.#<N-#(@5&0@*&9I;F<@3F5T=V]R:RP@3$Q#+"!D871E9"!-87)C:" Q+" R
M,#$I(%1J($54(%$*<2 P(# @,2!R9R!"5" S,C,N,# @,3@W+C0R(%1D("@Q
M(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP
M86YY)W,@1F]R;2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU
M(#$W-BXP.#,S.3@T,S<U,# P,B!M"C0R-RXP-C4T,CDV.#<U(#$W-BXP.#,S
M.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," Q-S<N-#(@5&0@
M*#$P+4L@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$T(&%N
M9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q
M,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @,38S+C,R(%1D("@Q,"XR.2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.34@,38Q+C X,S,Y.#0S-S4P,# R(&T*-34U+C,W,3 Y,S<U(#$V,2XP.#,S
M.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y-2XP," Q-C(N-#(@5&0@
M*$5I9VAT:" I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q,C,N-C$@,38R+C0R
M(%1D("A!;65N9&UE;G0@=&\@3&5A<V4@*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,C$Q+C Y(#$V,BXT,B!49" H06=R965M96YT(&)Y(&%N9"!B971W965N
M("D@5&H@150@40IQ(# @," Q(')G($)4(#,R,RXP.2 Q-C(N-#(@5&0@*%0I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" S,C@N-3 @,38R+C0R(%1D("AE86-H
M97)S($EN<W5R86YC92!A;F0@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-#$X
M+C<S(#$V,BXT,B!49" H06YN=6ET>2 I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" T-3,N-#4@,38R+C0R(%1D("A!<W-O8VEA=&EO;B!O9B I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" U,3,N-#4@,38R+C0R(%1D("A!;65R:6-A+" @*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 Q-3$N,#@S,SDX-#,W
M-3 P,#(@;0HU-#8N,34W,C(V-38R-2 Q-3$N,#@S,SDX-#,W-3 P,#(@; IS
M"G$@," P(#$@<F<@0E0@.34N,# @,34R+C0R(%1D("AA;F0@365D:6-A;"!3
M=&%F*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,38S+C$S(#$U,BXT,B!49" H
M9FEN9R!.971W;W)K+"!,3$,L(&1A=&5D($YO=F5M8F5R(#(R+" R,#$I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" S-#0N,3$@,34R+C0R(%1D("@Q(%PH4')E
M=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YY)W,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 Q-#$N,#@S,SDX
M-#,W-3 P,#(@;0HT-3$N,C,U,S4Q-38R-2 Q-#$N,#@S,SDX-#,W-3 P,#(@
M; IS"G$@," P(#$@<F<@0E0@.34N,# @,30R+C0R(%1D("A&;W)M(#$P+4L@
M9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$T(&%N9"!I;F-O
M<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @
M,3(X+C,R(%1D("@Q,"XS,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,3(V
M+CDX,S,Y.#0S-S4@;0HU,S,N.# X-3DS-S4@,3(V+CDX,S,Y.#0S-S4@; IS
M"G$@," P(#$@<F<@0E0@.34N,# @,3(X+C,R(%1D("A396-O;F0@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,3(V+C,Y(#$R."XS,B!49" H06UE;F1M96YT
M('1O(%-E8V]N9"!,:65N($QO86X@86YD(%-E8W5R:71Y("D@5&H@150@40IQ
M(# @," Q(')G($)4(#,Q-BXV,B Q,C@N,S(@5&0@*$%G<F5E;65N="P@9&%T
M960@2G5L>2 R,BP@,C Q-2P@8GD@86YD(&%M;VYG($-R;W-S("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.34@,3$V+CDX,S,Y.#0S-S4@;0HU
M-30N,38Y.3(Q.#<U(#$Q-BXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DU+C P(#$Q."XS,B!49" H0V]U;G1R>2!(96%L=&AC87)E+"!);F,N+"!A
M<R!B;W)R;W=E<BD@5&H@150@40IQ(# @," Q(')G($)4(#(T-2XY,R Q,3@N
M,S(@5&0@*"P@8V5R=&%I;B!O9B!I=',@9&]M97-T:6,@<W5B<VED:6%R:65S
M+"!A<R!G=6%R86YT;W)S+"!T:&4@;&5N9&5R<R!P87)T>2!T:&5R971O+" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDU(#$P-BXY.#,S.3@T
M,S<U(&T*-38Q+C$T,C4W.#$R-2 Q,#8N.3@S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y-2XP," Q,#@N,S(@5&0@*&%N9"!"4U I(%1J($54(%$*<2 P
M(# @,2!R9R!"5" Q,CDN,S8@,3 X+C,R(%1D("@@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,3,Q+C,Q(#$P."XS,B!49" H06=E;F-Y*2!4:B!%5"!1"G$@
M," P(#$@<F<@0E0@,38Q+C<V(#$P."XS,B!49" H+"!,3$,L(&%S(&%G96YT
M(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP
M86YYDBD@5&H@150@40IQ(# @," Q(')G($)4(#0Q-"XW-R Q,#@N,S(@5&0@
M*',@1F]R;2 X+4L@9&%T960@2G5L>2 R,RP@,C Q-2!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY-2 Y-BXY.#,S.3@T,S<U(&T*,C,Q
M+C S,#(W,S0S-S4@.38N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M-2XP," Y."XS,B!49" H:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E
M:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IE
M;F1S=')E86T*96YD;V)J"CDU(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N
M=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R
M8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@.38@,"!2/CX*96YD;V)J
M"CDV(# @;V)J"CP\+TQE;F=T:" R,#,Y,CX^"G-T<F5A;0I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#0T*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S,"XY
M," W-#(N,3 @5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C,S+C0P(#<T,BXQ,"!49" H15A(24))5"D@5&H@150@
M40IQ(# @," P(')G($)4(#(W-BXP,2 W-#(N,3 @5&0@*"!)3D1%6"!<*$-/
M3E1)3E5%1%PI*2!4:B!%5"!1"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y+C4@-S$V+C8@;0HY,BXU(#<Q-BXV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HY-BXU(#<Q-BXV(&T*-38Q+C4@-S$V+C8@; IS"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#<R,BXS,R!49" H3F\N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU
M+C P(#<R,BXQ-R!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,#,N-S4@-S(R+C,S(%1D("A$97-C<FEP=&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP
M," W,#<N,3<@5&0@*#$P+C,Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 W
M,#4N.#,S,SDX-#,W-2!M"C4T-RXR,S(T,C$X-S4@-S U+C@S,S,Y.#0S-S4@
M; IS"G$@," P(#$@<F<@0E0@.3DN,# @-S W+C$W(%1D("A!9W)E96UE;G0@
M86YD(%!L86X@;V8@365R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C$P+C0U
M(#<P-RXQ-R!49" H9V5R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C(R+C@R
M(#<P-RXQ-R!49" H+"!D871E9"!A<R!O9B!*=6QY(#(W+" R,#$U+"!B>2!A
M;F0@86UO;F<@0W)O<W,@0V]U;G1R>2!%9'5C871I;VXL($Q,0RP@0W)O<W,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V.34N.#,S,SDX
M-#,W-2!M"C4S-RXQ,#4T-C@W-2 V.34N.#,S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," V.3<N,3<@5&0@*$-O=6YT<GD@2&5A;'1H8V%R92P@
M26YC+BP@0T,@161U8V%T:6]N+"!,3$,@86YD(%!%4RP@26YC+B!<*%!R979I
M;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>2=S("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-C@U+C@S,S,Y.#0S
M-S4@;0HS-S(N-3$U-C(U(#8X-2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#8X-RXQ-R!49" H1F]R;2 X+4L@9&%T960@2G5L>2 S,"P@
M,C Q-2!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6Y<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@
M,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N,# @-C<S+C$W(%1D("@Q,"XS,BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!4
M3" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@
M:@HS($T*.3D@-C<Q+C@S,S,Y.#0S-S4@;0HU-#8N,#DY-C Y,S<U(#8W,2XX
M,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#8W,RXQ-R!49" H
M1F]U<G1H("D@5&H@150@40IQ(# @," Q(')G($)4(#$R-RXV,B V-S,N,3<@
M5&0@*$%M96YD;65N="!T;R!,96%S92 I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" R,34N,#D@-C<S+C$W(%1D("A!9W)E96UE;G0@8GD@86YD(&)E='=E96X@
M1W)A;FET92!-97)I9&EA;B!,3$,@86YD($-R;W-S($-O=6YT<GD@2&5A;'1H
M8V%R92P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V-C$N
M.#,S,SDX-#,W-2!M"C4U-2XR.3@X,C@Q,C4@-C8Q+C@S,S,Y.#0S-S4@; IS
M"G$@," P(#$@<F<@0E0@.3DN,# @-C8S+C$W(%1D("A);F,N+"!D871E9"!3
M97!T96UB97(@,CDL(#(P,34@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X
M:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#$U+C,R(#8V,RXQ-R!49" H<R!&;W)M(#@M2R!D871E9"!/8W1O8F5R(#(L
M(#(P,34@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V-3$N
M.#,S,SDX-#,W-2!M"C(U,2XY-C@W-2 V-3$N.#,S,SDX-#,W-2!L"G,*<2 P
M(# @,2!R9R!"5" Y.2XP," V-3,N,3<@5&0@*&%N9"!I;F-O<G!O<F%T960@
M8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-C,Y+C$W(%1D
M("@Q,"XS,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P
M(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-C,W+C@S,S,Y.#0S
M-S4@;0HU,C0N-3<Q,C@Y,#8R-2 V,S<N.#,S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," V,SDN,3<@5&0@*$YI;G1H("D@5&H@150@40IQ(# @
M," Q(')G($)4(#$R,RXW,R V,SDN,3<@5&0@*$%M96YD;65N="!T;R!,96%S
M92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,3$N,C @-C,Y+C$W(%1D("A!
M9W)E96UE;G0@8GD@86YD(&)E='=E96X@36%I;G-T<F5E="!#5BD@5&H@150@
M40IQ(# @," Q(')G($)4(#,X,BXS-2 V,SDN,3<@5&0@*"!.;W)T:" T,"P@
M3$Q#(&%N9"!#<F]S<R!#;W5N=')Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.3D@-C(W+C@S,S,Y.#0S-S4@;0HU,S8N,SDR-3<X,3(U(#8R
M-RXX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#8R.2XQ-R!4
M9" H2&5A;'1H8V%R92P@26YC+BP@9&%T960@4V5P=&5M8F5R(#(Y+" R,#$U
M(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP
M86YYDBD@5&H@150@40IQ(# @," Q(')G($)4(#0V,RXV,B V,CDN,3<@5&0@
M*',@1F]R;2 X+4L@9&%T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HY.2 V,3<N.#,S,SDX-#,W-2!M"C,Q.2XQ-S4W.#$R-2 V,3<N.#,S
M,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," V,3DN,3<@5&0@*$]C
M=&]B97(@,BP@,C Q-2!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H
M97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3
M,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R+C P(#8P-2XQ-R!49" H,3 N,S0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@
M,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@
M,"!D"C$@2@HQ(&H*,R!-"CDY(#8P,RXX,S,S.3@T,S<U(&T*-3,P+C,U-S0R
M,3@W-2 V,#,N.#,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," V
M,#4N,3<@5&0@*$QE87-E("D@5&H@150@40IQ(# @," Q(')G($)4(#$R-"XR
M-B V,#4N,3<@5&0@*$%G<F5E;65N="!B>2!A;F0@8F5T=V5E;B!-86EN<W1R
M965T($-6*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,CDU+C0R(#8P-2XQ-R!4
M9" H($YO<G1H(#0P+"!,3$,@86YD($-R;W-S($-O=6YT<GD@2&5A;'1H8V%R
M92P@26YC+BP@9&%T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HY.2 U.3,N.#,S,SDX-#,W-2!M"C4R-RXX,3,T-S8U-C(U(#4Y,RXX,S,S
M.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#4Y-2XQ-R!49" H4V5P
M=&5M8F5R(#(Y+" R,#$U(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI
M8FET('1O('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," Q(')G($)4(#,W
M,"XY," U.34N,3<@5&0@*',@1F]R;2 X+4L@9&%T960@3V-T;V)E<B R+" R
M,#$U(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'
M"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4X
M,RXX,S,S.3@T,S<U(&T*,C,U+C S,#(W,S0S-S4@-3@S+C@S,S,Y.#0S-S4@
M; IS"G$@," P(#$@<F<@0E0@.3DN,# @-3@U+C$W(%1D("AI;F-O<G!O<F%T
M960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-3<Q+C$W
M(%1D("@Q,"XS-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO
M1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-38Y+C@S,S,Y
M.#0S-S4@;0HU-#0N,38V,#$U-C(U(#4V.2XX,S,S.3@T,S<U(&P*<PIQ(# @
M," Q(')G($)4(#DY+C P(#4W,2XQ-R!49" H4W1O8VL@4'5R8VAA<V4@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,38R+C,S(#4W,2XQ-R!49" H06=R965M
M96YT+"!D871E9"!/8W1O8F5R(#$Y+" R,#$U+"!B>2!A;F0@86UO;F<@0W)O
M<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N(&%N9"!$96YN:7,@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 U-3DN.#,S,SDX-#,W-2!M
M"C4T.2XT-S,V,S(X,3(U(#4U.2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#4V,2XQ-R!49" H1'5C:&%M+"!%;6EL>2!397)E8G)Y86YY
M*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C Y+C<Q(#4V,2XQ-R!49" H+"!%
M;6EL>2!397)E8G)Y86YY("D@5&H@150@40IQ(# @," Q(')G($)4(#(X.2XU
M,2 U-C$N,3<@5&0@*%0I(%1J($54(%$*<2 P(# @,2!R9R!"5" R.34N,C8@
M-38Q+C$W(%1D("AR=7-T(&1A=&5D(#0O,38O,30L("D@5&H@150@40IQ(# @
M," Q(')G($)4(#,W,BXS," U-C$N,3<@5&0@*%8I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" S-S@N-#$@-38Q+C$W(%1D("AA;"!397)E8G)Y86YY*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@-#,S+C Q(#4V,2XQ-R!49" H+"!A;F0@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@-#4T+C<W(#4V,2XQ-R!49" H5BD@5&H@
M150@40IQ(# @," Q(')G($)4(#0V,"XX." U-C$N,3<@5&0@*&%L(%-E<F5B
M<GEA;GD@1F%M:6QY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.3D@-30Y+C@S,S,Y.#0S-S4@;0HU,CDN-30Q.3DR,3@W-2 U-#DN.#,S,SDX
M-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," U-3$N,3<@5&0@*%0I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" Q,#0N-S8@-34Q+C$W(%1D("AR=7-T(&1A
M=&5D(#(O,3@O,30@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@
M=&\@=&AE($-O;7!A;GDG<R!&;W)M(#@M2R!D871E9"!/8W1O8F5R(#(P+" R
M,#$U(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'
M"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4S
M.2XX,S,S.3@T,S<U(&T*,C,R+C4S,#(W,S0S-S4@-3,Y+C@S,S,Y.#0S-S4@
M; IS"G$@," P(#$@<F<@0E0@.3DN,# @-30Q+C$W(%1D("AI;F-O<G!O<F%T
M960@8GD@<F5F97)E;F-E(&AE<F5I;EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," U,C<N,3<@
M5&0@*#$P+C,V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 U,C4N.#,S,SDX
M-#,W-2!M"C4U."XP-3<V,3<Q.#<U(#4R-2XX,S,S.3@T,S<U(&P*<PIQ(# @
M," Q(')G($)4(#DY+C P(#4R-RXQ-R!49" H07-S970@4'5R8VAA<V4@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,38Q+C<W(#4R-RXQ-R!49" H06=R965M
M96YT(&)E='=E96X@365D:7-C86XL($EN8RX@86YD($1I<F5C="!%9"!3;VQU
M=&EO;G,L($EN8RX@86YD($UI:&%L(%-P:65G96PL(&1A=&5D("D@5&H@150@
M40IQ(# @," Q(')G($)4(#4R-BXV-R U,C<N,3<@5&0@*$%U9W5S=" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4Q-2XX,S,S.3@T,S<U
M(&T*-34W+C$P-30V.#<U(#4Q-2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#4Q-RXQ-R!49" H,3DL(#(P,30@7"A0<F5V:6]U<VQY(&9I
M;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M(#@M2R!D
M871E9"!.;W9E;6)E<B S+" R,#$U(&%N9"!I;F-O<G!O<F%T960@8GD@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 U,#4N.#,S,SDX-#,W
M-2!M"C$V.2XT.3@P-#8X-S4@-3 U+C@S,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.3DN,# @-3 W+C$W(%1D("AR969E<F5N8V4@:&5R96EN+EPI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P
M(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,BXP," T.3,N,3<@5&0@*#$P+C,W(",I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @
M5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"CDY(#0Y,2XX,S,S.3@T,S<U(&T*-30T+CDX-C,R.#$R-2 T.3$N
M.#,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," T.3,N,3<@5&0@
M*$5M<&QO>6UE;G0@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,34R+C8Q(#0Y
M,RXQ-R!49" H06=R965M96YT(&)E='=E96X@0W)O<W,@0V]U;G1R>2!(96%L
M=&AC87)E+"!);F,N(&%N9"!$96YN:7,@1'5C:&%M+"!D871E9"!/8W1O8F5R
M(#,P+" R,#$U("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@
M4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@
M-#@Q+C@S,S,Y.#0S-S4@;0HU-3DN,C@X,#@U.3,W-2 T.#$N.#,S,SDX-#,W
M-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," T.#,N,3<@5&0@*%PH4')E=FEO
M=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YY)W,@1F]R
M;2 X+4L@9&%T960@3F]V96UB97(@,RP@,C Q-2!A;F0@:6YC;W)P;W)A=&5D
M(&)Y(')E9F5R96YC92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-
M"CDY(#0W,2XX,S,S.3@T,S<U(&T*,3(Y+C@Q-30R.38X-S4@-#<Q+C@S,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-#<S+C$W(%1D("AH97)E
M:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C P(#0U.2XQ-R!49" H,3 N,S@@(RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q
M,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P
M(&0*,2!*"C$@:@HS($T*.3D@-#4W+C@S,S,Y.#0S-S4@;0HU-# N.#$V-# V
M,C4@-#4W+C@S,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-#4Y
M+C$W(%1D("A%;7!L;WEM96YT("D@5&H@150@40IQ(# @," Q(')G($)4(#$U
M,BXV,2 T-3DN,3<@5&0@*$%G<F5E;65N="!B971W965N($-R;W-S($-O=6YT
M<GD@2&5A;'1H8V%R92P@26YC+B!A;F0@*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,S<X+C<T(#0U.2XQ-R!49" H5BD@5&H@150@40IQ(# @," Q(')G($)4
M(#,X-"XX-2 T-3DN,3<@5&0@*&%L(%-E<F5B<GEA;GDI(%1J($54(%$*<2 P
M(# @,2!R9R!"5" T,SDN-#4@-#4Y+C$W(%1D("@L(&1A=&5D($]C=&]B97(@
M,S L(#(P,34@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 T
M-#<N.#,S,SDX-#,W-2!M"C4U.2XR.#@P.#4Y,S<U(#0T-RXX,S,S.3@T,S<U
M(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#0T.2XQ-R!49" H7"A0<F5V:6]U
M<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M
M(#@M2R!D871E9"!.;W9E;6)E<B S+" R,#$U(&%N9"!I;F-O<G!O<F%T960@
M8GD@<F5F97)E;F-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.3D@-#,W+C@S,S,Y.#0S-S4@;0HQ,CDN.#$U-#(Y-C@W-2 T,S<N.#,S,SDX
M-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," T,SDN,3<@5&0@*&AE<F5I
M;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S
M"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(N,# @-#(U+C$W(%1D("@Q,"XS.2 C*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P
M,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @
M9 HQ($H*,2!J"C,@30HY.2 T,C,N.#,S,SDX-#,W-2!M"C4T,"XU,S@P.#4Y
M,S<U(#0R,RXX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#0R
M-2XQ-R!49" H4F5S=')I8W1E9"!3=&]C:R I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" Q-C8N-S<@-#(U+C$W(%1D("A!9W)E96UE;G0@8F5T=V5E;B!#<F]S
M<R!#;W5N=')Y($AE86QT:&-A<F4L($EN8RX@86YD($YE=R!-961I<V-A;B!$
M:6%G;F]S=&EC(%-E<G9I8V5S+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"CDY(#0Q,RXX,S,S.3@T,S<U(&T*-34S+C<V-38R-2 T,3,N.#,S
M,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," T,34N,3<@5&0@*$EN
M8RXL(&1A=&5D($]C=&]B97(@,S L(#(P,34@7"A0<F5V:6]U<VQY(&9I;&5D
M(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M(#@M2R!D871E
M9"!.;W9E;6)E<B S+" R,#$U("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@
M:@HS($T*.3D@-# S+C@S,S,Y.#0S-S4@;0HR-3$N.38X-S4@-# S+C@S,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-# U+C$W(%1D("AA;F0@
M:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P
M(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C P(#,Y,2XQ-R!49" H,3 N-# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY
M(#,X.2XX,S,S.3@T,S<U(&T*-3(S+C8Y-S(V-38R-2 S.#DN.#,S,SDX-#,W
M-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," S.3$N,3<@5&0@*$QE87-E("D@
M5&H@150@40IQ(# @," Q(')G($)4(#$R-"XR-B S.3$N,3<@5&0@*$%G<F5E
M;65N="!B971W965N($=O;&1E;B!%9V<L($Q,0R!A;F0@365D:7-C86X@4W1A
M9BD@5&H@150@40IQ(# @," Q(')G($)4(#,U-2XV." S.3$N,3<@5&0@*&9I
M;F<@4V5R=FEC97,L(&1B82!-961I<V-A;B!$:6%G;F]S=&EC<RP@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S-SDN.#,S,SDX-#,W-2!M
M"C4Q,RXQ-34R-S,T,S<U(#,W.2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#,X,2XQ-R!49" H365D:7-C86X@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,30P+C(P(#,X,2XQ-R!49" H5&AE<F%P>2!);F,N+"!$:7)E
M8W0@160@4V]L=71I;VYS+"!A;F0@1&ER96-T($5D(%-P96-I86QI>F5D(%-E
M<G9I8V5S+"!D871E9" I(%1J($54(%$*<2 P(# @,2!R9R!"5" T-#DN,C8@
M,S@Q+C$W(%1D("A!=6=U<W0@-"P@,C Q-2 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"CDY(#,V.2XX,S,S.3@T,S<U(&T*-34Y+C(X.# X-3DS
M-S4@,S8Y+C@S,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,S<Q
M+C$W(%1D("A<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T
M:&4@0V]M<&%N>2=S($9O<FT@."U+(&1A=&5D($YO=F5M8F5R(#,L(#(P,34@
M86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 S-3DN.#,S,SDX-#,W-2!M"C$R.2XX,34T
M,CDV.#<U(#,U.2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#,V,2XQ-R!49" H:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S-#<N,3<@5&0@
M*#$P+C0Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S-#4N.#,S,SDX-#,W
M-2!M"C4T."XS,S$P-30V.#<U(#,T-2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q
M(')G($)4(#DY+C P(#,T-RXQ-R!49" H1FER<W0@*2!4:B!%5"!1"G$@," P
M(#$@<F<@0E0@,3$Y+C(Y(#,T-RXQ-R!49" H06UE;F1M96YT('1O($QE87-E
M("D@5&H@150@40IQ(# @," Q(')G($)4(#(P-BXW-B S-#<N,3<@5&0@*$%G
M<F5E;65N="!B971W965N($=O;&1E;B!%9V<L($Q,0R!A;F0@365D:7-C86X@
M1&EA9VYO<W1I8R!397)V:6-E<RP@365D:7-C86X@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 S,S4N.#,S,SDX-#,W-2!M"C4T-2XQ,#@S
M.3@T,S<U(#,S-2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#,S-RXQ-R!49" H3G5R<VEN9R!3=&%F*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,30Y+C8U(#,S-RXQ-R!49" H9FEN9RP@1&ER96-T($5D(%-O;'5T:6]N
M<RP@86YD($1I<F5C="!%9"!3<&5C:6%L:7IE9"!397)V:6-E<RP@9&%T960@
M3V-T;V)E<B S,"P@,C Q-2!<*%!R979I;W5S;'D@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 S,C4N.#,S,SDX-#,W-2!M"C4T,2XT.34Q
M,3<Q.#<U(#,R-2XX,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#,R-RXQ-R!49" H9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N
M>2=S($9O<FT@."U+(&1A=&5D($YO=F5M8F5R(#,L(#(P,34@86YD(&EN8V]R
M<&]R871E9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P
M(%1,( I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S
M,3,N,3<@5&0@*#$P+C0R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO
M1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S,3$N
M.#,S,SDX-#,W-2!M"C4S-2XQ,S<V.34S,3(U(#,Q,2XX,S,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DY+C P(#,Q,RXQ-R!49" H5&AI<F0@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,3(S+C$W(#,Q,RXQ-R!49" H06UE;F1M96YT
M('1O($QE87-E("D@5&H@150@40IQ(# @," Q(')G($)4(#(Q,"XV-" S,3,N
M,3<@5&0@*$%G<F5E;65N="!B971W965N(%).4TD@0VET>2!0;&%C92!/=VYE
M<BD@5&H@150@40IQ(# @," Q(')G($)4(#,X.2XS-B S,3,N,3<@5&0@*"P@
M3$Q#(&%N9"!#96IK82!396%R8V@L($EN8RXL(&1A=&5D("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,S Q+C@S,S,Y.#0S-S4@;0HU-3<N
M,#<Q,C@Y,#8R-2 S,#$N.#,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M.2XP," S,#,N,3<@5&0@*$1E8V5M8F5R(#(L(#(P,34@7"A0<F5V:6]U<VQY
M(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M(#$P
M+4M!*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-#(Q+C S(#,P,RXQ-R!49" H
M(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B S,2P@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY.2 R.3$N.#,S,SDX-#,W-2!M"C(W-"XT
M-C@W-2 R.3$N.#,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," R
M.3,N,3<@5&0@*#(P,34@86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N8V4@
M:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXP," R-SDN,3<@5&0@*#$P+C0S(",I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @
M,C<Y+C$W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R
M"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 R-S8N.3,S
M,SDX-#,W-3 P,#4@;0HU-#8N-C4Q,S8W,3@W-2 R-S8N.3,S,SDX-#,W-3 P
M,#4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,C<X+C(W(%1D("A%;7!L;WEM
M96YT("D@5&H@150@40IQ(# @," Q(')G($)4(#$U,BXV,2 R-S@N,C<@5&0@
M*$%G<F5E;65N="P@9&%T960@87,@;V8@36%R8V@@.2P@,C Q-BP@8F5T=V5E
M;B I(%1J($54(%$*<2 P(# @,2!R9R!"5" S-#<N,#@@,C<X+C(W(%1D("A7
M*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S4V+C$R(#(W."XR-R!49" H:6QL
M:6%M($HN($=R=6)B<R!A;F0@=&AE(%)E9VES=')A;G0@7"A0<F5V:6]U<VQY
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,C8V+CDS,S,Y
M.#0S-S4P,# U(&T*-3,P+C8W.38X-S4@,C8V+CDS,S,Y.#0S-S4P,# U(&P*
M<PIQ(# @," Q(')G($)4(#DY+C P(#(V."XR-R!49" H9FEL960@87,@86X@
M97AH:6)I="!T;R!T:&4@0V]M<&%N>2=S($9O<FT@,3 M2R!F;W(@=&AE('EE
M87(@96YD960@1&5C96UB97(@,S$L(#(P,34@86YD(&EN8V]R<&]R871E9"!B
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#(U-BXY,S,S
M.3@T,S<U,# P-2!M"C$V.2XT.3@P-#8X-S4@,C4V+CDS,S,Y.#0S-S4P,# U
M(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#(U."XR-R!49" H<F5F97)E;F-E
M(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO
M1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N,# @,C0T+C$W(%1D("@Q,"XT-"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!4
M8R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;
M72 P(&0*,2!*"C$@:@HS($T*.3D@,C0Q+CDS,S,Y.#0S-S4P,# U(&T*-34S
M+C$Y.3(Q.#<U(#(T,2XY,S,S.3@T,S<U,# P-2!L"G,*<2 P(# @,2!R9R!"
M5" Y.2XP," R-#,N,C<@5&0@*$-R961I=" I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" Q,C4N.30@,C0S+C(W(%1D("A!9W)E96UE;G0L(&1A=&5D($IU;F4@
M,C(L(#(P,38L(&)Y(&%N9"!A;6]N9R!#<F]S<R!#;W5N=')Y($AE86QT:&-A
M<F4L($EN8RXL(&%S(&)O<G)O=V5R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#DU+C<R(#(T,RXR-R!49" H+"!C97)T86EN(&]F(&ET<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#(S,2XY,S,S.3@T,S<U,# P-2!M
M"C4U-RXT-S$V-SDV.#<U(#(S,2XY,S,S.3@T,S<U,# P-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," R,S,N,C<@5&0@*&1O;65S=&EC('-U8G-I9&EA<FEE
M<RP@87,@9W5A<F%N=&]R<RP@=&AE($QE;F1E<G,@<F5F97)E;F-E9"!T:&5R
M96EN+"!A;F0@4W5N=')U<W0@0F%N:RP@87,@86=E;G0@7"AP<F5V:6]U<VQY
M(&9I;&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,C(Q
M+CDS,S,Y.#0S-S4P,# U(&T*-3 Q+C<Y,CDV.#<U(#(R,2XY,S,S.3@T,S<U
M,# P-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," R,C,N,C<@5&0@*&%S(&%N
M(&5X:&EB:70@=&\@=&AE($-O;7!A;GDG<R!&;W)M(#@M2R!D871E9"!*=6YE
M(#(R+" R,#$V(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I
M;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S
M"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(N,# @,C Y+C$W(%1D("@Q,"XT-2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @
M5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*
M,2!*"C$@:@HS($T*.3D@,C W+C@S,S,Y.#0S-S4P,# R(&T*-30Q+C U,#<X
M,3(U(#(P-RXX,S,S.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y.2XP
M," R,#DN,3<@5&0@*%0I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q,#0N-#$@
M,C Y+C$W(%1D("AE;G1H("D@5&H@150@40IQ(# @," Q(')G($)4(#$R,RXU
M." R,#DN,3<@5&0@*$%M96YD;65N="!T;R!,96%S92!A9W)E96UE;G0@8F5T
M=V5E;B!-86EN<W1R965T($-6*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S4P
M+C4S(#(P.2XQ-R!49" H($YO<G1H(#0P+"!,3$,@86YD($-R;W-S($-O=6YT
M<GD@2&5A;'1H8V%R92P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP
M(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HY.2 Q.3<N.#,S,SDX-#,W-3 P,#(@;0HU-34N,# U.#4Y,S<U(#$Y-RXX
M,S,S.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," Q.3DN,3<@
M5&0@*$EN8RXL(&1A=&5D(%-E<'1E;6)E<B Q.2P@,C Q-B!<*%!R979I;W5S
M;'D@9FEL960@87,@86X@97AH:6)I="!T;R!T:&4@0V]M<&%N>9(I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" T,34N,S(@,3DY+C$W(%1D("AS($9O<FT@,3 M
M42!F;W(@=&AE('%U87)T97(@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HY.2 Q.#<N.#,S,SDX-#,W-3 P,#(@;0HS,S0N-S,R-#(Q
M.#<U(#$X-RXX,S,S.3@T,S<U,# P,B!L"G,*<2 P(# @,2!R9R!"5" Y.2XP
M," Q.#DN,3<@5&0@*%-E<'1E;6)E<B S,"P@,C Q-B!A;F0@:6YC;W)P;W)A
M=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#$W-"XQ
M-R!49" H,3 N-#8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*
M+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#$W,BXX,S,S
M.3@T,S<U,# P,B!M"C4S-BXW-#0Q-# V,C4@,3<R+C@S,S,Y.#0S-S4P,# R
M(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#$W-"XQ-R!49" H06UE;F1M96YT
M('1O($QE87-E(&%G<F5E;65N="!B971W965N($UA:6YS=')E970@0U8I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" S,C4N.38@,3<T+C$W(%1D("@@3F]R=&@@
M-# L($Q,0R!A;F0@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N+" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#$V,BXX,S,S.3@T
M,S<U,# P,B!M"C4S-"XW,S<S,#0V.#<U(#$V,BXX,S,S.3@T,S<U,# P,B!L
M"G,*<2 P(# @,2!R9R!"5" Y.2XP," Q-C0N,3<@5&0@*&1A=&5D(%-E<'1E
M;6)E<B Q.2P@,C Q-B!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I
M="!T;R!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,2!R9R!"5" S.34N
M,#4@,38T+C$W(%1D("AS($9O<FT@,3 M42!F;W(@=&AE('%U87)T97(@96YD
M960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P
M(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 Q-3(N.#,S
M,SDX-#,W-3 P,#(@;0HS,S0N-S,R-#(Q.#<U(#$U,BXX,S,S.3@T,S<U,# P
M,B!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," Q-30N,3<@5&0@*%-E<'1E;6)E
M<B S,"P@,C Q-B!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E
M:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C P(#$S.2XQ-R!49" H,3 N-#<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P
M(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"CDY(#$S-RXX,S,S.3@T,S<U,# P,B!M"C4U-BXQ,3DQ
M-# V,C4@,3,W+C@S,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4(#DY
M+C P(#$S.2XQ-R!49" H06UE;F1M96YT($YO+B R+"!D871E9"!/8W1O8F5R
M(#,Q+" R,#$V('1O($-O;G9E<G1I8FQE($YO=&4@4'5R8VAA<V4@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,SDT+C0Y(#$S.2XQ-R!49" H06=R965M96YT
M+"!D871E9"!*=6YE(#,P+" R,#$T+&%M;VYG("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P
M(&0*,2!*"C$@:@HS($T*.3D@,3(W+C@S,S,Y.#0S-S4P,# R(&T*-30T+CDX
M-C,R.#$R-2 Q,C<N.#,S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@
M.3DN,# @,3(Y+C$W(%1D("A#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L($EN
M8RXL('1H92!'=6%R86YT;W(@<W5B<VED:6%R:65S(&]F('1H92!#;VUP86YY
M(&YA;65D('1H97)E:6XL(&%N9"!T:&5.;W1E:&]L9&5R<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#$Q-RXX,S,S.3@T,S<U,# P,B!M
M"C4T-RXU,# Y-S8U-C(U(#$Q-RXX,S,S.3@T,S<U,# P,B!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," Q,3DN,3<@5&0@*&YA;65D('1H97)E:6X@7"A0<F5V
M:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A;GF2*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,S0W+C4U(#$Q.2XQ-R!49" H<R!&;W)M
M(#$P+5$@9F]R('1H92!Q=6%R=&5R(&5N9&5D(%-E<'1E;6)E<B S,"P@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 Q,#<N.#,S,SDX-#,W
M-3 P,#(@;0HR-S0N-#8X-S4@,3 W+C@S,S,Y.#0S-S4P,# R(&P*<PIQ(# @
M," Q(')G($)4(#DY+C P(#$P.2XQ-R!49" H,C Q-B!A;F0@:6YC;W)P;W)A
M=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#DT+C$W
M(%1D("@Q,"XT."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO
M1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G
M<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@.3(N.#,S,SDX
M-#,W-3 P,#(@;0HU,3(N-S<Y,CDV.#<U(#DR+C@S,S,Y.#0S-S4P,# R(&P*
M<PIQ(# @," Q(')G($)4(#DY+C P(#DT+C$W(%1D("A!;65N9&UE;G0@3F\N
M(#,L(&1A=&5D($1E8V5M8F5R(#(W+" R,#$V('1O($-O;G9E<G1I8FQE($YO
M=&4@4'5R8VAA<V4@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-# S+C,W(#DT
M+C$W(%1D("A!9W)E96UE;G0L(&1A=&5D($IU;F4@,S L("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.3D@.#(N.#,S,SDX-#,W-3 P,#(@;0HU
M,S,N-C Y,S<U(#@R+C@S,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G($)4
M(#DY+C P(#@T+C$W(%1D("@R,#$T+&%M;VYG($-R;W-S($-O=6YT<GD@2&5A
M;'1H8V%R92P@26YC+BP@=&AE($=U87)A;G1O<B!S=6)S:61I87)I97,@;V8@
M=&AE($-O;7!A;GD@;F%M960@=&AE<F5I;BP@86YD("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;
M72 P(&0*,2!*"C$@:@HS($T*.3D@-S(N.#,S,SDX-#,W-3 P,#(@;0HU,S@N
M-S0V,#DS-S4@-S(N.#,S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@0E0@
M.3DN,# @-S0N,3<@5&0@*'1H94YO=&5H;VQD97)S(&YA;65D('1H97)E:6X@
M7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A
M;GDG<R!&;W)M(#$P+4L@9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I
M( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-C(N.#,S,SDX-#,W-3 P,#(@;0HS
M,S,N,#4R-S,T,S<U(#8R+C@S,S,Y.#0S-S4P,# R(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#8T+C$W(%1D("A$96-E;6)E<B S,2P@,C Q-B!A;F0@:6YC
M;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z
M(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,#8N,# @-#DN,3 @5&0@** I(%1J($54(%$*96YD
M<W1R96%M"F5N9&]B:@HY-R P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@
M,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E
M<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#DX(# @4CX^"F5N9&]B:@HY
M." P(&]B:@H\/"],96YG=&@@,3DP,C<^/@IS=')E86T*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S Q+C P(#,Q+C8P(%1D("@T-2D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S(N,34@
M-S0R+C(U(%1D("A%6$A)0DE4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<T
M+C<V(#<T,BXR-2!49" H($E.1$58(%PH0T].5$E.545$7"DI(%1J($54(%$*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-#DN-2 W,38N-S4@;0HY,BXU(#<Q-BXW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*.38N-2 W,38N
M-S4@;0HU-C$N-2 W,38N-S4@; IS"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R+C P(#<R,BXT."!49" H3F\N*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU+C P(#<R,BXS,B!49" H
MH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,#,N-S4@-S(R+C0X(%1D("A$97-C<FEP=&EO;BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," W,#<N,S(@5&0@*#$P
M+C0Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*
M,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 W,#4N.3@S,SDX-#,W-2!M
M"C4U-RXQ,# U.#4Y,S<U(#<P-2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#<P-RXS,B!49" H07-S970@4'5R8VAA<V4@*2!4:B!%5"!1
M"G$@," P(#$@<F<@0E0@,38Q+C<W(#<P-RXS,B!49" H06=R965M96YT+"!D
M871E9"!*=6YE(#$S+" R,#$W+"!A;6]N9R!#<F]S<R!#;W5N=')Y($AE86QT
M:&-A<F4L($EN8RXL(&%S($)U>65R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#@Y+C@Y(#<P-RXS,B!49" H+$%D=F%N=&%G92!23BP@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V.34N.3@S,SDX-#,W-2!M"C4T-2XY
M-#,S-3DS-S4@-CDU+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN
M,# @-CDW+C,R(%1D("A,3$,L("D@5&H@150@40IQ(# @," Q(')G($)4(#$R
M,BXS,R V.3<N,S(@5&0@*$%D=F%N=&%G92!/;B!#86QL+"!,3$,L("D@5&H@
M150@40IQ(# @," Q(')G($)4(#(R-RXX-R V.3<N,S(@5&0@*$%D=F%N=&%G
M92!,;V-U;7,L($Q,0RP@86YD("D@5&H@150@40IQ(# @," Q(')G($)4(#,U
M,2XQ." V.3<N,S(@5&0@*$%D=F%N=&%G92!23B!,;V-A;%-T868I(%1J($54
M(%$*<2 P(# @,2!R9R!"5" T-3(N,#@@-CDW+C,R(%1D("AF:6YG+"!T:&4@
M4V5L;&5R(%!A<G1I97,L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*.3D@-C@U+CDX,S,Y.#0S-S4@;0HU,S<N,S<X.3 V,C4@-C@U+CDX,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-C@W+C,R(%1D("AA;F0@
M4V5L;&5R(%)E<')E<V5N=&%T:79E(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A
M;B!E>&AI8FET('1O('1H92!#;VUP86YY)W,@1F]R;3@M2R!D871E9"!*=6YE
M(#$S+" R,#$W(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-
M"CDY(#8W-2XY.#,S.3@T,S<U(&T*,C,U+C S,#(W,S0S-S4@-C<U+CDX,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-C<W+C,R(%1D("AI;F-O
M<G!O<F%T960@8GD@<F5F97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @
M-C8S+C,R(%1D("@Q,"XU,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-C8Q
M+CDX,S,Y.#0S-S4@;0HU-#@N-34U-C8T,#8R-2 V-C$N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y.2XP," V-C,N,S(@5&0@*$EN8W)E;65N=&%L
M("D@5&H@150@40IQ(# @," Q(')G($)4(#$T.2XP-R V-C,N,S(@5&0@*%0I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" Q-30N-#@@-C8S+C,R(%1D("AE<FT@
M3&]A;B I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q.34N,#(@-C8S+C,R(%1D
M("A!9W)E96UE;G0L(&1A=&5D($IU;'D@,2P@,C Q-R!T;R!#<F5D:70@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,S4W+C0Y(#8V,RXS,B!49" H06=R965M
M96YT+"!D871E9"!*=6YE(#(R+" R,#$V+"!B>2!A;F1A;6]N9R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#8U,2XY.#,S.3@T,S<U(&T*
M-34Q+C@R-S$T.#0S-S4@-C4Q+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@
M0E0@.3DN,# @-C4S+C,R(%1D("A#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L
M($EN8RXL(&%S(&)O<G)O=V5R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C<U
M+C(Q(#8U,RXS,B!49" H+"!C97)T86EN(&]F(&ET<R!D;VUE<W1I8R!S=6)S
M:61I87)I97,L(&%S(&=U87)A;G1O<G,L4W5N=')U<W0@0F%N:RP@87,@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V-#$N.3@S,SDX-#,W
M-2!M"C4U,BXU-30V.#<U(#8T,2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#DY+C P(#8T,RXS,B!49" H;&5N9&5R*2!4:B!%5"!1"G$@," P(#$@
M<F<@0E0@,3(S+C4X(#8T,RXS,B!49" H+"!A;F0@4W5N=')U<W0@0F%N:RP@
M87,@86=E;G0@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@
M=&AE($-O;7!A;GDG<R!&;W)M."U+(&1A=&5D($IU;'D@-BP@,C Q-R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#8S,2XY.#,S.3@T,S<U
M(&T*,C4Q+CDV.#<U(#8S,2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4
M(#DY+C P(#8S,RXS,B!49" H86YD(&EN8V]R<&]R871E9"!B>2!R969E<F5N
M8V4@:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R
M"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXP," V,3@N,S(@5&0@*#$P+C4Q*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P
M(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V,38N.3@S,SDX-#,W-2!M"C4T,RXS
M-C S-3$U-C(U(#8Q-BXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY
M+C P(#8Q."XS,B!49" H4V5C;VYD("D@5&H@150@40IQ(# @," Q(')G($)4
M(#$S,"XS.2 V,3@N,S(@5&0@*$%M96YD;65N="!T;R!#<F5D:70@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,C$Y+C4T(#8Q."XS,B!49" H06=R965M96YT
M+"!D871E9"!*=6QY(#4L(#(P,3<@=&\@0W)E9&ET("D@5&H@150@40IQ(# @
M," Q(')G($)4(#,X,BXP,2 V,3@N,S(@5&0@*$%G<F5E;65N="P@9&%T960@
M2G5N92 R,BP@,C Q-BP@8GEA;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*
M,2!J"C,@30HY.2 V,#8N.3@S,SDX-#,W-2!M"C4U."XQ.#DT-3,Q,C4@-C V
M+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-C X+C,R(%1D
M("AA;6]N9R!#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L($EN8RXL(&%S(&)O
M<G)O=V5R*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S T+CDS(#8P."XS,B!4
M9" H+"!C97)T86EN(&]F(&ET<R!D;VUE<W1I8R!S=6)S:61I87)I97,L(&%S
M(&=U87)A;G1O<G,L=&AE($QE;F1E<G,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ
M($H*,2!J"C,@30HY.2 U.38N.3@S,SDX-#,W-2!M"C4T."XW-#8P.3,W-2 U
M.38N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," U.3@N,S(@
M5&0@*')E9F5R96YC960@=&AE<F5I;BP@86YD(%-U;G1R=7-T($)A;FLL(&%S
M(&%G96YT(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H
M92!#;VUP86YY)W-&;W)M(#@M2R!D871E9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D
M"C$@2@HQ(&H*,R!-"CDY(#4X-BXY.#,S.3@T,S<U(&T*,S S+C8S.#8W,3@W
M-2 U.#8N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," U.#@N
M,S(@5&0@*$IU;'D@-BP@,C Q-R!A;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R
M96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#4W,RXS,B!49" H,3 N-3(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W
M(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4W,2XY.#,S.3@T,S<U(&T*-3 S
M+CDQ,C$P.3,W-2 U-S$N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M.2XP," U-S,N,S(@5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-R961I=" I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" R,C$N,3D@-3<S+C,R(%1D("A!9W)E
M96UE;G0L(&1A=&5D("D@5&H@150@40IQ(# @," Q(')G($)4(#(Y-"XR,B U
M-S,N,S(@5&0@*$%U9W5S=" Q+" R,#$W('1O($-R961I=" I(%1J($54(%$*
M<2 P(# @,2!R9R!"5" S.34N,S,@-3<S+C,R(%1D("A!9W)E96UE;G0L(&)Y
M(&%N9"!A;6]N9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY
M(#4V,2XY.#,S.3@T,S<U(&T*-#DS+C<V-38R-2 U-C$N.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y.2XP," U-C,N,S(@5&0@*$-R;W-S0V]U;G1R
M>2!(96%L=&AC87)E+"!);F,N+"!A<R!B;W)R;W=E<BD@5&H@150@40IQ(# @
M," Q(')G($)4(#(W,BXW,2 U-C,N,S(@5&0@*"P@8V5R=&%I;B!O9B!I=',@
M9&]M97-T:6,@<W5B<VED:6%R:65S+"!A<R!G=6%R86YT;W)S+"!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 U-3$N.3@S,SDX-#,W
M-2!M"C4S,RXU-#$P,34V,C4@-34Q+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.3DN,# @-34S+C,R(%1D("A,96YD97)S<F5F97)E;F-E9"!T:&5R
M96EN+"!3=6Y4*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C(Y+CDW(#4U,RXS
M,B!49" H<G5S="!"86YK+"!A<R I(%1J($54(%$*<2 P(# @,2!R9R!"5" R
M.#,N.#8@-34S+C,R(%1D("A!9&UI;FES=')A=&EV92 I(%1J($54(%$*<2 P
M(# @,2!R9R!"5" S-#4N.# @-34S+C,R(%1D("A!9V5N="P@4W=I;F=L:6YE
M($QE;F1E<B!A;F0@86X@:7-S=6EN9R!B86YK.R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@
M,"!D"C$@2@HQ(&H*,R!-"CDY(#4T,2XY.#,S.3@T,S<U(&T*-#DR+C8V,C$P
M.3,W-2 U-#$N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," U
M-#,N,S(@5&0@*$)-3TAA<G)I<R!"86YK+"!.+D$N(&%S(%-Y;F1I8V%T:6]N
M("D@5&H@150@40IQ(# @," Q(')G($)4(#(U-RXX." U-#,N,S(@5&0@*$%G
M96YT.R!A;F0@0F%N:R!5;FET960@3BY!+B!A;F0@1FEF=&@@*2!4:B!%5"!1
M"G$@," P(#$@<F<@0E0@-#$X+C4Q(#4T,RXS,B!49" H5&AI<F0@0F%N:R!A
M<R!#;RTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'
M4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4S,2XY
M.#,S.3@T,S<U(&T*-3,R+C8X-C4R,S0S-S4@-3,Q+CDX,S,Y.#0S-S4@; IS
M"G$@," P(#$@<F<@0E0@.3DN,# @-3,S+C,R(%1D("A$;V-U;65N=&%T:6]N
M06=E;G1S(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H
M92!#;VUP86YY)W,@1F]R;2 X+4L@9&%T960@*2!4:B!%5"!1"G$@," P(#$@
M<F<@0E0@-#4Q+C@V(#4S,RXS,B!49" H075G=7-T(#(L(#(P,3<@86YD("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-3(Q+CDX,S,Y.#0S
M-S4@;0HR,S(N-3,P,C<S-#,W-2 U,C$N.3@S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," U,C,N,S(@5&0@*&EN8V]R<&]R871E9"!B>7)E9F5R
M96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#4P."XS,B!49" H,3 N-3,I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W
M(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#4P-BXY.#,S.3@T,S<U(&T*-34W
M+CDR,#@Y.#0S-S4@-3 V+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@
M.3DN,# @-3 X+C,R(%1D("A&;W5R=&@@*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,3(W+C8R(#4P."XS,B!49" H06UE;F1M96YT('1O($QE87-E("D@5&H@
M150@40IQ(# @," Q(')G($)4(#(Q-2XP.2 U,#@N,S(@5&0@*$%G<F5E;65N
M="!B971W965N(%).4TD@0VET>2!0;&%C92!/=VYE<BD@5&H@150@40IQ(# @
M," Q(')G($)4(#,Y,RXX,2 U,#@N,S(@5&0@*"P@3$Q#(&%N9"!#96IK82!3
M96%R8V@L($EN8RXL9&%T960@36%Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.3D@-#DV+CDX,S,Y.#0S-S4@;0HU-#<N,3 U-#8X-S4@-#DV
M+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-#DX+C,R(%1D
M("@S,2P@,C Q-R!<*%!R979I;W5S;'D@9FEL960@87,@86X@97AH:6)I="!T
M;R!T:&4@0V]M<&%N>2=S($9O<FT@,3 M42!F;W(@=&AE('%U87)T97(@96YD
M960@4V5P=&5M8F5R(#,P+" R,#$W("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.3D@-#@V+CDX,S,Y.#0S-S4@;0HR-3$N.38X-S4@-#@V+CDX
M,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-#@X+C,R(%1D("AA
M;F0@:6YC;W)P;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@
M,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R+C P(#0W,RXS,B!49" H,3 N-30@(RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *
M," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS
M($T*.3D@-#<Q+C X,S,Y.#0S-S4@;0HU-#,N,#0R.38X-S4@-#<Q+C X,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-#<R+C0R(%1D("A!;65N
M9&5D(&%N9"!297-T871E9"!%;7!L;WEM96YT("D@5&H@150@40IQ(# @," Q
M(')G($)4(#(T-RXX-B T-S(N-#(@5&0@*$%G<F5E;65N="P@9&%T960@2F%N
M=6%R>2 R."P@,C Q."P@8F5T=V5E;B I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" T,S N-C<@-#<R+C0R(%1D("A7*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#,Y+C<Q(#0W,BXT,B!49" H:6QL:6%M($HN($)U<FYS(&%N9"!#<F]S<R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#0V,2XP.#,S.3@T
M,S<U(&T*-34P+C(X.3 V,C4@-#8Q+C X,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.3DN,# @-#8R+C0R(%1D("A#;W5N=')Y($AE86QT:&-A<F4L($EN
M8RX@7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O
M;7!A;GF2*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S@Y+C0X(#0V,BXT,B!4
M9" H<R!&;W)M(#@M2R!D871E9"!*86YU87)Y(#(V+" R,#$X(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#0U,2XP.#,S.3@T,S<U
M(&T*,C,U+C S,#(W,S0S-S4@-#4Q+C X,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.3DN,# @-#4R+C0R(%1D("AI;F-O<G!O<F%T960@8GD@<F5F97)E
M;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4
M<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-#,X+C,R(%1D("@Q,"XU-2 C
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4
M=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP
M(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 T,S8N.3@S,SDX-#,W-2!M"C4U
M,BXR,C(V-38R-2 T,S8N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M.2XP," T,S@N,S(@5&0@*$-R;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@26YC
M+B!%>&5C=71I=F4@3F]N<75A;&EF:65D($5X8V5S<R!0;&%N("D@5&H@150@
M40IQ(# @," Q(')G($)4(#,W,RXS-R T,S@N,S(@5&0@*$%D;W!T:6]N("D@
M5&H@150@40IQ(# @," Q(')G($)4(#0Q,RXQ," T,S@N,S(@5&0@*$%G<F5E
M;65N="!<*%!R979I;W5S;'D@9FEL960@87,@86X@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 T,C8N.3@S,SDX-#,W-2!M"C4P-BXW-S@S
M,C S,3(U(#0R-BXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#0R."XS,B!49" H97AH:6)I="!T;R!T:&4@0V]M<&%N>2=S($9O<FT@,3 M
M2R!D871E9"!$96-E;6)E<B S,2P@,C Q-R!A;F0@:6YC;W)P;W)A=&5D(&)Y
M(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#0Q,RXS,B!49" H
M,3 N-38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#0Q,2XY.#,S.3@T,S<U
M(&T*-3(T+C8V.#DT-3,Q,C4@-#$Q+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@.3DN,# @-#$S+C,R(%1D("A)4T1!*2!4:B!%5"!1"G$@," P(#$@
M<F<@0E0@,3(Q+C<X(#0Q,RXS,B!49" H($UA<W1E<B I(%1J($54(%$*<2 P
M(# @,2!R9R!"5" Q-30N,# @-#$S+C,R(%1D("A!9W)E96UE;G0@8F5T=V5E
M;B I(%1J($54(%$*<2 P(# @,2!R9R!"5" R,S8N-38@-#$S+C,R(%1D("A7
M*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C0U+C(P(#0Q,RXS,B!49" H96QL
M<R!&87(I(%1J($54(%$*<2 P(# @,2!R9R!"5" R-S0N-S,@-#$S+C,R(%1D
M("AG;R!"86YK+"!.+D$N(&%N9"!#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L
M($EN8RX@9&%T960@87,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J
M"C,@30HY.2 T,#$N.3@S,SDX-#,W-2!M"C4U.2XP-#@X,C@Q,C4@-# Q+CDX
M,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @-# S+C,R(%1D("A&
M96)R=6%R>2 Q-" R,#$X(%PH=VET:"!38VAE9'5L92!T;R!T:&4@36%S=&5R
M("D@5&H@150@40IQ(# @," Q(')G($)4(#(Y,"XP-R T,#,N,S(@5&0@*$%G
M<F5E;65N=%PI(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O
M('1H92!#;VUP86YY)W,@1F]R;2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"CDY(#,Y,2XY.#,S.3@T,S<U(&T*,S@P+C(U.3<V-38R-2 S.3$N
M.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," S.3,N,S(@5&0@
M*#$P+4L@9&%T960@1&5C96UB97(@,S$L(#(P,3<@86YD(&EN8V]R<&]R871E
M9"!B>2!R969E<F5N8V4@:&5R96EN+EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," S-SDN,S(@
M5&0@*#$P+C4W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S
M"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S-S<N.3@S,SDX
M-#,W-2!M"C4S-2XX-C4R,S0S-S4@,S<W+CDX,S,Y.#0S-S4@; IS"G$@," P
M(#$@<F<@0E0@.3DN,# @,S<Y+C,R(%1D("A&:7)S=" I(%1J($54(%$*<2 P
M(# @,2!R9R!"5" Q,3DN,CD@,S<Y+C,R(%1D("A!;65N9&UE;G0@=&\@*2!4
M:B!%5"!1"G$@," P(#$@<F<@0E0@,3@P+CDU(#,W.2XS,B!49" H06UE;F1E
M9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@150@40IQ(# @," Q(')G($)4
M(#,P,RXQ-" S-SDN,S(@5&0@*$%G<F5E;65N="P@9&%T960@3V-T;V)E<B S
M,"P@,C Q."P@8GD@86YD(&%M;VYG($-R;W-S("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P
M(&0*,2!*"C$@:@HS($T*.3D@,S8W+CDX,S,Y.#0S-S4@;0HU-#4N,S<R,#<P
M,S$R-2 S-C<N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," S
M-CDN,S(@5&0@*$-O=6YT<GD@2&5A;'1H8V%R92P@26YC+B!A<R!B;W)R;W=E
M<BD@5&H@150@40IQ(# @," Q(')G($)4(#(T-RXT,R S-CDN,S(@5&0@*"P@
M8V5R=&%I;B!O9B!I=',@9&]M97-T:6,@<W5B<VED:6%R:65S(&%S(&=U87)A
M;G1O<G,L('1H92!,96YD97)S(')E9F5R96YC960@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 S-3<N.3@S,SDX-#,W-2!M"C4U,"XP-SDQ
M,#$U-C(U(#,U-RXY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#,U.2XS,B!49" H=&AE<F5I;BP@86YD(%-U;E0I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" Q-S N,#(@,S4Y+C,R(%1D("AR=7-T($)A;FLL(&%S(&%G96YT
M(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP
M86YY)W,@1F]R;2 Q,"U1(&9O<B!T:&4@<75A<G1E<B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *
M6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#,T-RXY.#,S.3@T,S<U(&T*,S8Q+C$P
M.3,W-2 S-#<N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," S
M-#DN,S(@5&0@*&5N9&5D(%-E<'1E;6)E<B S,"P@,C Q."!A;F0@:6YC;W)P
M;W)A=&5D(&)Y(')E9F5R96YC92!H97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @
M5$P@"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#,S
M-"XS,B!49" H,3 N-3@@(RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,S,P
M+C X,S,Y.#0S-S4@;0HU-#<N-S<Y,CDV.#<U(#,S,"XP.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DY+C P(#,S,2XT,B!49" H06UE;F1M96YT('1O
M($5M<&QO>6UE;G0@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C$T+C@R(#,S
M,2XT,B!49" H06=R965M96YT+"!D871E9"!397!T96UB97(@,3 L(#(P,3@L
M(&)Y(&%N9"!B971W965N($-R;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N
M-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S,C N,#@S,SDX-#,W
M-2!M"C4U,BXY,C X.3@T,S<U(#,R,"XP.#,S.3@T,S<U(&P*<PIQ(# @," Q
M(')G($)4(#DY+C P(#,R,2XT,B!49" H26YC+B!A;F0@*2!4:B!%5"!1"G$@
M," P(#$@<F<@0E0@,3,S+C4S(#,R,2XT,B!49" H5RD@5&H@150@40IQ(# @
M," Q(')G($)4(#$T,BXU-B S,C$N-#(@5&0@*&EL;&EA;2!*+B!'<G5B8G,@
M7"A0<F5V:6]U<VQY(&9I;&5D(&%S(&%N(&5X:&EB:70@=&\@=&AE($-O;7!A
M;GDG<R!&;W)M(#@M2R!D871E9"!397!T96UB97(@,3 L(#(P,3@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 S,3 N,#@S,SDX-#,W-2!M
M"C(T.2XT-C@W-2 S,3 N,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y
M.2XP," S,3$N-#(@5&0@*&%N9"!I;F-O<G!O<F%T960@8GD@<F5F97)E;F-E
M(&AE<F5I;EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'
M4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXP," R.3<N,S(@5&0@*#$P+C4Y(",I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @
M5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *
M6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#(Y-2XY.#,S.3@T,S<U(&T*-3,Y+CDY
M-C Y,S<U(#(Y-2XY.#,S.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P
M(#(Y-RXS,B!49" H16UP;&]Y;65N=" I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" Q-3(N-C$@,CDW+C,R(%1D("A!9W)E96UE;G0@8F5T=V5E;B!#<F]S<R!#
M;W5N=')Y($AE86QT:&-A<F4L($EN8RX@86YD($ME=FEN($,N($-L87)K+"!D
M871E9"!*86YU87)Y(#$V+" R,#$Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*.3D@,C@U+CDX,S,Y.#0S-S4@;0HU-3,N,3<Y-C@W-2 R.#4N
M.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" Y.2XP," R.#<N,S(@5&0@
M*%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP
M86YY)W,@1F]R;2 X+4L@9&%T960@2F%N=6%R>2 Q-BP@,C Q.2!A;F0@:6YC
M;W)P;W)A=&5D(&)Y(')E9F5R96YC92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@
M2@HQ(&H*,R!-"CDY(#(W-2XY.#,S.3@T,S<U(&T*,3(Y+C@Q-30R.38X-S4@
M,C<U+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,C<W+C,R
M(%1D("AH97)E:6XN7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#(V,BXS,B!49" H,3 N-C @
M(RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @
M5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,C4Y+C X,S,Y.#0S-S4@;0HU
M-38N-C@P-C8T,#8R-2 R-3DN,#@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y.2XP," R-C N-#(@5&0@*$%M96YD;65N="!A;F0@4F5S=&%T96UE;G0@
M=&\@16UP;&]Y;65N=" I(%1J($54(%$*<2 P(# @,2!R9R!"5" R.#,N-CD@
M,C8P+C0R(%1D("A!9W)E96UE;G0L(&1A=&5D($IA;G5A<GD@,S$L(#(P,3DL
M(&)Y(&%N9"!B971W965N($-R;W-S($-O=6YT<GD@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=
M(# @9 HQ($H*,2!J"C,@30HY.2 R-#DN,#@S,SDX-#,W-3 P,#(@;0HU-#8N
M-3 T.#@R.#$R-2 R-#DN,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@
M0E0@.3DN,# @,C4P+C0R(%1D("A(96%L=&AC87)E+"!);F,N(&%N9" I(%1J
M($54(%$*<2 P(# @,2!R9R!"5" Q.#$N.#,@,C4P+C0R(%1D("A7*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,3DP+C@W(#(U,"XT,B!49" H:6QL:6%M($HN
M($)U<FYS(%PH4')E=FEO=7-L>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H
M92!#;VUP86YY)W,@1F]R;2 X+4L@9&%T960@2F%N=6%R>2 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @
M:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#(S.2XP.#,S.3@T,S<U,# P,B!M
M"C(X-BXY-C@W-2 R,SDN,#@S,SDX-#,W-3 P,#(@; IS"G$@," P(#$@<F<@
M0E0@.3DN,# @,C0P+C0R(%1D("@S,2P@,C Q.2!A;F0@:6YC;W)P;W)A=&5D
M(&)Y(')E9F5R96YC92!H97)E:6Y<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @,C(V+C,R(%1D
M("@Q-"XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#DU+C P(#(R-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.3D@,C(T+CDX,S,Y.#0S-S4@;0HU,S8N-34X-3DS-S4@,C(T+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,C(V+C,R(%1D("A#;V1E(&]F
M($5T:&EC<RP@<F5V:7-E9"!&96)R=6%R>2 R+" R,#$V(%PH4')E=FEO=7-L
M>2!F:6QE9"!A<R!A;B!E>&AI8FET('1O('1H92!#;VUP86YY)W,@1F]R;2 Q
M,"U1(&9O<B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY
M.2 R,30N.3@S,SDX-#,W-2!M"C,W-2XR-3DW-C4V,C4@,C$T+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,C$V+C,R(%1D("AQ=6%R=&5R
M(&5N9&5D($UA<F-H(#,Q+" R,#$X(&%N9"!I;F-O<G!O<F%T960@8GD@<F5F
M97)E;F-E(&AE<F5I;BY<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @,C S+C,R(%1D("@J,C$N
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M-2XP," R,#,N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'
M"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#(P
M,2XY.#,S.3@T,S<U(&T*,C0T+C(U,SDP-C(U(#(P,2XY.#,S.3@T,S<U(&P*
M<PIQ(# @," Q(')G($)4(#DY+C P(#(P,RXS,B!49" H3&ES="!O9B!S=6)S
M:61I87)I97,@;V8@=&AE(%)E9VES=')A;G0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#$X."XS
M,B!49" H*C(S+C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*
M+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#$X-BXY.#,S
M.3@T,S<U(&T*-#,V+C8W,#@Y.#0S-S4@,3@V+CDX,S,Y.#0S-S4@; IS"G$@
M," P(#$@<F<@0E0@.3DN,# @,3@X+C,R(%1D("A#;VYS96YT(&]F($1E;&]I
M='1E("8@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,3@Y+CDR(#$X."XS,B!4
M9" H5"D@5&H@150@40IQ(# @," Q(')G($)4(#$Y-2XS,R Q.#@N,S(@5&0@
M*&]U8VAE($Q,4"D@5&H@150@40IQ(# @," Q(')G($)4(#(S."XS." Q.#@N
M,S(@5&0@*"P@26YD97!E;F1E;G0@4F5G:7-T97)E9"!0=6)L:6,@*2!4:B!%
M5"!1"G$@," P(#$@<F<@0E0@,S8X+C W(#$X."XS,B!49" H06-C;W5N=&EN
M9R!&:7)M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @
M9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,BXP," Q-S,N,S(@5&0@*"HS,2XQ*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU+C P(#$W,RXS
M,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P
M(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,3<Q+CDX,S,Y.#0S
M-S4@;0HU,S@N,#4W-C$W,3@W-2 Q-S$N.3@S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," Q-S,N,S(@5&0@*$-E<G1I9FEC871I;VX@4'5R<W5A
M;G0@=&\@4G5L9: Q,V$M,31<*&%<*2\Q-60M,31<*&%<*2!A;F0@<'5R<W5A
M;G0@=&\@4V5C=&EO;J S,#(@;V8@=&AE(%-A<F)A;F5S+4]X;&5Y("D@5&H@
M150@40IQ(# @," Q(')G($)4(#4Q,"XR.2 Q-S,N,S(@5&0@*$%C="!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*
M,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"CDY(#$V,2XY.#,S.3@T
M,S<U(&T*-#4V+C@U-C0T-3,Q,C4@,38Q+CDX,S,Y.#0S-S4@; IS"G$@," P
M(#$@<F<@0E0@.3DN,# @,38S+C,R(%1D("@R,# R(&)Y($ME=FEN($,N($-L
M87)K+"!0<F5S:61E;G0L($-H:65F($5X96-U=&EV92!/9BD@5&H@150@40IQ
M(# @," Q(')G($)4(#,Q.2XV,2 Q-C,N,S(@5&0@*&9I8V5R(%PH4')I;F-I
M<&%L($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," Q(')G($)4(#0S-2XR
M,2 Q-C,N,S(@5&0@*&9I8V5R7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#$T-RXS,B!49" H
M*C,Q+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.34N,# @,30W+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @
M,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY
M.2 Q-#4N.3@S,SDX-#,W-2!M"C4S."XP-3<V,3<Q.#<U(#$T-2XY.#,S.3@T
M,S<U(&P*<PIQ(# @," Q(')G($)4(#DY+C P(#$T-RXS,B!49" H0V5R=&EF
M:6-A=&EO;B!0=7)S=6%N="!T;R!2=6QEH#$S82TQ-%PH85PI+S$U9"TQ-%PH
M85PI(&%N9"!P=7)S=6%N="!T;R!396-T:6]NH#,P,B!O9B!T:&4@4V%R8F%N
M97,M3WAL97D@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-3$P+C(Y(#$T-RXS
M,B!49" H06-T(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P
M(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*
M.3D@,3,U+CDX,S,Y.#0S-S4@;0HU-30N-38V-# V,C4@,3,U+CDX,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@.3DN,# @,3,W+C,R(%1D("@R,# R(&)Y
M("D@5&H@150@40IQ(# @," Q(')G($)4(#$S,RXX,B Q,S<N,S(@5&0@*%<I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" Q-#(N.#8@,3,W+C,R(%1D("AI;&QI
M86T@2BX@0G5R;G,L($5X96-U=&EV92 I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" R-#@N-S<@,3,W+C,R(%1D("A6*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M,C4U+C,Y(#$S-RXS,B!49" H:6-E(%!R97-I9&5N="P@0VAI968@1FEN86YC
M:6%L($]F*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S@V+C4V(#$S-RXS,B!4
M9" H9FEC97(@7"A0<FEN8VEP86P@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#0X+C<V(#$S-RXS,B!49" H06-C;W5N=&EN9R!A;F0@1FEN86YC:6%L("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP
M+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@,3(U+CDX,S,Y.#0S
M-S4@;0HQ,S$N,#$V-C Q-38R-2 Q,C4N.3@S,SDX-#,W-2!L"G,*<2 P(# @
M,2!R9R!"5" Y.2XP," Q,C<N,S(@5&0@*$]F*2!4:B!%5"!1"G$@," P(#$@
M<F<@0E0@,3 Y+C,W(#$R-RXS,B!49" H9FEC97)<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@
M,"!43" *0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A;0IE;F1O8FH*.3D@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q,# @,"!2/CX*96YD;V)J"C$P," P(&]B:@H\/"],96YG
M=&@@-3DU.#X^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,#$N,# @,S$N-C @5&0@*#0V*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(S,BXQ-2 W-#(N,C4@5&0@*$582$E"
M250I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S0N-S8@-S0R+C(U(%1D("@@
M24Y$15@@7"A#3TY424Y5141<*2D@5&H@150@40HP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.2XU(#<Q-BXW-2!M
M"CDR+C4@-S$V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HY-BXU(#<Q-BXW-2!M"C4V,2XU(#<Q-BXW
M-2!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @
M-S(R+C0X(%1D("A.;RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.34N,# @-S(R+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,RXW-2 W,C(N-#@@5&0@
M*$1E<V-R:7!T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R+C P(#<P-RXS,B!49" H*C,R+C$I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.34N,# @-S W+C,R(%1D
M("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*
M,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 W,#4N.3@S,SDX-#,W-2!M
M"C4T.2XW-C$W,3@W-2 W,#4N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y.2XP," W,#<N,S(@5&0@*$-E<G1I9FEC871I;VX@4'5R<W5A;G0@=&\@
M,3@@52Y3+D,N(%-E8W1I;VZ@,3,U,"P@87,@861O<'1E9"!P=7)S=6%N="!T
M;R!396-T:6]NH#DP-B!O9B!T:&4@4V%R8F%N97,M3WAL97D@*2!4:B!%5"!1
M"G$@," P(#$@<F<@0E0@-3,R+C@R(#<P-RXS,B!49" H06-T("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-CDU+CDX,S,Y.#0S-S4@;0HT
M-S N,3@V-3(S-#,W-2 V.34N.3@S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" Y.2XP," V.3<N,S(@5&0@*&]F(#(P,#(L(&)Y($ME=FEN($,N($-L87)K
M+"!0<F5S:61E;G0L($-H:65F($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @
M," Q(')G($)4(#,S,BXY-" V.3<N,S(@5&0@*&9I8V5R(%PH4')I;F-I<&%L
M($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," Q(')G($)4(#0T."XU-" V
M.3<N,S(@5&0@*&9I8V5R7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#8X,2XS,B!49" H*C,R
M+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M.34N,# @-C@Q+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!2
M1PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V
M-SDN.3@S,SDX-#,W-2!M"C4T.2XW-C$W,3@W-2 V-SDN.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y.2XP," V.#$N,S(@5&0@*$-E<G1I9FEC871I
M;VX@4'5R<W5A;G0@=&\@,3@@52Y3+D,N(%-E8W1I;VZ@,3,U,"P@87,@861O
M<'1E9"!P=7)S=6%N="!T;R!396-T:6]NH#DP-B!O9B!T:&4@4V%R8F%N97,M
M3WAL97D@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@-3,R+C@R(#8X,2XS,B!4
M9" H06-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*," P(#$@4D<*
M+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*.3D@-C8Y
M+CDX,S,Y.#0S-S4@;0HU,C@N,3@T-3<P,S$R-2 V-CDN.3@S,SDX-#,W-2!L
M"G,*<2 P(# @,2!R9R!"5" Y.2XP," V-S$N,S(@5&0@*&]F(#(P,#(L(&)Y
M("D@5&H@150@40IQ(# @," Q(')G($)4(#$T-RXQ-2 V-S$N,S(@5&0@*%<I
M(%1J($54(%$*<2 P(# @,2!R9R!"5" Q-38N,3D@-C<Q+C,R(%1D("AI;&QI
M86T@2BX@0G5R;G,L($5X96-U=&EV92 I(%1J($54(%$*<2 P(# @,2!R9R!"
M5" R-C(N,3 @-C<Q+C,R(%1D("A6*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M,C8X+C<R(#8W,2XS,B!49" H:6-E(%!R97-I9&5N="P@0VAI968@1FEN86YC
M:6%L($]F*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,SDY+C@Y(#8W,2XS,B!4
M9" H9FEC97(@7"A0<FEN8VEP86P@*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@
M-#8R+C Y(#8W,2XS,B!49" H06-C;W5N=&EN9R!A;F0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 HP(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@
M"EM=(# @9 HQ($H*,2!J"C,@30HY.2 V-3DN.3@S,SDX-#,W-2!M"C$W,"XW
M,C@U,34V,C4@-C4Y+CDX,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@.3DN
M,# @-C8Q+C,R(%1D("A&:6YA;F-I86P@3V8I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" Q-#DN,#@@-C8Q+C,R(%1D("AF:6-E<EPI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P
M(%1,( I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,N,# @-C$R+C,R(%1D("@J*C$P,2Y)3E,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3$P+C P(#8Q
M,BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q,CDN,# @-C$R+C,R(%1D("A80E),*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,34U+C0X(#8Q,BXS,B!49" H($EN<W1A;F-E($1O8W5M96YT
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#4Y."XS,B!49" H*BHQ,#$N4T-(*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$Q,"XP," U.3@N,S(@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(Y+C P
M(#4Y."XS,B!49" H6$)23"D@5&H@150@40IQ(# @," P(')G($)4(#$U-2XT
M." U.3@N,S(@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3<N-S$@
M-3DX+C,R(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38S+C,X(#4Y
M."XS,B!49" H87AO;F]M>2!%>'1E;G-I;VX@4V-H96UA($1O8W5M96YT*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P
M(#4X-"XS,B!49" H*BHQ,#$N1$5&*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$Q,"XP," U.#0N,S(@5&0@** I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(Y+C P(#4X
M-"XS,B!49" H6$)23"D@5&H@150@40IQ(# @," P(')G($)4(#$U-2XT." U
M.#0N,S(@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3<N-S$@-3@T
M+C,R(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38S+C,X(#4X-"XS
M,B!49" H87AO;F]M>2!%>'1E;G-I;VX@1&5F:6YI=&EO;B!,:6YK8F%S92!$
M;V-U;65N="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," U-S N,S(@5&0@*"HJ,3 Q+DQ!0BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,3 N,# @-3<P+C,R(%1D
M("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$R.2XP," U-S N,S(@5&0@*%A"4DPI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q-34N-#@@-3<P+C,R(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,34W+C<Q(#4W,"XS,B!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$V
M,RXS." U-S N,S(@5&0@*&%X;VYO;7D@17AT96YS:6]N($QA8F5L($QI;FMB
M87-E($1O8W5M96YT*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S+C P(#4U-BXS,B!49" H*BHQ,#$N0T%,*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Q,"XP," U-38N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3(Y+C P(#4U-BXS,B!49" H6$)23"D@5&H@150@40IQ(# @," P
M(')G($)4(#$U-2XT." U-38N,S(@5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-3<N-S$@-34V+C,R(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,38S+C,X(#4U-BXS,B!49" H87AO;F]M>2!%>'1E;G-I;VX@0V%L8W5L
M871I;VX@3&EN:V)A<V4@1&]C=6UE;G0I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-30R+C,R(%1D("@J*C$P,2Y0
M4D4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3$P+C P(#4T,BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q,CDN,# @-30R+C,R(%1D("A04D4@6$)23"D@
M5&H@150@40IQ(# @," P(')G($)4(#$W-BXQ-" U-#(N,S(@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-S@N-#8@-30R+C,R(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3@S+C@W(#4T,BXS,B!49" H87AO;F]M>2!%
M>'1E;G-I;VX@4')E<V5N=&%T:6]N($QI;FMB87-E($1O8W5M96YT*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,"XP," U,C8N,C4@5&0@*%]?7U]?7U]?7U]?7U]?7U\I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-3$T+C(U(%1D("@CH" I(%1J($54(%$*<2 P(# @,"!R9R!"5" V,"XP
M," U,30N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" V,BXU," U
M,30N,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-2XP," U,30N
M,C4@5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-RXU," U,30N,C4@
M5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,"XP," U,30N,C4@5&0@
M*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,BXU," U,30N,C4@5&0@*" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" W-2XP," U,30N,C4@5&0@*" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" W-RXU," U,30N,C4@5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" X,"XP," U,30N,C4@5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" X,BXU," U,30N,C4@5&0@*%)E<')E<V5N=',@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3(X+C@X(#4Q-"XR-2!49" H82 I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q,S4N.#(@-3$T+C(U(%1D("AM86YA9V5M
M96YT("D@5&H@150@40IQ(# @," P(')G($)4(#$X.2XT," U,30N,C4@5&0@
M*&-O;G1R86-T("D@5&H@150@40IQ(# @," P(')G($)4(#(R-"XQ,2 U,30N
M,C4@5&0@*&]R("D@5&H@150@40IQ(# @," P(')G($)4(#(S-"XY-" U,30N
M,C4@5&0@*&-O;7!E;G-A=&]R>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.3,N-3,@-3$T+C(U(%1D("AP;&%N("D@5&H@150@40IQ(# @," P(')G($)4
M(#,Q,RXR-2 U,30N,C4@5&0@*&]R("D@5&H@150@40IQ(# @," P(')G($)4
M(#,R-"XP." U,30N,C4@5&0@*&%R<F%N9V5M96YT*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4P,BXR-2!49" H
M*J"@H*"@H*"@H*"@1FEL960@:&5R97=I=&@I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#DP+C(U(%1D("@J*J"@
MH*"@H*"@H$9U<FYI<VAE9"!H97)E=VET:"D@5&H@150@40IE;F1S=')E86T*
M96YD;V)J"C$P,2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*
M+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @
M4@HO4F]T871E(# *+T-O;G1E;G1S(#$P,B P(%(^/@IE;F1O8FH*,3 R(# @
M;V)J"CP\+TQE;F=T:" Q,C0W,SX^"G-T<F5A;0I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,#$N,# @,S$N-C @5&0@*#0W*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<T,BXR
M-2!49" H271E;2 Q-BX@(" @(" @(" @($9O<FT@,3 M2R!3=6UM87)Y*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C T+C$U(#<T,BXR-2!49" H+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W
M,3@N,C4@5&0@*$YO="!A<'!L:6-A8FQE+BD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-S,N.#4@-CDT+C(U(%1D("A324=.
M02D@5&H@150@40IQ(# @," P(')G($)4(#,P-"XW." V.30N,C4@5&0@*%15
M4D53*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#8X,BXR-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V-S N,C4@5&0@*%!U<G-U86YT('1O
M('1H92!R97%U:7)E;65N=',@;V8@4V5C=&EO;J Q,R!O<B Q-5PH9%PI(&]F
M('1H92!396-U<FET:65S($5X8VAA;F=E("D@5&H@150@40IQ(# @," P(')G
M($)4(#,V-BXX-R V-S N,C4@5&0@*$%C="!O9B Q.3,T+"!T:&4@4F5G:7-T
M<F%N="!H87,@9'5L>2!C875S960@=&AI<R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X+C(U(%1D("A297!O
M<G0@=&\@8F4@<VEG;F5D(&]N(&ET<R!B96AA;&8@8GD@=&AE('5N9&5R<VEG
M;F5D+"!T:&5R975N=&\@9'5L>2!A=71H;W)I>F5D+BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V-#8N,C4@5&0@
M** I(%1J($54(%$*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,S(P+C4@-C S+C<U(&T*-38R+C4@-C S+C<U(&P*
M<PI"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V,C8N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,CDT+C P(#8R-BXT,R!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S<R+C@S(#8R-BXT,R!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#,W.2XV." V,C8N-#,@5&0@*"!(14%,*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-# Y+C8P(#8R-BXT,R!49" H5$A#05)%+"!)3D,N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#8P."XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R.30N,# @-C X+C,R(%1D("A">3HI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S(S+C P(#8P."XS
M,B!49" H+W,O($ME=FEN($,N($-L87)K*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#4Y-"XS,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.30N,# @
M-3DT+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,R,RXP," U.30N,S(@5&0@*$YA;64Z($ME=FEN($,N($-L
M87)K*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#4X,"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.30N,# @-3@P+C,R(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R,RXP," U.# N
M,S(@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C@N.3,@-3@P+C,R
M(%1D("AI=&QE.B!0<F5S:61E;G0L($-H:65F($5X96-U=&EV92!/9BD@5&H@
M150@40IQ(# @," P(')G($)4(#0V-BXV." U.# N,S(@5&0@*&9I8V5R*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R,RXP
M," U-C8N,S(@5&0@*%!R:6YC:7!A;"!%>&5C=71I=F4@3V8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T,30N-34@-38V+C,R(%1D("AF:6-E<BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," U-3(N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,CDT+C P(#4U,BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,C,N,# @-34R+C,R(%1D("A$871E
M.B!&96)R=6%R>: R."P@,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3,V
M+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#4R-"XR-2!49" H4'5R<W5A;G0@=&\@=&AE(')E<75I
M<F5M96YT<R!O9B!T:&4@4V5C=7)I=&EE<R!%>&-H86YG92 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R-S8N,#4@-3(T+C(U(%1D("A!8W0@;V8@,3DS-"P@
M=&AI<R!297!O<G0@:&%S(&)E96X@<VEG;F5D(&)Y('1H92!F;VQL;W=I;F<@
M<&5R<V]N<R!I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3 N,# @-3$R+C(U(%1D("AT:&4@8V%P86-I=&EE<R!I;F1I
M8V%T960@86YD(&]N('1H92!D871E<R!I;F1I8V%T960Z*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#4P,"XR-2!4
M9" HH"D@5&H@150@40HP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HU,"XU(#0W-2XW-2!M"C(P,RXU(#0W-2XW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,C W+C4@-#<U+C<U(&T*-#,X+C4@-#<U+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N
M-2 T-S4N-S4@;0HU-C(N-2 T-S4N-S4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P+C4@-#,S+C<U(&T*
M,C S+C4@-#,S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HU,"XU(#,Y,2XW-2!M"C(P,RXU(#,Y,2XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 N-2 S-#,N-S4@;0HR,#,N-2 S-#,N-S4@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P
M+C4@,S Q+C<U(&T*,C S+C4@,S Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,"XU(#(U.2XW-2!M
M"C(P,RXU(#(U.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-3 N-2 R,3<N-S4@;0HR,#,N-2 R,3<N
M-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C4P+C4@,3<U+C<U(&T*,C S+C4@,3<U+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU
M,"XU(#$S,RXW-2!M"C(P,RXU(#$S,RXW-2!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 N-2 Y,2XW-2!M
M"C(P,RXU(#DQ+C<U(&P*<PI"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q,#4N-S4@-#@P+C0X(%1D("A3:6=N871U<BD@5&H@150@40IQ(# @
M," P(')G($)4(#$T,BXX.2 T.# N-#@@5&0@*&4I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C V+C P(#0X,"XS,B!49" H
MH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,3(N-34@-#@P+C0X(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$Y
M+C$S(#0X,"XT."!49" H:71L92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-#$N,# @-#@P+C,R(%1D("B@*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,BXP," T.# N
M-#@@5&0@*$1A=&4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,N,# @-#8V+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P-BXP," T-C8N,S(@5&0@** I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P
M+C P(#0V-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-#$N,# @-#8V+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-2XP," T-C8N,S(@
M5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.3 N,3 @-#,X+C,R(%1D("@O<R\@2V5V:6X@0RX@0VQA<FLI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C V+C P(#0S
M."XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R,3 N,# @-#,X+C,R(%1D("A0<F5S:61E;G0L($-H:65F($5X
M96-U=&EV92!/9BD@5&H@150@40IQ(# @," P(')G($)4(#,R.2XX." T,S@N
M,S(@5&0@*&9I8V5R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T,2XP," T,S@N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(P(#0S."XS,B!49" H
M1F5B<G5A<GD@,C@L(#(P,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.38N,#4@-#(T+C,R(%1D("A+979I;B!#+B!#;&%R
M:RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,#8N,# @-#(T+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(Q,"XP," T,C0N,S(@5&0@*%PH4')I;F-I<&%L
M($5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," P(')G($)4(#,P-"XX." T
M,C0N,S(@5&0@*&9I8V5R7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#0Q+C P(#0R-"XS,B!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#4N,# @-#(T+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#0Q,"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R,#8N,# @-#$P+C,R(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,"XP," T
M,3 N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#0Q+C P(#0Q,"XS,B!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#4N,# @-#$P+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V
M+C<U(#,Y-BXS,B!49" H+W,O("D@5&H@150@40IQ(# @," P(')G($)4(#DX
M+C8Q(#,Y-BXS,B!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#$P-RXW
M-B S.38N,S(@5&0@*&EL;&EA;2!*+B!"=7)N<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,#8N,# @,SDV+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q
M,"XP," S.38N,S(@5&0@*$5X96-U=&EV92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-3(N,SD@,SDV+C,R(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C4Y+C(R(#,Y-BXS,B!49" H:6-E(%!R97-I9&5N=" F($-H:65F($9I
M;F%N8VEA;"!/9BD@5&H@150@40IQ(# @," P(')G($)4(#,Y-RXY-B S.38N
M,S(@5&0@*&9I8V5R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T,2XP," S.38N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(P(#,Y-BXS,B!49" H
M1F5B<G5A<GD@,C@L(#(P,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3(N-C4@,S@R+C,R(%1D("A7*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3 Q+C@Y(#,X,BXS,B!49" H:6QL:6%M($HN($)U<FYS
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P
M-BXP," S.#(N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C$P+C P(#,X,BXS,B!49" H7"A0<FEN8VEP86P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4Q+C8V(#,X,BXS,B!49" H06-C
M;W5N=&EN9R!A;F0@1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S8W+C8U(#,X,BXS,B!49" H9FEC97)<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N,# @,S@R+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M-2XP," S.#(N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3$N-3 @,S0X+C,R(%1D("@O<R\@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3 S+C,V(#,T."XS,B!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#$Q,BXR-2 S-#@N,S(@5&0@*"X@3&%R<GD@0V%S:"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,#8N
M,# @,S0X+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(Q,"XP," S-#@N,S(@5&0@*$1I<F5C=&]R*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XP," S
M-#@N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#8U+C(P(#,T."XS,B!49" H1F5B<G5A<GD@,C@L(#(P,3DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.3<N
M,S4@,S,T+C,R(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 V+C,S
M(#,S-"XS,B!49" H+B!,87)R>2!#87-H*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(P-BXP," S,S0N,S(@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P
M(#,S-"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-#$N,# @,S,T+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-2XP," S,S0N,S(@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @,S(P+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(P-BXP," S,C N,S(@5&0@** I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P(#,R,"XS
M,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-#$N,# @,S(P+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0T-2XP," S,C N,S(@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#0N,#4@
M,S V+C,R(%1D("@O<R\@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.34N.3$@
M,S V+C,R(%1D("A4:&]M87,@0RX@1&ER8VMS*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P-BXP," S,#8N,S(@5&0@** I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P
M+C P(#,P-BXS,B!49" H1&ER96-T;W(I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#0Q+C P(#,P-BXS,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C @
M,S V+C,R(%1D("A&96)R=6%R>2 R."P@,C Q.2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X.2XY-2 R.3(N,S(@5&0@*%1H
M;VUA<R!#+B!$:7)C:W,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C V+C P(#(Y,BXS,B!49" HH"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3 N,# @,CDR+C,R(%1D
M("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0T,2XP," R.3(N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#0U+C P(#(Y,BXS,B!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," R-S@N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C V+C P(#(W."XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,3 N,# @,C<X+C,R(%1D("B@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XP
M," R-S@N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#0U+C P(#(W."XS,B!49" HH"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X.2XU-2 R-C0N,S(@5&0@
M*"]S+R!'86QE($9I='IG97)A;&0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C V+C P(#(V-"XS,B!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3 N,# @,C8T
M+C,R(%1D("A$:7)E8W1O<BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-#$N,# @,C8T+C,R(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-2XR," R-C0N,S(@
M5&0@*$9E8G)U87)Y(#(X+" R,#$Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#DU+C4P(#(U,"XS,B!49" H1V%L92!&:71Z
M9V5R86QD*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(P-BXP," R-3 N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P(#(U,"XS,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N,# @
M,C4P+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T-2XP," R-3 N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C,V+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P
M-BXP," R,S8N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C$P+C P(#(S-BXS,B!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N,# @,C,V+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0T-2XP," R,S8N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-S0N-# @,C(R+C,R(%1D("@O<R\@1&%R
M<F5L;"!3+B!&<F5E;6%N+"!3<BD@5&H@150@40IQ(# @," P(')G($)4(#$W
M-BXS,R R,C(N,S(@5&0@*"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C$P+C P(#(R,BXS,B!49" H1&ER96-T;W(I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(P
M(#(R,BXS,B!49" H1F5B<G5A<GD@,C@L(#(P,3DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.# N,S4@,C X+C,R(%1D("A$
M87)R96QL(%,N($9R965M86XL(%-R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3<P+C,S(#(P."XS,B!49" H+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" W.2XP," Q.# N,S(@5&0@*"]S+R!2:6-H87)D
M($TN($UA<W1A;&5R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(P-BXP," Q.# N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$P+C P(#$X,"XS,B!49" H
M1&ER96-T;W(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0Q+C P(#$X,"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C @,3@P+C,R(%1D("A&96)R
M=6%R>2 R."P@,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-"XY-2 Q-C8N,S(@5&0@*%)I8VAA<F0@32X@36%S=&%L
M97(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C V+C P(#$V-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R,3 N,# @,38V+C,R(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XP," Q-C8N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0U+C P(#$V-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y,2XU-2 Q,S@N,S(@5&0@*"]S+R!-
M87)K(%!E<FQB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-38N-#4@,3,X
M+C,R(%1D("AG*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Q,"XP," Q,S@N,S(@5&0@*$1I<F5C=&]R*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-2XR," Q,S@N,S(@
M5&0@*$9E8G)U87)Y(#(X+" R,#$Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#DW+C4U(#$R-"XS,B!49" H36%R:R!097)L
M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34P+C4P(#$R-"XS,B!49" H
M9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,RXP," Q,3 N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C V+C P(#$Q,"XS,B!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3 N,# @,3$P+C,R
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0T,2XP," Q,3 N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#0U+C P(#$Q,"XS,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-"XX," Y
M-BXS,B!49" H+W,O($IO<V5P:" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,C4N.3(@.38N,S(@5&0@*$$N("D@5&H@150@40IQ(# @," P(')G($)4(#$S
M-RXY-B Y-BXS,B!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$T,RXW
M,B Y-BXS,B!49" H<G5N9FEO*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(P-BXP," Y-BXS,B!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3 N,# @.38N,S(@
M5&0@*$1I<F5C=&]R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T,2XP," Y-BXS,B!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C @.38N,S(@5&0@*$9E
M8G)U87)Y(#(X+" R,#$Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#DP+C<U(#@R+C,R(%1D("A*;W-E<&@@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3$Y+CDR(#@R+C,R(%1D("A!+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,S$N.38@.#(N,S(@5&0@*%0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,S<N-S(@.#(N,S(@5&0@*')U;F9I;RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,#8N,# @.#(N,S(@
M5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C$P+C P(#@R+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0T,2XP," X,BXS,B!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#4N,# @.#(N
M,S(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A
M;0IE;F1O8FH*,3 S(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @
M4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@
M,"!2"B]!;FYO=',@6SP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]2
M96-T(%LV,B V.#0N,3 X,C S,3(U(#(Y-2XX-#(W-S,T,S<U(#8Y,RXR72 O
M0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$P-2 P(%(@+UA96B P(#<Y
M,BXP,"!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E
M8W0@6S8R(#8V-"XQ,#@R,#,Q,C4@,S(P+C(V-C8P,34V,C4@-C<S+C)=("]"
M;W)D97(@6S @," P72 O2" O22 O1&5S="!;,3 W(# @4B O6%E:(# @-SDR
M+C P(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C
M="!;-C(@-C0T+C$P.#(P,S$R-2 T-#<N-S4V.#,U.3,W-2 V-3,N,ET@+T)O
M<F1E<B!;," P(#!=("](("])("]$97-T(%LQ,#D@,"!2("]865H@," W.3(N
M,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T
M(%LV,B V,C0N,3 X,C S,3(U(#4R-RXQ.# V-C0P-C(U(#8S,RXR72 O0F]R
M9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$Q,2 P(%(@+UA96B P(#<Y,BXP
M,"!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@
M6S8R(#8P-"XQ,#@R,#,Q,C4@-#@W+C@T.38P.3,W-2 V,3,N,ET@+T)O<F1E
M<B!;," P(#!=("](("])("]$97-T(%LQ,3,@,"!2("]865H@," W.3(N,# @
M;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LV
M,B U.#0N,3 X,C S,3(U(#0U,"XX,S,P,#<X,3(U(#4Y,RXR72 O0F]R9&5R
M(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$Q-2 P(%(@+UA96B P(#<Y,BXP,"!N
M=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S8R
M(#4V-"XQ,#@R,#,Q,C4@,C,V+CDW-34X-3DS-S4@-3<S+C)=("]";W)D97(@
M6S @," P72 O2" O22 O1&5S="!;,3$W(# @4B O6%E:(# @-SDR+C P(&YU
M;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;-C(@
M-3(T+C$P.#(P,S$R-2 T.#<N.#,T.38P.3,W-2 U,S,N,ET@+T)O<F1E<B!;
M," P(#!=("](("])("]$97-T(%LQ.#D@,"!2("]865H@," W.3(N,# @;G5L
M;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T(%LU,S@N
M." V.#0N,3 X,C S,3(U(#4U-2XQ.3$V,#$U-C(U(#8Y,RXR72 O0F]R9&5R
M(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$P-2 P(%(@+UA96B P(#<Y,BXP,"!N
M=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E8W0@6S4S
M."XX(#8V-"XQ,#@R,#,Q,C4@-34U+C$Y,38P,34V,C4@-C<S+C)=("]";W)D
M97(@6S @," P72 O2" O22 O1&5S="!;,3 W(# @4B O6%E:(# @-SDR+C P
M(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O4F5C="!;
M-3,X+C@@-C0T+C$P.#(P,S$R-2 U-34N,3DQ-C Q-38R-2 V-3,N,ET@+T)O
M<F1E<B!;," P(#!=("](("])("]$97-T(%LQ,#D@,"!2("]865H@," W.3(N
M,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK("]296-T
M(%LU,S@N." V,C0N,3 X,C S,3(U(#4U-2XQ.3$V,#$U-C(U(#8S,RXR72 O
M0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$Q,2 P(%(@+UA96B P(#<Y
M,BXP,"!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI;FL@+U)E
M8W0@6S4S."XX(#8P-"XQ,#@R,#,Q,C4@-34U+C$Y,38P,34V,C4@-C$S+C)=
M("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;,3$S(# @4B O6%E:(# @
M-SDR+C P(&YU;&Q=/CX\/"]4>7!E("]!;FYO=" O4W5B='EP92 O3&EN:R O
M4F5C="!;-3,X+C@@-3@T+C$P.#(P,S$R-2 U-34N,3DQ-C Q-38R-2 U.3,N
M,ET@+T)O<F1E<B!;," P(#!=("](("])("]$97-T(%LQ,34@,"!2("]865H@
M," W.3(N,# @;G5L;%T^/CP\+U1Y<&4@+T%N;F]T("]3=6)T>7!E("],:6YK
M("]296-T(%LU,S@N." U-C0N,3 X,C S,3(U(#4U-2XQ.3$V,#$U-C(U(#4W
M,RXR72 O0F]R9&5R(%LP(# @,%T@+T@@+TD@+T1E<W0@6S$Q-R P(%(@+UA9
M6B P(#<Y,BXP,"!N=6QL73X^/#PO5'EP92 O06YN;W0@+U-U8G1Y<&4@+TQI
M;FL@+U)E8W0@6S4S."XR-2 U,C0N,3 X,C S,3(U(#4U-2XW-# R,S0S-S4@
M-3,S+C)=("]";W)D97(@6S @," P72 O2" O22 O1&5S="!;,3@Y(# @4B O
M6%E:(# @-SDR+C P(&YU;&Q=/CY="B]2;W1A=&4@, HO0V]N=&5N=',@,3 T
M(# @4CX^"F5N9&]B:@HQ,#0@,"!O8FH*/#PO3&5N9W1H(#8S,#$^/@IS=')E
M86T*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDW+C@P(#,Q
M+C8P(%1D("A&+2 Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$W-"XY," W-#(N,3 @5&0@** I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<W+C0P(#<T,BXQ,"!49" H
M24Y$15@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Q+CDU(#<T,BXQ,"!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(Q."XT-" W-#(N,3 @5&0@
M*$\@0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C4T(#<T
M,BXQ,"!49" H5$5$($9)3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G($)4
M(#,V-RXW,B W-#(N,3 @5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4
M(#,X,2XW,2 W-#(N,3 @5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M.#@N,3D@-S0R+C$P(%1D("A414U%3E13*2!4:B!%5"!1"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4S,BXU(#<Q
M-BXV(&T*-38R+C4@-S$V+C8@; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S+C P(#<R,BXQ-R!49" HH"D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N-S @-S(R+C,S(%1D("A0
M86=E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#<P-BXX,R!49" H0W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" V
M-"XT." W,#8N.#,@5&0@*&]S<R!#;W5N=')Y($AE86QT:&-A<BD@5&H@150@
M40IQ(# @," P(')G($)4(#$V,"XY-B W,#8N.#,@5&0@*&4L($EN8RXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C P
M(#<P-RXQ-R!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4
M<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3
M,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-C(@-C@T+CDS
M,S,Y.#0S-S4@;0HR.34N.#0R-S<S-#,W-2 V.#0N.3,S,SDX-#,W-2!L"G,*
M<2 P(# @,2!R9R!"5" V,BXP," V.#8N,C<@5&0@*%)E<&]R="!O9B!);F1E
M<&5N9&5N="!296=I<W1E<F5D(%!U8FQI8R I(%1J($54(%$*<2 P(# @,2!R
M9R!"5" R,C<N,C0@-C@V+C(W(%1D("A!8V-O=6YT:6YG($9I<FTI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@
M,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*
M,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @,2!21PHO1U,P(&=S"C N-#D@
M=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HV,B V-C0N.3,S,SDX-#,W-2!M
M"C,R,"XR-C8V,#$U-C(U(#8V-"XY,S,S.3@T,S<U(&P*<PIQ(# @," Q(')G
M($)4(#8R+C P(#8V-BXR-R!49" H0V]N<V]L:61A=&5D($)A;&%N8V4@4VAE
M971S(&%S(&]F($1E8V5M8F5RH#,Q+" R,#$X(&%N9" R,#$W*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P
M,"!4>B P(%1,( I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @
M5'<@,"!48R Q,# @5'H@,"!43" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*
M,"!I( I;72 P(&0*,2!*"C$@:@HS($T*-C(@-C0T+CDS,S,Y.#0S-S4@;0HT
M-#<N-S4V.#,U.3,W-2 V-#0N.3,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"
M5" V,BXP," V-#8N,C<@5&0@*$-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F
M($]P97)A=&EO;G,@9F]R('1H92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" R
M-#DN,S<@-C0V+C(W(%1D("A9*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,C4U
M+C4Y(#8T-BXR-R!49" H96%R<R!%;F1E9"!$96-E;6)E<J S,2P@,C Q."P@
M,C Q-RP@86YD(#(P,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @
M5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP
M,"!49B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP
M(# @,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@
M30HV,B V,C0N.3,S,SDX-#,W-2!M"C4R-RXQ.# V-C0P-C(U(#8R-"XY,S,S
M.3@T,S<U(&P*<PIQ(# @," Q(')G($)4(#8R+C P(#8R-BXR-R!49" H0V]N
M<V]L:61A=&5D(%-T871E;65N=',@;V8@0V]M<')E:&5N<VEV92!<*$QO<W-<
M*2!);F-O;64@9F]R('1H92 I(%1J($54(%$*<2 P(# @,2!R9R!"5" S,C@N
M-SD@-C(V+C(W(%1D("A9*2!4:B!%5"!1"G$@," P(#$@<F<@0E0@,S,U+C Q
M(#8R-BXR-R!49" H96%R<R!%;F1E9"!$96-E;6)E<J S,2P@,C Q."P@,C Q
M-RP@86YD(#(P,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C @5'(*
M+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"D)4("]&,2 Q,"XP,"!4
M9B!%5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( HP(# @
M,2!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HV
M,B V,#0N.3,S,SDX-#,W-2!M"C0X-RXX-#DV,#DS-S4@-C T+CDS,S,Y.#0S
M-S4@; IS"G$@," P(#$@<F<@0E0@-C(N,# @-C V+C(W(%1D("A#;VYS;VQI
M9&%T960@4W1A=&5M96YT<R!O9B!3=&]C:VAO;&1E<G.2*2!4:B!%5"!1"G$@
M," P(#$@<F<@0E0@,C(Y+C(Y(#8P-BXR-R!49" H($5Q=6ET>2!F;W(@=&AE
M("D@5&H@150@40IQ(# @," Q(')G($)4(#(X.2XT-B V,#8N,C<@5&0@*%DI
M(%1J($54(%$*<2 P(# @,2!R9R!"5" R.34N-C@@-C V+C(W(%1D("AE87)S
M($5N9&5D($1E8V5M8F5RH#,Q+" R,#$X+" R,#$W+"!A;F0@,C Q-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!4
M8R Q,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q(%)'"B]'4S @9W,*,"XT
M.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C8R(#4X-"XY,S,S.3@T,S<U
M(&T*-#4P+C@S,S P-S@Q,C4@-3@T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@-C(N,# @-3@V+C(W(%1D("A#;VYS;VQI9&%T960@4W1A=&5M96YT
M<R!O9B!#87-H($9L;W=S(&9O<B!T:&4@*2!4:B!%5"!1"G$@," P(#$@<F<@
M0E0@,C4R+C0T(#4X-BXR-R!49" H62D@5&H@150@40IQ(# @," Q(')G($)4
M(#(U."XV-R U.#8N,C<@5&0@*&5A<G,@16YD960@1&5C96UB97*@,S$L(#(P
M,3@L(#(P,3<L(&%N9" R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 HP(%1R"B]'4S @9W,*,"!4=R P(%1C(#$P,"!4>B P(%1,( I"5" O1C$@
M,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q,# @5'H@,"!4
M3" *," P(#$@4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*"C$@
M:@HS($T*-C(@-38T+CDS,S,Y.#0S-S4@;0HR,S8N.3<U-3@U.3,W-2 U-C0N
M.3,S,SDX-#,W-2!L"G,*<2 P(# @,2!R9R!"5" V,BXP," U-C8N,C<@5&0@
M*$YO=&5S('1O($-O;G-O;&ED871E9"!&:6YA;F-I86P@4W1A=&5M96YT<RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@
M,"!48R Q,# @5'H@,"!43" *0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,N,# @-30W+C,S(%1D("A&:6YA;F-I86P@4W1A=&5M96YT(%-C
M:&5D=6QE*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S-2XP," U-#8N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @
M," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-
M"C8R(#4R-"XY,S,S.3@T,S<U(&T*-#@W+C@S-#DV,#DS-S4@-3(T+CDS,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-C(N,# @-3(V+C(W(%1D("A38VAE
M9'5L92!)22"6("D@5&H@150@40IQ(# @," Q(')G($)4(#$Q-RXV,R U,C8N
M,C<@5&0@*%8I(%1J($54(%$*<2 P(# @,2!R9R!"5" Q,C,N-S4@-3(V+C(W
M(%1D("AA;'5A=&EO;B!A;F0@475A;&EF>6EN9R I(%1J($54(%$*<2 P(# @
M,2!R9R!"5" R,C N-C<@-3(V+C(W(%1D("A!8V-O=6YT<R!F;W(@=&AE("D@
M5&H@150@40IQ(# @," Q(')G($)4(#(X.2XT-2 U,C8N,C<@5&0@*%DI(%1J
M($54(%$*<2 P(# @,2!R9R!"5" R.34N-C<@-3(V+C(W(%1D("AE87)S($5N
M9&5D($1E8V5M8F5RH#,Q+" R,#$X+" R,#$W+"!A;F0@,C Q-BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*,"!4<@HO1U,P(&=S"C @5'<@,"!48R Q
M,# @5'H@,"!43" *0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#4Q,"XQ,"!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," T.3@N
M,3 @5&0@*%-C:&5D=6QE<R!N;W0@9FEL960@:&5R97=I=&@@87)E(&5I=&AE
M<B!N;W0@87!P;&EC86)L92P@=&AE(&EN9F]R;6%T:6]N(&ES(&YO="!M871E
M<FEA;"!O<B!T:&4@:6YF;W)M871I;VX@:7,@<V5T(&9O<G1H(&EN('1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-#@V+C$P(%1D("AC;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N
M=',@;W(@;F]T97,@=&AE<F5T;RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @5'(*+T=3,"!G<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S
M."XX(#8X-"XY,S,S.3@T,S<U(&T*-34U+C$Y,38P,34V,C4@-C@T+CDS,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X+C@P(#8X-BXR-R!49" H1BT@
M,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F
M($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"C4S."XX(#8V-"XY,S,S.3@T,S<U(&T*-34U+C$Y,38P,34V,C4@
M-C8T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X+C@P(#8V-BXR
M-R!49" H1BT@,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q
M(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@
M,"!D"C$@2@HQ(&H*,R!-"C4S."XX(#8T-"XY,S,S.3@T,S<U(&T*-34U+C$Y
M,38P,34V,C4@-C0T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X
M+C@P(#8T-BXR-R!49" H1BT@-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S."XX(#8R-"XY,S,S.3@T,S<U
M(&T*-34U+C$Y,38P,34V,C4@-C(T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@
M<F<@0E0@-3,X+C@P(#8R-BXR-R!49" H1BT@-2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @
M9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S."XX(#8P-"XY
M,S,S.3@T,S<U(&T*-34U+C$Y,38P,34V,C4@-C T+CDS,S,Y.#0S-S4@; IS
M"G$@," P(#$@<F<@0E0@-3,X+C@P(#8P-BXR-R!49" H1BT@-BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"C @," Q
M(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4S
M."XX(#4X-"XY,S,S.3@T,S<U(&T*-34U+C$Y,38P,34V,C4@-3@T+CDS,S,Y
M.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X+C@P(#4X-BXR-R!49" H1BT@
M-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F
M($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"C4S."XX(#4V-"XY,S,S.3@T,S<U(&T*-34U+C$Y,38P,34V,C4@
M-38T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X+C@P(#4V-BXR
M-R!49" H1BT@."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q
M(#$P+C P(%1F($54"C @," Q(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@
M,"!D"C$@2@HQ(&H*,R!-"C4S."XR-2 U,C0N.3,S,SDX-#,W-2!M"C4U-2XW
M-# R,S0S-S4@-3(T+CDS,S,Y.#0S-S4@; IS"G$@," P(#$@<F<@0E0@-3,X
M+C(U(#4R-BXR-R!49" H24DM(#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"F5N9'-T<F5A;0IE;F1O8FH*,3 U(# @;V)J"CP\+U1Y<&4@+U!A9V4*
M+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO
M4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3 V(# @4CX^
M"F5N9&]B:@HQ,#8@,"!O8FH*/#PO3&5N9W1H(#8S-30^/@IS=')E86T*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDW+C@P(#,Q+C8P(%1D
M("A&+2 R*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$S-2XT," W-#(N,C4@5&0@*%)%4$]2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3<P+C U(#<T,BXR-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#$W-BXU-" W-#(N,C4@5&0@*"!/1BD@5&H@150@40IQ(# @," P(')G
M($)4(#$Y,BXU-2 W-#(N,C4@5&0@*"!)3D1%4$5.1$5.5"D@5&H@150@40IQ
M(# @," P(')G($)4(#(V-RXV-B W-#(N,C4@5&0@*"!214=)4U1%4D5$(%!5
M0DQ)0R I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S<N.3<@-S0R+C(U(%1D
M("A!0T-/54Y424Y'($9)4DTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S V+C(U(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-34N-#$@-S V+C(U(%1D("AO('1H92!3=&]C:VAO;&1E
M<G,@86YD('1H92!";V%R9"!O9B!$:7)E8W1O<G,@;V8@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8Y-"XR-2!4
M9" H0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," V.#(N,C4@
M5&0@*$)O8V$@4F%T;VXL($9L;W)I9&$I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-C4X+C(U(%1D("A/<&EN:6]N
M("D@5&H@150@40IQ(# @," P(')G($)4(#@W+C4R(#8U."XR-2!49" H;VX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 P+C4X(#8U."XR-2!49" H=&AE
M("D@5&H@150@40IQ(# @," P(')G($)4(#$Q-BXT,2 V-3@N,C4@5&0@*$9I
M;F%N8VEA;" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3@N.3(@-C4X+C(U
M(%1D("A3=&%T96UE;G1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#8S-"XR-2!49" H5RD@5&H@150@40IQ(# @
M," P(')G($)4(#4X+C8T(#8S-"XR-2!49" H92!H879E(&%U9&ET960@=&AE
M(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',@;V8@
M0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N(&%N9"!S=6)S:61I87)I
M97,@7"AT:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#8R,BXR-2!49" H(D-O;7!A;GDB7"D@87,@;V8@1&5C
M96UB97(@,S$L(#(P,3@@86YD(#(P,3<L('1H92!R96QA=&5D(&-O;G-O;&ED
M871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,L(&-O;7!R96AE;G-I=F4@
M:6YC;VUE+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-C$P+C(U(%1D("AS=&]C:VAO;&1E<G,G(&5Q=6ET>2D@
M5&H@150@40IQ(# @," P(')G($)4(#$R.2XQ.2 V,3 N,C4@5&0@*"P@86YD
M(&-A<V@@9FQO=W,L(&9O<B!E86-H(&]F('1H92!T:')E92!Y96%R<R!I;B!T
M:&4@<&5R:6]D(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!A;F0@=&AE(')E
M;&%T960@;F]T97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#4Y."XR-2!49" H86YD('1H92!S8VAE9'5L92!L
M:7-T960@:6X@=&AE($EN9&5X(&%T($ET96T@,34@7"AC;VQL96-T:79E;'D@
M<F5F97)R960@=&\@87,@=&AE(")F:6YA;F-I86P@<W1A=&5M96YT<R)<*2X@
M26X@;W5R(&]P:6YI;VXL('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-3@V+C(U(%1D("AF:6YA;F-I86P@
M<W1A=&5M96YT<R!P<F5S96YT(&9A:7)L>2D@5&H@150@40IQ(# @," P(')G
M($)4(#$X-"XU." U.#8N,C4@5&0@*"P@:6X@86QL(&UA=&5R:6%L(')E<W!E
M8W1S+"!T:&4@9FEN86YC:6%L('!O<VET:6]N(&]F('1H92!#;VUP86YY(&%S
M(&]F($1E8V5M8F5R(#,Q+" R,#$X(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3<T+C(U(%1D("@R,#$W
M+"!A;F0@=&AE(')E<W5L=',@;V8@:71S(&]P97)A=&EO;G,@86YD(&ET<R!C
M87-H(&9L;W=S(&9O<B!E86-H(&]F('1H92!T:')E92!Y96%R<R!I;B!T:&4@
M<&5R:6]D(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!I;B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-38R+C(U
M(%1D("AC;VYF;W)M:71Y('=I=&@@86-C;W5N=&EN9R!P<FEN8VEP;&5S(&=E
M;F5R86QL>2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E<R!O9B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-S0N,#<@-38R+C(U(%1D("A!;65R:6-A
M+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-30R+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N
M-C0@-30R+C(U(%1D("AE(&AA=F4@86QS;R!A=61I=&5D+"!I;B!A8V-O<F1A
M;F-E('=I=&@@=&AE('-T86YD87)D<R!O9B!T:&4@4'5B;&EC($-O;7!A;GD@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C0T(#4T,BXR-2!49" H06-C
M;W5N=&EN9R!/=F5R<VEG:'0@0F]A<F0@7"A5;FET960@4W1A=&5S7"D@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#4S,"XR-2!49" H7"A00T%/0EPI+"!T:&4@0V]M<&%N>2=S(&EN=&5R;F%L
M(&-O;G1R;VP@;W9E<B!F:6YA;F-I86P@<F5P;W)T:6YG(&%S(&]F($1E8V5M
M8F5R(#,Q+" R,#$X+"!B87-E9"!O;B!C<FET97)I82!E<W1A8FQI<VAE9"!I
M;B I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-3$X+C(U(%1D("A);G1E<FYA;"!#;VYT<BD@5&H@150@40IQ(# @
M," P(')G($)4(#$P-RXV.2 U,3@N,C4@5&0@*&]L("T@26YT96=R871E9"!&
M<F%M97=O<FL@7"@R,#$S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C0S+C<W(#4Q."XR-2!49" H(&ES<W5E9"!B>2!T
M:&4@0V]M;6ET=&5E(&]F(%-P;VYS;W)I;F<@3W(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,3<N,3D@-3$X+C(U(%1D("AG86YI>F%T:6]N<R!O9B!T:&4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DP+C8P(#4Q."XR-2!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#0Y-BXS-2 U,3@N,C4@5&0@*')E861W
M87D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#4P-BXR-2!49" H0V]M;6ES<VEO;B!A;F0@;W5R(')E<&]R="!D
M871E9"!&96)R=6%R>2 R."P@,C Q.2P@97AP<F5S<V5D(&%N('5N<75A;&EF
M:65D(&]P:6YI;VX@;VX@=&AE($-O;7!A;GDG<R!I;G1E<FYA;"!C;VYT<F]L
M(&]V97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#0Y-"XR-2!49" H9FEN86YC:6%L(')E<&]R=&EN9RXI(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @
M-#<T+C(U(%1D("A"87-I<R!F;W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" X
M-RXS,B T-S0N,C4@5&0@*"!/<&EN:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0U-"XR-2!49" H5&AE<V4@
M9FEN86YC:6%L('-T871E;65N=',@87)E('1H92!R97-P;VYS:6)I;&ET>2!O
M9B!T:&4@0V]M<&%N>2=S(&UA;F%G96UE;G0N($]U<B!R97-P;VYS:6)I;&ET
M>2!I<R!T;R!E>'!R97-S(&%N(&]P:6YI;VX@;VX@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#0T,BXR-2!49" H
M=&AE($-O;7!A;GDG<R!F:6YA;F-I86P@<W1A=&5M96YT<R!B87-E9"!O;B!O
M=7(@875D:71S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S8N,CD@-#0R
M+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@T+CDS(#0T,BXR
M-2!49" H92!A<F4@82!P=6)L:6,@86-C;W5N=&EN9R!F:7)M(')E9VES=&5R
M960@=VET:"!T:&4@4$-!3T(@86YD(&%R92 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#,P+C(U(%1D("AR97%U
M:7)E9"!T;R!B92!I;F1E<&5N9&5N="!W:71H(')E<W!E8W0@=&\@=&AE($-O
M;7!A;GD@:6X@86-C;W)D86YC92!W:71H('1H92!5+E,N(&9E9&5R86P@<V5C
M=7)I=&EE<R!L87=S(&%N9"!T:&4@87!P;&EC86)L92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-#$X+C(U(%1D
M("AR=6QE<R!A;F0@<F5G=6QA=&EO;G,@;V8@=&AE(%-E8W5R:71I97,@86YD
M($5X8VAA;F=E($-O;6UI<W-I;VX@86YD('1H92!00T%/0BX@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,Y."XR
M-2!49" H5RD@5&H@150@40IQ(# @," P(')G($)4(#4X+C8T(#,Y."XR-2!4
M9" H92!C;VYD=6-T960@;W5R(&%U9&ET<R!I;B!A8V-O<F1A;F-E('=I=&@@
M=&AE('-T86YD87)D<R!O9B!T:&4@4$-!3T(N("D@5&H@150@40IQ(# @," P
M(')G($)4(#,T."XQ," S.3@N,C4@5&0@*%1H;W-E('-T86YD87)D<R!R97%U
M:7)E('1H870@=V4@<&QA;B!A;F0@<&5R9F]R;2!T:&4@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,X-BXR-2!4
M9" H875D:70@=&\@;V)T86EN(')E87-O;F%B;&4@87-S=7)A;F-E(&%B;W5T
M('=H971H97(@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%R92!F<F5E(&]F
M(&UA=&5R:6%L(&UI<W-T871E;65N="P@=VAE=&AE<B!D=64@=&\@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,W
M-"XR-2!49" H97)R;W(@;W(@9G)A=60N($]U<B!A=61I=',@:6YC;'5D960@
M<&5R9F]R;6EN9R!P<F]C961U<F5S('1O(&%S<V5S<R!T:&4@<FES:W,@;V8@
M;6%T97)I86P@;6ES<W1A=&5M96YT(&]F('1H92!F:6YA;F-I86P@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,V
M,BXR-2!49" H<W1A=&5M96YT<RP@=VAE=&AE<B!D=64@=&\@97)R;W(@;W(@
M9G)A=60L(&%N9"!P97)F;W)M:6YG('!R;V-E9'5R97,@=&AA="!R97-P;VYD
M('1O('1H;W-E(')I<VMS+B!3=6-H('!R;V-E9'5R97,@:6YC;'5D960@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#,U,"XR-2!49" H97AA;6EN:6YG+"!O;B!A('1E<W0@8F%S:7,L(&5V:61E
M;F-E(')E9V%R9&EN9R!T:&4@86UO=6YT<R!A;F0@9&ES8VQO<W5R97,@:6X@
M=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S+B!/=7(@875D:71S(&%L<V\@:6YC
M;'5D960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#,S."XR-2!49" H979A;'5A=&EN9R!T:&4@86-C;W5N=&EN
M9R!P<FEN8VEP;&5S('5S960@86YD('-I9VYI9FEC86YT(&5S=&EM871E<R!M
M861E(&)Y(&UA;F%G96UE;G0L(&%S('=E;&P@87,@979A;'5A=&EN9R!T:&4@
M;W9E<F%L;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @,S(V+C(U(%1D("AP<F5S96YT871I;VX@;V8@=&AE(&9I
M;F%N8VEA;"!S=&%T96UE;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,3$N-#,@,S(V+C(U(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(P
M+C W(#,R-BXR-2!49" H92!B96QI979E('1H870@;W5R(&%U9&ET<R!P<F]V
M:61E(&$@<F5A<V]N86)L92!B87-I<R!F;W(@;W5R(&]P:6YI;VXN("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," R
M.#8N,S(@5&0@*"]S+R!$14Q/251412 F("D@5&H@150@40IQ(# @," P(')G
M($)4(#$R-2XY-2 R.#8N,S(@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,S$N.#@@,C@V+C,R(%1D("A/54-(12!,3% I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C4X+C,R(%1D("A"
M;V-A(%)A=&]N+"!&;&]R:61A*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#(T-"XS,B!49" H1F5B<G5A<GD@,C@L
M(#(P,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#$X.2XX-2!49" H5RD@5&H@
M150@40IQ(# @," P(')G($)4(#4X+C8T(#$X.2XX-2!49" H92!H879E('-E
M<G9E9"!A<R!T:&4@0V]M<&%N>2=S(&%U9&ET;W(@<VEN8V4@,C Q-2XI(%1J
M($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,#<@,"!O8FH*/#PO5'EP92 O4&%G
M90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!=
M"B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q,#@@,"!2
M/CX*96YD;V)J"C$P." P(&]B:@H\/"],96YG=&@@,3@V-S8^/@IS=')E86T*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDW+C@P(#,Q+C8P
M(%1D("A&+2 S*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Q,RXX-2 W,S N,C4@5&0@*$-23U-3($-/54Y44BD@5&H@150@
M40IQ(# @," P(')G($)4(#(Y,BXV." W,S N,C4@5&0@*%DI(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R.3DN-3,@-S,P+C(U(%1D("@@2$5!3"D@5&H@150@
M40IQ(# @," P(')G($)4(#,R.2XT-2 W,S N,C4@5&0@*%1(0T%212P@24Y#
M+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,3DN-# @-S$X+C(U(%1D("A#3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-SDN,C(@-S$X+C(U(%1D("A4140@0D%,04Y#12!32$5%5%,I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C X+C@P
M(#<P-BXR-2!49" H7"AA;6]U;G1S(&EN('1H;W5S86YD<RP@97AC97!T(&9O
M<BD@5&H@150@40IQ(# @," P(')G($)4(#,U,BXX," W,#8N,C4@5&0@*"!S
M:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<T+C Q(#<P-BXR-2!49" H
M92!D871A7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-CDT+C(U(%1D("B@*2!4:B!%5"!1"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#8U.2XW-2 S-S@N,# @
M+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,C@N-3 @-C4Y+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS
M+C4P(#8U.2XW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#8U.2XW-2 V-2XP
M," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C4P(#8S-2XW-2 S-S@N,# @+3$R+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M,C@N-3 @-C,U+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#8S-2XW-2 T
M+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DW+C4P(#8S-2XW-2 V-2XP," M,3(N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C4P(#8Q,2XW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-C$Q+C<U
M(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#8Q,2XW-2 T+C P("TQ,BXP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DW+C4P(#8Q,2XW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4X-RXW
M-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-3@W+C<U(#8U+C P("TQ,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DS+C4P(#4X-RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#4X
M-RXW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4V,RXW-2 S-S@N,# @+3$R
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT,C@N-3 @-38S+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P
M(#4V,RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#4V,RXW-2 V-2XP," M
M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P+C4P(#4S.2XW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N
M-3 @-3,Y+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#4S.2XW-2 T+C P
M("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#DW+C4P(#4S.2XW-2 V-2XP," M,3(N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C4P(#4Q-2XW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-3$U+C<U(#8U
M+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DS+C4P(#4Q-2XW-2 T+C P("TQ,BXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#DW+C4P(#4Q-2XW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0Y,2XW-2 S
M-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-#DQ+C<U(#8U+C P("TQ,BXP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DS+C4P(#0Y,2XW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#0Y,2XW
M-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0V-RXW-2 S-S@N,# @+3$R+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,C@N-3 @-#8W+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#0V
M-RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#0V-RXW-2 V-2XP," M,3(N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C4P(#0T,RXW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @
M-#0S+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#0T,RXW-2 T+C P("TQ
M,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DW+C4P(#0T,RXW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P
M(#0Q.2XW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-#$Y+C<U(#8U+C P
M("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#DS+C4P(#0Q.2XW-2 T+C P("TQ,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW
M+C4P(#0Q.2XW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#,Y-2XW-2 S-S@N
M,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,C@N-3 @,SDU+C<U(#8U+C P("TQ,BXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#DS+C4P(#,Y-2XW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#,Y-2XW-2 V
M-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#,W,2XW-2 S-S@N,# @+3$R+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,C@N-3 @,S<Q+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#,W,2XW
M-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#,W,2XW-2 V-2XP," M,3(N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4P+C4P(#,T-RXW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @,S0W
M+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#,T-RXW-2 T+C P("TQ,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DW+C4P(#,T-RXW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#,R
M,RXW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @,S(S+C<U(#8U+C P("TQ
M,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DS+C4P(#,R,RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P
M(#,R,RXW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#(Y.2XW-2 S-S@N,# @
M+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,C@N-3 @,CDY+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS
M+C4P(#(Y.2XW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#(Y.2XW-2 V-2XP
M," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C4P(#(W-2XW-2 S-S@N,# @+3(R+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M,C@N-3 @,C<U+C<U(#8U+C P("TR,BXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#(W-2XW-2 T
M+C P("TR,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DW+C4P(#(W-2XW-2 V-2XP," M,C(N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C4P(#(T,2XW-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @,C0Q+C<U
M(#8U+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#(T,2XW-2 T+C P("TQ,BXP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DW+C4P(#(T,2XW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#(Q-RXW
M-2 S-S@N,# @+3$R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @,C$W+C<U(#8U+C P("TQ,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DS+C4P(#(Q-RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#(Q
M-RXW-2 V-2XP," M,3(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#$Y,RXW-2 S-S@N,# @+3$R
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT,C@N-3 @,3DS+C<U(#8U+C P("TQ,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P
M(#$Y,RXW-2 T+C P("TQ,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#$Y,RXW-2 V-2XP," M
M,3(N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#8W,2XW-2!M"C0Y,RXU(#8W
M,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DS+C4@-C<Q+C<U(&T*-#DW+C4@-C<Q+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 V-S$N-S4@;0HU-C(N-2 V-S$N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#8U
M.2XW-2!M"C0Y,RXU(#8U.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW+C4@-C4Y+C<U(&T*-38R
M+C4@-C4Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT,C@N-2 U-S4N-S4@;0HT.3,N-2 U-S4N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0Y-RXU(#4W-2XW-2!M"C4V,BXU(#4W-2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X
M+C4@-#DQ+C<U(&T*-#DS+C4@-#DQ+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3<N-2 T.3$N-S4@
M;0HU-C(N-2 T.3$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#0X,"XW-2!M"C0Y,RXU(#0X
M,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#(X+C4@-#<X+C<U(&T*-#DS+C4@-#<X+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 T.# N-S4@;0HU-C(N-2 T.# N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-RXU(#0W
M."XW-2!M"C4V,BXU(#0W."XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X+C4@,SDU+C<U(&T*-#DS
M+C4@,SDU+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3<N-2 S.34N-S4@;0HU-C(N-2 S.34N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0R."XU(#,S-2XW-2!M"C0Y,RXU(#,S-2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW
M+C4@,S,U+C<U(&T*-38R+C4@,S,U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C@N-2 R,3<N-S4@
M;0HT.3,N-2 R,3<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-RXU(#(Q-RXW-2!M"C4V,BXU(#(Q
M-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#(X+C4@,3DS+C<U(&T*-#DS+C4@,3DS+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 Q.3,N-S4@;0HU-C(N-2 Q.3,N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#$X
M,2XW-2!M"C0Y,RXU(#$X,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X+C4@,3<P+C<U(&T*-#DS
M+C4@,3<P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT,C@N-2 Q-C@N-S4@;0HT.3,N-2 Q-C@N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0Y-RXU(#$X,2XW-2!M"C4V,BXU(#$X,2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW
M+C4@,3<P+C<U(&T*-38R+C4@,3<P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3<N-2 Q-C@N-S4@
M;0HU-C(N-2 Q-C@N-S4@; IS"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,N,# @-C<U+C Q(%1D("B@*2!4:B!%5"!1"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8X+C@P(#8W-2XQ-2!49" H1&5C96UB
M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#<N-CD@-C<U+C$U(%1D("@@
M,S$L*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @-C8S+C Q(%1D("B@*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#4Q+C4P(#8V,RXQ-2!49" H,C Q."D@5&H@150@
M40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R,"XU," V-C,N
M,34@5&0@*#(P,3<I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,RXP," V-3$N,34@5&0@*$%S<V5T<RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XP," V-3$N,#$@5&0@
M** I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,# N,# @-C4Q+C Q(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,N,# @-C,Y+C Q(%1D("A#=7)R96YT(&%S<V5T
M<SHI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,S$N,# @-C,Y+C Q(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 P+C P(#8S.2XP,2!49" HH"D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#8R-RXP,2!4
M9" H0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<RD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XP," V,C<N,#$@5&0@*"0I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N
M,C4@-C(W+C Q(%1D("@Q-BPP,3DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,# N,# @-C(W+C Q(%1D("@D*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,T+C(U(#8R-RXP
M,2!49" H,C4L-3,W*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3DN,# @-C$U+C Q(%1D("A!8V-O=6YT<R!R96-E:79A8FQE
M+"!N970@;V8@86QL;W=A;F-E<R!O9B D,RPW,#4@:6X@,C Q."!A;F0@)#,L
M-C@X(&EN(#(P,3<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-C N-S4@-C$U+C Q(%1D("@Q-C8L,3(X*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Y+C<U(#8Q-2XP,2!4
M9" H,3<S+#8P,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Y+C P(#8P,RXP,2!49" H4')E<&%I9"!E>'!E;G-E<RD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V.2XW-2 V
M,#,N,#$@5&0@*#8L,C X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,X+C<U(#8P,RXP,2!49" H-2PR.#<I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U.3$N,#$@
M5&0@*$EN<W5R86YC92!R96-O=F5R>2!R96-E:79A8FQE*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Y+C<U(#4Y,2XP,2!4
M9" H-"PQ.#8I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,S@N-S4@-3DQ+C Q(%1D("@S+#0Y-RD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#4W.2XP,2!49" H3W1H
M97(@8W5R<F5N="!A<W-E=',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-CDN-S4@-3<Y+C Q(%1D("@R+#,V-"D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-2XU," U-SDN
M,#$@5&0@*#DV,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S+C P(#4V-RXP,2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#4X+C$X(#4V-RXP,2!49" H;W1A;"!C=7)R96YT(&%S<V5T<RD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,"XW-2 U
M-C<N,#$@5&0@*#$Y-"PY,#4I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,CDN-S4@-38W+C Q(%1D("@R,#@L.#@W*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-34U
M+C Q(%1D("A0<F]P97)T>2!A;F0@97%U:7!M96YT+"!N970I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@-34U+C Q
M(%1D("@Q,RPV,C@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S0N,C4@-34U+C Q(%1D("@Q-"PP.#8I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," U-#,N,#$@5&0@
M*$=O;V1W:6QL*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#8P+C<U(#4T,RXP,2!49" H,3 Q+# V,"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R.2XW-2 U-#,N,#$@5&0@
M*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S0N,C4@-30S+C Q(%1D("@Q
M-RPU.#DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," U,S$N,#$@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M."XS-" U,S$N,#$@5&0@*')A9&4@;F%M97,I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@-3,Q+C Q(%1D("@R,"PT
M,#(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S0N,C4@-3,Q+C Q(%1D("@R-BPW,#(I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,RXP," U,3DN,#$@5&0@*$]T:&5R(&EN
M=&%N9VEB;&4@87-S971S+"!N970I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-C4N,C4@-3$Y+C Q(%1D("@U-2PQ.#(I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N,C4@
M-3$Y+C Q(%1D("@V,"PY-S8I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," U,#<N,#$@5&0@*$YO;BUC=7)R96YT(&1E
M9F5R<F5D('1A>"!A<W-E=',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C4N,C4@-3 W+C Q(%1D("@R,RPW-3 I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N,C4@-3 W
M+C Q(%1D("@R,"PR,3DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,RXP," T.34N,#$@5&0@*$]T:&5R(&YO;BUC=7)R96YT
M(&%S<V5T<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V-2XR-2 T.34N,#$@5&0@*#$X+# W-BD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XR-2 T.34N,#$@5&0@*#$Y
M+#(R."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#0X,RXP,2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#4X
M+C$X(#0X,RXP,2!49" H;W1A;"!A<W-E=',I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,S$N,# @-#@S+C Q(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8P+C<U
M(#0X,RXP,2!49" H-#(W+# P,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P,"XP," T.#,N,#$@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,CDN-S4@-#@S+C Q
M(%1D("@T-C<L-C@W*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,N,# @-#4Y+C$U(%1D("A,:6%B:6QI=&EE<R!A;F0@4W1O
M8VMH;VQD97)S)R!%<75I='DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.3 N,# @-#4Y+C Q(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#0U.2XP,2!4
M9" HH"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#0T-RXP,2!49" H0W5R<F5N="!L:6%B:6QI=&EE<SHI(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.3 N,# @-#0W
M+C Q(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-34Y+C P(#0T-RXP,2!49" HH"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0S-2XP,2!49" H06-C;W5N
M=',@<&%Y86)L92!A;F0@86-C<G5E9"!E>'!E;G-E<RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XP," T,S4N,#$@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-C4N,C4@-#,U+C Q(%1D("@T,RPW-#0I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,# N,# @-#,U+C Q(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,T+C(U(#0S
M-2XP,2!49" H-3 L-3DW*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3DN,# @-#(S+C Q(%1D("A!8V-R=65D(&-O;7!E;G-A
M=&EO;B!A;F0@8F5N969I=',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C4N,C4@-#(S+C Q(%1D("@S,RPS,S(I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N,C4@-#(S
M+C Q(%1D("@S-"PR-S$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U.2XP," T,3$N,#$@5&0@*$-U<G)E;G0@<&]R=&EO;B!O
M9B!L;VYG+71E<FT@9&5B="D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0V.2XW-2 T,3$N,#$@5&0@*#4L,C,U*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,X+C<U(#0Q,2XP
M,2!49" H-BPX-S4I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U.2XP," S.3DN,#$@5&0@*$]T:&5R(&-U<G)E;G0@;&EA8FEL
M:71I97,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-CDN-S4@,SDY+C Q(%1D("@S+# W-2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S."XW-2 S.3DN,#$@5&0@*#(L.#0U
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N
M,# @,S@W+C Q(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N,3@@
M,S@W+C Q(%1D("AO=&%L(&-U<G)E;G0@;&EA8FEL:71I97,I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@,S@W+C Q
M(%1D("@X-2PS.#8I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S0N,C4@,S@W+C Q(%1D("@Y-"PU.#@I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," S-S4N,#$@5&0@
M*$QO;F<M=&5R;2!D96)T+"!L97-S(&-U<G)E;G0@<&]R=&EO;BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-2XR-2 S-S4N
M,#$@5&0@*#<W+#DT-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S-"XR-2 S-S4N,#$@5&0@*#DR+#(U.2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#,V,RXP,2!4
M9" H3&]N9RUT97)M(&%C8W)U960@8VQA:6US*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(U(#,V,RXP,2!49" H,CDL
M,CDY*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,T+C(U(#,V,RXP,2!49" H,C@L-S4W*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,S4Q+C Q(%1D("A#;VYT:6YG
M96YT(&-O;G-I9&5R871I;VXI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-CDN-S4@,S4Q+C Q(%1D("@W+#0P.2D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S."XW-2 S-3$N
M,#$@5&0@*#4L,#@X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,N,# @,S,Y+C Q(%1D("A/=&AE<B!L;VYG+71E<FT@;&EA
M8FEL:71I97,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-CDN-S4@,S,Y+C Q(%1D("@X+#<V-RD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S."XW-2 S,SDN,#$@5&0@*#DL
M,C<V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,N,# @,S(W+C Q(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N
M,3@@,S(W+C Q(%1D("AO=&%L(&QI86)I;&ET:65S*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8P+C<U(#,R-RXP,2!49" H
M,C X+#@P-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4R.2XW-2 S,C<N,#$@5&0@*#(R.2PY-C@I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," S,#,N,#$@5&0@*$-O
M;6UI=&UE;G1S(&%N9"!C;VYT:6YG96YC:65S*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C<Y+C Q(%1D("A3=&]C
M:VAO;&1E<G,G(&5Q=6ET>3HI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.3 N,# @,C<Y+C Q(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#(W.2XP,2!4
M9" HH"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S+C P(#(V-RXP,2!49" HH* @0V]M;6]N('-T;V-KER0P+C P,#$@<&%R
M('9A;'5E.R Q,# L,# P+# P,"!S:&%R97,@875T:&]R:7IE9#L@,S4L-C(U
M+#8Y,B!A;F0@,S4L.#,X+#$P."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#<Q+C P(#(U."XP,2!49" H<VAA<F5S(&ES<W5E
M9"!A;F0@;W5T<W1A;F1I;F<@870@1&5C96UB97*@,S$L(#(P,3@@86YD(#(P
M,3<L(')E<W!E8W1I=F5L>2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0X-2XU," R-3@N,C$@5&0@*#0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-30N-3 @,C4X+C(Q(%1D
M("@T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3DN,# @,C0U+C Q(%1D("A!9&1I=&EO;F%L('!A:60M:6X@8V%P:71A;"D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,"XW
M-2 R-#4N,#$@5&0@*#,P,RPP-#@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,CDN-S4@,C0U+C Q(%1D("@S,#4L,S8R*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @
M,C,S+C Q(%1D("A!8V-U;75L871E9"!O=&AE<B!C;VUP<F5H96YS:79E(&QO
M<W,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-C8N-S4@,C,S+C Q(%1D("A<*#$L-#8R*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#(S,RXP,2!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N-S4@
M,C,S+C Q(%1D("A<*#$L,38V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34Y+C P(#(S,RXP,2!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," R,C$N,#$@
M5&0@*$%C8W5M=6QA=&5D(&1E9FEC:70I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-C(N,C4@,C(Q+C Q(%1D("A<*#@T+# V
M,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M,"XP," R,C$N,#$@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,Q+C(U(#(R,2XP,2!49" H7"@V-RPQ*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-34P+C P(#(R,2XP,2!49" H,2D@5&H@150@
M40IQ(# @," P(')G($)4(#4U-"XU," R,C$N,#$@5&0@*#$I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,# @,C(Q+C Q
M(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#(P.2XP,2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#4X+C$X(#(P.2XP,2!49" H;W1A;"!#<F]S<R!#;W5N=')Y($AE86QT:&-A
M<F4L($EN8RX@<W1O8VMH;VQD97)S)R!E<75I='DI(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C N-S4@,C Y+C Q(%1D("@R
M,3<L-3(X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3(Y+C<U(#(P.2XP,2!49" H,C,W+# X.2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#$Y-RXP,2!49" H3F]N
M8V]N=')O;&QI;F<@:6YT97)E<W0@:6X@<W5B<VED:6%R>2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-BXU," Q.3<N,#$@
M5&0@*#8W,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4T-2XU," Q.3<N,#$@5&0@*#8S,"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#$X-2XP,2!49" H5"D@5&H@
M150@40IQ(# @," P(')G($)4(#4X+C$X(#$X-2XP,2!49" H;W1A;"!S=&]C
M:VAO;&1E<G,G(&5Q=6ET>2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0V,"XW-2 Q.#4N,#$@5&0@*#(Q."PQ.3@I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,CDN-S4@,3@U
M+C Q(%1D("@R,S<L-S$Y*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,N,# @,3<S+C Q(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3<N.#<@,3<S+C Q(%1D("AO=&%L(&QI86)I;&ET:65S(&%N
M9"!S=&]C:VAO;&1E<G,G(&5Q=6ET>2D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0S,2XP," Q-S,N,#$@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C N-S4@,3<S
M+C Q(%1D("@T,C<L,# S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 P+C P(#$W,RXP,2!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R.2XW-2 Q-S,N,#$@5&0@
M*#0V-RPV.#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-2XU-2 Q-#8N,C4@5&0@*%-E
M92!A8V-O;7!A;GEI;F<@;F]T97,I(%1J($54(%$*0E0@+T8Q(#@N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-30N-#$@,30V+C(U(%1D("@N*2!4:B!%5"!1
M"F5N9'-T<F5A;0IE;F1O8FH*,3 Y(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A
M<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S
M;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3$P(# @4CX^"F5N
M9&]B:@HQ,3 @,"!O8FH*/#PO3&5N9W1H(#(R-S S/CX*<W1R96%M"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-RXX," S,2XV,"!49" H
M1BT@-"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R,3,N.#4@-S,P+C(U(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R.3(N-C@@-S,P+C(U(%1D("A9*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,CDY+C4S(#<S,"XR-2!49" H($A%04PI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,CDN-#4@-S,P+C(U(%1D("A42$-!4D4L($E.0RXI(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@Y+C$U
M(#<Q."XR-2!49" H0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C0X+CDW(#<Q."XR-2!49" H5$5$(%-4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C@S+C4R(#<Q."XR-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4
M(#(Y,"XP," W,3@N,C4@5&0@*%1%345.5%,@3T8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-30N.3(@-S$X+C(U(%1D("@@3U!%4D$I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.3$N-C@@-S$X+C(U(%1D("A424].4RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,#<N.34@-S V+C(U
M(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S+"!E>&-E<'0@<&5R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S4S+C8R(#<P-BXR-2!49" H('-H87(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-S0N.#,@-S V+C(U(%1D("AE(&1A=&%<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,"XP," V.30N,C4@5&0@** I(%1J($54(%$*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-C4U+C<U(#,S,"XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,X,"XU," V-34N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @-C4U
M+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @-C4U+C<U(#4X+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 P+C4P(#8U-2XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 T+C4P(#8U
M-2XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#8R-RXW-2 S,S N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS.# N-3 @-C(W+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X+C4P
M(#8R-RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P(#8R-RXW-2 U."XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P,"XU," V,C<N-S4@-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P-"XU
M," V,C<N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," U.3DN-S4@,S,P+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S@P+C4P(#4Y.2XW-2 U."XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S
M."XU," U.3DN-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU," U.3DN-S4@-3@N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,# N-3 @-3DY+C<U(#0N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,#0N-3 @-3DY+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-3<Q+C<U(#,S
M,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,X,"XU," U-S$N-S4@-3@N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S@N-3 @-3<Q+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @-3<Q+C<U
M(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 P+C4P(#4W,2XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 T+C4P(#4W,2XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#4T,RXW
M-2 S,S N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS.# N-3 @-30S+C<U(#4X+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#,X+C4P(#4T,RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P(#4T
M,RXW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,"XU," U-#,N-S4@-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P-"XU," U-#,N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," U
M,34N-S4@,S,P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@P+C4P(#4Q-2XW-2 U."XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0S."XU," U,34N-S4@-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU
M," U,34N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,# N-3 @-3$U+C<U(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,#0N-3 @-3$U+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N
M-3 @-#@W+C<U(#,S,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,"XU," T.#<N-S4@-3@N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,S@N-3 @-#@W+C<U(#0N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-#(N-3 @-#@W+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 P+C4P(#0X-RXW-2 T
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3 T+C4P(#0X-RXW-2 U."XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C4P(#0U.2XW-2 S,S N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.# N-3 @-#4Y+C<U
M(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#,X+C4P(#0U.2XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#0R+C4P(#0U.2XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,"XU," T-3DN
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P-"XU," T-3DN-S4@-3@N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XU," T,S$N-S4@,S,P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@P+C4P(#0S
M,2XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S."XU," T,S$N-S4@-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0T,BXU," T,S$N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,# N-3 @
M-#,Q+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#0N-3 @-#,Q+C<U(#4X+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 N-3 @-# S+C<U(#,S,"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,"XU
M," T,#,N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @-# S+C<U(#0N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-#(N-3 @-# S+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 P
M+C4P(#0P,RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 T+C4P(#0P,RXW-2 U."XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C4P(#,W-2XW-2 S,S N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M.# N-3 @,S<U+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X+C4P(#,W-2XW-2 T
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#0R+C4P(#,W-2XW-2 U."XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P,"XU," S-S4N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P-"XU," S-S4N-S4@
M-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XU," S-#@N-S4@,S,P+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S@P+C4P(#,T."XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S."XU," S-#@N
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU," S-#@N-S4@-3@N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,# N-3 @,S0X+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#0N-3 @,S0X
M+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @,S(P+C<U(#,S,"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,X,"XU," S,C N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @
M,S(P+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @,S(P+C<U(#4X+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 P+C4P(#,R,"XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 T+C4P
M(#,R,"XW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#(Y,BXW-2 S,S N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS.# N-3 @,CDR+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X
M+C4P(#(Y,BXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P(#(Y,BXW-2 U."XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P,"XU," R.3(N-S4@-"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M-"XU," R.3(N-S4@-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," R-C0N-S4@,S,P
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S@P+C4P(#(V-"XW-2 U."XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0S."XU," R-C0N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU," R-C0N-S4@
M-3@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,# N-3 @,C8T+C<U(#0N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,#0N-3 @,C8T+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @,C,V+C<U
M(#,S,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,X,"XU," R,S8N-S4@-3@N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,S@N-3 @,C,V+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @,C,V
M+C<U(#4X+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 P+C4P(#(S-BXW-2 T+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 T+C4P(#(S-BXW-2 U."XP," M,30N,# @<F4@9@HO1U,P(&=S
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,X,"XU(#8V.2XW-2!M"C0S."XU(#8V.2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@
M-C8Y+C<U(&T*-#0R+C4@-C8Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N-2 V-CDN-S4@;0HU
M,# N-2 V-CDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C4P,"XU(#8V.2XW-2!M"C4P-"XU(#8V.2XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 T+C4@-C8Y+C<U(&T*-38R+C4@-C8Y+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.# N-2 V-CDN-S4@;0HT,S@N-2 V-CDN-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X,"XU(#8U-2XW
M-2!M"C0S."XU(#8U-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0R+C4@-C8Y+C<U(&T*-3 P+C4@
M-C8Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-#(N-2 V-34N-S4@;0HU,# N-2 V-34N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C4P-"XU(#8V.2XW-2!M"C4V,BXU(#8V.2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@
M-C4U+C<U(&T*-38R+C4@-C4U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.# N-2 V-34N-S4@;0HT
M,S@N-2 V-34N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0T,BXU(#8U-2XW-2!M"C4P,"XU(#8U-2XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 T+C4@-C4U+C<U(&T*-38R+C4@-C4U+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.# N-2 U,#$N-S4@;0HT,S@N-2 U,#$N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T,BXU(#4P,2XW
M-2!M"C4P,"XU(#4P,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@-3 Q+C<U(&T*-38R+C4@
M-3 Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS.# N-2 T.#<N-S4@;0HT,S@N-2 T.#<N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0T,BXU(#0X-RXW-2!M"C4P,"XU(#0X-RXW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@
M-#@W+C<U(&T*-38R+C4@-#@W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.# N-2 T,#,N-S4@;0HT
M,S@N-2 T,#,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0T,BXU(#0P,RXW-2!M"C4P,"XU(#0P,RXW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 T+C4@-# S+C<U(&T*-38R+C4@-# S+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.# N-2 S-S4N-S4@;0HT,S@N-2 S-S4N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T,BXU(#,W-2XW
M-2!M"C4P,"XU(#,W-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@,S<U+C<U(&T*-38R+C4@
M,S<U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS.# N-2 S-#@N-S4@;0HT,S@N-2 S-#@N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,X,"XU(#,S-2XW-2!M"C0S."XU(#,S-2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@P+C4@
M,S,S+C<U(&T*-#,X+C4@,S,S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N-2 S-#@N-S4@;0HU
M,# N-2 S-#@N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0T,BXU(#,S-2XW-2!M"C4P,"XU(#,S-2XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#0R+C4@,S,S+C<U(&T*-3 P+C4@,S,S+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU
M,#0N-2 S-#@N-S4@;0HU-C(N-2 S-#@N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P-"XU(#,S-2XW
M-2!M"C4V,BXU(#,S-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@,S,S+C<U(&T*-38R+C4@
M,S,S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS.# N-2 S,#<N-S4@;0HT,S@N-2 S,#<N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,X,"XU(#,P-2XW-2!M"C0S."XU(#,P-2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0R+C4@
M,S W+C<U(&T*-3 P+C4@,S W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N-2 S,#4N-S4@;0HU
M,# N-2 S,#4N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C4P-"XU(#,P-RXW-2!M"C4V,BXU(#,P-RXW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 T+C4@,S U+C<U(&T*-38R+C4@,S U+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.# N-2 R-SDN-S4@;0HT,S@N-2 R-SDN-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X,"XU(#(W-RXW
M-2!M"C0S."XU(#(W-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0R+C4@,C<Y+C<U(&T*-3 P+C4@
M,C<Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-#(N-2 R-S<N-S4@;0HU,# N-2 R-S<N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C4P-"XU(#(W.2XW-2!M"C4V,BXU(#(W.2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@
M,C<W+C<U(&T*-38R+C4@,C<W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.# N-2 R,S<N-S4@;0HT
M,S@N-2 R,S<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,X,"XU(#(S-2XW-2!M"C0S."XU(#(S-2XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#0R+C4@,C,W+C<U(&T*-3 P+C4@,C,W+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M-#(N-2 R,S4N-S4@;0HU,# N-2 R,S4N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P-"XU(#(S-RXW
M-2!M"C4V,BXU(#(S-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 T+C4@,C,U+C<U(&T*-38R+C4@
M,C,U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS.# N-2 R,C,N-S4@;0HT,S@N-2 R,C,N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,X,"XU(#(R,2XW-2!M"C0S."XU(#(R,2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0R+C4@
M,C(S+C<U(&T*-3 P+C4@,C(S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N-2 R,C$N-S4@;0HU
M,# N-2 R,C$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C4P-"XU(#(R,RXW-2!M"C4V,BXU(#(R,RXW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 T+C4@,C(Q+C<U(&T*-38R+C4@,C(Q+C<U(&P*<PI"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V-S0N,S(@5&0@
M** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$U+C8P(#8W-"XT,R!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#0R
M,BXR-R V-S0N-#,@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0S
M-2XU," V-S0N-#,@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @
M," P(')G($)4(#4Q,2XT,B V-S0N-#,@5&0@** S,2PI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C8P+C,R(%1D
M("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,Y.2XP," V-C N-#,@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8Q+C P(#8V,"XT,R!49" H,C Q-RD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C,N
M,# @-C8P+C0S(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S+C P(#8S,BXS,B!49" H4F5V96YU92!F<F]M
M('-E<G9I8V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,X,RXP," V,S(N,S(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-# R+C$U(#8S,BXS,B!49" H.#$V
M+#0X-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-#4N,# @-C,R+C,R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V-"XQ-2 V,S(N,S(@5&0@*#@V-2PP-#@I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 W
M+C P(#8S,BXS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,C8N,34@-C,R+C,R(%1D("@X,S,L-3,W*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#8Q
M."XS,B!49" H3W!E<F%T:6YG(&5X<&5N<V5S.BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," V,#0N,S(@5&0@*$1I
M<F5C="!O<&5R871I;F<@97AP96YS97,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-# R+C$U(#8P-"XS,B!49" H-C V+#DR
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-C0N,34@-C T+C,R(%1D("@V,S8L-#8R*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R-BXQ-2 V,#0N,S(@5&0@*#8Q*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3,V+C$U(#8P-"XS,B!49" H,2PX,#(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN
M,# @-3DP+C,R(%1D("A396QL:6YG+"!G96YE<F%L+"!A;F0@861M:6YI<W1R
M871I=F4@97AP96YS97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-# R+C$U(#4Y,"XS,B!49" H,3@P+#(S,"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C0N,34@-3DP
M+C,R(%1D("@Q.#<L-#,U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R-BXQ-2 U.3 N,S(@5&0@*#$W.2PX,C I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-3<V
M+C,R(%1D("A"860@9&5B="!E>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Q,BXQ-2 U-S8N,S(@5&0@*#(L,C T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W
M-"XQ-2 U-S8N,S(@5&0@*#$L.#(X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T,RXV-2 U-S8N,S(@5&0@*#4Y,RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U
M-C(N,S(@5&0@*$1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXQ-2 U
M-C(N,S(@5&0@*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3(N,34@-38R
M+C,R(%1D("@Q+#<X,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-CDN,34@-38R+C,R(%1D("@Q,"PQ-S0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C$U(#4V,BXS
M,B!49" H.2PQ.#(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3DN,# @-30X+C,R(%1D("A!8W%U:7-I=&EO;BUR96QA=&5D
M(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,3(N,34@-30X+C,R(%1D("@R+#4U
M-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#8N-C4@-30X+C,R(%1D("@T-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-#,N-C4@-30X+C,R(%1D("@X,30I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-3,T
M+C,R(%1D("A!8W%U:7-I=&EO;B!A;F0@:6YT96=R871I;VX@8V]S=',I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Y+C8U
M(#4S-"XS,B!49" H-#DQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0W-"XQ-2 U,S0N,S(@5&0@*#$L.3<U*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T."XV-2 U,S0N
M,S(@5&0@*#<X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Y+C P(#4R,"XS,B!49" H4F5S=')U8W1U<FEN9R!C;W-T<RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3(N
M,34@-3(P+C,R(%1D("@R+#<U."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-S0N,34@-3(P+C,R(%1D("@Q+# R-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#,N-C4@
M-3(P+C,R(%1D("@W-3,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3DN,# @-3 V+C,R(%1D("A);7!A:7)M96YT(&-H87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C4N,C<@-3 V+C,R(%1D("AG97,I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W
M+C$U(#4P-BXS,B!49" H,C(L-#(S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V.2XQ-2 U,#8N,S(@5&0@*#$T+#,U-BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N
M,34@-3 V+C,R(%1D("@R-"PS,2D@5&H@150@40IQ(# @," P(')G($)4(#4U
M,RXV-2 U,#8N,S(@5&0@*#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-C4N,# @-#DR+C,R(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-S N-#$@-#DR+C,R(%1D("AO=&%L(&]P97)A=&EN9R!E
M>'!E;G-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,#(N,34@-#DR+C,R(%1D("@X,CDL,S8T*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-"XQ-2 T.3(N,S(@5&0@
M*#@U,RPS,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(V+C$U(#0Y,BXS,B!49" H.#(W+#,U,RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," T-S@N,S(@5&0@
M*%PH3&]S<UPI(&EN8V]M92!F<F]M(&]P97)A=&EO;G,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# S+C@P(#0W."XS-R!4
M9" H7"@Q,BPX.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#,T+C8U(#0W."XS,B!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Y+C$U(#0W."XS,B!49" H
M,2D@5&H@150@40IQ(# @," P(')G($)4(#0W-"XQ-2 T-S@N,S(@5&0@*#$L
M-S0X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S-BXQ-2 T-S@N,S(@5&0@*#8L,3@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#0V-"XS,B!49" H3W1H97(@
M97AP96YS97,@7"AI;F-O;65<*3HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3DN,# @-#4P+C,R(%1D("A);G1E<F5S="!E
M>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Q,BXQ-2 T-3 N,S(@5&0@*#4L-C4T*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-"XQ-2 T-3 N,S(@5&0@*#0L
M,C$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S-BXQ-2 T-3 N,S(@5&0@*#8L,3 V*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0S-BXS,B!49" H1V%I;B!O
M;B!D97)I=F%T:79E(&QI86)I;&ET>2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,C0N-C4@-#,V+C,R(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,"XX," T
M,S8N,S<@5&0@*%PH,2PU.#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DV+C8U(#0S-BXS,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,R+C@P(#0S-BXS
M-R!49" H7"@U+#@P-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U-3@N-C4@-#,V+C,R(%1D("A<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," T,C(N,S(@5&0@
M*$QO<W,@;VX@96%R;'D@97AT:6YG=6ES:&UE;G0@;V8@9&5B="D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C0N-C4@-#(R
M+C,R(%1D("@W.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-S0N,34@-#(R+C,R(%1D("@T+#DV.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N,34@-#(R+C,R(%1D
M("@Q+#4V."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U.2XP," T,#@N,S(@5&0@*$]T:&5R(&EN8V]M92P@;F5T*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-BXS," T
M,#@N,S<@5&0@*%PH-#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0S-"XV-2 T,#@N,S(@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W."XS," T,#@N,S<@
M5&0@*%PH,34U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y-BXV-2 T,#@N,S(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,"XS," T,#@N,S<@5&0@*%PH
M,C,P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4U."XV-2 T,#@N,S(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S+C P(#,Y-"XS,B!49" H7"A,;W-S7"D@
M:6YC;VUE(&)E9F]R92!I;F-O;64@=&%X97,I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-# S+C@P(#,Y-"XS-R!49" H7"@Q
M."PQ.34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#,T+C8U(#,Y-"XS,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<T+C$U(#,Y-"XS,B!49" H-"PS,#$I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V
M+C$U(#,Y-"XS,B!49" H-"PU-#4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @,S@P+C,R(%1D("A);F-O;64@=&%X
M(&)E;F5F:70I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# X+C@P(#,X,"XS-R!49" H7"@R+#0W."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S0N-C4@,S@P+C,R(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-C4N.# @,S@P+C,W(%1D("A<*#,T+#4P,2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.38N-C4@,S@P+C,R(%1D("A<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S(N.# @,S@P+C,W(%1D("A<*#0L,3@V*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4U."XV-2 S.# N,S(@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P
M(#,V-BXS,B!49" H0V]N<V]L:61A=&5D(&YE="!<*&QO<W-<*2!I;F-O;64I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# S
M+C@P(#,V-BXS-R!49" H7"@Q-2PW,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#,T+C8U(#,V-BXS,B!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Y+C$U
M(#,V-BXS,B!49" H,S@L.# R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S-BXQ-2 S-C8N,S(@5&0@*#@L-S,Q*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#,U
M,BXS,B!49" H3&5S<SH@3F5T(&EN8V]M92!A='1R:6)U=&%B;&4@=&\@;F]N
M8V]N=')O;&QI;F<@:6YT97)E<W0@:6X@<W5B<VED:6%R>2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3(N,34@,S4R+C,R
M(%1D("@Q+#(S-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-S0N,34@,S4R+C,R(%1D("@Q+#(X.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#,N-C4@,S4R+C,R(%1D
M("@W-C0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,N,# @,S,Y+C,R(%1D("A.970@7"AL;W-S7"D@:6YC;VUE(&%T=')I
M8G5T86)L92!T;R!C;VUM;VX@<VAA<F5H;VQD97)S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X,RXP," S,SDN,S(@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-# S+C@P(#,S.2XS-R!49" H7"@Q-BPY-3$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#,T+C8U(#,S.2XS,B!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0U
M+C P(#,S.2XS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-CDN,34@,S,Y+C,R(%1D("@S-RPU,3,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 W+C P(#,S
M.2XS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S8N,34@,S,Y+C,R(%1D("@W+#DV-RD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," S,3$N,S(@5&0@
M*$YE="!<*&QO<W-<*2!I;F-O;64@<&5R('-H87)E(&%T=')I8G5T86)L92!T
M;R!C;VUM;VX@<VAA<F5H;VQD97)S("T@0F%S:6,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@S+C P(#,Q,2XS,B!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,3,N.# @,S$Q+C,W(%1D("A<*# N-#@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#,T+C8U(#,Q,2XS,B!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0U+C P
M(#,Q,2XS,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-SDN,34@,S$Q+C,R(%1D("@Q+C W*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P-RXP," S,3$N,S(@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-30Q+C$U(#,Q,2XS,B!49" H,"XR-2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," R.#,N,S(@5&0@*$YE="!<
M*&QO<W-<*2!I;F-O;64@<&5R('-H87)E(&%T=')I8G5T86)L92!T;R!C;VUM
M;VX@<VAA<F5H;VQD97)S("T@1&EL=71E9"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S.#,N,# @,C@S+C,R(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,RXX
M," R.#,N,S<@5&0@*%PH,"XT."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,S0N-C4@,C@S+C,R(%1D("A<*2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#4N,# @,C@S
M+C,R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0W.2XQ-2 R.#,N,S(@5&0@*#$N,#$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 W+C P(#(X,RXS,B!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-#$N,34@,C@S+C,R(%1D("@P+C$U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S+C P(#(U-2XS,B!49" H5RD@5&H@150@
M40IQ(# @," P(')G($)4(#8R+C T(#(U-2XS,B!49" H96EG:'1E9"!A=F5R
M86=E(&-O;6UO;B!S:&%R97,@;W5T<W1A;F1I;F<Z*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#(T,2XS,B!49" H
M0F%S:6,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# W+C$U(#(T,2XS,B!49" H,S4L-C4W*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V.2XQ-2 R-#$N,S(@5&0@*#,U
M+# Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S$N,34@,C0Q+C,R(%1D("@S,BPQ,S(I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,C(W+C,R(%1D("A$:6QU
M=&5D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0P-RXQ-2 R,C<N,S(@5&0@*#,U+#8U-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN,34@,C(W+C,R(%1D("@S-BPQ
M-C8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,Q+C$U(#(R-RXS,B!49" H,S8L,C0V*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," R,3$N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C4U+C,P(#$Y.2XR-2!49" H4V5E(&%C8V]M<&%N>6EN
M9R!N;W1E<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,3$@,"!O8FH*
M/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q
M,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT
M96YT<R Q,3(@,"!2/CX*96YD;V)J"C$Q,B P(&]B:@H\/"],96YG=&@@,3(X
M-#D^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,CDW+C@P(#,Q+C8P(%1D("A&+2 U*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W,S N,C4@5&0@*$-23U-3($-/
M54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W,S N,C4@5&0@
M*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S,P+C(U(%1D("@@
M2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W,S N,C4@5&0@
M*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q,S<N-# @-S$X+C(U(%1D("A#3TY33TQ)1$$I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.3<N,C(@-S$X+C(U(%1D("A4140@4U0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,S$N-S@@-S$X+C(U(%1D("A!*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,X+C(U(#<Q."XR-2!49" H5$5-14Y44R!/
M1BD@5&H@150@40IQ(# @," P(')G($)4(#,P,RXQ-R W,3@N,C4@5&0@*"!#
M3TU04D5(14Y3259%(%PH3$]34UPI($E.0T]-12D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-34N.34@-S V+C(U(%1D("A<
M*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-CDT+C(U(%1D("B@*2!4:B!%
M5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P
M(#8U,RXW-2 S,C0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S0N-3 @-C4S+C<U(#8P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#,T+C4P(#8U,RXW-2 T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X
M+C4P(#8U,RXW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y."XU," V-3,N-S4@-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P,BXU," V-3,N-S4@-C N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,"XU," V,C,N-S4@,S(T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<T+C4P(#8R,RXW-2 V
M,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0S-"XU," V,C,N-S4@-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0S."XU," V,C,N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3@N-3 @-C(S+C<U
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,#(N-3 @-C(S+C<U(#8P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 N-3 @-3DS+C<U(#,R-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W-"XU," U.3,N
M-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S0N-3 @-3DS+C<U(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,S@N-3 @-3DS+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DX+C4P(#4Y
M,RXW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 R+C4P(#4Y,RXW-2 V,"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C4P(#4V,RXW-2 S,C0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S0N-3 @
M-38S+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,T+C4P(#4V,RXW-2 T+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#,X+C4P(#4V,RXW-2 V,"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y."XU
M," U-C,N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,BXU," U-C,N-S4@-C N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,"XU," U,S,N-S4@,S(T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<T
M+C4P(#4S,RXW-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-"XU," U,S,N-S4@-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0S."XU," U,S,N-S4@-C N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.3@N-3 @-3,S+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#(N-3 @-3,S+C<U(#8P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3 N-3 @-3 S+C<U(#,R-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,W-"XU," U,#,N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S0N-3 @-3 S+C<U
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S@N-3 @-3 S+C<U(#8P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DX+C4P(#4P,RXW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 R+C4P(#4P,RXW
M-2 V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0W,RXW-2 S,C0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS-S0N-3 @-#<S+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,T+C4P(#0W
M,RXW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#,X+C4P(#0W,RXW-2 V,"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0Y."XU," T-S,N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P,BXU," T
M-S,N-S4@-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," T-#,N-S4@,S(T+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S<T+C4P(#0T,RXW-2 V,"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-"XU
M," T-#,N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S."XU," T-#,N-S4@-C N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.3@N-3 @-#0S+C<U(#0N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#(N
M-3 @-#0S+C<U(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,T+C4@
M-C8X+C<U(&T*-#,X+C4@-C8X+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3@N-2 V-C@N-S4@;0HU
M,#(N-2 V-C@N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,W-"XU(#8V."XW-2!M"C0S-"XU(#8V."XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S<T+C4@-C4S+C<U(&T*-#,T+C4@-C4S+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M,S@N-2 V-C@N-S4@;0HT.3@N-2 V-C@N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0S."XU(#8U,RXW
M-2!M"C0Y."XU(#8U,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 R+C4@-C8X+C<U(&T*-38R+C4@
M-C8X+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HU,#(N-2 V-3,N-S4@;0HU-C(N-2 V-3,N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,W-"XU(#4V,RXW-2!M"C0S-"XU(#4V,RXW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@
M-38S+C<U(&T*-#DX+C4@-38S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N-2 U-C,N-S4@;0HU
M-C(N-2 U-C,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,W-"XU(#0X."XW-2!M"C0S-"XU(#0X."XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#,X+C4@-#@X+C<U(&T*-#DX+C4@-#@X+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU
M,#(N-2 T.#@N-S4@;0HU-C(N-2 T.#@N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W-"XU(#0W,RXW
M-2!M"C0S-"XU(#0W,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@-#<S+C<U(&T*-#DX+C4@
M-#<S+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HU,#(N-2 T-S,N-S4@;0HU-C(N-2 T-S,N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,W-"XU(#0U."XW-2!M"C0S-"XU(#0U."XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@
M-#4X+C<U(&T*-#DX+C4@-#4X+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N-2 T-3@N-S4@;0HU
M-C(N-2 T-3@N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,W-"XU(#0R."XW-2!M"C0S-"XU(#0R."XW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S<T+C4@-#$T+C<U(&T*-#,T+C4@-#$T+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M-S0N-2 T,3(N-S4@;0HT,S0N-2 T,3(N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0S."XU(#0R."XW
M-2!M"C0Y."XU(#0R."XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X+C4@-#$T+C<U(&T*-#DX+C4@
M-#$T+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT,S@N-2 T,3(N-S4@;0HT.3@N-2 T,3(N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C4P,BXU(#0R."XW-2!M"C4V,BXU(#0R."XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 R+C4@
M-#$T+C<U(&T*-38R+C4@-#$T+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#(N-2 T,3(N-S4@;0HU
M-C(N-2 T,3(N-S4@; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#8W,RXT,B!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,3(N-C @-C<S+C0S(%1D("A9*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#$Y+C(W(#8W,RXT,R!49" H96%R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#,R+C4P(#8W,RXT,R!49" H($5N9&5D($1E
M8V5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 X+C0R(#8W,RXT,R!4
M9" HH#,Q+"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,RXP," V-3@N-#(@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDT+C P(#8U."XT,R!49" H,C Q."D@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3@N
M,# @-C4X+C0S(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R,BXP," V-3@N-#,@5&0@*#(P,38I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4S+C P(#8U,"XS-2 Q,C0N,34@+3DN,#D@<F4@9@HO
M1U,P(&=S"G$@," P(# @<F<@0E0@-3,N,# @-C0S+C0R(%1D("A#;VYS;VQI
M9&%T960@;F5T(%PH;&]S<UPI(&EN8V]M92D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S-S<N,# @-C0S+C0R(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y.2XX
M," V-#,N-#<@5&0@*%PH,34L-S$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0S,"XV-2 V-#,N-#(@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XP," V
M-#,N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#8W+C$U(#8T,RXT,B!49" H,S@L.# R*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P-2XP," V-#,N-#(@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,V+C$U(#8T,RXT,B!49" H."PW,S$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C$S+C0R(%1D("A/=&AE
M<B!C;VUP<F5H96YS:79E(%PH;&]S<UPI(&EN8V]M92P@8F5F;W)E(&EN8V]M
M92!T87@Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0S,2XP," V,3,N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DU+C P(#8Q,RXT,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,# @
M-C$S+C0R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4Y+C P(#4Y."XT,B!49" H56YR96%L:7IE9"!F;W)E:6=N
M(&-U<G)E;F-Y('1R86YS;&%T:6]N(%PH;&]S<UPI(&=A:6XI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$R+C,P(#4Y."XT
M-R!49" H7"@Q-3,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#,P+C8U(#4Y."XT,B!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T+C8U(#4Y."XT,B!49" H
M-S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-30U+C,P(#4Y."XT-R!49" H7"@S-"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U-3@N-C4@-3DX+C0R(%1D("A<*2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U
M.#,N-#(@5&0@*%5N<F5A;&EZ960@;&]S<R!O;B!I;G1E<F5S="!R871E(&-O
M;G1R86-T<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,3(N,S @-3@S+C0W(%1D("A<*#0R,"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N-C4@-3@S+C0R(%1D("A<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#0N-C4@-3@S+C0R(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4T."XV-2 U.#,N-#(@5&0@*)<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-38X+C0R
M(%1D("A296-L87-S:69I8V%T:6]N(&%D:G5S=&UE;G0@=&\@:6YT97)E<W0@
M97AP96YS92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,34N-C4@-38X+C0R(%1D("@Q.#8I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T+C8U(#4V."XT,B!49" HERD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#@N
M-C4@-38X+C0R(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q,BXS," U-3,N-#<@5&0@*%PH,S@W*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XV-2 U-3,N
M-#(@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0X-"XV-2 U-3,N-#(@5&0@*#<U*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-2XS," U-3,N-#<@5&0@*%PH
M,S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-34X+C8U(#4U,RXT,B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,N,# @-3,X+C0R(%1D("A4*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3@N-S8@-3,X+C0R(%1D("AA>&5S(&]N(&]T:&5R
M(&-O;7!R96AE;G-I=F4@7"AL;W-S7"D@:6YC;VUE.BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U,C,N-#(@5&0@
M*$EN8V]M92!T87@@8F5N969I="!R96QA=&5D('1O(&9O<F5I9VX@8W5R<F5N
M8WD@=')A;G-L871I;VX@861J=7-T;65N=',I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#$W+C,P(#4R,RXT-R!49" H7"@S
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,S N-C4@-3(S+C0R(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.#0N-C4@-3(S+C0R(%1D("B7*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T."XV-2 U,C,N
M-#(@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3DN,# @-3 X+C0R(%1D("A);F-O;64@=&%X(&)E;F5F:70@<F5L
M871E9"!T;R!U;G)E86QI>F5D(&QO<W,@;VX@:6YT97)E<W0@<F%T92!C;VYT
M<F%C=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#$R+C,P(#4P."XT-R!49" H7"@Q,#<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#,P+C8U(#4P."XT,B!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T
M+C8U(#4P."XT,B!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#@N-C4@-3 X+C0R(%1D("B7*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0Y,RXT,B!4
M9" H26YC;VUE('1A>"!E>'!E;G-E(')E;&%T960@=&\@<F5C;&%S<VEF:6-A
M=&EO;B!A9&IU<W1M96YT('1O(&EN=&5R97-T(&5X<&5N<V4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(P+C8U(#0Y,RXT
M,B!49" H-#@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#@T+C8U(#0Y,RXT,B!49" HERD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-#@N-C4@-#DS+C0R(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-RXS
M," T-S@N-#<@5&0@*%PH.3 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#,P+C8U(#0W."XT,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T+C8U(#0W."XT
M,B!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-#@N-C4@-#<X+C0R(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#0V,RXT,B!49" H3W1H97(@
M8V]M<')E:&5N<VEV92!<*&QO<W-<*2!I;F-O;64L(&YE="!O9B!T87@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$R+C,P
M(#0V,RXT-R!49" H7"@R.3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#,P+C8U(#0V,RXT,B!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T+C8U(#0V,RXT
M,B!49" H-S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-30U+C,P(#0V,RXT-R!49" H7"@S-"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3@N-C4@-#8S+C0R(%1D("A<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,RXP," T-#@N-#(@5&0@*$-O;7!R96AE;G-I=F4@7"AL;W-S7"D@:6YC;VUE
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y
M.2XX," T-#@N-#<@5&0@*%PH,38L,#$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XV-2 T-#@N-#(@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-RXQ
M-2 T-#@N-#(@5&0@*#,X+#@W-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S8N,34@-#0X+C0R(%1D("@X+#8Y-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," T
M,S,N-#(@5&0@*$QE<W,Z($YE="!I;F-O;64@871T<FEB=71A8FQE('1O(&YO
M;F-O;G1R;VQL:6YG(&EN=&5R97-T(&EN('-U8G-I9&EA<GDI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# X+C$U(#0S,RXT
M,B!49" H,2PR,S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#<R+C$U(#0S,RXT,B!49" H,2PR.#DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C8U(#0S,RXT,B!4
M9" H-S8T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#0Q."XT,B!49" H0V]M<')E:&5N<VEV92!<*&QO<W-<*2!I
M;F-O;64@871T<FEB=71A8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<W+C P
M(#0Q."XT,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S.3DN.# @-#$X+C0W(%1D("A<*#$W+#(T."D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N-C4@-#$X
M+C0R(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-#$N,# @-#$X+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-RXQ-2 T,3@N-#(@5&0@*#,W
M+#4X."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,#4N,# @-#$X+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S-BXQ-2 T,3@N-#(@5&0@*#<L.3,S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," T,#(N,C4@5&0@** I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4U+C,P(#,Y,"XR-2!4
M9" H4V5E(&%C8V]M<&%N>6EN9R!N;W1E<RXI(%1J($54(%$*96YD<W1R96%M
M"F5N9&]B:@HQ,3,@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q,30@,"!2/CX*96YD;V)J"C$Q-" P
M(&]B:@H\/"],96YG=&@@-# Q,#@^/@IS=')E86T*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,CDW+C@P(#,S+C8P(%1D("A&+2 V*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W
M,C@N,C4@5&0@*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4
M(#(Y,BXV." W,C@N,C4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.3DN-3,@-S(X+C(U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4
M(#,R.2XT-2 W,C@N,C4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-3<N.3 @-S$V+C(U(%1D
M("A#3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3<N-S(@-S$V
M+C(U(%1D("A4140@4U0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3(N,C@@
M-S$V+C(U(%1D("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4X+C<U(#<Q
M-BXR-2!49" H5$5-14Y44R!/1BD@5&H@150@40IQ(# @," P(')G($)4(#,R
M,RXV-R W,38N,C4@5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4(#,S
M."XR,B W,38N,C4@5&0@*$]#2TA/3$1%4E.2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#$R+C0Y(#<Q-BXR-2!49" H($5154E462D@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-34N.34@-S T+C(U(%1D
M("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S8N,# @-CDR+C(U(%1D("B@*2!4
M:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,V
M+C4P(#8S,BXW-2 Q,S4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHQ-S$N-3 @-C,R+C<U(#0P
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,C$Q+C4P(#8S,BXW-2 T+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,C$U+C4P(#8S,BXW-2 T,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U-2XU," V,S(N-S4@
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C(U.2XU," V,S(N-S4@-#@N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS,#<N-3 @-C,R+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3$N-3 @-C,R+C<U
M(#8W+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S<X+C4P(#8S,BXW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S@R+C4P(#8S,BXW-2 V,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU," V,S(N
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0T-BXU," V,S(N-S4@-C8N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,3(N-3 @-C,R+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,38N-3 @-C,R
M+C<U(#8P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S8N-3 @-C T+C<U(#$S-2XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C$W,2XU," V,#0N-S4@-# N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,3$N-3 @
M-C T+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,34N-3 @-C T+C<U(#0P+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,C4U+C4P(#8P-"XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C4Y+C4P
M(#8P-"XW-2 T."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,P-RXU," V,#0N-S4@-"XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,Q,2XU," V,#0N-S4@-C<N,# @+3$T+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S@N
M-3 @-C T+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#(N-3 @-C T+C<U(#8P+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#0R+C4P(#8P-"XW-2 T+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0V
M+C4P(#8P-"XW-2 V-BXP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,BXU," V,#0N-S4@-"XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4Q-BXU," V,#0N-S4@-C N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M-BXU," U-C<N-S4@,3,U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,3<Q+C4P(#4V-RXW-2 T
M,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C(Q,2XU," U-C<N-S4@-"XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C(Q-2XU," U-C<N-S4@-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-34N-3 @-38W+C<U
M(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHR-3DN-3 @-38W+C<U(#0X+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S W+C4P(#4V-RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$Q+C4P(#4V-RXW
M-2 V-RXP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,W."XU," U-C<N-S4@-"XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,X,BXU," U-C<N-S4@-C N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @-38W
M+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#8N-3 @-38W+C<U(#8V+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3$R+C4P(#4V-RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$V+C4P(#4V
M-RXW-2 V,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,V+C4P(#4S,"XW-2 Q,S4N,# @+3(S
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHQ-S$N-3 @-3,P+C<U(#0P+C P("TR,RXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$Q+C4P
M(#4S,"XW-2 T+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$U+C4P(#4S,"XW-2 T,"XP," M
M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C(U-2XU," U,S N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U.2XU
M," U,S N-S4@-#@N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#<N-3 @-3,P+C<U(#0N,# @
M+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,3$N-3 @-3,P+C<U(#8W+C P("TR,RXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<X
M+C4P(#4S,"XW-2 T+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@R+C4P(#4S,"XW-2 V,"XP
M," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0T,BXU," U,S N-S4@-"XP," M,C,N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T
M-BXU," U,S N-S4@-C8N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,3(N-3 @-3,P+C<U(#0N
M,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,38N-3 @-3,P+C<U(#8P+C P("TR,RXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S8N-3 @-#DS+C<U(#$S-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C$W,2XU," T.3,N-S4@
M-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHR,3$N-3 @-#DS+C<U(#0N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHR,34N-3 @-#DS+C<U(#0P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C4U+C4P(#0Y,RXW
M-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,C4Y+C4P(#0Y,RXW-2 T."XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,P-RXU," T.3,N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,2XU," T.3,N
M-S4@-C<N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S@N-3 @-#DS+C<U(#0N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS.#(N-3 @-#DS+C<U(#8P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P(#0Y
M,RXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#0V+C4P(#0Y,RXW-2 V-BXP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4Q,BXU," T.3,N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q-BXU," T
M.3,N-S4@-C N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-BXU," T-C4N-S4@,3,U+C P("TR
M,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,3<Q+C4P(#0V-2XW-2 T,"XP," M,C,N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Q,2XU
M," T-C4N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Q-2XU," T-C4N-S4@-# N,# @
M+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHR-34N-3 @-#8U+C<U(#0N,# @+3(S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-3DN
M-3 @-#8U+C<U(#0X+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S W+C4P(#0V-2XW-2 T+C P
M("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S$Q+C4P(#0V-2XW-2 V-RXP," M,C,N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W
M."XU," T-C4N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,BXU," T-C4N-S4@-C N
M,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT-#(N-3 @-#8U+C<U(#0N,# @+3(S+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-#8N-3 @-#8U+C<U(#8V+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$R+C4P(#0V-2XW-2 T
M+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3$V+C4P(#0V-2XW-2 V,"XP," M,C,N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,V+C4P(#0Q.2XW-2 Q,S4N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHQ-S$N-3 @-#$Y+C<U
M(#0P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,C$Q+C4P(#0Q.2XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,C$U+C4P(#0Q.2XW-2 T,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U-2XU," T,3DN
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C(U.2XU," T,3DN-S4@-#@N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS,#<N-3 @-#$Y+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3$N-3 @-#$Y
M+C<U(#8W+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S<X+C4P(#0Q.2XW-2 T+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S@R+C4P(#0Q.2XW-2 V,"XP," M,30N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU," T
M,3DN-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-BXU," T,3DN-S4@-C8N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,3(N-3 @-#$Y+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,38N-3 @
M-#$Y+C<U(#8P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8N-3 @,S@R+C<U(#$S-2XP," M
M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C$W,2XU," S.#(N-S4@-# N,# @+3(S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,3$N
M-3 @,S@R+C<U(#0N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,34N-3 @,S@R+C<U(#0P+C P
M("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,C4U+C4P(#,X,BXW-2 T+C P("TR,RXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C4Y
M+C4P(#,X,BXW-2 T."XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,P-RXU," S.#(N-S4@-"XP
M," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,Q,2XU," S.#(N-S4@-C<N,# @+3(S+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M-S@N-3 @,S@R+C<U(#0N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#(N-3 @,S@R+C<U(#8P
M+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#0R+C4P(#,X,BXW-2 T+C P("TR,RXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#0V+C4P(#,X,BXW-2 V-BXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,BXU," S.#(N-S4@
M-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4Q-BXU," S.#(N-S4@-C N,# @+3(S+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS-BXU," S,S8N-S4@,3,U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,3<Q+C4P(#,S-BXW
M-2 T,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C(Q,2XU," S,S8N-S4@-"XP," M,30N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C(Q-2XU," S,S8N-S4@-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-34N-3 @,S,V
M+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHR-3DN-3 @,S,V+C<U(#0X+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S W+C4P(#,S-BXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$Q+C4P(#,S
M-BXW-2 V-RXP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W."XU," S,S8N-S4@-"XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,X,BXU," S,S8N-S4@-C N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @
M,S,V+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#8N-3 @,S,V+C<U(#8V+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3$R+C4P(#,S-BXW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$V+C4P
M(#,S-BXW-2 V,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,V+C4P(#,P."XW-2 Q,S4N,# @
M+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHQ-S$N-3 @,S X+C<U(#0P+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$Q
M+C4P(#,P."XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C$U+C4P(#,P."XW-2 T,"XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C(U-2XU," S,#@N-S4@-"XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U
M.2XU," S,#@N-S4@-#@N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#<N-3 @,S X+C<U(#0N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHS,3$N-3 @,S X+C<U(#8W+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S<X+C4P(#,P."XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@R+C4P(#,P."XW-2 V
M,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0T,BXU," S,#@N-S4@-"XP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0T-BXU," S,#@N-S4@-C8N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,3(N-3 @,S X+C<U
M(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,38N-3 @,S X+C<U(#8P+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S8N-3 @,C<Q+C<U(#$S-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C$W,2XU," R-S$N
M-S4@-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHR,3$N-3 @,C<Q+C<U(#0N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHR,34N-3 @,C<Q+C<U(#0P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C4U+C4P(#(W
M,2XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,C4Y+C4P(#(W,2XW-2 T."XP," M,30N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,P-RXU," R-S$N-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q,2XU," R
M-S$N-S4@-C<N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S@N-3 @,C<Q+C<U(#0N,# @+3$T
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS.#(N-3 @,C<Q+C<U(#8P+C P("TQ-"XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P
M(#(W,2XW-2 T+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0V+C4P(#(W,2XW-2 V-BXP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4Q,BXU," R-S$N-S4@-"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q-BXU
M," R-S$N-S4@-C N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-BXU," R-#,N-S4@,3,U+C P
M("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,3<Q+C4P(#(T,RXW-2 T,"XP," M,C,N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Q
M,2XU," R-#,N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Q-2XU," R-#,N-S4@-# N
M,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHR-34N-3 @,C0S+C<U(#0N,# @+3(S+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR
M-3DN-3 @,C0S+C<U(#0X+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S W+C4P(#(T,RXW-2 T
M+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S$Q+C4P(#(T,RXW-2 V-RXP," M,C,N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C,W."XU," R-#,N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,BXU," R-#,N-S4@
M-C N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT-#(N-3 @,C0S+C<U(#0N,# @+3(S+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-#8N-3 @,C0S+C<U(#8V+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$R+C4P(#(T,RXW
M-2 T+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3$V+C4P(#(T,RXW-2 V,"XP," M,C,N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,V+C4P(#$Y-RXW-2 Q,S4N,# @+3(S+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHQ-S$N-3 @,3DW
M+C<U(#0P+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,C$Q+C4P(#$Y-RXW-2 T+C P("TR,RXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,C$U+C4P(#$Y-RXW-2 T,"XP," M,C,N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U-2XU," Q
M.3<N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U.2XU," Q.3<N-S4@-#@N,# @+3(S
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS,#<N-3 @,3DW+C<U(#0N,# @+3(S+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3$N-3 @
M,3DW+C<U(#8W+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<X+C4P(#$Y-RXW-2 T+C P("TR
M,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S@R+C4P(#$Y-RXW-2 V,"XP," M,C,N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T,BXU
M," Q.3<N-S4@-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-BXU," Q.3<N-S4@-C8N,# @
M+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,3(N-3 @,3DW+C<U(#0N,# @+3(S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,38N
M-3 @,3DW+C<U(#8P+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8N-3 @,38P+C<U(#$S-2XP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C$W,2XU," Q-C N-S4@-# N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR
M,3$N-3 @,38P+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,34N-3 @,38P+C<U(#0P
M+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,C4U+C4P(#$V,"XW-2 T+C P("TQ-"XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,C4Y+C4P(#$V,"XW-2 T."XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,P-RXU," Q-C N-S4@
M-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,Q,2XU," Q-C N-S4@-C<N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS-S@N-3 @,38P+C<U(#0N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#(N-3 @,38P+C<U
M(#8P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#0R+C4P(#$V,"XW-2 T+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#0V+C4P(#$V,"XW-2 V-BXP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,BXU," Q-C N
M-S4@-"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4Q-BXU," Q-C N-S4@-C N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HQ-S$N-2 V.#$N-S4@;0HR,3$N-2 V.#$N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C$W,2XU(#8T-BXW-2!M"C(Q,2XU(#8T-BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$Q
M+C4@-C@Q+C<U(&T*,C$U+C4@-C@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR,3$N-2 V-#8N-S4@
M;0HR,34N-2 V-#8N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(Q-2XU(#8X,2XW-2!M"C(U-2XU(#8X
M,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,C$U+C4@-C0V+C<U(&T*,C4U+C4@-C0V+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HR-34N-2 V.#$N-S4@;0HR-3DN-2 V.#$N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(U.2XU(#8X
M,2XW-2!M"C,P-RXU(#8X,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S W+C4@-C@Q+C<U(&T*,S$Q
M+C4@-C@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS,3$N-2 V.#$N-S4@;0HS-S@N-2 V.#$N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,W."XU(#8X,2XW-2!M"C,X,BXU(#8X,2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@R
M+C4@-C@Q+C<U(&T*-#0R+C4@-C@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#(N-2 V.#$N-S4@
M;0HT-#8N-2 V.#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T-BXU(#8X,2XW-2!M"C4Q,BXU(#8X
M,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-3$R+C4@-C@Q+C<U(&T*-3$V+C4@-C@Q+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HU,38N-2 V.#$N-S4@;0HU-S8N-2 V.#$N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$W,2XU(#8S
M,BXW-2!M"C(Q,2XU(#8S,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$U+C4@-C,R+C<U(&T*,C4U
M+C4@-C,R+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HR-34N-2 V,S(N-S4@;0HR-3DN-2 V,S(N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(U.2XU(#8S,BXW-2!M"C,P-RXU(#8S,BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S W
M+C4@-C,R+C<U(&T*,S$Q+C4@-C,R+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3$N-2 V,S(N-S4@
M;0HS-S@N-2 V,S(N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W."XU(#8S,BXW-2!M"C,X,BXU(#8S
M,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S@R+C4@-C,R+C<U(&T*-#0R+C4@-C,R+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT-#(N-2 V,S(N-S4@;0HT-#8N-2 V,S(N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T-BXU(#8S
M,BXW-2!M"C4Q,BXU(#8S,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$R+C4@-C,R+C<U(&T*-3$V
M+C4@-C,R+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HU,38N-2 V,S(N-S4@;0HU-S8N-2 V,S(N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0T-BXU(#8S,BXW-2!M"C4Q,BXU(#8S,BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3<Q
M+C4@-#DS+C<U(&T*,C$Q+C4@-#DS+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR,34N-2 T.3,N-S4@
M;0HR-34N-2 T.3,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(U.2XU(#0Y,RXW-2!M"C,P-RXU(#0Y
M,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S$Q+C4@-#DS+C<U(&T*,S<X+C4@-#DS+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS.#(N-2 T.3,N-S4@;0HT-#(N-2 T.3,N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T-BXU(#0Y
M,RXW-2!M"C4Q,BXU(#0Y,RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$V+C4@-#DS+C<U(&T*-3<V
M+C4@-#DS+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HQ-S$N-2 S,C(N-S4@;0HR,3$N-2 S,C(N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(Q-2XU(#,R,BXW-2!M"C(U-2XU(#,R,BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C4Y
M+C4@,S(R+C<U(&T*,S W+C4@,S(R+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3$N-2 S,C(N-S4@
M;0HS-S@N-2 S,C(N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X,BXU(#,R,BXW-2!M"C0T,BXU(#,R
M,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#0V+C4@,S(R+C<U(&T*-3$R+C4@,S(R+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HU,38N-2 S,C(N-S4@;0HU-S8N-2 S,C(N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$W,2XU(#$V
M,"XW-2!M"C(Q,2XU(#$V,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$U+C4@,38P+C<U(&T*,C4U
M+C4@,38P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HR-3DN-2 Q-C N-S4@;0HS,#<N-2 Q-C N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,Q,2XU(#$V,"XW-2!M"C,W."XU(#$V,"XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@R
M+C4@,38P+C<U(&T*-#0R+C4@,38P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-#8N-2 Q-C N-S4@
M;0HU,3(N-2 Q-C N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4Q-BXU(#$V,"XW-2!M"C4W-BXU(#$V
M,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,3<Q+C4@,30W+C<U(&T*,C$Q+C4@,30W+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HQ-S$N-2 Q-#4N-S4@;0HR,3$N-2 Q-#4N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(Q-2XU(#$T
M-RXW-2!M"C(U-2XU(#$T-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C$U+C4@,30U+C<U(&T*,C4U
M+C4@,30U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HR-3DN-2 Q-#<N-S4@;0HS,#<N-2 Q-#<N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(U.2XU(#$T-2XW-2!M"C,P-RXU(#$T-2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$Q
M+C4@,30W+C<U(&T*,S<X+C4@,30W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,3$N-2 Q-#4N-S4@
M;0HS-S@N-2 Q-#4N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X,BXU(#$T-RXW-2!M"C0T,BXU(#$T
M-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S@R+C4@,30U+C<U(&T*-#0R+C4@,30U+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT-#8N-2 Q-#<N-S4@;0HU,3(N-2 Q-#<N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T-BXU(#$T
M-2XW-2!M"C4Q,BXU(#$T-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3$V+C4@,30W+C<U(&T*-3<V
M+C4@,30W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HU,38N-2 Q-#4N-S4@;0HU-S8N-2 Q-#4N-S4@
M; IS"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDN,# @-C,W
M+C(Q(%1D("B@*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3@S+C,U(#8U,2XR,"!49" H0V]M;6]N(%-T;V-K*2!4:B!%5"!1
M"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C8R+C0U(#8U-2XR
M,"!49" H061D:71I;VYA;"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(V."XT-2 V-#8N,C @5&0@*%!A:60M26XI(%1J($54
M(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-C@N-S @-C,W
M+C(P(%1D("A#87!I=&%L*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S$Y+C P(#8V-"XR,"!49" H06-C=6UU;&%T960I(%1J
M($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,C(N,C @
M-C4U+C(P(%1D("A/=&AE<BD@5&H@150@40IQ(# @," P(')G($)4(#,T-2XQ
M,2 V-34N,C @5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#<N,C @
M-C4U+C(P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4R+C<Q(#8U
M-2XR,"!49" H;W1A;"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,Q-"XU-2 V-#8N,C @5&0@*$-O;7!R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S0Q+CDW(#8T-BXR,"!49" H96AE;G-I=F4I(%1J($54
M(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,C<N-#4@-C,W
M+C(P(%1D("A,;W-S+"!N970I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.#4N,# @-C8T+C(P(%1D("A<*$%C8W5M=6QA=&5D
M*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW
M+C<U(#8U-2XR,"!49" H1&5F:6-I=%PI*2!4:B!%5"!1"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDT+C<U(#8T-BXR,"!49" H4F5T86EN
M960I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M.30N-#4@-C,W+C(P(%1D("A%87)N:6YG<RD@5&H@150@40I"5" O1C(@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0U,"XP-2 V-34N,C @5&0@*$YO;F-O
M;G1R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@V+C0W(#8U-2XR,"!49" H
M;VQL:6YG*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4Y+C(P(#8T-BXR,"!49" H26YT97(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-S@N-C$@-C0V+C(P(%1D("AE<W0@:6XI(%1J($54(%$*0E0@+T8R
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-3@N,C @-C,W+C(P(%1D("A3
M=6)S:61I87)Y*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3$Y+C@P(#8T-BXR,"!49" H4W1O8VMH;VQD97)SDBD@5&H@150@
M40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,BXY-2 V,S<N
M,C @5&0@*$5Q=6ET>2D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$W."XP-2 V,S<N,C @5&0@*%-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q.38N-#<@-C,W+C(P(%1D("AE<RD@5&H@150@40I"5" O
M1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(R,2XP," V,S<N,C @5&0@
M*$1O;&QA<G,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.2XP," V,#DN,C$@5&0@*$)A;&%N8V5S(&%T($1E8V5M8F5RH#,Q
M+" R,#$U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3@S+C(U(#8P.2XR,2!49" H,S$L.34R*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C$X+C P(#8P.2XR,2!49" H)"D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T-RXU
M," V,#DN,C$@5&0@*#,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" R-C(N,# @-C Y+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C<T+C<U(#8P.2XR,2!49" H
M,C4T+#$P."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,Q-"XP," V,#DN,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-3$N-S4@-C Y+C(Q(%1D("A<*#$L,C W
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S<U
M+C P(#8P.2XR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.#4N,# @-C Y+C(Q(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-# V+C<U(#8P.2XR,2!4
M9" H7"@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C(U(#8P.2XR,2!4
M9" H,3(L,#4V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#,Y+C P(#8P.2XR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#0Y+C P(#8P.2XS,B!49" H)"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3,N
M-C4@-C Y+C,R(%1D("@T.38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,3DN,# @-C Y+C(Q(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C<U(#8P.2XR,2!4
M9" H,30Q+#,T-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U+C P(#4Y-2XR,2!49" H17AE<F-I<V4@;V8@<VAA<F4@;W!T
M:6]N<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$Y-"XU," U.34N,C$@5&0@*#$P,RD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(T,RXP," U.34N,C$@5&0@*)<I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N,# @-3DU
M+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S8V+C P(#4Y-2XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XP," U.34N,C$@5&0@*)<I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.3DN-C4@
M-3DU+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-38T+C P(#4Y-2XR,2!49" HERD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0U+C P(#4X,2XR,2!49" H5BD@
M5&H@150@40IQ(# @," P(')G($)4(#4Q+C P(#4X,2XR,2!49" H97-T:6YG
M(&]F(')E<W1R:6-T960@<W1O8VL@86YD*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @-3<R+C(Q(%1D("AP97)F;W)M
M86YC92!S=&]C:R!A=V%R9',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q.30N-3 @-3<R+C(Q(%1D("@R.#0I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-#,N,# @-3<R+C(Q
M(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C@W+C4P(#4W,BXR,2!49" H7"@Y,3<I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,#0N,# @-3<R+C(Q(%1D("A<*2D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-BXP
M," U-S(N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,S N,# @-3<R+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DY+C8U(#4W,BXR,2!49" H
MERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U
M-BXU," U-S(N,C$@5&0@*%PH.3$W*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3<S+C P(#4W,BXR,2!49" H7"DI(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-2XP," U-3@N
M,C$@5&0@*$5Q=6ET>2!C;VUP96YS871I;VXI(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3DN,# @-34X+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C0S+C P
M(#4U."XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(X,RXW-2 U-3@N,C$@5&0@*#,L,S<Y*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S8V+C P(#4U."XR,2!4
M9" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,"XP," U-3@N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.3DN-C4@-34X+C(Q(%1D("B7*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34R+C<U(#4U."XR
M,2!49" H,RPS-SDI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-2XP," U-#0N,C$@5&0@*$9O<F5I9VX@8W5R<F5N8WD@=')A
M;G-L871I;VXI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-2XP," U,S4N,C$@5&0@*&%D:G5S=&UE;G0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3DN,# @-3,U+C(Q(%1D
M("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C0S+C P(#4S-2XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(Y-2XP," U,S4N,C$@5&0@*)<I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C,N,# @-3,U+C(Q
M(%1D("A<*#,T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S<U+C P(#4S-2XR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N,# @-3,U+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DY+C8U
M(#4S-2XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4V,2XP," U,S4N,C$@5&0@*%PH,S0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-S,N,# @-3,U+C(Q(%1D
M("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0U+C P(#4R,2XR,2!49" H1&ES=')I8G5T:6]N('1O(&YO;F-O;G1R;VQL
M:6YG*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#4N,# @-3$R+C(Q(%1D("AS:&%R96AO;&1E<BD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y.2XP," U,3(N,C$@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-#,N
M,# @-3$R+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,CDU+C P(#4Q,BXR,2!49" HERD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-BXP," U,3(N,C$@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,S N,# @-3$R+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DR+C$U(#4Q,BXR,2!49" H7"@W,#$I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,#@N-C4@-3$R
M+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4U-BXU," U,3(N,C$@5&0@*%PH-S Q*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3<S+C P(#4Q,BXR,2!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-2XP," T.3@N,C$@5&0@*$YE="!I;F-O;64I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3DN,# @-#DX+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C0S+C P
M(#0Y."XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(Y-2XP," T.3@N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N,# @-#DX+C(Q(%1D("B7
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#$X
M+C<U(#0Y."XR,2!49" H-RPY-C<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.34N,34@-#DX+C(Q(%1D("@W-C0I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3(N-S4@-#DX
M+C(Q(%1D("@X+#<S,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,Y+C P(#0X-"XR,2!49" H0F%L86YC97,@870@1&5C96UB
M97*@,S$L(#(P,38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q.#,N,C4@-#@T+C(Q(%1D("@S,BPS,SDI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-#<N-3 @-#@T+C(Q(%1D
M("@S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C<T+C<U(#0X-"XR,2!49" H,C4V+#4W,"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,U,2XW-2 T.#0N,C$@5&0@*%PH,2PR
M-#$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-S4N,# @-#@T+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0P-BXW-2 T.#0N,C$@5&0@*%PH,3 T+# X.2D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S.2XP
M," T.#0N,C$@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DU+C$U(#0X-"XR,2!49" H-34Y*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C<U(#0X-"XR,2!4
M9" H,34Q+#@P,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U+C P(#0W,"XR,2!49" H17AE<F-I<V4@;V8@<VAA<F4@;W!T
M:6]N<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$Y.2XP," T-S N,C$@5&0@*#0Q*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C0S+C P(#0W,"XR,2!49" HERD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XP," T-S N
M,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-C8N,# @-#<P+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#,P+C P(#0W,"XR,2!49" HERD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y.2XV-2 T
M-S N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-C0N,# @-#<P+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @-#4V+C(Q(%1D("A6*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3$N,# @-#4V+C(Q(%1D("AE<W1I;F<@
M;V8@<F5S=')I8W1E9"!S=&]C:R!A;F0I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-2XP," T-#<N,C$@5&0@*'!E<F9O<FUA
M;F-E('-T;V-K(&%W87)D<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$Y-"XU," T-#<N,C$@5&0@*#(X,BD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T,RXP," T-#<N,C$@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" R.# N-S4@-#0W+C(Q(%1D("A<*#$L-S<T*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S T+C P(#0T-RXR,2!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N
M,# @-#0W+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,P+C P(#0T-RXR,2!49" HERD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y.2XV-2 T-#<N,C$@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-#DN-S4@-#0W+C(Q(%1D("A<*#$L-S<T*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3<S+C P(#0T-RXR,2!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-2XP," T
M,S,N,C$@5&0@*%-H87)E<R!I<W-U960@9F]R($-O;G9E<G1I8FQE*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @-#(T
M+C(Q(%1D("A.;W1E<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$X-RXW-2 T,C0N,C$@5&0@*#,L,3<V*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C0W+C4P(#0R-"XR,2!4
M9" H,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(W.2XR-2 T,C0N,C$@5&0@*#0U+#DU,2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,V-BXP," T,C0N,C$@5&0@*)<I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N,# @
M-#(T+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DY+C8U(#0R-"XR,2!49" HERD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T."XR-2 T,C0N,C$@5&0@*#0U
M+#DU,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0U+C P(#0Q,"XR,2!49" H17%U:71Y(&-O;7!E;G-A=&EO;BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y.2XP," T,3 N
M,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-#,N,# @-#$P+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C@S+C<U(#0Q,"XR,2!49" H-"PP.# I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N
M,# @-#$P+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,P+C P(#0Q,"XR,2!49" HERD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y.2XV-2 T,3 N,C$@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-3(N-S4@-#$P+C(Q(%1D("@T+# X,"D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0U+C P(#,Y-BXR,2!49" H0W5M=6QA=&EV
M92UE9BD@5&H@150@40IQ(# @," P(')G($)4(#DV+CDP(#,Y-BXR,2!49" H
M9F5C="!A9&IU<W1M96YT("TI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-2XP," S.#<N,C$@5&0@*'-H87)E+6)A<V5D(&-O
M;7!E;G-A=&EO;BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$Y.2XP," S.#<N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-#,N,# @,S@W+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,CDP+C4P
M(#,X-RXR,2!49" H-3,U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S8V+C P(#,X-RXR,2!49" HERD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,BXU," S.#<N,C$@5&0@
M*%PH-3,U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#,Y+C P(#,X-RXR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.3DN-C4@,S@W+C(Q(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-38T+C P(#,X
M-RXR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U+C P(#,W,RXR,2!49" H1F]R96EG;B!C=7)R96YC>2!T<F%N
M<VQA=&EO;BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0U+C P(#,V-"XR,2!49" H861J=7-T;65N="D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y.2XP," S-C0N,C$@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R
M-#,N,# @,S8T+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,CDU+C P(#,V-"XR,2!49" HERD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-BXP," S-C0N,C$@
M5&0@*#<U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#,P+C P(#,V-"XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y.2XV-2 S-C0N,C$@5&0@*)<I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-C0N,# @,S8T
M+C(Q(%1D("@W-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U+C P(#,U,"XR,2!49" H1&ES=')I8G5T:6]N('1O(&YO;F-O
M;G1R;VQL:6YG*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#4N,# @,S0Q+C(Q(%1D("AS:&%R96AO;&1E<BD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y.2XP," S-#$N,C$@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" R-#,N,# @,S0Q+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,CDU+C P(#,T,2XR,2!49" HERD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V-BXP," S-#$N
M,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,S N,# @,S0Q+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#@U+C0P(#,T,2XR,2!49" H7"@Q+#(Q
M."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M."XV-2 S-#$N,C$@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30Y+C<U(#,T,2XR,2!49" H7"@Q+#(Q."D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4W,RXP," S
M-#$N,C$@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#4N,# @,S(W+C(Q(%1D("A.970@:6YC;VUE*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,3DY+C P(#,R-RXR
M,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(T,RXP," S,C<N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.34N,# @,S(W+C(Q(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S8V+C P(#,R
M-RXR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Q-"XR-2 S,C<N,C$@5&0@*#,W+#4Q,RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0X."XT," S,C<N,C$@5&0@
M*#$L,C@Y*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-30X+C(U(#,R-RXR,2!49" H,S@L.# R*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@,SDN,# @,S$S+C(Q(%1D("A"86QA
M;F-E<R!A="!$96-E;6)E<J S,2P@,C Q-RD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$X,RXR-2 S,3,N,C$@5&0@*#,U+#@S
M."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T
M-RXU," S,3,N,C$@5&0@*#0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" R-S0N-S4@,S$S+C(Q(%1D("@S,#4L,S8R*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S4Q+C<U(#,Q
M,RXR,2!49" H7"@Q+#$V-BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,W-2XP," S,3,N,C$@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C(U(#,Q,RXR,2!4
M9" H7"@V-RPQ*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,P+C P(#,Q,RXR
M,2!49" H,2D@5&H@150@40IQ(# @," P(')G($)4(#0S-"XU," S,3,N,C$@
M5&0@*#$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,SDN,# @,S$S+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y-2XQ-2 S,3,N,C$@5&0@*#8S,"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,RXW-2 S
M,3,N,C$@5&0@*#(S-RPW,3DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-2XP," R.3DN,C$@5&0@*$5X97)C:7-E(&]F('-H
M87)E(&]P=&EO;G,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q.3DN,# @,CDY+C(Q(%1D("@R,2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T,RXP," R.3DN,C$@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N
M,# @,CDY+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S8V+C P(#(Y.2XR,2!49" HERD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XP," R.3DN,C$@5&0@
M*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.3DN-C4@,CDY+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-38T+C P(#(Y.2XR,2!49" HERD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0U+C P(#(X-2XR,2!4
M9" H5BD@5&H@150@40IQ(# @," P(')G($)4(#4Q+C P(#(X-2XR,2!49" H
M97-T:6YG(&]F(')E<W1R:6-T960@<W1O8VL@86YD*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @,C<V+C(Q(%1D("AP
M97)F;W)M86YC92!S=&]C:R!A=V%R9',I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.30N-3 @,C<V+C(Q(%1D("@Q.3DI(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-#,N,# @
M,C<V+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@W+C4P(#(W-BXR,2!49" H7"@X.#DI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,#0N,# @,C<V+C(Q(%1D
M("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,V-BXP," R-S8N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,S N,# @,C<V+C(Q(%1D("B7*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DY+C8U(#(W-BXR
M,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4U-BXU," R-S8N,C$@5&0@*%PH.#@Y*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3<S+C P(#(W-BXR,2!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-2XP
M," R-C(N,C$@5&0@*$5Q=6ET>2!C;VUP96YS871I;VXI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3DN,# @,C8R+C(Q(%1D
M("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C0S+C P(#(V,BXR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(X,RXW-2 R-C(N,C$@5&0@*#,L-3<U*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S8V+C P(#(V
M,BXR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0S,"XP," R-C(N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.3DN-C4@,C8R+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34R+C<U
M(#(V,BXR,2!49" H,RPU-S4I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-2XP," R-#@N,C$@5&0@*%-T;V-K(')E<'5R8VAA
M<V4@86YD(')E=&ER96UE;G0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q.3$N-3 @,C0X+C(Q(%1D("A<*#0S,BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(P."XP," R-#@N
M,C$@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C0S+C P(#(T."XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(X,"XW-2 R-#@N,C$@5&0@*%PH-2PP
M,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,#0N,# @,C0X+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,V-BXP," R-#@N,C$@5&0@*)<I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N,# @,C0X+C(Q
M(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DY+C8U(#(T."XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4T.2XW-2 R-#@N,C$@5&0@*%PH-2PP,# I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-S,N
M,# @,C0X+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0U+C P(#(S-"XR,2!49" H1F]R96EG;B!C=7)R96YC
M>2!T<F%N<VQA=&EO;BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0U+C P(#(R-2XR,2!49" H861J=7-T;65N="P@;F5T(&]F
M('1A>&5S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3DY+C P(#(R-2XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(T,RXP," R,C4N,C$@5&0@*)<I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N,# @,C(U
M+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S4X+C4P(#(R-2XR,2!49" H7"@Q,C$I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-S4N,# @,C(U+C(Q(%1D("A<
M*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S
M,"XP," R,C4N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.3DN-C4@,C(U+C(Q(%1D("B7*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34V+C4P(#(R-2XR,2!4
M9" H7"@Q,C$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-S,N,# @,C(U+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0U+C P(#(Q,2XR,2!49" H3F5T(&-H
M86YG92!I;B!H961G:6YG*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#4N,# @,C R+C(Q(%1D("AT<F%N<V%C=&EO;BP@;F5T
M(&]F('1A>&5S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3DY+C P(#(P,BXR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(T,RXP," R,#(N,C$@5&0@*)<I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N,# @
M,C R+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S4X+C4P(#(P,BXR,2!49" H7"@Q-S4I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-S4N,# @,C R+C(Q(%1D
M("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,"XP," R,#(N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.3DN-C4@,C R+C(Q(%1D("B7*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34V+C4P(#(P,BXR
M,2!49" H7"@Q-S4I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-S,N,# @,C R+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0U+C P(#$X."XR,2!49" H1&ES
M=')I8G5T:6]N('1O(&YO;F-O;G1R;VQL:6YG*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @,3<Y+C(Q(%1D("AS:&%R
M96AO;&1E<BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$Y.2XP," Q-SDN,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" R-#,N,# @,3<Y+C(Q(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,CDU+C P(#$W
M.2XR,2!49" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,V-BXP," Q-SDN,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N,# @,3<Y+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@U+C0P
M(#$W.2XR,2!49" H7"@Q+#$Y-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P."XV-2 Q-SDN,C$@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30Y+C<U(#$W.2XR
M,2!49" H7"@Q+#$Y-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4W,RXP," Q-SDN,C$@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#4N,# @,38U+C(Q(%1D("A.
M970@7"AL;W-S7"D@:6YC;VUE*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3DY+C P(#$V-2XR,2!49" HERD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T,RXP," Q-C4N,C$@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" R.34N,# @,38U+C(Q(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S8V+C P(#$V-2XR,2!49" HERD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,2XR-2 Q-C4N
M,C$@5&0@*%PH,38L.34Q*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,Y+C P(#$V-2XR,2!49" H7"DI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#@N-# @,38U+C(Q(%1D
M("@Q+#(S-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4T-2XR-2 Q-C4N,C$@5&0@*%PH,34L-S$W*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3<S+C P(#$V-2XR,2!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M.2XP," Q-3$N,C$@5&0@*$)A;&%N8V5S(&%T($1E8V5M8F5RH#,Q+" R,#$X
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,3@S
M+C(U(#$U,2XR,2!49" H,S4L-C(V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C$X+C P(#$U,2XR,2!49" H)"D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(T-RXU," Q-3$N
M,C$@5&0@*#0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-C(N,# @,34Q+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C<T+C<U(#$U,2XR,2!49" H,S S+# T
M."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q
M-"XP," Q-3$N,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-3$N-S4@,34Q+C(Q(%1D("A<*#$L-#8R*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S<U+C P(#$U
M,2XR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" S.#4N,# @,34Q+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C(U(#$U,2XR,2!49" H7"@X
M-"PP-C(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,SDN,# @,34Q+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0T.2XP," Q-3$N,C$@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.34N,34@,34Q
M+C(Q(%1D("@V-S I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,3DN,# @,34Q+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C<U(#$U,2XR,2!49" H,C$X
M+#$Y."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S8N,# @,3,U+C(U(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-2XS," Q
M,C,N,C4@5&0@*%-E92!A8V-O;7!A;GEI;F<@;F]T97,N*2!4:B!%5"!1"F5N
M9'-T<F5A;0IE;F1O8FH*,3$U(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N
M=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R
M8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3$V(# @4CX^"F5N9&]B
M:@HQ,38@,"!O8FH*/#PO3&5N9W1H(#,Q-3$Y/CX*<W1R96%M"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-RXX," S,2XV,"!49" H1BT@
M-RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,3,N.#4@-S0R+C(U(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3(N-C@@-S0R+C(U(%1D("A9*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDY+C4S(#<T,BXR-2!49" H($A%04PI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,CDN-#4@-S0R+C(U(%1D("A42$-!4D4L($E.0RXI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@X+C8U(#<S
M,"XR-2!49" H0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0X
M+C0W(#<S,"XR-2!49" H5$5$(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C@S+C R(#<S,"XR-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#(X
M.2XU," W,S N,C4@5&0@*%1%345.5%,@3T8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-30N-#(@-S,P+C(U(%1D("@@0T%32"!&3$]74RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-34N.34@-S$X+C(U
M(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-C@U+C<U(#,P
M.2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,U.2XU," V.#4N-S4@-C4N,# @+3$Q+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,C0N-3 @-C@U+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-C@U+C<U
M(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#8X-2XW-2 T+C P("TQ,2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#DW+C4P(#8X-2XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#8V,RXW
M-2 S,#DN,# @+3(Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3DN-3 @-C8S+C<U(#8U+C P("TR,2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#(T+C4P(#8V,RXW-2 T+C P("TR,2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(X+C4P(#8V
M,RXW-2 V-2XP," M,C$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXU," V-C,N-S4@-"XP," M,C$N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0Y-RXU," V-C,N-S4@-C4N,# @+3(Q+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," V
M,S$N-S4@,S Y+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4Y+C4P(#8S,2XW-2 V-2XP," M
M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0R-"XU," V,S$N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XU
M," V,S$N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N-3 @-C,Q+C<U(#0N,# @
M+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.3<N-3 @-C,Q+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N
M-3 @-C Y+C<U(#,P.2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U.2XU," V,#DN-S4@-C4N
M,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,C0N-3 @-C Y+C<U(#0N,# @+3$Q+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M,C@N-3 @-C Y+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#8P.2XW-2 T
M+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DW+C4P(#8P.2XW-2 V-2XP," M,3$N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C4P(#4X-RXW-2 S,#DN,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3DN-3 @-3@W+C<U
M(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P(#4X-RXW-2 T+C P("TQ,2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#(X+C4P(#4X-RXW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXU," U.#<N
M-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," U.#<N-S4@-C4N,# @+3$Q+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XU," U-C4N-S4@,S Y+C P("TQ,2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4Y+C4P(#4V
M-2XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XU," U-C4N-S4@-"XP," M,3$N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0R."XU," U-C4N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N-3 @
M-38U+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @-38U+C<U(#8U+C P("TQ
M,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 N-3 @-30R+C<U(#,P.2XP," M,3$N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U.2XU
M," U-#(N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C0N-3 @-30R+C<U(#0N,# @
M+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,C@N-3 @-30R+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS
M+C4P(#4T,BXW-2 T+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#4T,BXW-2 V-2XP
M," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C4P(#4R,"XW-2 S,#DN,# @+3$Q+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M-3DN-3 @-3(P+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P(#4R,"XW-2 T
M+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#(X+C4P(#4R,"XW-2 V-2XP," M,3$N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y,RXU," U,C N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," U,C N-S4@
M-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XU," T.3@N-S4@,S Y+C P("TQ,2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S4Y+C4P(#0Y."XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XU," T.3@N
M-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XU," T.3@N-S4@-C4N,# @+3$Q+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.3,N-3 @-#DX+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @-#DX
M+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-#<V+C<U(#,P.2XP," M-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S4Y+C4P(#0W-BXW-2 V-2XP," M-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P(#0W
M-BXW-2 T+C P("TU+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-#<V+C<U(#8U+C P("TU+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.3,N-3 @-#<V+C<U(#0N,# @+34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," T-S8N
M-S4@-C4N,# @+34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0V,"XW-2 S,#DN,# @+3$Q+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS-3DN-3 @-#8P+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P(#0V
M,"XW-2 T+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#(X+C4P(#0V,"XW-2 V-2XP," M,3$N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0Y,RXU," T-C N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," T
M-C N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," T,S@N-S4@,S Y+C P("TQ
M,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S4Y+C4P(#0S."XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XU
M," T,S@N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XU," T,S@N-S4@-C4N,# @
M+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.3,N-3 @-#,X+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N
M-3 @-#,X+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @-#$V+C<U(#,P.2XP
M," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,U.2XU," T,38N-S4@-C4N,# @+3$Q+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M,C0N-3 @-#$V+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @-#$V+C<U(#8U
M+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DS+C4P(#0Q-BXW-2 T+C P("TQ,2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#DW+C4P(#0Q-BXW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#0P,"XW-2 S
M,#DN,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHS-3DN-3 @-# P+C<U(#8U+C P("TQ,2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#(T+C4P(#0P,"XW-2 T+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(X+C4P(#0P,"XW
M-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXU," T,# N-S4@-"XP," M,3$N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0Y-RXU," T,# N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," S-S@N
M-S4@,S Y+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S4Y+C4P(#,W."XW-2 V-2XP," M,3$N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0R-"XU," S-S@N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XU," S
M-S@N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N-3 @,S<X+C<U(#0N,# @+3$Q
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.3<N-3 @,S<X+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @
M,S4V+C<U(#,P.2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U.2XU," S-38N-S4@-C4N,# @
M+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,C0N-3 @,S4V+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N
M-3 @,S4V+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P(#,U-BXW-2 T+C P
M("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#DW+C4P(#,U-BXW-2 V-2XP," M,3$N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C4P(#,S-"XW-2 S,#DN,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3DN-3 @,S,T+C<U(#8U
M+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#(T+C4P(#,S-"XW-2 T+C P("TQ,2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#(X+C4P(#,S-"XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXU," S,S0N-S4@
M-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," S,S0N-S4@-C4N,# @+3$Q+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,"XU," S,3(N-S4@,S Y+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4Y+C4P(#,Q,BXW
M-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XU," S,3(N-S4@-"XP," M,3$N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0R."XU," S,3(N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N-3 @,S$R
M+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @,S$R+C<U(#8U+C P("TQ,2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 N-3 @,CDP+C<U(#,P.2XP," M,3$N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U.2XU," R
M.3 N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C0N-3 @,CDP+C<U(#0N,# @+3$Q
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT,C@N-3 @,CDP+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C4P
M(#(Y,"XW-2 T+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#(Y,"XW-2 V-2XP," M
M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P+C4P(#(V.2XW-2 S,#DN,# @+3$Q+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3DN
M-3 @,C8Y+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P(#(V.2XW-2 T+C P
M("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#(X+C4P(#(V.2XW-2 V-2XP," M,3$N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M,RXU," R-CDN-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU," R-CDN-S4@-C4N
M,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XU," R-#@N-S4@,S Y+C P("TQ,2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S4Y+C4P(#(T."XW-2 V-2XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XU," R-#@N-S4@
M-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0R."XU," R-#@N-S4@-C4N,# @+3$Q+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.3,N-3 @,C0X+C<U(#0N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N-3 @,C0X+C<U
M(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 N-3 @,C(V+C<U(#,P.2XP," M,3,N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,U.2XU," R,C8N-S4@-C4N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C0N-3 @,C(V
M+C<U(#0N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C@N-3 @,C(V+C<U(#8U+C P("TQ,RXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DS+C4P(#(R-BXW-2 T+C P("TQ,RXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C4P(#(R
M-BXW-2 V-2XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C4P(#(P,BXW-2 S,#DN,# @+3$Q
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS-3DN-3 @,C R+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C4P
M(#(P,BXW-2 T+C P("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(X+C4P(#(P,BXW-2 V-2XP," M
M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0Y,RXU," R,#(N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXU
M," R,#(N-S4@-C4N,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," Q.# N-S4@,S Y+C P
M("TQ,2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S4Y+C4P(#$X,"XW-2 V-2XP," M,3$N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R
M-"XU," Q.# N-S4@-"XP," M,3$N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XU," Q.# N-S4@-C4N
M,# @+3$Q+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.3,N-3 @,3@P+C<U(#0N,# @+3$Q+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.3<N-3 @,3@P+C<U(#8U+C P("TQ,2XP,"!R92!F"B]'4S @9W,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y
M+C4@-CDV+C<U(&T*-#(T+C4@-CDV+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C0N-2 V.38N-S4@
M;0HT,C@N-2 V.38N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#8Y-BXW-2!M"C0Y,RXU(#8Y
M-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DS+C4@-CDV+C<U(&T*-#DW+C4@-CDV+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 V.38N-S4@;0HU-C(N-2 V.38N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#8X
M-2XW-2!M"C0R-"XU(#8X-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X+C4@-C@U+C<U(&T*-#DS
M+C4@-C@U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3<N-2 V.#4N-S4@;0HU-C(N-2 V.#4N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,U.2XU(#0X-RXW-2!M"C0R-"XU(#0X-RXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y
M+C4@-#<V+C<U(&T*-#(T+C4@-#<V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C@N-2 T.#<N-S4@
M;0HT.3,N-2 T.#<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#0W-BXW-2!M"C0Y,RXU(#0W
M-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DW+C4@-#@W+C<U(&T*-38R+C4@-#@W+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 T-S8N-S4@;0HU-C(N-2 T-S8N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#0Q
M-BXW-2!M"C0R-"XU(#0Q-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y+C4@-# U+C<U(&T*-#(T
M+C4@-# U+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT,C@N-2 T,38N-S4@;0HT.3,N-2 T,38N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0R."XU(#0P-2XW-2!M"C0Y,RXU(#0P-2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW
M+C4@-#$V+C<U(&T*-38R+C4@-#$V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3<N-2 T,#4N-S4@
M;0HU-C(N-2 T,#4N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#(Y,"XW-2!M"C0R-"XU(#(Y
M,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#(X+C4@,CDP+C<U(&T*-#DS+C4@,CDP+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 R.3 N-S4@;0HU-C(N-2 R.3 N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#(W
M.2XW-2!M"C0R-"XU(#(W.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X+C4@,C<Y+C<U(&T*-#DS
M+C4@,C<Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3<N-2 R-SDN-S4@;0HU-C(N-2 R-SDN-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,U.2XU(#(R-BXW-2!M"C0R-"XU(#(R-BXW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X
M+C4@,C(V+C<U(&T*-#DS+C4@,C(V+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3<N-2 R,C8N-S4@
M;0HU-C(N-2 R,C8N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#(Q-"XW-2!M"C0R-"XU(#(Q
M-"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S4Y+C4@,C$R+C<U(&T*-#(T+C4@,C$R+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT,C@N-2 R,30N-S4@;0HT.3,N-2 R,30N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#(Q
M,BXW-2!M"C0Y,RXU(#(Q,BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW+C4@,C$T+C<U(&T*-38R
M+C4@,C$T+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3<N-2 R,3(N-S4@;0HU-C(N-2 R,3(N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,U.2XU(#$X,2XW-2!M"C0R-"XU(#$X,2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y
M+C4@,3<Y+C<U(&T*-#(T+C4@,3<Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C@N-2 Q.#$N-S4@
M;0HT.3,N-2 Q.#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#$W.2XW-2!M"C0Y,RXU(#$W
M.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DW+C4@,3@Q+C<U(&T*-38R+C4@,3@Q+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 Q-SDN-S4@;0HU-C(N-2 Q-SDN-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U.2XU(#$W
M.2XW-2!M"C0R-"XU(#$W.2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y+C4@,3@Q+C<U(&T*-#(T
M+C4@,3@Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS-3DN-2 Q-S N-S4@;0HT,C0N-2 Q-S N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,U.2XU(#$V."XW-2!M"C0R-"XU(#$V."XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X
M+C4@,3<Y+C<U(&T*-#DS+C4@,3<Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C@N-2 Q.#$N-S4@
M;0HT.3,N-2 Q.#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R."XU(#$W,"XW-2!M"C0Y,RXU(#$W
M,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#(X+C4@,38X+C<U(&T*-#DS+C4@,38X+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.3<N-2 Q-SDN-S4@;0HU-C(N-2 Q-SDN-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-RXU(#$X
M,2XW-2!M"C4V,BXU(#$X,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DW+C4@,3<P+C<U(&T*-38R
M+C4@,3<P+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3<N-2 Q-C@N-S4@;0HU-C(N-2 Q-C@N-S4@
M; IS"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#$P+C8U(#8Y
M.2XR,"!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#0Q-BXV-2 V.3DN
M,C @5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0R."XU-B V.3DN
M,C @5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#0Y-BXX.2 V.3DN,C @5&0@** S,2PI(%1J($54(%$*0E0@+T8R(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" S.#(N-3 @-C@X+C(P(%1D("@R,#$X*2!4
M:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#4Q+C4P
M(#8X."XR,"!49" H,C Q-RD@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R,"XU," V.#@N,C @5&0@*#(P,38I(%1J($54(%$*
M0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V-S<N,C @
M5&0@*$-A<V@@9FQO=W,@9G(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#,N
M.3(@-C<W+C(P(%1D("AO;2!O<&5R871I;F<@86-T:79I=&EE<RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#8V-BXP
M-B!49" H0V]N<V]L:61A=&5D(&YE="!<*&QO<W-<*2!I;F-O;64I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C(N,# @-C8V
M+C V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,SDS+C(U(#8V-BXP-B!49" H7"@Q-2PW,3<I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,C$N,# @-C8V+C V(%1D
M("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,2XP," V-C8N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-C4N,C4@-C8V+C V(%1D("@S."PX,#(I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,# N,# @
M-C8V+C V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,X+C<U(#8V-BXP-B!49" H."PW,S$I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V-34N,#$@5&0@
M*$%D:G5S=&UE;G1S('1O(')E8V]N8VEL92!N970@7"AL;W-S7"D@:6YC;VUE
M('1O(&YE="!C87-H('!R;W9I9&5D(&)Y(&]P97)A=&EN9RD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#8T-BXP,2!4
M9" H86-T:79I=&EE<SHI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,C$N,# @-C0W+C(Q(%1D("B@*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#8T-RXR,2!49" H
MH"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U
M.2XP," V-#<N,C$@5&0@** I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U.2XP," V,S0N,#8@5&0@*$1E<')E8VEA=&EO;B!A
M;F0@86UO<G1I>F%T:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDV+C(U(#8S-"XP-B!49" H,2D@5&H@150@40IQ(# @
M," P(')G($)4(#0P,"XW-2 V,S0N,#8@5&0@*#$L-S@P*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(U(#8S-"XP-B!4
M9" H,3 L,3<T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,X+C<U(#8S-"XP-B!49" H.2PQ.#(I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," V,C,N,#8@5&0@*$%M
M;W)T:7IA=&EO;B!O9B!D96)T(&1I<V-O=6YT(&%N9"!D96)T(&ES<W5A;F-E
M(&-O<W1S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# W+C4P(#8R,RXP-B!49" H-#0X*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<V+C4P(#8R,RXP-B!49" H-C4Q*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,X+C<U
M(#8R,RXP-B!49" H,2PW,C@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U.2XP," V,3(N,#8@5&0@*%!R;W9I<VEO;B!F;W(@
M86QL;W=A;F-E<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0P,"XW-2 V,3(N,#8@5&0@*#4L.3<T*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Y+C<U(#8Q,BXP-B!49" H
M-"PW,#4I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S@N-S4@-C$R+C V(%1D("@T+# S-"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#8P,2XP-B!49" H1&5F97)R
M960@:6YC;VUE('1A>"!B96YE9FET*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDW+C<U(#8P,2XP-B!49" H7"@S+#0Q,"D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XP
M," V,#$N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8R+C(U(#8P,2XP-B!49" H7"@S,RPX,3(I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.3 N,# @-C Q
M+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S-2XW-2 V,#$N,#8@5&0@*%PH-2PS,C(I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,# @-C Q+C V(%1D
M("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4Y+C P(#4Y,"XP-B!49" H1V%I;B!O;B!D97)I=F%T:79E(&QI86)I;&ET
M>2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q
M,BXP," U.3 N,#8@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C8N-S4@-3DP+C V(%1D("A<*#$L-3@Q*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#4Y
M,"XP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S4N-S4@-3DP+C V(%1D("A<*#4L.# U*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#4Y,"XP-B!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U.2XP," U-SDN,#8@5&0@*$EM<&%I<FUE;G0@8VAA<BD@5&H@150@40IQ
M(# @," P(')G($)4(#$Q."XV-" U-SDN,#8@5&0@*&=E<RD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y-BXR-2 U-SDN,#8@
M5&0@*#(R+#0R,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0V-2XR-2 U-SDN,#8@5&0@*#$T+#,U-BD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XR-2 U-SDN,#8@5&0@
M*#(T+#,Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-34T+C4P(#4W.2XP-B!4
M9" H,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4Y+C P(#4V."XP-B!49" H3&]S<R!O;B!E87)L>2!E>'1I;F=U:7-H;65N
M="!O9B!D96)T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#$R+C P(#4V."XP-B!49" H-SDI(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN-S4@-38X+C V(%1D("@T+#DV
M.2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M."XW-2 U-C@N,#8@5&0@*#$L-38X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3DN,# @-34W+C V(%1D("A%<75I='D@8V]M
M<&5N<V%T:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# P+C<U(#4U-RXP-B!49" H,RPU-S4I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN-S4@-34W+C V(%1D("@T
M+# X,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S."XW-2 U-3<N,#8@5&0@*#,L,S<Y*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @-30V+C Q(%1D("A/=&AE<B!N
M;VXM8V%S:"!C;W-T<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0P,"XW-2 U-#8N,#$@5&0@*#,L,C,Q*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@Q+C P(#4T-BXP,2!4
M9" H-C@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-#4N-3 @-30V+C Q(%1D("@W-S4I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U.2XP," U,S0N,#8@5&0@*$-H86YG97,@
M:6X@;W!E<F%T:6YG(&%S<V5T<R!A;F0@;&EA8FEL:71I97,Z*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-C4N,# @-3(S+C V
M(%1D("A!8V-O=6YT<R!R96-E:79A8FQE*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-# P+C<U(#4R,RXP-B!49" H,BPX,C I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN
M-S4@-3(S+C V(%1D("@Y+#<P."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S,2XR-2 U,C,N,#8@5&0@*%PH,S L-S@Q*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P
M(#4R,RXP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" V-2XP," U,3(N,#8@5&0@*%!R97!A:60@97AP96YS97,@
M86YD(&]T:&5R(&%S<V5T<RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,Y-RXW-2 U,3(N,#8@5&0@*%PH,BPU,30I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,C$N,# @-3$R
M+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0V.2XW-2 U,3(N,#8@5&0@*#$L.#$V*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C<U(#4Q,BXP-B!49" H
M7"@Q+#@X,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4U.2XP," U,3(N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-C4N,# @-3 Q+C V(%1D("A!8V-O=6YT
M<R!P87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C<U(#4P,2XP-B!49" H
M7"@W+# Y-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0R,2XP," U,#$N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8V+C<U(#4P,2XP-B!49" H7"@Y+#(W
M-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M,"XP," U,#$N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,T+C(U(#4P,2XP-B!49" H,C L,S<P*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-C4N,# @-#DP
M+C V(%1D("A/=&AE<B!L:6%B:6QI=&EE<RD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P-"XU," T.3 N,#8@5&0@*%PH-3DW
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Q
M+C P(#0Y,"XP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-S8N-3 @-#DP+C V(%1D("@X-#<I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-#(N-3 @-#DP+C V
M(%1D("A<*#$T,RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4U.2XP," T.3 N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-#<Y+C V(%1D("A.970@
M8V%S:"!P<F]V:61E9"!B>2!O<&5R871I;F<@86-T:79I=&EE<RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y-BXR-2 T-SDN
M,#8@5&0@*#(P+#DY-RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0V-2XR-2 T-SDN,#8@5&0@*#0U+#4P."D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XR-2 T-SDN,#8@
M5&0@*#,P+#$T-2D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S+C P(#0V,RXR,"!49" H0V%S:"!F;&]W<R!F<BD@5&H@150@
M40IQ(# @," P(')G($)4(#$P,RXY,B T-C,N,C @5&0@*&]M(&EN=F5S=&EN
M9R!A8W1I=FET:65S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3DN,# @-#4R+C V(%1D("A0<F]C965D<R!F<F]M('-A;&4@
M;V8@8G5S:6YE<W,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,3(N,# @-#4R+C V(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#@Q+C P(#0U,BXP-B!49" HERD@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-2XU
M," T-3(N,#8@5&0@*#4P,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4Y+C P(#0T,2XP-B!49" H06-Q=6ES:71I;VYS+"!N
M970@;V8@8V%S:"!A8W%U:7)E9"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,Y-RXW-2 T-#$N,#8@5&0@*%PH,2PY,S I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,C$N,# @
M-#0Q+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0V,BXR-2 T-#$N,#8@5&0@*%PH.#4L.3<W*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#0T,2XP
M-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,S4N-S4@-#0Q+C V(%1D("A<*#$L.3 P*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#0T,2XP-B!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M.2XP," T,S N,#8@5&0@*$%C<75I<VET:6]N+7)E;&%T960@<V5T=&QE;65N
M=',I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,#0N-3 @-#,P+C V(%1D("A<*#$U,2D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0R,2XP," T,S N,#8@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#<S+C4P(#0S
M,"XP-B!49" H7"@R.3(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.3 N,# @-#,P+C V(%1D("A<*2D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XW-2 T,S N,#8@5&0@
M*%PH,2PX-3@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-3DN,# @-#,P+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#0Q.2XP-B!49" H4'5R8VAA
M<V5S(&]F('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S.3<N-S4@-#$Y+C V(%1D("A<
M*#0L-3DW*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#(Q+C P(#0Q.2XP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-C8N-S4@-#$Y+C V(%1D("A<*#4L,2D@
M5&H@150@40IQ(# @," P(')G($)4(#0X,2XP," T,3DN,#8@5&0@*#$I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.#4N-3 @-#$Y+C V(%1D("@Q*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#0Q
M.2XP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S4N-S4@-#$Y+C V(%1D("A<*#8L-3(R*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#0Q.2XP-B!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," T,#@N,#8@5&0@*$YE="!C87-H('5S960@:6X@:6YV97-T:6YG
M(&%C=&EV:71I97,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" S.3<N-S4@-# X+C V(%1D("A<*#8L-C<X*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Q+C P(#0P."XP-B!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-C(N,C4@-# X+C V(%1D("A<*#DQ+#,X,"D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,"XP," T,#@N,#8@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U
M+C<U(#0P."XP-B!49" H7"@Y+#<X,"D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4U.2XP," T,#@N,#8@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @,SDR
M+C(P(%1D("A#87-H(&9L;W=S(&9R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 S+CDR(#,Y,BXR,"!49" H;VT@9FEN86YC:6YG(&%C=&EV:71I97,I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," S
M.#$N,#8@5&0@*%!R;V-E961S(&9R;VT@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3$S+C0P(#,X,2XP-B!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#$Q."XU," S.#$N,#8@5&0@*&5R;2!,;V%N<RD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,BXP," S.#$N,#8@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N
M,C4@,S@Q+C V(%1D("@V,BPP,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S0N,C4@,S@Q+C V(%1D("@T,"PP,# I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP," S
M-S N,#8@5&0@*%!R:6YC:7!A;"!P87EM96YT<R!O;B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-#$N-C4@,S<P+C V(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,30V+C<V(#,W,"XP-B!49" H97)M($QO86YS*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDS+C(U(#,W,"XP
M-B!49" H7"@Q-BPQ,C0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,C$N,# @,S<P+C V(%1D("A<*2D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-BXW-2 S-S N,#8@5&0@
M*%PH,2PU,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.3 N,# @,S<P+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XR-2 S-S N,#8@5&0@*%PH,S L
M-3 P*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-34Y+C P(#,W,"XP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U.2XP," S-3DN,#8@5&0@*$-O;G9E<G1I8FQE
M($YO=&4@8V%S:"!P87EM96YT*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#$R+C P(#,U.2XP-B!49" HERD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-BXW-2 S-3DN,#8@
M5&0@*%PH-2PP,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.3 N,# @,S4Y+C V(%1D("A<*2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U,"XP," S-3DN,#8@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U.2XP
M," S-#@N,#8@5&0@*$)O<G)O=VEN9W,@;VX@<F5V;VQV:6YG(&-R961I="!F
M86-I;&ET>2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Q,BXP," S-#@N,#8@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@,S0X+C V(%1D("@S.2PP,# I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N
M,C4@,S0X+C V(%1D("@U.2PX,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U.2XP," S,S<N,#8@5&0@*%)E<&%Y;65N=',@
M;VX@<F5V;VQV:6YG(&-R961I="!F86-I;&ET>2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,BXP," S,S<N,#8@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C(N
M,C4@,S,W+C V(%1D("A<*#,Y+# P,"D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y,"XP," S,S<N,#8@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C(U(#,S
M-RXP-B!49" H7"@V-RPX,# I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-3DN,# @,S,W+C V(%1D("A<*2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y+C P(#,R-BXP-B!4
M9" H1&5B="!I<W-U86YC92!C;W-T<RD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P-"XU," S,C8N,#8@5&0@*%PH,S X*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Q+C P
M(#,R-BXP-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-S,N-3 @,S(V+C V(%1D("A<*#DP,2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,"XP," S,C8N,#8@
M5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,U+C<U(#,R-BXP-B!49" H7"@Q+#$X,BD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XP," S,C8N,#8@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN
M,# @,S$U+C V(%1D("A%>'1I;F=U:7-H;65N="!F965S*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#$R+C P(#,Q-2XP-B!4
M9" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0W,RXU," S,34N,#8@5&0@*%PH-3<X*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DP+C P(#,Q-2XP-B!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-#(N-3 @
M,S$U+C V(%1D("A<*#8T,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4U.2XP," S,34N,#8@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3DN,# @,S T+C V(%1D
M("A3=&]C:R!R97!U<F-H87-E(&%N9"!R971I<F5M96YT*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C<U(#,P-"XP-B!4
M9" H7"@U+# P,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0R,2XP," S,#0N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#@Q+C P(#,P-"XP-B!49" HERD@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U,"XP
M," S,#0N,#8@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U.2XP," R.3,N,#8@5&0@*$]T:&5R*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C<U(#(Y,RXP-B!4
M9" H7"@R+#,S-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0R,2XP," R.3,N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C<U(#(Y,RXP-B!49" H7"@S
M+#(V-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y,"XP," R.3,N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,U+C<U(#(Y,RXP-B!49" H7"@Q+#@T,2D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XP
M," R.3,N,#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,N,# @,C@R+C V(%1D("A.970@8V%S:"!<*'5S960@
M:6Y<*2!P<F]V:61E9"!B>2!F:6YA;F-I;F<@86-T:79I=&EE<RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,RXR-2 R.#(N
M,#8@5&0@*%PH,C,L-S8W*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#(Q+C P(#(X,BXP-B!49" H7"DI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@,C@R+C V(%1D
M("@U,"PW-38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,S4N-S4@,C@R+C V(%1D("A<*#(L,38T*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#(X,BXP-B!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,RXP," R-C$N,#8@5&0@*$5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C$N
M-#$@,C8Q+C V(%1D("AF96-T(&]F(&5X8VAA;F=E(')A=&4@8VAA;F=E<R!O
M;B!C87-H*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-# Y+C P(#(V,2XP-B!49" H7"@W,"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XP," R-C$N,#8@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@Q+C P
M(#(V,2XP-B!49" H,C,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U-#<N,# @,C8Q+C V(%1D("A<*#(T*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C P(#(V,2XP-B!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,RXP," R-# N,#8@5&0@*$-H86YG92!I;B!C87-H(&%N9"!C87-H(&5Q
M=6EV86QE;G1S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,SDW+C<U(#(T,"XP-B!49" H7"@Y+#4Q."D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XP," R-# N,#8@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#8Y+C<U(#(T,"XP-B!49" H-"PY,#<I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,S0N,C4@,C0P+C V(%1D("@Q."PQ-S<I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP
M," R,CDN,#8@5&0@*$-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@870@8F5G
M:6YN:6YG(&]F('EE87(I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" S.38N,C4@,C(Y+C V(%1D("@R-2PU,S<I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N,C4@,C(Y+C V
M(%1D("@R,"PV,S I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S@N-S4@,C(Y+C V(%1D("@R+#0U,RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#(Q."XP,2!49" H
M0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!A="!E;F0@;V8@>65A<BD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXP," R
M,3@N,#$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" S.38N,C4@,C$X+C Q(%1D("@Q-BPP,3DI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,S$N,# @,C$X+C Q(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#8U+C(U(#(Q."XP,2!49" H,C4L-3,W*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 P+C P(#(Q."XP,2!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XR-2 R
M,3@N,#$@5&0@*#(P+#8S,"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4S+C P(#$Y-"XR,"!49" H4W5P<&QE;65N=&%L(&1I
M<V-L;W-U<BD@5&H@150@40IQ(# @," P(')G($)4(#$T,BXV," Q.30N,C @
M5&0@*&4@;V8@8V%S:"!F;&]W(&EN9F]R;6%T:6]N.BD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#$X,RXP-B!49" H
M26YT97)E<W0@<&%I9"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V,BXP," Q.#,N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N-S4@,3@S+C V(%1D("@V
M+#,T,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,2XP," Q.#,N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-CDN-S4@,3@S+C V(%1D("@S+#0P."D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4P,"XP," Q
M.#,N,#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S@N-S4@,3@S+C V(%1D("@S+#@Y,RD@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#$W,BXP-B!49" H
M26YC;VUE('1A>&5S('!A:60I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-C(N,# @,3<R+C V(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-# P+C<U(#$W,BXP-B!4
M9" H,2PP-#,I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,S$N,# @,3<R+C V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<V+C4P(#$W,BXP-B!49" H-CDW*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3 P+C P
M(#$W,BXP-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S."XW-2 Q-S(N,#8@5&0@*#$L-S<S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-34N,S @,30V+C(U(%1D("A3964@86-C;VUP86YY:6YG(&YO=&5S
M+BD@5&H@150@40IE;F1S=')E86T*96YD;V)J"C$Q-R P(&]B:@H\/"]4>7!E
M("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y
M,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$Q
M." P(%(^/@IE;F1O8FH*,3$X(# @;V)J"CP\+TQE;F=T:" Q,S4P.#X^"G-T
M<F5A;0I"5" O1C(@-BXP,"!49B!%5 IQ(# @," P(')G($)4(#,P-BXP," W
M-S4N-#4@5&0@*" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C$S+C@U(#<V,RXT-2!49" H0U)/4U,@0T]53E12*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,RXT-2!49" H62D@5&H@150@
M40IQ(# @," P(')G($)4(#(Y.2XU,R W-C,N-#4@5&0@*"!(14%,*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,RXT-2!49" H5$A#05)%+"!)
M3D,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$W-2XS," W-3$N-#4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G
M($)4(#(Q,2XU,B W-3$N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R,3@N,#$@-S4Q+C0U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @
M," P(')G($)4(#(X."XQ,2 W-3$N-#4@5&0@*%1%1"!&24Y!3D-)04PI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S4Q+C0U(%1D("@@4U0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S4Q+C0U(%1D("A!*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S@W+C<V(#<U,2XT-2!49" H5$5-14Y44RD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N
M,S4@-S,Y+C0U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.3<N.# @,S,N-C @5&0@
M*$8M(#@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-S U+C<U(%1D("@Q+B!/<F=A;FEZ871I;VX@86YD($)A<VES
M(&]F(%!R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@S+C(R(#<P-2XW-2!4
M9" H97-E;G1A=&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," V.3,N-S4@5&0@** I(%1J($54(%$*0E0@+T8S
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@Q+C<U(%1D("A.
M871U<F4@;V8@0G5S:6YE<W,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#8U-RXW-2!49" H0W)O<W,@0V]U;G1R
M>2!(96%L=&AC87)E+"!);F,N(%PH=&AE($-O;7!A;GE<*2!W87,@:6YC;W)P
M;W)A=&5D(&EN($1E;&%W87)E(&]N($IU;'D@,CDL(#$Y.3D@87,@82!B=7-I
M;F5S<R!P<F]V:61I;F<@=')A=F5L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#4N-S4@5&0@*&YU<G-E(&%N
M9"!A;&QI960@:&5A;'1H('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-38N-3 @-C0U+C<U(%1D("AF:6YG('-E<G9I8V5S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,3$N-S<@-C0U+C<U(%1D("A!<R!O9B!$96-E;6)E<B S
M,2P@,C Q."P@=&AE($-O;7!A;GD@:7,@82!L96%D:6YG(&YA=&EO;F%L('!R
M;W9I9&5R(&]F(&YU<G-E(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-C,S+C<U(%1D("AA;&QI960@<W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#@X+C0W(#8S,RXW-2!49" H9FEN
M9RP@<F5C<G5I=&EN9RP@86YD('9A;'5E+6%D9&5D('=O<FMF;W)C92!S;VQU
M=&EO;B!S97)V:6-E<RP@;75L=&DM<W!E8VEA;'1Y(&QO8W5M('1E;F5N<R!<
M*'1E;7!O<F%R>2!P:'ES:6-I86X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8R,2XW-2!49" H<W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#8S+C<V(#8R,2XW-2!49" H9FEN9UPI('-E
M<G9I8V5S+"!A<R!W96QL(&%S(&$@<')O=FED97(@;V8@;W1H97(@:'5M86X@
M8V%P:71A;"!M86YA9V5M96YT('-E<G9I8V5S(&9O8W5S960@;VX@:&5A;'1H
M8V%R92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-3DW+C<U(%1D("A4:&4@8V]N<V]L:61A=&5D(&9I;F%N8VEA
M;"!S=&%T96UE;G1S(&EN8VQU9&4@=&AE(&%C8V]U;G1S(&]F('1H92!#;VUP
M86YY(&%N9"!I=',@9&ER96-T(&%N9"!I;F1I<F5C="!W:&]L;'DM;W=N960@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#4X-2XW-2!49" H<W5B<VED:6%R:65S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#$N-30@-3@U+C<U(%1D("A4:&4@8V]N<V]L:61A=&5D(&9I
M;F%N8VEA;"!S=&%T96UE;G1S(&EN8VQU9&4@86QL(&%S<V5T<RP@;&EA8FEL
M:71I97,L(')E=F5N=64L(&%N9"!E>'!E;G-E<R!O9B!#<F]S<R!#;W5N=')Y
M("D@5&H@150@40IQ(# @," P(')G($)4(#4S,RXQ.2 U.#4N-S4@5&0@*%0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S@N-C @-3@U+C<U(%1D("AA;&5N
M=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-3<S+C<U(%1D("A!8W%U:7-I=&EO;B!'<F]U<"P@3$Q#(%PH9F]R
M;65R;'D@26YT96QI4W1A9B!O9B!/:VQA:&]M82P@3$Q#7"DL('=H:6-H(&ES
M(&-O;G1R;VQL960@8GD@=&AE($-O;7!A;GD@8G5T(&YO="!W:&]L;'D@;W=N
M960N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," U-C$N-S4@5&0@*%1H92!#;VUP86YY(')E8V]R9',@=&AE(&]W
M;F5R<VAI<"!I;G1E<F5S="!O9B!T:&4@;F]N8V]N=')O;&QI;F<@<VAA<F5H
M;VQD97(@87,@;F]N8V]N=')O;&QI;F<@:6YT97)E<W0@:6X@<W5B<VED:6%R
M>2D@5&H@150@40IQ(# @," P(')G($)4(#4R,BXV,R U-C$N-S4@5&0@*"X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(W+C X(#4V,2XW-2!49" H06QL
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," U-#DN-S4@5&0@*&EN=&5R8V]M<&%N>2!T<F%N<V%C=&EO;G,@86YD
M(&)A;&%N8V5S(&AA=F4@8F5E;B!E;&EM:6YA=&5D(&EN(&-O;G-O;&ED871I
M;VXN("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," U,C4N-S4@5&0@*$-E<G1A:6X@<')I;W(@>65A<B!A;6]U;G1S
M(&AA=F4@8F5E;B!R96-L87-S:69I960@=&\@8V]N9F]R;2!T;R!T:&4@8W5R
M<F5N="!Y96%R('!R97-E;G1A=&EO;BX@4V5E(&-O;G-O;&ED871E9"!B86QA
M;F-E('-H965T<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3$S+C<U(%1D("AA;F0@8V]N<V]L:61A=&5D('-T
M871E;65N=',@;V8@8V%S:"!F;&]W<RXI(%1J($54(%$*0E0@+T8S(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#@Y+C<U(%1D("A,:7%U:61I
M='D@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#DN,C(@-#@Y+C<U(%1D("AA
M;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 W+C(X(#0X.2XW-2!49" H
M3W!E<F%T:6]N<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," T-C4N-S4@5&0@*$)A<V5D("D@5&H@150@40IQ(# @
M," P(')G($)4(#<V+C,W(#0V-2XW-2!49" H=7!O;B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y."XX," T-C4N-S4@5&0@*&-U<G)E;G0@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3(Y+C4U(#0V-2XW-2!49" H<')O:F5C=&EO;G,L
M("D@5&H@150@40IQ(# @," P(')G($)4(#$W."XY,2 T-C4N-S4@5&0@*'1H
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3,N-38@-#8U+C<U(%1D("A#
M;VUP86YY("D@5&H@150@40IQ(# @," P(')G($)4(#(S-"XX." T-C4N-S4@
M5&0@*'=I;&P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4R+C@W(#0V-2XW
M-2!49" H;F]T("D@5&H@150@40IQ(# @," P(')G($)4(#(V."XP." T-C4N
M-S4@5&0@*'-A=&ES9GD@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDV+C8R
M(#0V-2XW-2!49" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,2XR
M-R T-C4N-S4@5&0@*')E<75I<F5D("D@5&H@150@40IQ(# @," P(')G($)4
M(#,T-RXP,2 T-C4N-S4@5&0@*&QE=F5R86=E("D@5&H@150@40IQ(# @," P
M(')G($)4(#,X,RXS,2 T-C4N-S4@5&0@*')A=&EO("D@5&H@150@40IQ(# @
M," P(')G($)4(#0P-"XP-R T-C4N-S4@5&0@*'5N9&5R("D@5&H@150@40IQ
M(# @," P(')G($)4(#0R.2XR-R T-C4N-S4@5&0@*&ET<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-#$N,34@-#8U+C<U(%1D("A#<F5D:70@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#8X+C T(#0V-2XW-2!49" H06=R965M96YT
M("D@5&H@150@40IQ(# @," P(')G($)4(#4Q-"XX.2 T-C4N-S4@5&0@*&%S
M("D@5&H@150@40IQ(# @," P(')G($)4(#4R-2XV-2 T-C4N-S4@5&0@*&]F
M("D@5&H@150@40IQ(# @," P(')G($)4(#4S-BXT,2 T-C4N-S4@5&0@*$UA
M<F-H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," T-3,N-S4@5&0@*#,Q+" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" V-"XR.2 T-3,N-S4@5&0@*#(P,3DN("D@5&H@150@40IQ(# @," P(')G
M($)4(#@X+C4X(#0U,RXW-2!49" H07,@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3 Q+CDY(#0U,RXW-2!49" H82 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,#@N-S,@-#4S+C<U(%1D("AR97-U;'0L("D@5&H@150@40IQ(# @," P
M(')G($)4(#$S-2XW-" T-3,N-S4@5&0@*&$@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,30R+C0W(#0U,RXW-2!49" H9&5B=" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-C$N.3@@-#4S+C<U(%1D("AP<F5P87EM96YT("D@5&H@150@
M40IQ(# @," P(')G($)4(#(Q,2XT." T-3,N-S4@5&0@*&]F("D@5&H@150@
M40IQ(# @," P(')G($)4(#(R,BXQ," T-3,N-S4@5&0@*&)E='=E96X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C4W+C<Q(#0U,RXW-2!49" H)#$P("D@
M5&H@150@40IQ(# @," P(')G($)4(#(W-2XP,2 T-3,N-S4@5&0@*&UI;&QI
M;VX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S V+C(P(#0U,RXW-2!49" H
M86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,R,BXY,R T-3,N-S4@5&0@
M*"0Q,B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-# N,C(@-#4S+C<U(%1D
M("AM:6QL:6]N("D@5&H@150@40IQ(# @," P(')G($)4(#,W,2XT,2 T-3,N
M-S4@5&0@*'=O=6QD("D@5&H@150@40IQ(# @," P(')G($)4(#,Y."XW,2 T
M-3,N-S4@5&0@*&)E("D@5&H@150@40IQ(# @," P(')G($)4(#0Q,"XT-" T
M-3,N-S4@5&0@*')E<75I<F5D("D@5&H@150@40IQ(# @," P(')G($)4(#0T
M-BXP-2 T-3,N-S4@5&0@*'1O("D@5&H@150@40IQ(# @," P(')G($)4(#0U
M-BXQ,B T-3,N-S4@5&0@*')E;6%I;B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.#8N,3@@-#4S+C<U(%1D("AI;B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.38N,C4@-#4S+C<U(%1D("AC;VUP;&EA;F-E+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U-#8N.3<@-#4S+C<U(%1D("A4:&4@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0T,2XW-2!4
M9" H0V]M<&%N>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,BXP." T-#$N
M-S4@5&0@*&)E;&EE=F5S("D@5&H@150@40IQ(# @," P(')G($)4(#$R."XU
M-" T-#$N-S4@5&0@*'-U8V@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34P
M+C4V(#0T,2XW-2!49" H<')E<&%Y;65N=" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,#$N-#8@-#0Q+C<U(%1D("AW:6QL("D@5&H@150@40IQ(# @," P
M(')G($)4(#(R,"XW,2 T-#$N-S4@5&0@*&)E("D@5&H@150@40IQ(# @," P
M(')G($)4(#(S,RXX-" T-#$N-S4@5&0@*'-U9BD@5&H@150@40IQ(# @," P
M(')G($)4(#(T-2XX." T-#$N-S4@5&0@*&9I8VEE;G0@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C<U+C$R(#0T,2XW-2!49" H=&\@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C@V+C4Y(#0T,2XW-2!49" H;6%I;G1A:6X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S(U+C(W(#0T,2XW-2!49" H8V]M<&QI86YC
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S4N,#8@-#0Q+C<U(%1D("AW
M:71H("D@5&H@150@40IQ(# @," P(')G($)4(#,Y-BXU,R T-#$N-S4@5&0@
M*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3(N-#0@-#0Q+C<U(%1D
M("AL979E<F%G92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3 N,# @-#0Q
M+C<U(%1D("AR871I;R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S(N,#$@
M-#0Q+C<U(%1D("AC;W9E;F%N=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M,3$N.# @-#0Q+C<U(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3(Y+CDS(#0T,2XW-2!49" H;65E=" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U-3,N,#8@-#0Q+C<U(%1D("AI=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0R.2XW-2!49" H;V)L:6=A
M=&EO;G,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.38N,C8@-#(Y+C<U(%1D
M("AF;W(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$P+C(S(#0R.2XW-2!4
M9" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#$R-"XW-B T,CDN-S4@
M5&0@*&YE>'0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30T+C(Y(#0R.2XW
M-2!49" H='=E;'9E("D@5&H@150@40IQ(# @," P(')G($)4(#$W,RXR-B T
M,CDN-S4@5&0@*&UO;G1H<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C W
M+C4S(#0R.2XW-2!49" H26X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X
M+C$W(#0R.2XW-2!49" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(S
M,BXW," T,CDN-S4@5&0@*&5V96YT("D@5&H@150@40IQ(# @," P(')G($)4
M(#(U-BXV-R T,CDN-S4@5&0@*&%C='5A;" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R.#(N.#8@-#(Y+C<U(%1D("AR97-U;'1S("D@5&H@150@40IQ(# @
M," P(')G($)4(#,Q,2XR." T,CDN-S4@5&0@*&1I9BD@5&H@150@40IQ(# @
M," P(')G($)4(#,R,BXR,2 T,CDN-S4@5&0@*&9E<B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,S4N-C(@-#(Y+C<U(%1D("AS:6=N:69I8V%N=&QY("D@
M5&H@150@40IQ(# @," P(')G($)4(#,X-RXY,R T,CDN-S4@5&0@*&9R;VT@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# Y+C8X(#0R.2XW-2!49" H8W5R
M<F5N=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-# N,S$@-#(Y+C<U(%1D
M("AP<F]J96-T:6]N<RP@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@Y+C4V
M(#0R.2XW-2!49" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#4P-"XP
M.2 T,CDN-S4@5&0@*$-O;7!A;GD@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-30U+C(Y(#0R.2XW-2!49" H;6%Y("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,3<N-S4@5&0@*&)E("D@5&H@
M150@40IQ(# @," P(')G($)4(#8R+C S(#0Q-RXW-2!49" H<F5Q=6ER960@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3@N-#,@-#$W+C<U(%1D("AT;R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#DN,CD@-#$W+C<U(%1D("AM86ME
M("D@5&H@150@40IQ(# @," P(')G($)4(#$S-"XP-" T,3<N-S4@5&0@*&%D
M9&ET:6]N86P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<W+C$Q(#0Q-RXW
M-2!49" H9&5B=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3<N-#(@-#$W
M+C<U(%1D("AP<F5P87EM96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C4T+C$P(#0Q-RXW-2!49" H1G5R=&AE<BD@5&H@150@40IQ(# @," P(')G
M($)4(#(X,RXQ-" T,3<N-S4@5&0@*"P@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C@X+C<S(#0Q-RXW-2!49" H=&AE("D@5&H@150@40IQ(# @," P(')G
M($)4(#,P-"XP,R T,3<N-S4@5&0@*$-O;7!A;GD@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S0V+C P(#0Q-RXW-2!49" H;6%Y("D@5&H@150@40IQ(# @
M," P(')G($)4(#,V-BXS,2 T,3<N-S4@5&0@*&)E("D@5&H@150@40IQ(# @
M," P(')G($)4(#,W."XX,R T,3<N-S4@5&0@*&%B;&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,SDX+C4X(#0Q-RXW-2!49" H=&\@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# Y+C0T(#0Q-RXW-2!49" H86UE;F0@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#,Y+C$Y(#0Q-RXW-2!49" H:71S("D@5&H@150@
M40IQ(# @," P(')G($)4(#0U,2XW,B T,3<N-S4@5&0@*$-R961I=" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T-SDN,3(@-#$W+C<U(%1D("A!9W)E96UE
M;G0L("D@5&H@150@40IQ(# @," P(')G($)4(#4R.2XQ,R T,3<N-S4@5&0@
M*&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#8N-C8@-#$W+C<U(%1D
M("AA<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-3@N,#@@-#$W+C<U(%1D
M("AA("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," T,#4N-S4@5&0@*')E<W5L="P@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-S8N-S(@-# U+C<U(%1D("AW;W5L9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#0N,C(@-# U+C<U(%1D("AN;W0@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3$Y+C4P(#0P-2XW-2!49" H8F4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3,Q+C0S(#0P-2XW-2!49" H<F5Q=6ER960@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,38W+C(U(#0P-2XW-2!49" H=&\@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3<W+C4S(#0P-2XW-2!49" H;6%K92 I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,#$N-C@@-# U+C<U(%1D("AA;GD@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C$X+C8R(#0P-2XW-2!49" H9&5B=" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,S@N,S0@-# U+C<U(%1D("AP<F5P87EM
M96YT<RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S@Q+C<U(%1D("@R+B!3=6UM87)Y(&]F(%-I9VYI9FEC86YT
M("D@5&H@150@40IQ(# @," P(')G($)4(#$V,RXQ,B S.#$N-S4@5&0@*$%C
M8V]U;G1I;F<@4&]L:6-I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,S8Y+C<U(%1D("B@*2!4:B!%5"!1"D)4
M("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,U-RXW-2!4
M9" H57-E(&]F($5S=&EM871E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," S-#4N-S4@5&0@** I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,S0N,#4@
M5&0@*%1H92!P<F5P87)A=&EO;B!O9B!C;VYS;VQI9&%T960@9FEN86YC:6%L
M('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(%5N:71E9"!3=&%T97,@
M9V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<R I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S
M,C(N,S4@5&0@*%PH52Y3+B!'04%07"DL(')E<75I<F5S(&UA;F%G96UE;G0@
M=&\@;6%K92!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS('1H870@868I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-3<N,C @,S(R+C,U(%1D("AF96-T('1H
M92!R97!O<G1E9"!A;6]U;G1S(&EN('1H92!C;VYS;VQI9&%T960@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S$P
M+C8U(%1D("AF:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@86-C;VUP86YY:6YG
M(&YO=&5S+B!3:6=N:69I8V%N="!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS
M(&%R92!U<V5D(&9O<BD@5&H@150@40IQ(# @," P(')G($)4(#0R-RXV-" S
M,3 N-C4@5&0@*"P@8G5T(&YO="!L:6UI=&5D('1O.B!<*#%<*2!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,CDX+CDU(%1D("AV86QU871I;VX@;V8@86-C;W5N=',@<F5C96EV86)L93L@
M7"@R7"D@9V]O9'=I;&PL('1R861E(&YA;65S+"!A;F0@;W1H97(@:6YT86YG
M:6)L92!A<W-E=',[(%PH,UPI(&]T:&5R(&QO;F<M;&EV960@87-S971S.R!<
M*#1<*2!S:&%R92UB87-E9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R.#<N,C4@5&0@*&-O;7!E;G-A=&EO;CL@
M7"@U7"D@86-C<G5A;',@9F]R(&AE86QT:"P@=V]R:V5R<Y(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R,S,N-#(@,C@W+C(U(%1D("@@8V]M<&5N<V%T:6]N
M+"!A;F0@<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;&%I;7,[(%PH-EPI('9A
M;'5A=&EO;B!O9B!D969E<G)E9"!T87@@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C<U+C4U(%1D("AA<W-E=',[
M(%PH-UPI('!U<F-H87-E('!R:6-E(&%L;&]C871I;VX[(%PH.%PI(&9A:7(@
M=F%L=64@;V8@:6YT97)E<W0@<F%T92!S=V%P(&%G<F5E;65N=#L@7"@Y7"D@
M;&5G86P@8V]N=&EN9V5N8VEE<SL@7"@Q,%PI(&-O;G1I;F=E;G0@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C8S
M+C@U(%1D("AC;VYS:61E<F%T:6]N<SL@7"@Q*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3$X+C<S(#(V,RXX-2!49" H,5PI(&EN8V]M92!T87AE<SL@86YD
M(%PH,3)<*2!S86QE<R!A;F0@;W1H97(@;F]N+6EN8V]M92!T87@@;&EA8FEL
M:71I97,N("D@5&H@150@40IQ(# @," P(')G($)4(#,X-2XQ-B R-C,N.#4@
M5&0@*$%C8W)U960@:6YS=7)A;F-E(&-L86EM<R!A;F0@<F5S97)V97,@*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,C4R+C$U(%1D("AI;F-L=61E(&5S=&EM871E9"!S971T;&5M96YT<R!F<F]M
M(&MN;W=N(&-L86EM<R!A;F0@86-T=6%R:6%L(&5S=&EM871E<R!F;W(@8VQA
M:6US(&EN8W5R<F5D(&)U="!N;W0@<F5P;W)T960N("D@5&H@150@40IQ(# @
M," P(')G($)4(#0W.2XT-B R-3(N,34@5&0@*$%C='5A;"!R97-U;'1S(&-O
M=6QD("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#(T,"XT-2!49" H9&EF*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-C N,34@,C0P+C0U(%1D("AF97(@9G)O;2!T:&]S92!E<W1I;6%T97,N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(R."XT-2!49" HH"D@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," R,38N-#4@5&0@*$-A<V@@86YD($-A<V@@17%U
M:79A;&5N=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,C T+C0U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3DR+C<U(%1D("A4:&4@0V]M
M<&%N>2!C;VYS:61E<G,@86QL(&EN=F5S=&UE;G1S('=I=&@@;W)I9VEN86P@
M;6%T=7)I=&EE<R!O9B!T:')E92!M;VYT:',@;W(@;&5S<R!T;R!B92!C87-H
M(&%N9"!C87-H(&5Q=6EV86QE;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,3DN.30@,3DR+C<U(%1D("A4:&4@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@Q+C U(%1D("A#;VUP86YY
M(&EN=F5S=',@:71S(&5X8V5S<R!C87-H(&EN(&AI9VAL>2!R871E9"!O=F5R
M;FEG:'0@9G5N9',@86YD(&]T:&5R(&AI9VAL>2!R871E9"!L:7%U:60@86-C
M;W5N=',N("D@5&H@150@40IQ(# @," P(')G($)4(#0U-"XQ-2 Q.#$N,#4@
M5&0@*%1H92!#;VUP86YY(&ES(&5X<&]S960@*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,38Y+C,U(%1D("AT;R!C
M<F5D:70@<FES:R!A<W-O8VEA=&5D('=I=&@@=&AE<V4@:6YV97-T;65N=',N
M("D@5&H@150@40IQ(# @," P(')G($)4(#(S-RXR-" Q-CDN,S4@5&0@*%1H
M92!#;VUP86YY(&UI;FEM:7IE<R!I=',@8W)E9&ET(')I<VL@<F5L871I;F<@
M=&\@=&AE<V4@<&]S:71I;VYS(&)Y(&UO;FET;W)I;F<@*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,34W+C8U(%1D
M("AT:&4@9FEN86YC:6%L(&-O;F1I=&EO;B!O9B!T:&4@9FEN86YC:6%L(&EN
M<W1I='5T:6]N<R!I;G9O;'9E9"!A;F0@8GD@<')I;6%R:6QY(&-O;F1U8W1I
M;F<@8G5S:6YE<W,@=VET:"!L87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-C(N,# @,34W+C8U(%1D("AG92P@=V5L;"!E<W1A8FQI<VAE9" I(%1J($54
M(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-#4N
M.34@5&0@*&9I;F%N8VEA;"!I;G-T:71U=&EO;G,L(&%N9"!D:79E<G-I9GEI
M;F<@:71S(&-O=6YT97)P87)T:65S+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R-S$N.3$@,30U+CDU(%1D("A4:&4@0V]M<&%N>2!D;V5S(&YO="!C=7)R
M96YT;'D@86YT:6-I<&%T92!N;VYP97)F;W)M86YC92!B>2!A;GD@;V8@:71S
M("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$S-"XR-2!49" H<VEG;FEF:6-A;G0@8V]U;G1E<G!A<G1I97,N*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3(R+C4U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,3$P+C@U(%1D("A);G1E<F5S="!I;F-O;64@;VX@
M8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!O9B I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R,S<N.30@,3$P+C@U(%1D("@D
M,"XT(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" R.#4N-C$@,3$P+C@U(%1D("@@9F]R('1H92!Y96%R(&5N9&5D
M($1E8V5M8F5R(#,Q+" R,#$X+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#4Y+C$T(#$Q,"XX-2!49" H)# N,2!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@-3 V+C@Q(#$Q,"XX-2!49" H(&9O<B!T:&4@>65A<G,@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.3DN,34@
M5&0@*&5N9&5D($1E8V5M8F5R(#,Q+" R,#$W(&%N9" R,#$V+"!I<R!I;F-L
M=61E9"!I;B!O=&AE<B!I;F-O;64L(&YE="P@;VX@=&AE($-O;7!A;GF2*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,SDP+C$S(#DY+C$U(%1D("AS(&-O;G-O
M;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#@W+C$U(%1D
M("B@*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3$Y(# @;V)J"CP\+U1Y
M<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @
M-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@
M,3(P(# @4CX^"F5N9&]B:@HQ,C @,"!O8FH*/#PO3&5N9W1H(#$R.3(Y/CX*
M<W1R96%M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX
M-2 W-C N-S4@5&0@*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G
M($)4(#(Y,BXV." W-C N-S4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.3DN-3,@-S8P+C<U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G
M($)4(#,R.2XT-2 W-C N-S4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S0X+C<U
M(%1D("A.3U1%4R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S0X
M+C<U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<T."XW
M-2!49" H3R!#3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N
M,3$@-S0X+C<U(%1D("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S8W+C(Y(#<T."XW-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S@Q+C(X(#<T."XW-2!49" H02D@5&H@150@40IQ(# @," P(')G
M($)4(#,X-RXW-B W-#@N-S4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4X+C,U(#<S-BXW-2!49" H
M1$5#14U"15*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-S$R+C<U(%1D("@R+B!3=6UM87)Y(&]F
M(%-I9VYI9FEC86YT("D@5&H@150@40IQ(# @," P(')G($)4(#$V,RXV,B W
M,3(N-S4@5&0@*$%C8V]U;G1I;F<@4&]L:6-I97,@7"AC;VYT:6YU961<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.3<N
M.# @,S,N-C @5&0@*$8M(#DI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-CDU+C(U(%1D("A!8V-O=6YT<R!296-E
M:79A8FQE+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,SDN,SD@-CDU+C(U
M(%1D("A!;&QO=V%N8V4@9F]R($1O=6)T9G5L("D@5&H@150@40IQ(# @," P
M(')G($)4(#(S.2XS," V.34N,C4@5&0@*$%C8V]U;G1S+"!A;F0@0V]N8V5N
M=')A=&EO;B!O9B!#<F5D:70@4FES:RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.#,N,C4@5&0@** I(%1J($54
M(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-S$N
M-34@5&0@*$%C8V]U;G1S(')E8V5I=F%B;&4@<&]T96YT:6%L;'D@<W5B:F5C
M="!T:&4@0V]M<&%N>2!T;R!C;VYC96YT<F%T:6]N<R!O9B!C<F5D:70@<FES
M:RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@S+CDX(#8W,2XU-2!49" H
M5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0R+C(P(#8W
M,2XU-2!49" H<R!C=7-T;VUE<G,@87)E('!R:6UA<FEL>2 I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-3DN.#4@
M5&0@*&AE86QT:&-A<F4@<')O=FED97)S+"!A;F0@86-C;W5N=',@<F5C96EV
M86)L92!R97!R97-E;G0@86UO=6YT<R!D=64@9G)O;2!T:&5M+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C0N.3D@-C4Y+C@U(%1D("A4:&4@0V]M<&%N
M>2!G96YE<F%L;'D@9&]E<R!N;W0@<F5Q=6ER92 I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#@N,34@5&0@*&-O
M;&QA=&5R86P@86YD(&UI=&EG871E<R!I=',@8W)E9&ET(')I<VL@8GD@<&5R
M9F]R;6EN9R!C<F5D:70@979A;'5A=&EO;G,@86YD(&UO;FET;W)I;F<@870M
M<FES:R!A8V-O=6YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4T+C8U
M(#8T."XQ-2!49" H5&AE(&%L;&]W86YC92!F;W(@9&]U8G1F=6P@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C,V
M+C0U(%1D("AA8V-O=6YT<R!R97!R97-E;G1S('1H92!#;VUP86YYDBD@5&H@
M150@40IQ(# @," P(')G($)4(#$X,BXY." V,S8N-#4@5&0@*',@97-T:6UA
M=&4@;V8@=6YC;VQL96-T:6)L92!R96-E:79A8FQE<R!R97-U;'1I;F<@9G)O
M;2!T:&4@:6YA8FEL:71Y(&]F(&ET<R!C=7-T;VUE<G,@=&\@;6%K92 I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M,C0N-S4@5&0@*')E<75I<F5D('!A>6UE;G1S+"!W:&EC:"!R97-U;'1S(&EN
M(&$@<')O=FES:6]N(&9O<B!B860@9&5B="!E>'!E;G-E+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S,C(N-3,@-C(T+C<U(%1D("A4:&4@861E<75A8WD@
M;V8@=&AI<R!A;&QO=V%N8V4@:7,@9&5T97)M:6YE9"!B>2!C;VYT:6YU86QL
M>2 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," V,3,N,#4@5&0@*&5V86QU871I;F<@:6YD:79I9'5A;"!C=7-T;VUE
M<B!R96-E:79A8FQE<RP@8V]N<VED97)I;F<@=&AE(&-U<W1O;65R)W,@9FEN
M86YC:6%L(&-O;F1I=&EO;BP@8W)E9&ET(&AI<W1O<GDI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T-38N-S8@-C$S+C U(%1D("@L(&%N9"!C=7)R96YT(&5C
M;VYO;6EC("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#8P,2XS-2!49" H8V]N9&ET:6]N<RX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@.30N.#(@-C Q+C,U(%1D("A4:&4@0V]M<&%N>2!W<FET
M97,@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#8N.3@@-C Q+C,U(%1D
M("AF('-P96-I9FEC*2!4:B!%5"!1"D)4("]&,B Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@,C(R+CDX(#8P,2XS-2!49" HH"D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#(R-2XT,B V,#$N,S4@5&0@*&%C
M8V]U;G1S(&)A<V5D(&]N(&%N(&]N9V]I;F<@<F5V:65W(&]F(&-O;&QE8W1A
M8FEL:71Y(&%S('=E;&P@87,@<&%S="!E>'!E<FEE;F-E('=I=&@@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3@Y
M+C,U(%1D("AT:&4@8W5S=&]M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y
M.2XP-2 U.#DN,S4@5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$P,RXY,R U.#DN,S4@5&0@*$EN(&%D9&ET:6]N
M+"!T:&4@0V]M<&%N>2!M86EN=&%I;G,@82!S86QE<R!A;&QO=V%N8V4@9F]R
M(&-U<W1O;65R(&1I<W!U=&5S('=H:6-H(&UA>2!A<FES92!I;B!T:&4@;W)D
M:6YA<GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#4W-RXS-2!49" H8V]U<G-E+"!W:&EC:"!I<R!R96-O<F1E
M9"!A<R!C;VYT<F$M<F5V96YU92X@2&ES=&]R:6-A;&QY*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C<V+C4T(#4W-RXS-2!49" H+"!L;W-S97,@;VX@=6YC
M;VQL96-T:6)L92!A8V-O=6YT<R!A;F0@<V%L97,@86QL;W=A;F-E<R!H879E
M(&YO=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-38U+C,U(%1D("AE>&-E961E9"!O=7(@86QL;W=A;F-E<RXI
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U,S4N.34@5&0@*%1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G
M($)4(#$P-RXW,B U,S4N.34@5&0@*',@8V]N=')A8W0@=&5R;7,@='EP:6-A
M;&QY(')E<75I<F4@<&%Y;65N="!B971W965N("D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,P.2XT,B U,S4N.34@5&0@*#$U
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S$Y
M+C$W(#4S-2XY-2!49" H('1O("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#,S,2XV,R U,S4N.34@5&0@*#8P*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S0Q+C,X(#4S-2XY
M-2!49" H(&1A>7,@9G)O;2!T:&4@9&%T92!O9B!I;G9O:6-E(&%N9"!A<F4@
M8V]N<VED97)E9"!P87-T("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#4R-"XR-2!49" H9'5E(&)A<V5D(&]N('1H
M92!P87)T:6-U;&%R(&YE9V]T:6%T960@8V]N=')A8W0@=&5R;7,N("D@5&H@
M150@40IQ(# @," P(')G($)4(#(V,"XR,B U,C0N,C4@5&0@*%1H92!M86IO
M<FET>2!O9B!T:&4@0V]M<&%N>2=S(&)U<VEN97-S(&%C=&EV:71Y(&ES('=I
M=&@@:&]S<&ET86QS(&QO8V%T960@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-3$R+C4U(%1D("AT:')O=6=H;W5T
M('1H92!5;FET960@4W1A=&5S+B!.;R!S:6YG;&4@8W5S=&]M97(@86-C;W5N
M=&5D(&9O<B!M;W)E('1H86X@,3 E(&]F('1H92!#;VUP86YYDBD@5&H@150@
M40IQ(# @," P(')G($)4(#0R-RXW." U,3(N-34@5&0@*',@86-C;W5N=',@
M<F5C96EV86)L92!B86QA;F-E(&%S("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4P,"XX-2!49" H;V8@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-C N,#8@-3 P
M+C@U(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@.2XW
M-2!49B!%5 IQ(# @," P(')G($)4(#$S-BXV." U,# N.#4@5&0@*"!A;F0@
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,34U
M+C8S(#4P,"XX-2!49" H,C Q-RD@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#$W-2XQ,R U,# N.#4@5&0@*"P@;W(@<F5V96YU
M92!F;W(@=&AE('EE87)S(&5N9&5D("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#,P,"XW-" U,# N.#4@5&0@*$1E8V5M8F5R
MH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@,S<W+C,V(#4P,"XX-2!49" H+" I(%1J($54(%$*0E0@+T8Q(#DN
M-S4@5&8@150*<2 P(# @,"!R9R!"5" S.#(N,C0@-3 P+C@U(%1D("@R,#$W
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-# Q
M+C<T(#4P,"XX-2!49" H+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@-#(S+C$S(#4P,"XX-2!49" H,C Q-BD@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0T,BXV,R U
M,# N.#4@5&0@*"X@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#0W.2XX-2!49" H4')E<&%I9"!296YT(&%N9"!$
M97!O<VET<RD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0U.2XQ-2!49" H5&AE($-O;7!A;GD@;&5A<V5S(&%P87)T
M;65N=',@9F]R(&5L:6=I8FQE(&9I96QD(&5M<&QO>65E<R!U;F1E<B!S:&]R
M="UT97)M(&%G<F5E;65N=',@7"AT>7!I8V%L;'D@*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#0R+C8S(#0U.2XQ-2!49" H
M=&AR964I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" T-C(N,3$@-#4Y+C$U(%1D("@@=&\@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#<T+C4W(#0U.2XQ-2!49" H<VEX*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#@U+CDU
M(#0U.2XQ-2!49" H(&UO;G1H<UPI+"!W:&EC:" I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-#<N-#4@5&0@*&=E
M;F5R86QL>2!C;VEN8VED92!W:71H(&5A8V@@96UP;&]Y9662*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C T+C,U(#0T-RXT-2!49" H<R!S=&%F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C(T+C0X(#0T-RXT-2!49" H9FEN9R!C;VYT
M<F%C="X@0V]S=',@<F5L871I;F<@=&\@=&AE<V4@;&5A<V5S(&%R92!I;F-L
M=61E9"!I;B!D:7)E8W0@;W!E<F%T:6YG(&5X<&5N<V5S("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0S-2XW-2!4
M9" H;VX@=&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@<W1A=&5M96YT
M<R!O9B!O<&5R871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#8N
M,34@-#,U+C<U(%1D("A!<R!A(&-O;F1I=&EO;B!O9B!T:&5S92!A9W)E96UE
M;G1S+"!T:&4@0V]M<&%N>2!M87D@<&QA8V4@<V5C=7)I='D@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#(T+C U
M(%1D("AD97!O<VET<R!O;B!T:&4@;&5A<V5D(&%P87)T;65N=',N($1E<&]S
M:71S(&]N(&9I96QD(&5M<&QO>65E<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.3@N,38@-#(T+C U(%1D("@@87!A<G1M96YT<R!R96QA=&5D('1O('1H
M97-E('-H;W)T+71E<FT@86=R965M96YT<R!A<F4@:6YC;'5D960@:6X@*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-#$R+C,U(%1D("AO=&AE<B!C=7)R96YT(&%S<V5T<R!O;B!T:&4@86-C;VUP
M86YY:6YG(&-O;G-O;&ED871E9"!B86QA;F-E('-H965T<RXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-# P+C,U
M(%1D("B@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,X."XS-2!49" H4')O<&5R='D@86YD($5Q=6EP;65N="D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S-S8N,S4@5&0@** I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," S-C0N-C4@5&0@*%!R;W!E<G1Y(&%N9"!E<75I
M<&UE;G0@87)E('-T871E9"!A="!C;W-T+"!L97-S(&%C8W5M=6QA=&5D(&1E
M<')E8VEA=&EO;BX@1&5P<F5C:6%T:6]N(&ES(&1E=&5R;6EN960@;VX@82!S
M=')A:6=H="UL:6YE(&)A<VES(&]V97(@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S4R+CDU(%1D("AT:&4@97-T
M:6UA=&5D('5S969U;"!L:79E<R!O9B!T:&4@87-S971S+"!W:&EC:"!G96YE
M<F%L;'D@<F%N9V4@9G)O;2 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" S,3,N-S8@,S4R+CDU(%1D("AT:')E92D@5&H@150@
M40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,S,RXR-" S-3(N
M.34@5&0@*"!T;R I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" S-#4N-S @,S4R+CDU(%1D("AS979E;BD@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,V-RXY," S-3(N.34@5&0@
M*"!Y96%R<RX@3&5A<V5H;VQD(&EM<')O=F5M96YT<R!A<F4@9&5P<F5C:6%T
M960@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S0Q+C(U(%1D("AO=F5R('1H92!S:&]R=&5R(&]F('1H96ER(&5S
M=&EM871E9"!U<V5F=6P@;&EF92!O<B!T:&4@=&5R;2!O9B!T:&4@:6YD:79I
M9'5A;"!L96%S92X@3VX@86X@86YN=6%L(&)A<VES+"!T:&4@0V]M<&%N>2!R
M979I97=S(&ET<R I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," S,CDN-34@5&0@*'!R;W!E<G1Y(&%N9"!E<75I<&UE
M;G0@;&ES=&EN9W,@86YD(&1I<W!O<V5S(&]F(&%S<V5T<R!T:&%T(&%R92!N
M;R!L;VYG97(@:6X@=7-E+B I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," S,3<N.#4@5&0@** I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,#8N,34@5&0@
M*$-E<G1A:6X@<V]F='=A<F4@9&5V96QO<&UE;G0@8V]S=',@:&%V92!B965N
M(&-A<&ET86QI>F5D(&EN(&%C8V]R9&%N8V4@=VET:"!T:&4@<')O=FES:6]N
M<R!O9B!T:&4@*2!4:B!%5"!1"D)4("]&-" Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#,V+C$R(#,P-BXQ-2!49" H26YT86YG:6)L97,M1V]O9'=I;&P@
M86YD("D@5&H@150@40I"5" O1C0@.2XW-2!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#(Y-"XT-2!49" H3W1H97(O26YT97)N86PM57-E(%-O9G1W87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3<N,3D@,CDT+C0U(%1D("AE*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,38Q+C4R
M(#(Y-"XT-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#$V,RXW." R
M.30N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN,#8@,CDT
M+C0U(%1D("AO<&EC(&]F('1H92!&:6YA;F-I86P@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C4Q+C,W(#(Y-"XT-2!49" H06-C;W5N=&EN9R!3=&%N9&%R
M9',@0F]A<F0@7"A&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<T+C0P(#(Y
M-"XT-2!49" H05-"7"D@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDX+C4R
M(#(Y-"XT-2!49" H06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N
M("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(X,BXW-2!49" H7"A!4T-<*2X@4W5C:"!C;W-T<R!I;F-L=61E(&-H
M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S$N-#4@,C@R+C<U(%1D("AG
M97,@9F]R(&-O;G-U;'1I;F<@<V5R=FEC97,@86YD(&-O<W1S(&9O<B!#;VUP
M86YY('!E<G-O;FYE;"!A<W-O8VEA=&5D('=I=&@@<')O9W)A;6UI;F<L(&-O
M9&EN9RP@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,C<Q+C U(%1D("AA;F0@=&5S=&EN9R!S=6-H('-O9G1W87)E
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3(N-C<@,C<Q+C U(%1D("A!
M;6]R=&EZ871I;VX@;V8@8V%P:71A;&EZ960@<V]F='=A<F4@8V]S=',@8F5G
M:6YS('=H96X@=&AE('-O9G1W87)E(&ES(')E861Y(&9O<B!U<V4@86YD(&ES
M(&EN8VQU9&5D(&EN("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#(U.2XS-2!49" H9&5P<F5C:6%T:6]N(&5X<&5N
M<V4@:6X@=&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@<W1A=&5M96YT
M<R!O9B!O<&5R871I;VYS+B!3;V9T=V%R92!D979E;&]P;65N="!C;W-T<R!A
M<F4@8F5I;F<@86UO<G1I>F5D("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#(T-RXV-2!49" H=7-I;F<@=&AE('-T
M<F%I9VAT+6QI;F4@;65T:&]D(&]V97(@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@,3@X+C0Q(#(T-RXV-2!49" H=&AR964I
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R,#<N
M.3 @,C0W+C8U(%1D("@@=&\@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54
M"G$@," P(# @<F<@0E0@,C(P+C,V(#(T-RXV-2!49" H9FEV92D@5&H@150@
M40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#(S-2XU,B R-#<N
M-C4@5&0@*"!Y96%R<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,C,U+C8U(%1D("B@*2!4:B!%5"!1"D)4("]&
M,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(R,RXV-2!49" H
M0G5S:6YE<W,@0V]M8FEN871I;VYS*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,3DY+CDU(%1D("A4:&4@0V]M<&%N
M>2!A<'!L:65S(&%C8V]U;G1I;F<@:6X@86-C;W)D86YC92!W:71H('1H92 I
M(%1J($54(%$*0E0@+T8T(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R-S,N
M,3,@,3DY+CDU(%1D("A"=7-I;F5S<R!#;VUB:6YA=&EO;G,I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S-C0N-#$@,3DY+CDU
M(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8V+C8W(#$Y.2XY-2!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#,W,2XY-2 Q.3DN.34@5&0@
M*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C N-S@@
M,3DY+CDU(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0Q+C8U
M(#$Y.2XY-2!49" H05-#('=H96X@:70@86-Q=6ER97,@8V]N=')O;" I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M.#@N,C4@5&0@*&]V97(@82!B=7-I;F5S<RX@0G5S:6YE<W,@8V]M8FEN871I
M;VYS(&%R92!A8V-O=6YT960@9F]R(&%T(&9A:7(@=F%L=64N("D@5&H@150@
M40IQ(# @," P(')G($)4(#,R-RXS.2 Q.#@N,C4@5&0@*%1H92!A<W-O8VEA
M=&5D(&%C<75I<VET:6]N(&-O<W1S(&%R92!E>'!E;G-E9"!A<R!I;F-U<G)E
M9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," Q-S8N-34@5&0@*&%N9"!R96-O<F1E9"!A<R!A8W%U:7-I=&EO;B!A
M;F0@:6YT96=R871I;VX@8V]S=',[(&YO;F-O;G1R;VQL:6YG(&EN=&5R97-T
M<RP@:68@86YY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8S+C(S(#$W-BXU
M-2!49" H+"!A<F4@<F5F;&5C=&5D(&%T(&9A:7(@=F%L=64@870@=&AE(&%C
M<75I<VET:6]N(&1A=&4[("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#$V-"XX-2!49" H<F5S=')U8W1U<FEN9R!C
M;W-T<R!A<W-O8VEA=&5D('=I=&@@82!B=7-I;F5S<R!C;VUB:6YA=&EO;B!A
M<F4@97AP96YS960[(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B!I<R!M96%S
M=7)E9"!A="!F86ER('9A;'5E(&%T('1H92 I(%1J($54(%$*0E0@+T8Q(#DN
M-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-3,N,34@5&0@*&%C<75I
M<VET:6]N(&1A=&4L('=I=&@@8VAA;F=E<R!I;B!T:&4@9F%I<B!V86QU92!A
M9G1E<B!T:&4@86-Q=6ES:71I;VX@9&%T92!A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#,S.2XR." Q-3,N,34@5&0@*&9E8W1I;F<@96%R;FEN9W,[(&%N
M9"!G;V]D=VEL;"!I<R!D971E<FUI;F5D(&%S('1H92 I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-#$N-#4@5&0@
M*&5X8V5S<R!O9B!T:&4@9F%I<B!V86QU92!O9B!T:&4@8V]N<VED97)A=&EO
M;B!C;VYV97EE9"!I;B!T:&4@86-Q=6ES:71I;VX@;W9E<B!T:&4@9F%I<B!V
M86QU92!O9B!T:&4@;F5T(&%S<V5T<R!A8W%U:7)E9"X@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3 W+C0Q(#$T,2XT-2!49" H5&AE("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$R.2XW-2!4
M9" H86-C;W5N=&EN9R!F;W(@8G5S:6YE<W,@8V]M8FEN871I;VYS(')E<75I
M<F5S(&5S=&EM871E<R!A;F0@:G5D9VUE;G1S(&%S('1O(&5X<&5C=&%T:6]N
M<R!F;W(@9G5T=7)E(&-A<V@@9FQO=W,@;V8@=&AE(&%C<75I<F5D("D@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Q
M."XP-2!49" H8G5S:6YE<W,L(&%N9"!T:&4@86QL;V-A=&EO;B!O9B!T:&]S
M92!C87-H(&9L;W=S('1O(&ED96YT:69I86)L92!I;G1A;F=I8FQE(&%S<V5T
M<RP@:6X@9&5T97)M:6YI;F<@=&AE(&5S=&EM871E9"!F86ER('9A;'5E(&9O
M<B!A<W-E=',@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,3 V+C,U(%1D("AA;F0@;&EA8FEL:71I97,@86-Q=6ER
M960N("D@5&H@150@40IQ(# @," P(')G($)4(#$T,RXP," Q,#8N,S4@5&0@
M*%1H92!F86ER('9A;'5E<R!A<W-I9VYE9"!T;R!T86YG:6)L92!A;F0@:6YT
M86YG:6)L92!A<W-E=',@86-Q=6ER960@86YD(&QI86)I;&ET:65S(&%S<W5M
M960@87)E(&)A<V5D(&]N("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#DT+C8U(%1D("AM86YA9V5M96YT)W,@97-T
M:6UA=&5S(&%N9"!A<W-U;7!T:6]N<RP@:6YC;'5D:6YG('9A;'5A=&EO;G,@
M=&AA="!U=&EL:7IE(&-U<W1O;6%R>2!V86QU871I;VX@<')O8V5D=7)E<R!A
M;F0@=&5C:&YI<75E<RX@268@=&AE("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#@R+CDU(%1D("AA8W1U86P@<F5S
M=6QT<R!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,3,N-S8@.#(N.34@
M5&0@*&9E<B!F<F]M('1H92!E<W1I;6%T97,@86YD(&IU9&=M96YT<R!U<V5D
M(&EN('1H97-E(&5S=&EM871E<RP@=&AE(&%M;W5N=',@<F5C;W)D960@:6X@
M=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S("D@5&H@150@40I"5" O1C$@.2XW
M-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#<Q+C(U(%1D("AC;W5L9"!R
M97-U;'0@:6X@82!P;W-S:6)L92!I;7!A:7)M96YT(&]F('1H92!I;G1A;F=I
M8FQE(&%S<V5T<R!A;F0@9V]O9'=I;&PL(&]R(')E<75I<F4@86-C96QE<F%T
M:6]N(&]F('1H92!A;6]R=&EZ871I;VX@97AP96YS92!O9B I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.2XU-2!4
M9" H9FEN:71E+6QI=F5D(&EN=&%N9VEB;&4@87-S971S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C0N,3,@-3DN-34@5&0@*%1H92!R97-U;'1S(&]F
M('1H92!A8W%U:7)E9"!B=7-I;F5S<V5S)R!O<&5R871I;VYS(&%R92!I;F-L
M=61E9"!I;B!T:&4@8V]N<V]L:61A=&5D('-T871E;65N=',@;V8@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#<N
M.#4@5&0@*&]P97)A=&EO;G,@;V8@=&AE(&-O;6)I;F5D(&5N=&ET>2!B96=I
M;FYI;F<@;VX@=&AE(&1A=&4@;V8@86-Q=6ES:71I;VXN(%-E92!.;W1E(#0@
M+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S@N,C(@-#<N.#4@5&0@*$%C
M<75I<VET:6]N<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,C$@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R Q,C(@,"!2/CX*96YD;V)J"C$R,B P(&]B:@H\/"],96YG=&@@
M,3$T.#0^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ(# @
M," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS
M," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q
M,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N
M,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G
M($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,V
M+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#(N(%-U
M;6UA<GD@;V8@4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,38S+C8R(#<Q,BXW-2!49" H06-C;W5N=&EN9R!0;VQI8VEE<R!<*&-O;G1I
M;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(Y-2XS," S,RXV,"!49" H1BT@,3 I(%1J($54(%$*0E0@+T8S(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-CDU+C(U(%1D("A';V]D
M=VEL;"P@5"D@5&H@150@40IQ(# @," P(')G($)4(#DW+C0V(#8Y-2XR-2!4
M9" H<F%D92!.86UE<RP@86YD($]T:&5R($EN=&%N9VEB;&4@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C0P+CDY(#8Y-2XR-2!49" H07-S971S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8X
M,RXR-2!49" HH"D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#8W,2XU-2!49" H1V]O9'=I;&P@<F5P<F5S96YT<R!T
M:&4@97AC97-S(&]F('!U<F-H87-E('!R:6-E(&%N9"!R96QA=&5D(&-O<W1S
M(&]V97(@=&AE(&9A:7(@=F%L=64@87-S:6=N960@=&\@=&AE(&YE="!T86YG
M:6)L92!A;F0@:61E;G1I9FEA8FQE("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8U.2XX-2!49" H:6YT86YG:6)L
M92!A<W-E=',@;V8@8G5S:6YE<W-E<R!A8W%U:7)E9"X@3W1H97(@:61E;G1I
M9FEA8FQE(&EN=&%N9VEB;&4@87-S971S('=I=&@@9&5F:6YI=&4@;&EV97,@
M87)E(&)E:6YG(&%M;W)T:7IE9"!U<VEN9R!T:&4@*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C0X+C$U(%1D("AS
M=')A:6=H="UL:6YE(&UE=&AO9"!O=F5R('1H96ER(&5S=&EM871E9"!U<V5F
M=6P@;&EV97,@=VAI8V@@<F%N9V4@9G)O;2 I(%1J($54(%$*0E0@+T8Q(#DN
M-S4@5&8@150*<2 P(# @,"!R9R!"5" S,CDN-#<@-C0X+C$U(%1D("@Q*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S,T+C,T
M(#8T."XQ-2!49" H('1O("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#,T-BXX," V-#@N,34@5&0@*#$V*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S4V+C4U(#8T."XQ-2!4
M9" H('EE87)S+B!';V]D=VEL;"!A;F0@8V5R=&%I;B!I;G1A;F=I8FQE(&%S
M<V5T<R!W:71H("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#8S-BXT-2!49" H:6YD969I;FET92!L:79E<R!A<F4@
M;F]T(&%M;W)T:7IE9"X@26YS=&5A9"P@:6X@86-C;W)D86YC92!W:71H('1H
M92 I(%1J($54(%$*0E0@+T8T(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S
M,#8N-CD@-C,V+C0U(%1D("A);G1A;F=I8FQE<RU';V]D=VEL;"!A;F0@3W1H
M97(I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M,S(N,S8@-C,V+C0U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,T
M+C8R(#8S-BXT-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#0S.2XX
M.2 V,S8N-#4@5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T.#@N-S(@-C,V+C0U(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3 Y+C4Y(#8S-BXT-2!49" H05-#+"!T:&5S92 I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,C0N-S4@
M5&0@*&%S<V5T<R!A<F4@<F5V:65W960@9F]R(&EM<&%I<FUE;G0@86YN=6%L
M;'D@870@=&AE(&)E9VEN;FEN9R!O9B!T:&4@9F]U<G1H('%U87)T97(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C@N,#0@-C(T+C<U(%1D("@L(&%N9"!W
M:&5N979E<B!C:7)C=6US=&%N8V5S(&-H86YG92!T:&%T('=O=6QD("D@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Q
M,RXP-2!49" H;6]R92!L:6ME;'D@=&AA;B!N;W0@<F5D=6-E('1H92!F86ER
M('9A;'5E(&]F(&$@<F5P;W)T:6YG('5N:70@8F5L;W<@:71S(&-A<G)Y:6YG
M(&%M;W5N="XI(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," U.#DN-C4@5&0@*%=H96X@<F5V:65W960L('1H92!#;VUP
M86YY(&AA<R!T:&4@;W!T:6]N('1O(&9I<G-T(&%S<V5S<R!Q=6%L:71A=&EV
M92!F86-T;W)S('1O(&1E=&5R;6EN92!W:&5T:&5R(&ET(&ES(&UO<F4@;&EK
M96QY('1H86X@;F]T('1H870@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-3<W+CDU(%1D("AT:&4@9F%I<B!V86QU
M92!O9B!A(')E<&]R=&EN9R!U;FET(&ES(&QE<W,@=&AA;B!I=',@8V%R<GEI
M;F<@86UO=6YT+"!A<R!A(&)A<VES(&9O<B!D971E<FUI;FEN9R!W:&5T:&5R
M(&ET(&ES(&YE8V5S<V%R>2!T;R!P97)F;W)M('1H92 I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U-C8N,C4@5&0@
M*'%U86YT:71A=&EV92!T97-T:6YG+B!)9B!I="!I<R!D971E<FUI;F5D('1H
M870@82!Q=6%N=&ET871I=F4@=&5S="!I<R!N96-E<W-A<GD@;W(@;6]R92!E
M9BD@5&H@150@40IQ(# @," P(')G($)4(#,W."XX,R U-C8N,C4@5&0@*&9I
M8VEE;G0@=&AA;B!A('%U86QI=&%T:79E(&%P<')O86-H+"!T:&4@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-34T
M+C4U(%1D("A#;VUP86YY(&=E;F5R86QL>2!M96%S=7)E<R!T:&4@9F%I<B!V
M86QU92!O9B!I=',@<F5P;W)T:6YG('5N:71S('5S:6YG(&$@8V]M8FEN871I
M;VX@;V8@:6YC;VUE(&%N9"!M87)K970@87!P<F]A8VAE<RXI(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U,S$N,34@
M5&0@*$9O<B!T:&4@<&5R:6]D<R!P<FEO<B!T;R!T:&4@9F]U<G1H('%U87)T
M97(@;V8@,C Q-RP@=&AE('!E<F9O<FUA;F-E(&]F('1H92!Q=6%N=&ET871I
M=F4@:6UP86ER;65N="!T97-T(&EN=F]L=F5D(&$@='=O+7-T97 @<')O8V5S
M<RX@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-3$Y+C0U(%1D("A4:&4@9FER<W0@<W1E<"!R97%U:7)E9"!T:&4@
M0V]M<&%N>2!T;R!D971E<FUI;F4@=&AE(&9A:7(@=F%L=64@;V8@96%C:"!O
M9B!I=',@<F5P;W)T:6YG('5N:71S(&%N9"!C;VUP87)E(&ET('1O('1H92!R
M97!O<G1I;F<@=6YI=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-3$N-S4@
M-3$Y+C0U(%1D("AS("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#4P-RXW-2!49" H8V%R<GEI;F<@86UO=6YT+B!)
M9B!T:&4@<F5P;W)T:6YG('5N:70G<R!F86ER('9A;'5E('=A<R!L97-S('1H
M86X@:71S(&-A<G)Y:6YG(&%M;W5N="P@=&AE($-O;7!A;GD@=V%S(')E<75I
M<F5D('1O('!E<F9O<FT@82!S96-O;F0@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#DV+C U(%1D("AS=&5P('1O
M(&-A;&-U;&%T92!T:&4@:6UP;&EE9"!V86QU92!O9B!G;V]D=VEL;"X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C,T+C@P(#0Y-BXP-2!49" H5&AE(&EM
M<&QI960@=F%L=64@=V%S('1H96X@8V]M<&%R960@=&\@:71S(&-A<G)Y:6YG
M(&%M;W5N="!T;R!C86QC=6QA=&4@=&AE("D@5&H@150@40I"5" O1C$@.2XW
M-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0X-"XS-2!49" H:6UP86ER
M;65N="!C:&%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$S+C0Y(#0X-"XS
M-2!49" H9V4L(&EF(&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#$T.2XT
M," T.#0N,S4@5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-#8T+C8U(%1D("A"96=I;FYI;F<@:6X@=&AE
M(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3<L(&9O<B!I=',@86YN=6%L(')E=FEE
M=R!O;B!/8W1O8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,T+C(S(#0V
M-"XV-2!49" H+" Q+" R,#$W+"!T:&4@0V]M<&%N>2!E87)L>2!A9&]P=&5D
M('1H92!P<F]V:7-I;VYS(&]F("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#0U,BXY-2!49" H06-C;W5N=&EN9R!3
M=&%N9&%R9',@57!D871E(%PH05-57"D@,C Q-RTP-"P@*2!4:B!%5"!1"D)4
M("]&-" Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C,T+C<R(#0U,BXY-2!4
M9" H26YT86YG:6)L97,M1V]O9'=I;&P@86YD($]T:&5R(%PH5"D@5&H@150@
M40IQ(# @," P(')G($)4(#,W,"XU.2 T-3(N.34@5&0@*&]P:6,@,S4P7"DZ
M(%-I;7!L:69Y:6YG('1H92!4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Y
M+C$P(#0U,BXY-2!49" H97-T(&9O<B!';V]D=VEL;" I(%1J($54(%$*0E0@
M+T8T(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-#$N,C4@5&0@
M*$EM<&%I<FUE;G0N("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#DY+C@W(#0T,2XR-2!49" H56YD97(@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3(V+C$S(#0T,2XR-2!49" H05-5(#(P,3<M,#0L('1H
M92!S96-O;F0@<W1E<"!O9B!T:&4@<75A;G1I=&%T:79E(&%S<V5S<VUE;G0@
M:7,@96QI;6EN871E9"P@86YD+"!I9B!T:&4@<F5P;W)T:6YG('5N:722*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3$Y+C,Q(#0T,2XR-2!49" H<R!C87)R
M>6EN9R I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," T,CDN-34@5&0@*'9A;'5E(&5X8V5E9',@:71S(&9A:7(@=F%L
M=64L(&%N(&EM<&%I<FUE;G0@8VAA<BD@5&H@150@40IQ(# @," P(')G($)4
M(#(S-2XU." T,CDN-34@5&0@*&=E(&ES(')E8V]G;FEZ960@9F]R('1H92!A
M;6]U;G0@8GD@=VAI8V@@=&AE(&-A<G)Y:6YG(&%M;W5N="!E>&-E961S('1H
M92 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," T,3<N.#4@5&0@*')E<&]R=&EN9R!U;FETDBD@5&H@150@40IQ(# @
M," P(')G($)4(#$P-2XU-2 T,3<N.#4@5&0@*',@9F%I<B!V86QU92!N;W0@
M=&\@97AC965D('1H92!T;W1A;"!A;6]U;G0@;V8@9V]O9'=I;&P@86QL;V-A
M=&5D('1O('1H870@<F5P;W)T:6YG('5N:70N("D@5&H@150@40IQ(# @," P
M(')G($)4(#0T,2XU-R T,3<N.#4@5&0@*$%D9&ET:6]N86QL>2D@5&H@150@
M40IQ(# @," P(')G($)4(#0Y,"XR,R T,3<N.#4@5&0@*"P@:6YC;VUE('1A
M>" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," T,#8N,34@5&0@*&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-38N
M.3 @-# V+C$U(%1D("AF96-T<R!F<F]M(&%N>2!T87@@9&5D=6-T:6)L92!G
M;V]D=VEL;"!O;B!T:&4@8V%R<GEI;F<@86UO=6YT(&]F('1H92!R97!O<G1I
M;F<@=6YI="!W:&5N(&UE87-U<FEN9R!T:&4@9V]O9'=I;&P@:6UP86ER;65N
M=" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," S.30N-#4@5&0@*&QO<W,@:7,@8V]N<VED97)E9"P@:68@87!P;&EC
M86)L92XI(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," S-S0N-S4@5&0@*%1H92!#;VUP86YY(&1E=&5R;6EN97,@:71S
M(')E<&]R=&EN9R!U;FET<R!B>2!I9&5N=&EF>6EN9R!I=',@;W!E<F%T:6YG
M('-E9VUE;G1S(&%N9"!A;GD@8V]M<&]N96YT(&)U<VEN97-S97,@86YD(&%G
M9W)E9V%T97,@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,S8S+C U(%1D("AT:&4@8V]M<&]N96YT<R!B=7-I;F5S
M<V5S(&EF('1H97D@:&%V92!S:6UI;&%R(&5C;VYO;6EC(&-H87)A8W1E<FES
M=&EC<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,U+C<X(#,V,RXP-2!4
M9" H5&AE($-O;7!A;GD@:&%D('1H92!F;VQL;W=I;F<@<F5P;W)T:6YG('5N
M:71S('1H870@:70@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,S4Q+C,U(%1D("AR979I97=E9"!F;W(@:6UP86ER
M;65N=#H@,5PI($YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,#,N.#,@,S4Q+C,U(%1D("A!;&QI960@4W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#(T-BXQ-R S-3$N,S4@5&0@*&9I;F<[(#)<*2!0:'ES:6-I86X@
M4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#,S,RXT-B S-3$N,S4@5&0@
M*&9I;F<[(&%N9" S7"D@4V5A<F-H+BD@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,S,2XV-2!49" H36%N86=E;65N
M="!C;VYS:61E<G,@:&ES=&]R:6-A;"!E>'!E<FEE;F-E(&%N9"!A;&P@879A
M:6QA8FQE(&EN9F]R;6%T:6]N(&%T('1H92!T:6UE('1H92!F86ER('9A;'5E
M<R!O9B!I=',@<F5P;W)T:6YG('5N:71S(&%R92 I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,3DN.34@5&0@*&5S
M=&EM871E9"X@2&]W979E<BD@5&H@150@40IQ(# @," P(')G($)4(#$R-RXP
M." S,3DN.34@5&0@*"P@9F%I<B!V86QU97,@=&AA="!C;W5L9"!B92!R96%L
M:7IE9"!I;B!A;B!A8W1U86P@=')A;G-A8W1I;VX@;6%Y(&AA=F4@9&EF*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-# T+C8W(#,Q.2XY-2!49" H9F5R960@
M9G)O;2!T:&]S92!U<V5D('1O(&5V86QU871E('1H92 I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,#@N,C4@5&0@
M*'!O=&5N=&EA;"!I;7!A:7)M96YT(&]F(&=O;V1W:6QL+BD@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X."XU-2!4
M9" H3&]N9RUL:79E9"!A<W-E=',@86YD(&ED96YT:69I86)L92!I;G1A;F=I
M8FQE(&%S<V5T<R!W:71H(&1E9FEN:71E(&QI=F5S(&%R92!E=F%L=6%T960@
M9F]R(&EM<&%I<FUE;G0@:6X@86-C;W)D86YC92!W:71H('1H92 I(%1J($54
M(%$*0E0@+T8T(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-S8N
M.#4@5&0@*%!R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N.#D@,C<V+C@U
M(%1D("AO<&5R='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" X,RXR-B R-S8N
M.#4@5&0@*"P@4&QA;G0L(&%N9"!%<75I<&UE;G0I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" Q-S,N-#0@,C<V+C@U(%1D("@@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<U+C<P(#(W-BXX-2!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#$X,"XY-R R-S8N.#4@5&0@*&]P:6,@
M;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,CDN.# @,C<V+C@U
M(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4P+C8W(#(W-BXX
M-2!49" H05-#+B!);B!A8V-O<F1A;F-E('=I=&@@=&AI<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-C<N-#<@,C<V+C@U(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S<R+C<T(#(W-BXX-2!49" H;W!I8RP@;&]N9RUL:79E
M9"!A<W-E=',@86YD(&1E9FEN:71E+6QI=F5D("D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(V-2XQ-2!49" H:6YT
M86YG:6)L92!A<W-E=',@87)E(')E=FEE=V5D(&9O<B!I;7!A:7)M96YT('=H
M96YE=F5R(&5V96YT<R!O<B!C:&%N9V5S(&EN(&-I<F-U;7-T86YC97,@:6YD
M:6-A=&4@=&AE(&-A<G)Y:6YG(&%M;W5N="!M87D@;F]T("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(U,RXT-2!4
M9" H8F4@<F5C;W9E<F%B;&4N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,C,P+C U(%1D("A296-O=F5R86)I;&ET
M>2!O9B!L;VYG+6QI=F5D(&%S<V5T<R!I<R!M96%S=7)E9"!B>2!A(&-O;7!A
M<FES;VX@;V8@=&AE(&-A<G)Y:6YG(&%M;W5N="!O9B!T:&4@87-S970@9W)O
M=7 @=&\@=&AE(&9U='5R92 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R,3@N,S4@5&0@*'5N9&ES8V]U;G1E9"!N
M970@8V%S:"!F;&]W('1H870@:7,@97AP96-T960@=&\@8F4@9V5N97)A=&5D
M(&)Y('1H;W-E(&%S<V5T<RX@268@<W5C:"!A<W-E=',@87)E(&-O;G-I9&5R
M960@=&\@8F4@:6UP86ER960L('1H92 I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,#8N-C4@5&0@*&EM<&%I<FUE
M;G0@8VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#$Q,RXT.2 R,#8N-C4@
M5&0@*&=E(')E8V]G;FEZ960@:7,@=&AE(&%M;W5N="!B>2!W:&EC:"!T:&4@
M8V%R<GEI;F<@86UO=6YT(&]F('1H92!A<W-E=',@97AC965D<R!T:&4@9F%I
M<B!V86QU92!O9B!T:&4@87-S971S+B I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q.#8N.34@5&0@*$%N>2!R96QA
M=&5D(&EM<&%I<FUE;G0@;&]S<V5S(&%R92!R96-O9VYI>F5D(&EN(&5A<FYI
M;F=S(&%N9"!I;F-L=61E9"!I;B!T:&4@8V%P=&EO;B!I;7!A:7)M96YT(&-H
M87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#<N.#8@,3@V+CDU(%1D("AG
M97,@;VX@=&AE(&-O;G-O;&ED871E9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-S4N,C4@5&0@*'-T871E;65N
M=',@;V8@;W!E<F%T:6]N<RX@4V5E($YO=&4@-2 M($=O;V1W:6QL+" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R-#$N-3@@,3<U+C(U(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C0W+C$Y(#$W-2XR-2!49" H<F%D92!.86UE
M<RP@86YD($]T:&5R($EN=&%N9VEB;&4@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S@P+CDT(#$W-2XR-2!49" H07-S971S+BD@5&H@150@40I"5" O1C,@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-34N,C4@5&0@*$1E
M8G0@1&ES8V]U;G0@86YD($1E8G0@27-S=6%N8V4@0V]S=',@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$T,RXR
M-2!49" HH"D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#$S,2XU-2!49" H4W1A=&5D(&1I<V-O=6YT<R!O;B!P<F]C
M965D<RP@86YD(&]T:&5R(&9E97,@<F5I;6)U<G-E9"!T;R!L96YD97(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,#0N-S @,3,Q+C4U(%1D("@L(&%S('=E
M;&P@87,@=&AE(&EN:71I86P@=F%L=64@;V8@86YY(&5M8F5D9&5D(&1E<FEV
M871I=F4@9F5A='5R97,@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,3$Y+C@U(%1D("AO9B!T:&4@0V]N=F5R=&EB
M;&4@3F]T97,@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#$V-"XT," Q
M,3DN.#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-CDN-C@@,3$Y
M+C@U(%1D("AE<FT@3&]A;G,L(&%S(&1E9FEN960@:6X@3F]T92 X("T@1&5B
M="P@87)E('1R96%T960@87,@82!D:7-C;W5N="!A<W-O8VEA=&5D('=I=&@@
M=&AE(')E<W!E8W1I=F4@9&5B=" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," Q,#@N,34@5&0@*&EN<W1R=6UE;G0@
M86YD('!R97-E;G1E9"!I;B!T:&4@8F%L86YC92!S:&5E="!A<R!A;B!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#(U.2XQ-2 Q,#@N,34@5&0@*&9S970@
M=&\@=&AE(&-A<G)Y:6YG(&%M;W5N="!O9B!T:&4@9&5B="X@1&ES8V]U;G1S
M(&%R92!A;6]R=&EZ960@=&\@:6YT97)E<W0@*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.38N-#4@5&0@*&5X<&5N
M<V4@=7-I;F<@=&AE(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(X+C8U
M(#DV+C0U(%1D("AF96-T:79E(&EN=&5R97-T(')A=&4@;65T:&]D+"!O<B!A
M(&UE=&AO9"!T:&%T(&%P<')O>&EM871E<R!T:&4@968I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.#(N-S @.38N-#4@5&0@*&9E8W1I=F4@:6YT97)E<W0@
M<F%T92!M971H;V0L(&]V97(@=&AE("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#@T+C<U(%1D("AE>'!E8W1E9"!L
M:69E(&]F('1H92!D96)T+BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#8Q+C,U(%1D("A$969E<G)E9"!C;W-T<R!R
M96QA=&5D('1O('1H92!I<W-U86YC92!O9B!T:&4@0V]N=F5R=&EB;&4@3F]T
M97,@86YD('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C8N-3<@-C$N
M,S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S$N.#0@-C$N,S4@
M5&0@*&5R;2!,;V%N<R!W97)E(&-A<&ET86QI>F5D(&%N9"!A<F4@<')E<V5N
M=&5D(&EN('1H92 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," T.2XV-2!49" H8F%L86YC92!S:&5E="!A<R!A(&1I
M<F5C="!D961U8W1I;VX@9G)O;2!T:&4@8V%R<GEI;F<@86UO=6YT(&]F('1H
M92!D96)T(&QI86)I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#,V,RXR
M," T.2XV-2!49" H+B!$969E<G)E9"!C;W-T<R!A<F4@86UO<G1I>F5D('5S
M:6YG('1H92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#4R."XQ-B T.2XV
M-2!49" H9F5C=&EV92 I(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,C,@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q,C0@,"!2/CX*96YD;V)J"C$R-" P(&]B:@H\/"],96YG
M=&@@,3$Q-C8^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W
M-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4
M(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P
M(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@
M-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#(N
M(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,38S+C8R(#<Q,BXW-2!49" H06-C;W5N=&EN9R!0;VQI8VEE<R!<*&-O
M;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Y-2XT-2 S,RXV,"!49" H1BT@,2D@5&H@150@40IQ(# @," P
M(')G($)4(#,Q,2XT-R S,RXV,"!49" H,2D@5&H@150@40I"5" O1C$@.2XW
M-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y-2XR-2!49" H:6YT97)E
M<W0@;65T:&]D+B!$969E<G)E9"!C;W-T<R!R96QA=&5D('1O('1H92!#;VYV
M97)T:6)L92!.;W1E<R!W97)E('=R:71T96X@;V8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-C N,30@-CDU+C(U(%1D("AF(&EN(&-O;FYE8W1I;VX@=VET
M:"!T:&4@<F5P87EM96YT(&]F('-U8V@@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C4U(%1D("A#;VYV97)T
M:6)L92!.;W1E<RX@4V5E($YO=&4@." M($1E8G0N("D@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8V,"XQ-2!49" H
M1&5F97)R960@8V]S=',@<F5L871E9"!T;R!T:&4@:7-S=6%N8V4@;V8@=&AE
M($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8R+C@U(#8V,"XQ
M-2!49" H<R!2979O;'9I;F<@0W)E9&ET($9A8VEL:71I97,L(&%S(&1E9FEN
M960@:6X@3F]T92 X("T@1&5B="P@:&%V92!B965N("D@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8T."XT-2!49" H
M8V%P:71A;&EZ960@86YD(&EN8VQU9&5D(&EN(&]T:&5R(&%S<V5T<R!O;B!T
M:&4@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE971S+"!A;F0@86UO<G1I>F5D
M('5S:6YG('1H92!S=')A:6=H="!L:6YE(&UE=&AO9"!O=F5R('1H92 I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M,S8N-S4@5&0@*'1E<FT@;V8@=&AE(')E;&%T960@8W)E9&ET(&%G<F5E;65N
M="XI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-C$R+C<U(%1D("A$97)I=F%T:79E("D@5&H@150@40IQ(# @," P
M(')G($)4(#DT+C(P(#8Q,BXW-2!49" H1FEN86YC:6%L("D@5&H@150@40IQ
M(# @," P(')G($)4(#$S-RXR-R V,3(N-S4@5&0@*$EN<W1R=6UE;G1S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#4X."XW-2!49" H5&AE($-O;7!A;GD@:7,@97AP;W-E9"!T;R!I;G1E<F5S
M="!R871E(')I<VL@9'5E('1O(&ET<R!O=71S=&%N9&EN9R!S96YI;W(@<V5C
M=7)E9"!T97)M(&QO86X@96YT97)E9"!I;G1O(&]N("D@5&H@150@40IQ(# @
M," P(')G($)4(#0X,2XS-2 U.#@N-S4@5&0@*$%U9W5S=" Q+" R,#$W("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U-S8N-S4@5&0@*'=I=&@@82!V87)I86)L92!I;G1E<F5S="!R871E+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C(N-SD@-3<V+C<U(%1D("A!<R!A
M(')E<W5L="P@=&AE($-O;7!A;GD@:&%S(&5N=&5R960@:6YT;R!A;B!I;G1E
M<F5S="!R871E('-W87 @86=R965M96YT('1O(&5F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#<X+C@X(#4W-BXW-2!49" H9F5C=&EV96QY(&-O;G9E<G0@
M82 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-38T+C<U(%1D("AP;W)T:6]N(&]F(&ET<R!V87)I86)L92!I;G1E
M<F5S="!P87EM96YT<R!T;R!A(&9I>&5D(')A=&4N("D@5&H@150@40IQ(# @
M," P(')G($)4(#(W,2XQ.2 U-C0N-S4@5&0@*%1H92!P<FEN8VEP86P@;V)J
M96-T:79E(&]F('1H92!I;G1E<F5S="!R871E('-W87 @:7,@=&\@96QI;6EN
M871E(&]R(')E9'5C92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-34R+C<U(%1D("AT:&4@=F%R:6%B:6QI='D@
M;V8@=&AE(&-A<V@@9FQO=W,@:6X@=&AO<V4@:6YT97)E<W0@<&%Y;65N=',@
M87-S;V-I871E9"!W:71H('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P
M(')G($)4(#0P-2XR-2 U-3(N-S4@5&0@*',@;&]N9RUT97)M(&1E8G0L('1H
M=7,@<F5D=6-I;F<@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," U-# N-S4@5&0@*&EM<&%C="!O9B!I;G1E
M<F5S="!R871E(&-H86YG97,@;VX@9G5T=7)E(&EN=&5R97-T('!A>6UE;G0@
M8V%S:"!F;&]W<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(Y+C(R(#4T
M,"XW-2!49" H5&AE($-O;7!A;GD@:&%S(&1E=&5R;6EN960@=&AA="!T:&4@
M:6YT97)E<W0@<F%T92!S=V%P("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," U,C@N-S4@5&0@*'%U86QI9FEE<R!A
M<R!A(&-A<V@@9FQO=R!H961G92!I;B!A8V-O<F1A;F-E('=I=&@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C0Y+C$T(#4R."XW-2!49" H05-#(#@Q-2P@
M*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y
M,2XQ," U,C@N-S4@5&0@*$1E<FEV871I=F5S(&%N9"!(961G:6YG*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,2XV,R U
M,C@N-S4@5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDV+C X(#4R
M."XW-2!49" H07,@=&AE(&-R:71I8V%L('1E<FUS(&]F('1H92!H961G:6YG
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," U,38N-S4@5&0@*&EN<W1R=6UE;G0@86YD('1H92!H961G960@9F]R
M96-A<W1E9"!T<F%N<V%C=&EO;B!A<F4@=&AE('-A;64L('1H92!#;VUP86YY
M(&AA<R!C;VYC;'5D960@=&AA="!C:&%N9V5S(&EN('1H92!C87-H(&9L;W=S
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," U,#0N-S4@5&0@*&%T=')I8G5T86)L92!T;R!T:&4@<FES:R!B96EN
M9R!H961G960@87)E(&5X<&5C=&5D('1O(&-O;7!L971E;'D@;V8I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,30N,C(@-3 T+C<U(%1D("AF<V5T(&%T(&EN
M8V5P=&EO;B!A;F0@;VX@86X@;VYG;VEN9R!B87-I<RX@0VAA;F=E<R!I;B!T
M:&4@9F%I<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-#DR+C<U(%1D("AV86QU92!O9B!A;B!I;G1E<F5S="!R
M871E('-W87 @86=R965M96YT(&1E<VEG;F%T960@87,@82!C87-H(&9L;W<@
M:&5D9V4@87)E(')E8V]R9&5D(&%S(&$@8V]M<&]N96YT(&]F(&%C8W5M=6QA
M=&5D(&]T:&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," T.# N-S4@5&0@*&-O;7!R96AE;G-I=F4@:6YC;VUE
M(%PH;&]S<UPI+"!N970@;V8@9&5F97)R960@=&%X97,L('=I=&AI;B!S=&]C
M:VAO;&1E<G.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,Y+C<X(#0X,"XW
M-2!49" H(&5Q=6ET>2!A;F0@87)E(&%M;W)T:7IE9"!T;R!I;G1E<F5S="!E
M>'!E;G-E(&]V97(@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," T-C@N-S4@5&0@*'1E<FT@;V8@=&AE(')E
M;&%T960@9&5B="!A<R!T:&4@:6YT97)E<W0@<&%Y;65N=',@87)E(&UA9&4N
M($EN=&5R97-T(')A=&4@<W=A<"!P87EM96YT<R!A<F4@:6YC;'5D960@:6X@
M;F5T(&-A<V@@<')O=FED960@8GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0U-BXW-2!49" H;W!E<F%T:6YG
M(&%C=&EV:71I97,@;VX@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3DW+C(T(#0U-BXW-2!49" H<R!C;VYS;VQI9&%T960@<W1A=&5M
M96YT(&]F(&-A<V@@9FQO=W,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#0S,BXW-2!49" H26X@8V]N:G5N8W1I
M;VX@=VET:"!E;G1E<FEN9R!I;G1O('1H92!I;G1E<F5S="!R871E('-W87 @
M86=R965M96YT+"!T:&4@0V]M<&%N>2!E87)L>2!A9&]P=&5D("D@5&H@150@
M40IQ(# @," P(')G($)4(#0R.2XV-B T,S(N-S4@5&0@*$%352 R,#$W+3$R
M+" I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DP+C4P(#0S,BXW-2!49" H1&5R:79A=&EV92!A;F0@*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0R,"XW-2!4
M9" H2&5D9VEN9R!<*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-"XT,2 T
M,C N-S4@5&0@*&]P:6,@.#$U7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$S-"XY-B T,C N-S4@5&0@*'1O('-I;7!L
M:69Y('1H92!A<'!L:6-A=&EO;B!O9B!H961G92!A8V-O=6YT:6YG+B!3964@
M3F]T92 Y("T@1&5R:79A=&EV97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y-BXW-2!49" H5&AE($-O;7!A
M;GD@979A;'5A=&5S(&5M8F5D9&5D(&-O;G9E<G-I;VX@9F5A='5R97,@=VET
M:&EN(&ET<R!C;VYV97)T:6)L92!D96)T(&EN(&%C8V]R9&%N8V4@=VET:"!T
M:&4@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0W,BXV.2 S.38N-S4@5&0@*$1E<FEV871I=F5S(&%N9" I(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S@T+C<U
M(%1D("A(961G:6YG*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#@S+CDT(#,X-"XW-2!49" H("D@5&H@150@40IQ(# @," P
M(')G($)4(#@V+C(V(#,X-"XW-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#DQ+C8W(#,X-"XW-2!49" H;W!I8R!O9B!T:&4@1BD@5&H@150@40IQ
M(# @," P(')G($)4(#$T,2XW-2 S.#0N-S4@5&0@*$%30B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C,N,34@,S@T+C<U(%1D("A!4T,@=&\@9&5T97)M
M:6YE('=H971H97(@=&AE(&5M8F5D9&5D(&-O;G9E<G-I;VX@9F5A='5R92!S
M:&]U;&0@8F4@8FEF=7)C871E9"!F<F]M('1H92!H;W-T("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-S(N-S4@
M5&0@*&EN<W1R=6UE;G0@86YD(&%C8V]U;G1E9"!F;W(@87,@82!D97)I=F%T
M:79E(&%T(&9A:7(@=F%L=64N($-H86YG97,@:6X@=&AE(&9A:7(@=F%L=64@
M;V8@=&AE<V4@9&5R:79A=&EV97,@9'5R:6YG(&5A8V@@<F5P;W)T:6YG("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S-C N-S4@5&0@*'!E<FEO9"!W97)E(')E<&]R=&5D(&EN(&]T:&5R(&5X
M<&5N<V5S(%PH:6YC;VUE7"D@;VX@=&AE(&-O;G-O;&ED871E9"!S=&%T96UE
M;G1S(&]F(&]P97)A=&EO;G,N("D@5&H@150@40IQ(# @," P(')G($)4(#0R
M."XP." S-C N-S4@5&0@*%1H92!F86ER('9A;'5E(&%T(&EN8V5P=&EO;B!H
M860@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#,T."XW-2!49" H8F5E;B!R96-O<F1E9"!A<R!D96)T(&1I<V-O
M=6YT(&%N9"!W87,@8F5I;F<@86UO<G1I>F5D('1O(&EN=&5R97-T(&5X<&5N
M<V4@;W9E<B!T:&4@=&5R;2!O9B!T:&4@;F]T92!U<VEN9R!T:&4@968I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" U,#$N.30@,S0X+C<U(%1D("AF96-T:79E
M(&EN=&5R97-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," S,S8N-S4@5&0@*&UE=&AO9"X@3VX@36%R8V@@,3<L
M(#(P,3<L('1H92!#;VUP86YY('!A:60@:6X@9G5L;"!I=',@0V]N=F5R=&EB
M;&4@3F]T97,@86YD+"!A<R!A(')E<W5L="P@9&5R96-O9VYI>F5D('1H92!D
M97)I=F%T:79E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," S,C0N-S4@5&0@*&QI86)I;&ET>2D@5&H@150@40IQ
M(# @," P(')G($)4(#<Y+CDV(#,R-"XW-2!49" H+B!3964@3F]T92 X("T@
M1&5B="XI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S P+C<U(%1D("A386QE<R!A;F0@3W1H97(@4W1A=&4@3F]N
M+6EN8V]M92!4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DY+CDX(#,P,"XW
M-2!49" H87@@3&EA8FEL:71I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,C@X+C<U(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C<W+C U
M(%1D("A4:&4@0V]M<&%N>2!A8V-R=65S('-A;&5S(&%N9"!O=&AE<B!S=&%T
M92!N;VXM:6YC;VUE('1A>"!L:6%B:6QI=&EE<R!B87-E9"!O;B!T:&4@0V]M
M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3,N-C<@,C<W+C U(%1D
M("AS(&)E<W0@97-T:6UA=&4@;V8@:71S('!R;V)A8FQE(&QI86)I;&ET>2 I
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," R-C4N,S4@5&0@*'5T:6QI>FEN9R!C=7)R96YT;'D@879A:6QA8FQE(&EN
M9F]R;6%T:6]N(&%N9"!I;G1E<G!R971A=&EO;B!O9B!R96QE=F%N="!T87@@
M<F5G=6QA=&EO;G,N($=I=F5N('1H92!N871U<F4@;V8@=&AE($-O;7!A;GF2
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$Y+C4R(#(V-2XS-2!49" H<R!B
M=7-I;F5S<RP@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,C4S+C8U(%1D("AS:6=N:69I8V%N="!S=6)J96-T:79I
M='D@97AI<W1S(&%S('1O(&)O=&@@=VAE=&AE<B!S86QE<R!A;F0@;W1H97(@
M<W1A=&4@;F]N+6EN8V]M92!T87AE<R!C86X@8F4@87-S97-S960@;VX@:71S
M(&%C=&EV:71Y(&%N9"!H;W<@=&AE("D@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(T,2XY-2!49" H<V%L97,@=&%X
M('=I;&P@=6QT:6UA=&5L>2!B92!M96%S=7)E9"!B>2!T:&4@<F5L979A;G0@
M:G5R:7-D:6-T:6]N<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S Y+C4S
M(#(T,2XY-2!49" H5&AE($-O;7!A;GD@;6%K97,@82!D971E<FUI;F%T:6]N
M(&9O<B!E86-H(')E<&]R=&EN9R!P97)I;V0@*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C,P+C(U(%1D("AW:&5T
M:&5R('1H92!E<W1I;6%T97,@9F]R('-A;&5S(&%N9"!O=&AE<B!N;VXM:6YC
M;VUE('1A>&5S(&EN(&-E<G1A:6X@<W1A=&5S('-H;W5L9"!B92!R979I<V5D
M+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," R,3@N,C4@5&0@** I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,C V+C(U(%1D("A);G-U<F%N8V4@0VQA
M:6US*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$R,RXQ,R R,#8N,C4@5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,3DT+C(U(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@R+C4U
M(%1D("A4:&4@0V]M<&%N>2!P<F]V:61E<R!W;W)K97)SDBD@5&H@150@40IQ
M(# @," P(')G($)4(#$W-RXS.2 Q.#(N-34@5&0@*"!C;VUP96YS871I;VX@
M:6YS=7)A;F-E(&-O=F5R86=E+"!P<F]F97-S:6]N86P@;&EA8FEL:71Y(&-O
M=F5R86=E+"!A;F0@:&5A;'1H8V%R92!B96YE9FET<R!F;W(@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3<P+C@U
M(%1D("AE;&EG:6)L92!E;7!L;WEE97,N("D@5&H@150@40IQ(# @," P(')G
M($)4(#$R-RXU-R Q-S N.#4@5&0@*%1H92!#;VUP86YY(')E8V]R9',@:71S
M(&5S=&EM871E(&]F('1H92!U;'1I;6%T92!C;W-T(&]F+"!A;F0@<F5S97)V
M97,@9F]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$U+C4T(#$W,"XX-2!4
M9" H+"!W;W)K97)S)R!C;VUP96YS871I;VX@86YD("D@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$U.2XQ-2!49" H
M<')O9F5S<VEO;F%L(&QI86)I;&ET>2!B96YE9FET<R!B87-E9"!O;B!A8W1U
M87)I86P@;6]D96QS('!R97!A<F5D(&]R(')E=FEE=V5D(&)Y(&%N(&EN9&5P
M96YD96YT(&%C='5A<GD@=7-I;F<@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3,W+CDT(#$U.2XQ-2!49" H<R!L;W-S("D@5&H@150@
M40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$T-RXT
M-2!49" H:&ES=&]R>2!A<R!W96QL(&%S(&EN9'5S=')Y('-T871I<W1I8W,N
M("D@5&H@150@40IQ(# @," P(')G($)4(#$Y,BXP-" Q-#<N-#4@5&0@*%1H
M92!H96%L=&AC87)E(&EN<W5R86YC92!A8V-R=6%L(&ES(&9O<B!E<W1I;6%T
M960@8VQA:6US('1H870@:&%V92!O8V-U<G)E9"!B=70@:&%V92!N;W0@8F5E
M;B I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," Q,S4N-S4@5&0@*')E<&]R=&5D(&%N9"!I<R!B87-E9"!O;B!T:&4@
M0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#$N-C<@,3,U+C<U
M(%1D("AS(&AI<W1O<FEC86P@8VQA:6T@<W5B;6ES<VEO;B!P871T97)N<RX@
M1G5R=&AE<FUO<F4L(&EN(&1E=&5R;6EN:6YG(&ET<R!R97-E<G9E<RP@=&AE
M("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$R-"XP-2!49" H0V]M<&%N>2!I;F-L=61E<R!R97-E<G9E<R!F;W(@
M97-T:6UA=&5D(&-L86EM<R!I;F-U<G)E9"!B=70@;F]T(')E<&]R=&5D(&%S
M('=E;&P@87,@=6YF879O<F%B;&4@8VQA:6US(&1E=F5L;W!M96YT+BD@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Q
M,BXS-2!49" HH"D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#$P,"XV-2!49" H5&AE("D@5&H@150@40I"5" O1C0@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#8W+C$P(#$P,"XV-2!49" H3W1H
M97(@17AP96YS97,O26YS=7)A;F-E($-O<W1S*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@,3DT+C,W(#$P,"XV-2!49" H("D@
M5&H@150@40IQ(# @," P(')G($)4(#$Y-BXV,R Q,# N-C4@5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,#$N.3$@,3 P+C8U(%1D("AO<&EC(&]F
M('1H92!&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4P+C<T(#$P,"XV-2!4
M9" H05-"("D@5&H@150@40IQ(# @," P(')G($)4(#(W,2XV,2 Q,# N-C4@
M5&0@*$%30R!P<F5V:6]U<VQY(&ES<W5E9"!A=71H;W)I=&%T:79E(&%C8V]U
M;G1I;F<@9W5I9&%N8V4@:6X@=&AE(&%R96$@;V8@*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.#@N.34@5&0@*&EN
M<W5R86YC92!C;VYT<F%C=',@86YD(')E;&%T960@86-T:79I='D@=&AE<F5T
M;RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,U+C@U(#@X+CDU(%1D("A4
M:&ES('1O<&EC(&-O;F-L=61E9"!T:&%T+"!U;F1E<B!C:7)C=6US=&%N8V5S
M('-U8V@@87,@:6X@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3$W+C<R(#@X+CDU(%1D("AS(&EN<W5R960@*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-S<N,C4@5&0@*'!R
M;V9E<W-I;VYA;"!L:6%B:6QI='D@86YD('=O<FME<G,G(&-O;7!E;G-A=&EO
M;B!P;VQI8VEE<RP@<VEN8V4@82!R:6=H="!O9B!L96=A;"!O9BD@5&H@150@
M40IQ(# @," P(')G($)4(#,V-BXR-2 W-RXR-2!49" H9G-E="!D;V5S(&YO
M="!E>&ES="!D=64@=&\@=&AE(&9A8W0@=&AA="!T:&5R92!A<F4@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C4N
M-34@5&0@*'1H<F5E('!A<G1I97,@=&\@86X@:6YC=7)R960@8VQA:6TL('1H
M92!I;G-U<F5D+"!T:&4@:6YS=7)E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#(W,2XY,R V-2XU-2!49" H+"!A;F0@=&AE(&-L86EM86YT+"!T:&4@<F5L
M871E9"!L:6%B:6QI='D@=&\@=&AE(&-L86EM86YT('-H;W5L9"!B92!C;&%S
M<VEF:65D("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#4S+C@U(%1D("AS97!A<F%T96QY(&]N(&$@9W)O<W,@8F%S
M:7,@=VET:"!A('-E<&%R871E(')E;&%T960@<F5C96EV86)L92!F<F]M('1H
M92!I;G-U<F5R(')E8V]G;FEZ960@87,@8F5I;F<@9'5E(&9R;VT@:6YS=7)A
M;F-E(&-A<G)I97)S+B I(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,C4@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q,C8@,"!2/CX*96YD;V)J"C$R-B P(&]B:@H\/"],96YG
M=&@@,3(T-S@^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W
M-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4
M(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P
M(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@
M-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#(N
M(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,38S+C8R(#<Q,BXW-2!49" H06-C;W5N=&EN9R!0;VQI8VEE<R!<*&-O
M;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Y-2XS," S,RXV,"!49" H1BT@,3(I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,C4@5&0@*$%C
M8V]R9&EN9VQY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3<N-C @-CDU+C(U
M(%1D("@L('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#$U
M-RXT-2 V.34N,C4@5&0@*',@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE971S
M(&%S(&]F("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G
M($)4(#(Y-"XY.2 V.34N,C4@5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S<Q+C8Q(#8Y
M-2XR-2!49" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P
M(# @,"!R9R!"5" S.3 N-38@-CDU+C(U(%1D("@R,#$W*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#$P+C V(#8Y-2XR-2!4
M9" H(')E9FQE8W0@=&AE(')E;&%T960@<VAO<G0M=&5R;2!L:6%B:6QI=&EE
M<R I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," V.#,N-34@5&0@*&EN(&%C8W)U960@8V]M<&5N<V%T:6]N(&%N9"!B
M96YE9FET<R!A;F0@=&AE(')E;&%T960I(%1J($54(%$*0E0@+T8R(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" R-38N,#8@-C@S+C4U(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C4X+C4P(#8X
M,RXU-2!49" H;&]N9RUT97)M(&QI86)I;&ET:65S(&%S(&QO;F<M=&5R;2!A
M8V-R=65D(&-L86EM<RP@86YD('1H92!S:&]R="UT97)M("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W,2XX-2!4
M9" H<F5C96EV86)L92!P;W)T:6]N(&%S(&EN<W5R86YC92!R96-O=F5R>2!R
M96-E:79A8FQE(&%N9"!T:&4@;&]N9RUT97)M('!O<G1I;VX@87,@;F]N+6-U
M<G)E;G0@:6YS=7)A;F-E(')E8V]V97)Y(')E8V5I=F%B;&4N(%-E92 I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M-C N,34@5&0@*$YO=&4@-R M($)A;&%N8V4@4VAE970@1&5T86EL<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3<T+C$T(#8V,"XQ-2!49" H5&AE('5L
M=&EM871E(&-O<W0@;V8@=V]R:V5R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.#@N-S8@-C8P+C$U(%1D("@@8V]M<&5N<V%T:6]N+"!P<F]F97-S:6]N
M86P@;&EA8FEL:71Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,P+C Q(#8V
M,"XQ-2!49" H+"!A;F0@:&5A;'1H(&EN<W5R86YC92!C;&%I;7,@=VEL;" I
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," V-#@N-#4@5&0@*&1E<&5N9"!O;B!A8W1U86P@86UO=6YT<R!I;F-U<G)E
M9"!T;R!S971T;&4@=&AO<V4@8VQA:6US(&%N9"!M87D@9&EF*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S$X+C<S(#8T."XT-2!49" H9F5R(&9R;VT@=&AE
M(&%M;W5N=',@<F5S97)V960@8GD@=&AE($-O;7!A;GD@9F]R('1H;W-E("D@
M5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#8S-BXW-2!49" H8VQA:6US+BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#8Q,RXS-2!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#4W+CDR(#8Q,RXS-2!49" H;W)K97)SDBD@5&H@150@
M40IQ(# @," P(')G($)4(#@T+C@Q(#8Q,RXS-2!49" H(&-O;7!E;G-A=&EO
M;B!B96YE9FET<R!A<F4@<')O=FED960@=6YD97(@82!P87)T:6%L;'D@<V5L
M9BUI;G-U<F5D('!L86XN("D@5&H@150@40IQ(# @," P(')G($)4(#,V-"XX
M-B V,3,N,S4@5&0@*%1H92!#;VUP86YY(&AA<R!L971T97)S(&]F(&-R961I
M="!T;R!G=6%R86YT964@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-C Q+C8U(%1D("AP87EM96YT<R!O9B!C;&%I
M;7,N("D@5&H@150@40IQ(# @," P(')G($)4(#$R.2XV-2 V,#$N-C4@5&0@
M*$%T("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4
M(#$T,2XX-" V,#$N-C4@5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C$X+C0V(#8P,2XV
M-2!49" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" R,S<N-#$@-C Q+C8U(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C4V+CDQ(#8P,2XV-2!49" H
M+"!T:&4@0V]M<&%N>2!H860@;W5T<W1A;F1I;F<@87!P<F]X:6UA=&5L>2 I
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T,SDN
M-S @-C Q+C8U(%1D("@D,3@N."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DR+C(T(#8P,2XV-2!49" H(&%N
M9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U
M,3$N,3D@-C Q+C8U(%1D("@D,3DN-B I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.#DN.34@5&0@*&UI;&QI;VXI
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" W-RXV
M-R U.#DN.34@5&0@*"P@<F5S<&5C=&EV96QY*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3(Y+C R(#4X.2XY-2!49" H+"!O9B!S=&%N9&)Y(&QE='1E<G,@
M;V8@8W)E9&ET(&%S(&-O;&QA=&5R86P@=&\@<V5C=7)E('1H92!S96QF+6EN
M<W5R960@<&]R=&EO;B!O9B!T:&ES('!L86XN*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-38V+C4U(%1D("A4:&4@
M0V]M<&%N>2!H87,@;V-C=7)R96YC92UB87-E9"!P<FEM87)Y('!R;V9E<W-I
M;VYA;"!L:6%B:6QI='D@<&]L:6-I97,@=&AA="!P<F]V:61E('1H92!#;VUP
M86YY(&%N9"!E86-H('=O<FMI;F<@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-34T+C@U(%1D("AP<F]F97-S:6]N
M86P@:6X@:71S(&YU<G-E(&%N9"!A;&QI960@:&5A;'1H8V%R92!B=7-I;F5S
M<R!W:71H(&-O=F5R86=E+B!%9BD@5&H@150@40IQ(# @," P(')G($)4(#,S
M,BXR-B U-30N.#4@5&0@*&9E8W1I=F4@2F%N=6%R>2 Q+" R,#$V+"!T:&4@
M0V]M<&%N>2!H87,@82!C;&%I;7,M;6%D92 I(%1J($54(%$*0E0@+T8Q(#DN
M-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U-#,N,34@5&0@*'!R;V9E
M<W-I;VYA;"!L:6%B:6QI='D@<&]L:6-Y(&9O<B!I=',@<&AY<VEC:6%N<R!A
M;F0@861V86YC960@<')A8W1I=&EO;F5R<RP@=VET:"!A("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,V-"XQ,R U-#,N,34@
M5&0@*"0P+C4@;6EL;&EO;BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#0Q,2XX," U-#,N,34@5&0@*"!S96QF+6EN<W5R960@
M<F5T96YT:6]N('!E<B!C;&%I;2X@4')I;W(@*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3,Q+C0U(%1D("AT;R!*
M86YU87)Y(#$L(#(P,38L('1H92!#;VUP86YY(&AA9"!A;B!O8V-U<G)E;F-E
M+6)A<V5D('!R;V9E<W-I;VYA;"!L:6%B:6QI='D@<&]L:6-Y(&9O<B!I=',@
M:6YD97!E;F1E;G0@8V]N=')A8W1O<B!P:'ES:6-I86YS("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Q.2XW-2!4
M9" H86YD(&%D=F%N8V5D('!R86-T:71I;VYE<G,@=VAI8V@@=V%S(&EN<W5R
M960@8GD@82!W:&]L;'DM;W=N960@<W5B<VED:6%R>2D@5&H@150@40IQ(# @
M," P(')G($)4(#,T."XV," U,3DN-S4@5&0@*"P@2F%M97-T;W=N($EN9&5M
M;FET>2D@5&H@150@40IQ(# @," P(')G($)4(#0S."XV.2 U,3DN-S4@5&0@
M*"P@3'1D+BP@82!W:&]L;'DM;W=N960@0V%Y;6%N("D@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4P."XP-2!49" H
M27-L86YD(&-A<'1I=F4@8V]M<&%N>2!<*'1H92!#87!T:79E7"DL('5N=&EL
M(&ET<R!V;VQU;G1A<GD@;&EQ=6ED871I;VX@:6X@=&AE('1H:7)D('%U87)T
M97(@;V8@,C Q-2X@0F5G:6YN:6YG(&EN($UA<F-H(#(P,34L('1H92 I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T
M.38N,S4@5&0@*$-O;7!A;GDG<R!0:'ES:6-I86X@<W5B<VED:6%R>2!S96QF
M+6EN<W5R960@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@,C(V+C<T(#0Y-BXS-2!49" H)# N-2!M:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C<T+C0Q(#0Y-BXS
M-2!49" H(&9O<B!E86-H(&]F(&ET<R!P<F]F97-S:6]N86P@;&EA8FEL:71Y
M(&-L86EM<RX@56YD97(@=&AE('1E<FUS(&]F('1H92 I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T.#0N-C4@5&0@
M*$-A<'1I=F62*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#(N-30@-#@T+C8U
M(%1D("AS(')E:6YS=7)A;F-E('!O;&EC>2!T:&5R92!W87,@82!R97%U:7)E
M;65N="!T;R!G=6%R86YT964@=&AE('!A>6UE;G0@;V8@8VQA:6US('1O(&ET
M<R!I;G-U<F5D('!A<G1YDBD@5&H@150@40IQ(# @," P(')G($)4(#0W,RXT
M.2 T.#0N-C4@5&0@*',@<')I;6%R>2!M961I8V%L("D@5&H@150@40I"5" O
M1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0W,BXY-2!49" H
M;6%L<')A8W1I8V4@:6YS=7)A;F-E(&-A<G)I97(@=FEA(&$@;&5T=&5R(&]F
M(&-R961I="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0U+C<U(#0W,BXY
M-2!49" H07,@82!R97-U;'0@;V8@=&AE($-A<'1I=F4G<R!L:7%U:61A=&EO
M;BP@=&AE(&QE='1E<B!O9B!C<F5D:70@=V%S(')E9'5C960N("D@5&H@150@
M40IQ(# @," P(')G($)4(#4R-2XP,R T-S(N.34@5&0@*$%S(&]F("D@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0V
M,2XR-2!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#DN
M-S4@5&8@150*<2 P(# @,"!R9R!"5" Q,C8N,3(@-#8Q+C(U(%1D("@@86YD
M("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#$T
M-2XP-R T-C$N,C4@5&0@*#(P,3<I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@
M150*<2 P(# @,"!R9R!"5" Q-C0N-3<@-#8Q+C(U(%1D("@L('1H92!V86QU
M92!O9B!T:&4@;&5T=&5R(&]F(&-R961I="!W87,@*2!4:B!%5"!1"D)4("]&
M,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S W+C4R(#0V,2XR-2!49" H
M)#$N."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@,S4U+C$Y(#0V,2XR-2!49" H(&%N9" I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S-S0N,30@-#8Q+C(U(%1D
M("@D,BXP*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@,SDQ+C(P(#0V,2XR-2!49" H(&UI;&QI;VXL(')E<W!E8W1I=F5L>2D@
M5&H@150@40IQ(# @," P(')G($)4(#0W,RXQ-B T-C$N,C4@5&0@*"X@*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-#,W+C@U(%1D("A3=6)J96-T('1O(&-E<G1A:6X@;&EM:71A=&EO;G,L('1H
M92!#;VUP86YY(&%L<V\@:&%S('5M8G)E;&QA(&QI86)I;&ET>2!C;W9E<F%G
M92!F;W(@:71S('=O<FMI;F<@;G5R<V5S(&%N9"!A;&QI960@:&5A;'1H8V%R
M92 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," T,C8N,34@5&0@*'!R;V9E<W-I;VYA;',N("D@5&H@150@40IQ(# @
M," P(')G($)4(#$P-2XV-2 T,C8N,34@5&0@*%=H:6QE('1H:7,@=6UB<F5L
M;&$@8V]V97)A9V4@9&]E<R!N;W0@97AT96YD('1O('!R;V9E<W-I;VYA;"!L
M:6%B:6QI='D@8VQA:6US(&%G86EN<W0@:71S(&EN9&5P96YD96YT(&-O;G1R
M86-T;W(@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-#$T+C0U(%1D("AP:'ES:6-I86YS(&%N9"!A9'9A;F-E9"!P
M<F%C=&ET:6]N97)S+"!I="!D;V5S(&-O=F5R(&-L86EM<R!B<F]U9VAT(&%G
M86EN<W0@86QL(&]F('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G
M($)4(#0R,RXQ-2 T,30N-#4@5&0@*',@<W5B<VED:6%R:65S(&9O<B!N;VXM
M<&%T:65N=" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," T,#(N-S4@5&0@*&=E;F5R86P@;&EA8FEL:71Y*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3$P+C,R(#0P,BXW-2!49" H+BD@5&H@150@
M40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-S@N
M-S4@5&0@*%)E=F5N=64@4F5C;V=N:71I;VX@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,U-"XW-2!49" H26X@
M=&AE(&9I<G-T('%U87)T97(@;V8@,C Q."P@=&AE($-O;7!A;GD@861O<'1E
M9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3 N,#$@,S4T+C<U(%1D("A!
M4U4@3F\N(#(P,30M,#DL("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,C@N,#8@,S4T+C<U(%1D("A2979E;G5E(&9R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S<P+C<S(#,U-"XW-2!49" H;VT@0V]N
M=')A8W1S('=I=&@@0W5S=&]M97)S(%PH5"D@5&H@150@40IQ(# @," P(')G
M($)4(#4P,"XS." S-30N-S4@5&0@*&]P:6,@-C V7"DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,X+C0S(#,U-"XW-2!4
M9" H+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S0R+C<U(%1D("A!4U4@,C Q-"TP.2!I;G1R;V1U8V5S(&$@
M;F5W(&9I=F4M<W1E<"!R979E;G5E(')E8V]G;FET:6]N(&UO9&5L(&EN('=H
M:6-H(&%N(&5N=&ET>2!R96-O9VYI>F5S(')E=F5N=64@=VAE;B!I=',@8W5S
M=&]M97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,S,"XW-2!49" H;V)T86EN<R!C;VYT<F]L(&]F('!R;VUI
M<V5D(&=O;V1S(&]R('-E<G9I8V5S+"!I;B!A;B!A;6]U;G0@=&AA="!R969L
M96-T<R!T:&4@8V]N<VED97)A=&EO;B!T;R!W:&EC:"!T:&4@96YT:71Y(&5X
M<&5C=',@=&\@8F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#,Q."XW-2!49" H96YT:71L960@:6X@97AC:&%N
M9V4@9F]R('1H;W-E(&=O;V1S(&]R('-E<G9I8V5S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-#0N-30@,S$X+C<U(%1D("A4:&4@;F5W('-T86YD87)D
M(&%L<V\@<F5Q=6ER97,@861D:71I;VYA;"!D:7-C;&]S=7)E<R!A8F]U="!T
M:&4@;F%T=7)E+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,S V+C<U(%1D("AA;6]U;G0L('1I;6EN9RP@86YD
M('5N8V5R=&%I;G1Y(&]F(')E=F5N=64@86YD(&-A<V@@9FQO=W,@87)I<VEN
M9R!F<F]M(&-U<W1O;65R(&-O;G1R86-T<RX@4V5E($YO=&4@,R M(%)E=F5N
M=64@4F5C;V=N:71I;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(Y-"XW-2!49" H9F]R(&%D9&ET:6]N86P@
M86-C;W5N=&EN9R!P;VQI8WD@86YD(')E;&%T960@9&ES8VQO<W5R97,N("D@
M5&H@150@40IQ(# @," P(')G($)4(#(W-2XY,B R.30N-S4@5&0@*%1H92!#
M;VUP86YY(&5L96-T960@=&\@861O<'0@=&AE('-T86YD87)D('5S:6YG(&$@
M;6]D:69I960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#(X,BXW-2!49" H<F5T<F]S<&5C=&EV92!M971H;V0L
M('=H:6-H(&]N;'D@:6UP86-T<R!C;VYT<F%C=',@;F]T(&-O;7!L971E9"!A
M<R!O9B!$96-E;6)E<B S,2P@,C Q-RXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C4X+C<U(%1D("A2979E;G5E
M(&9R;VT@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38U
M+C,Q(#(U."XW-2!49" H<R!S97)V:6-E<R!I<R!R96-O9VYI>F5D('=H96X@
M8V]N=')O;"!O9B!T:&4@<')O;6ES960@<V5R=FEC97,@87)E('1R86YS9F5R
M<F5D('1O('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#4T
M-"XP-R R-3@N-S4@5&0@*',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#(T-BXW-2!49" H8W5S=&]M97)S+"!I
M;B!A;B!A;6]U;G0@=&AA="!R969L96-T<R!T:&4@8V]N<VED97)A=&EO;B!I
M="!E>'!E8W1S('1O(')E8V5I=F4@:6X@97AC:&%N9V4@9F]R('1H92!S97)V
M:6-E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C0N.3D@,C0V+C<U(%1D
M("A4:&4@0V]M<&%N>2!H87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#(S-"XW-2!49" H8V]N8VQU9&5D('1H
M870@=')A;G-F97(@;V8@8V]N=')O;"!O9B!I=',@<W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#(R,BXS,B R,S0N-S4@5&0@*&9I;F<@<V5R=FEC97,L
M('=H:6-H(')E<')E<V5N=',@=&AE(&UA:F]R:71Y(&]F(&ET<R!R979E;G5E
M<RP@;V-C=7)S(&]V97(@=&EM92!A<R!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(R,BXW-2!49" H<V5R
M=FEC97,@87)E('!R;W9I9&5D+"!W:&EC:"!I<R!C;VYS:7-T96YT('=I=&@@
M<F5V96YU92!R96-O9VYI=&EO;B!U;F1E<B!T:&4@<')I;W(@9W5I9&%N8V4N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$Y."XW-2!49" H5&AE(&9O;&QO=VEN9R!I<R!A(&1E<V-R:7!T:6]N
M(&]F('1H92!N871U<F4L(&%M;W5N="P@=&EM:6YG+"!A;F0@=6YC97)T86EN
M='D@;V8@<F5V96YU92!A;F0@8V%S:"!F;&]W<R!F<F]M('=H:6-H('1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,3@V+C<U(%1D("A#;VUP86YY(&=E;F5R871E<R!R979E;G5E+BD@5&H@
M150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M-C$N,S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-"XQ-" Q-C$N
M,S4@5&0@*&5M<&]R87)Y(%-T869F:6YG(%)E=F5N=64I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,30Q+C,U(%1D
M("A2979E;G5E(&9R;VT@=&5M<&]R87)Y('-T868I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-C8N-S@@,30Q+C,U(%1D("AF:6YG(&ES(')E8V]G;FEZ960@
M87,@8V]N=')O;"!O9B!T:&4@<V5R=FEC97,@:7,@=')A;G-F97)R960@;W9E
M<B!T:6UE+"!A;F0@:7,@8F%S960@;VX@:&]U<G,@=V]R:V5D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,CDN
M,S4@5&0@*&)Y('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4
M(#$Q."XS." Q,CDN,S4@5&0@*',@9FEE;&0@<W1A9BD@5&H@150@40IQ(# @
M," P(')G($)4(#$U.2XX-B Q,CDN,S4@5&0@*&8N("D@5&H@150@40IQ(# @
M," P(')G($)4(#$V."XP,2 Q,CDN,S4@5&0@*%1H92!#;VUP86YY(')E8V]G
M;FEZ97,@=&AE(&UA:F]R:71Y(&]F(&ET<R!R979E;G5E(&%T('1H92!C;VYT
M<F%C='5A;"!A;6]U;G0@=&AE($-O;7!A;GD@:&%S("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,3<N,S4@5&0@
M*'1H92!R:6=H="!T;R!I;G9O:6-E(&9O<B!S97)V:6-E<R!C;VUP;&5T960@
M=&\@9&%T92X@1V5N97)A;&QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDQ
M+C4T(#$Q-RXS-2!49" H+"!B:6QL:6YG('1O(&-U<W1O;65R<R!O8V-U<G,@
M=V5E:VQY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,U+C,Q(#$Q-RXS-2!4
M9" H+"!B:2UW965K;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T-SDN-C0@
M,3$W+C,U(%1D("@L(&]R(&UO;G1H;'D@86YD(&ES("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,#4N,S4@5&0@
M*&%L:6=N960@=VET:"!T:&4@<&%Y;65N="!O9B!S97)V:6-E<R!T;R!T:&4@
M=&5M<&]R87)Y('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#$N-S4@
M,3 U+C,U(%1D("AF+"!W:71H('!A>6UE;G0@=&5R;7,@;V8@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X,BXX,R Q,#4N
M,S4@5&0@*#$U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Y,BXX,R Q,#4N,S4@5&0@*"!T;R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# U+C8Q(#$P-2XS-2!49" H
M-C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$U+C8Q(#$P-2XS-2!49" H(&1A>7,N("D@5&H@150@40IQ(# @," P(')G
M($)4(#0T,"XX.2 Q,#4N,S4@5&0@*$%C8V]U;G1S(')E8V5I=F%B;&4@:6YC
M;'5D97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#DS+C,U(%1D("AE<W1I;6%T960@<F5V96YU92!F;W(@96UP
M;&]Y965SDBD@5&H@150@40IQ(# @," P(')G($)4(#$X,RXY." Y,RXS-2!4
M9" H(&%N9"!I;F1E<&5N9&5N="!C;VYT<F%C=&]R<Y(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,#$N.# @.3,N,S4@5&0@*"!T:6UE('=O<FME9"!B=70@
M;F]T('EE="!I;G9O:6-E9"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0Q
M+C(R(#DS+C,U(%1D("A!="!$96-E;6)E<B S,2P@,C Q."!A;F0@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#@Q
M+C,U(%1D("A$96-E;6)E<B S,2P@,C Q-RP@=&AE($-O;7!A;GDG<R!E<W1I
M;6%T92!O9B!A;6]U;G1S('1H870@:&%D(&)E96X@=V]R:V5D(&)U="!H860@
M;F]T(&)E96X@8FEL;&5D('1O=&%L960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y,"XP." X,2XS-2!49" H)#0T+C$@
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-#,N.3<@.#$N,S4@5&0@*"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y+C,U(%1D("@D-#$N
M."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$P,RXS.2 V.2XS-2!49" H+"!R97-P96-T:79E;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-38N,#4@-CDN,S4@5&0@*"P@86YD(&%R92!I
M;F-L=61E9"!I;B!A8V-O=6YT<R!R96-E:79A8FQE(&]N('1H92!C;VYS;VQI
M9&%T960@8F%L86YC92!S:&5E=',N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O
M8FH*,3(W(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D
M:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2
M;W1A=&4@, HO0V]N=&5N=',@,3(X(# @4CX^"F5N9&]B:@HQ,C@@,"!O8FH*
M/#PO3&5N9W1H(#DS,#@^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@
M150@40IQ(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%
M+"!)3D,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$W-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P
M(')G($)4(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ
M(# @," P(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y4
M4RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M-3@N,S4@-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@
M5&0@*#(N(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,38S+C8R(#<Q,BXW-2!49" H06-C;W5N=&EN9R!0;VQI8VEE
M<R!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H1BT@,3,I(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-CDU+C$P
M(%1D("A/=&AE<B!397)V:6-E(%)E=F5N=64I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C<U+C$P(%1D("A4:&4@
M0V]M<&%N>2!O9BD@5&H@150@40IQ(# @," P(')G($)4(#$Q-RXP." V-S4N
M,3 @5&0@*&9E<G,@;W1H97(@;W!T:6]N86P@<V5R=FEC97,@=&\@:71S(&-U
M<W1O;65R<R!T:&%T(&%R92!T<F%N<V9E<G)E9"!O=F5R('1I;64@:6YC;'5D
M:6YG.B!M86YA9V5D('-E<G9I8V4@<')O9W)A;7,@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8V,RXQ,"!49" H
M7"A-4U!<*2!P<F]V:61I;F<@86=E;F-Y('-E<G9I8V5S(%PH87,@9G5R=&AE
M<B!D97-C<FEB960@8F5L;W<@:6X@1W)O<W,@=F5R<W5S($YE="!0;VQI8VEE
M<UPI+"!R96-R=6ET;65N="!P<F]C97-S(&]U='-O=7)C:6YG("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-3$N
M,3 @5&0@*%PH4E!/7"DL(&]T:&5R(&]U='-O=7)C:6YG('-E<G9I8V5S+"!A
M;F0@<F5T86EN960@<V5A<F-H('-E<G9I8V5S+"!W:&EC:"!I<R!L97-S('1H
M86X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,X,"XW.2 V-3$N,3 @5&0@*#4E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y-"XQ,B V-3$N,3 @5&0@*"!O9B!I=',@
M8V]N<V]L:61A=&5D(')E=F5N=64@9F]R('1H92!Y96%R<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C,Y+C$P
M(%1D("AE;F1E9"!$96-E;6)E<B S,2P@,C Q."P@,C Q-RP@86YD(#(P,38N
M($=E;F5R86QL>2D@5&H@150@40IQ(# @," P(')G($)4(#(V-2XQ-R V,SDN
M,3 @5&0@*"P@8FEL;&EN9R!A;F0@<&%Y;65N="!T97)M<R!F;W(@35-0*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#$Q+C$X(#8S.2XQ,"!49" H(&%G96YC
M>2!S97)V:6-E<R!I<R!C;VYS:7-T96YT('=I=&@@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8R-RXQ,"!49" H
M=&5M<&]R87)Y('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#<N,S4@
M-C(W+C$P(%1D("AF:6YG(&%S('1H92!C=7-T;VUE<G,@87)E('-I;6EL87(@
M;W(@=&AE('-A;64N(%)E=F5N=64@9G)O;2!T:&5S92!S97)V:6-E<R!A<F4@
M<F5C;V=N:7IE9"!B87-E9"!O;B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Q-2XQ,"!49" H8V]N=')A
M8W1U86P@86UO=6YT(&9O<B!S97)V:6-E<R!C;VUP;&5T960@=&\@9&%T92!W
M:&EC:"!B97-T(&1E<&EC=',@=&AE('1R86YS9F5R(&]F(&-O;G1R;VP@;V8@
M<V5R=FEC97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#4Y,2XQ,"!49" H1F]R('1H92!#;VUP86YYDBD@5&H@
M150@40IQ(# @," P(')G($)4(#$R,BXR-R U.3$N,3 @5&0@*',@4E!/+"!O
M=&AE<B!O=71S;W5R8VEN9RP@86YD(')E=&%I;F5D('-E87)C:"!S97)V:6-E
M<RP@<F5V96YU92!I<R!G96YE<F%L;'D@<F5C;V=N:7IE9"!I;B!T:&4@86UO
M=6YT('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," U-SDN,3 @5&0@*'=H:6-H('1H92!E;G1I='D@:&%S(&$@
M<FEG:'0@=&\@:6YV;VEC92!W:&EC:"!C;W)R97-P;VYD<R!D:7)E8W1L>2!W
M:71H('1H92!V86QU92!T;R!T:&4@8W5S=&]M97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,S,N.#4@-3<Y+C$P(%1D("@N("D@5&H@150@40IQ(# @," P
M(')G($)4(#0S."XV-R U-SDN,3 @5&0@*%1H92!#;VUP86YY(&1O97,@;F]T
M+"!I;B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#4V-RXQ,"!49" H;W)D:6YA<GD@8V]U<G-E(&]F(&)U
M<VEN97-S+"!O9BD@5&H@150@40IQ(# @," P(')G($)4(#$W,BXS-2 U-C<N
M,3 @5&0@*&9E<B!W87)R86YT:65S(&]R(')E9G5N9',N*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4T,2XW,"!4
M9" H1W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" V,"XR-" U-#$N-S @5&0@
M*&]S<R!6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.# N-3,@-30Q+C<P(%1D
M("AE<G-U<R!.970@4&]L:6-I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-3(Q+C<P(%1D("A4:&4@0V]M<&%N
M>2!R96-O<F1S(')E=F5N=64@;VX@82!G<F]S<R!B87-I<R!A<R!A('!R:6YC
M:7!A;"!O<B!O;B!A(&YE="!B87-I<R!A<R!A;B!A9V5N="!D97!E;F1I;F<@
M;VX@=&AE(&-O;G1R86-T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#4P.2XW,"!49" H87)R86YG96UE;G0L
M(&%S(&9O;&QO=W,Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP(# @
M,"!21PHO1U,P(&=S"C N-#D@=PHP(&D@"EM=(# @9 HQ($H*,2!J"C,@30HT
M.2XU(#0X,BXY-C8Y.3(Q.#<U(&T*,38P+C R,C0V,#DS-S4@-#@R+CDV-CDY
M,C$X-S4@; IS"G$@," P(# @<F<@0E0@-#DN-3 @-#@T+C,P(%1D("A-86YA
M9V5D(%-E<G9I8V4@4')O9W)A;7,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-#8T+C,P(%1D("A4:&4@0V]M<&%N
M>2!H87,@8V5R=&%I;B!C;VYT<F%C=',@=VET:"!H96%L=&AC87)E(&9A8VEL
M:71I97,@=&\@<')O=FED92!C;VUP<F5H96YS:79E('-E<G9I8V5S('1H<F]U
M9V@@:71S($U34',N(%5N9&5R('1H97-E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-3(N,S @5&0@*&-O;G1R
M86-T=6%L(&%R<F%N9V5M96YT<RP@=&AE(&-U<W1O;65R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C W+C R(#0U,BXS,"!49" HDBD@5&H@150@40IQ(# @
M," P(')G($)4(#(P.2XX," T-3(N,S @5&0@*',@;W)D97)S(&%R92!F:6QL
M960@=VET:"!E:71H97(@;VYE(&]F('1H92!#;VUP86YY)W,@:&5A;'1H8V%R
M92!P<F]F97-S:6]N86QS(&]R(&$@=&AI<F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0T,"XS,"!49" H<&%R
M='DG<R!H96%L=&AC87)E('!R;V9E<W-I;VYA;',@7"AS=6)C;VYT<F%C=&]R
M<UPI+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," T,38N,S @5&0@*%=H96X@:71S(&AE86QT:&-A<F4@<')O9F5S
M<VEO;F%L(&ES('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#8N,C$@
M-#$V+C,P(%1D("AF960L('1H92!#;VUP86YY(&1E=&5R;6EN960@=&AA="!I
M="!A8W1S(&%S(&$@<')I;F-I<&%L(&EN('1H92!A<G)A;F=E;65N="P@87,@
M:70@:7,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0P-"XS,"!49" H8V]N<VED97)E9"!T:&4@96UP;&]Y97(@
M;V8@<F5C;W)D+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3$N,3$@-# T
M+C,P(%1D("A!8V-O<F1I;F=L>2D@5&H@150@40IQ(# @," P(')G($)4(#(T
M,"XT-2 T,#0N,S @5&0@*"P@<F5V96YU92!I<R!R97!O<G1E9"!O;B!A(&=R
M;W-S(&)A<VES(&]N('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,SDR+C,P(%1D("AO<&5R871I;VYS+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-C@N,S @5&0@*$%L=&5R
M;F%T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#$N-C$@,S8X+C,P
M(%1D("@L('1H92!#;VUP86YY(&1E=&5R;6EN960@=&AA="!I="!A8W1S(&%S
M(&%N(&%G96YT(&EN('1H92!A<G)A;F=E;65N="!W:&5N(&$@<W5B8V]N=')A
M8W1E9"!H96%L=&AC87)E('!R;V9E<W-I;VYA;" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S4V+C,P(%1D("AI
M<R!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S(N.3,@,S4V+C,P(%1D
M("AF960L(&%S('1H92!#;VUP86YY(&1O97,@;F]T(&-O;G1R;VP@=&AE('-E
M<G9I8V5S(&)E9F]R92!T:&5Y(&%R92!T<F%N<V9E<G)E9"!T;R!T:&4@8W5S
M=&]M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#,N,S4@,S4V+C,P(%1D
M("@N("D@5&H@150@40IQ(# @," P(')G($)4(#0T-RXX," S-38N,S @5&0@
M*$%C8V]R9&EN9VQY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DW+C$T(#,U
M-BXS,"!49" H+"!R979E;G5E(&ES("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-#0N,S @5&0@*')E<&]R=&5D
M(&]N(&$@;F5T(&)A<VES(&]N('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT
M<R!O9B!O<&5R871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C0N
M,C4@,S0T+C,P(%1D("A4:&4@8W5S=&]M97(@:7,@:6YV;VEC960@9F]R('1H
M92!H;W5R<R!W;W)K960@8GD@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,S(N,S @5&0@*'-U8F-O;G1R
M86-T960@:&5A;'1H8V%R92!P<F]F97-S:6]N86P@;75L=&EP;&EE9"!B>2!T
M:&4@:&]U<FQY(&)I;&P@<F%T92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S,W+C$Y(#,S,BXS,"!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,T
M,RXX-B S,S(N,S @5&0@*"!S=6)C;VYT<F%C=&]R(&QI86)I;&ET>2D@5&H@
M150@40IQ(# @," P(')G($)4(#0S,RXW-" S,S(N,S @5&0@*"P@=VAI8V@@
M:7,@<F5C;V=N:7IE9"!A<R!A("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," S,C N,S @5&0@*')E9'5C=&EO;B!O
M9B!R979E;G5E+"!I<R!E<W1A8FQI<VAE9"!I;B!A8V-R=65D(&5X<&5N<V5S
M(&9O<B!T:&4@:6YV;VEC960@86UO=6YT+"!N970@;V8@86X@861M:6YI<W1R
M871I=F4@9F5E+"!A;F0@:7,@9V5N97)A;&QY("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,#@N,S @5&0@*'!A
M>6%B;&4@869T97(@=&AE($-O;7!A;GD@:&%S(')E8V5I=F5D('!A>6UE;G0@
M9G)O;2!I=',@8W5S=&]M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3DN
M,3,@,S X+C,P(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#,R,RXY
M-2 S,#@N,S @5&0@*%1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G
M($)4(#,X,RXV-B S,#@N,S @5&0@*',@861M:6YI<W1R871I=F4@9F5E(&ES
M(&-A;&-U;&%T960@87,@82 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,CDV+C,P(%1D("AP97)C96YT86=E(&]F
M('1H92!C=7-T;VUE<BD@5&H@150@40IQ(# @," P(')G($)4(#$U-RXX-R R
M.38N,S @5&0@*)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C N-C4@,CDV
M+C,P(%1D("AS(&EN=F]I8V4@86YD(&ES(')E8V]G;FEZ960@;W9E<B!T:6UE
M(&%S('1H92!S97)V:6-E<R!A<F4@<F5N9&5R960@8GD@=&AE('-U8F-O;G1R
M86-T960@:&5A;'1H8V%R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,C@T+C,P(%1D("AP<F]F97-S:6]N86PN
M("D@5&H@150@40IQ(# @," P(')G($)4(#$P,RXR," R.#0N,S @5&0@*%1H
M92!#;VUP86YY(&1O97,@;F]T(&-O;&QE8W0@;W(@<F5C;V=N:7IE(&%N('5P
M9G)O;G0@<&QA8V5M96YT(&9E92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"C @," P(%)'"B]'4S @9W,*,"XT.2!W"C @:2 *6UT@,"!D"C$@2@HQ
M(&H*,R!-"C0Y+C4@,C4W+C4V-CDY,C$X-S4@;0HQ,C(N.3(R.#4Q-38R-2 R
M-3<N-38V.3DR,3@W-2!L"G,*<2 P(# @,"!R9R!"5" T.2XU," R-3@N.3 @
M5&0@*%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 V
M+C@Q(#(U."XY,"!49" H9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," R,S@N.3 @5&0@*%1H92!0:'ES:6-I
M86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#$R-"XX-B R,S@N.3 @
M5&0@*&9I;F<@8G5S:6YE<W,@:&%S(&-O;G1R86-T<R!W:71H(&ET<R!H96%L
M=&AC87)E(&-U<W1O;65R<R!T;R!P<F]V:61E('1E;7!O<F%R>2!S=&%F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#4T+C,Q(#(S."XY,"!49" H9FEN9R!S
M97)V:6-E<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 Y+CDU(#(S."XY
M,"!49" H5&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," R,C8N.3 @5&0@*$-O;7!A;GD@=7-E<R!I;F1E<&5N
M9&5N="!C;VYT<F%C=&]R<R!F;W(@=&AE<V4@<V5R=FEC97,N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(X,RXQ-" R,C8N.3 @5&0@*%1H92!#;VUP86YY
M(&1E=&5R;6EN960@=&AA="!I="!A8W1S(&%S(&$@<')I;F-I<&%L(&EN('1H
M97-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," R,30N.3 @5&0@*&%R<F%N9V5M96YT<R!A;F0L('1H97)E9F]R
M92P@<F5V96YU92!I<R!R97!O<G1E9"!O;B!A(&=R;W-S(&)A<VES(&]N('1H
M92!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M.3 N.3 @5&0@*%-E92!.;W1E(#,@+2!2979E;G5E(%)E8V]G;FET:6]N(&9O
M<B!T:&4@0V]M<&%N>2=S(')E=F5N=65S(&1I<V%G9W)E9V%T960@8GD@<F5V
M96YU92!S;W5R8V4N(%-A;&5S(&%N9"!U<V%G92UB87-E9"!T87AE<R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3<X+CDP(%1D("AA<F4@97AC;'5D960@9G)O;2!R979E;G5E+BD@5&H@150@
M40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-30N
M.3 @5&0@*$-O;G1R86-T($-O<W1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S,"XY,"!49" H06QL(&-O;G1R
M86-T(&9U;&9I;&QM96YT(&-O<W1S(&%R92!E>'!E;G-E9"!A<R!I;F-U<G)E
M9"!T;R!D:7)E8W0@;W!E<F%T:6YG(&5X<&5N<V5S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.#4N,#,@,3,P+CDP(%1D("A7*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,SDT+C W(#$S,"XY,"!49" H:71H(')E<W!E8W0@=&\@1BD@
M5&H@150@40IQ(# @," P(')G($)4(#0U,RXP-" Q,S N.3 @5&0@*$%30B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S0N-#0@,3,P+CDP(%1D("A!4T,@
M-C V+" I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3$V+C,Y(#$S,"XY,"!49" H4F5V96YU92 I(%1J($54(%$*0E0@+T8T
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3$X+CDP(%1D("AF
M<BD@5&H@150@40IQ(# @," P(')G($)4(#4U+C@P(#$Q."XY,"!49" H;VT@
M0V]N=')A8W1S('=I=&@@0W5S=&]M97)S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$W-"XY." Q,3@N.3 @5&0@*"P@=&AE
M<F4@=V5R92!N;R!C;VYT<F%C="!A<W-E=',@;W(@;6%T97)I86P@8V]N=')A
M8W0@;&EA8FEL:71I97,@87,@;V8@1&5C96UB97(@,S$L(#(P,3@@86YD(#(P
M,3<N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#DT+CDP(%1D("A0<F%C=&EC86P@17AP961I96YT<R!A;F0@17AE
M;7!T:6]N<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," W,"XY,"!49" H1F]R('1H92!#;VUP86YYDBD@5&H@150@
M40IQ(# @," P(')G($)4(#$R,BXR-R W,"XY,"!49" H<R!C;VYT<F%C=',@
M=&AA="!H879E(&%N(&]R:6=I;F%L(&1U<F%T:6]N(&]F(&]N92!Y96%R(&]R
M(&QE<W,L('1H92!#;VUP86YY('5S97,@=&AE('!R86-T:6-A;"!E>'!E9&EE
M;G1S(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-3@N.3 @5&0@*&AA<R!E;&5C=&5D('1O(')E8V]G;FEZ
M92!A;GD@:6YC<F5M96YT86P@8V]S=',@;V8@;V)T86EN:6YG('1H97-E(&-O
M;G1R86-T<R!A<R!E>'!E;G-E9"!W:&5N(&EN8W5R<F5D+B!&=7)T:&5R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#DQ+C<Q(#4X+CDP(%1D("@L('1H92!#
M;VUP86YY("D@5&H@150@40IE;F1S=')E86T*96YD;V)J"C$R.2 P(&]B:@H\
M/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R
M+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E
M;G1S(#$S," P(%(^/@IE;F1O8FH*,3,P(# @;V)J"CP\+TQE;F=T:" Q.38R
M-3X^"G-T<F5A;0I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,3,N.#4@-S8P+C<U(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3(N-C@@-S8P+C<U(%1D("A9*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDY+C4S(#<V,"XW-2!49" H($A%04PI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,CDN-#4@-S8P+C<U(%1D("A42$-!4D4L($E.0RXI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<U+C,P(#<T
M."XW-2!49" H3D]415,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R
M(#<T."XW-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(Q."XP,2 W
M-#@N-S4@5&0@*$\@0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C@X+C$Q(#<T."XW-2!49" H5$5$($9)3D%.0TE!3"D@5&H@150@40IQ(# @
M," P(')G($)4(#,V-RXR.2 W-#@N-S4@5&0@*"!35"D@5&H@150@40IQ(# @
M," P(')G($)4(#,X,2XR." W-#@N-S4@5&0@*$$I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#<N-S8@-S0X+C<U(%1D("A414U%3E13*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U."XS-2 W,S8N-S4@
M5&0@*$1%0T5-0D52H#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#<Q,BXW-2!49" H,BX@4W5M;6%R
M>2!O9B!3:6=N:69I8V%N=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C,N
M-C(@-S$R+C<U(%1D("A!8V-O=6YT:6YG(%!O;&EC:65S(%PH8V]N=&EN=65D
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,CDU+C,P(#,S+C8P(%1D("A&+2 Q-"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @5&0@*&1O97,@;F]T
M(&1I<V-L;W-E('1H92!V86QU92!O9B!U;G-A=&ES9FEE9"!P97)F;W)M86YC
M92!O8FQI9V%T:6]N<R!F;W(Z(%PH:5PI(&-O;G1R86-T<R!W:71H(&%N(&]R
M:6=I;F%L(&5X<&5C=&5D(&QE;F=T:"!O9B!O;F4@>65A<B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C$P
M(%1D("AO<B!L97-S+"!A;F0@7"AI:5PI(&-O;G1R86-T<R!F;W(@=VAI8V@@
M:70@<F5C;V=N:7IE<R!R979E;G5E(&%T('1H92!A;6]U;G0@=&\@=VAI8V@@
M:70@:&%S('1H92!R:6=H="!T;R!I;G9O:6-E(&9O<B!S97)V:6-E<R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-C<Q+C$P(%1D("AP97)F;W)M960N("D@5&H@150@40I"5" O1C,@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#<N,3 @5&0@*%-H87)E+4)A
M<V5D("D@5&H@150@40IQ(# @," P(')G($)4(#$P-"XW." V-#<N,3 @5&0@
M*$-O;7!E;G-A=&EO;BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#8R,RXT,"!49" H5&AE($-O;7!A;GD@:&%S+"!F
M<F]M('1I;64@=&\@=&EM92P@9W)A;G1E9"!S=&]C:R!O<'1I;VYS+"!S=&]C
M:R!A<'!R96-I871I;VX@<FEG:'1S+"!P97)F;W)M86YC92UB87-E9"!S=&]C
M:R!A=V%R9',L(&%N9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," V,3$N-S @5&0@*')E<W1R:6-T960@<W1O8VL@
M9F]R(&$@9FEX960@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@=&\@96UP;&]Y
M965S+B!);B!A8V-O<F1A;F-E('=I=&@@=&AE("D@5&H@150@40I"5" O1C0@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0P-RXY-B V,3$N-S @5&0@*$-O
M;7!E;G-A=&EO;BU3=&]C:RU#;VUP96YS871I;VXI(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U-#@N,C0@-C$Q+C<P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C P+C P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30N-S<@
M-C P+C P(%1D("AO<&EC(&]F('1H92!&*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3 S+C8Q(#8P,"XP,"!49" H05-"("D@5&H@150@40IQ(# @," P(')G
M($)4(#$R-"XT-R V,# N,# @5&0@*$%30RP@8V]M<&%N:65S(&UA>2!C:&]O
M<V4@9G)O;2!A;'1E<FYA=&EV92!V86QU871I;VX@;6]D96QS+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-S<N-S0@-C P+C P(%1D("A4:&4@0V]M<&%N
M>2!U<V5D('1H92!";&%C:RU38VAO;&5S(&UE=&AO9" I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.#@N,S @5&0@
M*&]F('9A;'5I;F<@:71S(&]P=&EO;G,@86YD('-T;V-K(&%P<')E8VEA=&EO
M;B!R:6=H=',N("D@5&H@150@40IQ(# @," P(')G($)4(#(U,2XV,2 U.#@N
M,S @5&0@*%1H92!#;VUP86YY(&AA<R!E;&5C=&5D('1O(')E8V]G;FEZ92!C
M;VUP96YS871I;VX@97AP96YS92!O;B!A('-T<F%I9VAT+6QI;F4@*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3<V
M+C8P(%1D("AB87-I<R!O=F5R('1H92!R97%U:7-I=&4@<V5R=FEC92!P97)I
M;V0@;V8@=&AE(&5N=&ER92!A=V%R9"X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C<W+C Q(#4W-BXV,"!49" H5&AE($-O;7!A;GD@=F%L=65S(&ET<R!R
M97-T<FEC=&5D('-T;V-K(&%W87)D<R!A;F0@=&AE(&9A:7(@=F%L=64@;V8@
M:71S("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#4V-"XY,"!49" H<&5R9F]R;6%N8V4M8F%S960@<W1O8VL@87=A
M<F1S(&)Y(')E9F5R96YC92!T;R!I=',@<W1O8VL@<')I8V4@;VX@=&AE(&1A
M=&4@;V8@9W)A;G0N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-30Q+C4P(%1D("A4:&4@0V]M<&%N>2!G<F%N=&5D
M('!E<F9O<FUA;F-E+6)A<V5D('-T;V-K(&%W87)D<R!T;R!C97)T86EN(&ME
M>2!P97)S;VYN96P@<'5R<W5A;G0@=&\@:71S(#(P,30@3VUN:6)U<R!);F-E
M;G1I=F4@4&QA;BP@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3(Y+C@P(%1D("AA;65N9&5D(&%N9"!R97-T871E
M9"!O;B!-87D@,C,L(#(P,3<@7"@R,#$W(%!L86Y<*2!A<R!D97-C<FEB960@
M:6X@3F]T92 Q-" M(%-T;V-K:&]L9&5R<R<@17%U:71Y*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#,S+C<W(#4R.2XX,"!49" H+B!0=7)S=6%N="!T;R!T
M:&4@<&QA;BP@=&AE("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#4Q."XQ,"!49" H;G5M8F5R(&]F('1A<BD@5&H@
M150@40IQ(# @," P(')G($)4(#$P,BXS.2 U,3@N,3 @5&0@*&=E="!S:&%R
M97,@=&AA="!V97-T(&%R92!D971E<FUI;F5D(&)A<V5D(&]N('1H92!L979E
M;"!O9B!A='1A:6YM96YT(&]F('1H92!T87(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,#$N,3 @-3$X+C$P(%1D("AG971S+J!)9B!A(&UI;FEM=6T@;&5V
M96P@;V8@<&5R9F]R;6%N8V4@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-3 V+C0P(%1D("AI<R!A='1A:6YE9"!F
M;W(@=&AE(&%W87)D<RP@<F5S=')I8W1E9"!S=&]C:R!I<R!I<W-U960@8F%S
M960@;VX@=&AE(&QE=F5L(&]F(&%T=&%I;FUE;G0N("D@5&H@150@40IQ(# @
M," P(')G($)4(#,W."XX-" U,#8N-# @5&0@*%1H92!#;VUP86YY(')E8V]G
M;FEZ97,@<&5R9F]R;6%N8V4M8F%S960@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#DT+C<P(%1D("AR97-T<FEC
M=&5D('-T;V-K(&%S(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&)A<V5D(&]N('1H
M92!M;W-T(&QI:V5L>2!P<F]B86)I;&ET>2!O9B!A='1A:6YI;F<@=&AE('!R
M97-C<FEB960@<&5R9F]R;6%N8V4@86YD(&]V97(@=&AE("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0X,RXP,"!4
M9" H<F5Q=6ES:71E('-E<G9I8V4@<&5R:6]D(&)E9VEN;FEN9R!A="!I=',@
M9W)A;G0@9&%T92!A;F0@=&AR;W5G:"!T:&4@9&%T92!T:&4@<F5S=')I8W1E
M9"!S=&]C:R!V97-T<RXI(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," T-3DN-C @5&0@*$-O;7!E;G-A=&EO;B!E>'!E
M;G-E(')E;&%T960@=&\@<VAA<F4M8F%S960@<&%Y;65N=',@:7,@:6YC;'5D
M960@:6X@<V5L;&EN9RP@9V5N97)A;"!A;F0@861M:6YI<W1R871I=F4@97AP
M96YS97,@:6X@=&AE("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#0T-RXY,"!49" H8V]N<V]L:61A=&5D('-T871E
M;65N=',@;V8@;W!E<F%T:6]N<RP@86YD('1O=&%L960@*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C0V+C,U(#0T-RXY,"!4
M9" H)#,N-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@,CDT+C R(#0T-RXY,"!49" H+" I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R.3@N.#D@-#0W+CDP(%1D
M("@D-"XQ*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@,S$U+CDU(#0T-RXY,"!49" H(&UI;&QI;VXL(&%N9" I(%1J($54(%$*
M0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S-C<N.34@-#0W+CDP
M(%1D("@D,RXT*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@,S@U+C Q(#0T-RXY,"!49" H(&UI;&QI;VXL(&1U<FEN9R!T:&4@
M>65A<G,@96YD960@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-#,U+CDP(%1D("A$96-E;6)E<J S,2P@,C Q."D@
M5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#$R-BXQ
M,B T,S4N.3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@,3,Q+C P(#0S-2XY,"!49" H,C Q-RD@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#$U,"XU," T,S4N.3 @
M5&0@*"P@86YD("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P
M(')G($)4(#$W,2XX.2 T,S4N.3 @5&0@*#(P,38I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" Q.3$N,SD@-#,U+CDP(%1D("@L
M(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#(T,BXW,R T
M,S4N.3 @5&0@*"X@4V5E($YO=&4@,30@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(Y-RXW," T,S4N.3 @5&0@*"TI(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S,#$N,#,@
M-#,U+CDP(%1D("@@4W1O8VMH;VQD97)SDBD@5&H@150@40IQ(# @," P(')G
M($)4(#,U-BXY," T,S4N.3 @5&0@*"!%<75I='DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#0N-S @-#,U+CDP(%1D("@N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0R,RXY,"!49" HH"D@
M5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," T,3$N.3 @5&0@*$%D=F5R=&ES:6YG*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y.2XY,"!49" HH"D@5&H@
M150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,X
M."XR,"!49" H5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 W+C<R(#,X."XR,"!49" H<R!A9'9E<G1I<VEN9R!E>'!E;G-E(&-O;G-I
M<W1S('!R:6UA<FEL>2!O9B!O;FQI;F4@861V97)T:7-I;F<L(&EN=&5R;F5T
M(&1I<F5C="!M87)K971I;F<L('!R:6YT(&UE9&EA+"!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S<V+C4P
M(%1D("AP<F]M;W1I;VYA;"!M871E<FEA;"X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3,U+C@X(#,W-BXU,"!49" H061V97)T:7-I;F<@8V]S=',@87)E
M(&5X<&5N<V5D(&%S(&EN8W5R<F5D(&%N9"!T;W1A;&5D("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,U,"XS,2 S-S8N-3 @
M5&0@*"0V+C<@;6EL;&EO;BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#,Y-RXY." S-S8N-3 @5&0@*"P@*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-# R+C@U(#,W-BXU,"!4
M9" H)#<N-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@-#4P+C4R(#,W-BXU,"!49" H+"!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#<Q+CDQ(#,W-BXU
M,"!49" H)#$P+C(I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" T.3,N.#4@,S<V+C4P(%1D("@@;6EL;&EO;BP@9F]R('1H92 I
M(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S-C0N.# @5&0@*'EE87)S(&5N9&5D("D@5&H@150@40I"5" O1C$@.2XW
M-2!49B!%5 IQ(# @," P(')G($)4(#DX+C(S(#,V-"XX,"!49" H1&5C96UB
M97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" Q-S0N.#4@,S8T+C@P(%1D("@L("D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#$W.2XW,B S-C0N.# @5&0@*#(P
M,3<I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" Q
M.3DN,C(@,S8T+C@P(%1D("@L(&%N9" I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" R,C N-C$@,S8T+C@P(%1D("@R,#$V*2!4
M:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C0P+C$Q
M(#,V-"XX,"!49" H+"!R97-P96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R.3$N-#8@,S8T+C@P(%1D("@N*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,T,"XX,"!49" H4F5S=')U
M8W1U<FEN9R!#;W-T<RD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#,Q-RXT,"!49" H5&AE($-O;7!A;GD@8V]N<VED
M97)S(')E<W1R=6-T=7)I;F<@86-T:79I=&EE<R!T;R!B92!P<F]G<F%M<R!W
M:&5R96)Y(&ET(&9U;F1A;65N=&%L;'D@8VAA;F=E<R!I=',@;W!E<F%T:6]N
M<RP@<W5C:"!A<R!C;&]S:6YG("D@5&H@150@40I"5" O1C$@.2XW-2!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#,P-2XW,"!49" H86YD(&-O;G-O;&ED
M871I;F<@9F%C:6QI=&EE<RP@<F5D=6-I;F<@:&5A9&-O=6YT+"!A;F0@<F5A
M;&EG;FEN9R!O<&5R871I;VYS(&EN(')E<W!O;G-E('1O(&-H86YG:6YG(&UA
M<FME="!C;VYD:71I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3$N
M-S @,S U+C<P(%1D("A!<R!A(')E<W5L="P@*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,CDT+C P(%1D("AR97-T
M<G5C='5R:6YG(&-O<W1S(&]N('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT
M<R!O9B!O<&5R871I;VYS(&EN8VQU9&4@;VXM9V]I;F<@8F5N969I="!C;W-T
M<R!F;W(@:71S(&5M<&QO>65E<RP@97AI="!C;W-T<RP@86YD("D@5&H@150@
M40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X,BXS
M,"!49" H;W1H97(@8V]S=',@:6YC;'5D:6YG('=R:71E+6]F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,38T+C0P(#(X,BXS,"!49" H9G,@<F5L871E9"!T
M;R!A8F%N9&]N960@;&]C871I;VYS+BD@5&H@150@40I"5" O1C$@.2XW-2!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(U."XY,"!49" H4F5C;VYC:6QI
M871I;VYS(&]F('1H92!B96=I;FYI;F<@86YD(&5N9&EN9R!T;W1A;"!R97-T
M<G5C='5R:6YG(&QI86)I;&ET>2!B86QA;F-E<R!A<F4@<')E<V5N=&5D(&)E
M;&]W.BD@5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.2XP," R,#,N-# @,30P+C P("TR,RXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,3@Y+C P(#(P
M,RXT," V,RXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U,BXP," R,#,N-# @-34N,# @+3(S
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS,#<N,# @,C S+C0P(#$P+C P("TR,RXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$W+C P
M(#(P,RXT," V,RXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,"XP," R,#,N-# @-34N,# @
M+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,S4N,# @,C S+C0P(#$P+C P("TR,RXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0U
M+C P(#(P,RXT," V,RXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P."XP," R,#,N-# @-30N
M,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.2XP," Q-C4N-# @,30P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,3@Y+C P(#$V-2XT," V,RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U,BXP," Q-C4N-# @
M-34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHS,#<N,# @,38U+C0P(#$P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S$W+C P(#$V-2XT," V,RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X,"XP," Q-C4N
M-# @-34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S4N,# @,38U+C0P(#$P+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#0U+C P(#$V-2XT," V,RXP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P."XP," Q
M-C4N-# @-30N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," Q,S4N-# @,30P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,3@Y+C P(#$S-2XT," V,RXP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U,BXP
M," Q,S4N-# @-34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#<N,# @,3,U+C0P(#$P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S$W+C P(#$S-2XT," V,RXP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X
M,"XP," Q,S4N-# @-34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S4N,# @,3,U+C0P(#$P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#0U+C P(#$S-2XT," V,RXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P."XP," Q,S4N-# @-30N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HQ
M.#D@,C,S+C,Y.3DY.3DY.3DY.3DX(&T*,C4R(#(S,RXS.3DY.3DY.3DY.3DY
M."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,3@Y(#(Q."XS.3DY.3DY.3DY.3DY."!M"C(U,B R,3@N,SDY
M.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C(U,B R,S,N,SDY.3DY.3DY.3DY.3@@;0HS
M,#<@,C,S+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR-3(@,C$X+C,Y.3DY.3DY
M.3DY.3DX(&T*,S W(#(Q."XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S W(#(S
M,RXS.3DY.3DY.3DY.3DY."!M"C,Q-R R,S,N,SDY.3DY.3DY.3DY.3@@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,Q-R R,S,N,SDY.3DY.3DY.3DY.3@@;0HS.# @,C,S+C,Y.3DY.3DY
M.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS,3<@,C$X+C,Y.3DY.3DY.3DY.3DX(&T*,S@P(#(Q
M."XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@P(#(S,RXS.3DY.3DY.3DY.3DY
M."!M"C0S-2 R,S,N,SDY.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X," R,3@N,SDY
M.3DY.3DY.3DY.3@@;0HT,S4@,C$X+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M,S4@,C,S+C,Y.3DY.3DY.3DY.3DX(&T*-#0U(#(S,RXS.3DY.3DY.3DY.3DY
M."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#0U(#(S,RXS.3DY.3DY.3DY.3DY."!M"C4P." R,S,N,SDY
M.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0T-2 R,3@N,SDY.3DY.3DY.3DY.3@@;0HU
M,#@@,C$X+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#@@,C,S+C,Y.3DY.3DY
M.3DY.3DX(&T*-38R(#(S,RXS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 X(#(Q
M."XS.3DY.3DY.3DY.3DY."!M"C4V,B R,3@N,SDY.3DY.3DY.3DY.3@@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C$X.2 Q.# N,SDY.3DY.3DY.3DY.3@@;0HR-3(@,3@P+C,Y.3DY.3DY
M.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HR-3(@,3@P+C,Y.3DY.3DY.3DY.3DX(&T*,S W(#$X
M,"XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S$W(#$X,"XS.3DY.3DY.3DY.3DY
M."!M"C,X," Q.# N,SDY.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X," Q.# N,SDY
M.3DY.3DY.3DY.3@@;0HT,S4@,3@P+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M-#4@,3@P+C,Y.3DY.3DY.3DY.3DX(&T*-3 X(#$X,"XS.3DY.3DY.3DY.3DY
M."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 X(#$X,"XS.3DY.3DY.3DY.3DY."!M"C4V,B Q.# N,SDY
M.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C$X.2 Q,S4N,SDY.3DY.3DY.3DY.3@@;0HR
M-3(@,3,U+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HQ.#D@,3(Q+C,Y.3DY.3DY
M.3DY.3DX(&T*,C4R(#$R,2XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3@Y(#$Q
M.2XS.3DY.3DY.3DY.3DY."!M"C(U,B Q,3DN,SDY.3DY.3DY.3DY.3@@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C(U,B Q,S4N,SDY.3DY.3DY.3DY.3@@;0HS,#<@,3,U+C,Y.3DY.3DY
M.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HR-3(@,3(Q+C,Y.3DY.3DY.3DY.3DX(&T*,S W(#$R
M,2XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C4R(#$Q.2XS.3DY.3DY.3DY.3DY
M."!M"C,P-R Q,3DN,SDY.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Q-R Q,S4N,SDY
M.3DY.3DY.3DY.3@@;0HS.# @,3,U+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M,3<@,3(Q+C,Y.3DY.3DY.3DY.3DX(&T*,S@P(#$R,2XS.3DY.3DY.3DY.3DY
M."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S$W(#$Q.2XS.3DY.3DY.3DY.3DY."!M"C,X," Q,3DN,SDY
M.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,X," Q,S4N,SDY.3DY.3DY.3DY.3@@;0HT
M,S4@,3,U+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.# @,3(Q+C,Y.3DY.3DY
M.3DY.3DX(&T*-#,U(#$R,2XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@P(#$Q
M.2XS.3DY.3DY.3DY.3DY."!M"C0S-2 Q,3DN,SDY.3DY.3DY.3DY.3@@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0T-2 Q,S4N,SDY.3DY.3DY.3DY.3@@;0HU,#@@,3,U+C,Y.3DY.3DY
M.3DY.3DX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-#4@,3(Q+C,Y.3DY.3DY.3DY.3DX(&T*-3 X(#$R
M,2XS.3DY.3DY.3DY.3DY."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0U(#$Q.2XS.3DY.3DY.3DY.3DY
M."!M"C4P." Q,3DN,SDY.3DY.3DY.3DY.3@@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P." Q,S4N,SDY
M.3DY.3DY.3DY.3@@;0HU-C(@,3,U+C,Y.3DY.3DY.3DY.3DX(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU
M,#@@,3(Q+C,Y.3DY.3DY.3DY.3DX(&T*-38R(#$R,2XS.3DY.3DY.3DY.3DY
M."!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-3 X(#$Q.2XS.3DY.3DY.3DY.3DY."!M"C4V,B Q,3DN,SDY
M.3DY.3DY.3DY.3@@; IS"D)4("]&,B Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@,S(Q+C P(#(S."XP-2!49" H62D@5&H@150@40IQ(# @," P(')G($)4
M(#,R-BXY-B R,S@N,#4@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4
M(#,T,"XS,2 R,S@N,#4@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#0Q-"XS,R R,S@N,#4@5&0@*" S,2PI(%1J($54(%$*
M0E0@+T8R(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R,S<N-S4@,C(S+C U
M(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,B Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@,S8U+C<U(#(R,RXP-2!49" H,C Q-RD@5&H@150@40I"5" O1C(@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y,RXR-2 R,C,N,#4@5&0@*#(P
M,38I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S
M,CDN-3 @,C X+C T(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J
M($54(%$*0E0@+T8R(#DN-S4@5&8@150*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,3DY+C$P(#(P,"XY," T-"XQ-B M."XW,2!R92!F
M"B]'4S @9W,*<2 P(# @,"!R9R!"5" Q.3DN,3 @,3DT+C,P(%1D("A/;BU'
M;VEN9R I(%1J($54(%$*0E0@+T8R(#DN-S4@5&8@150*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,3DR+C4P(#$Y,2XQ-2 U-"XY-R M
M."XW,2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" Q.3(N-3 @,3@T+C4U
M(%1D("A"96YE9FET($-O<W1S*2!4:B!%5"!1"D)4("]&,B Y+C<U(%1F($54
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U-RXW," Q
M.3$N-C4@-#(N-3(@+3@N-S$@<F4@9@HO1U,P(&=S"G$@," P(# @<F<@0E0@
M,C4W+C<P(#$X-2XP-2!49" H17AI="!#;W-T<RD@5&H@150@40I"5" O1C(@
M.2XW-2!49B!%5 HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS,C<N,3 @,C P+CDP(#0T+C$V("TX+C<Q(')E(&8*+T=3,"!G<PIQ(# @
M," P(')G($)4(#,R-RXQ," Q.30N,S @5&0@*$]N+4=O:6YG("D@5&H@150@
M40I"5" O1C(@.2XW-2!49B!%5 HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,C N-3 @,3DQ+C$U(#4T+CDW("TX+C<Q(')E(&8*+T=3
M,"!G<PIQ(# @," P(')G($)4(#,R,"XU," Q.#0N-34@5&0@*$)E;F5F:70@
M0V]S=',I(%1J($54(%$*0E0@+T8R(#DN-S4@5&8@150*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@U+C<P(#$Y,2XV-2 T,BXU,B M
M."XW,2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" S.#4N-S @,3@U+C U
M(%1D("A%>&ET($-O<W1S*2!4:B!%5"!1"D)4("]&,B Y+C<U(%1F($54"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0U-2XQ," R,# N
M.3 @-#0N,38@+3@N-S$@<F4@9@HO1U,P(&=S"G$@," P(# @<F<@0E0@-#4U
M+C$P(#$Y-"XS,"!49" H3VXM1V]I;F<@*2!4:B!%5"!1"D)4("]&,B Y+C<U
M(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T
M."XU," Q.3$N,34@-30N.3<@+3@N-S$@<F4@9@HO1U,P(&=S"G$@," P(# @
M<F<@0E0@-#0X+C4P(#$X-"XU-2!49" H0F5N969I="!#;W-T<RD@5&H@150@
M40I"5" O1C(@.2XW-2!49B!%5 HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,3,N,C @,3DQ+C8U(#0R+C4R("TX+C<Q(')E(&8*+T=3
M,"!G<PIQ(# @," P(')G($)4(#4Q,RXR," Q.#4N,#4@5&0@*$5X:70@0V]S
M=',I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U
M,2XU," Q-S N,#0@5&0@*$)A;&%N8V4@870@8F5G:6YN:6YG(&]F('!E<FEO
M9"D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#$Y
M,2XU," Q-S N,#0@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" R,S@N-3 @,3<P+C T(%1D("@X-RD@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#(U-"XU," Q-S N,#0@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" R.#@N-C @,3<P+C T(%1D("@T-#$I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*<2 P(# @,"!R9R!"5" S,3DN-3 @,3<P+C T(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,S8Q+C4U(#$W
M,"XP-"!49" H,S(U*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@,S@R+C4P(#$W,"XP-"!49" H)"D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Q-BXU-2 Q-S N,#0@5&0@*#(W
M,RD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0T
M-RXU," Q-S N,#0@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*
M<2 P(# @,"!R9R!"5" T.30N-3 @,3<P+C T(%1D("@T-"D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#4Q,"XU," Q-S N,#0@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" U-#,N-C @,3<P+C T(%1D("@S,S@I(%1J($54(%$*0E0@+T8Q(#DN-S4@
M5&8@150*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$N
M-3 @,38Q+C@P(#$S,"XS,R M."XX-B!R92!F"B]'4S @9W,*<2 P(# @,"!R
M9R!"5" U,2XU," Q-34N,#0@5&0@*$-H87(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" W,"XR." Q-34N,#0@5&0@*&=E9"!T;R!R97-T<G5C='5R:6YG(&-O
M<W1S(%PH85PI*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@,C(V+C,P(#$U-2XP-"!49" H,2PV,# I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R.#@N-C @,34U+C T(%1D("@Q
M.#0I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S
M-C$N-34@,34U+C T(%1D("@U,C(I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@
M150*<2 P(# @,"!R9R!"5" T,38N-34@,34U+C T(%1D("@U,#0I(%1J($54
M(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.#DN-C @,34U
M+C T(%1D("@U-C,I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @
M,"!R9R!"5" U-#,N-C @,34U+C T(%1D("@Q.3 I(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U,2XU," Q-# N,#0@5&0@*%!A
M>6UE;G1S*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@,C(S+C U(#$T,"XP-"!49" H7"@Q+#$S,2D@5&H@150@40I"5" O1C$@
M.2XW-2!49B!%5 IQ(# @," P(')G($)4(#(T."XR-2 Q-# N,#0@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@,C@U
M+C,U(#$T,"XP-"!49" H7"@R,S4I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@
M150*<2 P(# @,"!R9R!"5" S,#,N,C4@,30P+C T(%1D("A<*2D@5&H@150@
M40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#,U."XS," Q-# N
M,#0@5&0@*%PH-S8P*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@,S<V+C(U(#$T,"XP-"!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T,3,N,S @,30P+C T(%1D("A<
M*#,S-BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4
M(#0S,2XR-2 Q-# N,#0@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@-#@V+C,U(#$T,"XP-"!49" H7"@R.#(I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U,#0N,C4@
M,30P+C T(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @
M," P(')G($)4(#4T,"XS-2 Q-# N,#0@5&0@*%PH,C4U*2!4:B!%5"!1"D)4
M("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-34X+C(U(#$T,"XP-"!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$N-3 @,3,Q+C@P(#DU+C(Y("TX
M+C@V(')E(&8*+T=3,"!G<PIQ(# @," P(')G($)4(#4Q+C4P(#$R-2XP-"!4
M9" H0F%L86YC92!A="!E;F0@;V8@<&5R:6]D*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@,3DQ+C4P(#$R-2XP-"!49" H)"D@
M5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#(S,RXV
M," Q,C4N,#0@5&0@*#4U-BD@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#(U-"XU," Q,C4N,#0@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" R.#@N-C @,3(U+C T(%1D
M("@S.3 I(%1J($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"
M5" S,3DN-3 @,3(U+C T(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F
M($54"G$@," P(# @<F<@0E0@,S8V+C4P(#$R-2XP-"!49" H.#<I(%1J($54
M(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" S.#(N-3 @,3(U
M+C T(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#$V+C4U(#$R-2XP-"!49" H-#0Q*2!4:B!%5"!1"D)4("]&,2 Y
M+C<U(%1F($54"G$@," P(# @<F<@0E0@-#0W+C4P(#$R-2XP-"!49" H)"D@
M5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0X.2XV
M," Q,C4N,#0@5&0@*#,R-2D@5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ
M(# @," P(')G($)4(#4Q,"XU," Q,C4N,#0@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" U-#,N-C @,3(U+C T(%1D
M("@R-S,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#DW+C(P(%1D("A?7U]?7U]?
M7U]?7U]?7U]?*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#<S+C(P(%1D("A<*&%<*2 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" V,BXY,B W,RXR,"!49" H5&AE(')E<W1R=6-T=7)I;F<@8V]S
M=',@;VX@=&AE(&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO
M;G,@:6YC;'5D92!D:7)E8W0@=W)I=&4M;V8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T,C8N,C0@-S,N,C @5&0@*&9S(&]F("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N-SD@-S,N,C @5&0@*"0P
M+C0@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.34N-C@@-S,N,C @5&0@*"!R96QA=&5D('1O("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,2XR
M,"!49" H86)A;F1O;F5D(&QO8V%T:6]N<RP@87,@=V5L;"!A<R!O=&AE<B!C
M;W-T<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C,T+C$W(#8Q+C(P(%1D("@D,"XU(&UI;&QI;VXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@S+C V(#8Q+C(P
M(%1D("@N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3,Q(# @;V)J"CP\
M+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N
M,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N
M=',@,3,R(# @4CX^"F5N9&]B:@HQ,S(@,"!O8FH*/#PO3&5N9W1H(#$P.34V
M/CX*<W1R96%M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q
M,RXX-2 W-C N-S4@5&0@*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P
M(')G($)4(#(Y,BXV." W-C N-S4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R.3DN-3,@-S8P+C<U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P
M(')G($)4(#,R.2XT-2 W-C N-S4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S0X
M+C<U(%1D("A.3U1%4R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@
M-S0X+C<U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<T
M."XW-2!49" H3R!#3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.#@N,3$@-S0X+C<U(%1D("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S8W+C(Y(#<T."XW-2!49" H(%-4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S@Q+C(X(#<T."XW-2!49" H02D@5&H@150@40IQ(# @," P
M(')G($)4(#,X-RXW-B W-#@N-S4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4X+C,U(#<S-BXW-2!4
M9" H1$5#14U"15*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-S$R+C<U(%1D("@R+B!3=6UM87)Y
M(&]F(%-I9VYI9FEC86YT("D@5&H@150@40IQ(# @," P(')G($)4(#$V,RXV
M,B W,3(N-S4@5&0@*$%C8V]U;G1I;F<@4&]L:6-I97,@7"AC;VYT:6YU961<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M.34N,S @,S,N-C @5&0@*$8M(#$U*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y-2XR-2!49" H1&5F97)R960@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#@N-C4@-CDU+C(U(%1D("A296YT
M*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C@S+C4U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-C<Q+C@U(%1D("A$969E<G)E9"!R96YT(&-O
M;G-I<W1S(&]F(&9R964@<F5N="P@<F5N="!E<V-A;&%T:6]N+"!T96YA;G0@
M:6UP<F]V96UE;G0@86QL;W=A;F-E<RP@86YD(&]T:&5R(&EN8V5N=&EV97,@
M<F5C96EV960@9G)O;2!L86YD;&]R9',@*2!4:B!%5"!1"D)4("]&,2 Y+C<U
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C8P+C$U(%1D("AR96QA=&5D
M('1O('1H92!O<&5R871I;F<@;&5A<V5S(&9O<B!O=7(@9F%C:6QI=&EE<RX@
M4F5N="!E<V-A;&%T:6]N(')E<')E<V5N=',@=&AE(&1I9BD@5&H@150@40IQ
M(# @," P(')G($)4(#,V-"XW,R V-C N,34@5&0@*&9E<F5N8V4@8F5T=V5E
M;B!A8W1U86P@;W!E<F%T:6YG(&QE87-E('!A>6UE;G1S("D@5&H@150@40I"
M5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8T."XT-2!4
M9" H9'5E(&%N9"!S=')A:6=H="UL:6YE(')E;G0@97AP96YS92P@=VAI8V@@
M=V4@<F5C;W)D(&]V97(@=&AE('1E<FT@;V8@=&AE(&QE87-E+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-38N.#<@-C0X+C0U(%1D("A4:&4@97AC97-S
M(&ES(')E8V]R9&5D(&%S(&$@9&5F97)R960@8W)E9&ET(&EN('1H92 I(%1J
M($54(%$*0E0@+T8Q(#DN-S4@5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M,S8N-S4@5&0@*&5A<FQY('!E<FEO9',@;V8@=&AE(&QE87-E+"!W:&5N(&-A
M<V@@<&%Y;65N=',@87)E(&=E;F5R86QL>2!L;W=E<B!T:&%N('-T<F%I9VAT
M+6QI;F4@<F5N="!E>'!E;G-E+"!A;F0@:7,@<F5D=6-E9"!I;B!T:&4@;&%T
M97(@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-C(U+C U(%1D("AP97)I;V1S(&]F('1H92!L96%S92!W:&5N('!A
M>6UE;G1S(&)E9VEN('1O(&5X8V5E9"!T:&4@<W1R86EG:'0M;&EN92!E>'!E
M;G-E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-30N-#4@-C(U+C U(%1D
M("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4Y+C<S(#8R-2XP-2!49" H
M96YA;G0@86QL;W=A;F-E<R!F<F]M(&QA;F1L;W)D<R!F;W(@=&5N86YT("D@
M5&H@150@40I"5" O1C$@.2XW-2!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#8Q,RXS-2!49" H:6UP<F]V96UE;G1S(&%R92!G96YE<F%L;'D@8V]M<')I
M<V5D(&]F(&-A<V@@<F5C96EV960@9G)O;2!T:&4@;&%N9&QO<F0@;W(@<&%I
M9"!O;B!O=7(@8F5H86QF(&%S('!A<G0@;V8@=&AE(&YE9V]T:6%T960@=&5R
M;7,@;V8@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-C Q+C8U(%1D("AT:&4@;&5A<V4N("D@5&H@150@40IQ(# @
M," P(')G($)4(#@X+C S(#8P,2XV-2!49" H5&AE<V4@=&5N86YT(&EM<')O
M=F5M96YT(&%L;&]W86YC97,@86YD(&]T:&5R(&QE87-E:&]L9"!I;F-E;G1I
M=F5S(&%R92!R96-O<F1E9"!W:&5N(')E86QI>F%B;&4@87,@9&5F97)R960@
M<F5N="!A;F0@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-3@Y+CDU(%1D("AA<F4@86UO<G1I>F5D(&%S(&$@<F5D
M=6-T:6]N(&]F('!E<FEO9&EC(')E;G0@97AP96YS92P@;W9E<B!T:&4@=&5R
M;2!O9B!T:&4@87!P;&EC86)L92!L96%S92X@4V5E($YO=&4@,3(@+2!#;VUM
M:71M96YT<R!A;F0@*2!4:B!%5"!1"D)4("]&,2 Y+C<U(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3<X+C(U(%1D("A#;VYT:6YG96YC:65S+BD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U
M-30N,C4@5&0@*$EN8V]M92!4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#@N
M,S @-34T+C(U(%1D("AA>&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#4S,"XR-2!49" H5&AE($-O;7!A;GD@
M86-C;W5N=',@9F]R(&EN8V]M92!T87AE<R!U;F1E<B!T:&4@*2!4:B!%5"!1
M"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-2XU-" U,S N
M,C4@5&0@*$EN8V]M92!4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C$R
M(#4S,"XR-2!49" H87AE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,#DN.#D@-3,P+C(U(%1D("@@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S$R+C(Q(#4S,"XR-2!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#,Q-RXV,B U,S N,C4@5&0@*&]P:6,@;V8@=&AE($8I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C<N-S @-3,P+C(U(%1D("A!4T(@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S@Y+C$P(#4S,"XR-2!49" H05-#+B!$
M969E<G)E9"!I;F-O;64@=&%X(&%S<V5T<R!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Q."XR-2!49" H
M;&EA8FEL:71I97,@87)E(&1E=&5R;6EN960@8F%S960@=7!O;B!D:68I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,3 N,3 @-3$X+C(U(%1D("AF97)E;F-E
M<R!B971W965N('1H92!F:6YA;F-I86P@<F5P;W)T:6YG(&%N9"!T87@@8F%S
M:7,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE<RP@86YD(&%R92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3 V
M+C(U(%1D("AM96%S=7)E9"!U<VEN9R!T:&4@96YA8W1E9"!T87@@<F%T97,@
M86YD(&QA=W,@=&AA="!W:6QL(&)E(&EN(&5F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S Q+C0U(#4P-BXR-2!49" H9F5C="!W:&5N('1H92!D:68I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C@N-S0@-3 V+C(U(%1D("AF97)E;F-E
M<R!A<F4@97AP96-T960@=&\@<F5V97)S92X@("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T.#(N,C4@5&0@*%1H
M92!#;VUP86YY(')E8V]G;FEZ97,@:6X@:71S(&9I;F%N8VEA;"!S=&%T96UE
M;G1S('1H92!I;7!A8W0@;V8@82!T87@@<&]S:71I;VX@:68@=&AA="!P;W-I
M=&EO;B!I<R!M;W)E(&QI:V5L>2!T:&%N(&YO="!O9B!B96EN9R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#<P
M+C(U(%1D("AS=7-T86EN960@;VX@875D:70L(&)A<V5D(&]N('1H92!T96-H
M;FEC86P@;65R:71S(&]F('1H92!P;W-I=&EO;BX@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S W+C@W(#0W,"XR-2!49" H5&AE($-O;7!A;GD@<F5C;V=N
M:7IE<R!I;G1E<F5S="!A;F0@<&5N86QT:65S(')E;&%T960@=&\@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0U
M."XR-2!49" H=6YR96-O9VYI>F5D('1A>"!B96YE9FET<R!I;B!T:&4@<')O
M=FES:6]N(&9O<B!I;F-O;64@=&%X97,N("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,S0N,C4@5&0@*%1H92!#
M;VUP86YY(&UA:6YT86EN<R!V86QU871I;VX@86QL;W=A;F-E<R!W:&5N(&ET
M(&ES(&UO<F4@;&EK96QY('1H86X@;F]T('1H870@86QL(&]R(&$@<&]R=&EO
M;B!O9B!A(&1E9F5R<F5D('1A>"!A<W-E="!W:6QL(&YO=" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#(R+C(U
M(%1D("AB92!R96%L:7IE9"X@26X@9&5T97)M:6YI;F<@=VAE=&AE<B!A('9A
M;'5A=&EO;B!A;&QO=V%N8V4@:7,@=V%R<F%N=&5D+"!T:&4@0V]M<&%N>2!E
M=F%L=6%T97,@9F%C=&]R<R!S=6-H(&%S('!R:6]R(&5A<FYI;F=S("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T
M,3 N,C4@5&0@*&AI<W1O<GDI(%1J($54(%$*<2 P(# @,"!R9R!"5" W-BXV
M,R T,3 N,C4@5&0@*"P@97AP96-T960@9G5T=7)E(&5A<FYI;F=S+"!C87)R
M>6)A8VL@86YD(&-A<G)Y9F]R=V%R9"!P97)I;V1S+"!A;F0@=&%X('-T<F%T
M96=I97,N("D@5&H@150@40IQ(# @," P(')G($)4(#0P-RXQ,R T,3 N,C4@
M5&0@*%1H92!#;VUP86YY(&-O;G-I9&5R<R!A;&P@<&]S:71I=F4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y
M."XR-2!49" H86YD(&YE9V%T:79E(&5V:61E;F-E('1O(&5S=&EM871E(&EF
M('-U9BD@5&H@150@40IQ(# @," P(')G($)4(#(P-RXU.2 S.3@N,C4@5&0@
M*&9I8VEE;G0@9G5T=7)E('1A>&%B;&4@:6YC;VUE('=I;&P@8F4@9V5N97)A
M=&5D('1O(')E86QI>F4@=&AE(&1E9F5R<F5D('1A>"!A<W-E="X@270@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,X-BXR-2!49" H8V]N<VED97)S(&-U;75L871I=F4@;&]S<V5S(&EN(')E
M8V5N="!Y96%R<R!A<R!W96QL(&%S('1H92!I;7!A8W0@;V8@;VYE+71I;64@
M979E;G1S(&EN(&%S<V5S<VEN9R!I=',@<')E+71A>"!E87)N:6YG<RX@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,W-"XR-2!49" H07-S=6UP=&EO;G,@<F5G87)D:6YG(&9U='5R92!T87AA
M8FQE(&EN8V]M92!R97%U:7)E('-I9VYI9FEC86YT(&IU9&=M96YT+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-3(N.#4@,S<T+C(U(%1D("A4:&4@0V]M
M<&%N>2=S(&%S<W5M<'1I;VYS(&%R92!C;VYS:7-T96YT('=I=&@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,V
M,BXR-2!49" H97-T:6UA=&5S(&%N9"!P;&%N<R!U<V5D('1O(&UA;F%G92!I
M=',@8G5S:6YE<W,L('=H:6-H(&EN8VQU9&5S(')E<W1R=6-T=7)I;F<@86YD
M(&]T:&5R(&EN:71I871I=F5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," S,S@N,C4@5&0@*$EN('1H92!E=F5N
M="!T:&%T(&%C='5A;"!R97-U;'1S(&1I9BD@5&H@150@40IQ(# @," P(')G
M($)4(#$X,BXV,2 S,S@N,C4@5&0@*&9E<B!F<F]M('1H97-E(&5S=&EM871E
M<RP@;W(@=&AE($-O;7!A;GD@861J=7-T<R!T:&5S92!E<W1I;6%T97,@:6X@
M9G5T=7)E('!E<FEO9',@9F]R(&-U<G)E;G0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,R-BXR-2!49" H=')E
M;F1S(&]R(&-H86YG97,@:6X@:71S(&5S=&EM871I;F<@87-S=6UP=&EO;G,L
M(&ET(&UA>2!M;V1I9GD@=&AE(&QE=F5L(&]F('1H92!V86QU871I;VX@86QL
M;W=A;F-E('=H:6-H(&-O=6QD(&UA=&5R:6%L;'D@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Q-"XR-2!49" H
M:6UP86-T(&ET<R!B=7-I;F5S<RP@9FEN86YC:6%L(&-O;F1I=&EO;B!A;F0@
M<F5S=6QT<R!O9B!O<&5R871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,3 N-C8@,S$T+C(U(%1D("A4:&4@0V]M<&%N>2!W:6QL(&-O;G1I;G5E
M('1O(&%S<V5S<R!T:&4@<F5A;&EZ86)I;&ET>2!O9B!I=',@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,P,BXR
M-2!49" H9&5F97)R960@=&%X(&%S<V5T<RX@4V5E($YO=&4@,3,@+2!);F-O
M;64@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$W+C@V(#,P,BXR-2!49" H
M5"D@5&H@150@40IQ(# @," P(')G($)4(#(R,RXR-R S,#(N,C4@5&0@*&%X
M97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#(Y,"XR-2!49" HH"D@5&H@150@40I"5" O1C,@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," R-S@N,C4@5&0@*$-O;7!R96AE;G-I
M=F4@26YC;VUE(%PH3&]S<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#(V-BXR-2!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-30N,C4@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-"XY,2 R-30N,C4@5&0@
M*&]T86P@8V]M<')E:&5N<VEV92!I;F-O;64@7"AL;W-S7"D@:6YC;'5D97,@
M;F5T(&EN8V]M92!O<B!L;W-S+"!F;W)E:6=N(&-U<G)E;F-Y('1R86YS;&%T
M:6]N(&%D:G5S=&UE;G1S+"!A;F0@;F5T(&-H86YG92!I;B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C0R+C(U
M(%1D("AD97)I=F%T:79E('1R86YS86-T:6]N<RP@;F5T(&]F(&%N>2!R96QA
M=&5D(&1E9F5R<F5D('1A>&5S+B!#97)T86EN(&]F('1H92!#;VUP86YYDBD@
M5&H@150@40IQ(# @," P(')G($)4(#,W-RXT,R R-#(N,C4@5&0@*',@9F]R
M96EG;B!S=6)S:61I87)I97,@=7-E('1H96ER(')E<W!E8W1I=F4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(S
M,"XR-2!49" H;&]C86P@8W5R<F5N8WD@87,@=&AE:7(@9G5N8W1I;VYA;"!C
M=7)R96YC>2D@5&H@150@40IQ(# @," P(')G($)4(#(Q-RXY,R R,S N,C4@
M5&0@*"X@26X@86-C;W)D86YC92!W:71H('1H92 I(%1J($54(%$*0E0@+T8T
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$V+C(R(#(S,"XR-2!49" H
M1F]R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,P+C@U(#(S,"XR-2!49" H
M96EG;B!#=7)R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8Y+C8U(#(S,"XR
M-2!49" H96YC>2!-871T97)S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0R,2XU-R R,S N,C4@5&0@*" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T,C,N.#D@,C,P+C(U(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#(Y+C,P(#(S,"XR-2!49" H;W!I8R!O9B!T:&4@1BD@
M5&H@150@40IQ(# @," P(')G($)4(#0W.2XS." R,S N,C4@5&0@*$%30B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,# N-S@@,C,P+C(U(%1D("A!4T,L
M*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M,BXW-" R,S N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(U+C(T(#(S,"XR-2!49" H87-S971S("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R
M,3@N,C4@5&0@*&%N9"!L:6%B:6QI=&EE<R!O9B!T:&5S92!O<&5R871I;VYS
M(&%R92!T<F%N<VQA=&5D(&%T('1H92!E>&-H86YG92!R871E<R!I;B!E9BD@
M5&H@150@40IQ(# @," P(')G($)4(#,T-"XR," R,3@N,C4@5&0@*&9E8W0@
M;VX@=&AE(&)A;&%N8V4@<VAE970@9&%T92X@26YC;VUE('-T871E;65N="!I
M=&5M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,C V+C(U(%1D("AA<F4@=')A;G-L871E9"!A="!T:&4@879E
M<F%G92!E>&-H86YG92!R871E<R!F;W(@=&AE('!E<FEO9"X@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C@T+C0W(#(P-BXR-2!49" H5&AE(&-U;75L871I
M=F4@:6UP86-T(&]F(&-U<G)E;F-Y(&9L=6-T=6%T:6]N<R!R96QA=&5D('1O
M('1H92!B86QA;F-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," Q.30N,C4@5&0@*'-H965T('1R86YS;&%T:6]N
M(&ES(&EN8VQU9&5D(&EN(&%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE;G-I
M=F4@;&]S<R!I;B!T:&4@86-C;VUP86YY:6YG(&-O;G-O;&ED871E9"!B86QA
M;F-E('-H965T<R!A;F0@=V%S("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," Q.#(N,C4@5&0@*&%N('5N<F5A;&EZ
M960@;&]S<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3,T+C0W(#$X,BXR-2!49" H)#$N,R!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X,RXS-B Q
M.#(N,C4@5&0@*"!A="!$96-E;6)E<B S,2P@,C Q."!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y,RXV," Q.#(N
M,C4@5&0@*"0Q+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S$Q+C$P(#$X,BXR-2!49" H(&UI;&QI;VX@870@1&5C96UB
M97*@,S$L(#(P,3<N("D@5&H@150@40IQ(# @," P(')G($)4(#0S."XQ,2 Q
M.#(N,C4@5&0@*%1H92!C=6UU;&%T:79E(&EM<&%C="!O9B!N970@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$W
M,"XR-2!49" H8VAA;F=E<R!I;B!D97)I=F%T:79E(&EN<W1R=6UE;G1S(&EN
M8VQU9&5D(&EN(&]T:&5R(&-O;7!R96AE;G-I=F4@;&]S<R!I;B!T:&4@8V]N
M<V]L:61A=&5D(&)A;&%N8V4@<VAE971S('=A<R!A;B!U;G)E86QI>F5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," Q-3@N,C4@5&0@*&QO<W,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#<X+C,Y(#$U."XR-2!49" H)# N,B!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$R-RXR." Q-3@N,C4@5&0@*"!A="!$96-E;6)E<B S,2P@,C Q."X@4V5E
M($YO=&4@.2 M($1E<FEV871I=F5S+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,S0N,C4@5&0@*%1H92!I;F-O
M;64@=&%X(&EM<&%C="!R96QA=&5D('1O(&-O;7!O;F5N=',@;V8@;W1H97(@
M8V]M<')E:&5N<VEV92!I;F-O;64@9F]R('1H92!P97)I;V0@96YD960@1&5C
M96UB97(@,S$L(#(P,3@@:7,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#$R,BXR-2!49" H<F5F;&5C=&5D(&]N
M('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O9B!C;VUP<F5H96YS:79E
M(&EN8V]M92X@1'5R:6YG('1H92!P97)I;V0@96YD960@1&5C96UB97(@,S$L
M(#(P,3<L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,#,N-SD@,3(R+C(U(%1D("@D,"XR(&UI;&QI;VXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34R+C8X(#$R,BXR
M-2!49" H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," Q,3 N,C4@5&0@*&]F(&EN8V]M92!T87@@97AP96YS92!W
M87,@:6YC;'5D960@:6X@=&AE(&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F
M(&]P97)A=&EO;G,@9'5E('1O('1H92!I;7!A8W0@;V8@82!C:&%N9V4@:6X@
M9F5D97)A;"!T87@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#DX+C(U(%1D("AR871E(&]N('1H92!D969E<G)E
M9"!T87@@87-S970@<F5L871E9"!T;R!F;W)E:6=N(&-U<G)E;F-Y(&-U;75L
M871I=F4@=')A;G-L871I;VXN(%-E92!.;W1E(#$S("T@26YC;VUE("D@5&H@
M150@40IQ(# @," P(')G($)4(#0U.2XQ-2 Y."XR-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#0V-"XU-B Y."XR-2!49" H87AE<RX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#@W+C$U(#DX+C(U(%1D("A4:&5R92!W87,@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M,2XP,2 Y."XR-2!49" H;F\I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30Q+C Q(#DX+C(U(%1D("@@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#@V+C(U(%1D
M("AI;F-O;64@=&%X(&EM<&%C="!R96QA=&5D('1O(&9O<F5I9VX@8W5R<F5N
M8WD@=')A;G-L871I;VX@861J=7-T;65N=',@9F]R('1H92!P97)I;V0@96YD
M960@1&5C96UB97*@,S$L(#(P,38N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O
M8FH*,3,S(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D
M:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2
M;W1A=&4@, HO0V]N=&5N=',@,3,T(# @4CX^"F5N9&]B:@HQ,S0@,"!O8FH*
M/#PO3&5N9W1H(#$S,3@Q/CX*<W1R96%M"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(Q,RXX-2 W-C N-S4@5&0@*$-23U-3($-/54Y44BD@
M5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W-C N-S4@5&0@*%DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8P+C<U(%1D("@@2$5!3"D@
M5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W-C N-S4@5&0@*%1(0T%2
M12P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q-S4N,S @-S0X+C<U(%1D("A.3U1%4R I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R,3$N-3(@-S0X+C<U(%1D("A4*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C$X+C Q(#<T."XW-2!49" H3R!#3TY33TQ)1$$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R.#@N,3$@-S0X+C<U(%1D("A4140@1DE.04Y#24%,
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y(#<T."XW-2!49" H(%-4
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X(#<T."XW-2!49" H02D@
M5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W-#@N-S4@5&0@*%1%345.
M5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C4X+C,U(#<S-BXW-2!49" H1$5#14U"15*@,S$L(#(P,3@I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$R+C<U
M(%1D("@R+B!3=6UM87)Y(&]F(%-I9VYI9FEC86YT("D@5&H@150@40IQ(# @
M," P(')G($)4(#$V,RXV,B W,3(N-S4@5&0@*$%C8V]U;G1I;F<@4&]L:6-I
M97,@7"AC;VYT:6YU961<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R.34N,S @,S,N-C @5&0@*$8M(#$V*2!4:B!%5"!1
M"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y-2XR
M-2!49" H1F%I<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,"XS-" V.34N
M,C4@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" W-2XY," V.34N,C4@
M5&0@*&%L=64@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.38N,3@@-CDU+C(U
M(%1D("A-96%S=7)E;65N=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C(U(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W,2XR-2!4
M9" H5&AE($-O;7!A;GD@8V]M<&QI97,@=VET:"!T:&4@<')O=FES:6]N<R!O
M9B!T:&4@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(U,BXR-2 V-S$N,C4@5&0@*$9A:7(@5BD@5&H@150@40IQ(# @," P
M(')G($)4(#(W-RXU,R V-S$N,C4@5&0@*&%L=64@365A<W5R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(W+C0R(#8W,2XR-2!49" H96UE;G1S(&%N9"!$
M:7-C;&]S=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3,N-S$@-C<Q+C(U
M(%1D("AE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,C(N,#0@-C<Q+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#(T+C,V(#8W,2XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#0R.2XW-R V-S$N,C4@5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T-SDN.#8@-C<Q+C(U(%1D("A!4T(@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-3 Q+C(V(#8W,2XR-2!49" H05-#+"!W:&EC:" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-C4Y+C(U(%1D("AD969I;F5S(&9A:7(@=F%L=64L(&5S=&%B;&ES:&5S(&$@
M9G)A;65W;W)K(&9O<B!M96%S=7)I;F<@9F%I<B!V86QU92!U;F1E<B!5+E,N
M($=!05 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3,N-38@-C4Y+C(U(%1D
M("@L(&%N9"!E>'!A;F1S(&1I<V-L;W-U<F5S(&%B;W5T(&9A:7(@=F%L=64@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#8T-RXR-2!49" H;65A<W5R96UE;G1S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,3$N,34@-C0W+C(U(%1D("A!<R!O9B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3,U+C4Y(#8T-RXR-2!4
M9" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C$T+C$X(#8T-RXR-2!49" H(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,S+C8R
M(#8T-RXR-2!49" H,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R-3,N-C(@-C0W+C(U(%1D("@L('1H92!#;VUP86YY
MDBD@5&H@150@40IQ(# @," P(')G($)4(#,Q-2XP," V-#<N,C4@5&0@*',@
M9FEN86YC:6%L(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@<F5Q=6ER960@=&\@
M8F4@;65A<W5R960@;VX@82 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-C,U+C(U(%1D("AR96-U<G)I;F<@8F%S
M:7,@=V5R92!I=',@9&5F97)R960@8V]M<&5N<V%T:6]N(&QI86)I;&ET>2D@
M5&H@150@40IQ(# @," P(')G($)4(#(V.2XS,R V,S4N,C4@5&0@*"P@:71S
M(&EN=&5R97-T(')A=&4@<W=A<"!A9W)E96UE;G1S+"!A;F0@:71S(&-O;G1I
M;F=E;G0@8V]N<VED97)A=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-C(S+C(U(%1D("AL:6%B:6QI=&EE
M<RX@4V5E($YO=&4@,3 @+2!&86ER("D@5&H@150@40IQ(# @," P(')G($)4
M(#$V-RXS-2 V,C,N,C4@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-S,N-#8@-C(S+C(U(%1D("AA;'5E($UE87-U<F5M96YT<RXI(%1J($54(%$*
M0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3DY+C(U
M(%1D("A%87)N:6YG<R!097(@4VAA<F4I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3@W+C(U(%1D("B@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4W
M-2XR-2!49" H26X@86-C;W)D86YC92!W:71H('1H92!R97%U:7)E;65N=',@
M;V8@=&AE("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,C,N,#0@-3<U+C(U(%1D("A%87)N:6YG<R!097(@4VAA<BD@5&H@
M150@40IQ(# @," P(')G($)4(#(Y-RXV-B U-S4N,C4@5&0@*&4I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S R+C$P(#4W
M-2XR-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#,P-"XT,B U-S4N
M,C4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,#DN.#,@-3<U+C(U
M(%1D("AO<&EC(&]F('1H92!&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4Y
M+CDR(#4W-2XR-2!49" H05-"("D@5&H@150@40IQ(# @," P(')G($)4(#,X
M,2XS,B U-S4N,C4@5&0@*$%30RP@8F%S:6,@96%R;FEN9W,@<&5R('-H87)E
M(&ES(&-O;7!U=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," U-C,N,C4@5&0@*&)Y(&1I=FED:6YG(&YE="!I
M;F-O;64@879A:6QA8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,@7"AN=6UE
M<F%T;W)<*2!B>2!T:&4@=V5I9VAT960@879E<F%G92!N=6UB97(@;V8@=F5S
M=&5D('5N<F5S=')I8W1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-34Q+C(U(%1D("AC;VUM;VX@<VAA<F5S
M(&]U='-T86YD:6YG(&1U<FEN9R!T:&4@<&5R:6]D(%PH9&5N;VUI;F%T;W)<
M*2X@1&EL=71E9"!E87)N:6YG<R!P97(@<VAA<F4@9VEV97,@968I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,S8N,38@-34Q+C(U(%1D("AF96-T('1O(&%L
M;"!D:6QU=&EV92!P;W1E;G1I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4S.2XR-2!49" H8V]M;6]N('-H
M87)E<R!O=71S=&%N9&EN9R!D=7)I;F<@=&AE('!E<FEO9"!I;F-L=61I;F<@
M<W1O8VL@87!P<F5C:6%T:6]N(')I9VAT<R!A;F0@;W!T:6]N<R!A;F0@=6YV
M97-T960@<F5S=')I8W1E9"!S=&]C:RP@87,@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4R-RXR-2!49" H8V%L
M8W5L871E9"!U=&EL:7II;F<@=&AE('1R96%S=7)Y('-T;V-K(&UE=&AO9"P@
M86YD($-O;G9E<G1I8FQE($YO=&5S('5S:6YG('1H92!I9BUC;VYV97)T960@
M;65T:&]D('!R:6]R('1O('1H96ER('!A>6UE;G0@:6X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Q-2XR-2!4
M9" H9G5L;"!I;B!T:&4@9FER<W0@<75A<G1E<B!O9B R,#$W+BD@5&H@150@
M40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T.3$N
M,C4@5&0@*%)E8V5N=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" W.2XY-2 T
M.3$N,C4@5&0@*$%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#8W+C(U
M(%1D("A);B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U.2XW." T-C<N,C4@
M5&0@*$%U9W5S=" R,#$X+"!T:&4@1BD@5&H@150@40IQ(# @," P(')G($)4
M(#$S-2XW,2 T-C<N,C4@5&0@*$%30B!I<W-U960@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3@T+C8Q(#0V-RXR-2!49" H05-5($YO+B R,#$X+3$U+" I
M(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8R
M+C8V(#0V-RXR-2!49" H26YT86YG:6)L97,@+2!';V]D=VEL;"!A;F0@3W1H
M97(@+2!);G1E<FYA;"U5<V4@4V]F='=A<BD@5&H@150@40IQ(# @," P(')G
M($)4(#0X.2XR,B T-C<N,C4@5&0@*&4@7"A3=6)T;W!I8R I(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#4U+C(U
M(%1D("@S-3 M-#!<*2P@0W5S=&]M97(G<R I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,S,N-# @-#4U+C(U(%1D("A!8V-O=6YT:6YG(&9O<B!);7!L96UE
M;G1A=&EO;B!#;W-T<R!);F-U<G(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M,3 N-SD@-#4U+C(U(%1D("AE9"!I;B!A($-L;W5D($-O;7!U=&EN9R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T,30N,C(@-#4U+C(U(%1D("A!<G)A;F=E
M;65N="!4:&%T(&ES(&$@4V5R=FEC92 I(%1J($54(%$*0E0@+T8T(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#0S+C(U(%1D("A#;VYT<F%C
M="X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#DP+C V(#0T,RXR-2!49" H5&AE(&%M96YD;65N=',@:6X@=&AI<R!U<&1A
M=&4@86QI9VX@=&AE(')E<75I<F5M96YT<R!F;W(@8V%P:71A;&EZ:6YG(&EM
M<&QE;65N=&%T:6]N(&-O<W1S(&EN8W5R<F5D(&EN(&$@:&]S=&EN9R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-#,Q+C(U(%1D("AA<G)A;F=E;65N="!T:&%T(&ES(&$@<V5R=FEC92!C;VYT
M<F%C="!W:71H('1H92!R97%U:7)E;65N=',@9F]R(&-A<&ET86QI>FEN9R!I
M;7!L96UE;G1A=&EO;B!C;W-T<R!I;F-U<G)E9"!T;R!D979E;&]P(&]R(&]B
M=&%I;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-#$Y+C(U(%1D("AI;G1E<FYA;"UU<V4@<V]F='=A<F4@7"AA
M;F0@:&]S=&EN9R!A<G)A;F=E;65N=',@=&AA="!I;F-L=61E(&%N(&EN=&5R
M;F%L('5S92!S;V9T=V%R92!L:6-E;G-E7"DN("D@5&H@150@40IQ(# @," P
M(')G($)4(#0R-RXW.2 T,3DN,C4@5&0@*%1H92!A;65N9&UE;G1S(&EN('1H
M:7,@=7!D871E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," T,#<N,C4@5&0@*&%R92!E9BD@5&H@150@40IQ(# @
M," P(')G($)4(#<Q+C<Y(#0P-RXR-2!49" H9F5C=&EV92!F;W(@<'5B;&EC
M(&)U<VEN97-S(&5N=&ET:65S(&9O<B!F:7-C86P@>65A<G,@8F5G:6YN:6YG
M(&%F=&5R($1E8V5M8F5R(#$U+" R,#$Y+"!A;F0@:6YT97)I;2!P97)I;V1S
M('=I=&AI;B!T:&]S92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,SDU+C(U(%1D("AF:7-C86P@>65A<G,L(&%N
M9"!S:&]U;&0@8F4@87!P;&EE9"!E:71H97(@<F5T<F]S<&5C=&EV96QY(&]R
M('!R;W-P96-T:79E;'D@=&\@86QL(&EM<&QE;65N=&%T:6]N(&-O<W1S(&EN
M8W5R<F5D(&%F=&5R('1H92!D871E(&]F("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S.#,N,C4@5&0@*&%D;W!T
M:6]N+B!%87)L>2!A9&]P=&EO;B!I<R!P97)M:71T960@9F]R(&%L;"!E;G1I
M=&EE<RP@:6YC;'5D:6YG(&%D;W!T:6]N(&EN(&%N(&EN=&5R:6T@<&5R:6]D
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C,N-#$@,S@S+C(U(%1D("A4
M:&4@0V]M<&%N>2!I<R!C=7)R96YT;'D@:6X@=&AE("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-S$N,C4@5&0@
M*'!R;V-E<W,@;V8@979A;'5A=&EN9R!T:&4@<&]T96YT:6%L(&EM<&%C="!T
M:&4@861O<'1I;VX@;V8@=&AI<R!S=&%N9&%R9"!M87D@:&%V92!A;F0@97AP
M96-T<R!T;R!A9&]P="!T:&ES('-T86YD87)D(&EN(&ET<R!F:7)S=" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,S4Y+C(U(%1D("AQ=6%R=&5R(&]F(#(P,C N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,S-2XR-2!49" H26X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3DN-S@@,S,U+C(U(%1D("A!=6=U
M<W0@,C Q."P@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S4N-S$@
M,S,U+C(U(%1D("A!4T(@:7-S=65D("D@5&H@150@40IQ(# @," P(')G($)4
M(#$X-"XV,2 S,S4N,C4@5&0@*$%352!.;RX@,C Q."TQ,RP@*2!4:B!%5"!1
M"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(V,BXV-B S,S4N
M,C4@5&0@*$9A:7(@5BD@5&H@150@40IQ(# @," P(')G($)4(#(X-RXY-" S
M,S4N,C4@5&0@*&%L=64@365A<W5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S,W+C@T(#,S-2XR-2!49" H96UE;G0@7"A4*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S<R+C$Y(#,S-2XR-2!49" H;W!I8R X,C!<*2P@1&ES8VQO<W5R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4S+C<V(#,S-2XR-2!49" H92!&
M<F%M97=O<FL@+2!#:&%N9V5S('1O("D@5&H@150@40I"5" O1C0@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,C,N,C4@5&0@*'1H92!$:7-C
M;&]S=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#(N-S0@,S(S+C(U(%1D
M("AE(%)E<75I<BD@5&H@150@40IQ(# @," P(')G($)4(#$S-BXU,B S,C,N
M,C4@5&0@*&5M96YT<R!F;W(@1F%I<B!6*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C V+C(T(#,R,RXR-2!49" H86QU92!-96%S=7(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-38N,30@,S(S+C(U(%1D("AE;65N="X@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X-2XP,2 S,C,N
M,C4@5&0@*%1H92!A;65N9&UE;G1S(&EN('1H:7,@=7!D871E(&UO9&EF>2!T
M:&4@9&ES8VQO<W5R92!R97%U:7)E;65N=',@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Q,2XR-2!49" H;VX@
M9F%I<B!V86QU92!M96%S=7)E;65N=',@:6X@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3<R+C,S(#,Q,2XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#$W-RXW-" S,3$N,C4@5&0@*&]P:6,@.#(P+" I(%1J($54(%$*0E0@
M+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$W+C0V(#,Q,2XR-2!4
M9" H1F%I<B!6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0R+C<T(#,Q,2XR
M-2!49" H86QU92!-96%S=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N
M-C,@,S$Q+C(U(%1D("AE;65N="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,38N-3$@,S$Q+C(U(%1D("@L(&)A<V5D(&]N
M('1H92!C;VYC97!T<R!I;B!T:&4@0V]N8V5P=',@4W1A=&5M96YT+"!I;F-L
M=61I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(Y.2XR-2!49" H=&AE(&-O;G-I9&5R871I;VX@;V8@8V]S
M=',@86YD(&)E;F5F:71S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#<N
M,S,@,CDY+C(U(%1D("A4:&4@86UE;F1M96YT<R!I;B!T:&ES('5P9&%T92!A
M<F4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3<N,3 @,CDY+C(U(%1D
M("AF96-T:79E(&9O<B!A;&P@96YT:71I97,@9F]R(&9I<V-A;"!Y96%R<RP@
M86YD(&EN=&5R:6T@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#(X-RXR-2!49" H<&5R:6]D<R!W:71H:6X@=&AO
M<V4@9FES8V%L('EE87)S+"!B96=I;FYI;F<@869T97(@1&5C96UB97(@,34L
M(#(P,3DL(&%N9"!S:&]U;&0@8F4@87!P;&EE9"!E:71H97(@<')O<W!E8W1I
M=F5L>2!O<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,C<U+C(U(%1D("AR971R;W-P96-T:79E;'D@9&5P96YD
M:6YG(&]N('1H92!N871U<F4@;V8@=&AE(&1I<V-L;W-U<F4N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(X,"XX,B R-S4N,C4@5&0@*$%N(&5N=&ET>2!I
M<R!P97)M:71T960@=&\@96%R;'D@861O<'0@86YY(')E;6]V960@;W(@;6]D
M:69I960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(V,RXR-2!49" H9&ES8VQO<W5R97,@=7!O;B!I<W-U86YC
M92!O9B!T:&ES('5P9&%T92!A;F0@9&5L87D@861O<'1I;VX@;V8@=&AE(&%D
M9&ET:6]N86P@9&ES8VQO<W5R97,@=6YT:6P@=&AE:7(@968I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-34N,#8@,C8S+C(U(%1D("AF96-T:79E(&1A=&4N
M("D@5&H@150@40IQ(# @," P(')G($)4(#4P-BXR-" R-C,N,C4@5&0@*%1H
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,C4Q+C(U(%1D("A#;VUP86YY(&ES(&-U<G)E;G1L>2!I;B!T:&4@
M<')O8V5S<R!O9B!E=F%L=6%T:6YG('1H:7,@<W1A;F1A<F0@86YD(&5X<&5C
M=',@=&\@861O<'0@=&AE(&9U;&P@<')O=FES:6]N<R!I;B!I=',@9FER<W0@
M<75A<G1E<B!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,C,Y+C(U(%1D("@R,#(P+BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,34N,C4@5&0@
M*$EN($IU;'D@,C Q-RP@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,C0N,#0@,C$U+C(U(%1D("A!4T(@:7-S=65D("D@5&H@150@40IQ(# @," P
M(')G($)4(#$W,BXY-" R,34N,C4@5&0@*$%352!.;RX@,C Q-RTQ*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C0P+C8R(#(Q-2XR-2!49" H,2P@*2!4:B!%
M5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U,"XV,B R
M,34N,C4@5&0@*$5A<FYI;F=S(%!E<B!3:&%R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S(U+C(U(#(Q-2XR-2!49" H92!<*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-# N,38@,C$U+C(U(%1D("AO<&EC(#(V,%PI.R!$:7-T:6YG
M=6ES:&EN9R!,:6%B:6QI=&EE<R!F<BD@5&H@150@40IQ(# @," P(')G($)4
M(#0Y-"XX," R,34N,C4@5&0@*&]M($5Q=6ET>2 I(%1J($54(%$*0E0@+T8T
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C S+C(U(%1D("A<
M*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-RXT-R R,#,N,C4@5&0@*&]P
M:6,@-#@P7"D[(&%N9"!$97)I=F%T:79E<R!A;F0@2&5D9VEN9R!<*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,CDN.#8@,C S+C(U(%1D("AO<&EC(#@Q
M-5PI.B!)+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#$N.#@@,C S+C(U
M(%1D("A!8V-O=6YT:6YG(&9O<B!#97)T86EN($9I;F%N8VEA;"!);G-T<G5M
M96YT<R!W:71H($1O=VX@4F]U;F0@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Y,2XR-2!49" H1F5A='5R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-S8N,S4@,3DQ+C(U(%1D("AE<RP@86YD
M($E)+B!297!L86-E;65N="!O9B!T:&4@26YD969I;FET92!$969E<G)A;"!F
M;W(@36%N9&%T;W)I;'D@4F5D965M86)L92!&:6YA;F-I86P@26YS=')U;65N
M=',@;V8@0V5R=&%I;B I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,3<Y+C(U(%1D("A.;VYP=6)L:6,@16YT:71I
M97,@86YD($-E<G1A:6X@36%N9&%T;W)I;'D@4F5D965M86)L92!.;VYC;VYT
M<BD@5&H@150@40IQ(# @," P(')G($)4(#,Q."XU-" Q-SDN,C4@5&0@*&]L
M;&EN9R!);G1E<BD@5&H@150@40IQ(# @," P(')G($)4(#,V,RXT-" Q-SDN
M,C4@5&0@*&5S=',@=VET:"!A(%-C;W!E($5X8V5P=&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S0N-3(@,3<Y+C(U
M(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#0W.2XS-" Q-SDN,C4@
M5&0@*%1H92!A;65N9&UE;G1S(&EN("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-C<N,C4@5&0@*%!A<G0@22!O
M9B!T:&ES(%5P9&%T92!C:&%N9V4@=&AE(&-L87-S:69I8V%T:6]N(&%N86QY
M<VES(&]F(&-E<G1A:6X@97%U:71Y+6QI;FME9"!F:6YA;F-I86P@:6YS=')U
M;65N=',@7"AO<B!E;6)E9&1E9"!F96%T=7)E<UPI("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-34N,C4@5&0@
M*'=I=&@@9&]W;B!R;W5N9"!F96%T=7)E<RX@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,34V+C<Y(#$U-2XR-2!49" H5VAE;B!D971E<FUI;FEN9R!W:&5T
M:&5R(&-E<G1A:6X@9FEN86YC:6%L(&EN<W1R=6UE;G1S('-H;W5L9"!B92!C
M;&%S<VEF:65D(&%S(&QI86)I;&ET:65S(&]R(&5Q=6ET>2 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,30S+C(U
M(%1D("AI;G-T<G5M96YT<RP@82!D;W=N(')O=6YD(&9E871U<F4@;F\@;&]N
M9V5R('!R96-L=61E<R!E<75I='D@8VQA<W-I9FEC871I;VX@=VAE;B!A<W-E
M<W-I;F<@=VAE=&AE<B!T:&4@:6YS=')U;65N="!I<R!I;F1E>&5D("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M,S$N,C4@5&0@*'1O(&%N(&5N=&ET>9(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Y-RXR-R Q,S$N,C4@5&0@*',@;W=N('-T;V-K+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-#DN,S$@,3,Q+C(U(%1D("A4:&4@86UE;F1M96YT<R!I
M;B!087)T($E)(&]F('1H:7,@57!D871E(')E8VAA<F%C=&5R:7IE('1H92!I
M;F1E9FEN:71E(&1E9F5R<F%L(&]F(&-E<G1A:6X@<')O=FES:6]N<R!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,3$Y+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30N.3$@
M,3$Y+C(U(%1D("AO<&EC(#0X,"!T:&%T(&YO=R!A<F4@<')E<V5N=&5D(&%S
M('!E;F1I;F<@8V]N=&5N="!I;B!T:&4@0V]D:69I8V%T:6]N+"!T;R!A('-C
M;W!E(&5X8V5P=&EO;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(X+C4Q
M(#$Q.2XR-2!49" H5&AO<V4@86UE;F1M96YT<R!D;R!N;W0@:&%V92 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3 W+C(U(%1D("AA;B!A8V-O=6YT:6YG(&5F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3$U+C0P(#$P-RXR-2!49" H9F5C="X@1F]R('!U8FQI8R!B=7-I
M;F5S<R!E;G1I=&EE<RP@=&AE(&%M96YD;65N=',@:6X@4&%R="!)(&]F('1H
M:7,@57!D871E(&%R92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#0S,RXT
M-R Q,#<N,C4@5&0@*&9E8W1I=F4@9F]R(&9I<V-A;"!Y96%R<RP@86YD("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," Y-2XR-2!49" H:6YT97)I;2!P97)I;V1S('=I=&AI;B!T:&]S92!F:7-C
M86P@>65A<G,L(&)E9VEN;FEN9R!A9G1E<B!$96-E;6)E<B Q-2P@,C Q."P@
M86YD('-H;W5L9"!B92!A<'!L:65D(')E=')O<W!E8W1I=F5L>2!T;R I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M.#,N,C4@5&0@*&]U='-T86YD:6YG(&9I;F%N8VEA;"!I;G-T<G5M96YT<R!W
M:71H(&$@9&]W;B!R;W5N9"!F96%T=7)E(&)Y(&UE86YS(&]F(&5I=&AE<B!A
M(&-U;75L871I=F4M968I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S(N,C8@
M.#,N,C4@5&0@*&9E8W0@861J=7-T;65N="!O<B!F;W(@96%C:"!P<FEO<B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-S$N,C4@5&0@*')E<&]R=&EN9R!P97)I;V0@<')E<V5N=&5D+B!%87)L
M>2!A9&]P=&EO;B!I<R!P97)M:71T960@9F]R(&%L;"!E;G1I=&EE<RP@:6YC
M;'5D:6YG(&%D;W!T:6]N(&EN(&%N(&EN=&5R:6T@<&5R:6]D+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T.3,N.3,@-S$N,C4@5&0@*%1H92!#;VUP86YY
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," U.2XR-2!49" H97AP96-T<R!T;R!A9&]P="!T:&ES('-T86YD87)D
M(&EN(&ET<R!F:7)S="!Q=6%R=&5R(&]F(#(P,3DL(&%N9"!D;V5S(&YO="!E
M>'!E8W0@=&AI<R!G=6ED86YC92!T;R!H879E(&$@;6%T97)I86P@:6UP86-T
M(&]N(&ET<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-#<N,C4@5&0@*&-O;G-O;&ED871E9"!F:6YA;F-I86P@
M<W1A=&5M96YT<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ,S4@,"!O
M8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P
M(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#
M;VYT96YT<R Q,S8@,"!2/CX*96YD;V)J"C$S-B P(&]B:@H\/"],96YG=&@@
M,3@Q,3,^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ(# @
M," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS
M," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q
M,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N
M,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G
M($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,V
M+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#(N(%-U
M;6UA<GD@;V8@4VEG;FEF:6-A;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,38S+C8R(#<Q,BXW-2!49" H06-C;W5N=&EN9R!0;VQI8VEE<R!<*&-O;G1I
M;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(Y-2XS," S,RXV,"!49" H1BT@,3<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C$P(%1D("A);B!&
M96)R=6%R>2 R,#$V+"!T:&4@1BD@5&H@150@40IQ(# @," P(')G($)4(#$T
M,RXT-B V.#,N,3 @5&0@*$%30B!I<W-U960@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3DR+C,W(#8X,RXQ,"!49" H05-5($YO+B R,#$V+3 R+" I(%1J
M($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<P+C0R
M(#8X,RXQ,"!49" H3&5A<V5S(%PH5"D@5&H@150@40IQ(# @," P(')G($)4
M(#,P."XQ,B V.#,N,3 @5&0@*&]P:6,@.#0R7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0V+C$W(#8X,RXQ,"!49" H
M+"!W:&EC:"!W:6QL(')E<75I<F4L(&%M;VYG(&]T:&5R(&ET96US+"!L97-S
M965S('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," V-S$N,3 @5&0@*')E8V]G;FEZ92!M;W-T(&QE87-E<R!A
M<R!A<W-E=',@86YD(&QI86)I;&ET:65S(&]N('1H92!B86QA;F-E('-H965T
M+B!1=6%L:71A=&EV92!A;F0@<75A;G1I=&%T:79E(&1I<V-L;W-U<F5S('=I
M;&P@8F4@96YH86YC960@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#8U.2XQ,"!49" H8F5T=&5R('5N9&5R
M<W1A;F0@=&AE(&%M;W5N="P@=&EM:6YG(&%N9"!U;F-E<G1A:6YT>2!O9B!C
M87-H(&9L;W=S(&%R:7-I;F<@9G)O;2!L96%S97,N("D@5&H@150@40IQ(# @
M," P(')G($)4(#0P,"XP-B V-3DN,3 @5&0@*%1H92!&*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#(R+CDR(#8U.2XQ,"!49" H05-"(&AA<R!I<W-U960@
M<V5V97)A;"!O=&AE<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-C0W+C$P(%1D("AS=6)S97%U96YT('5P9&%T
M97,@:6YC;'5D:6YG('1H92!F;VQL;W=I;F<Z(#%<*2 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,S@N.3(@-C0W+C$P(%1D("A!4U4@3F\N(#(P,3@M,3 L
M("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,38N.3@@-C0W+C$P(%1D("A#;V1I9FEC871I;VX@26UP<BD@5&H@150@40IQ
M(# @," P(')G($)4(#,X."XU-2 V-#<N,3 @5&0@*&]V96UE;G1S('1O(%0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#,N,3@@-C0W+C$P(%1D("AO<&EC
M(#@T,BP@3&5A<V5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4Q,"XQ,B V-#<N,3 @5&0@*"P@=VAI8V@@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S-2XQ
M,"!49" H:6YC;'5D97,@<VEX=&5E;B!S97!A<F%T92!N87)R;W<M<V-O<&4@
M86UE;F1M96YT<R!T;R!C;&%R:69Y('1H92!C;V1I9FEC871I;VX@86YD('1O
M(&-O<G)E8W0@=6YI;G1E;F1E9"!A<'!L:6-A=&EO;B!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C(S+C$P
M(%1D("AG=6ED86YC93L@86YD(#)<*2 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,3@N,#D@-C(S+C$P(%1D("A!4U4@3F\N(#(P,3@M,2D@5&H@150@40IQ
M(# @," P(')G($)4(#$X-2XW-R V,C,N,3 @5&0@*#$L("D@5&H@150@40I"
M5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.34N-S<@-C(S+C$P
M(%1D("A,96%S97,@7"A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,S+C0W
M(#8R,RXQ,"!49" H;W!I8R X-#)<*3H@5"D@5&H@150@40IQ(# @," P(')G
M($)4(#(X,2XY.2 V,C,N,3 @5&0@*&%R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDP+C4Q(#8R,RXQ,"!49" H9V5T960@26UP<BD@5&H@150@40IQ(# @
M," P(')G($)4(#,S,RXW-" V,C,N,3 @5&0@*&]V96UE;G1S*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W,"XY-2 V,C,N
M,3 @5&0@*"P@=VAI8V@@<')O=FED97,@96YT:71I97,@=VET:"!R96QI968@
M9G)O;2!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#8Q,2XQ,"!49" H8V]S=',@;V8@:6UP;&5M96YT:6YG
M(&-E<G1A:6X@87-P96-T<R!O9B!T:&4@;F5W(&QE87-I;F<@<W1A;F1A<F0@
M8GD@86QL;W=I;F<@=&AE;2!T;R!E;&5C="!N;W0@=&\@<F5C87-T('1H92!C
M;VUP87)A=&EV92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3DY+C$P(%1D("AP97)I;V1S('!R97-E;G1E9"!W
M:&5N('1R86YS:71I;VYI;F<@=&\@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C Y+C$Y(#4Y.2XQ,"!49" H05-#(#@T,BX@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C4P+CDV(#4Y.2XQ,"!49" H5&AE(&YE=R!L96%S92!S=&%N9&%R
M9"P@86YD('1H92!S=6)S97%U96YT("D@5&H@150@40IQ(# @," P(')G($)4
M(#0R-RXU." U.3DN,3 @5&0@*$%357,@=&AA="!M;V1I9FEE9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U,#DN.#D@-3DY+C$P(%1D("A4*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3$U+C,P(#4Y.2XQ,"!49" H;W!I8R X-#(L("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U.#<N,3 @5&0@*&%R92!E9BD@5&H@150@40IQ(# @," P(')G($)4(#<Q
M+C<Y(#4X-RXQ,"!49" H9F5C=&EV92!F;W(@9FES8V%L('EE87)S(&)E9VEN
M;FEN9R!A9G1E<B!$96-E;6)E<B Q-2P@,C Q."P@86YD(&EN=&5R:6T@<&5R
M:6]D<R!W:71H:6X@=&AO<V4@9FES8V%L('EE87)S+"!W:71H(&5A<FQY("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U-S4N,3 @5&0@*&%D;W!T:6]N('!E<FUI='1E9"XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-34Q+C$P(%1D
M("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-30@-34Q+C$P(%1D("AI
M=&@@<F5S<&5C="!T;R!T:&4@861O<'1I;VX@;V8@=&AE(&YE=R!S=&%N9&%R
M9"P@87,@;V8@1&5C96UB97(@,S$L(#(P,3@L('1H92!#;VUP86YY(&AA9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(V
M+C<W(#4U,2XQ,"!49" H)#,T+C8@;6EL;&EO;BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.# N-C8@-34Q+C$P(%1D("@@
M;V8@=6YD:7-C;W5N=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," U,SDN,3 @5&0@*&9U='5R92!L96%S92!P
M87EM96YT<RP@<')I;6%R:6QY(')E;&%T960@=&\@<F5A;"!E<W1A=&4L('1H
M870@:7,@97AP96-T960@=&\@8F4@:6YC;'5D960@:6X@:71S(&EN:71I86P@
M;65A<W5R96UE;G0@;V8@:71S(&QE87-E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U,C<N,3 @5&0@*&QI86)I
M;&ET:65S(&%N9"!C;W)R97-P;VYD:6YG(')I9VAT(&]F('5S92!A<W-E="P@
M86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R-34N,CD@-3(W+C$P(%1D("@D-RXR(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S T+C$X(#4R-RXQ,"!4
M9" H(&]F(&%C8W)U960@<F5N="!T:&%T(&ES(&5X<&5C=&5D('1O(&)E(')E
M8VQA<W-I9FEE9"!F<F]M(&QI86)I;&ET>2 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3$U+C$P(%1D("AA8V-O
M=6YT<R!T;R!R961U8V4@:71S(&)E9VEN;FEN9R!R:6=H="!O9B!U<V4@87-S
M970@8F%L86YC92Z@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@V+C$Y(#4Q
M-2XQ,"!49" H5&AE($-O;7!A;GD@9&]E<R!N;W0@97AP96-T('1H92!A9&]P
M=&EO;B!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S(N.#(@-3$U+C$P
M(%1D("A!4U4@,C Q-BTP,B!T;R!H879E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U,#,N,3 @5&0@*&$@;6%T
M97)I86P@:6UP86-T(&]N(&ET<R!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O
M9B!O<&5R871I;VYS(&%N9"!S=&%T96UE;G1S(&]F(&-A<V@@9FQO=W,N*2!4
M:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#0W,BXU,"!49" H4F5V96YU92!296-O9VYI=&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-3(N-3 @5&0@
M*%1H92!#;VUP86YY(&AA<R!D971E<FUI;F5D('1H870@:71S(')E=F5N=65S
M(&%R92!G96YE<F%T960@9G)O;2!T96UP;W)A<GD@<W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#,W-2XU." T-3(N-3 @5&0@*&9I;F<@<V5R=FEC97,@
M86YD(&]T:&5R('-E<G9I8V5S+"!A<R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#0P+C4P(%1D("AD:7-A9V=R
M96=A=&5D(&EN('1H92!F;VQL;W=I;F<@=&%B;&4N(%-E92!.;W1E(#(@+2!3
M=6UM87)Y(&]F(%-I9VYI9FEC86YT("D@5&H@150@40IQ(# @," P(')G($)4
M(#,T."XV," T-# N-3 @5&0@*$%C8V]U;G1I;F<@4&]L:6-I97,N*2!4:B!%
M5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4X+C4P
M(#,T-"XP," Q-S,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,S$N-3 @,S0T+C P(#<S+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S T+C4P(#,T-"XP," Q,"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,Q
M-"XU," S-#0N,# @-S,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#<N-3 @,S0T+C P(#$P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,SDW+C4P(#,T-"XP," W,RXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0W,"XU," S-#0N,# @,3 N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.# N-3 @,S0T+C P
M(#<R+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3@N-3 @,S$T+C P(#$W,RXP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C(S,2XU," S,30N,# @-S,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#0N-3 @,S$T
M+C P(#$P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S$T+C4P(#,Q-"XP," W,RXP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,X-RXU," S,30N,# @,3 N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.3<N-3 @
M,S$T+C P(#<S+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<P+C4P(#,Q-"XP," Q,"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0X,"XU," S,30N,# @-S(N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HR,S$N-2 T,34@;0HS,#0N-2 T,34@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,P-"XU(#0Q
M-2!M"C,Q-"XU(#0Q-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S$T+C4@-#$U(&T*,S@W+C4@-#$U(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HS.#<N-2 T,34@;0HS.3<N-2 T,34@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#0Q-2!M
M"C0W,"XU(#0Q-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#<P+C4@-#$U(&T*-#@P+C4@-#$U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT.# N-2 T,34@;0HU-3(N-2 T,34@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(S,2XU(#,U.2!M"C,P
M-"XU(#,U.2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,S$T+C4@,S4Y(&T*,S@W+C4@,S4Y(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.3<N-2 S-3D@;0HT-S N-2 S-3D@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X,"XU(#,U.2!M"C4U,BXU
M(#,U.2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,C,Q+C4@,S4Y(&T*,S T+C4@,S4Y(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,30N
M-2 S-3D@;0HS.#<N-2 S-3D@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#,U.2!M"C0W,"XU(#,U
M.2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#@P+C4@,S4Y(&T*-34R+C4@,S4Y(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR,S$N-2 S
M,30@;0HS,#0N-2 S,30@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(S,2XU(#,P,"!M"C,P-"XU(#,P,"!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,C,Q+C4@,CDX(&T*,S T+C4@,CDX(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,30N-2 S,30@
M;0HS.#<N-2 S,30@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,Q-"XU(#,P,"!M"C,X-RXU(#,P,"!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,S$T+C4@,CDX(&T*,S@W+C4@,CDX(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.3<N-2 S,30@;0HT
M-S N-2 S,30@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,Y-RXU(#,P,"!M"C0W,"XU(#,P,"!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,SDW+C4@,CDX(&T*-#<P+C4@,CDX(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.# N-2 S,30@;0HU-3(N
M-2 S,30@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0X,"XU(#,P,"!M"C4U,BXU(#,P,"!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@P
M+C4@,CDX(&T*-34R+C4@,CDX(&P*<PI"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,#DN-S @-#$Y+C8X(%1D("A&;W(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,C4N,38@-#$Y+C8X(%1D("@@=&AE('EE87(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C(N,3@@-#$Y+C8X(%1D("@@96YD960@1&5C
M96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S4N.#<@-#$Y+C8X(%1D
M("@@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C4T+C<P(#,Y,RXV."!49" H3G5R<V4I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C0T+C4U(#,X,RXV."!4
M9" H06YD("D@5&H@150@40IQ(# @," P(')G($)4(#(V-2XQ,B S.#,N-C@@
M5&0@*$%L;&EE9"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R-3 N-34@,S<S+C8X(%1D("A3=&%F9FEN9RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-#DN,34@,S8S+C8X
M(%1D("A396=M96YT*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,R.2XY," S.#,N-C@@5&0@*%!H>7-I8VEA;BD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S,N-34@,S<S
M+C8X(%1D("A3=&%F9FEN9RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,S(N,34@,S8S+C8X(%1D("A396=M96YT*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,RXT-2 T
M,#,N-C@@5&0@*$]T:&5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(X+CDQ
M(#0P,RXV."!49" H($AU;6%N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Q-RXV-2 S.3,N-C@@5&0@*$-A<&ET86PI(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# U+C0U
M(#,X,RXV."!49" H36%N86=E;65N="D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,38N,# @,S<S+C8X(%1D("A397)V:6-E
M<RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,34N,34@,S8S+C8X(%1D("A396=M96YT*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P-2XP-2 S-C,N-C@@5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" U,3 N.# @,S8S+C8X(%1D("AO=&%L*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T-"XX
M," S-#@N-C<@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V,2XP," S,S,N
M-C<@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-BXW-B S,S,N-C<@
M5&0@*&5M<&]R87)Y(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C,N
M,C0@,S,S+C8W(%1D("AF:6YG(%-E<G9I8V5S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S-"XP," S,S,N-C<@5&0@*"0I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8X
M+C$U(#,S,RXV-R!49" H-S U+#0S-2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,3<N,# @,S,S+C8W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,U-BXQ-2 S
M,S,N-C<@5&0@*#<V+#DW.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,# N,# @,S,S+C8W(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U-BXV-2 S,S,N-C<@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#@S+C P(#,S,RXV-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,38N,34@,S,S+C8W(%1D("@W.#(L-#$T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8Q
M+C P(#,Q."XV-R!49" H3W1H97(@4V5R=FEC97,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<S+C$U(#,Q."XV-R!49" H
M,30L.#8W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,V,2XQ-2 S,3@N-C<@5&0@*#4L,S(V*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S.2XQ-2 S,3@N-C<@5&0@*#$S
M+#@W-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,C$N,34@,S$X+C8W(%1D("@S-"PP-S I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-C$N,# @,S S+C8W(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-C8N-#$@,S S+C8W(%1D("AO=&%L*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S-"XP
M," S,#,N-C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C8X+C$U(#,P,RXV-R!49" H-S(P+#,P,BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3<N,# @,S S
M+C8W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,U-BXQ-2 S,#,N-C<@5&0@*#@R+#,P-2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,# @,S S+C8W(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S.2XQ-2 S,#,N-C<@5&0@*#$S+#@W-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.#,N,# @,S S+C8W(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q-BXQ
M-2 S,#,N-C<@5&0@*#@Q-BPT.#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(V
M-RXU,"!49" H-"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N.34@,C8W
M+C4P(%1D("A!8W%U:7-I=&EO;G,I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,C0S+C4P(%1D("A!;65R:6-A;B!0
M97)S;VYN96PL($EN8RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,C$Y+C4P(%1D("A/;B!$96-E;6)E<B Q+" R
M,#$X+"!T:&4@0V]M<&%N>2!C;VUP;&5T960@=&AE(&%C<75I<VET:6]N(&]F
M("D@5&H@150@40IQ(# @," P(')G($)4(#,Q-"XT-" R,3DN-3 @5&0@*$%M
M97)I8V%N(%!E<G-O;FYE;"P@26YC+B!<*$%0*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#,T+C,Q(#(Q.2XU,"!49" H(%-T868I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-3(N-S0@,C$Y+C4P(%1D("AF:6YG7"D@9F]R(&$@=&]T86P@
M<'5R8VAA<V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#(P-RXU,"!49" H<')I8V4@;V8@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C@R(#(P-RXU,"!4
M9" H)#(N,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$S,2XW,2 R,#<N-3 @5&0@*"P@<W5B:F5C="!T;R!A
M(&YE="!W;W)K:6YG(&-A<&ET86P@861J=7-T;65N="X@0F%S960@:6X@0F]S
M=&]N+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#,N,S,@,C W+C4P(%1D
M("A!4"D@5&H@150@40IQ(# @," P(')G($)4(#,Y-2XW-2 R,#<N-3 @5&0@
M*"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$T+C$W(#(P-RXU,"!4
M9" H9FEN9R!O9BD@5&H@150@40IQ(# @," P(')G($)4(#0T,"XY,R R,#<N
M-3 @5&0@*&9E<G,@82!R86YG92!O9B!T86QE;G0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Y-2XU,"!49" H
M;6%N86=E;65N="!S;VQU=&EO;G,@=&\@:71S(&AE86QT:&-A<F4@8VQI96YT
M<R!P<FEM87)I;'D@:6X@36%S<V%C:'5S971T<RP@:6YC;'5D:6YG('!E<FUA
M;F5N="!P;&%C96UE;G0L(&-O;G-U;'1A=&EV92!S=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-30U+C R(#$Y-2XU,"!49" H9FEN9R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@S+C4P
M(%1D("AS;VQU=&EO;G,L(&%N9"!T<F%D:71I;VYA;"!S=&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,38U+C0Q(#$X,RXU,"!49" H9FEN9RX@(" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,34Y+C4P(%1D("A4:&4@0V]M<&%N>2!A<W-I9VYE9"!A('1O=&%L(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#,N
M.3$@,34Y+C4P(%1D("@D,"XT(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C,R+C@Q(#$U.2XU,"!49" H('1O
M(&1E9FEN:71E(&QI9F4@:6YT86YG:6)L92!A<W-E=',@=VET:"!A('=E:6=H
M=&5D(&%V97)A9V4@97-T:6UA=&5D('5S969U;"!L:69E(&]F("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-#<N
M-3 @5&0@*#$P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Y+C4P(#$T-RXU,"!49" H('EE87)S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" X-RXY,B Q-#<N-3 @5&0@*%1H92!R96UA:6YI;F<@97AC
M97-S('!U<F-H87-E('!R:6-E(&]V97(@=&AE(&9A:7(@=F%L=64@;V8@;F5T
M(&%S<V5T<R!A8W%U:7)E9"!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#$R+C<X(#$T-RXU,"!49" H)# N-R!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0V,2XV-R Q-#<N-3 @5&0@*"!W87,@<F5C;W)D960@87,@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S-2XU
M,"!49" H9V]O9'=I;&PL('=H:6-H(&ES(&YO="!D961U8W1I8FQE(&9O<B!T
M87@@<'5R<&]S97,@<VEN8V4@=&AI<R!W87,@82!S=&]C:R!A8W%U:7-I=&EO
M;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Y+C0U(#$S-2XU,"!49" H
M07-S;V-I871E9"!A8W%U:7-I=&EO;BUR96QA=&5D(&-O<W1S("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,C,N
M-3 @5&0@*&EN8W5R<F5D('=E<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$P-RXR-" Q,C,N-3 @5&0@*"0P+C(@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q-38N,30@,3(S+C4P(%1D("@@86YD(&AA=F4@8F5E;B!I;F-L=61E9"!I
M;B!A8W%U:7-I=&EO;B!A;F0@:6YT96=R871I;VX@8V]S=',@;VX@=&AE($-O
M;7!A;GDG<R!C;VYS;VQI9&%T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Q,2XU,"!49" H<W1A=&5M96YT
M(&]F(&]P97)A=&EO;G,@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q
M+" R,#$X+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," X-RXU,"!49" H5&AE("D@5&H@150@40IQ(# @," P(')G
M($)4(#8W+C<Q(#@W+C4P(%1D("AA8W%U:7-I=&EO;B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,30N,C8@.#<N-3 @5&0@*'=A<R I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q,S(N-#<@.#<N-3 @5&0@*&1E96UE9" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C8N,C,@.#<N-3 @5&0@*&EM;6%T97)I86P@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C$R+C(Q(#@W+C4P(%1D("AA;F0@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C(Y+C,Q(#@W+C4P(%1D("AH87,@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C0U+C,P(#@W+C4P(%1D("AB965N("D@
M5&H@150@40IQ(# @," P(')G($)4(#(V-BXX-" X-RXU,"!49" H86-C;W5N
M=&5D("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,"XP-" X-RXU,"!49" H
M9F]R("D@5&H@150@40IQ(# @," P(')G($)4(#,R-"XS-B X-RXU,"!49" H
M:6X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,T+C@Q(#@W+C4P(%1D("AA
M8V-O<F1A;F-E("D@5&H@150@40IQ(# @," P(')G($)4(#,X,BXT,R X-RXU
M,"!49" H=VET:" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#(N.#<@.#<N
M-3 @5&0@*'1H92 I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#$W+C<U(#@W+C4P(%1D("A"=7-I;F5S<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-34N-#(@.#<N-3 @5&0@*$-O;6)I;F%T:6]N<RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3$N
M-3,@.#<N-3 @5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,30N,# @
M.#<N-3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3DN-#(@.#<N
M-3 @5&0@*&]P:6,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,Y+C,P(#@W
M+C4P(%1D("AO9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-3 N,CD@.#<N
M-3 @5&0@*'1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-S4N-3 @5&0@*$8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U-"XS,B W-2XU,"!49" H05-"("D@5&H@150@40IQ(# @," P(')G
M($)4(#<V+C8T(#<U+C4P(%1D("A!4T,L("D@5&H@150@40IQ(# @," P(')G
M($)4(#$P,BXR-R W-2XU,"!49" H=7-I;F<@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3(W+C8R(#<U+C4P(%1D("AT:&4@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,30S+C4Q(#<U+C4P(%1D("AA8W%U:7-I=&EO;B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q.3$N,#<@-S4N-3 @5&0@*&UE=&AO9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,C0N-S4@-S4N-3 @5&0@*&]F("D@5&H@150@
M40IQ(# @," P(')G($)4(#(S-BXW-2 W-2XU,"!49" H86-C;W5N=&EN9RX@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@U+CDY(#<U+C4P(%1D("A!4"D@
M5&H@150@40IQ(# @," P(')G($)4(#(Y."XT,2 W-2XU,"!49" H("D@5&H@
M150@40IQ(# @," P(')G($)4(#,P,BXP." W-2XU,"!49" H4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#,Q."XP,2 W-2XU,"!49" H9FEN9R=S("D@
M5&H@150@40IQ(# @," P(')G($)4(#,T,RXT.2 W-2XU,"!49" H<F5S=6QT
M<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S,N,C@@-S4N-3 @5&0@*&]F
M("D@5&H@150@40IQ(# @," P(')G($)4(#,X-2XR.2 W-2XU,"!49" H;W!E
M<F%T:6]N<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,S N-C(@-S4N-3 @
M5&0@*&%R92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#8N-3 @-S4N-3 @
M5&0@*&EN8VQU9&5D("D@5&H@150@40IQ(# @," P(')G($)4(#0X-"XV,B W
M-2XU,"!49" H:6X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#DV+C W(#<U
M+C4P(%1D("AT:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$Q+CDW(#<U
M+C4P(%1D("AC;VYS;VQI9&%T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S+C4P(%1D("AS=&%T96UE;G1S
M("D@5&H@150@40IQ(# @," P(')G($)4(#DT+C8V(#8S+C4P(%1D("AO9B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#4N.3,@-C,N-3 @5&0@*&]P97)A
M=&EO;G,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34P+C4S(#8S+C4P(%1D
M("AF<F]M("D@5&H@150@40IQ(# @," P(')G($)4(#$W,BXY,2 V,RXU,"!4
M9" H1&5C96UB97(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$V+CDT(#8S
M+C4P(%1D("@Q+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C<N,SD@-C,N
M-3 @5&0@*#(P,3@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4P+C,S(#8S
M+C4P(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8W+C<Q(#8S
M+C4P(%1D("AH879E("D@5&H@150@40IQ(# @," P(')G($)4(#(X.2XU,R V
M,RXU,"!49" H8F5E;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3$N,S8@
M-C,N-3 @5&0@*&EN8VQU9&5D("D@5&H@150@40IQ(# @," P(')G($)4(#,T
M."XW,R V,RXU,"!49" H:6X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4Y
M+C0V(#8S+C4P(%1D("AT:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<T
M+C8R(#8S+C4P(%1D("A#;VUP86YY)W,@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#(R+C$T(#8S+C4P(%1D("A.=7)S92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-#@N.3<@-C,N-3 @5&0@*&%N9" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-C4N-S @-C,N-3 @5&0@*$%L;&EE9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T.3,N-C0@-C,N-3 @5&0@*%-T868I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U,#DN-3<@-C,N-3 @5&0@*&9I;F<@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3(X+C8R(#8S+C4P(%1D("AB=7-I;F5S<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3$N-3 @
M5&0@*'-E9VUE;G0N("D@5&H@150@40IQ(# @," P(')G($)4(#@W+C@S(#4Q
M+C4P(%1D("A3964@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 T+C<V(#4Q
M+C4P(%1D("A.;W1E("D@5&H@150@40IQ(# @," P(')G($)4(#$R-BXW," U
M,2XU,"!49" H-2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S0N,C @-3$N
M-3 @5&0@*"T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30P+C S(#4Q+C4P
M(%1D("A';V]D=VEL;"P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@R+C8S
M(#4Q+C4P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@X+C,Y(#4Q
M+C4P(%1D("AR861E("D@5&H@150@40IQ(# @," P(')G($)4(#(P."XP.2 U
M,2XU,"!49" H3F%M97,L("D@5&H@150@40IQ(# @," P(')G($)4(#(T,"XX
M-B U,2XU,"!49" H86YD("D@5&H@150@40IQ(# @," P(')G($)4(#(U-RXX
M," U,2XU,"!49" H3W1H97(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@S
M+C W(#4Q+C4P(%1D("A);G1A;F=I8FQE("D@5&H@150@40IQ(# @," P(')G
M($)4(#,R-2XU-B U,2XU,"!49" H07-S971S+BD@5&H@150@40IE;F1S=')E
M86T*96YD;V)J"C$S-R P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P
M(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R
M(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$S." P(%(^/@IE;F1O8FH*,3,X
M(# @;V)J"CP\+TQE;F=T:" Q,3 P-CX^"G-T<F5A;0I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R,3,N.#4@-S8P+C<U(%1D("A#4D]34R!#
M3U5.5%(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N-C@@-S8P+C<U(%1D
M("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDY+C4S(#<V,"XW-2!49" H
M($A%04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,CDN-#4@-S8P+C<U(%1D
M("A42$-!4D4L($E.0RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,3<U+C,P(#<T."XW-2!49" H3D]415,@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C$Q+C4R(#<T."XW-2!49" H5"D@5&H@150@40IQ
M(# @," P(')G($)4(#(Q."XP,2 W-#@N-S4@5&0@*$\@0T].4T],241!*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C$Q(#<T."XW-2!49" H5$5$($9)
M3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G($)4(#,V-RXR.2 W-#@N-S4@
M5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4(#,X,2XR." W-#@N-S4@
M5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N-S8@-S0X+C<U(%1D
M("A414U%3E13*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(U."XS-2 W,S8N-S4@5&0@*$1%0T5-0D52H#,Q+" R,#$X*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#<Q,BXW-2!49" H-"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3DN-#4@
M-S$R+C<U(%1D("A!8W%U:7-I=&EO;G,@7"AC;VYT:6YU961<*2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N,S @,S,N
M-C @5&0@*$8M(#$X*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#8Y-2XR-2!49" H061V86YT86=E(%).*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W
M,2XR-2!49" H168I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XW-B V-S$N
M,C4@5&0@*&9E8W1I=F4@2G5L>2 Q+" R,#$W+"!T:&4@0V]M<&%N>2!A8W%U
M:7)E9"!A;&P@;V8@=&AE(&%S<V5T<R!O9B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#DN.#$@-C<Q+C(U(%1D("A!9'9A;G1A9V4@4DXL($Q,0R!A;F0@
M:71S('-U8G-I9&EA<FEE<R!<*&-O;&QE8W1I=F5L>2D@5&H@150@40IQ(# @
M," P(')G($)4(#4R,RXX,R V-S$N,C4@5&0@*"P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8U.2XR-2!49" H
M061V86YT86=E7"D@9F]R(&-A<V@@8V]N<VED97)A=&EO;B!O9B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C P+C(X(#8U
M.2XR-2!49" H)#@V+C8@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R-30N,3<@-C4Y+C(U(%1D("@L(&YE="!O
M9B!C87-H(&%C<75I<F5D+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#0N
M,C,@-C4Y+C(U(%1D("A4:&4@=&]T86P@<'5R8VAA<V4@<')I8V4@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,RXY
M," V-3DN,C4@5&0@*"0X."XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 W+C<Y(#8U.2XR-2!49" H('=A
M<R!S=6)J96-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," V-#<N,C4@5&0@*'1O(&$@;F5T('=O<FMI;F<@8V%P
M:71A;"!R961U8W1I;VX@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$Y-RXU,2 V-#<N,C4@5&0@*"0P+C8@;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M-#8N-# @-C0W+C(U(%1D("@@870@=&AE(&-L;W-I;F<@86YD(&%N(&%D9&ET
M:6]N86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,W-BXP.2 V-#<N,C4@5&0@*"0P+C@@;6EL;&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C0N.3@@-C0W+C(U
M(%1D("@@=V%S(')E8V5I=F5D(&1U<FEN9R!T:&4@=&AI<F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S-2XR
M-2!49" H<75A<G1E<B!O9B R,#$W(&%S('1H92!F:6YA;"!A9&IU<W1M96YT
M(&9O<B!N970@=V]R:VEN9R!C87!I=&%L+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#(N,C$@-C,U+C(U(%1D("A!9&1I=&EO;F%L;'DI(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-3(N,3$@-C,U+C(U(%1D("@L("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-3<N,3$@-C,U+C(U
M(%1D("@D,"XV(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# V+C P(#8S-2XR-2!49" H(&]F('1H92!P=7)C
M:&%S92!P<FEC92!W87,@9&5F97)R960@87,@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8R,RXR-2!49" H;V8@
M=&AE(&-L;W-I;F<@86YD(&ES(&1U92!T:&4@<V5L;&5R('=I=&AI;B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$V+C0Q
M(#8R,RXR-2!49" H,C @;6]N=&AS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(U."XS-B V,C,N,C4@5&0@*"P@;&5S<R!A
M;GD@0T]"4D$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S$N-S @-C(S+C(U
M(%1D("@@86YD(&AE86QT:&-A<F4@<&%Y;65N=',@:6YC=7)R960@8GD@=&AE
M($-O;7!A;GD@;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#8Q,2XR-2!49" H8F5H86QF(&]F('1H92!S96QL
M97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C,N-C0@-C$Q+C(U(%1D("@N
M("D@5&H@150@40IQ(# @," P(')G($)4(#$R."XP." V,3$N,C4@5&0@*$%S
M(&]F($1E8V5M8F5R(#,Q+" R,#$X+"!A<'!R;WAI;6%T96QY("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.38N,S<@-C$Q
M+C(U(%1D("@D,"XU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S0U+C(V(#8Q,2XR-2!49" H(&AA<R!B965N
M('!A:60@9F]R(&-L86EM<R!A;F0@=&AE(')E;6%I;FEN9R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(R+C$U(#8Q,2XR
M-2!49" H)# N,2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3DY+C(U(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C,Y(#4Y.2XR-2!4
M9" H(&QI86)I;&ET>2!I<R!I;F-L=61E9"!I;B!O=&AE<B!C=7)R96YT(&QI
M86)I;&ET:65S(&]N('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G
M($)4(#,S,RXS-" U.3DN,C4@5&0@*',@8F%L86YC92!S:&5E=',N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4W
M-2XR-2!49" H26YC;'5D960@:6X@=&AE(&%M;W5N="!P86ED(&%T(&-L;W-I
M;F<@=V5R92!T=V\@97-C<F]W(&%C8V]U;G1S+"!T:&4@9FER<W0@=V%S("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N
M.3$@-3<U+C(U(%1D("@D,30N-2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,"XX," U-S4N,C4@5&0@*"!W
M:&EC:"!R96QA=&5D('1O('1A>"!L:6%B:6QI=&EE<R!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4V,RXR
M-2!49" H=&AE('-E8V]N9"!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$Q,BXU-" U-C,N,C4@5&0@*"0W+C4@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q-C$N-#,@-38S+C(U(%1D("@@=VAI8V@@=V%S('1O(&-O=F5R(&%N>2!P
M;W-T+6-L;W-E(&QI86)I;&ET:65S+B!/;B!*=6QY(#(X+" R,#$W+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(P+C P
M(#4V,RXR-2!49" H)#<N,R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0V."XX.2 U-C,N,C4@5&0@*"!R96QA
M=&5D('1O('1H92!T87@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#4U,2XR-2!49" H;&EA8FEL:71I97,@=V%S
M(')E;&5A<V5D(&9R;VT@97-C<F]W*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3DR+C$S(#4U,2XR-2!49" H+"!L96%V:6YG(&$@8F%L86YC92!O9B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<Y+C@W
M(#4U,2XR-2!49" H)#<N,B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,R."XW-B U-3$N,C4@5&0@*"X@26X@
M=&AE(&9I<G-T('%U87)T97(@;V8@,C Q.2P@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-"XU-B U-3$N,C4@5&0@*"0W
M+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.3,N-#4@-34Q+C(U(%1D("@@<F5L871E9"!T;R!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#4S.2XR-2!49" H<&]S="UC;&]S92!L:6%B:6QI=&EE<R!W87,@<F5L96%S
M960@9G)O;2!E<V-R;W<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S4N,3@@
M-3,Y+C(U(%1D("@L(&QE879I;F<@82!B86QA;F-E(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,C(N.3$@-3,Y+C(U
M(%1D("@D,"XU(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S<Q+C@P(#4S.2XR-2!49" H('1O(&-O=F5R('!E
M;F1I;F<@<&]S="UC;&]S92!L:6%B:6QI=&EE<RXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3$U+C(U(%1D("A4
M:&4@0V]M<&%N>2!F:6YA;F-E9"!T:&4@<'5R8VAA<V4@=7-I;F<@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R,BXW." U
M,34N,C4@5&0@*"0Q.2XY(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C<V+C8W(#4Q-2XR-2!49" H(&EN(&%V
M86EL86)L92!C87-H(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S8U+C(U(#4Q-2XR-2!49" H)#8V+CD@;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,3DN,30@-3$U+C(U(%1D("@@:6X@8F]R<F]W:6YG('5N9&5R(&ET<R!#<F5D
M:70@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#4P,RXR-2!49" H1F%C:6QI='DI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" W.2XT," U,#,N,C4@5&0@*"P@:6YC;'5D:6YG(&$@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$S,2XV,2 U,#,N
M,C4@5&0@*"0T,"XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3@U+C4Q(#4P,RXR-2!49" H(&EN8W)E;65N
M=&%L('1E<FT@;&]A;BP@=VAI8V@@=V%S('-U8G-E<75E;G1L>2!R969I;F%N
M8V5D(&]N("D@5&H@150@40IQ(# @," P(')G($)4(#0S-RXP.2 U,#,N,C4@
M5&0@*$%U9W5S=" Q+" R,#$W+B!3964@3F]T92 X("T@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Y,2XR-2!4
M9" H1&5B="!F;W(@9G5R=&AE<B!I;F9O<FUA=&EO;BX@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,38W+C,T(#0Y,2XR-2!49" H5&AE('1R86YS86-T:6]N
M('=A<R!T<F5A=&5D(&%S(&$@<'5R8VAA<V4@;V8@87-S971S(&9O<B!I;F-O
M;64@=&%X('!U<G!O<V5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," T-C<N,C4@5&0@*$%D=F%N=&%G92!I<R!P
M<FEM87)I;'D@82!T<F%V96P@;G5R<V4@<W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#(Q-"XX,B T-C<N,C4@5&0@*&9I;F<@8V]M<&%N>2!T:&%T(&1E
M<&QO>7,@;6%N>2!O9B!I=',@;G5R<V5S('1H<F]U9V@@35-0<R!A;F0@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#<V+C P(#0V-RXR-2!49" H5BD@5&H@
M150@40IQ(# @," P(')G($)4(#0X,BXQ,B T-C<N,C4@5&0@*&5N9&]R($UA
M;F%G96UE;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#0U-2XR-2!49" H4WES=&5M<RP@86YD("D@5&H@150@
M40IQ(# @," P(')G($)4(#$P-"XR,R T-34N,C4@5&0@*$%D=F%N=&%G92!M
M86EN=&%I;G,@9&ER96-T(')E;&%T:6]N<VAI<',@=VET:"!M86YY(&AO<W!I
M=&%L<R!T:')O=6=H;W5T('1H92!5;FET960@4W1A=&5S+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T-S(N.#<@-#4U+C(U(%1D("A4:&ES('=A<R!A('-T
M<F%T96=I8R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-#0S+C(U(%1D("AA8W%U:7-I=&EO;B!T;R!H96QP('1H
M92!#;VUP86YY(&9I;&P@:71S(')E8V5N="!-4U I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-30N-C8@-#0S+C(U(%1D("@@8V]N=')A8W0@=VEN<R!A;F0@
M9F]R(')E=F5N=64@9W)O=W1H+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," T,3DN,C4@5&0@*%1H92!A8W%U:7-I
M=&EO;B!H87,@8F5E;B!A8V-O=6YT960@9F]R(&EN(&%C8V]R9&%N8V4@=VET
M:"!T:&4@*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,P,2XP-B T,3DN,C4@5&0@*$)U<VEN97-S($-O;6)I;F%T:6]N<R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW
M+C$X(#0Q.2XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#0P,BXU
M.2 T,3DN,C4@5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-3(N-C<@-#$Y+C(U(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#<T+C X(#0Q.2XR-2!49" H05-#+"!U<VEN9R!T:&4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0P
M-RXR-2!49" H86-Q=6ES:71I;VX@;65T:&]D(&]F(&%C8V]U;G1I;F<N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$X-RXU,R T,#<N,C4@5&0@*$%S('-U
M8V@L('1H92!A;6]U;G1S(&]F(')E=F5N=64@86YD(&-O;G1R:6)U=&EO;B!I
M;F-O;64@:6YC;'5D960@:6X@=&AE($-O;7!A;GDG<R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,SDU+C(U(%1D
M("AC;VYS;VQI9&%T960@:6YC;VUE('-T871E;65N="!F<F]M('1H92!A8W%U
M:7-I=&EO;B!D871E('1O('1H92!P97)I;V0@96YD960@1&5C96UB97(@,S$L
M(#(P,3<@=V5R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#4Y+CDR(#,Y-2XR-2!49" H)#0W+C @;6EL;&EO;BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3,N.#$@
M,SDU+C(U(%1D("@@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,S,N,C4@,SDU+C(U(%1D("@D,RXX("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S.#,N
M,C4@5&0@*&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-S@N,SD@,S@S+C(U(%1D("@L(')E<W!E8W1I=F5L>2D@
M5&H@150@40IQ(# @," P(')G($)4(#$S,2XP-2 S.#,N,C4@5&0@*"X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3,U+C@W(#,X,RXR-2!49" H5&AE(&%C
M<75I<VET:6]N(')E<W5L=',@:&%V92!B965N('-U8G-T86YT:6%L;'D@86=G
M<F5G871E9"!W:71H('1H92!#;VUP86YY)W,@3G5R<V4@86YD("D@5&H@150@
M40IQ(# @," P(')G($)4(#0Y-2XY,B S.#,N,C4@5&0@*$%L;&EE9"!3=&%F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,Y+C,T(#,X,RXR-2!49" H9FEN
M9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S<Q+C(U(%1D("AB=7-I;F5S<R!S96=M96YT+B!3964@3F]T92 Q
M-R M(%-E9VUE;G0@1&%T82XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @,S0W+C(U(%1D("A4:&4@9F]L;&]W:6YG
M(&ES('1H92!E<W1I;6%T960@9F%I<B!V86QU92!O9B!T:&4@<'5R8VAA<V4@
M<')I8V4@9F]R("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,RXX-2 S-#<N
M,C4@5&0@*$%D=F%N=&%G92!O;B!*=6QY(#$L(#(P,3<Z*2!4:B!%5"!1"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#,R,2XW
M-2 S.#DN,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N,# @,S(Q+C<U(#$R-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0Y+C P(#(Y,2XW-2 S.#DN,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S@N,# @
M,CDQ+C<U(#$R-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#(V,2XW-2 S.#DN,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,S@N,# @,C8Q+C<U(#$R-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S." R.3$N-S4@;0HU-C(@,CDQ+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S@@
M,C8Q+C<U(&T*-38R(#(V,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,X(#(T-RXW-2!M"C4V,B R
M-#<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0S." R-#4N-S4@;0HU-C(@,C0U+C<U(&P*<PI"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3(N.# @,S(V+C0R(%1D
M("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @,S$Q+C0R(%1D("A0=7)C
M:&%S92!P<FEC92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-# N-3 @,S$Q+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,"XV-2 S,3$N-#(@5&0@*#@X
M+# P,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,2XU," R.38N-#(@5&0@*$YE="!W;W)K:6YG(&-A<&ET86P@861J=7-T
M;65N=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,R+C,P(#(Y-BXT-R!49" H7"@Q+#0S."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3@N,34@,CDV+C0R(%1D("A<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,2XU," R.#$N-#(@5&0@*$-A<V@@8V]N<VED97)A=&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S N-C4@,C@Q+C0R
M(%1D("@X-BPU-C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3$N-3 @,C8V+C0R(%1D("A#87-H(&%C<75I<F5D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 R
M-C8N-#(@5&0@*#(L.#,S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4W+C4P(#(U,2XT,B!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#8R+CDQ(#(U,2XT,B!49" H;W1A;"!C;VYS:61E<F%T:6]N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M,"XU," R-3$N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,P+C8U(#(U,2XT,B!49" H.#DL,SDU*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," R,C,N,C4@5&0@*%1H92!P=7)C:&%S92!P<FEC
M92!W87,@86QL;V-A=&5D('1O('1H92!A<W-E=',@86-Q=6ER960@86YD('1H
M92!L:6%B:6QI=&EE<R!A<W-U;65D(&)A<V5D(&]N('1H92!E<W1I;6%T960@
M9F%I<B!V86QU92!A="!T:&4@9&%T92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C$Q+C(U(%1D("AO9B!A8W%U
M:7-I=&EO;BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 Y+C S(#(Q,2XR
M-2!49" H5&AE($-O;7!A;GD@=7-E9"!A('1H:7)D+7!A<G1Y(&%P<')A:7-E
M<B!T;R!A<W-I<W0@=VET:"!T:&4@9&5T97)M:6YA=&EO;B!O9B!T:&4@9F%I
M<B!V86QU92!A;F0@97-T:6UA=&5D('5S969U;" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3DY+C(U(%1D("AL
M:79E<R!O9B!C97)T86EN(&%C<75I<F5D(&%S<V5T<R!A;F0@;&EA8FEL:71I
M97,N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3,Y(# @;V)J"CP\+U1Y
M<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @
M-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@
M,30P(# @4CX^"F5N9&]B:@HQ-# @,"!O8FH*/#PO3&5N9W1H(#DU,S0^/@IS
M=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S+C@U
M(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ(# @," P(')G($)4
M(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS," W-#@N-S4@
M5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU,B W-#@N
M-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@-S0X+C<U
M(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G($)4(#(X."XQ
M,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,V+C<U(%1D("A$
M14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#0N("D@5&H@150@40IQ
M(# @," P(')G($)4(#4Y+C0U(#<Q,BXW-2!49" H06-Q=6ES:71I;VYS(%PH
M8V]N=&EN=65D7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 Q.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @5&0@
M*%1H92!F;VQL;W=I;F<@=&%B;&4@:7,@86X@97-T:6UA=&4@;V8@=&AE(&9A
M:7(@=F%L=64@;V8@=&AE(&%S<V5T<R!A8W%U:7)E9"!A;F0@;&EA8FEL:71I
M97,@87-S=6UE9"!O;B!*=6QY(#$L(#(P,3<N*2!4:B!%5"!1"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#8V.2XV," S.#<N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,S8N,# @-C8Y+C8P(#$R-BXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y+C P(#8S.2XV," S.#<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S8N,# @-C,Y+C8P
M(#$R-BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#8P.2XV," S.#<N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,S8N,# @-C Y+C8P(#$R-BXP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#4W
M.2XV," S.#<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S8N,# @-3<Y+C8P(#$R-BXP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0Y+C P(#4T.2XV," S.#<N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S8N
M,# @-30Y+C8P(#$R-BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#4Q.2XV," S.#<N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,S8N,# @-3$Y+C8P(#$R-BXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0S-B U-SDN-B!M"C4V,B U-SDN-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,V
M(#4V-"XV(&T*-38R(#4V-"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S8@-3$Y+C8@;0HU-C(@-3$Y
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S-B U,#0N-B!M"C4V,B U,#0N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,V(#0Y
M,"XV(&T*-38R(#0Y,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,S8@-#@X+C8@;0HU-C(@-#@X+C8@
M; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,2XX," V
M-S0N,C<@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,2XU," V-3DN,C<@
M5&0@*$-A<V@@86YD(&-A<V@@97%U:79A;&5N=',I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,X+C4P(#8U.2XR-R!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S4N-C4@-C4Y+C(W(%1D("@R+#@S,RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,2XU," V-#0N,C<@5&0@*$%C8V]U;G1S
M(')E8V5I=F%B;&4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,P+C8U(#8T-"XR-R!49" H,30L,SDV*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q+C4P(#8R.2XR-R!4
M9" H3W1H97(@8W5R<F5N="!A<W-E=',I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-30S+C$U(#8R.2XR-R!49" H,SDR*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q+C4P
M(#8Q-"XR-R!49" H4')O<&5R='D@86YD(&5Q=6EP;65N="D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#,N,34@-C$T+C(W
M(%1D("@S,S,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3$N-3 @-3DY+C(W(%1D("A';V]D=VEL;"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S N-C4@-3DY+C(W(%1D
M("@T,RPU.38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3$N-3 @-3@T+C(W(%1D("A/=&AE<B!I;G1A;F=I8FQE(&%S<V5T
M<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S N-C4@-3@T+C(W(%1D("@R.2PY,# I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3<N-3 @-38Y+C(W(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-C,N,C8@-38Y+C(W(%1D("AO=&%L(&%S<V5T
M<R!A8W%U:7)E9"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S N-C4@-38Y+C(W(%1D("@Y,2PT-3 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @-34T+C(W(%1D
M("A!8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,RXQ-2 U
M-30N,C<@5&0@*#,V."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,2XU," U,SDN,C<@5&0@*$%C8W)U960@96UP;&]Y964@
M8V]M<&5N<V%T:6]N(&%N9"!B96YE9FET<RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N-C4@-3,Y+C(W(%1D("@Q+#8X
M-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,2XU," U,C0N,C<@5&0@*$]T:&5R(&-U<G)E;G0@;&EA8FEL:71I97,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34S+C$U
M(#4R-"XR-R!49" H,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U-RXU," U,#DN,C<@5&0@*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" V,RXR-B U,#DN,C<@5&0@*&]T86P@;&EA8FEL:71I97,@87-S
M=6UE9"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S4N-C4@-3 Y+C(W(%1D("@R+# U-2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU," T.30N,C<@5&0@*$YE="!A
M<W-E=',@86-Q=6ER960I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,X+C4P(#0Y-"XR-R!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S N-C4@-#DT+C(W(%1D
M("@X.2PS.34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0V-BXQ,"!49" H5&AE
M($-O;7!A;GD@87-S:6=N960@=&AE(&9O;&QO=VEN9R!V86QU97,@=&\@;W1H
M97(@:61E;G1I9FEA8FQE(&EN=&%N9VEB;&4@87-S971S.B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@R+C0X(#0V-BXQ
M,"!49" H)#0N-2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0S,2XS." T-C8N,3 @5&0@*"!T;R!T<F%D92!N
M86UE<R!W:71H(&$@=V5I9VAT960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0U-"XQ,"!49" H879E<F%G92!E
M<W1I;6%T960@=7-E9G5L(&QI9F4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$W-RXU," T-30N,3 @5&0@*#$P*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X-RXU
M," T-30N,3 @5&0@*"!Y96%R<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(Q-BXQ," T-30N,3 @5&0@*"0Q,RXX(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C8Y+CDY(#0U-"XQ,"!49" H('1O(&-U<W1O;65R(')E;&%T:6]N<VAI
M<',@=VET:"!A('=E:6=H=&5D(&%V97)A9V4@97-T:6UA=&5D('5S969U;"!L
M:69E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," T-#(N,3 @5&0@*&]F("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" V,"XS,R T-#(N,3 @5&0@*#$P*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<P+C,S(#0T
M,BXQ,"!49" H('EE87)S+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.3@N.3,@-#0R+C$P(%1D("@D,2D@5&H@150@40IQ
M(# @," P(')G($)4(#$P."XU-B T-#(N,3 @5&0@*#$N,R!M:6QL:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U,BXT
M-2 T-#(N,3 @5&0@*"!T;R!A(&1A=&%B87-E+"!C;VYS:7-T:6YG(&]F(&AE
M86QT:&-A<F4@<')O9F5S<VEO;F%L<RP@=VET:"!A('=E:6=H=&5D(&%V97)A
M9V4@97-T:6UA=&5D('5S969U;"!L:69E(&]F("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,S N,3 @5&0@*#$P
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Y
M+C4P(#0S,"XQ,"!49" H('EE87)S+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P-2XP-" T,S N,3 @5&0@*"0P
M+C,@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-3,N.3,@-#,P+C$P(%1D("@@=&\@;F]N+6-O;7!E=&4@86=R
M965M96YT<R!W:71H(&$@=V5I9VAT960@879E<F%G92!E<W1I;6%T960@=7-E
M9G5L(&QI9F4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0V,RXX,2 T,S N,3 @5&0@*#4I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8X+C@Q(#0S,"XQ,"!49" H
M('EE87)S+"!F;W(@82!T;W1A;"!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#$X+C$P(%1D("@D,CDN.2!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$P,RXS.2 T,3@N,3 @5&0@*"!I;B!D969I;FET92!L:69E(&EN=&%N
M9VEB;&4@87-S971S('=I=&@@82!W96EG:'1E9"!A=F5R86=E(&5S=&EM871E
M9"!U<V5F=6P@;&EF92!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#(W+C<S(#0Q."XQ,"!49" H,3 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,W+C<S(#0Q."XQ
M,"!49" H('EE87)S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," S.30N,3 @5&0@*%1H92!R96UA:6YI;F<@97AC
M97-S('!U<F-H87-E('!R:6-E(&]V97(@=&AE(&9A:7(@=F%L=64@;V8@;F5T
M(&%S<V5T<R!A8W%U:7)E9"!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S<T+C,V(#,Y-"XQ,"!49" H)#0S+C8@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,C@N,C4@,SDT+C$P(%1D("@@=V%S(')E8V]R9&5D(&%S(&=O;V1W:6QL
M+"!W:&EC:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @,S@R+C$P(%1D("AI<R!D961U8W1I8FQE(&9O<B!T87@@
M<'5R<&]S97,N("D@5&H@150@40IQ(# @," P(')G($)4(#$W,2XW," S.#(N
M,3 @5&0@*$%S<V]C:6%T960@86-Q=6ES:71I;VXM<F5L871E9"!C;W-T<R!I
M;F-U<G)E9"!W97)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S-S4N,C,@,S@R+C$P(%1D("@D,BXP(&UI;&QI;VXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(T+C$R
M(#,X,BXQ,"!49" H(&%N9"!H879E(&)E96X@:6YC;'5D960@:6X@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,W
M,"XQ,"!49" H86-Q=6ES:71I;VX@86YD(&EN=&5G<F%T:6]N(&-O<W1S(&]N
M('1H92!#;VUP86YY)W,@8V]N<V]L:61A=&5D('-T871E;65N=',@;V8@;W!E
M<F%T:6]N<R!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S
M-3@N,3 @5&0@*#(P,3<N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#,S-"XQ,"!49" H4'(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U.2XQ,R S,S0N,3 @5&0@*&\@1F]R;6$@1FEN86YC:6%L
M($EN9F]R;6%T:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#,Q,"XQ,"!49" H5&AE(&9O;&QO=VEN9R!U;F%U
M9&ET960@<')O(&9O<FUA(&9I;F%N8VEA;"!I;F9O<FUA=&EO;B!A<'!R;WAI
M;6%T97,@=&AE(&-O;G-O;&ED871E9"!R97-U;'1S(&]F(&]P97)A=&EO;G,@
M;V8@=&AE($-O;7!A;GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(Y."XQ,"!49" H87,@:68@=&AE("D@5&H@
M150@40IQ(# @," P(')G($)4(#@S+C$P(#(Y."XQ,"!49" H061V86YT86=E
M(&%C<75I<VET:6]N(&AA9"!O8V-U<G)E9"!A<R!O9B!*86YU87)Y(#$L(#(P
M,38L(&%F=&5R(&=I=FEN9R!E9BD@5&H@150@40IQ(# @," P(')G($)4(#,W
M-BXT,R R.3@N,3 @5&0@*&9E8W0@=&\@8V5R=&%I;B!A9&IU<W1M96YT<RP@
M:6YC;'5D:6YG("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," R.#8N,3 @5&0@*&%D9&ET:6]N86P@:6YT97)E<W0@
M97AP96YS92!O;B!T:&4@86UO=6YT('1H92!#;VUP86YY(&)O<G)O=V5D(&]N
M('1H92!D871E(&]F('1H92!T<F%N<V%C=&EO;BP@=&AE(&%M;W)T:7IA=&EO
M;B!O9B!A8W%U:7)E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,C<T+C$P(%1D("AI;G1A;F=I8FQE(&%S<V5T
M<RP@86YD('1H92!E;&EM:6YA=&EO;B!O9B!C97)T86EN(&5X<&5N<V5S('1H
M870@=VEL;"!N;W0@8F4@<F5C=7)R:6YG(&EN('!O<W0M86-Q=6ES:71I;VX@
M<&5R:6]D<RP@;F5T(&]F(&%N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," R-C(N,3 @5&0@*&5S=&EM871E9"!I
M;F-O;64@=&%X(&EM<&%C="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38Y
M+C P(#(V,BXQ,"!49" H5&AE<V4@861J=7-T;65N=',@:6YC;'5D92!R96UO
M=FEN9R!T<F%N<V%C=&EO;BUR96QA=&5D(&5X<&5N<V5S(&]F(&%P<')O>&EM
M871E;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P-2XP," R-C(N,3 @5&0@*"0R+C @;6EL;&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3,N.#D@,C8R+C$P
M(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(U,"XQ,"!49" H9F]R('1H92!Y96%R(&5N9&5D($1E8V5M
M8F5R(#,Q+" R,#$W+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#<N.#8@
M,C4P+C$P(%1D("A4:&5S92!R97-U;'1S(&%R92!N;W0@;F5C97-S87)I;'D@
M:6YD:6-A=&EV92!O9B!F=71U<F4@<F5S=6QT<R!A<R!T:&5Y(&1O(&YO="!I
M;F-L=61E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," R,S@N,3 @5&0@*&EN8W)E;65N=&%L(&EN=F5S=&UE;G1S
M(&EN('-U<'!O<G0@9G5N8W1I;VYS+"!E;&EM:6YA=&EO;B!O9B!C;W-T<R!F
M;W(@:6YT96=R871I;VX@;W(@;W!E<F%T:6YG('-Y;F5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#0X+C0P(#(S."XQ,"!49" H9VEE<RP@;W(@86X@97-T
M:6UA=&4@;V8@86YY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," R,C8N,3 @5&0@*&EM<&%C="!O;B!I;G1E<F5S
M="!E>'!E;G-E(')E<W5L=&EN9R!F<F]M('1H92!O<&5R871I;F<@8V%S:"!F
M;&]W(&]F('1H92!A8W%U:7)E9"!B=7-I;F5S<V5S+"!A;6]N9R!O=&AE<B!A
M9&IU<W1M96YT<R!T:&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R,30N,3 @5&0@*&-O=6QD(&)E(&UA9&4@
M:6X@=&AE(&9U='5R92!B=70@87)E(&YO="!F86-T=6%L;'D@<W5P<&]R=&%B
M;&4@;VX@=&AE(&1A=&4@;V8@=&AE('1R86YS86-T:6]N+B I(%1J($54(%$*
M96YD<W1R96%M"F5N9&]B:@HQ-#$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R
M96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O
M=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q-#(@,"!2/CX*96YD
M;V)J"C$T,B P(&]B:@H\/"],96YG=&@@,38P,3<^/@IS=')E86T*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H
M0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C8X(#<V
M,"XW-2!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#(Y.2XU,R W-C N
M-S4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V
M,"XW-2!49" H5$A#05)%+"!)3D,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$W-2XS," W-#@N-S4@5&0@*$Y/5$53("D@
M5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/
M3$E$02D@5&H@150@40IQ(# @," P(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@
M*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@
M-S0X+C<U(%1D("@@4U0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@
M-S0X+C<U(%1D("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C<V(#<T
M."XW-2!49" H5$5-14Y44RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R-3@N,S4@-S,V+C<U(%1D("A$14-%34)%4J S,2P@
M,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," W,3(N-S4@5&0@*#0N("D@5&H@150@40IQ(# @," P(')G($)4
M(#4Y+C0U(#<Q,BXW-2!49" H06-Q=6ES:71I;VYS(%PH8V]N=&EN=65D7"DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDU
M+C,P(#,S+C8P(%1D("A&+2 R,"D@5&H@150@40HP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHU,BXP," V-30N-3 @,C@Y+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0Q+C P(#8U-"XU," Q,#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#4N,# @
M-C4T+C4P(#$P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#4U+C P(#8U-"XU," Q,#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHU,BXP," V,C0N-3 @,C@Y+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0Q
M+C P(#8R-"XU," Q,#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#4N,# @-C(T+C4P(#$P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#4U+C P(#8R-"XU," Q,#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,BXP," U.30N-3 @,C@Y+C P("TR,BXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0Q+C P(#4Y-"XU
M," Q,#0N,# @+3(R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#4N,# @-3DT+C4P(#$P+C P("TR,BXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#4U+C P(#4Y-"XU," Q,#0N,# @+3(R+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,BXP," U
M-3<N-3 @,C@Y+C P("TR,BXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0Q+C P(#4U-RXU," Q,#0N,# @
M+3(R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-#4N,# @-34W+C4P(#$P+C P("TR,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#4U
M+C P(#4U-RXU," Q,#0N,# @+3(R+C P(')E(&8*+T=3,"!G<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#$@
M-C@V+C4@;0HT-#4@-C@V+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T,2 V-S$N-2!M"C0T-2 V-S$N
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#0U(#8X-BXU(&T*-#4U(#8X-BXU(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-34@-C@V
M+C4@;0HU-3D@-C@V+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U-2 V-S$N-2!M"C4U.2 V-S$N-2!L
M"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDT+C$P(#8Y
M,2XQ."!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#0P,"XW-R V.3$N
M,3@@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0Q-"XP," V.3$N
M,3@@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#0X.2XY,B V.3$N,3@@5&0@*" S,2PI(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S@R+C4P(#8W-BXQ."!49" H,C Q-RD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.38N
M-3 @-C<V+C$X(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S0X+C4P(#8U."XY-B!49" H7"AU;F%U9&ET960L
M(&%M;W5N=',@:6X@=&AO=7-A;F1S(&5X8V5P="!P97(@<VAA<F4@9&%T85PI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHU-"XU," V-3$N,3 @.3$N-C,@+3DN,#D@
M<F4@9@HO1U,P(&=S"G$@," P(# @<F<@0E0@-30N-3 @-C0T+C$W(%1D("A2
M979E;G5E(&9R;VT@<V5R=FEC97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S0S+C4P(#8T-"XQ-R!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#@N-C4@-C0T
M+C$W(%1D("@Y,38L,30Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0U-RXU," V-#0N,3<@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(R+C8U(#8T-"XQ-R!4
M9" H.3,T+#DP-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-30N-3 @-C(Q+C$P(#$Y
M-2XR,B M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U-"XU," V
M,30N,3<@5&0@*$YE="!I;F-O;64@871T<FEB=71A8FQE('1O(&-O;6UO;B!S
M:&%R96AO;&1E<G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S0S+C4P(#8Q-"XQ-R!49" H)"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3,N-C4@-C$T+C$W(%1D("@T
M,"PR-34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4W+C4P(#8Q-"XQ-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,C<N-C4@-C$T+C$W(%1D("@Q*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-3,R+C8U(#8Q-"XQ-R!49" H,2PS.3$I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4T+C4P(#4Y,BXP," R-S<N-#$@+3DN,#D@<F4@
M9@HO1U,P(&=S"G$@," P(# @<F<@0E0@-30N-3 @-3@U+C W(%1D("A.970@
M:6YC;VUE('!E<B!C;VUM;VX@<VAA<F4@871T<FEB=71A8FQE('1O(&-O;6UO
M;B!S:&%R96AO;&1E<G,@+2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-30N-3 @-3@R
M+C U(#(P+C4U("TY+C Y(')E(&8*+T=3,"!G<PIQ(# @," P(')G($)4(#4T
M+C4P(#4W-2XQ,B!49" H8F%S:6,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S0S+C4P(#4W-RXQ-R!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C,N-C4@-3<W
M+C$W(%1D("@Q+C$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0U-RXU," U-S<N,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,W+C8U(#4W-RXQ-R!49" H
M,"XS-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-30N-3 @-34U+C P(#(W-RXT,2 M
M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U-"XU," U-#@N,#<@
M5&0@*$YE="!I;F-O;64@<&5R(&-O;6UO;B!S:&%R92!A='1R:6)U=&%B;&4@
M=&\@8V]M;6]N('-H87)E:&]L9&5R<R M*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M-"XU," U-#4N,#4@,C<N-S<@+3DN,#D@<F4@9@HO1U,P(&=S"G$@," P(# @
M<F<@0E0@-30N-3 @-3,X+C$R(%1D("AD:6QU=&5D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T,RXU," U-# N,3<@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#(S+C8U(#4T,"XQ-R!49" H,2XP.2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-3<N-3 @-30P+C$W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-RXV-2 U
M-# N,3<@5&0@*# N,C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4
M("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Q,BXP,"!4
M9" H55,@4F5S;W5R8V5S($AE86QT:&-A<F4I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#@X+C P(%1D("A/;B!$
M96-E;6)E<B Q+" R,#$V+"!T:&4@0V]M<&%N>2!C;VUP;&5T960@=&AE(&%C
M<75I<VET:6]N(&]F(&$@<F5C<G5I=&UE;G0@<')O8V5S<R!O=71S;W5R8VEN
M9R!B=7-I;F5S<RP@55,@4F5S;W5R8V5S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-S8N,# @5&0@*$AE86QT
M:&-A<F4L($Q,0R!<*%534EPI+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-3 N,3(@-#<V+C P(%1D("A4:&ES(&%C<75I<VET:6]N(&5X<&%N9',@=&AE
M($-O;7!A;GDG<R!W;W)K9F]R8V4@<V]L=71I;VYS(&]F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# T+C(P(#0W-BXP,"!49" H9F5R:6YG<R!T;R!D96QI
M=F5R(&9I;F%N8VEA;"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#0V-"XP,"!49" H;W!E<F%T:6YG(&5F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3<N,S4@-#8T+C P(%1D("AF:6-I
M96YC:65S('1H<F]U9V@@;&%B;W(@;W!T:6UI>F%T:6]N('-E<G9I8V5S('=H
M:6QE(&5N:&%N8VEN9R!T:&4@<75A;&ET>2!O9B!C87)E+BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-# N,# @
M5&0@*%1H92!A9W)E96UE;G0@<W!E8VEF:65D('1H870@=&AE('-E;&QE<G,@
M=V5R92!E;&EG:6)L92!T;R!R96-E:79E(&%D9&ET:6]N86P@<'5R8VAA<V4@
M<')I8V4@8V]N<VED97)A=&EO;B!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<V+C@Q(#0T,"XP,"!49" H)#0N-2!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4R-2XW,2 T-# N,# @5&0@*"P@=VET:"!A("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,C@N,# @5&0@
M*&UA>&EM=6T@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$P,RXS." T,C@N,# @5&0@*"0Q+C @;6EL;&EO;BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-3(N,C<@
M-#(X+C P(%1D("@@9F]R(#(P,3<L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.3,N.3,@-#(X+C P(%1D("@D,BXP(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C0R+C@S(#0R."XP,"!49" H(&9O<B R,#$X+"!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XT,B T,C@N
M,# @5&0@*"0Q+C4@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-3 N,S(@-#(X+C P(%1D("@@9F]R(#(P,3DL
M(&)A<V5D(&]N(&%T=&%I;FUE;G0@;V8@<W!E8VEF:6,@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Q-BXP,"!4
M9" H<&5R9F]R;6%N8V4@8W)I=&5R:6$@86-H:65V960@:6X@96%C:"!O9B!T
M:&]S92!Y96%R<RX@26X@=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3<L('1H
M92!#;VUP86YY(')E8V]G;FEZ960@82!D96-R96%S92!I;B!T:&4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0P
M-"XP,"!49" H9F%I<B!V86QU92!O9B!T:&4@;&EA8FEL:71Y(&]F("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C N,#(@
M-# T+C P(%1D("@D,2XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C X+CDQ(#0P-"XP,"!49" H(&EN8VQU
M9&5D(&%S(&%C<75I<VET:6]N+7)E;&%T960@8V]N=&EN9V5N="!C;VYS:61E
M<F%T:6]N(&]N(&ET<R!C;VYS;VQI9&%T960@<W1A=&5M96YT<R I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,SDR
M+C P(%1D("AO9B!O<&5R871I;VYS+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,#8N.# @,SDR+C P(%1D("A4:&4@861J=7-T;65N="!W87,@9')I=F5N
M(&)Y('1H92!D96-R96%S92!I;B!T:&4@<')O:F5C=&5D(%534B R,#$X(&%N
M9" R,#$Y(')E=F5N=64@86YD($5"251$02D@5&H@150@40IQ(# @," P(')G
M($)4(#4Q-RXR-" S.3(N,# @5&0@*"!A;6]U;G1S+B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S@P+C P(%1D
M("A4:&4@96%R;F]U="!F;W(@,C Q-R!W87,@;F]T(&%C:&EE=F5D+B!);B!T
M:&4@=&AI<F0@<75A<G1E<B!O9B R,#$X+"!T:&4@0V]M<&%N>2!D971E<FUI
M;F5D('1H870@=&AE(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S8X
M+C P(%1D("AE87)N;W5T(')E;&%T960@=&\@=&AE(%534B!A8W%U:7-I=&EO
M;B!W;W5L9"!N;W0@8F4@86-H:65V960@9F]R(#(P,3@@86YD(#(P,3D@86YD
M+"!A<R!A(')E<W5L="P@=&AE(&5N=&ER92!L:6%B:6QI='D@=V%S("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S
M-38N,# @5&0@*')E=F5R<V5D+B!3964@3F]T92 Q," M($9A:7(@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,38T+C P(#,U-BXP,"!49" H5BD@5&H@150@
M40IQ(# @," P(')G($)4(#$W,"XQ,B S-38N,# @5&0@*&%L=64@365A<W5R
M96UE;G1S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," S,S(N,# @5&0@*%1H92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" V-RXW,2 S,S(N,# @5&0@*&%C<75I<VET:6]N("D@5&H@150@40IQ
M(# @," P(')G($)4(#$Q-"XR-B S,S(N,# @5&0@*'=A<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,S(N-#<@,S,R+C P(%1D("AD965M960@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,38V+C(S(#,S,BXP,"!49" H:6UM871E<FEA
M;" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3(N,C$@,S,R+C P(%1D("AA
M;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(Y+C,Q(#,S,BXP,"!49" H
M:&%S("D@5&H@150@40IQ(# @," P(')G($)4(#(T-2XS," S,S(N,# @5&0@
M*&)E96X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8V+C@T(#,S,BXP,"!4
M9" H86-C;W5N=&5D("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,"XP-" S
M,S(N,# @5&0@*&9O<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C0N,S8@
M,S,R+C P(%1D("AI;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S0N.#$@
M,S,R+C P(%1D("AA8V-O<F1A;F-E("D@5&H@150@40IQ(# @," P(')G($)4
M(#,X,BXT,R S,S(N,# @5&0@*'=I=&@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-# R+C@W(#,S,BXP,"!49" H=&AE("D@5&H@150@40I"5" O1C0@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,3<N-S4@,S,R+C P(%1D("A"=7-I
M;F5S<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-34N-#(@,S,R+C P(%1D
M("A#;VUB:6YA=&EO;G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3$Q+C4S(#,S,BXP,"!49" H("D@5&H@150@40IQ(# @
M," P(')G($)4(#4Q-"XP," S,S(N,# @5&0@*%0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U,3DN-#(@,S,R+C P(%1D("AO<&EC("D@5&H@150@40IQ(# @
M," P(')G($)4(#4S.2XS," S,S(N,# @5&0@*&]F("D@5&H@150@40IQ(# @
M," P(')G($)4(#4U,"XR.2 S,S(N,# @5&0@*'1H92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S(P+C P(%1D
M("A&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30N,S(@,S(P+C P(%1D("A!
M4T(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S4N.# @,S(P+C P(%1D("A!
M4T,L("D@5&H@150@40IQ(# @," P(')G($)4(#$P,"XS-B S,C N,# @5&0@
M*'5S:6YG("D@5&H@150@40IQ(# @," P(')G($)4(#$R-"XV,R S,C N,# @
M5&0@*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,SDN-#4@,S(P+C P
M(%1D("AA8W%U:7-I=&EO;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#4N
M.30@,S(P+C P(%1D("AM971H;V0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C$X+C4T(#,R,"XP,"!49" H;V8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C(Y+C0W(#,R,"XP,"!49" H86-C;W5N=&EN9RX@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C<X+C0U(#,R,"XP,"!49" H55-2)W,@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S V+C(P(#,R,"XP,"!49" H<F5S=6QT<R I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,S0N.3$@,S(P+C P(%1D("AO9B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-#4N.#4@,S(P+C P(%1D("AO<&5R871I;VYS
M("D@5&H@150@40IQ(# @," P(')G($)4(#,Y,"XQ," S,C N,# @5&0@*&%R
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#0N.3(@,S(P+C P(%1D("AI
M;F-L=61E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#$N.34@,S(P+C P
M(%1D("AI;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3(N,S0@,S(P+C P
M(%1D("AT:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8W+C$V(#,R,"XP
M,"!49" H8V]N<V]L:61A=&5D("D@5&H@150@40IQ(# @," P(')G($)4(#4R
M,"XS," S,C N,# @5&0@*'-T871E;65N=',@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,P."XP,"!49" H;V8@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C N,3D@,S X+C P(%1D("AO<&5R
M871I;VYS("D@5&H@150@40IQ(# @," P(')G($)4(#$P-"XR," S,#@N,# @
M5&0@*&9R;VT@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(V+C P(#,P."XP
M,"!49" H1&5C96UB97(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38Y+C0T
M(#,P."XP,"!49" H,2P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<Y+C,P
M(#,P."XP,"!49" H,C Q-B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#$N
M-C8@,S X+C P(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X
M+C0V(#,P."XP,"!49" H:&%V92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,SDN-CD@,S X+C P(%1D("AB965N("D@5&H@150@40IQ(# @," P(')G($)4
M(#(V,"XY,R S,#@N,# @5&0@*&EN8VQU9&5D("D@5&H@150@40IQ(# @," P
M(')G($)4(#(Y-RXW,B S,#@N,# @5&0@*&EN("D@5&H@150@40IQ(# @," P
M(')G($)4(#,P-RXX-2 S,#@N,# @5&0@*'1H92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,C(N-#,@,S X+C P(%1D("A#;VUP86YY)W,@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S8Y+C,W(#,P."XP,"!49" H3G5R<V4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,SDU+C8Q(#,P."XP,"!49" H86YD("D@5&H@
M150@40IQ(# @," P(')G($)4(#0Q,2XX." S,#@N,# @5&0@*$%L;&EE9" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,SDN,C0@,S X+C P(%1D("A3=&%F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4U+C$W(#,P."XP,"!49" H9FEN
M9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-S,N-C,@,S X+C P(%1D("AB
M=7-I;F5S<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#DN.#@@,S X+C P
M(%1D("AS96=M96YT+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#@N,#<@
M,S X+C P(%1D("A3964@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(Y-BXP,"!49" H3F]T92 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" W,2XT-" R.38N,# @5&0@*#4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-S@N.30@,CDV+C P(%1D("@M("D@5&H@150@40IQ(# @
M," P(')G($)4(#@T+C<W(#(Y-BXP,"!49" H1V]O9'=I;&PL("D@5&H@150@
M40IQ(# @," P(')G($)4(#$R-RXS-R R.38N,# @5&0@*%0I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,S,N,3(@,CDV+C P(%1D("AR861E("D@5&H@150@
M40IQ(# @," P(')G($)4(#$U,BXX,R R.38N,# @5&0@*$YA;65S+" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q.#4N-C @,CDV+C P(%1D("AA;F0@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C R+C4T(#(Y-BXP,"!49" H3W1H97(@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(W+C@Q(#(Y-BXP,"!49" H26YT
M86YG:6)L92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S N,S @,CDV+C P
M(%1D("A!<W-E=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDX+CDQ(#(Y
M-BXP,"!49" H86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,Q-2XX-2 R
M.38N,# @5&0@*$YO=&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,W+C<Y
M(#(Y-BXP,"!49" H,3 @*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S4P+C(Y
M(#(Y-BXP,"!49" H+2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-38N,3(@
M,CDV+C P(%1D("A&86ER("D@5&H@150@40IQ(# @," P(')G($)4(#,W-"XU
M-" R.38N,# @5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.# N-C8@
M,CDV+C P(%1D("AA;'5E("D@5&H@150@40IQ(# @," P(')G($)4(#,Y.2XX
M,2 R.38N,# @5&0@*$UE87-U<F5M96YT<RXI(%1J($54(%$*0E0@+T8S(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C<V+C P(%1D("A-961I
M<V-A;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," R-3(N,# @5&0@*$]N($]C=&]B97(@,S L(#(P,34L('1H92!#
M;VUP86YY(&-O;7!L971E9"!T:&4@86-Q=6ES:71I;VX@;V8@86QL(&]F('1H
M92!M96UB97)S:&EP(&EN=&5R97-T<R!O9B!.97<@365D:7-C86X@24DL($Q,
M0RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#(T,"XP,"!49" H365D:7-C86X@1&EA9VYO<W1I8R!397)V:6-E
M<RP@3$Q#+"!A;F0@365D:7-C86X@3G5R<VEN9R!3=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S X+C0S(#(T,"XP,"!49" H9FEN9RP@3$Q#(%PH8V]L
M;&5C=&EV96QY($UE9&ES8V%N7"D@9F]R(&$@<'5R8VAA<V4@<')I8V4@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(R."XP,"!49" H)#(Y+CD@;6EL;&EO;BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,#,N,SD@,C(X+C P(%1D("@@
M:6X@8V%S:"!<*"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q,SDN-S<@,C(X+C P(%1D("@D,C@N,"!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y,RXV-B R
M,C@N,# @5&0@*"!P;'5S('=O<FMI;F<@8V%P:71A;"!E<W1I;6%T95PI(&%N
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S,V+C0P(#(R."XP,"!49" H)#0N-R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X-2XR.2 R,C@N,# @5&0@
M*"!I;B!S:&%R97,@7"AO<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#,Y+C<R(#(R."XP,"!49" H,S0Y+#@W,2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S(N,C(@
M,C(X+C P(%1D("@@<VAA<F5S7"D@;V8@=&AE("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,38N,# @5&0@*$-O
M;7!A;GDG<R!#;VUM;VX@4W1O8VLL(&%N9"!A(&YE="!W;W)K:6YG(&-A<&ET
M86P@861J=7-T;65N="!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S(T+C@W(#(Q-BXP,"!49" H)# N,RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#(N,S<@,C$V
M+C P(%1D("@@;6EL;&EO;B!W87,@<V5T=&QE9"!I;B!T:&4@9FER<W0@<75A
M<G1E<B!O9B R,#$V+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,C T+C P(%1D("A!9&1I=&EO;F%L;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Y.2XT," R,#0N,# @5&0@*"P@86X@86UO
M=6YT(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q-3DN-C<@,C T+C P(%1D("@D-2XP(&UI;&QI;VXI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C X+C4V(#(P-"XP
M,"!49" H(&]F('1H92!P=7)C:&%S92!P<FEC92!T:&%T('=A<R!H96QD(&EN
M(&5S8W)O=R!T;R!C;W9E<B!A;GD@<&]S="UC;&]S:6YG(&QI86)I;&ET:65S
M+"!W87,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#$Y,BXP,"!49" H<F5L96%S960@=&\@=&AE('-E;&QE<G,@
M;VX@36%Y(#,L(#(P,3<N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#$W,BXP,"!49" H5&AE(&%G<F5E;65N="!A
M;'-O('-P96-I9FEE9"!T:&%T('1H92!S96QL97)S('=E<F4@96QI9VEB;&4@
M=&\@<F5C96EV92!A9&1I=&EO;F%L('!U<F-H87-E('!R:6-E(&-O;G-I9&5R
M871I;VX@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y-2XT,B Q-S(N,# @5&0@*"0W+C @;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#0N,S$@,3<R
M+C P(%1D("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," Q-C N,# @5&0@*'=I=&@@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8Y+C<X(#$V,"XP,"!49" H
M)#,N-2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Q."XV-R Q-C N,# @5&0@*"!P97(@>65A<B!B87-E9"!O
M;B!A='1A:6YM96YT(&]F('-P96-I9FEC('!E<F9O<FUA;F-E(&-R:71E<FEA
M(&EN(#(P,38@86YD(#(P,3<N("D@5&H@150@40IQ(# @," P(')G($)4(#0T
M,2XP-" Q-C N,# @5&0@*$%S(&]F($1E8V5M8F5R(#,Q+" R,#$V+"!T:&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$T."XP,"!49" H0V]M<&%N>2!D971E<FUI;F5D('1H870@=&AE(&9I
M<G-T('EE87(@96%R;F]U="!W87,@;F]T(&%C:&EE=F5D(&9O<B R,#$V(&%N
M9"P@87,@;V8@4V5P=&5M8F5R(#,P+" R,#$W+"!T:&4@0V]M<&%N>2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M,S8N,# @5&0@*&1E=&5R;6EN960@=&AA="!T:&4@<V5C;VYD('EE87(@96%R
M;F]U="!W;W5L9"!N;W0@8F4@86-H:65V960@9F]R(#(P,3<N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Q,BXP
M,"!49" H26X@8V]N;F5C=&EO;B!W:71H('1H92!-961I<V-A;B!A8W%U:7-I
M=&EO;BP@=&AE($-O;7!A;GD@86QS;R!A<W-U;65D(&%D9&ET:6]N86P@8V]N
M=&EN9V5N="!P=7)C:&%S92!P<FEC92!L:6%B:6QI=&EE<R!F;W(@82 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3 P+C P(%1D("AP<F5V:6]U<VQY(&%C<75I<F5D(&)U<VEN97-S('1H870@
M87)E('!A>6%B;&4@86YN=6%L;'D@8F%S960@;VX@<W!E8VEF:6,@<&5R9F]R
M;6%N8V4@8W)I=&5R:6$@9F]R('1H92 R,#$V('1H<F]U9V@@,C Q.2!Y96%R
M<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#@X+C P(%1D("A087EM96YT<R!R96QA=&5D('1O('1H92 R,#$V
M('1H<F]U9V@@,C Q."!Y96%R<R!A<F4@;&EM:71E9"!T;R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S S+C8Q(#@X+C P
M(%1D("@D,"XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S4R+C4P(#@X+C P(%1D("@@<&5R('EE87(@86YD
M(#(P,3D@:7,@=6YC87!P960N("D@5&H@150@40IQ(# @," P(')G($)4(#0X
M,2XS-2 X."XP,"!49" H07,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P-2XW.2 X."XP,"!49" H1&5C96UB97*@
M,S$L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," W-BXP,"!49" H,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" V.2XU," W-BXP,"!49" H+"!T:&4@9F%I
M<B!V86QU92!O9B!T:&4@<F5M86EN:6YG(&]B;&EG871I;VYS('=A<R!E<W1I
M;6%T960@870@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Q,RXX-R W-BXP,"!49" H)#<N-R!M:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,BXW-B W-BXP
M,"!49" H(&%N9"!I<R!I;F-L=61E9"!I;B!O=&AE<B!C=7)R96YT(&QI86)I
M;&ET:65S(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-C0N,# @5&0@*&-O;G1I;F=E;G0@8V]N<VED97)A
M=&EO;B!O;B!T:&4@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE971S+B!3964@
M3F]T92 Q," M($9A:7(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8X+CDU
M(#8T+C P(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<U+C V(#8T
M+C P(%1D("AA;'5E($UE87-U<F5M96YT<RXI(%1J($54(%$*96YD<W1R96%M
M"F5N9&]B:@HQ-#,@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q-#0@,"!2/CX*96YD;V)J"C$T-" P
M(&]B:@H\/"],96YG=&@@,C T,3@^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]5
M3E12*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H
M62D@5&H@150@40IQ(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(
M14%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H
M5$A#05)%+"!)3D,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$W-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ
M(# @," P(')G($)4(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@
M150@40IQ(# @," P(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!
M3D-)04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D
M("@@4U0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D
M("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H
M5$5-14Y44RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-3@N,S4@-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W
M,3(N-S4@5&0@*#0N("D@5&H@150@40IQ(# @," P(')G($)4(#4Y+C0U(#<Q
M,BXW-2!49" H06-Q=6ES:71I;VYS(%PH8V]N=&EN=65D7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDU+C,P(#,S+C8P
M(%1D("A&+2 R,2D@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," V.34N,C4@5&0@*$UE9&EC86P@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@.#4N,S,@-CDU+C(U(%1D("A3=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3 Q+C@Q(#8Y-2XR-2!49" H9FEN9R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,C N.3@@-CDU+C(U(%1D("A.971W;W)K*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W
M,2XR-2!49" H3VX@2G5N92 S,"P@,C Q-"P@=&AE($-O;7!A;GD@86-Q=6ER
M960@<W5B<W1A;G1I86QL>2!A;&P@;V8@=&AE(&%S<V5T<R!A;F0@8V5R=&%I
M;B!L:6%B:6QI=&EE<R!O9B!-961I8V%L(%-T868I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T.#,N,S@@-C<Q+C(U(%1D("AF:6YG($YE='=O<FL@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8U
M.2XR-2!49" H2&5A;'1H8V%R92P@3$Q#(%PH35-.7"DN($]F('1H92!P=7)C
M:&%S92!P<FEC92P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(T,RXS,2 V-3DN,C4@5&0@*"0R+C4@;6EL;&EO;BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.3(N,C$@
M-C4Y+C(U(%1D("@@=V%S(&1E9F5R<F5D(&%N9"!D=64@=&\@=&AE('-E;&QE
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#,Q+C4Y(#8U.2XR-2!49" H,C$@;6]N=&AS*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,RXU-" V-3DN,C4@5&0@*"!F
M<F]M('1H92!A8W%U:7-I=&EO;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-C0W+C(U(%1D("AD871E+"!L97-S
M(&%N>2!#3T)202D@5&H@150@40IQ(# @," P(')G($)4(#$S.2XU," V-#<N
M,C4@5&0@*"!E>'!E;G-E<R!I;F-U<G)E9"!B>2!T:&4@0V]M<&%N>2!O;B!B
M96AA;&8@;V8@9F]R;65R($U33B!E;7!L;WEE97,@;W9E<B!T:&%T('!E<FEO
M9"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3 S+C$P(#8T-RXR-2!49" H
M5&AE($-O;7!A;GD@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#8S-2XR-2!49" H:6YC=7)R960@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C,R(#8S-2XR
M-2!49" H)# N-"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$S-"XR,2 V,S4N,C4@5&0@*"!I;B!#3T)202D@
M5&H@150@40IQ(# @," P(')G($)4(#$X,"XX.2 V,S4N,C4@5&0@*"!E>'!E
M;G-E<R!S:6YC92!T:&4@35-.(&%C<75I<VET:6]N(&%N9"P@;VX@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S8Q+C8Y(#8S-2XR-2!49" H07!R:6P@,2P@
M,C Q-BP@<F5L96%S960@=&\@=&AE('-E;&QE<B!T:&4@<F5M86EN:6YG("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," V,C,N,C4@5&0@*&QI86)I;&ET>2!O9B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@.3,N.30@-C(S+C(U(%1D("@D,BXQ
M(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,30R+C@S(#8R,RXR-2!49" H+BD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.3DN,C4@5&0@*#4N($=O
M;V1W:6QL+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#,N,C(@-3DY+C(U
M(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 Y+C$T(#4Y.2XR-2!4
M9" H<F%D92!.86UE<RP@86YD($]T:&5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C X+CDU(#4Y.2XR-2!49" H($EN=&%N9VEB;&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C4W+C,P(#4Y.2XR-2!49" H07-S971S*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4W-2XR
M-2!49" H5&AE($-O;7!A;GD@:&%D('1H92!F;VQL;W=I;F<@86-Q=6ER960@
M:6YT86YG:6)L92!A<W-E=',Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#4V,RXR-2!49" HH"D@5&H@150@40HP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," T.30N
M-S4@,3$Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,38Y+C P(#0Y-"XW-2 S.30N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,"XP," T-34N-S4@,3$Y+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,38Y+C P
M(#0U-2XW-2 U-RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(R-BXP," T-34N-S4@-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C(S,"XP," T-34N-S4@-C4N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.34N
M,# @-#4U+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR.3DN,# @-#4U+C<U(#8U+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S8T+C P(#0U-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8X
M+C P(#0U-2XW-2 U-RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-2XP," T-34N-S4@-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0R.2XP," T-34N-S4@-C4N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.30N,# @-#4U+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3@N,# @-#4U+C<U(#8U
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3 N,# @-#(U+C<U(#$Q.2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C$V.2XP," T,C4N-S4@-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,C8N,# @-#(U+C<U
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHR,S N,# @-#(U+C<U(#8U+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,CDU+C P(#0R-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,CDY+C P(#0R-2XW
M-2 V-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,V-"XP," T,C4N-S4@-"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,V."XP," T,C4N-S4@-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C4N,# @-#(U
M+C<U(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,CDN,# @-#(U+C<U(#8U+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DT+C P(#0R-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DX+C P(#0R
M-2XW-2 V-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#,Y-2XW-2 Q,3DN,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHQ-CDN,# @,SDU+C<U(#4W+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C(V+C P
M(#,Y-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C,P+C P(#,Y-2XW-2 V-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C(Y-2XP," S.34N-S4@-"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(Y.2XP
M," S.34N-S4@-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-C0N,# @,SDU+C<U(#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-C@N,# @,SDU+C<U(#4W+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(U
M+C P(#,Y-2XW-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(Y+C P(#,Y-2XW-2 V-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y-"XP," S.34N-S4@-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M."XP," S.34N-S4@-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," S-38N-S4@,3$Y
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,38Y+C P(#,U-BXW-2 U-RXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C(R-BXP," S-38N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(S,"XP," S-38N-S4@
M-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHR.34N,# @,S4V+C<U(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHR.3DN,# @,S4V+C<U(#8U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8T+C P(#,U-BXW
M-2 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S8X+C P(#,U-BXW-2 U-RXP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0R-2XP," S-38N-S4@-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R.2XP," S-38N
M-S4@-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.30N,# @,S4V+C<U(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.3@N,# @,S4V+C<U(#8U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,38Y(#4S-RXW-2!M"C(R-B U,S<N-S4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(R-B U,S<N-S4@
M;0HR,S @-3,W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HR,S @-3,W+C<U(&T*,CDU(#4S-RXW-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,CDU(#4S-RXW-2!M"C(Y.2 U,S<N-S4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(Y.2 U,S<N
M-S4@;0HS-C0@-3,W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-C@@-3,W+C<U(&T*-#(U(#4S-RXW
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#(U(#4S-RXW-2!M"C0R.2 U,S<N-S4@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R.2 U
M,S<N-S4@;0HT.30@-3,W+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.30@-3,W+C<U(&T*-#DX(#4S
M-RXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DX(#4S-RXW-2!M"C4V,R U,S<N-S4@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$V
M.2 T.30N-S4@;0HR,C8@-#DT+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR,S @-#DT+C<U(&T*,CDU
M(#0Y-"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,CDY(#0Y-"XW-2!M"C,V-" T.30N-S4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,V." T.30N-S4@;0HT,C4@-#DT+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,CD@-#DT+C<U(&T*
M-#DT(#0Y-"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#DX(#0Y-"XW-2!M"C4V,R T.30N-S4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C$V.2 S.34N-S4@;0HR,C8@,SDU+C<U(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR,S @,SDU+C<U
M(&T*,CDU(#,Y-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,CDY(#,Y-2XW-2!M"C,V-" S.34N-S4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,V." S.34N-S4@;0HT,C4@,SDU+C<U(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,CD@,SDU
M+C<U(&T*-#DT(#,Y-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DX(#,Y-2XW-2!M"C4V,R S.34N
M-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C$V.2 S.34N-S4@;0HR,C8@,SDU+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HQ-CD@
M,S@Q+C<U(&T*,C(V(#,X,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,38Y(#,W.2XW-2!M"C(R-B S
M-SDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C(S," S.34N-S4@;0HR.34@,SDU+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR
M,S @,S@Q+C<U(&T*,CDU(#,X,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C,P(#,W.2XW-2!M"C(Y
M-2 S-SDN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,V." S.#$N-S4@;0HT,C4@,S@Q+C<U(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-C@@,S<Y+C<U(&T*-#(U(#,W.2XW-2!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(Y(#,X,2XW-2!M
M"C0Y-" S.#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0R.2 S-SDN-S4@;0HT.30@,S<Y+C<U(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HR.3D@,S0Q+C<U(&T*,S8T(#,T,2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DX(#,T,2XW
M-2!M"C4V,R S-#$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(Y.2 S,C<N-S4@;0HS-C0@,S(W+C<U
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HR.3D@,S(U+C<U(&T*,S8T(#,R-2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DX(#,R
M-RXW-2!M"C4V,R S,C<N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y." S,C4N-S4@;0HU-C,@,S(U
M+C<U(&P*<PI"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU
M," U-#(N-#(@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C(U+C8U(#4T,BXT,R!49" H1&5C96UB97(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R-C@N.#<@-30R+C0S(%1D("@@,S$L(#(P,3@I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(T
M+C8U(#4T,BXT,R!49" H1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-C<N.#<@-30R+C0S(%1D("@@,S$L(#(P,3<I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-#DY+C0R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X
M-"XU-2 U,3DN-#,@5&0@*$=R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3DV
M+C8X(#4Q.2XT,R!49" H;W-S*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$W-RXR-2 U,#DN-#,@5&0@*$-A<G)Y:6YG*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W.2XT
M-2 T.3DN-#,@5&0@*$%M;W5N="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R,S,N-C4@-3 Y+C0S(%1D("A!8V-U;75L871E
M9"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,S,N,S4@-#DY+C0S(%1D("A!;6]R=&EZ871I;VXI(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S(S+C4P(#4Q.2XT,R!49" H
M3F5T*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,Q,2XR-2 U,#DN-#,@5&0@*$-A<G)Y:6YG*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q,RXT-2 T.3DN-#,@5&0@*$%M
M;W5N="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S.#,N-34@-3$Y+C0S(%1D("A'<BD@5&H@150@40IQ(# @," P(')G($)4
M(#,Y-2XV." U,3DN-#,@5&0@*&]S<RD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-S8N,C4@-3 Y+C0S(%1D("A#87)R>6EN
M9RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-S@N-#4@-#DY+C0S(%1D("A!;6]U;G0I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#,R+C8U(#4P.2XT,R!49" H06-C=6UU
M;&%T960I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#,R+C,U(#0Y.2XT,R!49" H06UO<G1I>F%T:6]N*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R,BXU," U,3DN-#,@
M5&0@*$YE="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,3 N,C4@-3 Y+C0S(%1D("A#87)R>6EN9RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3(N-#4@-#DY+C0S(%1D
M("A!;6]U;G0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,C,N-3 @-#@T+C(Q(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3(N-3 @-#<P+C,R(%1D("A);G1A;F=I8FQE(&%S<V5T<R!S=6)J96-T('1O
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C4P(#0V,"XS,B!49" H86UO<G1I>F%T:6]N.BD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3<N,# @-#8P+C0S(%1D("B@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(V
M,BXP," T-C N-#,@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S,Q+C P(#0V,"XT,R!49" HH"D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.38N,# @-#8P+C0S
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0S,2XU," T-C N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 P+C4P(#0V,"XT,B!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," T
M-#4N-#(@5&0@*$1A=&%B87-E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q-S$N-3 @-#0U+C0R(%1D("@D*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y-"XV-2 T-#4N
M-#(@5&0@*#,P+#4S,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" R,S(N-3 @-#0U+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(V."XV-2 T-#4N-#(@5&0@
M*#DL,C$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,P,2XU," T-#4N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S,R+C8U(#0T-2XT,B!49" H,C$L,S$T
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W
M,"XU," T-#4N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,SDS+C8U(#0T-2XT,B!49" H-#(L.3 Y*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XU," T
M-#4N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#8R+C8U(#0T-2XT,B!49" H,3@L-S R*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P,"XU," T-#4N-#(@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,Q+C8U(#0T-2XT,B!49" H,C0L,C W*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P(#0S,"XT,B!49" H0W5S
M=&]M97(@<F5L871I;VYS:&EP<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q.30N-C4@-#,P+C0R(%1D("@T.2PW-3@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8S+C8U
M(#0S,"XT,B!49" H,C,L,CDV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,S,BXV-2 T,S N-#(@5&0@*#(V+#0V,BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3,N-C4@
M-#,P+C0R(%1D("@U-2PU,C0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#8R+C8U(#0S,"XT,B!49" H,C4L.3$R*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XV-2 T
M,S N-#(@5&0@*#(Y+#8Q,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U."XU," T,34N-#(@5&0@*$YO;BUC;VUP971E(&%G
M<F5E;65N=',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C W+C$U(#0Q-2XT,B!49" H,S(P*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X,2XQ-2 T,34N-#(@5&0@*#DW
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T
M-2XQ-2 T,34N-#(@5&0@*#(R,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.3@N-C4@-#$U+C0R(%1D("@S+#DQ.2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N-C4@
M-#$U+C0R(%1D("@S+#8P,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#0N,34@-#$U+C0R(%1D("@S,3DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @-# P+C0R
M(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C0N-#,@-# P+C0R(%1D
M("AR861E(&YA;65S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Y.2XV-2 T,# N-#(@5&0@*#@L.#<Y*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(V."XV-2 T,# N-#(@
M5&0@*#$L-CDV*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,S-RXV-2 T,# N-#(@5&0@*#<L,3@S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y."XV-2 T,# N-#(@5&0@
M*#<L-S$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0W-2XQ-2 T,# N-#(@5&0@*#@W."D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N-C4@-# P+C0R(%1D("@V+#@S
M."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,BXU," S.#4N-#(@5&0@*$]T:&5R(&EN=&%N9VEB;&4@87-S971S+"!N970I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<Q
M+C4P(#,X-2XT,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q.30N-C4@,S@U+C0R(%1D("@X.2PT.#<I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,R+C4P(#,X
M-2XT,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R-C,N-C4@,S@U+C0R(%1D("@S-"PS,#4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,R+C8U(#,X-2XT,B!4
M9" H-34L,3@R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,W,"XU," S.#4N-#(@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S@X+C8U(#,X-2XT,B!49" H,2D@
M5&H@150@40IQ(# @," P(')G($)4(#,Y,RXV-2 S.#4N-#(@5&0@*#$P+# V
M."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,S$N-3 @,S@U+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0V,BXV-2 S.#4N-#(@5&0@*#0Y+# Y,BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N-C4@
M,S@U+C0R(%1D("@V,"PY-S8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N-3 @,S<Q+C,R(%1D("A);G1A;F=I8FQE(&%S
M<V5T<R!N;W0@<W5B:F5C="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,BXU," S-C$N,S(@5&0@*'1O(&%M;W)T:7IA=&EO
M;CHI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C(R+C4P(#,V,2XT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.3$N-3 @,S8Q+C0R(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,"XU," S-C$N
M-#(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#(Q+C4P(#,V,2XT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.3 N-3 @,S8Q+C0R(%1D("B@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XU
M," S-C$N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3@N-3 @,S0V+C0R(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-C0N,C8@,S0V+C0R(%1D("AR861E(&YA;65S*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R,BXU," S-#8N
M-#(@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,CDQ+C4P(#,T-BXT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,S(N-C4@,S0V+C0R(%1D("@R,"PT
M,#(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#(Q+C4P(#,T-BXT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.3 N-3 @,S0V+C0R(%1D("B@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XV-2 S-#8N
M-#(@5&0@*#(V+#<P,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,BXU," S,S$N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C(R+C4P(#,S,2XT,B!49" H
MH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M.3$N-3 @,S,Q+C0R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P,2XU," S,S$N-#(@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,R+C8U(#,S,2XT
M,B!49" H-S4L-3@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0R,2XU," S,S$N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C4P(#,S,2XT,B!49" H
MH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,# N-3 @,S,Q+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S,2XV-2 S,S$N-#(@5&0@*#@W+#8W."D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,S$U+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,P,RXR-2!49" H
M26X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C N,S0@,S S+C(U(%1D("@R
M,#$X+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-2XS-" S,#,N,C4@5&0@
M*&9U;&QY("D@5&H@150@40IQ(# @," P(')G($)4(#$P-BXW-" S,#,N,C4@
M5&0@*&%M;W)T:7IE9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#DN,C,@
M,S S+C(U(%1D("AI;G1A;F=I8FQE("D@5&H@150@40IQ(# @," P(')G($)4
M(#$Y,2XW,B S,#,N,C4@5&0@*&%S<V5T<RP@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C(P+C V(#,P,RXR-2!49" H86QO;F<@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C0T+C<Y(#,P,RXR-2!49" H=VET:" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-C4N,#<@,S S+C(U(%1D("AT:&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C<Y+C@P(#,P,RXR-2!49" H<F5L871E9" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,#DN-3 @,S S+C(U(%1D("AA8V-U;75L871E
M9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C(N-30@,S S+C(U(%1D("AA
M;6]R=&EZ871I;VXL("D@5&H@150@40IQ(# @," P(')G($)4(#0Q."XP." S
M,#,N,C4@5&0@*'=E<F4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#0P+C R
M(#,P,RXR-2!49" H<F5M;W9E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-S<N-3$@,S S+C(U(%1D("AF<F]M("D@5&H@150@40IQ(# @," P(')G($)4
M(#0Y.2XT-B S,#,N,C4@5&0@*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,30N,3@@,S S+C(U(%1D("AT86)L92 I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,S8N,3(@,S S+C(U(%1D("AA8F]V92X@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(Y,2XR-2!49" H
M07,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C,N,3$@,CDQ+C(U(%1D("AO
M9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-S,N.30@,CDQ+C(U(%1D("A$96-E;6)E<J S,2P@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3,R+C4S(#(Y,2XR-2!49" H,C Q."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-3(N-3,@,CDQ+C(U(%1D
M("@L("D@5&H@150@40IQ(# @," P(')G($)4(#$U-RXU,R R.3$N,C4@5&0@
M*&5S=&EM871E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3@N,S4@,CDQ
M+C(U(%1D("AA;FYU86P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(W+C4P
M(#(Y,2XR-2!49" H86UO<G1I>F%T:6]N("D@5&H@150@40IQ(# @," P(')G
M($)4(#(X,"XU-" R.3$N,C4@5&0@*&5X<&5N<V4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S$U+C(U(#(Y,2XR-2!49" H:7,@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S(T+C0R(#(Y,2XR-2!49" H87,@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S,U+C(U(#(Y,2XR-2!49" H9F]L;&]W<SHI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C<Y+C(U
M(%1D("B@*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C P(#(V."XW-2 T,C$N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-S$N,# @
M,C8X+C<U(#DR+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @,C,X+C<U(#0R,2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0W,2XP," R,S@N-S4@.3(N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP
M," R,#@N-S4@-#(Q+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#<Q+C P(#(P."XW-2 Y,BXP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C P(#$W."XW-2 T,C$N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-S$N,# @,3<X+C<U(#DR+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<Q
M(#$V,RXW-2!M"C4V,R Q-C,N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0W,2 Q-#DN-S4@;0HU-C,@
M,30Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-S$@,30W+C<U(&T*-38S(#$T-RXW-2!L"G,*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,C4X+C0S(%1D
M("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-C$@,C4X+C0S(%1D("AE
M87)S($5N9&EN9R!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#$U
M-2XV-" R-3@N-#,@5&0@** S,3HI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-S0N-3 @,C4X+C(Q(%1D("A<*&%M;W5N=',@
M:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(N-3 @,C0S+C0R(%1D("@R,#$Y*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,RXU," R-#,N-#(@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3,V+C8U(#(T,RXT,B!49" H-RPU,S4I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,C(X+C0R(%1D("@R,#(P
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M-BXV-2 R,C@N-#(@5&0@*#<L-#,Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C4P(#(Q,RXT,B!49" H,C R,2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N-C4@
M,C$S+C0R(%1D("@W+#$S,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,BXU," Q.3@N-#(@5&0@*#(P,C(I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C8U(#$Y."XT
M,B!49" H-BPW.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3(N-3 @,3@S+C0R(%1D("@R,#(S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-BXV-2 Q.#,N-#(@5&0@
M*#8L-C<W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4R+C4P(#$V."XT,B!49" H5&AE<F5A9G1E<BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N-C4@,38X+C0R(%1D
M("@Q.2PV,C@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @,34S+C0R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W,RXU," Q-3,N-#(@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C8U
M(#$U,RXT,B!49" H-34L,3@R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,S<N
M,C4@5&0@** I(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ-#4@,"!O8FH*
M/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q
M,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT
M96YT<R Q-#8@,"!2/CX*96YD;V)J"C$T-B P(&]B:@H\/"],96YG=&@@,3@Y
M-CD^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ(# @," P
M(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS," W
M-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU
M,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@
M-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G($)4
M(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,V+C<U
M(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#4N($=O;V1W
M:6QL+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#,N-S(@-S$R+C<U(%1D
M("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 Y+C8T(#<Q,BXW-2!49" H
M<F%D92!.86UE<RP@86YD($]T:&5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C Y+C0U(#<Q,BXW-2!49" H($EN=&%N9VEB;&4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C4W+C@P(#<Q,BXW-2!49" H07-S971S(%PH8V]N=&EN=65D
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,CDU+C,P(#,S+C8P(%1D("A&+2 R,BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @5&0@*%1H92!C:&%N
M9V5S(&EN('1H92!C87)R>6EN9R!A;6]U;G0@;V8@9V]O9'=I;&P@8GD@<V5G
M;65N="!A<F4@87,@9F]L;&]W<SJ@*2!4:B!%5"!1"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#8R-2XV," R,#$N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHR-3$N,# @-C(U+C8P(#,Q,BXP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P
M(#4Y-2XV," R,#$N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-3$N,# @-3DU+C8P(#<U+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S(V+C P(#4Y-2XV," T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,P
M+C P(#4Y-2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-2XP," U.34N-C @-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0P.2XP," U.34N-C @-S4N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.#0N,# @-3DU+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @-3DU+C8P(#<U
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3 N,# @-38U+C8P(#(P,2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C(U,2XP," U-C4N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,C8N,# @-38U+C8P
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHS,S N,# @-38U+C8P(#<U+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-# U+C P(#4V-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#4V-2XV
M," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," U-C4N-C @-"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0X."XP," U-C4N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," U,S4N
M-C @,C Q+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,C4Q+C P(#4S-2XV," W-2XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,R-BXP," U,S4N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,S,"XP," U
M,S4N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @-3,U+C8P(#0N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT,#DN,# @-3,U+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@T+C P
M(#4S-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C P(#4S-2XV," W-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P+C P(#4P-2XV," R,#$N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-3$N
M,# @-3 U+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S(V+C P(#4P-2XV," T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S,P+C P(#4P-2XV," W-2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P
M-2XP," U,#4N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P.2XP," U,#4N-C @-S4N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.#0N,# @-3 U+C8P(#0N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.#@N,# @-3 U+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-#<U+C8P(#(P
M,2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C(U,2XP," T-S4N-C @-S4N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS,C8N,# @-#<U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,S N,# @-#<U+C8P
M(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-# U+C P(#0W-2XV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-# Y+C P(#0W-2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," T-S4N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," T-S4N-C @-S4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XP," T-#4N-C @,C Q+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C4Q+C P(#0T
M-2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,R-BXP," T-#4N-C @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,S,"XP," T-#4N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @
M-#0U+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#DN,# @-#0U+C8P(#<U+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#@T+C P(#0T-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C P
M(#0T-2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#0Q-2XV," R,#$N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHR-3$N,# @-#$U+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S(V
M+C P(#0Q-2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,P+C P(#0Q-2XV," W-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0P-2XP," T,34N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P
M.2XP," T,34N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#0N,# @-#$U+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.#@N,# @-#$U+C8P(#<U+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,C4Q(#8R-2XV(&T*,S(V(#8R-2XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,S @
M-C(U+C8@;0HT,#4@-C(U+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 V,C4N-B!M"C0X-" V,C4N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#@X(#8R-2XV(&T*-38S(#8R-2XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR-3$@-34P
M+C8@;0HS,C8@-34P+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,S," U-3 N-B!M"C0P-2 U-3 N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-# Y(#4U,"XV(&T*-#@T(#4U,"XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@-34P+C8@
M;0HU-C,@-34P+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C(U,2 T-S4N-B!M"C,R-B T-S4N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,S,P(#0W-2XV(&T*-# U(#0W-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,#D@-#<U+C8@;0HT
M.#0@-#<U+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0X." T-S4N-B!M"C4V,R T-S4N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,C4Q(#0P,"XV(&T*,S(V(#0P,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,S @-# P+C8@;0HT,#4@
M-# P+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0P.2 T,# N-B!M"C0X-" T,# N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@X
M(#0P,"XV(&T*-38S(#0P,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR-3$@,S@V+C8@;0HS,C8@,S@V
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C(U,2 S.#0N-B!M"C,R-B S.#0N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S,P(#,X
M-BXV(&T*-# U(#,X-BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,S @,S@T+C8@;0HT,#4@,S@T+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0P.2 S.#8N-B!M"C0X-" S.#8N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#,X-"XV
M(&T*-#@T(#,X-"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HT.#@@,S@V+C8@;0HU-C,@,S@V+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0X." S.#0N-B!M"C4V,R S.#0N-B!L"G,*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N-3 @-C,P+C(W(%1D("B@*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(V-2XY," V-3 N
M,C@@5&0@*$YU<G-E(&%N9"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R-3<N,# @-C0P+C(X(%1D("A!;&QI960@4W1A9F9I
M;F<I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C8Y+C8U(#8S,"XR."!49" H4V5G;65N="D@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S-#8N-# @-C4P+C(X(%1D("A0:'ES
M:6-I86XI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S4P+C U(#8T,"XR."!49" H4W1A9F9I;F<I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0X+C8U(#8S,"XR."!49" H
M4V5G;65N="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,34N.34@-C<P+C(X(%1D("A/=&AE<BD@5&H@150@40IQ(# @," P
M(')G($)4(#0T,2XS,B V-S N,C@@5&0@*"!(=6UA;BD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N,34@-C8P+C(X(%1D
M("A#87!I=&%L*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Q-RXY-2 V-3 N,C@@5&0@*$UA;F%G96UE;G0I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(X+C4P(#8T,"XR
M."!49" H4V5R=FEC97,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#(W+C8U(#8S,"XR."!49" H4V5G;65N="D@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,30N,#4@-C,P
M+C(X(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3$Y+C@P(#8S,"XR
M."!49" H;W1A;"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,V-"XU," V,34N,#8@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N
M9'-<*2D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,BXU," V,# N,C@@5&0@*$)A;&%N8V5S(&%S(&]F($1E8V5M8F5R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,34X+C$S(#8P,"XR."!49" H(#,Q+" R
M,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(U,RXU," V,# N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S,R+C4P(#8P,"XR-R!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N-3 @-C P
M+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y,"XU," V,# N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @-3@U+C(W(%1D("A!9V=R
M96=A=&4@9V]O9'=I;&P@86-Q=6ER960I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C4S+C4P(#4X-2XR-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.#DN-C4@
M-3@U+C(W(%1D("@S-#<L.#<S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,S,BXU," U.#4N,C<@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<S+C8U(#4X-2XR
M-R!49" H-#,L-# U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Q,2XU," U.#4N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R+C8U(#4X-2XR-R!49" H
M,3DL,S W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y,"XU," U.#4N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(V+C8U(#4X-2XR-R!49" H-#$P+#4X
M-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M."XU," U-S N,C<@5&0@*%-A;&4@;V8@8G5S:6YE<W,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$R+C$U(#4W,"XR-R!4
M9" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S.3$N,34@-3<P+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0U-"XS," U-S N,S(@5&0@*%PH.2PX.#DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@P
M+C$U(#4W,"XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,S+C,P(#4W,"XS,B!49" H7"@Y+#@X.2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,34@
M-3<P+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U."XU," U-34N,C<@5&0@*$%C8W5M=6QA=&5D(&EM<&%I
M<FUE;G0@;&]S<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R.#8N,S @-34U+C,R(%1D("A<*#(U.2PW,S(I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S(R+C$U(#4U-2XR
M-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S<P+C,P(#4U-2XS,B!49" H7"@R,RPS-S4I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# Q+C$U(#4U-2XR-R!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<P+C$U(#4U-2XR-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,C,N,S @-34U+C,R(%1D("A<*#(X,RPQ
M,#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-34Y+C$U(#4U-2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3@N-3 @-30P+C(W(%1D("A';V]D=VEL;"P@
M;F5T(&]F(&EM<&%I<FUE;G0@;&]S<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.30N-C4@-30P+C(W(%1D("@X."PQ-#$I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<S
M+C8U(#4T,"XR-R!49" H,C L,#,P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0U-RXV-2 U-# N,C<@5&0@*#DL-#$X*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R-BXV
M-2 U-# N,C<@5&0@*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S$N-C4@
M-30P+C(W(%1D("@Q-RPU.#DI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N-3 @-3$P+C(X(%1D("A#:&%N9V5S('1O(&%G
M9W(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C$N-S8@-3$P+C(X(%1D("AE
M9V%T92!G;V]D=VEL;"!I;B R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4X+C4P(#0Y-2XR-R!49" H1V]O9'=I;&P@
M86-Q=6ER960@7"AA7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S W+C$U(#0Y-2XR-R!49" H-CDT*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,2XQ-2 T.34N,C<@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<P+C$U(#0Y-2XR-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U-#0N,34@-#DU+C(W(%1D("@V.30I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @
M-#@P+C(W(%1D("A);7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,C0N-S<@-#@P+C(W(%1D("AG92D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,3(N,34@-#@P+C(W(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W,"XS
M," T.# N,S(@5&0@*%PH,3<L,C(S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P,2XQ-2 T.# N,C<@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,"XQ-2 T
M.# N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3(X+C,P(#0X,"XS,B!49" H7"@Q-RPR,C,I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C$U(#0X,"XR
M-R!49" H7"DI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @-#4P+C(X(%1D("A"86QA;F-E<R!A<R!O9B!$96-E;6)E
M<BD@5&H@150@40IQ(# @," P(')G($)4(#$U."XQ,R T-3 N,C@@5&0@*" S
M,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3@N-3 @-#0R+C(P(#$Q-BXV
M,R M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U."XU," T,S4N
M,C<@5&0@*$%G9W)E9V%T92!G;V]D=VEL;"!A8W%U:7)E9"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.#DN-C4@-#,U+C(W
M(%1D("@S-#@L-38W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,W,RXV-2 T,S4N,C<@5&0@*#0S+#0P-2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3(N-C4@-#,U+C(W
M(%1D("@Q.2PS,#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3(V+C8U(#0S-2XR-R!49" H-#$I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U,S8N-C4@-#,U+C(W(%1D("@Q+#(W.2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," T,C N,C<@5&0@
M*%-A;&4@;V8@8G5S:6YE<W,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S$R+C$U(#0R,"XR-R!49" HERD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3$N,34@-#(P+C(W
M(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0U-"XS," T,C N,S(@5&0@*%PH.2PX.#DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@P+C$U(#0R,"XR-R!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,S+C,P(#0R,"XS,B!49" H7"@Y+#@X.2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,34@-#(P+C(W(%1D("A<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3@N-3 @-#$R+C(P(#$Q.2XY-R M.2XP.2!R
M92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U."XU," T,#4N,C<@5&0@*$%C
M8W5M=6QA=&5D(&EM<&%I<FUE;G0@;&]S<RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R.#8N,S @-# U+C,R(%1D("A<*#(U
M.2PW,S(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S(R+C$U(#0P-2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S<P+C,P(#0P-2XS,B!49" H7"@T,"PU
M.3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-# Q+C$U(#0P-2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#<P+C$U(#0P-2XR-R!49" HERD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C,N,S @-# U
M+C,R(%1D("A<*#,P,"PS,S I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34Y+C$U(#0P-2XR-R!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @,SDP+C(W
M(%1D("A';V]D=VEL;"P@;F5T(&]F(&EM<&%I<FUE;G0@;&]S<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3,N-3 @,SDP
M+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(Y-"XV-2 S.3 N,C<@5&0@*#@X+#@S-2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S(N-3 @,SDP+C(W(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,W."XV-2 S.3 N,C<@5&0@*#(L.# W*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Q,2XU," S.3 N,C<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4W+C8U
M(#,Y,"XR-R!49" H.2PT,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DP+C4P(#,Y,"XR-R!49" H)"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C8N-C4@,SDP+C(W
M(%1D("@Q,#$L,#8P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-S0N,3 @5&0@
M*%]?7U]?7U]?7U]?7U]?7RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" W-RXU," S-3 N,3 @5&0@*%PH85PI("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-2XU," S-3 N
M,3 @5&0@*$=O;V1W:6QL(&%C<75I<F5D(&9R;VT@=&AE(&%C<75I<VET:6]N
M(&]F("D@5&H@150@40IQ(# @," P(')G($)4(#(V-BXP,B S-3 N,3 @5&0@
M*$%0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<X+C0S(#,U,"XQ,"!49" H
M(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.38N.#8@,S4P+C$P(%1D
M("AF:6YG+B!3964@3F]T92 T("T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S8Y+C8R(#,U,"XQ,"!49" H06-Q=6ES:71I;VYS+BD@5&H@150@40I"5" O
M1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,C8N,3 @5&0@
M*#(P,3@@86YD(#(P,3<@26UP86ER;65N="!#:&%R9V5S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,P-BXQ,"!4
M9" H5&AE($-O;7!A;GD@<&5R9F]R;65D(&ET<R!A;FYU86P@<75A;G1I=&%T
M:79E(&EM<&%I<FUE;G0@=&5S="!O9B!G;V]D=VEL;"!A;F0@;W1H97(@:6YD
M969I;FET92UL:79E9"!I;G1A;F=I8FQE(&%S<V5T<R!A<R!O9B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,CDT
M+C$P(%1D("A/8W1O8F5R(#$L(#(P,3@@86YD(#(P,3<N(%5P;VX@8V]M<&QE
M=&EO;B!O9B!T:&4@:6UP86ER;65N="!T97-T:6YG(&9O<B!B;W1H('EE87)S
M+"!I="!W87,@9&5T97)M:6YE9"!T:&%T('1H92!E<W1I;6%T960@9F%I<B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,C@R+C$P(%1D("AV86QU92!O9B!T:&4@4&AY<VEC:6%N(%-T868I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q-38N-3(@,C@R+C$P(%1D("AF:6YG(')E
M<&]R=&EN9R!U;FETDBD@5&H@150@40IQ(# @," P(')G($)4(#(S,BXV,B R
M.#(N,3 @5&0@*',@=')A9&4@;F%M92!W87,@;&5S<R!T:&%N(&ET<R!C87)R
M>6EN9R!A;6]U;G0@<F5S=6QT:6YG(&EN(&EM<&%I<FUE;G0N($9O<B!I=',@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(W,"XQ,"!49" H9V]O9'=I;&P@:6UP86ER;65N="!T97-T:6YG+"!W
M:71H('1H92!E>&-E<'1I;VX@;V8@:71S(%!H>7-I8VEA;B!3=&%F*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S(T+C(X(#(W,"XQ,"!49" H9FEN9R!R97!O
M<G1I;F<@=6YI="P@=&AE(&5S=&EM871E9"!F86ER('9A;'5E(&]F(&ET<R!R
M97!O<G1I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#(U."XQ,"!49" H=6YI=',@97AC965D960@=&AE:7(@
M<F5S<&5C=&EV92!C87)R>6EN9R!V86QU97,N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,S@N,3 @5&0@*%!R
M;VIE8W1I;VYS(&]F(')E=F5N=64L(&]P97)A=&EN9R!C;W-T<RP@86YD(&5X
M<&5C=&5D(&-A<V@@9FQO=W,@;V8@96%C:"!R97!O<G1I;F<@=6YI="!A<F4@
M:6YP=71S(&EN=&\@=&AE('%U86YT:71A=&EV92!T97-T:6YG("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,C8N
M,3 @5&0@*&9O<B!G;V]D=VEL;"!A;F0@:6YT86YG:6)L92!A<W-E=',N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$X.2XR.2 R,C8N,3 @5&0@*%1H92!#
M;VUP86YY(')E9'5C960@:71S(&QO;F<M=&5R;2!R979E;G5E(&9O<F5C87-T
M(&9O<B!T:&4@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T.3$N,C0@,C(V+C$P(%1D("AF:6YG(&)U<VEN97-S("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,30N,3 @
M5&0@*'-E9VUE;G0@:6X@=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3@@86YD
M(#(P,3<N("D@5&H@150@40IQ(# @," P(')G($)4(#(T,RXQ-B R,30N,3 @
M5&0@*%1H92!L;W=E<B!T:&%N(&5X<&5C=&5D(')E=F5N=64@=V%S(&1R:79E
M;B!B>2!L;W=E<B!B;V]K:6YG('9O;'5M97,L('!A<G1L>2 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C R+C$P
M(%1D("AD=64@=&\@=&AE(&QO<W,@;V8@8W5S=&]M97)S+B!);B!A9&1I=&EO
M;BP@;6%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(Y+C@T(#(P,BXQ,"!4
M9" H9VEN<R!O9B!T:&4@<F5P;W)T:6YG('5N:70@=V5R92!N96=A=&EV96QY
M(&EM<&%C=&5D(&9R;VT@8V]N=&EN=65D(&EN=F5S=&UE;G1S(&EN("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q
M.3 N,3 @5&0@*'1H92!B=7-I;F5S<RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3 R+C4V(#$Y,"XQ,"!49" H07,@82!R97-U;'0L(&1U<FEN9R!T:&4@
M9F]U<G1H('%U87)T97(@;V8@,C Q."!A;F0@,C Q-R!T:&4@0V]M<&%N>2!R
M96-O<F1E9"!N;VXM8V%S:"!I;7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,C$N.3@@,3DP+C$P(%1D("AG97,@;V8@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$W."XQ
M,"!49" H)#4N,B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#DX+C,Y(#$W."XQ,"!49" H(&%N9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3$W+C@S(#$W
M."XQ,"!49" H)#@N-R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$V-BXW,B Q-S@N,3 @5&0@*"P@<F5S<&5C
M=&EV96QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Y+C,X(#$W."XQ,"!4
M9" H+"!R96QA=&5D('1O(&ET<R!T<F%D92!N86UE(&%N9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,Y+C@Y(#$W."XQ
M,"!49" H)#$W+C(@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.3,N-S@@,3<X+C$P(%1D("@@86YD("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3,N,C(@
M,3<X+C$P(%1D("@D-2XW(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8R+C$Q(#$W."XQ,"!49" H+"!R97-P
M96-T:79E;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" U,30N-S<@,3<X+C$P
M(%1D("@L(')E;&%T960@=&\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#$V-BXQ,"!49" H9V]O9'=I;&P@9'5R
M:6YG('1H92!F;W5R=&@@<75A<G1E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#$X-2XU." Q-C8N,3 @5&0@*"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$T-BXQ,"!49" H1'5R:6YG('1H
M92!I;7!A:7)M96YT('1E<W1I;F<@87,@;V8@3V-T;V)E<B Q+" R,#$X+"!T
M:&4@0V]M<&%N>2!R96%S<V5S<V5D('1H92!0:'ES:6-I86X@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#0S-BXT-B Q-#8N,3 @5&0@*&9I;F<@8G)A
M;F0G<R!I;F1E9FEN:71E+6QI9F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S-"XQ,"!49" H8VQA<W-I9FEC
M871I;VX@86YD(&1E=&5R;6EN960@:70@:&%D(&-H87)A8W1E<FES=&EC<R!T
M:&%T(&EN9&EC871E9"!A(&1E9FEN:71E+6QI9F4@87-S:6=N;65N="!W87,@
M;6]R92!A<'!R;W!R:6%T92X@168I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M,34N-3,@,3,T+C$P(%1D("AF96-T:79E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,C(N,3 @5&0@*$]C=&]B
M97(@,2P@,C Q."P@=&AE('1R861E(&YA;64L('=I=&@@82!C87)R>6EN9R!V
M86QU92!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C@Q+C X(#$R,BXQ,"!49" H)#$N,2!M:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R.2XY-R Q,C(N
M,3 @5&0@*"!A9G1E<B!I;7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T,3@N.3$@,3(R+C$P(%1D("AG97,L('1H870@=V%S('!R979I
M;W5S;'D@87-S:6=N960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#$Q,"XQ,"!49" H86X@:6YD969I;FET92!L
M:69E('=A<R!A<W-I9VYE9"!A(&9I;FET92!L:69E(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S N,C<@,3$P+C$P
M(%1D("@S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(S-2XR-R Q,3 N,3 @5&0@*"!Y96%R<RX@1'5R:6YG('1H92!T:')E
M92!M;VYT:',@96YD960@1&5C96UB97(@,S$L(#(P,3@L('1H92!A;6]R=&EZ
M871I;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#DX+C$P(%1D("AE>'!E;G-E(')E;&%T960@=&\@=&AI<R!T
M<F%D92!N86UE('=A<R!A<'!R;WAI;6%T96QY("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-C8N,#D@.3@N,3 @5&0@*"0P
M+C$@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,30N.3@@.3@N,3 @5&0@*"XI(%1J($54(%$*96YD<W1R96%M
M"F5N9&]B:@HQ-#<@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q-#@@,"!2/CX*96YD;V)J"C$T." P
M(&]B:@H\/"],96YG=&@@,3 V.3(^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]5
M3E12*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H
M62D@5&H@150@40IQ(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(
M14%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H
M5$A#05)%+"!)3D,N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$W-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ
M(# @," P(')G($)4(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@
M150@40IQ(# @," P(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!
M3D-)04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D
M("@@4U0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D
M("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H
M5$5-14Y44RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-3@N,S4@-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W
M,3(N-S4@5&0@*#4N($=O;V1W:6QL+" I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,#,N-S(@-S$R+C<U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 Y+C8T(#<Q,BXW-2!49" H<F%D92!.86UE<RP@86YD($]T:&5R*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C Y+C0U(#<Q,BXW-2!49" H($EN=&%N9VEB
M;&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4W+C@P(#<Q,BXW-2!49" H
M07-S971S(%PH8V]N=&EN=65D7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 R,RD@5&H@
M150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M.34N,C4@5&0@*#(P,38@26UP86ER;65N="!#:&%R9V5S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W-2XR-2!4
M9" H5&AE($-O;7!A;GD@<&5R9F]R;65D(&ET<R!A;FYU86P@:6UP86ER;65N
M="!T97-T(&%S(&]F($]C=&]B97(@,2P@,C Q-BX@57!O;B!C;VUP;&5T:6]N
M(&]F('1H92!I;7!A:7)M96YT('1E<W1I;F<L('1H92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C8S+C(U(%1D
M("A#;VUP86YY(&1E=&5R;6EN960@=&AA="!N;R!I;7!A:7)M96YT(&]F(&=O
M;V1W:6QL+"!T<F%D92!N86UE<RP@;W(@;W1H97(@:6YT86YG:6)L92!A<W-E
M=',@=V%S('=A<G)A;G1E9"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-C0S+C(U(%1D("A$=7)I;F<@86X@979A
M;'5A=&EO;B!O9B!G;V]D=VEL;"P@=')A9&4@;F%M97,L(&%N9"!O=&AE<B!I
M;G1A;F=I8FQE(&%S<V5T<R!A="!*=6YE(#,P+" R,#$V+"!T:&4@0V]M<&%N
M>2!D971E<FUI;F5D('1H870@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#8S,2XR-2!49" H:6YD:6-A=&]R<R!W
M97)E('!R97-E;G0@:6X@=&AE(%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C(W+C U(#8S,2XR-2!49" H9FEN9R!R97!O<G1I;F<@
M=6YI="!W:&EC:"!W;W5L9"!S=6=G97-T('1H92!F86ER('9A;'5E(&]F('1H
M92!R97!O<G1I;F<@=6YI="!M87D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Q.2XR-2!49" H:&%V92!D96-L
M:6YE9"!B96QO=R!I=',@8V%R<GEI;F<@=F%L=64N("D@5&H@150@40IQ(# @
M," P(')G($)4(#(P."XT,R V,3DN,C4@5&0@*%1H92!0:'ES:6-I86X@4W1A
M9BD@5&H@150@40IQ(# @," P(')G($)4(#(X,RXW.2 V,3DN,C4@5&0@*&9I
M;F<@<F5P;W)T:6YG('5N:70@=V%S('5N9&5R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-# P+C(S(#8Q.2XR-2!49" H+7!E<F9O<FUI;F<@<F5L871I=F4@
M=&\@;6%N86=E;65N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#<N-C<@
M-C$Y+C(U(%1D("AS("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," V,#<N,C4@5&0@*&5X<&5C=&%T:6]N<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3 T+C,P(#8P-RXR-2!49" H5&AE(&QO
M=V5R('1H86X@97AP96-T960@<F5V96YU92!W87,@9')I=F5N(&)Y(&QO=V5R
M(&)O;VMI;F<@=F]L=6UE<R!P87)T;'D@9'5E('1O('1H92!L;W-S(&]F(&-U
M<W1O;65R<RP@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," U.34N,C4@5&0@*&UA<BD@5&H@150@40IQ(# @
M," P(')G($)4(#8T+C@W(#4Y-2XR-2!49" H9VEN<R!W97)E(&YE9V%T:79E
M;'D@:6UP86-T960@9G)O;2!C;VYT:6YU960@:6YV97-T;65N=',@:6X@=&AE
M(&)U<VEN97-S(&%L;"!T:')O=6=H('1H92!F:7)S="!H86QF(&]F(#(P,38N
M("D@5&H@150@40IQ(# @," P(')G($)4(#0Y-RXY,B U.34N,C4@5&0@*%1H
M92!#;VUP86YY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," U.#,N,C4@5&0@*&-O;G-I9&5R960@=&AE<V4@9F%C
M=&]R<R!T;R!B92!I;7!A:7)M96YT(&EN9&EC871O<G,@=&AA="!W87)R86YT
M960@:6UP86ER;65N="!T97-T:6YG(&]F(&=O;V1W:6QL+"!T<F%D92!N86UE
M<RP@86YD(&]T:&5R("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," U-S$N,C4@5&0@*&EN=&%N9VEB;&4@87-S971S
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C N,30@-3<Q+C(U(%1D("A4
M:&4@:6YT97)I;2!I;7!A:7)M96YT('1E<W1I;F<@<F5S=6QT960@:6X@=&AE
M(&-A<G)Y:6YG('9A;'5E<R!O9B!G;V]D=VEL;"P@=')A9&4@;F%M97,L(&%N
M9"!O=&AE<B!I;G1A;F=I8FQE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," U-3DN,C4@5&0@*&%S<V5T<R!F;W(@
M4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#8N.# @
M-34Y+C(U(%1D("AF:6YG('1O(&5X8V5E9"!T:&5I<B!E<W1I;6%T960@9F%I
M<B!V86QU97,N("D@5&H@150@40IQ(# @," P(')G($)4(#,Q,RXY-B U-3DN
M,C4@5&0@*$%S(&$@<F5S=6QT+"!T:&4@:6YT97)I;2!I;7!A:7)M96YT('1E
M<W1I;F<@=V%S('!E<F9O<FUE9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-30W+C(U(%1D("AW:&EC:"!R97-U
M;'1E9"!I;B!T:&4@8V%R<GEI;F<@=F%L=65S(&]F(&=O;V1W:6QL+"!T<F%D
M92!N86UE<RP@86YD(&]T:&5R(&EN=&%N9VEB;&4@87-S971S(&9O<B!0:'ES
M:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#0X,RXV-2 U-#<N
M,C4@5&0@*&9I;F<@=&\@97AC965D('1H96ER("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U,S4N,C4@5&0@*&5S
M=&EM871E9"!F86ER('9A;'5E<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3,V+C8Y(#4S-2XR-2!49" H07,@82!R97-U;'0L('1H92!#;VUP86YY(')E
M8V]R9&5D(&$@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S@Y+C(P(#4S-2XR-2!49" H9V4@=&]T86QI;F<@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-"XQ
M.2 U,S4N,C4@5&0@*"0R-"XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#@X+C X(#4S-2XR-2!49" H.B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DS
M+C,V(#4S-2XR-2!49" H)#$W+C<@;6EL;&EO;BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#<N,C4@-3,U+C(U(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#4R,RXR-2!49" H<F5L871E9"!T;R!G;V]D=VEL;"P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$S,"XP-" U,C,N
M,C4@5&0@*"0P+C8@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q-S@N.3,@-3(S+C(U(%1D("@@<F5L871E9"!T
M;R!T<F%D92!N86UE<RP@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.3$N,S@@-3(S+C(U(%1D("@D-BXP(&UI;&QI
M;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S0P+C(W(#4R,RXR-2!49" H(')E;&%T960@=&\@8W5S=&]M97(@<F5L871I
M;VYS:&EP<RXI(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-3 S+C(U(%1D("A1=6%N=&ET871I=F4@365T:&]D<R!A
M;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34X+C@W(#4P,RXR-2!49" H
M07-S=6UP=&EO;G,I(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-#@S+C(U(%1D("A4*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-30N-3$@-#@S+C(U(%1D("AR861E($YA;65S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0V,RXR-2!4
M9" H5&AE(%)E;&EE9B!&<F]M(%)O>6%L='D@;65T:&]D;VQO9WD@=V%S('5T
M:6QI>F5D('1O('9A;'5E('1H92!0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ
M(# @," P(')G($)4(#,V-2XQ," T-C,N,C4@5&0@*&9I;F<@=')A9&4@;F%M
M97,@=7-I;F<@<')O:F5C=&5D(&-A<V@@9FQO=W,@;V8@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0U,2XR-2!4
M9" H86X@97-T:6UA=&5D(')O>6%L='D@9F5E+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-3 N,3$@-#4Q+C(U(%1D("A4:&4@<F]Y86QT>2!R871E('=A
M<R!D971E<FUI;F5D(&)Y(&$@8FQE;F1E9"!R871E('5S:6YG('1H92!-87)K
M970@4F]Y86QT>2!2871E($UE=&AO9"!A;F0@=&AE("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,SDN,C4@5&0@
M*$%P<&]R=&EO;FUE;G0@;V8@4')O9FET($UE=&AO9"X@*2!4:B!%5"!1"D)4
M("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Q.2XR-2!4
M9" H1V]O9'=I;&PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,SDY+C(U(%1D("A4:&4@9&ES8V]U;G1E9"!C87-H
M(&9L;W=S('-E<G9E(&%S('1H92!P<FEM87)Y(&)A<VES(&9O<B!T:&4@:6YC
M;VUE(&%P<')O86-H(&%N9"!A<F4@8F%S960@;VX@=&AE($-O;7!A;GF2*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#@Y+CDR(#,Y.2XR-2!49" H<R!D:7-C
M<F5T92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S@W+C(U(%1D("AF:6YA;F-I86P@9F]R96-A<W0@;V8@<F5V
M96YU92P@9W)O<W,@<')O9FET(&UA<BD@5&H@150@40IQ(# @," P(')G($)4
M(#(S,BXS," S.#<N,C4@5&0@*&=I;G,L(&]P97)A=&EN9R!C;W-T<R!A;F0@
M8V%S:"!F;&]W<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@P+CDX(#,X
M-RXR-2!49" H5&AE(&9O<F5C87-T(&-O;G-I9&5R<R!H:7-T;W)I8V%L(&%N
M9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S<U+C(U(%1D("AE<W1I;6%T960@9G5T=7)E(')E<W5L=',L(&=E
M;F5R86P@96-O;F]M:6,@86YD(&UA<FME="!C;VYD:71I;VYS+"!A<R!W96QL
M(&%S('1H92!I;7!A8W0@;V8@<&QA;FYE9"!B=7-I;F5S<R!A;F0@;W!E<F%T
M:6]N86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,V,RXR-2!49" H<W1R871E9VEE<RX@1F]R(&ET<R R,#$X
M('1E<W1I;F<L('1H92!A<W-U;7!T:6]N<R!U<V5D(&EN('1H92!I;F-O;64@
M87!P<F]A8V@@:6YC;'5D960@9&ES8V]U;G0@<F%T97,@;V8@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,RXX-R S-C,N
M,C4@5&0@*#$R+C E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0X.2XW," S-C,N,C4@5&0@*"!T;R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 R+C0W(#,V,RXR-2!4
M9" H,34N,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(X+C,P(#,V,RXR-2!49" H(&%N9"!A("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-3$N,C4@5&0@
M*'1E<FUI;F%L('9A;'5E(&=R;W=T:"!R871E(&]F("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C@N-C(@,S4Q+C(U(%1D
M("@Q+C E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$X.2XT-2 S-3$N,C4@5&0@*"!T;R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C R+C(S(#,U,2XR-2!49" H,RXP
M)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,C,N,#8@,S4Q+C(U(%1D("@@9F]R(&-A<V@@9FQO=W,@8F5Y;VYD('1H92!D
M:7-C<F5T92!F;W)E8V%S="!P97)I;V0@;V8@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-RXY." S-3$N,C4@5&0@*'1E
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-3 N,C @,S4Q+C(U(%1D("@@>65A<G,N("D@5&H@150@40IQ(# @," P(')G
M($)4(#0W."XR-2 S-3$N,C4@5&0@*$%S<W5M<'1I;VYS('5S960@:6X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,S.2XR-2!49" H=&AE(&UA<FME="!A<'!R;V%C:"!T97-T:6YG(&EN8VQU
M9&5D('9A;'5A=&EO;B!M=6QT:7!L97,@8F%S960@;VX@86X@86YA;'ES:7,@
M;V8@;75L=&EP;&5S(&9O<B!C;VUP87)A8FQE('!U8FQI8R!C;VUP86YI97,N
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," S,C<N,C4@5&0@*%1H92!#;VUP86YY('5T:6QI>F5D('1O=&%L(&5N
M=&5R<')I<V4@=F%L=64O16%R;FEN9W,@0F5F;W)E($EN=&5R97-T+" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,S N-C$@,S(W+C(U(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S,V+C R(#,R-RXR-2!49" H87AE<RP@1&5P
M<F5C:6%T:6]N+"!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,Q+C@R
M(#,R-RXR-2!49" H06UO<G1I>F%T:6]N(%PH14))5$1!7"D@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Q-2XR
M-2!49" H;75L=&EP;&5S(')A;F=I;F<@9G)O;2 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,30T+C(Q(#,Q-2XR-2!49" H
M,RXP*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$U-BXW,2 S,34N,C4@5&0@*"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,38Y+C0Y(#,Q-2XR-2!49" H,3 N-2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#8N
M.3D@,S$U+C(U(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#$Y,2XX
M," S,34N,C4@5&0@*%1H92!C;VYC;'5D960@9F%I<B!V86QU92!W87,@8F%S
M960@;VX@82!W96EG:'1I;F<@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Q,"XP-B S,34N,C4@5&0@*#<U)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,C@N,SD@
M,S$U+C(U(%1D("@@87!P;&EE9"!T;R!T:&4@:6YC;VUE(&%P<')O86-H("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S,#,N,C4@5&0@*&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-C8N-#0@,S S+C(U(%1D("@R-24I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#0N-S<@,S S+C(U
M(%1D("@@=&\@=&AE(&UA<FME="!A<'!R;V%C:"!F;W(@:71S(%!H>7-I8VEA
M;B!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8U+C$P(#,P,RXR-2!4
M9" H9FEN9R!A;F0@4V5A<F-H(')E<&]R=&EN9R!U;FET<R!A;F0@82 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$U+C,S
M(#,P,RXR-2!49" H-3 E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0S,RXV-B S,#,N,C4@5&0@*"!W96EG:'1I;F<@=V%S
M(&%P<&QI960@=&\@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R.3$N,C4@5&0@*&-O;7!O;F5N=',@;V8@
M96%C:"!A<'!R;V%C:"!T;R!E<W1I;6%T92!T:&4@=&]T86P@9F%I<B!V86QU
M92!O9B!G;V]D=VEL;"!F;W(@:71S($YU<G-E(&%N9" I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,3 N-3 @,CDQ+C(U(%1D("A!;&QI960@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#0U,RXY,B R.3$N,C4@5&0@*&9I;F<@<F5P
M;W)T:6YG('5N:70N("D@5&H@150@40IQ(# @," P(')G($)4(#4S,BXP-B R
M.3$N,C4@5&0@*%1H:7,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(W.2XR-2!49" H=V5I9VAT:6YG('=A<R!A
M;B!E<W1I;6%T92!B>2!M86YA9V5M96YT(&%N9"!W87,@9&5V96QO<&5D(&)A
M<V5D(&]N('1H92!S<&5C:69I8R!C:&%R86-T97)I<W1I8W,L(')I<VMS(&%N
M9"!U;F-E<G1A:6YT:65S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," R-C<N,C4@5&0@*'1H92!R97!O<G1I
M;F<@=6YI=',N("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," R-#<N,C4@5&0@*$-U<W1O;65R(%)E;&%T:6]N<VAI
M<',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,C(W+C(U(%1D("A4:&4@375L=&DM4&5R:6]D($5X8V5S<R!%87)N
M:6YG<R!-971H;V0@7"A-4$5%35PI(&UE=&AO9&]L;V=Y('=A<R!U=&EL:7IE
M9"!F;W(@=F%L=6EN9R!T:&4@4&AY<VEC:6%N(%-T868I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T.3(N.#8@,C(W+C(U(%1D("AF:6YG(&-U<W1O;65R("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," R,34N,C4@5&0@*')E;&%T:6]N<VAI<',@:6X@:71S(&EN=&5R:6T@:6UP
M86ER;65N="!T97-T:6YG(&9O<B!T:&4@<V5C;VYD('%U87)T97(@;V8@,C Q
M-BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8P+C Y(#(Q-2XR-2!49" H
M5&AE($U0145-(&5S=&EM871E<R!T:&4@9F%I<B!V86QU92!B87-E9"!O;B!T
M:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#(P,RXR-2!49" H<')E<V5N="!V86QU92!O9B!T:&4@86QL;V-A
M=&5D(&9U='5R92!E8V]N;VUI8R!B96YE9FET<RX@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C<S+C,Y(#(P,RXR-2!49" H5&AE(&EN<'5T<R!I;F-L=61E
M('1H92!P<F]J96-T960@<F5V96YU92!A;F0@87-S;V-I871E9"!E>'!E;G-E
M<R!F<F]M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," Q.3$N,C4@5&0@*'1H92!C=7-T;VUE<G,L(&%N(&5S=&EM
M871E9"!A='1R:71I;VX@<F%T92P@86YD(&$@9&ES8V]U;G0@<F%T92!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S U
M+C(U(#$Y,2XR-2!49" H,3,N-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S,Q+C X(#$Y,2XR-2!49" H+B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3<Q
M+C(U(%1D("A!;'1H;W5G:"!M86YA9V5M96YT(&)E;&EE=F5S('1H870@=&AE
M($-O;7!A;GDG<R!C=7)R96YT(&5S=&EM871E<R!A;F0@87-S=6UP=&EO;G,@
M87)E(')E87-O;F%B;&4@86YD('-U<'!O<G1A8FQE+"!T:&5R92!C86X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#$U.2XR-2!49" H8F4@;F\@87-S=7)A;F-E('1H870@=&AE(&5S=&EM871E
M<R!A;F0@87-S=6UP=&EO;G,@;6%D92!F;W(@<'5R<&]S97,@;V8@=&AE(&EM
M<&%I<FUE;G0@=&5S=&EN9R!W:6QL('!R;W9E('1O(&)E(&%C8W5R871E("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," Q-#<N,C4@5&0@*'!R961I8W1I;VYS(&]F(&9U='5R92!P97)F;W)M86YC
M92XI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ-#D@,"!O8FH*/#PO5'EP
M92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W
M.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q
M-3 @,"!2/CX*96YD;V)J"C$U," P(&]B:@H\/"],96YG=&@@-S8P,3X^"G-T
M<F5A;0I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3,N.#4@
M-S8P+C<U(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.3(N-C@@-S8P+C<U(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,CDY+C4S(#<V,"XW-2!49" H($A%04PI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,CDN-#4@-S8P+C<U(%1D("A42$-!4D4L($E.0RXI(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<U+C,P(#<T."XW-2!4
M9" H3D]415,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R(#<T."XW
M-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(Q."XP,2 W-#@N-S4@
M5&0@*$\@0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C$Q
M(#<T."XW-2!49" H5$5$($9)3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G
M($)4(#,V-RXR.2 W-#@N-S4@5&0@*"!35"D@5&H@150@40IQ(# @," P(')G
M($)4(#,X,2XR." W-#@N-S4@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S.#<N-S8@-S0X+C<U(%1D("A414U%3E13*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U."XS-2 W,S8N-S4@5&0@*$1%
M0T5-0D52H#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P+C P(#<Q,BXW-2!49" H-BX@4'(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" W,"XS-R W,3(N-S4@5&0@*&]P97)T>2!A;F0@17%U
M:7!M96YT*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(Y-2XS," S,RXV,"!49" H1BT@,C0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-CDU+C$P(%1D("A4:&4@
M0V]M<&%N>2=S('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0@8V]N<VES=',@;V8@
M=&AE(&9O;&QO=VEN9SJ@*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C P(#8U-"XV," R.# N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS,S N,# @-C4T+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# U+C P(#8U-"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#8U-"XV," Q-30N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XP," V,S$N-C @,C@P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,P+C P(#8S
M,2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-2XP," V,S$N-C @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0P.2XP," V,S$N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#0N,# @
M-C,Q+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @-C,Q+C8P(#<U+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 N,# @-C Q+C8P(#(X,"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,S,"XP
M," V,#$N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @-C Q+C8P(#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,#DN,# @-C Q+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@T
M+C P(#8P,2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C P(#8P,2XV," W-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C P(#4W,2XV," R.# N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M,S N,# @-3<Q+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# U+C P(#4W,2XV," T
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-# Y+C P(#4W,2XV," W-2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0X-"XP," U-S$N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," U-S$N-C @
M-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XP," U-#$N-C @,C@P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S,P+C P(#4T,2XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-2XP," U-#$N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0P.2XP," U-#$N-C @-S4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.#0N,# @-30Q+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @-30Q
M+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#8V.2XV(&T*
M-#@T(#8V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.#0@-C8Y+C8@;0HT.#@@-C8Y+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0X." V-CDN-B!M"C4V,R V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S,P(#8U-"XV(&T*-# U
M(#8U-"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT,#D@-C4T+C8@;0HT.#0@-C4T+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X
M." V-30N-B!M"C4V,R V-30N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#4U-BXV(&T*-#@T(#4U
M-BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT.#@@-34V+C8@;0HU-C,@-34V+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 U
M,C8N-B!M"C0X-" U,C8N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@X(#4R-BXV(&T*-38S(#4R-BXV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HT,#D@-3$R+C8@;0HT.#0@-3$R+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 U,3 N
M-B!M"C0X-" U,3 N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#@X(#4Q,BXV(&T*-38S(#4Q,BXV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT.#@@-3$P+C8@;0HU-C,@-3$P+C8@; IS"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C4P(#8W-"XR-R!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S(N-3 @-C<T
M+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U-BXT," V-S0N,C@@5&0@*$1E8V5M8F5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-#DY+C8R(#8W-"XR."!49" HH#,Q+"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," V-3DN,C<@
M5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S0P+C<U(#8U.2XR."!49" H57-E9G5L($QI=F5S*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-BXP," V-3DN,C@@
M5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3$U+C P(#8U.2XR."!49" H,C Q-RD@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,RXU," V-#0N,#8@5&0@*%PH
M86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXU," V,C$N,C<@5&0@*$-O;7!U=&5R
M(&5Q=6EP;65N="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S-#@N-3 @-C(Q+C(W(%1D("@S+34@>65A<G,I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C4P(#8R,2XR
M-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-3<N-C4@-C(Q+C(W(%1D("@V+#(U-RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3 N-3 @-C(Q+C(W(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M-BXV-2 V,C$N,C<@5&0@*#8L-#,R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C4P(#8P-BXR-R!49" H0V]M<'5T97(@
M<V]F='=A<F4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S0X+C4P(#8P-BXR-R!49" H,RTU('EE87)S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,BXV-2 V,#8N,C<@
M5&0@*#(V+#8U,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S$N-C4@-C V+C(W(%1D("@R-"PY,S,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-3DQ+C(W(%1D
M("A/9BD@5&H@150@40IQ(# @," P(')G($)4(#8R+CDV(#4Y,2XR-R!49" H
M9FEC92!E<75I<&UE;G0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S0X+C4P(#4Y,2XR-R!49" H-2TW('EE87)S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U-RXV-2 U
M.3$N,C<@5&0@*#$L-3$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4S-BXV-2 U.3$N,C<@5&0@*#$L,S<Y*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#4W-BXR
M-R!49" H1G5R;FET=7)E(&%N9"!F:7AT=7)E<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#@N-3 @-3<V+C(W(%1D("@U
M+3<@>65A<G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#4W+C8U(#4W-BXR-R!49" H-"PY-C8I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C8U(#4W-BXR-R!49" H
M-"PV.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3(N-3 @-38Q+C(W(%1D("A,96%S96AO;&0@:6UP<F]V96UE;G1S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,2XT
M-2 U-C$N,C<@5&0@*%PH85PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0U-RXV-2 U-C$N,C<@5&0@*#<L-S$V*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-BXV-2 U
M-C$N,C<@5&0@*#<L,S0P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C4P(#4T-BXR-R!49" HH"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3(N-C4@-30V+C(W(%1D
M("@T-RPQ,#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,Q+C8U(#4T-BXR-R!49" H-#0L-S8T*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#4S,2XR-R!49" H
M3&5S<R!A8V-U;75L871E9"!D97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M,S(N-3 @-3,Q+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0T.2XS," U,S$N,S(@5&0@*%PH,S,L-#<V*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X,"XQ
M-2 U,S$N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R."XS," U,S$N,S(@5&0@*%PH,S L-C<X*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XQ-2 U
M,S$N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R+C4P(#4Q-BXR-R!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,S(N-3 @-3$V+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q
M,2XU," U,38N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#4R+C8U(#4Q-BXR-R!49" H,3,L-C(X*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,"XU," U
M,38N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,Q+C8U(#4Q-BXR-R!49" H,30L,#@V*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," U,# N,3 @5&0@*%]?7U]?7U]?7U]?7U]?7RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-RXU," T.#@N
M,3 @5&0@*%PH85PI("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Y-2XU," T.#@N,3 @5&0@*%-E92!.;W1E(#(@EB!3=6UM
M87)Y(&]F(%-I9VYI9FEC86YT("D@5&H@150@40IQ(# @," P(')G($)4(#(T
M-RXT,B T.#@N,3 @5&0@*$%C8V]U;G1I;F<@4&]L:6-I97,N*2!4:B!%5"!1
M"F5N9'-T<F5A;0IE;F1O8FH*,34Q(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A
M<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S
M;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,34R(# @4CX^"F5N
M9&]B:@HQ-3(@,"!O8FH*/#PO3&5N9W1H(#$V.3 T/CX*<W1R96%M"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C N-S4@5&0@
M*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W
M-C N-S4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8P
M+C<U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W
M-C N-S4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S0X+C<U(%1D("A.3U1%4R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S0X+C<U(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<T."XW-2!49" H3R!#3TY3
M3TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S0X+C<U(%1D
M("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y
M(#<T."XW-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X
M(#<T."XW-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W
M-#@N-S4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C4X+C,U(#<S-BXW-2!49" H1$5#14U"15*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S$R+C<U(%1D("@W+B!"86QA;F-E(%-H965T($1E=&%I;',I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDU
M+C,P(#,S+C8P(%1D("A&+2 R-2D@5&H@150@40HP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," V-S$N-3 @,S,Y+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S@X+C P(#8W,2XU," Q-S0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," V
M-#$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#8T,2XU," X-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0W,RXP," V-#$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP
M," V-#$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," V,3$N-3 @,S,Y+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S@X+C P(#8Q,2XU," X-2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W
M,RXP," V,3$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," V,3$N-3 @.#4N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.2XP," U.#$N-3 @,S,Y+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S@X+C P(#4X,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," U.#$N-3 @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0W-RXP," U.#$N-3 @.#4N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.2XP," U-3$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#4U,2XU
M," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," U-3$N-3 @-"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0W-RXP," U-3$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," U,C$N
M-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#4R,2XU," X-2XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0W,RXP," U,C$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," U
M,C$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," T.3$N-3 @,S,Y+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*,S@X+C P(#0Y,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP
M," T.3$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," T.3$N-3 @.#4N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.2XP," T-C$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X
M+C P(#0V,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," T-C$N-3 @-"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0W-RXP," T-C$N-3 @.#4N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M.2XP," T,S$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#0S,2XU," X
M-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0W,RXP," T,S$N-3 @-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0W-RXP," T,S$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," T,#$N-3 @
M,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#0P,2XU," X-2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0W,RXP," T,#$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," T,#$N
M-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," S-S$N-3 @,S,Y+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S@X+C P(#,W,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," S
M-S$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," S-S$N-3 @.#4N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.2XP," S-#$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P
M(#,T,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," S-#$N-3 @-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0W-RXP," S-#$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP
M," S,3$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#,Q,2XU," X-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0W,RXP," S,3$N-3 @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W
M-RXP," S,3$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," R.#$N-3 @,S,Y
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S@X+C P(#(X,2XU," X-2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0W,RXP," R.#$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," R.#$N-3 @
M.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.2XP," R-3$N-3 @,S,Y+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S@X+C P(#(U,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," R-3$N
M-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," R-3$N-3 @.#4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.2XP," R,C$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#(R
M,2XU," X-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W,RXP," R,C$N-3 @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0W-RXP," R,C$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," Q
M.3$N-3 @,S,Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@X+C P(#$Y,2XU," X-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0W,RXP," Q.3$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP
M," Q.3$N-3 @.#4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," Q-C$N-3 @,S,Y+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S@X+C P(#$V,2XU," X-2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W
M,RXP," Q-C$N-3 @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0W-RXP," Q-C$N-3 @.#4N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.#@@-C@V+C4@;0HT-S,@-C@V
M+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0W,R V.#8N-2!M"C0W-R V.#8N-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<W(#8X
M-BXU(&T*-38R(#8X-BXU(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.#@@-C<Q+C4@;0HT-S,@-C<Q+C4@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0W-R V-S$N-2!M"C4V,B V-S$N-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@X(#8Q,2XU
M(&T*-#<S(#8Q,2XU(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HT-S<@-C$Q+C4@;0HU-C(@-C$Q+C4@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,X." U.3<N-2!M"C0W,R U.3<N-2!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@X(#4Y-2XU(&T*
M-#<S(#4Y-2XU(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT-S<@-3DW+C4@;0HU-C(@-3DW+C4@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0W-R U.34N-2!M"C4V,B U.34N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@X(#0W-BXU(&T*-#<S
M(#0W-BXU(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-S<@-#<V+C4@;0HU-C(@-#<V+C4@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X
M." T-S8N-2!M"C0W,R T-S8N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S@X(#0V,BXU(&T*-#<S(#0V
M,BXU(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS.#@@-#8P+C4@;0HT-S,@-#8P+C4@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0W-R T
M-S8N-2!M"C4V,B T-S8N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#<W(#0V,BXU(&T*-38R(#0V,BXU
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HT-S<@-#8P+C4@;0HU-C(@-#8P+C4@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." S-#$N
M-2!M"C0W,R S-#$N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#<W(#,T,2XU(&T*-38R(#,T,2XU(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HS.#@@,S(W+C4@;0HT-S,@,S(W+C4@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." S,C4N-2!M
M"C0W,R S,C4N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#<W(#,R-RXU(&T*-38R(#,R-RXU(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT-S<@,S(U+C4@;0HU-C(@,S(U+C4@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." R-C8N-2!M"C0W
M,R R-C8N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#<W(#(V-BXU(&T*-38R(#(V-BXU(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M.#@@,C4R+C4@;0HT-S,@,C4R+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." R-3 N-2!M"C0W,R R
M-3 N-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#<W(#(U,BXU(&T*-38R(#(U,BXU(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-S<@
M,C4P+C4@;0HU-C(@,C4P+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." Q-#8N-2!M"C0W,R Q-#8N
M-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#<W(#$T-BXU(&T*-38R(#$T-BXU(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS.#@@,3,R
M+C4@;0HT-S,@,3,R+C4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,X." Q,S N-2!M"C0W,R Q,S N-2!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#<W(#$S,BXU(&T*-38R(#$S,BXU(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-S<@,3,P+C4@
M;0HU-C(@,3,P+C4@; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4Q+C4P(#8Y,2XQ-R!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-#4N-# @-CDQ+C$X(%1D("A$96-E;6)E
M<BD@5&H@150@40IQ(# @," P(')G($)4(#0X."XV,B V.3$N,3@@5&0@** S
M,2PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3$N-3 @-C<V+C$W(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0R,"XP," V-S8N,3@@5&0@*#(P,3@I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 Y+C P(#8W
M-BXQ."!49" H,C Q-RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0S,BXU," V-C N.38@5&0@*%PH86UO=6YT<R!I;B!T:&]U
M<V%N9'-<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,2XU," V-#8N,3<@5&0@*$EN<W5R86YC92!R96-O=F5R>2!R96-E
M:79A8FQE.BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.3 N-3 @-C0V+C$W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W.2XU," V-#8N,3<@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3<N-3 @
M-C,Q+C$W(%1D("A);G-U<F%N8V4@<F5C;W9E<GD@9F]R('=O<FME<G.2*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3@U+C8W(#8S,2XQ-R!49" H(&-O;7!E
M;G-A=&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.3 N-3 @-C,Q+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0T-BXV-2 V,S$N,3<@5&0@*#(L,CDU
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0W
M.2XU," V,S$N,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,U+C8U(#8S,2XQ-R!49" H,2PV,C,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3<N-3 @-C$V
M+C$W(%1D("A);G-U<F%N8V4@<F5C;W9E<GD@9F]R('!R;V9E<W-I;VYA;"!L
M:6%B:6QI='DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0V+C8U(#8Q-BXQ-R!49" H,2PX.3$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U(#8Q-BXQ-R!49" H
M,2PX-S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3$N-3 @-C Q+C$W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y,"XU," V,#$N,3<@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0V+C8U(#8P
M,2XQ-R!49" H-"PQ.#8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#<Y+C4P(#8P,2XQ-R!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N-C4@-C Q+C$W(%1D
M("@S+#0Y-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,2XU," U-S$N,3<@5&0@*$]T:&5R(&YO;BUC=7)R96YT(&%S<V5T
M<SHI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3<N-3 @-34V+C$W(%1D("A);G-U<F%N8V4@<F5C;W9E<GD@9F]R('=O<FME
M<G.2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@U+C8W(#4U-BXQ-R!49" H
M(&-O;7!E;G-A=&EO;B!C;&%I;7,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDP+C4P(#4U-BXQ-R!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N-C4@-34V
M+C$W(%1D("@U+#(X,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-SDN-3 @-34V+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 U-38N,3<@5&0@
M*#8L,#DS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4W+C4P(#4T,2XQ-R!49" H26YS=7)A;F-E(')E8V]V97)Y(&9O<B!P
M<F]F97-S:6]N86P@;&EA8FEL:71Y(&-L86EM<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N-C4@-30Q+C$W(%1D("@Y
M+#DR-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S N-C4@-30Q+C$W(%1D("@Q,"PP,2D@5&H@150@40IQ(# @," P(')G
M($)4(#4U,RXQ-2 U-#$N,3<@5&0@*#$I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3<N-3 @-3(V+C$W(%1D("A.;VXM8W5R
M<F5N="!S96-U<FET>2!D97!O<VET<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-30N,34@-3(V+C$W(%1D("@Y.#(I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U
M(#4R-BXQ-R!49" H,2PP.34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3<N-3 @-3$Q+C$W(%1D("A.;VXM8W5R<F5N="!I
M;F-O;64@=&%X(')E8V5I=F%B;&4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#4T+C$U(#4Q,2XQ-R!49" H-3(R*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 U
M,3$N,3<@5&0@*#$L,#0T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4W+C4P(#0Y-BXQ-R!49" H1&5F97)R960@8V]M<&5N
M<V%T:6]N(&%S<V5T<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-30N,34@-#DV+C$W(%1D("@T,S,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30X+C$U(#0Y-BXQ-R!4
M9" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-RXU," T.#$N,3<@5&0@*$YE="!D96)T(&ES<W5A;F-E(&-O<W1S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U-"XQ
M-2 T.#$N,3<@5&0@*#DS-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#,N,34@-#@Q+C$W(%1D("@Y.#4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDP+C4P(#0V-BXQ
M-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-#$N-C4@-#8V+C$W(%1D("@Q."PP-S8I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#<Y+C4P(#0V-BXQ-R!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S N-C4@-#8V+C$W(%1D("@Q.2PR,C@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @-#,V+C$W(%1D("A!8V-R=65D
M(&-O;7!E;G-A=&EO;B!A;F0@8F5N969I=',Z*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4W+C4P(#0R,2XQ-R!49" H4V%L
M87)I97,@86YD('!A>7)O;&P@=&%X97,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDP+C4P(#0R,2XQ-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N-C4@
M-#(Q+C$W(%1D("@Q-2PX.#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#<Y+C4P(#0R,2XQ-R!49" H)"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S N-C4@-#(Q+C$W
M(%1D("@Q-BPS-#(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3<N-3 @-# V+C$W(%1D("A";VYU<V5S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-BXV-2 T,#8N,3<@
M5&0@*#$L-#<V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S-2XV-2 T,#8N,3<@5&0@*#(L,#8W*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4W+C4P(#,Y,2XQ-R!49" H
M06-C<G5A;"!F;W(@=V]R:V5R<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-# N.3@@,SDQ+C$W(%1D("@@8V]M<&5N<V%T:6]N(&-L86EM<RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N-C4@,SDQ
M+C$W(%1D("@V+#0U-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S4N-C4@,SDQ+C$W(%1D("@U+#DU-RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU," S-S8N,3<@
M5&0@*$%C8W)U86P@9F]R('!R;V9E<W-I;VYA;"!L:6%B:6QI='D@8VQA:6US
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M-BXV-2 S-S8N,3<@5&0@*#(L-S@V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 S-S8N,3<@5&0@*#(L-C@S*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4W+C4P
M(#,V,2XQ-R!49" H06-C<G5A;"!F;W(@:&5A;'1H8V%R92!B96YE9FET<RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N
M-C4@,S8Q+C$W(%1D("@U+#$U."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S4N-C4@,S8Q+C$W(%1D("@U+#$P-2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU," S
M-#8N,3<@5&0@*$%C8W)U86P@9F]R('9A8V%T:6]N*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-BXV-2 S-#8N,3<@5&0@
M*#$L-3<T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S-2XV-2 S-#8N,3<@5&0@*#(L,2D@5&H@150@40IQ(# @," P(')G
M($)4(#4T."XQ-2 S-#8N,3<@5&0@*#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4Q+C4P(#,S,2XQ-R!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3 N-3 @
M,S,Q+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T,2XV-2 S,S$N,3<@5&0@*#,S+#,S,BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-SDN-3 @,S,Q+C$W
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S,"XV-2 S,S$N,3<@5&0@*#,T+#(W,2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,2XU," S,#$N,3<@5&0@*$QO
M;F<M=&5R;2!A8V-R=65D(&-L86EM<SHI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3<N-3 @,C@V+C$W(%1D("A!8V-R=6%L
M(&9O<B!W;W)K97)SDBD@5&H@150@40IQ(# @," P(')G($)4(#$T,"XY." R
M.#8N,3<@5&0@*"!C;VUP96YS871I;VX@8VQA:6US*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,"XU," R.#8N,3<@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#0Q+C8U(#(X-BXQ-R!49" H,3(L.3DW*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W.2XU," R.#8N,3<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C8U
M(#(X-BXQ-R!49" H,3,L,38P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4W+C4P(#(W,2XQ-R!49" H06-C<G5A;"!F;W(@
M<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;&%I;7,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0Q+C8U(#(W,2XQ-R!49" H
M,38L,S R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S,"XV-2 R-S$N,3<@5&0@*#$U+#4Y-RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3 N-3 @,C4V+C$W(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T
M,2XV-2 R-38N,3<@5&0@*#(Y+#(Y.2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-SDN-3 @,C4V+C$W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,"XV-2 R
M-38N,3<@5&0@*#(X+#<U-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,2XU," R,C8N,3<@5&0@*$]T:&5R(&QO;F<M=&5R
M;2!L:6%B:6QI=&EE<SHI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3<N-3 @,C$Q+C$W(%1D("A.;VXM8W5R<F5N="!D969E
M<G)E9"!T87@@;&EA8FEL:71I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDP+C4P(#(Q,2XQ-R!49" H)"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3DN,34@,C$Q
M+C$W(%1D("@Y-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-SDN-3 @,C$Q+C$W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,RXQ-2 R,3$N,3<@5&0@*#$P
M-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-RXU," Q.38N,3<@5&0@*$1E9F5R<F5D(&-O;7!E;G-A=&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#8N-C4@,3DV
M+C$W(%1D("@Q+#<R-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S4N-C4@,3DV+C$W(%1D("@Q+#0V-RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU," Q.#$N,3<@
M5&0@*$1E9F5R<F5D(')E;G0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#0V+C8U(#$X,2XQ-R!49" H-BPP,SDI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U(#$X
M,2XQ-R!49" H-BPX-S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3<N-3 @,38V+C$W(%1D("A,;VYG+71E<FT@=6YR96-O
M9VYI>F5D('1A>"!B96YE9FET<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-30N,34@,38V+C$W(%1D("@U.3 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C$U(#$V
M-BXQ-R!49" H-#@U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 HP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU-RXU," Q-3@N,3 @
M,C(N-S<@+3DN,#D@<F4@9@HO1U,P(&=S"G$@," P(# @<F<@0E0@-3<N-3 @
M,34Q+C$W(%1D("A/=&AE<BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-30N,34@,34Q+C$W(%1D("@S,3@I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30S+C$U(#$U,2XQ
M-R!49" H,S0T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Y,"XU," Q,S8N,3<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#0V+C8U(#$S-BXQ-R!49" H."PW
M-C<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#<Y+C4P(#$S-BXQ-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S4N-C4@,3,V+C$W(%1D("@Y+#(W-BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*96YD<W1R96%M"F5N9&]B:@HQ-3,@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q-30@,"!2/CX*96YD;V)J"C$U-" P(&]B:@H\/"],96YG
M=&@@,38S-#8^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$S+C@U(#<V,"XW-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,"XW-2!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#(Y.2XU,R W-C N-S4@5&0@*"!(14%,*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,"XW-2!49" H5$A#05)%+"!)3D,N
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W
M-2XS," W-#@N-S4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4
M(#(Q,2XU,B W-#@N-S4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,3@N,#$@-S0X+C<U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P
M(')G($)4(#(X."XQ,2 W-#@N-S4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S0X+C<U(%1D("@@4U0I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S0X+C<U(%1D("A!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@W+C<V(#<T."XW-2!49" H5$5-14Y44RD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@
M-S,V+C<U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,3(N-S4@5&0@*#@N
M($1E8G0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 R-BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @5&0@*%1H92!#
M;VUP86YY)W,@;&]N9RUT97)M(&1E8G0@8V]N<VES=',@;V8@=&AE(&9O;&QO
M=VEN9SJ@*2!4:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C4P+C P(#8S,2XV," R-3<N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#<N,# @
M-C,Q+C8P(#(U-BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#8P,2XV," R-3<N,# @
M+3(T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,#<N,# @-C Q+C8P(#4U+C P("TR-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8R
M+C P(#8P,2XV," T+C P("TR-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S8V+C P(#8P,2XV," V-"XP
M," M,C0N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0S,"XP," V,#$N-C @,3 N,# @+3(T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M-# N,# @-C Q+C8P(#4U+C P("TR-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DU+C P(#8P,2XV," T
M+C P("TR-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DY+C P(#8P,2XV," V-"XP," M,C0N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C P(#4V,BXV," R-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,#<N,# @-38R+C8P
M(#4U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S8R+C P(#4V,BXV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S8V+C P(#4V,BXV," V-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S,"XP," U-C(N
M-C @,3 N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-# N,# @-38R+C8P(#4U+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#DU+C P(#4V,BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DY+C P(#4V
M,BXV," V-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,P-R V-CDN-B!M
M"C,V,B V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,S8R(#8V.2XV(&T*,S8V(#8V.2XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-C8@-C8Y+C8@;0HT,S @-C8Y+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0T," V-CDN-B!M"C0Y
M-2 V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#DU(#8V.2XV(&T*-#DY(#8V.2XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M.3D@-C8Y+C8@;0HU-C,@-C8Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,P-R V-CDN-B!M"C,V,B V
M-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S W(#8S,2XV(&T*,S8R(#8S,2XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-C8@
M-C8Y+C8@;0HT,S @-C8Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,V-B V,S$N-B!M"C0S," V,S$N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#0P(#8V.2XV(&T*-#DU(#8V.2XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-# @-C,Q
M+C8@;0HT.34@-C,Q+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-2 V-CDN-B!M"C0Y.2 V-CDN-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#DY(#8V.2XV(&T*-38S(#8V.2XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3D@-C,Q+C8@
M;0HU-C,@-C,Q+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,P-R U-C(N-B!M"C,V,B U-C(N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-#0P(#4V,BXV(&T*-#DU(#4V,BXV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3D@-38R+C8@;0HU
M-C,@-38R+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,P-R U-#@N-B!M"C,V,B U-#@N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S W(#4T-BXV(&T*,S8R(#4T-BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-C8@-38R+C8@;0HT,S @
M-38R+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,V-B U-#@N-B!M"C0S," U-#@N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S8V
M(#4T-BXV(&T*-#,P(#4T-BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-# @-30X+C8@;0HT.34@-30X
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0T," U-#8N-B!M"C0Y-2 U-#8N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DY(#4T
M."XV(&T*-38S(#4T."XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3D@-30V+C8@;0HU-C,@-30V+C8@
M; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#8W
M-"XR-R!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,C<N-C4@-C<T+C(X(%1D("A$96-E;6)E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#,W,"XX-R V-S0N,C@@5&0@*" S,2P@,C Q."D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C N-C4@
M-C<T+C(X(%1D("A$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#4P
M,RXX-R V-S0N,C@@5&0@*" S,2P@,C Q-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," V,S8N,C<@5&0@** I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$T+C(U
M(#8S-BXR."!49" H4')I;F-I<&%L*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,X-RXR," V-38N,C@@5&0@*$1E8G0I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<Y+C$U
M(#8T-BXR."!49" H27-S=6%N8V4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S@U+C@P(#8S-BXR."!49" H0V]S=',I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C(U
M(#8S-BXR."!49" H4')I;F-I<&%L*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R,"XR," V-38N,C@@5&0@*$1E8G0I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$R+C$U
M(#8T-BXR."!49" H27-S=6%N8V4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3$X+C@P(#8S-BXR."!49" H0V]S=',I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S.3(N-3 @
M-C(Q+C V(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-3DR+C$W
M(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N,C8@-3DR+C$W(%1D
M("AE<FT@3&]A;BP@:6YT97)E<W0@;V8@-"XX,"4@86YD(#,N-C$E(&%T($1E
M8V5M8F5R(#,Q+"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,BXU," U.#(N,3<@5&0@*#(P,3@@86YD(#(P,3<L(')E<W!E
M8W1I=F5L>2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,#DN-3 @-3@R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,S,"XV-2 U.#(N,C<@5&0@*#@S+#@W
M-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-C@N-3 @-3@R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0P-RXX," U.#(N,S(@5&0@*%PH-CDW*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R-BXQ-2 U
M.#(N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0T,BXU," U.#(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4X+C8U(#4X,BXR-R!49" H
M,3 P+# P,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,#$N-3 @-3@R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4T,"XX," U.#(N,S(@5&0@*%PH.#8V
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U
M.2XQ-2 U.#(N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R+C4P(#4V-RXR-R!49" H3&5S<R!C=7)R96YT
M('!O<G1I;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S,R+C,P(#4V-RXS,B!49" H7"@U+#(S-2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-3@N,34@-38W+C(W(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,38N,34@-38W+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V-2XS," U-C<N,S(@5&0@*%PH-BPX-S4I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DQ
M+C$U(#4V-RXR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30Y+C$U(#4V-RXR-R!49" HERD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," U-3(N,C<@
M5&0@*$QO;F<M=&5R;2!D96)T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P.2XU," U-3(N,C<@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,P+C8U(#4U,BXR
M-R!49" H-S@L-C0Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,V."XU," U-3(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W+C@P(#4U,BXS,B!49" H
M7"@V.3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#(V+C$U(#4U,BXR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#0R+C4P(#4U,BXR-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C,N-C4@
M-34R+C(W(%1D("@Y,RPQ,C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 Q+C4P(#4U,BXR-R!49" H)"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-# N.# @-34R+C,R
M(%1D("A<*#@V-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-3DN,34@-34R+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-3,V+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#4R-"XQ,"!49" H06UE;F1E9"!A;F0@
M4F5S=&%T960@4V5N:6]R($-R961I="!&86-I;&ET>2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U,# N,3 @5&0@
M*$]N("D@5&H@150@40IQ(# @," P(')G($)4(#8S+C8W(#4P,"XQ,"!49" H
M075G=7-T(#$L(#(P,3<L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R-#<N-3,@-3 P+C$P(%1D("A!;65N
M9&UE;G0@86YD(%)E<W1A=&5M96YT(&]F(&ET<R!#<F5D:70@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#$X+C U(#4P,"XQ,"!49" H06=R965M96YT(&1A
M=&5D($IU;F4@,C(L(#(P,38@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#0X."XQ,"!49" H7"A!;65N9&5D(&%N
M9"!297-T871E9"!#<F5D:70@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<U
M+C R(#0X."XQ,"!49" H06=R965M96YT7"DL('1O(')E9FEN86YC92!A;F0@
M:6YC<F5A<V4@=&AE(&-U<G)E;G0@86=G<F5G871E(&-O;6UI='1E9"!S:7IE
M(&]F('1H92!F86-I;&ET>2!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-#<V+C$P(%1D("@D,C$U+C @;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,#@N,SD@-#<V+C$P(%1D("@L(&EN8VQU9&EN9R!A('1E<FT@;&]A;B!O
M9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C$Q+CDX(#0W-BXQ,"!49" H)#$P,"XP(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<P+C@W(#0W-BXQ,"!4
M9" H(%PH06UE;F1E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3<N.#D@
M-#<V+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(S+C,P(#0W
M-BXQ,"!49" H97)M($QO86Y<*2!A;F0@82 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,SDQ+C8P(#0W-BXQ,"!49" H)#$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#$N,C,@-#<V+C$P(%1D("@Q-2XP
M(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#4P+C$S(#0W-BXQ,"!49" H(')E=F]L=FEN9R!C<F5D:70@9F%C
M:6QI='D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0V-"XQ,"!49" H7"A!;65N9&5D(%)E=F]L=FEN9R!#<F5D
M:70@1F%C:6QI='E<*2!<*'1O9V5T:&5R('=I=&@@=&AE("D@5&H@150@40IQ
M(# @," P(')G($)4(#(W-2XR.2 T-C0N,3 @5&0@*$%M96YD960@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S$V+C0X(#0V-"XQ,"!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#,R,2XX.2 T-C0N,3 @5&0@*&5R;2!,;V%N+"!T
M:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<Y+C8U(#0V-"XQ,"!49" H
M06UE;F1E9"!#<F5D:70@1F%C:6QI=&EE<UPI+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T.3,N,S,@-#8T+C$P(%1D("A4:&4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3$P+C@S(#0V-"XQ,"!49" H06UE;F1E9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#4R+C$P
M(%1D("A2979O;'9I;F<@0W)E9&ET($9A8VEL:71Y(&EN8VQU9&5S(&$@<W5B
M9F%C:6QI='D@9F]R('-W:6YG;&EN92!L;V%N<R!U<"!T;R!A;B!A;6]U;G0@
M;F]T('1O(&5X8V5E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#0S+C@W(#0U,BXQ,"!49" H)#$U+C @;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3<N
M-S8@-#4R+C$P(%1D("@L(&%N9"!A("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,C8N-C,@-#4R+C$P(%1D("@D,S4N," I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-#0P+C$P(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#<X+C,Y(#0T,"XQ,"!49" H('-U8FQI;6ET
M(&9O<B!T:&4@:7-S=6%N8V4@;V8@<W1A;F1B>2!L971T97)S(&]F(&-R961I
M="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDQ+C(Q(#0T,"XQ,"!49" H
M5&AE('!R;V-E961S(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-3@N,3,@-#0P+C$P(%1D("@D,3 V+C4@;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,3<N,#(@-#0P+C$P(%1D("@@9G)O;2!T:&ES(')E9FEN86YC:6YG(&EN8VQU
M9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-#,N,S<@-#0P+C$P(%1D("@D-BXU("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,C@N,3 @5&0@*&UI;&QI
M;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-S@N,SD@-#(X+C$P(%1D("@@=6YD97(@=&AE(&YE=R!R979O;'9I;F<@8W)E
M9&ET(&9A8VEL:71Y(&%N9"!W97)E('5S960@=&\@<F5P87D@8F]R<F]W:6YG
M<R!U;F1E<B!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-C$N,S,@-#(X+C$P(%1D("AS(#(P,38@4V5N:6]R($-R961I=" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#$V
M+C$P(%1D("A&86-I;&ET:65S(%PH9&5F:6YE9"!B96QO=UPI+"!A<R!W96QL
M(&%S('1O('!A>2!R96QA=&5D(&EN=&5R97-T+"!F965S+"!A;F0@97AP96YS
M97,@;V8@=&AE('1R86YS86-T:6]N+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S.3(N,3 @5&0@*$EN(&%D9&ET
M:6]N('1O(&EN8W)E87-I;F<@=&AE('-I>F4@;V8@=&AE(&9A8VEL:71I97,L
M('1H92!M871U<FET>2!D871E('=A<R!E>'1E;F1E9"!T;R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.#,N.#0@,SDR+C$P(%1D("A!=6=U<W0@,2P@,C R
M,BX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4P+C U(#,Y,BXQ,"!49" H
M5&AE("D@5&H@150@40IQ(# @," P(')G($)4(#0V-RXU-2 S.3(N,3 @5&0@
M*$%M96YD960@86YD(%)E<W1A=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S.# N,3 @5&0@*$-R961I=" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" W-BXT-" S.# N,3 @5&0@*$%G<F5E
M;65N="!A;'-O(&EN8VQU9&5S(&%N(&%C8V]R9&EO;B!F96%T=7)E('!E<FUI
M='1I;F<@=&AE($-O;7!A;GDI(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3DN
M,#,@,S@P+C$P(%1D("@L('-U8FIE8W0@=&\@8V5R=&%I;B!C;VYD:71I;VYS
M+"!T;R!I;F-R96%S92!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#,V."XQ,"!49" H86=G<F5G871E(&%M
M;W5N="!O9B!T:&4@8V]M;6ET;65N=',@=6YD97(@=&AE("D@5&H@150@40IQ
M(# @," P(')G($)4(#(T-2XR." S-C@N,3 @5&0@*$%M96YD960@4F5V;VQV
M:6YG($-R961I="!&86-I;&ET>2!O<B!E<W1A8FQI<V@@;VYE(&]R(&UO<F4@
M861D:71I;VYA;"!T97)M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," S-38N,3 @5&0@*&QO86YS(&EN(&%N(&%G
M9W)E9V%T92!A;6]U;G0@;F]T('1O(&5X8V5E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C(T+CDY(#,U-BXQ,"!49" H
M)#4P+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" R-S@N.#@@,S4V+C$P(%1D("@@=VET:"!O<'1I;VYA;"!A
M9&1I=&EO;F%L(&-O;6UI=&UE;G1S(&9R;VT@97AI<W1I;F<@;&5N9&5R<R!O
M<B!N97<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,T-"XQ,"!49" H8V]M;6ET;65N=',@9G)O;2!A9&1I=&EO
M;F%L(&QE;F1E<G,N($]T:&5R('1E<FUS(&%N9"!P<FEC:6YG(&%R92!S=6)S
M=&%N=&EA;&QY('-I;6EL87(@=&\@=&AE(#(P,38@0W)E9&ET("D@5&H@150@
M40IQ(# @," P(')G($)4(#0W-"XY-B S-#0N,3 @5&0@*$%G<F5E;65N="!<
M*&1E9FEN960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#,S,BXQ,"!49" H8F5L;W=<*2XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S X+C$P(%1D
M("A";W)R;W=I;F=S('5N9&5R('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q,S@N-C8@,S X+C$P(%1D("A!;65N9&5D("D@5&H@150@40IQ(# @," P
M(')G($)4(#$W.2XX-2 S,#@N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q.#4N,C8@,S X+C$P(%1D("AE<FT@3&]A;B!A<F4@<&%Y86)L92!I
M;B!Q=6%R=&5R;'D@:6YS=&%L;&UE;G1S+"!W:&EC:"!C;VUM96YC960@2F%N
M=6%R>2 R+" R,#$X+"!P<F]V:61E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,CDV+C$P(%1D("AT:&%T+"!T
M;R!T:&4@97AT96YT(&YO="!P<F5V:6]U<VQY('!A:60L('1H92!A9V=R96=A
M=&4@=6YP86ED('!R:6YC:7!A;"!B86QA;F-E('=O=6QD(&)E(&1U92!A;F0@
M<&%Y86)L92!O;B!T:&4@;6%T=7)I='D@9&%T92X@26X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X-"XQ,"!4
M9" H861D:71I;VX@=&\@:71S('-C:&5D=6QE9"!P87EM96YT<RP@:6X@8F]T
M:"!T:&4@=&AI<F0@86YD(&9O=7)T:"!Q=6%R=&5R<R!O9B R,#$X+"!T:&4@
M0V]M<&%N>2!M861E(&]P=&EO;F%L('!R97!A>6UE;G1S(&]F("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-S(N
M,3 @5&0@*"0U+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Y."XS.2 R-S(N,3 @5&0@*"!E86-H(&%S('!E
M<FUI='1E9"!B>2!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C P+C R
M(#(W,BXQ,"!49" H06UE;F1E9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@
M150@40IQ(# @," P(')G($)4(#,R,BXR,2 R-S(N,3 @5&0@*$%G<F5E;65N
M="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<Q+C0V(#(W,BXQ,"!49" H
M5&AE($-O;7!A;GD@:&%S('1H92!R:6=H="!A="!A;GD@=&EM92!A;F0@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(V,"XQ,"!49" H9G)O;2!T:6UE('1O('1I;64@=&\@<')E<&%Y(&%N>2!B
M;W)R;W=I;F<L(&EN('=H;VQE(&]R(&EN('!A<G0L('=I=&AO=70@<')E;6EU
M;2!O<B!P96YA;'1Y*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$U+CDY(#(V
M,"XQ,"!49" H+"!B>2!G:79I;F<@=W)I='1E;B!N;W1I8V4@7"AO<B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,C0X+C$P(%1D("AT96QE<&AO;FEC(&YO=&EC92!P<F]M<'1L>2!C;VYF:7)M
M960@:6X@=W)I=&EN9UPI+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-3 N
M-C8@,C0X+C$P(%1D("A4:&4@0V]M<&%N>2!I<R!R97%U:7)E9"!T;R!P<F5P
M87D@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#0P.2XR,R R-#@N,3 @
M5&0@*$%M96YD960@0W)E9&ET($9A8VEL:71I97,@=6YD97(@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(S-BXQ
M,"!49" H8V5R=&%I;B!C:7)C=6US=&%N8V5S(&EN8VQU9&EN9R!F<F]M(&YE
M="!C87-H('!R;V-E961S(&9R;VT@87-S970@<V%L97,@;W(@9&ES<&]S:71I
M;VYS(&EN(&5X8V5S<R!O9B!C97)T86EN('1H<F5S:&]L9',L(&%S('=E;&P@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(R-"XQ,"!49" H87,@9G)O;2!N970@8V%S:"!P<F]C965D<R!F<F]M
M('1H92!I<W-U86YC92!O9B!C97)T86EN(&1E8G0@8GD@=&AE($-O;7!A;GDI
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S-30N,#,@,C(T+C$P(%1D("@N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(P,"XQ,"!49" H07,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#<S+CDT(#(P,"XQ,"!49" H1&5C96UB97*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,34R+C4S(#(P,"XQ,"!49" H+"!T:&4@86=G<F5G871E('-C:&5D=6QE
M9"!M871U<FET:65S(&]F(&1E8G0@87)E(&%S(&9O;&QO=W,Z*2!4:B!%5"!1
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#$W
M,RXV," S.3 N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,SDN,# @,3<S+C8P(#$R,RXP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0Y+C P(#$T,RXV," S.3 N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,SDN
M,# @,30S+C8P(#$R,RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#$Q,RXV," S.3 N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,SDN,# @,3$S+C8P(#$R,RXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y+C P(#@S+C8P(#,Y,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S.2XP," X,RXV," Q
M,C,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,SD@,3<S+C8P,# P,# P
M,# P,# R(&T*-38R(#$W,RXV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,Y(#8X
M+C8P,# P,# P,# P,# R(&T*-38R(#8X+C8P,# P,# P,# P,# R(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT,SD@-30N-C P,# P,# P,# P,#(@;0HU-C(@-30N-C P,# P,# P,# P
M,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S.2 U,BXV,# P,# P,# P,# P,B!M"C4V,B U,BXV,# P
M,# P,# P,# P,B!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#<V+C$U(#$W."XR."!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#0X,2XY," Q-S@N,C@@5&0@*&5R;2!,;V%N*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4X+C P(#$V,RXP-B!49" H7"AA
M;6]U;G1S(&EN('1H;W5S86YD<UPI*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4Q+C4P(#$T."XR."!49" H5&AR*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-C<N.3D@,30X+C(X(%1D("AO=6=H("D@5&H@
M150@40IQ(# @," P(')G($)4(#DQ+C(T(#$T."XR."!49" H62D@5&H@150@
M40IQ(# @," P(')G($)4(#DW+C,U(#$T."XR."!49" H96%R<R!%;F1I;F<@
M1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.30N,S@@,30X+C(X
M(%1D("B@,S$Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#8S+C4P(#$S,RXR-R!49" H,C Q.2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N-3 @,3,S+C(W(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M-2XV-2 Q,S,N,C<@5&0@*#4L,C,U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#8S+C4P(#$Q."XR-R!49" H,C R,"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N-C4@
M,3$X+C(W(%1D("@U+#8W,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" V,RXU," Q,#,N,C<@5&0@*#(P,C$I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U(#$P,RXR
M-R!49" H-BPY.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-C,N-3 @.#@N,C<@5&0@*#(P,C(I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C8U(#@X+C(W(%1D("@V
M-2PY.3 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-C,N-3 @-S,N,C<@5&0@*#(P,C,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-30X+C$U(#<S+C(W(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<U+C4P(#4X
M+C(W(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.# N.3$@-3@N,C<@
M5&0@*&]T86PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0Q+C4P(#4X+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S,"XV-2 U."XR-R!49" H.#,L.#<V
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IE;F1S=')E86T*96YD;V)J
M"C$U-2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@,2 P(%(*+TUE9&EA
M0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T
M871E(# *+T-O;G1E;G1S(#$U-B P(%(^/@IE;F1O8FH*,34V(# @;V)J"CP\
M+TQE;F=T:" R,S$R-CX^"G-T<F5A;0I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" R,3,N.#4@-S8P+C<U(%1D("A#4D]34R!#3U5.5%(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R.3(N-C@@-S8P+C<U(%1D("A9*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,CDY+C4S(#<V,"XW-2!49" H($A%04PI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,CDN-#4@-S8P+C<U(%1D("A42$-!4D4L
M($E.0RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3<U+C,P(#<T."XW-2!49" H3D]415,@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C$Q+C4R(#<T."XW-2!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#(Q."XP,2 W-#@N-S4@5&0@*$\@0T].4T],241!*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C@X+C$Q(#<T."XW-2!49" H5$5$($9)3D%.0TE!3"D@
M5&H@150@40IQ(# @," P(')G($)4(#,V-RXR.2 W-#@N-S4@5&0@*"!35"D@
M5&H@150@40IQ(# @," P(')G($)4(#,X,2XR." W-#@N-S4@5&0@*$$I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S.#<N-S8@-S0X+C<U(%1D("A414U%3E13
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U
M."XS-2 W,S8N-S4@5&0@*$1%0T5-0D52H#,Q+" R,#$X*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<Q,BXW-2!4
M9" H."X@1&5B="!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H1BT@,C<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-CDU+C$P(%1D("A3=6)J96-T('1O('1H92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,#8N-#0@-CDU+C$P(%1D("A!;65N9&5D(&%N9"!297-T871E
M9"!#<F5D:70@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(X+C8S(#8Y-2XQ
M,"!49" H06=R965M96YT+"!T:&4@0V]M<&%N>2!P87ES(&EN=&5R97-T(&]N
M.B!<*&E<*2!E86-H($)A<V4@4F%T92!,;V%N(&%T('1H92!"87-E("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M.#,N,3 @5&0@*%)A=&4@7"AA<R!D969I;F5D('1H97)E:6Y<*2!P;'5S('1H
M92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#,N.3 @-C@S+C$P(%1D("A!
M<'!L:6-A8FQE($UA<BD@5&H@150@40IQ(# @," P(')G($)4(#(T-BXW-2 V
M.#,N,3 @5&0@*&=I;B!I;B!E9BD@5&H@150@40IQ(# @," P(')G($)4(#(W
M.2XY," V.#,N,3 @5&0@*&9E8W0@9G)O;2!T:6UE('1O('1I;64[(%PH:6E<
M*2!E86-H($Q)0D]2($EN9&5X(%)A=&4@3&]A;B!A="!T:&4@3VYE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M-S$N,3 @5&0@*$UO;G1H($Q)0D]2($EN9&5X(%)A=&4@7"AA<R!D969I;F5D
M('1H97)E:6Y<*2!P;'5S('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M-S N.#0@-C<Q+C$P(%1D("A!<'!L:6-A8FQE($UA<BD@5&H@150@40IQ(# @
M," P(')G($)4(#,S,RXV.2 V-S$N,3 @5&0@*&=I;B!I;B!E9BD@5&H@150@
M40IQ(# @," P(')G($)4(#,V-BXX,R V-S$N,3 @5&0@*&9E8W0@9G)O;2!T
M:6UE('1O('1I;64[(&%N9"!<*&EI:5PI(&5A8V@@175R;V1O;&QA<B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-C4Y+C$P(%1D("A,;V%N(&%T('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Y-BXT,R V-3DN,3 @5&0@*$%D:G5S=&5D($Q)0D]2(&9O<B!T:&4@87!P
M;&EC86)L92!);G1E<F5S="!097)I;V0@7"AA<R!D969I;F5D('1H97)E:6Y<
M*2!I;B!E9BD@5&H@150@40IQ(# @," P(')G($)4(#,Y.2XR," V-3DN,3 @
M5&0@*&9E8W0@9F]R('-U8V@@3&]A;B!P;'5S('1H92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,#@N,#8@-C4Y+C$P(%1D("A!<'!L:6-A8FQE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M-#<N,3 @5&0@*$UA<BD@5&H@150@40IQ(# @," P(')G($)4(#8U+CDX(#8T
M-RXQ,"!49" H9VEN(&EN(&5F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3DN
M,3(@-C0W+C$P(%1D("AF96-T(&9R;VT@=&EM92!T;R!T:6UE+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q.3$N-CD@-C0W+C$P(%1D("A4:&4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C Y+C$Y(#8T-RXQ,"!49" H07!P;&EC86)L
M92!-87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S(N,#0@-C0W+C$P(%1D
M("AG:6XL(&%S(&]F(&%N>2!D871E+"!I<R!A('!E<F-E;G1A9V4@<&5R(&%N
M;G5M(&1E=&5R;6EN960@8GD@<F5F97)E;F-E("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,S4N,3 @5&0@*'1O
M('1H92!A<'!L:6-A8FQE($-O;G-O;&ED871E9"!.970@3&5V97)A9V4@4F%T
M:6\@7"AA<R!D969I;F5D(&)Y('1H92!A9W)E96UE;G1<*2!I;B!E9BD@5&H@
M150@40IQ(# @," P(')G($)4(#,Y,RXS-2 V,S4N,3 @5&0@*&9E8W0@;VX@
M<W5C:"!D871E(&%S('-E="!F;W)T:"!I;B!T:&4@=&%B;&4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8R,RXQ
M,"!49" H8F5L;W<I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,RXR.2 V,C,N
M,3 @5&0@*"XI(%1J($54(%$*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-C(@-C P+C8@;0HV,B U-3@N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,3$T(#8P,"XV(&T*,3$T(#4U."XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HV,B V,# N-B!M"C$Q
M-" V,# N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-C(@-34X+C8@;0HQ,30@-34X+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q
M-" V,# N-B!M"C$Q-" U-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#8P,"XV(&T*,C<W(#4U
M."XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HQ,30@-C P+C8@;0HR-S<@-C P+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" U
M-3@N-B!M"C(W-R U-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#8P,"XV(&T*,C<W(#4U."XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS-S(@-C P+C8@;0HS-S(@-34X+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(W-R V,# N
M-B!M"C,W,B V,# N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#4U."XV(&T*,S<R(#4U."XV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HS-S(@-C P+C8@;0HS-S(@-34X+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." V,# N-B!M
M"C0U." U-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,S<R(#8P,"XV(&T*-#4X(#8P,"XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-S(@-34X+C8@;0HT-3@@-34X+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." V,# N-B!M"C0U
M." U-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-30Y(#8P,"XV(&T*-30Y(#4U."XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M-3@@-C P+C8@;0HU-#D@-C P+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." U-3@N-B!M"C4T.2 U
M-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-C(@-34X+C8@;0HV,B U-#,N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3$T(#4U
M."XV(&T*,3$T(#4T,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HV,B U-3@N-B!M"C$Q-" U-3@N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-C(@-30S+C8@;0HQ,30@-30S+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" U-3@N-B!M
M"C$Q-" U-#,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,C<W(#4U."XV(&T*,C<W(#4T,RXV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HQ,30@-34X+C8@;0HR-S<@-34X+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" U-#,N-B!M"C(W
M-R U-#,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,C<W(#4U."XV(&T*,C<W(#4T,RXV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M-S(@-34X+C8@;0HS-S(@-30S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(W-R U-3@N-B!M"C,W,B U
M-3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,C<W(#4T,RXV(&T*,S<R(#4T,RXV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@
M-34X+C8@;0HS-S(@-30S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." U-3@N-B!M"C0U." U-#,N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S<R(#4U."XV(&T*-#4X(#4U."XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-30S
M+C8@;0HT-3@@-30S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." U-3@N-B!M"C0U." U-#,N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-30Y(#4U."XV(&T*-30Y(#4T,RXV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-3@@-34X+C8@
M;0HU-#D@-34X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0U." U-#,N-B!M"C4T.2 U-#,N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-C(@-30S+C8@;0HV,B U,3<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3$T(#4T,RXV(&T*,3$T
M(#4Q-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HV,B U-#,N-B!M"C$Q-" U-#,N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-C(@
M-3$W+C8@;0HQ,30@-3$W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" U-#,N-B!M"C$Q-" U,3<N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,C<W(#4T,RXV(&T*,C<W(#4Q-RXV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HQ,30@-30S
M+C8@;0HR-S<@-30S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" U,3<N-B!M"C(W-R U,3<N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,C<W(#4T,RXV(&T*,C<W(#4Q-RXV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-30S+C8@
M;0HS-S(@-3$W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C(W-R U-#,N-B!M"C,W,B U-#,N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,C<W(#4Q-RXV(&T*,S<R(#4Q-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-30S+C8@;0HS
M-S(@-3$W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0U." U-#,N-B!M"C0U." U,3<N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S<R(#4T,RXV(&T*-#4X(#4T,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-3$W+C8@;0HT-3@@
M-3$W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0U." U-#,N-B!M"C0U." U,3<N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-30Y
M(#4T,RXV(&T*-30Y(#4Q-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-3@@-30S+C8@;0HU-#D@-30S
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0U." U,3<N-B!M"C4T.2 U,3<N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-C(@-3$W
M+C8@;0HV,B T.3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,3$T(#4Q-RXV(&T*,3$T(#0Y,2XV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HV,B U,3<N-B!M"C$Q-" U,3<N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-C(@-#DQ+C8@;0HQ
M,30@-#DQ+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C$Q-" U,3<N-B!M"C$Q-" T.3$N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,C<W(#4Q-RXV(&T*,C<W(#0Y,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HQ,30@-3$W+C8@;0HR-S<@
M-3$W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C$Q-" T.3$N-B!M"C(W-R T.3$N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W
M(#4Q-RXV(&T*,C<W(#0Y,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-3$W+C8@;0HS-S(@-#DQ
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C(W-R U,3<N-B!M"C,W,B U,3<N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0Y
M,2XV(&T*,S<R(#0Y,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-3$W+C8@;0HS-S(@-#DQ+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0U." U,3<N-B!M"C0U." T.3$N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<R(#4Q-RXV
M(&T*-#4X(#4Q-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HS-S(@-#DQ+C8@;0HT-3@@-#DQ+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0U." U,3<N-B!M"C0U." T.3$N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-30Y(#4Q-RXV(&T*
M-30Y(#0Y,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT-3@@-3$W+C8@;0HU-#D@-3$W+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0U." T.3$N-B!M"C4T.2 T.3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-C(@-#DQ+C8@;0HV,B T
M-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,3$T(#0Y,2XV(&T*,3$T(#0V-2XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HV,B T
M.3$N-B!M"C$Q-" T.3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-C(@-#8U+C8@;0HQ,30@-#8U+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C$Q-" T.3$N-B!M"C$Q-" T-C4N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0Y,2XV
M(&T*,C<W(#0V-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HQ,30@-#DQ+C8@;0HR-S<@-#DQ+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C$Q-" T-C4N-B!M"C(W-R T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0Y,2XV(&T*
M,C<W(#0V-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HS-S(@-#DQ+C8@;0HS-S(@-#8U+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C(W-R T.3$N-B!M"C,W,B T.3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0V-2XV(&T*,S<R
M(#0V-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HS-S(@-#DQ+C8@;0HS-S(@-#8U+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U
M." T.3$N-B!M"C0U." T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<R(#0Y,2XV(&T*-#4X(#0Y
M,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS-S(@-#8U+C8@;0HT-3@@-#8U+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." T
M.3$N-B!M"C0U." T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-30Y(#0Y,2XV(&T*-30Y(#0V-2XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HT-3@@-#DQ+C8@;0HU-#D@-#DQ+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." T-C4N
M-B!M"C4T.2 T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-C(@-#8U+C8@;0HV,B T-3 N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,3$T(#0V-2XV(&T*,3$T(#0U,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HV,B T-C4N-B!M"C$Q
M-" T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-C(@-#4P+C8@;0HQ,30@-#4P+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q
M-" T-C4N-B!M"C$Q-" T-3 N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0V-2XV(&T*,C<W(#0U
M,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HQ,30@-#8U+C8@;0HR-S<@-#8U+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$Q-" T
M-3 N-B!M"C(W-R T-3 N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0V-2XV(&T*,C<W(#0U,"XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS-S(@-#8U+C8@;0HS-S(@-#4P+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C(W-R T-C4N
M-B!M"C,W,B T-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,C<W(#0U,"XV(&T*,S<R(#0U,"XV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HS-S(@-#8U+C8@;0HS-S(@-#4P+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." T-C4N-B!M
M"C0U." T-3 N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,S<R(#0V-2XV(&T*-#4X(#0V-2XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-S(@-#4P+C8@;0HT-3@@-#4P+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." T-C4N-B!M"C0U
M." T-3 N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-30Y(#0V-2XV(&T*-30Y(#0U,"XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M-3@@-#8U+C8@;0HU-#D@-#8U+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0U." T-3 N-B!M"C4T.2 T
M-3 N-B!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S4N
M.# @-38S+C(X(%1D("A,979E;"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q,C0N,S @-38S+C(X(%1D("A#;VYS;VQI9&%T
M960@3F5T($QE=F5R86=E(%)A=&EO*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(X-2XP," U.3$N,S,@5&0@*$5U<BD@5&H@
M150@40IQ(# @," P(')G($)4(#,P,2XU." U.3$N,S,@5&0@*&]D;VQL87(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S$N.38@-3DQ+C,S(%1D("@@3&]A
M;G,L*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(X,RXQ-2 U.#$N,S,@5&0@*$Q)0D]2($EN9&5X(%)A=&4I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@Q+C<P(#4W,2XS
M,R!49" H3&]A;G,@86YD($QE='1E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#,U-2XU," U-S$N,S,@5&0@*"!O9BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,#$N-#4@-38Q+C,S(%1D("A#<BD@5&H@
M150@40IQ(# @," P(')G($)4(#,Q,RXP,B U-C$N,S,@5&0@*&5D:70@1F5E
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W
M."XY," U-C,N,C@@5&0@*$)A<V4@4F%T92!,;V%N<RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C4N.3 @-38S+C(X(%1D
M("A#;VUM:71M96YT($9E92D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-2XX," U-#@N,C<@5&0@*$DI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,34U+C@P(#4T."XR-R!4
M9" H3&5S<R!T:&%N(#$N-3 Z,2XP,"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,3$N,#4@-30X+C(W(%1D("@Q+C<U)2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#$N
M-34@-30X+C(W(%1D("@P+C<U)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.3 N,#4@-30X+C(W(%1D("@P+C(U)2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-"XQ-2 U
M,C(N,C<@5&0@*$E)*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$R-RXS-2 U,S(N,C<@5&0@*$=R96%T97(@=&AA;B!O<B!E
M<75A;"!T;R Q+C4P.C$N,# @*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$T.2XX-2 U,C(N,C<@5&0@*&)U="!L97-S('1H
M86X@,BXP,#HQ+C P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,Q,2XP-2 U,C(N,C<@5&0@*#(N,# E*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,2XU-2 U,C(N,C<@
M5&0@*#$N,# E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y,"XP-2 U,C(N,C<@5&0@*# N,S E*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@R+C4P(#0Y-BXR-R!49" H
M24E)*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$R-RXS-2 U,#8N,C<@5&0@*$=R96%T97(@=&AA;B!O<B!E<75A;"!T;R R
M+C P.C$N,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,30X+C8P(#0Y-BXR-R!49" H(&)U="!L97-S('1H86X@,BXU,#HQ
M+C P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,Q,2XP-2 T.38N,C<@5&0@*#(N,C4E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P,2XU-2 T.38N,C<@5&0@*#$N,C4E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M,"XP-2 T.38N,C<@5&0@*# N,S E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@R+C,P(#0W,"XR-R!49" H258I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(W+C,U(#0X
M,"XR-R!49" H1W)E871E<B!T:&%N(&]R(&5Q=6%L('1O(#(N-3 Z,2XP,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-#@N
M-C @-#<P+C(W(%1D("@@8G5T(&QE<W,@=&AA;B S+C P.C$N,# I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$Q+C U(#0W
M,"XR-R!49" H,BXU,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-# Q+C4U(#0W,"XR-R!49" H,2XU,"4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C U(#0W,"XR
M-R!49" H,"XS-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#,N.34@-#4U+C(W(%1D("A6*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R-RXS-2 T-34N,C<@5&0@*$=R
M96%T97(@=&AA;B!O<B!E<75A;"!T;R S+C P.C$N,# I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S$Q+C U(#0U-2XR-R!4
M9" H,BXW-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# Q+C4U(#0U-2XR-R!49" H,2XW-24I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C U(#0U-2XR-R!49" H
M,"XT,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0R-RXQ,"!49" H07,@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<S
M+CDT(#0R-RXQ,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,34R+C4S(#0R-RXQ,"!4
M9" H+"!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<Q+C8Y(#0R-RXQ
M,"!49" H06UE;F1E9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3(N.#D@
M-#(W+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C,P(#0R
M-RXQ,"!49" H97)M($QO86X@86YD("D@5&H@150@40IQ(# @," P(')G($)4
M(#(W-2XW." T,C<N,3 @5&0@*$%M96YD960@4F5V;VQV:6YG($-R961I="!&
M86-I;&ET>2!B;W)E(&EN=&5R97-T(&%T(&$@<F%T92!E<75A;"!T;R!/;F4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#0Q-2XQ,"!49" H36]N=&@@3$E"3U(@<&QU<R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3,P+C,T(#0Q-2XQ,"!4
M9" H,BXU,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,34V+C$W(#0Q-2XQ,"!49" H+B I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-C N.3D@-#$U+C$P(%1D("A4:&4@:6YT97)E<W0@<F%T92!I<R!S
M=6)J96-T('1O(&%N(&EN8W)E87-E(&]F("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S,S8N-S4@-#$U+C$P(%1D("@R+C P
M)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-C(N-3@@-#$U+C$P(%1D("@@:68@86X@979E;G0@;V8@9&5F875L="!E>&ES
M=',@=6YD97(@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#4Q-2XU.2 T
M,34N,3 @5&0@*$%M96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#0P,RXQ,"!49" H86YD(%)E<W1A=&5D
M($-R961I=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S N,S(@-# S+C$P
M(%1D("A!9W)E96UE;G0N("D@5&H@150@40IQ(# @," P(')G($)4(#$W.2XU
M-B T,#,N,3 @5&0@*%1H92!#;VUP86YY(&ES(')E<75I<F5D('1O('!A>2!A
M(&-O;6UI=&UE;G0@9F5E(&]N('1H92!A=F5R86=E(&1A:6QY('5N=7-E9"!P
M;W)T:6]N(&]F('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,SDQ+C$P(%1D("A!;65N9&5D(%)E=F]L=FEN
M9R!#<F5D:70@1F%C:6QI='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3(N
M-#0@,SDQ+C$P(%1D("@L(&)A<V5D(&]N('1H92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-#DN,S<@,SDQ+C$P(%1D("A!<'!L:6-A8FQE($UA<BD@5&H@
M150@40IQ(# @," P(')G($)4(#,Q,BXR,B S.3$N,3 @5&0@*&=I;B!W:&EC
M:"!I<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S8S+C8Q(#,Y,2XQ,"!49" H,"XS-24I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S@Y+C0T(#,Y,2XQ,"!49" H(&%S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,3,N-C @,SDQ+C$P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3(N,3D@,SDQ
M+C$P(%1D("@N($1U<FEN9R!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,W.2XQ,"!49" H=&AR964@;6]N
M=&AS(&5N9&5D($UA<F-H(#,Q+" R,#$X+"!T:&4@0V]M<&%N>2!E;G1E<F5D
M(&EN=&\@86X@:6YT97)E<W0@<F%T92!S=V%P('1O(')E9'5C92!I=',@97AP
M;W-U<F4@=&\@9FQU8W1U871I;VYS(&EN('1H92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S8W+C$P(%1D("AI
M;G1E<F5S="!R871E<R!A<W-O8VEA=&5D('=I=&@@:71S(&1E8G0L('=H:6-H
M('=A<R!E9BD@5&H@150@40IQ(# @," P(')G($)4(#(U,RXT,R S-C<N,3 @
M5&0@*&9E8W1I=F4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@R+C4X(#,V
M-RXQ,"!49" H07!R:6P@,BP@,C Q."X@4V5E($YO=&4@.2 M($1E<FEV871I
M=F5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," S-#,N,3 @5&0@*%1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" V-RXP," S-#,N,3 @5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-R961I
M=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#DN,3D@,S0S+C$P(%1D("A!
M9W)E96UE;G0@8V]N=&%I;G,@8W5S=&]M87)Y(')E<')E<V5N=&%T:6]N<RP@
M=V%R<F%N=&EE<RP@86YD(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4R
M+C@P(#,T,RXQ,"!49" H9FER;6%T:79E(&-O=F5N86YT<RX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3,V+C<U(#,T,RXQ,"!49" H5&AE("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,S$N
M,3 @5&0@*$%M96YD960@86YD(%)E<W1A=&5D($-R961I=" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-S$N-CD@,S,Q+C$P(%1D("A!9W)E96UE;G0@86QS
M;R!C;VYT86EN<R!C=7-T;VUA<GD@;F5G871I=F4@8V]V96YA;G1S+"!S=6)J
M96-T('1O('-O;64@97AC97!T:6]N<RP@;VXZ(%PH:5PI("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,3DN,3 @
M5&0@*&EN9&5B=&5D;F5S<R!A;F0@<')E9F5R<F5D(&5Q=6ET>3L@7"AI:5PI
M(&QI96YS.R!<*&EI:5PI(&9U;F1A;65N=&%L(&-H86YG97,[(%PH:79<*2!I
M;G9E<W1M96YT<SL@7"AV7"D@<F5S=')I8W1E9"!P87EM96YT<SL@86YD(%PH
M=FE<*2!S86QE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," S,#<N,3 @5&0@*&]F(&%S<V5T<R!A;F0@8V5R=&%I
M;B!O=&AE<B!R97-T<FEC=&EV92!A9W)E96UE;G1S+B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-#@N-C@@,S W+C$P(%1D("A4:&4@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C8V+C$W(#,P-RXQ,"!49" H06UE;F1E9"!A;F0@4F5S
M=&%T960@0W)E9&ET("D@5&H@150@40IQ(# @," P(')G($)4(#,X."XS-R S
M,#<N,3 @5&0@*$%G<F5E;65N="!A;'-O(&-O;G1A:6YS(&-U<W1O;6%R>2!E
M=F5N=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(Y-2XQ,"!49" H;V8@9&5F875L="P@<W5C:"!A<R!P87EM
M96YT(&1E9F%U;'1S+"!C<F]S<RUD969A=6QT<R!T;R!O=&AE<B!M871E<FEA
M;"!I;F1E8G1E9&YE<W,L(&)A;FMR=7!T8WD@86YD(&EN<V]L=F5N8WDI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.#@N-S(@,CDU+C$P(%1D("@L('1H92!O
M8V-U<G)E;F-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," R.#,N,3 @5&0@*&]F(&$@9&5F:6YE9"!C:&%N9V4@
M:6X@8V]N=')O;"!A;F0@=&AE(&9A:6QU<F4@=&\@;V)S97)V92!T:&4@;F5G
M871I=F4@8V]V96YA;G1S(&%N9"!O=&AE<B!C;W9E;F%N=',@<F5L871E9"!T
M;R!T:&4@;W!E<F%T:6]N(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," R-S$N,3 @5&0@*'1H92!#;VUP86YY
MDBD@5&H@150@40IQ(# @," P(')G($)4(#$P-2XX." R-S$N,3 @5&0@*',@
M8G5S:6YE<W,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#(T-RXQ,"!49" H5&AE("D@5&H@150@40IQ(# @," P
M(')G($)4(#8W+C P(#(T-RXQ,"!49" H06UE;F1E9"!A;F0@4F5S=&%T960@
M0W)E9&ET("D@5&H@150@40IQ(# @," P(')G($)4(#$X.2XQ.2 R-#<N,3 @
M5&0@*$%G<F5E;65N="!A;'-O(&EN8VQU9&5S("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.3 N-30@,C0W+C$P(%1D("AT
M=V\I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S U+C4T(#(T-RXQ,"!49" H(&9I;F%N8VEA;"!C;W9E;F%N=',Z(%PH:5PI
M(&$@;6%X:6UU;2!#;VYS;VQI9&%T960@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3 W+C@Q(#(T-RXQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#4Q,RXR,B R-#<N,3 @5&0@*&]T86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(S-2XQ,"!49" H3&5V97)A
M9V4@<F%T:6\@7"AA<R!D969I;F5D('1H97)E:6Y<*3L@86YD(%PH:6E<*2!A
M(&UI;FEM=6T@0V]N<V]L:61A=&5D($9I>&5D($-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-S(N.#,@,C,U+C$P(%1D("AG92!#;W9E<F%G92!R871I
M;R!<*&%S(&1E9FEN960@=&AE<F5I;EPI(&%S(&]F('1H92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C(S+C$P
M(%1D("AE;F0@;V8@96%C:"!F:7-C86P@<75A<G1E<B!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38S+C@X(#(R,RXQ
M,"!49" H,2XU,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q.#$N,S@@,C(S+C$P(%1D("@Z,2XP,"X@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,C V+C$Q(#(R,RXQ,"!49" H07,@;V8@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S,"XU-2 R,C,N
M,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,P.2XQ-" R,C,N,3 @5&0@*"P@=&AE
M($-O;7!A;GD@=V%S(&EN(&-O;7!L:6%N8V4@=VET:"!T:&4@9FEN86YC:6%L
M(&-O=F5N86YT<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,C$Q+C$P(%1D("AA;F0@;W1H97(@8V]V96YA;G1S
M(&-O;G1A:6YE9"!I;B!T:&4@0W)E9&ET("D@5&H@150@40IQ(# @," P(')G
M($)4(#(R-2XR." R,3$N,3 @5&0@*$%G<F5E;65N="XI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@W+C$P(%1D
M("A/;B!/8W1O8F5R(#,P+" R,#$X+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN
M=&\@82!&:7)S=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S(N,C0@,3@W
M+C$P(%1D("A!;65N9&UE;G0@7"A&:7)S=" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S-#<N-SD@,3@W+C$P(%1D("A!;65N9&UE;G1<*2!T;R!I=',@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#(T+C<S(#$X-RXQ,"!49" H06UE;F1E
M9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-S4N,3 @5&0@*$%G<F5E;65N
M="!T:&%T+"!A;6]N9R!O=&AE<B!A9&UI;FES=')A=&EV92!A;F0@8VQA<FEF
M>6EN9R!C:&%N9V5S+"!M;V1I9FEE9"!T:&4@9F]L;&]W:6YG.B!<*#%<*2!T
M:&4@9&5F:6YI=&EO;B!U=&EL:7IE9"!I;B!I=',@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$V,RXQ,"!49" H
M9FEN86YC:6%L(&-O=F5N86YT<R!O9B!#;VYS;VQI9&%T960@14))5$1!*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C,Q+C8X(#$V,RXQ,"!49" H('1O(&%L
M;&]W(&9O<B!E>&-L=7-I;VX@;V8@8VAA<BD@5&H@150@40IQ(# @," P(')G
M($)4(#,U,BXP,2 Q-C,N,3 @5&0@*&=E<R!R96QA=&5D('1O('1H92!#;VUP
M86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#0V-"XR,2 Q-C,N,3 @5&0@
M*',@:6YI=&EA=&EV92!T;R!R97!L86-E(&ET<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,34Q+C$P(%1D("AF
M<F]N="UE;F0@<WES=&5M('-U<'!O<G1I;F<@:71S(&QE9V%C>2!T<F%V96P@
M;G5R<V4@;W!E<F%T:6]N<RP@<W5B:F5C="!T;R!A(&)A<VME="!O9B!A9&1B
M86-K<RP@;V8@=VAI8V@@=&AE(&)A<VME="!D;VQL87(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S.2XQ,"!4
M9" H86UO=6YT('=A<R!A;'-O(&EN8W)E87-E9#L@7"@R7"D@:6YC<F5A<V5D
M('1H92!M87AI;75M($-O;G-O;&ED871E9" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,C@N.38@,3,Y+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S,T+C,W(#$S.2XQ,"!49" H;W1A;"!,979E<F%G92!2871I;R!T;R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(V
M+C P(#$S.2XQ,"!49" H,RXW-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-#,N-3 @,3,Y+C$P(%1D("@Z,2XP,"!F<F]M
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.#@N,C(@,3,Y+C$P(%1D("@S+C(U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P-2XW,B Q,SDN,3 @5&0@*#HQ.C P(&9O
M<B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#$R-RXQ,"!49" H<&5R:6]D<R!O9B!397!T96UB97(@,S L
M(#(P,3@@=&AR;W5G:"!*=6YE(#,P+" R,#$Y+"!T;R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<Y+C<U(#$R-RXQ,"!4
M9" H,RXU,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R.3<N,C4@,3(W+C$P(%1D("@Z,3HP,"!F<F]M("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#(N,C0@,3(W+C$P
M(%1D("@S+C P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,U.2XW-" Q,C<N,3 @5&0@*#HQ+C P(&9O<B!T:&4@<&5R:6]D
M(&5N9&5D(%-E<'1E;6)E<B S,"P@,C Q.2P@=&\@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Q-2XQ,"!49" H
M,RXR-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" V-RXP," Q,34N,3 @5&0@*#HQ+C P(&9R;VT@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Q,2XW,B Q,34N,3 @5&0@
M*#,N,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(Y+C(R(#$Q-2XQ,"!49" H.C$Z,# @9F]R('1H92!P97)I;V0@96YD
M960@1&5C96UB97(@,S$L(#(P,3DL(&%N9"!M86EN=&%I;F5D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.#,N,#,@,3$U
M+C$P(%1D("@S+C P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0P,"XU,R Q,34N,3 @5&0@*#HQ.C P(&9O<B!T:&4@<&5R
M:6]D<R!T:&5R96%F=&5R(&%N9"!A<R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3 S+C$P(%1D("AA9&IU<W1E
M9"!P=7)S=6%N="!T;R!A(%%U86QI9FEE9"!097)M:71T960@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C(P+C4W(#$P,RXQ,"!49" H06-Q=6ES:71I;VX@
M7"AA<R!D969I;F5D('1H97)E:6Y<*3L@86YD(%PH,UPI(&EN8W)E87-E9"!T
M:&4@<')O(&9O<FUA($-O;G-O;&ED871E9" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" U,S8N,3,@,3 S+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-30Q+C4T(#$P,RXQ,"!49" H;W1A;" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.3$N,3 @5&0@*$QE=F5R
M86=E(%)A=&EO('1H<F5S:&]L9"!F;W(@86QL;W=I;F<@<F5S=')I8W1E9"!P
M87EM96YT<RX@26X@8V]N;F5C=&EO;B!W:71H('1H92!&:7)S=" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,# N,C0@.3$N,3 @5&0@*$%M96YD;65N="P@
M=&AE($-O;7!A;GD@<&%I9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,P+C4P(#DQ+C$P(%1D("@D,"XS("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," W.2XQ
M,"!49" H;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" W."XS.2 W.2XQ,"!49" H(&EN(&9E97,@=&\@:71S(&QE
M;F1E<G,L(&]F('=H:6-H(&$@<&]R=&EO;B!H87,@8F5E;B!I;F-L=61E9"!I
M;B!O=&AE<B!N;VYC=7)R96YT(&%S<V5T<R!A<R!D969E<G)E9"!I<W-U86YC
M92!C;W-T<R!R96QA=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," V-RXQ,"!49" H=&\@=&AE(')E=F]L=FEN
M9R!C<F5D:70@9F%C:6QI='D@86YD(&$@<&]R=&EO;B!H87,@8F5E;B!T<F5A
M=&5D(&%S(&$@9&5D=6-T:6]N('1O(&QO;F<M=&5R;2!D96)T(')E;&%T960@
M=&\@:71S("D@5&H@150@40IQ(# @," P(')G($)4(#0W-BXY-B V-RXQ,"!4
M9" H5"D@5&H@150@40IQ(# @," P(')G($)4(#0X,BXS-R V-RXQ,"!49" H
M97)M($QO86XN*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,34W(# @;V)J
M"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V
M,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N
M=&5N=',@,34X(# @4CX^"F5N9&]B:@HQ-3@@,"!O8FH*/#PO3&5N9W1H(#$T
M,C0X/CX*<W1R96%M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(Q,RXX-2 W-C N-S4@5&0@*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @
M," P(')G($)4(#(Y,BXV." W-C N-S4@5&0@*%DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3DN-3,@-S8P+C<U(%1D("@@2$5!3"D@5&H@150@40IQ(# @
M," P(')G($)4(#,R.2XT-2 W-C N-S4@5&0@*%1(0T%212P@24Y#+BD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @
M-S0X+C<U(%1D("A.3U1%4R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N
M-3(@-S0X+C<U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q
M(#<T."XW-2!49" H3R!#3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" R.#@N,3$@-S0X+C<U(%1D("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S8W+C(Y(#<T."XW-2!49" H(%-4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S@Q+C(X(#<T."XW-2!49" H02D@5&H@150@40IQ(# @
M," P(')G($)4(#,X-RXW-B W-#@N-S4@5&0@*%1%345.5%,I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4X+C,U(#<S-BXW
M-2!49" H1$5#14U"15*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S$R+C<U(%1D("@X+B!$96)T
M(%PH8V]N=&EN=65D7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 R."D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @
M5&0@*%1H92!F;W)E9V]I;F<@9&5S8W)I<'1I;VX@;V8@=&AE(&%M96YD;65N
M="!I<R!Q=6%L:69I960@:6X@:71S(&5N=&ER971Y(&)Y(')E9F5R96YC92!T
M;R!T:&4@9G5L;"!T97)M<R!A;F0@<')O=FES:6]N<R!O9B!T:&4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8X
M,RXQ,"!49" H06UE;F1E9"!A;F0@4F5S=&%T960@0W)E9&ET("D@5&H@150@
M40IQ(# @," P(')G($)4(#$W,2XV.2 V.#,N,3 @5&0@*$%G<F5E;65N="XI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C4Y+C$P(%1D("A4:&4@;V)L:6=A=&EO;G,@=6YD97(@=&AE("D@5&H@
M150@40IQ(# @," P(')G($)4(#$U,RXY,B V-3DN,3 @5&0@*$%M96YD960@
M86YD(%)E<W1A=&5D($-R961I=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M-S8N,3(@-C4Y+C$P(%1D("A!9W)E96UE;G0@87)E(&=U87)A;G1E960@8GD@
M86QL(&]F('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#0W
M-BXS,B V-3DN,3 @5&0@*',@9&]M97-T:6,@=VAO;&QY+2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#<N,3 @
M5&0@*&]W;F5D('-U8G-I9&EA<FEE<R!A;F0@87)E('-E8W5R960@8GD@82!F
M:7)S="UP<FEO<FET>2!S96-U<FET>2!I;G1E<F5S="!I;B!T:&4@0V]L;&%T
M97)A;"!<*&%S(&1E9FEN960@=&AE<F5I;EPI+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,C,N,3 @5&0@*$%S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" W,RXY-" V,C,N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U,BXU,R V,C,N
M,3 @5&0@*"P@=&AE($-O;7!A;GD@:&%S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,CDN-#8@-C(S+C$P(%1D("@D,C N
M-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(X,RXS-2 V,C,N,3 @5&0@*"!L971T97)S(&]F(&-R961I="!O
M=71S=&%N9&EN9RP@=VAI8V@@<F5L871E('1O('1H92!#;VUP86YYDBD@5&H@
M150@40IQ(# @," P(')G($)4(#4Q."XX-2 V,C,N,3 @5&0@*',@=V]R:V5R
M<Y(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-C N,#0@-C(S+C$P(%1D("@@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#8Q,2XQ,"!49" H8V]M<&5N<V%T:6]N(&%N9"!P<F]F97-S:6]N86P@
M;&EA8FEL:71Y(&EN<W5R86YC92!P;VQI8VEE<RXI(%1J($54(%$*0E0@+T8S
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3@W+C$P(%1D("@R
M,#$V(%-E;FEO<B!#<F5D:70@1F%C:6QI=&EE<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U-C,N,3 @5&0@*$]N
M($IU;F4@,C(L(#(P,38L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A('-E
M;FEO<B!C<F5D:70@86=R965M96YT(%PH,C Q-B!#<F5D:70@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@W+C$Y(#4V,RXQ,"!49" H06=R965M96YT7"DL
M('=H:6-H('!R;W9I9&5D(&9O<B!A;B!I;FET:6%L("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U-3$N,3 @5&0@
M*'1E<FT@;&]A;B!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,3 P+C@W(#4U,2XQ,"!49" H)#0P+C @;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-30N
M-S8@-34Q+C$P(%1D("@@7"A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38V
M+C P(#4U,2XQ,"!49" H97)M($QO86Y<*2!A;F0@82!R979O;'9I;F<@8W)E
M9&ET(&9A8VEL:71Y(&]F('5P('1O("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-C0N.#(@-34Q+C$P(%1D("@D,3 P+C @
M;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,C,N-S$@-34Q+C$P(%1D("@@7"A2979O;'9I;F<@0W)E9&ET($9A
M8VEL:71Y7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#4S.2XQ,"!49" H7"AT;V=E=&AE<B!W:71H('1H92 I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,C(N.3$@-3,Y+C$P(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3(X+C,R(#4S.2XQ,"!49" H97)M($QO
M86XL('1H92 R,#$V(%-E;FEO<B!#<F5D:70@1F%C:6QI=&EE<UPI(&)O=&@@
M;V8@=VAI8V@@=V]U;&0@:&%V92!M871U<F5D(&]N($IU;F4@,C(L(#(P,C$N
M("D@5&H@150@40IQ(# @," P(')G($)4(#4R,RXP-B U,SDN,3 @5&0@*%1H
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-3(W+C$P(%1D("A2979O;'9I;F<@0W)E9&ET($9A8VEL:71Y(&EN
M8VQU9&5D(&$@<W5B9F%C:6QI='D@9F]R('-W:6YG;&EN92!L;V%N<R!U<"!T
M;R!A;B!A;6]U;G0@;F]T('1O(&5X8V5E9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#0T+CDW(#4R-RXQ,"!49" H)#$U
M+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.3@N.#<@-3(W+C$P(%1D("@L(&%N9"!A("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C<N-S0@-3(W+C$P
M(%1D("@D,S4N,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-3 N,C0@-3(W+C$P(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Q-2XQ,"!49" H;6EL
M;&EO;B!S=6)L:6UI="!F;W(@=&AE(&ES<W5A;F-E(&]F('-T86YD8GD@;&5T
M=&5R<R!O9B!C<F5D:70N(%!R;V-E961S(&]F('1H92!396YI;W(@0W)E9&ET
M($9A8VEL:71I97,@=V5R92!U<V5D('!R:6UA<FEL>2!T;R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3 S+C$P
M(%1D("AR969I;F%N8V4@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,30U+C4W(#4P,RXQ,"!49" H<R!P<FEO<B!S96YI;W(@<V5C=7)E
M9"!A<W-E="UB87-E9"!C<F5D:70@9F%C:6QI='D@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-30N.30@-3 S+C$P
M(%1D("@D,S N,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0P."XX,R U,#,N,3 @5&0@*"!396-O;F0@3&EE
M;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C,N.3$@-3 S+C$P(%1D("A4
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8Y+C,R(#4P,RXQ,"!49" H97)M
M($QO86X@86YD('1O('!A>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-#DQ+C$P(%1D("AR96QA=&5D('1R86YS
M86-T:6]N(&9E97,@86YD(&5X<&5N<V5S+"!I;F-L=61I;F<@82!R961E;7!T
M:6]N('!R96UI=6T@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,T-BXY," T.3$N,3 @5&0@*"0P+C8@;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.34N
M-SD@-#DQ+C$P(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#0P,"XV
M,2 T.3$N,3 @5&0@*%1H92!R97!A>6UE;G0@;V8@=&AE(%-E8V]N9"!,:65N
M("D@5&H@150@40IQ(# @," P(')G($)4(#4T,2XT.2 T.3$N,3 @5&0@*%0I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#8N.3 @-#DQ+C$P(%1D("AE<FT@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#0W.2XQ,"!49" H3&]A;B!W87,@=')E871E9"!A<R!E>'1I;F=U:7-H
M;65N="!O9B!D96)T(&%N9"P@87,@82!R97-U;'0L('1H92!#;VUP86YY(')E
M8V]G;FEZ960@82!L;W-S(&]N(&5X=&EN9W5I<VAM96YT(&]F(&1E8G0@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#0V-RXQ,"!49" H87!P<F]X:6UA=&5L>2 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 Y+C<V(#0V-RXQ,"!49" H
M)#$N-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$U."XV-2 T-C<N,3 @5&0@*"!I;B!T:&4@<V5C;VYD('%U
M87)T97(@;V8@,C Q-BP@<F5L871E9"!T;R!T:&4@=W)I=&4M;V8I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-CDN-S@@-#8W+C$P(%1D("AF(&]F('5N86UO
M<G1I>F5D(&YE="!D96)T(&1I<V-O=6YT(&%N9"!I<W-U86YC92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#4U
M+C$P(%1D("AC;W-T<R!A<R!W96QL(&%S('1R86YS86-T:6]N(&9E97,@86YD
M(&5X<&5N<V5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," T,S$N,3 @5&0@*$]N($IU;'D@-2P@,C Q-RP@=&AE
M($-O;7!A;GD@96YT97)E9"!I;G1O(&$@4V5C;VYD("D@5&H@150@40IQ(# @
M," P(')G($)4(#(V,BXX," T,S$N,3 @5&0@*$%M96YD;65N="!T;R!I=',@
M,C Q-B!#<F5D:70@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@V+C0P(#0S
M,2XQ,"!49" H06=R965M96YT('!R:6UA<FEL>2!T;R!A;&QO=R!F;W(@=&AE
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," T,3DN,3 @5&0@*&%C<75I<VET:6]N(&]F("D@5&H@150@40IQ(# @
M," P(')G($)4(#$P-BXQ-B T,3DN,3 @5&0@*$%D=F%N=&%G92!I;F-L=61I
M;F<@82!R97-E="!O9B!T:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0U
M+C4V(#0Q.2XQ,"!49" H07!P;&EC86)L92!-87(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,#@N-#$@-#$Y+C$P(%1D("AG:6X@=&\@3&5V96P@24E)+"!B
M87-E9"!O;B!T:&4@:6YC<F5M96YT86P@8F]R<F]W:6YG<R!A;F0@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0P
M-RXQ,"!49" H8V]N<VES=&5N="!W:71H('1H92!P<FEO<B!P<FEC:6YG(&=R
M:60@7"AO<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$R+C4R(#0P-RXQ,"!49" H,BXR-24I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C,X+C,U(#0P-RXQ,"!49" H
M(&9O<B!%=7)O9&]L;&%R($QO86YS(&%N9"!,24)/4B!);F1E>"!2871E($QO
M86YS+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4R+C$Y(#0P-RXQ,"!49" H,2XR-24I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#<X+C R(#0P-RXQ,"!49" H(&9O
M<B!"87-E(%)A=&4@3&]A;G,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y-2XQ,"!49" H86YD(&$@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<S+C,X(#,Y
M-2XQ,"!49" H,"XS,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.3DN,C$@,SDU+C$P(%1D("@@8V]M;6ET;65N="!F965<
M*2X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<T+C<T(#,Y-2XQ,"!49" H
M06QS;RP@;VX@2G5L>2 U+" R,#$W+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN
M=&\@86X@26YC<F5M96YT86P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#,S
M+C,Y(#,Y-2XQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#0S."XX
M," S.34N,3 @5&0@*&5R;2!,;V%N("D@5&H@150@40IQ(# @," P(')G($)4
M(#0W.2XS-" S.34N,3 @5&0@*$%G<F5E;65N="!F;W(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,X,RXQ,"!4
M9" H)#0P+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q,#,N,SD@,S@S+C$P(%1D("@@=VET:"!3=6Y4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,30W+C0Y(#,X,RXQ,"!49" H<G5S="!A
M<R!,96YD97(@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#(R,RXP,B S
M.#,N,3 @5&0@*$%D;6EN:7-T<F%T:79E("D@5&H@150@40IQ(# @," P(')G
M($)4(#(X-"XY-B S.#,N,3 @5&0@*$%G96YT('1O('!A>2!F;W(@<&%R="!O
M9B!T:&4@8V]N<VED97)A=&EO;B!O9B!T:&4@86-Q=6ES:71I;VX@;V8@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,W,2XQ,"!49" H061V86YT86=E+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Y-RXV,R S-S$N,3 @5&0@*%1H92!);F-R96UE;G1A;" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C4N-S4@,S<Q+C$P(%1D("A4*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3<Q+C$V(#,W,2XQ,"!49" H97)M($QO86X@;6%T=7)I
M='D@9&%T92!W87,@2G5N92 R,BP@,C R,2!A;F0@=V%S('!R97!A>6%B;&4@
M870@86YY('1I;64@=VET:&]U="!P96YA;'1Y*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3,T+C(Y(#,W,2XQ,"!49" H+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-#<N,3 @5&0@*$)O<G)O
M=VEN9W,@=6YD97(@=&AE($EN8W)E;65N=&%L("D@5&H@150@40IQ(# @," P
M(')G($)4(#$X.2XR." S-#<N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q.30N-CD@,S0W+C$P(%1D("AE<FT@3&]A;B!W97)E('!A>6%B;&4@
M:6X@<75A<G1E<FQY(&EN<W1A;&QM96YT<RP@8V]M;65N8VEN9R!397!T96UB
M97(@,S L(#(P,3<L('=I=&@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#,S-2XQ,"!49" H96%C:"!S=6-H(&EN
M<W1A;&QM96YT(&)E:6YG(&EN('1H92!A9V=R96=A=&4@<')I;F-I<&%L(&%M
M;W5N="!<*'-U8FIE8W0@=&\@861J=7-T;65N="!A<R!A(')E<W5L="!O9B!P
M<F5P87EM96YT<UPI(&9O<B!T:&4@9FER<W0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,R,RXQ,"!49" H96EG
M:'0@:6YS=&%L;&UE;G1S(&5Q=6%L('1O("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-3<N,C8@,S(S+C$P(%1D("@Q+C@W
M-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3@X+C Y(#,R,RXQ,"!49" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C W+C4S(#,R,RXQ,"!49" H,BXU)2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,C@N
M,S8@,S(S+C$P(%1D("@@;V8@=&AE('!R:6YC:7!A;"!A;6]U;G0@;V8@=&AE
M($EN8W)E;65N=&%L("D@5&H@150@40IQ(# @," P(')G($)4(#0P,BXU-B S
M,C,N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#<N.3<@,S(S
M+C$P(%1D("AE<FT@3&]A;B!F;W(@=&AE(')E;6%I;FEN9R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S$Q+C$P
M(%1D("AI;G-T86QL;65N=',[('!R;W9I9&5D('1H870L('1O('1H92!E>'1E
M;G0@;F]T('!R979I;W5S;'D@<&%I9"P@=&AE(&%G9W)E9V%T92!U;G!A:60@
M<')I;F-I<&%L(&)A;&%N8V4@=V]U;&0@8F4@9'5E(&%N9"!P87EA8FQE("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," R.3DN,3 @5&0@*&]N('1H92!M871U<FET>2!D871E+B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,S0N,C @,CDY+C$P(%1D("A!<R!O9B!*=6QY(#4L
M(#(P,3<@=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(R-"XT." R.3DN
M,3 @5&0@*$%P<&QI8V%B;&4@36%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C@W+C,S(#(Y.2XQ,"!49" H9VEN(&9O<B!%=7)O9&]L;&%R($QO86YS(&%N
M9"!,24)/4B!);F1E>"!2871E($QO86YS('=A<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Y+C4P(#(Y.2XQ,"!49" H
M,BXR-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-34U+C,S(#(Y.2XQ,"!49" H("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R.#<N,3 @5&0@*&%N9"!T:&4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.# N-C @,C@W+C$P(%1D("A!<'!L
M:6-A8FQE($UA<BD@5&H@150@40IQ(# @," P(')G($)4(#$T,RXT-B R.#<N
M,3 @5&0@*&=I;B!F;W(@0F%S92!2871E($QO86YS('=A<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8P+C8U(#(X-RXQ
M,"!49" H,2XR-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@V+C0X(#(X-RXQ,"!49" H+BD@5&H@150@40I"5" O1C,@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-C,N,3 @5&0@*$-O
M;G9E<G1I8FQE($YO=&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(S.2XQ,"!49" H5&AE($-O;7!A;GD@86YD
M(&-E<G1A:6X@;V8@:71S(&1O;65S=&EC('-U8G-I9&EA<FEE<R!E;G1E<F5D
M(&EN=&\@82!#;VYV97)T:6)L92!.;W1E(%!U<F-H87-E("D@5&H@150@40IQ
M(# @," P(')G($)4(#0S,RXR.2 R,SDN,3 @5&0@*$%G<F5E;65N="!<*'1H
M92!.;W1E(%!U<F-H87-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R,C<N,3 @5&0@*$%G<F5E;65N=%PI+"!W
M:71H(&-E<G1A:6X@;F]T92!H;VQD97)S(%PH8V]L;&5C=&EV96QY*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C4S+C(R(#(R-RXQ,"!49" H+"!T:&4@3F]T
M96AO;&1E<G-<*2!O;B!*=6YE(#,P+" R,#$T+B @4'5R<W5A;G0@=&\@=&AE
M($YO=&4@4'5R8VAA<V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(Q-2XQ,"!49" H06=R965M96YT+"!T:&4@
M0V]M<&%N>2!S;VQD('1O('1H92!.;W1E:&]L9&5R<R!A;B!A9V=R96=A=&4@
M;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,Q-"XW," R,34N,3 @5&0@*"0R-2XP(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8X+C4Y(#(Q-2XQ,"!4
M9" H(&]F(&-O;G9E<G1I8FQE(&YO=&5S(%PH=&AE($-O;G9E<G1I8FQE($YO
M=&5S7"DN("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," R,#,N,3 @5&0@*$]N($UA<F-H(#$W+" R,#$W+"!T:&4@
M0V]M<&%N>2!P86ED(&EN(&9U;&P@=&AE($-O;G9E<G1I8FQE($YO=&5S+B!)
M;B!C;VYN96-T:6]N('=I=&@@=&AE(')E<&%Y;65N="P@=&AE($-O;7!A;GD@
M:7-S=65D('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," Q.3$N,3 @5&0@*'1H92!.;W1E:&]L9&5R<R!A;B!A
M9V=R96=A=&4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$W.2XW,B Q.3$N,3 @5&0@*#,L,3<U+#4X-"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3DN-S(@,3DQ
M+C$P(%1D("@@<VAA<F5S(&]F($-O;6UO;B!3=&]C:RP@<&%R('9A;'5E("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C<N
M-#<@,3DQ+C$P(%1D("@D,"XP,# Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y.2XY-R Q.3$N,3 @5&0@*"P@86YD(&-A
M<V@@:6X@=&AE(&%G9W)E9V%T92!A;6]U;G0@;V8@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$W.2XQ,"!49" H
M)#4N-B!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#DX+C,Y(#$W.2XQ,"!49" H(%PH;V8@=VAI8V@@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$T,2XY.2 Q
M-SDN,3 @5&0@*"0U+C @;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.3 N.#@@,3<Y+C$P(%1D("@@:7,@:6YC
M;'5D960@:6X@<F5P87EM96YT(&]F(&1E8G0@86YD("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#$N.34@,3<Y+C$P(%1D
M("@D,"XV(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDP+C@T(#$W.2XQ,"!49" H(&ES('!R97-E;G1E9"!A
M<R!E>'1I;F=U:7-H;65N="!F965S+"!B;W1H("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q-C<N,3 @5&0@*'=I
M=&AI;B!F:6YA;F-I;F<@86-T:79I=&EE<R!O;B!T:&4@8V]N<V]L:61A=&5D
M('-T871E;65N=',@;V8@8V%S:"!F;&]W<UPI+B!5<&]N(&1E<F5C;V=N:71I
M;VX@;V8@=&AE(&YE="!C87)R>6EN9R!A;6]U;G1S(&]F('1H92 I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,34U
M+C$P(%1D("A#;VYV97)T:6)L92!.;W1E<R!<*'1H92!R96UA:6YI;F<@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X-BXQ
M,R Q-34N,3 @5&0@*"0R,"XP(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C0P+C R(#$U-2XQ,"!49" H(&%F
M=&5R('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C<X+C U(#$U-2XQ,"!49" H)#4N,"!M:6QL:6]N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R-BXY-2 Q-34N
M,3 @5&0@*"!C87-H('!A>6UE;G1<*2!A;F0@9&5R:79A=&EV92!L:6%B:6QI
M='D@7"@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#@V+C,T(#$U-2XQ,"!49" H)#(V+C @;6EL;&EO;BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-# N,C,@,34U+C$P
M(%1D("A<*2P@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," Q-#,N,3 @5&0@*$-O;7!A;GD@<F5C;V=N:7IE
M9"!A(&YO;BUC87-H(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.3DN
M.#$@,30S+C$P(%1D("AG92!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C(R+C4X(#$T,RXQ,"!49" H)#4N,"!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(W,2XT-R Q-#,N,3 @5&0@*"!A<R!L;W-S(&]N(&5A<FQY(&5X=&EN9W5I
M<VAM96YT(&%N9"!A(&YO;BUC87-H(&%D9&ET:6]N('1O(&%D9&ET:6]N86P@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$S,2XQ,"!49" H<&%I9"UI;B!C87!I=&%L(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C N,S$@,3,Q+C$P
M(%1D("@D-#8N,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$W-"XR," Q,S$N,3 @5&0@*"!F;W(@=&AE(&9A
M:7(@=F%L=64@;V8@=&AE('-H87)E<RP@=VAI8V@@:7,@;F]T('!R97-E;G1E
M9"!O;B!T:&4@8V]N<V]L:61A=&5D('-T871E;65N=',@;V8@8V%S:" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3$Y+C$P(%1D("AF;&]W<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-S8N
M-30@,3$Y+C$P(%1D("A4:&4@;&]S<R!O;B!E87)L>2!E>'1I;F=U:7-H;65N
M="!O9B!D96)T(&EN8VQU9&5S('1H92!W<FET92UO9BD@5&H@150@40IQ(# @
M," P(')G($)4(#,R-"XY,2 Q,3DN,3 @5&0@*&8@;V8@=6YA;6]R=&EZ960@
M;&]A;B!F965S(&%N9"!R96UA:6YI;F<@:6YT97)E<W0@9'5E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,#<N
M,3 @5&0@*'1H<F]U9V@@=&AE($9O<F-E9"!#;VYV97)S:6]N(&1A=&4@7"AD
M969I;F5D(&)E;&]W7"D@;V8@2G5N92 S,"P@,C Q-RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.#,N,3 @5&0@
M*%1H92!#;VYV97)T:6)L92!.;W1E<R!W97)E(&-O;G9E<G1I8FQE(&%T('1H
M92!O<'1I;VX@;V8@=&AE(&AO;&1E<G,@=&AE<F5O9B!A="!A;GD@=&EM92!I
M;G1O('-H87)E<R!O9B!T:&4@0V]M;6]N(%-T;V-K(&%T(&$@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#<Q+C$P
M(%1D("AC;VYV97)S:6]N('!R:6-E(&]F("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q,CDN,3D@-S$N,3 @5&0@*"0W+C$P
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U
M,2XV.2 W,2XQ,"!49" H('!E<B!S:&%R92P@;W(@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P-BXS.2 W,2XQ,"!49" H
M,RPU,C$L,3(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(T-BXS.2 W,2XQ,"!49" H('-H87)E<R!O9B!#;VUM;VX@4W1O
M8VLN("D@5&H@150@40IQ(# @," P(')G($)4(#,U-"XQ-B W,2XQ,"!49" H
M069T97(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,W-RXW-B W,2XQ,"!49" H=&AR964I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C<U(#<Q+C$P(%1D("@@>65A
M<G,@9G)O;2!T:&4@:7-S=6%N8V4@9&%T92P@=&AE("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.2XQ,"!49" H
M0V]M<&%N>2!H860@=&AE(')I9VAT('1O(&9O<F-E(&$@8V]N=F5R<VEO;B!O
M9B!T:&4@0V]N=F5R=&EB;&4@3F]T97,@:68@=&AE('9O;'5M92UW96EG:'1E
M9"!A=F5R86=E('!R:6-E(%PH5E<I(%1J($54(%$*<2 P(# @,"!R9R!"5" U
M,#(N-#$@-3DN,3 @5&0@*$%07"D@<&5R('-H87)E("D@5&H@150@40IE;F1S
M=')E86T*96YD;V)J"C$U.2 P(&]B:@H\/"]4>7!E("]086=E"B]087)E;G0@
M,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E<V]U<F-E
M<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$V," P(%(^/@IE;F1O8FH*
M,38P(# @;V)J"CP\+TQE;F=T:" Q,#,Y,SX^"G-T<F5A;0I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,3,N.#4@-S8P+C<U(%1D("A#4D]3
M4R!#3U5.5%(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N-C@@-S8P+C<U
M(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDY+C4S(#<V,"XW-2!4
M9" H($A%04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,CDN-#4@-S8P+C<U
M(%1D("A42$-!4D4L($E.0RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3<U+C,P(#<T."XW-2!49" H3D]415,@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R(#<T."XW-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#(Q."XP,2 W-#@N-S4@5&0@*$\@0T].4T],241!
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C$Q(#<T."XW-2!49" H5$5$
M($9)3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G($)4(#,V-RXR.2 W-#@N
M-S4@5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4(#,X,2XR." W-#@N
M-S4@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N-S8@-S0X+C<U
M(%1D("A414U%3E13*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(U."XS-2 W,S8N-S4@5&0@*$1%0T5-0D52H#,Q+" R,#$X
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#<Q,BXW-2!49" H."X@1&5B="!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV
M,"!49" H1BT@,CDI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-CDU+C$P(%1D("AO9B!I=',@0V]M;6]N(%-T;V-K
M(&5X8V5E9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-S8N.3@@-CDU+C$P(%1D("@Q,C4E*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P,"XS,2 V.34N,3 @5&0@
M*"!O9B!T:&4@=&AE;B!C;VYV97)S:6]N('!R:6-E(&9O<B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,Q+C Y(#8Y-2XQ
M,"!49" H,C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S0Q+C Y(#8Y-2XQ,"!49" H(&1A>7,@;V8@82 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@R+C$Y(#8Y-2XQ
M,"!49" H,S I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,SDR+C$Y(#8Y-2XQ,"!49" H(&1A>2!T<F%D:6YG('!E<FEO9"!<
M*$9O<F-E9"!#;VYV97)S:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," V.#,N,3 @5&0@*&1A=&5<*2X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#8U.2XQ,"!49" H5&AE($-O;G9E<G1I8FQE($YO=&5S(&)O<F4@:6YT97)E
M<W0@870@82!R871E(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R-# N,C8@-C4Y+C$P(%1D("@X+C P)2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-C8N,#D@-C4Y
M+C$P(%1D("@@<&5R(&%N;G5M+"!P87EA8FQE(&EN('%U87)T97)L>2!C87-H
M(&EN<W1A;&QM96YT<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Q+CDV
M(#8U.2XQ,"!49" H5&AE($-O;G9E<G1I8FQE("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#<N,3 @5&0@*$YO
M=&5S('=O=6QD(&AA=F4@;6%T=7)E9"!O;B!*=6YE(#,P+" R,#(P+"!U;FQE
M<W,@96%R;&EE<B!R97!U<F-H87-E9"P@<F5D965M960@;W(@8V]N=F5R=&5D
M+B!3=6)J96-T('1O(&-E<G1A:6X@97AC97!T:6]N<RP@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S-2XQ,"!4
M9" H=&AE($-O;7!A;GD@=V%S(&YO="!P97)M:71T960@=&\@<F5D965M('1H
M92!#;VYV97)T:6)L92!.;W1E<R!U;G1I;"!*=6YE(#,P+" R,#$W+B I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-C$Q+C$P(%1D("@Y+B!$97)I=F%T:79E<RD@5&H@150@40I"5" O1C0@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.#<N,3 @5&0@*$EN=&5R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C@N-3<@-3@W+C$P(%1D("AE<W0@
M4F%T92!3=V%P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#4V,RXQ,"!49" H26X@36%R8V@@,C Q."P@=&AE($-O
M;7!A;GD@96YT97)E9"!I;G1O(&%N(&EN=&5R97-T(')A=&4@<W=A<"!A9W)E
M96UE;G0L('=I=&@@86X@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3 N
M.#<@-38S+C$P(%1D("AF96-T:79E(&1A=&4@;V8@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#4P+C P(#4V,RXQ,"!49" H07!R:6P@,BP@,C Q."!A;F0@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#4U,2XQ,"!49" H=&5R;6EN871I;VX@9&%T92!O9B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,C<N-3,@-34Q+C$P(%1D("A!=6=U<W0@,2P@,C R
M,BX@3F\@:6YI=&EA;"!I;G9E<W1M96YT<R!W97)E(&UA9&4@=&\@96YT97(@
M:6YT;R!T:&4@86=R965M96YT+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T
M-#(N.#,@-34Q+C$P(%1D("A4:&4@:6YT97)E<W0@<F%T92!S=V%P("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U
M,SDN,3 @5&0@*&%G<F5E;65N="!R97%U:7)E<R!T:&4@0V]M<&%N>2!T;R!P
M87D@82!F:7AE9"!R871E('1O('1H92!R97-P96-T:79E(&-O=6YT97)P87)T
M>2!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,SDQ+C S(#4S.2XQ,"!49" H,BXV,C<E*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XX-B U,SDN,3 @5&0@*"!P
M97(@86YN=6T@;VX@86X@86UO<G1I>FEN9R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3(W+C$P(%1D("AN;W1I
M;VYA;"!A;6]U;G0@8F5G:6YN:6YG(&%T("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-CDN-#@@-3(W+C$P(%1D("@D-#@N
M."!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(R,RXS-R U,C<N,3 @5&0@*"!<*&-O<G)E<W!O;F1I;F<@=VET
M:"!T:&4@:6YI=&EA;"!T97)M(&QO86X@<&%Y;65N="!S8VAE9'5L95PI+"!A
M;F0@=&\@<F5C96EV92!F<F]M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," U,34N,3 @5&0@*'1H92!R97-P96-T
M:79E(&-O=6YT97)P87)T>2D@5&H@150@40IQ(# @," P(')G($)4(#$U-RXQ
M,R U,34N,3 @5&0@*"P@:6YT97)E<W0@<&%Y;65N=',@8F%S960@;VX@=&AE
M(&%P<&QI8V%B;&4@;F]T:6]N86P@86UO=6YT<R!A;F0@,2!M;VYT:"!54T0@
M3$E"3U(L('=I=&@@;F\@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#4P,RXQ,"!49" H97AC:&%N9V5S(&]F(&YO
M=&EO;F%L(&%M;W5N=',N("D@5&H@150@40IQ(# @," P(')G($)4(#$W."XP
M." U,#,N,3 @5&0@*$%T(&EN:71I871I;VXL('1H92!I;G1E<F5S="!R871E
M('-W87 @968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C8N-#<@-3 S+C$P
M(%1D("AF96-T:79E;'D@9FEX960@=&AE(&EN=&5R97-T(')A=&4@;VX@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,RXV
M,R U,#,N,3 @5&0@*#4P)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.#$N.38@-3 S+C$P(%1D("@@;V8@=&AE(&%M;W)T
M:7II;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0Y,2XQ,"!49" H8F%L86YC92!O9B!T:&4@0V]M<&%N>9(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#DN-S0@-#DQ+C$P(%1D("AS('1E
M<FT@9&5B="P@97AC;'5S:79E(&]F('1H92!C<F5D:70@<W!R96%D(&]N('1H
M92!D96)T+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C<N-S,@-#DQ+C$P
M(%1D("A!<R!O9B!$96-E;6)E<B S,2P@,C Q."P@=&AE(&EN=&5R97-T(')A
M=&4@<W=A<" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-#<Y+C$P(%1D("AI<R!T<F5A=&5D(&%S(&$@8V%S:"!F
M;&]W(&AE9&=E(&%N9"!I=',@9F%I<B!V86QU92!O9B!A("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-C N.# @-#<Y+C$P
M(%1D("@D,"XR(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S Y+C<P(#0W.2XQ,"!49" H(&QI86)I;&ET>2!I
M<R!I;F-L=61E9"!I;B!C=7)R96YT(&%N9"!N;VYC=7)R96YT(&QI86)I;&ET
M:65S(&]N('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-#8W+C$P(%1D("AC;VYS;VQI9&%T960@8F%L86YC
M92!S:&5E=',N(%-E92!.;W1E(#(@+2!3=6UM87)Y(&]F(%-I9VYI9FEC86YT
M("D@5&H@150@40IQ(# @," P(')G($)4(#,Q-2XR-R T-C<N,3 @5&0@*$%C
M8V]U;G1I;F<@4&]L:6-I97,@86YD($YO=&4@,3 @+2!&86ER("D@5&H@150@
M40IQ(# @," P(')G($)4(#0W-"XR,B T-C<N,3 @5&0@*%8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T.# N,S,@-#8W+C$P(%1D("AA;'5E($UE87-U<F5M
M96YT<RXI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-#0S+C$P(%1D("A#;VYV97)T:6)L92!.;W1E<R!$97)I=F%T
M:79E($QI86)I;&ET>2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," T,3DN,3 @5&0@*%1H92!#;VUP86YY(&ES<W5E
M9"!#;VYV97)T:6)L92!.;W1E<R!W:71H(&9E871U<F5S('1H870@=V5R92!E
M:71H97(@7"AI7"D@;F]T(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8U
M+C@Y(#0Q.2XQ,"!49" H9F]R9&5D(&5Q=6ET>2!C;&%S<VEF:6-A=&EO;BP@
M7"AI:5PI(&5M8F]D>2!R:7-K<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @-# W+C$P(%1D("AN;W0@8VQE87)L
M>2!A;F0@8VQO<V5L>2!R96QA=&5D('1O(&AO<W0@8V]N=')A8W1S+"!O<B!<
M*&EI:5PI(&UA>2!B92!N970M8V%S:"!S971T;&5D(&)Y('1H92!C;W5N=&5R
M<&%R='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T-#,N.3D@-# W+C$P(%1D
M("@N("D@5&H@150@40IQ(# @," P(')G($)4(#0T."XT-" T,#<N,3 @5&0@
M*$%S(')E<75I<F5D(&)Y('1H92D@5&H@150@40I"5" O1C0@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,C(N-3@@-# W+C$P(%1D("@@*2!4:B!%5"!1
M"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y-2XQ
M,"!49" H06-C;W5N=&EN9R!F;W(@1&5R:79A=&EV92!&:6YA;F-I86P@26YS
M=')U;65N=',@86YD($AE9&=I;F<@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S Q+C<X(#,Y-2XQ,"!49" H06-T:79I=&EE<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0Q+C0X(#,Y-2XQ,"!49" H
M5"D@5&H@150@40IQ(# @," P(')G($)4(#,T-BXX.2 S.34N,3 @5&0@*&]P
M:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.38N.3@@,SDU
M+C$P(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$X+C,X(#,Y
M-2XQ,"!49" H05-#+"!I;B!C97)T86EN(&EN<W1A;F-E<RP@=&AE<V4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,X,RXQ,"!49" H:6YS=')U;65N=',@=V5R92!R97%U:7)E9"!T;R!B92!C
M87)R:65D(&%S(&1E<FEV871I=F4@;&EA8FEL:71I97,L(&%T(&9A:7(@=F%L
M=64L(&EN('1H92!F:6YA;F-I86P@<W1A=&5M96YT<RX@3VX@36%R8V@@,3<L
M(#(P,3<L('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,S<Q+C$P(%1D("A#;VUP86YY('!A:60@:6X@9G5L
M;"!I=',@0V]N=F5R=&EB;&4@3F]T97,@86YD+"!A<R!A(')E<W5L="P@9&5R
M96-O9VYI>F5D('1H92!D97)I=F%T:79E(&QI86)I;&ET>2D@5&H@150@40IQ
M(# @," P(')G($)4(#0S,BXV-" S-S$N,3 @5&0@*"X@4V5E($YO=&4@." M
M($1E8G0N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,T-RXQ,"!49" H5&AE(&9A:7(@=F%L=64@;V8@=&AE(&1E
M<FEV871I=F4@;&EA8FEL:71Y('=A<R!P<FEM87)I;'D@9&5T97)M:6YE9"!B
M>2!F;'5C='5A=&EO;G,@:6X@=&AE($-O;7!A;GDG<R!S=&]C:R!P<FEC92X@
M26X@861D:71I;VXL("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," S,S4N,3 @5&0@*&-H86YG97,@:6X@=&AE($-O
M;7!A;GDG<R!C<F5D:70@<FES:R!P<F]F:6QE(&EM<&%C=&5D('1H92!F86ER
M('9A;'5E(&1E=&5R;6EN871I;VXN("D@5&H@150@40IQ(# @," P(')G($)4
M(#,X,BXY-B S,S4N,3 @5&0@*%1H97-E(&9L=6-T=6%T:6]N<R!R97-U;'1E
M9"!I;B!A(&-U<G)E;G0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#,R,RXQ,"!49" H<&5R:6]D(&=A:6X@=&AA
M="!W87,@<')E<V5N=&5D(&]N('1H92!#;VUP86YY)W,@8V]N<V]L:61A=&5D
M('-T871E;65N=',@;V8@;W!E<F%T:6]N<R!A<R!G86EN(&]N(&1E<FEV871I
M=F4@;&EA8FEL:71Y(&EN(#(P,3<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Q,2XQ,"!49" H86YD(#(P,38@
M<F5L871E9"!T;R!I=',@0V]N=F5R=&EB;&4@3F]T97,N*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X-RXQ,"!4
M9" H,3 N($9A:7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" X,BXV-" R.#<N
M,3 @5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-"XY-B R.#<N,3 @
M5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y,2XR-R R.#<N,3 @5&0@
M*&%L=64@365A<W5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30T+C$S(#(X
M-RXQ,"!49" H96UE;G1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#(V,RXQ,"!49" H5&AE("D@5&H@150@40I"
M5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V-RXU-2 R-C,N,3 @
M5&0@*$9A:7(@5BD@5&H@150@40IQ(# @," P(')G($)4(#DR+C@S(#(V,RXQ
M,"!49" H86QU92!-96%S=7(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#(N
M-S(@,C8S+C$P(%1D("AE;65N=',@86YD($1I<V-L;W-U<BD@5&H@150@40IQ
M(# @," P(')G($)4(#(R.2XP,2 R-C,N,3 @5&0@*&5S*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S-RXS-" R-C,N,3 @
M5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,SDN-C8@,C8S+C$P(%1D
M("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0U+C W(#(V,RXQ,"!49" H
M;W!I8R!O9B!T:&4@1BD@5&H@150@40IQ(# @," P(')G($)4(#(Y-2XQ-2 R
M-C,N,3 @5&0@*$%30B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,38N-38@
M,C8S+C$P(%1D("A!4T,@9&5F:6YE<R!F86ER('9A;'5E(&%S('1H92!E>&-H
M86YG92!P<FEC92!T:&%T('=O=6QD(&)E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-3$N,3 @5&0@*')E8V5I
M=F5D(&9O<B!A;B!A<W-E="!O<B!P86ED('1O('1R86YS9F5R(&$@;&EA8FEL
M:71Y(%PH86X@97AI="!P<FEC95PI(&EN('1H92!P<FEN8VEP86P@;W(@;6]S
M="!A9'9A;G1A9V5O=7,@;6%R:V5T(&9O<B!T:&4@87-S970@;W(@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(S
M.2XQ,"!49" H;&EA8FEL:71Y(&EN(&%N(&]R9&5R;'D@=')A;G-A8W1I;VX@
M8F5T=V5E;B!M87)K970@<&%R=&EC:7!A;G1S(&]N('1H92!M96%S=7)E;65N
M="!D871E+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#(N.#$@,C,Y+C$P
M(%1D("A4:&ES('1O<&EC(&%L<V\@97-T86)L:7-H97,@82!F86ER('9A;'5E
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," R,C<N,3 @5&0@*&AI97)A<F-H>2!W:&EC:"!R97%U:7)E<R!A;B!E
M;G1I='D@=&\@;6%X:6UI>F4@=&AE('5S92!O9B!O8G-E<G9A8FQE(&EN<'5T
M<R!A;F0@;6EN:6UI>F4@=&AE('5S92!O9B!U;F]B<V5R=F%B;&4@:6YP=71S
M('=H96X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(Q-2XQ,"!49" H;65A<W5R:6YG(&9A:7(@=F%L=64N("D@
M5&H@150@40IQ(# @," P(')G($)4(#$S-BXU,2 R,34N,3 @5&0@*%1H92!S
M=&%N9&%R9"!D97-C<FEB97,@=&AR964@;&5V96QS(&]F(&EN<'5T<R!T:&%T
M(&UA>2!B92!U<V5D('1O(&UE87-U<F4@9F%I<B!V86QU93HI(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3DQ+C$P
M(%1D("A,979E;" I(%1J($54(%$*<2 P(# @,"!R9R!"5" W,RXV-B Q.3$N
M,3 @5&0@*#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-S@N-C8@,3DQ+C$P(%1D("B7475O=&5D("D@5&H@150@40IQ(# @
M," P(')G($)4(#$R,"XU.2 Q.3$N,3 @5&0@*'!R:6-E<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-#8N.3<@,3DQ+C$P(%1D("AI;B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-3<N,C4@,3DQ+C$P(%1D("AA8W1I=F4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3@S+C8R(#$Y,2XQ,"!49" H;6%R:V5T<R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3<N-S@@,3DQ+C$P(%1D("AF;W(@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,Q+CDT(#$Y,2XQ,"!49" H:61E
M;G1I8V%L("D@5&H@150@40IQ(# @," P(')G($)4(#(V."XX-R Q.3$N,3 @
M5&0@*&%S<V5T<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.30N-S @,3DQ
M+C$P(%1D("AO<B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,#4N-3,@,3DQ
M+C$P(%1D("AL:6%B:6QI=&EE<RXI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,38W+C$P(%1D("A,979E;" R*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C8V
M(#$V-RXQ,"!49" HET]B<V5R=F%B;&4@:6YP=71S(&]T:&5R('1H86X@3&5V
M96P@,2!P<FEC97,@<W5C:"!A<R!Q=6]T960@<')I8V5S(&9O<B!S:6UI;&%R
M(&%S<V5T<R!O<B!L:6%B:6QI=&EE<SL@<75O=&5D('!R:6-E<R!I;B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,34U+C$P(%1D("AM87)K971S('1H870@87)E(&YO="!A8W1I=F4[(&]R(&]T
M:&5R(&EN<'5T<R!T:&%T(&%R92!O8G-E<G9A8FQE(&]R(&-A;B!B92!C;W)R
M;V)O<F%T960@8GD@;V)S97)V86)L92!M87)K970@9&%T82!F;W(@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$T
M,RXQ,"!49" H<W5B<W1A;G1I86QL>2!T:&4@9G5L;"!T97)M(&]F('1H92!A
M<W-E=',@;W(@;&EA8FEL:71I97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S,2XQ,"!49" HH"D@5&H@150@
M40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,3DN
M,3 @5&0@*$QE=F5L(#,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-S@N-C8@,3$Y+C$P(%1D("B756YO8G-E<G9A8FQE(&EN
M<'5T<R!T:&%T(&%R92!S=7!P;W)T960@8GD@;&ET=&QE(&]R(&YO(&UA<FME
M="!A8W1I=FET>2!A;F0@=&AA="!A<F4@<VEG;FEF:6-A;G0@=&\@=&AE(&9A
M:7(@=F%L=64@;V8@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," Q,#<N,3 @5&0@*&%S<V5T<R!O<B!L:6%B
M:6QI=&EE<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @.34N,3 @5&0@** I(%1J($54(%$*96YD<W1R96%M"F5N
M9&]B:@HQ-C$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-
M961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*
M+U)O=&%T92 P"B]#;VYT96YT<R Q-C(@,"!2/CX*96YD;V)J"C$V,B P(&]B
M:@H\/"],96YG=&@@,3,Q,#(^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@
M5&0@*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV
M." W-C,N-#4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@
M-S8S+C0U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT
M-2 W-C,N-#4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%
M4R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#
M3TY33TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U
M(%1D("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W
M+C(Y(#<U,2XT-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q
M+C(X(#<U,2XT-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW
M-B W-3$N-#4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@
M,S$L(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-S$U+C0U(%1D("@Q,"X@1F%I<BD@5&H@150@40IQ(# @
M," P(')G($)4(#@S+C$T(#<Q-2XT-2!49" H("D@5&H@150@40IQ(# @," P
M(')G($)4(#@U+C0V(#<Q-2XT-2!49" H5BD@5&H@150@40IQ(# @," P(')G
M($)4(#DQ+C<W(#<Q-2XT-2!49" H86QU92!-96%S=7(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-#0N-C,@-S$U+C0U(%1D("AE;65N=',@7"AC;VYT:6YU
M961<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R.34N,S @,S,N-C @5&0@*$8M(#,P*2!4:B!%5"!1"D)4("]&,R Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y-2XR-2!49" H271E;7,@
M365A<W5R960@870@1F%I<B!6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,34U
M+C W(#8Y-2XR-2!49" H86QU92!O;B!A(%)E8W5R<FEN9R!"87-I<RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M.#,N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-C<Q+C(U(%1D("A4:&4@0V]M<&%N>9(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q,#DN,C$@-C<Q+C(U(%1D("AS(&9I;F%N8VEA
M;"!A<W-E=',O;&EA8FEL:71I97,@<F5Q=6ER960@=&\@8F4@;65A<W5R960@
M;VX@82!R96-U<G)I;F<@8F%S:7,@=V5R92!I=',Z(&1E9F5R<F5D(&-O;7!E
M;G-A=&EO;B!L:6%B:6QI='D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y+C4P(#8U.2XR-2!49" H:6YC;'5D960@:6X@
M;W1H97(@;&]N9RUT97)M(&QI86)I;&ET:65S+"!I;G1E<F5S="!R871E('-W
M87 @86=R965M96YT(&EN8VQU9&5D(&EN(&]T:&5R(&-U<G)E;G0@86YD(&YO
M;F-U<G)E;G0@;&EA8FEL:71I97,L("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#<N,C4@5&0@*$-O;G9E<G1I
M8FQE($YO=&5S(&1E<FEV871I=F4@;&EA8FEL:71Y(&EN8VQU9&5D(&EN(&QO
M;F<M=&5R;2!D96)T(&%N9"!C87!I=&%L(&QE87-E(&]B;&EG871I;VYS+"!A
M;F0@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,S4N,C4@5&0@*&QI
M86)I;&ET:65S+BD@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," V,3$N,C4@5&0@*$1E9F5R<BD@5&H@150@40IQ(# @
M," P(')G($)4(#<U+C<Y(#8Q,2XR-2!49" H960@8V]M<&5N<V%T:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$T,RXR
M-R V,3$N,C4@5&0@*)=4:&4@0V]M<&%N>2!U=&EL:7IE<R!,979E;" Q(&EN
M<'5T<R!T;R!V86QU92!I=',@9&5F97)R960@8V]M<&5N<V%T:6]N(&QI86)I
M;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#0W-"XT.2 V,3$N,C4@5&0@
M*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<Y+C,Q(#8Q,2XR-2!49" H
M5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,Y+C R(#8Q
M,2XR-2!49" H<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-3DY+C(U(%1D("AD969E<G)E9"!C;VUP96YS871I
M;VX@;&EA8FEL:71I97,@87)E(&UE87-U<F5D('5S:6YG('!U8FQI8VQY(&%V
M86EL86)L92!I;F1I8V5S('1H870@9&5F:6YE('1H92!L:6%B:6QI='D@86UO
M=6YT<RP@87,@<&5R('1H92!P;&%N("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.#<N,C4@5&0@*&1O8W5M96YT
M<RXI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-38S+C(U(%1D("A);G1E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#8X+C4W(#4V,RXR-2!49" H97-T(')A=&4@<W=A<"!A9W(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,S<N,S<@-38S+C(U(%1D("AE96UE;G0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38U+C8X(#4V
M,RXR-2!49" HEU1H92!#;VUP86YY('5T:6QI>F5D($QE=F5L(#(@:6YP=71S
M('1O('9A;'5E(&ET<R!I;G1E<F5S="!R871E('-W87 @86=R965M96YT+B!3
M964@3F]T92 X("T@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#4U,2XR-2!49" H1&5B="!A;F0@3F]T92 Y("T@
M1&5R:79A=&EV97,N*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#4R-RXR-2!49" H0V]N=F5R=&EB;&4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.3DN-CD@-3(W+C(U(%1D("AN;W1E<R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Q,C,N-S<@-3(W+C(U(%1D("AD97)I=F%T
M:79E("D@5&H@150@40IQ(# @," P(')G($)4(#$V-BXW,B U,C<N,C4@5&0@
M*&QI86)I;&ET>2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q.3<N.#,@-3(W+C(U(%1D("B75&AE("D@5&H@150@40IQ(# @
M," P(')G($)4(#(R-BXS-2 U,C<N,C4@5&0@*$-O;7!A;GD@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C8X+C(Q(#4R-RXR-2!49" H=71I;&EZ960@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,S Q+C$W(#4R-RXR-2!49" H3&5V96P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S(V+CDQ(#4R-RXR-2!49" H,R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S0N.#D@-3(W+C(U(%1D("AI;G!U
M=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8R+C,Q(#4R-RXR-2!49" H
M=&\@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<S+C V(#4R-RXR-2!49" H
M=F%L=64@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDW+C8Y(#4R-RXR-2!4
M9" H:71S("D@5&H@150@40IQ(# @," P(')G($)4(#0Q,"XQ,2 U,C<N,C4@
M5&0@*$-O;G9E<G1I8FQE("D@5&H@150@40IQ(# @," P(')G($)4(#0V,"XS
M," U,C<N,C4@5&0@*$YO=&5S("D@5&H@150@40IQ(# @," P(')G($)4(#0X
M-BXV," U,C<N,C4@5&0@*&1E<FEV871I=F4@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-3(Y+C4U(#4R-RXR-2!49" H;&EA8FEL:71Y*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-38P+C Q(#4R-RXR-2!49" H+B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3$U+C(U(%1D
M("A/;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-"XR,B U,34N,C4@5&0@
M*$UA<F-H("D@5&H@150@40IQ(# @," P(')G($)4(#DR+C@R(#4Q-2XR-2!4
M9" H,3<L("D@5&H@150@40IQ(# @," P(')G($)4(#$P-RXX,B U,34N,C4@
M5&0@*#(P,3<L("D@5&H@150@40IQ(# @," P(')G($)4(#$S,BXX,B U,34N
M,C4@5&0@*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#<N-30@-3$U
M+C(U(%1D("A#;VUP86YY("D@5&H@150@40IQ(# @," P(')G($)4(#$X."XY
M,B U,34N,C4@5&0@*'!A:60@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C X
M+C8T(#4Q-2XR-2!49" H:6X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$X
M+CDR(#4Q-2XR-2!49" H9G5L;" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,S4N,S$@-3$U+C(U(%1D("AI=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C0W+C(U(#4Q-2XR-2!49" H0V]N=F5R=&EB;&4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,CDV+CDW(#4Q-2XR-2!49" H3F]T97,@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,S(R+C@P(#4Q-2XR-2!49" H86YD+" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-#(N,C,@-3$U+C(U(%1D("AA<R I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-3,N,#8@-3$U+C(U(%1D("AA("D@5&H@150@40IQ
M(# @," P(')G($)4(#,V,"XP," U,34N,C4@5&0@*')E<W5L="P@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S@W+C(R(#4Q-2XR-2!49" H9&5R96-O9VYI
M>F5D("D@5&H@150@40IQ(# @," P(')G($)4(#0T,RXP,B U,34N,C4@5&0@
M*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3<N-S0@-3$U+C(U(%1D
M("AD97)I=F%T:79E("D@5&H@150@40IQ(# @," P(')G($)4(#4P,"XR,B U
M,34N,C4@5&0@*&QI86)I;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#4S
M,"XV." U,34N,C4@5&0@*"XI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-#DQ+C(U(%1D("A#;VYT:6YG96YT(&-O
M;G-I9&5R871I;VX@;&EA8FEL:71I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3DQ+C<R(#0Y,2XR-2!49" HEU!O=&5N
M=&EA;"!E87)N;W5T('!A>6UE;G1S(')E;&%T960@=&\@=&AE(&%C<75I<VET
M:6]N(&]F($UE9&ES8V%N(&%N9"!54U(@87)E(&-O;G1I;F=E;G0@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0W
M.2XR-2!49" H=7!O;B!M965T:6YG(&-E<G1A:6X@<&5R9F]R;6%N8V4@<F5Q
M=6ER96UE;G1S('1H<F]U9V@@,C Q.2X@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S R+C4W(#0W.2XR-2!49" H5&AE(&QO;F<M=&5R;2!P;W)T:6]N(&]F
M('1H97-E(&QI86)I;&ET:65S(&AA<R!B965N(&EN8VQU9&5D(&EN("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T
M-C<N,C4@5&0@*&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;BP@86YD('1H92!S
M:&]R="UT97)M('!O<G1I;VX@:7,@:6YC;'5D960@:6X@;W1H97(@8W5R<F5N
M="!L:6%B:6QI=&EE<R!O;B!T:&4@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE
M971S+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-#4U+C(U(%1D("A4:&4@0V]M<&%N>2!U=&EL:7IE9"!,979E
M;" S(&EN<'5T<R!T;R!V86QU92!T:&5S92!C;VYT:6YG96YT(&-O;G-I9&5R
M871I;VX@;&EA8FEL:71I97,@87,@<VEG;FEF:6-A;G0@=6YO8G-E<G9A8FQE
M(&EN<'5T<R!W97)E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," T-#,N,C4@5&0@*'5S960@:6X@=&AE(&-A;&-U
M;&%T:6]N(&]F('1H96ER(&9A:7(@=F%L=64N($)O=&@@;V8@=&AE($UE9&ES
M8V%N(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B!L:6%B:6QI=&EE<R!H879E
M(&)E96X@;65A<W5R960@870@9F%I<B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#,Q+C(U(%1D("AV86QU92!U
M<VEN9R!A(&1I<V-O=6YT960@8V%S:"!F;&]W(&UO9&5L(&EN(&$@36]N=&4@
M0V%R;&\@<VEM=6QA=&EO;B!S971T:6YG+"!U=&EL:7II;F<@<VEG;FEF:6-A
M;G0@=6YO8G-E<G9A8FQE(&EN<'5T<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Q.2XR-2!49" H:6YC;'5D
M:6YG('1H92!E>'!E8W1E9"!V;VQA=&EL:71Y(&]F('1H92!A8W%U:7-I=&EO
M;G,G(&=R;W-S('!R;V9I=',@86YD(&%N(&5S=&EM871E9"!D:7-C;W5N="!R
M871E(&-O;6UE;G-U<F%T92!W:71H('1H92!R:7-K<R!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-# W+C(U
M(%1D("AT:&4@97AP96-T960@9W)O<W,@<')O9FET('-T<F5A;2X@26X@=&AE
M('1H:7)D('%U87)T97(@;V8@,C Q-RP@=&AE($-O;7!A;GD@9&5T97)M:6YE
M9"!T:&%T(&]N92!O9B!T:&4@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S.34N,C4@5&0@*&5A<FYO=71S(')E;&%T960@=&\@=&AE($UE9&ES8V%N
M(&%C<75I<VET:6]N('=O=6QD(&YO="!B92!A8VAI979E9"!F;W(@,C Q-R!A
M;F0L(&%S(&$@<F5S=6QT+"!T:&4@96YT:7)E(&5A<FYO=70@=V%S(')E=F5R
M<V5D+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S@S+C(U(%1D("A4:&4@8V]N=&EN9V5N="!C;VYS:61E<F%T
M:6]N(')E;&%T960@=&\@=&AE($-O;7!A;GDG<R!A8W%U:7-I=&EO;B!O9B!5
M4U(@=V%S(')E8V]R9&5D(&%S(&$@;&EA8FEL:71Y(&%N9"!M96%S=7)E9"!A
M="!F86ER('9A;'5E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," S-S$N,C4@5&0@*'5S:6YG(&$@9&ES8V]U;G1E
M9"!C87-H(&9L;W<@;6]D96P@=71I;&EZ:6YG('-I9VYI9FEC86YT('5N;V)S
M97)V86)L92!I;G!U=',L(&EN8VQU9&EN9R!T:&4@<')O8F%B:6QI='D@;V8@
M86-H:65V:6YG(&5A8V@@;V8@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-3DN,C4@5&0@*'!O=&5N=&EA
M;"!M:6QE<W1O;F5S(&%N9"!A;B!E<W1I;6%T960@9&ES8V]U;G0@<F%T92!C
M;VUM96YS=7)A=&4@=VET:"!T:&4@<FES:W,@;V8@=&AE(&5X<&5C=&5D(&-A
M<V@@9FQO=W,@871T<FEB=71A8FQE('1O('1H92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S0W+C(U(%1D("AM
M:6QE<W1O;F5S+B!);B!T:&4@=&AI<F0@<75A<G1E<B!O9B R,#$X+"!T:&4@
M0V]M<&%N>2!D971E<FUI;F5D('1H870@=&AE(&-O;G1I;F=E;G0@8V]N<VED
M97)A=&EO;B!E87)N;W5T(')E;&%T960@=&\@=&AE(%534B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S,U+C(U
M(%1D("AA8W%U:7-I=&EO;B!W;W5L9"!N;W0@8F4@86-H:65V960@9F]R(#(P
M,3@@86YD(#(P,3D@86YD+"!A<R!A(')E<W5L="P@=&AE(&5N=&ER92!L:6%B
M:6QI='D@=V%S(')E=F5R<V5D+B!3964@3F]T92 T("T@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,R,RXR-2!4
M9" H06-Q=6ES:71I;VYS+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," R.3DN,C4@5&0@*%1H92!F86ER('9A;'5E
M(&]F(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B!A;F0@=&AE(&%S<V]C:6%T
M960@;&EA8FEL:71I97,@=VEL;"!B92!A9&IU<W1E9"!T;R!F86ER('9A;'5E
M(&%T(&5A8V@@<F5P;W)T:6YG(&1A=&4@=6YT:6P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X-RXR-2!49" H
M86-T=6%L('-E='1L96UE;G0@;V-C=7)S+"!W:71H('1H92!C:&%N9V5S(&EN
M(&9A:7(@=F%L=64@86YD(')E;&%T960@86-C<F5T:6]N(')E9FQE8W1E9"!A
M<R!A8W%U:7-I=&EO;BUR96QA=&5D(&-O;G1I;F=E;G0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(W-2XR-2!4
M9" H8V]N<VED97)A=&EO;B!O;B!T:&4@8V]N<V]L:61A=&5D('-T871E;65N
M=',@;V8@;W!E<F%T:6]N<RX@4VEG;FEF:6-A;G0@:6YC<F5A<V5S(%PH9&5C
M<F5A<V5S7"D@:6X@=&AE('9O;&%T:6QI='D@;W(@:6X@86YY(&]F('1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,C8S+C(U(%1D("AP<F]B86)I;&ET:65S(&]F('-U8V-E<W,L(&]R(&1E
M8W)E87-E<R!<*&EN8W)E87-E<UPI(&EN('1H92!D:7-C;W5N="!R871E('=O
M=6QD(')E<W5L="!I;B!A('-I9VYI9FEC86YT;'D@:&EG:&5R(%PH;&]W97)<
M*2!F86ER('9A;'5E+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @,C4Q+C(U(%1D("AR97-P96-T:79E;'DI(%1J
M($54(%$*<2 P(# @,"!R9R!"5" Y-RXQ-B R-3$N,C4@5&0@*"P@86YD(&-O
M;6UE;G-U<F%T92!C:&%N9V5S('1O('1H97-E(&QI86)I;&ET:65S+B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,C(W+C(U(%1D("A4:&4@=&%B;&4@=VAI8V@@9F]L;&]W<R!S=6UM87)I>F5S
M('1H92!E<W1I;6%T960@9F%I<B!V86QU92!O9B!T:&4@0V]M<&%N>9(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C(N-#8@,C(W+C(U(%1D("AS(&9I;F%N
M8VEA;"!A<W-E=',@86YD(&QI86)I;&ET:65S(&UE87-U<F5D(&]N(&$@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(Q-2XR-2!49" H<F5C=7)R:6YG(&)A<VES.BD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3$N,34@,3DQ+C(U(%1D("A&
M86ER*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8Y+C(Y(#$Y,2XR-2!49" H
M("D@5&H@150@40IQ(# @," P(')G($)4(#(W,2XV,2 Q.3$N,C4@5&0@*%8I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S<N.3(@,3DQ+C(U(%1D("AA;'5E
M($UE87-U<BD@5&H@150@40IQ(# @," P(')G($)4(#,S,"XW." Q.3$N,C4@
M5&0@*&5M96YT<RD@5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.2XP," Q-C4N-S4@,CDU+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0T
M+C P(#$V-2XW-2 R,3@N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," Q,S4N-S4@,CDU
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S0T+C P(#$S-2XW-2 Q,#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-#@N,# @,3,U+C<U(#$P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#4X+C P(#$S-2XW
M-2 Q,#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XP," Q,#4N-S4@,CDU+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0T+C P(#$P-2XW-2 Q,#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-#@N,# @
M,3 U+C<U(#$P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#4X+C P(#$P-2XW-2 Q,#0N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT.2XP," W-2XW-2 R.34N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#0N
M,# @-S4N-S4@,3 T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#0X+C P(#<U+C<U(#$P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#4X+C P(#<U+C<U(#$P-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C,T-" Q-C4N-S4@;0HT-#@@,38U+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-3@@
M,38U+C<U(&T*-38R(#$V-2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0T(#$R,2XW-2!M"C0T." Q
M,C$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,T-" Q,3DN-S4@;0HT-#@@,3$Y+C<U(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M-3@@,3(Q+C<U(&T*-38R(#$R,2XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#4X(#$Q.2XW-2!M"C4V
M,B Q,3DN-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,T-" Y,2XW-2!M"C0T." Y,2XW-2!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S0T(#@Y+C<U(&T*-#0X(#@Y+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-3@@.3$N-S4@;0HU-C(@
M.3$N-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0U." X.2XW-2!M"C4V,B X.2XW-2!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0T
M(#8Q+C<U(&T*-#0X(#8Q+C<U(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#0@-3DN-S4@;0HT-#@@-3DN
M-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0U." V,2XW-2!M"C4V,B V,2XW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#4X(#4Y
M+C<U(&T*-38R(#4Y+C<U(&P*<PI"5" O1C(@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S-34N,34@,3<P+C0S(%1D("A$96-E;6)E<BD@5&H@150@40IQ
M(# @," P(')G($)4(#,Y."XS-R Q-S N-#,@5&0@*" S,2P@,C Q."D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN,34@
M,3<P+C0S(%1D("A$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#4Q
M,BXR-R Q-S N-#,@5&0@*" S,2P@,C Q-RD@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,2XU," Q-34N-#,@5&0@*$9I;F%N
M8VEA;"!,:6%B:6QI=&EE<SHI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,3 N-3 @,34U+C(Q(%1D("A<*&%M;W5N=',@:6X@
M=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3$N-3 @,30P+C0S(%1D("A<*$QE=F5L(#%<*2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V,RXU," Q,C4N
M-#(@5&0@*$1E9F5R<F5D(&-O;7!E;G-A=&EO;BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#8N-3 @,3(U+C0R(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R
M,2XV-2 Q,C4N-#(@5&0@*#$L-S(U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V,"XU," Q,C4N-#(@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U(#$R
M-2XT,B!49" H,2PT-C<I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3$N-3 @,3$P+C0S(%1D("A<*$QE=F5L(#)<*2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#0N-3 @
M,3$P+C0R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4U."XU," Q,3 N-#(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C,N-3 @.34N-#(@5&0@*$EN
M=&5R97-T(')A=&4@<W=A<',I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S0V+C4P(#DU+C0R(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R.2XQ-2 Y-2XT,B!4
M9" H,C,T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0V,"XU," Y-2XT,B!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U-#@N,34@.34N-#(@5&0@*)<I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @.# N
M-#,@5&0@*%PH3&5V96P@,UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#8S+C4P(#8U+C0R(%1D("A#;VYT:6YG96YT(&-O
M;G-I9&5R871I;VX@;&EA8FEL:71I97,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S0V+C4P(#8U+C0R(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XV-2 V
M-2XT,B!49" H-RPV.#DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8P+C4P(#8U+C0R(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 V-2XT,B!49" H
M-2PS-C@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A;0IE
M;F1O8FH*,38S(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO
M365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2
M"B]2;W1A=&4@, HO0V]N=&5N=',@,38T(# @4CX^"F5N9&]B:@HQ-C0@,"!O
M8FH*/#PO3&5N9W1H(#$U,C4W/CX*<W1R96%M"D)4("]&,B V+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S V+C P(#<W-2XT-2!49" H("D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,3,N.#4@-S8S+C0U
M(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N
M-C@@-S8S+C0U(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDY+C4S
M(#<V,RXT-2!49" H($A%04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,CDN
M-#4@-S8S+C0U(%1D("A42$-!4D4L($E.0RXI(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,3<U+C,P(#<U,2XT-2!49" H3D]4
M15,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R(#<U,2XT-2!49" H
M5"D@5&H@150@40IQ(# @," P(')G($)4(#(Q."XP,2 W-3$N-#4@5&0@*$\@
M0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C$Q(#<U,2XT
M-2!49" H5$5$($9)3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G($)4(#,V
M-RXR.2 W-3$N-#4@5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4(#,X
M,2XR." W-3$N-#4@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N
M-S8@-S4Q+C0U(%1D("A414U%3E13*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(U."XS-2 W,SDN-#4@5&0@*$1%0T5-0D52
MH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<Q-2XT-2!49" H,3 N($9A:7(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" X,RXQ-" W,34N-#4@5&0@*" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" X-2XT-B W,34N-#4@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Y,2XW-R W,34N-#4@5&0@*&%L=64@365A<W5R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,30T+C8S(#<Q-2XT-2!49" H96UE;G1S(%PH8V]N=&EN
M=65D7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 S,2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @5&0@*%1H92!O
M<&5N:6YG(&)A;&%N8V5S(&]F(&-O;G1I;F=E;G0@8V]N<VED97)A=&EO;B!A
M;F0@0V]N=F5R=&EB;&4@3F]T97,@9&5R:79A=&EV92!L:6%B:6QI=&EE<R!A
M<F4@<F5C;VYC:6QE9"!T;R!T:&4@8VQO<VEN9R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C$P(%1D("AB
M86QA;F-E<R!F;W(@9F%I<B!V86QU92!M96%S=7)E;65N=',@;V8@=&AE<V4@
M;&EA8FEL:71I97,@8V%T96=O<FEZ960@=VET:&EN($QE=F5L(#,@;V8@=&AE
M(&9A:7(@=F%L=64@:&EE<F%R8VAY(&%S(&9O;&QO=W,Z*2!4:B!%5"!1"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#8T,"XV
M," R-S<N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,C8N,# @-C0P+C8P(#(S-BXP," M,38N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0Y+C P(#8Q-BXV," R-S<N,# @+3$V+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,C8N,# @
M-C$V+C8P(#$Q.2XP," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-2XP," V,38N-C @,3 N,# @
M+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT-34N,# @-C$V+C8P(#$P-RXP," M,38N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y
M+C P(#4X-"XV," R-S<N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,C8N,# @-3@T+C8P(#$Q
M.2XP," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0T-2XP," U.#0N-C @,3 N,# @+3$V+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-34N,# @-3@T+C8P(#$P-RXP," M,38N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#4U,BXV
M," R-S<N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,C8N,# @-34R+C8P(#$Q.2XP," M,38N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0T-2XP," U-3(N-C @,3 N,# @+3$V+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-34N,# @
M-34R+C8P(#$P-RXP," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#4R,"XV," R-S<N,# @
M+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,C8N,# @-3(P+C8P(#$Q.2XP," M,38N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T
M-2XP," U,C N-C @,3 N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-34N,# @-3(P+C8P(#$P
M-RXP," M,38N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#0X."XV," R-S<N,# @+3$V+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS,C8N,# @-#@X+C8P(#$Q.2XP," M,38N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-2XP," T.#@N
M-C @,3 N,# @+3$V+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT-34N,# @-#@X+C8P(#$P-RXP," M,38N
M,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C,R-B V-# N-B!M"C0T-2 V-# N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-#4U(#8T,"XV(&T*-38R(#8T,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,C8@-34R+C8@;0HT
M-#4@-34R+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0U-2 U-3(N-B!M"C4V,B U-3(N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S(V(#0X."XV(&T*-#0U(#0X."XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-34@-#@X+C8@;0HU-C(@
M-#@X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,R-B T-S,N-B!M"C0T-2 T-S,N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S(V
M(#0W,2XV(&T*-#0U(#0W,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-34@-#<S+C8@;0HU-C(@-#<S
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0U-2 T-S$N-B!M"C4V,B T-S$N-B!L"G,*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S(Y+C4U(#8V,2XR."!49" H0V]N
M=&EN9V5N="!#;VYS:61E<F%T:6]N*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V.2XU," V-C$N,C@@5&0@*$-O;G9E<G1I
M8FQE($YO=&5S*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,V,RXV," V-#4N,C@@5&0@*$QI86)I;&ET:65S*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-BXR," V-#4N
M,C@@5&0@*$1E<FEV871I=F4@3&EA8FEL:71Y*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-# Q+C4P(#8R.2XP-B!49" H7"AA
M;6]U;G1S(&EN('1H;W5S86YD<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4Q+C4P(#8P-2XR-R!49" H1&5C96UB97(@
M,S$L(#(P,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S(X+C4P(#8P-2XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,3@N-C4@-C U+C(W(%1D("@U+#8P
M,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-3<N-3 @-C U+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S,"XV-2 V,#4N,C<@5&0@*#(W+#4S,BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU," U
M.#DN,C<@5&0@*%!A>6UE;G1S+U-E='1L96UE;G1S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,BXX," U.#DN,S(@5&0@
M*%PH,C@P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0T,2XQ-2 U.#DN,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R-RXS," U.#DN,S(@5&0@*%PH,C4L
M.34Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4U."XQ-2 U.#DN,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4W+C4P(#4W,RXR-R!49" H06-C<F5T:6]N
M(&5X<&5N<V4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#(V+C$U(#4W,RXR-R!49" H.38W*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T."XQ-2 U-S,N,C<@5&0@*)<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3<N
M-3 @-34W+C(W(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C0N,3<@
M-34W+C(W(%1D("AA;'5A=&EO;B!G86EN(&9O<B!T:&4@<&5R:6]D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,BXX," U
M-3<N,S(@5&0@*%PH.3(R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0T,2XQ-2 U-3<N,C<@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,BXS," U-3<N,S(@
M5&0@*%PH,2PU.#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-34X+C$U(#4U-RXR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @-30Q+C(W(%1D("A$
M96-E;6)E<B S,2P@,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,3@N-C4@-30Q+C(W(%1D("@U+#,V."D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#@N,34@-30Q
M+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4W+C4P(#4R-2XR-R!49" H4&%Y;65N=',I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(R+C@P(#4R-2XS,B!4
M9" H7"@R.# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0Q+C$U(#4R-2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-30X+C$U(#4R-2XR-R!49" HERD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-RXU
M," U,#DN,C<@5&0@*$%C8W)E=&EO;B!E>'!E;G-E*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R-BXQ-2 U,#DN,C<@5&0@
M*#DP,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-#@N,34@-3 Y+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4W+C4P(#0Y,RXR-R!49" H5BD@5&H@150@
M40IQ(# @," P(')G($)4(#8S+C8Q(#0Y,RXR-R!49" H86QU871I;VX@;&]S
M<R!F;W(@=&AE('!E<FEO9"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,3@N-C4@-#DS+C(W(%1D("@Q+#8Y."D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#@N,34@-#DS
M+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Q+C4P(#0W-RXR-R!49" H1&5C96UB97(@,S$L(#(P,3@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S(X+C4P
M(#0W-RXR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,3@N-C4@-#<W+C(W(%1D("@W+#8X.2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3<N-3 @-#<W+C(W
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4T."XQ-2 T-S<N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#0T.2XQ,"!49" H271E;7,@365A<W5R960@870@1F%I<B!6*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,34U+C W(#0T.2XQ,"!49" H86QU92!O;B!A($YO
M;BUR96-U<G)I;F<@0F%S:7,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-#,W+C$P(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0R-2XQ,"!4
M9" H5&AE($-O;7!A;GDG<R!N;VXM9FEN86YC:6%L(&%S<V5T<RP@<W5C:"!A
M<R!G;V]D=VEL;"P@=')A9&4@;F%M97,L(&]T:&5R(&EN=&%N9VEB;&4@87-S
M971S+"!A;F0@<')O<&5R='D@86YD(&5Q=6EP;65N="P@87)E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,3,N
M,3 @5&0@*&UE87-U<F5D(&%T(&9A:7(@=F%L=64@=VAE;B!T:&5R92!I<R!A
M;B!I;F1I8V%T;W(@;V8@:6UP86ER;65N="!A;F0@87)E(')E8V]R9&5D(&%T
M(&9A:7(@=F%L=64@;VYL>2!W:&5N(&%N(&EM<&%I<FUE;G0@8VAA<BD@5&H@
M150@40IQ(# @," P(')G($)4(#4T-RXQ-B T,3,N,3 @5&0@*&=E("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T
M,#$N,3 @5&0@*&ES(')E8V]G;FEZ960N($1U<FEN9R!A;B!E=F%L=6%T:6]N
M(&]F(&=O;V1W:6QL+"!T<F%D92!N86UE<RP@86YD(&]T:&5R(&EN=&%N9VEB
M;&4@87-S971S(&1U<FEN9R!T:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," S.#DN,3 @5&0@*#(P,3@L(#(P,3<L(&%N9" R,#$V+"!T:&4@8V%R
M<GEI;F<@=F%L=64@;V8@9V]O9'=I;&PL('1R861E(&YA;65S+"!A;F0@;W1H
M97(@:6YT86YG:6)L92!A<W-E=',@:6X@=&AE(%!H>7-I8VEA;B!3=&%F*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-3$Q+C$V(#,X.2XQ,"!49" H9FEN9R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,S<W+C$P(%1D("AR97!O<G1I;F<@=6YI="!E>&-E961E9"!T:&5I<B!F
M86ER('9A;'5E<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$S+C8P(#,W
M-RXQ,"!49" H07,@82!R97-U;'0L('1H92!#;VUP86YY(')E8V]R9&5D(&EM
M<&%I<FUE;G0@8VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#0R,"XU-R S
M-S<N,3 @5&0@*&=E<R!T:&%T(&EN8V]R<&]R871E<R!F86ER('9A;'5E("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S-C4N,3 @5&0@*&UE87-U<F5M96YT<R!B87-E9"!O;B!,979E;" S(&EN
M<'5T<RX@1F]R(&9U<G1H97(@9&ES8W5S<VEO;B!O;B!M96%S=7)I;F<@=&AE
M($-O;7!A;GDG<R!N;VXM9FEN86YC:6%L(&%S<V5T<RP@<W!E8VEF:6-A;&QY
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," S-3,N,3 @5&0@*&=O;V1W:6QL+"!T<F%D92!N86UE<RP@86YD(&-U
M<W1O;65R(')E;&%T:6]N<VAI<',L('-E92!.;W1E(#4@+2!';V]D=VEL;"P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0X+C0R(#,U,RXQ,"!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#,U-"XQ." S-3,N,3 @5&0@*')A9&4@
M3F%M97,L(&%N9"!/=&AE<B!);G1A;F=I8FQE("D@5&H@150@40IQ(# @," P
M(')G($)4(#0Y,2XS-2 S-3,N,3 @5&0@*$%S<V5T<RX@*2!4:B!%5"!1"D)4
M("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,R.2XQ,"!4
M9" H3W1H97(@1F%I<B!6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 R+C(Y
M(#,R.2XQ,"!49" H86QU92!$:7-C;&]S=7)E<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,3<N,3 @5&0@** I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,S U+C$P(%1D("A&:6YA;F-I86P@:6YS=')U;65N=',@;F]T(&UE87-U
M<F5D(&]R(')E8V]R9&5D(&%T(&9A:7(@=F%L=64@:6X@=&AE(&%C8V]M<&%N
M>6EN9R!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',@8V]N<VES="!O9B!C
M87-H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," R.3,N,3 @5&0@*&%N9"!C87-H(&5Q=6EV86QE;G1S+"!A8V-O
M=6YT<R!R96-E:79A8FQE+"!A8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D
M(&5X<&5N<V5S+"!A;F0@<VAO<G0@86YD(&QO;F<M=&5R;2!D96)T+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" U,#,N.#8@,CDS+C$P(%1D("A4:&4@97-T
M:6UA=&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," R.#$N,3 @5&0@*&9A:7(@=F%L=64@;V8@86-C;W5N=',@
M<F5C96EV86)L92P@86-C;W5N=',@<&%Y86)L92P@86YDH&%C8W)U960@97AP
M96YS97,@87!P<F]X:6UA=&4@=&AE:7(@8V%R<GEI;F<@86UO=6YT(&1U92!T
M;R!T:&4@<VAO<G0M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#(V.2XQ,"!49" H=&5R;2!N871U<F4@;V8@=&AE
M<V4@:6YS=')U;65N=',N("D@5&H@150@40IQ(# @," P(')G($)4(#$X,RXQ
M-R R-CDN,3 @5&0@*%1H92!E<W1I;6%T960@9F%I<B!V86QU92!O9B!T:&4@
M0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#DN-S@@,C8Y+C$P
M(%1D("AS(&1E8G0@=V%S(&-A;&-U;&%T960@=7-I;F<@82!D:7-C;W5N=&5D
M(&-A<V@@9FQO=R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,C4W+C$P(%1D("AA;F%L>7-I<R!A;F0@87!P<F]P
M<FEA=&4@=F%L=6%T:6]N(&UE=&AO9&]L;V=I97,@=7-I;F<@3&5V96P@,B!I
M;G!U=',@9G)O;2!A=F%I;&%B;&4@;6%R:V5T(&EN9F]R;6%T:6]N+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R
M,S,N,3 @5&0@*%1H92!C87)R>6EN9R!A;6]U;G1S(&%N9"!E<W1I;6%T960@
M9F%I<B!V86QU92!O9B!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,#4N,C4@,C,S+C$P(%1D("AS('-I9VYI9FEC86YT(&9I;F%N8VEA
M;"!I;G-T<G5M96YT<R!T:&%T('=E<F4@;F]T(&UE87-U<F5D(&%T(&9A:7(@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(R,2XQ,"!49" H=F%L=64@87)E(&%S(&9O;&QO=W,Z*2!4:B!%5"!1
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C P(#$V
M.2XV," Q.3,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-#(N,# @,38Y+C8P(#,R,"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0Y+C P(#$S.2XV," Q.3,N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-#(N
M,# @,3,Y+C8P(#<Q+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S$S+C P(#$S.2XV," Q,"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,R,RXP," Q,SDN-C @-S,N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M.38N,# @,3,Y+C8P(#$P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# V+C P(#$S.2XV," W
M,RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0W.2XP," Q,SDN-C @,3 N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.#DN,# @,3,Y+C8P(#<S+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,C0R(#$Y-2XV,# P,# P,# P,# P,B!M"C,Q,R Q.34N-C P,# P,# P,# P
M,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C,Q,R Q.34N-C P,# P,# P,# P,#(@;0HS,C,@,3DU+C8P
M,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HS,C,@,3DU+C8P,# P,# P,# P,# R(&T*
M,SDV(#$Y-2XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# V(#$Y-2XV,# P,# P
M,# P,# P,B!M"C0W.2 Q.34N-C P,# P,# P,# P,#(@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0W.2 Q
M.34N-C P,# P,# P,# P,#(@;0HT.#D@,3DU+C8P,# P,# P,# P,# R(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT.#D@,3DU+C8P,# P,# P,# P,# R(&T*-38R(#$Y-2XV,# P,# P
M,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,C0R(#$V.2XV,# P,# P,# P,# P,B!M"C,Q,R Q
M-CDN-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,R,R Q-CDN-C P,# P,# P,# P
M,#(@;0HS.38@,38Y+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,#8@,38Y+C8P
M,# P,# P,# P,# R(&T*-#<Y(#$V.2XV,# P,# P,# P,# P,B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#@Y(#$V.2XV,# P,# P,# P,# P,B!M"C4V,B Q-CDN-C P,# P,# P,# P
M,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C(T,B Q,3 N-C P,# P,# P,# P,#(@;0HS,3,@,3$P+C8P
M,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HR-#(@,3 X+C8P,# P,# P,# P,# R(&T*
M,S$S(#$P."XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S(S(#$Q,"XV,# P,# P
M,# P,# P,B!M"C,Y-B Q,3 N-C P,# P,# P,# P,#(@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,R,R Q
M,#@N-C P,# P,# P,# P,#(@;0HS.38@,3 X+C8P,# P,# P,# P,# R(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT,#8@,3$P+C8P,# P,# P,# P,# R(&T*-#<Y(#$Q,"XV,# P,# P
M,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-# V(#$P."XV,# P,# P,# P,# P,B!M"C0W.2 Q
M,#@N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X.2 Q,3 N-C P,# P,# P,# P
M,#(@;0HU-C(@,3$P+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#D@,3 X+C8P
M,# P,# P,# P,# R(&T*-38R(#$P."XV,# P,# P,# P,# P,B!L"G,*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @,3<T+C(W(%1D
M("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(W."XQ-2 R,# N,C@@5&0@*$1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S(Q+C,W(#(P,"XR."!49" H(#,Q+" R,#$X*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,RXQ-2 R,# N,C@@
M5&0@*$1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@V+C,W(#(P
M,"XR."!49" H(#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(U-RXR-2 Q.#0N,C@@5&0@*$-A<G)Y:6YG*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U.2XT
M-2 Q-S0N,C@@5&0@*$%M;W5N="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-#DN.3 @,3@T+C(X(%1D("A&86ER*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T-BXY-2 Q
M-S0N,C@@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3,N-S$@,3<T
M+C(X(%1D("AA;'5E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0R,BXR-2 Q.#0N,C@@5&0@*$-A<G)Y:6YG*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R-"XT-2 Q-S0N
M,C@@5&0@*$%M;W5N="D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,34N.3 @,3@T+C(X(%1D("A&86ER*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q,BXY-2 Q-S0N,C@@
M5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,3DN,C4@,3<T+C(X(%1D
M("AA;'5E*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S4Y+C4P(#$U.2XP-B!49" H7"AA;6]U;G1S(&EN('1H;W5S86YD<UPI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q
M+C4P(#$T-"XR-R!49" H1FEN86YC:6%L($QI86)I;&ET:65S.BD@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,2XU," Q,CDN
M,C@@5&0@*%PH3&5V96P@,EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,P.2XU," Q,CDN,C<@5&0@** I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDR+C4P(#$R.2XR
M-R!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-S4N-3 @,3(Y+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4U."XU," Q,CDN,C<@5&0@** I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C,N-3 @
M,3$T+C(W(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C@N.3$@,3$T
M+C(W(%1D("AE<FT@3&]A;BP@;F5T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(T-"XU," Q,30N,C<@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@Q+C8U(#$Q
M-"XR-R!49" H.#,L,3<Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,R-2XU," Q,30N,C<@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8T+C8U(#$Q-"XR-R!4
M9" H.#$L.# P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0P."XU," Q,30N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C8U(#$Q-"XR-R!49" H.3DL
M,3,T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y,2XU," Q,30N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(U+C8U(#$Q-"XR-R!49" H,3 P+#4P,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @.3@N,3 @5&0@** I(%1J($54(%$*0E0@
M+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.#8N,3 @5&0@
M*$-O;F-E;G1R871I;VX@;V8@4FES:RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,BXQ,"!49" H5&AE($-O;7!A
M;GD@:&%S(&EN=F5S=&5D(&ET<R!E>&-E<W,@8V%S:"!I;B!H:6=H;'DM<F%T
M960@;W9E<FYI9VAT(&9U;F1S(&%N9"!O=&AE<B!H:6=H;'DM<F%T960@;&EQ
M=6ED(&%C8V]U;G1S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,#4N-C @
M-C(N,3 @5&0@*%1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-3 N,3 @5&0@*$-O;7!A;GD@:7,@97AP;W-E
M9"!T;R!C<F5D:70@<FES:R!A<W-O8VEA=&5D('=I=&@@=&AE<V4@:6YV97-T
M;65N=',L(&%S('1H92!C87-H(&)A;&%N8V5S('1Y<&EC86QL>2!E>&-E960@
M=&AE(&-U<G)E;G0@1F5D97)A;" I(%1J($54(%$*96YD<W1R96%M"F5N9&]B
M:@HQ-C4@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I
M84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O
M=&%T92 P"B]#;VYT96YT<R Q-C8@,"!2/CX*96YD;V)J"C$V-B P(&]B:@H\
M/"],96YG=&@@,3(S-3$^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@5&0@
M*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W
M-C,N-#4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8S
M+C0U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W
M-C,N-#4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%4R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#3TY3
M3TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U(%1D
M("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y
M(#<U,2XT-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X
M(#<U,2XT-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W
M-3$N-#4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S$U+C0U(%1D("@Q,"X@1F%I<BD@5&H@150@40IQ(# @," P
M(')G($)4(#@S+C$T(#<Q-2XT-2!49" H("D@5&H@150@40IQ(# @," P(')G
M($)4(#@U+C0V(#<Q-2XT-2!49" H5BD@5&H@150@40IQ(# @," P(')G($)4
M(#DQ+C<W(#<Q-2XT-2!49" H86QU92!-96%S=7(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q-#0N-C,@-S$U+C0U(%1D("AE;65N=',@7"AC;VYT:6YU961<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M.34N,S @,S,N-C @5&0@*$8M(#,R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Y-2XQ,"!49" H1&5P;W-I="!)
M;G-U<F%N8V4@0V]R<&]R871I;VX@7"A&1$E#7"D@;&EM:70@;V8@)#(U,"PP
M,# N("D@5&H@150@40IQ(# @," P(')G($)4(#(X,2XW.2 V.34N,3 @5&0@
M*%1H92!#;VUP86YY(&UI;FEM:7IE<R!I=',@8W)E9&ET(')I<VL@<F5L871I
M;F<@=&\@=&AE<V4@<&]S:71I;VYS(&)Y("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.#,N,3 @5&0@*&UO;FET
M;W)I;F<@=&AE(&9I;F%N8VEA;"!C;VYD:71I;VX@;V8@=&AE(&9I;F%N8VEA
M;"!I;G-T:71U=&EO;G,@:6YV;VQV960@86YD(&)Y('!R:6UA<FEL>2!C;VYD
M=6-T:6YG(&)U<VEN97-S('=I=&@@;&%R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3$Y+C4Q(#8X,RXQ,"!49" H9V4L('=E;&P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W,2XQ,"!49" H
M97-T86)L:7-H960@9FEN86YC:6%L(&EN<W1I='5T:6]N<R!A;F0@9&EV97)S
M:69Y:6YG(&ET<R!C;W5N=&5R<&%R=&EE<RXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C4Y+C$P(%1D("B@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#8T-RXQ,"!49" H5&AE($-O;7!A;GD@9V5N97)A;&QY(&1O97,@;F]T(')E
M<75I<F4@8V]L;&%T97)A;"!A;F0@;6ET:6=A=&5S(&ET<R!C<F5D:70@<FES
M:R!B>2!P97)F;W)M:6YG(&-R961I="!E=F%L=6%T:6]N<R!A;F0@;6]N:71O
M<FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-C,U+C$P(%1D("AA="UR:7-K(&%C8V]U;G1S+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q,3<N,S4@-C,U+C$P(%1D("A4:&4@86QL;W=A
M;F-E(&9O<B!D;W5B=&9U;"!A8V-O=6YT<R!R97!R97-E;G1S('1H92!#;VUP
M86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#,V-2XX." V,S4N,3 @5&0@
M*',@97-T:6UA=&4@;V8@=6YC;VQL96-T:6)L92!R96-E:79A8FQE<R!B87-E
M9"!O;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-C(S+C$P(%1D("AA(')E=FEE=R!O9B!S<&5C:69I8R!A8V-O
M=6YT<R!A;F0@=&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C0Q+C,X(#8R,RXQ,"!49" H<R!H:7-T;W)I8V%L(&-O;&QE8W1I;VX@97AP
M97)I96YC92X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<W+C4S(#8R,RXQ
M,"!49" H5&AE($-O;7!A;GD@=W)I=&5S(&]F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#<R+C U(#8R,RXQ,"!49" H9B!S<&5C:69I8Z!A8V-O=6YT<R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C$Q+C$P(%1D("AB87-E9"!O;B!A;B!O;F=O:6YG(')E=FEE=R!O9B!C
M;VQL96-T86)I;&ET>2!A<R!W96QL(&%S('!A<W0@97AP97)I96YC92!W:71H
M('1H92!C=7-T;VUE<BD@5&H@150@40IQ(# @," P(')G($)4(#0P-BXV,2 V
M,3$N,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$Q+C0S(#8Q
M,2XQ,"!49" H5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#<Q+C$T(#8Q,2XQ,"!49" H<R!C;VYT<F%C="!T97)M<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3DY+C$P
M(%1D("AT>7!I8V%L;'D@<F5Q=6ER92!P87EM96YT(&)E='=E96X@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y,"XU-2 U
M.3DN,3 @5&0@*#$U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(P,"XU-2 U.3DN,3 @5&0@*"!T;R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S+C,S(#4Y.2XQ,"!4
M9" H-C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C(S+C,S(#4Y.2XQ,"!49" H(&1A>7,@9G)O;2!T:&4@9&%T92!O9B!I
M;G9O:6-E(&%N9"!A<F4@8V]N<VED97)E9"!P87-T(&1U92!B87-E9"!O;B!T
M:&4@<&%R=&EC=6QA<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-3@W+C$P(%1D("AN96=O=&EA=&5D(&-O;G1R
M86-T('1E<FUS+B!/=F5R86QL+"!B87-E9"!O;B!T:&4@;&%R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C4S+C0Q(#4X-RXQ,"!49" H9V4@;G5M8F5R(&]F
M(&-U<W1O;65R<R!I;B!D:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S,N
M-#<@-3@W+C$P(%1D("AF97)I;F<@9V5O9W)A<&AI8R!A<F5A<RP@<')I;6%R
M:6QY('1H<F]U9VAO=70@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#4W-2XQ,"!49" H=&AE(%5N:71E9"!3=&%T
M97,@86YD(&ET<R!T97)R:71O<FEE<RP@=&AE($-O;7!A;GD@8F5L:65V97,@
M=&AE(&-O;F-E;G1R871I;VX@;V8@8W)E9&ET(')I<VL@:7,@;&EM:71E9"XI
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-34Q+C$P(%1D("@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,N.34@
M-34Q+C$P(%1D("@Q+B!%;7!L;WEE92!"96YE9FET(%!L86YS*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4S.2XQ
M,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," U,C<N,3 @5&0@*%1H92!#;VUP86YY(&UA:6YT86EN<R!A
M('9O;'5N=&%R>2!D969I;F5D(&-O;G1R:6)U=&EO;B T,#%<*&M<*2!P<F]F
M:70M<VAA<FEN9R!P;&%N(&-O=F5R:6YG(&%L;"!E;&EG:6)L92!E;7!L;WEE
M97,@87,@9&5F:6YE9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-3$U+C$P(%1D("AI;B!T:&4@<&QA;B!D;V-U
M;65N=',N("D@5&H@150@40IQ(# @," P(')G($)4(#$T,BXS-B U,34N,3 @
M5&0@*%1H92!P;&%N('!R;W9I9&5S(&9O<B!A(&1I<V-R971I;VYA<GD@;6%T
M8VAI;F<@8V]N=')I8G5T:6]N+"!W:&EC:"!I<R!E<75A;"!T;R!AH'!E<F-E
M;G1A9V4@;V8@96%C:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-3 S+C$P(%1D("AE;&EG:6)L92!C;VYT<FEB
M=71I;F<@<&%R=&EC:7!A;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<X
M+CDQ(#4P,RXQ,"!49" H<R!E;&5C=&EV92!D969E<G)A;"P@=VAI8V@@=&AE
M($-O;7!A;GDI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,S0N.#<@-3 S+C$P
M(%1D("@L(&%T(&ET<R!S;VQE(&1I<V-R971I;VXL(&1E=&5R;6EN97,@9G)O
M;2!Y96%R('1O('EE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,SDN-3(@
M-3 S+C$P(%1D("@N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#0Y,2XQ,"!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-SDN,3 @5&0@*$-O
M;G1R:6)U=&EO;G,@8GD@=&AE($-O;7!A;GDI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-S(N-#8@-#<Y+C$P(%1D("@L(&YE="!O9B!F;W)F96ET=7)E<RP@
M=6YD97(@=&AI<R!P;&%N(&%M;W5N=&5D('1O("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C,N.# @-#<Y+C$P(%1D("@D
M,"XX(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#$R+C8Y(#0W.2XQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$W+C8Y(#0W.2XQ,"!49" H
M)# N-R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0V-BXU." T-SDN,3 @5&0@*"P@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#@N-3(@-#<Y+C$P
M(%1D("@D,"XX(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,W+C0Q(#0W.2XQ,"!49" H(&9O<B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#8W
M+C$P(%1D("AT:&4@>65A<G,@96YD960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$Q-"XQ.2 T-C<N,3 @5&0@*$1E8V5M
M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Y,BXW." T-C<N,3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Y-RXW." T-C<N,3 @5&0@
M*#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C$W+C<X(#0V-RXQ,"!49" H+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S.2XW,2 T-C<N,3 @5&0@*#(P
M,38I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C4Y+C<Q(#0V-RXQ,"!49" H+"!R97-P96-T:79E;'DI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S,3(N,S@@-#8W+C$P(%1D("@N($5L:6=I8FQE(&5M<&QO
M>65E<R!W:&\@96QE8W0@=&\@<&%R=&EC:7!A=&4@:6X@=&AE('!L86X@87)E
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," T-34N,3 @5&0@*&=E;F5R86QL>2!V97-T960@:6X@86YY(&5X:7-T
M:6YG(&UA=&-H:6YG(&-O;G1R:6)U=&EO;B!A9G1E<B!T:')E92!Y96%R<R!O
M9B!S97)V:6-E('=I=&@@=&AE($-O;7!A;GDI(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-3$N-3 @-#4U+C$P(%1D("@N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0S,2XQ,"!49" H5&AE($-O
M;7!A;GD@;V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,3<N,#@@-#,Q+C$P
M(%1D("AF97)S(&$@;F]N+7%U86QI9FEE9"!D969E<G)E9"!C;VUP96YS871I
M;VX@<')O9W)A;2!T;R!C97)T86EN(&ME>2!E;7!L;WEE97,@=VAE<F5B>2!T
M:&5Y(&UA>2!D969E<B!A("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," T,3DN,3 @5&0@*'!O<G1I;VX@;V8@86YN
M=6%L(&-O;7!E;G-A=&EO;B!F;W(@<&%Y;65N="!U<&]N(')E=&ER96UE;G0N
M("D@5&H@150@40IQ(# @," P(')G($)4(#(Y."XT,B T,3DN,3 @5&0@*%1H
M92!P<F]G<F%M(&ES('5N9G5N9&5D(&9O<B!T87@@<'5R<&]S97,@86YD(&9O
M<B!P=7)P;W-E<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-# W+C$P(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-34N,C8@-# W+C$P(%1D("AI=&QE($D@;V8@=&AE($5M<&QO
M>65E(%)E=&ER96UE;G0@26YC;VUE(%-E8W5R:71Y("D@5&H@150@40IQ(# @
M," P(')G($)4(#(U.2XV-" T,#<N,3 @5&0@*$%C="!O9B Q.3<T+B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,3(N,C(@-# W+C$P(%1D("A4:&4@;&EA
M8FEL:71Y(&9O<B!T:&4@9&5F97)R960@8V]M<&5N<V%T:6]N(&ES(&EN8VQU
M9&5D(&EN("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," S.34N,3 @5&0@*&]T:&5R(&QO;F<M=&5R;2!L:6%B:6QI
M=&EE<R!O;B!T:&4@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE971S(&%N9"!A
M;6]U;G1E9"!T;R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S8S+C4X(#,Y-2XQ,"!49" H)#$N-R!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,BXT-R S
M.34N,3 @5&0@*"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0S,2XY,2 S.34N,3 @5&0@*"0Q+C4@;6EL;&EO;BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.# N
M.# @,SDU+C$P(%1D("@@870@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y,RXP,B S.34N,3 @5&0@*$1E8V5M8F5RH#,Q
M+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S@S+C$P(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#8Y+C4P(#,X,RXQ,"!49" H(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#@N.30@
M,S@S+C$P(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$P."XY-" S.#,N,3 @5&0@*"P@<F5S<&5C=&EV96QY
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38Q+C8P(#,X,RXQ,"!49" H+BD@
M5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S-3DN,3 @5&0@*#$R+B!#;VUM:71M96YT<R!A;F0@0V]N=&EN9V5N8VEE
M<RD@5&H@150@40I"5" O1C,@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," S,S4N,3 @5&0@*$-O;6UI=&UE;G1S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,R,RXQ,"!49" HH"D@
M5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S,3$N,3 @5&0@*$]P97)A=&EN9R!,96%S97,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C@W+C$P(%1D("A4
M:&4@0V]M<&%N>2!H87,@96YT97)E9"!I;G1O(&YO;BUC86YC96QA8FQE(&]P
M97)A=&EN9R!L96%S92!A9W)E96UE;G1S(&9O<B!T:&4@<F5N=&%L(&]F(&]F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(Q+C8V(#(X-RXQ,"!49" H9FEC
M92!S<&%C92!A;F0@97%U:7!M96YT+B!#97)T86EN("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-S4N,3 @5&0@
M*&]F('1H97-E(&QE87-E<R!I;F-L=61E(&]P=&EO;G,@=&\@<F5N97<@87,@
M=V5L;"!A<R!R96YT(&5S8V%L871I;VX@8VQA=7-E<R!A;F0@:6X@8V5R=&%I
M;B!C87-E<RP@:6YC96YT:79E<R!F<F]M('1H92!L86YD;&]R9"!F;W(@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(V,RXQ,"!49" H<F5N="UF<F5E(&UO;G1H<R!A;F0@<')E;6ES97,@<F5D
M=6-T:6]N<RP@86YD(&%L;&]W86YC97,@9F]R('1E;F%N="!I;7!R;W9E;65N
M=',N("D@5&H@150@40IQ(# @," P(')G($)4(#,X-BXY.2 R-C,N,3 @5&0@
M*%1H92!R96YT(&5S8V%L871I;VYS(&%N9"!I;F-E;G1I=F5S(&AA=F4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(U,2XQ,"!49" H8F5E;B!R969L96-T960@:6X@=&AE('1A8FQE(&)E;&]W
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<Y+C W(#(U,2XQ,"!49" H+B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,C(W+C$P(%1D("A&=71U<F4@;6EN:6UU;2!L96%S92!P87EM96YT<RP@
M87,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#(P-BXY-R R,C<N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X-2XU-2 R
M,C<N,3 @5&0@*"P@87-S;V-I871E9"!W:71H('1H97-E(&%G<F5E;65N=',@
M=VET:"!T97)M<R!O9B!O;F4@>65A<B!O<B!M;W)E("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,34N,3 @5&0@
M*&%R92!A<R!F;VQL;W=S.J I(%1J($54(%$*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DN,# @,3@Y+C8P(#0Q,RXP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0V,BXP," Q.#DN-C @,3 P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN,# @,34Y
M+C8P(#0Q,RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0V,BXP," Q-3DN-C @,3 P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DN,# @,3(Y+C8P(#0Q,RXP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0V,BXP
M," Q,CDN-C @,3 P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN,# @.3DN-C @-#$S+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#8R+C P(#DY+C8P(#$P,"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0V,B Y.2XV,# P,# P,# P,# P,B!M"C4V,B Y.2XV,# P
M,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#8R(#@U+C8P,# P,# P,# P,# R(&T*-38R
M(#@U+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-C(@.#,N-C P,# P,# P,# P
M,#(@;0HU-C(@.#,N-C P,# P,# P,# P,#(@; IS"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4Q+C4P(#$Y-"XR."!49" H62D@5&H@150@
M40IQ(# @," P(')G($)4(#4W+C8Q(#$Y-"XR."!49" H96%R<R!%;F1I;F<@
M1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-30N-C0@,3DT+C(X
M(%1D("B@,S$Z*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#8Y+C4P(#$Y-"XP-B!49" H7"AA;6]U;G1S(&EN('1H;W5S86YD
M<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#8S+C4P(#$W.2XR-R!49" H,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-C0N-3 @,3<Y+C(W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 Q
M-SDN,C<@5&0@*#<L-#4Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#8S+C4P(#$V-"XR-R!49" H,C R,"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N-C4@,38T+C(W
M(%1D("@V+#(X-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" V,RXU," Q-#DN,C<@5&0@*#(P,C$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,U+C8U(#$T.2XR-R!49" H
M-2PT,#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-C,N-3 @,3,T+C(W(%1D("@R,#(R*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4S-2XV-2 Q,S0N,C<@5&0@*#0L.#4W
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#8S
M+C4P(#$Q.2XR-R!49" H,C R,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S4N-C4@,3$Y+C(W(%1D("@T+#<P,"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V,RXU," Q
M,#0N,C<@5&0@*%1H97)E869T97(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,U+C8U(#$P-"XR-R!49" H-2PX.3,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$N-3 @
M.#DN,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#8T+C4P(#@Y+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,"XV-2 X.2XR-R!49" H,S0L
M-3DU*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,2XQ,"!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#4T+CDQ(#8Q+C$P(%1D("AO=&%L(&]P97)A=&EN
M9R!L96%S92!E>'!E;G-E(&EN8VQU9&5D(&EN('-E;&QI;F<L(&=E;F5R86PL
M(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E<R!W87,@87!P<F]X:6UA=&5L
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#<V+C<R(#8Q+C$P(%1D("@D.2XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(U+C8Q(#8Q+C$P(%1D("@L
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,S N-C$@-C$N,3 @5&0@*"0Y+C0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Y+C$P(%1D("AM:6QL:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X+C,Y
M(#0Y+C$P(%1D("@L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3 P+C,S(#0Y+C$P(%1D("@D."XT*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Q-RXX,R T.2XQ
M,"!49" H(&UI;&QI;VX@9F]R('1H92!Y96%R<R!E;F1I;F<@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(S,RXY,2 T.2XQ
M,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S$R+C4P(#0Y+C$P(%1D("@L("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3<N-3 @
M-#DN,3 @5&0@*#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S,W+C4P(#0Y+C$P(%1D("@L(&%N9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4Y+C0T(#0Y+C$P
M(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,W.2XT-" T.2XQ,"!49" H+"!R97-P96-T:79E;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,S(N,3 @-#DN,3 @5&0@*"XI(%1J($54(%$*
M96YD<W1R96%M"F5N9&]B:@HQ-C<@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R
M96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O
M=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q-C@@,"!2/CX*96YD
M;V)J"C$V." P(&]B:@H\/"],96YG=&@@-38Q-SX^"G-T<F5A;0I"5" O1C(@
M-BXP,"!49B!%5 IQ(# @," P(')G($)4(#,P-BXP," W-S4N-#4@5&0@*" I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S
M+C@U(#<V,RXT-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDR+C8X(#<V,RXT-2!49" H62D@5&H@150@40IQ(# @," P(')G
M($)4(#(Y.2XU,R W-C,N-#4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S(Y+C0U(#<V,RXT-2!49" H5$A#05)%+"!)3D,N*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS," W-3$N
M-#4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU,B W
M-3$N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@-S4Q
M+C0U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G($)4(#(X
M."XQ,2 W-3$N-#4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-C<N,CD@-S4Q+C0U(%1D("@@4U0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#$N,C@@-S4Q+C0U(%1D("A!*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S@W+C<V(#<U,2XT-2!49" H5$5-14Y44RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,Y+C0U(%1D
M("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," W,34N-#4@5&0@*#$R+B!#;VUM:71M
M96YT<R!A;F0@0V]N=&EN9V5N8VEE<R!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV
M,"!49" H1BT@,S,I(%1J($54(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-CDU+C(U(%1D("A#;VYT:6YG96YC:65S*2!4:B!%
M5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8W
M,2XR-2!49" H4V%L97,@86YD($]T:&5R(%-T871E($YO;BUI;F-O;64@5"D@
M5&H@150@40IQ(# @," P(')G($)4(#$Y-"XY-2 V-S$N,C4@5&0@*&%X($QI
M86)I;&ET:65S*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#8U.2XR-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-#<N,C4@5&0@*%1H92!#
M;VUP86YY)W,@<V%L97,@86YD(&]T:&5R('-T871E(&YO;BUI;F-O;64@=&%X
M(&9I;&EN9W,@87)E('-U8FIE8W0@=&\@<F]U=&EN92!A=61I=',@8GD@875T
M:&]R:71I97,@:6X@=&AE(&IU<FES9&EC=&EO;G,@=VAE<F4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S-2XR
M-2!49" H:70@8V]N9'5C=',@8G5S:6YE<W,@:6X@=&AE(%5N:71E9"!3=&%T
M97,@=VAI8V@@;6%Y(')E<W5L="!I;B!A<W-E<W-M96YT<R!O9B!A9&1I=&EO
M;F%L('1A>&5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C0N,C8@-C,U
M+C(U(%1D("A4:&4@0V]M<&%N>2!A8V-R=65S('-A;&5S(&%N9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C(S
M+C(U(%1D("AO=&AE<B!N;VXM:6YC;VUE('1A>"!L:6%B:6QI=&EE<R!B87-E
M9"!O;B!T:&4@0V]M<&%N>2=S(&)E<W0@97-T:6UA=&4@;V8@:71S('!R;V)A
M8FQE(&QI86)I;&ET>2!U=&EL:7II;F<@8W5R<F5N=&QY(&%V86EL86)L92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C$Q+C(U(%1D("AI;F9O<FUA=&EO;B!A;F0@:6YT97)P<F5T871I;VX@
M;V8@<F5L979A;G0@=&%X(')E9W5L871I;VYS+B!.;VXM:6YC;VUE('1A>"!E
M>'!E;G-E(&ES(&EN8VQU9&5D(&EN('-E;&QI;F<L(&=E;F5R86P@86YD("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U.3DN,C4@5&0@*&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S(&]N(&ET<R!C
M;VYS;VQI9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&%N9"!T:&4@
M;&EA8FEL:71Y(&ES(')E9FQE8W1E9"!I;B!S86QE<R!T87@@<&%Y86)L92!W
M:71H:6X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#4X-RXR-2!49" H;W1H97(@8W5R<F5N="!L:6%B:6QI=&EE
M<R!A<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,38T+C<T(#4X-RXR-2!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C0S+C,R
M(#4X-RXR-2!49" H(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C8R+C<V(#4X-RXR-2!49" H,C Q-RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.#(N-S8@-3@W
M+C(U(%1D("@L(&]N(&ET<R!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',N
M("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," U-C,N,C4@5&0@*$QE9V%L(%!R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@.#0N-#$@-38S+C(U(%1D("AO8V5E9&EN9W,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3,Y+C(U(%1D("A&
M<F]M('1I;64@=&\@=&EM92P@=&AE($-O;7!A;GD@:7,@:6YV;VQV960@:6X@
M=F%R:6]U<R!L:71I9V%T:6]N+"!C;&%I;7,L(&EN=F5S=&EG871I;VYS+"!A
M;F0@;W1H97(@<')O8V5E9&EN9W,@=&AA="!A<FES92!I;B!T:&4@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4R
M-RXR-2!49" H;W)D:6YA<GD@8V]U<G-E(&]F(&ET<R!B=7-I;F5S<RX@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3<U+CDV(#4R-RXR-2!49" H5&AE<V4@
M;6%T=&5R<R!P<FEM87)I;'D@<F5L871E('1O(&5M<&QO>65E+7)E;&%T960@
M;6%T=&5R<R!T:&%T(&EN8VQU9&4@:6YD:79I9'5A;"!A;F0@8V]L;&5C=&EV
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-3$U+C(U(%1D("AC;&%I;7,L('!R;V9E<W-I;VYA;"!L:6%B:6QI
M='DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C(N-#0@-3$U+C(U(%1D("@L
M('1A>"P@86YD('!A>7)O;&P@<')A8W1I8V5S+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-S(N-S<@-3$U+C(U(%1D("A4:&4@0V]M<&%N>2!E<W1A8FQI
M<VAE<R!R97-E<G9E<R!W:&5N(&%V86EL86)L92!I;F9O<FUA=&EO;B!I;F1I
M8V%T97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#4P,RXR-2!49" H=&AA="!A(&QO<W,@:7,@<')O8F%B;&4@
M86YD(&%N(&%M;W5N="P@;W(@<F%N9V4@;V8@;&]S<R!C86X@8F4@<F5A<V]N
M86)L>2!E<W1I;6%T960N("D@5&H@150@40IQ(# @," P(')G($)4(#,X-"XR
M,B U,#,N,C4@5&0@*%1H97-E(&%S<V5S<VUE;G1S(&%R92!P97)F;W)M960@
M870@;&5A<W0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#0Y,2XR-2!49" H<75A<G1E<FQY(&%N9"!A<F4@8F%S
M960@;VX@=&AE(&EN9F]R;6%T:6]N(&%V86EL86)L92!T;R!M86YA9V5M96YT
M(&%T('1H92!T:6UE(&%N9"!I;G9O;'9E(&$@<VEG;FEF:6-A;G0@;6%N86=E
M;65N="!J=61G;65N=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-#<Y+C(U(%1D("AT;R!D971E<FUI;F4@=&AE
M('!R;V)A8FEL:71Y(&%N9"!E<W1I;6%T960@86UO=6YT(&]F('!O=&5N=&EA
M;"!L;W-S97,L(&EF(&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#,U,RXR
M,B T-SDN,C4@5&0@*"X@0F%S960@;VX@=&AE(&%V86EL86)L92!I;F9O<FUA
M=&EO;B!C;VYS:61E<F5D(&EN("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," T-C<N,C4@5&0@*&ET<R!R979I97=S
M+"!T:&4@0V]M<&%N>2!A9&IU<W1S(&ET<R!L;W-S(&-O;G1I;F=E;F-Y(&%C
M8W)U86QS(&%N9"!I=',@9&ES8VQO<W5R97,@87,@;6%Y(&)E(')E<75I<F5D
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-38N-C0@-#8W+C(U(%1D("A!
M8W1U86P@;W5T8V]M97,@;W(@;&]S<V5S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-34N,C4@5&0@*&UA>2!D
M:68I(%1J($54(%$*<2 P(# @,"!R9R!"5" X,"XQ-" T-34N,C4@5&0@*&9E
M<B!M871E<FEA;&QY(&9R;VT@=&AO<V4@97-T:6UA=&5D(&)Y('1H92!#;VUP
M86YY)W,@8W5R<F5N="!A<W-E<W-M96YT<R!I;F-L=61I;F<@879A:6QA8FQE
M(&EN<W5R86YC92!R96-O=F5R:65S+" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#0S+C(U(%1D("AW:&EC:"!W
M;W5L9"!I;7!A8W0@:71S('!R;V9I=&%B:6QI='DI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q.3(N-S(@-#0S+C(U(%1D("@N("D@5&H@150@40IQ(# @," P
M(')G($)4(#$Y-RXQ-R T-#,N,C4@5&0@*$%D=F5R<V4@9&5V96QO<&UE;G1S
M(&EN(&5X:7-T:6YG(&QI=&EG871I;VX@8VQA:6US(&]R(&QE9V%L('!R;V-E
M961I;F=S(&EN=F]L=FEN9R!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0S,2XR-2!49" H0V]M<&%N>2!O
M<B!N97<@8VQA:6US(&-O=6QD(')E<75I<F4@:70@=&\@97-T86)L:7-H(&]R
M(&EN8W)E87-E(&QI=&EG871I;VX@<F5S97)V97,@;W(@96YT97(@:6YT;R!U
M;F9A=F]R86)L92!S971T;&5M96YT<R!O<B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#$Y+C(U(%1D("AS871I
M<V9Y(&IU9&=M96YT<R!F;W(@;6]N971A<GD@9&%M86=E<R!F;W(@86UO=6YT
M<R!I;B!E>&-E<W,@;V8@8W5R<F5N="!R97-E<G9E<RP@=VAI8V@@8V]U;&0@
M861V97)S96QY(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#@S+C W(#0Q
M.2XR-2!49" H9F5C="!I=',@9FEN86YC:6%L("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,#<N,C4@5&0@*')E
M<W5L=',N("D@5&H@150@40IQ(# @," P(')G($)4(#@P+C0S(#0P-RXR-2!4
M9" H5RD@5&H@150@40IQ(# @," P(')G($)4(#@Y+C0W(#0P-RXR-2!49" H
M:71H(')E9V%R9"!T;R!T:&4@;W5T<W1A;F1I;F<@8V]N=&EN9V5N8VEE<R!A
M<R!O9B!$96-E;6)E<B S,2P@,C Q."P@=&AE($-O;7!A;GD@8F5L:65V97,@
M=&AE(&]U=&-O;64@;V8@=&AE<V4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#,Y-2XR-2!49" H;6%T=&5R<R!W
M:6QL(&YO="!H879E(&$@;6%T97)I86P@861V97)S92!E9BD@5&H@150@40IQ
M(# @," P(')G($)4(#(Q."XY-R S.34N,C4@5&0@*&9E8W0@;VX@:71S(&)U
M<VEN97-S+"!F:6YA;F-I86P@8V]N9&ET:6]N+"!R97-U;'1S(&]F(&]P97)A
M=&EO;G,@;W(@8V%S:"!F;&]W<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B
M:@HQ-CD@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I
M84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O
M=&%T92 P"B]#;VYT96YT<R Q-S @,"!2/CX*96YD;V)J"C$W," P(&]B:@H\
M/"],96YG=&@@,34R-38^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@5&0@
M*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W
M-C,N-#4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8S
M+C0U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W
M-C,N-#4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%4R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#3TY3
M3TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U(%1D
M("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y
M(#<U,2XT-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X
M(#<U,2XT-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W
M-3$N-#4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S$U+C0U(%1D("@Q,RX@26YC;VUE("D@5&H@150@40IQ(# @
M," P(')G($)4(#DX+CDX(#<Q-2XT-2!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#$P-"XW,R W,34N-#4@5&0@*&%X97,@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H
M1BT@,S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-CDU+C$P(%1D("A4:&4@8V]M<&]N96YT<R!O9B!T:&4@0V]M
M<&%N>2=S(%PH;&]S<UPI(&EN8V]M92!B969O<F4@:6YC;VUE('1A>&5S(&%R
M92!A<R!F;VQL;W=S.BD@5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XP," V,SDN-C @,CDU+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S0U+C P(#8S.2XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q-2XP," V,SDN-C @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0Q.2XP," V,SDN-C @-S N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.#DN,# @-C,Y+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N,# @-C,Y+C8P
M(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-C Y+C8P(#(Y-2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,T-2XP," V,#DN-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,34N,# @-C Y
M+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT,3DN,# @-C Y+C8P(#<P+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#@Y+C P(#8P.2XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C P(#8P
M.2XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T-2 V-CDN-B!M
M"C0Q-2 V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#$U(#8V.2XV(&T*-#$Y(#8V.2XV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT,3D@-C8Y+C8@;0HT.#D@-C8Y+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X.2 V-CDN-B!M"C0Y
M,R V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#DS(#8V.2XV(&T*-38S(#8V.2XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M-#4@-C4T+C8@;0HT,34@-C4T+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Q.2 V-30N-B!M"C0X.2 V
M-30N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#DS(#8U-"XV(&T*-38S(#8U-"XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#4@
M-C Y+C8@;0HT,34@-C Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Q.2 V,#DN-B!M"C0X.2 V,#DN
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-#DS(#8P.2XV(&T*-38S(#8P.2XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#4@-3DU
M+C8@;0HT,34@-3DU+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T-2 U.3,N-B!M"C0Q-2 U.3,N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#$Y(#4Y-2XV(&T*-#@Y(#4Y-2XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,3D@-3DS+C8@
M;0HT.#D@-3DS+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0Y,R U.34N-B!M"C4V,R U.34N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-#DS(#4Y,RXV(&T*-38S(#4Y,RXV(&P*<PI"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXU," V-S0N,C<@5&0@** I(%1J($54(%$*
M0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDX+C$P(#8W-"XR
M."!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#0P-"XW-R V-S0N,C@@
M5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0Q."XP," V-S0N,C@@
M5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#0Y
M,RXY,B V-S0N,C@@5&0@** S,2PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N-3 @-C4Y+C(W(%1D("B@*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V.2XU," V-3DN
M,C@@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#0S+C4P(#8U.2XR."!49" H,C Q-RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3<N-3 @-C4Y+C(X(%1D
M("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#$Q+C4P(#8T-"XP-B!49" H7"AA;6]U;G1S(&EN('1H;W5S86YD<UPI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C4P(#8R.2XR-R!49" H56YI=&5D(%-T871E<RD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#<N-3 @-C(Y+C(W(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,X
M,"XS," V,CDN,S(@5&0@*%PH,3@L-C$Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Q,2XQ-2 V,CDN,C<@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XU
M," V,CDN,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#8R+C8U(#8R.2XR-R!49" H,RPX,C8I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DU+C4P(#8R.2XR
M-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,S8N-C4@-C(Y+C(W(%1D("@S+#,P.2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," V,30N,C<@5&0@*$9O
M<F5I9VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,SDV+C$U(#8Q-"XR-R!49" H-#(T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W,"XQ-2 V,30N,C<@5&0@*#0W-2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N
M-C4@-C$T+C(W(%1D("@Q+#(S-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXU," U.3DN,C<@5&0@*%PH3&]S<UPI(&EN
M8V]M92!B969O<F4@:6YC;VUE('1A>&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,T-RXU," U.3DN,C<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S@P+C,P
M(#4Y.2XS,B!49" H7"@Q."PQ.34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#$Q+C$U(#4Y.2XR-R!49" H7"DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#(Q+C4P(#4Y
M.2XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-C(N-C4@-3DY+C(W(%1D("@T+#,P,2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.34N-3 @-3DY+C(W(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4S-BXV-2 U.3DN,C<@5&0@*#0L-30U*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," U-S$N,3 @5&0@** I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,2XX,B U
M-S$N,3 @5&0@*%1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" V.2XX-R U
M-S$N,3 @5&0@*&-O;7!O;F5N=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3(P+C8Y(#4W,2XQ,"!49" H;V8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3,Q+C4R(#4W,2XQ,"!49" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4
M(#$T-BXR-" U-S$N,3 @5&0@*$-O;7!A;GF2*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3@W+CDP(#4W,2XQ,"!49" H<R I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q.30N,CD@-3<Q+C$P(%1D("AI;F-O;64@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C(V+C(S(#4W,2XQ,"!49" H=&%X("D@5&H@150@40IQ(# @
M," P(')G($)4(#(T,"XY-2 U-S$N,3 @5&0@*&)E;F5F:70@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C<Q+C(Q(#4W,2XQ,"!49" H87)E("D@5&H@150@
M40IQ(# @," P(')G($)4(#(X-2XY,B U-S$N,3 @5&0@*&%S("D@5&H@150@
M40IQ(# @," P(')G($)4(#(Y-BXW-2 U-S$N,3 @5&0@*&9O;&QO=W,Z*2!4
M:B!%5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M+C P(#4S,"XV," R.34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#4N,# @-3,P+C8P(#(Q
M."XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C P(#4P,"XV," R.34N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS-#4N,# @-3 P+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$U+C P(#4P,"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#$Y+C P(#4P,"XV," W,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0X.2XP," U,# N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXP," U,# N
M-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," T-S N-C @,CDU+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S0U+C P(#0W,"XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q-2XP," T
M-S N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q.2XP," T-S N-C @-S N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.#DN,# @-#<P+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N,# @
M-#<P+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-#0P+C8P(#(Y-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C,T-2XP," T-# N-C @-S N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,34N
M,# @-#0P+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,3DN,# @-#0P+C8P(#<P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#@Y+C P(#0T,"XV," T+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS
M+C P(#0T,"XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#0Q,"XV," R.34N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHS-#4N,# @-#$P+C8P(#<P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#$U+C P(#0Q,"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$Y+C P(#0Q,"XV," W
M,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0X.2XP," T,3 N-C @-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y,RXP," T,3 N-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," S.# N-C @
M,CDU+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S0U+C P(#,X,"XV," W,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0Q-2XP," S.# N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q.2XP," S.# N
M-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#DN,# @,S@P+C8P(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.3,N,# @,S@P+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,S0U(#4T-2XV(&T*-#$U(#4T-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,34@-30U+C8@;0HT
M,3D@-30U+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0Q.2 U-#4N-B!M"C0X.2 U-#4N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#@Y(#4T-2XV(&T*-#DS(#4T-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3,@-30U+C8@;0HU-C,@
M-30U+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C,T-2 U,S N-B!M"C0Q-2 U,S N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$Y
M(#4S,"XV(&T*-#@Y(#4S,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3,@-3,P+C8@;0HU-C,@-3,P
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C,T-2 T-34N-B!M"C0Q-2 T-34N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0U(#0T
M,"XV(&T*-#$U(#0T,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,3D@-#4U+C8@;0HT.#D@-#4U+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0Q.2 T-# N-B!M"C0X.2 T-# N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DS(#0U-2XV
M(&T*-38S(#0U-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HT.3,@-#0P+C8@;0HU-C,@-#0P+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,T-2 S.# N-B!M"C0Q-2 S.# N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$Y(#,X,"XV(&T*
M-#@Y(#,X,"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3,@,S@P+C8@;0HU-C,@,S@P+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,T-2 S-C4N-B!M"C0Q-2 S-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$Y(#,V-2XV(&T*-#@Y
M(#,V-2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT.3,@,S8U+C8@;0HU-C,@,S8U+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,T
M-2 S-3$N-B!M"C0Q-2 S-3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0U(#,T.2XV(&T*-#$U(#,T
M.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,3D@,S4Q+C8@;0HT.#D@,S4Q+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Q.2 S
M-#DN-B!M"C0X.2 S-#DN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DS(#,U,2XV(&T*-38S(#,U,2XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HT.3,@,S0Y+C8@;0HU-C,@,S0Y+C8@; IS"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#4U,"XR-R!49" HH"D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3@N,3 @
M-34P+C(X(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# T+C<W(#4U
M,"XR."!49" H96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$X+C P(#4U
M,"XR."!49" H($5N9&5D($1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-#DS+CDR(#4U,"XR."!49" HH#,Q+"D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," U,S4N,C<@5&0@** I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8Y+C4P
M(#4S-2XR."!49" H,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-#,N-3 @-3,U+C(X(%1D("@R,#$W*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q-RXU," U,S4N
M,C@@5&0@*#(P,38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,3$N-3 @-3(P+C V(%1D("A<*&%M;W5N=',@:6X@=&AO=7-A
M;F1S7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3(N-3 @-3 U+C(W(%1D("A#=7)R96YT.BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#<N-3 @-3 U+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R
M,2XU," U,#4N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DU+C4P(#4P-2XR-R!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," T.3 N,C<@
M5&0@*$9E9&5R86PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S0W+C4P(#0Y,"XR-R!49" H)"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#$N,34@-#DP+C(W(%1D("@T
M,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,C$N-3 @-#DP+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0V-BXX," T.3 N,S(@5&0@*%PH-34U*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-2XQ-2 T
M.3 N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y-2XU," T.3 N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30T+C$U(#0Y,"XR-R!49" H
M,C(W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4X+C4P(#0W-2XR-R!49" H4W1A=&4I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDV+C$U(#0W-2XR-R!49" H-C(P*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-BXX
M," T-S4N,S(@5&0@*%PH,C<S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0X-2XQ-2 T-S4N,C<@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-"XQ-2 T-S4N
M,C<@5&0@*#4X-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U."XU," T-C N,C<@5&0@*$9O<F5I9VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDV+C$U(#0V,"XR-R!4
M9" H,C8Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0W,"XQ-2 T-C N,C<@5&0@*#$S.2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-#0N,34@-#8P+C(W(%1D("@S,C(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N
M-3 @-#0U+C(W(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N,C8@
M-#0U+C(W(%1D("AO=&%L*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,Y-BXQ-2 T-#4N,C<@5&0@*#DS,BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C8N.# @-#0U+C,R
M(%1D("A<*#8X.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.#4N,34@-#0U+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N-C4@-#0U+C(W(%1D("@Q
M+#$S-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,BXU," T,S N,C<@5&0@*$1E9F5R<F5D.BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N-3 @-#,P+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X
M-2XU," T,S N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34Y+C4P(#0S,"XR-R!49" HH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," T,34N,C<@
M5&0@*$9E9&5R86PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S@U+C,P(#0Q-2XS,B!49" H7"@R+#$S-RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N,34@-#$U+C(W
M(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-30N,S @-#$U+C,R(%1D("A<*#(S+#(T-2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#4N,34@-#$U+C(W(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S,N,S @-#$U+C,R(%1D("A<*#0L,2D@5&H@150@40IQ(# @," P(')G
M($)4(#4T.2XQ,R T,34N,S(@5&0@*#$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XQ-2 T,34N,C<@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P
M(#0P,"XR-R!49" H4W1A=&4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S@U+C,P(#0P,"XS,B!49" H7"@Q+#(W-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3$N,34@
M-# P+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-30N,S @-# P+C,R(%1D("A<*#$P+#8X-"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#4N,34@-# P
M+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-# N.# @-# P+C,R(%1D("A<*#@V-BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,34@-# P+C(W(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U."XU," S.#4N,C<@5&0@*$9O<F5I9VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-# V+C$U(#,X-2XR-R!49" H-"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S N
M,34@,S@U+C(W(%1D("@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<U+C$U
M(#,X-2XR-R!49" H,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-30P+C@P(#,X-2XS,B!49" H7"@S-#(I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C$U(#,X-2XR
M-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @,S<P+C(W(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N,C8@,S<P+C(W(%1D("AO=&%L*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,X-2XS," S-S N,S(@5&0@*%PH,RPT
M,3 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$Q+C$U(#,W,"XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#4T+C,P(#,W,"XS,B!49" H7"@S,RPX,3(I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@U
M+C$U(#,W,"XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,S+C,P(#,W,"XS,B!49" H7"@U+#,R,BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN,34@
M,S<P+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,BXU," S-34N,C<@5&0@*$EN8V]M92!T87@@8F5N969I
M="D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-#<N-3 @,S4U+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,X-2XS," S-34N,S(@5&0@*%PH,BPT-S@I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C$U
M(#,U-2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#(Q+C4P(#,U-2XR-R!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-30N,S @,S4U+C,R(%1D
M("A<*#,T+#4P,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.#4N,34@,S4U+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.34N-3 @,S4U+C(W(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M,RXS," S-34N,S(@5&0@*%PH-"PQ.#8I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-34Y+C$U(#,U-2XR-R!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N9'-T<F5A;0IE;F1O8FH*,3<Q
M(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@
M6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@
M, HO0V]N=&5N=',@,3<R(# @4CX^"F5N9&]B:@HQ-S(@,"!O8FH*/#PO3&5N
M9W1H(#$W-C,W/CX*<W1R96%M"D)4("]&,B V+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S V+C P(#<W-2XT-2!49" H("D@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,3,N.#4@-S8S+C0U(%1D("A#4D]3
M4R!#3U5.5%(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N-C@@-S8S+C0U
M(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDY+C4S(#<V,RXT-2!4
M9" H($A%04PI(%1J($54(%$*<2 P(# @,"!R9R!"5" S,CDN-#4@-S8S+C0U
M(%1D("A42$-!4D4L($E.0RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3<U+C,P(#<U,2XT-2!49" H3D]415,@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R(#<U,2XT-2!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#(Q."XP,2 W-3$N-#4@5&0@*$\@0T].4T],241!
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C$Q(#<U,2XT-2!49" H5$5$
M($9)3D%.0TE!3"D@5&H@150@40IQ(# @," P(')G($)4(#,V-RXR.2 W-3$N
M-#4@5&0@*"!35"D@5&H@150@40IQ(# @," P(')G($)4(#,X,2XR." W-3$N
M-#4@5&0@*$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N-S8@-S4Q+C0U
M(%1D("A414U%3E13*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#(U."XS-2 W,SDN-#4@5&0@*$1%0T5-0D52H#,Q+" R,#$X
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#<Q-2XT-2!49" H,3,N("D@5&H@150@40IQ(# @," P(')G($)4(#8U
M+C P(#<Q-2XT-2!49" H26YC;VUE("D@5&H@150@40IQ(# @," P(')G($)4
M(#DX+CDX(#<Q-2XT-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$P
M-"XW,R W,34N-#4@5&0@*&%X97,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3(U+C4V(#<Q-2XT-2!49" H7"AC;VYT:6YU961<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.34N,S @,S,N-C @5&0@
M*$8M(#,U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#8Y-2XQ,"!49" H1&5F97)R960@:6YC;VUE('1A>&5S(')E
M9FQE8W0@=&AE(&YE="!T87@@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,C(N,C@@-CDU+C$P(%1D("AF96-T(&]F('1E;7!O<F%R>2!D:68I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,#4N,3(@-CDU+C$P(%1D("AF97)E;F-E<R!B
M971W965N('1H92!C87)R>6EN9R!A;6]U;G0@;V8@87-S971S(&%N9"!L:6%B
M:6QI=&EE<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-C@S+C$P(%1D("AF;W(@9FEN86YC:6%L(')E<&]R=&EN
M9R!P=7)P;W-E<R!A;F0@=&AE(&%M;W5N=',@=7-E9"!F;W(@:6YC;VUE('1A
M>"!P=7)P;W-E<RX@("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," V-3DN,3 @5&0@*%-I9VYI9FEC86YT("D@5&H@
M150@40IQ(# @," P(')G($)4(#DU+C@X(#8U.2XQ,"!49" H8V]M<&]N96YT
M<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-#8N-S$@-C4Y+C$P(%1D("AO
M9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-3<N-30@-C4Y+C$P(%1D("AT
M:&4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3<R+C(U(#8U.2XQ,"!49" H
M0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3,N.3(@-C4Y+C$P
M(%1D("AS("D@5&H@150@40IQ(# @," P(')G($)4(#(R,"XS,2 V-3DN,3 @
M5&0@*&1E9F5R<F5D("D@5&H@150@40IQ(# @," P(')G($)4(#(U-BXQ,B V
M-3DN,3 @5&0@*'1A>" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-S N.#,@
M-C4Y+C$P(%1D("AA<W-E=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDV
M+C8V(#8U.2XQ,"!49" H86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,Q
M,RXV," V-3DN,3 @5&0@*&QI86)I;&ET:65S("D@5&H@150@40IQ(# @," P
M(')G($)4(#,U,RXS,B V-3DN,3 @5&0@*&%R92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-C@N,#,@-C4Y+C$P(%1D("AA<R I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-S@N.#8@-C4Y+C$P(%1D("AF;VQL;W=S.BD@5&H@150@40HP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," V,3@N
M-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#8Q."XV," Q-30N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,"XP," U.#@N-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P
M(#4X."XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," U.#@N-C @-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0X."XP," U.#@N-C @-S4N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP
M," U-3@N-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#4U."XV," W-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0X-"XP," U-3@N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X
M."XP," U-3@N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," U,C@N-C @,S4Y
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-# Y+C P(#4R."XV," W-2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0X-"XP," U,C@N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," U,C@N-C @
M-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XP," T.3@N-C @,S4Y+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-# Y+C P(#0Y."XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," T.3@N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," T.3@N-C @-S4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XP," T-C@N-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#0V
M."XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," T-C@N-C @-"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0X."XP," T-C@N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," T
M,S@N-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#0S."XV," W-2XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0X-"XP," T,S@N-C @-"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP
M," T,S@N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," T,#@N-C @,S4Y+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-# Y+C P(#0P."XV," W-2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X
M-"XP," T,#@N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," T,#@N-C @-S4N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XP," S-S@N-C @,S4Y+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-# Y+C P(#,W."XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," S-S@N-C @
M-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0X."XP," S-S@N-C @-S4N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,"XP," S-#@N-C @,S4Y+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#,T."XV
M," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," S-#@N-C @-"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0X."XP," S-#@N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT,#D@-C,S+C8@;0HT.#0@-C,S+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X-" V,S,N-B!M"C0X
M." V,S,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#@X(#8S,RXV(&T*-38S(#8S,RXV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M,#D@-C$X+C8@;0HT.#0@-C$X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X." V,3@N-B!M"C4V,R V
M,3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-# Y(#0U,RXV(&T*-#@T(#0U,RXV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@
M-#4S+C8@;0HU-C,@-#4S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 T,C,N-B!M"C0X-" T,C,N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-# Y(#0P."XV(&T*-#@T(#0P."XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@-#(S
M+C8@;0HU-C,@-#(S+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X." T,#@N-B!M"C4V,R T,#@N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-# Y(#,T."XV(&T*-#@T(#,T."XV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@,S0X+C8@
M;0HU-C,@,S0X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 S,S,N-B!M"C0X-" S,S,N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*-#@X(#,S,RXV(&T*-38S(#,S,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,#D@,S$Y+C8@;0HT
M.#0@,S$Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0P.2 S,3<N-B!M"C0X-" S,3<N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#@X(#,Q.2XV(&T*-38S(#,Q.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@,S$W+C8@;0HU-C,@
M,S$W+C8@; IS"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C4P(#8S."XR-R!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-38N-# @-C,X+C(X(%1D("A$96-E;6)E<BD@5&H@
M150@40IQ(# @," P(')G($)4(#0Y.2XV,B V,S@N,C@@5&0@** S,2PI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @
M-C(S+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0S-BXP," V,C,N,C@@5&0@*#(P,3@I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$U+C P(#8R,RXR."!4
M9" H,C Q-RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0T,RXU," V,#@N,#8@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<
M*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,BXU," U.3,N,C<@5&0@*$1E9F5R<F5D("D@5&H@150@40IQ(# @," P(')G
M($)4(#DP+C0T(#4Y,RXR-R!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#DV+C$Q(#4Y,RXR-R!49" H87@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3 W+C0R(#4Y,RXR-R!49" H07-S971S.BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," U-S@N,C<@5&0@*$%C8W)U
M960@;W1H97(@86YD('!R97!A:60@97AP96YS97,I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C4P(#4W."XR-R!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M-3<N-C4@-3<X+C(W(%1D("@R+#<S-"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.3 N-3 @-3<X+C(W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-BXV-2 U
M-S@N,C<@5&0@*#(L.34U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4X+C4P(#4V,RXR-R!49" H06QL;W=A;F-E(&9O<B!D
M;W5B=&9U;"!A8V-O=6YT<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-C4N,34@-38S+C(W(%1D("@V,#<I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30T+C$U(#4V,RXR
M-R!49" H-C(T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4X+C4P(#4T."XR-R!49" H26YT86YG:6)L92 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q,#$N,C<@-30X+C(W(%1D("A!<W-E=',I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R+C8U(#4T
M."XR-R!49" H,2D@5&H@150@40IQ(# @," P(')G($)4(#0U-RXV-2 U-#@N
M,C<@5&0@*#$L,S P*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S-BXV-2 U-#@N,C<@5&0@*#<L-S<V*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P(#4S,RXR-R!4
M9" H3F5T(&]P97)A=&EN9Z!L;W-S(&-A<G)Y9F]R=V%R9',I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R+C8U(#4S,RXR
M-R!49" H,34L-S$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S,2XV-2 U,S,N,C<@5&0@*#$T+#<Q."D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," U,3@N,C<@
M5&0@*$%C8W)U960@<')O9F5S<VEO;F%L(&QI86)I;&ET>2!C;&%I;7,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4W+C8U
M(#4Q."XR-R!49" H,2PY-3(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,V+C8U(#4Q."XR-R!49" H,2PW,#DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @-3 S
M+C(W(%1D("A!8V-R=65D('=O<FME<G.2*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3,P+C T(#4P,RXR-R!49" H(&-O;7!E;G-A=&EO;B!C;&%I;7,I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4W+C8U
M(#4P,RXR-R!49" H,BPW,CDI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3,V+C8U(#4P,RXR-R!49" H,BPU,3(I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4X+C4P(#0Y-2XR," Q,#8N.3$@+3DN,#D@<F4@9@HO
M1U,P(&=S"G$@," P(# @<F<@0E0@-3@N-3 @-#@X+C(W(%1D("A3:&%R92UB
M87-E9"!C;VUP96YS871I;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#8U+C$U(#0X."XR-R!49" H-C0V*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-"XQ-2 T.#@N
M,C<@5&0@*#<S-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U."XU," T-S,N,C<@5&0@*$-R961I="!C87)R>69O<G=A<F1S
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V
M-2XQ-2 T-S,N,C<@5&0@*#$X."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U-#0N,34@-#<S+C(W(%1D("@Q.#DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4X+C4P(#0V-2XR," R,BXW-R M.2XP.2!R92!F"B]'
M4S @9W,*<2 P(# @,"!R9R!"5" U."XU," T-3@N,C<@5&0@*$]T:&5R*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-2XQ
M-2 T-3@N,C<@5&0@*#4T,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#0N,34@-#4X+C(W(%1D("@T-#0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @-#0S+C(W
M(%1D("A'<F]S<R!D969E<G)E9"!T87@@87-S971S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,BXV-2 T-#,N,C<@5&0@
M*#,V+#0Q-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,S$N-C4@-#0S+C(W(%1D("@S,2PV-C$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4X+C4P(#0S-2XR," X,2XS-B M.2XP.2!R92!F"B]'4S @9W,*<2 P
M(# @,"!R9R!"5" U."XU," T,C@N,C<@5&0@*%8I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" V-"XV,2 T,C@N,C<@5&0@*&%L=6%T:6]N(&%L;&]W86YC92D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-30N
M,S @-#(X+C,R(%1D("A<*#$L,3@Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0X,"XQ-2 T,C@N,C<@5&0@*%PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,RXS," T
M,C@N,S(@5&0@*%PH,2PP-S8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34Y+C$U(#0R."XR-R!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R+C8U(#0Q,RXR
M-R!49" H,S4L,C(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S,2XV-2 T,3,N,C<@5&0@*#,P+#4X-2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3(N-3 @-# U+C(P(#DX+C4R("TY+C Y(')E(&8*+T=3,"!G
M<PIQ(# @," P(')G($)4(#4R+C4P(#,Y."XR-R!49" H1&5F97)R960@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@.3 N,S4@,SDX+C(W(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.34N-S8@,SDX+C(W(%1D("AA>"!,:6%B:6QI
M=&EE<SHI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3@N-3 @,S@S+C(W(%1D("A$97!R96-I871I;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C@P(#,X,RXS,B!4
M9" H7"@U,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.# N,34@,S@S+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" U-#4N.# @,S@S+C,R(%1D("A<*#0Q
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U
M.2XQ-2 S.#,N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4X+C4P(#,V."XR-R!49" H26YD969I;FET92!I
M;G1A;F=I8FQE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-#DN,S @,S8X+C,R(%1D("A<*#$I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-3<N-C,@,S8X+C,R(%1D("@Q+#$S-BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.# N,34@,S8X+C(W(%1D
M("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,S,N,S @,S8X+C,R(%1D("A<*#DL.38T*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XQ-2 S-C@N,C<@5&0@*%PI
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X
M+C4P(#,U,RXR-R!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#8S+CDQ
M(#,U,RXR-R!49" H87@@;VX@=6YR97!A=')I871E9"!E87)N:6YG<RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C$N.# @
M,S4S+C,R(%1D("A<*#,X,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.# N,34@,S4S+C(W(%1D("A<*2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-# N.# @,S4S+C,R
M(%1D("A<*#0V-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U-3DN,34@,S4S+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#DN,S @,S,X+C,R(%1D("A<
M*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3<N-C,@,S,X+C,R(%1D("@Q
M+#4W,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.# N,34@,S,X+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,C@N,S @,S,X+C,R(%1D("A<*#$P+#0W
M,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M-3DN,34@,S,X+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXU," S,C,N,C<@5&0@*$YE="!D969E<G)E
M9"!T87AE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,3$N-3 @,S(S+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0U,BXV-2 S,C,N,C<@5&0@*#(S+#8U
M-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.3 N-3 @,S(S+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S,2XV-2 S,C,N,C<@5&0@*#(P+#$I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" U-#DN,34@,S(S+C(W(%1D("@Q-"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,CDU+C$P(%1D("A/;B!$96-E;6)E<B R,BP@,C Q
M-RP@=&AE(#(P,3<@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@T+C@T(#(Y
M-2XQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$Y,"XR-2 R.34N
M,3 @5&0@*&%X("D@5&H@150@40IQ(# @," P(')G($)4(#(P,2XV-" R.34N
M,3 @5&0@*$%C="!W87,@<VEG;F5D(&EN=&\@;&5G:7-L871I;VX@=VAI8V@L
M(&%M;VYG(&]T:&5R(&-H86YG97,L(')E9'5C960@=&AE(&-O<G!O<F%T92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,C@S+C$P(%1D("AF961E<F%L(&EN8V]M92!T87@@<F%T92!F<F]M("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C4N
M.#,@,C@S+C$P(%1D("@S-24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3@T+C$V(#(X,RXQ,"!49" H('1O("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.38N.30@,C@S
M+C$P(%1D("@R,24I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C$U+C(W(#(X,RXQ,"!49" H(&5F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C(U+C,U(#(X,RXQ,"!49" H9F5C=&EV92!F;W(@=&AE($-O
M;7!A;GDG<R!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+" R,#$X+B I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T-C N-3 @,C@S+C$P(%1D("A4:&4@0V]M<&%N
M>2!R96-O<F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,C<Q+C$P(%1D("AI;F-O;64@=&%X(&5X<&5N<V4@
M;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$T,2XV.2 R-S$N,3 @5&0@*"0X+C @;6EL;&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3 N-3@@,C<Q+C$P(%1D
M("@L('!R:6UA<FEL>2!D=64@=&\@82!R92UM96%S=7)E;65N="!O9B!I=',@
M9&5F97)R960@=&%X(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@:6X@=&AE(&9O
M=7)T:" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,C4Y+C$P(%1D("AQ=6%R=&5R(&]F(#(P,3<N("D@5&H@150@
M40IQ(# @," P(')G($)4(#$Q-2XY-B R-3DN,3 @5&0@*%1H92!I;7!A8W0@
M;V8@=&AE($=L;V)A;"!);G1A;F=I8FQE($QO=RU4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C@Y+C$P(#(U.2XQ,"!49" H87AE9"!);F-O;64@<')O=FES
M:6]N+"!T:&4@=')A;G-I=&EO;B!T87@@;VX@=&AE(&1E96UE9"!R97!A=')I
M871I;VX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#(T-RXQ,"!49" H;V8@9&5F97)R960@9F]R96EG;B!I;F-O
M;64L(&%N9"!A;GD@9G5T=7)E('1A>"!I;7!A8W0@87-S;V-I871E9"!W:71H
M(&)A<VES(&1I9BD@5&H@150@40IQ(# @," P(')G($)4(#,V,RXY,R R-#<N
M,3 @5&0@*&9E<F5N8V5S(&]N(&9O<F5I9VX@<W5B<VED:6%R:65S('=E<F4@
M:6UM871E<FEA;"X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#(R,RXQ,"!49" H26X@1&5C96UB97(@,C Q-RP@
M=&AE(%-E8W5R:71I97,@86YD($5X8VAA;F=E($-O;6UI<W-I;VX@7"A314-<
M*2!S=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S,Y+C(U(#(R,RXQ,"!4
M9" H9B!I<W-U960@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#,X."XU
M,2 R,C,N,3 @5&0@*&8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDS+C<Y
M(#(R,RXQ,"!49" H06-C;W5N=&EN9R!"=6QL971I;B!.;RX@,2D@5&H@150@
M40IQ(# @," P(')G($)4(#0Y.2XU,2 R,C,N,3 @5&0@*#$X(%PH4T%"(#$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#$N.3,@,C(S+C$P(%1D("@Q.%PI
M+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,C$Q+C$P(%1D("AW:&EC:"!P<F]V:61E9"!G=6ED86YC92!O;B!A
M8V-O=6YT:6YG(&9O<B!T:&4@=&%X(&5F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C8S+C$S(#(Q,2XQ,"!49" H9F5C=',@;V8@=&AE(#(P,3<@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S,R+C,X(#(Q,2XQ,"!49" H5"D@5&H@150@
M40IQ(# @," P(')G($)4(#,S-RXW.2 R,3$N,3 @5&0@*&%X("D@5&H@150@
M40IQ(# @," P(')G($)4(#,T.2XQ-R R,3$N,3 @5&0@*$%C="X@4T%"(#$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.34N,3D@,C$Q+C$P(%1D("@Q."!P
M<F]V:61E9"!A(&UE87-U<F5M96YT('!E<FEO9"!T:&%T("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q.3DN,3 @
M5&0@*'-H;W5L9"!N;W0@97AT96YD(&)E>6]N9"!O;F4@>65A<B!F<F]M('1H
M92!E;F%C=&UE;G0@9&%T92!F;W(@8V]M<&%N:65S('1O(&-O;7!L971E('1H
M92!A8V-O=6YT:6YG(')E<75I<F5D('5N9&5R('1H92 I(%1J($54(%$*0E0@
M+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@W+C$P(%1D
M("A);F-O;64@5"D@5&H@150@40IQ(# @," P(')G($)4(#@V+C W(#$X-RXQ
M,"!49" H87AE<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q,#,N.#0@,3@W+C$P(%1D("@@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3 V+C$V(#$X-RXQ,"!49" H5"D@5&H@150@40IQ(# @," P(')G
M($)4(#$Q,2XU-R Q.#<N,3 @5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-C$N-C4@,3@W+C$P(%1D("A!4T(@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3@S+C U(#$X-RXQ,"!49" H05-#+B!);B!A8V-O
M<F1A;F-E('=I=&@@4T%"(#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3(N
M-C8@,3@W+C$P(%1D("@Q."P@=&AE($-O;7!A;GD@<')O=FED960@82!P<F]V
M:7-I;VYA;"!A;6]U;G0@=VET:"!R96=A<F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$W-2XQ,"!49" H=&\@
M8V5R=&%I;B!F;W)E:6=N('1A>"!P<F]V:7-I;VYS(&EN(#(P,3<N($EN(#(P
M,3@L('1H92!#;VUP86YY(')E=FES960@:71S(&5S=&EM871E('=I=&@@<F5G
M87)D('1O('1H92 R,#$W("D@5&H@150@40IQ(# @," P(')G($)4(#0X,2XW
M,R Q-S4N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#<N,30@
M,3<U+C$P(%1D("AA>" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.3@N-3,@
M,3<U+C$P(%1D("A!8W0@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," Q-C,N,3 @5&0@*')E8V]R9&5D("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXY
M." Q-C,N,3 @5&0@*"0P+C$@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Q,S4N.#<@,38S+C$P(%1D("@@;V8@
M=&%X(&5X<&5N<V4N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#$S.2XQ,"!49" H07,@;V8@1&5C96UB97(@,S$L
M(#(P,38L('1H92!#;VUP86YY(&1E=&5R;6EN960@=&AA="!I="!C;W5L9"!N
M;W0@<W5S=&%I;B!A(&-O;F-L=7-I;VX@=&AA="!I="!W87,@;6]R92!L:6ME
M;'D@=&AA;B!N;W0@=&AA="!I=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,3(W+C$P(%1D("AW;W5L9"!R96%L
M:7IE(&%N>2!O9B!I=',@9&5F97)R960@=&%X(&%S<V5T<R!R97-U;'1I;F<@
M9G)O;2!R96-E;G0@;&]S<V5S+"!T:&4@9&EF*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S8S+C$P(#$R-RXQ,"!49" H9FEC=6QT>2!O9B!F;W)E8V%S=&EN
M9R!F=71U<F4@=&%X86)L92!I;F-O;64L(&%N9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3$U+C$P(%1D("AO
M=&AE<B!F86-T;W)S+"!A;F0@87,@82!R97-U;'0L('1H92!#;VUP86YY(&AA
M9"!A('9A;'5A=&EO;B!A;&QO=V%N8V4@;VX@:71S(&1E9F5R<F5D('1A>"!A
M<W-E=',L(&5X8VQU<VEV92!O9B!I;F1E9FEN:71E+6QI=F5D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,#,N
M,3 @5&0@*&EN=&%N9VEB;&4@9&5F97)R960@=&%X(&QI86)I;&ET:65S+B @
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#<Y+C$P(%1D("A&;W(@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L
M(#(P,3<L('!R961O;6EN86YT;'D@;VX@=&AE(&)A<VES(&]F(&$@<F5A<W-E
M<W-M96YT(&]F('1H92!A;6]U;G0@;V8@:71S(&1E9F5R<F5D('1A>"!A<W-E
M=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#8W+C$P(%1D("AT:&%T(&%R92!M;W)E(&QI:V5L>2!T:&%N(&YO
M="!T;R!B92!R96%L:7IE9"P@=&AE($-O;7!A;GD@<F5D=6-E9"!I=',@=F%L
M=6%T:6]N(&%L;&]W86YC92!B>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#(Q+C,R(#8W+C$P(%1D("@D-#4N-"!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0W-2XR,2 V-RXQ,"!49" H(%PH8V]M<')I<V5D(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N,#(@-C<N,3 @
M5&0@*"0Q-2XW("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," U-2XQ,"!49" H;6EL;&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W."XS.2 U-2XQ,"!49" H
M(')E;&%T960@=&\@52Y3+B!N970@;W!E<F%T:6YG(&QO<W-E<RP@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(R-2XP,R U
M-2XQ,"!49" H)#0N-"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(W,RXY,B U-2XQ,"!49" H(')E;&%T960@
M=&\@<W1A=&4@;F5T(&]P97)A=&EN9R!L;W-S97,L(&%N9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,X+C T(#4U+C$P
M(%1D("@D,C4N,R!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0Y,2XY,R U-2XQ,"!49" H(')E;&%T960@=&\@
M;W1H97(@*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3<S(# @;V)J"CP\
M+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N
M,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N
M=',@,3<T(# @4CX^"F5N9&]B:@HQ-S0@,"!O8FH*/#PO3&5N9W1H(#$Y.34U
M/CX*<W1R96%M"D)4("]&,B V+C P(%1F($54"G$@," P(# @<F<@0E0@,S V
M+C P(#<W-2XT-2!49" H("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R,3,N.#4@-S8S+C0U(%1D("A#4D]34R!#3U5.5%(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3(N-C@@-S8S+C0U(%1D("A9*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,CDY+C4S(#<V,RXT-2!49" H($A%04PI
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,CDN-#4@-S8S+C0U(%1D("A42$-!
M4D4L($E.0RXI(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3<U+C,P(#<U,2XT-2!49" H3D]415,@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C$Q+C4R(#<U,2XT-2!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#(Q."XP,2 W-3$N-#4@5&0@*$\@0T].4T],241!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C@X+C$Q(#<U,2XT-2!49" H5$5$($9)3D%.0TE!
M3"D@5&H@150@40IQ(# @," P(')G($)4(#,V-RXR.2 W-3$N-#4@5&0@*"!3
M5"D@5&H@150@40IQ(# @," P(')G($)4(#,X,2XR." W-3$N-#4@5&0@*$$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#<N-S8@-S4Q+C0U(%1D("A414U%
M3E13*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(U."XS-2 W,SDN-#4@5&0@*$1%0T5-0D52H#,Q+" R,#$X*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<Q-2XT
M-2!49" H,3,N("D@5&H@150@40IQ(# @," P(')G($)4(#8U+C P(#<Q-2XT
M-2!49" H26YC;VUE("D@5&H@150@40IQ(# @," P(')G($)4(#DX+CDX(#<Q
M-2XT-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#$P-"XW,R W,34N
M-#4@5&0@*&%X97,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(U+C4V(#<Q
M-2XT-2!49" H7"AC;VYT:6YU961<*2D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.34N,S @,S,N-C @5&0@*$8M(#,V*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#8Y-2XQ,"!49" H;F5T(&1E9F5R<F5D('1A>"!A<W-E='-<*2X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,30V+C(R(#8Y-2XQ,"!49" H5&AE('9A;'5A
M=&EO;B!A;&QO=V%N8V4@;VX@82!P;W)T:6]N(&]F('-T871E(&YE="!O<&5R
M871I;F<@;&]S<V5S(&YO="!M;W)E(&QI:V5L>2!T:&%N(&YO="!R96%L:7IA
M8FQE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," V.#,N,3 @5&0@*'=A<R!N;W0@<F5L96%S960@869T97(@86YA
M;'ES:7,@;V8@<F5S<&5C=&EV92!E>'!I<F%T:6]N('!E<FEO9',@86YD('-P
M96-I9FEC('-T871E('1A>&%B;&4@:6YC;VUE('!R;VIE8W1I;VYS+BD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M-3DN,3 @5&0@*$%S(&]F($1E8V5M8F5R(#,Q+" R,#$X+"!T:&4@0V]M<&%N
M>2!C;VYT:6YU97,@=&\@;6%I;G1A:6X@82!V86QU871I;VX@86QL;W=A;F-E
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,#(N-S0@-C4Y+C$P(%1D("@D,2XR(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4Q+C8S(#8U.2XQ,"!4
M9" H(&]N(&$@<&]R=&EO;B!O9B!S=&%T92!N970@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8T-RXQ,"!49" H
M;W!E<F%T:6YG(&QO<W-E<R!N;W0@;6]R92!L:6ME;'D@=&AA;B!N;W0@<F5A
M;&EZ86)L92XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-C(S+C$P(%1D("A!<R!O9B I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S,N.30@-C(S+C$P(%1D("A$
M96-E;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q-3(N-3,@-C(S+C$P(%1D("@@86YD("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S$N.3<@-C(S
M+C$P(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$Y,2XY-R V,C,N,3 @5&0@*"P@<F5S<&5C=&EV96QY*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C0T+C8S(#8R,RXQ,"!49" H+"!T:&4@
M0V]M<&%N>2!H860@87!P<F]X:6UA=&5L>2 I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S@R+CDS(#8R,RXQ,"!49" H)#$X
M-2XQ(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#0Q+C@R(#8R,RXQ,"!49" H(&%N9" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Q+C(V(#8R,RXQ,"!4
M9" H)#$V-BXQ(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(P+C$U(#8R,RXQ,"!49" H(&]F("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,3$N
M,3 @5&0@*&9E9&5R86PL('-T871E+"!A;F0@9F]R96EG;B!N970@;W!E<F%T
M:6YG(&QO<W,@8V%R<GEF;W)W87)D<RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C@W+C@S(#8Q,2XQ,"!49" H5&AE(&-A<G)Y9F]R=V%R9',@=VEL;"!E
M>'!I<F4@87,@9F]L;&]W<SH@9F5D97)A;"!B971W965N("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C(N,3@@-C$Q+C$P
M(%1D("@R,#,R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4T,BXQ." V,3$N,3 @5&0@*"!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Y.2XQ,"!49" H
M,C S-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" V.2XU," U.3DN,3 @5&0@*"P@<W1A=&4@8F5T=V5E;B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3,Q+C$T(#4Y.2XQ
M,"!49" H,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-3$N,30@-3DY+C$P(%1D("@@86YD("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S N-3@@-3DY+C$P(%1D
M("@R,#,X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$Y,"XU." U.3DN,3 @5&0@*"P@86YD(&9O<F5I9VX@8F5T=V5E;B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<Y
M+C<Q(#4Y.2XQ,"!49" H,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" R.3DN-S$@-3DY+C$P(%1D("@@86YD("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3DN,34@
M-3DY+C$P(%1D("@R,#(S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,S.2XQ-2 U.3DN,3 @5&0@*"X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4W-2XQ,"!4
M9" H5&AE(')E8V]N8VEL:6%T:6]N(&]F(&EN8V]M92!T87@@8V]M<'5T960@
M870@=&AE(%4N4RX@9F5D97)A;"!S=&%T=71O<GD@<F%T92!T;R!I;F-O;64@
M=&%XH&)E;F5F:70@:7,@87,@9F]L;&]W<SHI(%1J($54(%$*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-3,T+C8P(#(Y-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C,T-2XP," U,S0N-C @,C$X+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 N,# @-3 T+C8P(#(Y-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,T-2XP," U,#0N-C @
M-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,34N,# @-3 T+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,3DN,# @-3 T+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@Y+C P(#4P-"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#DS+C P(#4P-"XV," W,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4P+C P(#0W-"XV," R.34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#4N,# @-#<T
M+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#$U+C P(#0W-"XV," T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#$Y+C P(#0W-"XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X.2XP," T
M-S0N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXP," T-S0N-C @-S N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,"XP," T-#0N-C @,CDU+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S0U+C P
M(#0T-"XV," W,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q-2XP," T-#0N-C @-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0Q.2XP," T-#0N-C @-S N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#DN
M,# @-#0T+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3,N,# @-#0T+C8P(#<P+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3 N,# @-#$T+C8P(#(Y-2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,T
M-2XP," T,30N-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,34N,# @-#$T+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,3DN,# @-#$T+C8P(#<P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#@Y+C P(#0Q-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DS+C P(#0Q-"XV," W
M,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C P(#,X-"XV," R.34N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS-#4N,# @,S@T+C8P(#<P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$U+C P(#,X-"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#$Y+C P(#,X-"XV," W,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0X.2XP," S.#0N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,RXP," S.#0N
M-C @-S N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#4@-30Y+C8@;0HT
M,34@-30Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0Q-2 U-#DN-B!M"C0Q.2 U-#DN-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#$Y(#4T.2XV(&T*-#@Y(#4T.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#D@-30Y+C8@;0HT.3,@
M-30Y+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0Y,R U-#DN-B!M"C4V,R U-#DN-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0U
M(#4S-"XV(&T*-#$U(#4S-"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,3D@-3,T+C8@;0HT.#D@-3,T
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0Y,R U,S0N-B!M"C4V,R U,S0N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0U(#,V
M.2XV(&T*-#$U(#,V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-#4@,S4U+C8@;0HT,34@,S4U+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C,T-2 S-3,N-B!M"C0Q-2 S-3,N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$Y(#,V.2XV
M(&T*-#@Y(#,V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HT,3D@,S4U+C8@;0HT.#D@,S4U+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0Q.2 S-3,N-B!M"C0X.2 S-3,N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#DS(#,V.2XV(&T*
M-38S(#,V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3,@,S4U+C8@;0HU-C,@,S4U+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0Y,R S-3,N-B!M"C4V,R S-3,N-B!L"G,*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N-3 @-34T+C(W(%1D("B@*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y."XQ," U-30N,C@@
M5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#0N-S<@-34T+C(X(%1D
M("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3@N,# @-34T+C(X(%1D
M("@@16YD960@1&5C96UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.3,N
M.3(@-34T+C(X(%1D("B@,S$L*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R+C4P(#4S.2XR-R!49" HH"D@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-CDN-3 @-3,Y+C(X
M(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0T,RXU," U,SDN,C@@5&0@*#(P,3<I(%1J($54(%$*0E0@+T8R
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$W+C4P(#4S.2XR."!49" H
M,C Q-BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Q,2XU," U,C0N,#8@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU
M," U,#DN,C<@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XR-B U
M,#DN,C<@5&0@*&%X(&%T(%4N4RX@<W1A='5T;W)Y(')A=&4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0W+C4P(#4P.2XR
M-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.#4N,S @-3 Y+C,R(%1D("A<*#,L.#(Q*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,2XQ-2 U,#DN,C<@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0R,2XU," U,#DN,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#8R+C8U(#4P.2XR-R!49" H,2PU,#8I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DU+C4P
M(#4P.2XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S8N-C4@-3 Y+C(W(%1D("@Q+#4Y,2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," T.30N,C<@
M5&0@*%-T871E('1A>&5S+"!N970@;V8@9F5D97)A;"!B96YE9FET*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,BXX," T
M.30N,S(@5&0@*%PH-30S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q,2XQ-2 T.30N,C<@5&0@*%PI*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U.2XS," T.30N,S(@
M5&0@*%PH,2PS-S0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#@U+C$U(#0Y-"XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30T+C$U(#0Y-"XR-R!49" H
M,S0T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R+C4P(#0W.2XR-R!49" H3F]N8V]N=')O;&QI;F<@:6YT97)E<W0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDR+C@P
M(#0W.2XS,B!49" H7"@R-3(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#$Q+C$U(#0W.2XR-R!49" H7"DI(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C@P(#0W.2XS
M,B!49" H7"@T-34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#@U+C$U(#0W.2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30P+C@P(#0W.2XS,B!49" H
M7"@R-C I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-34Y+C$U(#0W.2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-#8T+C(W(%1D("A.;VXM9&5D
M=6-T:6)L92!I=&5M<R!<*&%<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.38N,34@-#8T+C(W(%1D("@V,C4I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8R+C8U(#0V
M-"XR-R!49" H,BPV-S8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,V+C8U(#0V-"XR-R!49" H,2PU-#8I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-#0Y+C(W
M(%1D("A&;W)E:6=N('1A>"!E>'!E;G-E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,Y-BXQ-2 T-#DN,C<@5&0@*#$X,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S N
M,34@-#0Y+C(W(%1D("@Q-S4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-34P+C@P(#0T.2XS,B!49" H7"@U*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U.2XQ-2 T-#DN
M,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4R+C4P(#0S-"XR-R!49" H5BD@5&H@150@40IQ(# @," P(')G
M($)4(#4Y+C$W(#0S-"XR-R!49" H86QU871I;VX@86QL;W=A;F-E<RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#$N,34@
M-#,T+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0U-"XS," T,S0N,S(@5&0@*%PH-#4L,S4T*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-2XQ-2 T,S0N
M,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S,RXS," T,S0N,S(@5&0@*%PH."PS-SDI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C$U(#0S-"XR-R!4
M9" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3(N-3 @-#$Y+C(W(%1D("A5;F-E<G1A:6X@=&%X('!O<VET:6]N<RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.#@N
M-C4@-#$Y+C(W(%1D("@Q+#8R.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-C(N-C4@-#$Y+C(W(%1D("@Q+#$T-2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N-C4@
M-#$Y+C(W(%1D("@Q+# Y,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,BXU," T,#0N,C<@5&0@*%)E='5R;B!T;R!P<F]V
M:7-I;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,SDR+C@P(#0P-"XS,B!49" H7"@T-3@I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C$U(#0P-"XR-R!49" H7"DI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#<U
M+C$U(#0P-"XR-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#DN,34@-# T+C(W(%1D("B7*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#,X.2XR-R!4
M9" H1F5D97)A;"!R871E(&-H86YG92D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,#$N,34@,S@Y+C(W(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,BXV-2 S
M.#DN,C<@5&0@*#@L,#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.# N,34@
M,S@Y+C(W(%1D("@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4T.2XQ-2 S.#DN,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,S<T+C(W(%1D("A/
M=&AE<BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S.38N,34@,S<T+C(W(%1D("@Q-C(I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8V+C@P(#,W-"XS,B!49" H7"@X,S$I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@U
M+C$U(#,W-"XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-30P+C@P(#,W-"XS,B!49" H7"@Q*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-30Y+C$S(#,W-"XS,B!49" H,3,I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-34Y+C$U(#,W-"XR
M-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @,S4Y+C(W(%1D("A);F-O;64@=&%X(&)E;F5F:70I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0W+C4P
M(#,U.2XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S.#4N,S @,S4Y+C,R(%1D("A<*#(L-#<X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,2XQ-2 S-3DN
M,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0R,2XU," S-3DN,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4T+C,P(#,U.2XS,B!49" H7"@S
M-"PU,#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#@U+C$U(#,U.2XR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DU+C4P(#,U.2XR-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S,N,S @
M,S4Y+C,R(%1D("A<*#0L,3@V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4U.2XQ-2 S-3DN,C<@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," S-#,N,3 @5&0@*%]?7U]?7U]?7U]?7U]?7U\I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,S$Y+C$P(%1D("A<*&%<*2!);F-L=61E<R!N;VXM9&5D=6-T:6)L92!M96%L
M<R!A;F0@:6YC:61E;G1A;',L(&UI<V-E;&QA;F5O=7,@;F]N+61E9'5C=&EB
M;&4@:71E;7,L(&%N9"!B96=I;FYI;F<@:6X@,C Q."P@;F]N+61E9'5C=&EB
M;&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#,P-RXQ,"!49" H<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N+BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," R.#,N,3 @5&0@*%1H92!T87@@>65A<G,@,C P."!A;F0@,C Q,"!T:')O
M=6=H(#(P,3<@<F5M86EN(&]P96X@=&\@97AA;6EN871I;VX@8GD@8V5R=&%I
M;B!T87AI;F<@:G5R:7-D:6-T:6]N<R!T;R!W:&EC:"!T:&4@0V]M<&%N>2!I
M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,C<Q+C$P(%1D("AS=6)J96-T('1O('1A>"X@1'5R:6YG(#(P,3@L
M('1H92!#;VUP86YY(&%C8W)U960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(U,RXS-" R-S$N,3 @5&0@*"0P+C$@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,#(N,C,@,C<Q+C$P(%1D("@@;V8@26YD:6$@=&%X(&]N(&5A<FYI;F=S
M(&]F(&%P<')O>&EM871E;'D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0W,RXR.2 R-S$N,3 @5&0@*"0P+C4@;6EL;&EO
M;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,C(N,3@@,C<Q+C$P(%1D("@N($EN9&EA("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-3DN,3 @5&0@*'=I=&AH
M;VQD:6YG('1A>&5S(&]N(&$@9&EV:61E;F0@;V8@26YD:6$@96%R;FEN9W,@
M87)E(&YO="!A9BD@5&H@150@40IQ(# @," P(')G($)4(#(X."XQ-" R-3DN
M,3 @5&0@*&9E8W1E9"!B>2!T:&4@8V%L8W5L871I;VX@;V8@52Y3+B!T87AE
M<R!D=64@86YD(&-O;G1I;G5E('1O(&)E("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-#<N,3 @5&0@*&%C8W)U
M960N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," R,S4N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,C(S+C$P(%1D("A!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-38N,3<@,C(S+C$P(%1D("@@<F5C;VYC:6QI871I
M;VX@;V8@=&AE(&)E9VEN;FEN9R!A;F0@96YD:6YG(&%M;W5N=',@;V8@=6YR
M96-O9VYI>F5D('1A>"!B96YE9FET<R!I<R!A<R!F;VQL;W=S.J I(%1J($54
M(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @
M,3DW+C8P(#,P.2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U.2XP," Q.3<N-C @,C T+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3 N,# @,38W+C8P(#,P.2XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U
M.2XP," Q-C<N-C @-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,C0N,# @,38W+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,C@N,# @,38W+C8P(#8U+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-#DS+C P(#$V-RXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DW+C P(#$V-RXV," V
M-BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C4P+C P(#$S-RXV," S,#DN,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHS-3DN,# @,3,W+C8P(#8U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(T+C P(#$S-RXV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#(X+C P(#$S-RXV," V-2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0Y,RXP," Q,S<N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-RXP," Q,S<N
M-C @-C8N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," Q,#<N-C @,S Y+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*,S4Y+C P(#$P-RXV," V-2XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R-"XP," Q
M,#<N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0R."XP," Q,#<N-C @-C4N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHT.3,N,# @,3 W+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3<N,# @
M,3 W+C8P(#8V+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4Y(#$Y-RXV
M,# P,# P,# P,# P,B!M"C0R-" Q.3<N-C P,# P,# P,# P,#(@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0R." Q.3<N-C P,# P,# P,# P,#(@;0HT.3,@,3DW+C8P,# P,# P,# P
M,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT.3<@,3DW+C8P,# P,# P,# P,# R(&T*-38S(#$Y-RXV
M,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S4Y(#DR+C8P,# P,# P,# P,# R(&T*
M-#(T(#DR+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,C@@.3(N-C P,# P,# P
M,# P,#(@;0HT.3,@.3(N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-R Y,BXV
M,# P,# P,# P,# P,B!M"C4V,R Y,BXV,# P,# P,# P,# P,B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M,S4Y(#<X+C8P,# P,# P,# P,# R(&T*-#(T(#<X+C8P,# P,# P,# P,# R
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS-3D@-S8N-C P,# P,# P,# P,#(@;0HT,C0@-S8N-C P,# P
M,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C0R." W."XV,# P,# P,# P,# P,B!M"C0Y,R W
M."XV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(X(#<V+C8P,# P,# P,# P,# R
M(&T*-#DS(#<V+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3<@-S@N-C P,# P
M,# P,# P,#(@;0HU-C,@-S@N-C P,# P,# P,# P,#(@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y-R W
M-BXV,# P,# P,# P,# P,B!M"C4V,R W-BXV,# P,# P,# P,# P,B!L"G,*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,C R+C(W
M(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,X,2XP," R,#(N,C@@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4P+C P(#(P,BXR."!49" H,C Q
M-RD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,3DN-3 @,C R+C(X(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#$X+C4P(#$X-RXP-B!49" H7"AA;6]U;G1S
M(&EN('1H;W5S86YD<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C4P(#$W,BXR-R!49" H0F%L86YC92!A="!*86YU
M87)Y(#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S8Q+C4P(#$W,BXR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S.3<N-C4@,3<R+C(W(%1D("@S+#@P-RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S N
M-3 @,3<R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0V-BXV-2 Q-S(N,C<@5&0@*#4L,3@P*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y.2XU," Q-S(N
M,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,V+C8U(#$W,BXR-R!49" H-"PP-S$I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,34W+C(W(%1D("A!
M9&1I=&EO;G,@8F%S960@;VX@=&%X('!O<VET:6]N<R!R96QA=&5D('1O('1H
M92!C=7)R96YT('EE87(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDW+C8U(#$U-RXR-R!49" H,2PT,#$I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V+C8U(#$U-RXR
M-R!49" H,2PQ-#4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,V+C8U(#$U-RXR-R!49" H,2PP-30I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,30R+C(W(%1D
M("A!9&1I=&EO;G,@8F%S960@;VX@=&%X('!O<VET:6]N<R!R96QA=&5D('1O
M('!R:6]R('EE87)S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0P-2XQ-2 Q-#(N,C<@5&0@*#(P-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-SDN,34@,30R+C(W(%1D
M("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4T.2XQ-2 Q-#(N,C<@5&0@*#4U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C4P(#$R-RXR-R!49" H4F5D=6-T:6]N
M<R!B87-E9"!O;B!S971T;&5M96YT<R!O9B!T87@@<&]S:71I;VYS(')E;&%T
M960@=&\@<')I;W(@>65A<G,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#$P+C$U(#$R-RXR-R!49" HERD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S N.# @,3(W+C,R
M(%1D("A<*#0S.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.#DN,34@,3(W+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#DN,34@,3(W+C(W(%1D("B7
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C4P(#$Q,BXR-R!49" H,C Q-R I(%1J($54(%$*<2 P(# @,"!R9R!"5" W
M-"XY,2 Q,3(N,C<@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" X,"XU
M." Q,3(N,C<@5&0@*&%X("D@5&H@150@40IQ(# @," P(')G($)4(#DQ+C@Y
M(#$Q,BXR-R!49" H06-T(&9E9&5R86P@=&%X(')A=&4@8VAA;F=E*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,"XQ-2 Q
M,3(N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#8S+C,P(#$Q,BXS,B!49" H7"@Q+#@U.2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#DN,34@,3$R+C(W
M(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U-#DN,34@,3$R+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#DW+C(W(%1D("A/=&AE<BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,3 N
M,34@.3<N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#<P+C@P(#DW+C,R(%1D("A<*#(R,"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#DN,34@.3<N,C<@
M5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4T.2XQ-2 Y-RXR-R!49" HERD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXU," X,BXR-R!49" H0F%L86YC92!A
M="!$96-E;6)E<J S,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S-C$N-3 @.#(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDW+C8U(#@R+C(W(%1D("@U
M+#0Q,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T,S N-3 @.#(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#8V+C8U(#@R+C(W(%1D("@S+#@P-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.3DN-3 @
M.#(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3,V+C8U(#@R+C(W(%1D("@U+#$X,"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-C8N,3 @5&0@** I(%1J($54(%$*96YD<W1R96%M"F5N9&]B
M:@HQ-S4@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I
M84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O
M=&%T92 P"B]#;VYT96YT<R Q-S8@,"!2/CX*96YD;V)J"C$W-B P(&]B:@H\
M/"],96YG=&@@,30P,C0^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4("]&
M,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@5&0@
M*$-23U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W
M-C,N-#4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8S
M+C0U(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W
M-C,N-#4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%4R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#3TY3
M3TQ)1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U(%1D
M("A4140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y
M(#<U,2XT-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X
M(#<U,2XT-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W
M-3$N-#4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@,S$L
M(#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-S$U+C0U(%1D("@Q,RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-C4N,# @-S$U+C0U(%1D("A);F-O;64@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@.3@N.3@@-S$U+C0U(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,3 T+C<S(#<Q-2XT-2!49" H87AE<R I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,C4N-38@-S$U+C0U(%1D("A<*&-O;G1I;G5E9%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV
M,"!49" H1BT@,S<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-CDU+C$P(%1D("A3:&]R="UT97)M('5N<F5C;V=N
M:7IE9"!T87@@8F5N969I=',@87)E(&EN8VQU9&5D(&EN(&]T:&5R(&-U<G)E
M;G0@;&EA8FEL:71I97,@;VX@=&AE(&-O;G-O;&ED871E9"!B86QA;F-E('-H
M965T<R!A;F0@=V5R92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,U+C$U(#8Y-2XQ,"!49" H)# N,2D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-3(N-C4@-CDU+C$P
M(%1D("@@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#8X,RXQ,"!49" H;6EL;&EO;B!A<R!O9B I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 R+C4U(#8X,RXQ
M,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3@Q+C$T(#8X,RXQ,"!49" H+" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@V+C$T
M(#8X,RXQ,"!49" H,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R,#8N,30@-C@S+C$P(%1D("@L(&%N9" R,#$V+B!,
M;VYG+71E<FT@=6YR96-O9VYI>F5D('1A>"!B96YE9FET<R!A<F4@:6YC;'5D
M960@:6X@;W1H97(@;&]N9RUT97)M("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-S$N,3 @5&0@*&QI86)I;&ET
M:65S(&]N('1H92!C;VYS;VQI9&%T960@8F%L86YC92!S:&5E=',@86YD('=E
M<F4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(V."XS,2 V-S$N,3 @5&0@*"0P+C8@;6EL;&EO;BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3<N,C$@-C<Q+C$P(%1D
M("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,C(N,C$@-C<Q+C$P(%1D("@D,"XU(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<Q+C$P(#8W,2XQ,"!4
M9" H+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,Y,RXP-" V-S$N,3 @5&0@*"0P+CD@;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#$N.3,@-C<Q
M+C$P(%1D("@@87,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0V-BXP.2 V-S$N,3 @5&0@*$1E8V5M8F5RH#,Q+" R
M,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4T-"XV-R V-S$N,3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8U.2XQ,"!49" H,C Q-RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V.2XU," V
M-3DN,3 @5&0@*"P@86YD(#(P,38L(')E<W!E8W1I=F5L>2D@5&H@150@40IQ
M(# @," P(')G($)4(#$V-"XQ," V-3DN,3 @5&0@*"X@4V5E($YO=&4@-R M
M($)A;&%N8V4@4VAE970@1&5T86EL<RX@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S$S+C4P(#8U.2XQ,"!49" H07,@;V8@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S-RXY-" V-3DN,3 @5&0@*$1E
M8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q-BXU,R V-3DN,3 @5&0@*"P@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0R,2XU,R V-3DN,3 @
M5&0@*#(P,3<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#0Q+C4S(#8U.2XQ,"!49" H+"!A;F0@,C Q-BP@=&AE($-O;7!A
M;GD@:&%D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," V-#<N,3 @5&0@*'5N<F5C;V=N:7IE9"!T87@@8F5N969I
M=',L('=H:6-H('=O=6QD(&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Y
M+C(V(#8T-RXQ,"!49" H9F5C="!T:&4@968I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R-3DN,#4@-C0W+C$P(%1D("AF96-T:79E('1A>"!R871E(&EF(')E
M8V]G;FEZ960L(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S.#DN,C8@-C0W+C$P(%1D("@D-2XV(&UI;&QI;VXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,X+C$U
M(#8T-RXQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#0S+C$U(#8T-RXQ,"!49" H)#0N,"!M:6QL:6]N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y,BXP
M-" V-#<N,3 @5&0@*"P@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,3,N.3@@-C0W+C$P(%1D("@D-"XY*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XT." V
M-#<N,3 @5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-C,U+C$P(%1D("AM:6QL:6]N+"!R97-P96-T:79E
M;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S$N,#4@-C,U+C$P(%1D("@N
M($1U<FEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,38V+C@X(#8S-2XQ,"!49" H,C Q."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#8N.#@@-C,U+C$P(%1D("@L
M('1H92!#;VUP86YY(&AA9"!G<F]S<R!I;F-R96%S97,@;V8@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S."XU,2 V,S4N
M,3 @5&0@*"0Q+C8@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.#<N-#$@-C,U+C$P(%1D("@@=&\@:71S(&-U
M<G)E;G0@>65A<B!U;G)E8V]G;FEZ960@=&%X("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,C,N,3 @5&0@*&)E
M;F5F:71S+"!R96QA=&5D('1O(&9E9&5R86P@86YD('-T871E('1A>"!P;W-I
M=&EO;G,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#8Q,2XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U.3DN,3 @5&0@*%1H92!#;VUP
M86YY(')E8V]G;FEZ97,@:6YT97)E<W0@86YD('!E;F%L=&EE<R!R96QA=&5D
M('1O('5N<F5C;V=N:7IE9"!T87@@8F5N969I=',@:6X@=&AE('!R;W9I<VEO
M;B!F;W(@:6YC;VUE('1A>&5S+B!$=7)I;F<@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4X-RXQ,"!49" H=&AE
M('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3<L('1H92!#;VUP86YY(')E
M8V]G;FEZ960@82!D96-R96%S92!I;B!I;G1E<F5S="!A;F0@<&5N86QT:65S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-#@N,C,@-3@W+C$P(%1D("@D,"XR(&UI;&QI;VXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DW+C$R(#4X-RXQ,"!4
M9" H+"!R96QA=&5D('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," U-S4N,3 @5&0@*'-T871U=&4@97AP:7)A
M=&EO;G,N("D@5&H@150@40IQ(# @," P(')G($)4(#$R-RXS-B U-S4N,3 @
M5&0@*%1H92!#;VUP86YY(&AA<R!A8V-R=65D("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,S8N,C @-3<U+C$P(%1D("@D
M,"XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C@U+C$P(#4W-2XQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,CDP+C$P(#4W-2XQ,"!49" H
M)# N,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S,#<N-C @-3<U+C$P(%1D("@@;6EL;&EO;BP@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C N.3,@-3<U+C$P
M(%1D("@D,"XU*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,W."XT,R U-S4N,3 @5&0@*"!M:6QL:6]N(&9O<B!T:&4@<&%Y
M;65N="!O9B!I;G1E<F5S="!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4V,RXQ,"!49" H<&5N86QT:65S
M(&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Y-RXR-B U-C,N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XX-" U-C,N
M,3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$X,"XX-" U-C,N,3 @5&0@*#(P,3<I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C P+C@T(#4V,RXQ,"!49" H
M+"!A;F0@,C Q-BP@<F5S<&5C=&EV96QY*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,CDU+C0T(#4V,RXQ,"!49" H+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U-3$N,3 @5&0@** I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3,Y
M+C$P(%1D("@Q-"X@4W1O8VMH;VQD97)SDBD@5&H@150@40IQ(# @," P(')G
M($)4(#$R,BXV-2 U,SDN,3 @5&0@*"!%<75I='DI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3(W+C$P(%1D("B@
M*2!4:B!%5"!1"D)4("]&,R Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#4Q-2XQ,"!49" H4W1O8VL@4F5P=7)C:&%S92!0<F]G<F%M<RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," U
M,#,N,3 @5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-#DQ+C$P(%1D("A5;F1E<B!A;B!A=71H;W)I>F5D
M('-H87)E(')E<'5R8VAA<V4@<')O9W)A;2P@9'5R:6YG('1H92!Y96%R(&5N
M9&5D($1E8V5M8F5R(#,Q+" R,#$X+"!T:&4@0V]M<&%N>2!R97!U<F-H87-E
M9"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0W.2XQ,"!49" H<F5T:7)E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S@N,#D@-#<Y+C$P(%1D("@T
M,S(L-#,Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$Q,"XU.2 T-SDN,3 @5&0@*"!S:&%R97,@;V8@:71S($-O;6UO;B!3
M=&]C:R!F;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#(T,BXU,R T-SDN,3 @5&0@*"0U+C @;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R.3$N-#(@-#<Y
M+C$P(%1D("@L(&%T(&%N(&%V97)A9V4@;6%R:V5T('!R:6-E(&]F("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,34N,C0@
M-#<Y+C$P(%1D("@D,2D@5&H@150@40IQ(# @," P(')G($)4(#0R-"XX-R T
M-SDN,3 @5&0@*#$N-30I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#0R+C,W(#0W.2XQ,"!49" H('!E<B!S:&%R92X@1'5R
M:6YG('1H92!Y96%R<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-#8W+C$P(%1D("AE;F1E9" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S4N.#@@-#8W+C$P
M(%1D("A$96-E;6)E<J S,2P@,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-30N-#8@-#8W+C$P(%1D("@@86YD("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-S,N
M.3 @-#8W+C$P(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$Y,RXY," T-C<N,3 @5&0@*"P@=&AE($-O;7!A
M;GD@9&ED(&YO="!R97!U<F-H87-E(&%N>2!S:&%R97,@;V8@:71S($-O;6UO
M;B!3=&]C:R!U;F1E<B!T:&ES('!R;V=R86TN("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T-#,N,3 @5&0@*$%S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" W,RXY-" T-#,N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U,BXU,R T-#,N
M,3 @5&0@*"P@=&AE($-O;7!A;GD@:&%S("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R,CDN-#8@-#0S+C$P(%1D("@U,3 L
M,# T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(V,2XY-B T-#,N,3 @5&0@*"!S:&%R97,@;V8@0V]M;6]N(%-T;V-K('5N
M9&5R('1H92!C=7)R96YT('-H87)E(')E<'5R8VAA<V4@<')O9W)A;2 I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-#,Q+C$P(%1D("AA=F%I;&%B;&4@=&\@<F5P=7)C:&%S92P@<W5B:F5C="!T
M;R!C97)T86EN(&-O;F1I=&EO;G,@:6X@=&AE($-O;7!A;GDG<R I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S,S,N,3<@-#,Q+C$P(%1D("A!;65N9&5D(&%N
M9"!297-T871E9"!#<F5D:70@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4U
M+C,V(#0S,2XQ,"!49" H06=R965M96YT+B I(%1J($54(%$*0E0@+T8S(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#$Q+C$P(%1D("A3:&%R
M97,@27-S=65D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#,X-RXQ,"!49" H3VX@36%R8V@@,3<L(#(P,3<L('1H
M92!#;VUP86YY(&ES<W5E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C$V+C0R(#,X-RXQ,"!49" H,RPQ-S4L-3@T*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-BXT
M,B S.#<N,3 @5&0@*"!S:&%R97,@=&\@:71S('!R:6]R($-O;G9E<G1I8FQE
M($YO=&5S(&YO=&5H;VQD97)S+B!3964@3F]T92 X("T@1&5B="XI(%1J($54
M(%$*0E0@+T8S(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S8W
M+C$P(%1D("A3:&%R92U"87-E9"!087EM96YT<RD@5&H@150@40I"5" O1C0@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-#,N,3 @5&0@*#(P
M,30@3VUN:6)U<R!);F-E;G1I=F4@4&QA;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,3DN,3 @5&0@*%1H92!#
M;VUP86YY)W,@,C Q-"!/;6YI8G5S($EN8V5N=&EV92!0;&%N(%PH,C Q-"!0
M;&%N7"D@<')O=FED97,@9F]R('1H92!I<W-U86YC92!O9B!S=&]C:R!O<'1I
M;VYS+"!S=&]C:R!A<'!R96-I871I;VX@<FEG:'1S+" I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S W+C$P(%1D
M("AR97-T<FEC=&5D('-T;V-K+"!P97)F;W)M86YC92!S:&%R97,L(&%N9"!P
M97)F;W)M86YC92UB87-E9"!C87-H(&%W87)D<R!T:&%T(&UA>2!B92!G<F%N
M=&5D('=I=&@@=&AE(&EN=&5N="!T;R!C;VUP;'D@=VET:" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,CDU+C$P
M(%1D("AT:&4@DW!E<F9O<FUA;F-E+6)A<V5D(&-O;7!E;G-A=&EO;I0@97AC
M97!T:6]N('5N9&5R(%-E8W1I;VX@,38R7"AM7"D@;V8@=&AE($EN=&5R;F%L
M(%)E=F5N=64@0V]D92P@86YD(&]T:&5R('-T;V-K+6)A<V5D("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R.#,N
M,3 @5&0@*&%W87)D<RP@86QL(&%S(&1E9FEN960@8GD@=&AE(#(P,30@4&QA
M;BP@=&\@96QI9VEB;&4@96UP;&]Y965S+"!C;VYS=6QT86YT<R!A;F0@;F]N
M+65M<&QO>65E($1I<F5C=&]R<RX@3VX@36%Y(#(S+" R,#$W+"!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(W,2XQ,"!49" H0V]M<&%N>2=S('-H87)E:&]L9&5R<R!A<'!R;W9E9"!A
M;B!A;65N9&UE;G0@86YD(')E<W1A=&5M96YT(&]F(&ET<R R,#$T(%!L86X@
M7"@R,#$W(%!L86Y<*2!W:&EC:"P@86UO;F<@;W1H97)S+"!I;F-L=61E9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,C4Y+C$P(%1D("AT:&4@9F]L;&]W:6YG(&UO9&EF:6-A=&EO;G,Z(%PH
M:5PI(&$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$X-"XW-2 R-3DN,3 @5&0@*#(L,# P+# P,"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,C0N-S4@,C4Y+C$P(%1D
M("@@<VAA<F4@:6YC<F5A<V4@;V8@=&AE(&%G9W)E9V%T92!S:&%R92!R97-E
M<G9E('1O("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,3@N,C4@,C4Y+C$P(%1D("@V+#$P,"PP,# I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4X+C(U(#(U.2XQ,"!4
M9" H('-H87)E<RP@7"@R7"D@97AT96YS:6]N(&]F("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R-#<N,3 @5&0@
M*'1H92 R,#$T(%!L86X@=6YT:6P@36%Y(#(S+" R,#(W+"!A;F0@7"@S7"D@
M<F4M87!P<F]V86P@;V8@=&AE(%-E8W1I;VX@,38R7"AM7"D@<&5R9F]R;6%N
M8V4@9V]A;',@<V\@=&AA="!C97)T86EN(&EN8V5N=&EV92!A=V%R9',@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(S-2XQ,"!49" H9W)A;G1E9"!T;R!C97)T86EN(&5X96-U=&EV92!O9BD@
M5&H@150@40IQ(# @," P(')G($)4(#$W,"XY,R R,S4N,3 @5&0@*&9I8V5R
M<R!O9B!T:&4@0V]M<&%N>2!M87D@<75A;&EF>2!A<R!E>&5M<'0@<&5R9F]R
M;6%N8V4M8F%S960@8V]M<&5N<V%T:6]N+BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R,3$N,3 @5&0@*%5N9&5R
M('1H92 R,#$W(%!L86XL('1H92!#;VUP96YS871I;VX@0V]M;6ET=&5E(&]F
M('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#,R-BXQ,R R
M,3$N,3 @5&0@*',@0F]A<F0@;V8@1&ER96-T;W)S(%PH=&AE($-O;6UI='1E
M95PI+"!H87,@=&AE(&1I<V-R971I;VX@=&\@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Y.2XQ,"!49" H9&5T
M97)M:6YE('1H92!T97)M<R!O9B!T:&4@87=A<F1S(&%T('1H92!T:6UE(&]F
M('1H92!G<F%N="!P<F]V:61E9"P@:&]W979E<BD@5&H@150@40IQ(# @," P
M(')G($)4(#,U-2XV-B Q.3DN,3 @5&0@*"P@=&AA="!I;B!T:&4@8V%S92!O
M9B!S=&]C:R!O<'1I;VYS(&%N9"!S=&]C:R I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3@W+C$P(%1D("AA<'!R
M96-I871I;VX@<FEG:'1S(%PH<VAA<F4@;W!T:6]N<UPI.B Q7"D@=&AE(&5X
M97)C:7-E('!R:6-E('!E<B!S:&%R92!O9B!T:&4@87=A<F0@:7,@;F]T(&QE
M<W,@=&AA;B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#(W+CDX(#$X-RXQ,"!49" H,3 P)2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3$N,S$@,3@W+C$P(%1D("@@
M7"AO<BD@5&H@150@40IQ(# @," P(')G($)4(#0V-2XP-R Q.#<N,3 @5&0@
M*"P@:6X@=&AE(&-A<V4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R-2XV," Q.#<N,3 @5&0@*#$P)2D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U-#,N.3,@,3@W
M+C$P(%1D("@@;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y+C4P(#$W-2XQ,"!49" H;6]R92!S=&]C:VAO;&1E<G,L
M('1H92!E>&5R8VES92!P<FEC92!O9B!T:&4@:6YC96YT:79E('-T;V-K(&]P
M=&EO;G,@7"A)4T]S7"D@9W)A;G1E9"!M87D@;F]T(&)E(&QE<W,@=&AA;B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8V
M+C8P(#$W-2XQ,"!49" H,2D@5&H@150@40IQ(# @," P(')G($)4(#0W,2XR
M,R Q-S4N,3 @5&0@*#$P)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.#DN-38@,3<U+C$P(%1D("A<*2!O9B!T:&4@9F%I
M<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,38S+C$P(%1D("AM87)K970@=F%L=64@;V8@=&AE(&-O;6UO;B!S
M=&]C:R!A="!T:&4@=&EM92!O9B!T:&4@9W)A;G0[(&%N9" R7"D@=&AE('1E
M<FT@;V8@=&AE(&%W87)D('=I;&P@8F4@;F\@;6]R92!T:&%N("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.#<N-CD@,38S
M+C$P(%1D("@Q,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.3<N-CD@,38S+C$P(%1D("@@>65A<G,@869T97(@=&AE("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," Q-3$N,3 @5&0@*&1A=&4@=&AE(&]P=&EO;B!I<R!G<F%N=&5D(%PH;W(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C0N,S0@,34Q+C$P(%1D("@L('-H
M86QL(&YO="!E>&-E960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#(S-BXR-B Q-3$N,3 @5&0@*&9I=F4I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C4Q+C@Q(#$U,2XQ
M,"!49" H('EE87)S+"!I;B!T:&4@8V%S92!O9B!A("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#(N.#@@,34Q+C$P(%1D
M("@Q,"4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S8Q+C(Q(#$U,2XQ,"!49" H(&]R(&UO<F4@<W1O8VMH;VQD97)<*2X@
M26X@=&AE(&-A<V4@;V8@<F5S=')I8W1E9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3,Y+C$P(%1D("AS=&]C
M:RP@=&AE('!U<F-H87-E('!R:6-E(&UA>2!B92!Z97)O('1O('1H92!E>'1E
M;G0@<&5R;6ET=&5D(&)Y(&%P<&QI8V%B;&4@;&%W*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S8T+C@T(#$S.2XQ,"!49" H+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,34N,3 @5&0@*%)E
M<W1R:6-T960@<W1O8VL@87=A<F1S(&=R86YT960@=6YD97(@=&AE($-O;7!A
M;GF2*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C8Q+C$Q(#$Q-2XQ,"!49" H
M<R R,#$W(%!L86X@96YT:71L92!T:&4@:&]L9&5R('1O(')E8V5I=F4L(&%T
M('1H92!E;F0@;V8@82!V97-T:6YG('!E<FEO9"P@82 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3 S+C$P(%1D
M("AS<&5C:69I960@;G5M8F5R(&]F('-H87)E<R!O9B!T:&4@0V]M<&%N>9(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C8N-C<@,3 S+C$P(%1D("AS(&-O
M;6UO;B!S=&]C:RX@4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@
M:7,@;65A<W5R960@8GD@=&AE(&UA<FME=" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @.3$N,3 @5&0@*'9A;'5E
M(&]F('1H92!#;VUP86YYDBD@5&H@150@40IQ(# @," P(')G($)4(#$T,"XX
M-R Y,2XQ,"!49" H<R!S=&]C:R!O;B!T:&4@9&%T92!O9B!G<F%N="X@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C4S+C0T(#DQ+C$P(%1D("A4:&4@<VAA
M<F5S('9E<W0@<F%T86)L>2!O=F5R(&$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,W-2XP-2 Y,2XQ,"!49" H=&AR964I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDU
M+C T(#DQ+C$P(%1D("@@>65A<B!P97)I;V0@96YD:6YG(&]N('1H92!A;FYI
M=F5R<V%R>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-SDN,3 @5&0@*&1A=&4@;V8@=&AE(&=R86YT+"!A;F0@
M=F5S=&EN9R!I<R!S=6)J96-T('1O('1H92!E;7!L;WEE92=S(&-O;G1I;G5I
M;F<@96UP;&]Y;65N="X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@P+C(Q
M(#<Y+C$P(%1D("A4:&5R92!I<R!N;R!P87)T:6%L('9E<W1I;F<@86YD(&%N
M>2!U;G9E<W1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-C<N,3 @5&0@*'!O<G1I;VX@:7,@9F]R9F5I=&5D
M+B!0=7)S=6%N="!T;R!T:&4@,C Q-R!0;&%N+"!T:&4@;G5M8F5R(&]F('1A
M<BD@5&H@150@40IQ(# @," P(')G($)4(#,P-BXR,2 V-RXQ,"!49" H9V5T
M('-H87)E<R!T:&%T(&%R92!I<W-U960@9F]R('!E<F9O<FUA;F-E+6)A<V5D
M('-T;V-K(&%W87)D<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-34N,3 @5&0@*&%R92!D971E<FUI;F5D(&)A
M<V5D(&]N('1H92!L979E;"!O9B!A='1A:6YM96YT(&]F('1H92!T87(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R-S<N-38@-34N,3 @5&0@*&=E=',NH"D@
M5&H@150@40IE;F1S=')E86T*96YD;V)J"C$W-R P(&]B:@H\/"]4>7!E("]0
M86=E"B]087)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP
M,%T*+U)E<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$W." P
M(%(^/@IE;F1O8FH*,3<X(# @;V)J"CP\+TQE;F=T:" R-#$R,#X^"G-T<F5A
M;0I"5" O1C(@-BXP,"!49B!%5 IQ(# @," P(')G($)4(#,P-BXP," W-S4N
M-#4@5&0@*" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,C$S+C@U(#<V,RXT-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,CDR+C8X(#<V,RXT-2!49" H62D@5&H@150@40IQ
M(# @," P(')G($)4(#(Y.2XU,R W-C,N-#4@5&0@*"!(14%,*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S(Y+C0U(#<V,RXT-2!49" H5$A#05)%+"!)3D,N
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W
M-2XS," W-3$N-#4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4
M(#(Q,2XU,B W-3$N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,3@N,#$@-S4Q+C0U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P
M(')G($)4(#(X."XQ,2 W-3$N-#4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S-C<N,CD@-S4Q+C0U(%1D("@@4U0I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" S.#$N,C@@-S4Q+C0U(%1D("A!*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S@W+C<V(#<U,2XT-2!49" H5$5-14Y44RD@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@
M-S,Y+C0U(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,34N-#4@5&0@*#$T
M+B!3=&]C:VAO;&1E<G,G($5Q=6ET>2!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV
M,"!49" H1BT@,S@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @-CDU+C$P(%1D("A4:&4@9F]L;&]W:6YG('1A8FQE
M('-U;6UA<FEZ97,@<F5S=')I8W1E9"!S=&]C:R!A=V%R9',@86YD('!E<F9O
M<FUA;F-E('-T;V-K(&%W87)D<R!A8W1I=FET>2!I<W-U960@=6YD97(@=&AE
M(#(P,3<@4&QA;B!F;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y+C4P(#8X,RXQ,"!49" H=&AE('EE87(@96YD960@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$Q
M,"XS," V.#,N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$X."XX." V.#,N,3 @
M5&0@*#HI(%1J($54(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 N-3 @-C W+C8P(#(R-RXP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(W-RXU," V
M,#<N-C @-C<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-#0N-3 @-C W+C8P(#0N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHS-#@N-3 @-C W+C8P(#8X+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#$V+C4P
M(#8P-RXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(P+C4P(#8P-RXV," V."XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0X."XU," V,#<N-C @-"XP," M,34N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y,BXU
M," V,#<N-C @-C@N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XU," U-S<N-C @,C(W+C P
M("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,C<W+C4P(#4W-RXV," V-RXP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,T
M-"XU," U-S<N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,T."XU," U-S<N-C @-C@N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,38N-3 @-3<W+C8P(#0N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT
M,C N-3 @-3<W+C8P(#8X+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C4P(#4W-RXV," T
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-#DR+C4P(#4W-RXV," V."XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C4P(#4T-RXV," R,C<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-S<N-3 @-30W+C8P
M(#8W+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,S0T+C4P(#4T-RXV," T+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S0X+C4P(#4T-RXV," V."XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Q-BXU," U-#<N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0R,"XU," U-#<N-C @-C@N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.#@N-3 @-30W+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3(N-3 @-30W
M+C8P(#8X+C P("TQ-2XP,"!R92!F"B]'4S @9W,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W+C4@-C4W+C8@
M;0HS-#0N-2 V-3<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*,S0T+C4@-C4W+C8@;0HS-#@N-2 V-3<N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S0X+C4@-C4W+C8@;0HT,38N-2 V-3<N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(P
M+C4@-C4W+C8@;0HT.#@N-2 V-3<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@X+C4@-C4W+C8@;0HT
M.3(N-2 V-3<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#DR+C4@-C4W+C8@;0HU-C N-2 V-3<N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*,C<W+C4@-C W+C8@;0HS-#0N-2 V,#<N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S0X+C4@
M-C W+C8@;0HT,38N-2 V,#<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(P+C4@-C W+C8@;0HT.#@N
M-2 V,#<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#DR+C4@-C W+C8@;0HU-C N-2 V,#<N-B!L"G,*
M," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS
M($T*,C<W+C4@-30W+C8@;0HS-#0N-2 U-#<N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(P+C4@-30W
M+C8@;0HT.#@N-2 U-#<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C<W+C4@-3,S+C8@;0HS-#0N-2 U
M,S,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,C<W+C4@-3,Q+C8@;0HS-#0N-2 U,S$N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#(P+C4@-3,S+C8@;0HT.#@N-2 U,S,N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#(P+C4@-3,Q+C8@
M;0HT.#@N-2 U,S$N-B!L"G,*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,CDT+C$P(#8V,BXR."!49" H4F5S=')I8W1E9"!3=&]C:R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-C8N-3@@-C8R+C(X(%1D("A!*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S<S+C$V(#8V,BXR."!49" H=V%R9',I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Q+C<U
M(#8V,BXR."!49" H4&5R9F]R;6%N8V4@4W1O8VL@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3$U+C@Y(#8V,BXR."!49" H02D@5&H@150@40IQ(# @," P
M(')G($)4(#4R,BXT-B V-C(N,C@@5&0@*'=A<F1S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S+C P(#8Q,BXR-R!49" H
MH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M.#<N,S4@-C(R+C(X(%1D("A.=6UB97(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S,C(N.#$@-C(R+C(X(%1D("@@;V8I(%1J($54(%$*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,CDV+C$P(#8Q,BXR."!49" H4VAA<BD@
M5&H@150@40IQ(# @," P(')G($)4(#,Q-BXU-R V,3(N,C@@5&0@*&5S*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V,2XW
M," V-#(N,C@@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S$N-#(@
M-C0R+C(X(%1D("AE:6=H=&5D*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,V-"XV," V,S(N,C@@5&0@*$$I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-S$N-#4@-C,R+C(X(%1D("AV97)A9V4I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S4W+C<P(#8R
M,BXR."!49" H1W)A;G0@1&%T92D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-3DN-S @-C$R+C(X(%1D("A&86ER*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,S<W+CDS(#8Q,BXR."!49" H("D@5&H@150@
M40IQ(# @," P(')G($)4(#,X,"XR-2 V,3(N,C@@5&0@*%8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S.#8N.3,@-C$R+C(X(%1D("AA;'5E*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,"XX-2 V,S(N
M,C@@5&0@*$YU;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#0V-BXS,2 V
M,S(N,C@@5&0@*"!O9BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-# N,# @-C(R+C(X(%1D("A4*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#0V+C(Q(#8R,BXR."!49" H87)G970I(%1J($54(%$*0E0@
M+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Y+C8P(#8Q,BXR."!4
M9" H4VAA<BD@5&H@150@40IQ(# @," P(')G($)4(#0V,"XP-R V,3(N,C@@
M5&0@*&5S*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P-2XW," V-#(N,C@@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" U,34N,34@-C0R+C(X(%1D("AE:6=H=&5D*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P."XV," V,S(N,C@@5&0@*$$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,34N,#@@-C,R+C(X(%1D("AV97)A
M9V4I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 Q+C<P(#8R,BXR."!49" H1W)A;G0@1&%T92D@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,#,N-S @-C$R+C(X(%1D("A&
M86ER*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3(Q+C@T(#8Q,BXR."!49" H
M("D@5&H@150@40IQ(# @," P(')G($)4(#4R-"XQ-B V,3(N,C@@5&0@*%8I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" U,S N-#<@-C$R+C(X(%1D("AA;'5E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M+C P(#4Y-RXR-R!49" H56YV97-T960@<F5S=')I8W1E9"!S=&]C:R!A=V%R
M9',L($IA;G5A<GF@,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S,#@N,34@-3DW+C(W(%1D("@U,34L-C Q*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,U,2XP
M," U.3<N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDP+C$U(#4Y-RXR-R!49" H,3,N,#,I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R+C$U(#4Y-RXR
M-R!49" H,C4W+#4W-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.34N,# @-3DW+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XQ-2 U.3<N,C<@5&0@
M*#$S+C0Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4Y+C P(#4X,BXR-R!49" H1W)A;G1E9"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#@N,34@-3@R+C(W(%1D("@S
M.3$L,3 X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,U,2XP," U.#(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,SDP+C$U(#4X,BXR-R!49" H,3 N.38I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R
M+C$U(#4X,BXR-R!49" H,C,X+#,R."D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.34N,# @-3@R+C(W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-"XQ-2 U
M.#(N,C<@5&0@*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" U,SDN,34@-3@R
M+C(W(%1D("@Q+C$I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-3$N-C4@-3@R
M+C(W(%1D("@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Y+C P(#4V-RXR-R!49" H5BD@5&H@150@40IQ(# @," P(')G
M($)4(#8U+C8W(#4V-RXR-R!49" H97-T960I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,S T+C@P(#4V-RXS,B!49" H7"@R
M,3DL.#@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#,T,"XV-2 U-C<N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,U,2XP," U-C<N,C<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDP+C$U
M(#4V-RXR-R!49" H,3(N-C0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#4S+C@P(#4V-RXS,B!49" H7"@V-BPV.3(I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@T+C8U
M(#4V-RXR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DU+C P(#4V-RXR-R!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N,34@-38W+C(W(%1D
M("@Q*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3,Y+C$U(#4V-RXR-R!49" H
M,2XV,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U.2XP," U-3(N,C<@5&0@*$9O<F9E:71E9"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#DN.# @-34R+C,R(%1D("A<
M*#DW+#<P."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-# N-C4@-34R+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" S-3$N,# @-34R+C(W(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y,"XQ
M-2 U-3(N,C<@5&0@*#$S+C$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0U,RXX," U-3(N,S(@5&0@*%PH-C0L,#8R*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0X-"XV
M-2 U-3(N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Y-2XP," U-3(N,C<@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,T+C$U(#4U,BXR-R!4
M9" H,3,N,#,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3,N,# @-3,W+C(W(%1D("A5;G9E<W1E9"!R97-T<FEC=&5D('-T
M;V-K(&%W87)D<RP@1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S X+C$U(#4S-RXR-R!49" H
M-3@Y+#$R,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-3$N,# @-3,W+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,Y,"XQ-2 U,S<N,C<@5&0@*#$R+C P
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U
M,BXQ-2 U,S<N,C<@5&0@*#,V-2PQ-#DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DU+C P(#4S-RXR-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N,34@
M-3,W+C(W(%1D("@Q,BXS-2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-3 Y+C$P
M(%1D("A/;B!-87)C:" S,2P@,C Q."!A;F0@,C Q-RP@=&AE($-O;7!A;GD@
M87=A<F1E9"!P97)F;W)M86YC92!S=&]C:R!A=V%R9',@=&]T86QI;F<@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-2XR
M,R U,#DN,3 @5&0@*#(S."PS,C@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#,W+C<S(#4P.2XQ,"!49" H(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4W+C$W
M(#4P.2XQ,"!49" H,3@Q+# V-RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.#DN-C<@-3 Y+C$P(%1D("@L(')E<W!E8W1I
M=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#4T,BXS,R U,#DN,3 @5&0@
M*"X@268@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#0Y-RXQ,"!49" H=&AE(&UI;FEM=6T@;&5V96P@;V8@<&5R
M9F]R;6%N8V4@:7,@871T86EN960@9F]R('1H92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8S+C4Y(#0Y-RXQ,"!49" H
M,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R.#,N-3D@-#DW+C$P(%1D("@@86YD(#(P,3<@87=A<F1S+"!R97-T<FEC
M=&5D('-T;V-K('=I;&P@8F4@:7-S=65D('=I=&@@82!V97-T:6YG(&1A=&4@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#0X-2XQ,"!49" H;V8@36%R8V@@,S$L(#(P,C$@86YD(#(P,C L(')E
M<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#(Q-BXP,R T.#4N
M,3 @5&0@*"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(P+C@U(#0X-2XQ
M,"!49" H5&AE(&QE=F5L(&]F(&%T=&%I;FUE;G0@=VEL;"!B92!C97)T:69I
M960@=VET:&EN(#,P(&1A>7,@;V8@=&AE('9E<W0@9&%T92X@1'5R:6YG('1H
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-#<S+C$P(%1D("AF:7)S="!Q=6%R=&5R(&]F(#(P,3<L('1H92!#
M;VUP86YY)W,@0V]M<&5N<V%T:6]N($-O;6UI='1E92!O9B!T:&4@0F]A<F0@
M;V8@1&ER96-T;W)S(&%P<')O=F5D(&$@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0U,RXT,R T-S,N,3 @5&0@*#0X)2D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S$N
M-S8@-#<S+C$P(%1D("@@;&5V96P@;V8@871T86EN;65N=" I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#8Q+C$P
M(%1D("AF;W(@=&AE(#(P,38@<&5R9F]R;6%N8V4M8F%S960@<VAA<F4@87=A
M<F1S+"!R97-U;'1I;F<@:6X@=&AE(&ES<W5A;F-E(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-#8N-C$@-#8Q+C$P
M(%1D("@V-BPV.3(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S<T+C$Q(#0V,2XQ,"!49" H('!E<F9O<FUA;F-E('-H87)E
M<R!T:&%T('9E<W1E9"!O;B!$96-E;6)E<B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-#0Y+C$P(%1D("@S,2P@
M,C Q."XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-#(U+C$P(%1D("A!<R!O9B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-S,N.30@-#(U+C$P(%1D("A$96-E
M;6)E<J S,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q-3(N-3,@-#(U+C$P(%1D("@L('1H92!#;VUP86YY(&AA
M9"!A<'!R;WAI;6%T96QY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" R.3 N.#,@-#(U+C$P(%1D("@D,RXX(&UI;&QI;VXI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,Y
M+C<R(#0R-2XQ,"!49" H('!R92UT87@@;V8@=&]T86P@=6YR96-O9VYI>F5D
M(&-O;7!E;G-A=&EO;B!C;W-T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," T,3,N,3 @5&0@*')E;&%T960@=&\@
M;F]N+79E<W1E9"!R97-T<FEC=&5D('-T;V-K(&%W87)D<R!W:&EC:"!M87D@
M8F4@861J=7-T960@9F]R(&9U='5R92!C:&%N9V5S(&EN(&9O<F9E:71U<F5S
M+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-38N,SD@-#$S+C$P(%1D("A4
M:&4@0V]M<&%N>2!E>'!E8W1S('1O("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," T,#$N,3 @5&0@*')E8V]G;FEZ
M92!S=6-H(&-O<W0@;W9E<B!A('=E:6=H=&5D(&%V97)A9V4@<&5R:6]D(&]F
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M-CDN,3(@-# Q+C$P(%1D("@Q+C0U('EE87)S*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q,"XR,B T,#$N,3 @5&0@*"X@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$U+C T(#0P,2XQ,"!49" H5&AE
M(&9A:7(@=F%L=64@;V8@<VAA<F5S('9E<W1E9"!W87,@87!P<F]X:6UA=&5L
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3$X+C,P(#0P,2XQ,"!49" H)#(N-2 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S@Y+C$P(%1D("AM:6QL:6]N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<X
M+C,Y(#,X.2XQ,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.#,N,SD@,S@Y+C$P(%1D("@D,RXW*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P,"XX.2 S.#DN
M,3 @5&0@*"!M:6QL:6]N+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$U-"XR,B S.#DN,3 @5&0@*"0T+C,@;6EL
M;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" R,#,N,3$@,S@Y+C$P(%1D("@@9F]R('1H92!Y96%R<R!E;F1E9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C@T+C0W
M(#,X.2XQ,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S8S+C U(#,X.2XQ,"!49" H
M+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S8X+C U(#,X.2XQ,"!49" H,C Q-RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S.#@N,#4@,S@Y+C$P(%1D("@L(&%N9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# Y
M+CDY(#,X.2XQ,"!49" H,C Q-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,CDN.3D@,S@Y+C$P(%1D("@L(')E<W!E8W1I
M=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#0X,BXV-2 S.#DN,3 @5&0@
M*"XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S8U+C$P(%1D("A!<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" V
M,RXP," S-C4N,3 @5&0@*&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" W,RXW,2 S-C4N,3 @5&0@*$1E8V5M8F5RH#,Q
M+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S(N,3@@,S8U+C$P(%1D("@R
M,#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$U,BXQ." S-C4N,3 @5&0@*"P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,34W+C V(#,V-2XQ,"!49" H=&AE("D@5&H@150@40IQ(# @," P(')G($)4
M(#$W,2XV-R S-C4N,3 @5&0@*$-O;7!A;GD@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C$R+CDT(#,V-2XQ,"!49" H:&%D("D@5&H@150@40IQ(# @," P
M(')G($)4(#(R.2XW-B S-C4N,3 @5&0@*&%P<')O>&EM871E;'D@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X.2XY," S
M-C4N,3 @5&0@*"0P+C,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S W+C0P(#,V-2XQ,"!49" H("D@5&H@150@40IQ(# @
M," P(')G($)4(#,P.2XW.2 S-C4N,3 @5&0@*&UI;&QI;VX@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S0Q+C V(#,V-2XQ,"!49" H<')E+71A>" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-S$N-S8@,S8U+C$P(%1D("AO9B I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S.#(N-#@@,S8U+C$P(%1D("AT;W1A;" I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T,#(N-C,@,S8U+C$P(%1D("AU;G)E
M8V]G;FEZ960@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#4X+C@X(#,V-2XQ
M,"!49" H8V]M<&5N<V%T:6]N("D@5&H@150@40IQ(# @," P(')G($)4(#4Q
M-BXX,2 S-C4N,3 @5&0@*&-O<W0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-3,U+C,P(#,V-2XQ,"!49" H<F5L871E9" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S4S+C$P(%1D("AT;R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" V,"XQ-R S-3,N,3 @5&0@*'!E<F9O
M<FUA;F-E("D@5&H@150@40IQ(# @," P(')G($)4(#$Q,RXU." S-3,N,3 @
M5&0@*'-T;V-K("D@5&H@150@40IQ(# @," P(')G($)4(#$S-RXU." S-3,N
M,3 @5&0@*&%W87)D<R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-C@N-SD@
M,S4S+C$P(%1D("AW:&EC:" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.38N
M,3(@,S4S+C$P(%1D("AM87D@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$V
M+C(R(#,U,RXQ,"!49" H8F4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(X
M+C4U(#,U,RXQ,"!49" H861J=7-T960@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C8T+C<W(#,U,RXQ,"!49" H9F]R("D@5&H@150@40IQ(# @," P(')G
M($)4(#(W.2XS,B S-3,N,3 @5&0@*&9U='5R92 I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,#8N,#@@,S4S+C$P(%1D("AC:&%N9V5S("D@5&H@150@40IQ
M(# @," P(')G($)4(#,T,2XQ." S-3,N,3 @5&0@*&EN("D@5&H@150@40IQ
M(# @," P(')G($)4(#,U,2XX-2 S-3,N,3 @5&0@*&9O<F9E:71U<F5S+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3@N-C<@,S4S+C$P(%1D("A4:&4@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$W+C$Q(#,U,RXQ,"!49" H0V]M
M<&%N>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" T-3@N.#D@,S4S+C$P(%1D
M("AE>'!E8W1S("D@5&H@150@40IQ(# @," P(')G($)4(#0Y,2XW-B S-3,N
M,3 @5&0@*'1O("D@5&H@150@40IQ(# @," P(')G($)4(#4P,BXT,R S-3,N
M,3 @5&0@*')E8V]G;FEZ92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-#0N
M,3@@,S4S+C$P(%1D("AS=6-H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," S-#$N,3 @5&0@*&-O<W0@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-C<N-C @,S0Q+C$P(%1D("AO=F5R("D@5&H@
M150@40IQ(# @," P(')G($)4(#@W+C,U(#,T,2XQ,"!49" H82 I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Y,RXW." S-#$N,3 @5&0@*'=E:6=H=&5D("D@
M5&H@150@40IQ(# @," P(')G($)4(#$S,BXT,B S-#$N,3 @5&0@*&%V97)A
M9V4@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,38U+C0Y(#,T,2XQ,"!49" H
M<&5R:6]D("D@5&H@150@40IQ(# @," P(')G($)4(#$Y,RXP,R S-#$N,3 @
M5&0@*&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,#,N,S0@,S0Q+C$P(%1D("@Q+C@W("D@5&H@150@40IQ(# @," P
M(')G($)4(#(R,BXX,R S-#$N,3 @5&0@*'EE87)S*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(T,RXY,R S-#$N,3 @5&0@
M*"P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C0X+C0R(#,T,2XQ,"!49" H
M=&AE("D@5&H@150@40IQ(# @," P(')G($)4(#(V,BXV,B S-#$N,3 @5&0@
M*')E;6%I;FEN9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,#4N,34@,S0Q
M+C$P(%1D("AS97)V:6-E("D@5&H@150@40IQ(# @," P(')G($)4(#,S-2XT
M-2 S-#$N,3 @5&0@*'!E<FEO9"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S8U+C,T(#,T,2XQ,"!49" H5&AE("D@5&H@150@40IQ(# @," P(')G($)4
M(#,X,BXX." S-#$N,3 @5&0@*&9A:7(@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,SDX+C<T(#,T,2XQ,"!49" H=F%L=64@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#(R+C,X(#,T,2XQ,"!49" H;V8@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@-#,R+C<P(#,T,2XQ,"!49" H<VAA<F5S("D@5&H@150@40IQ(# @
M," P(')G($)4(#0U.2XV." S-#$N,3 @5&0@*'9E<W1E9" I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T.#<N,C$@,S0Q+C$P(%1D("AW87,@*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3 T+C<U(#,T,2XQ,"!49" H87!P<F]X:6UA=&5L
M>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @,S(Y+C$P(%1D("@D,"XU("D@5&H@150@40IQ(# @," P(')G($)4
M(#8Y+C4P(#,R.2XQ,"!49" H;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" Y."XS.2 S,CDN,3 @5&0@*"P@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P,RXS
M.2 S,CDN,3 @5&0@*"0Q+C8@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3(S
M+C,Y(#,R.2XQ,"!49" H;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q-3(N,C@@,S(Y+C$P(%1D("@L("D@5&H@
M150@40IQ(# @," P(')G($)4(#$U-RXR." S,CDN,3 @5&0@*&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<T+C(R
M(#,R.2XQ,"!49" H)#$N,B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.30N
M,C(@,S(Y+C$P(%1D("AM:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(R,RXQ,2 S,CDN,3 @5&0@*" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,C4N-C$@,S(Y+C$P(%1D("AF;W(@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,Y+C<W(#,R.2XQ,"!49" H=&AE("D@5&H@
M150@40IQ(# @," P(')G($)4(#(U-"XT.2 S,CDN,3 @5&0@*'EE87)S("D@
M5&H@150@40IQ(# @," P(')G($)4(#(W."XP.2 S,CDN,3 @5&0@*&5N9&5D
M("D@5&H@150@40IQ(# @," P(')G($)4(#,P-"XT-R S,CDN,3 @5&0@*$1E
M8V5M8F5RH#,Q+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-C,N,#4@,S(Y
M+C$P(%1D("@R,#$X+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#@N,#4@
M,S(Y+C$P(%1D("@R,#$W+" I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3,N
M,#4@,S(Y+C$P(%1D("AA;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#(Y
M+CDY(#,R.2XQ,"!49" H,C Q-BP@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#4T+CDY(#,R.2XQ,"!49" H<F5S<&5C=&EV96QY*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3 R+C8U(#,R.2XQ,"!49" H+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,#4N,3 @5&0@*$1U
M<FEN9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" W.2XX-" S,#4N,3 @5&0@
M*'1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Y-"XP-B S,#4N,3 @5&0@
M*'EE87)S("D@5&H@150@40IQ(# @," P(')G($)4(#$Q-RXQ-B S,#4N,3 @
M5&0@*&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" Q-#,N,#4@,S U+C$P(%1D("A$96-E;6)E<J S,2P@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C Q+C$T(#,P-2XQ,"!49" H,C Q."D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R,C$N,30@
M,S U+C$P(%1D("@L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" R,C4N-C0@,S U+C$P(%1D("@R,#$W*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(T-2XV-" S,#4N,3 @
M5&0@*"P@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4P+C$U(#,P-2XQ,"!4
M9" H86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-C8N-3D@,S U+C$P(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(X-BXU.2 S,#4N,3 @5&0@*"P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDQ+C$P(#,P-2XQ,"!49" H=&AE
M("D@5&H@150@40IQ(# @," P(')G($)4(#,P-2XS,B S,#4N,3 @5&0@*$-O
M;7!A;GD@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S0V+C(Q(#,P-2XQ,"!4
M9" H9&ED("D@5&H@150@40IQ(# @," P(')G($)4(#,V,2XP," S,#4N,3 @
M5&0@*&YO=" I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S4N-S@@,S U+C$P
M(%1D("AI<W-U92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3<N-SD@,S U
M+C$P(%1D("AS=&]C:R I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C N.3 @
M,S U+C$P(%1D("AO<'1I;VYS("D@5&H@150@40IQ(# @," P(')G($)4(#0U
M,BXS-B S,#4N,3 @5&0@*&]R("D@5&H@150@40IQ(# @," P(')G($)4(#0V
M,BXV.2 S,#4N,3 @5&0@*'-T;V-K("D@5&H@150@40IQ(# @," P(')G($)4
M(#0X-2XX,2 S,#4N,3 @5&0@*&%P<')E8VEA=&EO;B I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,S<N,C,@,S U+C$P(%1D("AR:6=H=',N("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," R.3,N
M,3 @5&0@*%1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" V-RXU-2 R.3,N
M,3 @5&0@*&9O;&QO=VEN9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,#@N
M.3,@,CDS+C$P(%1D("AT86)L92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,S N.#<@,CDS+C$P(%1D("AR97!R97-E;G1S("D@5&H@150@40IQ(# @," P
M(')G($)4(#$W,RXY," R.3,N,3 @5&0@*&EN9F]R;6%T:6]N("D@5&H@150@
M40IQ(# @," P(')G($)4(#(R,RXV,B R.3,N,3 @5&0@*&%B;W5T("D@5&H@
M150@40IQ(# @," P(')G($)4(#(T."XS,R R.3,N,3 @5&0@*'-T;V-K("D@
M5&H@150@40IQ(# @," P(')G($)4(#(W,2XY-" R.3,N,3 @5&0@*&]P=&EO
M;G,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S S+C@Y(#(Y,RXQ,"!49" H
M86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,R,"XX,R R.3,N,3 @5&0@
M*'-T;V-K("D@5&H@150@40IQ(# @," P(')G($)4(#,T-"XT-" R.3,N,3 @
M5&0@*&%P<')E8VEA=&EO;B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.38N
M,S8@,CDS+C$P(%1D("AR:6=H=',@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#(Q+C8S(#(Y,RXQ,"!49" H97AE<F-I<V5D("D@5&H@150@40IQ(# @," P
M(')G($)4(#0V,2XX.2 R.3,N,3 @5&0@*&EN("D@5&H@150@40IQ(# @," P
M(')G($)4(#0W,BXQ-R R.3,N,3 @5&0@*&5A8V@@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-#DR+CDX(#(Y,RXQ,"!49" H>65A<BD@5&H@150@40IQ(# @
M," P(')G($)4(#4P.2XV-" R.3,N,3 @5&0@*"X@*2!4:B!%5"!1"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#(S-RXV," S
M,3 N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHS-C N,# @,C,W+C8P(#8U+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-#(U+C P(#(S-RXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#(Y+C P(#(S-RXV
M," V-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0Y-"XP," R,S<N-C @-"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C0Y."XP," R,S<N-C @-C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS-C @,C8W+C8@;0HT,C4@,C8W+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R-2 R-C<N-B!M"C0R
M.2 R-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#(Y(#(V-RXV(&T*-#DT(#(V-RXV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT
M.30@,C8W+C8@;0HT.3@@,C8W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y." R-C<N-B!M"C4V,R R
M-C<N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*,S8P(#(U,BXV,# P,# P,# P,# P,B!M"C0R-2 R-3(N
M-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0R.2 R-3(N-C P,# P,# P,# P,#(@
M;0HT.30@,C4R+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3@@,C4R+C8P,# P
M,# P,# P,# R(&T*-38S(#(U,BXV,# P,# P,# P,# P,B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S8P
M(#(U,BXV,# P,# P,# P,# P,B!M"C0R-2 R-3(N-C P,# P,# P,# P,#(@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0R.2 R-3(N-C P,# P,# P,# P,#(@;0HT.30@,C4R+C8P,# P
M,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.3@@,C4R+C8P,# P,# P,# P,# R(&T*-38S
M(#(U,BXV,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S8P(#(R,RXV,# P,# P,# P
M,# P,B!M"C0R-2 R,C,N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,V," R,C$N
M-C P,# P,# P,# P,#(@;0HT,C4@,C(Q+C8P,# P,# P,# P,# R(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HT,CD@,C(S+C8P,# P,# P,# P,# R(&T*-#DT(#(R,RXV,# P,# P,# P
M,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#(Y(#(R,2XV,# P,# P,# P,# P,B!M"C0Y-" R,C$N
M-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0Y." R,C,N-C P,# P,# P,# P,#(@
M;0HU-C,@,C(S+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!21PHO1U,P(&=S
M"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.3@@,C(Q+C8P,# P
M,# P,# P,# R(&T*-38S(#(R,2XV,# P,# P,# P,# P,B!L"G,*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,C<R+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P
M-2XV," R-S(N,C@@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3(N
M,C<@,C<R+C(X(%1D("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,C4N
M-3 @,C<R+C(X(%1D("@@16YD960@1&5C96UB97(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" U,#$N-#(@,C<R+C(X(%1D("B@,S$L*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#(U-RXR-R!49" H
MH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M.#(N,# @,C4W+C(X(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0U,2XP," R-3<N,C@@5&0@*#(P,3<I(%1J
M($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(P+C P
M(#(U-RXR."!49" H,C Q-BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0Q.2XP," R-#(N,#8@5&0@*%PH86UO=6YT<R!I;B!T
M:&]U<V%N9'-<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3(N-3 @,C,T+C(P(#$V
M,BXX-R M.2XP.2!R92!F"B]'4S @9W,*<2 P(# @,"!R9R!"5" U,BXU," R
M,C<N,C<@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-RXY,2 R,C<N
M,C<@5&0@*&]T86P@:6YT<FEN<VEC('9A;'5E(&]F(&]P=&EO;G,@97AE<F-I
M<V5D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,V,BXU," R,C<N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-# V+C$U(#(R-RXR-R!49" H,C,T*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XU," R
M,C<N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#<U+C$U(#(R-RXR-R!49" H-3$V*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P,"XU," R,C<N,C<@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,V+C8U(#(R-RXR-R!49" H,2PS,C,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#(Q,2XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T.2XU," Q.3DN,3 @5&0@*%1H92!S=&]C:R!A<'!R96-I
M871I;VX@<FEG:'1S(&-A;B!O;FQY(&)E('-E='1L960@=VET:"!S=&]C:R!O
M<B!C87-H+"!A="!T:&4@9&ES8W)E=&EO;B!O9B!T:&4@0V]M;6ET=&5E+B I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" T-C0N,C$@,3DY+C$P(%1D("A4:&4@
M<W1O8VL@87!P<F5C:6%T:6]N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T.2XU," Q.#<N,3 @5&0@*')I9VAT<R!V97-T
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y
M,RXS.2 Q.#<N,3 @5&0@*#(U)2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q,3$N-S(@,3@W+C$P(%1D("@@<&5R('EE87(@
M;W9E<B!A("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Q-S8N-# @,3@W+C$P(%1D("@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$X,2XT," Q.#<N,3 @5&0@*"!Y96%R
M('!E<FEO9"!A;F0@97AP:7)E(&%F=&5R("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R.38N.#D@,3@W+C$P(%1D("@W*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,P,2XX
M.2 Q.#<N,3 @5&0@*"!Y96%R<RX@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,S,P+C,Q(#$X-RXQ,"!49" H5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,SDP+C R(#$X-RXQ,"!49" H<R!P;VQI8WD@:7,@=&\@:7-S
M=64@;F5W('-H87)E<R!F<F]M(&ET<R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3<U+C$P(%1D("AA=71H;W)I
M>F5D(&)U="!U;FES<W5E9"!B86QA;F-E(&]F(&-O;6UO;B!S=&]C:R!O=71S
M=&%N9&EN9R!O<B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(')E86-Q=6ER960@
M8GD@=&AE($-O;7!A;GD@:68@<W1O8VL@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$V,RXQ,"!49" H87!P<F5C
M:6%T:6]N(')I9VAT<R!A<F4@<V5T=&QE9"!W:71H('-T;V-K+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," Q,SDN
M,3 @5&0@*%1H92!#;VUP86YY(')E8V]R9&5D(&-O;7!E;G-A=&EO;B!E>'!E
M;G-E(&9O<B!S=&]C:R!O<'1I;VYS(&)A<V5D(&]N('1H92!E<W1I;6%T960@
M9F%I<B!V86QU92!O9B!T:&4@;W!T:6]N<R!O;B!T:&4@9&%T92!O9B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M,3(W+C$P(%1D("AG<F%N="!U<VEN9R!T:&4@0FQA8VLM4V-H;VQE<R!O<'1I
M;VXM<')I8VEN9R!M;V1E;"X@1'5E('1O('1H92!A9&]P=&EO;B!O9B!T:&4@
M,C Q-"!0;&%N(%PH<')E=FEO=7-L>2!T:71L960@=&AE(#(P,#<@4W1O8VL@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#$Q-2XQ,"!49" H26YC96YT:79E(%!L86Y<*2P@;F\@9G5R=&AE<B!G
M<F%N=',@:&%V92!B965N(&ES<W5E9"!U;F1E<B!T:&4@0V]M<&%N>9(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S,S8N,S8@,3$U+C$P(%1D("AS(#$Y.3D@
M4&QA;G,@<F5F97)R960@=&\@8F5L;W<I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T-3<N-C,@,3$U+C$P(%1D("@N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$P,RXQ,"!49" HH"D@5&H@150@
M40IE;F1S=')E86T*96YD;V)J"C$W.2 P(&]B:@H\/"]4>7!E("]086=E"B]0
M87)E;G0@,2 P(%(*+TUE9&EA0F]X(%LP(# @-C$R+C P(#<Y,BXP,%T*+U)E
M<V]U<F-E<R R(# @4@HO4F]T871E(# *+T-O;G1E;G1S(#$X," P(%(^/@IE
M;F1O8FH*,3@P(# @;V)J"CP\+TQE;F=T:" Q,#,W.#X^"G-T<F5A;0I"5" O
M1C(@-BXP,"!49B!%5 IQ(# @," P(')G($)4(#,P-BXP," W-S4N-#4@5&0@
M*" I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,C$S+C@U(#<V,RXT-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,CDR+C8X(#<V,RXT-2!49" H62D@5&H@150@40IQ(# @," P
M(')G($)4(#(Y.2XU,R W-C,N-#4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S(Y+C0U(#<V,RXT-2!49" H5$A#05)%+"!)3D,N*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS," W
M-3$N-#4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU
M,B W-3$N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@
M-S4Q+C0U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G($)4
M(#(X."XQ,2 W-3$N-#4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S-C<N,CD@-S4Q+C0U(%1D("@@4U0I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" S.#$N,C@@-S4Q+C0U(%1D("A!*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S@W+C<V(#<U,2XT-2!49" H5$5-14Y44RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,Y+C0U
M(%1D("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,34N-#4@5&0@*#$T+B!3=&]C
M:VAO;&1E<G,G($5Q=6ET>2!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H
M1BT@,SDI(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-CDU+C$P(%1D("@Q.3DY(%-T;V-K($]P=&EO;B!0;&%N(&%N
M9"!%<75I='D@4&%R=&EC:7!A=&EO;B!0;&%N*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8X,RXQ,"!49" HH"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," V-S$N,3 @5&0@*$]N($1E8V5M8F5RH#$V+" Q.3DY+"!T:&4@0V]M<&%N
M>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#0N,3D@-C<Q+C$P(%1D("AS
M($)O87)D(&]F($1I<F5C=&]R<R!A<'!R;W9E9"!T:&4@,3DY.2!3=&]C:R!/
M<'1I;VX@4&QA;B!A;F0@17%U:71Y(%!A<G1I8VEP871I;VX@4&QA;B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-C4Y+C$P(%1D("A<*&-O;&QE8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G
M($)4(#DX+C@S(#8U.2XQ,"!49" H+"!T:&4@,3DY.2!0;&%N<UPI+"!W:&EC
M:"!W87,@86UE;F1E9"!A;F0@<F5S=&%T960@;VX@3V-T;V)E<J R-2P@,C P
M,2!A;F0@<')O=FED960@9F]R('1H92!I<W-U86YC92!O9B!)4T]S(&%N9" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-C0W+C$P(%1D("AN;VXM<75A;&EF:65D('-T;V-K(&]P=&EO;G,@=&\@
M96QI9VEB;&4@96UP;&]Y965S(&%N9"!N;VXM96UP;&]Y964@9&ER96-T;W)S
M(&9O<B!T:&4@<'5R8VAA<V4@;V8@=7 @=&\@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V-"XQ,2 V-#<N,3 @5&0@*#0L
M,SDX+# P,2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,#0N,3$@-C0W+C$P(%1D("@@<VAA<F5S(&]F("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V,S4N,3 @
M5&0@*&-O;6UO;B!S=&]C:RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DN-3 @-C(S+C$P(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8Q,2XQ,"!4
M9" H5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S('1H92!#;VUP86YY
MDBD@5&H@150@40IQ(# @," P(')G($)4(#(S-RXU,2 V,3$N,3 @5&0@*',@
M86-T:79I=&EE<R!W:71H(')E<W!E8W0@=&\@86QL(&]F(&ET<R!S:&%R92!O
M<'1I;VX@<&QA;G,@7"AI<W-U960@=6YD97(@=&AE(#(P,30@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#4Y.2XQ
M,"!49" H4&QA;B!A;F0@=&AE(#$Y.3D@4&QA;EPI(&9O<B!T:&4@>65A<B!E
M;F1E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C(R+C4P(#4Y.2XQ,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S Q+C Y(#4Y
M.2XQ,"!49" H.J I(%1J($54(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3 N,# @-3(S+C8P(#(P,BXP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U
M,BXP," U,C,N-C @-3@N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N,# @-3(S+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHS,30N,# @-3(S+C8P(#8T+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S<X+C P(#4R,RXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@R+C P(#4R,RXV," U
M.2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0T,2XP," U,C,N-C @-"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0T-2XP," U,C,N-C @-3DN,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#0N,# @-3(S+C8P
M(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,#@N,# @-3(S+C8P(#4U+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3 N,# @-#DS+C8P(#(P,BXP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U,BXP," T.3,N
M-C @-3@N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS,3 N,# @-#DS+C8P(#0N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS,30N,# @-#DS+C8P(#8T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<X+C P(#0Y
M,RXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*,S@R+C P(#0Y,RXV," U.2XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0T,2XP," T.3,N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-2XP," T
M.3,N-C @-3DN,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#0N,# @-#DS+C8P(#0N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,#@N,# @-#DS+C8P(#4U+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @
M-#8S+C8P(#(P,BXP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(U,BXP," T-C,N-C @-3@N,# @
M+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,3 N,# @-#8S+C8P(#0N,# @+3(S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,30N
M,# @-#8S+C8P(#8T+C P("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<X+C P(#0V,RXV," T+C P
M("TR,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S@R+C P(#0V,RXV," U.2XP," M,C,N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T
M,2XP," T-C,N-C @-"XP," M,C,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0T-2XP," T-C,N-C @-3DN
M,# @+3(S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,#0N,# @-#8S+C8P(#0N,# @+3(S+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,#@N,# @-#8S+C8P(#4U+C P("TR,RXP,"!R92!F"B]'4S @9W,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C4R
M(#4R,RXV(&T*,S$P(#4R,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,30@-3(S+C8@;0HS-S@@-3(S
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C,X,B U,C,N-B!M"C0T,2 U,C,N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#0U(#4R
M,RXV(&T*-3 T(#4R,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#@@-3(S+C8@;0HU-C,@-3(S+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(U,B T-C,N-B!M"C,Q," T-C,N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,C4R(#0T,2XV
M(&T*,S$P(#0T,2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HR-3(@-#,Y+C8@;0HS,3 @-#,Y+C8@; IS
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U-RXS-2 U,S@N
M,C@@5&0@*$YU;6)E<BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXW,B U
M,S@N,C@@5&0@*"!O9B I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C8V+C$P(#4R."XR."!49" H4VAA<BD@5&H@150@40IQ
M(# @," P(')G($)4(#(X-BXT." U,C@N,C@@5&0@*&5S*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q."XQ," U,C@N,C@@
M5&0@*$]P=&EO;B!0<FEC92D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.3 N-S @-34X+C(X(%1D("A7*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@-# P+C0R(#4U."XR."!49" H96EG:'1E9"D@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3,N-C @-30X
M+C(X(%1D("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# P+C0U(#4T."XR
M."!49" H=F5R86=E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,Y,RXP," U,S@N,C@@5&0@*$5X97(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T,3,N-#8@-3,X+C(X(%1D("AC:7-E*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y.2XX-2 U,C@N,C@@
M5&0@*%!R:6-E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0U,BXP-2 U-S@N,C@@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" T-C$N-3 @-3<X+C(X(%1D("AE:6=H=&5D+2D@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-38N-C @-38X+C(X(%1D
M("A!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#8S+C X(#4V."XR."!49" H
M=F5R86=E*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0U,"XV-2 U-3@N,C@@5&0@*%)E;6%I;FEN9RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#@N,34@-30X+C(X(%1D
M("A#;VYT<F%C='5A;"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T-3@N,S @-3,X+C(X(%1D("A,:69E(%PH:6XI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8P+CDU(#4R
M."XR."!49" H>65A<G-<*2D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,3,N,34@-3<X+C(X(%1D("A!9V=R*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3,T+C8S(#4W."XR."!49" H96=A=&4I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3$V+C8U(#4V
M."XR."!49" H26YT<FEN<VEC*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R,BXY-2 U-3@N,C@@5&0@*%8I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" U,CDN,C4@-34X+C(X(%1D("AA;'5E("D@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,30N.34@-30X
M+C(X(%1D("A<*&%M;W5N=',@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S,"XX," U,S@N,C@@5&0@*&EN("D@5&H@150@
M40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3$N-C4@-3(X
M+C(X(%1D("AT:&]U<V%N9'-<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,BXU," U,3,N,C<@5&0@*%-H87)E(&]P=&EO
M;G,@;W5T<W1A;F1I;F<L($IA;G5A<GD@,2P@,C Q."D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-S@N-C4@-3$S+C(W(%1D
M("@Y-"PU,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S(Q+C,P(#4Q,RXR-R!49" H)#0N,38M)#<N-#0I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDY+C<U(#4Q,RXR
M-R!49" H)#4N,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#0W+C4P(#4Q,RXR-R!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3 N-3 @-3$S+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X
M+C4P(#0Y."XR-R!49" H1W)A;G1E9"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.38N,34@-#DX+C(W(%1D("B7*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T,"XU," T
M.3@N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-# V+C P(#0Y."XR-R!49" HERD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#<N-3 @-#DX+C(W(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q
M,"XU," T.3@N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3@N-3 @-#@S+C(W(%1D("A%>&5R8VES960I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C<U+C,P
M(#0X,RXS,B!49" H7"@T,"PU,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S V+C$U(#0X,RXR-R!49" H7"DI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S(Q+C,P(#0X
M,RXR-R!49" H)#0N,38M)#<N-#0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,SDY+C<U(#0X,RXR-R!49" H)#4N-#8I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C4P
M(#0X,RXR-R!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,3 N-3 @-#@S+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P(#0V."XR-R!49" H
M1F]R9F5I=&5D+V5X<&ER960I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C@P+C,P(#0V."XS,B!49" H7"@R+#4P,"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,#8N,34@
M-#8X+C(W(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" S,S0N,C4@-#8X+C(W(%1D("@D-RXT-"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3DN-S4@-#8X+C(W
M(%1D("@D-RXT-"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T-#<N-3 @-#8X+C(W(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q,"XU," T-C@N,C<@5&0@** I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N
M-3 @-#4T+C$W(%1D("A3:&%R92!O<'1I;VYS(&]U='-T86YD:6YG(&%N9"!E
M>&5R8VES86)L92PI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3(N-3 @-#0T+C$W(%1D("A$96-E;6)E<B S,2P@,C Q."D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-S@N
M-C4@-#0U+C(W(%1D("@U,2PU,# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,S(Q+C,P(#0T-2XR-R!49" H)#0N,S4M)#4N
M,C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,SDY+C<U(#0T-2XR-R!49" H)#0N.#<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8U+C(U(#0T-2XR-R!49" H,2XP,BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3 N
M-3 @-#0U+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4T-"XQ-2 T-#4N,C<@5&0@*#$R-RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#DN-3 @-#(Y+C$P(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0Q-RXQ,"!49" H07,@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<S
M+CDT(#0Q-RXQ,"!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,34R+C4S(#0Q-RXQ,"!4
M9" H+"!T:&4@0V]M<&%N>2!H860@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(S,"XU-R T,3<N,3 @5&0@*#4Q+#4P,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N
M,#<@-#$W+C$P(%1D("@@<VAA<F4@;W!T:6]N<R!O=71S=&%N9&EN9RP@86QL
M(&]F('=H:6-H('=E<F4@=F5S=&5D(&%T(&$@=V5I9VAT960@879E<F%G92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @-# U+C$P(%1D("AE>&5R8VES92!P<FEC92!O9B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3$X+C W(#0P-2XQ,"!4
M9" H)#0N.#<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,30P+C4W(#0P-2XQ,"!49" H+"!I;G1R:6YS:6,@=F%L=64@;V8@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q
M-2XX,R T,#4N,3 @5&0@*"0P+C$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,C,S+C,S(#0P-2XQ,"!49" H(&UI;&QI;VXL
M(&%N9"!A('=E:6=H=&5D(&%V97)A9V4@8V]N=')A8W1U86P@;&EF92!O9B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Y
M+CDQ(#0P-2XQ,"!49" H,2XP,BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-3<N-#$@-# U+C$P(%1D("@@>65A<G,N("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," S.3,N,3 @5&0@** I(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ.#$@
M,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;
M," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P
M"B]#;VYT96YT<R Q.#(@,"!2/CX*96YD;V)J"C$X,B P(&]B:@H\/"],96YG
M=&@@,C Y,#<^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4("]&,B Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@5&0@*$-23U-3
M($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W-C,N-#4@
M5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8S+C0U(%1D
M("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W-C,N-#4@
M5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%4R I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#3TY33TQ)1$$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U(%1D("A4140@
M1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y(#<U,2XT
M-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X(#<U,2XT
M-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W-3$N-#4@
M5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@,S$L(#(P,3@I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-S$U+C0U(%1D("@Q-2X@16%R;FEN9W,@4&5R*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3(Q+C(Q(#<Q-2XT-2!49" H(%-H87(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Q-#0N,#D@-S$U+C0U(%1D("AE*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H
M1BT@-# I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-CDU+C$P(%1D("A4:&4@9F]L;&]W:6YG('1A8FQE('-E=',@
M9F]R=&@@=&AE(&-O;7!O;F5N=',@;V8@=&AE(&YU;65R871O<B!A;F0@9&5N
M;VUI;F%T;W(@9F]R('1H92!C;VUP=71A=&EO;B!O9B!T:&4@8F%S:6,@86YD
M(&1I;'5T960@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#8X,RXQ,"!49" H96%R;FEN9W,@<&5R('-H87)E.BD@
M5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,"XP," V-#(N-C @,S(U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<U+C P(#8T,BXV," Q
M.#@N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XP," V,3(N-C @,S(U+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S<U+C P(#8Q,BXV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S-2XP," V,3(N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0S.2XP," V,3(N-C @-C N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.3DN,# @-C$R+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#,N,# @-C$R
M+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-3@R+C8P(#,R-2XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,W-2XP," U.#(N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,S4N,# @
M-3@R+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,SDN,# @-3@R+C8P(#8P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DY+C P(#4X,BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 S+C P
M(#4X,BXV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#4U,BXV," S,C4N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS-S4N,# @-34R+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,U
M+C P(#4U,BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,Y+C P(#4U,BXV," V,"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y.2XP," U-3(N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M,RXP," U-3(N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," U,C(N-C @,S(U
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S<U+C P(#4R,BXV," V,"XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0S-2XP," U,C(N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S.2XP," U,C(N-C @
M-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.3DN,# @-3(R+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,#,N,# @-3(R+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-#DR+C8P
M(#,R-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,W-2XP," T.3(N-C @-C N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,S4N,# @-#DR+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,SDN,# @-#DR
M+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#DY+C P(#0Y,BXV," T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-3 S+C P(#0Y,BXV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#0V
M,BXV," S,C4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-S4N,# @-#8R+C8P(#8P+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#,U+C P(#0V,BXV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,Y+C P
M(#0V,BXV," V,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y.2XP," T-C(N-C @-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P,RXP," T-C(N-C @-C N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP
M," T,S(N-C @,S(U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S<U+C P(#0S,BXV," V,"XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0S-2XP," T,S(N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S
M.2XP," T,S(N-C @-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.3DN,# @-#,R+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,#,N,# @-#,R+C8P(#8P+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 N,# @-# R+C8P(#,R-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,W-2XP," T,#(N-C @
M-C N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,S4N,# @-# R+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,SDN,# @-# R+C8P(#8P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DY+C P(#0P,BXV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 S+C P(#0P,BXV," V,"XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@
M,"!D"C @2@HP(&H*,R!-"C,W-2 V-3<N-B!M"C0S-2 V-3<N-B!L"G,*," P
M(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*
M-#,U(#8U-RXV(&T*-#,Y(#8U-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,SD@-C4W+C8@;0HT.3D@
M-C4W+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0Y.2 V-3<N-B!M"C4P,R V-3<N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 S
M(#8U-RXV(&T*-38S(#8U-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S4@-C0R+C8@;0HT,S4@-C0R
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S.2 V-#(N-B!M"C0Y.2 V-#(N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 S(#8T
M,BXV(&T*-38S(#8T,BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,SD@-38W+C8@;0HT.3D@-38W+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C4P,R U-C<N-B!M"C4V,R U-C<N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<U(#4V-RXV
M(&T*-#,U(#4V-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HS-S4@-34S+C8@;0HT,S4@-34S+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C,W-2 U-3$N-B!M"C0S-2 U-3$N-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#,Y(#4V-RXV(&T*
M-#DY(#4V-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT,SD@-34S+C8@;0HT.3D@-34S+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C0S.2 U-3$N-B!M"C0Y.2 U-3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-3 S(#4V-RXV(&T*-38S
M(#4V-RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HU,#,@-34S+C8@;0HU-C,@-34S+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P
M,R U-3$N-B!M"C4V,R U-3$N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<U(#0V,BXV(&T*-#,U(#0V
M,BXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,SD@-#8R+C8@;0HT.3D@-#8R+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P,R T
M-C(N-B!M"C4V,R T-C(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S<U(#0V,BXV(&T*-#,U(#0V,BXV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS-S4@-#0X+C8@;0HT,S4@-#0X+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,W-2 T-#8N
M-B!M"C0S-2 T-#8N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#,Y(#0V,BXV(&T*-#DY(#0V,BXV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT,SD@-#0X+C8@;0HT.3D@-#0X+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0S.2 T-#8N-B!M
M"C0Y.2 T-#8N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-3 S(#0V,BXV(&T*-38S(#0V,BXV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HU,#,@-#0X+C8@;0HU-C,@-#0X+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P,R T-#8N-B!M"C4V
M,R T-#8N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*,S<U(#0Q."XV(&T*-#,U(#0Q."XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M-S4@-#$V+C8@;0HT,S4@-#$V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0S.2 T,3@N-B!M"C0Y.2 T
M,3@N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#,Y(#0Q-BXV(&T*-#DY(#0Q-BXV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#,@
M-#$X+C8@;0HU-C,@-#$X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4P,R T,38N-B!M"C4V,R T,38N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*,S<U(#,X."XV(&T*-#,U(#,X."XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS-S4@,S@V
M+C8@;0HT,S4@,S@V+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0S.2 S.#@N-B!M"C0Y.2 S.#@N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#,Y(#,X-BXV(&T*-#DY(#,X-BXV(&P*<PHP(# @,"!21PHO1U,P
M(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#,@,S@X+C8@
M;0HU-C,@,S@X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *
M6UT@,"!D"C @2@HP(&H*,R!-"C4P,R S.#8N-B!M"C4V,R S.#8N-B!L"G,*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-C8R+C(W
M(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Q,RXQ," V-C(N,C@@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T,3DN-S<@-C8R+C(X(%1D("AE87(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" T,S,N,# @-C8R+C(X(%1D("@@16YD960@1&5C96UB97(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" U,#@N.3(@-C8R+C(X(%1D("B@,S$L*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#8T-RXR
M-R!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.30N-3 @-C0W+C(X(%1D("@R,#$X*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U."XU," V-#<N,C@@5&0@*#(P
M,3<I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3(R+C4P(#8T-RXR."!49" H,C Q-BD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,X-BXT," V,S(N,#8@5&0@*%PH86UO=6YT
M<R!I;B!T:&]U<V%N9',L(&5X8V5P="!P97(@<VAA<F4@9&%T85PI*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#8Q
M-RXR-R!49" H3G5M97)A=&]R.BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U."XU," V,#(N,C<@5&0@*$YE="!<*&QO<W-<
M*2!I;F-O;64@871T<FEB=71A8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,@
M+2!"87-I8RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-S<N-3 @-C R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P,"XS," V,#(N,S(@5&0@*%PH,38L
M.34Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0S,2XQ-2 V,#(N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0T,2XU," V,#(N,C<@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#8W+C8U(#8P
M,BXR-R!49" H,S<L-3$S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4P-2XU," V,#(N,C<@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C8U(#8P,BXR-R!4
M9" H-RPY-C<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3@N-3 @-3@W+C(W(%1D("A);G1E<F5S="!O;B!#;VYV97)T:6)L
M92!.;W1E<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,C$N,34@-3@W+C(W(%1D("B7*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0X,"XQ-2 U.#<N,C<@5&0@*#8Y-"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S8N
M-C4@-3@W+C(W(%1D("@S+#,X,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U."XU," U-S(N,C<@5&0@*$=A:6X@;VX@9&5R
M:79A=&EV92!L:6%B:6QI='DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#(Q+C$U(#4W,BXR-R!49" HERD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-CDN,S @-3<R+C,R
M(%1D("A<*#$L-3@Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y-2XQ-2 U-S(N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,RXS," U-S(N,S(@5&0@
M*%PH-2PX,#4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-34Y+C$U(#4W,BXR-R!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @-34W+C(W(%1D("A.970@
M7"AL;W-S7"D@:6YC;VUE(&%T=')I8G5T86)L92!T;R!C;VUM;VX@<VAA<F5H
M;VQD97)S("T@1&EL=71E9"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-S<N-3 @-34W+C(W(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,"XS," U-3<N,S(@
M5&0@*%PH,38L.34Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0S,2XQ-2 U-3<N,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T,2XU," U-3<N,C<@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#8W+C8U(#4U-RXR-R!49" H,S8L-C(V*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P-2XU," U-3<N,C<@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C8U
M(#4U-RXR-R!49" H-2PU-#4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N-3 @-3(W+C(W(%1D("A$96YO;6EN871O<CHI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N
M-3 @-3$R+C(W(%1D("A7*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-C<N-30@
M-3$R+C(W(%1D("AE:6=H=&5D(&%V97)A9V4@8V]M;6]N('-H87)E<R M($)A
M<VEC*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0P,RXV-2 U,3(N,C<@5&0@*#,U+#8U-RD@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N-C4@-3$R+C(W(%1D("@S-2PP
M,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3,Q+C8U(#4Q,BXR-R!49" H,S(L,3,R*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P(#0Y-RXR-R!49" H168I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" V-RXX-2 T.3<N,C<@5&0@*&9E8W1I=F4@
M;V8@9&EL=71E9"!S:&%R97,Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#8T+C4P(#0X,BXR-R!49" H4VAA<F4M8F%S960@
M87=A<F1S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0R,2XQ-2 T.#(N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#@P+C$U(#0X,BXR-R!49" H-#(U*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T-"XQ
M-2 T.#(N,C<@5&0@*#4Y,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" V-"XU," T-C<N,C<@5&0@*$-O;G9E<G1I8FQE($YO
M=&5S*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0R,2XQ-2 T-C<N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#@P+C$U(#0V-RXR-R!49" H-S(S*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S-BXV-2 T
M-C<N,C<@5&0@*#,L-3(Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4X+C4P(#0U,BXR-R!49" H5RD@5&H@150@40IQ(# @
M," P(')G($)4(#8W+C$T(#0U,BXR-R!49" H96EG:'1E9"!A=F5R86=E(&-O
M;6UO;B!S:&%R97,@+2!$:6QU=&5D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P,RXV-2 T-3(N,C<@5&0@*#,U+#8U-RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N
M-C4@-#4R+C(W(%1D("@S-BPQ-C8I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,Q+C8U(#0U,BXR-R!49" H,S8L,C0V*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P
M(#0R,BXR-R!49" H3F5T(%PH;&]S<UPI(&EN8V]M92!P97(@<VAA<F4@871T
M<FEB=71A8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,@+2!"87-I8RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S<N-3 @
M-#(R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Q,"XS," T,C(N,S(@5&0@*%PH,"XT."D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,S$N,34@-#(R+C(W
M(%1D("A<*2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-#$N-3 @-#(R+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0W-RXV-2 T,C(N,C<@5&0@*#$N,#<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 U
M+C4P(#0R,BXR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U-#$N-C4@-#(R+C(W(%1D("@P+C(U*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#,Y,BXR
M-R!49" H3F5T(%PH;&]S<UPI(&EN8V]M92!P97(@<VAA<F4@871T<FEB=71A
M8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,@+2!$:6QU=&5D*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-RXU," S.3(N
M,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-#$P+C,P(#,Y,BXS,B!49" H7"@P+C0X*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XQ-2 S.3(N,C<@5&0@
M*%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0T,2XU," S.3(N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#<W+C8U(#,Y,BXR-R!49" H,2XP,2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,#4N-3 @
M,SDR+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4T,2XV-2 S.3(N,C<@5&0@*# N,34I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,W-BXQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-C0N,3 @5&0@*$9O<B!T:&4@
M>65A<G,@,C Q."P@,C Q-RP@86YD(#(P,38L(&YO('1A>"!B96YE9FET<R!W
M97)E(&%S<W5M960@:6X@=&AE('=E:6=H=&5D(&%V97)A9V4@<VAA<F4@8V%L
M8W5L871I;VX@9'5E('1O('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,S4R+C$P(%1D("A#;VUP86YY)W,@
M;F5T(&]P97)A=&EN9R!L;W-S('!O<VET:6]N+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,C@N,3 @5&0@*%1H
M92!F;VQL;W=I;F<@=&%B;&4@<F5P<F5S96YT<R!T:&4@<V5C=7)I=&EE<R!T
M:&%T(&-O=6QD('!O=&5N=&EA;&QY(&1I;'5T92!N970@:6YC;VUE('!E<B!S
M:&%R92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S,38N,3 @5&0@*'-H
M87)E:&]L9&5R<R!I;B!T:&4@9G5T=7)E('1H870@=V5R92!N;W0@:6YC;'5D
M960@:6X@=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@;F5T(&EN8V]M92!P
M97(@<VAA<F4@871T<FEB=71A8FQE('1O(&-O;6UO;B I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,S T+C$P(%1D
M("AS:&%R96AO;&1E<G,@8F5C875S92!T;R!D;R!S;R!W;W5L9"!H879E(&)E
M96X@86YT:2UD:6QU=&EV92!F;W(@=&AE('!E<FEO9',@<')E<V5N=&5D+BD@
M5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M."XP," R-C,N-C @,C@P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,X+C P(#(V,RXV," R
M,34N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N
M,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,S@@,C<X+C8@;0HT,#,@
M,C<X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D
M"C @2@HP(&H*,R!-"C0P,R R-S@N-B!M"C0Q,R R-S@N-B!L"G,*," P(# @
M4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#$S
M(#(W."XV(&T*-#<X(#(W."XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @
M=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT-S@@,C<X+C8@;0HT.#@@,C<X
M+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0X." R-S@N-B!M"C4U,R R-S@N-B!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S,X(#(V
M,RXV(&T*-# S(#(V,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP
M(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,3,@,C8S+C8@;0HT-S@@,C8S+C8@
M; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C0X." R-C,N-B!M"C4U,R R-C,N-B!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S,X(#(S-"XV
M,# P,# P,# P,# P,B!M"C0P,R R,S0N-C P,# P,# P,# P,#(@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,S." R,S(N-C P,# P,# P,# P,#(@;0HT,#,@,C,R+C8P,# P,# P,# P
M,# R(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HT,3,@,C,T+C8P,# P,# P,# P,# R(&T*-#<X(#(S-"XV
M,# P,# P,# P,# P,B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-#$S(#(S,BXV,# P,# P,# P,# P,B!M
M"C0W." R,S(N-C P,# P,# P,# P,#(@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X." R,S0N-C P,# P
M,# P,# P,#(@;0HU-3,@,C,T+C8P,# P,# P,# P,# R(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT.#@@
M,C,R+C8P,# P,# P,# P,# R(&T*-34S(#(S,BXV,# P,# P,# P,# P,B!L
M"G,*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S.34N,34@,C@S
M+C U(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-# P+C8U(#(X,RXP
M-2!49" H96%R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#$R+CDX(#(X,RXP
M-2!49" H($5N9&5D($1E8V5M8F5R*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M-#@Q+C,P(#(X,RXP-2!49" HH#,Q+"D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-C N,# @,C8X+C(X(%1D("@R,#$X*2!4
M:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-2XP
M," R-C@N,C@@5&0@*#(P,3<I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3$P+C P(#(V."XR."!49" H,C Q-BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,RXP," R-3,N
M,#8@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9'-<*2D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V,"XU," R,S@N,C<@5&0@
M*%-H87)E+6)A<V5D(&%W87)D<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.#0N,34@,C,X+C(W(%1D("@S-S,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4Y+C$U(#(S
M."XR-R!49" H,2D@5&H@150@40IQ(# @," P(')G($)4(#0V-"XQ-2 R,S@N
M,C<@5&0@*#$X*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4S.2XQ-2 R,S@N,C<@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y
M+C4P(#(Q,"XQ,"!49" H,38N(%)E;&%T960@4&%R='D@*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3(U+CDV(#(Q,"XQ,"!49" H5"D@5&H@150@40IQ(# @
M," P(')G($)4(#$S,2XX.2 R,3 N,3 @5&0@*')A;G-A8W1I;VYS*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$Y
M."XQ,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," Q.#8N,3 @5&0@*%1H92!#;VUP86YY('!R;W9I9&5S
M('-E<G9I8V5S('1O(&AO<W!I=&%L<R!W:&EC:"!A<F4@868I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" R-S@N,34@,3@V+C$P(%1D("AF:6QI871E9"!W:71H
M(&-E<G1A:6X@;65M8F5R<R!O9B!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T-C4N,S(@,3@V+C$P(%1D("AS($)O87)D(&]F($1I<F5C
M=&]R<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#$W-"XQ,"!49" H36%N86=E;65N="!B96QI979E<R!S97)V
M:6-E<R!W:71H(')E;&%T960@<&%R=&EE<R!W97)E(&-O;F1U8W1E9"!O;B!T
M97)M<R!E<75I=F%L96YT('1O('1H;W-E('!R979A:6QI;F<@:6X@86X@87)M
M)W,M;&5N9W1H("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" T.2XU," Q-C(N,3 @5&0@*'1R86YS86-T:6]N+B!2979E;G5E
M(')E;&%T960@=&\@=&AE<V4@=')A;G-A8W1I;VYS('=A<R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8W+C(P(#$V,BXQ
M,"!49" H)# N,2!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,Q-BXP.2 Q-C(N,3 @5&0@*"P@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R,2XP.2 Q-C(N
M,3 @5&0@*"0T+CD@;6EL;&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-CDN.3@@,38R+C$P(%1D("@L(&%N9" I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDQ+CDR
M(#$V,BXQ,"!49" H)#4N,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0T,"XX,2 Q-C(N,3 @5&0@*"!I;B I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4S
M+C4Y(#$V,BXQ,"!49" H,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-S,N-3D@,38R+C$P(%1D("@L("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-S@N-3D@,38R
M+C$P(%1D("@R,#$W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y."XU.2 Q-C(N,3 @5&0@*"P@86YD("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,C N-3,@,38R+C$P
M(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4T,"XU,R Q-C(N,3 @5&0@*"P@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$U,"XQ,"!49" H<F5S
M<&5C=&EV96QY*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3<N,38@,34P+C$P
M(%1D("@N("D@5&H@150@40IQ(# @," P(')G($)4(#$P,2XV,2 Q-3 N,3 @
M5&0@*$%C8V]U;G1S(')E8V5I=F%B;&4@9'5E(&9R;VT@=&AE<V4@:&]S<&ET
M86QS(&%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R.34N,34@,34P+C$P(%1D("A$96-E;6)E<J S,2P@,C Q."D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S,N-S0@
M,34P+C$P(%1D("@@86YD("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" S.3,N,3@@,34P+C$P(%1D("@R,#$W*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q,RXQ." Q-3 N
M,3 @5&0@*"!W97)E(&QE<W,@=&AA;B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<T+C@R(#$U,"XQ,"!49" H)# N,2!M
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4R,RXW,2 Q-3 N,3 @5&0@*"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#$S."XQ,"!49" H87!P
M<F]X:6UA=&5L>2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3 Y+C<V(#$S."XQ,"!49" H)# N-"!M:6QL:6]N*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$U."XV-2 Q
M,S@N,3 @5&0@*"P@<F5S<&5C=&EV96QY*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C$Q+C,Q(#$S."XQ,"!49" H+B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,3$T+C$P(%1D("A);B!C;VYN
M96-T:6]N('=I=&@@=&AE(&%C<75I<VET:6]N(&]F($U33BP@=&AE($-O;7!A
M;GD@86-Q=6ER960@82 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S(U+C4U(#$Q-"XQ,"!49" H-C@E*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,T,RXX." Q,30N,3 @
M5&0@*"!O=VYE<G-H:7 @:6YT97)E<W0@:6X@0W)O<W,@0V]U;G1R>2 I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" T.3,N,3,@,3$T+C$P(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#DX+C4T(#$Q-"XQ,"!49" H86QE;G0@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#$P,BXQ,"!49" H06-Q=6ES:71I;VX@1W)O=7 L($Q,0R!<*&9O<FUE<FQY
M($EN=&5L:5-T868@;V8@3VML86AO;6$L($Q,0UPI+"!A(&IO:6YT('9E;G1U
M<F4@8F5T=V5E;B!T:&4@0V]M<&%N>2!A;F0@82!H;W-P:71A;"!S>7-T96TN
M("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M.2XU," Y,"XQ,"!49" H5&AE($-O;7!A;GD@9V5N97)A=&5D(')E=F5N=64@
M<')O=FED:6YG('-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-# N,#D@
M.3 N,3 @5&0@*&9I;F<@<V5R=FEC97,@=&\@=&AE(&AO<W!I=&%L('-Y<W1E
M;2!O9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,SDS+C8W(#DP+C$P(%1D("@D,3DN-"!M:6QL:6]N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0T-RXU-B Y,"XQ,"!4
M9" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4R+C4V(#DP+C$P(%1D("@D,3<N.2!M:6QL:6]N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P-BXT-2 Y,"XQ,"!4
M9" H+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4R."XS.2 Y,"XQ,"!49" H)#$R+C8@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#<X+C$P(%1D("AM
M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#<X+C,Y(#<X+C$P(%1D("@@:6X@,C Q."P@,C Q-RP@86YD(#(P,38L
M(')E<W!E8W1I=F5L>2D@5&H@150@40IQ(# @," P(')G($)4(#(S,"XW-R W
M."XQ,"!49" H+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S4N,C(@-S@N
M,3 @5&0@*$%T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" R-#<N-S(@-S@N,3 @5&0@*$1E8V5M8F5RH#,Q+" R,#$X*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,R-BXS
M," W."XQ,"!49" H(&%N9" R,#$W+"!T:&4@0V]M<&%N>2!H860@82!R96-E
M:79A8FQE(&)A;&%N8V4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S."XQ-B W."XQ,"!49" H)#(N." I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C8N
M,3 @5&0@*&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-S@N,SD@-C8N,3 @5&0@*"!A;F0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DW+C@S(#8V+C$P(%1D
M("@D,"XX(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,30V+C<R(#8V+C$P(%1D("@L(')E<W!E8W1I=F5L>2D@
M5&H@150@40IQ(# @," P(')G($)4(#$Y.2XS." V-BXQ,"!49" H+"!A;F0@
M82!P87EA8FQE(&)A;&%N8V4@;V8@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,P-2XW,B V-BXQ,"!49" H)# N,R!M:6QL
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,U-"XV,2 V-BXQ,"!49" H(&%T(&)O=&@@<&5R:6]D<RXI(%1J($54(%$*
M96YD<W1R96%M"F5N9&]B:@HQ.#,@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R
M96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O
M=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q.#0@,"!2/CX*96YD
M;V)J"C$X-" P(&]B:@H\/"],96YG=&@@.#8Y,SX^"G-T<F5A;0I"5" O1C(@
M-BXP,"!49B!%5 IQ(# @," P(')G($)4(#,P-BXP," W-S4N-#4@5&0@*" I
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S
M+C@U(#<V,RXT-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDR+C8X(#<V,RXT-2!49" H62D@5&H@150@40IQ(# @," P(')G
M($)4(#(Y.2XU,R W-C,N-#4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S(Y+C0U(#<V,RXT-2!49" H5$A#05)%+"!)3D,N*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W-2XS," W-3$N
M-#4@5&0@*$Y/5$53("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,2XU,B W
M-3$N-#4@5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,3@N,#$@-S4Q
M+C0U(%1D("A/($-/3E-/3$E$02D@5&H@150@40IQ(# @," P(')G($)4(#(X
M."XQ,2 W-3$N-#4@5&0@*%1%1"!&24Y!3D-)04PI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S-C<N,CD@-S4Q+C0U(%1D("@@4U0I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#$N,C@@-S4Q+C0U(%1D("A!*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S@W+C<V(#<U,2XT-2!49" H5$5-14Y44RD@5&H@150@40I"5" O
M1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3@N,S4@-S,Y+C0U(%1D
M("A$14-%34)%4J S,2P@,C Q."D@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," W,34N-#4@5&0@*#$V+B!296QA=&5D
M(%!A<G1Y("D@5&H@150@40IQ(# @," P(')G($)4(#$R-BXT-B W,34N-#4@
M5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S(N,SD@-S$U+C0U(%1D
M("AR86YS86-T:6]N<R!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H1BT@
M-#$I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#DN-3 @-CDU+C$P(%1D("A3=6)S97%U96YT('1O('1H92!#;VUP86YY)W,@
M86-Q=6ES:71I;VX@;V8@365D:7-C86X@;VX@3V-T;V)E<B S,"P@,C Q-2P@
M365D:7-C86X@8V]N=&EN=65D('1O(&]P97)A=&4@870@<')E;6ES97,@;W=N
M960L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.2XU," V.#,N,3 @5&0@*&EN('!A<G0L(&)Y('1H92!F;W5N9&EN9R!M
M96UB97)S(&]F($UE9&ES8V%N+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,SDN.#,@-C@S+C$P(%1D("A4:&4@0V]M<&%N>2!P86ED("D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S,3@N.3@@-C@S+C$P
M(%1D("@D,"XS(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,S8W+C@W(#8X,RXQ,"!49" H(&EN(#(P,3@L("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#4N
M-C4@-C@S+C$P(%1D("@D,"XT(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#4T+C4T(#8X,RXQ,"!49" H(&EN
M(#(P,3<L(&%N9" R,#$V(&9O<B!R96YT("D@5&H@150@40I"5" O1C$@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-S$N,3 @5&0@*&9O<B!T
M:&5S92!P<F5M:7-E<RX@26X@=&AE(&9O=7)T:"!Q=6%R=&5R(&]F(#(P,3@L
M('1H92!#;VUP86YY('9A8V%T960@=&AE('!R96UI<V5S+BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V-3DN,3 @
M5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @-C0W+C$P(%1D("@Q-RX@4V5G;65N="!$871A*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#8S-2XQ
M,"!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," V,C,N,3 @5&0@*$EN(&%C8V]R9&%N8V4@=VET:"!T:&4@
M*2!4:B!%5"!1"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$T
M,BXW.2 V,C,N,3 @5&0@*%-E9VUE;G0@4F5P;W)T:6YG*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q.2XQ-B V,C,N,3 @
M5&0@*" I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C$N-#@@-C(S+C$P(%1D
M("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(V+C@Y(#8R,RXQ,"!49" H
M;W!I8R!O9B!T:&4@1BD@5&H@150@40IQ(# @," P(')G($)4(#(W-BXY-R V
M,C,N,3 @5&0@*$%30B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3@N,S<@
M-C(S+C$P(%1D("A!4T,L('1H92!#;VUP86YY(')E<&]R=',@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P.2XR," V,C,N
M,3 @5&0@*'1H<F5E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0R.2XQ." V,C,N,3 @5&0@*"!B=7-I;F5S<R!S96=M96YT
M<R"6($YU<G-E(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#DN-3 @-C$Q+C$P(%1D("A!;&QI960@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#DR+CDR(#8Q,2XQ,"!49" H9FEN9RP@4&AY
M<VEC:6%N(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-S$N,S4@-C$Q
M+C$P(%1D("AF:6YG+"!A;F0@3W1H97(@2'5M86X@0V%P:71A;"!-86YA9V5M
M96YT(%-E<G9I8V5S+B I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3$N,S@@
M-C$Q+C$P(%1D("A4:&4@0V]M<&%N>2!M86YA9V5S(&%N9"!S96=M96YT<R!I
M=',@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#4Y.2XQ,"!49" H8G5S:6YE<W,@8F%S960@;VX@=&AE('-E<G9I
M8V5S(&ET(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@Y+C(Y(#4Y.2XQ
M,"!49" H9F5R<R!T;R!I=',@8W5S=&]M97)S(&%S(&1E<V-R:6)E9"!B96QO
M=SJ@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#4X-RXQ,"!49" HH"D@5&H@150@40I"5" O1C0@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" V-RXU," U-S4N,3 @5&0@*)4@*2!4:B!%5"!1
M"D)4("]&-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C4P(#4W-2XQ
M,"!49" H3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#$R.2XR
M,2 U-S4N,3 @5&0@*$%L;&EE9"!3=&%F9FEN9R M("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.34N,#0@-3<U+C$P(%1D
M("A.=7)S92!A;F0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,W+C@P(#4W
M-2XQ,"!49" H06QL:65D(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M.#$N,C,@-3<U+C$P(%1D("AF:6YG('!R;W9I9&5S('1R861I=&EO;F%L('-T
M868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.30N-C,@-3<U+C$P(%1D("AF
M:6YG+"!R96-R=6ET:6YG+"!A;F0@=F%L=64M861D960@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C4P(#4V,RXQ,"!4
M9" H=V]R:V9O<F-E('-O;'5T:6]N<R!I;F-L=61I;F<Z('1E;7!O<F%R>2!A
M;F0@<&5R;6%N96YT('!L86-E;65N="!O9B!T<F%V96P@86YD(&QO8V%L(&)R
M86YC:"UB87-E9"!N=7)S92!A;F0@86QL:65D("D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-2XU," U-3$N,3 @5&0@*'!R
M;V9E<W-I;VYA;',L($U34"D@5&H@150@40IQ(# @," P(')G($)4(#$V,BXY
M,2 U-3$N,3 @5&0@*"!S97)V:6-E<RP@961U8V%T:6]N(&AE86QT:&-A<F4@
M<V5R=FEC97,L(&%N9"!O=71S;W5R8VEN9R!S97)V:6-E<RX@271S(&-L:65N
M=',@:6YC;'5D93H@<'5B;&EC(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.#4N-3 @-3,Y+C$P(%1D("AP<FEV871E
M(&%C=71E(&-A<F4@86YD(&YO;BUA8W5T92!C87)E(&AO<W!I=&%L<RP@9V]V
M97)N;65N="!F86-I;&ET:65S+"!P=6)L:6,@<V-H;V]L<R!A;F0@8VAA<G1E
M<B!S8VAO;VQS+"!O=71P871I96YT("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" X-2XU," U,C<N,3 @5&0@*&-L:6YI8W,L
M(&%M8G5L871O<GD@8V%R92!F86-I;&ET:65S+"!P:'ES:6-I86X@<')A8W1I
M8V4@9W)O=7!S+"!R971A:6QE<G,L(&%N9"!M86YY(&]T:&5R(&AE86QT:&-A
M<F4@<')O=FED97)S('1H<F]U9VAO=70@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@U+C4P(#4Q-2XQ,"!49" H=&AE(%5N
M:71E9"!3=&%T97,N(%-U8G-T86YT:6%L;'D@86QL(&]F('1H92!R97-U;'1S
M(&]F('1H92 I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,#4N,3D@-3$U+C$P
M(%1D("A!9'9A;G1A9V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#,V
M-RXS.2 U,34N,3 @5&0@*$%0*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S<Y
M+C@P(#4Q-2XQ,"!49" H(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M.3@N,C,@-3$U+C$P(%1D("AF:6YG(&%C<75I<VET:6]N<R!H879E(&)E96X@
M86=G<F5G871E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#4N-3 @-3 S+C$P(%1D("AW:71H('1H92!#;VUP86YY)W,@
M3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#(Q,"XS-" U,#,N
M,3 @5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C4S
M+C<W(#4P,RXQ,"!49" H9FEN9R!B=7-I;F5S<R!S96=M96YT+B!3964@3F]T
M92 T("T@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,SDX+C<U(#4P,RXQ,"!4
M9" H06-Q=6ES:71I;VYS+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.2XU," T.3$N,3 @5&0@** I(%1J($54(%$*0E0@
M+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C<N-3 @-#<Y+C$P(%1D
M("B5("D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" X-2XU," T-SDN,3 @5&0@*%!H>7-I8VEA;B!3=&%F9FEN9R M*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$V-"XS." T
M-SDN,3 @5&0@*"!0:'ES:6-I86X@4W1A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#(R-"XQ.2 T-SDN,3 @5&0@*&9I;F<@<')O=FED97,@<&AY<VEC:6%N
M<R!I;B!M86YY('-P96-I86QT:65S+"!A<R!W96QL(&%S(&-E<G1I9FEE9"!R
M96=I<W1E<F5D(&YU<G-E("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-2XU," T-C<N,3 @5&0@*&%N97-T:&5T:7-T<RP@
M;G5R<V4@<')A8W1I=&EO;F5R<RP@86YD('!H>7-I8VEA;B!A<W-I<W1A;G1S
M(&%S(&EN9&5P96YD96YT(&-O;G1R86-T;W)S(&]N('1E;7!O<F%R>2!A<W-I
M9VYM96YT<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.#4N-3 @-#4U+C$P(%1D("AT:')O=6=H;W5T('1H92!5;FET960@
M4W1A=&5S(&%T('9A<FEO=7,@:&5A;'1H8V%R92!F86-I;&ET:65S+"!S=6-H
M(&%S(&%C=71E(&%N9"!N;VXM86-U=&4@8V%R92!F86-I;&ET:65S+"!M961I
M8V%L(&=R;W5P("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" X-2XU," T-#,N,3 @5&0@*'!R86-T:6-E<RP@9V]V97)N;65N
M="!F86-I;&ET:65S+"!A;F0@;6%N86=E9"!C87)E(&]R*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,CDX+C4U(#0T,RXQ,"!49" H9V%N:7IA=&EO;G,N*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#0S,2XQ,"!49" HH"D@5&H@150@40I"5" O1C0@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" V-RXU," T,3DN,3 @5&0@*)4@*2!4:B!%5"!1"D)4("]&
M-" Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C4P(#0Q.2XQ,"!49" H
M3W1H97(@2'5M86X@0V%P:71A;"!-86YA9V5M96YT(%-E<G9I8V5S("TI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C8Y+C8S
M(#0Q.2XQ,"!49" H($]T:&5R($AU;6%N($-A<&ET86P@36%N86=E;65N="!3
M97)V:6-E<R!I;F-L=61E<R!R971A:6YE9"!A;F0@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@U+C4P(#0P-RXQ,"!49" H
M8V]N=&EN9V5N="!S96%R8V@@<V5R=FEC97,@9F]R('!H>7-I8VEA;G,L(&AE
M86QT:&-A<F4@97AE8W5T:79E<RP@86YD(&]T:&5R(&AE86QT:&-A<F4@<')O
M9F5S<VEO;F%L<R!W:71H:6X@=&AE(%5N:71E9" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#4N-3 @,SDU+C$P(%1D("A3
M=&%T97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0Y+C4P(#,W,2XQ,"!49" H5&AE($-O;7!A;GF2*2!4:B!%5"!1"G$@
M," P(# @<F<@0E0@,3 Y+C(Q(#,W,2XQ,"!49" H<R!M86YA9V5M96YT(&5V
M86QU871E<R!P97)F;W)M86YC92!O9B!E86-H('-E9VUE;G0@<')I;6%R:6QY
M(&)A<V5D(&]N(')E=F5N=64@86YD(&-O;G1R:6)U=&EO;B!I;F-O;64N("D@
M5&H@150@40IQ(# @," P(')G($)4(#4T,RXU.2 S-S$N,3 @5&0@*%1H92 I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN
M-3 @,S4Y+C$P(%1D("A#;VUP86YY(&1E9FEN97,@8V]N=')I8G5T:6]N(&EN
M8V]M92!A<R!I;F-O;64@;W(@;&]S<R!F<F]M(&]P97)A=&EO;G,@8F5F;W)E
M(&1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N+"!A8W%U:7-I=&EO;B!A
M;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y+C4P(#,T-RXQ,"!49" H:6YT96=R871I;VX@8V]S=',L(&%C<75I<VET
M:6]N+7)E;&%T960@8V]N=&EN9V5N="!C;VYS:61E<F%T:6]N+"!R97-T<G5C
M='5R:6YG(&-O<W1S+"!I;7!A:7)M96YT(&-H87(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" T-#4N,#0@,S0W+C$P(%1D("AG97,L(&%P<&QI8V%N="!T<F%C
M:VEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S,U+C$P(%1D("AS>7-T96T@8V]S=',L(&%N9"!C;W)P;W)A
M=&4@97AP96YS97,@;F]T('-P96-I9FEC86QL>2!I9&5N=&EF:65D('1O(&$@
M<F5P;W)T:6YG('-E9VUE;G0N($-O;G1R:6)U=&EO;B!I;F-O;64@:7,@82!F
M:6YA;F-I86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Y+C4P(#,R,RXQ,"!49" H;65A<W5R92!U<V5D(&)Y(&UA;F%G
M96UE;G0@=VAE;B!A<W-E<W-I;F<@<V5G;65N="!P97)F;W)M86YC92!A;F0@
M:7,@<')O=FED960@:6X@86-C;W)D86YC92!W:71H('1H92 I(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#@Q+C@U(#,R,RXQ
M,"!49" H4V5G;65N="!297!O<G1I;F<I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-34X+C(S(#,R,RXQ,"!49" H("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S
M,3$N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" U-"XY,2 S,3$N
M,3 @5&0@*&]P:6,@;V8@=&AE($8I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,#0N.3D@,S$Q+C$P(%1D("A!4T(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,3(V+C,Y(#,Q,2XQ,"!49" H05-#+B I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q-3 N-C<@,S$Q+C$P(%1D("A4:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,3 N,S@@,S$Q+C$P(%1D("AS(&UA;F%G96UE;G0@9&]E
M<R!N;W0@979A;'5A=&4L(&UA;F%G92P@;W(@;65A<W5R92!P97)F;W)M86YC
M92!O9B!S96=M96YT<R!U<VEN9R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,CDY+C$P(%1D("AA<W-E="!I;F9O
M<FUA=&EO;CL@86-C;W)D:6YG;'DI(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M-S N-#@@,CDY+C$P(%1D("@L('1O=&%L(&%S<V5T(&EN9F]R;6%T:6]N(&)Y
M('-E9VUE;G0@:7,@;F]T('!R97!A<F5D(&]R(&1I<V-L;W-E9"X@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#,P+C4R(#(Y.2XQ,"!49" H5&AE(&EN9F]R
M;6%T:6]N(&EN('1H92!F;VQL;W=I;F<@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#(X-RXQ,"!49" H=&%B;&4@
M:7,@9&5R:79E9"!F<F]M('1H92!S96=M96YT<Y(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q.#DN-34@,C@W+C$P(%1D("@@:6YT97)N86P@9FEN86YC:6%L
M(&EN9F]R;6%T:6]N(&%S('5S960@9F]R(&-O<G!O<F%T92!M86YA9V5M96YT
M('!U<G!O<V5S+B!#97)T86EN(&-O<G!O<F%T92 I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @,C<U+C$P(%1D("AE
M>'!E;G-E<R!A<F4@;F]T(&%L;&]C871E9"!T;R!A;F0O;W(@86UO;F<@=&AE
M(&]P97)A=&EN9R!S96=M96YT<RXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#DN-3 @,C8S+C$P(%1D("B@*2!4:B!%5"!1
M"F5N9'-T<F5A;0IE;F1O8FH*,3@U(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A
M<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S
M;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3@V(# @4CX^"F5N
M9&]B:@HQ.#8@,"!O8FH*/#PO3&5N9W1H(#$U-#(R/CX*<W1R96%M"D)4("]&
M,B V+C P(%1F($54"G$@," P(# @<F<@0E0@,S V+C P(#<W-2XT-2!49" H
M("D@5&H@150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,3,N.#4@-S8S+C0U(%1D("A#4D]34R!#3U5.5%(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3(N-C@@-S8S+C0U(%1D("A9*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDY+C4S(#<V,RXT-2!49" H($A%04PI(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S,CDN-#4@-S8S+C0U(%1D("A42$-!4D4L($E.0RXI(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3<U+C,P(#<U
M,2XT-2!49" H3D]415,@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C$Q+C4R
M(#<U,2XT-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#(Q."XP,2 W
M-3$N-#4@5&0@*$\@0T].4T],241!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,C@X+C$Q(#<U,2XT-2!49" H5$5$($9)3D%.0TE!3"D@5&H@150@40IQ(# @
M," P(')G($)4(#,V-RXR.2 W-3$N-#4@5&0@*"!35"D@5&H@150@40IQ(# @
M," P(')G($)4(#,X,2XR." W-3$N-#4@5&0@*$$I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" S.#<N-S8@-S4Q+C0U(%1D("A414U%3E13*2!4:B!%5"!1"D)4
M("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(U."XS-2 W,SDN-#4@
M5&0@*$1%0T5-0D52H#,Q+" R,#$X*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#<Q-2XT-2!49" H,3<N(%-E9VUE
M;G0@1&%T82!<*&-O;G1I;G5E9%PI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#(Y-2XS," S,RXV,"!49" H1BT@-#(I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-CDU+C$P(%1D("A);F9O<FUA=&EO;B!O;B!O<&5R871I;F<@<V5G;65N=',@
M86YD(&$@<F5C;VYC:6QI871I;VX@=&\@:6YC;VUE(&9R;VT@;W!E<F%T:6]N
M<R!F;W(@=&AE('!E<FEO9',@:6YD:6-A=&5D(&%R92!A<R!F;VQL;W=S.BD@
M5&H@150@40HP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU
M,"XP," V-30N-C @,C@P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,P+C P(#8U-"XV," R
M,S,N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,"XP," V,C0N-C @,C@P+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S,P+C P(#8R-"XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-2XP," V,C0N
M-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C0P.2XP," V,C0N-C @-S4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.#0N,# @-C(T+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @-C(T
M+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-3DT+C8P(#(X,"XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C,S,"XP," U.30N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @
M-3DT+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#DN,# @-3DT+C8P(#<U+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#@T+C P(#4Y-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C P
M(#4Y-"XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#4V-"XV," R.# N,# @
M+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHS,S N,# @-38T+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# U
M+C P(#4V-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P(#4V-"XV," W-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0X-"XP," U-C0N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X
M."XP," U-C0N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP," U,S0N-C @,C@P
M+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*,S,P+C P(#4S-"XV," W-2XP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0P-2XP," U,S0N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P.2XP," U,S0N-C @
M-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.#0N,# @-3,T+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT.#@N,# @-3,T+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-3 T+C8P
M(#(X,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,S,"XP," U,#0N-C @-S4N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,#4N,# @-3 T+C8P(#0N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#DN,# @-3 T
M+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#@T+C P(#4P-"XV," T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#@X+C P(#4P-"XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#0W
M-"XV," R.# N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,S N,# @-#<T+C8P(#<U+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-# U+C P(#0W-"XV," T+C P("TQ-2XP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Y+C P
M(#0W-"XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," T-S0N-C @-"XP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0X."XP," T-S0N-C @-S4N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,"XP
M," T-#0N-C @,C@P+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,P+C P(#0T-"XV," W-2XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0P-2XP," T-#0N-C @-"XP," M,34N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P
M.2XP," T-#0N-C @-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY
M,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#0N,# @-#0T+C8P(#0N
M,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT.#@N,# @-#0T+C8P(#<U+C P("TQ-2XP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 N,# @-#$T+C8P(#(X,"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,S,"XP," T,30N-C @
M-S4N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @-#$T+C8P(#0N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,#DN,# @-#$T+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@T+C P(#0Q-"XV
M," T+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-#@X+C P(#0Q-"XV," W-2XP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C4P+C P(#,X-"XV," R.# N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS,S N,# @,S@T
M+C8P(#<U+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-# U+C P(#,X-"XV," T+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-# Y+C P(#,X-"XV," W-2XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X-"XP," S
M.#0N-C @-"XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," S.#0N-C @-S4N,# @+3$U
M+C P(')E(&8*+T=3,"!G<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HS,S @-C8Y+C8@;0HT,#4@-C8Y+C8@; IS
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C0P-2 V-CDN-B!M"C0P.2 V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G
M<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#8V.2XV(&T*
M-#@T(#8V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=
M(# @9 HP($H*,"!J"C,@30HT.#0@-C8Y+C8@;0HT.#@@-C8Y+C8@; IS"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,S," V-30N-B!M"C0P-2 V-30N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#8V.2XV(&T*-#@T
M(#8V.2XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT,#D@-C4T+C8@;0HT.#0@-C4T+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X
M." V-CDN-B!M"C4V,R V-CDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P
M('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@X(#8U-"XV(&T*-38S(#8U
M-"XV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP
M($H*,"!J"C,@30HS,S @-3<Y+C8@;0HT,#4@-3<Y+C8@; IS"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 U
M-SDN-B!M"C0X-" U-SDN-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-#@X(#4W.2XV(&T*-38S(#4W.2XV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HS,S @-38U+C8@;0HT,#4@-38U+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,S," U-C,N
M-B!M"C0P-2 U-C,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I
M( I;72 P(&0*,"!*"C @:@HS($T*-# Y(#4V-2XV(&T*-#@T(#4V-2XV(&P*
M<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J
M"C,@30HT,#D@-38S+C8@;0HT.#0@-38S+C8@; IS"C @," P(%)'"B]'4S @
M9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X." U-C4N-B!M
M"C4V,R U-C4N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*-#@X(#4V,RXV(&T*-38S(#4V,RXV(&P*<PHP
M(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@
M30HS,S @-3 T+C8@;0HT,#4@-3 T+C8@; IS"C @," P(%)'"B]'4S @9W,*
M,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 U,#0N-B!M"C0X
M-" U,#0N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P
M(&0*,"!*"C @:@HS($T*-#@X(#4P-"XV(&T*-38S(#4P-"XV(&P*<PHP(# @
M,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS
M,S @,S@T+C8@;0HT,#4@,S@T+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0P.2 S.#0N-B!M"C0X-" S
M.#0N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*
M,"!*"C @:@HS($T*-#@X(#,X-"XV(&T*-38S(#,X-"XV(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HS,S @
M,S<P+C8@;0HT,#4@,S<P+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W
M"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,S," S-C@N-B!M"C0P-2 S-C@N
M-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*
M"C @:@HS($T*-# Y(#,W,"XV(&T*-#@T(#,W,"XV(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HT,#D@,S8X
M+C8@;0HT.#0@,S8X+C8@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @
M:2 *6UT@,"!D"C @2@HP(&H*,R!-"C0X." S-S N-B!M"C4V,R S-S N-B!L
M"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @
M:@HS($T*-#@X(#,V."XV(&T*-38S(#,V."XV(&P*<PI"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXU," V-S0N,C<@5&0@** I(%1J($54
M(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDP+C8P(#8W
M-"XR."!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#,Y-RXR-R V-S0N
M,C@@5&0@*&5A<BD@5&H@150@40IQ(# @," P(')G($)4(#0Q,"XU," V-S0N
M,C@@5&0@*"!%;F1E9"!$96-E;6)E<BD@5&H@150@40IQ(# @," P(')G($)4
M(#0X-BXT,B V-S0N,C@@5&0@** S,2PI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-C4Y+C(W(%1D("B@*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,U-RXP," V
M-3DN,C@@5&0@*#(P,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,V+C P(#8U.2XR."!49" H,C Q-RD@5&H@150@40I"
M5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,34N,# @-C4Y+C(X
M(%1D("@R,#$V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# T+C P(#8T-"XP-B!49" H7"AA;6]U;G1S(&EN('1H;W5S86YD
M<UPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4R+C4P(#8R.2XR-R!49" H4F5V96YU97,Z*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S,BXU," V,CDN,C<@5&0@** I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#$Q
M+C4P(#8R.2XR-R!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" T.3 N-3 @-C(Y+C(W(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4X+C4P(#8Q-"XR-R!4
M9" H3G5R<V4@86YD("D@5&H@150@40IQ(# @," P(')G($)4(#$P,2XU-" V
M,30N,C<@5&0@*$%L;&EE9"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@
M,30T+C<X(#8Q-"XR-R!49" H9FEN9RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S,S(N-3 @-C$T+C(W(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,V."XV-2 V
M,30N,C<@5&0@*#<R,"PS,#(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#$Q+C4P(#8Q-"XR-R!49" H)"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-#<N-C4@-C$T+C(W
M(%1D("@W-3@L,C8W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0Y,"XU," V,30N,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(V+C8U(#8Q-"XR-R!49" H
M-S(Q+#0X-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" U."XU," U.3DN,C<@5&0@*%!H>7-I8VEA;B!3=&%F*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3$U+CDP(#4Y.2XR-R!49" H9FEN9RD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S,N-C4@-3DY
M+C(W(%1D("@X,BPS,#4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#4R+C8U(#4Y.2XR-R!49" H.3,L-C$P*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XV-2 U.3DN
M,C<@5&0@*#DX+#(X,RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U."XU," U.#0N,C<@5&0@*$]T:&5R($AU;6%N($-A<&ET
M86P@36%N86=E;65N="!397)V:6-E<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-S,N-C4@-3@T+C(W(%1D("@Q,RPX-S<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#4R
M+C8U(#4X-"XR-R!49" H,3,L,3<Q*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4S,2XV-2 U.#0N,C<@5&0@*#$S+#<V."D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU
M," U-CDN,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S,R+C4P(#4V.2XR-R!49" H)"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-C@N-C4@-38Y+C(W(%1D
M("@X,38L-#@T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0Q,2XU," U-CDN,C<@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C8U(#4V.2XR-R!49" H.#8U
M+# T."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.3 N-3 @-38Y+C(W(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R-BXV-2 U-CDN,C<@5&0@*#@S,RPU,S<I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N
M-3 @-34T+C(W(%1D("A#;VYT<FEB=71I;VX@:6YC;VUE.BD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T,#$N-3 @-34T+C(W
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#0X,"XU," U-30N,C<@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-34Y+C4P(#4U-"XR-R!49" HH"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U."XU," U
M,SDN,C<@5&0@*$YU<G-E(&%N9" I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,#$N-30@-3,Y+C(W(%1D("A!;&QI960@4W1A9BD@5&H@150@40IQ(# @," P
M(')G($)4(#$T-"XW." U,SDN,C<@5&0@*&9I;F<I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S,R+C4P(#4S.2XR-R!49" H
M)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-S,N-C4@-3,Y+C(W(%1D("@V-BPS-C4I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#$Q+C4P(#4S.2XR-R!49" H)"D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3(N-C4@
M-3,Y+C(W(%1D("@W,RPV,30I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#DP+C4P(#4S.2XR-R!49" H)"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S$N-C4@-3,Y+C(W
M(%1D("@W,2PY.3(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3@N-3 @-3(T+C(W(%1D("A0:'ES:6-I86X@4W1A9BD@5&H@
M150@40IQ(# @," P(')G($)4(#$Q-2XY," U,C0N,C<@5&0@*&9I;F<I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S<X+C8U
M(#4R-"XR-R!49" H-"PW-34I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#4W+C8U(#4R-"XR-R!49" H-2PR-38I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V+C8U(#4R
M-"XR-R!49" H."PR-C4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3@N-3 @-3 Y+C(W(%1D("A/=&AE<B!(=6UA;B!#87!I
M=&%L($UA;F%G96UE;G0@4V5R=FEC97,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S@V+C$U(#4P.2XR-R!49" H-3DX*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0V,2XX
M," U,#DN,S(@5&0@*%PH,S4W*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#0X,"XQ-2 U,#DN,C<@5&0@*%PI*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,"XX," U,#DN
M,S(@5&0@*%PH-3,U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4U.2XQ-2 U,#DN,C<@5&0@*%PI*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#0Y-"XR-R!49" H
MH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S
M-S,N-C4@-#DT+C(W(%1D("@W,2PW,3@I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#4R+C8U(#0Y-"XR-R!49" H-S@L-3$S
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M,2XV-2 T.30N,C<@5&0@*#<Y+#<R,BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXU," T-C0N,C<@5&0@*%5N86QL;V-A
M=&5D(&-O<G!O<F%T92!O=F5R:&5A9"!<*&%<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S-S,N-C4@-#8T+C(W(%1D("@T
M-"PU.#DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#4R+C8U(#0V-"XR-R!49" H,SDL,3DP*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4S,2XV-2 T-C0N,C<@5&0@*#,X
M+#0P,"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,BXU," T-#DN,C<@5&0@*$1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T
M:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,W,RXV-2 T-#DN,C<@5&0@*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S
M-S@N-C4@-#0Y+C(W(%1D("@Q+#<X,"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T-3(N-C4@-#0Y+C(W(%1D("@Q,"PQ-S0I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,V
M+C8U(#0T.2XR-R!49" H.2PQ.#(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N-3 @-#,T+C(W(%1D("A!8W%U:7-I=&EO
M;B!A;F0@:6YT96=R871I;VX@8V]S=',I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S@V+C$U(#0S-"XR-R!49" H-#DQ*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U-RXV
M-2 T,S0N,C<@5&0@*#$L.3<U*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4T.2XQ-2 T,S0N,C<@5&0@*#<X*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#0Q.2XR
M-R!49" H06-Q=6ES:71I;VXM<F5L871E9"!C;VYT:6YG96YT(&-O;G-I9&5R
M871I;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S<X+C8U(#0Q.2XR-R!49" H,BPU-3<I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#<P+C$U(#0Q.2XR-R!49" H-#0I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-30T
M+C$U(#0Q.2XR-R!49" H.#$T*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R+C4P(#0P-"XR-R!49" H4F5S=')U8W1U<FEN
M9R!C;W-T<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S-S@N-C4@-# T+C(W(%1D("@R+#<U."D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T-3<N-C4@-# T+C(W(%1D("@Q
M+# R-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-#0N,34@-# T+C(W(%1D("@W-3,I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,S@Y+C(W(%1D("A);7!A:7)M
M96YT(&-H87(I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,3@N-S<@,S@Y+C(W
M(%1D("AG97,@7"AB7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S<S+C8U(#,X.2XR-R!49" H,C(L-#(S*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0U,BXV-2 S.#DN
M,C<@5&0@*#$T+#,U-BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S$N-C4@,S@Y+C(W(%1D("@R-"PS,2D@5&H@150@40IQ
M(# @," P(')G($)4(#4U-"XQ-2 S.#DN,C<@5&0@*#$I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @,S<T+C(W(%1D
M("A<*$QO<W-<*2!I;F-O;64@9G)O;2!O<&5R871I;VYS*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,S,BXU," S-S0N,C<@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,S<P+C,P(#,W-"XS,B!49" H7"@Q,BPX.# I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# Q+C$U(#,W-"XR-R!49" H
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#$Q+C4P(#,W-"XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T-3(N-C4@,S<T+C(W(%1D("@Q*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-#4W+C8U(#,W-"XR-R!49" H,2PW-#@I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C4P(#,W
M-"XR-R!49" H)"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,S8N-C4@,S<T+C(W(%1D("@V+#$X-"D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#DN-3 @,S4X+C$P(%1D("A?7U]?7U]?7U]?7U]?7U\I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3@N-3 @,S,T+C$P
M(%1D("A<*&%<*2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-S8N-3 @,S,T+C$P(%1D("A4:&4@0V]M<&%N>2!H87,@8F5E
M;B!C96YT<F%L:7II;F<@861M:6YI<W1R871I=F4@9G5N8W1I;VYS('1O(&=A
M:6X@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-3DN.#0@,S,T+C$P(%1D
M("AF:6-I96YC:65S+"!W:&EC:"!H879E(&)E96X@<F5C;W)D960@:6X@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<V+C4P
M(#,R,BXQ,"!49" H=6YA;&QO8V%T960@8V]R<&]R871E(&]V97)H96%D+"!W
M:&EC:"!I;F-L=61E<R!C;W)P;W)A=&4@8V]M<&5N<V%T:6]N(&%N9"!B96YE
M9FET<RP@86YD(&=E;F5R86P@86YD(&%D;6EN:7-T<F%T:79E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-BXU," S,3 N
M,3 @5&0@*&5X<&5N<V5S(&EN8VQU9&EN9R!R96YT(&%N9"!U=&EL:71I97,L
M(&-O;7!U=&5R('-U<'!L:65S(&%N9"!E>'!E;G-E<RP@:6YS=7)A;F-E+"!P
M<F]F97-S:6]N86P@97AP96YS97,L(&-O<G!O<F%T92UW:61E("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-BXU," R.3@N
M,3 @5&0@*'!R;VIE8W1S(%PH:6YI=&EA=&EV97-<*2P@86YD('!U8FQI8R!C
M;VUP86YY(&5X<&5N<V5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U.2XU," R-S0N,3 @5&0@*%PH8EPI("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" W-RXU," R-S0N
M,3 @5&0@*%-E92!.;W1E(#4@+2!';V]D=VEL;"P@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3<R+C,P(#(W-"XQ,"!49" H5"D@5&H@150@40IQ(# @," P
M(')G($)4(#$W."XP-B R-S0N,3 @5&0@*')A9&4@3F%M97,L(&%N9"!/=&AE
M<B!);G1A;F=I8FQE("D@5&H@150@40IQ(# @," P(')G($)4(#,Q-2XR,R R
M-S0N,3 @5&0@*$%S<V5T<RXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HQ
M.#<@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O
M>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T
M92 P"B]#;VYT96YT<R Q.#@@,"!2/CX*96YD;V)J"C$X." P(&]B:@H\/"],
M96YG=&@@,3DU-C<^/@IS=')E86T*0E0@+T8R(#8N,# @5&8@150*<2 P(# @
M,"!R9R!"5" S,#8N,# @-S<U+C0U(%1D("@@*2!4:B!%5"!1"D)4("]&,B Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Q,RXX-2 W-C,N-#4@5&0@*$-2
M3U-3($-/54Y44BD@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXV." W-C,N
M-#4@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" R.3DN-3,@-S8S+C0U
M(%1D("@@2$5!3"D@5&H@150@40IQ(# @," P(')G($)4(#,R.2XT-2 W-C,N
M-#4@5&0@*%1(0T%212P@24Y#+BD@5&H@150@40I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q-S4N,S @-S4Q+C0U(%1D("A.3U1%4R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,3$N-3(@-S4Q+C0U(%1D("A4*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C$X+C Q(#<U,2XT-2!49" H3R!#3TY33TQ)
M1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#@N,3$@-S4Q+C0U(%1D("A4
M140@1DE.04Y#24%,*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8W+C(Y(#<U
M,2XT-2!49" H(%-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S@Q+C(X(#<U
M,2XT-2!49" H02D@5&H@150@40IQ(# @," P(')G($)4(#,X-RXW-B W-3$N
M-#4@5&0@*%1%345.5%,I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,C4X+C,U(#<S.2XT-2!49" H1$5#14U"15*@,S$L(#(P
M,3@I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-S$U+C0U(%1D("@Q."X@475A<G1E<FQY($9I;F%N8VEA;"!$871A
M(%PH56YA=61I=&5D7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,CDU+C,P(#,S+C8P(%1D("A&+2 T,RD@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V.34N,3 @
M5&0@*%1H92!F;VQL;W=I;F<@=&%B;&5S(&-O;G1A:6X@<V5L96-T960@=6YA
M=61I=&5D('-T871E;65N=',@;V8@;W!E<F%T:6]N<R!I;F9O<FUA=&EO;B!F
M;W(@96%C:"!Q=6%R=&5R(&]F(#(P,3@@86YD(#(P,3<N("D@5&H@150@40IQ
M(# @," P(')G($)4(#4S,RXV,B V.34N,3 @5&0@*%1H92 I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @-C@S+C$P
M(%1D("AF;VQL;W=I;F<@:6YF;W)M871I;VX@<F5F;&5C=',@86QL(&YO<FUA
M;"!R96-U<G)I;F<@861J=7-T;65N=',@;F5C97-S87)Y(&9O<B!A(&9A:7(@
M<')E<V5N=&%T:6]N(&]F('1H92!I;F9O<FUA=&EO;B!F;W(@=&AE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU," V
M-S$N,3 @5&0@*'!E<FEO9',@<')E<V5N=&5D+B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Q,C0N-3<@-C<Q+C$P(%1D("A4:&4@;W!E<F%T:6YG(')E<W5L
M=',@9F]R(&%N>2!Q=6%R=&5R(&%R92!N;W0@;F5C97-S87)I;'D@:6YD:6-A
M=&EV92!O9B!R97-U;'1S(&9O<B!A;GD@9G5T=7)E('!E<FEO9"X@*2!4:B!%
M5"!1"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P
M(#8S,BXV," S,#$N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3$N,# @-C,R+C8P(#(Q,BXP
M," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C4P+C P(#8P-BXV," S,#$N,# @+3$S+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M-3$N,# @-C V+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Q+C P(#8P-BXV," T
M+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-# U+C P(#8P-BXV," U,"XP," M,3,N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0U-2XP," V,#8N-C @-"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0U.2XP," V,#8N-C @
M-3 N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHU,#DN,# @-C V+C8P(#0N,# @+3$S+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHU,3,N,# @-C V+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @-3@P+C8P
M(#,P,2XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C,U,2XP," U.# N-C @-3 N,# @+3$S+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT,#$N,# @-3@P+C8P(#0N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N,# @-3@P
M+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#4U+C P(#4X,"XV," T+C P("TQ,RXP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#4Y+C P(#4X,"XV," U,"XP," M,3,N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P.2XP," U
M.# N-C @-"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,RXP," U.# N-C @-3 N,# @+3$S
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,"XP," U-30N-C @,S Q+C P("TQ,RXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4Q+C P
M(#4U-"XV," U,"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P,2XP," U-30N-C @-"XP," M
M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0P-2XP," U-30N-C @-3 N,# @+3$S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-34N
M,# @-34T+C8P(#0N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3DN,# @-34T+C8P(#4P+C P
M("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-3 Y+C P(#4U-"XV," T+C P("TQ,RXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3$S
M+C P(#4U-"XV," U,"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C @," P(%)'
M"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C,U,2 V
M,S(N-B!M"C0P,2 V,S(N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# U(#8S,BXV(&T*-#4U(#8S,BXV
M(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*
M,"!J"C,@30HT-3D@-C,R+C8@;0HU,#D@-C,R+C8@; IS"C @," P(%)'"B]'
M4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4Q,R V,S(N
M-B!M"C4V,R V,S(N-B!L"G,*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,BXU," V,S<N,#8@5&0@** I(%1J($54(%$*0E0@+T8R(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-C8N,C4@-C0V+C U(%1D("A&:7)S="D@
M5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,U.2XX
M," V,S<N,#4@5&0@*%%U87)T97(I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,34N-S @-C0V+C U(%1D("A396-O;F0I(%1J
M($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,3,N.# @
M-C,W+C U(%1D("A1=6%R=&5R*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#<R+C(P(#8T-BXP-2!49" H5&AI<F0I(%1J($54
M(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N.# @-C,W
M+C U(%1D("A1=6%R=&5R*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(T+C P(#8T-BXP-2!49" H1F]U<G1H*2!4:B!%5"!1
M"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Q+C@P(#8S-RXP
M-2!49" H475A<G1E<BD@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4R+C4P(#8R-"XP,"!49" H,C Q."D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-"XT," V,C,N.#8@5&0@
M*%PH86UO=6YT<R!I;B!T:&]U<V%N9',L(&5X8V5P="!P97(@<VAA<F4@9&%T
M85PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3(N-3 @-C$P+C@V(%1D("A2979E;G5E(&9R;VT@<V5R=FEC97,I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-3,N-3 @-C$P
M+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S8X+C(U(#8Q,"XX-B!49" H,C$P+#(X."D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXU," V,3 N.#8@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,C(N,C4@-C$P+C@V(%1D("@R,#0L-3<R*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#8Q+C4P(#8Q,"XX-B!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-BXR-2 V
M,3 N.#8@5&0@*#(P,"PW,3<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,34N-3 @-C$P+C@V(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C(U(#8Q,"XX-B!4
M9" H,C P+#DP-RD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4R+C4P(#4Y-RXX-B!49" H1W)O<W,@<')O9FET(%PH85PI*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S<R+C<U
M(#4Y-RXX-B!49" H-3,L-S4S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#(V+C<U(#4Y-RXX-B!49" H-3,L-C@Y*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@P+C<U(#4Y
M-RXX-B!49" H-3$L-38R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3,T+C<U(#4Y-RXX-B!49" H-3 L-34Y*2!4:B!%5"!1
M"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-3@T+C@V
M(%1D("A#;VYS;VQI9&%T960@;F5T(%PH;&]S<UPI(&EN8V]M92D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-RXR-2 U.#0N
M.#8@5&0@*#$L.3(P*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#,Q+C(U(#4X-"XX-B!49" H,2PX,C0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#DN,# @-3@T+C@V(%1D
M("A<*#$I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.38N-3 @-3@T+C@V(%1D
M("@Q."D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P-2XU," U.#0N.#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,Q+C<U(#4X-"XX-B!49" H7"@Q.2PS-#,I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN
M-3 @-3@T+C@V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C4P(#4W,2XX-B!49" H3F5T(&EN8V]M92!<*&QO
M<W-<*2!A='1R:6)U=&%B;&4@=&\@8V]M;6]N('-H87)E:&]L9&5R<RD@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-RXR-2 U
M-S$N.#8@5&0@*#$L-C0R*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,Q+C(U(#4W,2XX-B!49" H,2PU,SDI(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#DN,# @-3<Q+C@V
M(%1D("A<*#0T,2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P-2XU," U-S$N.#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3,Q+C<U(#4W,2XX-B!49" H7"@Q
M.2PV.3$I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-3DN-3 @-3<Q+C@V(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C4P(#4U."XX-B!49" H3F5T(&EN8V]M
M92!<*&QO<W-<*2!P97(@<VAA<F4@871T<FEB=71A8FQE('1O(&-O;6UO;B!S
M:&%R96AO;&1E<G,@+2!"87-I8R!<*&)<*2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#,U,RXU," U-3@N.#8@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S.#$N-S4@
M-34X+C@V(%1D("@P+C U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-# W+C4P(#4U."XX-B!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-2XW-2 U-3@N.#8@5&0@
M*# N,#0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" T-C$N-3 @-34X+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-#@V+C<U(#4U."XX-B!49" H7"@P+C Q*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3 U+C4P
M(#4U."XX-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,34N-3 @-34X+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30P+C<U(#4U."XX-B!49" H
M7"@P+C4U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-34Y+C4P(#4U."XX-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXU," U-#4N.#8@5&0@*$YE="!I;F-O
M;64@7"AL;W-S7"D@<&5R('-H87)E(&%T=')I8G5T86)L92!T;R!C;VUM;VX@
M<VAA<F5H;VQD97)S("T@1&EL=71E9"!<*&)<*2D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,U,RXU," U-#4N.#8@5&0@*"0I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S.#$N
M-S4@-30U+C@V(%1D("@P+C U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# W+C4P(#4T-2XX-B!49" H)"D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S-2XW-2 U-#4N.#8@
M5&0@*# N,#0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T-C$N-3 @-30U+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#@V+C<U(#4T-2XX-B!49" H7"@P+C Q
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3 U
M+C4P(#4T-2XX-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,34N-3 @-30U+C@V(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-30P+C<U(#4T-2XX-B!4
M9" H7"@P+C4U*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-34Y+C4P(#4T-2XX-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C4P+C P(#4P,RXV," S,#$N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-3$N,# @-3 S+C8P
M(#(Q,BXP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P+C P(#0W-RXV," S,#$N,# @+3$S+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHS-3$N,# @-#<W+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# Q+C P(#0W
M-RXV," T+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-# U+C P(#0W-RXV," U,"XP," M,3,N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0U-2XP," T-S<N-C @-"XP," M,3,N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0U.2XP," T
M-S<N-C @-3 N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHU,#DN,# @-#<W+C8P(#0N,# @+3$S
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHU,3,N,# @-#<W+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 N,# @
M-#4Q+C8P(#,P,2XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U,2XP," T-3$N-C @-3 N,# @
M+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,#$N,# @-#4Q+C8P(#0N,# @+3$S+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#4N
M,# @-#4Q+C8P(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#4U+C P(#0U,2XV," T+C P
M("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*-#4Y+C P(#0U,2XV," U,"XP," M,3,N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4P
M.2XP," T-3$N-C @-"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C4Q,RXP," T-3$N-C @-3 N
M,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,"XP," T,C4N-C @,S Q+C P("TQ,RXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M,S4Q+C P(#0R-2XV," U,"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P,2XP," T,C4N-C @
M-"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0P-2XP," T,C4N-C @-3 N,# @+3$S+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT-34N,# @-#(U+C8P(#0N,# @+3$S+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT-3DN,# @-#(U+C8P
M(#4P+C P("TQ,RXP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-3 Y+C P(#0R-2XV," T+C P("TQ,RXP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*-3$S+C P(#0R-2XV," U,"XP," M,3,N,# @<F4@9@HO1U,P(&=S"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C,U,2 U,#,N-B!M"C0P,2 U,#,N-B!L"G,*," P(# @4D<*+T=3,"!G<PHQ
M+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*-# U(#4P,RXV(&T*-#4U
M(#4P,RXV(&P*<PHP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @
M9 HP($H*,"!J"C,@30HT-3D@-3 S+C8@;0HU,#D@-3 S+C8@; IS"C @," P
M(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C4Q
M,R U,#,N-B!M"C4V,R U,#,N-B!L"G,*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,BXU," U,#@N,#8@5&0@** I(%1J($54(%$*0E0@+T8R
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-C8N,C4@-3$W+C U(%1D("A&
M:7)S="D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,U.2XX," U,#@N,#4@5&0@*%%U87)T97(I(%1J($54(%$*0E0@+T8R(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,34N-S @-3$W+C U(%1D("A396-O
M;F0I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,3,N.# @-3 X+C U(%1D("A1=6%R=&5R*2!4:B!%5"!1"D)4("]&,B Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#<R+C(P(#4Q-RXP-2!49" H5&AI<F0I
M(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C<N
M.# @-3 X+C U(%1D("A1=6%R=&5R*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(T+C P(#4Q-RXP-2!49" H1F]U<G1H*2!4
M:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(Q+C@P
M(#4P."XP-2!49" H475A<G1E<BD@5&H@150@40I"5" O1C(@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4R+C4P(#0Y-2XP,"!49" H,C Q-RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-"XT," T.30N
M.#8@5&0@*%PH86UO=6YT<R!I;B!T:&]U<V%N9',L(&5X8V5P="!P97(@<VAA
M<F4@9&%T85PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @-#@Q+C@V(%1D("A2979E;G5E(&9R;VT@<V5R=FEC97,I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-3,N
M-3 @-#@Q+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S8X+C(U(#0X,2XX-B!49" H,C W+#4W,RD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXU," T.#$N
M.#8@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" T,C(N,C4@-#@Q+C@V(%1D("@R,#DL,S$S*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#8Q+C4P(#0X,2XX-B!49" H
M)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W
M-BXR-2 T.#$N.#8@5&0@*#(R."PT.#@I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,34N-3 @-#@Q+C@V(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3,P+C(U(#0X
M,2XX-B!49" H,C$Y+#8W-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#4R+C4P(#0V."XX-B!49" H1W)O<W,@<')O9FET(%PH
M85PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S<R+C<U(#0V."XX-B!49" H-3,L,C<U*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-#(V+C<U(#0V."XX-B!49" H-38L-3(X
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#@P
M+C<U(#0V."XX-B!49" H-C L-#@P*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,T+C<U(#0V."XX-B!49" H-3@L,S S*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @
M-#4U+C@V(%1D("A#;VYS;VQI9&%T960@;F5T(%PH;&]S<UPI(&EN8V]M92D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W-"XR
M-2 T-34N.#8@5&0@*%PH,2PW,3@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" S.3<N-3 @-#4U+C@V(%1D("A<*2D@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0S,2XR-2 T-34N
M.#8@5&0@*#4L,C(P*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#@U+C(U(#0U-2XX-B!49" H-RPP-#0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,S0N-S4@-#4U+C@V(%1D
M("@R."PR-38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,BXU," T-#(N.#8@5&0@*$YE="!<*&QO<W-<*2!I;F-O;64@871T
M<FEB=71A8FQE('1O(&-O;6UO;B!S:&%R96AO;&1E<G,I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-S0N,C4@-#0R+C@V(%1D
M("A<*#(L,#$P*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,SDW+C4P(#0T,BXX-B!49" H7"DI(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,S$N,C4@-#0R+C@V(%1D("@T+#@U
M,"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0X
M-2XR-2 T-#(N.#8@5&0@*#8L-S(S*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,T+C<U(#0T,BXX-B!49" H,C<L.34P*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @
M-#(Y+C@V(%1D("A.970@7"AL;W-S7"D@:6YC;VUE('!E<B!S:&%R92!A='1R
M:6)U=&%B;&4@=&\@8V]M;6]N('-H87)E:&]L9&5R<R M($)A<VEC(%PH8EPI
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S4S
M+C4P(#0R.2XX-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,W."XW-2 T,CDN.#8@5&0@*%PH,"XP-BD@5&H@150@
M40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y-RXU," T,CDN
M.#8@5&0@*%PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-# W+C4P(#0R.2XX-B!49" H)"D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0S-2XW-2 T,CDN.#8@5&0@*# N,30I
M(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-C$N
M-3 @-#(Y+C@V(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#@Y+C<U(#0R.2XX-B!49" H,"XQ.2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4Q-2XU," T,CDN.#8@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U-#,N-S4@-#(Y+C@V(%1D("@P+C<X*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @-#$V+C@V(%1D("A.970@7"AL
M;W-S7"D@:6YC;VUE('!E<B!S:&%R92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N
M('-H87)E:&]L9&5R<R M($1I;'5T960I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" S-3,N-3 @-#$V+C@V(%1D("@D*2!4:B!%
M5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S<X+C<U(#0Q
M-BXX-B!49" H7"@P+C X*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,SDW+C4P(#0Q-BXX-B!49" H7"DI(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,#<N-3 @-#$V+C@V(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-#,U+C<U(#0Q-BXX-B!49" H,"XQ,RD@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0V,2XU," T,38N.#8@5&0@*"0I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T.#DN-S4@-#$V
M+C@V(%1D("@P+C$Y*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@-3$U+C4P(#0Q-BXX-B!49" H)"D@5&H@150@40I"5" O1C$@
M.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4T,RXW-2 T,38N.#8@5&0@*# N
M-S<I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y+C4P(#0P,2XQ,"!49" H7U]?7U]?7U]?
M7U]?7U]?7RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" T.2XU," S-S<N,3 @5&0@*%PH85PI($5X8VQU9&5S(&1E<')E8VEA
M=&EO;B!A;F0@86UO<G1I>F%T:6]N+BD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" T.2XU," S-C4N,3 @5&0@*%PH8EPI("D@
M5&H@150@40IQ(# @," P(')G($)4(#8S+C0X(#,V-2XQ,"!49" H5&AE('-U
M;2!O9B!T:&4@<75A<G1E<FQY('!E<B!S:&%R92!A;6]U;G1S(&UA>2!N;W0@
M97%U86P@86UO=6YT<R!R97!O<G1E9"!F;W(@>65A<BD@5&H@150@40IQ(# @
M," P(')G($)4(#0P,BXV,2 S-C4N,3 @5&0@*"UT;RUD871E(&1U92!T;R!T
M:&4@968I(%1J($54(%$*<2 P(# @,"!R9R!"5" T.#4N-S,@,S8U+C$P(%1D
M("AF96-T<R!O9B!R;W5N9&EN9R @(" @(" @(" @(" @(" @(" @(" @*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0Y+C4P
M(#,U,RXQ,"!49" H86YD(&-H86YG97,@:6X@=&AE(&YU;6)E<B!O9B!W96EG
M:'1E9"!A=F5R86=E('-H87)E<R!O=71S=&%N9&EN9R!U<V5D(&EN('1H92!C
M86QC=6QA=&EO;BXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@-#DN-3 @,S(Y+C$P(%1D("A4:&4@9F]L;&]W:6YG(&ET96US
M(&%R92!T:&4@;6]S="!S:6=N:69I8V%N="!I=&5M<R!T:&%T(&EM<&%C="!T
M:&4@8V]M<&%R86)I;&ET>2!A;F0@<')E<V5N=&%T:6]N(&]F(&]U<B!C;VYS
M;VQI9&%T960@9&%T83HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-S8N-3 @,S U+C$P(%1D("B5("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-"XU," S,#4N,3 @5&0@
M*$1U<FEN9R!T:&4@9F]U<G1H('%U87)T97(@;V8@,C Q."!A;F0@,C Q-RP@
M=&AE($-O;7!A;GD@<F5C;W)D960@;F]N+6-A<V@@:6UP86ER;65N="!C:&%R
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-#<P+C@W(#,P-2XQ,"!49" H9V5S
M(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" T.3<N-3,@,S U+C$P(%1D("@D,C(N-"!M:6QL:6]N*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4U,2XT,B S,#4N,3 @
M5&0@*" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@.30N-3 @,CDS+C$P(%1D("AA;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$Q,2XT-" R.3,N,3 @5&0@*"0Q-"XT
M(&UI;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,38U+C,S(#(Y,RXQ,"!49" H+"!R97-P96-T:79E;'DI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R,3<N.3D@,CDS+C$P(%1D("@L(')E;&%T960@
M=&\@=&AE(&=O;V1W:6QL(&%N9"!T<F%D92!N86UE<R!O9B!0:'ES:6-I86X@
M4W1A9BD@5&H@150@40IQ(# @," P(')G($)4(#0U,2XS-B R.3,N,3 @5&0@
M*&9I;F<N(%-E92!.;W1E(#4@+2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@.30N-3 @,C@Q+C$P(%1D("A';V]D=VEL;"P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,W+C$P(#(X,2XQ,"!49" H5"D@
M5&H@150@40IQ(# @," P(')G($)4(#$T,BXX-2 R.#$N,3 @5&0@*')A9&4@
M3F%M97,L(&%N9"!/=&AE<B!);G1A;F=I8FQE("D@5&H@150@40IQ(# @," P
M(')G($)4(#(X,"XP,R R.#$N,3 @5&0@*$%S<V5T<RXI(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-S8N-3 @,C8Y+C$P(%1D
M("B5("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Y-"XU," R-CDN,3 @5&0@*$1U<FEN9R!T:&4@9FER<W0@<75A<G1E<B!O
M9B R,#$W+"!T:&4@0V]M<&%N>2!S971T;&5D(&ET<R!#;VYV97)T:6)L92!.
M;W1E<R!A;F0@<F5C;V=N:7IE9"!A(&QO<W,@;VX@97AT:6YG=6ES:&UE;G0@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT
M+C4P(#(U-RXQ,"!49" H;V8@9&5B="!O9B I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,3,U+C@X(#(U-RXQ,"!49" H)#4N
M,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#$X-"XW-R R-3<N,3 @5&0@*"X@4V5E($YO=&4@." M($1E8G0N
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<V
M+C4P(#(T-2XQ,"!49" HE2 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.30N-3 @,C0U+C$P(%1D("A/;B!$96-E;6)E<B Q
M+" R,#$X+"!T:&4@0V]M<&%N>2!A8W%U:7)E9" I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.# N,C@@,C0U+C$P(%1D("A!4"D@5&H@150@40IQ(# @," P
M(')G($)4(#(Y,BXV.2 R-#4N,3 @5&0@*"!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,S$Q+C$R(#(T-2XQ,"!49" H9FEN9R!A;F0@;VX@2G5L>2 Q
M+" R,#$W+"!T:&4@0V]M<&%N>2!A8W%U:7)E9"!A;&P@;V8@=&AE("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-"XU," R
M,S,N,3 @5&0@*&%S<V5T<R!O9B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M,S N-C$@,C,S+C$P(%1D("A!9'9A;G1A9V4N("D@5&H@150@40IQ(# @," P
M(')G($)4(#$W."XW-" R,S,N,3 @5&0@*%1H92!A8W%U:7-I=&EO;G,@:&%V
M92!B965N(&%C8V]U;G1E9"!F;W(@:6X@86-C;W)D86YC92!W:71H('1H92 I
M(%1J($54(%$*0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#,Y
M+C<T(#(S,RXQ,"!49" H0G5S:6YE<W,@0V]M8FEN871I;VYS("D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,S4N.#8@,C,S
M+C$P(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-30Q+C(W(#(S,RXQ
M,"!49" H;W!I8R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.30N-3 @,C(Q+C$P(%1D("AO9B!T:&4@1BD@5&H@150@40IQ
M(# @," P(')G($)4(#$R-"XX-R R,C$N,3 @5&0@*$%30B I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" Q-#8N,C<@,C(Q+C$P(%1D("A!4T,I(%1J($54(%$*
M0E0@+T8T(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,38U+C<R(#(R,2XQ
M,"!49" H+" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3<P+C<R(#(R,2XQ,"!49" H=7-I;F<@=&AE(&%C<75I<VET:6]N
M(&UE=&AO9"X@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,CDP+C@P(#(R,2XQ
M,"!49" H5&AE(')E<W5L=',@;V8@=&AE(&%C<75I<VET:6]N<R<@;W!E<F%T
M:6]N<R!H879E(&)E96X@:6YC;'5D960@:6X@=&AE("D@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Y-"XU," R,#DN,3 @5&0@
M*&-O;G-O;&ED871E9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@9G)O;2!T
M:&5I<B!D871E<R!O9B!A8W%U:7-I=&EO;BX@4V5E($YO=&4@-" M("D@5&H@
M150@40IQ(# @," P(')G($)4(#0R-"XT,B R,#DN,3 @5&0@*$%C<75I<VET
M:6]N<RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#<V+C4P(#$Y-RXQ,"!49" HE2 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@.30N-3 @,3DW+C$P(%1D("A);B!T:&4@
M9F]U<G1H('%U87)T97(@;V8@,C Q-RP@=&AE($-O;7!A;GD@8F5N969I=&5D
M(&9R;VT@82 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S,X+C,Q(#$Y-RXQ,"!49" H)#0S+C,@;6EL;&EO;BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3(N,C$@,3DW
M+C$P(%1D("@@<F5V97)S86P@;V8@=F%L=6%T:6]N(&%L;&]W86YC92!O;B!I
M=',@;F5T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" Y-"XU," Q.#4N,3 @5&0@*&1E9F5R<F5D('1A>"!A<W-E=',L(&]F
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@Q+C4P(#$X-2XQ,"!49" H9G-E
M="!B>2!A9&1I=&EO;F%L(&EN8V]M92!T87@@97AP96YS92!O9B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,S0U+C8R(#$X
M-2XQ,"!49" H)#@N,"!M:6QL:6]N*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y-"XU,2 Q.#4N,3 @5&0@*"!R96QA=&5D
M('1O('1H92!R96UE87-U<F5M96YT(&]F(&ET<R I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.30N-3 @,3<S+C$P(%1D("AD
M969E<G)E9"!T87@@87-S971S(&%S(&$@<F5S=6QT(&]F('1H92 R,#$W("D@
M5&H@150@40IQ(# @," P(')G($)4(#(V,2XR," Q-S,N,3 @5&0@*%0I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R-C8N-C$@,3<S+C$P(%1D("AA>" I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R-S@N,# @,3<S+C$P(%1D("A!8W0N(%-E
M92!.;W1E(#$S("T@26YC;VUE("D@5&H@150@40IQ(# @," P(')G($)4(#,X
M-BXY-2 Q-S,N,3 @5&0@*%0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.3(N
M,S8@,3<S+C$P(%1D("AA>&5S+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" W-BXU," Q-C$N,3 @5&0@*)4@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT+C4P(#$V,2XQ
M,"!49" H5&AE($-O;7!A;GD@<F5C;W)D960@8VAA;F=E<R!I;B!T:&4@9F%I
M<B!V86QU92!O9B!#;VYV97)T:6)L92!.;W1E<R!D97)I=F%T:79E(&QI86)I
M;&ET>2D@5&H@150@40IQ(# @," P(')G($)4(#0U,"XY-B Q-C$N,3 @5&0@
M*"P@<F5C;W)D:6YG(&$@9V%I;B!I;B!T:&4@*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DT+C4P(#$T.2XQ,"!49" H9FER
M<W0@<75A<G1E<B!O9B R,#$W(&]F("D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.#@N,#@@,30Y+C$P(%1D("@D,2XV(&UI
M;&QI;VXI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C,V+CDX(#$T.2XQ,"!49" H+B!3964@3F]T92 Y("T@1&5R:79A=&EV
M97,N*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3@Y(# @;V)J"CP\+U1Y
M<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @
M-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@
M,3DP(# @4CX^"F5N9&]B:@HQ.3 @,"!O8FH*/#PO3&5N9W1H(#$S,3$P/CX*
M<W1R96%M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(Y-RXR
M-2 S,RXV,"!49" H24DM(#$I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3$S+C@U(#<R,BXR-2!49" H4V-H961U;&4@24DI
M(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,C$S
M+C@U(#8Y."XR-2!49" H0U)/4U,@0T]53E12*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,CDR+C8X(#8Y."XR-2!49" H62D@5&H@150@40IQ(# @," P(')G
M($)4(#(Y.2XU,R V.3@N,C4@5&0@*"!(14%,*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,S(Y+C0U(#8Y."XR-2!49" H5$A#05)%+"!)3D,N*2!4:B!%5"!1
M"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#(P,2XX-2 V.#8N
M,C4@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,#<N-S@@-C@V+C(U
M(%1D("A!3%5!*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,U+C,X(#8X-BXR
M-2!49" H5$E/3B I(%1J($54(%$*<2 P(# @,"!R9R!"5" R-C(N.#D@-C@V
M+C(U(%1D("A!3D0@455!3$E&64E.1R I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" S-30N,# @-C@V+C(U(%1D("A!0T-/54Y44RD@5&H@150@40I"5" O1C(@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q-C$N,C4@-C<T+C(U(%1D("A&
M3U(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3@T+C8X(#8W-"XR-2!49" H
M5$A%("D@5&H@150@40IQ(# @," P(')G($)4(#(P-RXY,B V-S0N,C4@5&0@
M*%E%05)3($5.1$5$($1%0T5-0D52H#,Q+" R,#$X+" R,#$W+" I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" T,#8N-38@-C<T+C(U(%1D("A!3D0@,C Q-BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T.2XU
M," V-C(N,C4@5&0@** I(%1J($54(%$*,"XX(# N.3,S,S,S,S,S,S,S,S,S
M,R Q(')G"B]'4S @9W,*-3 N,# @-3<Y+C<U(#$U-RXP," M,34N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C(P-RXP," U-SDN-S4@-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR-C0N,# @-3<Y+C<U
M(#$X+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*,C@R+C P(#4W.2XW-2 U-RXP," M,34N,# @
M<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P
M(&=S"C,S.2XP," U-SDN-S4@,3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP
M+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS-38N,# @-3<Y
M+C<U(#4W+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S
M,S,S,S,S,R Q(')G"B]'4S @9W,*-#$S+C P(#4W.2XW-2 Q."XP," M,34N
M,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO
M1U,P(&=S"C0S,2XP," U-SDN-S4@-3<N,# @+3$U+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @
M-3<Y+C<U(#$X+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-3 V+C P(#4W.2XW-2 U-RXP," M
M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C4P+C P(#4T.2XW-2 Q-3<N,# @+3$U+C P(')E(&8*+T=3
M,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHR,#<N
M,# @-30Y+C<U(#4W+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S
M,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C8T+C P(#4T.2XW-2 Q."XP
M," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C(X,BXP," U-#DN-S4@-3<N,# @+3$U+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M,SDN,# @-30Y+C<U(#$W+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S4V+C P(#4T.2XW-2 U
M-RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C0Q,RXP," U-#DN-S4@,3@N,# @+3$U+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,S$N,# @-30Y+C<U(#4W+C P("TQ-2XP,"!R92!F"B]'4S @9W,*,"XX
M(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#@X+C P(#4T.2XW
M-2 Q."XP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S
M,S,S,S,@,2!R9PHO1U,P(&=S"C4P-BXP," U-#DN-S4@-3<N,# @+3$U+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHU,"XP," U,3DN-S4@,34W+C P("TR,BXP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,C W+C P(#4Q
M.2XW-2 U-RXP," M,C(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(V-"XP," U,3DN-S4@,3@N,# @+3(R
M+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*
M+T=3,"!G<PHR.#(N,# @-3$Y+C<U(#4W+C P("TR,BXP,"!R92!F"B]'4S @
M9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S,Y+C P
M(#4Q.2XW-2 Q-RXP," M,C(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S
M,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,U-BXP," U,3DN-S4@-3<N,# @
M+3(R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@
M<F<*+T=3,"!G<PHT,3,N,# @-3$Y+C<U(#$X+C P("TR,BXP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#,Q
M+C P(#4Q.2XW-2 U-RXP," M,C(N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0X."XP," U,3DN-S4@,3@N
M,# @+3(R+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHU,#8N,# @-3$Y+C<U(#4W+C P("TR,BXP,"!R92!F
M"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*
M-3 N,# @-#@R+C<U(#$U-RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N." P
M+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C(P-RXP," T.#(N-S4@
M-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHR-C0N,# @-#@R+C<U(#$X+C P("TQ-2XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,C@R+C P(#0X,BXW-2 U-RXP," M,34N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,S.2XP," T.#(N
M-S4@,3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS-38N,# @-#@R+C<U(#4W+C P("TQ-2XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-#$S+C P(#0X,BXW-2 Q."XP," M,34N,# @<F4@9@HO1U,P(&=S
M"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0S,2XP," T
M.#(N-S4@-3<N,# @+3$U+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S
M,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.#@N,# @-#@R+C<U(#$X+C P("TQ
M-2XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-3 V+C P(#0X,BXW-2 U-RXP," M,34N,# @<F4@9@HO1U,P
M(&=S"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP
M(&H*,R!-"C(P-R V,3 N-S4@;0HR-C0@-C$P+C<U(&P*<PHP(# @,"!21PHO
M1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HR.#(@-C$P
M+C<U(&T*,S,Y(#8Q,"XW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*
M,"!I( I;72 P(&0*,"!*"C @:@HS($T*,S4V(#8Q,"XW-2!M"C0Q,R V,3 N
M-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C0S,2 V,3 N-S4@;0HT.#@@-C$P+C<U(&P*<PHP(# @,"!2
M1PHO1U,P(&=S"C$N,# @=PHP(&D@"EM=(# @9 HP($H*,"!J"C,@30HU,#8@
M-C$P+C<U(&T*-38S(#8Q,"XW-2!L"G,*0E0@+T8R(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" R,30N.#4@-C,S+C(P(%1D("A"86QA;F-E(&%T*2!4:B!%
M5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C$U+C0U(#8R
M-"XR,"!49" H0F5G:6YN:6YG*2!4:B!%5"!1"D)4("]&,B Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C$W+C,U(#8Q-2XR,"!49" H;V8@4&5R:6]D*2!4
M:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C@X+C,U
M(#8R-"XR,"!49" H0VAA<F=E9"!T;R I(%1J($54(%$*0E0@+T8R(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" R.#@N-#4@-C$U+C(P(%1D("A/<&5R871I
M;VYS*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S0W+C P(#8Q-2XR,2!49" HH"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,V,2XY-2 V,S,N,C @5&0@*%<I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" S-S N-SD@-C,S+C(P(%1D("AR:71E+4]F9G,L("D@
M5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,W,RXQ
M," V,C0N,C @5&0@*&YE="!O9B I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" S-C0N-34@-C$U+C(P(%1D("AR*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,S8X+C,X(#8Q-2XR,"!49" H96-O=F5R:65S*2!4
M:B!%5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#0W+C4U
M(#8R-"XR,"!49" H3W1H97(I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T-#(N-#4@-C$U+C(P(%1D("A#:&%N9V5S*2!4:B!%
M5"!1"D)4("]&,B Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#DP+C4P(#8Q
M-2XR,"!49" HH"D@5&H@150@40I"5" O1C(@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4Q,RXX-2 V,S,N,C @5&0@*$)A;&%N8V4@870I(%1J($54(%$*
M0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,C4N.34@-C(T+C(P
M(%1D("A%;F0I(%1J($54(%$*0E0@+T8R(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" U,38N,S4@-C$U+C(P(%1D("AO9B!097)I;V0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-#(N-3 @-C P+C(Q(%1D
M("A<*&%M;W5N=',@:6X@=&AO=7-A;F1S7"DI(%1J($54(%$*0E0@+T8R(#DN
M,# @5&8@150*," P(# @4D<*+T=3,"!G<PHP+C@V('<*,"!I( I;72 P(&0*
M,2!*"C$@:@HS($T*-3(N-2 U.#(N-SDV,S,W.#DP-C(U(&T*,3DP+C4V,CDX
M.#(X,3(U(#4X,BXW.38S,S<X.3 V,C4@; IS"G$@," P(# @<F<@0E0@-3(N
M-3 @-3@T+C(P(%1D("A!;&QO=V%N8V5S(&9O<BD@5&H@150@40IQ(# @," P
M(')G($)4(#$P.2XU." U.#0N,C @5&0@*" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q,3$N,S,@-3@T+C(P(%1D("A!8V-O=6YT<R!296-E:79A8FQE*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N-3 @
M-38Y+C(Q(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@0E0@-3@N-34@-38Y
M+C(Q(%1D("AE87(@16YD960@1&5C96UB97(@,S$L(#(P,3@I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R,#DN-3 @-38Y+C(Q
M(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@,C,Y+CDP(#4V.2XR,2!49" H,RPV.#@I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" R.#0N-3 @-38Y+C(Q(%1D("@D*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S$T+CDP
M(#4V.2XR,2!49" H-2PY-S0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" S-#<N,# @-38Y+C(Q(%1D("B@*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S4X+C4P(#4V.2XR,2!4
M9" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#,X-2XY," U-CDN,C$@5&0@*%PH-2PY-3<I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,#DN,34@-38Y+C(Q(%1D("A<*2D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-RXU
M," U-CDN,C$@5&0@*%PH85PI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@-#,S+C4P(#4V.2XR,2!49" H)"D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W-2XQ-2 U-CDN,C$@
M5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,#@N-3 @-38Y+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3,X+CDP(#4V.2XR,2!49" H,RPW,#4I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXU," U
M-30N,C$@5&0@*%DI(%1J($54(%$*<2 P(# @,"!R9R!"5" U."XU-2 U-30N
M,C$@5&0@*&5A<B!%;F1E9"!$96-E;6)E<B S,2P@,C Q-RD@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(P.2XU," U-30N,C$@
M5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"
M5" R,SDN.3 @-34T+C(Q(%1D("@S+#(T-2D@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#(X-"XU," U-30N,C$@5&0@*"0I(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,30N.3 @
M-34T+C(Q(%1D("@T+#<P-2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,T-RXP," U-30N,C$@5&0@** I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-3@N-3 @-34T+C(Q(%1D
M("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S@U+CDP(#4U-"XR,2!49" H7"@T+#(V,BD@5&H@150@40I"5" O1C$@.2XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P.2XQ-2 U-30N,C$@5&0@*%PI*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#$W+C4P
M(#4U-"XR,2!49" H7"AA7"DI(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*
M<2 P(# @,"!R9R!"5" T,S,N-3 @-34T+C(Q(%1D("@D*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#<U+C$U(#4U-"XR,2!4
M9" HERD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P."XU," U-30N,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,S@N.3 @-34T+C(Q(%1D("@S+#8X."D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#4S
M.2XR,2!49" H62D@5&H@150@40IQ(# @," P(')G($)4(#4X+C4U(#4S.2XR
M,2!49" H96%R($5N9&5D($1E8V5M8F5R(#,Q+" R,#$V*2!4:B!%5"!1"D)4
M("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C Y+C4P(#4S.2XR,2!4
M9" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#(S.2XY," U,SDN,C$@5&0@*#0L,#0U*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C@T+C4P(#4S.2XR,2!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,Q-"XY," U
M,SDN,C$@5&0@*#0L,#,T*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@,S0W+C P(#4S.2XR,2!49" HH"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#,U."XU," U,SDN,C$@5&0@
M*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S
M.#4N.3 @-3,Y+C(Q(%1D("A<*#0L.#,T*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-# Y+C$U(#4S.2XR,2!49" H7"DI(%1J
M($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,3<N-3 @
M-3,Y+C(Q(%1D("A<*&%<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#0S,RXU," U,SDN,C$@5&0@*"0I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T-S4N,34@-3,Y+C(Q(%1D
M("B7*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 X+C4P(#4S.2XR,2!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4S."XY," U,SDN,C$@5&0@*#,L,C0U*2!4:B!%
M5"!1"D)4("]&,B Y+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XX-B!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4R+C4@-3 Y+C<T-C,S-S@Y,#8R
M-2!M"C$Y-RXX,S4Y,S<U(#4P.2XW-#8S,S<X.3 V,C4@; IS"G$@," P(# @
M<F<@0E0@-3(N-3 @-3$Q+C$U(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N,3<@-3$Q+C$U(%1D("AA;'5A=&EO;B I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Y,2XT-" U,3$N,34@5&0@*$%L;&]W86YC92!F;W(I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Q-#4N,#$@-3$Q+C$U(%1D("@@1&5F97)R*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3<R+C4W(#4Q,2XQ-2!49" H960@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,3@S+C8V(#4Q,2XQ-2!49" H5"D@5&H@
M150@40IQ(# @," P(')G($)4(#$X."XX-" U,3$N,34@5&0@*&%X*2!4:B!%
M5"!1"D)4("]&,B Y+C P(%1F($54"C @," P(%)'"B]'4S @9W,*,"XX-B!W
M"C @:2 *6UT@,"!D"C$@2@HQ(&H*,R!-"C4R+C4@-3 P+C<T-C,S-S@Y,#8R
M-2!M"C<V+C0Y.#4S-3$U-C(U(#4P,"XW-#8S,S<X.3 V,C4@; IS"G$@," P
M(# @<F<@0E0@-3(N-3 @-3 R+C$U(%1D("A!<W-E=',I(%1J($54(%$*0E0@
M+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R-C N-3 @-3 R+C(Q(%1D
M("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@
M,S,U+C4P(#4P,BXR,2!49" HH"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#,T-RXP," U,#(N,C$@5&0@** I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" T,#DN-3 @-3 R+C(Q
M(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@
M0E0@-#@T+C4P(#4P,BXR,2!49" HH"D@5&H@150@40I"5" O1C$@.2XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0Y,"XU," U,#(N,C$@5&0@** I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" U-3DN-3 @-3 R
M+C(Q(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N-3 @-#@W+C(Q(%1D("A9*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@-3@N-34@-#@W+C(Q(%1D("AE87(@16YD960@1&5C96UB97(@,S$L(#(P
M,3@I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R
M,#DN-3 @-#@W+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54
M"G$@," P(# @<F<@0E0@,C,Y+CDP(#0X-RXR,2!49" H,2PP-S8I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" R.#0N-3 @-#@W
M+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @
M<F<@0E0@,S(Q+C8U(#0X-RXR,2!49" H,2D@5&H@150@40IQ(# @," P(')G
M($)4(#,R-BXQ-2 T.#<N,C$@5&0@*#$S*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,S4X+C4P(#0X-RXR,2!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0P,"XQ-2 T
M.#<N,C$@5&0@*)<I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @
M,"!R9R!"5" T,S,N-3 @-#@W+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@-#<U+C$U(#0X-RXR,2!49" HERD@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4P."XU
M," T.#<N,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,S@N.3 @-#@W+C(Q(%1D("@Q+#$X.2D@5&H@150@40I"
M5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C4P(#0W,BXR,2!4
M9" H62D@5&H@150@40IQ(# @," P(')G($)4(#4X+C4U(#0W,BXR,2!49" H
M96%R($5N9&5D($1E8V5M8F5R(#,Q+" R,#$W*2!4:B!%5"!1"D)4("]&,2 Y
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C Y+C4P(#0W,BXR,2!49" H)"D@
M5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#(S-2XT
M," T-S(N,C$@5&0@*#0V+#0U-"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%
M5 IQ(# @," P(')G($)4(#(X-"XU," T-S(N,C$@5&0@*"0I(%1J($54(%$*
M0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,3$N.3 @-#<R+C(Q
M(%1D("A<*#,L,# W*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P
M(# @<F<@0E0@,S,U+C$U(#0W,BXR,2!49" H7"DI(%1J($54(%$*0E0@+T8Q
M(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S-3@N-3 @-#<R+C(Q(%1D("@D
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,S@Q
M+C0P(#0W,BXR,2!49" H7"@T,RPS,S,I(%1J($54(%$*0E0@+T8Q(#DN,# @
M5&8@150*<2 P(# @,"!R9R!"5" T,#DN,34@-#<R+C(Q(%1D("A<*2D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0Q-RXP," T
M-S(N,C$@5&0@*%PH8EPI*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-#,S+C4P(#0W,BXR,2!49" H)"D@5&H@150@40I"5" O
M1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#0W,"XV-2 T-S(N,C$@5&0@
M*#DV,BD@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4
M(#0Y,"XU," T-S(N,C$@5&0@*%PH8UPI*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 X+C4P(#0W,BXR,2!49" H)"D@5&H@
M150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S."XY," T
M-S(N,C$@5&0@*#$L,#<V*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(N-3 @-#4W+C(Q(%1D("A9*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@-3@N,3 @-#4W+C(Q(%1D("AE87(@16YD960@1&5C96UB97(@
M,S$L(#(P,38I(%1J($54(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R
M9R!"5" R,#DN-3 @-#4W+C(Q(%1D("@D*2!4:B!%5"!1"D)4("]&,2 Y+C P
M(%1F($54"G$@," P(# @<F<@0E0@,C,U+C0P(#0U-RXR,2!49" H-34L,S,V
M*2!4:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@,C@T
M+C4P(#0U-RXR,2!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ
M(# @," P(')G($)4(#,Q,2XY," T-3<N,C$@5&0@*%PH."PX.30I(%1J($54
M(%$*0E0@+T8Q(#DN,# @5&8@150*<2 P(# @,"!R9R!"5" S,S4N,34@-#4W
M+C(Q(%1D("A<*2D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P
M(')G($)4(#,U."XU," T-3<N,C$@5&0@*"0I(%1J($54(%$*0E0@+T8Q(#DN
M,# @5&8@150*<2 P(# @,"!R9R!"5" T,# N,34@-#4W+C(Q(%1D("B7*2!4
M:B!%5"!1"D)4("]&,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-#,S+C4P
M(#0U-RXR,2!49" H)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @
M," P(')G($)4(#0W-2XQ-2 T-3<N,C$@5&0@*#$R*2!4:B!%5"!1"D)4("]&
M,2 Y+C P(%1F($54"G$@," P(# @<F<@0E0@-3 X+C4P(#0U-RXR,2!49" H
M)"D@5&H@150@40I"5" O1C$@.2XP,"!49B!%5 IQ(# @," P(')G($)4(#4S
M-"XT," T-3<N,C$@5&0@*#0V+#0U-"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-#DN-3 @
M-#0Q+C(U(%1D("A?7U]?7U]?7U]?7U]?7U]?*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<W+C4P(#0Q-RXR-2!49" H7"AA
M7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#DU+C4P(#0Q-RXR-2!49" H56YC;VQL96-T:6)L92!A8V-O=6YT<R!W<FET
M=&5N(&]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C(X+C,S(#0Q-RXR-2!4
M9" H9BP@;F5T(&]F(')E8V]V97)I97,N*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#<W+C4P(#0P-2XR-2!49" H7"AB7"D@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#DU
M+C4P(#0P-2XR-2!49" H4F5L96%S92!O9B!V86QU871I;VX@86QL;W=A;F-E
M<R!O;B!T:&4@0V]M<&%N>9(I(%1J($54(%$*<2 P(# @,"!R9R!"5" R.34N
M-#0@-# U+C(U(%1D("AS(&1E9F5R<F5D('1A>"!A<W-E=',N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#<W+C4P(#,Y,RXR
M-2!49" H7"AC7"D@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#DU+C4P(#,Y,RXR-2!49" H5BD@5&H@150@40IQ(# @," P
M(')G($)4(#$P,2XV,2 S.3,N,C4@5&0@*&%L=6%T:6]N(&%L;&]W86YC92!O
M;B!D969E<G)E9"!T87@@87-S970@<F5L871E9"!T;R!S:&%R92UB87-E9"!C
M;VUP96YS871I;VXN*2!4:B!%5"!1"F5N9'-T<F5A;0IE;F1O8FH*,3DQ(# @
M;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q(# @4@HO365D:6%";W@@6S @
M," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S(#(@,"!2"B]2;W1A=&4@, HO
M0V]N=&5N=',@,3DR(# @4CX^"F5N9&]B:@HQ.3(@,"!O8FH*/#PO3&5N9W1H
M(#<Q,S0^/@IS=')E86T*0E0@+T8R(#$P+C P(%1F($54"C @5'(*+T=3,"!G
M<PHP(%1W(# @5&,@,3 P(%1Z(# @5$P@"G$@," P(# @<F<@0E0@-3$P+C,P
M(#<T,BXR-2!49" H17AH:6)I=* R,2XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#<S,"XR-2!49" HH"D@5&H@
M150@40I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" R-3 N,3 @
M-S V+C(U(%1D("A,25-4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C<R+C<Q
M(#<P-BXR-2!49" H($]&*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C@X+C<S
M(#<P-BXR-2!49" H(%-50E-)1$E!4DE%4RD@5&H@150@40HP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XU," V-CDN-S4@,S0P+C P
M("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q
M(')G"B]'4S @9W,*,S@Y+C4P(#8V.2XW-2 Q-2XP," M,30N,# @<F4@9@HO
M1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P
M-"XU," V-CDN-S4@,34W+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN-3 @-C0Q+C<U(#,T
M,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S
M,S,@,2!R9PHO1U,P(&=S"C,X.2XU," V-#$N-S4@,34N,# @+3$T+C P(')E
M(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G
M<PHT,#0N-3 @-C0Q+C<U(#$U-RXP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0Y+C4P(#8Q,RXW
M-2 S-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S
M,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#DN-3 @-C$S+C<U(#$U+C P("TQ-"XP
M,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'
M4S @9W,*-# T+C4P(#8Q,RXW-2 Q-3<N,# @+3$T+C P(')E(&8*+T=3,"!G
M<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT.2XU," U
M.#4N-S4@,S0P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S
M,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@Y+C4P(#4X-2XW-2 Q-2XP," M
M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R
M9PHO1U,P(&=S"C0P-"XU," U.#4N-S4@,34W+C P("TQ-"XP,"!R92!F"B]'
M4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-#DN
M-3 @-34W+C<U(#,T,"XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS
M,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X.2XU," U-3<N-S4@,34N
M,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S
M(#$@<F<*+T=3,"!G<PHT,#0N-3 @-34W+C<U(#$U-RXP," M,30N,# @<F4@
M9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S
M"C0Y+C4P(#4R.2XW-2 S-# N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@
M,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS.#DN-3 @-3(Y+C<U
M(#$U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S
M,S,S,R Q(')G"B]'4S @9W,*-# T+C4P(#4R.2XW-2 Q-3<N,# @+3$T+C P
M(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3
M,"!G<PHT.2XU," U,#$N-S4@,S0P+C P("TQ-"XP,"!R92!F"B]'4S @9W,*
M,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*,S@Y+C4P(#4P
M,2XW-2 Q-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S
M,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-"XU," U,#$N-S4@,34W+C P("TQ
M-"XP,"!R92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G
M"B]'4S @9W,*-#DN-3 @-#<S+C<U(#,T,"XP," M,30N,# @<F4@9@HO1U,P
M(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C,X.2XU
M," T-S,N-S4@,34N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S
M,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHT,#0N-3 @-#<S+C<U(#$U-RXP
M," M,30N,# @<F4@9@HO1U,P(&=S"C N." P+CDS,S,S,S,S,S,S,S,S,S,@
M,2!R9PHO1U,P(&=S"C0Y+C4P(#0T-2XW-2 S-# N,# @+3$T+C P(')E(&8*
M+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S,S,S(#$@<F<*+T=3,"!G<PHS
M.#DN-3 @-#0U+C<U(#$U+C P("TQ-"XP,"!R92!F"B]'4S @9W,*,"XX(# N
M.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @9W,*-# T+C4P(#0T-2XW-2 Q
M-3<N,# @+3$T+C P(')E(&8*+T=3,"!G<PHP+C@@,"XY,S,S,S,S,S,S,S,S
M,S,S(#$@<F<*+T=3,"!G<PHT.2XU," T,3<N-S4@,S0P+C P("TQ-"XP,"!R
M92!F"B]'4S @9W,*,"XX(# N.3,S,S,S,S,S,S,S,S,S,R Q(')G"B]'4S @
M9W,*,S@Y+C4P(#0Q-RXW-2 Q-2XP," M,30N,# @<F4@9@HO1U,P(&=S"C N
M." P+CDS,S,S,S,S,S,S,S,S,S,@,2!R9PHO1U,P(&=S"C0P-"XU," T,3<N
M-S4@,34W+C P("TQ-"XP,"!R92!F"B]'4S @9W,*0E0@+T8R(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3(N,# @-C<T+C0S(%1D("A3=6)S:61I87)Y
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#,Y
M,BXP," V-S0N,S(@5&0@** I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# W+C P(#8W-"XT,R!49" H4&QA8V4@;V8@26YC
M;W)P;W)A=&EO;BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" U,BXP," V-C N,S(@5&0@*$%D=F%N=&%G92!23BP@3$Q#*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXP
M," V-C N,S(@5&0@*$1E;&%W87)E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4R+C P(#8T-BXS,B!49" H061V86YT86=E
M(%).($QO8V%L(%-T868I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q-34N-#D@
M-C0V+C,R(%1D("AF:6YG+"!,3$,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-# W+C P(#8T-BXS,B!49" H1&5L87=A<F4I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N
M,# @-C,R+C,R(%1D("A!;65R:6-A;B!097)S;VYN96PL($EN8RXI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W+C P(#8S
M,BXS,B!49" H36%S<V%C:'5S971T<RD@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,BXP," V,3@N,S(@5&0@*$%S<VEG;FUE
M;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3 R+C P(#8Q."XS,B!49" H
M06UE<FEC82P@3$Q#*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#,Y,BXP," V,3@N,S(@5&0@** I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W+C P(#8Q."XS,B!49" H
M1&5L87=A<F4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3(N,# @-C T+C,R(%1D("A#96IK82!396%R8V@L($EN8RXI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,SDR+C P
M(#8P-"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" T,#<N,# @-C T+C,R(%1D("A$96QA=V%R92D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP," U.3 N
M,S(@5&0@*$-R961E;G0@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.#8N,#8@
M-3DP+C,R(%1D("A6*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3(N-C0@-3DP
M+C,R(%1D("AE<FEF:6-A=&EO;B!A;F0@3&EC96YS:6YG(%-E<G9I8V5S+"!,
M3$,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,SDR+C P(#4Y,"XS,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" T,#<N,# @-3DP+C,R(%1D("A$96QA=V%R92D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP
M," U-S8N,S(@5&0@*$-R;W-S($-O=6YT<GD@2&]L9&-O(%PH0WEP<G5S7"D@
M3&EM:71E9"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" S.3(N,# @-3<V+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXP," U-S8N,S(@5&0@*$-Y<')U
M<RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,BXP," U-C(N,S(@5&0@*$-R;W-S($-O=6YT<GD@26YF;W1E8V@L(%!V="X@
M3'1D+BD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" S.3(N,# @-38R+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P-RXP," U-C(N,S(@5&0@*$EN9&EA*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P
M(#4T."XS,B!49" H0W)O<W,@0V]U;G1R>2!3=&%F*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3(X+C4X(#4T."XS,B!49" H9FEN9RP@26YC+BD@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3(N,# @-30X
M+C,R(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#0P-RXP," U-#@N,S(@5&0@*$1E;&%W87)E*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#4S-"XS,B!4
M9" H0W)O<W,@0V]U;G1R>2!3=7!P;W)T(%-E<G9I8V5S+"!,3$,I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W+C P(#4S
M-"XS,B!49" H1&5L87=A<F4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N,# @-3(P+C,R(%1D("A);G1E;&ES=&%F(&]F
M($]K;&%H;VUA($Q,0RHI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-# W+C P(#4R,"XS,B!49" H1&5L87=A<F4I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N,# @-3 V
M+C,R(%1D("A,;V-A;"!3=&%F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@.3,N
M,C@@-3 V+C,R(%1D("AF+"!,3$,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-# W+C P(#4P-BXS,B!49" H1&5L87=A<F4I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3(N
M,# @-#DR+C,R(%1D("A-1$$I(%1J($54(%$*<2 P(# @,"!R9R!"5" W-2XP
M-B T.3(N,S(@5&0@*"!(;VQD:6YG<RP@26YC+BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" S.3(N,# @-#DR+C,R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#0P
M-RXP," T.3(N,S(@5&0@*$1E;&%W87)E*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#0W."XS,B!49" H365D:6-A
M;"!$;V-T;W(@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3$W+C(V(#0W."XS
M,B!49" H07-S;V-I871E<RP@3$Q#*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#,Y,BXP," T-S@N,S(@5&0@** I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-# W+C P(#0W
M."XS,B!49" H1&5L87=A<F4I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3(N,# @-#8T+C,R(%1D("A-961I<V-A;B!$:6%G
M;F]S=&EC(%-E<G9I8V5S+"!,3$,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-# W+C P(#0V-"XS,B!49" H0V%L:69O<FYI
M82D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U
M,BXP," T-3 N,S(@5&0@*$UE9&ES8V%N($YU<G-I;F<@4V5R=FEC97,L($Q,
M0RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" T
M,#<N,# @-#4P+C,R(%1D("A#86QI9F]R;FEA*2!4:B!%5"!1"D)4("]&,2 Q
M,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R+C P(#0S-BXS,B!49" H3F5W
M($UE9&ES8V%N($E)+"!,3$,I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-# W+C P(#0S-BXS,B!49" H0V%L:69O<FYI82D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,BXP
M," T,C(N,S(@5&0@*$]74RP@3$Q#*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#0P-RXP," T,C(N,S(@5&0@*$1E;&%W87)E
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4R
M+C P(#0P."XS,B!49" H5"D@5&H@150@40IQ(# @," P(')G($)4(#4W+CDS
M(#0P."XS,B!49" H<F%V96P@4W1A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#DV+C(V(#0P."XS,B!49" H9BP@3$Q#*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#0P-RXP," T,#@N,S(@5&0@*$1E;&%W
M87)E*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@,3 N,# @
M5&8@150*," P(# @4D<*+T=3,"!G<PHP+C0Y('<*,"!I( I;72 P(&0*,2!*
M"C$@:@HS($T*-3 @,SDP+CDQ-CDY,C$X-S4@;0HQ,C(@,SDP+CDQ-CDY,C$X
M-S4@; IS"G$@," P(# @<F<@0E0@-3 N,# @,SDR+C(U(%1D("@@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@.#8N,# @,SDR+C(U(%1D("@@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#,X,"XR
M-2!49" H("D@5&H@150@40IQ(# @," P(')G($)4(#<W+C P(#,X,"XR-2!4
M9" H*B I(%1J($54(%$*<2 P(# @,"!R9R!"5" X-BXP," S.# N,C4@5&0@
M*"!-86IO<FET>2UO=VYE9"!J;VEN="!V96YT=7)E("D@5&H@150@40IQ(# @
M," P(')G($)4(#(S,"XP," S.# N,C4@5&0@*" I(%1J($54(%$*96YD<W1R
M96%M"F5N9&]B:@HQ.3,@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@
M,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@
M,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R Q.30@,"!2/CX*96YD;V)J"C$Y
M-" P(&]B:@H\/"],96YG=&@@,3<V,SX^"G-T<F5A;0I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,3 N,S @-S0R+C(U(%1D("A%>&AI8FET
MH#(S+C$I(%1J($54(%$*0E0@+T8R(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3,Q+C@U(#<R,BXR-2!49" H0T].4T5.5"D@5&H@150@40IQ(# @," P
M(')G($)4(#$X,"XP,2 W,C(N,C4@5&0@*"!/1BD@5&H@150@40IQ(# @," P
M(')G($)4(#$Y-BXP,R W,C(N,C4@5&0@*"!)3D1%4$5.1$5.5"D@5&H@150@
M40IQ(# @," P(')G($)4(#(W,2XQ-" W,C(N,C4@5&0@*"!214=)4U1%4D5$
M(%!50DQ)0R I(%1J($54(%$*<2 P(# @,"!R9R!"5" S.#$N-#0@-S(R+C(U
M(%1D("A!0T-/54Y424Y'($9)4DTI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C<X+C(U(%1D("A7*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@-3@N-C0@-C<X+C(U(%1D("AE(&-O;G-E;G0@=&\@
M=&AE(&EN8V]R<&]R871I;VX@8GD@<F5F97)E;F-E(&EN(%)E9VES=')A=&EO
M;B!3=&%T96UE;G0@3F]S+B S,S,M,30U-#@T+" S,S,M,3@X-3$Y+" S,S,M
M,3DV-C,Y+"!A;F0@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4P+C P(#8V-BXR-2!49" H,S,S+3(Q.#4U-R!O;B!&;W)M
M(%,M."!O9B!O=7(@<F5P;W)T<R!D871E9"!&96)R=6%R>2 R."P@,C Q.2P@
M<F5L871I;F<@=&\@=&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M
M96YT<R!O9B!#<F]S<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C4T+C(U(%1D("A#;W5N=')Y($AE86QT:&-A
M<F4L($EN8RX@86YD('-U8G-I9&EA<FEE<RP@86YD('1H92!E9BD@5&H@150@
M40IQ(# @," P(')G($)4(#(U.2XW-2 V-30N,C4@5&0@*&9E8W1I=F5N97-S
M(&]F($-R;W-S($-O=6YT<GD@2&5A;'1H8V%R92P@26YC+B!A;F0@<W5B<VED
M:6%R:65S)R!I;G1E<FYA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@-3 N,# @-C0R+C(U(%1D("AC;VYT<F]L(&]V97(@
M9FEN86YC:6%L(')E<&]R=&EN9RP@87!P96%R:6YG(&EN('1H:7,@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C0X+C@S(#8T,BXR-2!49" H06YN=6%L(%)E
M<&]R="!O;B!&;W)M(#$P+4L@;V8@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E
M+"!);F,N(&9O<B!T:&4@>65A<B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-3 N,# @-C,P+C(U(%1D("AE;F1E9"!$96-E
M;6)E<B S,2P@,C Q."XI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3(N,# @-3DW+C8R(%1D("@O<R^@*2!4:B!%5"!1"D)4
M("]&,2 Q,2XP,"!49B!%5 IQ(# @," P(')G($)4(#8S+CDU(#4Y-RXV,B!4
M9" H1$5,3TE45$4@)B I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,S N.34@
M-3DW+C8R(%1D("A4*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,3,W+C0W(#4Y
M-RXV,B!49" H3U5#2$4@3$Q0*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP," U-S0N
M,C4@5&0@*$)O8V$@4F%T;VXL($9L;W)I9&$I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-38R+C(U(%1D("A&96)R
M=6%R>: R."P@,C Q.2D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q,C,N-C @-38R+C(U(%1D("@@*2!4:B!%5"!1"F5N9'-T
M<F5A;0IE;F1O8FH*,3DU(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N=" Q
M(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R8V5S
M(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3DV(# @4CX^"F5N9&]B:@HQ
M.38@,"!O8FH*/#PO3&5N9W1H(#<Y,S ^/@IS=')E86T*0E0@+T8R(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3$P+C,P(#<T,BXR-2!49" H17AH:6)I
M=" S,2XQ*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#<S,"XR-2!49" HH"D@5&H@150@40I"5" O1C(@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" R-C4N-S @-S$X+C(U(%1D("A#15(I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R.#8N-#8@-S$X+C(U(%1D("A4249)0T$I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C N-S(@-S$X+C(U(%1D("A424].
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P
M+C P(#<P-BXR-2!49" H22P@2V5V:6X@0RX@0VQA<FLL(&-E<G1I9GD@=&AA
M=#HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-CDT+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#8X+C P(#8W,"XR-2!49" H,2X@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#8W,"XR
M-2!49" H22!H879E(')E=FEE=V5D('1H:7,@86YN=6%L(')E<&]R="!O;B!&
M;W)MH#$P+4L@;V8@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N.RD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP
M," V-3(N,C4@5&0@*#(N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," V-3(N,C4@5&0@*$)A<V5D(&]N(&UY(&MN
M;W=L961G92P@=&AI<R!R97!O<G0@9&]E<R!N;W0@8V]N=&%I;B!A;GD@=6YT
M<G5E('-T871E;65N="!O9B!A(&UA=&5R:6%L(&9A8W0@;W(@;VUI="!T;R!S
M=&%T92!A(&UA=&5R:6%L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" X-BXP," V-# N,C4@5&0@*&9A8W0@;F5C97-S87)Y
M('1O(&UA:V4@=&AE('-T871E;65N=',@;6%D92P@:6X@;&EG:'0@;V8@=&AE
M(&-I<F-U;7-T86YC97,@=6YD97(@=VAI8V@@<W5C:"!S=&%T96UE;G1S('=E
M<F4@;6%D92P@;F]T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," V,C@N,C4@5&0@*&UI<VQE861I;F<@=VET:"!R
M97-P96-T('1O('1H92!P97)I;V0@8V]V97)E9"!B>2!T:&ES(')E<&]R=#LI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N
M,# @-C$P+C(U(%1D("@S+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@.#8N,# @-C$P+C(U(%1D("A"87-E9"!O;B!M>2!K
M;F]W;&5D9V4L('1H92!F:6YA;F-I86P@<W1A=&5M96YT<RP@86YD(&]T:&5R
M(&9I;F%N8VEA;"!I;F9O<FUA=&EO;B!I;F-L=61E9"!I;B!T:&ES(')E<&]R
M="P@9F%I<FQY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" X-BXP," U.3@N,C4@5&0@*'!R97-E;G0@:6X@86QL(&UA=&5R
M:6%L(')E<W!E8W1S('1H92!F:6YA;F-I86P@8V]N9&ET:6]N+"!R97-U;'1S
M(&]F(&]P97)A=&EO;G,@86YD(&-A<V@@9FQO=W,@;V8@=&AE(')E9VES=')A
M;G0@87,@;V8L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#8N,# @-3@V+C(U(%1D("AF;W(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" Y-RXR-B U.#8N,C4@5&0@*"P@=&AE('!E<FEO9',@<')E
M<V5N=&5D(&EN('1H:7,@<F5P;W)T.R I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @-38X+C(U(%1D("@T+B I(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @
M-38X+C(U(%1D("A4:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" Q-#0N-3D@-38X+C(U(%1D("AS(&]T:&5R(&-E<G1I9GEI;F<@;V8I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,C,N-34@-38X+C(U(%1D("AF:6-E
M<B!A;F0@22!A<F4@<F5S<&]N<VEB;&4@9F]R(&5S=&%B;&ES:&EN9R!A;F0@
M;6%I;G1A:6YI;F<@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4U-BXR
M-2!49" H<')O8V5D=7)E<R!<*&%S(&1E9FEN960@:6X@17AC:&%N9V4@*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@,C,P+C8V(#4U-BXR-2!49" H06-T(%)U
M;&5SH#$S82TQ-5PH95PI(&%N9" Q-60M,35<*&5<*5PI(&%N9"!I;G1E<FYA
M;"!C;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R=&EN9R I(%1J($54(%$*
M0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-30T+C(U
M(%1D("A<*&%S(&1E9FEN960@:6X@17AC:&%N9V4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,3@T+C,P(#4T-"XR-2!49" H06-T(%)U;&5S(#$S82TQ-5PH
M9EPI(&%N9" Q-60M,35<*&9<*5PI(&9O<B!T:&4@<F5G:7-T<F%N="!A;F0@
M:&%V93HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3 T+C P(#4R-BXR-2!49" H82X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," U,C8N,C4@5&0@*$1E<VEG
M;F5D('-U8V@@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@<')O8V5D=7)E<RP@
M;W(@8V%U<V5D('-U8V@@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@<')O8V5D
M=7)E<R!T;R!B92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3(R+C P(#4Q-"XR-2!49" H9&5S:6=N960@=6YD97(@;W5R
M('-U<&5R=FES:6]N+"!T;R!E;G-U<F4@=&AA="!M871E<FEA;"!I;F9O<FUA
M=&EO;B!R96QA=&EN9R!T;R!T:&4@<F5G:7-T<F%N="P@:6YC;'5D:6YG(&ET
M<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3(R+C P(#4P,BXR-2!49" H8V]N<V]L:61A=&5D('-U8G-I9&EA<FEE<RP@
M:7,@;6%D92!K;F]W;B!T;R!U<R!B>2!O=&AE<G,@=VET:&EN('1H;W-E(&5N
M=&ET:65S+"!P87)T:6-U;&%R;'D@9'5R:6YG('1H92!P97)I;V0@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," T
M.3 N,C4@5&0@*&EN('=H:6-H('1H:7,@<F5P;W)T(&ES(&)E:6YG('!R97!A
M<F5D.RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" Q,#0N,# @-#<R+C(U(%1D("AB+B I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#0W,BXR-2!49" H1&5S:6=N
M960@<W5C:"!I;G1E<FYA;"!C;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R
M=&EN9RP@;W(@8V%U<V5D('-U8V@@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I
M;F%N8VEA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3(R+C P(#0V,"XR-2!49" H<F5P;W)T:6YG('1O(&)E(&1E<VEG
M;F5D('5N9&5R(&]U<B!S=7!E<G9I<VEO;BP@=&\@<')O=FED92!R96%S;VYA
M8FQE(&%S<W5R86YC92!R96=A<F1I;F<@=&AE(')E;&EA8FEL:71Y(&]F("D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N
M,# @-#0X+C(U(%1D("AF:6YA;F-I86P@<F5P;W)T:6YG(&%N9"!T:&4@<')E
M<&%R871I;VX@;V8@9FEN86YC:6%L('-T871E;65N=',@9F]R(&5X=&5R;F%L
M('!U<G!O<V5S(&EN(&%C8V]R9&%N8V4@=VET:" I(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#0S-BXR-2!49" H
M9V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<SLI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 T+C P
M(#0Q."XR-2!49" H8RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$R,BXP," T,3@N,C4@5&0@*$5V86QU871E9"!T:&4@
M968I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#8N-SD@-#$X+C(U(%1D("AF
M96-T:79E;F5S<R!O9B!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R.3DN.# @-#$X+C(U(%1D("AS(&1I<V-L;W-U<F4@8V]N=')O
M;',@86YD('!R;V-E9'5R97,@86YD('!R97-E;G1E9"!I;B!T:&ES(')E<&]R
M=" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3(R+C P(#0P-BXR-2!49" H;W5R(&-O;F-L=7-I;VYS(&%B;W5T('1H92!E
M9BD@5&H@150@40IQ(# @," P(')G($)4(#(S-"XU-R T,#8N,C4@5&0@*&9E
M8W1I=F5N97-S(&]F('1H92!D:7-C;&]S=7)E(&-O;G1R;VQS(&%N9"!P<F]C
M961U<F5S+"!A<R!O9B!T:&4@96YD(&]F('1H92!P97)I;V0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," S.30N
M,C4@5&0@*&-O=F5R960@8GD@=&AI<R!R97!O<G0@8F%S960@;VX@<W5C:"!E
M=F%L=6%T:6]N.R!A;F0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@,3 T+C P(#,W-BXR-2!49" H9"X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," S-S8N,C4@
M5&0@*$1I<V-L;W-E9"!I;B!T:&ES(')E<&]R="!A;GD@8VAA;F=E(&EN('1H
M92!R96=I<W1R86YTDBD@5&H@150@40IQ(# @," P(')G($)4(#,S,"XX,R S
M-S8N,C4@5&0@*',@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I;F%N8VEA;"!R
M97!O<G1I;F<@=&AA="!O8V-U<G)E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#,V-"XR-2!49" H9'5R:6YG
M('1H92!R96=I<W1R86YTDBD@5&H@150@40IQ(# @," P(')G($)4(#(P-2XX
M-R S-C0N,C4@5&0@*',@;6]S="!R96-E;G0@9FES8V%L('%U87)T97(@7"AT
M:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S0N-CD@
M,S8T+C(U(%1D("AS(&9O=7)T:"!F:7-C86P@<75A<G1E<B!I;B!T:&4@8V%S
M92!O9B!A;B!A;FYU86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$R,BXP," S-3(N,C4@5&0@*')E<&]R=%PI('1H870@
M:&%S(&UA=&5R:6%L;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S4N
M-C8@,S4R+C(U(%1D("AF96-T960L(&]R(&ES(')E87-O;F%B;'D@;&EK96QY
M('1O(&UA=&5R:6%L;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3<N
M,#<@,S4R+C(U(%1D("AF96-T+"!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" T.3(N,S(@,S4R+C(U(%1D("AS(&EN=&5R;F%L(&-O
M;G1R;VP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$R,BXP," S-# N,C4@5&0@*&]V97(@9FEN86YC:6%L(')E<&]R=&EN
M9SL@86YD*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#8X+C P(#,R,BXR-2!49" H-2X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#,R,BXR-2!49" H5&AE(')E
M9VES=')A;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30T+C4Y(#,R,BXR
M-2!49" H<R!O=&AE<B!C97)T:69Y:6YG(&]F*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,C(S+C4U(#,R,BXR-2!49" H9FEC97(@86YD($D@:&%V92!D:7-C
M;&]S960L(&)A<V5D(&]N(&]U<B!M;W-T(')E8V5N="!E=F%L=6%T:6]N(&]F
M(&EN=&5R;F%L(&-O;G1R;VP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#@V+C P(#,Q,"XR-2!49" H;W9E<B!F:6YA;F-I
M86P@<F5P;W)T:6YG+"!T;R!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R-3 N.30@,S$P+C(U(%1D("AS(&%U9&ET;W)S(&%N9"!T
M:&4@875D:70@8V]M;6ET=&5E(&]F('1H92!R96=I<W1R86YTDBD@5&H@150@
M40IQ(# @," P(')G($)4(#0U-RXP," S,3 N,C4@5&0@*',@8F]A<F0@;V8@
M9&ER96-T;W)S(%PH;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@V+C P(#(Y."XR-2!49" H<&5R<V]N<R!P97)F;W)M
M:6YG('1H92!E<75I=F%L96YT(&9U;F-T:6]N<UPI.BD@5&H@150@40I"5" O
M1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,#0N,# @,C@P+C(U(%1D
M("AA+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(R+C P(#(X,"XR-2!49" H06QL('-I9VYI9FEC86YT(&1E9FEC:65N
M8VEE<R!A;F0@;6%T97)I86P@=V5A:VYE<W-E<R!I;B!T:&4@9&5S:6=N(&]R
M(&]P97)A=&EO;B!O9B!I;G1E<FYA;"!C;VYT<F]L(&]V97(@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," R-C@N
M,C4@5&0@*&9I;F%N8VEA;"!R97!O<G1I;F<@=VAI8V@@87)E(')E87-O;F%B
M;'D@;&EK96QY('1O(&%D=F5R<V5L>2!A9BD@5&H@150@40IQ(# @," P(')G
M($)4(#,W,"XP-2 R-C@N,C4@5&0@*&9E8W0@=&AE(')E9VES=')A;G22*2!4
M:B!%5"!1"G$@," P(# @<F<@0E0@-#0R+C@P(#(V."XR-2!49" H<R!A8FEL
M:71Y('1O(')E8V]R9"P@<')O8V5S<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP
M,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," R-38N,C4@5&0@*'-U;6UA
M<FEZ92!A;F0@<F5P;W)T(&9I;F%N8VEA;"!I;F9O<FUA=&EO;CL@86YD*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P-"XP
M," R,S@N,C4@5&0@*&(N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q,C(N,# @,C,X+C(U(%1D("A!;GD@9G)A=60L('=H
M971H97(@;W(@;F]T(&UA=&5R:6%L+"!T:&%T(&EN=F]L=F5S(&UA;F%G96UE
M;G0@;W(@;W1H97(@96UP;&]Y965S('=H;R!H879E(&$@<VEG;FEF:6-A;G0@
M<F]L92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(R+C P(#(R-BXR-2!49" H:6X@=&AE(')E9VES=')A;G22*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3@W+C4T(#(R-BXR-2!49" H<R!I;G1E<FYA
M;"!C;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R=&EN9RX@*2!4:B!%5"!1
M"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*
M,R!-"C$X-BXU(#$X,RXW-2!M"C4V,BXU(#$X,RXW-2!L"G,*," P(# @4D<*
M+T=3,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3@V+C4@
M,3@S+C<U(&T*-38R+C4@,3@S+C<U(&P*<PI"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,RXP," Q.#@N,S(@5&0@*$1A=&4Z*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@Q+C P(#$X."XS
M,B!49" H1F5B<G5A<GD@,C@L(#(P,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@,3@Y+C P(#$X."XS,B!49" H+W,O($ME
M=FEN($,N($-L87)K*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#4S+C P(#$T-2XT,B!49" HH"D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#DN,# @,3<T+C,R(%1D("A+
M979I;B!#+B!#;&%R:RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q.#DN,# @,38T+C,R(%1D("A0<F5S:61E;G0L($-H:65F
MH$5X96-U=&EV92!/9BD@5&H@150@40IQ(# @," P(')G($)4(#,P."XW.2 Q
M-C0N,S(@5&0@*&9I8V5R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#$X.2XP," Q-30N,S(@5&0@*%PH4')I;F-I<&%LH$5X
M96-U=&EV9:!/9BD@5&H@150@40IQ(# @," P(')G($)4(#(X,RXW.2 Q-30N
M,S(@5&0@*&9I8V5R7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"F5N
M9'-T<F5A;0IE;F1O8FH*,3DW(# @;V)J"CP\+U1Y<&4@+U!A9V4*+U!A<F5N
M=" Q(# @4@HO365D:6%";W@@6S @," V,3(N,# @-SDR+C P70HO4F5S;W5R
M8V5S(#(@,"!2"B]2;W1A=&4@, HO0V]N=&5N=',@,3DX(# @4CX^"F5N9&]B
M:@HQ.3@@,"!O8FH*/#PO3&5N9W1H(#@S,#$^/@IS=')E86T*0E0@+T8R(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@-3$P+C,P(#<T,BXR-2!49" H17AH
M:6)I=" S,2XR*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P
M(')G($)4(#4P+C P(#<S,"XR-2!49" HH"D@5&H@150@40I"5" O1C(@,3 N
M,# @5&8@150*<2 P(# @,"!R9R!"5" R-C4N-S @-S$X+C(U(%1D("A#15(I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R.#8N-#8@-S$X+C(U(%1D("A4249)
M0T$I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,C N-S(@-S$X+C(U(%1D("A4
M24].*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#4P+C P(#<P-BXR-2!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,"XP," V.30N,C4@5&0@*$DL("D@5&H@150@
M40IQ(# @," P(')G($)4(#4X+C$U(#8Y-"XR-2!49" H5RD@5&H@150@40IQ
M(# @," P(')G($)4(#8W+C$Y(#8Y-"XR-2!49" H:6QL:6%M($HN($)U<FYS
M+"!C97)T:69Y('1H870Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#8X+C P(#8V-"XR-2!49" H,2X@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#8V-"XR-2!4
M9" H22!H879E(')E=FEE=V5D('1H:7,@86YN=6%L(')E<&]R="!O;B!&;W)M
MH#$P+4L@;V8@0W)O<W,@0V]U;G1R>2!(96%L=&AC87)E+"!);F,N.RD@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" V."XP," V
M-#8N,C4@5&0@*#(N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," V-#8N,C4@5&0@*$)A<V5D(&]N(&UY(&MN;W=L
M961G92P@=&AI<R!R97!O<G0@9&]E<R!N;W0@8V]N=&%I;B!A;GD@=6YT<G5E
M('-T871E;65N="!O9B!A(&UA=&5R:6%L(&9A8W0@;W(@;VUI="!T;R!S=&%T
M92!A(&UA=&5R:6%L("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" X-BXP," V,S0N,C4@5&0@*&9A8W0@;F5C97-S87)Y('1O
M(&UA:V4@=&AE('-T871E;65N=',@;6%D92P@:6X@;&EG:'0@;V8@=&AE(&-I
M<F-U;7-T86YC97,@=6YD97(@=VAI8V@@<W5C:"!S=&%T96UE;G1S('=E<F4@
M;6%D92P@;F]T("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @
M,"!R9R!"5" X-BXP," V,C(N,C4@5&0@*&UI<VQE861I;F<@=VET:"!R97-P
M96-T('1O('1H92!P97)I;V0@8V]V97)E9"!B>2!T:&ES(')E<&]R=#LI(%1J
M($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-C@N,# @
M-C T+C(U(%1D("@S+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#8N,# @-C T+C(U(%1D("A"87-E9"!O;B!M>2!K;F]W
M;&5D9V4L('1H92!F:6YA;F-I86P@<W1A=&5M96YT<RP@86YD(&]T:&5R(&9I
M;F%N8VEA;"!I;F9O<FUA=&EO;B!I;F-L=61E9"!I;B!T:&ES(')E<&]R="P@
M9F%I<FQY("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" X-BXP," U.3(N,C4@5&0@*'!R97-E;G0@:6X@86QL(&UA=&5R:6%L
M(')E<W!E8W1S('1H92!F:6YA;F-I86P@8V]N9&ET:6]N+"!R97-U;'1S(&]F
M(&]P97)A=&EO;G,@86YD(&-A<V@@9FQO=W,@;V8@=&AE(')E9VES=')A;G0@
M87,@;V8L(&%N9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@.#8N,# @-3@P+C(U(%1D("AF;W(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" Y-RXR-B U.# N,C4@5&0@*"P@=&AE('!E<FEO9',@<')E<V5N
M=&5D(&EN('1H:7,@<F5P;W)T.R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@-C@N,# @-38R+C(U(%1D("@T+B I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-38R
M+C(U(%1D("A4:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"
M5" Q-#0N-3D@-38R+C(U(%1D("AS(&]T:&5R(&-E<G1I9GEI;F<@;V8I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,C,N-34@-38R+C(U(%1D("AF:6-E<B!A
M;F0@22!A<F4@<F5S<&]N<VEB;&4@9F]R(&5S=&%B;&ES:&EN9R!A;F0@;6%I
M;G1A:6YI;F<@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@V+C P(#4U,"XR-2!4
M9" H<')O8V5D=7)E<R!<*&%S(&1E9FEN960@:6X@17AC:&%N9V4@*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C,P+C8V(#4U,"XR-2!49" H06-T(%)U;&5S
MH#$S82TQ-5PH95PI(&%N9" Q-60M,35<*&5<*5PI(&%N9"!I;G1E<FYA;"!C
M;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R=&EN9R I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-3,X+C(U(%1D
M("A<*&%S(&1E9FEN960@:6X@17AC:&%N9V4@*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@,3@T+C,P(#4S."XR-2!49" H06-T(%)U;&5S(#$S82TQ-5PH9EPI
M(&%N9" Q-60M,35<*&9<*5PI(&9O<B!T:&4@<F5G:7-T<F%N="!A;F0@:&%V
M93HI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3 T+C P(#4R,"XR-2!49" H82X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$R,BXP," U,C N,C4@5&0@*$1E<VEG;F5D
M('-U8V@@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@<')O8V5D=7)E<RP@;W(@
M8V%U<V5D('-U8V@@9&ES8VQO<W5R92!C;VYT<F]L<R!A;F0@<')O8V5D=7)E
M<R!T;R!B92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@,3(R+C P(#4P."XR-2!49" H9&5S:6=N960@=6YD97(@;W5R('-U
M<&5R=FES:6]N+"!T;R!E;G-U<F4@=&AA="!M871E<FEA;"!I;F9O<FUA=&EO
M;B!R96QA=&EN9R!T;R!T:&4@<F5G:7-T<F%N="P@:6YC;'5D:6YG(&ET<R I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R
M+C P(#0Y-BXR-2!49" H8V]N<V]L:61A=&5D('-U8G-I9&EA<FEE<RP@:7,@
M;6%D92!K;F]W;B!T;R!U<R!B>2!O=&AE<G,@=VET:&EN('1H;W-E(&5N=&ET
M:65S+"!P87)T:6-U;&%R;'D@9'5R:6YG('1H92!P97)I;V0@*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," T.#0N
M,C4@5&0@*&EN('=H:6-H('1H:7,@<F5P;W)T(&ES(&)E:6YG('!R97!A<F5D
M.RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q
M,#0N,# @-#8V+C(U(%1D("AB+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3(R+C P(#0V-BXR-2!49" H1&5S:6=N960@
M<W5C:"!I;G1E<FYA;"!C;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R=&EN
M9RP@;W(@8V%U<V5D('-U8V@@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I;F%N
M8VEA;" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@,3(R+C P(#0U-"XR-2!49" H<F5P;W)T:6YG('1O(&)E(&1E<VEG;F5D
M('5N9&5R(&]U<B!S=7!E<G9I<VEO;BP@=&\@<')O=FED92!R96%S;VYA8FQE
M(&%S<W5R86YC92!R96=A<F1I;F<@=&AE(')E;&EA8FEL:71Y(&]F("D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,C(N,# @
M-#0R+C(U(%1D("AF:6YA;F-I86P@<F5P;W)T:6YG(&%N9"!T:&4@<')E<&%R
M871I;VX@;V8@9FEN86YC:6%L('-T871E;65N=',@9F]R(&5X=&5R;F%L('!U
M<G!O<V5S(&EN(&%C8V]R9&%N8V4@=VET:" I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R+C P(#0S,"XR-2!49" H9V5N
M97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<SLI(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3 T+C P(#0Q
M,BXR-2!49" H8RX@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$R,BXP," T,3(N,C4@5&0@*$5V86QU871E9"!T:&4@968I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" Q.#8N-SD@-#$R+C(U(%1D("AF96-T
M:79E;F5S<R!O9B!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R.3DN.# @-#$R+C(U(%1D("AS(&1I<V-L;W-U<F4@8V]N=')O;',@
M86YD('!R;V-E9'5R97,@86YD('!R97-E;G1E9"!I;B!T:&ES(')E<&]R=" I
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(R
M+C P(#0P,"XR-2!49" H;W5R(&-O;F-L=7-I;VYS(&%B;W5T('1H92!E9BD@
M5&H@150@40IQ(# @," P(')G($)4(#(S-"XU-R T,# N,C4@5&0@*&9E8W1I
M=F5N97-S(&]F('1H92!D:7-C;&]S=7)E(&-O;G1R;VQS(&%N9"!P<F]C961U
M<F5S+"!A<R!O9B!T:&4@96YD(&]F('1H92!P97)I;V0@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," S.#@N,C4@
M5&0@*&-O=F5R960@8GD@=&AI<R!R97!O<G0@8F%S960@;VX@<W5C:"!E=F%L
M=6%T:6]N.R!A;F0I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P
M(# @<F<@0E0@,3 T+C P(#,W,"XR-2!49" H9"X@*2!4:B!%5"!1"D)4("]&
M,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," S-S N,C4@5&0@
M*$1I<V-L;W-E9"!I;B!T:&ES(')E<&]R="!A;GD@8VAA;F=E(&EN('1H92!R
M96=I<W1R86YTDBD@5&H@150@40IQ(# @," P(')G($)4(#,S,"XX,R S-S N
M,C4@5&0@*',@:6YT97)N86P@8V]N=')O;"!O=F5R(&9I;F%N8VEA;"!R97!O
M<G1I;F<@=&AA="!O8V-U<G)E9" I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F
M($54"G$@," P(# @<F<@0E0@,3(R+C P(#,U."XR-2!49" H9'5R:6YG('1H
M92!R96=I<W1R86YTDBD@5&H@150@40IQ(# @," P(')G($)4(#(P-2XX-R S
M-3@N,C4@5&0@*',@;6]S="!R96-E;G0@9FES8V%L('%U87)T97(@7"AT:&4@
M<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S0N-CD@,S4X
M+C(U(%1D("AS(&9O=7)T:"!F:7-C86P@<75A<G1E<B!I;B!T:&4@8V%S92!O
M9B!A;B!A;FYU86P@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#$R,BXP," S-#8N,C4@5&0@*')E<&]R=%PI('1H870@:&%S
M(&UA=&5R:6%L;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S4N-C8@
M,S0V+C(U(%1D("AF96-T960L(&]R(&ES(')E87-O;F%B;'D@;&EK96QY('1O
M(&UA=&5R:6%L;'D@868I(%1J($54(%$*<2 P(# @,"!R9R!"5" T,3<N,#<@
M,S0V+C(U(%1D("AF96-T+"!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" T.3(N,S(@,S0V+C(U(%1D("AS(&EN=&5R;F%L(&-O;G1R
M;VP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$R,BXP," S,S0N,C4@5&0@*&]V97(@9FEN86YC:6%L(')E<&]R=&EN9SL@
M86YD*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#8X+C P(#,Q-BXR-2!49" H-2X@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#@V+C P(#,Q-BXR-2!49" H5&AE(')E9VES
M=')A;G22*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,30T+C4Y(#,Q-BXR-2!4
M9" H<R!O=&AE<B!C97)T:69Y:6YG(&]F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,C(S+C4U(#,Q-BXR-2!49" H9FEC97(@86YD($D@:&%V92!D:7-C;&]S
M960L(&)A<V5D(&]N(&]U<B!M;W-T(')E8V5N="!E=F%L=6%T:6]N(&]F(&EN
M=&5R;F%L(&-O;G1R;VP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@V+C P(#,P-"XR-2!49" H;W9E<B!F:6YA;F-I86P@
M<F5P;W)T:6YG+"!T;R!T:&4@<F5G:7-T<F%N=)(I(%1J($54(%$*<2 P(# @
M,"!R9R!"5" R-3 N.30@,S T+C(U(%1D("AS(&%U9&ET;W)S(&%N9"!T:&4@
M875D:70@8V]M;6ET=&5E(&]F('1H92!R96=I<W1R86YTDBD@5&H@150@40IQ
M(# @," P(')G($)4(#0U-RXP," S,#0N,C4@5&0@*',@8F]A<F0@;V8@9&ER
M96-T;W)S(%PH;W(@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @
M," P(')G($)4(#@V+C P(#(Y,BXR-2!49" H<&5R<V]N<R!P97)F;W)M:6YG
M('1H92!E<75I=F%L96YT(&9U;F-T:6]N<UPI.BD@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q,#0N,# @,C<T+C(U(%1D("AA
M+B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3(R+C P(#(W-"XR-2!49" H06QL('-I9VYI9FEC86YT(&1E9FEC:65N8VEE
M<R!A;F0@;6%T97)I86P@=V5A:VYE<W-E<R!I;B!T:&4@9&5S:6=N(&]R(&]P
M97)A=&EO;B!O9B!I;G1E<FYA;"!C;VYT<F]L(&]V97(@*2!4:B!%5"!1"D)4
M("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$R,BXP," R-C(N,C4@
M5&0@*&9I;F%N8VEA;"!R97!O<G1I;F<@=VAI8V@@87)E(')E87-O;F%B;'D@
M;&EK96QY('1O(&%D=F5R<V5L>2!A9BD@5&H@150@40IQ(# @," P(')G($)4
M(#,W,"XP-2 R-C(N,C4@5&0@*&9E8W0@=&AE(')E9VES=')A;G22*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@-#0R+C@P(#(V,BXR-2!49" H<R!A8FEL:71Y
M('1O(')E8V]R9"P@<')O8V5S<RP@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$R,BXP," R-3 N,C4@5&0@*'-U;6UA<FEZ
M92!A;F0@<F5P;W)T(&9I;F%N8VEA;"!I;F9O<FUA=&EO;CL@86YD*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$P-"XP," R
M,S(N,C4@5&0@*&(N("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" Q,C(N,# @,C,R+C(U(%1D("A!;GD@9G)A=60L('=H971H
M97(@;W(@;F]T(&UA=&5R:6%L+"!T:&%T(&EN=F]L=F5S(&UA;F%G96UE;G0@
M;W(@;W1H97(@96UP;&]Y965S('=H;R!H879E(&$@<VEG;FEF:6-A;G0@<F]L
M92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3(R+C P(#(R,"XR-2!49" H:6X@=&AE(')E9VES=')A;G22*2!4:B!%5"!1
M"G$@," P(# @<F<@0E0@,3@W+C4T(#(R,"XR-2!49" H<R!I;G1E<FYA;"!C
M;VYT<F]L(&]V97(@9FEN86YC:6%L(')E<&]R=&EN9RX@*2!4:B!%5"!1"C @
M," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-
M"C$X-BXU(#$X.2XW-2!M"C4V,BXU(#$X.2XW-2!L"G,*," P(# @4D<*+T=3
M,"!G<PHQ+C P('<*,"!I( I;72 P(&0*,"!*"C @:@HS($T*,3@V+C4@,3@Y
M+C<U(&T*-38R+C4@,3@Y+C<U(&P*<PI"5" O1C$@,3 N,# @5&8@150*<2 P
M(# @,"!R9R!"5" U,RXP," Q.30N,S(@5&0@*$1A=&4ZH"D@5&H@150@40I"
M5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X,2XP," Q.30N,S(@
M5&0@*$9E8G)U87)Y(#(X+" R,#$Y*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#$X.2XP," Q.30N,S(@5&0@*"]S+R I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" R,# N-S<@,3DT+C,R(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,C Y+C@Q(#$Y-"XS,B!49" H:6QL:6%M($HN
M($)U<FYS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4S+C P(#$U-"XT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" Q.#DN,# @,3@P+C,R(%1D("A7*2!4:B!%
M5"!1"G$@," P(# @<F<@0E0@,3DX+C T(#$X,"XS,B!49" H:6QL:6%M($HN
M($)U<FYS*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#$X.2XP," Q-S N,S(@5&0@*$5X96-U=&EV92 I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" R,S$N,S @,3<P+C,R(%1D("A6*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@,C,W+CDR(#$W,"XS,B!49" H:6-E(%!R97-I9&5N="P@0VAI
M96:@1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S8Y+C Y
M(#$W,"XS,B!49" H9FEC97(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54
M"G$@," P(# @<F<@0E0@,3@Y+C P(#$V,"XS,B!49" H7"A0<FEN8VEP86P@
M*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,C,P+C,X(#$V,"XS,B!49" H06-C
M;W5N=&EN9R!A;F0@1FEN86YC:6%L($]F*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S0V+C4V(#$V,"XS,B!49" H9FEC97)<*2D@5&H@150@40I"5" O1C$@
M,3 N,# @5&8@150*96YD<W1R96%M"F5N9&]B:@HQ.3D@,"!O8FH*/#PO5'EP
M92 O4&%G90HO4&%R96YT(#$@,"!2"B]-961I84)O>"!;," P(#8Q,BXP," W
M.3(N,#!="B]297-O=7)C97,@,B P(%(*+U)O=&%T92 P"B]#;VYT96YT<R R
M,# @,"!2/CX*96YD;V)J"C(P," P(&]B:@H\/"],96YG=&@@,S(R-CX^"G-T
M<F5A;0I"5" O1C(@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,3 N,S @
M-S0R+C(U(%1D("A%>&AI8FET(#,R+C$I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-S,P+C(U(%1D("B@*2!4:B!%
M5"!1"D)4("]&,B Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#$W,BXW-2 W
M,3@N,C4@5&0@*$-%4BD@5&H@150@40IQ(# @," P(')G($)4(#$Y,RXU,2 W
M,3@N,C4@5&0@*%1)1DE#02D@5&H@150@40IQ(# @," P(')G($)4(#(R-RXW
M-R W,3@N,C4@5&0@*%1)3TX@4%524U5!3E0I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" S,3 N,3 @-S$X+C(U(%1D("@@*2!4:B!%5"!1"G$@," P(# @<F<@
M0E0@,S$R+C0R(#<Q."XR-2!49" H5"D@5&H@150@40IQ(# @," P(')G($)4
M(#,Q."XY,2 W,3@N,C4@5&0@*$\@,3@@52Y3+D,N(%-%0U1)3TX@,3,U,"D@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,"XP
M," W,#8N,C4@5&0@** I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@.#8N,# @-CDT+C(U(%1D("A);B!C;VYN96-T:6]N('=I
M=&@@=&AE(&%C8V]M<&%N>6EN9R I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,S@N-#8@-CDT+C(U(%1D("A!;FYU86P@4F5P;W)T(&]N($9O<FV@,3 M2R!O
M9B!#<F]S<R!#;W5N=')Y($AE86QT:&-A<F4L($EN8RX@7"AT:&4@0V]M<&%N
M>5PI("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"
M5" U,"XP," V.#(N,C4@5&0@*&9O<B!T:&4@>65A<B!E;F1E9" I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3(T+CDV(#8X
M,BXR-2!49" H1&5C96UB97*@,S$L(#(P,3@I(%1J($54(%$*0E0@+T8Q(#$P
M+C P(%1F($54"G$@," P(# @<F<@0E0@,C S+C4T(#8X,BXR-2!49" H+"!<
M*'1H92 B4&5R:6]D:6,@4F5P;W)T(EPI+"!)+"!+979I;B!#+B!#;&%R:RP@
M4')E<VED96YT(&%N9"!#:&EE9B!%>&5C=71I=F4@3V8I(%1J($54(%$*<2 P
M(# @,"!R9R!"5" U,30N-3$@-C@R+C(U(%1D("AF:6-E<B!O9B!T:&4@*2!4
M:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P
M(#8W,"XR-2!49" H0V]M<&%N>2D@5&H@150@40IQ(# @," P(')G($)4(#@X
M+C(T(#8W,"XR-2!49" H+"!H97)E8GD@8V5R=&EF>2!P=7)S=6%N="!T;R Q
M.*!5+E,N0RX@4V5C=&EO;J Q,S4P+"!A<R!A9&]P=&5D('!U<G-U86YT('1O
M(%-E8W1I;VZ@.3 V(&]F('1H92!387)B86YE<RU/>&QE>2 I(%1J($54(%$*
M<2 P(# @,"!R9R!"5" U,S$N-S8@-C<P+C(U(%1D("A!8W0@;V8@*2!4:B!%
M5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8U
M."XR-2!49" H,C P,BP@=&AA="!T;R!M>2!K;F]W;&5D9V4@=&AE(%!E<FEO
M9&EC(%)E<&]R="!F=6QL>2!C;VUP;&EE<R!W:71H('1H92!R97%U:7)E;65N
M=',@;V8@4V5C=&EO;J Q,UPH85PI(&]R(#$U7"AD7"D@;V8@=&AE(%-E8W5R
M:71I97,@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G
M($)4(#4P+C P(#8T-BXR-2!49" H17AC:&%N9V4@*2!4:B!%5"!1"G$@," P
M(# @<F<@0E0@.3$N,S<@-C0V+C(U(%1D("A!8W0@;V8@,3DS-"!A;F0@=&AA
M="!T:&4@:6YF;W)M871I;VX@8V]N=&%I;F5D(&EN('1H92!097)I;V1I8R!2
M97!O<G0@9F%I<FQY('!R97-E;G1S+"!I;B!A;&P@;6%T97)I86P@<F5S<&5C
M=',L('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@-3 N,# @-C,T+C(U(%1D("AF:6YA;F-I86P@8V]N9&ET:6]N(&%N
M9"!R97-U;'1S(&]F(&]P97)A=&EO;G,@;V8@=&AE($-O;7!A;GDI(%1J($54
M(%$*<2 P(# @,"!R9R!"5" R.3(N,#<@-C,T+C(U(%1D("@N*2!4:B!%5"!1
M"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#4P+C P(#8R,BXR
M-2!49" HH"D@5&H@150@40HP(# @,"!21PHO1U,P(&=S"C$N,# @=PHP(&D@
M"EM=(# @9 HP($H*,"!J"C,@30HQ.#@N-2 U.3<N-S4@;0HU-C(N-2 U.3<N
M-S4@; IS"C @," P(%)'"B]'4S @9W,*,2XP,"!W"C @:2 *6UT@,"!D"C @
M2@HP(&H*,R!-"C$X."XU(#4Y-RXW-2!M"C4V,BXU(#4Y-RXW-2!L"G,*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-C R+C,R(%1D
M("A$871E.J I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @
M<F<@0E0@.#,N,# @-C R+C,R(%1D("A&96)R=6%R>2 R."P@,C Q.2D@5&H@
M150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.3$N,# @
M-C R+C,R(%1D("@O<R\@2V5V:6X@0RX@0VQA<FLI(%1J($54(%$*0E0@+T8Q
M(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-38Q+C0R(%1D("B@
M*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4(#@S
M+C P(#4V,2XT,B!49" HH"D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" Q.3$N,# @-3@X+C,R(%1D("A+979I;B!#+B!#;&%R
M:RD@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q
M.3$N,# @-3<X+C,R(%1D("A0<F5S:61E;G0L($-H:65FH$5X96-U=&EV92!/
M9BD@5&H@150@40IQ(# @," P(')G($)4(#,Q,"XW.2 U-S@N,S(@5&0@*&9I
M8V5R*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$Y,2XP," U-C@N,S(@5&0@*%PH4')I;F-I<&%LH$5X96-U=&EV9:!/9BD@
M5&H@150@40IQ(# @," P(')G($)4(#(X-2XW.2 U-C@N,S(@5&0@*&9I8V5R
M7"DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"D)4("]&,2 Q,"XP,"!4
M9B!%5 IQ(# @," P(')G($)4(#4P+C P(#4S,RXR-2!49" HH"D@5&H@150@
M40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U,C$N
M,C4@5&0@*%1H92!F;W)E9V]I;F<@8V5R=&EF:6-A=&EO;B!I<R!P<F]V:61E
M9"!S;VQE;'D@9F]R('!U<G!O<V5S(&]F(&-O;7!L>6EN9R!W:71H('1H92!P
M<F]V:7-I;VYS(&]F(%-E8W1I;VZ@.3 V(&]F('1H92 I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3 Y+C(U(%1D
M("A387)B86YE<RU/>&QE>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,34N
M.#(@-3 Y+C(U(%1D("A!8W0@;V8@,C P,BXI(%1J($54(%$*96YD<W1R96%M
M"F5N9&]B:@HR,#$@,"!O8FH*/#PO5'EP92 O4&%G90HO4&%R96YT(#$@,"!2
M"B]-961I84)O>"!;," P(#8Q,BXP," W.3(N,#!="B]297-O=7)C97,@,B P
M(%(*+U)O=&%T92 P"B]#;VYT96YT<R R,#(@,"!2/CX*96YD;V)J"C(P,B P
M(&]B:@H\/"],96YG=&@@,S0V,SX^"G-T<F5A;0I"5" O1C(@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" U,3 N,S @-S0R+C(U(%1D("A%>&AI8FET(#,R
M+C(I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-S,P+C(U(%1D("B@*2!4:B!%5"!1"D)4("]&,B Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#$W,BXW-2 W,3@N,C4@5&0@*$-%4BD@5&H@150@
M40IQ(# @," P(')G($)4(#$Y,RXU,2 W,3@N,C4@5&0@*%1)1DE#02D@5&H@
M150@40IQ(# @," P(')G($)4(#(R-RXW-R W,3@N,C4@5&0@*%1)3TX@4%52
M4U5!3E0I(%1J($54(%$*<2 P(# @,"!R9R!"5" S,3 N,3 @-S$X+C(U(%1D
M("@@*2!4:B!%5"!1"G$@," P(# @<F<@0E0@,S$R+C0R(#<Q."XR-2!49" H
M5"D@5&H@150@40IQ(# @," P(')G($)4(#,Q."XY,2 W,3@N,C4@5&0@*$\@
M,3@@52Y3+D,N(%-%0U1)3TX@,3,U,"D@5&H@150@40I"5" O1C$@,3 N,# @
M5&8@150*<2 P(# @,"!R9R!"5" U,"XP," W,#8N,C4@5&0@** I(%1J($54
M(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@.#8N,# @-CDT
M+C(U(%1D("A);B!C;VYN96-T:6]N('=I=&@@=&AE(&%C8V]M<&%N>6EN9R I
M(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S@N-#8@-CDT+C(U(%1D("A!;FYU
M86P@4F5P;W)T(&]N($9O<FV@,3 M2R!O9B!#<F]S<R!#;W5N=')Y($AE86QT
M:&-A<F4L($EN8RX@7"AT:&4@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%
M5 IQ(# @," P(')G($)4(#4P+C P(#8X,BXR-2!49" H(D-O;7!A;GDB7"D@
M9F]R('1H92!Y96%R(&5N9&5D("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@
M150*<2 P(# @,"!R9R!"5" Q-S<N.#0@-C@R+C(U(%1D("A$96-E;6)E<J S
M,2P@,C Q."D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R
M9R!"5" R-38N-#,@-C@R+C(U(%1D("@L(%PH=&AE(")097)I;V1I8R!297!O
M<G0B7"DL($DL("D@5&H@150@40IQ(# @," P(')G($)4(#,V-RXQ-B V.#(N
M,C4@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-S8N,C @-C@R+C(U
M(%1D("AI;&QI86T@2BX@0G5R;G,L($-H:65F($9I;F%N8VEA;"!/9BD@5&H@
M150@40IQ(# @," P(')G($)4(#4Q-"XV,2 V.#(N,C4@5&0@*&9I8V5R(&]F
M('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@
M0E0@-3 N,# @-C<P+C(U(%1D("A#;VUP86YY*2!4:B!%5"!1"G$@," P(# @
M<F<@0E0@.#@N,C0@-C<P+C(U(%1D("@L(&AE<F5B>2!C97)T:69Y('!U<G-U
M86YT('1O(#$XH%4N4RY#+B!396-T:6]NH#$S-3 L(&%S(&%D;W!T960@<'5R
M<W5A;G0@=&\@4V5C=&EO;J Y,#8@;V8@=&AE(%-A<F)A;F5S+4]X;&5Y("D@
M5&H@150@40IQ(# @," P(')G($)4(#4S,2XW-B V-S N,C4@5&0@*$%C="!O
M9B I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M-3 N,# @-C4X+C(U(%1D("@R,# R+"!T:&%T('1O(&UY(&MN;W=L961G92!T
M:&4@4&5R:6]D:6,@4F5P;W)T(&9U;&QY(&-O;7!L:65S('=I=&@@=&AE(')E
M<75I<F5M96YT<R!O9B!396-T:6]NH#$S7"AA7"D@;W(@,35<*&1<*2!O9B!T
M:&4@4V5C=7)I=&EE<R I(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@
M," P(# @<F<@0E0@-3 N,# @-C0V+C(U(%1D("A%>&-H86YG92 I(%1J($54
M(%$*<2 P(# @,"!R9R!"5" Y,2XS-R V-#8N,C4@5&0@*$%C="!O9B Q.3,T
M(&%N9"!T:&%T('1H92!I;F9O<FUA=&EO;B!C;VYT86EN960@:6X@=&AE(%!E
M<FEO9&EC(%)E<&]R="!F86ER;'D@<')E<V5N=',L(&EN(&%L;"!M871E<FEA
M;"!R97-P96-T<RP@=&AE("D@5&H@150@40I"5" O1C$@,3 N,# @5&8@150*
M<2 P(# @,"!R9R!"5" U,"XP," V,S0N,C4@5&0@*&9I;F%N8VEA;"!C;VYD
M:71I;VX@86YD(')E<W5L=',@;V8@;W!E<F%T:6]N<R!O9B!T:&4@0V]M<&%N
M>2D@5&H@150@40IQ(# @," P(')G($)4(#(Y,BXP-R V,S0N,C4@5&0@*"XI
M(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3 N
M,# @-C(R+C(U(%1D("B@*2!4:B!%5"!1"C @," P(%)'"B]'4S @9W,*,2XP
M,"!W"C @:2 *6UT@,"!D"C @2@HP(&H*,R!-"C$X-BXU(#4Y-BXW-2!M"C4V
M,BXU(#4Y-BXW-2!L"G,*," P(# @4D<*+T=3,"!G<PHQ+C P('<*,"!I( I;
M72 P(&0*,"!*"C @:@HS($T*,3@V+C4@-3DV+C<U(&T*-38R+C4@-3DV+C<U
M(&P*<PI"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" U,RXP," V
M,#$N-#(@5&0@*$1A=&4Z*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ
M(# @," P(')G($)4(#@Q+C P(#8P,2XT,B!49" H1F5B<G5A<GD@,C@L(#(P
M,3DI(%1J($54(%$*0E0@+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@
M,3@Y+C P(#8P,2XT,B!49" H+W,O("D@5&H@150@40IQ(# @," P(')G($)4
M(#(P,"XW-R V,#$N-#(@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" R
M,#DN.#$@-C Q+C0R(%1D("AI;&QI86T@2BX@0G5R;G,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@-3,N,# @-38R+C0R(%1D
M("B@*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 IQ(# @," P(')G($)4
M(#$X.2XP," U.#<N,S(@5&0@*%<I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q
M.3@N,#0@-3@W+C,R(%1D("AI;&QI86T@2BX@0G5R;G,I(%1J($54(%$*0E0@
M+T8Q(#$P+C P(%1F($54"G$@," P(# @<F<@0E0@,3@Y+C P(#4W-RXS,B!4
M9" H17AE8W5T:79E("D@5&H@150@40IQ(# @," P(')G($)4(#(S,2XS," U
M-S<N,S(@5&0@*%8I(%1J($54(%$*<2 P(# @,"!R9R!"5" R,S<N.3(@-3<W
M+C,R(%1D("AI8V4@4')E<VED96YT+"!#:&EE9J!&:6YA;F-I86P@3V8I(%1J
M($54(%$*<2 P(# @,"!R9R!"5" S-CDN,#D@-3<W+C,R(%1D("AF:6-E<BD@
M5&H@150@40I"5" O1C$@,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" Q.#DN
M,# @-38W+C,R(%1D("A<*%!R:6YC:7!A;" I(%1J($54(%$*<2 P(# @,"!R
M9R!"5" R,S N,S@@-38W+C,R(%1D("A!8V-O=6YT:6YG(&%N9"!&:6YA;F-I
M86P@3V8I(%1J($54(%$*<2 P(# @,"!R9R!"5" S-#8N-38@-38W+C,R(%1D
M("AF:6-E<EPI*2!4:B!%5"!1"D)4("]&,2 Q,"XP,"!49B!%5 I"5" O1C$@
M,3 N,# @5&8@150*<2 P(# @,"!R9R!"5" X-BXP," U,S0N,C4@5&0@*%1H
M92!F;W)E9V]I;F<@8V5R=&EF:6-A=&EO;B!I<R!P<F]V:61E9"!S;VQE;'D@
M9F]R('!U<G!O<V5S(&]F(&-O;7!L>6EN9R!W:71H('1H92!P<F]V:7-I;VYS
M(&]F(%-E8W1I;VZ@.3 V(&]F('1H92 I(%1J($54(%$*0E0@+T8Q(#$P+C P
M(%1F($54"G$@," P(# @<F<@0E0@-3 N,# @-3(R+C(U(%1D("A387)B86YE
M<RU/>&QE>2 I(%1J($54(%$*<2 P(# @,"!R9R!"5" Q,34N.#(@-3(R+C(U
M(%1D("A!8W0@;V8@,C P,BXI(%1J($54(%$*96YD<W1R96%M"F5N9&]B:@HR
M,#,@,"!O8FH*/#PO5'EP92 O3T-'("].86UE("AP<FEN="D*+U5S86=E(#P\
M+U!R:6YT(#P\+U!R:6YT4W1A=&4@+T]./CX@+U9I97<@/#PO5FEE=U-T871E
M("]/1D8^/CX^/CX*96YD;V)J"C(P-" P(&]B:@H\/"]4>7!E("]/0T<@+TYA
M;64@*'9I97<I"B]5<V%G92 \/"]0<FEN=" \/"]0<FEN=%-T871E("]/1D8^
M/B O5FEE=R \/"]6:65W4W1A=&4@+T]./CX^/CX^"F5N9&]B:@HR,#4@,"!O
M8FH*/#PO5'EP92 O17AT1U-T871E"B]C82 Q"B]#02 Q"B]302!T<G5E"B]"
M32 O3F]R;6%L"B]N(#(P-0H^/@IE;F1O8FH*,C V(# @;V)J"CP\+TQE;F=T
M:" Q-# S-C<*+T9I;'1E<B O1FQA=&5$96-O9&4*+TQE;F=T:#$@,C$U,34R
M/CX*<W1R96%M"GC:[+UYG%Q%U3=^;N_;[7M[O;UWW]Z[I[NGIR>S9*8GF349
M,L$$$B#!2-9A1Z(!W%!002& @"**&Z"RR"*3"6+ +:X(R":R:!""+(HK#^ZH
MZ=_W5,], H_/^WGS_K8_GJ?*.G5K/W7.J6^=ZO@92"(B/XB)AL?7'+'\5Z,/
M?H>,C=\2!2Y8N7;-Y+8S_)\F<FT@,ERY:DUGX[5WOFTGD?1#C-JT>FSEVO6/
MO?]Y]+\3Y=YCQX]<]Z;,R1\@<K]"Y+EJZQF;MY]XM>$&HA-<1):[MIYS5NI
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M@>F/"$Q_1&#ZPP+3'Q:8_K# ](<%IC\D,/TA@>D/"4Q_2&#Z0P+3'Q28_J#
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MJXR"Q^-2'$X/WT=L?4+C?(NP-4"+4#-T895M[7<QJTS8A,6CVNWD\RL$M<.
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M'ILX61J :1MH=%=&NNBH7</216N.7W>W"M?ZHK7K9G%QCFT:7;\KB[9U=Z>
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M&L?K57=/#CTS.SGGV3BS.[.1A>TEYUW)("L+(B @["(BH!YK7,$ >HH8#C"
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M*@/9GM.[$662[7E%\F+%Z<#"58/%#SI0ZNPZJO'<BAW38V8T;K>2<QEPOZN
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MS)\XV 5"[EP4^L.ZK3=NOJ;]P,OOK)D]^[&]N>]JQ'*VZFXL:OD$Y&<%C#Q
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MWBW5*O1*MX)YV6 HZ7<G@J'ZQK[N>H'GW8)1]KI^OSL>#/?)U+G[ "$A@[X
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MC<0)W# OXZ^KH3+@E;S4:ZIG?Z^!YA<%#?/T#O:R8<518GOQV?SXXH5W8"K
MS=YU<<4L,8/.5$K<X"B% B76; +61(V^%)P4"[/*6DKLO+64_.;%Y!M1@=&S
MF$029&6U_)JQ27[1Q6P2XS':!2JX.;<\]W7N=.[FCX_^L&_!RKNOVGWTIY4+
M,.E=F'LG]WIN#MP-]3#@C9W#.K?D#N?V[+X=BJ 1IFZ[G8WMLIFG8CEG*8&E
M!T@9=O7W=97)LFL<B]V+/=<GVLKN]RB7.?9'#B8^<G_D^3"B<,;%LD2L-EH;
M[Y-(E4V)7QEO*^LHT[Y,P.4I](SPO._\R"UL2<!KD0_L'T8^B)](?!U1>*2P
M-Z$R,%,: K];&0RCH;4&P\0;*"GR)AK"36$:#BNM10F;S4I52I69N$17RB6Y
MVER":UA9[W@P*0.I;$<9W5!VK.QX&5=6 K*#!-D5@NP@(60TR-K6.V(E^T?#
M^M*R+%R[.\B&J'X31_7J6\LH-D\3R\_3Q-@\37[ 2IZ582\4U)KS'I2-%4<*
M[1Y'-!$KM,?2$/%@$7<6I2'J#J=_-58\;!RF!CXT/^$^?,@7Z(,L]!.0QT%(
M<7[)Y")8Q-2Q^'^QL/*,R\57(&V_S+,HX0E/;%2F^Q#ZYP(W^F?XU[Z_K/GH
ME?)%C95CO',>&'K+N'0SO2YW38<?_7.-?S$WG]5&[%J^^;AAB$;S:,>D!T98
MF%;D%@K+4"NL)$:ZI<)!,$EY/W * TS$VBQ8 K?!&K)6]2?CYT3-&R72'[@)
M*NX!/DN/2TF5+2%RQ+==I6+Q"UL Q),Q*I6>*P[5^RU)"_UE+;9@&9:XH$$)
M*4$3KGI1']!3H]ZOI_IA\?]-@TZQN; 6U*/Z!O:6HDQV21T+1#TQK4ZCHPI'
M-!*.AJG";PV5@E?M0N4Q8A$SX6&PP%>*O7+K<*=6.0VV4@B;L9#?ZKCP8D<1
M>Y.L=^&JP*+06"02[WV'F.E: 8&+JI9_I2S&W3:KZX%5N9=S_YBU9MSR3E@%
M&++ K:A[R_<MO//N!7L/7]TYO/8YXX[-NH!PQ>XKZAJG@_MY2,&]N:MR;_Z4
MNYW_ZJ;'<SMR^W>M7/D8U/][<\>R"[,K<U #$R1#J;0KXF!B&Y6%MS,$YEMC
M+X5?*N6&19XLI0Z_O6Q6A%.#.AJ+#B&38"%=&+D.KJ-7^Z\.+ DMC:Z"SL"Z
MTFVP+;H_=KBT)V)5!&Z!.R.WQ!^*;((GZ.;(LZ5'2T^D_EG:4ZHW$QNXJ#F!
M6E9>5U:7FA6Y,JDI4E&/!ZQ^MS$8(M&$FV >;L ,G(T>A25:$HU$0A0**(7(
M=AJ@RJ+"3?($@YVAJQ25S<I6);=&?@&"N+=[,EFX1S)6)+Q>#S4:#)A&JLSR
M4H5)^:4*@YHJ2?#9(&W"H(@&]XI5(%6U51VOXJHR*EFS53(=5+)FJT(VJZS9
M5OFD5=9LZ_K*Z0?D].@W(\]B"QMO*I:_&I[,:W6R5ZM[@R?V/0I,C!8EBUF6
MY'2)71<R(C#7NAR]*5"Q_.96_D,5GM)R7]@?+0TGTU#NPZ(L5)(FX4@J4)$&
M<D&R,.]?E)^CD_UK5'[U"O.@[W85U"98GE0@.TRL?K=7K$V)1G21D/>,D]E7
M!H)!D%7^_\DD*%G>!!47WR!0"G-R:W.5Z8#>)WIB(RMEXR '[_#MB3=7/[X-
M'*VK%I[O:_&H7WAIP\UUE]/E%""WY+<FHF'K-3=D8[GK;INDH_?!EIM6;+"P
M\86.GD]Y >U$#9TH.<WWEX 1C%3+$2.?((5"<1,T4;6I+@N#I>-5-54NSLU/
M<TQS3G--<RL$O6 @1<?J^,7:Q?K%AB7&-E^;ORW9EEJINDW;J>\TW&+L+-["
M;TF+9GU:G]%7>M/>C+>23>V6\@%?P%]86)KN!_UH Y]RIGPI?RK8-].W<JA^
M:-$X[03]1'%"X81BKQ_\U)WV5[JKQCG&.<>Y)E=,34_-3*V<6C6EVL!IM846
MK;LPK W4]2E,U2TR+[*LC*Q3KDL^F-J2/)9XONCEXO_#V'O QU'=B>/SIL]L
MFYUMLWU6V[55TJZDE85WA'O# E?9""M@.HEE48(!Q[I0C$,N5@(I0"YR"C67
MV!ACRQ""2 PAES@XN80C^1V!Y.\C<*"+DY_#GQQH_7_?-[NVR-W]/R=[YKUY
M4W;*M[<WW7>JSWV!V!NDMM'!_>AE1*-=J.D9-FS5!SI"P?"V:# 2>3H,(Q7_
M VY,//JM=K?5:L]9V^UL2B(-'T>S6 /*=##Q#'B,D1%IJR $52RF4-Q02L[G
MG/3K3J0[]SM?=S+.*7KWD>@_1G(*Y#CB Z*31?1<\8_%,YBU&4NJ1O%EO,%0
M1;U8Q@R/+7X/+:9J:#$)- "2.9S;CHGEV&E(31R;':N5<J;L0?A6,]H0U'V[
MJ>>WK/FD-XR4[3--TMJ=* NN3,J2E[JHK .8F@NOA#+>E O6+LIBS>?2"F9Q
M#GNV/:EB-B>6>(#YW$=*YC2#%JFQ8; 77&:YPG:E<ED.[ 4(\UAJNYF09+5H
MCAI;=M2ZR@XB'@XAXN!I%EB)T,VL 3,MTMD5H5NI28E4*^X1G #,MY/J\#]>
M?-7=N?EO?_^>%7_\WKQ*](<!?UA()@,;G[INY^=[^M*-;]V[\HWO7+>CUQ>(
MR5@BRNW>=\FN"^=WK=AYQ<?ON_"!UR6N'BFAGW_A\R-W;.J\(A_YX0V?7?N%
M?Z[ZHR6 _/E8-CI 9*,_&7V;T"9Z4WA3Y%IT+7UM^-J(6(K58ZMC7^&^''R4
M>S@HT"@<\8).WR8!]8P+6IR*THI#C$W1TX9+0CG*\-GKJ@-?;I#:#XDT=,8(
MB!*A<Q(A:1*A<U*;SQO-18 ^VN$,*J)$MD3V1=C(TW2&\IYYU[  %?02^N?%
M5W]2WSIL.E!/#P/!BV ":ZG"!0Y:'!7\@G,GE?ZF0PZ^#&58JGAI[7J3B#I@
MAD?*C\UB)]2PZ9=)F6ZW.72(&&*$N(O]NB-E<46O7/L<ELA+L\^#>/[-+9G*
M<B&E<"L;/UB;Z.OYX'1+%&>M=M=U%Z/Y\%8M9][@GL!OM8AN/TJ5L=K17JJ4
M251;@K3&6F^HDN'[^)7\#@>;C"?3G?'.]*+XHO1#:2&;KJ7IP?(-EEL=#Z2?
M2[^?XOOMIJDX&@WZ8VWMQ&#L B-@'*OFF$_1R8Q-:L<ZVI\.P5O#G3>) D<Z
M\ :SH*DIDB0:UIIH8"%%+(NT"%9DI]L-O(?P(9[8BD'I,XWNY$X7UJM*&8V6
M]Y4/E-\HL^6H3CZF3CZF3CZFWJ:JNUQHFPNY".]RV6&?*P+[7/[2Z7/ZWW#+
M;@-9:D0#S V?,^:0C+56)&='><6%.Y[H$3'JIF(9V0G9K33O2*:3";M>H!1G
MRIHM((L<4Y(%*F-)@E:!3.&'Q/Z@88R+U'9 6?0WUNET"O.:CYC["?XU.1#S
M<_1&UV#.<^',3W_[9EE?!"$^E;4)?WCEWJON_,4JS'' 7+T@NGWV-S_]W=<?
M^/307VAUYP7)9#4Q-OO$ZI^.+;_AJ5?IY"X]C^% Q5K9=P&[:/60[."CM.EM
M.^1%$<4VQ?S^B#U*>P4[%B3 ]U579D^<F$8E")ZTJDH,>45+[3$O(M*$9H9%
M=E7-L,A\B;3&[7J\\G_5#Z*G8LS3OJ/:,X$#L;\*W&/^?PQ\CSO,'Q6XQ[E'
M^,>$QSV/>+D'A0G'A/J =R+&7>W9ZKN!W2&/Q[A-W@V^P=CE_-4"MUD8$C?+
ME]B'/)P1&Z36,ANX-3RGQRILKV<QM<S.)?FLD!$SGHR7PQ)DK!P;B9V(<4W#
M=HBRQW39&_"V>QFO8(-'#-HQ'Q?$J!ULVO5A9?:%%UX 4ZT9YV^X*0X%*8='
M"3KL(CXXZHL$HU-G=AM.K\#KHB!@:<B-I0&.YP& JUX?% "(.K"81=$"+WW@
M0[X_E+V&=\)[RLMZWRI[#,^@YX#GE(?3/2.>4<^XA_5,T>\<UF-?BD$T)28>
MP_[3PR>'*:UI<2"9>L [<*N1SO\<0&FFG)[[(Q(-UFS&@.1+LJ;6'(9:8\&*
MH-1$T57#8N.KAUTU.>."T5>?<-1:6N\09*EZH,@+BD.%F%2Z"B67,'= J)FC
M6N6^NS19S3;2R0:;5OS+YM/ME_06T1 R2GV+."NW,FF+=5S^P:?8SV]R1^-<
M,BD5$YW7?/AOC/.&0KAJP40!*%'PS.^$G1@":TS$A+W#$NK-IMQ.#'U@X*#3
M=$@J!UF+2EM$"ERPOEJ= .)94/1+O$VPBK(DR'*9KPFJ77/5K'@) B"*4B4(
M,8FX#>'6> MWNJ5J:;DTQ&Z4'I'X%)\3\Y:,->/*!++!]DRZHYNO!2KE)?Q"
M885E:7 MOU'8* [)&ZT; QO+:SNNYK<*UUFN"EP5O+;K)O8F_B;A)OEFRZW6
M6P,W!W>&;M9O+-W)?E;\3.CNTMWE/1U?$.ZWW.NZ5[L_\)7@?9DOENXK/RH^
M+CUN>3SP:/"QT./A1TI/"D^*1^2IP*'RC\I_%?]J^3#\5WWY5:7+RU=U[)'8
MWN!UD6W13Q38RX7+Q:LD9H6T,KHTLZ+$#@4WE"XL,X/"H+C)PK ")6,Q*^0M
MM8>RT0ZA9FFY<\*4.J\O6)9"K,5IOMF@*@H69!%K:17 'L-]/P'\%UXXF^,6
M-/)2*"1*DAS"<E<D(E(\1@17P!UT94K98$:UXJND(ZE@NM;1&ZQ-G1E],FB1
M]:DSVPQW611TJ\72%L1'!P.A4$2296*("X;P0*@4%L4VL-262QV\(,">4+D#
M;W:XU'0F@Y5\BK;(LB@*TKRO\0]UX&]VT*AVF$&F)&@T52A7RAWC'1,=S.J.
M+1TC':-DXXV.4QUBQUOB'Z2++,&G I:G:9T*H/\T+(9UT'K"RE@?Z9LW15_S
MI(EHD!3K5TYJRNQIHJ3D9M\\JY?,J4H).;($\\YUQ)US</%_1L:Y:T&Q]XOX
MGZ#TDSR;YA^F_V"JP#@'".K.9+RV>@16>AFOHIIJJ5--5\WP$/*T-=&QB9$F
M>R HZ4JG4^:_.8--/(U7A9W5\R/N7..N3.,GC>.)QL<+5O>B>>@]K=J;1Y;?
M972LQ;G\?E>65A*]E0)B$9T/>U/G80Q.5>)W?/ ,<]F'_\!>\2E?*IE,EMOB
MGYH5Z-UCFSM3+ILJ\G@HV[5K-DJ_<UO9EQ'M!*L=6)_>C[&ZSN2;',7)"EH0
MX_0AOJ\GDP3D5E+.&%5D4_Y>.D7[15ZDZOB/A.P#FU$^/(O@R@XGLOFE5!^Z
MF?IDC%.CD'!D=]1*BKNF#!@Y8X 9 ,#8&XU7;J)N=M[2-IJ[I?! V_WQA]'#
MRF.QQ]H>BS]<>*ST3/R9Y#.IIWL/UU]27@B^H+]4FQ[XE?HK_:^64P,AM:3H
M:IN>R&6*I=)Y2EDMZ_-BW>ER;@F%U?0!?: \<&* ?;& ;BC<5KHSMZ?$+L@-
M68=BC!3WQ[WSZP,K @O2O.HNHD3Q\MA#L8>*;!,#V]C @)%UIHJTDXH5V6 2
M7D4PP =$>!7!5&^JZ5%]X85F R^AQ8-6%/42*L3TDM+F5-K4.H4*:IU7A" ?
MT/%5TH4,1L)Z7[#&(3;(^54MZ$^UP55+/<'>0INBM*&"&Z$"IIPJ\9+H);>N
MEXHQ)\62%6JK]?9"+%K [^=Y3KRJCNHY"C+0=%1&%Z,1-(H.H&GT!CJ%9#1%
M_Z?A6*BOT;?JC-Y)M>UKH]NFZ!\>-@:^U$*LT\-8%<(L;&Z023/7&10A@DGV
M)DK]K]!G[AH*PD+RX3"6H@_B-P/E%/ ?VKY@X^$2RK:5YC-8UP$)^^K8UMRV
MTL@ \94BK/L0+'-<D;ZZEVX'KVE<L8&5_"W#9:W%-4NMB)?X4F\M5?;"^/1A
M;ZTMXP7.^,9!;PUF=SQL(<X:&KP'%K56$-5:FZ[6>L$\[ZBES09,\[C1S29G
M-O,_RE[/35AF&N:'B9=GJ.6+-9/-,#XSB)^3]M#=@] <3NQRF4>9(Z 2, M1
M?,>-FV:?[@MY@I)0?K-QLJ!VKVQ$NY+S1Y<BH_&7CW_E,OKZP7GE$W]J=UD=
MQ:7H=[5$]Z:+Z#\V+CBT!?-H9)&2+I_/N01=W+BO+^W1VYEDDE,"&S>C^]#N
MR<OP%E,,)9<T?HPZNC,>C^)Q(CSD\%UP->"]"^/]8T2O^-4ACD(JD= ?K5>-
M\B7:)?[!,IOWW>K;D=J1OL>W)\W[.3]/4V6/X,GHY<$RQW'X*3(>FB2L)81,
M.I%)%LOEQ<@H7X@V"ILB&S.#Y>OYZX7K,]>WCY;'T3A_AW!'9KQ]O#S9_DWT
M37I?^5CX5^$WROJ=_&YA=X9! AU$ID(83>G!*)4I!BE3-8QHX6 DD=)\/JSF
MNC'X"Z((Z-&6SN"MC);RE3)"6<P(Z93&115$4=%H!%1)G[<5[N)M^:&@8SB(
M)MAFB!)-U$@\=H1HDO^HI^$MJ+:JGBZGC?1@>C0]GIY("^DI^BM/E@!I_%!@
M*H!UC/Z =BX0Z"S>G*W8RC9%0;;)?I!::X4.S(T<(.MF*8V^5%_:+*5!_)!@
M $!C*$?L8AR048P(* .<!E8:@+ 5Y$)H *"?L-9:">P@$A+N@KG0W_H;4_\-
M[\&JR@GTZT!@ZT7]C:.AU$7YV6G04!N?/;^TW)VB%T9*J\]#023WA[N[,:\I
MKO_8[&SC'UOJ*AJ@>[=VQN5D,I]/7-)8@;YQ23&4]U.DY@W%@A?2B>A#J@$Y
MI/C]7NH*5'H=O<I";KGC+G:/[8@$F512$EU +4(7R%O92X41UPWLF##JNHN]
M71AW/48])C]D>XZ:0L_)4S:W0\'0QS$,[^1X"+9IDV0WEG\D1901A4=)"2S#
MZ!)E2]SII""F5X ,&+,DY23/\H&2J^Y:[6)<SDY=0<KG1+_JVA&[=IAX.U9A
MJ1XKE6\.DQ)BJT@<]6R_\F:S])Y9@L=T+)HC<\P .1#@#U&*%8(XP(8I3YUY
M_PG32XQI1@Q2#YA8%<7:3+/  Q_>2>?']U1CQ@<'F"L:%USWL2Y/*L2M_( ?
M_3;?N#_)OE(:N@6MP6_RT<8U] AW+250?V=H!A0/E!B62S&T(O IC+^2SQ=@
M0/0RJHPI@3$@0\=[JN";&V7&&7:<F6#H?0QB=G/\ 80&Z1&:QNQ<FD(=3\9^
M81:!-=VJ$'R([_@"LTBI^0[, '*S\F",E#V,T2.-I6BJ\5O4UKA&0*O_^M5F
MA;[S2(6^K4\@;@HQAB6TM?LJ=!7,?T,J]3GF5NI#WR&^5-5=(:U%P2TJ':&^
MP_A9[KX8/A_*]<%7F<4Z_NQ'*_9!X4$L8JU!_S[8\#9+]B%J1>-JFB%OZ@XC
M84C[)'I$0OA=\4(*40K'IFA&K6,8P2\,(?H SYFO"QHC@E\7IW.CD*\_SDUP
M]#X.<;O+U'Z*IO";^A[JH&+46E)N@>3 FB^*U.6&=S4\YV4UBQH,NV*D4F1L
M!7Y32_&;^BUW[?N-U?Q6R&BG'V0>Y*ZB>.I[1AL2-]JW=K]*P\QV]&)V,3>$
MANCU['KN:G0U?05[!6=M"BE6AJ-HCL,*+R<*Y)M0]:X2Q"T%#S$L0[,DP9WC
MW9A(-]/=;:UT=XYE:2P8/&5(/,515_)7,O3WT4+\80Y3#%Y8M/ I;B.I-0#%
M&F9FH:XXO/0/0=(^&SB!:9K82D3?CDC=1/C_9_38Q8UO-+YQ"=K/737;12^?
M/4P?AUB$/S86LVKC 0P3^E&*)O?C8*ANCD97LDN6:CGE+_UF03)\0?RN6/6#
MU]AX8_%:H" WL1[T'/<)?.X\PSW*G>#H,H<<>,>O2)7[.] 4FCT,Y;6^RG)3
MM/1D[*NOF8"\:A;*=\X.FQ^ARQ6_Z?5KXMPG&H^ %VG9F1EF#[.?ZJ3.8Y8U
M,UGU.HD^K1O ,3Q!H9@4+1;P+<%HDK)VF;*$2J_K\L(A>/NWQ$C6!4S% ZRD
MBQS;51-(*Q2((U:7\"G%+BK"9O/EBM60\$6M1C@,:R?>99TZ\TLC @=9K>PN
M#6ED5"-':$HR(O3G6:HT4Y_!.LRP6B.1S,=+L_#A?YD[CDIX@X@FT].OY7+'
ME%\>AY#4H+'-$OI,%ZVNZ4:J'JV-UQ^5#LN,FE-W4CN[[J+NL=Q3Y<.JMT^I
MC]=9*;226\DOTA>UK>PSZGO"HFP7=*IM&5HA+[,LJZ[H6="W[+P-EBLM=TIW
MR'=8'&N]MWOI:'U+G1X1NZA*?S%;J#R#U4XK9<7"F%2S9BPU*_%B]E45K-/1
MH-B-6!F=-#=966N_!F$164MMM;9%VZ8Q)6V71FN?PNP;GKC<;_33^+%'H>1=
MH8K?VQ2SV'"REN)T 15&DE27S6JM5/"+_Q!_ 7Y=US,PHSJ5A%^TUZAD-#F>
MG$BR1O)4DAY/HJ0"!R6?H1=@HN#!V!ZM>:;0E48D6*IU"(:]I@N#PKC * (Z
M)2 H8+-@_H)/F$Z#[6-C.<APSRFS$/0/.3>M>,'WAOLAX_WDL#*SO3X#\84Y
M9\VDG"435P\R5H0Y^DRSF"_Q'BRIS@O%.5=/;W<OS4NB+-)\K$UOH_FJI:93
MSK K1*DN1]060FWQ>5PM1/6*%1U5*Q8UI(20O0VO^OC^$$7\=N!(:%HJV\TT
M]3&$)0>T?8P"J;NN$GDU1Q&VU(&?M @BLD*:P_9:CVX'Z1<D"!TT-0N6FG5+
MS8>7$$![P%*3\:?LR4 KXU;&K81;Z6RD2NMO"#]GLE4C#01@T]7&>WQS*S#X
MO!Z26P391A[3<0?B,,F#IY?\?:+[O"VW1K(_>7?#FGHR19=2R=*!R5LNF!=2
M99]#L7KZ1Z_HZ$-?SJ]>N+YWY1T?=_H_?<V"CH4WKT_LN:*M+=]7[*P4UD]D
MH^?G[FS\^/9Y;L'6W_NEA?>BX7Y_?J2V= O&_#,?G#G)',7\R4LET"],S'\B
MP@$&*X#+G-M*:23<2+."R1L0W0I@!D.D WANA>-M<+S5JODHEI9<H"<[W8:$
M#W-[J&!2LL2&:('XE^JOY4P'$\'3UW+3RHL8:;&ZW"3H6+2E&'P)?!Z< ^=&
M."Z5I"!'DE^GT0"]<#OO'X)MW/F/(S!DM::23D(0,.)/0^]X\_>.FX4S@L8.
M)86^Q1_FGQ+^/8JEA06VX6X]=2-S$WL7LYM]F/FV*"P14)_H3ML&7!'W0LUG
MI=B@EU)BZ.R==$2!#T*IFOT<P[UC]6+FE[!:%=N@;=0V86/'\>J C:%L$*90
MQMUIVPF;8,/8?Z2_:AM)_F!%,[\38N?-&-O9X3'3\S96=_IJI#8K08V,7V<L
M0DIG(CH*R%J(\FL6:TC$6U$VIB._)1BBPGQ0;Q9J:MKW8=X)1')DQH:&T+GZ
M<1BVS!"0=+++Z?2><__R:-Z=#_S]+[YQS[<''UKOT+50NQVY"ET?KVW^AW_8
M6JUFZ/>._NGGI[\XWM?'//75I0$E/CJ;F?W7SJZ7GCOP;-"-6<UB#$/+,?>(
MH;\<%%G4XA]TX"/)E80'\-ZD0Q)@G@\:C.PD(286QA3_D,M-K\.=?SH,'"7<
MP6 2C\EW;KA^;(8 RG&H?/"$2G([KV\O5*@X?#V?;0-'AUQKV37<&GZML#&X
M,21<R=W$C5/CL4/!%_03^AO4OW%2#UJ"UFOK0EOB(]I(Z"9M+/09]7.N">>$
M]C#Z%KT__B1Z'OU(^)'_;?%DZ-_UTTCCZ>7J!O6>Z#WZ>/Q47'#JZ'MGWJ!T
MO$0QP:#"%!#@,H:+D=AXC*9B2DPG:1*CL8DY$9JG8K;8%>'7'<CQ(V]2$L*@
M4;MKT!B]:@T_I"7VTZ@5K;;NM=+6DD)B>4>H46J".D!!O1P)!FCJ\>L#MP?H
MP0":#*# %+(:ZBD>4;S"FQ(\QR]H6W"4_KSIUH5\X>&Q[;/;AT]N)V"5R]5G
M9K83TGU2;:*8O"9\6?CZ,'-O&$$%6HP;O;V]J)>4^(+$*F+7PW*[!I;H4X==
M-4Y16N'8^IQP; 3F]NT(?#]TM4)U=;:*MC5+*!-"AFD;LSSYZNU??0NA0[N_
MVY&?%W%:XO'Y6\^[\.M[+KV@IX(N?NJ'B'_]563?NRI52GENBD:67_KU;WVP
MH+@#/_W",R=9#E.H*%6@5S1A*U4B^3%97B- )9H 1H"-TL->0K"\%IVXX0">
M=.*&T\G1>/1]P_2Q:7"&'GH:TJF 44-28E0E)CZ7(=GI=2XWE<0?+I]GB,0!
ME*N$%]24,%[#\L4T 4Y(H&J^VXM4?!:E6Q@&3@V-AI$1'@G3X:@%7\;B)33,
MRP+!PG?HAE9G'0Z\IF$/&+BRY!CR</PZGB\5"54[GC.)&Z1MY8!<O#8\?+P.
M.?^8P&'<.$J5L,:P9$FE!"AR?JY8&2G=QM[&?88=+^TO39<$HS1>HJF2M]V3
M6\>M$]?FOB0(2P6DEWKD)?)Z^2OL(^W[2L)TZ52.UG5*CSV-H=V"N>"B?GVU
M?HE^A7R=?HL^24WJCPM'A1?;+2G1E;8.J!'70D\X[1T(1<(+H_@T"YOWD+<6
MS:-\/LI8HI0E9M5!P% ](]YQ[WXO$_5.>&GO.]E!'K2<3+$"[9$E57Y!<<&N
MID\3B]MC4 (+_B 2?0P_,B:/"J&/E'*.3 92.59,)U-B5J=R+%YEA*2.VKF\
M3ITMAD0-]P*$0\ 6!-B FRC9*D&#&7'U'&4TV;&/BU>=$%;0A&'Z1PO&EW_I
MC?=_N&,UII"!G TY"XZ8-UBP-$X5^?[+2AL7;3YPW>8K%Y_WP0LOH"6K'OL'
M0B@_>.WK2T+.^/8?HU<7CM967_72/_T+AFBHL[F&.4"YJ3"SLPG1&=&+^9T5
M2D-0=M(TLV4]90,F'BWC\R@%)E\^,TUH)70,)T054Y0EF'0*D&5-0SC5(3A;
M(-05'R>P4V=>(6?@SC\= 6Q@.RP60AA @B:YFN! 'B9@C=EQZ?CT.68<]D!1
MLP,4T\HT(#=A_J*9'9X $%8$73@@,)0P(D !6U;X OL-]B#+P$\)^-$ $U,
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M>8"%1="$VT&0+&*RF,DBAYU 2Y8X63*PD]<DH0LFN:9A\7!PV#S<\E;R19@
M'MAY@GU+18MU]"0P#(<=/&&V\WS;@\Y''B>RF^7BD'7\@_'RWP?C'X""N1"W
MJ(5?Y&_\ A#RD5,';3?"/G\VVU#%3ZY@)9L$Q4SX6<;*$5'Y.SL5==1H-'$(
MR;U,K2&1BG!M'6L3T5QSQ&*0+<WW0$YDRK;'0AUB:3?3W;)";30EFILC#1L3
MH2 ;329\I<7P%)1^[V3DFF6BVD@V&&KD<-#*! WVAM'VIIX9#75U_F-=G-G/
M<+E0(!?72_'2U<&SI8>H!^PU&*,WV'5 1F2PNTE_;GG.O#([:CEB><&"&\3:
ME[ ?</ [0([])P VT)^8_%01$4P_*CDB>4&"'9*$A,C"DN?,E&#4!#Y>I")E
ML>P('X(FA4QE R9HL$&-B)1T+"DII7(;-"*R4HNU-J!GR&K"F',+T8"GQNZ;
MJBZ:1.2$#]YR\M3H[E,G1X=NO75HR6VWLNOHSU.[1T_-H[]O6S)T*WFO6TIW
MX-O9&(B +)S.WP0B<7W$=D?VG)%59Z')V.#I]JR1K0VMB>V0W1#:"_=X]H7V
MQ@X93NO?SKV?^[16(W5(G<@FENBBL5J]7LP9W1Z#010!T5C$XW88=1).:E5P
M$B8:\0 F$',[L,VH2QA$HH28G"[6B\1IA=Y@S8@8,1' 3YU)>#4BG4@\!C6\
M.U#/R*QQ"G]OC>=X(I6DZ^-$^T0*2X->;U4TY+[I?!%*X5ZJ.PCQTF8Z,]XW
M3C7/S7U$Y2Q. .(&5@2V!O # 0$0=[Q0*(Y7%64A@4DYQ479?TYPU*CFNKA3
MK7PMG\^+U.&\,L^2I9SN5UN?4JJ37I6O7IUV@)0RX8"@B@HGI(V& G/[L5OG
M*^,Z$1[7I;!QPN6()M$Q"B:); .KJ\+IXMOCUUUUV^S9]W8]/-N3^MJ.0_K@
MW3WWK?(F$K$&NU;,*"[D?+7!EI&F;$G^7JUC=7Z.&PZ]M&:VN[03/CMSUL:[
M2WO7,G!W:6,TE&WQQWS&O-U5W.=32%/31D;0L'SZRJ=GW$Q:O>72[_&/V36D
MA^N'>_FL*J%JC"?BC?V-K(>W==\C5BB]G8X IW?#=MRJ4-;K^SJEG*-;H?39
M&G+IYJ[TX5B'_SQ>0CHZ'UQT*L;:W-UCN(E/2X]K^KI,)HVL(6>OA_6[@%UY
M0(F4UMDXYTX[LH%L:RZTRS\\O0M8#UB/6+'5,C![#-YXTCEO:27)1/%_B/YQ
M\2)IQ ^':&R\8($>5Q<_'B\4J:/-^+BFW&BT[1HG+0F5IJ3)24@#K>SIS[6$
M$TZ7MI:11'QBGY-U7P=[:J?;0#[::@--\9P--N9FFLF.6<9.&S3H^SLE6LX&
M1)Q.[V(<UP&6<SIZ:[IML"7<3,Y-D-4,2Y\-]!O(2J23VD#%P%I.<3L)&59.
MI1D.5Y#":++W,].ZZNS3[-UCZ,1)MJNNDVQ/P6F==L=$SG?JBN$LZ^130"M]
M_DG[%0V$S*3][DS*5P87O R-N6S(=<(I?MKH)Z42K'&_5IM.SEUC]AB>6-6Y
M\<N!H4RR8TF/)F1%T/"=[RBN.;;BYMWU-I]%)JZSY_J'Y2(,46FA,62()OU6
M9P$]$#,N/;*FP,G[YDJ^\63]IH&!:?F.08:Q^A2+_K3LP>3.'ZS?V^E(^K37
MU];N>J1WRPQG\46ELM[O";72?O.1T@A>23BM!RR$V_E_<@V^JEF9#4.OQS&8
M].1Z$H,[>[?/OJOWR. +@[(]OCVSD91A@]M\>[V,Q*&:9;$'[=WVZ7QO1V^G
MV"\.1.)M\8YX9WQ6S_R%LW: G?!Z[PY2?Q_8!_?V/FG_9OO3'>=[/F0NM/RA
MP]2PL'O6HOGX;/_KOE_4XCVSS_A>[W^79V9[NP*]0()G>T$O$^9L=GMN/M3/
MGP_;.CIRLWSZ6;-\';/:?$R@"]KFVQD7IANZ1\S5G\<R$ 8*+.-MIC5QKL M
MXXYP+W#O<QS7O";<D(OI<Y*<.AMX"6M!*WH=S,7:DYNH@P-<=+HKEDMG,3UB
M)4=F8"VO47<YNA)=1[I>Z&*[7EVTKFS7(>,!G7\1MC0A"=')XT-"0G)3-27/
M9.+F"5@(<%E")B$/F3!W.30$PU48NBI2/.V.!&SX,L^4^Z2R*6B"UP2;QA3
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M8%ENV9M^V/A-B^@.\5X5XBT[<BAA3=0@8%:;'>:$F9DA9H-U8+I+DW+8O;:
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MO/Z-YTJ?+6\/1<,>M<8LTRJ5F:[[W[XH;;SI_CT[1E_^["^ (7K,;]FWV?6
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M- ;%8N@W0B.U(ZLMHHC#89%%51X/RMDD!AHU9KQ?+I'2P#"73";G513'."L
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MW,'/D@ );@0-*(>O E?AM6 8K<4[P4Z\@[D=W<ZH$(VO/L8R>I8E7S'Y9$,
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M[<!&EE:*DT66'!$UDF31D,5$%CW0H]^>].)=O6TZ^ TB];2#F6392)8E9%E
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MCFI(^KSU+G($A_6!P8Q(6Y-L:6JT!^Z9C25F9[W/GW2:R) +[D,-<!,V$.W
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M$IS"[!KK:-!9!555<&O5X2I457@=41BZ5"P\1"K'3^\\@SZ@61)&TUP97U8
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M0CSDT7C'1.=UYNL\3SA_@9HU<(UBM?()R%YON=YQ8_YJP%ZGO%:[7+_<P Y
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M7,MVF,5\RO8&<O E'X!("C@Q(Y&+6$:"J;H4R47<6U(L]<A%S%MR% -2Q %
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M+;'^B=K:0FN6TVS-U4#-U6DF_/Q2S]'E=FK_R_ /]R=D,[5J\,I/KAH(X!.
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M@A*?49KB@/K$<E3-OHJ?&H.?,H+/?A2><3@X+O5,#5YY@L]161)V'@P[K!/
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M2ZA,HL@%C#97) 4>Z&EC)O!F@Z':R829)H8!C)IQ,44,SW#,@ (:N;JVQ%7
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M(%5BT!+FR"845+H\ER$+_)8Y=8FV*1E>D#8OOY22Y*G(V85?5%^0@[%[L6[
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M;;^R-BDM:%+;E=>PGW5QD&OPF\X#^.75O (79W7;[234HR/S73QCGV;N\C#
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M%ZYZ]W?JN-!U5URWDOQ;D7%=N8+\6_EOW >@NO/[_SZ= #> 5> 6<!NX$VP
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MT PMK_Q-DRO_C6>2C#637?ZV++#4%1F,];__/"CL[(S?Q7V(>7(/T!/T!0/
M$# ,C +C0".8 F: .> :T *N!=>#E> FL!;< =:#>\#]X$'P!_ 8V Z> 3O
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M<TU/UZ_NO.Q"^@^7MZQ,/X.?ATOQ0X2'KEB945'FKROO<>\EUJU(K%LI7%?
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M> R=06^))Q0-EI5#1J5,'!$Z51$Z&2JK&''"H9#1:%!!A+QE\7B)PQY2[]7
M0QJHU_1K]FG>T' :"CX>*:GRALICI:7>DNZ2OI+^$FY;R=X2=*@$@A*AY&3)
MJ1*NI*_ZX1-8SFP6QK>&=)K5@60L3'F7AFP+S$L+YN<)0=F]@3$PUK$\"R!\
M03P_6B*W98LH.%T*E4OA<$.ERJET$T,Z!H6&V+77TDI_&Z@1/!"++6)K@/*!
M7FH(CW-OOH9N 6.LTA E_%R <80S82#WIS4[6N:N*ZUIL.0:+4TI09RSYBI'
M>$&N;E$:_NB'*.RUENNAL9R[9D[NEY=U]/SPX=RS W6A4*BZ&[8>NO3ZG'N]
M-1(*M:W$C;XYO>42UIB56%MWR:CTC#.Y1B0LO$F2@_XRA8.(M(J)<G#T3^3\
MI0QKZ?>0:K&W7P9,*YVRD[\/[)_;L6COMI^T8V#W$<>??(4T4+(.%H\A/C$)
M;"-W^@&S$*26B9=.+ 0[+9,7#-"6)YE:M.VWR!62/2"U_<[/[Z):#.YU0M$)
M3SH_<'[NQ$FGZ.QV8N!TL':=8V*_H,4D/.R_C[7[[N@HL1/8&Y=);UPVZ8US
MY/PZ9AU(K;[[$D4;,T/!!OML_;8/;!C8_*RMT/@[2LC;N;GH<D8KJ:4_@MUY
M_14.TX8D_=5 SI+SMY*S9C"[X(\S"NB-6NT8>N/HA]C M$]97OOL)=HG)%H@
M",&^$!1#W2$$0F$W-?U*OX-(-;HLUXXJ^=7$GO;!.M'V:P[*3?!JL!5MQ1]S
MW"_QK[EW.!R@XS167;DW\(AR,(!]@6YB5V(AL#=P*H 5@2-DT".,>5[&O:$G
MLNXMV1!Z0HQQG!Y!=.=>&11D)V7H<QD49=VR/MF@C)-YHXYFC\?;*K<J?'*Y
M80CJ1)U:+K>\KM;OTT&?PJX;@JO$D#]@LSGE<@638PJ.2BN%@HHJ1<AN=_CH
M4<?0Z!>BDQ[;2R%W8)]CT/&Y SN.^ -O^H\\2+,#OF3%XVC=39:+0D/J,QDN
M"(. H>6(R1#566U*E55E=T.;TN*F%+KVVCS^'V20#2,]M0F0/=<S/*:'8AL&
MF"H" SVFM"D8E@?Y257&J)\A#=UH^/FAGWMSG_W5 Z\Z^<AYO67A\M9*?T7,
M7N$JUD$SOSIW[*VWUI];^>$_&HL]U?7)Y3]%MSRP6!^BHS! +)UW&:>4YRV=
M/31L2L:"OE5L1: UZTR+$R)NDD5IR&WA-(QS9DE7,7O*0OBKHZ/<,.E\"@4'
M#,1RU> [03F\1VQ4]2M/*Y%2KK!:G'JK12%7JG1(JR9#T!T)FYR4[*8D);G)
MIU3*YO6;H,GDUC"\QU!X:/0CIE_"!?T2IG7WW?3TL)*>[J5XZEW4EQ'"6\-[
MPEPX7]TOQHK)4UW#4M5LM6R);$\#R&M,C4L'L;_4XE<I2F52;(?6=G.)CUZO
MV^Y"[;#-M1WB=^!9^(7N?UU<6'\WNDN'[<X2IYB\#._4\9R&TRJ=6*:1:;5$
M_!#KAUAX<>YCW5D=:K#V)3=K_VCGXM9Z>8.BP<()R3)YF2)NX2(EGM)H$)1X
M8M% F$)04B!*7S2HU^E"+J?9Y7)"B%QNE].I=T%"*+G<JO(HY1Z%R6.V>LP6
MB\_G5RD5BEB,/O:XV9/'HZ%O@14":;-0_MJ>KZK.LAP&!@8 _5P$+=)L![%A
MB 4C-^7M&WJ(XD\65$-&PK*1P:Z_MCJFPEN[UXL?_\]EO:(CU])<G/LXMCI7
MOJRR9@G\KPNKT&N_?;/)*Y1SD0@LK_]][IV[9H3#L-B:AJMRIU:TAL-3+H2C
M:^HC$9%B71&.>HKQ82+/AT5YB5414<)QBWL+TC.^HUB35CA,=$#-81@A$N1)
MHTDVCVZ(5@K"($8@B/@B?9'^" <B$2(E)S$QX0.&"<GL?-IJ1;[56TFK I'(
MQ)0 -65^0<QSO":W!7_%D+1G?X?C6VM+%/_)\1'BL8C\&B+SCXI;E\%EGDT0
MSP?SX'P/OL%QE$/MW!8%RG!5?(T"A[@(3RWV$ ACF1;X00#'O:Z(/^#UNL+^
M8)G7E?('@<<5!@(4!,M^E3*=0J[-&$?""F-#0IO5[J$ "M[==FAOD"VK)'J&
M2+] 67>\+X[B]V6HO5Q83CP\8*#(1@PT@<+'IB1TF D<T4/X 5([ 1C,:')5
MPRJ#@"@DQ7>LWPP#DX6/S'WQ1Q]"^:K/!LZ_JKIT3D0?<2V8\9-'5SRYRMR9
MH?9NHL/5/#L)K^-:KGLX=R#W^FNY'[U^V8Q8\XTUSK_!E; ;5FX_/.+NS981
M,[?A8KQQQ\P(Q?0@7M8:?! DH?O8H=2I%%)3P)P&G2'3G[H+(7TJD>I*X9)H
ML+G84](:HP!=2*G4BDI-1JO%^KBUO*@T)C?'R^7N(I5,9A"2PM#H5V*0B@PA
M! 2* P.L3,0#> C ?> -@/2@GSA1U*RS!F+QN-5J8^K!)J?GV4)!HK.^>I)>
M23;^)=KHT7T!Z UD V@KC8J @!! 5+$=,ULS@;Z*<?Y@I4<W4(TQ0K6&5+:S
M1X*X8)@@^:ZAO9)-)ZC,DO1$83Y%$RCQ%'4&;"4>=S1([#K6;[&>\/?KA@F6
MWIBV2%O(20:\YN>/SN])!,M;JWRITN895VR,GV?)U9O;4O8*=T0/S;'[[_C4
M\N$_FJ*^2J8S'KJF_[I<T8JV<+A].3SO\'RB0%YX(7< %-!-F465RL=<;J7B
M7-2C?B\$7H\2BQ2OU#LY+L$03IE5-2=OASTV>A>["OC[_338HN$F!5O&D529
M%97*1UMN)584C7M]3DWM$@#(-263(U@2ENJLL9;>!7>3T5LJ.A$Y!<1\L6TQ
M_$$,GJ0[,7:#V,08!+M'D,B*BYBLJ,S+B@OR:-=M=8HQ":4E$NHI)B?F21**
MF+5VBIS]CR>)+?\=U3B&8$KMJZJ\??770C0@6T]4*8392=$ ":V41E3F2[&X
M.A9O@#XJKS)1/;F@9AR7E:( UM/<0WX&$2N?BU/7.-8XT6+GFJ(U'KS8L;AH
ML0??;7O8AA+!;+ KB/5>E\H?X+PNI3_H*7(X(0!&4U! V( %,K L0;<+$5U#
MC..3HHN#Z!/.:/A$7Q1SBS9=UJAW>]W=[H-NSCV$BI_R<P&SWA5S4I&LHS\#
MI^#L=0XZ.><SJ!CHT4DR2+X\V].R\ 1PCIX\HJZDIQY1ZS.$J6-G**0#_5%4
MND5U)?E?.,ZRB5AHG-6YK<T#A]!/*+PBO)*79"R=E+H\$P< *WU /?2@R6\*
M$K&%3L$5N1^WSDB,_")Y7D/N(;CDP0LN;)%%!&ZN/F+\Z'GTK]FYSJU3P^$Y
M&^'QV8B/],^%3;D7_D;H*HS^$]5POP >>%O>@@C9&;*JC7UBXWY@,FD]_4JH
MU#I<UM46.,T"+9XAZ#KNDLGC6C6Q+3\2W<S*= &.&:$<FQ?DF#/-F05JX]##
M9.,L,W;(QC?,F18$GW>2,WWJM[')D*EC#C1#2JWL=?6ZT?/6YVTHZX/[?%!M
M[[ CEX>XQ&:#0+K9;#81(]M@,.XG#VWS. ==15;/,V00NT 1=(DE;K=+UJ7J
M52%5)7UV=U$1\8<YDW&%8'O#>MKZF15;5U@<OW$J*5QVJ4\%5>4)WR$?\CE=
M+H^'"UFZ!;A-@(>$D\(I 0-!$#X0L-#GS3O">?74\V6/E(5!^YCZPZS@^,B9
M'@D[F^R>,=:2%YL8NF$K1O+KRHF[2WI^PR)(5Q&8QP'F6(2&PJ::&(X';'_[
M;=$U,Q@-;6N9=>%MM]UV_ +OVV^CJ7.^7EDQ^X+EE]P(]7.@W#<#RG._:Q]#
M)I6]3T9=C>2KPL/$4F"C--E@I*Y/<M(HQ43>Y)BL6 @EWY9:"W2<BE$(HFDC
M==JBXTX;LS!(&T>8#*V!D@Q]KN"5IBIH&_H43$WT2J56F/R46GD'/#)ZER0-
MJ"0L9JV43):>4BM_'VM%DI[L31*U[$T:ON=-9HVU\6XA<DI,G"1K(#TI1JW.
MS>4/LS>7*/5'M#9OQV4RXUXERLW%(_A.>M?\6=G\65.FP#%9ZAK]4'XUDXUU
MDFQ$&PJR46S0R$C;XN1(Z>@9_DDF&Q<7(JL%JJ<A2"=*@I,>E]'#! #_4]9&
MPW>CL945=KG(D+PGM$&MD;.LC25Y>?U<@1ZUE7'JP]>.TX-("2L N)Z_!12!
MN\1XPIOU(KW!:T &@R6LA@BJ^G3].J33.9P*)[,PG,P!=8;D!4>';)QA8U\^
ME,?1DE.):JJKRW3+8;]\KQP!N2 ?E&,Y=20E1R<FP62!O(4W9CK(G_2@G0'G
MDQZXLV ZA,>,@\D@=3(6)$+ZG+RD-?N7'Z^XJ[(H72]V5K7I&UI"H="L;>A/
M?_AP?:VW<O[2UMM^..*^:DYA-DNA(]19QJBS&]Z*!D%8='*@OM[G$[G^^E/U
M2*PG6LE7OZW^@WJNGA5?K\SW.)O1DL?)]>NDZ\%6^',0$94<6+2HJ4GD%@Z-
M;J-E/S-@H6]A<B%>.(17D@$1R\=I/@% =H9=OU>Z'M61Z]E<1T=[11W1ZQV3
M>G,:X1@[OXZ<OR__O/,+\P(+YKFS(H8+)G'WM-$W^2WL_K?ES]\CW1^#=(61
M!OO3D^X?'7T.O\?N/YA_G[%YA[*8D2?GETWBEB/HO^!>? BH@?M9EO(N Q@N
M.;Y-"?<0-4*Q]*2)SHGIYOYX2W-Y>7,+/I1-EC<WER>SXV,G/C9V6LC8^;G$
MI_7U;.PT?L_863<V=EK8V&'GEY>S@9.<1(GOWG_W^/T;&]G]&_Y?[[][_/[)
M)+M_XC_O+WM\[/ZWH@%X*7"(&@1!%VL H0GS))+MQ=JH'6OC5N;-2==,88T@
ME!V?YV'72.,_/C;^6UB/TMD5D/ E$$A(0B UV9Z4I,"Z,2G0POK5>QBF&8RB
M4L@0<<>D0=786TE^X1!> ?]&_$(+2(I.T&2Q:#0R;/F,Y@@HC3_+XPHK<8*:
M_1)N(,4,3+->CWP729+B=,)G+MU[<6O%G%:_T654AQ?.PBMB#VV8NZ&A)E6M
ME#>V+BDCQN<?N%[T)G>:UENB]<@H$AV&9#0@@*48"&E!"CMA8C*%T9<C*N[T
M-IH)T#CZ"7Z3OPAD00<TB+83I3 U52QIB-1-B<=!3(BA6*RD2#:$EXB"1\][
M*0XD,AIM[9H@) >/!P!*(H2&X$)1I>%!G5"'ZH)3AG"=:"LYG)C:GLDDU  W
M<)%4D]OKQR%G; CN%CUQ&;E-D<<3--<D]%!_53 8\L;W$F?6V1FJ:7H6_ATT
MP"; P;^+=F>-\BJTJK7]4/7):@2J]U8/5N-JQ[3.(7CE4?]Y2]GZG9Z>F2-?
MG!T^>_;L,,4EF$GH.O/LP/"8#<&")%*LO19(IL:7PSW9LPR3;)B!??;D8;#3
MB3QXF)3W0\P*%BR?T#&1/,:GC4%1D0^SW#:^(B0Z[J5556;D!?1/F'S])<7S
M0^CM'U]Q?:HH%.;D&WH6:Z V]S5"$.=&FXY.GW8@%C+L6]\Z<-O,M:F69<V^
M2N+<EO1&7-THW=?;5QI^?WC'5%^JNGG]K9<7/=L7KNO[X>%:^Z#RMN,5ZP?;
MZSOG*,1(W3_=BX*EM%\7C_Z)NXKK $;@  .B6,)U<%,%;+8[K!!@69/ 0YY7
MFAS$:B="7:3);4IK6(_#2CXLDQG-)I-HA$:CQNYPT/02#>$?::Z-D:@AGUZ=
M&,Y/O='#9Z0\1(ENAC&* )9:#4Q1 W-78?.V1W.[.U:\L6\X]]\P\C]OPZ3Z
MXVV/']R"3+G=6[Z,W;H3BE]\16SP,[F/.V')EBMR[P(>[!Q]E?\%X5(CT;=E
MQ),2X0SQ?*6=]ZL"6%'^D/] ^0'Q_>J_5W];+;]%O$]\V(/K[?7E5XHX9H^5
M(Y?=58YV!7>6OUS];C4G*Y?5['1A65!6AB+!2)FO!LL#D4"D'//EYH EB*T6
M"TT;TYE-9F(UVZH#Y5Q1L>SG4 1RH"2?"I""NX\7Z8NR1:CH:;B0\.KNH\5J
MN8*.@@70> ]X D'>;#%9+6HK3^LK*I1*#;M/MC89]_G"E7&GLY8-K]$8CL6R
M<3'<'4;A,$TK!-NU"+^A)68A^=-\TTS8Q\1-::8<G$>\$L[T,,!VZ3\5(A)_
M2_W20-/86)#P++6H:?)48BQ0N(MG"7 4_8XA^$@+H7I,U>D\ROM8%"$,@Q!/
M2(>>L+*LFC"V- +&TF%V_C;HG)Y[9J9#;[:4<YO/+5Z,#S2MB.WJ6W75OLOJ
M;EJS_MKF%Y=OKFJ?/:^EK78J;U@P<JC= 7T^5QO<O"!DOO2;"_G[OGU[QHS(
MS-Z^ND6+9I]?-FM-?TMBWM539ZVI+NUX:LK2S+S:LF["":5Y3@@3H2N":6 N
MO$NLE9E4,7GEN]YSD-= F<,-#8HRR*M,!^9^Y/T:?N'].B3;SPW*'U0\E#G0
MS-?''JY G7:K/=-,(TV-#E>F652J,W-%P9AQ$?L*Z1U>1YGCY<YW.WG9])WE
MNZIW-G/R*EFUM2I2%:GV39?QS>8J2S4N*2ZFG**-1LS1:*2TLZJ9:V@C NZ8
M/IE-HB3EC2XB[O0-ZFAQI*187<++Y4A3- 1%47/*_8$;N=T::BH.P;U/:4 X
M?)K.2T'Y,:!):I"&LE,2\>RV<V:TQ-/IVHYX6=F,.)VU'Z6S]G/B8FUW+:JM
MG5>TSPW=;J4N3,4K&;(ZN2_.\_9X7M_HBJ,E$6[>>90'J.JAN<.UAOQB"092
M^Q_L1+S-GN$!HIJ8@&1PZ6PE@3W/7H2OAO^#HVCXG4[#P8$>4X%Q&-],B%NQ
M:&(!"_$[;":;P&?A_V2SRK;[>U:OONUG]]X9LKDK:B/5LS?.]V0OZTS,:^+N
M.+=H$3[@6Q[?=<&ZC;4K*==MO IR$M>UM=1.Y7[[XYZJJ>=577O1[5F3T^J<
M63W]?/=Y4ZMK%CXV@?U65!9WUS'^V]"\9/\8^U7-I>Q',47R_(>)Q5\)FHC6
MO%R,R8M47GF)K8@+F^'ESAN<]S@?<Q[H.*'XN5/^4/&!*E3O?3B,LI3CJBC'
MU1*.JZ(<U\$XSAOSHNOD+V??S6*9N#.P*[:SBI.7RF+6TDAI).8397R5N=02
MPQ@AQFT0F"$$GFQI%9>L8]P6RH90B');*^E]=5)-]3Y28][]-+P-R.E25%=&
M3ACKJ,QHM [!96*1ED_*Z'P:!C)!AF0R0/%Z!:U/F]1R6LIX+44\:V%J<TT\
M&BUKC/O]S7&0%M('TZ-I+IV>&A?+NLM065FG7%:$.;=;X#G.$?]<!54J@2+4
M<)W3QK@MS1;D2#+J>QFMA\( ,U4LY&+#_Y<<1I-N>7EP LN,LUC4!+^?J[Y/
M>G&?,-X9V5OY>?G-0[_:WCF]L:BXK*2UY]@3@WCWBMBU*U==U;:8<=354X@<
MJVG-R[&+*./HEL\QWK7RDOL313&[:W']XNLA='Y[AC#3M&5]=8F957EFDH19
M3<FX,"/<%![C)AV1:.7$9Y\G1A0RE>"4.92+9(N4^^4?R3Z2*P_4P(<<!R*H
M7GC8BA*4D2*4D:I)OT8H(]4P1A)B GHY\6X"R9([3;M<.R.<W"ES69T19\3E
M2\KXB-EI<5$P["&\2E3*96:Y7#:9J?0)9X3SE3*FLF0MR$*9*D.9RC?&5+IG
MB&FF)0SSE6CFE$F5J.HF[HY*4"&5"B@@TX(E',]N55U1'+?;B\KB1F-%' 2%
MX&@0!X/5<;JV!Q45U5%>VRVJ=#H%8YFZVCS+#*>_GU/.Y!EE)''F>YF$0F%]
M#Z](K.*WP"!#W(["_VO%EF>-;S^&+^3.=GWV7G.G)\QU+X]?NVK=QGV2C)GR
M@B1C6EL;6O,<X1R9ABX.9S3G[F%LL*(RK](8%[1U,YG2OC@SKS[&JB"\F$O"
MPZ,'@!G4BEXDR&0J/6B"9"#IR:\"],$DY(@-QEU)#+*$1 _)I,\+<%A3D30Q
MD4J3TO/"EK[6BU-76>5&AV%>2R0S>WLN63*_VJ_4+4@FY\Y:<Q%M^9G<%OCY
MZ"^)M[) U )1)614:BU %I-B"&T1U5IZ1*^%6JV)8F8AXOL8B.^#U( .<\!?
M)@@6D&@8?Z08C4;$AJ7:O-02C-G&'9K*<0C<;V+^.0NO7QXJM1OK6Y-!I:Z9
MGY^=LUP1XUI+?:6(>&"?<A9423PP*\MLP*-_)_LG^75LI;\+/"7&;P(W8;0#
M_ #L!SB$ G@3P (.@1#$'!*  >%MY/WT&.*WD.H9XJ/17.PGQ KY6JT@F&3S
MM%KD6&L"1W'6U&7J-6'3/6C[/@R[,/3B!%Z/M^+3F,>XR,U4W\"&L__H8494
M.A%CDVOYD+!2V,;!/@YRUH8_$L9T/0<$/ M827L<GC6<'5XDG.MIR&.6]X !
MPH<F_O^PKAR5Y=X/K(:RLJP8+Q/%7()\E,5%D5^7.P 7;:/;V;(R,5M>EJ7?
MA6@,\U)#;*Y@]], F(@W#()!G8YX?SZ<#SR0GB-^+-_#Z%<._BE.O1U );P5
MWH#Q+-B)4,#K<OL#09KV%U3[]7JOQJ56^64RK]*E(N,>$$_R+8QE?% O".YR
M;G]Q#)0*I:AT"/U.-)24%".+>;_;^8G+Y5:@[7@(CHAU03K3=HIX(J)6GP&@
MV&5P:AY7JY6/9U504'41:;$Y]GA)S%N:(/>YQ-'A=/*"P!D"P4!" J,D7'6V
MY\S(EST,^)0Z%X3V/0,C= 6C\"DU;1N$7(^$5DLOR7[:PZ8(AC\%PA?YKSRZ
M>(^)TMW@IVL#&(2S-&N0HJ"H>/(LIXG^O#_W7F UN@V6;CR?#X>U2U?GWHYV
M?+1IW=JZXDW??IHLG^:J793DS$+4M6*7U#V7C'PRY])<\?;V7/-%R>#F@=SC
MX5#C:CQP=6<X]\XM<_,]()O%>B +#A]30YBG%!F(-2:O2^L/^+TNES]0X77%
M_(&LER9?RKPNC3]H]KJ<?N(ANTK]P927)E^.]PG/30L$@S&M1D/3+YTN5VEI
M3,$' GZ.^-0F<T#F]V=#@12H@!7,4TL7,'OR6)_C^003J5A(I82$YBR?GU$0
M^@T4>;V0!FGY_TB:G'1NGJ1HDVEZN@*U51 :FLG6R#,5Y1VND9M-TS,T>Y(>
M[<S0I$JR)5%V9#7<WBO2*>/&B\_]H#!Y3-,EQR:2UQ1^EZB,[8S*'M![3#-&
M93((3$ZOR^P/:+PNF3_@\KIX?U#K=9DF45.F,)L(%0/$_]I+3'!&,C83-4Z7
M[]#D^U^7\A=[93QWY-GBVFEVY[1F#VKU9#M=32NE%_OFJ7"X6%R&+[F@/10.
MA]HN/'?GECFCHZ/'Z?PG&]72_.?NW*LT]B1:49=WCQ<!KT _W$HE&>%N7$@*
M*W#8Q>S=8^!O8K'6MM"&5 &X6;%9N3F*ZTI:@W,"W4%.!95V9;@JR)$O>YX\
M)>326,SK=:>*9#ROY&*QJ-?C";N+BNQ6K\O@#ZB]+L$?C$8B0^@5,:-2FE61
ML$H9CD0"-KO9%HG:[)$BPT2VY#R>(B08%!&5.F [;876!/5=:QDQ&=,Q@E+4
M=H64MD*^[87\%5AP9L><VORZ($AI7UX.RLNE= ::/$7'-B6['$Z:"Z0IOE)W
M$(4.(=6.K$>XU^#[SFOVY)YN[2H;.9F8UY"[N2FZL@2U>)*SFJ +*AMNE#HH
M$/[KR$CN\?SL8#.JZ8W7A,/Q>&AI;CI\8&G9A8#TUE$B5X_3WD*:?&^])/46
M[(KOB2,0%^A'"5LY43+>6^3*PZ-GT"YVI8/-)']&+@R)%DSD=B*9$!,8)(KD
M!A$BC.,3YC0J*\<D_QJB'8GDIUE> ' ?\3/(?AC0Z _A'.Y?_!K""3+PJ=C2
MP5_!W\3_D.=X.[$3$?W <;4AP\65ADP8;Y'=(/M*QFF0"R$5=,(KX$WPWY!7
M\RY^(8\I.A( M-NM,MXL(^S!\3(N@)&9(C_*L(S\= 0H^"'$BQ:*W @!\<.X
M?FX;A_6<R'!.CXAZ'NSURA*R];*MLCTR"C'WJ6CQ\K"+/\B?YC_CN6UD _&\
M0NXH:-P>^["#YG_;APTL;$?4*>$ :NE1M%/R;8_M4ES]RWQ>"QV:H"<-TS *
M80KU!5#39[DUN4Y^S3<_F(?/G'.#P@H+1J=B1C<GV7^4[3>R_7Q6/=F/L7V6
MT<GVXP4ZLVPZ*\VF(R:%F^P/$3H[H4;<\I3L-=,?3'BJK%/>I>[2=&D[C&_Q
M[YB_E"M_S;^L_[4-KY"=D#TEQY?CS;*=5JR0*XSS95@NARJMUN& +J!*JD4U
M4JOEVJ2&J'%!XR,B2&-TZ)U>)W(ZS; 7K">="SB3T60V!B0#GHPTVC<54K3*
MQ*LU&J<3*&0\EIGD2:-H1$8C;^*29F@V]YK@'A-<SQ+N7 4ZI^V)'F*MI=GG
MV/ DXU)7'N,IH75Y?%DR*.WY8 '[R&^"<12"@7Q^49K"C9.>L+*8$DL[@Y#:
MU#:+>^:<,OA>&/X[W=DS\DYO=7GN0.YD6<V\L&;&)=QUWUZ^N0V'PXID)'$Q
M=IW[;&VZM$(6SE->]B]&^23MB=&_COZ=EWJN@MJ'-%^,>YN? 51$[I>!G!A1
M$5G>&IP5Y=Y7P%>Y5Q7O\YB0A\)86*S6HB*/1]BGA_HATG$&QWHG)#0K(R.-
M G+(B*L<8)C:L=)2G\_KC83I@>GQ,H4I9;:FS+T6:+'$-"FUNBC5[8$>CQ>G
MB*)Y/*9, =7CWI+25"S6%=\:1Y_'X;;X8!QUQ_OC*!XO\_M27J]8!LL2S&YA
M1&3N#"N@0M,>F"$]G/^F*7YLA6 JD=?38YOY-0\]#?FX;*J \TB3NP9,?LG*
M"<B#MC21B<3PH=/C&7I(QNK%4DU-CY+#_BU<.B+K6S7RQ/.*R%!DX0607S8_
M')[6G_MV8UODS^%T]T)T^]H+(]]NX6?DCLV9?N\U2ZJJEN2RW2WM,]OL,V8Y
M.E?;<]>/90DQJ91BHX/((OX!TB=><+^XW.>'I_P?^%&_?]"/K'ZV2(7N6YAZ
M\3+3AR@9N3]@9>8.HFHZJ&%J!\"@0:!X;2Z74V&Q!H#HA3[O:2\:])[R?N#%
M/F_2V^_%7KJ>1.N'**#I5O>1D72?+Y\:-Y)/0A@S> JK10KK00:@/Q\!E52Y
ME"9I&3_&>49N;MLZ,G1->_LU_-7T<^3$U>T\^O:+G1U<.,QU[,1+"UOG'I"V
MINXJR.88X]0THXJ/[%]*J&(&Q\3$#BV\G+]"BQ+6\S5K-#10'"#CV*14F<Q*
ME5*A"M*1;B3C76GF@(&P*W=4IU.KAN #HL%@$!3$)X<8RQ7[";>JGA[]-3 1
M3G4HE09=2H]3".GU1F F=Q ,<)L!&A(#&PIA_'2"N3..A'VXAC$99;@LY<54
MXDPA5JPHZ&4^CR]-!C?-K"&JU0\AM:=MQ'Z&Q-/XVA615RU=F:L@EEDIPK?<
M&8[4??LQ4HU\2;CFL15KDB/_&'EK\1YE;F4(781^0NC21.APB-&E&HS-U+']
M!K9/G%^B$NA^/:.;G>R?XI> &O"*>.,"M*!T0=T*M*)T$]I4N@/M*%5J9+)(
ML2P2X5S5+JL_4%/M2OL#0K7+X@^65=,,2XM5 >+Z>-#M3ED5*3D*ID(HG4)R
MO0(J%.J CWAQG! "01@,^@*)8EA<7 . 7B^4Q>-NMQ#(NKI<6UU[7*==O(]L
M?.;"+E==K21$AR?DJQ Z4B^8C6ZV(27\2:N7&?,5& _TP!2KKI*FO&:6R<86
M:32A2D,YHG&L2@^R>5":6I>4)W7(@L^[87="+K]Y7VW)[+-ON1:</_+PH@5%
M[_QC7J1AQ573>7G9WEVN^4O0XB7S76CODNT_>NQ A)M]_<DWK^-S+VYJ*PV'
M87CJ9;"1W_;&KZZ9*XN@AGNN^N'V'OCDIK9B2'Z,MF^BU&Y@=LT:4 S+Q;;]
MVG][T?7:'ZMOU^*KU /:&]6X0SW-BV;*9QHN\N)(N$'>:,!154@7<6-79*Y1
M)K/;;)"AB!-]1=42SU&>#1<[G,YHM!C[BC78Y#(Z^8@L:MSLE&V.BD[8Y^QW
M;G-BYQ"^2-04=47A^NC6Z)XHCM(#<X.VE,,^5P]3Q6"NLJA!+XIB9J\>)O19
M?:\>=^O[]'OU&.A]^J0>?ZZ'], ;]("@[])CO3[8H%<FE$A4CBJ17NE3)I58
M21,JAB4A3%,VA_-2>%@XT]/#_K-ID\*\X7!VX@IUVK/TNY"%)<4DB:N9IJ(U
M&J'S7GX?L)B17"XYGGY3B.77TBIS-I._(<S-F L-:%_N&[@61F 1O/C#DRIH
M[6U$X9%33HA&'CTV?/%=II%3L'9J38L/!O[X!5R<.S'Z1NYT34M'=>XE6#X;
MW@(Q-.?^<&9_[I_5N?\:LUEDCZ-"O8Y;1T?'9M83)08CG26/?&=FG8T]=DV#
M= U\@%QC(TH0H9IH:4>4?(_GR= K%HR>X8+4>H5E^<R'IT!AU6G$9B.^2732
M?/_4T3.XCIV?R)]_2R$_H*8R74:LX^KOY!EUXA>8=6S+G_]BX7R?Q\B3\WV3
MS@\3:SHY;DV#W2_ES[;;% IRMGWBV:/?D*=YA)T=8+F>GX&'V:H(';5>&TH-
MF)G=$S)]*NF:RW7DF5[G;P$VXDWKCMT8NS&!5$.CGQSU^C.&H='?BW:=D.%5
M5A72:HM]Q;[(OP(!4UFE MJ'H.*(Q>(<@BY19U)#H/,5EX9"159M*4LG*(UG
MNDO[2M'>4EA*#1)-EQJJU7H%S3\NH@ON:%90T=,X!?2C_Q9#+#]0OT>/$H3!
MB82W6RP55D13B*P:#?G-&N+PT.@73VK)$4S3ESTTSV@O/H71(0Q/X<\Q2N*3
M&-& F0]CS/B_D+ L"; !FF-$+1&RQ40<L0_SR49$DE%!5EO+[$>F/XG=#8,L
MPZ@04Y4*ST0M9D,A'L_"DM*DN)1]!$W[0XV'=]SWSF.CNPY?><O"6;?LNF9N
M<T-RQ;S*KJGK%TU=$<EU_O1&KOG1A[<>^-&3EUZ>&[WECTM7/WT2_O[:7^V^
MY,-Z?672?OGN:W9VK[^&59+-M>/+\ / "AX6&VNL:\'5X%:P"QX !U1RO=UK
MKT'8*JB0%9MD$,@$EJ25,&1III9.9Y+)]$A0$"HA0'M4K%!99/-4!BMW>U)!
M*]<HK$+"8+!Z80)FR8"#>K 'L(HP>XB?1TLJ6AV)@0%F22<V&/+Q4"HZ8N0/
M9%F&1T]/?LU)#5.DU#RV")0JU1%$8Z)!(9TRFM!/7\^MUZ^>T6_MFCOS&F7H
MEP/KZO"=YY[:M2+W\>8??;(7WG7H6=B9^R+73-^ZG;RUR.\"M>"<6#)7N5R)
MTLI6)7I*]6L56JJ\4KE;B;/*+N5Z)7;4PD29Q<8Y*BH%FL*942A A5I-1B-1
M=]'57GVE(%-P6K\_73IKCQMFW7WNO6[L=J>!#Y)_6(PE:-6)(M%=4V/4:[-:
MPN1IHYG23"H.8NPEOA=]_YX8?7D:)(D1&<FF? 8HRQALM86E.%Y'JK;2D0J$
M,HZ43I]Q!+25,QT]#J1QN!W(4:'._E9:T>,Z 1Q0=Y@<&%Y$>2^;GXH<R:_=
M@1ORRQGR 7M6X8;.]P"#M%N(/4^<&F(Q<I]!8), \$)AV;0$K^KX34/YLP=R
M_[KBQX;&-L>F58,W7]]NKBX/-4WK7F*9';;G?@A#TY?QNT(E,RIKX(R;PE.N
M=>;^)W?3CW[(X7LNN>^IA6T&_06-K4TR!)^$M\-*U-E^*>D?)L7P05 $7A.G
M ZC Q1A#N\6>44&%%@'!:'<XK%:77!='<H-1)5?H@"!7\"IBE8DF>T9OWV-'
M=CK!8[<;.>*0*[2$WGR(\.@W8HB*!Y53JY/-RZJ@GDV\&4P&=HHA9#31GXU#
MHW\2+?244T8(C+#+N->(@%$@_968L"B!C7AIDP99R>@G5$X)^<C7,&-?NE95
MJA8W .GR H/9%HP4%B$$I>\@)3B\ZMZ[/XW\-"!V7W[I_G!\JA R/3'S0O3W
M7^7VCSA_OG+I-^CE5<MVC,Q&!WO:;_D;C5',)M)X!Y&K:F(N6,&[QRRB1I\Q
M4<E*OO54LBK)AC9./N1TST(V>'H.I(>Z[+\VOF+!UJ>)!RU UY-6@T&F(Z+V
M",!FFHPM4VNL@L$Z-/IO)A&M5([BT<_%*BI'L=B8S6"QKBXCX"1&;^#3&*W'
M>_!!_#SF!C$$N!OWX6V8P]B@H9<;AG!*))8YO?@4S=D;D-:=40N"I69*<55)
M2C:P"B(]A6!JRBCI?X-@A&3D&RR",9TRP;,__>2;A^[_XG_AKC^=N6+5:<3?
MDMN4>S'W:&XSW H[X#1XS\@L=/G(#4VY$[E7$)-V3-L1OK* XZ)&L(FV41M6
MJW404'U2I-9F:,(W5FL37AW4Z02]7/L\W9"3X4[/4!*--0@.T14P9,^FI.<+
M!H6!O94!4U5BH!FJ?V9+8.24VPQ,Z\BA3]XM[Y.?DG,L2U5M-&=H=FH_RTZ-
M20PE+7.)L7D@(A ($U%AR)@H1A= LZS4M%1V<6S)"ANP2$-XI7%!D3WII@L;
MXX&RUI?^TC)O-9P^2)<SCI0O8ADR%AH"(6_OAXWBT>OTUPIW&'ZJ?T0X8)1M
M1!OT \(F [=,OTQ ;0(<-+]L>-GZLNT;*R\&^X);C%=:N6)4+'0:\>7H1O3?
M"-MYMOK=S%:_"W2HF!,6K\_G,%LL!J,Q9+41F]SFL=M##J?988-& ^?0<2H5
M)_<FO+Z$#_E\P"^W6*UVNT/E=_CD4"_W$H)L(R22 PAM-KO3S@AK9PG Y#Y#
MHW]Y,K_X]'.6^DLV_BW:Z3D)1Y<#;74,.A!P"(X]CKT.SI%/^QTN+"=BP]50
M.^;+YJEKK"42%A.G#>L*41NZ 8E68OX>$(;9:GNZ[I3&38G8-,!)Z89R.:3N
M+BP,YV@8SH/<CV^H;$[[BY))9R9[$';.OS7W;&[GP\YRUD7X8&XZ-#V0*HZ6
M.YVMS^4NO(0+P__)65!R_SS28[2W'*/_PO_#WPP\X'W16:.^2/VR&J_ J[6;
M,-;[NGSSB/NJ=CHH+<1&A9D0(ZF0FQ4*N4*ID"L%2A1E2*4VJU1J Z Y:;J#
M%CAQ7K2HB%.J5" !A]"_1*4S(?]084B(QJ?A0: F!I=2X5/>+":)>!Q"SXAZ
M'Z *?9_B<ZK5?=Y\$,PYTN.T#SMI@<RS3AIUM+-Z8 ULCI7H;>HDL,BCY!%3
MVC+BCL6A85I*#<0P".G*>AF1A6PIOHDNM$SAET*K9F8WEL_/O?T<?#S0-[66
M2''<?U[5!5.G3XWU3NF'OOOV]KX!MX\LP3\Z^OB"\^\XO.B=W,]R+_YJ!Z'@
MQEP[-PW?24S1?XBF:Q70#<P<TN@]1446TG?A$!V)1C+H0Z% (*IVQI$:N,,)
M=EA+1OK6T&#H4.ADB&-'3$IZHI?CK28*3VKR>(O<A/V.4T*[0UXRZ,40J_L0
MH4=\7JCW]GOW>=_P<EZOQ6JV*K7,Q"3B^1QC8K+Q3]%,16.W"0Z:3IH0, FF
MO29LDOAV@H(9B15"#\RI2C,9(4E+23CD.=I0:Y#2",.2$6D;FR2M)E9FFCG)
MJ6J#)#.JF21![Q[;.;_3[:N+Q3-.SWYO5VK1K0^'8JUF(E"F+WOXA2F52WI6
M^<L;VBM"2R^Z$-\\<G#Q>957H*='IBULV?&7%11W]'=$"UU)I(H='!;%K!/J
M?1I#QF:W"PHCK30HL2#AO!"=_% I56H;Y$R DR42<BB7*TQRPJ]VH%;;M%AE
M8*4IR/6&+WR6]9:M%FRQV)4* &4RE9Q6JY#+E42W -5!U?,JK%(1_F>,:$N3
MT1HCM@VQG(9C+.6!:F!F3=86@C*Z0O2;;=$QW<-CJ9Q#=1J:6,$Y:O 00QS"
M>_]H[<AZ0KJOXU#^8)E!NZ9W>^[/;K2W^1IM<.6Y43AS<;JDL\JU;/&B;T?^
MDK<HMY+1.@VFQ<H9+CA7MDRV08:)P2ZS:K:KMVMV>F17M5PS#<E$I3FC<>J;
M'<W8.<6 37:[R00:V[74NG3P/&A4**AUF4BD5Y?HIS@-[5I>IM)3'VB)KS79
MVM^*6UMQ1SPN5LT:C)!!(P(ZH$5J7N-*T"%TH(X.NB)IO6JK:@\AU!LJN4HE
M"I8^2[]ET'+2PELLHELR0-U>=X(:JUX1BHD-!1.4$C0U(1C#C%"6R&8<-T4=
M06)\!E.!8"9(3=%9P:5!I W"8&/!""4V:)#8H(W?M4&'F5_$LIIHY#M&#=$!
M:*&3304KE&VS35JEW#+9)(U,3HECB1N12B%,N9P:II=<V"_^K#7]\LUS^O8.
MKMNX]OSYN:^WW^F,7UJ\9=V3 PVS2IQ&?U.X=59#JZ?TZM(COX?.E?/W\#='
M=!VSK&VKRQLWH[D]%V:[JL,9[2-O+;T**W^RZ:''*DH](;5YZ=343"0_]2 $
M3\R^Z,(+0NNN!(4UE/@@LM(UE,0T6$1LUR$R'@Q$<G\CUJ]UP ;'#,=2!U8[
M7G.@?RG@(XZ#OB$'WBG;H;A;@==H+K;V*XA(7ZQ9:,6<PJR8HL%Z+8 Z"S7&
MM&H7&1-/$5/6Y9++[=0MU5'C0K##/CO<:Z=.LN:X2DY%BHJNWTU3Q=A'''B5
M5X4$E4\EJDZKN&Y5GVH;'3&"7N\Q<D:>GF5449ED#!%G]VO1Q!;GR=EJ.BQB
M%B E+1\E8@\G)E@H>:FT@8HH:@G3-/R85)-E?":#?$F>;8AU&Y!\6O-8IQ$W
MEGLL#'4/'GXW=_;QC:NW+=MT[]O7+VK)=5[Z-Y3Y[*/__=4[N5]V7O\F:MBR
M]97];YY=?W7!:]/1%<_@%7%9@JFX.MB@[X33]=S3Z&G=J^A5';?+^"AZ3(=O
M1+ KM36%]A);DXA>+/?[PZN+]%XO**[T.N$>YVDG\M'I"Z\,^F1$O@AL2 AT
M>;0@=(%>TI/4*XM19VQ#BKXQ'0<%]O?9_-I*6W%M7<967)8@'X%PQD8'@L;F
MMB%;.1T%L;PK9B/#H'QL&##-2(4TM29Z8B::Y3UA>9'E_^B Y5F]'<9^>\'R
M,G>X?4[5GH>NOB>6+-'TKSBP8X=HG1&P)GO7F=WG1?>]#%=^">>V5'B*G9Y_
M'KCB&@3W]/_XY*)FBVK^_"N1_$TBMUDLAU S (Z= #QQ#]PZ(:,/)4('0UCH
M-:RG+KXID !RXN?+W53^F&1J(;'>  T&%= 'O $4"'@+81:OY!Y\)J:E19Y4
ML7FI5^##^S#:1N,FE*WZ,:8US26[+J16F?-\^SGS,50)%DUI2.>=+.8)2REM
MDK++2O,[TNR#E2(>3+"&@V,U? K!$]1^[(ES!R\8K J4MUA"VN--L[VNWMJ^
MS0N7X(/6W#>/_RYW:O5=-\#IBZ?L_(LX=UWNT.;+9IS^\)7G/2QN3KCM5?P
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M>CT?)=H8!NTVE!G"96)Z6_!@$ 6#93:KM8N:.4;39J2'Z^%!ZM(6>3SEY8D
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M(F %U-:J[1.Z:+750BU6K.T3;5_K4A_T]6EK;0NM:!>EVFHM*IGYG7N^,TE
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M5,I][+Q<\7XYC!_&WY>=&X,:1KT&UO!?LH'G@Z3+=]+_K)^_)_B@G][COR<
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M$1)>EMW/#WRF2Q8*J7INN/35U1F]]R _<-T,%01,O_[25V\J-X5W\ -[ID$
M+>M:<NFK:QL2C,^YZY#/D\DUV=>R6:6F>G_KD>21*OZP^K"&>I*>*JI7ZS7T
M6/)8%3VJ/JJAP\GA*CJD'M+01#)11;UJKX;JDKHJRJDY#?6VD3-MY]@UZ=FV
MHVV\MVVHC=:U(;M9<,#C\KSKSWA<J7>9RR3.YV=R[+M^IE)ZETFPPKL!4:9M
M;FGA6E+-S4U-=8&@,^C7.88=]*SC;0<]S>S1ZF2IJBJ/1Q#4ZA)VER6,WH')
MG")3YZ_(QLG9./'&V8J3U[,59Y9Y=?#&DW$:1Z:WZ0U^.;NBC,KNFS*NZ9[(
M=/T_Y7I!Q3>N_OYG_(^E_^_LMZ%JL/X3MH"E_O*1AQ_XO[8"DNO[^E>;8&W)
M=@V7%33ESV97O^4GK_K?XB\(_//"\_Y7!7Z[[";^)AF_G2>]?J8NYWN$)4Q9
M'A4:!"JN/C3LPA*V ->;J=FLU04L+C?;>P^1KD# HE"RA8;%E$J82:OY;19%
M@\IR+TQ46>;HV,EQH9#+K_5JR%'-<<TY#<\<75)-8J)A"O!!/*M87YSOF?*<
M[>.*OA$FJ-'9>8_+].?%.T?&=&BB&IU^5U2@OSWZ](T=<P^L:U.5Z?B:&SOF
MU(AJ=/JG,06ZI,2[<#6),_*C2P4E.L]D8]G/H>YL(!4W<S_)[BZK)&]YR*L>
MJ$ 7_[SK><^KKF(%;G9M]FSG^2[7$M<2#Q]U-;AHE2OEB\5PA5W/ML[]#;BB
MMC&O5WZMA\U/8M7:G:PZ_:3+ZS5"=09#BG0*YB8*H]TQYMK<+>X]L+JTV>%-
M#=$4Q[6"OKKH)NNRFBN<>]._QUT8KSNRA5RY^3!1^RC6W+]PJT4>FK K(4[O
M8]L2Y<S95F';N^!L:T(=C\_WQ2H>/7@5'UP3=G=8O7\V>\TGK?)$L,'%?[QV
M+Z]<J-:QZN2*-:JY+S"^E7-9^[LP\>JN@4]2=0_^T_KYEW7!UE:-^=])1J7K
MR6Q:*>WDN%.PK.'\63MG]5@35LK,0;W6I#5KE5J[ DR,GJY_?V"K@>TNA_._
MD_]%NIXKA_Y^/'OCPO"<^)SDPM3"6JDK;(Z;DZZ4JU9Z792L2Z^KO<[+KZI8
ME5B5Y->%5I6OCO/R9-R[)L!#G2E\_E+L\I2Y@@GH4 515191QLI\O.#FW %"
M+'(%Z_#53<'E=95-PA*.>)CFE5U90ZA?IV5*A:8Q)PW,B\[[XU4J7KQZ(79Y
MK?XK@PN#S\@<.1CT,*T$*<'CFVD\RDF?ROWI*J86Q*8EMQ$5X<B!W"VYWWX_
M]]M'Z<%GWOK-?_WTS=_0S^96?-S(XEH2)D.YG;F?YE[)+3Q.ZOGYN:=R_YG[
M?>X+I)E4DA09R.?S?X%Q-"V=1F9S-=*Y!=[8LDK"P1(G"8(&$P]K&4,,->-W
M;>!YCC;<L9R1/\__6GJ0*^7*N#>S,^>I=O([Y-<I)6OD&U0[";\XLI*LY/DV
M7T]DEH^O]C5&*$<5]JVG].2P_JC^N)[7Z\TF=X@Y>),'0HH24\)LEG)X.HKS
MEH1/YO]Z@IV>##,#>FG^3]E*-*>7)J1+I/PA*3DC)4/2P]+C4CXKG2D=9'[%
MO.CAP&MDKWG9:R7YBUD7LZ0OP1.Y)=Z2F27\VR7D6,GI$EHR):I_?TOA $>Z
MX+3@ C/1B*$[>F#KP(4$VMQ?$%79!46VT5<P&J0UU4;TMY)):ZE<RX?\8WY>
MZ5W;B.&I=]__KY?/;1]Y\*5[LNZ(;_&&6^_:MJ>=+%HQ\O"6-;N^1 \27^[W
M)_\]]QQ9GO\QF?>-&91J?<OFN"62T*$_SGG@T;]>?.3?GR=J&+>3L%P>X3_'
M6=D=D<257?PM[BGN1]9G0Q](_F&5U9C:331HBIB]%?P?W7\*?>CF?^E^D_^C
ME=\;.A!YD/ VD]5,I2:I66GE.2YJ<\2B'F]([PA%HWI87X2D4IG*H)=QI56G
MF=EVF-D!E[/KOF5]67J$ODUY+SU'X8_79HO%?"4^/'GJP\OM?.ST^*].%,XK
MO([G3]G!A:P&S_NI2%)U3D71<EEI,%=SJC/PJW"V]_(SJ -H1SB:$M<>HRE4
MU*%;*T/:P3R%CUU+4Q(5]-T!5520=?OQ6AI4HJ*_%(**U*+C>:8_Q0%..N8J
M?.)T>O-'/WLRU]2?L%1TD >N^\+2G#6NW'_=GGW5J?9=V^^ZV1<FYZL?OV%/
M:,IF\L:&L"<<'IKY)1M9VS-OQJ6<?LVL1<LH#!0>=F,/\,;&?2&K;^2ZN2$'
MKP3II)SC"67%UBO5U;"^E84XFTRMD7&4V=.;"6$F2.AF0XX5*0\:3N;_C">D
M@7@OBY=ZP3!A.&S@#>PBTN(U/6/;\NR(8[%.C,:H8(L$#%%!$_'+HX*Z.Q K
M7O9';.(>?<$9T-@&/6\-Q</3]SQC373D:I?563/3^<]]N*=Y]*9U40](7O6[
MR!M+,W82QKWL/.5?AU*RO>Q<=K*W;+^#9LOV:6\Q\:59A[NZ1*VV6*Q6OR]D
M-*C"0HAP,I]942KK([1;KDZ4E*A4<DL"1$:;SR=P;K?K9/ZM$^RYBYV@48*,
MC/>""^STIPM/+@O3A!'AF" 1!)D\+%>)510ZF?]#\3[7MXKWN5[*HOGZS! Y
MQ7; WPG1XAVNQ<.BXGV[HAWDV$XXNSBL*590$HP6]\"+%5JB$FR"@0K$+7"B
M8F:T7[1E-16,[,P%^5<4U@RUM<::ZHC-HA=WQG_ E[55.*L6A"5=GQY^:].>
MV<K0K+VKOOB;1\F<1:7\Y\*NLDVYQD.3^-QO9EV7BNQ92 +\'K+NV,-25R9G
M><>SG!Z&,7<:C+&S^>,PYG:BSL4&8_86_@@WC_PLVRU12)2J&:I>20??6=DQ
MA]]OWY_=/XE_O/-4/]UOV!\<Z7]")]G4=OV4Z]OXZ6U=75V]?*QMJF*JEE>V
MZ?H=;=Y^R2NZESMIO*)PDJXBDIP[C[78 /R8%YD=*V>N(LHC$L(Q@HM(@(N:
M:=.G=^LT&M;%0WAJ(*A4F)5*16=W-[*A.SBCUSQC1J_!4-71$:Z2SF+-O:&U
MJK?J4!5?517C- I=P"3M[NVL;I/&N$GZ29GFY@P3!9Q.;R83\WKC,=GT&3,X
ME5(YCU,QOPW9&B6P7*G0Z (&D]PM:;.SWS-ZNSNK.]KD#0UN=W)V9';PB(0D
MV)9Y4G)8DI?PN'-^H;!A;H-1W6ACSE.:)NR7B]99QOJZ N*^>*$%/%:24$U+
M3&><[\>%U>C8_OGX@>UQ"@\$B<NN]V*7_2VD]_A<(G 5Y4(,'1R.-O47_(T,
MB"<]MXCF?_["_CJ;53ZVO\XN5:T9D]$L*?3U=?G.^MC&.MM61P^)Y/<#J<FQ
M],.YOW5T-@_,3377.@6GV5/A**OL2,Q:7A';,+-F ?G1PNK>#;':'36-S95E
MC@J/P2TX:YNKY_:W=G;D_O9P.C:Y<4Y(><T-9X1EN1,A:?OU3_9*G <F1=7&
MVG \L?2&79UW?6J:,AQ631NYJW/7O6VUH7"M41V==, IF?.=&]NE(3)MF7#F
M4',)[IG;\^?I'_ACJ&/72I52%:V3=<KH5!610+MZ3!(D&HV;#0SV5J%7H(*@
M,%KL5JL]G!#WQ&5!]K!,(;?7&$L$MY>UNU9W+[/CXW0:G_6GO99A"_58$K".
ML^C8@'N"A!/,G<4?LQ8<75@Z.IV/]/J([XZ2$A>;\IP>W;".9ID7I%.Z=Q@U
MI*-Z'5,4B>(!<QZ_!;?"8X6M\(&!\^*.$H2(YV"*!YJ,HBNW47$CO YWPLF6
MRW;!Y9+"!4 9<4X*C5UC,:?<:#74+VFZZ=MO$N/Q!S=]?9GS:W?.V9#+7[MQ
M8/JC#70'\>CUKNM6?K&C_MFU7^Y=[!S>NO GZH9/=4]:EF?U6PGK#2>,UA6D
M+UNFM)-7['^R?V#GN^SWV)^S\TJ[PQZU\[V27NG,Q&!B)"&-A+M]MI/\X EF
M&<8!D5UL-QB-I>P&7*FTK"PB([82M8W=5"WK4P>M!C8$6QU:YO]$AYX\K,-6
MFK"V6@>M_)#UL/6LE3]D/6(];CUME5BM%1QGE[#(Q0../G8W'4O#QVZJ9$^
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M)BJDN_W^J!#I#L2AC6"+J.P54E=O$9R^D-ZWFX0+_>C(X_RXD>\6L7F8QF_
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MC_I.DEE9M9=Y@$TR1XGET3$3"-:3FYQV-A4PTX<!UC(P (_O%Z7PV'@/+RP
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ME?:GA5"H;16_M6EY3!\8RKW=!/,0VH&AI_'E!9_4_U;T-#ZIU10'R6#2!,F
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M'(PS'[$?PKNX+LAM%_<8MX7K@SQ_"U"?_P6@ =[MX[KA:1\\G<;UP]/K 0V
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M0ZR(=D0!,818GC]!83&1?X%R++>48_ED/D3R'D#()R#DDTI8S0-"S5,)JWE
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M@/.1'L#P#1AS$^(0A("TD'< &A!9'39A'39A'3;!%WV S5 _333+I0';\JL
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MPGNB;J%NN!8N-P"R)Z:AD0K]9H''_SP9_]QY%(V]SP\S#S+0 (W  (P@!)A
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M-> =L!:\"]X#Z\!ZL %L!.^##\ FL!E\"+; <+ -; <?@1U@)]@%=H./P3_
M'O )V OV@?\!GX+]X#/P.?@"'  'P5?@$/@:? ,.@R/@6W 4? >.@>/@!#B)
M[.%[\ ,X#?X)?@1GP%E4@YX#Y\'/X!=P 5P$OX)+X#*X GX#5\$U<!W\#FZ
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M@#II@'[R 08$#)(.&*(@8!CP!8I0"#!*8<"8@'&*-O]!"8H!)@5,41PP30G
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M,;H!\./T7L!/T/L ;Q7PD_2!YA/T*?H@X&UT(^#M GZ:;@*\@S[4/$AWTD<
M/R/@9^FCS<?I<W0SX%T"SM+'FC^EO?1QE!OT"93W"?AYNA7P/^E3@'?3;8!?
M 'R,]M/M@/?0IP'O%? ^NK/Y$[J?/@/X 'T6\(L"?HD^!WB 9@&_3'N;/Z:O
M"/A5:@!^C?8!?AWP4?H&_2?@@W0WX#?I"X#?$O#;M+_Y(_H.W0OX7;H/\"$!
MOT?W-W](#],#@(_0%P&_3U]J_H!^0 =0_B%]&>4?"?@H?040NP'^A+X.^!C@
M]^FG] W Q^E!P(/T3< GZ%O-1^AG]&W 0_0=P,,"'J'O OZ<OM=\F'Y!#P,^
M*>!3] C@+^G[@+^B'S2_1[^F'P+^AGX$^%MZ%/!W@ _1[^G'@$_38X!_H)\"
M/B/@L_1X\[OT'!T$_",] ?@\_:SY'?H3'4+YSW08Y;\(^%?Z.>#?Z!> ?Z<G
MF]^F?PCX CT%^"+]$O"?]"O E^C7S6_1R_0;P";]%O#?.OW?.OW?.OW_/9W^
MX7_K]'_K]/_G=7K[_X,Z_=E_Z_1_Z_1_^^G_/]3I/_F_J-,)&I<,>YPN.QF-
M)HO%XK ;3<B-)J/QZ$<\;D&7S6:W62QVN\EBLSIL#B2KQ69S66U6$\\U\:=
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M'!R!D[@*\O$%MU/C@(F:S^-F*P<^J4YH+15J$?^ T9P,RO:6DF.DX,N)Z+#
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MP%+=KP$=-^B/Q16+RVOC1Q+C-">#;@=CVXKS\NBT0 .YS<I<,^,IMXZ!"*[
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M/MUMCVH<?1 BMXHC^OC"^D-N/>"W:5ZXKKI#UT(^+Q2>%_ST^QT^,!+LATT
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MNHKQSU(2:1>2D6X!E$1]!(G'/[M/\_/ROVXH'C'O<*/6W2KL4X/UU:,^XQ/
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MU=B2 .XG-K N3URUKW^@7KO/N$K08E4CD6DU-[20*"QMV%MR-;[/X6%,)L3
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M8/F8P/(QS'Q,[/T8UD4)*0-L?R+&_03C?B+&_03CN/1J;9L =XC2".!J4<H
MUKAD^$DCTZ>,!@P?PHJG =Z,=!C)2!V 2Y N$+4$CS!\"'#$<-.^0CL,ON&F
M1AXZ$EFZE<5;651D^T+A^FFCBN$F+'D3EKP)BW M@;2$:\T#AAL;$SSVQL90
M*QOH.CS:!RO*J-Q(=R$9Z 3 FT6I W")*-TEQB@+]5G (Z*T _"6A7FGB5("
M<'ZNT7 3XHTH*88WH?5-(TX#^?W$?ZG2YMUON+=QEC>QW_#Y1E%%MJ^5-3@;
MU0Q&T%Z6GA'P<P+>+.![!7RM@,J(,R/_(R-_/2/?EI%''885E$7S<P+^5L"S
M1]Q9^3=9^1M9^1-9^>-9^3[I24JC(S423LN_3,L_2\M?2,MWI.4;TO+&M'QB
M6EZ9YJ6*E"39$&,HG2I@="20E/^9E'^>E+^3E+^9E#^6E#<DY8$DADO/PY[*
MTH<%_(" /5_HEA/=<JQ;OM< S22=TE#(?I_!()U"LM'1* TG]AOM(C.D&C,Y
M9-'&S"BR2&-F#;)P8^8B9%ICYH;$J-V@2'OAK"0,;FFOC7-7HW0%NIVMS-8H
MG8K,W"@M2NR77FZ4,LA>;&R+(7NAL2V.[*^-;=W(_L+9_=*?:)L!RTA_;&S[
M*):7?D=%7E;Z->4-=R+?WYA9@M%?:.TN?9Z&I1R:\:QB+*3/-$I 3KJ]42HB
MNZU1RB+[5"O[1*.40/:QQK8JLH\VMMV [".-;4\ANZE1/)?7NY&*8IT/4E[D
M.QLS$71?V)CA%78T9CJ07="8Z4%V3F/X(61G-8:?XJEG2GLE2+:TC4H"T\V-
M;25TGS9WD-=1471OI!ZQ\K+&#)-D*2\R*DN3<P>9D,;9YY/&I+UBE9%&J89A
MPXU2'ME0BW*#C6UE9/V-(F@L]36*'P7E>N<V:&/^W"]E@08OE&F4[L2@1&-;
M&[)X8]LDL@C/!%+:W*Y>&A9(>1HE'J4V2LG$%R4G;1,K.B@OW71WXB6L^^+P
M?NFD1N*%D?TVJ9'X6Q'9W8FG9TY/_'YF/SS>Q.]PA>^\.W$80P\-HSCB3#Q1
M>BIQ<%LZ\>T21HQ$$M\J51-?S;\QL;]X7V+?3#RQ%XC-;CL]<=<VL<+G\IC6
M2-Q>W&^0,/N6;2L3'RR5$Q_([V<<WH/!5_,>6.BJTAL3;\M?D;@$HG#QS#L2
M.TNQQ([BJ8FSB[Q1('%6:4UB.PYR)N9LW79F8G/IAL2F'H'QJ:6'$FM[Q!FF
MMXD3+1\6'5/;UB26 @-T+.$.8+ 8<EG'U&K/?4PC>"KC^QY*O*;O?@.LL+0+
MZ:*1JO4!ZV76TZWKK&.P-P5KSIJRQJT^F]>FVMS\>X?$K^ SV0PVLI'!M[]Y
M9*3,GQY]%I4SBXFA2915 T-#Z\ND0;(9\-":U8S3ANFU8[-]Y>G]UN::V?[R
M]*QM]2GK]TK2NS9(T[,'SJ#ITY.S?UV;V2\Y\ HV9\:D6>\T3:\;"V+PK.$:
M/"?7K=\O-7G&51'^M'0/25+[5>^,<+[TJG=NV$#^2Y<$EWB'/8N63KP*V#0'
M)R?*1T.P7'Y%+3;[_NFUZV?OB&V8K7.A&=LP/=O&GY_N,9QK.'MRXA[#.9QM
M6'^/M-UP[N0:;I>V3VS L,5B& T;SL$PFN$,PPP;:9B'H7WC,<.DO6B>V#L\
MW!IT@K27!^'2G" &G=P:-'[L(..UTK@8-&Z\5@SZ:&O#$O# AB.<89CY7"J)
M#4OF<\6P( _;F\]CI6UY'K*WGL> O?FZZ#[Q:'>QU?W95O=GN7N_)!WM[\FW
ML"U27NR0-Q0QIOQ_,6P=^S^8).T;NO3\]?S9<%-F<BO2IMEK+]T>G-UU>C*Y
M]_Q+Y[XGYC>=?L9VSC=OG;TTLW5B]OS,1'+OT/I7Z5[/W4.9B;VT?G+=^KWK
M1[9.-(9&AB8SFR<V[%MU1?^%K]CK'0M[]5_Q*HM=P8OU\UZK+GR5[@NY>Q7O
M=2'O=2'OM6IDE=AK>LV8-+UZ_5X;C6T8W]C*]QF<#MR639'4AC&_NF-87)W%
MJ>!ED7M-_->OG>4-LZ[,V*R,Q%V5T<HH=^%*<Y>;/PW/=04O6YR*W"O=/M>E
MHMF3&:.+@Y-G3>#?3H2++[X$ 33>N7/N2K4Z+BY/BGX,N!BEBT7 2)0Y[12M
M<_T7TR5'0[G<&DL[R^/K]\[,3 ;/FHC B=_'?G=YPTXJEUL;ELN$/7%JX>C[
MA:/OM/B['IWYY<Q?9HP'A(?_"-(1X>$?@'?_"-(1>/AQXX'A1X:/#!L/S#PR
M<P1C#SURZ,@AXX'*(Y4C%6/?' :\U08)&!Z-EY1W7L+-94F<5IR;$0'2*/"I
MY\FP4W1<+ B#T&H74\M8J+PPO7RTL+/5>8F8TFK=>52&T<'+7WS)J\CW7"O_
M=/]=E#"O%"EJ?"]%B)H_1WH*Z3<OKVC^TWP.95X^NWG$J$%=9UMI+N3H2CAZ
MOZ'WTY?H=?0=^(V34I76DTD*4@B*?1%-@WP!,L.\%N$U3M-JTJ'K?RG)=!=U
MTN^DI70%C/,)]&'XA:OP2!^E=],MTK+F;^D*^J%T%MV)V;=+(U2@E=)4\S"=
M2*N;7\ >1(OI W23Y(:Q6BDYI$SS$%;825?3O?1C:M+)]$'S+5AE-:VA\YM?
MH(WT?>EDZ91FE);3_\?8>P!&566-X_?<-V]Z>=-[IL\DF60F/9DD9!XD 0*$
MHE)EI A(42"(H-@0Z1:P4M05%1#+)T@=L+'(6E%PU=5/61=71-TUZGX;T14R
M^9_[)D'<K_S^F9S7YKW[SCW]G'O?F[GD%K*1/$9>(J=A-1R6\3V323692A:
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MZ28YH,A/'I3XR>->AIQI1FF9#-.1M_G/C; ,UL!&_#P$OX/'D+[2N#O\!;Z
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MO(4R\Q;2Y9TQA!Q'&AQ?@K"+D!/8Y_>0%G_$8W\\0<C[2/,/\+L/T,)^6(:
MUWR$]/H8V_[X:4(^P?6G>/YG*$N?K65S) DY92+DB]4(2(,OD'ZG\;O3B,=I
M//\T]O=+-0+*XI?(IR^1UV>4"'4(2*\SR+>OD(9?H9Q\C?+R];>$?(/T_09I
M\ WJQ]^0SW]'7?H[RL.W>)]O448ZD9[?(<V_1_R^1_Y_C_BPB9X_H*S\%_+J
MGWCN/['=+FSW1VSS[(N$_(3W_!GI\C/*TK^0'N=0+KJ11CV8V,%( FQTB)N/
M\"S"9P30$X!L)L(6A+\2X(,($P@H+D.X&^&/!)1*A$:$J0BK$5XDH-Y+0#L7
MX4$$W-=Y$#!VU:U$V$_ X"(@,,"VA<T(V(Y1C]"$L SA+0(F.0)>8[H3 ;\W
M:Q%PWXSW,#^'@,<L>(ZU#F$VPN\0/B%@PW9L5R!D$7X@8$?<[-\1<&+_7*\1
M\)00\(XC4(#]\2&>_N4$ K@.8M^"V/_01 +1 @1L(XIM1I$.,<0_M@3A8P*%
M Q%F$"C">Q:=)5",[15C/XM/$8@7(^#W<:1%'/L1?QSA" +>JP3I5)) 0-J5
M8%LE3R-@'TI^(5 :1;@$ >E3N@OA)(&$"0%Q3R"-$HA'X@V$_R*0Q'.38Q#6
M(KR+D"-05H&P$&$' M*@'/$MQ_Z6+T7 ^U<@G2J&(>#W%4<1$->*\P0J'0A5
M!*H0SUK\/H6\2F$?4WB?>J1C/?:G'OM3C_VI?QGA9P(-N(WV$AJ1+OV0ETTU
M"/A=&G%((XXBXB=>C8 \[(^TZ8_;_0\3&(#; Q#G 8A/"^+5BG@.1+D;Z$?
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MTWK0NP+JE6[52O?.)";WE(@&4Q5Q^N>MD<@=1WJ?%DY+)._LZD3ZQQL;I:6
M'\8#_"0SC=(:/]U]&XWIBY;_]M4J/A&_63BZ*N%@JW]_MS^R,6,WAZHK):CD
M @B5UI $(7. ,P?,@0EC5C_>\.>?QBX?![$QR\?=N:WQ\U_&K!B3^_.$A1"M
MSWWB@1TK(+P,GL^-8+ L=W)%;ASLR(VCI1!&;1[1LXA[A>\@49(@U3!:#.I
M4^H%=^F;1K[:6J7T$(^R%!)N52E85&YK%9269CF5&+-66:S6JE*P5LE<ZBIK
MA1U*97'V(JU 0.UEOR[!7G2N5&7I&[O5'O?+F'^[2!(VHO4PP\:]BO?4NN@+
MN.LE,=BXQ^N2!;+PP&Z_W_<"GBDC!GA@KUZO>\^>I5W[XJ+14A5_B?X3!5!&
MNTA%S^$]>*0B2_\I>MF/]223U=68/D:]7H]*K49AL"02L9C+Y<G"1%%P^]UE
M[LGN^6Z9N[;FQW\XXJ@AF63GK^SX[Y^S\4Z$[B[4*X$MD+N=0F?Z-"[0?N&_
M*95LQ&:2#-C.!<TC1I,]M4J?B.M[^5E>1C)@8P\JR!764'4T&C-6%E"[,<K4
ML;:ZTFJS&T-X%,V,7"&WHIJ8:VJJJZ(Q6O/]@'$G#HZ=O75VL67,[5/^\>@;
M;XQ]^MF8=Y18/G)L6\G _DO&CADY:!+7O*%]YEV;/Q2NFTM]1= \=W6K$K[;
ML._Z9:\[DTEM)O>7J;>4!FR</%@]-''%J/-[+5/:TG,Q[>+)W3VO*Q:@->*(
M ?E?0=I@Y+Y7R:L<C6=[?M[C\E8I>]=)7(MZW- K79ZJ<@=:+3ST]1Y<XZE?
MBWK<*&)']6RA[/U*R[Y2X8:<'1W*M,Z &YBP[*2<A3V, UG.N+\TUCB_$BJS
MM$HT-#66)$IUJ-;JQEO=X&;'!*&1-\CXH6CF3Q2?*J;%6?K.@9:/3M2=JJ-U
MN+U7/%P&95D8N-]/=A[F@,.+]BI@ITBE8R<4IQ14P:X)?'3">LI*K;@MJ@[K
M3NBHSCEDZ(OP$0F0)>! 9Q4?CD:U>\'9[@6N;I<#12#CZ'9U9UP.Z=APYA]0
M$M"5G<UT"HVHT8W25E>?&C.S2WXS^I@!"$'@(I=A#RKDR&7V5M[*BMJ:6F0U
MLCX*_^]3Y)'S_59R1\Z+=[]Z])YU+QVYVZ9W.HUJA\%BT]DU1D'CU,J*[WGU
MM3OO>/7E>RQZA\N@<>FL9JU3:T1[K.7G_#*1W_KFHT^\?73+MG>J=?:.Y^]J
M+['IM-;DL#4[AE8Y--VS7G_LB6/'MCSV5I76=LWFK8,K[5J-O:KM_H<'5UDU
MS/-?TO.Y?!3*2QGI1X9 O7CC)OD#[@=;MC5O;=G;<K1"4:C=X:'[6HZT_*&5
MN\&\K(76R:<;%AFX-*1IO8Q+)I-EL3:N4)LL32:X))J#).7B1>7R<KF\R>*U
M6"S>\J*X7*9M\#:U661QOQR_E-6I+&U-7EEH(#T"94> $&/=CA ,S-+SN^T:
M=99VBRJCIFP2F8<6.\L%1(N6LBEZ%$JT1PPZ'W+Y%5?T$/T7J4+Y8]*8KAI1
M1:NR\(JH23:D&T8T<+X&:,C27T2=X-_BI_[=A@&^ 71 EI[;YQHSE)E_X6QG
MIBO3F<$%6H;N3'=7AIE^M/J=[,., )H&IOH,H&^CSPZLTA]ELI')_Y%,!@)6
M/57D&6Q'M4?&Q^2][*^-7G#4<CQ%L@61&DD(0D%F(+B\G<!K\5S9W;!EX,BE
M"V>(I?$AC4679 9=/ORNZ3>?7/SRJ3\=<[D^WWG7MJ<.='QR7WU=;L&LP0VQ
M5++9OW=D('G-YO;HI+I_</&8.GWF[HEAYQ3;8RV5S1,O&_KN'0]^-JK_3?5;
M/KSKBH['FE\_LVU1<8/\RMCX]/SVRB'I\OFY]X/1NM8K#LT(!'YB,S_NI'^$
M/5),$]U#U#+ R 7U3[U*]B+4$UVO:B$%D5C,3"(A?A.+I,IF648W#6JW8S.W
M#&KL/W9B3>GEK-U+<C/HO=BNB8P4"U?I#QAHK6PCO5^U@VY3\7"$<-HC.K-.
MJ\5SRRP&!9L]R:&B/R"J1 &$,>9Y#[+;(M<P!LV[:&259(XS8)5^(M.(X8G-
M;HT2HT#HO3/+6Z)E8X=69?Z1>QZ&\W,2+?TGW+4S]UKNXUQV^L#JBE'P3V@!
M$=@8DA-Q&R_A=HD8K)&MXE<;L@;9@W23:CM]2B5#[,R('<;*@L+?BY5Q!,,*
MTPK0:G5EYDN86'7UNAM$\B+LS-4U3.V- D6]K[8Q[)PSRYMC>>1@1.[YW(Q$
M:_\)=^Z">BB$01)R.5WNQ=SO<VQPERR@T[F[$;NAY!M1IW:H!C0X&@;(_&8P
M9^F2_4ZGSS\(!KU$EY#^G)$TDD+.N(]4"9)2#-S;>$(!BBS&>18]\6U/;"='
M;FV$OS1"H^*4&M3,B#MUQBIU?_WW&(R*N"GK3VQB?;6M6]\BF?CZZI9N(NJW
MD^V^(XU'(GAL?TFB:GT$(ED8(*IJ1=Q[M!9J7X$!Q$\2M)@,(Q\ QF%QIW#6
MU;D@SO[QS^$26%P>%T['.QB0](),I_/'+X5&1^<"5,+30E=GA\!"7R1;!R3H
M!;61*VJ0?I6]-I7IC0)=;J^%C469KBEZU:V)UL:"BE[5PROL-NCDC/W[Q^+I
M)B-?5Y9,UY<T#FFP5#H\D:'QLD4N<WU1O%6G-/L"-J5N0$E10^D-B9(Y'F>#
M+36XH32]T.C@3M4WWA)*#.Q?5;2P7Z,]6-%<7Q@?P(&L/-(8=,;B#8,N;ZBI
MJJZON;RE+E:8;@Z6,$)B2]?KC(Q[A62U[!K9&T1#QN]A$6H6+*(&=JH5.V4[
M_8P%8-FK\O/ X\8!3IFF?A6HV$G"/+(3 U>./7_CU%YRI12V=F3:T5!U-Y[.
MD&17IANMU^E,>9DY8*PT!JP!8\@8*(3/;X?/<[[;<S[Z-9S*^9?GPG"283(@
MMPE>0L[82:UH_!<%A239QTQM6K5LJ!6%!?&J]!G T-_Q'W<Q<<YT=3,U[T)%
MEY(0)LJ]ENLB&B,?9BR<Q7YH6.N--XR=-FC,DO_(;2JI>/12HTJI,$YL&C!M
MQ<)UGS$,*F >O8$VH>]QB5KZ*2$N'IPR=K/APFGA#$FVH\Y H#I ;^@^2 ?!
MO./LJ@D]7\&34(44#.XE;7(-QW(_C5]5IJ(JIS8?SY_'*)XPC;O8]0(9.&5J
M:^N4*5 EK5I;ITHSW'H^IVDI3JH1O:C Z7SX0C@ JN%V,J1VTA+9BZV,!BPI
M8TUC>/!K6(!1 $WGFI?"*^B'%_%K658U!+.J?9A5V4@<AHA.E5ONDT=417:%
MPVWU6R..(I5""8N5WBRH=YOX&*[VR'4F>Y93BQ$BAJ-51(PG<%%9@XN&?E4B
M&4FV,$J5F@Q!7Y &V9GZ=3K0B69KE<Y9PF)?1"Z^ //>YG&B/2B&8U5!UDB0
M-1)DC<P+0@>+7,;CB=)&>R>;?F?'D!M/MK/9.'B^M,9+V'H?7C79WGM5KQ5K
MOD&<"L7^@"] Y0:]H*?R<"@2HG+V^USLYR)E<O:3#53N=+@<;@<GEQYH!TY>
M'"^*4WF!,3B51!6X\)CM4Z&0QT5 [YT*(6UL*G'8<"L.N"5%6&S1]PZJV] ,
M=(!%H:>2GK.\O;8FK]6\P/:9&*+5M]ORD16W+Q6\]MXQ4W_7KR00;ZH\L7#1
M.V7-N6,R==19%W=&7!9#7:+"62RGV]_>=?7:4=,R+1V;GOCSP4U//+;ZA9,P
MK>&.<K\C]'SW][E34P>5^>NN8[*R"@.E*Y&K=G+[BT0/_P'51 G;]@<G*>8I
M*/3724<4\"\2(C;8AHG.3\2*1VR4BGJ#DO!*A18/^H#%QNC(]/J1AGF&G09.
M0#5S.O0O4T*4]#7BH';XB^173[-20*:Q'2TBRT+3IM2/G>?A1XP]XRAX1A8H
M5%H#U1@MU%0;JZ*,!K$(?<@VL-W771,>.\1E*O=7MIG@G_S,<\_<W%H2B10.
M7$I?N2(9\(=/2SJ(/7H8>^0A7XOAU?0Y^BS'Q;0/<%2M46N \&[3%MM>&[5Y
M*.*DUB@QZYJ\WY2T[[)3>Q:"N\&D9.*BT6%BP(7WZGG0HD)VB6[""SSE3YK>
M-WC@%0]X7 4&@%<P>W=Z#\$X6$\D+<]TH'_L:.]"@T_2Z4XV[4LT*T6;+JT4
M[7I<. VXT*4D^4,B-$_LE5<\0Y)3/$E:NP5IO=MC3$OGGC9**1N+23+&E"F%
MN\*;S&B13"!034P8>#%:20+$(A4Y!O+H5RJYD>?_"O,>67;%YM&1FI/KKWIZ
M\I#IN6<A<G7_XF#8!OL@L7[6'9MUA[.3GVQ;L>9@;I\IWLKH&.CY@EN+=(R3
MXZ)/8; ;9L9OB*^PKK ]9'[ ]I1IN^V065/J27NH18DQ%(8QA+!'_TA TU\%
MDXF2!.@Q$J7O8B*MQ.Z@YY7H:L(D/4O?W2_J>9>.6++4O-</P*L/P0-$ Z[]
M!7DRHS$X8'R?% E%M(@9!J/!#G97J:$ "IAY*'"67$1S=+AG.]!*=&'PU-5M
M3"6=KLY&XDBG79WQ.'H0X32&O)E.*9A#<D%U$[V86E+DBDL2"/;6SB2-8Z$L
M)!>,$V^8<.?4R.#/U]YU8/3EU]V8>R>7>W9$:D \X!5>'3UD]F&Z(Q1(7==X
MZ>+[=4_N>/;:H7=4IYZ\Y8/<1ZG"=**_7OGH=1/6?(6$J42Y_ ^DIQJ#S$VB
M(ZV#2@".R*A"I>:5.BV1*=G/HDDU  (69(&&@$*IT8&,O #G,?]54T'4*H%7
M:G5$*2BI\@5.A0TK8++H2,K2,FJ0^614YC(01B+BU.<MZ&D65J);;90T+HU1
MW-G&WNJ;*;4J$9?E4_\\;<Q0::RTAMAOHM2BTZ7+E]QT4ZXS9YT":Z&'FW5^
MP_'<"2@[3NTH(:WH$?;PPT@01HH)O1Q4:J>Z$,,SF45M=5L]7)V\37Z YS0\
MN-QJC\PKX-(K Y>,X_*]#&(O@VC]@00%R0&H]IH(1A=9^'Z_R<^]PE$\,;@'
MB,R5A<VBVF#VF:GYI%9'L_2-/?">DKQ Y21(O/"CZ!*5(Y5;E)S2%1;>6Q>$
M(*-!T!G*TZ +O<AI%)).=,-=J)B=F<YTHZ1\HH434<4X$?6-8QK*,5V5-"[7
M(2FG#*46SY#U*J6L5TFE-9[*UKLM6NF2^/C.#+M(+ BR1H.LT2!K-,@:#6*R
MAPN3)G]N?'ROPR47LC 6&69@0:8# EQ (9-B0%FH3RIM^1P;Y3(<""J@CMXX
MO?MOE3#^T*:[<[G-V\<W]8_'1D[I5^*+77)M;DNNRUW##\OE5ND>O?W5F[^_
MK:FD+C[ WU(L:*^_;-=)-@]^&/+OB&3[8ZCC*@L',VR+;%3-JB=6S#R+N;#U
M=2N75O)!A\/'JZ+6E^A;&$\\0 A1P>9]T:A >!\Z^KV"+GA2FX7/]Q!7D2-+
MW]R7+V4SQ=58&",LSL(^1J">2C&'E&&A^4]B*GI:DL5\NH7...&.J,WAJ,?M
M=5.Y*:*/1M3!J5!@=$TE?@-NA331J> V^Z:2@ X7I,^QQHOCM]U&,NA+,&7"
MC/5"5,WB)51Y4Q@P%37EB2@P_\H=V??IK:$2;_\!&]^>^]:U-W^P^%.X+_>F
MLCH1*$T,;HZW%?(S/8E[CF\J4%G^_,K*4TO6@/*AT[#FF^ZY:\6UN5Q59,Y6
ML,QJZ=6&XZ@-:O*@J"$J)T_E2E1MC']_)QKR"JT&PJD4H%0P?Z(U^>DKE!(J
M4(I!<W"_2J64$:T\2]\6U2J7=CWF-6<U/QZ$>YC?/)-A-&,NI1&=1EYP*9,Q
MRF2,,AFC%P3WM"DO3JLD\>H+;GE J9$K0N8 P!SHR'VU[=+Z:'0J5YA+>623
MX@67PK9?-K*ZR6#L29:_$N4BC!'M8+&0T\K,1JW%W*J=&;TAJHA K7U,Q6+9
M[72Y<[/NH?#3NJ?#6>5^B_9Y.7MD7K2K.*NAN#SHUD8<1%M5R58R'WLRB$6&
M"5P]+]=)H=<%P7>+R3A)DRHM=ZEV9.1*[;7:VPD?T>IT%8YPF&@-CDAYD%C=
M$0>:2;FI L)A%FY8=146/ 7"7+!"5V[0A:%")K_H-KOE.G>O+W=G.2)ZK67E
M)T5N)+>%XSA753[L/&DH*Q95NJIB=H9^'28G3&!5SDHFL"S\[(PSOX*VHZL[
M+F&=1SI?0&4UDU7ZFR_HL'30E%+HA<95>N'H498@C^_-XFV_1NZ_J9K\>[6D
MKUQ2744/K9OWTP=OGKSU_L<N_^K-(^]UO!H)UQ4/:;YB5JE/9_&7C4^V3:.Y
M6?NNV_K%:^NNV=IRX\-7K3Y^8.GD^Y05-PU9UEH]97#;([DW//;0RK8K;JV;
MDSF"6I]&[AZ0XOA"<EATJSD75\QQ&U4[5%G5&UI9BY*WAWBEW1>#%R1-5\+F
M/;$88605M0:>Z.SO$:?@I$ZFW2:SJSAT4O,>,)J!L^B"DN?SBMX@**_DO]7Q
M"E=490I$=%%CQ.WRN+PN3AZ)^O6AJ:1 <$Z%J JW@EK?5'"9<!%6QR[2\V($
MINB0L:,KK^TK13%ZFJP6*H/>&B2+GZT"4_?T]J]6N9O&EFU^9]Z[\Q9_<,L[
MN=E0I"YV))V%%9[8@'A;S..)WO_)W7[G9[]?^9<;5^=RV_Z4N[Z3KIX_>O\C
M8XML\8;MN;^CFDNC?5_!>>X(9FMV4G&0.%F%P62NDK<1A;;-I#%P;:J25ZQ@
M=3HN#'QU=?=5<S 3N"A_,U^<RXV1$K@I4UIZ<SKNR)1\3C>E>\&OV1TE&W.;
MJ%FZ?XB,/T@B>'\_WO]?>C!;!1U#PZC6'=$>*VASJ!&7,K<P-,!R7X.NTN#V
MN5]Q<VYG>,GF"ZAU8@XH)<'I?,%+LA6_09/[7[)B&-TZ>4I+ZY3)E_Y[>LP=
MF9S'>/(O'_WW1!E($3DHNT9V!Y&3U6+4QM?P8WE.SO-I(!;@9>CO<9LEK;R<
M<C),7)5R# 3B>^D1.,+CQ@$_P1B"$#DKX)A1=T4YR%U*$"E0IZ*ODM#(4L)\
M*0T#PO;NSL[.O%54)AQ2T'-A@_4X M5@!9!=<^Y%6<OY/5S[07AY%+RZ-O=H
M;AL;4X179'.YU=)X\A!1+5,07JX"!7I_+K*?8-  ^9%<"V(#+A6K:8AF)P9A
MRCPZ+$8]$^]@%8"S>3)+E.[[S:-"V<!SAQAPJY?]8=EO*'2O&*[CQZ$W^3_H
MHY"3W]*'^Y4^:KVI2FZWNQ0@#21J5*8J:K?WX=4ZO>4L$@E77?__:65&2E4#
M%,E:SKW(M9_?([LCUWQ)KM\=,!DN1UK=W/,E=Q<_!P.S!%DNFA1NNYMNT('J
M.1=LL0#*S2'.24+0LK](PP; 2[+0(MI(5(A2MO!'ET9ET95$+LBIG'VE\WF3
MWK3WE%?F_;G,F(70/F(7,%EC]=ID;RE."NU87;(KT]&-UH:DN\^D,Y+&L8 _
M%.V+^*61B@N2W6N Y7+%Q9IXIH@Z9P5F#JJ)>,SQYHJZ8<<.''E[Y@/3TJ;F
M*ZYH1H!#\^;^_KHQ*V[QVAQ"L+VF?,"(_HMV'[Q]TF-3!UQU'D]AX^=7("4F
MY@8J6I 2S60,;! ;>! ,@D7P"L&Q[F=*7RA5^@3!;+*;7,&F.]SR(>Z9[B5N
M[EEE<UD9*4N0YDM!(W,X8V7-+>WD$&<DP)E$BZB?C*2;+"H\C0):F5L5D^-H
MB;VBH?W>FAH?VD?U@".77I^ 0[ #(XXK1;=LHY" 1&+LN,+GU,_%^CM=XRK[
MC_AYR(K4;E,6:O?YG&/G7>G(0LD*IC3MZ.3.L$%C9AB,4M;$QHZ_).D,QAU?
M"MU=&6D( 8-H)L.]#H_YPM0J0=\H6?94Z[#:-%\ZN&U0V\ V3MY0WUC?K[ZI
M7B8OBJHB0B00C41:TT-N(<-JAP2(O$06(,IBS4M@\2(^2_<0FQNQ67H 7$Z[
MPQ!DQT0OT87QC+;ZEEM@:%U[@/"EB@!1%RI>(N8"JW25W95?&_UZ7.\#;53_
M$EP8W$*OP63[HJ&NXN+;F =A;KF68PX7_:VI6L 44$:MN/*3VDK*5D;!% Y4
MR"2_(LE'K52+[ZO&2F$Y*\DJ\HW4,D&+164/=1WP)8.MGZ[+/9+[XFQN[K=P
M$$:#$U[.]+L^5YT[D;LUI_T9#H/P9QBZ?4_NQ\U7SG1<FD@W%58.FM)__GT3
MDS5U;;KKHI&*U(R(S1RN7#C$9>8>47??.;/*GWP48D^"!:[\*C?X?&Y[;A D
M_I7[)/<Z_ -N!CF\\E_/YP[O/IY[^HFI[35CUU8/"E@[KIG_T4L/EKL&CAU=
MG%KQ_3TE99[8H2\FMX;=S*,([%VK&!$$2!C*Q/N"@L:4GB$L$A:'5@DK0T_K
M#@B*!W5[=!3"(4J"H5! K==XU?: PVO78+A$E5Z5S6CUVM!+DZ#MVI!!\(=(
M0 C00(@&2MF/ZAJ%$ T%:*'>P'[]F2[2@UZ]Q @!HV"0V4(!HQY]MCUD"(8+
M468!3@NB8.#L[&> 54J##6R'8!D:C(08\JN=9='Y:"&V1$]$3T7E$68OQ.A(
M/+(^NBNJ6'<-&K4.(=,E&;$,<?1-9G"Q>E,WYKT70LZ,*961PC>E-.2%Y@TW
M,D?CK,R22CF(T G"X?PR<_&.0FAL5#0V]L9T<0CD;8K=&D W68M)O2V_PTIV
M4A@2PV#SLEP@Y4FX9^?ZM5W1"E^:X9N!I<&F[OGN$7Z;G'IFOW4"EBT?$$^Y
M!64DHKGR(5G]N1V_*_+QD8A-*#"950/^">_G2M'[Q)%7>LPRW!B;E\-H\9Z-
M=C!-=R^BB\J>=#Q3<JC@4,DQQ<G2?R75A5 '@Z'-/9J.=T^G*^GRLAWP>LD'
M)6<*O@Z>+?@YB+9TL#(:\83#,;W?JPH&#7ZO)1@JBQ1P89+PEY47DTA!V(.I
MGL63B$14EG#"BDI0G% J54KB%_S4_YGS$9/,51DN-\1\,1HK->B=%959D.T)
M]!LG#4\WL@B069/F<?M)0DC01/LW&??SB?;.\5UL#*E1Z&3 #$VGLW>"@JFO
MRH4\PD84:%8:\X:E(EX:"-D<O,(>"4;M$7FT)!*R^9,09(NX(I&$@"/,%B$\
M%BKEBY,8,C*MASZMO^VV?-C(TB?3DK)O2FFT)%Z6"HXO65GR)W2B+%COF_^@
MD <"U1>JD-4!J:HFYRNDZ0Y1A=&HD(R&M,>M^_WP^3=NR)WJ'G%%L]O=DJ%K
MOSDR_^[NS^]>-7C0\GNAMF;DJL'C-M/CI>+E]VR:=D,D5#>7FS\W%8Q<NBTS
M=9-)7#AAPK6-T/UPKKVBIG;0JDLG;6AD-;A1/9]C:#0']=)[D-AZENY1J:L\
MV?Q:WKO6X5H<CQM:E\I=8VYWK;3=X5KG7N-1SC'.,=U@O,&TQOBD?(=NF_UU
M^]MNM1P];;.MOV>I;85]I7NYYX#LA0)U,CK3MUB^2+?(O=)\R*"HU1M-82^9
M0+T8U( %[>^$P%-&DYZ?[>7TLZTJF)0T@M$U/PI14V3N0:B0RG#-XT250>U3
M4W6[T]G%&+TGO]4Y?KB0.9MAV2O+^5*I;[M0D="Q$%; ''KI#<]7*)&]89M'
MKM,B8Y4JA8K*W5&=31TA<@\N- Y]A*A<? 3RS"QFK(1,!\ET2+P%-B<%$RBF
MBB9II-G*DH*PE/.S<AX[Q(^-E?RP\=8/RM,3CSZ\],-%"W[:]I^YG0?>AO%'
MUCTZT>E/*O@YN>+LT7L7;3BX/_?AIOEKKEL\YSD8F#T"$P\WA9.5S%:BP>0[
M)/V+@T:<Z%J*A ^QA< 6<;:XRCS3<55D<U&VD+_*. MW-A@WVK::Y5?J%7XO
M"0:5?J\^&/(D#'H:K':[B=)4ZC%X?5[J;5*6*6 DYOTWE_3;EP_0.Y@*-;8S
MX@I2B!1M)Q;!4F;A+#5(4B3R_FA[&495;*]S?*]*=<;C><)>P0@[)!077":S
MT4SEA;&B6'&,D_^Z1^4V*_L14J=5)@]'XD(T L5L$7+A(F;VL$4<C\4CUF#D
M(G7*CV!(VL1V*UG%OK9769BVV%DJIJ?H*3FCI7=NB%$:U7"7-J0-*EMSJI1.
M^N?]^UZ8>.\K:_O=/D$PNRN?''?])?UG#(Y$_-99W$TSJV*1 :-RV>/K_O'(
M))=6UG/NL\NB:L."S= "_,-+2GQ2G$QDOR _RF&XV&F3.5747UE6.;]R?>4.
M^T>6C^QG[#_953>H%UIO2JSA[K7P:]0;N8WJ^ZP[N!UJN=_2:A4K1U;>P/%J
M3JVFE:Q =[_L8=56V7.J[19>"T0Q2JM]6^E5^/U>1S 8'U5>_GF)-RX?!? V
M[Y4'_-ZB8 CD1*O0$:M@I59;W&*U<7:%W;;'E'"4%Q9!0JMU%%&'4JXP*$8H
M:!H7ZQ0[%<<5?U'(#6R415%1N3/^2IPFX^GXB/BD^+SXK?%U\4?CROCM@FV^
M;;V-L[G$2@QS\]-#F@)^9T6O>$C"T:M<F0XV,M"Q(,F*O/F,6^CL;.RK2V3R
MH5H<%>];(G3WKOIV.8'O=6GQ#FG21P<8&4,KC:$$#>5'9=@NE_=K$J.E#!M9
MG9\/%J()]VT+A6A4VSYCBKFJ?M3+7U9$^IV[NK0A[-)K>+4[.J!4-B_JG36Y
M;K,LU_WQX[_KKE]X?V5NV?P*_ZZ]N5$1JS[HF,'=--$:0J'+S;MO:0%[8V("
M^;L=^5L" ;%=(5.I2[B@9HB&E_-R-2H#AZF".JJ):D=P ]4C-#/4B]0KU?HE
M1>L3^V3[U*_)7E.?D9U1G^7/JM5ZR;UY_5YK,!@=55*2I87B[)@W:E""DC%9
MY5425+U1E+XM]RH*_-YP,*14**)4.T)'1T#TE0A$7+LPE":@,^A]>JIO\AJ(
M#VU"4T&!UUEJL984AFDA%&IUNK!%[TVQ Q%2& E3J[(T\2)@.$GZ@8)-W&)E
M/,:?QBYI6EYCI[0#$D>%S@R+51KS?,7],\(9Z:1>7OV8^;<UTW5F"_,LDWC&
M=/"BH;3:BS6SCUV5L0D+1FA#(?-3<V)V5,;NACRKF&+*KB_27WM-X^/(J/=K
MEE[3/?;W-^:F,'7LXQ+;SMVX9KG;@#RZM.>4/,Q?32KA:M&F%O@P%]$77>];
M[5L>7AZYJVAUL3K4ZZNT_^:[BIGO:L:-F8J9FL6:Q>&#W,NRK/Q ^$#T0+&Z
M)32P2"Q>5;2RF-\4W5#\I/P)Q0[-'R)O%RF&Z!VL[#G? 05O>!T3@W8I]<8C
MM]K!^(;7'@Q57N2^@F1"V5/Q A\(/IW=X0CRU7%.5QU486QOI,8F*'!5L^M5
M6J&JVE3HK*I^$2Y%7LV%4_E)=BQZ,:A\*JJ2HA>5Y-#B9QO;>Z?!Y"=5IH#-
MIQ3Z?!L;T,P/:A)FB%N9(:[P%\L-&B1_)!9&(ZR(:$.J"-$'A '@]QD$>3'N
MJ6.Z"#'X=0.(LDCR=VAN>W.7?'4;.B2#R]@=BH;1Z=$^G]?'82N;+V(ULI$#
MQFJ6U?2.:-7R*R+-N:Y'-[YUV<1W[BJ_JL;66AZB]PUM$%3+<E]M^'W/J[4#
M 5W>]%$E?S!YRBSH$(-'CSV3>_>Q5W.?K+5:P#4RB>D;[PN;A^3.U#?,>F;.
MVF>@ K8+RJ%%*1:Q8'PJMZ"^-D-:-#4',0_ 2-&K# 8=;-S#P>BLK_6DB4-P
M;'%PS*IFZ7\>"%;XO<7!8+U4S\'SZD4\QU#OJ]]9SPWP>^OQG/U!!6M!<:$%
MA:#8HN# [U6P%D)&/V-[45\+15(+1;ZBG45<"*TTGB->$:KT>U/!4#!0V$R8
MZJ99.:>XJ,CAL-/Z5$JI5"A#9( P@ YHJC!4 OY/0KM[,VF=W$K%UI&M6UIW
MM<I:_?GQ[B8C$0#_1PH@W-S2;U&OOU[0Z[ S'6?[=LC%,ZI-*;30W8V2;,1[
MEQ=M2H988+88_C<%MH;RZ:8Q\-^._/L5M.S?-9O^@6T;-/ 76TNJA!XM:0SA
M'MON;LQOTSMS$_]=U?/;N:6P]->]\\M_W8:M).^+Z7?LG1YDK5@:8 Q0^[TT
M&'3YO:9@T.WW8E2N\7N-P9#)2"DH7:P>2=U-&FF:EF-@*'U*#65J43U??5@M
MFX0+JG;Z ^Q+M]M;=2H \P.' [0L( 8F!98&=N&.7*([$CHNT3[>1^^TE.NS
M>FOD_R @(Q?][G\B#Y(M\C]00.HS]M36\SG7A3TM)F-%=;Z34>Q>EGX@.D)6
MJX$"#50;5%$2$2(TTJ1^5 .:+$S=4^)%>8<9>TPCXNL.2N9%.-N92@IHY[OS
MTS/9[&P)\8O1E%]<KNJ=;?OK! D(T?=*&L-.@V;XZW<^\_Z8IGZ7*F2UKFB_
M>)T=^\'W(=\]\]7G%^^]9N#8X2F/53W*Z#)[2C(?T ]9E_*>5CX2^]0 4PZ2
M?CV']P0+J_HQVC\L&*N4H-9IDIJ&-FC3S=4M(JO(9MBLV](O"R]IL[H##;OZ
MG2>F+>C=$O9$ S3I+DU>UC ;KDHHB;ZAP6 P-"02R5(#NE>=4O*MMF"PU.^-
M3@S6-M1Y:^6 L12:">O$D,_OC01#AAJH259[:UY/0C+QAP9(%!H:+-@*>QTW
MFV10JM=9]'H=:="QX1T4G :&:!W;2&)<K0.B["=<V+35UD0CU&95R)5RE]@/
M^I6RQRNHT.3;4@ %SL9^+]++)-_LS-O[CKZP2IH^S>9--_85#>)QY:KV1#S#
MILG*V&,0TE:FMUJ "GQ1H:!W)R,H&Y6-4AHK!5C,? -+,2NEBD%U50P4DB3^
M#X+:*P"]XQEYR\Z-AC]/;ZMNZ&YJCDW,O5GA:!G:?=E%$OQ$*PJP%GZ:%;>-
MI<9!H^[E6KN?N:74'XG("VS%"V%5<>[NV57_)MT6?<!Y56X";!A=&;5I.#3Q
M18M0)J*8[>A0)B)DG5@S%1;#C:'Y,=GZT/KP]C#WJW(/"^;5&KT1YPZ%"1/[
M^9&ED2T1/I*%@Z+@#Q12U'E04F7DC^015)2=HNU7]7=&RV)B;$N,8V6#X9G>
MN+:KJQOC)#;>V=B5:63%1D;_>&_AA?N_U-HNA:OH[G25YX9=1)OW&R3M=H2<
MDSNN7C\K"2=SX?]!R[?,3.E5P[9NR=LTQ4RD0 V,$!<4L,J8I@!4!3<6T+*Z
MUIJ1=4^2-P@?\=3 8K+8L]B[DJSRK/)N\N[P_LW[BU<[G\WZ]YE\9I]%" L1
MWF RF T6$B8158W\8N.8J/=&@[U4]-4S%4CZO=5!C)M6B\W$Z_&CY!=ZW!:/
MQTUJ:@@I]198O-X" C5>#^<#%ZFI1IL3C7@])J.2D-HZM^ "5Y/ZN.8O&JIQ
MU4GQC:>@:G[^,02,NE166U5=@:\PF6#?&=EWB5,)>CAQ(D$3SMJZ+%RV)X#6
M5:H,LR<-)..*6A%?$&=A*3)(JM@X)!W):TEOU4:Y*A'G42V43$'81M^[[*1)
MY0M8VDXZ4 ?^=[\%(?1^]EZ=L-5<S&7N!,RGA7E[U^>VV';WSX[N'WC=V$RN
M3%\ZO%!#\<LX+89WN5N0JP'']//++O)JG>?BLF/G6Z?9*]*1"/BJDIK+N0E7
M5<8BS!)Z>S[G-R#/ ]"QVV1"__/S;EV*K<3%VI3@\1@$C]=KT-6SL,;-PHX@
MK?<J@BP$L0WKK7QBGA$0/'8P>+U-^<%_KSM(C 8]@-<>8$\!$6JW*0TJ8%51
M'4S2@>[FD6C+!6.AA[AAI!N(>QZJQ\W!WM"B(\.B"199G,UOL22B+Z;HG<V#
M"VE 6G;S48(''7U6*1Y?)33>?'25<!08%]@42=*S2XR;JXE!,-22!?[Y@:7^
MI8%[R'K#>O_ZP%ZR-Z"3^66!8EE,$S07N^1"MN?RW>9J7&W'^(J]9U.P@""L
MARV>7<(NCY(PJX:FC;W<;9^@M+C3 GL5H\KD2!.EWIPFV9X?>O<,EK0AV_/5
M'CP'UY_LUMO3^0*=]!8S8(FEHIH]<6 U,C'(2P9S=FPJ=#7DZ".AL@XX/*8A
M$#P_9TZK/^>;/\X;']#$#SM_@ Y:$J^GD8@F-&+RN0VR6><?O^X29/"$J[F7
MPC5!&F$O@$;N_L#/(3I2 ,^(E3.%F>:-ZH],'SD_=GWL^<C[E4FE<"@*[-2A
MM;OLGI@0,\<LA2YU 2OMV-G"VIN\&"XJP+&UDJG5-);=L+. +4P;X$&Z2;Y)
M^:!V@VX[W:Y]G7]=]9KW(_A(IZ,RA5*NDJOM8*=VK5UG\ZIF.&=XKN<7:Q<Y
M%WDW&/8[]GL_<O^@U(S1ZZL)9ZM6J$P:IV_N.$D<,"D1G<0MH(BTBQQPKJ0_
M[:=^@\EGHB;,4UCVV,'R%='PFQ-,[#%,]E5GW^Q7EIZ,8NE)(Q0($6_4$E5%
M^*C3Y7!1N4%GBB"=W!&P*G'++L<MHU8? 9V'XA+,:EN$N&2XB,<;\7-A>#X>
MOPU0RUFE=:]2;DKQV9XN46-*48<II46@V9ZO=QM3F!!^BRN>[>E2*MQ[7I>Z
M,&PS_D+A%D4+PIBO*6C 'XL:!<('%=+,6&8Q3-4"C7)V:($'-KR1NR]W[QN_
M@X>@[M"4$4M&;[JJ==S4:0_QD[2YN;D_YG)'<^=_/@HZ2,!]PUY^.'<RMVW[
MP@H1G'_%8YJYK,)718AL&VJ_"\WT\8/$C]JO3?F9]D_4I$9$88/CK/VL_U]!
M6;'20T"+^4<PB%F(/!C2,5,><B=,).'QR,TFB@&'$(# 9Y-M2VV/VCC;VF04
MHNY\^E"J(UI!2T=J)VNI]N9(]#?U 69N^_((5M?+2"%MOJC3ER1()?$"7\CB
M<MB==BH/60))\+EP$;2&D^"W%[#R-^-(;YF.[?0%&A?5M?WY(5#.V#OE,42+
MW*T3+Q2R1T XMW7]E*\"QB7+E]].9^16L[+UKP7L$P\O?S'HH!N[]]-[-FZX
MDU%P9.YN_A^H8382A3?%5IEFIG.FYZJ(S*0QJ,UMAC;S*MT=AC7"&M,=YE56
M=0LTJV<&KXILTFT0-I@V6;<[GO9OC;YE>,NLLS$=\B^]J'!0T+L6>M<.IG-I
MW(A*ZL86A*A4:K56PVOE@MJDMO47AIA6&E:;M8NUBX7K;8N#BR)WJ#<X7H/7
MU*I1^I?5@*;I8]%A,%9I"G'!7EKUK88CFI#;7FWD6+ZY)U)2I<A"S5ZN7%[-
M9V&Z:-3X_DB4\K$FO3-6>'5@[KB^.H&H(R$VUM5N<1TNA$)IP%UGJBK,ASJ2
M6L8S9YE:'KCHG'WL%#=33/9EYWA6*&\\RXH(O5,RT+AF\HHZC"EJC38:0$5U
M1B)1ORT4@0*M.X(9-2ZB)MP-6GT1)+Y'ARNMQF6P1R!LQ@5AHZ#L_]?Q$,AT
M]&V3_,Q%02<84U8$ VJI&8'D-3'#2[/0K:RL'I,>09(&1PE<I(BLOLN]GSAR
M;V'IAL6'<I\..9M['S9"/:3@P=R1W-R]4R^Y<<R&C:-O;)^L7;%2V2^Z?U<5
M+ $YE,%]N:MS[^5^SBWA^1<>R7V6V[KCNFNWP5 8>"_[J0D6A_XGZF2(E,+U
M8GJT:X%KHY53AARAH:Y!GD'!*9XK@PH3X8E<X 6YK"QYE7NQ>W%P=>B8^^W0
MB:1RD^T#U[\<YYSG7'Q2J<W2#_=*6BMM,,7%#3'%E!?#*\FDEH:"EE H>&OH
M#F0F*?8$W$N#IX-=04X(C@R>"'(G@A"T%WN"H6@DX<["7T5["-.G<&G"C&KO
M_V,@$ QBJ*[$Y!5X4:4EQ4(Q+?[,GN6H:-.&(QAF]%H!K78D\_R)?@>E[(-E
M@JSZEW_NFE4"^ZH'TDA9M_0D;V=W8^\06<>"3(H-::8RS.U+N8A#BK-02/RQ
M$HO+&G%&"R,EEN(DQ%RXB-M*DU#DB":)R_WKR%C>/N2GHA>BH=-H4W&E-N5Q
MF*U-D'?+;!;%_V \>J>:*WH'/8$S]@Z)A:@?K4?WD%XKLNCLZ?57M]X$ T5W
M44UN=&[H^-0=:T?<\QB=G5O^6WO2<N#&!Z<V^7+5XVT^+D)GTTW=SU6NF//0
M_2PRF]US2A9 RY*"4C'E*!M;M#C R?6@,BCB\C*'P1XO-<2%(F,RZ(^'2VJ*
M:^)7%:TI6E/\5%6V^%"5.76A)M@F6LD$0XVOAM8\58YQ] 2_U^?W@2^+TC6P
M8 )Q"2[J>LI:%#<HHP:-P>#1> RR189%10\9MFGV:8X:Y/$B@T86XJO+N5"U
M534"^GYF@8>Q^6&:+ BBWN1J0/VO:C H?9CZX*&]OO*$LSX+J>=[O?CI3F82
MSDJO=L@/C]E3F0Y)Z5DQD4UI[QTJ8]O29N\L2S^GX0PT4A2-S];,,BS1W&!8
M6;0B_H#A6<T+FK<T;QETJ-#2S,,.S);,^?&Q_&.Z=FE\4R8]=,(&S4+&RK[Y
M[M%8[W-IO?5"[HBFR/O%\AF+K5XQ^?1WEUZ2^^F8N&!,F<]5;XI$2L[=,W]%
MY<SE!Q\?^]V^ 4W)56Y7@8Z?DVM\^O@U@TI#R43@LNMFSESY](^NL*6PB)*/
MOU@RJFS"J/Z7+_W=I,=/"]K^_GZ,JT-0N[6HW7[R[$$21'OK<%4%F>EL$$Q5
M_J"(*G<X*"O##0I_5BC.(P\=?J\0#*K\7@/F2W]VN<X7>'T*5R'Q4\&@)//9
M9"PH%H/*?-FVR2DXP.\8Z5COX!Q^P0=^WTC?K;[U/IGO$!03!WUNCV3#A;-L
MP$U 8.EG;R&IN[%OK*1OL 33&"F)[ZVD__=*NY36A(R\-NP?WA*=--W>7%_:
M79^O+$U=TS36'N6'Y>ZY=5[ =.YOOR8E,EO]J =A'J-(6<\I?BM2) &<^)C#
MX Q2ASH6+ [=&+I+?W=H9^B=4$]();W+G!- H (W'Y.B6VVWV@_JWRC\N/#K
M0CT?LNJ%H#\0#94')@051P(_ANAV_7X]K50J6"$NZ),&M(K]"2\)AO/%4X?=
M#MBF=G98A5F(_U8?3/+U^*COYK(RL6QDV?RR+65\F9(]NDH5345%(XNA^.9D
M7^$S_T2/%*]TY+.3SKSABO<9I&"@4&501Z,1?403429)K% 7$C!:":ABVB0Q
M!''!2"QYJ%ZCU+$ '=0",TL4Y;UI8J_QB47S&?^O!3+,#B2KI"BC+X9&-#AK
M;YD\]Z'VJ+?T$OC0DQIFU*6[WM\U^?:K7>(8?E@D4+^P>^;^1<.O?.YC6G3Y
M</21D43"?VEW]_<?[$Z*;SQ%-UZ7"H+TUGC,%W9+V:#W( FA5-:[PE4G0E I
MVV"E0@CJ[)"RS[(_9<_:93:[W>IP.MFKA[W$B8;=JO?JM$J-5QMP8D(H9GON
M%&OL"KE?R<K75*$HM:-*VJV\7%YH=^*6TZI4R&5:WHDAG57)\XJ 3DLPCE2%
M4!\.E+95A>QV%SD$"6*'9:+)KQ7QV&0M:)W!T-6!==?\FJ['7<[V[FZ']!:
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M[YP*J/OY=AB+A:W1;U<K\.&=1:_%S5+^$<(C78='V@:=LAX*ED %R_>NBH-
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MC,#D06_<JF9'8&#8H-=2V42/1]<AN\,EQ^6 S" RV(!LLQX?UIM*@!I[FLO
M(X4KX:7AS\*J<#"E;(?5";691\N 12GCA1*E&@,FIQ,"%-RAV@RDEBV*B]G
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MR[@,WY>2?ODA%MK? R!5Z_2TX00/^?=.8 [YGM%H21EJ 6Y(*4NINE+0<,*
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MY?&VCHVW]4OX"/0#CVS" ET^B:OA)AN9U(C28(;6F5.]A>2UP77BM,ZOX%L
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M")@)QN!VO.H"0 8T\G_6G@R>Q;5%V8RD"%0BC)I\I&ILXOB<K_G >,UWP5Y
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MU)9'T/"!EM>2+Z-A8&/,0&+$PR)H26J=G2/PZ@-UMX?Q#8>2KSG-MSO)F>_
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MAYD2UUB);TPU<U2*J[='B*Q6VV&M5_J74U_ 4A*1<GW\@K )$SU^;1:F9L=
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M=FX+X2XOJ (!O]R32!)? X7K$'RA>#9UOT&P!K.&[5&"VA/%PJC>DK)-JD^
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MC/XM&_)!5=V@T^6$@"=>27E].A3'4B*F$I10^5=-G7.-O;7*C>=(VJ'=MK4
M"QL4N;;"HR*77;PTA2#J4?K/:@J2]MC0"&BL5N3NUE6YZZKI  0_88#&U(P0
M6GE/(JCUYS+9IAIS3E4;/K'B9X*'D"LJ5.Q%FZ;RI=H\MF(>7Z?I[S_SO5O.
MNK5S\MBBS1_1V8N"-ZY3,?>5 PN+;" @"9L7H#7EJ\^P^%6! !,V+49K%M_]
M5%]V7CP]P>(-.?-JLT)O\32&+B#S4Q.N^3&XYD,@#_XJ:(!$X])*W"XV*:UQ
M*)WM"P;<;C]E4O+[;0&WR^_70J7%%HQF--9X)F2$(?6@)A(.:[4:WNUR20@+
M^SE6JRT6%8(P^%="J*G%-;M*F:^1)R5QK=NVML 67,7-+=]3Q:5:'0^-0-57
M RF+0T=/P$J*44N$""G5I#/G@OI08RAKR+M VI1T06Q4Z#(NF#+C36UQ5D2X
M@*>V0D@T0C($XKZ:C(&_"'ISHQ 6:(-HC!T5\T2[>N5*6'IA;6A1Z]N::*)2
M%X_+^$H9,@Z+VN!LF1]S,4+YVC/MA#Y8$C&=B2Y:=M_.51KM-Y?.2KE1(,!Z
M'<;I^. !A\,2,>MT2L.XU UX')Q7.9>YF9L,5L,V07UG^YT=+[:_V/%V^]L=
M?,?@\#M"0FTH<EJ\R4L-]NP+\,WVX^W,M?S&]HT=5XUEQXX1BAWM/(<'+53.
MEE0#<B@J8;U26Y2 Y?,+ CY2(!$UA<[)LR6;<"<GX1*;"DQA MC0>:03=79.
MR!W$<XE:9$]7#Z(]>UODAZ-VLI,TWN^?0+Y=@3]TK3H\<]%!M =,972"=<G]
M\X#<?K@E&NW2)99[$O-#B=GIQ.0+!QGO[N57S2=7KUITN&LF >69?-7L)V$/
MN #\ 68HL^Y1FMIW]",2IDG_X:8NB^ [](ODL0+=B1_%ENE 0==2PENJXL;C
MXI:N3L !JJL,0%'EQ6:FA,0HC@3U$\@=LV74VA]9,QV5"VX)A<)B* S%\SGY
MFU%@/C3P\<2OXI\UHZL+#77&UO:(K&=#U)INQR*OM\EE#/$2A3/4GLYT3%4$
M]8ZF6;G&0D?4FMPL*.(MK69G0[&I4=KQRX:&0C%N2U\O*&:-;4B-40NR:/9Z
M=R+L+#0ZS(J&CEP]UX ^S)][QN5CD['FSK2LH&R))UH"-AG'Q"V^]FF)=*$]
MF7BDA^&DMF!++-:A%KBV<0V)AHXE%_?GHKU-[-3V6*1=7>3:=Z;2X\>D[.F;
MNUCMF( C'FOFD:E.*\E/Q/UO'JS AYA>K&''#H )/,5'&(2&/00B@;Q[B80G
MX7/5?+[D=U 2X/BSSAK?==993.]97>(ND>];*G<B;)6)5L17(U:$?H)2_A]:
M$4/_-ZR(RIW4HCG)BL#V9>5.9@?,_:!]&9L0D-<*]__8OL3%+@[]OV]?5NX\
MQ92^ZJTQWSD")*!M^ 7)LQ1=58=UXSR8BC64"U"=()= "T3-FAX-(D'9.ND)
MS??<PIP%A6D'X65@#J/;#\<5&IL+L4%XF:!H! S#N@H*?0'K Y?MU2B@HI&X
MT_&\JKR(0+*K;=F+< ^:]20L@G[8"I; XN[39S>0CQ/QQPY8%.JR@LZ4S6YH
MSF4WY)JRQ>S4+)J:A=DE4K"#&42'!*44[IB&%B&$QJBEY,H OM**KU2HB2ZB
MMEU8S?8G*L>0]MBJ(1&.AP2!$X,._Q.AL>F:T=%DJ4P<6G0JH9XMLB5Z.[5U
M2+C&>]P%,X*K!LX?0/QY?3_J0_Q9B\]<O&@QP\\/G;UTV=+E2QD^$9P\J7<2
MX@OM;>VM[0S?%/+YO7[$XYG#8K0PO#9DMSEL=3:&%XICBF.+#-\SH7M"UP2&
MYX.A8#@8"3+\ZNG]7KAR-MXL+"WQ@G/FXLV4^$0O;,EW>(%''O!"@\[J!4XE
MWG2F\;'Q*?QME,-?#,R\P O[3EOA!8O/6."%2^>=ZP63ZJ=Z87NNV0O],K<7
M6#1Z+[2I7%Y0S(SS@@E)O E*]#1"]21FV1-_A/V1,D"2_W3_QUB44DO&>PHP
MEP@&/X+R/0+S\I^<%?R/SF)_\^V,JYE=Y>B46R;OW'#IGEEW=&O5%EZMD5H4
M!JW<S"N5$I,"K9Q^\]1?K?K1LU-_,MF@,'(ZE<2@-.+_O$K#&Q3H]NFW]#ZS
M<M6OIFV:IE>:.(U&@L\RR@V<1BTQRKD57\_G[C_]H<6[?OW\@\L?G9U6F:-G
MO[*FZ#?)Y<9P]T-[N^,&1?GL,QY:LO?)_0=6_G)62JX/#6RY9U)8IU 80_,.
MWC SH)<US+M_R;,[G]QQSB.SDPI#<,D#-\\-ZA1R77C5 S=."^CEW[.F\P:\
M!EX#7/O0S@B,:"F.:!QK12>MN>2^!^/U#3@37^<Y %/Y#?G->6P=?GP@G_'&
M! CS)Y9:<M]SQQOI*I)+4*.(H#5D(QJ*N1@Z:>UHY([4HHY4+>HYV**."W4(
M+NJ&J6ZA>T/WYNXCW1]T\Z [1^Z,4/-),*_?ATW;2;%I+7NP%1(;K&CW]H0A
MS(U<5;T"_8->D:@B(.;P%013TZ<P$NA"[PD8VN\[_PV0P35#<6N#7H4=5TCP
M)-Q:>CY]KD35'Y''S]4C>@I"I^+EYOSX)^(.P78H"9-"K"&;%+P!O+$Z\ ;;
MSTG[X'" .@[PWRH1I_74$G6"+'GFW=!G)PU,GL%_\C/0U31Z1;K:1B_A*SR"
M'&E\"WV;?(P/# Y_2Q?2/">W[JE7O@%?P$]/\2U]0$[P+0,GU>ZIYW?2.]'S
M/2#2$Z;PJ*/.ISB]]/SF:LG.Q^?'!"M,"R9+-DT0(-."4I=-*USDP5(GKT'&
M<]_S&V_ AW$9QQ-LR=1WL97]V53,3:J\+BTXR(\KM-E#:;@I?2B-WD\/IU%:
M00 G*1/BO-SWE;$3_@*7T2?HH#N53*'U*9A2)"@LZ4G#:B"'M1&"W^IG'L2C
MY$[!^/Y_S$Q?YP=:?C0S_2)%OP*)S/,B(;U/)*17&,S9*A4]91<U&<U9MW[1
M"4YZ1N2?QT]# U<'5GV7?/Z[U/.[1ZCGF0?+CA'J>>0C7*F$#X$UH3NX6_&C
M-.WI82!\DG$##K\8Z!8T/,/@00'_\1!GD]1@&2XLEVPDF"(Y].FG-&K.X ]+
M_ ;XRLN]__A\QAO<K97+?_LBO)CH;T9V++J+.QU8P8R]$"A5).AEC]9\"_\K
M; RH@!:Z@8PQ"785.,PFQ.K)VY7;U0F5S6;_AY?<D29=D)D96\W);^EJ.M7S
M\<-FJA,"#50)50-5"(3=TAR\9.Z8Y[RNB+2575]R&>O&+4N8(]Q<H_J\JQ9$
MLI??QDL]R8!8PDYT._L1UFSL@A+L9*"= S9V1@VK0=142?:J$5U>OHS]Z.<$
MKYR-HXU8&U*!>21F]4M!97-DV5L4$BDDX5>#3)V !2G^L!U*MTO$QQJ$X_95
ML?OQGL2FGE%+H2J52]HAT5X]2M/^AB@A9S4*1V021)UC)+M7G[]7-M:VXJR^
M<[D5-^W>?5-1Z"!/\ R;AG^EJ!J>O?S5 &#%>_=NK'@?A/?#FT#U)M^#2S:[
M??;L=OSBYM(W_")V_4;F:Q3F[J%1#Q%!KU_$\\I%P+3H" ,9F6:1;.WCT(I_
M-#FD_1.)GAS*)+^;'7 "?O.TN6O7S9F];NU< LK1-*67NV?MG#GKULV9L[:W
M-Y^G+_P$-U<N@Q\")=8M3Q.T.JM,E;U+![4ZM0)M!S(2_Z14%.1 CAX BD?4
MN"8_/@"X;>H4L.E)8./UU6?$':-,LJX^!,7DT%'MB:6,># C@L])>)&)(.2'
M<\8F"\6.U.2?+NE.)I03Y+VMV=DZ&TRR+6E7A-1#/^M%_Z(8*!*P<J3EL$J_
MGJ2"U=!0!!V!0^%HIMS%(\TK:/D' -RNP55V\<BI>Y!-^H?'X2?5T@Z5CI:&
MM)_3-X*;,E1*EH;("(8$WP._X-YCTU8C]?],7<6MK3P(YY$7KJNYE2[X 2@
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MPIR"@AW*IR5')$ABR[;/K='>B+%.)!1*A&VEH5 -8BA4DJZ!DB1P[5 U,JI
M?,B39J[9M4"*[?^)\8S112QYQ*>2C<ETDN%/?$*\:-D[;2R?"&:,#4&8)INX
M"V^2%@_99/"Q3+TM%@24D9UJQ#'R5PV#PF(D4\/_\><R-1F"E1Z]R:@FN:$,
M@6PP&*LFL4Y+PY_JVXH:^=-/6SI;ZM&B_[UMW\$S;CUT7>&*TR&LK_P>:O5U
MZ0?G731#.+LG&/28E\.G)L+5R[/AX-CIE<'7-OW//0OM2G:X_#\3*_E9(;EF
MU4_A.,C=O3;A%C//"9;]"MQRC>"M QI.(K-@;8Y@K%^LUF9U4KQA&$XFD\CE
M""B5*H4",CQ <H[G>(O+J90!KB'@]"AE'&#E#JPYR6&7'B$Y5I=0P")7:!H4
M"#)R!P_ET!-R\-&00=$@:,3$G( [@ )"RB)8T#3+$0NRG,C+&4G,*5<#U49G
MYM+0?6E-9(]PG+4 [4L:"86\EM0H)47\')(TDS>;+7F+A-0TJF:QT\7 4$A"
ML-RT-0@=TBCPK6^\_^Q999EZSI1/W;][?/_RWVZX[+<K9BX_W#[;F^'JA:!!
M.2Z1&*LV^#K8"V]HN;IWNM_5W'1EZ^K;*WM>^$5E^/(-'URWZ_+[G*?-?[MQ
MW8[*WV>VMN3;9T!P^+)4;>V:VB^%JHUU -LO04$!02-L%!2Z;&-P<'B0&HY)
MT82)BO:5R'$@KK"O'5EAOQ%\A"6%3S#1_-E-C8<:7VOD0&,C9\)Z?^,)>47B
M,(E]?@\>J?6@!=PH-&YA'V8?D#(+6Q]J?+B) 0U)A;+.XS3Z?/4>9Y .2X//
M[_0X SY_LD%#D;1#^XTM#: :"FD+!@S& #)*L^_Q]K9Z I*,E/7.NDM;!^'I
MN^92SJ;JD"0S+Q$JQTHD@9>0U\<9+4?X1:L@ T3W%_.<_&(8F)ASGJ^90;7I
M5F2RUU4S5_%AY.IY?/&&N_K?_%>WL2[8'"_/;"P&;'+.9 _BF?>Q>L&//]RP
MS!'H;DNL9%TV[^"&%7M/[[@HK;4$@PY]4#^/N?"BG,;L]]OT0>.YUY=W9;(3
MUIU[O8/$IH-PI8NUXQ'B TGP%R%V5^"1P!,!Y@[KG2Z4E!J2?@ U/!:R.C>O
ME6AU/%DJ>\Y?74#;ZU,%W#HRV\K]]6=;K+@+2I('X4)@0.\)#7J]#OB_ &N"
M@VX/UI$4$EZMQ4TM..R-^IJ=J3RB@BI;:LI 3<!I:]59JL&/$#\S69 4/U K
MDE%KQ8HERV.AA-5E"\9#SE XF+!&PS#DPIN8O3X,(W7!<#584UP> Z524%>E
M>APQ/[VZIGQMH5)<]QC)J,*M 7=84EWEOU/K%%[3F)DP>]G#<\]X[-S>SG1^
M]EE-_FQ+2%@Z9F'E_HDY:RB$O);%W+;%36RP_.L>3_+R#S?>]/=U/OO]:UMF
M??JO>6V4;RV"EK _0I_@N:MQ/RA2XY7FA6*C IMV)Q*-6-'^.AH?T'X4'SAA
MYD5H?,XG&\EO_10<9[YEB65U1 ACC8C!)AV'9!(IH^#E"EZ&4()G$IR4 0FI
M(B'C%4@F(RR2==;ZK*PH98Q2_!7'>?!'KL@K< 4H9-P@8]K-(_ $8\)E5*".
M/5)>IAA$'7L1/X9C\(Z@\F#C<;,4 :E'BDA0_QZ=*2L=1*_N49)9UD9"+P>L
M!4*Z6[ =*^ M2!9L9;)CT^(-@:([@=M-]Z!4^X'V [JI @I":(%0 F$8PB^P
MTC%K?N4Q.*M4>;2R?3Z<7GF4G5MY%,Z<CS\_6H*S*COP07@:J9.): LR<LN!
M'0SLT3V>Q6JA<Z\//IZ5_@HZ\51NPUL].KS;FK4-HE\*:KL=ZJQ2F]TLP_:P
ME+C[[8 #>/@OWJO?@/7")^%]V)3IHX:JN')+_.VXFXJ)M@0O#1M)WT(*KPEU
MH\!L:D.;=*-P$-XKX;QQ5V6L-VM4<3*I65>7T<-&;GGYF;$&I=[CD4L4IK%P
M68-9;72OP<]AQ<^1P\_A $\(GI<0UF(>9WYM9)XU_M[X%\-?C/\$W"[#+N.S
M!L8(B$6O%Q1R.93:!<<T!W*0QC,!Q#@/0.,.TR'"NXG.WPM)_1 E22V=I.9
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M,<I-E]Y)U=#K53^I<M5_D":#;/DH]--K"<U6YB';_WMZ ,K[^M(;N&,84YM
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MY?$'L!3?RNPB<Y09SWL/,+LN=9(?6;L"L$G>A_:3=X23D/=]#]%^\1;,M5<
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MI4RY6D[ ^S!]\ LFN+_Z2#4Z4PU!=07]FD2^<ZG<]\S+U7:"\B2E+\,U)=+
MQ6Q)"64EK)C[+@G3V@OSQ#6I?K&->XK2C]J,-]#BC+PVB"?52F.^66QC*YF=
MN;KZ4Z5"$&93F?H^E_^#4H9ZB3*@7V+*0+T%UO34[*]A0$W" 'X:!=W8=XI[
MB=*&R1E)[UX@40=]E5"%J@2OGP=5Y<I"(=]UGY17BL]&ZFS,Y.W)4"-#8DT"
M@43<)K\<>,E<5#92X]49&D:HK%<PP(5)&$]"D)0"LB7S/$X16B0'@%%AGLX/
MU@O*7HP)8668H_+X(,RO62R>J XR,A^G&FF'=L'JY.UV_/4;C=N,VXV,T1AD
M0@(H47(AH-RNW*4\J60-^'1 >5;)'L5W2$G]1NAXI2 DE7$JRG^;Y<7HRDOW
M(N(90O)+A:\R7JDB%FH132?)ZBLX +'#G543TL?')>K>N._&-:.KDPT<6S40
M_7I*?3A<-Y6I6+AY^82FJJ;JD,)A5\7G/9/S8*U(8@C-H!"Z%]Z'7@,>P<SB
MQD4B @M2N//]J34I)@7B&#HPSX>UO!SGNT'*!YZ +X-BP<L:)OHG(N7$B4U-
M JN?T#QAZH0S$U@?/FV;P$S(%$'EPKZ_ 2!_BI:Q22H#_0\N@^SO= A* Q_L
MZ!@X$$^$'7D.7''-DS$6;>"6XUS;LBW.[(P$QXYU.'ZR,S*J;S=WAM9R?R;]
M.Z26W8R^$O;VG=A766FQX$Q5EV/.0#P_OTYKV9[Y/H(Y$4'-4'>V^J0OB7K[
MOMN73.()E,GS,4@0"&-0#UH,+V$^5 T\+\L& SG3"\V"4BE$B_B-2JB,=Q&W
M8S]Q,CYH^O1!@ZZ9P;PY?=# Z=<,:I^6&VWEN=$V #V'VT_I64(:9LG+Z)\T
MRI;G1MD "A^"\_%RN+\<@G)IA%7D-_D*]=Q+ZR%434\&2I)6Q5]I1/?7)?4%
M&=&&"JBO6%"QNH+!TARM+WZE^F0?Y^J[#[T-UX*8X$9P83LTM$]M1YO:>]KW
MMS.@G5:.T, \TIC1R9%:,#'7@OMH"RJ% (*@=63KU%;&T"JT?M;*Z/&IKY4!
MK;0U"#7G-2=3ED1CRG,T9@!\$D/ NP=_S-D*W-M_W5=1(9-)\1M_2F66YZC,
M (HK4<$.IU9"C&6 1G]DLM$?JRZK&>/*%O1'1#Q"6D'%OO,6:"7.('OAP)=E
M4)F@CA]5IJ$;F?T,8I;;B"(*T?))GZ,D ?[$Y1(1X>$_GGM^V82AT\8VEGDT
MG&W^0O3'RB_NOO&NV:FFJ49Y8-S/RP'L.\$.0._3".W&O6 7@Q 'Z)X4V8XB
MKJJ+T,4T1P*S$U=1>#0<XQ:"9C 8*O=.5L/S)"!2WUFAW&CFMZJ_TJ#!_"1^
ML8:)FZ'YLX)I6BX@[PGJL9 J.#V\3%8(>Z)X)!/O?+NQY$3.>XT6S* 4M/8R
MP=T"\9#$6'<;2%0>IF"OOQ3&L93:"X,O555U]#(NP5FM9@PXIX)C0*HD$O(K
M5<&1A5,+4>%KZ$U0! PP*!AM B[3-L_KU1<M+#I"%O_0&<&J5_E42*6J*S\8
MGSE4!DL'+:B;.83XO"!.,(F#N]-==?'S,1H?CBROX&%)O&1VG^HZ1R/OQ&+=
MF+LAWIBH$YK379+42U;@R'IV(3E(GL!^[(^)&(/8R$$FIWXO+!G'85GE17G&
M0U:B"A;W?:#4O?X<_.2I%7L'U[<,0G#4F+)OCLG@D3^PL6N6'? 5]ZY<>L>H
M%1.F7GM]21VK;*XM3];X)B)V?;!M@]^X%\JV3$L-ZZQ7%9OU4Y<..KTA5;+^
MUM6.^:_\^J:;YC4TWV0<^VE%>3!4@OMR<M^?V95L!\9V)_A8*"YFZ]C!["#5
M&-58W62#?*D";F&WZ+88=K([=3L-QUDYD!ED7\L866_?7L&$NT"F!)R!&\5=
MP[& .N]Y7FAWN7F.<;8159X#1+5%:6O3,VU*)==6)QLFNUHV7_::['>R3V6G
M98K=LD.R#V5D4];!RZ:9H8 Q1F8^8^HS(1-UJ*?4\":3VSF2. H2-)LT2$-V
M;#5X/DR02#9D8B2[IMW4D1ON++K%VG7:F(AU=^%#5W91PIC3WP942Q:8"XUT
M/P*VK/FE>&_'K"/;3HM_@M&_'X,5ZJ_6/-^S#)G%>Y>=C]UW)Q3^]1U,B:?$
MKX; XF7+Q1. V.'W'>(^Y:X%%N  95@F$N"-0K<L9 M%0\R*X!)A76Q+;$=H
M;^APZ'"S@BVWE;MK&#XT,#2^<*(PNW!>V9+"%66OU9PK5TTNF.P?5S@N-K=@
MKG]6X:S8DL(-P<>":H?59NNQ.RQVNZ/<CX'@)(<0.90[0S5L0Q6O+X;%)!25
MM8'W:JT.SF;7<@H>OJ)Y!>"1]AJ\!;=-BP[N-O&"F42)-%NX4* F5><L+:](
M6AVE<:)00H-117=LK-M& ]<U[@;$YQM\8Z][3<4FLM;.-.X52G?X4S#U&OP>
M=ZB;L)8J ^^>V6JQVQAH;M% #]#@*CV$4R)'. -HX,]!"QY0).K0MW@8&<['
M+M\@3W>=[CJ7>Y07OLQ4!YIQBF])"BQ-4%?<ITF4.^K"/!/,CG;J(BE>W>4N
M.;.1ZLQY.^)Y6L%D)!(5O,SJ A^%CWD:2$BS 7Z3)R]>W1LO;]J^8MF&1X<)
M#RZ]9>7AT.1 I:7DF@@_EX0V&Q[U^T.=<$["EPUJ]MW5-W3=.&?$[,%58QN&
MS9LM3+.5=*R(12:^537IGJIXX[487WP87_Z$\26,R5,3: .=\&MALBQA2T03
MS(JJ)9WK&K8T[-3N2.Q-'$X<'JF,&CX)?QMFV)0MY6YG^,3 Q/B:B9VS:^8U
M+:E9T?1:^[F4:G+IY(IQ->,:YI;.K9A5,ZMA2<V&JL>JU"$2,DU%0J:5DY!I
M!HL!10N+BGHB44LD$DT1#"HFAP0YI(H3[>S05EY/U& P+GF'\N7:2!$7+=2.
M5$Q5+%"L5K *A55F(#'0U"X2 \VWEKB%)8EMLEF"FDM4MH\87-R8$@9%BAKC
M@^ @":>J=VP<O&TP&DQQJA)6$IR*K1$V"4B@.-6XPS\"CL!I7S;L(NI49*T*
MHU5LYNAHH<D.(:/82S;,T1','O7"V,N"GX&8:_I^KT&7\)/E&5R+P: WP;BI
MV332M-JTT<29>N&!/?LQ#_[8*"EH6C_.Y2]3=;LR4=2("D:^"[G_ #5=N1AK
M";KG>67\S 1-HSC:U6U.7C%J6D9#NC]FVG^,M/L?2U5UUA1/WCWIIFONW/W4
M6W&?PY^LCI=6S6:^O92Z@_DUQM[ER]=O'=KRT!*"O9/"<6O)M$AR+O,OMV<V
M#:IV=6H,W[1D]E,3W6%]M# 522V'=_][5"X/]J,RQN58!I<9+!$E00ITP)\)
M*V0Q6RP:V^=B5Y0LZ5B7V"K?DGA6OB/VBGQO['#L<+N:K;95NYL9/C8P-CX^
ML6-V?%YR27Q%\K7F<]6JR>')1>/BXQ)SPW.+9L5G)9;$-Y0\5O*N2@,1P_0
M:,&,5#7!UP YQ,BA.A!K9@?4\WJ*6[<(Z@%\5 L8#B(M6;78;3#QWE>91J#
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M4_ H&@D'BV0R#4(:H- (&A.O46C8[08"KZ[3=&,+Q/&)>&(E4E4MJ+73/8E
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M/<1H*>8]O8;9"".C146VO4J4!@S0$KE2J9=/DV^3,V0O7(YICMGE<_<RI4)
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MDI'EY9X>K9U$6GS1DCTPDW9N0 +9I]K%&J3^&K)62:I6([)>-@*>HK3 /C-
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MO^#&37^]N_<;=]VW>9]RTQTC)_[YE1]BOEL1WU^@'Z4$X);7ZKQ>+_R$ 0;
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M,= $FK:V$=:/DGW D=%9^ ]1IC;B"XZ2N1GJ0 ,UZC9R;*HBK>G1H=.4)LX
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M1O(S4RA)&\ F7"\SY4V2&"&C!M7H >8.F:<SA"U_$/N;D)=%.Q7!:(,<1LX
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M3P!K H\\WY;8DV '$B"!SW.B+\.IYYF42J0-%DU,-@P8-AJV&YAA SAD.&*
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M ;WRX6"#)$U;"AL65X DU0V>[,#L6KORZ=K\1::-G4/EP,-RE6&=K,@VL2_
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M,1EQ$.(0Q&&  ;0Y@-8&T-H 6AO@UC)>]^8S7O=V,E[W@.819KSBO<K"N.6
M70+C >,Y0E0/ IX)C 0, !U.38'[6 3/=D"H,X!=@3."UQG ),1DCF )\("/
M'-,X#_@X"W DTA)B!N)IT@+8'L@'/!-P  8XS5 +BT&,XYRL"V("EP^KN0ZP
M-X[V0SH1^Y.19T#@=L 4[!F(HX,1A^#H4* CT=-(M#\2_8T$^SER"9%@_P[
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M!1IYS^R !7 >]IBY%F9!6D&T(K^-ZP7;>(\7:1]B,U@^BK6 G$+47L@J21_
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M"[R8@?PS<*_-@/7EM!G1 A5L!E:5&1BQ&;!J'%V('N1I :S'ZE2/<NI!PDN
M9NRQP+ZN!PDG ?GNJ\?Z5@_2=@+:H1K4H[1ZE%8/TCYE,_%]-!/?1S-!YCV
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MCQWURO)=%__K,NNW+*.D8I]"SB"&9GW7.!U@579=O.L2Z[? !3-]("F7\1C
MO](@'88U%/)0.^T/L:U6K,"ED&JX2;D?/1;C=<8ZM8F\?.ZCWDA'*CYA5!2S
M:C(:K:KA1E)N'Z8S_CF'NW-DU1CIE/ZG8CQNUQ)1-^OBOO5$-[S\*R+U B-S
M-@WI]8F$I&2VJ$DZV7"RV ^"78&RK^E6>M'41X<H?6*1<BL=I=S:B*+]7</G
M:85"C<?0YL3SMTI?XT"TGXS2@6)!X7$YE.4H9Z/\!64?E ,P9R6*8!SSA>@'
MIEL:[QD_UK@,Y2GCQ^@BX^.-N_ ^@W<R/DZ?,_4U'E23C1D#-=Y"^X.&5QL/
MFI.-^S#N0?1O0OU1?J+O(<.IC5\87J6;4=^*^7\S)^E]M%^(-I[W!/;Q(Z6/
M;L0SB?5_!IS[@*:W04<+BE^]G+KQ+.%946[=Q6M>8SB5HIA34OIVW84^!]Y3
MX$T [3'4:QACPK,('F9!9P/]1?0M 8X^T-"'_IO5RQO#Z/N3\B0=(!ZE&Y0G
M&R-8OSB[[\ODOGG/LWMB^F=I^B^%:63Z/EBPYH?*;MH^4D#7APK1%K5.=^*Y
M"64I:'U-V48;\7S>0+MN-OZ#3N!BH<:_E%O%%\"K>PP;J6:^O'$Y:-S?>"<M
M0#W%;;)0XW7#5QOGJF_3ONAK-5U#&Y5.Z)A.ERE'TI0I3RV85\!:&HH5/&LQ
MO(!U-])JS&U('+^5M*]"<>'$W3[/(_#%?#F=@V<58_\"FOZ,,7_E MJR* 6>
MC[7;F=\L<_&Q71>C7P?=9Z#T&4[==27*%9C_-O3^*VA+X/V'6*=K=IV9#SQG
M6.\^6&9E,U>VSA7)]UOI2RAWH=P"6MPHEZ*L0-V.IP:=:^#]9:F'?3CKT%76
M%ZZS;K!>L/Q!;Q?3WMQ#XV&I7R_0!/3E.O#P;)0C4$XT$9TY6R"[QFE\5EA?
MY5F9Q<UZQ?HR]V3=-I 0RFWB3=XGZ]/\D\_=OZ@D=9#W#KV:>_*98[UG6@VM
MI'-=)4I)>J%KNY]2CVI\%OD\S#UW[Y5NALTXAY^&85X+>@X]G'O.\6+^^6SC
M(5.<3C*MH/,,FZ ;4<JK$^0UK*!1T-5E^+X\7_L8E]#'E2?(:MY*.<AR7]!P
M[4>>7^9B?E8<:]Q*.Z3MV4;7XEDP/*MD#,\*H_&VQG\87A=;C;<IG^;W__K\
M:)D;RT\N'^S;T_;_*T5YSG@;'8GW/QJ?!6^?I2^PAS+_272@I.>>:)]&.1>E
M;&D57[8<)V;,^Y,'>O,VRHF00[]QF'H,6VF1(4C#X%,>[?N;KH8>'4>3X->!
MRK!89#A.[&>ZC:Y5CX-]QUK*<[2."^/'<]EN??JPSGU4E^:?L_KZT2?;>[:Y
M<T_69SY?__MGXS;V"[#-,](WP#[+(O6U<>B<7IK&&_<95E%D7C\_I*>-WW]
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M\96%5/EN5%6>#MO^9_M6>L_2( M9&O_"?<S:V$4V">UD1XN#'(!.P/?)14Y
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M/=3W#,CLS%0@T+LSH#-G@%\_@#[^"'7\$>XY"^\X"_4Z"SP\"\\Z^QU"YU)
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M#02\B0*?HG M-A,(WE72#K0)Z N$XW <OQKH/Q$N-0$!STJA+&7'$$[ ]Q/
MD\0D("AKXB#"%1007*\ N57<!_0ZT%F$*Z&.E7. [@2"[U9"':K@657 BZH-
M0,"+*BA[M1-H%,*U<*UV*A"4HPZN-< ]#63_=X0;[4# G\;K@4#NC5#WQ@&$
MFZ!NX -PZG8@D%TSU+$9WM<,,FG^&$'JA[ (Y1P)SQ@%SQ@%.!@%GT?!O:.
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MRR0@W!]R+=9KYHX9/?]H_E#)M+) (-+CLT5&SEG6=<-W!*4:/(.ZEXJ!KPA
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M BL2;)K=PNY@/V._9DFF4$"1CD>(YSTNM\E-4.1RN2/AD4IZ*1B8 . FA.*
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MZK]D"&1%5]'POWO:BPV J%+A9TS/"B^97A9DTC (P ^)_P!#1GS>"Y]WPCA
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M$^!HEA<)AT+10#"(K9"@7"K4&77GCVJA]I T%4@FKXT*I-*,Q:ER5F.#G4$
M,M&0*HK?1J.AY/G4CG0: $^2RPL%A=J2EL&;PFAV2>5&D27C<UJB(5IZV'*&
M1"8%T@4ET0]"^HQ%&]*&,L(K3I.=X_A 56B3D8E-$E#:0K^/<4>+EXC32[=*
M)@7K,% @B0I8%;XJ6'=+J\)UP^#5;%#0) 0X.8D%,ZG6*\=7/DDZ)Y1(XK'*
ME[OK%]Q43';J=LJE K'8YA*HO+,?:FUHTVT3RT6NTHTWSOLG[%"I#!D>[.&L
M_G+KC]N6M?<PF>F5V3FE0";49Z4FS5VKF%AH.GPJI!+)BULK_ZK\G%K58=5+
ME4B[K.I/R&I;#41(GKY]7"R4YR7EL8M,FI8WD%JEUJDM!=JM&ZT[ P^(GQ(?
MU!S4'@F<M'YND6H5,HU>2/YZOP *!#*3]OQ^+"M)AHG+O &/YUK$F\1!NTEE
MK^;<F;B_!DB=.8)SPCSGO3M\&B0+-?LU!S64IDP$&;4>V7P\D]]GI_N1P:4U
M^2?TG0T30?%5&VIDN(04GW^GX=26-8Z4 ;4T>19?;X+!*B>'7TM<.O9(KWF]
M8=;L^N+L65O?D"N$<GFXY+C_J<8>^9TJCUVFEL 9G-6SZ^MGX[]*:C1?KQ0I
M9>XEJLJ_.G/N//QMJU/C@+XLTDDK)RMMQ!)V3&/@+\P=3HF'=GI"T:0DZ9DF
M;C-V>3O]TR+3HC.-*\6KW2O]ZR+KHMO<>]R[O6J)5"JVV'0.EU$F]=B-UF@@
M$KG6+T5#Z?=4MQ#]?L^4H8R<C^Z(Q<0\H$/RT]&LD'GB/K^'MJY1#QD/><A?
M"VR"F. %P9M(_]GA/R8M8XN(\4#/,;]'ZXD+RS#Z7$T.8OC4D2W_1 ,\3%>&
M)Z3@\/ &=@7\VR$?WY=B^2<6?.R07SK>O*_%U%?'?\JXO]$P>TY]PYPYWWRG
M:2#_PK*9TYM3OHA1))&$;)K<ZYJ02R03P>F<U7,:ZN?@&RNI+X?_NF?IE4V!
M0&/08C:+N3Q1POYSDIBA5KFA)XL&1CSV&65$%$C VYGS?J2%SO&<]E)")]_-
M#PA#5- 8- <MT5@TG@,Q52Y0BI7BK'F@:O-V!*;%IL7G:09C@_&K8E?%M\>V
MQ^_U'%>=TIQTG_*993%9W!JSQJF WQ]"XAVJ5&J/URN'D/#ZO'(?D*N$C@ 0
M^SP$M.C-I-#A 0%2+-(!+[I"I9)(%5KJE:N\$'CE\4 L]G%H,?#Y@OZ0*E2E
M;\A+0%+DB)V/[P# )SDO%@O/,R*NWR?TF8&9-MO,I!ES.9E^L4,4\M.6\V9&
M$A";S\ F("8:CXEPQ.S?&-%BWV&_/NG77E&OJ[*X44-E9/@3^H*!#8L$):S#
M('H'2_CU<-7!-<(:"9-I\[60Q_%\-=9%(<]/YE54!6=P7(CNQKL,F/U5C^Q?
M51?"1D;V*WL,7!Y/68,)R]:L1J^75^6!.$#633Q<^>3#:78)W]<C@O<+.\+.
MY#1[J-XI%\F<,9[8W7U9*9EL<2367C$&IZE5SI0 SD1\L/?M%H=.)E&;.!Z/
M7"/WUMG\E4\.ZF4#(I5V3V>\\^'?+ZT\2:WLT&O-4G<!6]46Q 5O0_/%#/[.
MM !&;BJ=ED.!%@*10$.+:+%;Y! 70!86M/7&>E/)V@4Z(,X:VJC>:7T:'%8?
ML9X!)XE3I Z;B#+1>2&V#[0*74K(R%3(X!.K2HQPO_"@\*B0$F(NV4Z: D;C
MM5IL-&H5U4AJK59A/&_:838#(,1&8O5^CO"P3*2P^+0T>5C8C^Q#BP\?M0K+
M)(?L#=)O;< V84UZ_8D57O_!#L1!;%AD(9DU#@,<O,0 K!E^V4E1=%OEA%DN
M5-"Q.N^BA:7VIEX=E&K4V(V!EN47#UVAERBDWD'% XVA]H1[@'QHFAY[+SPX
M U@U]G?.:TC/[(>O,-]3-+1ND1'SPG,B\XJSVCX=X,@&WAL@@(MV>5P>=U:7
MR68[VG5MKK9<6VM[QUSU8.]@WT;QIN+N_.Z6?0/W\N]5W5_W4''_P"'^D^(G
M5$^&GRR>TG]>_&>;O;6M#8@A:'>9#4ZO4)P5%"!H<YVGG/"<\VTGX3RD-A@R
M@6A5=P@$HH)"(5C7H&K ;^OJ&D!;6["]2]6%W[:W=_6>[]O1GSR+:*, C21@
M_ IN/Q?PVMO:ZNH*0I^SY&2<^YT'G4>='.=AKR@PW1<---1UM=,#9;*3$1D.
M4P'X8N#M !$HDP%&4#A,U<$7ZV =?J=I.]S>%^C]N.M8NWYZ0%NG;=<&IE^B
MC53!O+':BO<;T-_HE\%J3/LD<8.U[4. <8&PSCM51YE04:9J*[JJ R!?BW.O
MN1RKZ@H[#:ZNI3](PD@'J+?(\UTJ.M^.$P/IO*X\]NXQF;RA%HQ#3NHS/!:F
MY_]#MY&2/)YS0M%!BUPYL<AMNVZHF[,AWU@PAF_,SVT,)]/MEG5Z"5_$=_D$
M"D?KXVWU7?H-6BE/(E'VW9,WU8^>E4EX[OXM5TP?>]Y$NY)".(L\4!EXN759
M0V\TONBQ5YJ6NPSM>69YY<X9.KZ49\Z)]9H;-C6'@W/@K=-5/ E7./,76Y;\
ME-B;5O'$2^X[7_F N&F1C]9*T)1%<]: =&,>MHU@ W._HMZ_F2+FVF8$^C.D
MR"8*Q3+K,Y1;EQ6WB]O\"Q,+DU?R[^,_&'J"_U3HE/3]C(32J72$/Q  X5 P
M&)%J#4+HAWX0T)W7'L(:K;D&1& V(SD!,I&@*H+?1B)!=Y++!8GSR1VI%. %
M U65=K_VH);2'C:(S&F?PQP)(HWVG!F:\5Q2!).!Q,>18T%]VJP-:LWIKVFU
M>!KABA>7SAYV$W%DF(V$GZ+9ZL99A>XB&R$)JC.EZBJ:Y.2UB7(:"=G?#:%)
M8<59HS+TPHXF3=A"YT.6:K#CI3/ETMGQ=<5W<CXXMVUO6'!S(=6EVT7+^$*1
M$^F]GKN_C=3>[1*%V).YXX:!L;-&VI5 [ ?1?<;SK5=T]#3D^BNS<G(AS3>G
MI2;M/YA88 9\.H"4WM3-E2\J/R=N7.23LP0F0 )CTB+ZRI!M>8JQIY1U)F*Q
M8Y?CH.-%QUL.#ET'>+HZOLA24%!,(IW"\?%#,IH],Q;L-J5>H AJA4-=4(B8
M9#IU0/2"B! Y[9@?L]XY-@=,A&U;4<UA)*JY7O'YF%,Q[OMA_:K!ZOT4OI^J
MW4_5[J<NO7\BW'ZP!AM-U2"=M%,\<M5HX\?Z[FP_47GWOMON7??T;WO3SK:C
M.8_7$MHUD" /=-[8]^W*\V>_?=V=?SNQ(6TM5>)G(D6=ZPL8W9'*X]AA;J6+
MQ%S;B=: Z[B&87-_7V3FRO+=)&Q3SE;.UO1K-YIP #>/=*5HFB!I5THN)U))
M%TG%O"D735*$7!O0:#Z6ZP)Z_2LF$' Z/S83<GG&9%:9\8PWF<S.\V 'TIQB
M9;+U.)=+\.@R>8S)>)LE(OUYG>:\3BLUI7UF$QT."7 +%M_Q@ !BK981+!:L
M%QP0'$'Z+5^P(D.<@6>!F>PXD4;60QH)V8[GIKK\O^[QQWRS-/HAB[)00YZ>
M=/%,PFV,@VZPKE,<HT$7BSB;FCW7]GJ#0:4[R9NR%^#Q\J:$X=>FMA+# $^X
MZGC;8'<QO/+6ILN6__CH6^Y4-&4*31>,_D'(S'*/&&E;[K E9K/5SY^1R'J=
MUG ]>67N.XN;O[&R\L%OSTEUQY<F;6Z)VTWTWD!V7N:5:X6CWKC=N>J)\XM[
MVA2&=C3+O8B&OV5IF(;3F(T"1,20(A1W):8Y'E=RCF;1*-J$0:0!I\D,)R%(
M"&.BM"SKRR4Z0 O9SF$$C' NL8+8##<3=\?V9Y_PE>4G8Z?C'TO?SYKGR^?'
M!Y/D MD:Z7;I/NE3]%-.+NUPRAU.IUSN4#M<$7G220L#&+%7QUA)44 L?H4&
M))FA:_8\33M='5:>$W!]$>P=5ZI%8O%YD4!P7B24TLAXIVGR+#R&UBB-)IY8
MJBU9:6BEWV-!6=P,G17LRL) 2._,T%HZ(W2>A@^ *>0>#-(7,+TA/4EO[&!E
M=RU*[%9NZ3]17%X#Y:IY\W9+$;GAAIHY7U66>!,IUCA=DSN.]:S(C._+34&O
MK$;_D[^M_,+"%>CM[:+13X5U^9#IEO6+NSH[0W4;?W1YHM30(_,<=KF;6@8T
MM-[IG/E8EKSI2\D*8\AB51FY;K? /6<%?.G%]DRF8^L-T/B+I*%C8(?+7O?L
MS[:FS&I;-[QL36L;EEU. ,@<HKH=%IA6A4\(;=:8<RXY1[^"7*Y:KEFNWT1N
M5)>)'X$?V24:+8!0:S":2#W0:C,ZO4I?S>C3VWF 9Q5'Q24Q*2Z3029"%SC6
M\S*;U;;?1MIL0&?G\'1"O8Y6'.##1?P7^._QQ_@4_P, =PC ,2VV,U4Z6R!F
M9:R$]6/]XSJ]0U<U1.B1"R.#.'0B> &R)&(#TOA,6%OB,TH;.DCQ*[.553;F
ML89*J5@U[.GAX<%2:0JF%[9% %J2YZ;$X(.QCX8\6HS7]1'&4P L\]97SU)M
M]2RJ74>=Q>>3RKR1F8PVQG)+D9T"Y%O37R9%%/SP_C.79>L#J:C%[?/1 J%(
MT[ZBD/KL<872CFR0"'E@]*?PX46Y^MR2ID"7A"L>_.7];Q/W=^F,%JFY"<"Q
M,61O?(ZHE(1<Y@ZNB"L1^KA!*DH$*(\X$"]2=>YBO)OJCB^D%L974ZOCVZAM
M\7OCC\=/Q/\>5[Z8AGJ/D_30H5 A%$MWA0X#OM<M%%,V8QS&.6&-3>'E!\12
MIUYA- $3;;*92%,8$H0BR:D+\VS-"E$2\5T9826B!$F<ASN<>5K:A_/MX.M,
M** _;]AA.@^,M)$P?LS/RP)O!@A98 P?K(%8@ F\@*Z\%^ %]*DSY!,P-%XB
MXFH61!?#%PX.?SD\6(-.9:$OY!CYCBY.2<C'L</RZG;WU>QVM_-KT?I>SU?"
M];V>*?'Z6>+SD)M_4W>D: A_JZ7_P.S"K)Q);Y*[XS9G_?)HMB,ZZSJWX=&[
M&N:'C5X=TA->VW1'QF/+Q9[:U=FW=Y:6ENE@S^8KZUMCT;F#.UL3S%7[-2([
M6D%>1)L=U-W #*\\#3ACOSNFS'/*8[]C=LOR?D/&0-@(&^F0VF0.VF5RF6-$
MC,S2#,&0+;)FND_?9V@RSP%S=0OT"PQSS,O!,F(9N4Z_SK#8M-Q\+7$MN56_
MU;#3>C-Q,WF+[$[]G8;]Q'[R?LY#AJ?((_J3Q$GR97".?-E\'IPW_Y[X/9F!
M%(\'9$*IP@@,>IT9J/6L_URF6TSVRZ#L/'.W]" F'#(I+;S%/&1-ZM15L#V=
M3EV2,M+]Z'-*>EBAQR#))%QQ#)I!&38Q-%2(D-%G\>G4-/4*[[":K6%AP4GK
M[P]ELCAU\'U&9HFGU&<L./]^TMH,XA1 Q 5')YQ$)7JDR()8#4ZQ-PTZNC)H
M&!U,5+=*+O$5L1DWYR:$)R0Q</K7PQV43BP]B>[^FYPW'*85(KDB4N]L?:*_
MI=OPK=M4NXYNH^ZN_.6:T><S)HE2ZIRCV;2^-5U80)B[HCO8"CYM8Q<H%[O*
M-C&W*IJT<":<)R8<T"5UZAS!O"B5;H?MTOG"^;95PE6VK<*MM@?!P\+[I$^"
MIX1/2)_TGC&="OY,^C;])]$%F3&6AB(AT)F%M([2*6FM@13S;, @M%FL(DIL
MQMH]G0C$%\77Q8GXCJ"$IC-FL4I<U?3%V,X/^E1!C*ABT4A*01V+ >!#*CY6
M\$FDX,?/)W8DDP#QV^<8K00@*X7WBMMM$/G,*9_8'/31]&%6ZZ?)P[XS*;/6
MIS7[4D+G1^/1_BRRZB7H,\.(,A=8W0:)/:3W5ZDSU30<EWV#K&M@>!R-J+9,
MJS[4JM3#&JI-AY[<@=;"D%+50)?9I0&1]H^4XX8 OHS.4GQYW%2LY3O57#S*
M+/EOMYFG&@-5@_"_I#R^*-*S=O."T1=U,KY4XJISW'FXH5T?O[%N_M9<ND>_
MP42[$ZS=-SHWJA!P^ ,;WX,)P>A5,\5\N=@\5_=%*9F9\>3WFRYOZBTF9\/]
M2QTR5ON'((^T_SM8O>B?3(<BJ C:NQ1=MEWN(^XSG*/NM]P"IUI%"B$M!4XM
MH*%2:Y%)I5!*TT'(54%:#KGB\Y*/#5(>%"VV0,8"+05&B[5C!2+I+I:<1[6?
M:CDX#PJMRQ.T9"?.IX5KCW%WT%@R:FW]$*+_8Y!!I_5LYL[[D ?/D'W 17B>
M6U7=S;K:H!_67;@X6-33%_&>E$$WC"B!A.'(\(0[CH76KOY?XZJU8JBL5 4X
MG(/%G0!8<088N:@:YHV3:0@V8LW!2[L5)+M;-<Y;641++C2X2*=&;E):Y(A1
M7D'>O:Y5WI+*6@+QC9VWF@8"5\,C'6D=3;GF53ZMS-[S;"&RR*=+M3GCS:VW
MG.BZ#51'FM.+1CH 9S$K%$:-RD^(E"(-Y2=M&H_#YD_Y=_D/^KE^PJ\,:B.Z
ML#WL" ?BVKI -]FM;'.T^GL"\_V7!58&-@=NT=X9>(!X2'D@]%WJ2<61T/.!
M%T(F40#Z=0$NCZ+DPKV: + %-%HV*]"G"ZATNH!&K=&J@]4"A5J_(0 T0,*S
MGW=\[.3IM%J5R&%'5&'D.D8.Y07A>B'<+X1]0BAD6:$NQ3KJA' '&%+O8/#N
M!K&0$86\A?6&78:#!M* &PMMNO6Z7;J#N/0D7#L4[,+$^\/@Q4%<:?+"Z,B6
MSX)7#V[018<'V4HMV&<S,EP:%X2[(U4X$EQ08O=VC/3#EFNASM7P* 9KEK8?
MS2X)]A"RB6!5^!" %E<U1'=2*B*#$",-.''!,T^5MM5:))#<T'7_0E61XK6E
MT];0VY5;?0V5_J!,+DQ::#V<:Q+**7@36DQ-]WZOH GU"I7&9+LKU;*N\D"E
M3"P??0AJ/OM6FS] N1?TMJ[:FUA..) 6\QW$7^6(O@RD3X/"V$?,U1)YJ=[5
M[>W+W0\>\3Q:>,KS9.YYS_.YGWA>+8@U( L((S(-B]YBMD/=[>KQ].07>N9Z
MY^86YN<6;O?<GGN@\&#QC.;'A5?J?J%5\]0:-5'P%'*>H)K$3G8U2:H+'@HZ
MBH6D1Z8F(5\$Y&<09Y5"BA'S^9 Y#Y YR3.;7X ZH(>'@0/$( 52)&"D@8!#
M5 KO#!/A5Y@ *).K&)7(?-ZR@[72;2)&M%Y$B@Q-9?CE<_55('L8[,&ZS,B%
M#2PO12^W(#E6PN!NK.MD&$X:A?PJ(:O ]GBQ*M' 7[*]SYI\BDN=W1ZOE)BL
MEU'SC1#LHAR$@XN\2Q/-<^+9NKJ0;08=\*2FS4I:K :EN>B:.Y-I8&8UA:^[
M96XB5=^4-#H2&K/6$C%U+\XX4D8O>7GQWJ%O%'JCQ62L7FOQWUIYN\DK4<]4
MWU4(YV^XZ][; \58LHG6B64)ZS)X15N8CZC)5-I8OI@#[S-IAPX&!$%=05#0
MY0WY2(^NS3N?/U^W4K?,NUFWJW"T(!/(U&$_3P?=N?/@8P7DN0_[R_ P8[7*
M]#R16N;U.9#*25(<+C<>BT8H7H)10S4;0,-H<!24K%]&E&3[9/ME!V5'92_*
MN#*TW([S^AS0428N,OIP( %RAWB'98DC"2*66)=8G]B5.)C 91_6#N6=-28Y
M?!&)MPN#5>-^>! 30YN?B,K&^U>87U;S?>%$<#:F#OI7JQ@UI:8#P<;3?)4F
M&)^GRBM3,.66&45J_NH[ DMTG:GL].X[GGMJS:T=P4!^>F>\/NE 7VO)</ER
M@<L4EJO)UOD1?_OVBY4_[?VHK<';YK4FNF;FFY_[>67X)[LVV)7]V>PT!ND*
MA>W,[$?@]I41!XDH\?'8 !DF;P)>V'4<L>^\#0]:O4K=,%<S1W^?[#A)R40R
ML4"VT$NY(?JSN3TYT ?:J3Y[JV<A6&B?[E[H7>9:YE[EW>+=;WO*J_24H>:$
MP_$W=]A3'OLMMGOP&3%E4<G#$1EX$ALE-WNM!M*GXU"D%-IMMJ4LWV0=+O!I
M>!;GD4*Y'3AXS=K'#?+_,COPSH9CR.L%7+/0)C0(H=1WP [M0FE>F%=5&15N
MK#JB(E0XNDTD2:DV^?&68SVF'0MK.XS#G;"J42KA?+=A,%Y:Q,$HU"G$XEC7
M=BW"'C6(!,<WH2:2M-D4!X@5&[:B5:V]'5<Q \&)0H=(R80:;<V0F%IASU&3
M@LY:F#X9'GV%L?I<$1UM$O/;$^'Z!];MVIJP*DPZ,T.TO#6OSQF<0=XTND3I
M2?PX;58H@V9C;EIS9L9MUT?E CEQ-,1 7*)R3F4)^01G-?"!&QB;FYLA,]QN
M#R6T[T'6L^H9M0(^ TCASVP@"K=1G#)\[I@K2F$('/<VNSJJVBO_/EP##(BS
MK4%V",E(#%%[E+%!8&.0^?$\N0GXP6JX"M3B7D:JC(IFP>/QS@%K>6$HB5I5
M3BE!<"<J4Q&L9XI;!2Q@M^,:"$4#03XA6;@Y)6.V=^>OVQSK?JQAAF1I:O:B
MI]NZY;.W,9+BO:<YJ\/R69LJG^[=[#%9_)'VE7V5GW?EVN11J#!OG34#)@?R
MT\3UTGE[H.'F.UNQ!G"@T@;M;+QX%F< R A(<K1: X%K+CQQ MVAQYW/#-EQ
M+D"P=Z380^-*\^/U?7'PN#PI/W!CI8WG_N>O</QZ8V4IL9]S%1K7'8S-1_JY
M.3+'I82V/78['E<2C:MB8ER?A\\!%_D@H/[CP KQP)9L?>RH'@8!<C-Y?754
M__.@CM9*BZ)18S$V6/E;'<@,:[Q6!QB-N91XX?\UIN+Z>T]7ED;D,S=#^=Y-
M7G9,5_3! ![3")3C,:V\41O3O94_UL;4"V^D5A OHTYTG08Z"(>HN$10AO D
M;9/LDA"2,BPS*CH.3&B@P1XHW@.OENB-E]6JQ&(SK5H_.8K+^0RR"PSUIU8@
MMVIR9VH%G-B\>"J:YSZX-KWQM6\VMBR0%_AWKTPGEQU;G+0XVY<0+QTXY)A5
M/V/QH0-2\[2 E'\9&!O#V/R<E[AO$A[@0@_, W<1^^ >H,7%PI! _U:'%YUS
MIXE7T"1&AN1XBR;N#R=:_)(8@%&0/D7BNI%9]K[JPCX!(CZ%D@D:&4E?:E%J
M76IG:E^*DU*4QXX^UQ$,#LY+I]'W@5LKMV$L=/1]'O;[?@77 0 4C!A"KZ38
MX870R6=_'/TVBW/-_0+=ZV/OW0O+<#_P( LY&B_%^Y ]]T)\+,Z-^\L5_O$.
MQ$=2$X\^F$;M6:0E[O.H?9QM_S,X M<#/?JM4A1UXC[<Q#>E"7X^%K&'>Y+
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MIL,4NZ_M! V,7-=H$3<JXA;0R(U;1,9&>YE\Z)BL$9D6#YT@&P5ZU\NG65=
M=8L;36-0PD\R3/\_]KDOV?.>U;9D:6OKDB7$7]"A^J)M,?L"IM@/6EN7PB75
M%TN(\1>U'#%JE$=/Y(@U$YO@XVRV@D=9_K_4O7E\6\75,#QS%^W6OLN2K%V6
M9$N6;,F[KNW86>S$V7?'V0-9R :![($$ F0AA#64G08*& ()3D0(!&C30GF
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MU<5HSWW,N.!]:U&NS^&]$MU_E$NB^]?O) %X+^8COJ;.,-UH]=,!/[B&B[Y
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M^# _:SF_%FZOX_O@1+B(W9U-91NH$]3K<[)W9_=1BS#/0+R@$(O!F8(=Z40
MW)P.4K%NKIMZIAMVJP!>^JFN8@-<;&M((I02J_?&G(7V8;@3\0T:B V*L4VQ
M\K4184AA@^+7"F;6-0#RVP=.4&^1.(GI@S1%84T"A>"U"%(TDH^/PB2@J<L/
M4O^ QQ!_R% 3J3H2E5*(G1AM9+?G8Q)"#Z3>.M^TC3[.7G:VAWT$+2FN@=/,
M&ZCT!'BDOZ1,KJ@.8G<B$]2:ZJ W%.*D\NI0J-*ITBF59EG"R0&'@Y,JJAT6
MULQ8+++*&B\MVZ*3BF@89R0LPTA (B$)AH:7*X>K:DQ6>QDC,3B<9HMDM"%Z
MYITW3[V)EQGUJ3.GSB0T==$WR66J(U0,JX%_V*C^>1BH&ZWF#XE71[*E%0WC
M-0D?((6A2X3/OA$R#7K**=-48Q,EP5")[$DB:8?P ,1"R47OYUM5"OB2B6\/
MW;5J3GR%=VWG#8_R#YD6F&:SDI)>TZ)YQ]_YZ[*1QK&3 O(#&]?-[8;/4Y^$
MRL?\9,T?1OHV>'8GY\!;9B\;HW;XQOSEP8,.:17_;FWL]0<V8UD=7#/P+;6*
MWH/@KHF3U=)(_)6Q0"3.4./[,<=.,T?A:H3(C0?9G8CA>OZ0:-Q>-#=9Q!OC
M)?CT!4($M8KGFYJ^AR_0>Y"T$(=O(6D!>\KZEDJ0.M*<+HGK$+% )D9 /J2*
M(Z@*B^C.[_.PCFL8XBT#]I@(^U\'J>;F[_EV.6+VW^+CB-F'_*U\!]. *,U$
MF.1BK3)(=WOD=9:ZRN$(%R;JI\4D1K/)- X?"*EDU37)%!/K:&P-."J\4>S/
MGN:>HQOK6EM?H!)@'*B"9LX:P_Y<M0:]5FL89S*%HS&TSL5D:>Q "_$T)2IY
M>O^HMCHP$8@-53@TD"T^?MRXN*C,!5W[PVTV550[*6C0QJ)J^C'M"_!MA.Y&
M:#YLBAV,.NJ\+] <>C .F@^:%D8SM)^33M*:HB9M=%)1U KB]0YO89#(3>HA
M[N^RIWORX9OP-H;@^?JBTW]H5I\F(9S.$/=WN=@&ID3.13KV]LMNS'LJI"_A
M)%_GNB#&DUA<\'<GA'BZ:",D;U@G%KOB*2;T;$0MTVHKTZZ9,YJ[TR.LC_*G
M5TV^X]1U,\:U5%<D=#)&6A**.YM_O<,Y<;AOT8*;CVQ8V1:KY-0*E;JL,=Q4
M;DNH(+QY-OU ]HY]AA*MRC]'=P\7&583FDI5\FW\ ?[3![B*\L:HQV%4LK1H
M3/0KNGP-%1[YYH@Y4YOB;;5N6YE1KBQ1.,/=B:,UI8#B]R!(>0Y!2A,8"T=P
MBSD9W#=\WPCJGO0#P^\?05O3]:#>4E]9EQX)AIM&IJ<9>BJFQGKCRSN6#]_<
MOKEC\W"-H3F=UF-P&EL1#7D#@: K+)(/PE5::]<F::"G:3#69$H*@).'&ZU*
M )"F9:"SK1[;RA/@,37'12IYN &!#3TN"&@$-L.7M2U+9ZCH(2V"%QSR*P>H
M!POPA,#T8.R@"?L11DP7 B+%.!H!$1T=)_N\R&]B^ S$.U_8A.\[+%:?+@*C
M,VFR#Y8F$-:#75P6@U#>0K;(H[ZP4RR$ <.*LH4M=OB_AA[$D3?3F .G!1\S
M1< C9I[C?UZAE2J-\:1O^O3FL5RG[6'^;U=.ON.=K3/'<HE80B]GI27E"7?3
MKW8Y)X[PC5JZ;D>7;Z3OZ4XM*U(KU!IG-S<I6<(N.??Z/3J%7A>:IM^7KFB/
MEL]&4-.,H.;//VJ)!)LJ'2Z3BJ79T36?T>$K0R-V;1KA42CX&*^4J4H-I7HE
M ISVZ9\F$4_]#8(:-8*:C>#/7-(G#SG#HY/R!F?#Z$[;*&=[SWQVGGPENU*^
MWK'#\7B)ND,^FF528T'O<N;JJ17V%B5C3,E?H)\$'6 T_217PK+^CHY%_DE3
M8S/@#*S,4C*VKQ?T]2Y?-S5V);SR*/T46 Y?.[@(^#/0R\GL+7T5]5/3"9A
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M>J KCYOQ"Y$3@7;RWX VZR6*6-E_">@+/4/QEWZ1;\E>WD8 WW/=9 3X7R/
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M1& BI_A&-(?R-[\JUBG"C[X[(_C^_>8,B98FA ,ZG4ZG2818HLH=)@[0PF=
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MQ>U9Y<I V[,YD\S1.- H^1M4O8_FC+9='DTU<8GFH!!.(_"J#E32'C>.Q&>
M/=>*%"VW_.;JE6_O:Y4Q6T2R^)+]4Z<^=45$Q% 3?FB[YD=W]DR[Y\EKJ[_(
M/D5-?Z_YBBTK1X[>>,?\Y FT:HR%-N9.)DSX#CD8A80FB1CQ C*IB&5*(&C!
MT2EHV APH%4Q^I;@8)\R.;26 (MB+G%T0'1)&HE3]&Q>$T PPLG_'XL#<1:N
M\'4GT'\T@_L 8*J9:P&#S682:,PT/A?ZW(==-YX_3/W ;^6W4>LH<?:'[ WC
M*#%\DL=V+7YXG%E*HFFD#L(J2HC<S<!-_6@&1!2-1UW&,A81C!*7^R0H>2YH
M6RZ.!C3XT @R2\_7;Z%OV$+Q1^ O *3<V2S]*]'KP C2G%RG4M(2HU*GEK,9
M^ 57 E02*+&:J4D(S,Q'40/W@9P#ZC'J3WNP(DQQ:"\T/47B4,[IH8$Z=.NA
ME6W#$SZ'31LU:90R1IS-BG4??-02"5:K9",5$IUK,88U-INE#I&6- @M,4J4
M.KD:O "_0%TUPQN>0^W8(,$>44VH*5\1%P??G,&&1,6M2&CT1=$J<O%K:BBW
MT JOLU1;*;1"]/KW9X16J&4CY!)#&6[%P-\H(_L*A6'$UD\% 3V-S5#7]%-1
MAGB*_N:;,P5/T>PK9X/L>Y3Q &K[R]G;J.7B$<2""-$B^/*![&W2_N\ZT2VU
M*7L;^RHJ$>.0@40R>36[Y !UXL"YC6P<UYB]C8[DWJ-B-1YJ8W8IW78 E7SV
M+9P?M>A55#8KE.TR4)L.4'>@A_%S&P\(+:8CN?<X?X*.G'^1NAWG9[;FZT?O
MQ?G\+@TI(;L$MQ&5<6YCOA7Y5*08#6X'*B=[&[,5E80Z0U*1T1$+=1ERK67?
MPSTR'L!%Y<<P5Y90%!DLW*8[2*OR-9)4\L%4^?)(2J%(G!@72PW\#4YE7T'2
M(UTHMS )9"+>.9!]]P"@\%S0?R=SD>\QMNQNQ&^%22$3DQL75)Z4]%A 630R
M]+#L$F%PV"\/O'G@/%ZO<)ED#O-IT2QZT"PS%%]^X$WT+HZ:R%QY;B<0ZB?M
M9$G//(1J:O 7M?P  \\_#3<<H*XGI?/;SC<P5Q[(CWZN+:A7-04XH&XGL "G
MHJ:<5>=2?I9KB8XDPRTY#OER!N*FH+DZ^Q8984I(6V@)F54!PNB&\T\S,/LN
M'Z*N1X/"MJ"R:020.PF\HG'&\"(MP(LA!W-X8-#++\\WH-;@4<E!)FDUEL7)
M3+]ZCD>OX6\%""5-P:."9X] J3P_AGB%TB2HY?3X<P-4&)[*KC\@'G'V^ %2
M 7,E@20XE4!E\;CDX)M "1D7^D0."SX;3"FTAO[LW  \A9+D  GA X$CDE)H
M20(/"^EG#=UPX-P /9[?=B"['C5$?0!NH$^<VWF@"(?DQ6-2P*,\+I%Q00 C
MP(" <X,Y\G (?\N7YV"1@+9 )^A"'AKU027DTI&<N=%ZF8QJ=AUU \I/ )EM
M8:Y$=9X]CH"(P&D!BW,X%1!&0H"D.R 9LOR8H4IS$%)HIZXP< )$D:$KH'^N
MG84\1>T48$N3@RT$U]GU\%0.N 2,0\-(GT!#BD",$C"?8'*NG7E:(F#S^6-Y
MBD)0&G=MD/+DVVDH@GSV/0$-44,+>$@7U2*T,U>/QN,BXRG4=8XGS80;\*@*
M]9W;*0QGCN(41B='H_)4A]"H'.&A3YQOP,2GB/;)B^%0H']D.#%>Y& 1(09=
MJ(,E_MAS>6"A)NH*/)0'Z G9=2AKH3K<1J'*03JJ*\:1 H@6J$B.IA*ZF@.!
M/+P.+:,("H:,<J[YA:'.=^) KB],H13<%PTPX?9@#!>P2QA[@1+2?R?8GD7C
MG0<4*H*H(HU*1?TB6$=F K<Q1R&I9:1LFM":_.*[C/F@ !O+AKY#;7R_J&?H
M'8V&U(1?Y%9F_(YZM^@=]?G@JGVJ@(V86FFH4X67#K"0E^3*%)-9TZ&^8G[<
M P(@#*(@ 5*@ :1!&Q@..I&T,0%, 3- +Y@'%H$E8#E8#:Y&<E/"X/'E+K;H
MM_@_>&[ZOTB_<.-&^#6Z_KEQ8U:/OS=LP/<_;-S(EZ!+N7$C\Q'^WK !W_\P
MF/J'2S[]-V7\,/A4/&(C_K>AZ'/C!OQOXW_P'#0.?/;_8+37@\U@*]@.=H!;
MP&W@+O C\ !X!#P&G@0'P"%P!+P CH.?@E^ -\#;X"3X+?@ ? S^!/X"_@Z^
M$&8J=8F+_7_P/#\[_RZ][Q+I\?/ )2[QORG']+],OVC#AA_0'YG$L^3WV?WD
M)G=/?IQ[X*)4Y^Z_((F;S.@ERL)@44AVWH9 ;J[P3JB&_-YX494;_X,T.6 K
M!J&+?PM@MJ$(V/[OTP-0.3"0W<F>0I#:!%I .Q@)1H-Q8!*8!GK '+  7 Z6
M@97@*K 6; 37@NO!36 7N!7<@>3!^\!#8#]X'#P%G@7]X'GP(G@%G "O@S?!
MK\&[X'?@0_ )^#/X&S@#OL+4R&-(%%^8Q-9X+K@2ADM='H/O$L]-J)# !9?X
M$NE8]#QUX3-TN= EKADL6X=^>RZX+E7>?YJ./94?_+/E16._8:/PAP#//7@W
M%!Q^*+PX?_?&0AJ4'JY!B3 8;MA85%#QW87/V-_P-V_@;]XH?&Z 5VU$910^
M!__]L/'2-X,@],._28R*O53RXL=%$ <@V L TTH_@]<H'5KW]M+/G!^++^)S
M#3:)!ZCC^!WF),0#WT/J.+\)<>TQ $3'V!U8+<0%T2WU<^KG[(ZS5V$YIVS@
M$]$;[$WXG92"9>R39R>Q-V4CV0C.A]X=8Y<*[T3'LO79>G;IV:M024/R00T4
MO8&SG9U*O8//S Z"FQ@/?1:4D!TQLG<K*(_@(-JB02>-?FK)%>^LX?G#1WA^
MS3O+>YZ>>^JNN]Z=^S1]=M4[J] S2!U9?7)5UZQG9MUUZM1=Z N5O06-P$3Z
M'>*3&F"6"19Y?=Q"O\,;)ZZY>L+$-6OH=\Y'J.?63)QP-;Y%Z4,HYU,,Y@XU
M>"<MEQ=EQAHMQ,U+W%CDSSW$;,V^M/SD&D@=/@*I-2>7SS@P]]V[[GYW+F&#
M<!-7'\9-/+SZ'=3$ [/O>O?=NV8?F 4 "^\>N$ET.[,-M=")UJL46J?0*.#@
MV#C^KI?"YZHF-T,9]%HF$??BXW5OL7&1J]@+>FHP<#-C?!#&^Q[G?[7_4?[7
MCS\)XP_=Q)^[;0]D=NV"S!Y\V'Z=.QIUNV(Q2B;\B/*2YNY]^\:DX[?-F;N7
MV;:??_/1_2COXS"Z_U&8V-^SBS^[>Q>?W;,'TKMV0]$N_CF2WY4K!WWSL[Q[
M]GA[Y\\'#,R@?CU'^F5#*W'BXE[117/A*OH-R;YZ*H"WB9CD!;V8F*L0_L(=
M)3^R/XOOG3OGMGAZS+Y]W1<WFI]R<1M1^WI1.Q%\J =<X@[1)( =B6)9SV@T
M01/$OO@19RH20S$4B<2()?7[ S  T2=B4K&CGQ1$GSGHQ(TE\$G?T+7P@:G0
M7<W_<:3#3\&Q_+.Z#=!>Q_]Y[MXE72OVC>7?3T![ZS Y_PP<*VUMYT_'H'?!
M?3,]UWYWT_9OKK_^FQMO_DXTB3\@3@^'I37\'WM'S>YI?_%^_L,XM(ZH4_ '
MX#A5<Q/_60(Z)OYX<?OB!R9"9QW_:4>39.2V?^'L-Z)"_K4-X]0W_$A6SOX)
M6(BU5HY/QPPVB:!'SD0PFM%#()HNA6_P-0TX9.6B;V_=\?U--_YP,__)F36?
M;(*Z5W\*=9L^@6_R5S3P(^&1!KAWZ[F=-YZ]><</-_Z:_S7]SMH_KOLI?P;J
M?KKNCVM1_<OYL^QVT41@)G:<)IV8A@1;<B'\4(TF" .Z(=4S+WL?J=O-WW/[
MW3?_@*N&B0_&3(679?]B+BMJ@FBB.KM01;5G02=_ZXT_[$ -^!V,VVB:_U=-
M]O"09B J5X^P6,2\#5SD'(')[3TZ*),)VTL$\F<_Q/DZY;(NA8916Z;?.P]V
M_O@F\?F_BC-O,!773YA^75G%BIVC:YFWESYQ;GM[[Y:7;GMJGM3G^^V[O;W7
M31O5,&'&ZE43<&TIA,X25!N"=:P(2/QR!8IBXPXJA(B+=3X"_@ )_\",.O^,
M9']RW"+8=&#&E0_?/JMQ4<AR_]57/=0^46-SS[_MH97-U\<]U<RTF<T/N3WN
MQ&M7J)T;5CV\YLH'$NTCRE??=]_RJ7.#K.2^*Z]YI"GAF_K \TWE^& \/?!7
MYEK4*BMJG1]7YL]O?A8B^8E%(FJN<_7^M:65Y;=?L6Q<D]][3\^RNZ9L_O$-
MYC5OO_]@N..JQN5WCJE?O7GC[0MGO/K@V_] Y7(#?Z5/H7*5>&P!MI(0X]+Q
M2$JG0?/,43^Y<7QX>\\+"QY8P[Q]%[]CT9@_'-XS[MBUGZY^EWC]] U\0'_
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M56OEQE<J:F)S685^--;$"URJ=,8";_YNU>?[^Q=6*ZFLC_%F2BVO.;,1/<N
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MBF\%/@R0VR-7!I_4O:RCO8$@ 7TC3]#*D1["$B(]-BMGLK.6D,D>XCB?QG<
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MN6:F8N%IY'6[<(K1>/..?G!%.=5+LN&O(1')$X7*@]E=#KF-<J%^-H$*CMJ
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M6-:L SG=D&Z=;A_*:?)FL]>E[DX]FJ)2J2C<#!!=M 4YSHL2>FFOEXNVV>%
M46\;37>$W3R20[<:3EK(G&.S 6,C17; #1 ,!T):NLV[O^W)-E+7-J-M<=N>
M-CJJJR8971N;B^Z+DASTK/=%_Q"%K[JB+EVT.K:HA='5/![0P]4L'_7@A)Q_
MUS\%4TN4YC=UMXLXI5<FI^R8VMMWR0]>P@T4T-I'O .HY''/$(3E3)1F')JK
MV.)U9G*I4L\==&'H1[Y,;F/:3^,?FK-S:GK6+W_AYMI;VS(==W_RPK!]1\0
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MF<+#NSX$9\-O!WTRZG;X[7CB9G%RF^-YGHRD=?:BG-,8\SD.V^\U!7P^P<1
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MBWI_-*J%KK\;Q>F>ADKEYT^E4@"( *0FW('EC.^(*3RA?802-VMJC$3$\=3
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MM3-V/BVDT]*V<#3_B76"7-P:+G"CM#4<V.E<&(6XH+86D KRYZ.D& ;X"V"
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M-KM0R3_CRW20?,$HSZR4NUVD4I#KJO@WF=69E2:Y"<*2OF=)^AA:FC#2BW4
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MM*FSC:EY#=V9I[YP^->W3EEX J/)[T+M^[YB /I&7_47^<A!!4O9PFN/++'
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M!UF2P[T.[())WX)R!9-SR5=K9XC1#C >_T-BR/&)(0H(0V^", ' DL<-8X
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MP3N7 U#VP_B/#-<TGE;_08/H:S5=09<H7="O*32F?(M>-^5I?^RU'6L964?
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M5QDET=@D0F.10ZKCC4T;5D8/ =VGBS7<<+]ZE@@Q08U-RNUC7;7!<50566T
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M>K V0+H2&"MTZ^.*?ZPP Y5E+'FO/C.BF"AI$>@UHJQ#,4S4*ND&;A?4Q59
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M$#H"SQT!&AV%-H",Z 3@]@2<O "X_<T-"+T(>'H1Z/8B].M%P,]+0._?'06
M^EX&&OT>7._?PWA>@?&] I^_"GWX ^#O#]"'/T ;?_@6H3\"W?X(O/8Z\/*?
M =X$'/W/*83>B@  S_T%^OX.//L.C.M=X.%W@=[O0CWO0A_>?0NA]Z"-]YH
M@,;O05_? YR^#SA]'_CC??C>^_#,7W^/T-^ ]G^#\?\=/OO[5H!W$?H :/$!
M\/B'0,L/SR#T$=3["=3_Z7: DP" CU/0CU- [U,PKL^ %SX'WOP<Y.D++T)?
MPOE70*>OK@<5"SCJN ZA?TY&Z!O R;] ;K\#.GP/=?P'^/X_,-8?X#L_0%T_
M +Y^@#'_\ E"/YH X+L_PKVS0+.S,(:ST*=SP/_G@'_. 0^< UJ? UH68#P%
MJ+, _%XX![YZ&@!XHQOXO/M]"*HG(TSM /@SPK0)H!_ 4H"G +Y F*D%N F@
M!>!KA%DOP'B K0 G ?Z!L$(/,!9AY5& ;Q%6@?^C6@[P.X S"'-I@-D T(X:
MZM7.1%@/8-B&,/\JPB818;,"88L:8>O- %"'S0&*=CK"KL4 _T38?2T ],<#
M]P1X3CB,L/=. &C?!_7Z0P!05\ & -<B]%.$/HGS 6X#> X QBA"W4%X)I@#
MN )@(T [P$<(AU0 50!3 > [(6@C]!G"80\ X"4,=84?!W@=X >$(Q4 @+\(
MC","=4=!Y48S -#GZ!Z OR$<@W[$1@, #F. KS)HHVP$ 'Q>!O@I^P3@',+E
MT*=RP%/\(823@Q!.0Y_2;P( SBL!-Y6 H\H& &BO\@  C*-J(L+5\)WJMQ#.
M/(UP#?2G9C_"M?!L+7R_C@<8!? LPO5P7@_]J(<ZLX#;; R@'F'0NS@'=>2@
MWAST._<H /!%GPC U0#0GSXPW@8(I1M@; V LP9HJ^$#A!N![HU- , OC8#?
MQE,(2Q8 P)5T'0#007H- ,;7%_K>#_HW .H= )\- #X8 +@=",\/A+8' KX'
M0M\'OHOP("W"@X$&@X''!@/?#05<#85^#X5ZA@&=APU#> 3@"]0 '@7\.0IX
M:12T-0KH/PJ>N03&?PGPZ"7K$!X#GXTK!X VQ\'8QD$]XP$7XX&/Q@/_C <:
MCP?:3X![$R0 H/$$&/-$&.-$J&L2]'D2]&42]&42\/<DH,=D:',RU#OY;@"@
MX63@\2G0QA3 S12X-P7H/'4( -!\&O#7I="WRP&'5[Z(\ SHPRSX;!;09/8
M .CG54"/.8#?N=#O>8"[^=<@O #J6@CC7@1M+H%^+0$Z+KD,X:7 GTL!YTN!
MEDOAF:4PKJ70SC)X;AG@>AGPW U0WPU WY7 JRL!IZMA;*O] $#GU5#7C=<C
MO/8& *#96I"M=<"CZP"GZ^#>.ACW.ACCS<"C&X#^&Q] >#-\;PN,>0OT]Q;
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MG/\W=J3BRS^6CQ=< $_$.W.([SK-=W4T@C([S9^.GR,W.HPF>]:4Q:38(+,
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MA;^B^V/V[T"-%-!A$'JW=3)TOQWODT26ZH/1@8I4'Y3V](DQ!G% N3)%52C
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M7P(;LS(J+G88L(XX"/WCH7*UKL]F<!!BJRH:ZV(^NR=R(S@$&&TM#*$WL]O
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MDRNRO&O+"B$S7=7UM6XD*!%7Y%O!63-<2]DUS?Z4S1NBOL$CKZ@ENB*,#=9
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M:2QO;& 1&W4PCM"#PH/A(V'E<M]:U;U:.A:J#UWEHTENQ($Q9BD!\Z"?Q*B
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M? ?P8B.>*KDV,?<S>QG:81O/SPT\6=U6S:I4*EN=@ZXA]F6 (=M7<J8S$CE
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M!IW.J%'HG&&CCCE;<:W\"#R*?]+/*5% !W3PF.X]':4KP49.[I3I6)U3?O7
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M]="(&PX)LV*A:[YZ%QWZN@^25M._*#<,E0LKX!:X[:O>$>)G]3< Z*\P7U*
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M6Z\*.Q6IAD\OSF\(MW\CR\;_6X99PCQ4,XQ7&(F**E_RC7Q']1[AWQ0&.H%
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MYE#@DWL7K_OSW</KUA9JEN]MJEWT.#V^\_<7S][ZQ]61^N*9C0TM7^%5W0V
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M<Q*\+_SVPG#5^P ._3=\@](0*C$_8?;?Y"?4X/R$\(U.'OT-GI!6$>K_Y:E
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M33L2"9DG\C+\ ^.6?DE9Y/?,$9>J+=;"6;RD=Y8MF*VEF *\<(L]@,\*7C\
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MH]'QRBN/H9<7O:3E?64;T&?_%:\?*^_?/8]^I]#XWT?[M?V&-O$_4CQ?W]Y
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M)9R3:(_NBG9&#T4I#/'!15=$*1 5&:ZC?2N !'20%+)+%/5Y'DT!E0'NZCT
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M( "7<-''[,\QQ^S_!)318K4:2!"@V(#'Q;JMR+$R:TW09+(2&+9._1S9 %1
M1C9P"KF*44H8)50JNT@9IS#(&8\BI2 4BBYR*1>@&(/5Z@Y0QD" ,EOP9*B?
M,!D%_@A63QLHOT(E[R()CE&BG[!N62 8H1CK1GT ]YE,-AO(A_C"UA\5MVZ/
ML.645GMV4V!_X&" #'01;DX1E <L* !;\*LB-'=+,;(/<$95+B#V4[$TO;![
M @7J 2YMR^5#].Y8'@PUEJN[+*SXKP-XZ68_4LV"T8VM9_!*T9;82^L9C"^Y
MLBKV$D1N7T^U8(&1H<[\!+T:]%9Z#0+TC:& 6.0O$*IE,$P*[I6$AG_&"B?M
MG?C44]Y@*R59'C),W+ID#YQHY0_.BS\04/4<5MJ7C<D2#TXDU'=L@POY^T;E
M)M3U_,]$_J'[P]."P3F_P/:T#,4?<ZB;@!>VG 2&WC]SSVJK[9RV>HWA4<-Q
M_7'C^X8O57\U?$=>LLFG2+8JOE&2 5F-8J:-U/I=?F*3_X#V2S\I5]CL2HT6
MH]V0P.NEQ 5,-Q.,5DL"@B$\&(["*9/*)4I:*I-[#2CBUFLU2I6"14Z[1J.^
M6]&I4DJ<2H7)Q+(4<L<HUA>A6(9C-C%?,B3#<'@9/:L:H56S:J)7#=5+_8J#
M)OM6VRD(@0DY?BH]RU549T^S;[ $BWU\A4_.6EA?D6]1,)U(U)R6Y2+&',LY
M=>C-K<\)<L4@;!B&?^5Y+)BTX,$A01=DB5$I"UAL(CB;",.&@3/J^D0OQ9CL
M6P1<=OQ01'PL@L?66 Q/E%0*R&L9 6,_4P1&* 3/K]QKO;=VC_+:W5/C&(NM
M;I]UWW2GO6J-]_Y;$Y4>PC#A#V%7VP[^J]P?)O!O7N4,_,SV<4U)^;5%5NNW
MBFAK[Q )9 <2."KDKH@*U=DLL@HH*E0NYS9Q!."R&DTQ+L2V\TLA_IV>CZ6?
M 'GK,+(A58=D,'+ ?*E8[]QBO>_"B\A"B]8D2]A$:W+%['RW8)M%A+=W;SP
M0IP5HFB3X3AN/+>".\W1@&LHQ?$GUS=AOK*OMDO%VMXC?.@NJ_%=5EX9^U96
M0CN^2S-; [4U;$VN9GG-IIK>&@FH$6]X9=\=?R]8\NEY2_Y X8Z'-)36B>:S
M_QWSDR2;A1BX*H\1_7$!S[ R&"Q@%=:A2/DE >-W>OZL_?FSZNM)1>&L[WH_
MDFX7K'>-:+V)UL*<<&4F9>+ZW990M[_W,UIDNFS.6_NIA6LM2]AQBZ4&7*O
MQ2>47Y<_?V*A_(HT@%=*)\_"MR3/PH=&AAGYTAMJT" HS*SWC0S\/G3V*_1.
M$ -;.;;*.B[1FEB>V)0XF#B3^$M"5H(ZJ\EJ1"."_*3>@V,F;72K'>B7DEI3
M/&(U,7Y\3!'N8EVS79TNTO5+@@<,"K,E& HHI8*J9^(FBRFN>+T/.!:SYG7W
MM'3W(ZSL.<^<+W@W@N&\PG45_!?DP.C!%=@U?A\)QZWES^VNF%C%.D(VE8_;
MU-CX;!-T_HR;&P^Q84:1?GTC7,^7\ ]7Q8,QK\5D54J-RW[10QR )CBJ*8T&
M&9O>KE.Z>77^*=PJ60I)_!I!XMN).XGCH)PS4H!+<9W<(>XKCF[F&GPRCN+P
MX,2X/-E=Z"#AX=JY#SF2 QARJ[PP_N,G<CYI"9+%M7G4P$9X",7G*@J,'U=1
MP5&MX^%X])/R?+QT#P#289)OT?F[Q//)K"AK HP:,2R&/))1 W0I@72I2D 9
MW)\O?U7AN4O3,&>.(V'3 %UJZNVB/Q'*OS//;" 5RT>N2\IE0N>G!Y1/]YX@
M/Q?*[\RCC#Y5*+\LZ3"B\\OZ:Q,<0[Q(V,BM0 E<G%PR%F <>9L*D^^PX*?H
MQ>&1DKJZ$O0BM]:B36VLI+;8J[XM]JK!A+R@]>69E OI<?9'>M7Z8J\:C#S&
MO-XG$W;[@$>2Y3]2_G9B3Z'\;#J5^K^6OQTNSY??7!J/N7^B_)/%\G<00T3D
M;P*"X>6X H(8<@5RIEA'7;&.'1#]%K6DEH#MV!%,V@7 S89^\Y;E1;9.X5Y$
M"S$81O/^HR>+;R<BY0:2=?Z JU,"!NORK5570TFX_CR=6*[/DT\1/T=QMQ:,
MY8PHO%6SD%4GD/^:5">T,I42=!%QSDU3&NUCP"?79L\@C^2"3*W"\R^JD2G,
MNR)+=K=<C*69GI983QHI0;68WS$P0+40WKD3*J,UHTO\I>13;>VSKTDEZJ/6
M>$FR"95X@MI./D.K,<,5\NLQY.1F"""Y_VMK+)D4P&EP_(Q7'$N]_T6\$>Q)
MTNIV0"#?Z",J32]$MGX(S''WU6KNTQ EE365[Y1=*/LD?=DK.0&?LY]RO>!^
MP7>B[%!:NM.]T[LUMM^]WWO0_6A:.L(UVCW+/3>].KW3)7G"_I3OF=@CR<=2
MCY5)'G3='[NW[%% :=T@!<I .@ABKD"Z'-2YRM,*5X6[W%LE"1E<;J_7+I-K
MJI7UA%5BSGBB69:SA;/L=<XJ1[32XX1.IU\9[2(4G"(QSD_GY./DA!PCI"@E
MP,R8/6;2W%"/%]E')%,&=S!*914V?IFTE*CV>EBWR^FP6]$MQ35R;I_!-E36
M@7Z\_%C(/FR70&'WS9B+W4+?TUD$]ME<73?RDUJ8\RTY@0Y->(S \/AQ5 &N
M!'D]^$G22X55OB+@'XXM)5*S"#0BI.#UI8,)1#7XI?<6%R0+"]6]PC^,WE;
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M,G*^V!$GWKQL2*$C(CGACCBQ<AKR?T?S0^"JWL.  ='#H);I(GS'Z7L5S 2
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M%K(<Q172VU\' (6>T NZ>M\YBEF[/<7S\;V7HZOY3Z%\G[!>Y\M) $0X&TE
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MRI4:;6B;AG0@58&>Y7BP(/5+#5*##[NQ<E*J#EB5"HD$^P>LQX%&)X=^A-;
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MO[)92H.EB^<,_61@4U4'_L#(BB";G 9Z.ZO,W%-7]O\TB"][8L2V*R9ZE1
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M!BDWR(.GC =LS_*#QA-*JHN:8UQLNY(@*5JCF6R:QA^T4MBJ XBFPA#0*KB
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M_3@R^?+@<#,/>)ZX$X8/'HC3P^H4L@,>^%<P&"R'&08'="3,6CB=U^ON]'B
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MU7+#51DJJA>KIJMF9!:I*'V572?H8SHR.@X01M,QI <L1(2Q&)Z&*-"[:E
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ME\URP70HD LX+=E,6@Q2T9R5LQ$^"\#&]4?IJNZL>=-M4"1.I,,A/6IZ>@D
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MZ1[W/'!\O2<HABJO> ^>RO_7WI= 1U5D?U=5=_;=[$"@"0$2R-)+.AM!$I(
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M)>!U=U:&$2O#B)5A:QG$:BK@!*3KP?(RD+,-<";2W)XR&,U#K (X.4X&&RJ
MDZ,%<2;@<(C,)L#!P#,<QF@;8#G2U;X5@#5@SW 8D8V 8[!U$F E1+@:,,9G
M .01K@0Y4 -RC(!#(#*5X/5>P'+?#$ >[4J,=B5(=@+R+*H$R0L )R'/9"X9
M(K\+L![1@M@*=E9") ^QD9A1(UDY6#42XS 2\W DV,9Q,HD$K$.L1YR.. /1
M@C@3L1GFU$AF1[H5L H\V@@8 _94@4?5@#U!2Q5Y"+RK(@]S!.W0"O."T]S^
M*K!Y%^ 4Q'I$R?<&H EI,Z*,:$%LPE8K^%(%\><U-JQQ(+H0/5CO16Q#G WU
MU6#A'8#<PFJ,>378E@S(;:O&#*^&^&\%+(?<JX9HOPI8 _E6#1'F6 =1J@9K
M-P-.!7^K(=J\IAYKIF/-#$0)UH%JUH"M)K"V&GSA]3)B(]98L%<3Y'\U>,3U
MSL0:!Z(3^\Y"="&V(>=L:*T!:S<"#D::S\<:R)"? 8>#1S6P)O"::E\#()\C
M-3A#:\"&HVP4^'4'X$C(A%&8VZ/ DO<!;8#C</T<!_POLUJD:T'7'L#!(*$6
M,O, 8 G2%<!?"](. 8Y$N@HDUT)&;04<X^L.. &TU*+V"="78PE$>P+:/ $X
MMP$JK=,@HR9 OG$T^TX"RI"W$V!%2F$3P8;5@-R&B2#G$& YXG"LJ4(<!=HG
M@EY>/PUR<B)F[V3PZTO %L Z&"..,Q#-P%D'6K8!6K!F)J(-T8[H +_J1%\W
M\K<BS6?3%,C>DX \*Z9 )AP&G(&T!7$FHAUYW$C/!N3G%$#0_B6;!K,L&="&
MM!N1RZ\'R1SK$*>!KGJPG.,,K#$C+2-:L&8F8C.B'>L=2'/+IZ.TZ2AM.N0J
MQQF(%N"<CBO>=,');9B!63T#8S4#.6>@QAFH<09JG($:9X#E)P%;D.9]3>0A
MF#4FO!>80"/'>D0NQ\3,) .0K[0FD,"Q&>OMR-."-(^ &=:B9, ZQ'K(&3.L
M0IRV(,Y$M"&G'6G>UX(^6M!^"T;,@GHM:+\%Q]J">6[!D;5 K]< 6Y&'CXX5
M^UJQKQ7[6J'O-D ^<ZUHK17U6E&"%?5:48(5)<P$WU\#K$.Z'G$ZX@Q$'O.9
M&+>9Z/5,'*F9*&<FQK"91(&_S20&_&K&.#2C[\W0ZQ @OT?;<+VUX6IF@_WV
MEX ]P4X;V'\>D-MO0XTVL/]50!EKK%CC0&Q%G UK@AWC8\?XV'%\[>BI'?<V
M=K3-CMXY,)<<.+(.E.] CQR810[TR('\#IPO#M3B1"^<.(Y.],6)X^C$<71B
M/%W 8P"L1^2M+JSWHB5>D+F-M6)46W&,6M''5K2A%>UO1?M;T?Y6S,]6[-N*
M<[D5QZL59VX;RFG#<6G#OFW8MPW[MF'?-N#?"MB"-/=B"<9\"<9\"<9\"<9\
M"=Y'EL!]))DM YY#@#%0OPSO,LOP#K@,[S(K^>F>$#)%/1(_-<O_S414X:ML
M/?%*A=];$DZ6"UI%AI+;!*TFF>0100>0;N0]0?-?5CPAZ"#R.DT2=#!)IU\)
M.H0L99&"CE"=9+?QU_7PGS%PJ: IB0I\1M",! 8>%+2*] Y\4]!JDA!X1- !
M)"+P)T$'DKC "X(.(I:@:P0=3.*"V@4=0M*"5@LZE&T)>E+08:1':*V@PTEV
MZ"Q!1["W0^\1="3I$^$"2ZA:!;9%1JP7M)ID1]R/= #6OR5H7O\ITH$\GI$1
M@H881B8C'83U%8+F]=<A'8SU\P3-ZU<@'2+&2Z&5\5)H9;P46ADOA5;&2Z&5
M\5)H9;P46ADOA5;&2Z%#R C8G2AT:,"(R)V"#B,%L;\+.IQ,C3,*.B)@6]Q:
M04>28=W*D [E,>FV0M 0DVZW(QT&]7'=7A:TFN1V.XQT.-1'=X\0M)IHNZ<@
M'0GUP=UK!*TFZ=UKD8[F\KO/$S3([[X2Z5BLWRUH7G\ Z3B_F,?YQ3P>^4\+
M&OA[J)!.X/4]=(+F]4.03N9R>M@%#7)ZM"/='?D?$#3GWXYTBI_>%#^]O5#.
M44%S.=\CG<;EI"0+&N2D]$=Z -;7"IK7FY#.XG)2U@H:Y*3<S>E@O_@'^\4_
MV,^O8#^_POWXP_WXP_W&);QC7!XF&J(G6OC+ VH\:2(RE#7$21SPWT/:20O6
ME,&5"VB.$M1;D2,;6DJ)#?XT9"S46:"_A[CQ2H92!NY60#-PCH=V.]9JR"@H
MVY#+"7422*J$?A+(L1(32'0#RE!K1@D:DH6V_5%_31<)$["?6UBI(4;0SWV4
M_*0H,BY*R.HBX<^T6;%%@O\>C BWE+>Y2#/4.4GC?Q%-+M6!$I5^M7!EA2L>
M/PT9A]9YA$T21B<')6A0=I.(E0FNO-#*[;(B=_85(GIE"RZW='PG58Z<;6BC
M!:Y'@X^-&"M9C)!BH0,B*$,OQ6\71HI+S82:"<CO$5978[S,:)<'KG6DD!@@
M&WG<E/@V8D_>YL:8>D _[R-WCD!'K%IQY+R #:A? U:[H$\+^NM!>Y11N=I8
M7!ICJ\AL-VAI@3\;1M?E-QH7>;R8^QJPA>MMQQ'IL)B/3ROV5,;5ZV=)AS<>
MO+8COV(USS2;B+9#2)=@'+@4&3.5QRE;9-W51J^K1#-J=OI9K-A_]1%K%+%2
M^KMP%)08\78)UPF%HP%CQ'.)9ZA_S!1)/,8=UO L:Q5C>JDT$\[)%N#WB#8>
M@\G"?CXCN0=*3E_4X;FJ&"F6V-'BCEZ2\/,_L4@98UNGIQW1Y=):A:8&G#M*
M/,S_9KP;,:/M5QP1)5)F1&X-CT(%F8U<+>B?)+*76VP"R<K<E7#U;N_TQ(XY
MW+'F*./?D95=[<GT\^32.)MPYK5?9:2S'];HM=H\S?@F65/C=#@][2VRILSI
M:G&Z)(_5Z<C6E-ILFK%62Y/'K1DKNV57JVS.'F^URV[-*+E-,]9IEQR5'LEF
M-96Z3;+#++LT69I+VC4*PP39Y0:1&F.V5BLA"W @0Y;"<&DWJULC:3PNR2S;
M)5>SQMGX;\W46!T:#[35.JP>V:P9YY$\($ERF'.<+HT36EP:D]/K\+BLLCN[
MTU _ =##89/;0;C+ZG8Z,C43K"8/]*V67&;9X='H"@WZ\4U@D MMD1ILLH8;
MT2B99$VCU>7V:*26%EER@7:PA;/SDMNK> 7&5SL=9C#5(;>Y6Z06V96I:00-
M;4U64Y/&ZM&T26Z-679;+0Z(L 9BIFF"&K>WP2W/\H(-MG9-@VQRVF6-TR%S
M>=SA-J?+9G9K[$XPP.TUF62WN]%K0],T)I>,OKE!&C<$7+-8'9)-8W9);5:'
MQ:UIDUVRQ@[QU7@Q()=$H3\89'7))HQP0_NE,9$\%_U3# :+'"#4P2F7TVMI
M@B'0R+,]LL-M;97!29E'&Z@6EY.;"B%J==I:P19-H]>%PP0.-7>,YGCN1;EB
MK&9T8Z/5)(.>H9(;@NSD@B&(H-P!J2DLAI"98:0=9J^)YX'7S7N.D5TMLL<K
M\7S0C+%)#H\5!MBJQ!?RK%WCM)DU;D\[C*FI27))T!>D>:PFMZ;!JPR,9)9:
MN$2/4V/A#LBS3;+-QCVUR19K@]5F];3S%&NQ 5.;U=.DL3B=9@V,E\-I;P>K
M)UK-,HR@UZTD2(/3V8P)"@98I#E6A^Q6TL$E0TIZX,*)_FK,3I-7<9$S2S:W
M$]G,5G>+36I7*LVMLLMCY;YF-WD\+44Y.6UM;=F22',39'DVY$W.'[7QA!')
MYW*#%+L-L[W1"1ZZG8V>-LAL/A_YL+1*-B]. !A%& %P')+Q2I.J8P):/3R/
M6UIL5A".)O,:" 5/JG:GEPLV.<$)/F0HA*N!0;#CO)$TL#9 "LD:R>*291Z-
M;,V5S1.,.$Y<,,B_HF$\A-#NTH#]D#8P)Z"B@:<+STIN&3!Y6[@8HR:]$48\
MXR(KQ*O%Z^%QTDP&'788!EB1L)?G<JM D-WIXDTP%_Y &'ANX\JYV4T2I)BS
MP2.!/68__QM=3OM%A\ XLQ,496LJ(!M;8$)"F%MDDQ421[)!LH$2N]7#TQ;B
MP$,JY&2BD@Z[3<Z6]BL8GAT14=EXT1H^36 9<N."DJF!/(=I"-G::H7EVD_V
MQ3'"OK!ZR."PF!.7:\GLR!&8*!Z8>%<<+C"E3#17.F#H[%A;%'$EWH@_R'+1
M=%GRRUZ;I--BUL/MTRN.+ZU=CBQ7/HITY6[&JSGD^ZOJVY6[V4_2U?54>*O^
M@WY^O*K-JF=4CZFVJW:KGORS?I?P=FPJ7'['KHM;_X[C2R/4F<36R8I:E8U0
M"[9*G5MPY=C5<?SHN.XXOOE;IFS&JW$K8Q8;1 =:RS=6DMA$9?IMA=O05A.@
M<CS0X+;'C9LU&>-@$9L^OF53CK'*UK#CL-& VZU90"F;?&6[UH#;."=:IFQ5
MY4[[.C9L;6B##62[Q4;6+39@7NAK$AO21KBR^46-9Y0+X].QL7<+VSHBHASK
M+!@G9=-K[G(X=*-N66R;[>)XW/6H\\>'Q?XB0E:48?([8BA;TC\^2$J(EX^?
M?X25&#F$I8[..A=N:2TX7DK&RK"-]HAM;\>VWRHV]TJ,6OT.G*;.;3Z/12O4
MV  [#LV-F/T7#^O*"#5?=O2_NF.WXL]0S!4EDYV=%BN9:.T\&KHOB[&296:Q
M7><CX\68=AQ+W9TZQZ L+M&#1^R+!]XQX)V$\JWBB&_MDK_*[%4.WS;LX<8\
MLXD\:\*1DX1>Q38/>N<6AT3_&<.ME? XXW]8M72.@"P./#:4KXPIISA' _RW
MH77MG2^2M&"K&358,?9<FA/^S"C-)%X.L4,?)=83@<^,&MH[CY,75Y &[-O<
MY24!.Q[3)5AC.PZ[_JN#"X]G3LP)I<79Y645,V:4M\LH=DCF,\\M#LB*-#/&
MKP7'I+T+IUF\Y.!!#F5<L_'%.@_P%Y$<^&O#OVR,M?_ATB0.^]EBO<GYK_MU
MK#!=5S[ET,YEVL'R_WWQYW]?_/%_\<<(_],[7W#)^'_H1:#_SK+_?3'H3UX,
M(A$D%/]78NY?'I^..XJR(W+[[5(RT7(;[EV4*'&)K3A7V_ZM[5>:2Q?U*OL/
M68QRUWO%U?B3>=E:8A*\REWOZF?8Q<B472*A$JZ4V6?WXR]"WJN5SGG_NW6]
M:Z\_OPO(N-^48+^M]5OWR_ZC,T]7;O_SAQ-'Q_N?G$,Z^UQ\ TC)K:M_RTGA
M+Z?7P97G3_MU\"DCT6'#G_OLSWTQ OR<<_7QXMP=9[=VS-*K/>DIW-SGHV(&
M.:\J0IW<ZF[J,G6)NE1=H-;_6<\NO%7_T9FV"S?5=HY1\Y_U[,([ACBIA*N'
MXRK\[,KMP/.#E7R#U)_U[<I= 3;,P98_]]2?EW\UO>_'1U[P]8:)=X5_;#5E
M5$75A#_MP+]*-X@$DQ"8]&$D'"9_)(DBT22&?_R:Q)%XDD 221+_$1O2G?0@
M*:0GZ04*>Y-4TH>DD;ZD'QS1TN&F-X ,A"4N"R9R#M'2 #@^&T@NW!KS2#XI
M@ -U$1E$BLE@<BT90DI@,1H*J5@.A@\CP\D(2(^1,%S5<# 9!0>;,>0Z<&\<
MN%T+![R)9!+<PNO(%#*53"/U9#J9@1L\$RXLC2)H,V&H;! 0!]YD9HE#OA<&
MH@UN>.T0GKGD>C*/S"<+R$*RB"PF-Y ;R1*RE"PCR\D*<A-925:1U>1FLH;<
M0M:2=>16<AM93S;00'('N9-L)'>1N\DF&D0VDWO)?>1^LH4\0!XD?Z7!Y&'R
M"'F4_(UL)8^3)\B39!O93G:0G607>8H\37:3/>09LI>&D.?(/O(\>8&\2/:3
ME\C+Y._D 'F%O$H.DM?(/\@A\CIY@[Q)WB)ODW?(N^0]\C[Y@!PF'Y(CY"/R
M,?F$?$H^@TGT.?F"'"-?DJ_(U^0X^1>DR[?D.TCR'\B/Y 3YB9PDI\C/Y#0Y
M0\Z2<^07<I[\2GXCOY,+Q$<)#:5A-)Q&T$@:1:-I#+V&QM(X&D\3:")-HLFT
M&^U.>] 4VI/VHAK:FZ;2/C2-]J7]:'^:3C/H #J09M(LFDUSJ);JJ)X::"XU
MTCR:3PMH(2VB@V@Q'4ROI4-H"2VE0VD9+:<5=!@=3D?02CJ25M%J6D-'T=%T
M#+V.CJ7CZ'A:2R?0B702G4SKZ!0ZE4ZC]70ZG4$EVD!-U$QEVD@MM(E:Z4S:
M3&W43AW425OH+.JB;NJA7MI*V^ALVD[GT+GT>CJ/SJ<+Z$*ZB"ZF-] ;Z1*Z
ME"ZCR^D*>A-=25?1U?1FNH;>0M?2=?16>AM=3S?0V^D=]$ZZD?Z%WD7OIIOH
M/70SO9?>1^^G6^@#]$'Z5_H0?9@^0A^EC]&_T:WT<?H$?9)NH]OI#KJ3[J)/
MT:?I;KJ'/D/WTF?I<W0??9Z^0%^D^^E+]&7Z=WJ OD)?I0?I:_0?]!!]G;Y!
MWZ1OT7_2M^D[]%WZ'GV??D /TP_I$?H1_9A^0C^EG]&C]'/Z!3U&OZ1?T:_I
M<?HO^@W]EGY'OZ<_T!_I"?H3/4E/T9_I:7J&GJ7GZ"_T//V5_D9_IQ>HCQ'^
M06ZF8FH6P )9$ MF(2R4A;%P%L$_,\*B60R[AL6R.!;//]=![F%)+)EU8]U9
M#Y;"/WW!-*PW2V5]6!KKR_J1VUE_ELXRV  VD&6R+);-<IB6Z9B>&5@N,[(\
MEL\*6"$K8H-8,1O,KF5#6 DK94-9&2MG%6P8&\Y&L$HVDE7QIZ'9*#::C6'7
ML;%L'!O/G_!E$]DD-IG5L2EL*G^BE3]=RB36P)_V9#)K9!;6Q*QL)G]^D=F9
M@SE9"YO%7,S-/,S+6ED;F\W:V1PVEUW/YK'Y; %;R!:QQ>P&=B-;PI:R96PY
M6\%N8BO9*K::W<S6L%O86K:.W<IN(W\ASP9Y'58M_!-E>;3#Z>#OL%D=%I?L
M\;H<P19;>TM3@2Y?X1AJY*5>I\]3&HS:?'6%U^7$5IU.IW"5#E-:]<;\P-(&
ME]PJ!TI8!)4Z+4Z'W!PD*65@N4ER.1V!9BR$$&U0A>"2!5>%PB4K1;5D\GKD
M0)M25"N5-BS4U6:G1VT#"!RE-#N48I3"Y?#38]2*4A<X5F%R*<58A=>E%..4
M2C<62H\\O2@-@>,5)@\6 ;4NB%N EZ/"D2]TY.L"ZQ0Y<_SDY \595G <,EN
MEP+&-\D>236FR1H@V5J:I "S;/-(07*+VVH#Z6ZKQ2ZI/))7U=)DC<!W:MPF
MITLV-]A"Y-DFFV3GE,/MY>_+.5V!+;(;Q(5(+I>SS28W>H*0\K:$8NGB;RHK
MC69GFT.A&IR>IA#!9G:$=U(-;CG4Z?(T\?&0;.%6!W_+1'EG,DR>Y;6V2C;9
M89(#FIQ>MQP!(VUS6OB[( ZG)Y0S6UR2S=/2239X,(N,2MY!J1=EF5+J1+TN
M5Y0%HA3M>E&O%]<&<6T0UT;1WZ@3I9!O-(A2\!N-HLP39;XHA3YCH2A+13E4
ME!UZRD59(<IA2IDG].<)_7E"?Y[0GR?TYPG]>4)_GM"?)_3G"?UY0G^>T)\'
M^EL:;$Y3<Q",#2\#E"M;HU*Z/.+:XVZ2S'( 8I"Y&<N01JO-!EGCG!VJ4/P]
MYB"/RRI9O"U*Z1+79H=2VAH#35:7R2:'6!VM#5[HY.&4J'/;K39\*QX2H[7S
M0N7V.@(;93NDAII#@+L%E*M--F]#0),L@0JS5;(['>8PN]<MDD6.]*,AFUGE
M2&:=&>:06IQNC\O9TB0'VJT.G(_\O5VSLAAIQ:*D$^$M%6$O%6$K%6$K&Q;J
M;)$=BOU!I7;)Q!<#22G#RK@W7GNC39X=9KI(*U-46RK*H4$5HI^LE($5R@(G
M*PN<LH3EB3(_;+B?5,NE4O5B>=#K1"D6%KTA;(1?OZ:+M'I$@^12-P$$5GJL
M-K,<:,4BJ%)8915652I6616K*L6":E7*L)%^TF=>:I5!6&_(#V_F[R8Z;)+#
M;#6)2K%F*5--J\LUBC)/5>&PJ&18^48+4YS"E-&**4Z_ !F%"F-^V#@_4]Q^
MCH[GCGJXH[6*HU[%T5HAW2NDURK2O8KT6N&H5S@ZT4]ZFQ\]V8]NOT@'P#IK
M<8>6\A4<%VI8*SO(H-(*I91D+,-&NVT23"BDG1?I$(DGKTVV2H$38;$#V]J4
M8J)R!VA3N"::K;)+=EO=(6T=5.!DA;$=BXA97I##O8*E5LETK:%";;.ZI!#^
M1K!=@BD2 E[*?"5O"O<TP5@IM#N,O\TMZ' WB'!T-)B<<*.13";9X8GV*F_#
M=E8$>)P.ISNBPQR\"BWE=R(DPRN4&Q%>!%=XE-J02J>@PD?;K7Q(E(M:/^;0
MT7;9HC#%6(&]BX8 U* >"O>J@'*\X0D]ZCI^-P0]:JXBH$IJ:9'@YF]O,$NL
MQLM&>=DD:Y#0R<9856.;G 'C\!XY7O(&"?VJLB:K:HS;&E[IIS=*-'9<ATH7
MG93]G90[G+1V.!GG[=H5*]4-W'@+OX>KYW"C^:6'W\S5O&- ,YIN4TQW>-EL
M*TP.M%OE:G(&XHT=E@!AL0DL!C+ R8,6[A^OJ$N4ASO](^[UC[BS,^(XTW*U
M.E'J16D09:XHC:+,$V6^* M$62C*4E$.%669*"M$.4PIE5LXE$*O3NC5";TZ
MH5<G](HE,U=L-'-U0J].Z-4)O3JA5R?TZLI%*?3KA'ZQM.:*I357+*VY>J%?
M+_3KA7Z]T*\7^O5"OU[HUPO]>J%?+_3KA7Z]T*\7^@U"OT'H-PC]!J'?(/0;
MA'ZQZ.8:A'Z#T&\0^@U"OUA_<\7ZFVL0^@U"OT'HSQ7Z<X7^7*$_5^C/%?K%
M^IV;*_3G"OVY0G^NT)\K].<*_;E"?Z[0GROTYPK]1J'7*/0:A5ZCT&L4>L6=
M(-<H]!J%7J/0:Q1ZC4*O4>@U"GU&H:]0^%NHW/NUNHX]09[R"1S^J90X_MO?
M_#, A-2PKXH94<TB=&A 0#5<^STT6>G1:'SPCPSQ71A?,ZI2JR5D(1&?\*'X
M>1KX'S\7RCBE.MZM71SO# P9L'3$TK,1-(AM7AP_ ZJF,DIUD=KPP&"EA04$
M$.V,P-"!@51-%^<SJMX\5CM&F^E7T^.^G@M[D&+\&XT/0#CQ97W^5L2U_$^K
MZ2I/'7UB994YTCRX^]!-+[SYT1O?16Y>'!.G7:R:HUW,&C:K^(DXNJ#O^^?/
M28]O^OF6K_OM?*_N76U$I[&4VS1.%Z8-"535J@-C6>TX7:(VGE^$QD9.@*,$
MK*F.3$VEPY2M&ZC-X VJV-2.!HP;?W+1WL(?]ALGNUJM)@AD6:FV9V*$-E^;
M!P<M_%>7& $;GCP=3$%CH;&P3COU*I7"FJ4H'?AG2L?A W2:+,UPO7;1/?Y.
MT@"B6K2::!>M8(L6D9=VGAP;OW?YTAD9"2.GY%2M;5ZV]I1Q_"3C-V_EU3?4
MC+TN=]:+<QM35KSR\8"79H:>R3]\AV?MF75;G]C9NN&GAT>:*H9G-X>M&U4U
M<-4/DT:N?"?H6+?,<XL?F73XT-!36<][/UG]Z(&;4S;:JH/7]_SDR(^6HZX7
M*U_<-*/XZ.?/)=QOFFV-F_NW+*:"-+I_T4O:12]H<P.#8? # H(H5:=K^VG3
M.JZU=&F2>&3*:7*W9+?RIR+!0?[,%*2 JC8EEE*?FFF)UL"O>JDSM0.TZ9O[
M;4Y;FBHZFERV+OUR/&YWEDG*AGIM N_4EXL(UX9V*%4%:R-Y?12O5ZM8X//:
MGOPZ1@W#LR56&Z.+@K#B: 2.'U>JR])?DDJJQ922,2]7O9*V\--C$6DO?M+M
MR7O9O0\NS@J_(7Y1?NCBR,PGZA*EG1\$7%A^Y*>U:[=/Z%;RX+?KGBLH?,*;
MYRFZ8_2Q_#UWKCBX?FC*$[L/;%X]\;/S[YK50XVCZ%N&^Q)?J7FD_X&31Y=6
MLX*:&V;__;=QGWW[6>"RC[=LV%0??L?G#SRW;_&2_3..?OJW] \./%!E_O!
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MAX8GEDW^]:\CCT:-GC,[R_#VL0]_'%CYVZNGMN\^M^/<@P]^7I9DGSXTOWO
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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MX?VGAVQV37C8FU&["X-S.1\S?[HZ*.P'KFO./^"@?_)OS?\ 87MOY/0!@_\
M!-[_ ))/XA_[#K?^B(J^HZ^7/^";W_))_$/_ &'6_P#1$5?4= '%_'C_ )(?
MX\_[%O4/_2:2OC#_ ()S_P#)<M4_[%V?_P!*+>OL_P"/'_)#_'G_ &+>H?\
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MH ^L?^";W_))_$/_ &'6_P#1$5?4=?+G_!-[_DD_B'_L.M_Z(BKZCH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9"F5N9'-T
M<F5A;0IE;F1O8FH*,C(S(# @;V)J"CP\+U1Y<&4@+UA/8FIE8W0*+U-U8G1Y
M<&4@+TEM86=E"B]7:61T:" W- HO2&5I9VAT(#@T"B]#;VQO<E-P86-E("]$
M979I8V521T(*+T)I='-097)#;VUP;VYE;G0@. HO1FEL=&5R("]$0U1$96-O
M9&4*+TQE;F=T:" R-#8S/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0
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M $/!_P#!3>__ !FO'_\ AAJU_P"BES?^"4?_ !ZE_P"&&K/_ **5/_X)A_\
M'J /7_\ AJ3X%?\ 0\'_ ,%-[_\ &:/^&I/@5_T/!_\ !3>__&:\+\8?L?\
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M+7SU_P % _\ DWYO^PO;?R>@#!_X)O?\DG\0_P#8=;_T1%7U'7RY_P $WO\
MDD_B'_L.M_Z(BKZCH XOX\?\D/\ 'G_8MZA_Z325\8?\$Y_^2YZI_P!B[/\
M^E%O7V?\>/\ DA_CS_L6]0_])I*_.;]G3XJ?\*@\<W7B?^PO[;\_3I++[/\
M:_L^W=)&^[=L?./+QC'?KQ0!^IM?&O[9GP/\1^+?C%H>K>"M(-U-KUN8;Y@
ML4,D.T>;*W\(*,HS_L8&20*;_P -SG_HEP_\'W_W/1_PW.?^B7#_ ,'W_P!S
MT >R?LX?L_>'_A)$VJR7+:KXFN(/*GO6&V.)202D2]AD#YCR<=AQ7M%?&?\
MPW.?^B7#_P 'W_W/1_PW.?\ HEP_\'W_ -ST ?9E?/7_  4#_P"3?F_["]M_
M)Z\X_P"&YS_T2X?^#[_[GKSS]H']IL_%CX?GPG_PA/\ 8V;N*Y^T_P!J^?\
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M (9<^.W_ $(W_E6LO_CU'_#+GQV_Z$;_ ,JUE_\ 'J /LS_AJ3X$_P#0\_\
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MOBEMHW'5D!..<>4*^KJ ,+XA_P#(@>(O^P5=?^BFKX1_X)Y?\EZN/^P'<?\
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M9&4*+TQE;F=T:" R-# Q/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0
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M6_V;/V>-"^$X76[VZ.K>*983%)=#*PP*V-R1+^ !8\GMM!(KW&OC/_AN<_\
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M G_H1O\ RK7O_P >H_X9<^!/_0C?^5:]_P#CU>S44 >,_P##+GP)_P"A&_\
M*M>__'J/^&7/@3_T(W_E6O?_ (]7LU% '*?#;X=>#?AQIUUI_@S1_P"R[:[F
M$TZ?:9IM[@;<YD=B.!VKJZ** "BBB@ HHHH **** "BBB@ HHHH _]D*96YD
M<W1R96%M"F5N9&]B:@HR,C<@,"!O8FH*/#PO5'EP92 O6$]B:F5C= HO4W5B
M='EP92 O26UA9V4*+U=I9'1H(#<T"B](96EG:'0@.#$*+T-O;&]R4W!A8V4@
M+T1E=FEC95)'0@HO0FET<U!E<D-O;7!O;F5N=" X"B]&:6QT97(@+T1#5$1E
M8V]D90HO3&5N9W1H(#$T.34^/@IS=')E86T*_]C_X  02D9)1@ ! 0   0 !
M  #_VP!#  4#! 0$ P4$! 0%!04&!PP(!P<'!P\+"PD,$0\2$A$/$1$3%AP7
M$Q0:%1$1&"$8&AT='Q\?$Q<B)"(>)!P>'Q[_VP!# 04%!0<&!PX(" X>%!$4
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'A[_P  1" !1 $H# 2(  A$! Q$!_\0 'P   04! 0$! 0$
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M%)O^2B>%O^P2_P#Z.:ONNOA3_@I-_P E$\+?]@E__1S4 >D?\$WO^23^(?\
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MOBEMHW'5D!..<>4*^KJ ,+XA_P#(@>(O^P5=?^BFKX1_X)Y?\EZN/^P'<?\
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M9&4*+TQE;F=T:" Q,C8Q/CX*<W1R96%M"O_8_^  $$I&248  0$   $  0
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MG\0_]AUO_1$5?4= '%_'C_DA_CS_ +%O4/\ TFDK\R_@C_R6?P/_ -C%I_\
MZ4QU^FGQX_Y(?X\_[%O4/_2:2OS+^"/_ "6?P/\ ]C%I_P#Z4QT ?K11110
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M35^5?PD_Y*KX1_[#EE_Z/2@#]<:*** "BBB@ KX@_P""E?\ R-/@W_KQN?\
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MC\VVN8FAF3<1N1@0PR.1P3TKR#_AESX$_P#0C?\ E6O?_CU>S44 >,_\,N?
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
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M -C%I_\ Z4QU^FGQX_Y(?X\_[%O4/_2:2OS+^"/_ "6?P/\ ]C%I_P#Z4QT
M?K11110 4444 %?"G_!2;_DHGA;_ +!+_P#HYJ^ZZ^%/^"DW_)1/"W_8)?\
M]'-0!Z1_P3>_Y)/XA_[#K?\ HB*OJ.OES_@F]_R2?Q#_ -AUO_1$5?4= '%_
M'C_DA_CS_L6]0_\ 2:2OS+^"/_)9_ __ &,6G_\ I3'7Z:?'C_DA_CS_ +%O
M4/\ TFDK\I]$U.^T76K'6=,G\B^L+B.YMI=H;RY48,C88$'! .""* /V,HK\
MS?\ AJ/X[?\ 0]?^4FR_^,T?\-1_';_H>O\ RDV7_P 9H _3*BOS-_X:C^.W
M_0]?^4FR_P#C-'_#4?QV_P"AZ_\ *39?_&: /TRKX4_X*3?\E$\+?]@E_P#T
M<U><?\-1_';_ *'K_P I-E_\9KA/B3\1?&7Q&U&UU#QGK']J7-I"88'^S10[
M$)SC$:J#R>] 'V5_P3>_Y)/XA_[#K?\ HB*OJ.OES_@F]_R2?Q#_ -AUO_1$
M5?4= %+7M*L-=T._T358/M%AJ%M):W46]E\R*12KKE2",@D9!!]*\F_X9<^!
M/_0C?^5:]_\ CU>S44 >,_\ #+GP)_Z$;_RK7O\ \>H_X9<^!/\ T(W_ )5K
MW_X]7LU% 'C/_#+GP)_Z$;_RK7O_ ,>H_P"&7/@3_P!"-_Y5KW_X]7LU% 'C
M/_#+GP)_Z$;_ ,JU[_\ 'J/^&7/@3_T(W_E6O?\ X]7LU% '+?#?X?>$/ASI
M-QI7@W2/[+L[F?[1+']IEFW2;0N[,C,1PH& <<5U-%% !1110 4444 %%%%
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" *5 X\# 2(  A$! Q$!_\0
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M'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__  !C_P#B:V** ,?_ (17PO\
M]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\ ^)K8HH Q_P#A%?"__0N:/_X
MQ_\ Q-'_  BOA?\ Z%S1_P#P!C_^)K8HH Q_^$5\+_\ 0N:/_P" ,?\ \31_
MPBOA?_H7-'_\ 8__ (FMBB@#'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__
M  !C_P#B:V** ,?_ (17PO\ ]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\
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M\(KX7_Z%S1__  !C_P#B:V** ,?_ (17PO\ ]"YH_P#X Q__ !-'_"*^%_\
MH7-'_P# &/\ ^)K8HH Q_P#A%?"__0N:/_X Q_\ Q-'_  BOA?\ Z%S1_P#P
M!C_^)K8HH Q_^$5\+_\ 0N:/_P" ,?\ \31_PBOA?_H7-'_\ 8__ (FMBB@#
M'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__  !C_P#B:V** ,?_ (17PO\
M]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\ ^)K8HH Q_P#A%?"__0N:/_X
MQ_\ Q-'_  BOA?\ Z%S1_P#P!C_^)K8HH Q_^$5\+_\ 0N:/_P" ,?\ \31_
MPBOA?_H7-'_\ 8__ (FMBB@#'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__
M  !C_P#B:V** ,?_ (17PO\ ]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\
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M\(KX7_Z%S1__  !C_P#B:V** ,?_ (17PO\ ]"YH_P#X Q__ !-'_"*^%_\
MH7-'_P# &/\ ^)K8HH Q_P#A%?"__0N:/_X Q_\ Q-'_  BOA?\ Z%S1_P#P
M!C_^)K8HH Q_^$5\+_\ 0N:/_P" ,?\ \31_PBOA?_H7-'_\ 8__ (FMBB@#
M'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__  !C_P#B:V** ,?_ (17PO\
M]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\ ^)K8HH Q_P#A%?"__0N:/_X
MQ_\ Q-'_  BOA?\ Z%S1_P#P!C_^)K8HH Q_^$5\+_\ 0N:/_P" ,?\ \31_
MPBOA?_H7-'_\ 8__ (FMBB@#'_X17PO_ -"YH_\ X Q__$T?\(KX7_Z%S1__
M  !C_P#B:V** ,?_ (17PO\ ]"YH_P#X Q__ !-'_"*^%_\ H7-'_P# &/\
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M?NRO7IM]ZX3]I_Q?XX^',WAKQKHFI.WA:"^2W\0:?]EB?=$S#$@<KO7C<O#
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MAU:00?;M?:SD$2JA0^7YJ C);G'/X5]R6EQ!=VL5U:3QSV\J!XI8W#*ZD9#
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M["+_ /I+<5L5C^(/^0MX>_["+_\ I+<4 '@?_D2M#_[!UO\ ^BUK8K'\#_\
M(E:'_P!@ZW_]%K6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHS:@!MIS+G9][CKUXI[ZAL:EM;P6MM%;6T,<,$2A(XXU"JBC@* . !Z5SZ^
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ME1G<R@IX2\56WB"6_LWT[4-(U/3W1;S3[\1B:(.-R/F)WC96 .&5V&0P."I
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MU<\AT#PKXG\,WGA[Q)_PC,^J^5-J\DNC6EQ;+-IWVZX$Z,AD=(F9 IC?:_\
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M $EN* #P/_R)6A_]@ZW_ /1:UL5C^!_^1*T/_L'6_P#Z+6MB@ HHHH ****
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M62S;%B32O*\F020?=?<26<.'!&!]%@>U+@ 4HKE27;_)+]/Q"V_G_P '_/\
M \>^'NK6X^+.IZ2_B"'Q/=RF[E6ZL/$<UPEFBR+B&YL-WDVS+N$:NN2_EL3M
M).<#7M9TVU\">/O ]S=PP^)]1U.^BL-)=PMU=_:9,PO%&?F>,AQ\X&T;7R1M
M;'OXI:%%)I^5OQ!J_P!]SQ#Q'JFE^&_B->OH>O:/J=[J^J60U3PG>0!KUYE$
M:+<VV/G4(BI(2R.F(BP:/EJH_&'4HK/XL7]K-XS\+^%8[_PB;=Y=<@$JS*TT
MH*Q@S1#=SZ/_ +OK[X>G'-'2IE#F27:_Y6_K[AQ=G?T_!W/"_#WC*#P_;Z,V
MO7-WX<LKSP5;+INGWD[EGN8R0T<2X!DGVM%\JKO;*\5FQ>(# / %_J_B@ZI-
M=:-I8.BQ^)9[/43-(R@W"P1N/MH<N"RRXP(F(+;F6OH; H'OBM;WES/O?\6_
MU(Y+*R[6_+_(\(:]UG5$ETZ3Q!K-LD_Q!EL7DMKQTD%L+8L85;.53V7&,Y7:
MP#"IXDU'7M'\.ZKH]EJUT='L?%XLKJ\U+7+B!K>R:U2?;)?8DFB3SG5?,Y(#
M!=R@Y'T$,<4>^*S4;*W];+_+\1Q5OZ]?\_P/GP:C<'X=-<7'Q)\*0Z6NNYM$
M'CR=HYX?)^:T?5=J3AQ(6E'#':%0Y7I-?^);$:KX/U5]7N7MKRQL1;^&9/%=
MQ;ZK"SRX$PB60F_#;AN\T_=B)!;<RU[]VHJUO?T_*Q3O:W];W///BK_R-GPZ
MP/\ F8W_ /2&ZKG+BYGM_%?Q1\27NI>)[I/#WEFPL+&^<)"&TZ-W*09\MV);
M($BNH8;@H)8GV7O0<8I6T?\ 7;_(I/57]/Q;_4^8K7Q5J8\*_$1=(UTFUM;#
M3+FSGT_Q3=:PD4LDTJ2>7=S*KC(C4%%RJD'G)('6?$)-1>?XEZ\GB/Q#;S>'
MEMYM+M[?4Y8;>%Q;1R,3$A"R!CC<LFY>N%!9B?<1^%!XJG:]R$MSQ/QSJVM?
MVA\1;>UUS4[+R)-"2U>"<@VOFR*)#&#E5+9YXP>X-4O&=U?>#;;QKI.G:MKU
MQI]NNBW!-QK$CSPQSW#QW02ZN)08 T<?WBZJA)(*]1[S^-8?C3PU:>*-*CL;
MFZN[-X+F*ZM[FU*>9#-&P9' =61L$='5A[5#TV[C6B/-OA=J3P?#7Q=XHT=K
MWQ*&EN)M/TV3Q"VL2JD<0V6QD6:= [,"VU&8XD4')&*\]^&_BNQ\)ZQI-M;Z
MSI'BFWD2TMK?7XYBUGX?L'(,EE.N\_9F+J%B:0EG.U7)\H"OHCPEX9BT"2_N
MI-4U#5]1U"1'NKV^,0DDV+M1=L2)&H X^5!GODUO]JI:2OZ?@3;W7'U_'_+H
M>+^/?$']@?&IY#XV\)>%/-\/P#S-?AWI/BXFXC_TB'!'?ENHX'>CX^DO[R/X
MA:]9^*M=@DT5[*;2#8ZD\=O"6MX79O+4[)5?/*R!TQG"@LQ;W:E]NE3"/*K>
MOXNY3W;1X%XPO-2\*MX[T33?$'B%+6SM-$O89WO)KRZADGNY(YFC,F]N5B7$
M0!7.0%^8@Y?BN^L[CP=X^M_"OB.[\0^%(].T]ENIM5DU!([TSMYL:32,S9V"
M%FCW84D<+N->]^*-#M/$>BOI-[)/'!)+#*6A(#9CD61>H(QN0 \=,UJU2Z@]
M4U_70\&^(>M(FN^-(M6\6:II'BBR$1\(Z;;:I+!]I7R$:)HK96"7C/<>:C*Z
MR#Y0I '6[J>I>(H/B ?A]+J6IQS^(+RVUB&XCF<FTM(TS=P))_"OF0*H''%W
MP.#7MI Q6(?#=B_C-?%4DMP]ZEB;&*-F'E11M('=E&,[F*H"<]$7@<Y2NK?U
MM_F[7%)73M_5_P#);'CEW;ZI>6PUEO%/B:"[D\;2:6!#JDJ1):/<-$T(B!\O
MHS$.5+J<;67:H6KK^K>(-+T?7=%L]5N?[&T[QBMC<W>HZY<0-;V+64<^V2_Q
M)-&AF<+YAR0&"[E!R/H<=*"!22M&WI^G^3^\%O?^NO\ G^!X#I5QJVH^&]'L
M8O&<,^F7OBU+:&;0?$\NI216QMF:2W>]9%D8EPQ&?F567# JI%3QA9V<?AR^
MM]:US6ETKP]XYM8(KNYURZ1K>WD%N[>;/Y@8A6D.UY&)3(P17T3BEQ0XN]_Z
MZ?Y?B%GM_77_ #_ \E^+6HKJ%]X5\':7HU[XFL[AUU._M;.:)WDLX-IB)>>5
M$8-,8>2^6"MUYKB)O%MYI7PPT71-:BUK34T+7VTG6(%U2'3KD6BV\LEKNNO/
MCC0E3:DE9AO(903D@_2'&:Y[QAX5A\13:;>)JNHZ3J&F3/-:7EEY3/&70QN-
MLT<D9!5B.5)'8CFA72?F[_U\M!K]+?U_78\-GU#5=/\ !O@TS^(K>70-0-_=
MWU_?>.;FVA\[>HM[=M3B\ULJC.-BLJ.\3?,<8;H]"@U773X$T?4O&$UW8W4.
MJO)-H&ORRI=01R1^0CW:!))612%,@VLQ5LD[FW>K>$?#UKX;TR2TM[BZNY9Y
MWN;FZNF4RW$SG+.P0*@SZ*JJ,<"MH_44_7^O^&Z"1\^VNM(;7PE9>-_%VIZ7
MX93^V+=]0?6);(W%S;W?E6T<]VCH^[R1*P!8;RI)W%:J^,]?\0V^L:M:6&N7
MLFA+/HR7EUJ.J3:<L-L]K,Y>2=$+VOF2)$'=44Y;!V9R/HSV%+CTH:TM_6]_
M^!Z#6_\ 7]?\$^>QJ%P?AVUQ<?$GPG%I::[FT1?'<[1SP^3\UHVJA4G#B0M*
M.&.T*ARO3HO%M_#JGP^^&^H6]I?6L-QKNER)%>SM/,H).-TCLS.?]HDENO>O
M8>/:CMS2DK_>G]W^8FKJWDU]YX3#_:<:'Q4?$7B"2^C\<?V?'"^IR_95MGO1
M"T/D!O+8;78@LK,#C! 4 8NM:E8:AJ,0U/Q)JA\8Q^-H8Y]&&HS/'#:IJ"K"
M3:$[(XC$(7$VQ=S,OSG?M;Z1Q2415DEVM^%O\OQ!JZDN_P#P?\_P/G.'6_$$
MWCVX34?%6@Z-KJ>(6CCMM0\:7%K(;)9MBQKI?E>2XD@Y5]Q8LX<.",#I/@OK
M6I7WC&6UU?6M5NM.%A)+X5:X+JNH6/GD-/*2Q\V51Y(5FP?+9'ZROCVFDIQ7
M*DOZ_K_@][CEKL.HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !6/X@_Y"WA[_ +"+_P#I+<5L5C^(/^0MX>_[
M"+_^DMQ0 >!_^1*T/_L'6_\ Z+6MBL?P/_R)6A_]@ZW_ /1:UL4 %%%% !11
M10 4444 )11GM7">+_B%_8_BV'PQI'AW4?$&H) E[J2VCQK]BM&9E\W#L&E;
M*G$<89CM/3Y0T]4NXNESN\^U%<9=_$?P_;_$ZP^'OEW\NKWD,LI=(/\ 1X=D
M8DVO(2/G*L#M4,1D9QD9PKOXW>$K*]F^W6FJVNE1W-Y:+J\B1-;236J,\R*J
M2&8$"-P"T8!QP3D9+_U^ +7^OG^1ZAFBN/\ !7CZS\2ZO=:-+HVKZ'J=O:PW
MGV34EA#R02[@DBF*1UQE2""0P/4"L_Q)\5M!T+6[NRNM/U66PL+NWLM1U:)(
MOL=C//M,:2%I!)T>,ED1E7>,D<X=];?UV_/3\ 3OL>@4<UP?@[XH:+XFURQT
MV#2]8L4U2TEO=)N[R.)8=1@C90SQ;9&=>&5MLBHVU@<5W9(%%F@N.HHHIC"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME?\ H>*V+[0=#OQ_INCZ?<YZ^=;(_P#,5A7_ ,-/ MYGS?#=FN?^>.Z+_P!
M(JJ,*].G&#:=D<7-@9;J2^:?^1T=GJNF7W-EJ-I<_P#7&97_ )&K@.17FE]\
M$O!%R#Y*:A:?]<;G./\ OL-5)O@_<V?_ "!/'6NV [?,6Q_WRRUKSU5O'\0]
MA@Y:QJM>L?\ )L]8[4=:\G/@SXJV QIGQ!BN/3[7$?\ V97H,OQPTX?\>^A:
MKCW5<_JE'M7UBP^H1?P5HOYM?FCUBC\Z\H/COXEZ>/\ B9_#>6XQU^R2,?\
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MO8]7^(=[);6:G=!I,!V[1_M?W?U;GJ*]4TG3;#2;".QTVTAM;:(82.-< ?\
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M** "BBB@ HHHH **** ,?P__ ,A;Q#_V$4_]);>MBL?P_P#\A;Q#_P!A%/\
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M6\MG+YGFM#"^/7&>O8].M;.FZ?9Z;:BVLK=((EZ*HZ^Y]36=ZLY)K2/X_P#
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M%+7B'PR\8^+KKQ-X%;6=?DU.V\9:'<ZC+:/;0QQV$J>4ZK"R('*;9"N)&<\
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M_P"DMQ6Q6/X@_P"0MX>_["+_ /I+<4 '@?\ Y$K0_P#L'6__ *+6MBL?P/\
M\B5H?_8.M_\ T6M;% !1110 4444 %%%% !1110 4444 %%%% !1110!C^'_
M /D+>(?^PBG_ *2V];%8_A__ )"WB'_L(I_Z2V];% !1110 4444 %%%% !1
M110 4444 %%%% !1110 444UV"KD]!4MI*[ &( H4@CK7SG\:?C/JFEZ]-H/
MAU8D>WP+BXD7=M;'W57IQQDG//&/6G\*?C/K^I:J- U:2V6YO%:.SO!%PDN/
ME#IT()],?X>:JV/>$_M%8?\ <6O>_O\ +_-R6VMK:_-;IT.Y8&;C>^I] >*O
M$NB^&=.-]K-\ENAX1#R\A]%7J:\Q?4_'/Q1=H=&CD\.>&F)#7<G^MG7VQU^B
MX'4%C6KX3^%_VF^'B'QW?G7=4?#")SF"/T&/XOI@+ST->GQJL:!$4*JC"J!@
M 5UQYJRN]$:^UH832E[\^[V7HNOJSF_ W@;0?"%L4TRVW7++B6ZE^:63\>P]
MAQ73].E'UH-=$8J*LCSJE2=67/-W;%HHHIDA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 8HIKL%4LQ  Y)-4AJ^EM<K;+J-H9W.%
MC$REB?IFHE)+=@7OPI:Y[6_%^B:1=O:75Q(;A "T:1DD9&1STI\?B..Z\-R:
MUIUC=W04X6 +AV.<=L\?3-8_6:5W'FU0N9&[17)Z+KWB/4-2ACF\-O:6;$^8
M\K$%1Z\@?RI^N6WC2XU*5=,OK&TLN-A89;&!G/RGG.:GZU%PYH1;^7^=A<QU
M)/K1D>M87]D:E=>&O[.U#5Y?MC'+7, VGKG'&..U4]#\%6.F:G%J1O;VYN8\
M[3(XQR"/3)ZGO3=6JY)*&C\]AW9D_&KQW9>#/ VIW\-S"^HJHAMX@P+"5\[<
MC\V^@-<5\#/'>O>,?AK#8V$T4NN6$@MKN65QN\L@[)>>N1P2<\@\>GF_[3T?
MB3Q+XV:QT7POK$NF6?S-+#8RLEQ,P&7R!@@# '_ O7-8GP!3QKX)^(5I>3^&
M->33;O\ T:]S82A0AZ.>/X3@Y],U\E4S&%2J\2YI=-']G_@_%]RZ'W]#(,//
M(FY27MG[RU5_)?=^)];^$?#KZ-Y]S=7LMY>W.#,[,=O'I^?4_I70GI38V5T#
M*<@C(-.ZU]C1A"$$H;'P"5M HHHK884444 %%%% !1110 4444 )BH+VTM;V
MV>UO+>*X@<8>.5 RL/<&IZ#0).QY=KWPBM8KPZIX,U6Y\/Z@.0J.QB;V_O*/
MS'M5.W\=^-?"-Q'8^._#\EY;%@B:C9*"&R<#./E)/I\I]J]=%17,8F@>(@$,
MI'-<M6FX1<J6_;N>C','-<F(CSKSW7S_ ,[GBGQ>^-B^&=5.CZ/:+=7J*#,7
M?$<.1D XY+=.!C&>M1?"3XX#Q'K4>C:W:):7<W^I='S'(0,[>>0W7'7/UZ^+
M_''1+_1_B)J4MW&_DWTS7%O*<X96Z@'U!XQ["H/@UHU]J_Q!TN2TC?RK*X2Z
MN)OX8T0[N3[XQ^-1')\"^'O[5=9^UY.?GYG;FM>W+?EM?W>6WEOJ=GL*7):Q
M]QJ0P!!XIQZ5#;(8X$0]0 *FZBMZ,Y3IQE)6;1X;"BBBM@"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "L?Q!_R%O#W_81?_TEN*V*Q_$'
M_(6\/?\ 81?_ -);B@ \#_\ (E:'_P!@ZW_]%K6Q6/X'_P"1*T/_ +!UO_Z+
M6MB@ HHHH **** "BBB@!IH.!0:\(_: 34[/Q,OBR]CN==\+:%:QRW%GI>M_
M8[S1IP78WWE$A+@[-H5)#Z@*0S5-]4*UT['N]%>0:_=:['^T)X"G7Q+J!T76
M++4"NDJ/*A01V\;!G _UCEG)RWW<  #DGDOBGK&OZ?XF\2^(/A_X@UVXB\.:
M-?MKTT]Y)/8_:W1?L\$4))B66$#>VQ!A=N\DLV6[JU_/\+_Y!#WMO+\3Z,&,
MT5XKX&UB#PK\2=5TFY\474GAW_A'=.OWGUG5Y+E8;F622,8FG<[/, 7Y,X)Q
MM KD?BIXI\16D'C[Q;8:KJZ:WX:\1:?8Z1IL-]*D$L3+;DQM;*VR8RF67EE9
MNFTC:*4M';^M[?F_N%%\VW]75_R/IBEQS7SY\(=7U<^*OAW='Q!JVI/XH\.7
M=_K4=UJ$EQ$)E,++)'&S%( 'D=,(%7'RXXKWRZ>X6W=K6**6<#Y$DD**?JP5
MB/R-5*+COY_@VOT!.YG^'_\ D+>(?^PBG_I+;UL5@>$FNGO->:]AAAG.HKO2
M*4R*/]%@QABJD\8["M^@H**** "BBB@ HHHH **** "BBB@ HHI"0!DG % !
M25PWBOXJ^$=!W1"].I70./(LL/S[M]T?GGVKF/[5^*_C?C2K"/PMIC_\MY\B
M4CV)&[\0H^M8NM%.RU9VT\NK2CSS]R/=Z?\ !9Z5XB\1Z%X>M_/UC5+:S7&5
M5W^=O]U1R?P%>=W7Q4U'Q#='3O WA>\U(;MLEU,NU%'?C.!QT+,/I5_P]\'M
M!MKC[=X@N;GQ#?L=SR7+D(3_ +N23_P(FO1K.VM[2W6WM+>*"%!A(XT"JH]@
M.*SG3G6BXST3-.?!T/A3G+ST7W;O\#XW^/'@[5M%\:7^JM9S/I]]*9UF"Y".
MW+(Q['.?J*B^!W@[5M=\:Z;J$=I,EA8W"W#W#*0I9#N55/<DX^@K[+NK6&<9
MD0$COT-%I:PP#,<8!/?O62QN;++_ .RUR\O+R>TN^;EM;X+6YK=>:U];="OK
MRY-M22WC\J%$_NC%2"BE%==.G&G!0CLM#S HHHK0 HHHH **** "BBB@ HHI
M"0!DGB@ I:S&U[1%D$;:M8AR<!?/7.?SJ+7/$FCZ-*L6H7?E2NNY4",Q(SC/
M K%UZ<5S.2L*Z1L45BZ7XETS5+*ZN[)II4M03(!$=QX)X'?I6-;^.3=SQQVG
MA_4Y5=@"VSH/7C-9RQE&*3YM]A<R1UES/#;6TEQ,ZI'&I9F)P  *J>']7L==
MT>UU73IEGM;J,21.O=3]:\;_ &M?'4N@>$O^$<LV"7&KIL+!OF$0/[SCM_"O
MON/I7+_L@^-;B;2M1\#23I'=1H]QIKR<@!OO+^#$-_P(^E>9/,I+%<J^!>Z_
M7O\ ?I]Y]'3X?JSRJ68=GM_=ZO[_ ,F?3U-8J!DD#WKCK/0O%\EU%/J'B8*J
M.&9(4X89Z= /TK0\2>$K+7KV.ZO+J\0(@01QN O!//(/K7HJM5E%N-/7S:7^
M9\Y=]#;:[M5MWN6N(A#&"7DW#:N.N36,GC#PY)>16L>HJ\LKA$"QL1DG YQB
MK.D>'=*TS39M/MX"\$QS*LK;M^1CFIK+0]&LG62UTRTB=>0XB&X?CUJG]8=K
M67?=_P"0>\9GB+Q4FD7PL4TR]NYR@<>6ORG/O_\ 6J:PU;5M0T"XO8=&>UO%
M)$-O<-CS,8P><<'/Z=:WL44U2J<[;GIVLAV9R&EOX]N-0@>^BT^UM@X,J#!)
M7N!@MS^-6/$7A_6-4U RP>([BQMBH AB4C'KR&&<UT]%0L)%PY)R;]7_ )6%
MRF%9^'(4\/RZ->WEU>QRMN=Y'.[J#@>@X_G3-+\'>'].N8[FWLB9XSE'>1F(
M/TSC]*Z"EK18:CH^5:;#Y45I+&SDG\][2!Y?[[1@M^=6  !@# %+16R26PPH
MHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D[<"CM6
M/XIUF/1K2WD?3[Z^%Q<I;[+6/>R[L_,?0<?J*FTI:16HG))79X]^U-\5O"7@
M30!;W>GV.M:U=*39Z?.@D0GIYL@/1!S[MT'<C#^ _CGP5\7_  '=>&S:V_AW
M65C!N[2Q B4'H)8U'WXR<9!SCH?X6/*_MB_ &]UF>X\?>$UGNM0$8-]9;BYG
M15P'CST8 #Y!U XYX; _9M^#>J^#=,B^*7B+1M1NM0C .GZ7 Q1X4<$-+-CG
M[I/RX.,_,/3\\6%H5*7M+?[8YWY+:<_\O+>W+;7G_P"WKWT.U5YTG=.T5U_K
M\CWWPQXLUGP%JT7A/QX[26+_ "V&J\E2O8,?3]5[\8(]>C=717C961AE64Y!
M'K7*V2Z!\1? T9N+";[#< A8YEVR1.I(W*?4'H1_B*X/3]3UWX2:G'I.NM-J
M?A.=]MK>*I+6W^R1_P"R_BO<5]XO:4/=J?\ #?UW-^6GF$>>CI/MTEYKS\ON
M/:J3I5?3[RUO[.*\LIXY[>50T<B-E6'J#5D]*Z3R[-:,****!A1110 4444
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MQX:T2_O-0T;P]I.FWE\V^[N+2RCADN#DMF1E +G))YSR36R>E'6B@#'\/_\
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MQND++_-<#\ZUO$]SXGBEA30;"VG1E/FO*X^0_3(_K6_Q1Q4+#SY6I5'KZ+]
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M;2M;D\.:#HEWJVLJ%W(J'RTW $'CEN"#V'O78Z!_:IT>U;6UMUU$I_I M\[
MWMFKH10Q?: QZG'-:4W"$KS7,9S4IQ]UV.0^'MOX[-Q=:AXOO+98YU'DV,*+
M^Y.>3N'\LM]:[(]***FI/GES6MZ#A#DC:XR:-)8RDBAE(Y!HAC2*,1QJ%4=
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M2PMP\+?W6']>A[5O5:::NC@G"5.3C)6:%HHHIDA1110 4444 %%%% !1110
M4444 %%%% !1110 5C^(/^0MX>_["+_^DMQ6Q6/X@_Y"WA[_ +"+_P#I+<4
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M110 5C^(/^0MX>_["+_^DMQ6Q6/X@_Y"WA[_ +"+_P#I+<4 '@?_ )$K0_\
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M?6?K/+[V_E?;FMMS6TOO;0KG=K"T445Z1(4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A]J\O\
M?> ;VWU4^,/ DALM:CR\UNG$=T._'3<>X/!Z\'D^GCCBE[5$X*:LS;#8F>'G
MS1^:Z/R9Q7PU\?67BR![2XC^P:W;Y%U9/P01P67/)'MU'0^I[0^N*X#XE?#Y
M==G37_#\_P#9GB*V^:*XC.T3$#@-COVS^!R*C^&_Q!;5+MO#7BB#^S/$=N=C
M1N-JW'NO^UCG'?J..F<9N+Y9_>=5;#0K0=;#;=8]5_FOZ9Z+1116YYX4444
M%%%% !6/X@_Y"WA[_L(O_P"DMQ6Q6/X@_P"0MX>_["+_ /I+<4 '@?\ Y$K0
M_P#L'6__ *+6MBL?P/\ \B5H?_8.M_\ T6M;% !1110 4444 %%%% !1110
M4444 %%%% !1110!C^'_ /D+>(?^PBG_ *2V];%8_A__ )"WB'_L(I_Z2V];
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $%S;0S\RQAB._>DMK6"#F*,*?7O4^*,5Q?V=A/;_
M %CV4>?^:RO]^X^>5K7T%HHHKM$%%%% !6/X@_Y"WA[_ +"+_P#I+<5L5C^(
M/^0MX>_["+_^DMQ0 >!_^1*T/_L'6_\ Z+6MBL?P/_R)6A_]@ZW_ /1:UL4
M%%%% !1110 4444 %%%% '"?\+!,_CZ;PSI/AO4M4M=/EC@UC4X7C$=A+*JM
M$GEEO,DR&!9E7:@()/#;;6C^.K76?$-[I^E:+JMWI]A<R6MWK"F!+.&:-<NG
MSRB5MIPI9(V7=QGAL<!XX\$:UXD^,5E=V?AW3]*NK"2"\7Q?:7,]O<-;;U#V
MCQJFR9R(RIWR;0CY"C.#2T[X(ZA;>+3*+?PY:VBZ[>:H=<M2PU6X@N$E'V21
M?* V@RD%O,8$(OR#MFFW%-?T]/\ @_\ !ZK3^OZ]#O\ P?\ %#1O$NMV.F0Z
M7K%@NJ6DM[I-U>1Q+#J,$;*&>+;(SKPRMMD5&VL#CK2:_P#%/0]'UZYTZ;3=
M6GM+*\MK&_U6&.(VEE<3[?+CD+2"0GYX\E$95WKDCG'$:+\./B7I)\,2V4_A
M%;GPAICZ9ICS3W$B7R2/$KRS*(U,+"&+A5:3YV^]M'-WQ+\+O$E_JGB'2[.Y
MTG_A'?$.N6>L75U+/(+RV,/E%XDB$920,8$PQ==NXY5L<Z6CS)7T_P#MO_D=
M?7[B=;/^NG^9U-G\4]"N?$EMI0TW5H[.[U&;2[35WCB%G/=Q!M\*_O/-!RCJ
M&:,*2AP3QGO@<CM7C&B?"WQ+::KHNE7-SI/_  CNB>([K7K:[CGD-Y.9?-98
M7A,81 K3MEQ(VX*/E7)Q[#=VMO=V[6UW!%<0N,/'*@96[\@\&I5W%7_K1?K<
MI_%IM_P7^EC/\/\ _(6\0_\ 813_ -);>MBL#PE:VME>:]:V=M#;0)J*[(HH
MPBKFU@)P!P.2:WZH84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !6/X@_P"0MX>_["+_ /I+<5L5C^(/^0MX
M>_["+_\ I+<4 '@?_D2M#_[!UO\ ^BUK8K'\#_\ (E:'_P!@ZW_]%K6Q0 44
M44 %%%% !1110 4444 %%%% !1110 4444 8_A__ )"WB'_L(I_Z2V];%8_A
M_P#Y"WB'_L(I_P"DMO6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6/X@_Y"WA[_ +"+_P#I+<5L5C^(
M/^0MX>_["+_^DMQ0 >!_^1*T/_L'6_\ Z+6MBL?P/_R)6A_]@ZW_ /1:UL4
M%%%% !1110 4444 %%%% !1110 4444 %%%% &/X?_Y"WB'_ +"*?^DMO6Q6
M/X?_ .0MXA_["*?^DMO6Q0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !6/X@_Y"WA[_L(O_P"DMQ6Q6/X@
M_P"0MX>_["+_ /I+<4 '@?\ Y$K0_P#L'6__ *+6MBL?P/\ \B5H?_8.M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L?Q!_R%O#W_81?_P!);BMBL?Q!_P A;P]_V$7_ /26XH / _\
MR)6A_P#8.M__ $6M;%8_@?\ Y$K0_P#L'6__ *+6MB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH Q_#_P#R%O$/_813_P!);>MBL?P__P A;Q#_ -A%
M/_26WK8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K'\0?\A;P]_V$7_]);BMBL?Q!_R%O#W_ &$7_P#2
M6XH / __ ")6A_\ 8.M__1:UL5C^!_\ D2M#_P"P=;_^BUK8H **** "BBB@
M HHHH **** "BBB@ HHHH **** ,?P__ ,A;Q#_V$4_]);>MBL?P_P#\A;Q#
M_P!A%/\ TEMZV* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *Q_$'_ "%O#W_81?\ ]);BMBL?Q!_R%O#W
M_81?_P!);B@ \#_\B5H?_8.M_P#T6M;%8_@?_D2M#_[!UO\ ^BUK8H ****
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MKF&8H67_ $6#KL9E]^#WK?K'\/\ _(6\0_\ 813_ -);>MBJ&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5C^(/^0MX>_["+_^DMQ6Q6/X@_Y"WA[_ +"+_P#I+<4 '@?_ )$K0_\ L'6_
M_HM:V*Q_ _\ R)6A_P#8.M__ $6M;% !1110 4444 %%%% !1110 4444 %%
M%% !1110!C^'_P#D+>(?^PBG_I+;UL5C^'_^0MXA_P"PBG_I+;UL4 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5C^(/\ D+>'O^PB_P#Z2W%;%8_B#_D+>'O^PB__ *2W% !X'_Y$K0_^
MP=;_ /HM:V*Q_ __ ")6A_\ 8.M__1:UL4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% &/X?_P"0MXA_["*?^DMO6Q6/X?\ ^0MXA_["*?\ I+;UL4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5C^(/^0MX>_P"PB_\ Z2W%;%8_B#_D+>'O^PB__I+<4 '@?_D2
MM#_[!UO_ .BUK8K'\#_\B5H?_8.M_P#T6M;% !1110 4444 %%%% !1110 T
MYKYYLKK5O"OQ8;6-?M;S6I]=GO(M$U[3=9,]M-&JRR1V$MF3B-8UC)WQAOG
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MD_\ D>C[1XH_Z ^C_P#@TD_^1ZV** ,?[1XH_P"@/H__ (-)/_D>C[1XH_Z
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M_M'BC_H#Z/\ ^#23_P"1Z/M'BC_H#Z/_ .#23_Y'K8HH Q_M'BC_ * ^C_\
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M%'_0'T?_ ,&DG_R/6Q10!C_:/%'_ $!]'_\ !I)_\CT?:/%'_0'T?_P:2?\
MR/6Q10!C_:/%'_0'T?\ \&DG_P CT?:/%'_0'T?_ ,&DG_R/6Q10!C_:/%'_
M $!]'_\ !I)_\CT?:/%'_0'T?_P:2?\ R/6Q10!SNG:KXCO[9IXM&TI56:6$
MA]4DSNCD:-O^6'3*G'M5^QFUQ[D+?:=IT,'.YX;YY&'I\IB4?K5^&..)2L4:
MQJ69B%7 )8Y)^I))_&I* "BBB@ HHHH *Q_$'_(6\/?]A%__ $EN*V*Q_$'_
M "%O#W_81?\ ]);B@ \#_P#(E:'_ -@ZW_\ 1:UL5C^!_P#D2M#_ .P=;_\
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MXK:%8(V!C3S<O*SD=&7 )PP[*7P7\/-.\&ZIX>\'>,U\/_;K26T1W\0W%Y#
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MHO\ 8(O]/L[: ?NLW+1JTDA&]G(7) (49  XW'N_^$J\,?\ 0QZ1_P"!T?\
M\57)KHOPQ7QE)XP&OC^VI$,33_\ "47&TQDD^7Y?G[ F22$V[0>0,U.O,GT$
M]8M>AG> =9\47'Q9\1:6?$S^(?#>F6427=Q+:PQ)::F6+/;PM&B[D6,J65FD
M9,J"V<YX/Q)XL^(J?##6_B=H.NK9V6I:U&]JMU&96BT]9XK:%8(V!C3S<O*S
MD=&7 )PP[*7P7\/-.\&ZIX>\'>,U\/\ VZTEM$=_$-Q>0P+*V9&2"6X*!SEC
MN !!8G/7.SK^A?"S7O"MAX7U35[-M(L(DBAM+?7I+6/:FW8&$,J;PNQ2-V<$
M9%..C3]/GK=_\ 35_G_E;\=_4YGXK>/O$%A\0K_1;)O$5IH>AZ$NK:C=:%#8
M27'SNXRWVPE?+5(G.(T9R3VQ@^QZ;=V]_86][;2&2">-9(W((W*PR#@].#7G
MNM^&OA)K1MFU34[6Z>"S^PF1O$4P>XM]VXPSL)LW"9&=LI<<GU.>QB\2^%(H
MDBB\0:*D:*%15O(@% Z #-*-TK/^M7_P!O5_UV7ZW-RBL?\ X2KPO_T,>C_^
M!T?_ ,51_P )5X7_ .ACT?\ \#H__BJH9L45C_\ "5>%_P#H8]'_ / Z/_XJ
MC_A*O"__ $,>C_\ @='_ /%4 ;%%8_\ PE7A?_H8]'_\#H__ (JC_A*O"_\
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M='_\50!L45C_ /"5>%_^ACT?_P #H_\ XJC_ (2KPO\ ]#'H_P#X'1__ !5
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M_P A;P]_V$7_ /26XK8K'\0?\A;P]_V$7_\ 26XH V**** "BBB@ K'\0?\
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MO,*S'  90D>,G#';\U<RLWV.):RY5N=E]I\3_P#0'T?_ ,&DG_R/1]I\3_\
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MYCAO)A*\K,7C=L0X"C;\H(D).1QLYW">9?C83=ON-S[1XG_Z!&C_ /@TD_\
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MRBLK>6XN9-3MY9P^U1MB54=""QS\^6Q@ (V[@<K)M] 6KL:OVCQ.?^8/H_\
MX-)/_D>D^T>)_P#H$:/_ .#23_Y'KBOB#XT\4:';Z9?6D5E9Q36T,TUM=Z3=
M3@NS@2))=HR06:JI'SR[L\_*-N&]-!!&156:W$G?8R?M'BC_ * ^C_\ @TD_
M^1Z/M'BC_H#Z/_X-)/\ Y'K8HH*,?[1XH_Z ^C_^#23_ .1Z/M'BC_H#Z/\
M^#23_P"1ZV** ,?[1XH_Z ^C_P#@TD_^1Z/M'BC_ * ^C_\ @TD_^1ZV** ,
M?[1XH_Z ^C_^#23_ .1Z/M'BC_H#Z/\ ^#23_P"1ZV** ,;[1XG_ .@1H_\
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M?_P:2?\ R/5O0[J2]T:SO)0HDG@21@O0$J"<>U7>U6U9V8HRYE=&1]H\4?\
M0'T?_P &DG_R/1]H\4?] ?1__!I)_P#(];%%!1C_ &CQ1_T!]'_\&DG_ ,CT
M?:/%'_0'T?\ \&DG_P CUL44 8_VCQ1_T!]'_P#!I)_\CT?:/%'_ $!]'_\
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M_P#PCFG_ //QK'_@XNO_ (Y1_P (YI__ #\:Q_X.+K_XY0!L45C_ /".:?\
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MF_M*U\4>(;7Q \LLESK:&U-U<"1(T:-E: PA-L,( 2-<>4IZEBW4?\(YI_\
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M=?\ QRC_ (1S3_\ GXUC_P '%U_\<H V**Q_^$<T_P#Y^-8_\'%U_P#'*/\
MA'-/_P"?C6/_  <77_QR@#G=1\#WNI^-#?ZCXDU2;0(YK>^@T<O%Y0NXSP=W
ME>:(P4B<*)<%]V1MX-R/P9,GCF3Q5_PENO%WB\@V!CL_LPB^8A!^X\S 9BV=
M^?4D<5?;1-'2ZCM7O]36XD5GCB.M70=U7:&8#S<D#<N3VW#UJ;_A&]._Y^-8
M_P#!Q=?_ !RILM/(EI,YKP[\.#HNG:GIZ^-O$]Y!J44RS-<+9>:)9, SB5+=
M7:4 8!=F &!C 7'2PZ#:VNCZ?H^G2RZ?IUDBQ+;0*FV2%4*"%MRDA<8/RE6R
MH^;&04/AS3P/^/C6/_!Q=?\ QRE_X1S3_P#GXUC_ ,'%U_\ '*+)JUOZ0^MS
ME=.^%>D1016>J:SK.MZ?;Z;+I=G9WS0+':VTJJCHODQ1LQVHB[I&<C'7)).U
MX2\(1Z'?3ZA=:[K&NW\T$=L+G4FAW1PH6*HJPQQKU9B6*ECGEC@8T/\ A'-.
M YN-8_\ !Q=?_'*3_A'-/Z_:-8_\'%U_\<IO7^OZ[BMI8VJ*Q_\ A'-/_P"?
MC6/_  <77_QRC_A'-/\ ^?C6/_!Q=?\ QRF4;%%8_P#PCFG_ //QK'_@XNO_
M (Y1_P (YI__ #\:Q_X.+K_XY0!L45C_ /".:?\ \_&L?^#BZ_\ CE'_  CF
MG_\ /QK'_@XNO_CE &Q16/\ \(YI_P#S\:Q_X.+K_P".4?\ ".:?_P _&L?^
M#BZ_^.4 ;!JGJ]D=1TJZL!>75F9XFC%Q:R;)821@.AP0&'49!'J#5/\ X1S3
M_P#GXUC_ ,'%U_\ '*AN=$T>UB\VYU#4X(]RH&DUJZ4;F8*JY,G4L0!ZDBDT
M!B>&/ UW:Z)JG]N^)-3U#Q!K5HEO?ZFIA1XE5&"K"$B2-0I=R"4W$MSG@#5O
M_"D3:%INCZ)K&J>&XM,"I:OIC196-4*",I+')&RX/\2G! (P15O_ (1S3_\
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M *%75_\ O[:__'J/[7U#'_(K:Q_W]M?_ (]5;6ML)Z^NOXZ#O#__ "%O$/\
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M4/\ H5=8_P"_MK_\?H V**Q_[7U#_H5=8_[^VO\ \?H_M?4/^A5UC_O[:_\
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M9J.U_/\ $\)\526%_P#$ 2Z%?^"?$NMZAK6GW6FZC:ZOOUFPM<P%XTBCB?\
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M_P!"KK'_ ']M?_C] &Q16/\ VOJ'_0JZQ_W]M?\ X_1_:^H?]"KK'_?VU_\
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M10 5C^(/^0MX>_["+_\ I+<5L5C^(/\ D+>'O^PB_P#Z2W% !X'_ .1*T/\
M[!UO_P"BUK8K'\#_ /(E:'_V#K?_ -%K6Q0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %8_B#_D+>'O^PB__I+<5L5C^(/^0MX>
M_P"PB_\ Z2W% !X'_P"1*T/_ +!UO_Z+6MBL?P/_ ,B5H?\ V#K?_P!%K6Q0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_B#_
M )"WA[_L(O\ ^DMQ6Q6/X@_Y"WA[_L(O_P"DMQ0!Y7HGQ>_LO1K+3/\ A'O.
M^R6Z0>9]MV[]B 9QLXSCI5O_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:
MZ/\ A=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHH
MH /^%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:Z/\
MA=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHHH /^
M%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:Z/\ A=W_
M %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHHH /^%W?]
M2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:Z/\ A=W_ %+'
M_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHHH /^%W?]2Q_Y
M/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:Z/\ A=W_ %+'_D__
M /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHHH /^%W?]2Q_Y/_\
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M=_U+'_D__P#:Z/\ A=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\
M4L?^3_\ ]KHHH /^%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+
M'_D__P#:Z/\ A=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^
M3_\ ]KHHH /^%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D_
M_P#:Z/\ A=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\
M]KHHH /^%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:
MZ/\ A=W_ %+'_D__ /:Z** #_A=W_4L?^3__ -KH_P"%W?\ 4L?^3_\ ]KHH
MH /^%W?]2Q_Y/_\ VNC_ (7=_P!2Q_Y/_P#VNBB@ _X7=_U+'_D__P#:Z/\
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MJ3X$_P#0\_\ E)O?_C-'_#4GP)_Z'G_RDWO_ ,9KXS_X9<^.W_0C?^5:R_\
MCU'_  RY\=O^A&_\JUE_\>H ^S/^&I/@3_T//_E)O?\ XS1_PU)\"?\ H>?_
M "DWO_QFOC/_ (9<^.W_ $(W_E6LO_CU'_#+GQV_Z$;_ ,JUE_\ 'J /LS_A
MJ3X$_P#0\_\ E)O?_C-'_#4GP)_Z'G_RDWO_ ,9KXS_X9<^.W_0C?^5:R_\
MCU</\2_AKXU^&]U9VOC31?[+FO4:2W7[5#-O52 3F)V Y(ZXH _3_P"&OQ%\
M&_$?3KK4/!FL?VI;6DPAG?[-+#M<C=C$BJ3P>U=77RE_P39_Y)WXH_["R?\
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M;V1E"B],96YG=&@@,3@S.#X^"G-T<F5A;0K_V/_@ !!*1DE&  $!   !  $
M /_; $, !0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3
M%!H5$1$8(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'O_  !$( %0 2@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M15]1T <7\>/^2'^//^Q;U#_TFDK\R_@C_P EG\#_ /8Q:?\ ^E,=?II\>/\
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M^2'^//\ L6]0_P#2:2ORGT34[[1=:L=9TR?R+ZPN([FVEVAO+E1@R-A@0<$
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M\-_A]X0^'.DW&E>#=(_LNSN9_M$L?VF6;=)M"[LR,Q'"@8!QQ74T44 %%%%
M!1110 4444 %%%% !1110!__V0IE;F1S=')E86T*96YD;V)J"C(S-B P(&]B
M:@H\/"]4>7!E("]83V)J96-T"B]3=6)T>7!E("]);6%G90HO5VED=&@@-S0*
M+TAE:6=H=" X- HO0V]L;W)3<&%C92 O1&5V:6-E4D=""B]":71S4&5R0V]M
M<&]N96YT(#@*+T9I;'1E<B O1$-41&5C;V1E"B],96YG=&@@,3<Y-CX^"G-T
M<F5A;0K_V/_@ !!*1DE&  $!   !  $  /_; $, !0,$! 0#!00$! 4%!08'
M# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?'Q\3%R(D(AXD
M'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %0 2@,!(@ "$0$#
M$0'_Q  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,#
M @0#!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S
M8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 #
M 0$! 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  !
M G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q
M%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X
M>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(
MR<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /L3
M4;RWT_3[F_O)/+MK:)IIGVD[44$L<#D\ ]*\@_X:D^!/_0\_^4F]_P#C->D_
M$/\ Y$#Q%_V"KK_T4U?D=I&GW>K:K9Z5I\/G7EY.EO;Q[@N^1V"J,D@#)(Y)
M H _2C_AJ3X$_P#0\_\ E)O?_C-'_#4GP)_Z'G_RDWO_ ,9KXS_X9<^.W_0C
M?^5:R_\ CU'_  RY\=O^A&_\JUE_\>H ^S/^&I/@3_T//_E)O?\ XS1_PU)\
M"?\ H>?_ "DWO_QFOC/_ (9<^.W_ $(W_E6LO_CU'_#+GQV_Z$;_ ,JUE_\
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MZMH POB'_P B!XB_[!5U_P"BFK\J_A)_R57PC_V'++_T>E?JI\0_^1 \1?\
M8*NO_135^1VD:A=Z3JMIJFGS>3>6<Z7%O)M#;)$8,IP00<$ X((H _8ZBOS-
M_P"&H_CM_P!#U_Y2;+_XS1_PU'\=O^AZ_P#*39?_ !F@#],J*_,W_AJ/X[?]
M#U_Y2;+_ .,T?\-1_';_ *'K_P I-E_\9H _3*OB#_@I7_R-/@W_ *\;G_T-
M*\L_X:C^.W_0]?\ E)LO_C-</\2_B5XU^)%U9W7C36O[4FLD:.W;[+##L5B"
M1B-%!Y ZYH ^O?\ @FS_ ,D[\4?]A9/_ $2M?5M?*7_!-G_DG?BC_L+)_P"B
M5KZMH @U&SM]0T^YL+R/S;:YB:&9-Q&Y&!##(Y'!/2O(/^&7/@3_ -"-_P"5
M:]_^/5[-10!XS_PRY\"?^A&_\JU[_P#'J/\ AESX$_\ 0C?^5:]_^/5[-10!
MXS_PRY\"?^A&_P#*M>__ !ZC_AESX$_]"-_Y5KW_ ./5[-10!XS_ ,,N? G_
M *$;_P JU[_\>H_X9<^!/_0C?^5:]_\ CU>S44 <I\-OAUX-^'&G76G^#-'_
M ++MKN833I]IFFWN!MSF1V(X':NKHHH **** "BBB@ HHHH **** "BBB@#_
MV0IE;F1S=')E86T*96YD;V)J"C(S-R P(&]B:@H\/"]4>7!E("]83V)J96-T
M"B]3=6)T>7!E("]);6%G90HO5VED=&@@-S0*+TAE:6=H=" X- HO0V]L;W)3
M<&%C92 O1&5V:6-E4D=""B]":71S4&5R0V]M<&]N96YT(#@*+T9I;'1E<B O
M1$-41&5C;V1E"B],96YG=&@@,C0P,3X^"G-T<F5A;0K_V/_@ !!*1DE&  $!
M   !  $  /_; $, !0,$! 0#!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1
M$1,6'!<3%!H5$1$8(1@:'1T?'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(
M#AX4$10>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'O_  !$( %0 2@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M("]$0U1$96-O9&4*+TQE;F=T:" Q,C8Q/CX*<W1R96%M"O_8_^  $$I&248
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MHY8^Y.2?<FJ7P\\">%/A_H8T;PGHUOIMMD-(4&9)FQC<[GYF/N372T %%%%
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M4#)))Z "OSF_:Q^.-]\5/$__  COA]Y4\*V,^VUC3.Z_E!QYS#N.R+V'/4X
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M!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!
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M5$1E8V]D90HO3&5N9W1H(#$X,S@^/@IS=')E86T*_]C_X  02D9)1@ ! 0
M 0 !  #_VP!#  4#! 0$ P4$! 0%!04&!PP(!P<'!P\+"PD,$0\2$A$/$1$3
M%AP7$Q0:%1$1&"$8&AT='Q\?$Q<B)"(>)!P>'Q[_VP!# 04%!0<&!PX(" X>
M%!$4'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'A[_P  1" !4 $H# 2(  A$! Q$!_\0 'P   04! 0$! 0$
M      $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0   %] 0(#  01!1(A
M,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'B
MX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%
M!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B
M,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'
M2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:
MHJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ
M\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z^U[5;#0M#O\ 6]5G^SV&GVTEU=2[
M&;RXHU+.V%!)P 3@ GTKR;_AJ3X$_P#0\_\ E)O?_C-=E\>/^2'^//\ L6]0
M_P#2:2ORGT33+[6M:L=&TR#S[Z_N([:VBWJN^61@J+EB ,D@9) H _2;_AJ3
MX$_]#S_Y2;W_ .,T?\-2? G_ *'G_P I-[_\9KXS_P"&7/CM_P!"-_Y5K+_X
M]1_PRY\=O^A&_P#*M9?_ !Z@#[,_X:D^!/\ T//_ )2;W_XS1_PU)\"?^AY_
M\I-[_P#&:^,_^&7/CM_T(W_E6LO_ (]1_P ,N?';_H1O_*M9?_'J /LS_AJ3
MX$_]#S_Y2;W_ .,T?\-2? G_ *'G_P I-[_\9KXS_P"&7/CM_P!"-_Y5K+_X
M]7"?$GX=>,OAQJ-KI_C/1_[+N;N$S0)]IAFWH#C.8W8#D=Z /U$^&WQ"\(?$
M;2;C5?!NK_VG9VT_V>63[-+#MDVAMN)%4GA@<@8YKJ:^7/\ @F]_R2?Q#_V'
M6_\ 1$5?4= '%_'C_DA_CS_L6]0_])I*_,OX(_\ )9_ _P#V,6G_ /I3'7Z:
M?'C_ )(?X\_[%O4/_2:2OS+^"/\ R6?P/_V,6G_^E,= 'ZT4444 %%%% !7P
MI_P4F_Y*)X6_[!+_ /HYJ^ZZ^%/^"DW_ "43PM_V"7_]'-0!Z1_P3>_Y)/XA
M_P"PZW_HB*OJ.OES_@F]_P DG\0_]AUO_1$5?4= '%_'C_DA_CS_ +%O4/\
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MU% '+?#?X?>$/ASI-QI7@W2/[+L[F?[1+']IEFW2;0N[,C,1PH& <<5U-%%
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M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !4 #(# 2(
M A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1
M @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152
MT? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D
M969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0
M'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%
M! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D
M-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$
M/P#[+HHHH **** "BBB@ HHHH ***\/_ &H?C]IWPDL(]*TR"'4O%-Y$9(+:
M1OW5LG02RX.2,@X48)P>0* /<**_)WQ]\5_B'XYO)I_$?BO4[B*4%3:1S&*V
M53GY1$N%Q@XY&2.I-87ACQ5XF\,7*W/AWQ!J>DRJX?-I=/$">.H!P>@X/6@#
M]?Z*^/?V8OVJKS5]8M/!_P 3)86GN76&RUA4$89SP$G P,D\!P!R1D=Z^PJ
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M!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!
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M:^[OB'_R('B+_L%77_HIJ^$?^">7_)>KC_L!W'_HR&@#3_;F^%OC32?$<GQ
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MF+,<O(Q/95#,?8&OU3^'WA32O!'@S2_"VBQ".RT^ 1*< &1NK.W^TS$L?<T
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M"PL)#!$/$A(1#Q$1$Q8<%Q,4&A41$1@A&!H='1\?'Q,7(B0B'B0<'A\>_]L
M0P$%!04'!@<." @.'A01%!X>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>_\  $0@ 5 !  P$B  (1 0,1 ?_$ !\
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M<-[HMY9[XT9%=E,\2!L&1,@'/S"NMH *X^Y_Y+38?]B[=?\ I3;UV%<?<_\
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B,#D@,"!2"CX^"G-T87)T>')E9@HR,#(S-#4R"B4E14]&"@$!

end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>a2018graph.jpg
<TEXT>
begin 644 a2018graph.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" *5 X\# 2(  A$! Q$!_\0
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MQX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\
M\)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_
M .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_
MPRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP
M_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)Q
MX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG
M[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C=
M=[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '
M!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,
MK_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^
MB<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_
M /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T
M_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T
M?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\
M,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B
M<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\
M)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_X
MW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10
M!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\
M#*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##
M_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<>
M_P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?
MM/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C
M='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K
M_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\
MHG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> _
M_"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_
M^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T
M4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_
M  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_P
MP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'
M@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#P
MG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\
MXW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#
M*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_
M *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@
M/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M
M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UW
MM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%
M_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO
M\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)
MQX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\
M\)^T_P#C='_#*_PP_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_
M .-T?\,K_##_ *)QX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_
MPRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP
M_P"B<> __"?M/_C==[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)Q
MX#_\)^T_^-UWM% '!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG
M[3_XW7>T4 <%_P ,K_##_HG'@/\ \)^T_P#C='_#*_PP_P"B<> __"?M/_C=
M=[10!P7_  RO\,/^B<> _P#PG[3_ .-T?\,K_##_ *)QX#_\)^T_^-UWM% '
M!?\ #*_PP_Z)QX#_ /"?M/\ XW1_PRO\,/\ HG'@/_PG[3_XW7>T4 <%_P ,
MK_##_HG'@/\ \)^T_P#C=<WXJ^#7A#X;?%3X8WGAWPIX;T"\N/$5Q;RSZ;ID
M-K))$='U)BC-&H)7<B'!XRH/85[#7!?%_P#Y*#\*_P#L:)__ $RZI0 ?LK_\
MFP_#C_L5],_])(J[VN"_97_Y-A^''_8KZ9_Z215WM !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^;/_!2C_@IC\8M>_P""AW@S
M]CO]F1_#FB?$?Q!IW]M>)_&FM6RWT'A.Q*M)^YMF^1YQ&H?]XK ^9$H7YRZ?
MI-7XF?M7^,+#_@EW_P '2>E?''XH--H7PF^-?A4:+;^)YHF>QL+M+."V:.1E
M'R;9+6 L3PJ7 <X4,5B-I8FE3G\+;ZVNU%N,;JS2;71IO;J7=QHU)Q^))6TO
M;WHJ3MMI%MZIKK;0^\_V=_AU^TW^QSX@\0^(/CE^T/X2^.'PHTOP[>:K?WDO
M@6#PSKFD7$ 611#'9LT$T!B68N9"'#! HQFOE#]BW]H?]M;_ (+>^$]?^+OP
M\^,GA3]EGX1)JESI7A/3+?P39^*]6UI86 >:\:[.R/!.W=$1EE<>7A5=_KGX
M^?M;?!G_ (*"?!3XG_ GX4?%WX?>._B!XZ^'^N16-GX=UR+4TB5[8V^^6:V9
MHX@))XAAW4L&. 0#CXD_X-L/^"DGPA_9<_X)]W/P3^,GCOPK\(/B-\)?$&IV
M>J:/XQU.'19Y4EN'G#Q>>ZB4AGDC94RP,?*X9"U4FJE2I[1_#!./2_OM2?\
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MM.E*T/W3C+=1C-S=VM;JUG+TWZBP[G*C0A-7GS5%);.3BH*U^FM[>NQ]^?\
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M>Z?! SHQRN_R'D7(!*2(>XKZM_X*.?#K4?\ @G?J7[/G[<'@O3V;19/!6F^
M/B[96:8?4=*N[*&&WO6 'SM$WEKDG):&S7.T'&N,M".*Z7<8+^Y.=)25NW[Q
M<K73FOT,\+:<\.HZV4I_XXQJ-6?>]-W3;U<5O<^Q_P#@W@_; ^(O[='_  3"
M\+_$/XI^(?\ A*/&.HZMJ=M<:A]@MK+S(X;IXXU\JVCCC&% &0H)[Y->=_\
M!0O_ (*3?&KQU_P4C\.?L<_LROX7\,^.;[1_[?\ %GCGQ!:?;H?#%F5\S_1K
M8Y228)L/[Q75FGC3"C=(D'_!I9_RA8\%?]A[6O\ TMDKY^^.?CJR_P""8?\
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M4JQIOLXU$HKTY)N5O[B.:$E"<*E?X:5.E*:ZM2@W)^O-%*_]YGV!_P $3?\
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M6/#7[2?P1^(^LKH>JZLW@ZT\*ZOX8FX8M%':,8Y!Y6^4;]^_R9$/E95SQ?\
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M-9^'4NNWF@_V99MYUZ([XB7[28C<#F&/Y1*%^7IR<_HO7XR?M7_&KP;\"/\
M@[@^&WB?QQXM\,^#?#5O\)7275M=U2#3K&-I$U)4#33,J LQ  )Y) %?K5\%
M?VA_ '[2?ABXUOX=>.?!_C[1K2Y:RGO_  YK-MJMK#.%5S$TD#NH<*Z,5)SA
MU..12I>]AZ<EO[]_E5FE?Y67I9$R=J]1=/<M\Z4'I\[OUNS\UO\ @H[^U/\
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M'7]JKQ?XJDT*Q^,G[/$.L:3#XCTBRC:PU&YM[1GBN1"X:)G616)&P1L/+.P
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M\1OVOO%WP7L;77H_$O@^S^US7\]O&NEZ@RI:27$%M*)"[RVZW]D908U"_:4
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M,_B]^S=\1?B7I^F^,+.R^%UXUIK>C7UG;Q:N%^7R;B.(3F-X)E;=')Y@#;)
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MO!7AVWD>6+2M!TN#3;*)W.YV6&%50%B<D@<GK6+\;_V3_A9^TT++_A9'PU\
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M_&W]M'X._LT:[::7\1_BQ\-/A_J=_!]JM;/Q)XGLM*GN8=Q7S$2>5&9-P(W
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MO^D/Q!^(OA_X2^#-0\1^*M=T?PSX>TF+S[[5-6O8[*RLH\@;Y9I&5$7) RQ
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M+X:D8ZJNH6<DTE^L>O))"J0PRB-W.V$K$YB947](JYSXF?%GP_\ ![2-/O\
MQ'?_ -G6NJ:K9:):OY$DWFWEY<);VT6(U8C?+(B[B JYRQ !-*E>')&&Z:MY
MM^S2^=Z<+)==EM;2LU4<YSZW;\M:DF_+^)._D?G]\#O 7Q)_X)Q>,O%_Q+U/
MX5V6M2?&18&T3PW9^(%\_P $ZI>:Y(T?AN.1GF003+J!NY);9# ES!>EF6W-
MN8_TDHHH3]Q0[:+TZ+U6NO56O>5Y235YRJ=9:OUZOYZ:='>UE9(HHHI#"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQW\.?&.AZ/8>(CHOBN&P2YO-,O3(L%Y"UG=7,93?$Z,K.LB,,,BY%<M\;/\
M@JWX ^!'Q2US0]5T#QK=>&_!^MZ7X;\5^-;2"R_X1[PIJ.HB)K:WNVDNDNC\
MMQ;,\D%O+'$+B/>ZG<%N2Y9*,M&_\^7Y>][KOM+W7KH*+YDW'6W^5_G=:JVZ
MU6FI].T5\U_LU?\ !4+P7^TU\4O#GAJQ\+^//#4/CS1+OQ)X)UG7;6SBT_QK
MIUM+''+<6?DW,L\?RRQ2B.[BMY#'(&V=<?2E#BTDVM[_ (-I_<TTUT:"^K7;
M_*_Y.X4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *X+XO_ /)0?A7_ -C1/_Z9=4KO:X+XO_\ )0?A
M7_V-$_\ Z9=4H /V5_\ DV'X<?\ 8KZ9_P"DD5=[7!?LK_\ )L/PX_[%?3/_
M $DBKO: "BBB@ HHHH **** "OS\_P""N'[%WB[]L3XU>$/#_A[X9>#;G7+Z
MREN/"_Q?BU?5-"U[X47=K]Z5I[*!S=!OM'F6]NUQ;QO*CAU^7S1^@=%2XIN+
M?1W_ *>Z]4T_,J,FDTNNG]+9^C37D?'GQ\_9A^-_B_\ ;X^ OQ#T#3/AIJ_A
M+X,6.J:?<76L^,+ZRUC7!J=I;6\\YMX]*FBC>$P,ZKY[";< 6AZU\<_&K_@W
M,^(GQZ^*_C76;G7_  7X5\3^.]4\0OXC^*%AXDU.^UGQ5I%['<+9Z5/H,MJF
MGVT<>ZS5WAN6?;:90AV!7]B:*;5W=[VDK^4GS/;I?ILTW%IQT%!\D5".R<7W
MUBFEOZ^J=FK-)GPYX"_9,_:4\-_%/Q;\8D7X':/\5;WPAX?\!Z/HS:MJFK>'
M_L-G>/<7MY<7'V6UN!-(L\HBA2(JA1-\DFX[>'_:[_X(_?$/]HL?'/X;6>L>
M#+;X0?M$>,]*\8Z]KLVH7,?B3P]]FCM%N;2ULA:O;7/F&QA\N:2YB\OSGW12
M;!O_ $;HISM-^\N_XR4VO1SBI:=;K9V%3O3^!]K>7+'D3]5#W?QWU/A+]B'_
M ()O?%#X/?%;X'W7C^^\!1^'_P!F_P $:CX*\-S^']1N[N\\5BZ-O$MY>0S6
MT*6)6WM(\PQRW.9)6_>A5 ;[@\1>&].\7Z+/INK6%EJFG70"S6MW L\,P!!
M9&!4\@'D=0*NT5<ZDI_%J]7ZN4G)OYMO]-"8P4=([:?))))?<CS3]GKPOIO@
MOQ+\3-+T?3K'2=,M/%$0@M+*W6""'=H^F.VU% 499F8X')8GO7I=<%\(/^2@
M_%3_ +&B#_TRZ77>U!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_L:(/_3+I==[7!?"#_DH/Q4_[&B#_P!,NEUWM !1110 4444 %%%% !1110
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M110 4444 %%%% !1110 5P7Q?_Y*#\*_^QHG_P#3+JE=[7!?%_\ Y*#\*_\
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MH *X+XO_ /)0?A7_ -C1/_Z9=4KO:X+XO_\ )0?A7_V-$_\ Z9=4H /V5_\
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M+F7/&+T3=K]%UN_NLN[:74KE;C*2U:5[=7TT^^[[)-]#]!Z*^+_BE^T=\7M
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M4 "K->I@*U6KA:=6O'EG**;79M:KY/0_-I))M(****ZQ!1110 4444 %%%%
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M[N"/_B3Z9MVRO%$S97!.8UP21SC)],K(L**** "BBB@ HHHH **** "BBB@
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MAAZ*M&"44O)*R_ ^0;;=V%%%%;B"BBB@ HHHH **** "BBD=Q&A9B H&22>
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MM[;V2NW8XY5(QU;/9OB#X[TSX8>!M7\1:S=166DZ':2WUW<2MM2&*-2S,3V
M KF/V7?VB] _:P^ _ASQ_P"&9C+I/B*U$\8; >!^CQ. 2 Z,"K#)P01DU^=?
M_!R9^W?)X#^ ^A?"/1I9++6?'T*:AK4);$]G8*<B)P#\IDD 7N"L<H->0_\
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M8SN4, &Y8\,.B8]S6[+XR\>?$+X&#4]"T&+PQXJNGPECJSEO)0/@MRJ_,5Y
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MT5':W<5[ LL,B2Q/]UT8,K?0BI*8!1110 4444 %%%% !1110 4444 %%%%
M!17GW[3'[3/A#]DWX1:UXU\:ZU8Z%H.A6S75W=73[4A0<9..6))"JJ@L[,%4
M$D"HOV7/VI?!O[7WP=T7QOX(UJRUS0M=MA<VMS;/E9%/!X/S*RL"K(P#(P*L
M 17RG^N^3+.?[!]M^_[6?+S6YO9\]N3VG+[_ +._/R>]:VIO]6J>S]K;3^M?
M3S/1J***^K, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVV=CK$'1W(P4R QYR>,<5#?_  S^#?[(%IIWB'5HK'12]['96NH7\LMPQN9
MVP+G<%. QR%  !)(QFNN^ W[+_@7]F33=0M/ ^@QZ)#JLB2W>+F:X>=D!"Y:
M5W; W-@ XY/'-==XE\):5XSL$M=8TS3]5MHIDN$AO+9)XTD0Y1PK @,IY!Z@
M]*Z_[(RJ.(A*--RC"R3DDYV7F^;6_FSDA3J^R7,H\_S:_1FA7RG\7O\ @KO\
M/_A-\3=:\(GPYXYU?6="NWLI_LMC"(7=#A]A:4.0,'!V8/4$@@U]645Z>#JX
M>G)O$TW-=N;E_1E8JG7G%*A/E?I?]4>&?LD_MM)^U=K>JVL'@;Q;X9M].MTN
M4O-3@"V]R&; 4,.-Y'( SP#SQSZ3\;?%OB'P-\+M6U7PIX=/BS7[2-6M-*%R
M+?[42ZJWSG@;5+-CJ=N!R:ZJBE6K477]I2IVCI[K;?WO1Z_(*5*JJ7)4G>6N
MMDOPU6A4T"\N=1T*RN+VT^P7D\$<EQ:F02?9I"H+1[APVTY&1P<5\Z?M'0?M
M07_Q7OH?AO-X&LO"#)$MG/=X-RIV+YC2!PW._=C:I&W;QG-?2U%&%Q?L*CJ*
M$9>4E=!B,-[:')SN/FG9GSG^S%X _:3T?XF+J'Q2\<>$-4\+FWD5M+TZT3SQ
M*>$(=;>/: >?OMGICG(]W\=:!=>*_!6K:99:G<Z)>:C9RVT&H6P!FL7="JRH
M#QN4D$?3J*U:*,3C)5JJJ\L8M=(Q27W!0PRI4_9\S?JVW]YSOPE\&7_P[^&N
MC:)JFO7WBC4--ME@N-5O!B>^<=789//U). ,DGFO+_VD/V!/"7[3WQ2T/Q=K
M>L>*[#5/#\4<5K'I]W"+;]W*958QRPR#=N/., @#(XKW*BLXXFI&<IIZRNGH
MK-/=6VL^VQ53"TJE-4IJZ5OPV/P<_P"#EK_@W[USXNZQJO[0'PFCU/7/$Z6Z
M'Q'H)D>>358(8PBSV@.<3QQH T"_+(JY0!P5DH_\&T/_  ;^:Y\.?$&C?M"?
M%J+4]#UU86E\,Z!YCV\NGQ2QE3<78!!,KQN0L#<(K9<%B%3]Z[ZQBU*T>">-
M9(I!AE/>BPL(=+M$@@C$<48PJBOQG_B'>8JG_JZL2O[(_D][VW)M]6Y]O8?W
MK^TY/W5[>\>M];A?VUOWGX>OK^'4P_AE\*]$^$&@W&FZ#:&TM;N]GU&93(SF
M2>=R\CY).,L>@P!V%<'^U3^Q/X+_ &PH]%_X2W^V$?03-]E>PNQ"0)=F\,"K
M*<^6O;/'6O7J*_9,)6J8649X=\KCHK:65K:?+0\JKAZ56G[*I%./8^2/"/\
MP1C^%?@KQSINO66L^/1/I=W'>0PG4H!%N1@P!*P"3&1SAP?<5];T45T8S,<3
MBVGB9N5MKF>%P5##)JA%1OV.(^#WP.M?@WJ/BJYM]:\0ZPWBO5Y=8F74[OSU
MLV?_ )90C VQCH!R<  DX%9?[4W[/]]^T;\/8-$T_P :>(? ]Q;WB7?VW29"
MKS *R^6X#*63YLXW#E5/.*]+HK..,K1K+$)^\NNG_#%O#4W2=%KW6?&=O_P2
MK\7VTZ2)^T3\1U>-@RLKS @CD$?Z37V'H]B^F:3:VTEQ-=R6\*1-/+CS)RH
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M%0_LA_LA>"?V*?@GHG@7P+HEGHNB:);B"&& ?BS,Q^9W=LL[M\SL22:_F_\
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M$.JMU (+#_@3?WCG=K!3C"4)TMUJ[V:O?MU6V_F;<LIJ4:FS[7VM^>^Q\N_
M;_@E)\/OAIJ8USQ=)=_$KQ5*WFSWNM_/;M)W80$L&_[:F0_2OJ"&%;>%8XU5
M$0!551@*!T %.HK3&8_$8J?/B)N3_+T6R^1GAL'1P\>2C%)?UN^H4445R'2%
M%%% !1110 4444 %%%% !1110 4444 %%%% 'SE^W%_P3]TO]J*&#Q+X?N_^
M$4^)NB!9=+URW)B,S)RD<Y7YB!CY7'S)VR,J>1_8T_X* ZI=^.C\(OC79_\
M"+?$_366V@N9P([?7O[I4CY!*PY&T[),Y7!(6OKNO&?VR_V)/"G[9?@866KI
M_9VOV"DZ3K<"#[18/U /3?$3U0GW!4X-<%;#3C/V^'^+JNDO^#YGU66YS0KT
M%EN;7=)?!-:RI/R[P[Q^:LSL/CE\,]>^*&BZ1;:!XRU+P5/IVK07]Q<6<"S-
M?0Q[MULP+#"OD9/(^7E6'%=G<7"6D#RRNL<<:EW=SA4 Y))["OB']FW]MCQ9
M^RQ\2(/@[^T,QM[I<1:#XND8M;:E%G:GG2D#<.@\TX(/$@!RU?;=S;0:M820
MS)%<VUS&4=' =)488((Z$$']:[*&.5>FH[<O2RNK[WZ^E_D>1FV15LMK>_[T
M9J\9)WC)=''IZ]>YD^ ?B9X=^*FB?VEX:US2=?L-YC-QI]TEQ&K#JI*DX/L:
MW*^-_B3_ ,$M[SX<>*I/%WP#\77_ ,/]?&6?3)IWDTZZ[[,G<0N?X9%D3IPN
M*^D_V>;KQQ>?"'2'^(]MIEIXPVNM]'I[AH3AV"-P2 Q0*2%)&2<8Z#U\;A,-
M&"K86KS1>EGI)>JV:\TSYW"XFO*;I8BGRM=5K%_/=/R:.UHHHKRSO"BBB@ H
MHHH **** "BBB@ K@OB__P E!^%?_8T3_P#IEU2N]K@OB_\ \E!^%?\ V-$_
M_IEU2@ _97_Y-A^''_8KZ9_Z215WM<%^RO\ \FP_#C_L5],_])(J[V@ HHHH
M **** "BBB@ K.O_  AI.J>)-/UFYTO3KC5])CFBL;Z6V1[FR2;;YJQ2$;D#
M[$W!2-VQ<YP*T:* "BBB@ HHHH **** /SP_:"_X(>_#O]OC]I7XA>,O&7C;
MXDPZU9:K!I;)9WEF+58QI]I<*(8WMF,:#[01M+-DJS9RV!!\(_\ @VS^%/P1
M^)VA>+M ^(?Q3MM9\.WL=]:.;JQ*ET;.U@+8$HPRK+GE6([U]L_"#_DH/Q4_
M[&B#_P!,NEUWM? 3\,.'9T7AYTIN#337MZ]FGNG^\Z]3]!H^*G%=+"K T\;)
M4E'E4;1MRVM:W+M;09;1M%;QJ[!W50&8+M#'')QVI]%%?>4X*$%".RT[_B]7
M\S\^>NH44458!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >9_M8?L
MG>"_VRO@QK?@;QSHEEKFA:[;FWN+>X7AAU4AA\R.K ,KJ0R, RD$5#^R'^R%
MX)_8I^">B>!? NB6>BZ)HEN((88!^+,S'YG=VRSNWS.Q))KU*BOD?]1<F><_
MV[[+]]ON^3GMR^UY+\GM>7W/:6Y^7W;V-_K-3V?LKZ?UI?MY!1117UQ@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %'Q+X:T_P 9:!>:5JUE;:CINH1-!<VMS&)(IXV&"K*>"#7P5\0?@WXZ
M_P""3_CR\\<_#2.\\5?!S49A+KOAJ65GDTD=#(K<G 'W9<$@ +(& #'] Z9/
M EU \4J+)'(I5T895@>"".XKFQ.%56S3M);/M_P/(]O)L[J8%RIRBIT9_'![
M27Z2722U1Q7[/O[1'A3]ISX<6OB?PCJ*7UA/\LL386XLI< M#,F<HXSTZ$8(
M)4@GN*^%?V@_V.O&/[%?Q'NOB_\ L_(QL6_>>(O!JJ7M[J('<QAC'5>IV+\Z
M$DQG!VCZ._9!_;,\)?MD?#\:MX?G^S:G:*JZII$[C[3ITA]1_%&3G:X&#CL0
M5&>'Q3<O8UU:?X/S7^70Z\VR2G&C_:.6R<\.]_YJ;_EFORELSURJ?B'2XM;T
M"^LKB$W$%W;R021!RAE5E*E=P((R#C(/%7**ZYJ3BU%\K[K=>:O=:>:/F=.I
M_,/_ ,'-G[2GQ3^!^MZ+^SAI'AS6/ /P/M+87=G<&Y:;_A-)-_FR^9+DXCAF
M<YMR<[MLC#!A"[/_  :;?MZ?''1?CK)\'-+T74_&GPJ6*2]N9W?">#';<597
M;@Q3R#:;<')<F1 "LF[]W/\ @HQ_P3F^'_\ P4A_9_U3P/XXTI;F*Z'FVEW%
MM2[TVY4$1W,$A!V2KD\_=9248,K$57_X)M?\$V?A_P#\$UOV?M,\$^"M,6'R
M0)KZ^F"M=ZG<E0'N)W ^:1L8X^5% 50%%?SO4X=S>>!EPA/"MXJ53VOUYWY6
M[W^MN?-S_6[Z>RYM^OL-#U83I0:K1=HI6Y/_ &VVW+Y_J?0]K(\UM&TB>6[*
M"R9SL..1FI***_H:E"4(*$I<S2W=KOS=DEKY)+LCRGN%%%%: %<%\7_^2@_"
MO_L:)_\ TRZI7>UP7Q?_ .2@_"O_ +&B?_TRZI0 ?LK_ /)L/PX_[%?3/_22
M*N]K@OV5_P#DV'X<?]BOIG_I)%7>T %%%% !1110 4444 %%%% 'AOB[_@H9
M\.O"/[3]E\)R?$^J:\\T-IJVI:;H-U=Z%X6NK@*;.UU+4%3R+6>Z+J(HF;<Q
M>/<%\V,O)X8_X*+_  ?\8_'./X=V'B>^?Q)<ZG>:):2R^']2@TG4-0LT9[JS
MMM3>W6QN+B())OBBG9U,<@*Y1@/D+]HSX5^,9_\ @J:J_!#P_P#%'X;_ !4N
MM1TKQ'XMUK3_ !183?#WQ=X;:2*TENM5TZXE,K7RP6US;1+;VJR+)M<S,H$B
M>6?"K_@EO\=+']N6+Q5+H'B_0_M_C?Q5J.LO>ZQHMQ\,M+TV_M[V&"^T/3(;
M@ZC;:M('M=\[PQL6>YWL5<ALJ<Y2I1J6O=3\O>BX)+TNY*[UO%JR<7>ZB492
MC?5./GHU)Z^>D7II:2=WS*WZ+? G_@H1\(_VE/B2_A/P;XGNM2UDV4^IV?VC
M0]0L+36K."<6\MUI]U<01V]_ LI53+:22I\RG=A@2GQ%_P""A7PB^%'QLB^'
MVN^*+FU\1M>V.F3M'H>H7.F:;>7W_'G:W>H10-9VD\^5,<5Q-&["2,A2'0GX
M7^!?[.'[2/P0NOV=-2MO@-<ZIJ7[+W@.\\$S6MUXRTBTM_&\]Y/869NM/F2:
M9H[>*VMI;H_;(H)&RD2QEB2O0?M&?L(?&/QAXV^.'P\TOP7<ZMX<^-WQ5\-^
M/K7QR-7L$TOP_8V?]FFZM[JWDN%OFN$_LPK&L$$D;B>+,D>'"]2A!U813]UM
MIO:]JJCL_AO3?/=W6C7IDY/DG*UFDK+>WN-[_:M)<MHV;OY:_9&B?\%"OA%X
MB^/Z_#*T\47,GBJ;4KK1;<G0]032KS4+6(RW-C!J;0"QFNHD#%X(YVE0HX90
M48#VFOS.^#O["'QCTGQY\*/AYJW@NYM?#OPI^-NN_%"Z\>RZO82Z7KEA=/J,
M]O!;VZW#7PNV?452036Z1IY$C"60%-WZ2>(M @\4:+/87+WL4%P KM:7DUG,
M,$'Y98661>G\+#C(Z&LH:T8S>[M_Z3%WMNO><HV>JY?,JII6E"/PJ_\ Z5);
M]?=4976GO6Z''_"#_DH/Q4_[&B#_ -,NEUWM>9_L\^'+?PCXE^)NGVLE_+!;
M^*(MKWM]/>SG=H^F,=TTSO(W).-S' P!@ "O3* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "OCG]K_\ 8$UOP]X_;XQ? BX_X1SXA6):>_TN
M#"6NO*>7PA^3S&_B4_)(>?E?YF^QJ*PQ&'A6CRS^3ZKS1Z>4YOB,OK>VH/?2
M47K&2ZQDNJ?_  VI\^_L0?M]Z)^UGI4^D:A;?\(S\1-%!CU?0+C*.&0[7DA#
M?,R9ZJ?FC/#=F;Z"KY@_;?\ ^">\?QSU6'Q]X OO^$/^+&B$3V>I6[F%-291
M\J3%>C8X$GH=K!EQBK^Q)_P4(E^*7B27X:?%&P_X1#XLZ,WV>6VN$\F+6"!G
M?$.@D(PQ0$A@0R$J<+S4L1.G-4<1OTET?^3_ *1[6/RC#XRA+,<G7NK6=/>5
M/S7\T//=?:[GU31117H'R04444 %%%% !7!?%_\ Y*#\*_\ L:)__3+JE=[7
M!?%__DH/PK_[&B?_ -,NJ4 '[*__ ";#\./^Q7TS_P!)(J[VN"_97_Y-A^''
M_8KZ9_Z215WM !1110 4444 %%%% !1110 4444 %%%% !1110!P7P@_Y*#\
M5/\ L:(/_3+I==[7!?"#_DH/Q4_[&B#_ -,NEUWM !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 5P7Q?\ ^2@_"O\ [&B?_P!,NJ5WM<%\7_\ DH/PK_[&B?\ ],NJ4 '[*_\
MR;#\./\ L5],_P#22*N]K@OV5_\ DV'X<?\ 8KZ9_P"DD5=[0 4444 %%%%
M!1110 4444 %%%% !1110 4444 <%\(/^2@_%3_L:(/_ $RZ77>UP7P@_P"2
M@_%3_L:(/_3+I==[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7!?%_\ Y*#\*_\ L:)__3+JE=[7!?%_
M_DH/PK_[&B?_ -,NJ4 '[*__ ";#\./^Q7TS_P!)(J[VN"_97_Y-A^''_8KZ
M9_Z215WM !1110 4444 %%%% !1110 4444 %%%% !1110!P7P@_Y*#\5/\
ML:(/_3+I==[7!?"#_DH/Q4_[&B#_ -,NEUWM !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBK4/@=#<:;XGB\!M<VSPR^(;2Z$R.TKVANTL5,5O*L$=VJF8/\@C)1K>I_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P7Q?_
M .2@_"O_ +&B?_TRZI7>UP7Q?_Y*#\*_^QHG_P#3+JE !^RO_P FP_#C_L5]
M,_\ 22*N]K@OV5_^38?AQ_V*^F?^DD5=[0 4444 %%%% !1110 4444 %%%%
M !1110 4444 <%\(/^2@_%3_ +&B#_TRZ77>UP7P@_Y*#\5/^QH@_P#3+I==
M[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7!?%__ )*#\*_^QHG_ /3+JE=[7!?%_P#Y*#\*_P#L:)__
M $RZI0 ?LK_\FP_#C_L5],_])(J[VN"_97_Y-A^''_8KZ9_Z215WM !1110
M4444 %%%% !1110 4444 %%%% !1110!P7P@_P"2@_%3_L:(/_3+I==[7!?"
M#_DH/Q4_[&B#_P!,NEUWM !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ4_[&B#_ -,NEUWM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P7Q?_Y*#\*_
M^QHG_P#3+JE=[7!?%_\ Y*#\*_\ L:)__3+JE !^RO\ \FP_#C_L5],_])(J
M[VN"_97_ .38?AQ_V*^F?^DD5=[0 4444 %%%% !1110 4444 %%%% !1110
M 4444 <%\(/^2@_%3_L:(/\ TRZ77>UP7P@_Y*#\5/\ L:(/_3+I==[0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7!?%_P#Y*#\*_P#L:)__ $RZI7>UP7Q?_P"2@_"O_L:)_P#TRZI0
M ?LK_P#)L/PX_P"Q7TS_ -)(J[VN"_97_P"38?AQ_P!BOIG_ *215WM !111
M0 4444 %%%% !1110 5^5WACQAXL_91_X*$R^,?B!INO_$/5/BSJ&NV/P_\
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MG^(V@>,#\+_AV?%WA2SBT_1-</ANS_M'1[:)62*"VN/+\R&-%=U5$8*H9@
M374JD?;0J6LHO9=/WOM-/2*]FMO=<NGNO)I\DH7NWNWU]SEU]97F_-1ZW9^<
M?P;_ &@/'.N_%7X+?$Q_&_CF7QE\0_VA/$W@'Q#X;E\1WLVBQ:':_P!J11VJ
M:09/LL#6T-G:R><D*S;BSR.WF'/ZI^(I]1MM%G?2;6RO=14#R8+NZ:UAD.1G
M=(L<C+QGHC<@#WKD]&_9A^&OASXSW_Q'T_X>>!K#XAZK&8;WQ1;Z#:Q:U>(5
M12DEXL8F=2L:##.1A%'85W-90]VC&F]U;_TF,;+RO%R]9/U=5/>K2J+9W_\
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M ,K*/^$A^)__ $*'@/\ \*^[_P#E97>T4 <%_P )#\3_ /H4/ ?_ (5]W_\
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M@/\ \*^[_P#E91_PD/Q/_P"A0\!_^%?=_P#RLKO:* ."_P"$A^)__0H> _\
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M2Q)Y-3T %%%% !1110 5P7Q?_P"2@_"O_L:)_P#TRZI7>UP7Q?\ ^2@_"O\
M[&B?_P!,NJ4 '[*__)L/PX_[%?3/_22*N]K@OV5_^38?AQ_V*^F?^DD5=[0
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M/X#_ /"@M/\ XY1_PU1\,/\ HH_@/_PH+3_XY0!WM%<%_P -4?##_HH_@/\
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M (4%I_\ '* .]HK@O^&J/AA_T4?P'_X4%I_\<H_X:H^&'_11_ ?_ (4%I_\
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M,@+&.^:=26?(^=L^\V'[3/PITJPAM;7X@?#VVMK:-8H88M=LTCB11A550^
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MDW^#2OY!1110,*X+XO\ _)0?A7_V-$__ *9=4KO:X+XO_P#)0?A7_P!C1/\
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MO$L^J0*LLULD+F*"U0/(R@2D.\QAVL%V+*&+)M_\-4?##_HH_@/_ ,*"T_\
MCE>$_&+7CX]_:L\$^/-#_:)^ VC>&_!:7$,>B7VC_P!H7UU'="%;L&]36845
MBL(\L_9B(R26$O2D[W5N_P#5^OW=?*X=&>AV7[3OC/2?VL-'\ ^)_A[I>B^'
M/%Z:H?#FL6WBA;W4KC[!Y1>2\L!;HEO#*KEHWCN;@X,0E2%Y-B\9\8OV]]:^
M&B?$;7+:R^&EMX-\'^(K+PE:ZOXV\8Q^$=)-Y]G::^GGU!TN,1)));VD<<=L
MTAN$E!^3+Q\1X:U+5OA;^T)XX^*-S^T%\"_B-_:<%XFFZ&^E)9:S:V"J\EGH
M]I?OKGV.!//$322FS#3L,RL-L9BW? .JQ?##]F+P3X?\&?M"_"7PQXWT^XEU
M?Q+>ZU%::]IVOWUX9[C4/,@BO;25=UY<O,C17";2JJ0Z$K25W!/K9776[E]S
MM%-2MHG)--V]YNRFUT;=NUDOO7O-./-ND[]5'I?"7[?'B/Q-X.^!^M2?"N]L
M=/\ BU?PV%]?3:Y$+/1VE6Y,9M\QBXO!)Y"RQLT%NC02JY=7_<GOOB]\>M?\
M,_'CPYX+\*:"GB*Z?0]2\3:W &1)5M8$$-K;1.\L<<<]S=RH$:3*;+:XSMP&
M'R_=?!:'PK\-OA[X>\%?M._ O2E\'^)KKQM?RZSX>744U#6+FYN[F46T4&LV
MJVE@'O9ECMOWKHJQ@SN0S/Z-X"\?:5?:]\:/%MQ\6?ASX5\=^-=N@>&M1FU/
M3]1AT;3K&"2.RG-NMR!(K75Q>W?E/*&Q<*CE2I =])WW3FTEUCRQ44F]+J;;
M5]7%:VW22M*.NEHJ[VOS2YFTM;."6VBD].E[W_#P'Q;X7\+^.=.\4_#CP_9?
M$OPMXAT7PSIVBZ1XQ;4-'UF\U<0_8@=0DLH)8 IF+3AK0M'&F]%FW(ILW7[=
M/CSPU\*/BO/K7PAMV^(GPH*R7NAZ/XL2ZT>ZM9;(W<-ZNHW%M;2_9\+(D@6T
M:9'C;;#*,,?)O!/P4TZQ_9^N_"/B+]I;X(:AXAL_$%AXQT7Q-I>CFSNFUVVN
M!<->ZHESK5W]O$S)$C1QO;!(E,<31J(O)WM1\)Q:G\)/BG!-^TQ\%)_B1\7M
MEIK&N2Z0IT6QT]+0VB6UGIHU<2QL(V=_,DO)<RR.Q4J5C3/$JHJ%3V5N>VG;
M:%M];\W/>^G+LE*Q6'Y?:0]I\'7OO+MI;EY;6UYKW;CJ>S?M(?MGCX$?LRV'
MC:Q\-GQ)XFUW2_M^C^&EO_LQNV6U-W/ON/+?RH88$D>27RVP% ",[HC>N> ?
M%'_"<>!=%UKR/LO]KV$%[Y._?Y/FQJ^W=@9QNQG SCI7QKX__9T^$'[07P-T
M31_B9\;/!]_\0/#GAC4/"FG>*?!OB[4?!\$5I=+&I62RMM8;ST/V>V:2.:9T
MD:'H@.T>]_!+XJ?";X'_  A\-^$++XI^%=0MO#FGPV$=SJ'BY+VYG$:@;GEN
M+B25B3G[\C8& #@"NJ?)[2MR_#=<GI>=_/;D;NMW9-ZLPAS\E+FWL^;U]VWR
M^*UOG;1'LM%<%_PU1\,/^BC^ _\ PH+3_P".4?\ #5'PP_Z*/X#_ /"@M/\
MXY61J=[17!?\-4?##_HH_@/_ ,*"T_\ CE'_  U1\,/^BC^ _P#PH+3_ ..4
M =[17!?\-4?##_HH_@/_ ,*"T_\ CE'_  U1\,/^BC^ _P#PH+3_ ..4 8G[
M7O[1NL_LR_#ZSU[2_!-SXO@DU&TM+Z7^U(-/MM*AFNH8#+(S!Y7;]]\B10ON
M9<.T*GS!C_M<_M.^,_V9TMM<T_X>Z7XC\"V#V0U[5;GQ0NG7T7VJ\2U6.PM/
ML\HNYDWAV2::U#;XUC>5V94X_P#;<\4:/^TQ\)%\*>#OCU\&?!:7-W!<ZA<Z
MS:IKQF6">*XB6)8M3L_*/F1#<6,F5) "GYJX?XX6FN?%WXE>!/$,?[4/[.R6
M_@VRAG?0]4\+R7NDW.MJS$ZJD46OP."JD"&&=[A86'F F4+(JA?VBOM=?=;7
M;6WXW?\ +JB7PNV]M/6_]7W5EMS63]U^.O[1FM> /C#HWA?PWH]IK4D'A[5?
M%FOK//';^39VT8CMH$FDD2.&6XNI%"R2YC$=M<DXP&'D'PR_X*=^)/B7^SS\
M3_&FD?#WP;XWE^'N&M[OP%\0XM>\+:LOV1[B0_VM+:6I!M]@6=(;:=X_-BVK
M*Q9$T/ _CG0]7\3?&CQ9=?%OP/X.\9>-9$T+PWJ*ZQI=_P#V-IEA%(EE+Y)E
M9) ]U/>W1C=MVVY5&V%?EX?6OAVWB;2/BIJ]]^TW\!1\1?BKHEIX5O=1M/#H
M@T*TTJW2[4;=/_MHSR7K&^F_TF2]9 J0J(0$8OC6]K["7L_C<;KU;;7W)J,D
M^S:UT-*?(ZJY](J5GYK1/7UYI1:W5D]-3Z)^./[1VI^#/V;=$\2>'M,M9_%W
MC:32]-\/:=<DS0_;M0>-4\W#1L\,*N\TFUE/E02$8-8M]^UOXJ\!_M)V?A/Q
MMX#TCP]X0U^UU>ZT37;?Q.+W49$TU8WFFO-/%NJ6T$B,7C>*YN& ,0E2%Y-B
M^8?#C7[%?BI\*+7QW\6_A1XBT7X1Z+=7=OJND75KI%GJFKS(UC;$6DE_=S(U
MO8-=!F,NQVO05QM*I4\&^&XK?]I'QGXN\7_M(_ KQCX<\9QW>EO8R:.;76=)
MT617\G3+2^&M-;PHCE'DD%EON&7+G*Q&+HQ6LIO#[/G<;[*VD$UO?F3:>W*]
M=ES84+J$56W7)S6W;WDT_AM:R[J6FFO+V_P._;O\;^/_ !+X-_X2CX3VF@^'
M_BGX?N_$7@FYTCQ6NK7]\L,,5S':7T$MK;0V=U+;2AU"7-Q"&CD1IAA6:KXR
M_P""CNJ> ?V)/'WQ:UKP)I>A:GX&\1R^'Y]$U3Q4D%I$5U&*R$UU?I;R) JK
M,))=D<R1['"O*H$AX[X%> =+^&.N>#I?$'[3/PI\3Z;\)] N= \!6L%C;Z<]
MJ)(8[>.YU5QJ,@OYHX(D3]PEDAWS-L!9/+T/@'J6N_!/P)X^LY/VFOV<-5UW
MQ5K4VOZ9>KX6DM[32[JYN/-NA-;_ /"0.]Q$5^6-5FA:,_,S2_=I5;.K)4_@
MY7:^]^=6OTOR<U_LVY?M7*I\W+!U+<W,KVO;EY7>U];<UK?:WZ6/>?V0OV@)
M_P!IGX-P^*Y;KX7WT=S=S00W'@#QJ?%^C3)&0I*WWV2US(&W!D$7R[1\QR0/
M4*^:/V4M5\!? -?&^K^(OC3\-/$_C'XD:_\ \)%K]YIEQ:Z/I8G6TMK*-;6S
M:ZN'B46]I!N,EQ,[R>8VX*RQIZU_PU1\,/\ HH_@/_PH+3_XY5SY=.7LK^ME
M?\;BC?6_=_=?3\#O:*X+_AJCX8?]%'\!_P#A06G_ ,<H_P"&J/AA_P!%'\!_
M^%!:?_'*@H[VBN"_X:H^&'_11_ ?_A06G_QRC_AJCX8?]%'\!_\ A06G_P <
MH [VL?Q[XAO_  IX/O\ 4-+T'4/$^H6T>ZWTNRGMX9[QB0 JO<21Q+C.26<<
M XR<*>:_X:H^&'_11_ ?_A06G_QRL?X@_M->$=2\&:A!X5^+7PJT;Q#)%BQO
M=6O(=3LK:3(^:6VCN[=Y5QGY5FC/(^;C!F5^5V_K[]!K?4P_ /[2GC[XR_LF
M>#O'7@[X=Z#J'BSQ7&CRZ+J'BQK+2M)'[SS7EOQ9R3/&#'M0QV;.SR1[DC3?
M(F-<?MMZEXM_8D\)_$7P[X>@M?&/Q!FLM'T/1;N<7MO'J=U<BVYDC:/S[6+$
ML[2(4+P0LX"DX'B-O\,]9LOV)],^$-M^UK\#K&:POU2?5K/P\]M'J>CX<RZ=
M-&FO"=&E=SNN+>YA<1C8JJ27/;>"O$NCS?%_X60^+_B5\&KOPY\)M'N[VTN/
M#<UIH>DW.JS![&U2"P>^NIH%M-.:X3F4HQNU*XV[$JGK*TNZ^Y+FDD^E_A3=
MWS>5N:974;KL_OO:+:ZZZNUER^=^6O\ $#_@K-_PJ?XV^-_#FL^&?!>IZ7X*
MT[5K^\C\->/(=7\3:8MD@:%M4TQ;98M.CO&9$@+WCL6G@#HA:01>G_"+]K3Q
M:GQ"\2>%?C!X(\._#K5=#\-1^+H;K1?%,GB#2[G3]\D=QOGELK-XIH'1=Z>4
MR%9499&^8+X'^T?^SWX<_;,O%TKXH_M/_#74_!FBW6J7_AU-#L++2O$-E-=V
M]S;0K=7YOI8+B&"&Z;$<=G;^:\-NTI<*ZR5?B;X)D^(L.HR>-_C[\*_'FL^/
M+?3_  /JT_A\6GAK3=&\,"X:YU-C;SZC=R2W%VH-NSI)\HDBV1($D<S%2:C&
M]FU9M]&U))Z=I.+GKR\BT=[E2LG)]-U;>R:YEKO[J?)U<G9K:_J>K_MP?%7P
M)\ /"/Q'UCX4Z)/X9U:"SU/7))O$G]E:CI=MJ%^(K2VM;(Q7 N[V&WE@,Z2S
MVJ-(P6%G+%([WQ2_;\\4>"/&GB^_TCX<:3KOPL^'/B*R\,^*/$!\4M;ZQ;W$
MPM6GEM=-%F\<\%LM[#YC27<,AV3[(VV)YG,_M01GXS?'/PGXE\,?M(_ C1?"
M_@^%+BR\+>)-%_MNT&J*[%=2+VVM6.^2-"JQ)*LB1,/,4>8$=,7Q]\(O"_BK
MQ?XPT[3OVD?AGI7PL^)'B*U\4>*- :"VFUB>ZC%L)X;34A?JEO;7'V.#>DEI
M/( \X25-Z>5I%Q<[M6C=V3Z>]'EYFOL\O/\ #[VW719RYU'2U[*_;X7?EOUY
MN7XO=^+I9OZ%\'_M*:MKO[5'BGX>:KX+G\.Z9H.A1:W9:S=ZK!+)JT;7,L#N
M+>+>(H?W8*,\HD;YPT,>U2_G'[#'_!2.Q_;I\=ZA'X?F^$7_  CL=@^HVUII
MWQ(CU7QE:Q>:B1-J6C16@2P#JQ8@WDCQDQHR!RP3)AU-)OVS;_XC7O[1'P&N
M/!^H:/\ \(Z_AR/1_*U$6"R2S(/[0_MDQ^>)93ND^R;2@VB-3\]<]^S#\)O!
MGP,\>>!+K7OV@_A7XG\-_!_P]=^%O >GV=M:Z;?6-A<?9T_T^\>^G^URI!:6
M\8:&.U1B'=HV8ILC#7Y8^VWM*_K>=KVZ\OLTN72_->QI5MS3Y-KQMZ6CS6_[
M>YM];6M<^V:*X+_AJCX8?]%'\!_^%!:?_'*/^&J/AA_T4?P'_P"%!:?_ !RF
M([VBN"_X:H^&'_11_ ?_ (4%I_\ '*/^&J/AA_T4?P'_ .%!:?\ QR@#O:*X
M+_AJCX8?]%'\!_\ A06G_P <H_X:H^&'_11_ ?\ X4%I_P#'* .]KQCX/_M0
M^)/B?K7Q7TZ[^&VH:)JOP[N(HK#2GUFTN+[6UELUN(@Y4_9K>1R=JK]HD4*R
M,SH2R)U7_#5'PP_Z*/X#_P#"@M/_ (Y7S?X!GUSPA\1_BSXBE_:C_9]-Q\1[
M3%B;'PP()=!O8K9;:SN"TNN3)<)&BAGB,:>:_(>-?E.<^;[/9]OE:_5[*^G<
MJ-KJ_==_QMT[VU['K_P!_:KUOQ=/\2]-^)7ACP_X%UOX6R02:L^C^)&U[26M
M9K-;M95N9+6TE5U3=YD;P+M 1@SJX->?ZO\ MP?%7P)\ /"/Q'UCX4Z)/X9U
M:"SU/7))O$G]E:CI=MJ%^(K2VM;(Q7 N[V&WE@,Z2SVJ-(P6%G+%(_*-,\$3
M>%?V:=2^%FM?'+X)^.;#XAZW:P^)M9T:%-"U"6QF=GUF[OY;O6+TW<MU!&ML
MHA6/R1*H1!$BB+O_ -J",_&;XY^$_$OAC]I'X$:+X7\'PI<67A;Q)HO]MV@U
M178KJ1>VUJQWR1H56))5D2)AYBCS CILK<ZOM>*>]E97D]=6G=)6M[R>RORY
M>]R-=;-^>KM';1-6?,G?2S5W;FZ+X<?\%$M8\<_$?PK-/X"TRT^%OCWQ=JG@
M?0/$4'B5KC5UU.Q-ZK?;M--HD=M!))IUVB,EW-("8 \49D<1=1+^T;\2?&?B
M[XB0_#WP/X=\56'A77+7PSIK:MK;:):SW4=L;C4;F>[2*Z?[/$9(;9%BM'?[
M0DH;$>9(_G^^^ GPQTS]J6Y^.>H>+/V8-;\6>%YM2UWP];^$/"^F>&]?UJ_E
MM9K>)-3UB?4;A[O$4SKP+9&E*2/Q&JKM^(/!EEJO[#GAKX:>&OVC_AEX*\17
M-R=3\:ZI=R1:HGB.6[DFNM4@_P!&U"RF@6XN[B1C)#.CJF54KG<,]73_ +UE
M][:UOUM:7-9;2C977O:RM[33X7?\+O2VV\%'F>K4KZ:KN_#W_!0+Q=\9/"/P
MTC^&OPVT#6O&OCOP[>>)[[2M?\8G2=.T:TM)HK67;>P65VUPTES,JPE8%22-
M7D9HL*C:NB?M^:CXJ\-_!/6M/^&VJQZ-\5K^'3-2O+_5K>W'AJZ=+@26OEKO
MEN9XYK=U.$CA* L)MP$;>>:EX?33[SP/XH\+_M&?L]^&/B)X3\/W?A*YF@\-
M(_AB[TF6:*6&*#2QK*S6TD!MX CB]="/-!B(9!%F^,/AC8Z3\,?A)X2^'O[3
M'P8T;3OA=>Q:S)<^*=*77K[7-23S]\\CV^KV21QR&XE9HUC/S$;751MJ_M0[
M<ZYNW)SRO;K;V=KW][FM;2YE[SC);/E=N_-RJU^GQWM96Y=U<]A^.O[3OQ6^
M#/QT\'Z%'\./AUK'A7QQXGM?#VEWJ>/KV+798WC,UU<G3O[':$"W@BN967[;
MADA'SJSA:^A:^=W\1_#36?VI=.^)FL_&#P%?OX?\,R:!HNEQZM;0PZ?-<SK+
M?79)N&#O,L%I&@V@Q+%(-S^:=OI?_#5'PP_Z*/X#_P#"@M/_ (Y2CI32>]W]
MVR\NG-LOBMT+>LVUM9??N_/KR_\ ;MUN=[17!?\ #5'PP_Z*/X#_ /"@M/\
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M&)"@LHSTRP]:R+/8J*** "BBB@ K@OB__P E!^%?_8T3_P#IEU2N]K@OB_\
M\E!^%?\ V-$__IEU2@ _97_Y-A^''_8KZ9_Z215WM<%^RO\ \FP_#C_L5],_
M])(J[V@ HHHH X+XO_\ )0?A7_V-$_\ Z9=4KO:X+XO_ /)0?A7_ -C1/_Z9
M=4KQ3XR_\$B?AQ\<OB?K/BS6-?\ 'T>HZY<M<S1P:C;F&(G^%/,MW8*.R[B
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M6>@^%]4\0:C>6\:)))<"TL+>>X6%%EBWRM&$0RQJS!G4'P?PC:_&B#_@G?\
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MY,%[>/:02?\ $GU/=NE2*5EPNXC$;9( XSD7_P#A(?B?_P!"AX#_ /"ON_\
MY64?%_\ Y*#\*_\ L:)__3+JE>%?&O\ X+(?"_X%?%36_".J:+X\O-2T"Y:T
MN9;33K?R3(O7:99T8CT.W!Z@D$&L:V(I45S579'HY;E&-S"HZ6"IN<DKNW8]
MU_X2'XG_ /0H> __  K[O_Y64?\ "0_$_P#Z%#P'_P"%?=__ "LKP+X4_P#!
M9+X;_'#Q_I_A70M$\;6NKZP7CM9=0L[6.V1UC9_G*7+-T4XPIR<"O!_V0_\
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M'R]LF$^KJUG3E!\L]&KIKLT[6_K0F$XS7-!W71]UO<X+_A(?B?\ ]"AX#_\
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MRC=M6CS>:7WZ?U\^SM] ?\)#\3_^A0\!_P#A7W?_ ,K*/^$A^)__ $*'@/\
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M .A0\!_^%?=__*RN]HH X+_A(?B?_P!"AX#_ /"ON_\ Y64?\)#\3_\ H4/
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M;QWBP.[.#&8Y)(VP_"O_  3=TOPGX#U/P3%\3_BS<?#6XT6_T#2O!TU_I_\
M9OAVUNH7@V6\JV:WDRPQ2ND*7EQ<QQC8=A,<13IM,TGX3:UINIWEG\0]1N[/
M1=9'AS4)X?B?J4D=AJAFC@%A*PO<1W)FEBC\EL/OD1=N6 .EK/PW^'OAWQEH
MWAW4/%WB.Q\0>(UN'TG2[CXBZM%>:HMNJO.8(6O \HC5E+E =H8$XS245R\J
MV:MZJWXVCMV6UD5SR4^=;WO?S3N_G??N][F!\0?^"?7@KXA:QJUY)?\ B33/
M[?3P[_:D-A<0)%J$VAW\5[8W,BM"W[[,2PR."-\(5< I&R;7P=_8O\(_ O\
M:4^)_P 4=!FUN/6OBPFGC6+":Z5]-MGLQ/B6VBV!HFE:XD>7YR'<[@%9F+8.
MF:Q\$-:\4^+-#L_BO]KUKP' ]SXFT^'XKW\EUX=B0$O)>Q"^W6RJ <M*% Q3
MO@=JGP2_:<LM0N?AM\5F^(5OI+I%?2^&?BOJ&K)9.X)193;WSA"P5B V,[3C
MI51DW[T>MW\I-7^3<5Y:+LB+*,?9/;16\XI6^:27],]WHKRG0OAO\/?%/BO7
M-!TSQ=XCU'7/##0IK.G6OQ%U::[TEIH_-A%Q$MX7B,D?SJ' W+R,CFN5^$OB
MWX#?'WQ?JGA_P+\8(/&NO:&K/J6FZ#\6[[4KS3U5_+8S10W[/& Y"DL!ACCK
M26KLM]_EW&]%=['H?P@_Y*#\5/\ L:(/_3+I==[7AOPL^ 6AWWCGXDQ/?>-0
MMGXCAAC,?C'5XV93I&FOEV6Y!D;+GYG);:%7.U5 [7_AG'P__P!!'QY_X7&M
M?_)= '>T5P7_  SCX?\ ^@CX\_\ "XUK_P"2Z/\ AG'P_P#]!'QY_P"%QK7_
M ,ET =[7SS^U-^Q-K?[4'Q.@BNOB9XUT;X5:YI#:?XQ\'V-Q9?9-?\N5&AC4
MS6<MQ;I-&]Q'</;7,#LJ0[<-N<>D_P##./A__H(^//\ PN-:_P#DNJ>J?!+P
M?HEU807NO^,+2?5;C[)91S^/M8C:\F\MY?+C!N\N_EQR/M7)VQL>BFA:-/M_
M7S#H_P"O^&]3GOBA^QW>_$O]HOPM\1(_BW\2_#K>$%:.PT#3+?0FTKRY1&+E
M'-QILUTPG6) Y^T!E&?+,9.:\_\ ''_!(CX>_%"TN] \3>)OB#KGPRDU*]UN
MQ^'\]]:1Z%HVH77G,]U;R16R7^Y);B>:))+MXH9) T:(8X?+]M_X9Q\/_P#0
M1\>?^%QK7_R71_PSCX?_ .@CX\_\+C6O_DNERK^OD_P:5NW2P[VV_K1K\4VG
MW6CN<5\+_P!B:7X<ZYJWB"[^+'Q0\6>-]5M++2U\4:T-&:_L=.M;CS_L,,4&
MGQ6BQRLT@ED:W:=Q)_K04B,>-HW_  34\)Z9XVM9[GQ9X[U;P-I>LWGB+2OA
M_>SV+>'-*U"Z\XRS1[;5;V1=]S<ND,UU)#&TQ*1KLB$?IW_#./A__H(^//\
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MQG'IM]X8\.ZKJ<FFM)X=T>2Y$D>P06%ND]U(L-H\TETD_P"\@ 4[2_F>G_\
M#./A_P#Z"/CS_P +C6O_ )+JGIOP2\'ZQ?W]K::_XPNKG2IEMKZ&'Q]K#R6<
MK1I*L<BB[RC&.2-P&P=KJ>A!H2LW);M6_33L[-JZULVMFQO6/*]KI_=K]U[.
MW=)]$<5\(?V'-:^#'@?QGI&G?'KXPW=UXRU!M6.JWEGX8:\TB\DF\ZXFME31
MU@)F^ZRSQ2HJ_P"K6,_-6#'_ ,$P=(TW4QXETOXI?%71_BE<WMW=ZI\0;9]&
M?7=92Y@M;>2VFBETY]/2#RK"P54@LXMILXV!#M*TGK__  SCX?\ ^@CX\_\
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M//\ PN-:_P#DNM)SE.3G+5LB$%"/+'8[VBN"_P"&<?#_ /T$?'G_ (7&M?\
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M,AEB=EAVE&S"T<NZ),2!2RM!_P ,X^'_ /H(^//_  N-:_\ DNC_ (9Q\/\
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MJU]=SR7-W>3LJJGF33RR2,L:)&I?;&B(JH.WK@O^&<?#_P#T$?'G_A<:U_\
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M1\.]6\+:1X=M9=&NK"/1%O;JUBLS)<W5Q9Q1Q02O%(UNNQF;R0_U_P#\+?\
M$'_1*_'G_@7HO_RPH_X6_P"(/^B5^//_  +T7_Y85M&2BXQBK15K+R3;2O\
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M9?%/6].LXK>#X4>.HH8$$<:+=Z+A% P /^)AV%2?\+?\0?\ 1*_'G_@7HO\
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MX8TZ+4I4GU&.UB2[D08624( [#V+9KD?^%O^(/\ HE?CS_P+T7_Y84?\+?\
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MX%M)!HD8MYS;C68C+;LGDR".WBNM3>*.93&K_KC_ ,+?\0?]$K\>?^!>B_\
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MA6D:C52G/^3;_P #YM/RZ]7OM4[RC43>L]W\DOTO^&V_S?\ #K]E'X5>+/\
M@J1J?BCP;\+/AYX8?X-VLL^K>(M'\-6%G?:WXEU>%FDBEN8D$SFWL93+(KGY
MWU6)CS'7V;7!?\+?\0?]$K\>?^!>B_\ RPH_X6_X@_Z)7X\_\"]%_P#EA6:T
MA&';_-O]=.RL@>LW/O\ HDO^"_-L[VBN"_X6_P"(/^B5^//_  +T7_Y84?\
M"W_$'_1*_'G_ (%Z+_\ +"@#O:X+XO\ _)0?A7_V-$__ *9=4H_X6_X@_P"B
M5^//_ O1?_EA63JFJ>(OB/\ $3P*[^!?$N@V>@ZS-J-W=ZC=::T2QG3;ZW
M@NY7+&2XC_AQC))&* /4Z*** "BBB@ K@OB__P E!^%?_8T3_P#IEU2N]K@O
MB_\ \E!^%?\ V-$__IEU2@ _97_Y-A^''_8KZ9_Z215WM<%^RO\ \FP_#C_L
M5],_])(J[V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@OB_\ \E!^%?\
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M^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J9?\ EQ?_ '+1_P /MO\
MJF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF7_EQ?_<M%% !_P /MO\
MJF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P^V_ZIE_Y<7_W+1_P^V_Z
MIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V_P"J9?\ EQ?_ '+110 ?
M\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J9?\ EQ?_ '+1_P /
MMO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF7_EQ?_<M%% !_P /
MMO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P^V_ZIE_Y<7_W+1_P
M^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V_P"J9?\ EQ?_ '+1
M10 ?\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J9?\ EQ?_ '+1
M_P /MO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF7_EQ?_<M%% !
M_P /MO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P^V_ZIE_Y<7_W
M+1_P^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V_P"J9?\ EQ?_
M '+110 ?\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J9?\ EQ?_
M '+1_P /MO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF7_EQ?_<M
M%% !_P /MO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P^V_ZIE_Y
M<7_W+1_P^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V_P"J9?\
MEQ?_ '+110 ?\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J9?\
MEQ?_ '+1_P /MO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF7_EQ
M?_<M%% !_P /MO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P^V_Z
MIE_Y<7_W+1_P^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V_P"J
M9?\ EQ?_ '+110 ?\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V_P"J
M9?\ EQ?_ '+1_P /MO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[;_JF
M7_EQ?_<M%% !_P /MO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%% !_P
M^V_ZIE_Y<7_W+1_P^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_  ^V
M_P"J9?\ EQ?_ '+110 ?\/MO^J9?^7%_]RT?\/MO^J9?^7%_]RT44 '_  ^V
M_P"J9?\ EQ?_ '+1_P /MO\ JF7_ )<7_P!RT44 '_#[;_JF7_EQ?_<M'_#[
M;_JF7_EQ?_<M%% !_P /MO\ JF7_ )<7_P!RT?\ #[;_ *IE_P"7%_\ <M%%
M !_P^V_ZIE_Y<7_W+1_P^V_ZIE_Y<7_W+110 ?\ #[;_ *IE_P"7%_\ <M'_
M  ^V_P"J9?\ EQ?_ '+110 ?\/MO^J9?^7%_]RUT'P0_X*'?\-=?M'?#WPY_
HPB'_  C_ /9^IW6I_:/[5^U^9MTN^BV;?)3&?.SG/\.,<Y!10!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cchcoverlogo.jpg
<TEXT>
begin 644 cchcoverlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  24DJ  @    $ !H!!0 !
M    /@   !L!!0 !    1@   "@! P !     @   #$! @ 0    3@
M  !@     0   &     !    4&%I;G0N3D54('8U+C P /_; $, !0,$! 0#
M!00$! 4%!08'# @'!P<'#PL+"0P1#Q(2$0\1$1,6'!<3%!H5$1$8(1@:'1T?
M'Q\3%R(D(AXD'!X?'O_; $,!!04%!P8'#@@(#AX4$10>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'O_  !$( %@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M8G?MOCZ8SW7!^M._9!U[Q!JWPVO=-\23R7-YH6JS:8)Y'WLZHJG!;O@L1GT
MK.<8.#E3>G8J+DI6FOF>ST445SFX4444 %%%% !1110!1\0?\@#4?^O67_T
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M8C+*.$DP.Y P?<'UK7?PCX=\>_%=_%-[H]G<V/AT/8VTCQ*1=W>097;^\L6
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=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800502896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 22, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DocumentDocumentandEntityInformationAbstract', window );"><strong>Document Documentand Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CCRN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CROSS COUNTRY HEALTHCARE INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,139,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395,272,643<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DocumentDocumentandEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document Documentand Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DocumentDocumentandEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if company meets the shell company criteria: a company with no or nominal operations, and with no or nominal assets or assets consisting solely of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800861280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 16,019<span></span>
</td>
<td class="nump">$ 25,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $3,705 in 2018 and $3,688 in 2017</a></td>
<td class="nump">166,128<span></span>
</td>
<td class="nump">173,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">6,208<span></span>
</td>
<td class="nump">5,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance recovery receivable</a></td>
<td class="nump">4,186<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="nump">963<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">194,905<span></span>
</td>
<td class="nump">208,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">13,628<span></span>
</td>
<td class="nump">14,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">101,060<span></span>
</td>
<td class="nump">117,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names</a></td>
<td class="nump">20,402<span></span>
</td>
<td class="nump">26,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">55,182<span></span>
</td>
<td class="nump">60,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent', window );">Non-current deferred tax assets</a></td>
<td class="nump">23,750<span></span>
</td>
<td class="nump">20,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">18,076<span></span>
</td>
<td class="nump">19,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">427,003<span></span>
</td>
<td class="nump">467,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">43,744<span></span>
</td>
<td class="nump">50,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">33,332<span></span>
</td>
<td class="nump">34,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">5,235<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,075<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">85,386<span></span>
</td>
<td class="nump">94,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">77,944<span></span>
</td>
<td class="nump">92,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Long-term accrued claims</a></td>
<td class="nump">29,299<span></span>
</td>
<td class="nump">28,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">7,409<span></span>
</td>
<td class="nump">5,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">8,767<span></span>
</td>
<td class="nump">9,276<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">208,805<span></span>
</td>
<td class="nump">229,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock&#8212;$0.0001 par value; 100,000,000 shares authorized; 35,625,692 and 35,838,108 shares issued and outstanding at December 31, 2018 and 2017, respectively</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">303,048<span></span>
</td>
<td class="nump">305,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,462)<span></span>
</td>
<td class="num">(1,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(84,062)<span></span>
</td>
<td class="num">(67,111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cross Country Healthcare, Inc. stockholders' equity</a></td>
<td class="nump">217,528<span></span>
</td>
<td class="nump">237,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest in subsidiary</a></td>
<td class="nump">670<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">218,198<span></span>
</td>
<td class="nump">237,719<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 427,003<span></span>
</td>
<td class="nump">$ 467,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99382578&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=99382578&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800910384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 3,705<span></span>
</td>
<td class="nump">$ 3,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">35,625,692<span></span>
</td>
<td class="nump">35,838,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">35,625,692<span></span>
</td>
<td class="nump">35,838,108<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800765632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from services</a></td>
<td class="nump">$ 816,484<span></span>
</td>
<td class="nump">$ 865,048<span></span>
</td>
<td class="nump">$ 833,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectOperatingCosts', window );">Direct operating expenses</a></td>
<td class="nump">606,921<span></span>
</td>
<td class="nump">636,462<span></span>
</td>
<td class="nump">611,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative expenses</a></td>
<td class="nump">180,230<span></span>
</td>
<td class="nump">187,435<span></span>
</td>
<td class="nump">179,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">11,780<span></span>
</td>
<td class="nump">10,174<span></span>
</td>
<td class="nump">9,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense', window );">Acquisition-related contingent consideration</a></td>
<td class="nump">2,557<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="nump">491<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">22,423<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="nump">24,311<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">829,364<span></span>
</td>
<td class="nump">853,300<span></span>
</td>
<td class="nump">827,353<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="num">(12,880)<span></span>
</td>
<td class="nump">11,748<span></span>
</td>
<td class="nump">6,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">5,654<span></span>
</td>
<td class="nump">4,214<span></span>
</td>
<td class="nump">6,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(418)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(230)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) income before income taxes</a></td>
<td class="num">(18,195)<span></span>
</td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">4,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(2,478)<span></span>
</td>
<td class="num">(34,501)<span></span>
</td>
<td class="num">(4,186)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">(15,717)<span></span>
</td>
<td class="nump">38,802<span></span>
</td>
<td class="nump">8,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Less: Net income attributable to noncontrolling interest in subsidiary</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to common shareholders</a></td>
<td class="num">$ (16,951)<span></span>
</td>
<td class="nump">$ 37,513<span></span>
</td>
<td class="nump">$ 7,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share attributable to common shareholders - Basic (usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share attributable to common shareholders - Diluted (usd per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding&#8212;basic (shares)</a></td>
<td class="nump">35,657<span></span>
</td>
<td class="nump">35,018<span></span>
</td>
<td class="nump">32,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding&#8212;diluted (shares)</a></td>
<td class="nump">35,657<span></span>
</td>
<td class="nump">36,166<span></span>
</td>
<td class="nump">36,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationArrangementsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate direct operating costs incurred during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800564864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">$ (15,717)<span></span>
</td>
<td class="nump">$ 38,802<span></span>
</td>
<td class="nump">$ 8,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income, before income tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Unrealized foreign currency translation (loss) gain</a></td>
<td class="num">(153)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax', window );">Unrealized loss on interest rate contracts</a></td>
<td class="num">(420)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax', window );">Reclassification adjustment to interest expense</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive (loss) income, before income tax:</a></td>
<td class="num">(387)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OtherComprehensiveIncomeLossTax1Abstract', window );"><strong>Other Comprehensive Income (Loss), Tax1 [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Income tax benefit related to foreign currency translation adjustments</a></td>
<td class="num">(31)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Income tax benefit related to unrealized loss on interest rate contracts</a></td>
<td class="num">(107)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax', window );">Income tax expense related to reclassification adjustment to interest expense</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Taxes on other comprehensive (loss) income:</a></td>
<td class="num">(90)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(297)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive (loss) income</a></td>
<td class="num">(16,014)<span></span>
</td>
<td class="nump">38,877<span></span>
</td>
<td class="nump">8,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interest in subsidiary</a></td>
<td class="nump">1,234<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income attributable to common shareholders</a></td>
<td class="num">$ (17,248)<span></span>
</td>
<td class="nump">$ 37,588<span></span>
</td>
<td class="nump">$ 7,933<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OtherComprehensiveIncomeLossTax1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Tax1 [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OtherComprehensiveIncomeLossTax1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801538768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Total Comprehensive Loss, net</div></th>
<th class="th"><div>(Accumulated Deficit) Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2015</a></td>
<td class="nump">$ 141,344<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 254,108<span></span>
</td>
<td class="num">$ (1,207)<span></span>
</td>
<td class="num">$ (112,056)<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards</a></td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">$ 3,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchase and retirement (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">$ (34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling shareholder</a></td>
<td class="num">(701)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">8,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,967<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2016</a></td>
<td class="nump">151,802<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">256,570<span></span>
</td>
<td class="num">(1,241)<span></span>
</td>
<td class="num">(104,089)<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards</a></td>
<td class="num">(1,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued for Convertible Notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued for Convertible Notes</a></td>
<td class="nump">45,952<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">45,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">$ 4,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchase and retirement (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1', window );">Cumulative-effect adjustment - share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling shareholder</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">38,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,513<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2017</a></td>
<td class="nump">$ 237,719<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">305,362<span></span>
</td>
<td class="num">(1,166)<span></span>
</td>
<td class="num">(67,111)<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="nump">40,500<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock and performance stock awards</a></td>
<td class="num">$ (889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(889)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">3,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchase and retirement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(432,439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change in hedging transaction, net of taxes</a></td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling shareholder</a></td>
<td class="num">(1,194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(15,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,951)<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,626,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 218,198<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 303,048<span></span>
</td>
<td class="num">$ (1,462)<span></span>
</td>
<td class="num">$ (84,062)<span></span>
</td>
<td class="nump">$ 670<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cumulative effect on retained earnings net of related income tax effect.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109240241&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800348768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">$ (15,717)<span></span>
</td>
<td class="nump">$ 38,802<span></span>
</td>
<td class="nump">$ 8,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">11,780<span></span>
</td>
<td class="nump">10,174<span></span>
</td>
<td class="nump">9,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">651<span></span>
</td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances', window );">Provision for allowances</a></td>
<td class="nump">5,974<span></span>
</td>
<td class="nump">4,705<span></span>
</td>
<td class="nump">4,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="num">(3,410)<span></span>
</td>
<td class="num">(33,812)<span></span>
</td>
<td class="num">(5,322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">22,423<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="nump">24,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">3,575<span></span>
</td>
<td class="nump">4,080<span></span>
</td>
<td class="nump">3,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash costs</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">2,820<span></span>
</td>
<td class="nump">9,708<span></span>
</td>
<td class="num">(30,781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(2,514)<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
<td class="num">(1,882)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(7,095)<span></span>
</td>
<td class="num">(9,275)<span></span>
</td>
<td class="nump">20,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(597)<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">20,997<span></span>
</td>
<td class="nump">45,508<span></span>
</td>
<td class="nump">30,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(1,930)<span></span>
</td>
<td class="num">(85,977)<span></span>
</td>
<td class="num">(1,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromPreviousAcquisition', window );">Acquisition-related settlements</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="num">(1,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(4,597)<span></span>
</td>
<td class="num">(5,111)<span></span>
</td>
<td class="num">(6,522)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,678)<span></span>
</td>
<td class="num">(91,380)<span></span>
</td>
<td class="num">(9,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Term Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on Term Loans</a></td>
<td class="num">(16,124)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="num">(30,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Convertible Note cash payment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">59,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments on revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(39,000)<span></span>
</td>
<td class="num">(67,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(308)<span></span>
</td>
<td class="num">(901)<span></span>
</td>
<td class="num">(1,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(578)<span></span>
</td>
<td class="num">(641)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchase and retirement</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(2,335)<span></span>
</td>
<td class="num">(3,265)<span></span>
</td>
<td class="num">(1,841)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(23,767)<span></span>
</td>
<td class="nump">50,756<span></span>
</td>
<td class="num">(2,164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Change in cash and cash equivalents</a></td>
<td class="num">(9,518)<span></span>
</td>
<td class="nump">4,907<span></span>
</td>
<td class="nump">18,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">25,537<span></span>
</td>
<td class="nump">20,630<span></span>
</td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">16,019<span></span>
</td>
<td class="nump">25,537<span></span>
</td>
<td class="nump">20,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">6,340<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 1,043<span></span>
</td>
<td class="nump">$ 697<span></span>
</td>
<td class="nump">$ 1,773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ProvisionforDoubtfulAccountsandOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for Doubtful Accounts and Other Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ProvisionforDoubtfulAccountsandOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow associated with the aggregate amount of adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791087024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Basis of Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Business </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cross Country Healthcare, Inc. (the Company) was incorporated in Delaware on July 29, 1999 as a business providing travel nurse and allied health staffing services. As of December 31, 2018, the Company is a leading national provider of nurse and allied staffing, recruiting, and value-added workforce solution services, multi-specialty locum tenens (temporary physician staffing) services, as well as a provider of other human capital management services focused on healthcare.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its direct and indirect wholly-owned subsidiaries. The consolidated financial statements include all assets, liabilities, revenue, and expenses of Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), which is controlled by the Company but not wholly owned. The Company records the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. All intercompany transactions and balances have been eliminated in consolidation. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation. See consolidated balance sheets and consolidated statements of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity and Operations</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon current projections, the Company will not satisfy the required leverage ratio under its Credit Agreement as of March 31, 2019. As a result, a debt prepayment of between $10 million and $12 million would be required to remain in compliance. The Company believes such prepayment will be sufficient to maintain compliance with the leverage ratio covenant and meet its obligations for the next twelve months. In the event actual results differ significantly from current projections, the Company may be required to make additional debt prepayments. Further, the Company may be able to amend its Credit Agreement, and as a result, would not be required to make any debt prepayments.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784177744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles (U.S. GAAP), requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation, and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) fair value of interest rate swap agreement; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers all investments with original maturities of three months or less to be cash and cash equivalents. The Company invests its excess cash in highly rated overnight funds and other highly rated liquid accounts. The Company is exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions, and diversifying its counterparties. The Company does not currently anticipate nonperformance by any of its significant counterparties.</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Interest income on cash and cash equivalents of </font><font style="font-family:inherit;font-size:9.75pt;">$0.4 million</font><font style="font-family:inherit;font-size:9.75pt;"> for the year ended December 31, 2018, and </font><font style="font-family:inherit;font-size:9.75pt;">$0.1 million</font><font style="font-family:inherit;font-size:9.75pt;"> for the years ended December 31, 2017 and 2016, is included in other income, net, on the Company&#8217;s consolidated statements of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Accounts receivable potentially subject the Company to concentrations of credit risk. The Company&#8217;s customers are primarily healthcare providers, and accounts receivable represent amounts due from them. The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables resulting from the inability of its customers to make required payments, which results in a provision for bad debt expense. The adequacy of this allowance is determined by continually evaluating individual customer receivables, considering the customer's financial condition, credit history, and current economic conditions. The Company writes off specific</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">accounts based on an ongoing review of collectability as well as past experience with the customer. </font><font style="font-family:inherit;font-size:10pt;">In addition, the Company maintains a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:9.75pt;">15</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">60</font><font style="font-family:inherit;font-size:9.75pt;"> days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's business activity is with hospitals located throughout the United States. No single customer accounted for more than 10% of the Company&#8217;s accounts receivable balance as of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, or revenue for the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Prepaid Rent and Deposits</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company leases apartments for eligible field employees under short-term agreements (typically </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">six</font><font style="font-family:inherit;font-size:9.75pt;"> months), which generally coincide with each employee&#8217;s staffing contract. Costs relating to these leases are included in direct operating expenses on the accompanying consolidated statements of operations. As a condition of these agreements, the Company may place security deposits on the leased apartments. Deposits on field employees&#8217; apartments related to these short-term agreements are included in other current assets on the accompanying consolidated balance sheets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property and Equipment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">seven</font><font style="font-family:inherit;font-size:9.75pt;"> years. Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the individual lease. On an annual basis, the Company reviews its property and equipment listings and disposes of assets that are no longer in use. </font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Certain software development costs have been capitalized in accordance with the provisions of the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other/Internal-Use Software</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). Such costs include charges for consulting services and costs for Company personnel associated with programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is ready for use and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">five</font><font style="font-family:inherit;font-size:9.75pt;"> years.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company applies accounting in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC when it acquires control over a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded as acquisition and integration costs; noncontrolling interests, if any, are reflected at fair value at the acquisition date; restructuring costs associated with a business combination are expensed; contingent consideration is measured at fair value at the acquisition date, with changes in the fair value after the acquisition date affecting earnings; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the consolidated statements of operations of the combined entity beginning on the date of acquisition. See Note 4 - Acquisitions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill, Trade Names, and Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable intangible assets of businesses acquired. Other identifiable intangible assets with definite lives are being amortized using the straight-line method over their estimated useful lives which range from </font><font style="font-family:inherit;font-size:9.75pt;">1</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">16</font><font style="font-family:inherit;font-size:9.75pt;"> years. Goodwill and certain intangible assets with indefinite lives are not amortized. Instead, in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC, these assets are reviewed for impairment annually at the beginning of the fourth quarter, and whenever circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">When reviewed, the Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, as a basis for determining whether it is necessary to perform the quantitative testing. If it is determined that a quantitative test is necessary or more efficient than a qualitative approach, the Company generally measures the fair value of its reporting units using a combination of income and market approaches.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">For the periods prior to the fourth quarter of 2017, the performance of the quantitative impairment test involved a two-step process. The first step required the Company to determine the fair value of each of its reporting units and compare it to the reporting unit&#8217;s carrying amount. If the reporting unit's fair value was less than its carrying amount, the Company was required to perform a second step to calculate the implied value of goodwill. The implied value was then compared to its carrying amount to calculate the impairment charge, if any. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Beginning in the fourth quarter of 2017, for its annual review on October, 1, 2017, the Company early adopted the provisions of Accounting Standards Update (ASU) 2017-04, </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. </font><font style="font-family:inherit;font-size:9.75pt;">Under ASU 2017-04, the second step of the quantitative assessment is eliminated, and, if the reporting unit&#8217;s carrying value exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value not to exceed the total amount of goodwill allocated to that reporting unit. Additionally, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss is considered, if applicable.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company determines its reporting units by identifying its operating segments and any component businesses and aggregates the components businesses if they have similar economic characteristics. The Company had the following reporting units that it reviewed for impairment: 1) Nurse and Allied Staffing; 2) Physician Staffing; and 3) Search.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. However, fair values that could be realized in an actual transaction may have differed from those used to evaluate the potential impairment of goodwill.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Long-lived assets and identifiable intangible assets with definite lives are evaluated for impairment in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Property, Plant, and Equipment</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC. In accordance with this Topic, long-lived assets and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Recoverability of long-lived assets is measured by a comparison of the carrying amount of the asset group to the future undiscounted net cash flow that is expected to be generated by those assets. If such assets are considered to be impaired, the impairment charge recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Any related impairment losses are recognized in earnings and included in the caption impairment charges on the consolidated statements of operations. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Debt Discount and Debt Issuance Costs </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Stated discounts on proceeds, and other fees reimbursed to lender, as well as the initial value of any embedded derivative features of the Convertible Notes and Term Loans, as defined in Note 8 - Debt, are treated as a discount associated with the respective debt instrument and presented in the balance sheet as an offset to the carrying amount of the debt. Discounts are amortized to interest expense using the effective interest rate method, or a method that approximates the effective interest rate method, over the expected life of the debt.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Convertible Notes and the Term Loans were capitalized and are presented in the balance sheet as a direct deduction from the carrying amount of the debt liability. Deferred costs are amortized using the effective interest method. Deferred costs related to the Convertible Notes were written off in connection with the repayment of such Convertible Notes. See Note 8 - Debt. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Company&#8217;s Revolving Credit Facilities, as defined in Note 8 - Debt, have been capitalized and included in other assets on the consolidated balance sheets, and amortized using the straight line method over the term of the related credit agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to interest rate risk due to its outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, the Company has entered into an interest rate swap agreement to effectively convert a portion of its variable interest payments to a fixed rate. The principal objective of the interest rate swap is to eliminate or reduce the variability of the cash flows in those interest payments associated with the Company&#8217;s long-term debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company has determined that the interest rate swap qualifies as a cash flow hedge in accordance with ASC 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">. As the critical terms of the hedging instrument and the hedged forecasted transaction are the same, the Company has concluded that changes in the cash flows attributable to the risk being hedged are expected to completely offset at inception and on an ongoing basis. Changes in the fair value of an interest rate swap agreement designated as a cash flow hedge are recorded as a component of accumulated other comprehensive income (loss), net of deferred taxes, within stockholders&#8217; equity and are amortized to interest expense over the term of the related debt as the interest payments are made. Interest rate swap payments are included in net cash provided by operating activities on the Company&#8217;s consolidated statement of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with entering into the interest rate swap agreement, the Company early adopted ASU 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative and Hedging (Topic 815) </font><font style="font-family:inherit;font-size:10pt;">to simplify the application of hedge accounting. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates embedded conversion features within its convertible debt in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value. Changes in the fair value of these derivatives during each reporting period were reported in other expenses (income) on the consolidated statements of operations. The fair value at inception had been recorded as debt discount and was being amortized to interest expense over the term of the note using the effective interest method. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sales and Other State Non-income Tax Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company accrues sales and other state non-income tax liabilities based on the Company&#8217;s best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company&#8217;s business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Insurance Claims</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company provides workers&#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for eligible employees. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using the Company&#8217;s loss history as well as industry statistics. The healthcare insurance accrual is for estimated claims that have occurred but have not been reported and is based on the Company&#8217;s historical claim submission patterns. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported as well as unfavorable claims development.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Other Expenses/Insurance Costs</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC previously issued authoritative accounting guidance in the area of insurance contracts and related activity thereto. This topic concluded that, under circumstances such as in the Company&#8217;s insured professional liability and workers' compensation policies, since a right of legal offset does not exist due to the fact that there are three parties to an incurred claim, the insured, the insurer, and the claimant, the related liability to the claimant should be classified separately on a gross basis with a separate related receivable from the insurer recognized as being due from insurance carriers. Accordingly, the Company&#8217;s consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;"> reflect the related short-term liabilities in accrued compensation and benefits and the related</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">long-term liabilities as long-term accrued claims, and the short-term receivable portion as insurance recovery receivable and the long-term portion as non-current insurance recovery receivable. See Note 7 - Balance Sheet Details. The ultimate cost of workers&#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved by the Company for those claims.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Workers&#8217; compensation benefits are provided under a partially self-insured plan. The Company has letters of credit to guarantee payments of claims. At </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the Company had outstanding approximately </font><font style="font-family:inherit;font-size:9.75pt;">$18.8 million</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">$19.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, respectively, of standby letters of credit as collateral to secure the self-insured portion of this plan.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has occurrence-based primary professional liability policies that provide the Company and each working professional in its nurse and allied healthcare business with coverage. Effective January 1, 2016, the Company has a claims-made professional liability policy for its physicians and advanced practitioners, with a </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;"> self-insured retention per claim. Prior to January 1, 2016, the Company had an occurrence-based professional liability policy for its independent contractor physicians and advanced practitioners which was insured by a wholly-owned subsidiary, Jamestown Indemnity, Ltd., a wholly-owned Cayman Island captive company (the Captive), until its voluntary liquidation in the third quarter of 2015. Beginning in March 2015, the Company's Physician subsidiary self-insured </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;"> for each of its professional liability claims. Under the terms of the Captive&#8217;s reinsurance policy there was a requirement to guarantee the payment of claims to its insured party&#8217;s primary medical malpractice insurance carrier via a letter of credit. As a result of the Captive's liquidation, the letter of credit was reduced. As of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the value of the letter of credit was </font><font style="font-family:inherit;font-size:9.75pt;">$1.8 million</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">$2.0</font><font style="font-family:inherit;font-size:9.75pt;"> million, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Subject to certain limitations, the Company also has umbrella liability coverage for its working nurses and allied healthcare professionals. While this umbrella coverage does not extend to professional liability claims against its independent contractor physicians and advanced practitioners, it does cover claims brought against all of the Company&#8217;s subsidiaries for non-patient general liability.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2018, the Company adopted ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2014-09 introduces a new five-step revenue recognition model in which an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. See Note 3 - Revenue Recognition for additional accounting policy and related disclosures. The Company elected to adopt the standard using a modified retrospective method, which only impacts contracts not completed as of December 31, 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from the Company&#8217;s services is recognized when control of the promised services are transferred to the Company&#8217;s customers, in an amount that reflects the consideration it expects to receive in exchange for the service. The Company has concluded that transfer of control of its staffing services, which represents the majority of its revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the nature, amount, timing, and uncertainty of revenue and cash flows from which the Company generates revenue.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Temporary Staffing Revenue</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by the Company&#8217;s field staff. The Company recognizes the majority of its revenue at the contractual amount the Company has the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days. Accounts receivable includes estimated revenue for employees&#8217; and independent contractors&#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, the Company's estimate of amounts that had been worked but had not been billed totaled </font><font style="font-family:inherit;font-size:10pt;">$44.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$41.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and are included in accounts receivable on the consolidated balance sheets.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Service Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers other optional services to its customers that are transferred over time including: managed service programs (MSP) providing agency services (as further described below in Gross versus Net Policies), recruitment process outsourcing (RPO), other outsourcing services, and retained search services, which is less than </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. The Company does not, in the ordinary course of business, offer warranties or refunds.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Gross Versus Net Policies</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Managed Service Programs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has certain contracts with healthcare facilities to provide comprehensive services through its MSPs. Under these contractual arrangements, the customer&#8217;s orders are filled with either one of the Company's healthcare professionals or a third party's healthcare professionals (subcontractors).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When its healthcare professional is staffed, the Company determined that it acts as a principal in the arrangement, as it is considered the employer of record. Accordingly, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Alternatively, the Company determined that it acts as an agent in the arrangement when a subcontracted healthcare professional is staffed, as the Company does not control the services before they are transferred to the customer. Accordingly, revenue is reported on a net basis on the consolidated statements of operations. The customer is invoiced for the hours worked by the subcontracted healthcare professional multiplied by the hourly bill rate. A subcontractor liability, which is recognized as a reduction of revenue, is established in accrued expenses for the invoiced amount, net of an administrative fee, and is generally payable after the Company has received payment from its customer. The Company&#8217;s administrative fee is calculated as a percentage of the customer&#8217;s invoice and is recognized over time as the services are rendered by the subcontracted healthcare professional. The Company does not collect or recognize an upfront placement fee.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Physician Staffing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Physician Staffing business has contracts with its healthcare customers to provide temporary staffing services. The Company uses independent contractors for these services. The Company determined that it acts as a principal in these arrangements and, therefore, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 3 - Revenue Recognition for the Company's revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract Costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All contract fulfillment costs are expensed as incurred to direct operating expenses. With respect to FASB ASC 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, there were no contract assets or material contract liabilities as of December 31, 2018 and 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Practical Expedients and Exemptions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s contracts that have an original duration of one year or less, the Company uses the practical expedients and has elected to recognize any incremental costs of obtaining these contracts as expensed when incurred. Further, the Company does not disclose the value of unsatisfied performance obligations for: (i) contracts with an original expected length of one year or less, and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has, from time to time, granted stock options, stock appreciation rights, performance-based stock awards, and restricted stock for a fixed number of common shares to employees. In accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Compensation-Stock-Compensation</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC, companies may choose from alternative valuation models. The Company used the Black-Scholes method of valuing its options and stock appreciation rights. The Company has elected to recognize compensation expense on a straight-line basis over the requisite service period of the entire award. The Company values its restricted stock awards and the fair value of its performance-based stock awards by reference to its stock price on the date of grant.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company granted performance-based stock awards to certain key personnel pursuant to its 2014 Omnibus Incentive Plan, amended and restated on May 23, 2017 (2017 Plan) as described in Note 14 - Stockholders' Equity. Pursuant to the plan, the number of target shares that vest are determined based on the level of attainment of the targets.&#160;If a minimum level of performance is attained for the awards, restricted stock is issued based on the level of attainment. The Company recognizes performance-based restricted stock as compensation expense based on the most likely probability of attaining the prescribed performance and over the requisite service period beginning at its grant date and through the date the restricted stock vests.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Compensation expense related to share-based payments is included in selling, general and administrative expenses in the consolidated statements of operations, and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$3.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$4.1</font><font style="font-family:inherit;font-size:9.75pt;"> million, and </font><font style="font-family:inherit;font-size:9.75pt;">$3.4</font><font style="font-family:inherit;font-size:9.75pt;"> million, during the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively. See Note 14 </font><font style="font-family:inherit;font-size:10pt;">-</font><font style="font-family:inherit;font-size:9.75pt;"> Stockholders&#8217; Equity.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s advertising expense consists primarily of online advertising, internet direct marketing, print media, and promotional material. Advertising costs are expensed as incurred and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$6.7 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$7.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">$10.2</font><font style="font-family:inherit;font-size:9.75pt;"> million, for the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring Costs</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring costs on the consolidated statements of operations include on-going benefit costs for its employees, exit costs, and other costs including write-offs related to abandoned locations.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Reconciliations of the beginning and ending total restructuring liability balances are presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">338</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Charged to restructuring costs (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(1,131</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(235</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(760</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(336</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(282</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(255</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) The restructuring costs on the consolidated statements of operations include direct write-offs of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> related to abandoned locations, as well as other costs of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Rent</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred rent consists of free rent, rent escalation, tenant improvement allowances, and other incentives received from landlords related to the operating leases for our facilities. Rent escalation represents the difference between actual operating lease payments due and straight-line rent expense, which we record over the term of the lease. The excess is recorded as a deferred credit in the early periods of the lease, when cash payments are generally lower than straight-line rent expense, and is reduced in the later periods of the lease when payments begin to exceed the straight-line expense. Tenant allowances from landlords for tenant improvements are generally comprised of cash received from the landlord or paid on our behalf as part of the negotiated terms of the lease. These tenant improvement allowances and other leasehold incentives are recorded when realizable as deferred rent and are amortized as a reduction of periodic rent expense, over the term of the applicable lease. See Note 12 - Commitments and Contingencies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for income taxes under the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes in its financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. The Company considers all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. It considers cumulative losses in recent years as well as the impact of one-time events in assessing its pre-tax earnings. Assumptions regarding future taxable income require significant judgment. The Company's assumptions are consistent with estimates and plans used to manage its business, which includes restructuring and other initiatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that actual results differ from these estimates, or the Company adjusts these estimates in future periods for current trends or changes in its estimating assumptions, it may modify the level of the valuation allowance which could materially impact its business, financial condition and results of operations. The Company will continue to assess the realizability of its deferred tax assets. See Note 13 - Income Taxes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total comprehensive income (loss) includes net income or loss, foreign currency translation adjustments, and net change in derivative transactions, net of any related deferred taxes. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying consolidated balance sheets and was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2018 and </font><font style="font-family:inherit;font-size:10pt;">$1.2</font><font style="font-family:inherit;font-size:10pt;"> million at December&#160;31, 2017. The cumulative impact of net changes in derivative instruments included in other comprehensive loss in the consolidated balance sheets was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2018. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax impact related to components of other comprehensive income for the period ended December 31, 2018 is reflected on the consolidated statements of comprehensive income. During the period ended December 31, 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> of income tax expense was included in the consolidated statements of operations due to the impact of a change in federal tax rate on the deferred tax asset related to foreign currency cumulative translation. See Note 13 - Income Taxes. There was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> income tax impact related to foreign currency translation adjustments for the period ended December&#160;31, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company complies with the provisions of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, which defines fair value, establishes a framework for measuring fair value under U.S. GAAP, and expands disclosures about fair value measurements. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s financial assets and liabilities required to be measured on a recurring basis were its deferred compensation liability, its interest rate swap agreements, and its contingent consideration liabilities. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the requirements of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, basic earnings per share is computed by dividing net income available to common shareholders (numerator) by the weighted average number of vested unrestricted common shares outstanding during the period (denominator). Diluted earnings per share gives effect to all dilutive potential common shares outstanding during the period including stock appreciation rights and options and unvested restricted stock, as calculated utilizing the treasury stock method, and Convertible Notes using the if-converted method prior to their payment in full in the first quarter of 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted for all entities, including adoption in an interim period. The Company is currently in the process of evaluating the potential impact the adoption of this standard may have and expects to adopt this standard in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, and should be applied either prospectively or retrospectively depending on the nature of the disclosure. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company is currently in the process of evaluating this standard and expects to adopt the full provisions in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the FASB issued ASU No. 2017-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception</font><font style="font-family:inherit;font-size:10pt;">. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and should be applied retrospectively to outstanding financial instruments with a down round feature by means of either a cumulative-effect adjustment or for each prior reporting period presented. Early adoption is permitted for all entities, including adoption in an interim period. The Company expects to adopt this standard in its first quarter of 2019, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. The FASB has issued several other subsequent updates including the following: 1) ASU No. 2018-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases</font><font style="font-family:inherit;font-size:10pt;">, which includes sixteen separate narrow-scope amendments to clarify the codification and to correct unintended application of guidance; and 2) ASU No. 2018-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842): Targeted Improvements</font><font style="font-family:inherit;font-size:10pt;">, which provides entities with relief from the costs of implementing certain aspects of the new leasing standard by allowing them to elect not to recast the comparative periods presented when transitioning to ASC 842. The new lease standard, and the subsequent ASUs that modified Topic 842, are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the adoption of the new standard, as of December 31, 2018, the Company had </font><font style="font-family:inherit;font-size:10pt;">$34.6 million</font><font style="font-family:inherit;font-size:10pt;"> of undiscounted future lease payments, primarily related to real estate, that is expected to be included in its initial measurement of its lease liabilities and corresponding right of use asset, and </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;"> of accrued rent that is expected to be reclassified from liability accounts to reduce its beginning right of use asset balance.&#160;The Company does not expect the adoption of ASU 2016-02 to have a material impact on its consolidated statements of operations and statements of cash flows.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791140400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">American Personnel, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2018, the Company completed the acquisition of American Personnel, Inc. (AP Staffing) for a total purchase price of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, subject to a net working capital adjustment. Based in Boston, AP Staffing offers a range of talent management solutions to its healthcare clients primarily in Massachusetts, including permanent placement, consultative staffing solutions, and traditional staffing.   </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assigned a total of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> to definite life intangible assets with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years. The remaining excess purchase price over the fair value of net assets acquired of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded as goodwill, which is not deductible for tax purposes since this was a stock acquisition. Associated acquisition-related costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and have been included in acquisition and integration costs on the Company's consolidated statement of operations for the year ended December 31, 2018.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, using the acquisition method of accounting. AP Staffing's results of operations are included in the consolidated statements of operations from December 1, 2018 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advantage RN</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective July 1, 2017, the Company acquired all of the assets of Advantage RN, LLC and its subsidiaries (collectively, Advantage) for cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$86.6 million</font><font style="font-family:inherit;font-size:10pt;">, net of cash acquired. The total purchase price of </font><font style="font-family:inherit;font-size:10pt;">$88.0 million</font><font style="font-family:inherit;font-size:10pt;"> was subject to a net working capital reduction of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> at the closing and an additional </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> was received during the third quarter of 2017 as the final adjustment for net working capital. Additionally, </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price was deferred as of the closing and is due the seller within </font><font style="font-family:inherit;font-size:10pt;">20 months</font><font style="font-family:inherit;font-size:10pt;">, less any COBRA and healthcare payments incurred by the Company on behalf of the seller. As of December 31, 2018, approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> has been paid for claims and the remaining </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> liability is included in other current liabilities on the Company&#8217;s balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Included in the amount paid at closing were two escrow accounts, the first was </font><font style="font-family:inherit;font-size:10pt;">$14.5 million</font><font style="font-family:inherit;font-size:10pt;"> which related to tax liabilities and the second was </font><font style="font-family:inherit;font-size:10pt;">$7.5 million</font><font style="font-family:inherit;font-size:10pt;"> which was to cover any post-close liabilities. On July 28, 2017, </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to the tax liabilities was released from escrow, leaving a balance of </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;">. In the first quarter of 2019, </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to the post-close liabilities was released from escrow, leaving a balance of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> to cover pending post-close liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company financed the purchase using </font><font style="font-family:inherit;font-size:10pt;">$19.9 million</font><font style="font-family:inherit;font-size:10pt;"> in available cash and </font><font style="font-family:inherit;font-size:10pt;">$66.9 million</font><font style="font-family:inherit;font-size:10pt;"> in borrowing under its Credit Facility, including a </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> incremental term loan, which was subsequently refinanced on August 1, 2017. See Note 8 - Debt for further information. The transaction was treated as a purchase of assets for income tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advantage is primarily a travel nurse staffing company that deploys many of its nurses through MSPs and Vendor Management Systems, and Advantage maintains direct relationships with many hospitals throughout the United States. This was a strategic acquisition to help the Company fill its recent MSP contract wins and for revenue growth.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, using the acquisition method of accounting. As such, the amounts of revenue and contribution income included in the Company's consolidated income statement from the acquisition date to the period ended December 31, 2017 were </font><font style="font-family:inherit;font-size:10pt;">$47.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The acquisition results have been substantially aggregated with the Company's Nurse and Allied Staffing business segment. See Note 17 - Segment Data.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is the estimated fair value of the purchase price for Advantage on July 1, 2017:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net working capital adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The purchase price was allocated to the assets acquired and the liabilities assumed based on the estimated fair value at the date of acquisition. The Company used a third-party appraiser to assist with the determination of the fair value and estimated useful lives of certain acquired assets and liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is an estimate of the fair value of the assets acquired and liabilities assumed on July 1, 2017.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,396</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">392</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,900</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company assigned the following values to other identifiable intangible assets: </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> to trade names with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years, </font><font style="font-family:inherit;font-size:10pt;">$13.8 million</font><font style="font-family:inherit;font-size:10pt;"> to customer relationships with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years, </font><font style="font-family:inherit;font-size:10pt;">$11.3 million</font><font style="font-family:inherit;font-size:10pt;"> to a database, consisting of healthcare professionals, with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years, and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> to non-compete agreements with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">5</font><font style="font-family:inherit;font-size:10pt;"> years, for a total of </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;"> in definite life intangible assets with a weighted average estimated useful life of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining excess purchase price over the fair value of net assets acquired of </font><font style="font-family:inherit;font-size:10pt;">$43.6 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded as goodwill, which is deductible for tax purposes. Associated acquisition-related costs incurred were </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> and have been included in acquisition and integration costs on the Company's consolidated statements of operations for the year ended December 31, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pro Forma Financial Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma financial information approximates the consolidated results of operations of the Company as if the Advantage acquisition had occurred as of January 1, 2016, after giving effect to certain adjustments, including additional interest expense on the amount the Company borrowed on the date of the transaction, the amortization of acquired intangible assets, and the elimination of certain expenses that will not be recurring in post-acquisition periods, net of an estimated income tax impact. These adjustments include removing transaction-related expenses of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the year ended December 31, 2017. These results are not necessarily indicative of future results as they do not include incremental investments in support functions, elimination of costs for integration or operating synergies, or an estimate of any impact on interest expense resulting from the operating cash flow of the acquired businesses, among other adjustments that could be made in the future but are not factually supportable on the date of the transaction. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.83040935672514%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(unaudited, amounts in thousands except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">916,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934,904</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,255</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">US Resources Healthcare</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2016, the Company completed the acquisition of a recruitment process outsourcing business, US Resources Healthcare, LLC (USR). This acquisition expands the Company's workforce solutions offerings to deliver financial and operating efficiencies through labor optimization services while enhancing the quality of care.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">, with a maximum of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> for 2017, </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for 2018, and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> for 2019, based on attainment of specific performance criteria achieved in each of those years. In the fourth quarter of 2017, the Company recognized a decrease in the fair value of the liability of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> included as acquisition-related contingent consideration on its consolidated statements of operations. The adjustment was driven by the decrease in the projected USR 2018 and 2019 revenue and EBITDA amounts. The earnout for 2017 was not achieved. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition was deemed immaterial and has been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, using the acquisition method of accounting. USR's results of operations are included in the consolidated statements of operations from December 1, 2016 and have been included in the Company's Nurse and Allied Staffing business segment. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets and Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mediscan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2015, the Company completed the acquisition of all of the membership interests of New Mediscan II, LLC, Mediscan Diagnostic Services, LLC, and Mediscan Nursing Staffing, LLC (collectively Mediscan) for a purchase price of </font><font style="font-family:inherit;font-size:10pt;">$29.9 million</font><font style="font-family:inherit;font-size:10pt;"> in cash (</font><font style="font-family:inherit;font-size:10pt;">$28.0 million</font><font style="font-family:inherit;font-size:10pt;"> plus working capital estimate) and </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> in shares (or </font><font style="font-family:inherit;font-size:10pt;">349,871</font><font style="font-family:inherit;font-size:10pt;"> shares) of the Company's Common Stock, and a net working capital adjustment of </font><font style="font-family:inherit;font-size:10pt;">$0.3</font><font style="font-family:inherit;font-size:10pt;"> million was settled in the first quarter of 2016. Additionally, an amount of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price that was held in escrow to cover any post-closing liabilities, was released to the sellers on May 3, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement also specified that the sellers were eligible to receive additional purchase price consideration of </font><font style="font-family:inherit;font-size:10pt;">$7.0 million</font><font style="font-family:inherit;font-size:10pt;">, with </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> per year based on attainment of specific performance criteria in 2016 and 2017. As of December 31, 2016, the Company determined that the first year earnout was not achieved for 2016 and, as of September 30, 2017, the Company</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">determined that the second year earnout would not be achieved for 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the Mediscan acquisition, the Company also assumed additional contingent purchase price liabilities for a previously acquired business that are payable annually based on specific performance criteria for the 2016 through 2019 years. Payments related to the 2016 through 2018 years are limited to </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> per year and 2019 is uncapped. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the fair value of the remaining obligations was estimated at </font><font style="font-family:inherit;font-size:10pt;">$7.7 million</font><font style="font-family:inherit;font-size:10pt;"> and is included in other current liabilities and contingent consideration on the consolidated balance sheets. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Medical Staffing Network</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 30, 2014, the Company acquired substantially all of the assets and certain liabilities of Medical Staffing Network Healthcare, LLC (MSN). Of the purchase price, </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> was deferred and due to the seller </font><font style="font-family:inherit;font-size:10pt;">21 months</font><font style="font-family:inherit;font-size:10pt;"> from the acquisition date, less any COBRA expenses incurred by the Company on behalf of former MSN employees over that period. The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> in COBRA expenses since the MSN acquisition and, on April 1, 2016, released to the seller the remaining liability of </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784097248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has determined that its revenues are generated from temporary staffing services and other services, as disaggregated in the following table. See Note 2 - Summary of Significant Accounting Policies.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the year ended December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse<br clear="none"/>And Allied<br clear="none"/>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician<br clear="none"/>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human<br clear="none"/>Capital<br clear="none"/>Management<br clear="none"/>Services Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary Staffing Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782,414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,326</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,070</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791153008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill, Trade Names, and Other Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,909</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,758</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,183</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">878</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,487</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,068</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,092</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,976</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,584</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,678</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2018, fully amortized intangible assets, along with the related accumulated amortization, were removed from the table above. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,677</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,628</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment are as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Allied Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate goodwill acquired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">347,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">410,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,375</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(283,107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,141</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,030</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,589</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes to aggregate goodwill in 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charge</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Aggregate goodwill acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,835</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,060</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired from the acquisition of AP Staffing. See Note 4 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2018 and 2017 Impairment Charges</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company performed its annual quantitative impairment test of goodwill and other indefinite-lived intangible assets as of October 1, 2018 and 2017. Upon completion of the impairment testing for both years, it was determined that the estimated fair value of the Physician Staffing reporting unit&#8217;s trade name was less than its carrying amount resulting in impairment. For its goodwill impairment testing, with the exception of its Physician Staffing reporting unit, the estimated fair value of its reporting units exceeded their respective carrying values. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projections of revenue, operating costs, and expected cash flows of each reporting unit are inputs into the quantitative testing for goodwill and intangible assets. The Company reduced its long-term revenue forecast for the Physician Staffing business segment in the fourth quarter of 2018 and 2017. The lower than expected revenue was driven by lower booking volumes, partly due to the loss of customers. In addition, margins of the reporting unit were negatively impacted from continued investments in the business. As a result, during the fourth quarter of 2018 and 2017 the Company recorded non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$5.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to its trade name and </font><font style="font-family:inherit;font-size:10pt;">$17.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to goodwill during the fourth quarter. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the impairment testing as of October 1, 2018, the Company reassessed the Physician Staffing brand's indefinite-life classification and determined it had characteristics that indicated a definite-life assignment was more appropriate. Effective October 1, 2018, the trade name, with a carrying value of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> after impairment charges, that was previously assigned an indefinite life was assigned a finite life of </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> years. During the three months ended December 31, 2018, the amortization expense related to this trade name was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Impairment Charges</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company performed its annual impairment test as of October 1, 2016. Upon completion of the impairment testing, the Company determined that no impairment of goodwill, trade names, or other intangible assets was warranted.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During an evaluation of goodwill, trade names, and other intangible assets at June 30, 2016, the Company determined that indicators were present in the Physician Staffing reporting unit which would suggest the fair value of the reporting unit may have declined below its carrying value. The Physician Staffing reporting unit was under-performing relative to management&#8217;s expectations. The lower than expected revenue was driven by lower booking volumes partly due to the loss of customers, and margins were negatively impacted from continued investments in the business all through the first half of 2016. The Company considered these factors to be impairment indicators that warranted impairment testing of goodwill, trade names, and other intangible assets. The interim impairment testing resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the interim impairment testing was performed which resulted in the carrying values of goodwill, trade names, and other intangible assets for Physician Staffing to exceed their estimated fair values. As a result, the Company recorded a non-cash impairment charge totaling </font><font style="font-family:inherit;font-size:10pt;">$24.3 million</font><font style="font-family:inherit;font-size:10pt;">: </font><font style="font-family:inherit;font-size:10pt;">$17.7 million</font><font style="font-family:inherit;font-size:10pt;"> related to goodwill, </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> related to trade names, and </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to customer relationships.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Quantitative Methods and Assumptions</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Trade Names</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Relief From Royalty methodology was utilized to value the Physician Staffing trade names using projected cash flows of an estimated royalty fee. The royalty rate was determined by a blended rate using the Market Royalty Rate Method and the Apportionment of Profit Method. </font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The discounted cash flows serve as the primary basis for the income approach and are based on the Company&#8217;s discrete financial forecast of revenue, gross profit margins, operating costs and cash flows. The forecast considers historical and estimated future results, general economic and market conditions, as well as the impact of planned business and operational strategies. For its 2018 testing, the assumptions used in the income approach included discount rates of </font><font style="font-family:inherit;font-size:10pt;">12.0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">15.0%</font><font style="font-family:inherit;font-size:10pt;"> and a terminal value growth rate of </font><font style="font-family:inherit;font-size:10pt;">1.0%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">3.0%</font><font style="font-family:inherit;font-size:10pt;"> for cash flows beyond the discrete forecast period of </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;"> years. Assumptions used in the market approach testing included valuation multiples based on an analysis of multiples for comparable public companies. The Company utilized total enterprise value/Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiples ranging from </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">10.5</font><font style="font-family:inherit;font-size:10pt;">. The concluded fair value was based on a weighting of </font><font style="font-family:inherit;font-size:10pt;">75%</font><font style="font-family:inherit;font-size:10pt;"> applied to the income approach and </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> to the market approach for its Physician Staffing and Search reporting units and a </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> weighting was applied to the components of each approach to estimate the total fair value of goodwill for its Nurse and Allied Staffing reporting unit. This weighting was an estimate by management and was developed based on the specific characteristics, risks and uncertainties of the reporting units. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Customer Relationships</font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Multi-Period Excess Earnings Method (MPEEM) methodology was utilized for valuing the Physician Staffing customer relationships in its interim impairment testing for the second quarter of 2016. The MPEEM estimates the fair value based on the present value of the allocated future economic benefits. The inputs include the projected revenue and associated expenses from the customers, an estimated attrition rate, and a discount rate of </font><font style="font-family:inherit;font-size:10pt;">13.5%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although management believes that the Company's current estimates and assumptions are reasonable and supportable, there can be no assurance that the estimates and assumptions made for purposes of the impairment testing will prove to be accurate predictions of future performance.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791163552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's property and equipment consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,651</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Office equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,680</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,476</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,678</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,628</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,086</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 2 &#8211; Summary of Significant Accounting Policies.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791153008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery receivable:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,623</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,891</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,497</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,280</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current security deposits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,095</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current income tax receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">935</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">985</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and benefits:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries and payroll taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bonuses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,476</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for healthcare benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for vacation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,332</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term accrued claims:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,160</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,597</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,299</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,039</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term unrecognized tax benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,767</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791144128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's long-term debt consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,235</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,641</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Amended and Restated Senior Credit Facility</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 1, 2017, the Company entered into an Amendment and Restatement of its Credit Agreement dated June 22, 2016 (Amended and Restated Credit Agreement), to refinance and increase the current aggregate committed size of the facility to </font><font style="font-family:inherit;font-size:10pt;">$215.0 million</font><font style="font-family:inherit;font-size:10pt;">, including a term loan of </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> (Amended Term Loan) and a </font><font style="font-family:inherit;font-size:10pt;">$115.0 million</font><font style="font-family:inherit;font-size:10pt;"> revolving credit facility (Amended Revolving Credit Facility) (together with the Amended Term Loan, the Amended Credit Facilities). The Amended Revolving Credit Facility includes a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;"> sublimit for the issuance of standby letters of credit. The proceeds of </font><font style="font-family:inherit;font-size:10pt;">$106.5 million</font><font style="font-family:inherit;font-size:10pt;"> from this refinancing included </font><font style="font-family:inherit;font-size:10pt;">$6.5 million</font><font style="font-family:inherit;font-size:10pt;"> under the new revolving credit facility and were used to repay borrowings under the Company&#8217;s 2016 Senior Credit Facilities (defined below), as well as to pay related interest, fees, and expenses of the transaction.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to increasing the size of the facilities, the maturity date was extended to August 1, 2022. The Amended and Restated Credit Agreement also includes an accordion feature permitting the Company, subject to certain conditions, to increase the aggregate amount of the commitments under the Amended Revolving Credit Facility or establish one or more additional term loans in an aggregate amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$50.0 million</font><font style="font-family:inherit;font-size:10pt;"> with optional additional commitments from existing lenders or new commitments from additional lenders. Other terms and pricing are substantially similar to the 2016 Credit Agreement (defined below).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Amended Term Loan are payable in quarterly installments, which commenced January 2, 2018, provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. In addition to its scheduled payments, in both the third and fourth quarters of 2018, the Company made optional prepayments of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> each as permitted by the Amended and Restated Credit Agreement. The Company has the right at any time and from time to time to prepay any borrowing, in whole or in part, without premium or penalty, by giving written notice (or telephonic notice promptly confirmed in writing). The Company is required to prepay the Amended Credit Facilities under certain circumstances including from net cash proceeds from asset sales or dispositions in excess of certain thresholds, as well as from net cash proceeds from the issuance of certain debt by the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Amended and Restated Credit Agreement, the Company pays interest on: (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time; (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time; and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time. The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.9317738791423%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 1.50:1.00 </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.00:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.50:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Amended Term Loan and Amended Revolving Credit Facility bore interest at a rate equal to One Month LIBOR plus </font><font style="font-family:inherit;font-size:10pt;">2.50%</font><font style="font-family:inherit;font-size:10pt;">. The interest rate is subject to an increase of </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> if an event of default exists under the Amended and Restated Credit Agreement. The Company is required to pay a commitment fee on the average daily unused portion of the Amended Revolving Credit Facility, based on the Applicable Margin which is </font><font style="font-family:inherit;font-size:10pt;">0.35%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. During the three months ended March 31, 2018, the Company entered into an interest rate swap to reduce its exposure to fluctuations in the interest rates associated with its debt, which was effective April 2, 2018. See Note 9 - Derivatives.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains customary representations, warranties, and affirmative covenants. The Amended and Restated Credit Agreement also contains customary negative covenants, subject to some exceptions, on: (i) indebtedness and preferred equity; (ii) liens; (iii) fundamental changes; (iv) investments; (v) restricted payments; and (vi) sale of assets and certain other restrictive agreements. The Amended and Restated Credit Agreement also contains customary events of default, such as payment defaults, cross-defaults to other material indebtedness, bankruptcy and insolvency, the occurrence of a defined change in control and the failure to observe the negative covenants and other covenants related to the operation of the Company&#8217;s business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement also includes </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> financial covenants: (i) a maximum Consolidated Total Leverage ratio (as defined therein); and (ii) a minimum Consolidated Fixed Charge Coverage ratio (as defined therein) as of the end of each fiscal quarter of </font><font style="font-family:inherit;font-size:10pt;">1.50</font><font style="font-family:inherit;font-size:10pt;">:1.00. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company was in compliance with the financial covenants and other covenants contained in the Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 30, 2018, the Company entered into a First Amendment (First Amendment) to its Amended and Restated Credit Agreement that, among other administrative and clarifying changes, modified the following: (1) the definition utilized in its financial covenants of Consolidated EBITDA to allow for exclusion of charges related to the Company&#8217;s initiative to replace its front-end system supporting its legacy travel nurse operations, subject to a basket of addbacks, of which the basket dollar amount was also increased; (2) increased the maximum Consolidated Total Leverage Ratio to </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;">:1.00 from </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the periods of September 30, 2018 through June 30, 2019, to </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;">:1:00 from </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the period ended September 30, 2019, to </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;">:1.00 from </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the period ended December 31, 2019, and maintained </font><font style="font-family:inherit;font-size:10pt;">3.00</font><font style="font-family:inherit;font-size:10pt;">:1:00 for the periods thereafter and as adjusted pursuant to a Qualified Permitted Acquisition (as defined therein); and (3) increased the pro forma Consolidated Total Leverage Ratio threshold for allowing restricted payments. In connection with the First Amendment, the Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> in fees to its lenders, of which a portion has been included in other noncurrent assets as deferred issuance costs related to the revolving credit facility and a portion has been treated as a deduction to long-term debt related to its Term Loan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foregoing description of the amendment is qualified in its entirety by reference to the full terms and provisions of the Amended and Restated Credit Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The obligations under the Amended and Restated Credit Agreement are guaranteed by all of the Company&#8217;s domestic wholly-owned subsidiaries and are secured by a first-priority security interest in the Collateral (as defined therein).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has </font><font style="font-family:inherit;font-size:10pt;">$20.6 million</font><font style="font-family:inherit;font-size:10pt;"> letters of credit outstanding, which relate to the Company&#8217;s workers&#8217; compensation and professional liability insurance policies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2016 Senior Credit Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 22, 2016, the Company entered into a senior credit agreement (2016 Credit Agreement), which provided for an initial term loan of </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> (Term Loan) and a revolving credit facility of up to </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> (Revolving Credit Facility) (together with the Term Loan, the 2016 Senior Credit Facilities) both of which would have matured on June 22, 2021. The Revolving Credit Facility included a subfacility for swingline loans up to an amount not to exceed </font><font style="font-family:inherit;font-size:10pt;">$15.0 million</font><font style="font-family:inherit;font-size:10pt;">, and a </font><font style="font-family:inherit;font-size:10pt;">$35.0</font><font style="font-family:inherit;font-size:10pt;"> million sublimit for the issuance of standby letters of credit. Proceeds of the Senior Credit Facilities were used primarily to refinance the Company&#8217;s prior senior secured asset-based credit facility and </font><font style="font-family:inherit;font-size:10pt;">$30.0 million</font><font style="font-family:inherit;font-size:10pt;"> Second Lien Term Loan and to pay related transaction fees and expenses, including a redemption premium of </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">. The repayment of the Second Lien Term Loan was treated as extinguishment of debt and, as a result, the Company recognized a loss on extinguishment of debt of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> in the second quarter of 2016, related to the write-off of unamortized net debt discount and issuance costs as well as transaction fees and expenses.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 5, 2017, the Company entered into a Second Amendment to its 2016 Credit Agreement primarily to allow for the acquisition of Advantage including a reset of the Applicable Margin to Level III, based on the incremental borrowings and consistent with the prior pricing grid (or </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> for Eurodollar Loans and LIBOR Index Rate Loans, </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;"> for Base Rate Loans and a </font><font style="font-family:inherit;font-size:10pt;">0.30%</font><font style="font-family:inherit;font-size:10pt;"> commitment fee). Also, on July 5, 2017, the Company entered into an Incremental Term Loan Agreement for </font><font style="font-family:inherit;font-size:10pt;">$40.0 million</font><font style="font-family:inherit;font-size:10pt;"> with SunTrust as Lender and Administrative Agent to pay for part of the consideration of the acquisition of Advantage. The Incremental Term Loan maturity date was June 22, 2021 and was prepayable at any time without penalty.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Incremental Term Loan were payable in quarterly installments, commencing September 30, 2017, with each such installment being in the aggregate principal amount (subject to adjustment as a result of prepayments) for the first eight installments equal to </font><font style="font-family:inherit;font-size:10pt;">1.875%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;"> of the principal amount of the Incremental Term Loan for the remaining installments; provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. As of July 5, 2017 the Applicable Margin for Eurodollar Loans and LIBOR Index Rate Loans was </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> and the Applicable Margin for Base Rate Loans was </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Convertible Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company and certain of its domestic subsidiaries entered into a Convertible Note Purchase Agreement (the Note Purchase Agreement), with certain note holders (collectively, the Noteholders) on June 30, 2014.  Pursuant to the Note Purchase Agreement, the Company sold to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;"> of convertible notes (the Convertible Notes). On March 17, 2017, the Company paid in full the Convertible Notes. In connection with the repayment, the Company issued to the Noteholders an aggregate of </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock, par value </font><font style="font-family:inherit;font-size:10pt;">$0.0001</font><font style="font-family:inherit;font-size:10pt;">, and cash in the aggregate amount of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> (of which </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> is included in repayment of debt and </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;"> is presented as extinguishment fees, both within financing activities on the consolidated statements of cash flows). Upon derecognition of the net carrying amounts of the Convertible Notes (the remaining </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> after the </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> cash payment) and derivative liability (</font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">), the Company recognized a non-cash charge of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> as loss on early extinguishment and a non-cash addition to additional paid-in capital of </font><font style="font-family:inherit;font-size:10pt;">$46.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the fair value of the shares, which is not presented on the consolidated statements of cash flows. The loss on early extinguishment of debt includes the write-off of unamortized loan fees and remaining interest due through the Forced Conversion date (defined below) of June 30, 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes were convertible at the option of the holders thereof at any time into shares of the Common Stock at a conversion price of </font><font style="font-family:inherit;font-size:10pt;">$7.10</font><font style="font-family:inherit;font-size:10pt;"> per share, or </font><font style="font-family:inherit;font-size:10pt;">3,521,126</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock. After </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years from the issuance date, the Company had the right to force a conversion of the Convertible Notes if the volume-weighted average price (VWAP) per share of its Common Stock exceeded </font><font style="font-family:inherit;font-size:10pt;">125%</font><font style="font-family:inherit;font-size:10pt;"> of the then conversion price for </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> days of a </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> day trading period (Forced Conversion date). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Convertible Notes bore interest at a rate of </font><font style="font-family:inherit;font-size:10pt;">8.00%</font><font style="font-family:inherit;font-size:10pt;"> per annum, payable in quarterly cash installments. The Convertible Notes would have matured on June 30, 2020, unless earlier repurchased, redeemed or converted. Subject to certain exceptions, the Company was not permitted to redeem the Convertible Notes until June 30, 2017.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791178080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Swap</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2018, the Company entered into an interest rate swap agreement, with an effective date of April 2, 2018 and termination date of August 1, 2022. No initial investments were made to enter into the agreement. The interest rate swap agreement requires the Company to pay a fixed rate to the respective counterparty of </font><font style="font-family:inherit;font-size:10pt;">2.627%</font><font style="font-family:inherit;font-size:10pt;"> per annum on an amortizing notional amount beginning at </font><font style="font-family:inherit;font-size:10pt;">$48.8 million</font><font style="font-family:inherit;font-size:10pt;"> (corresponding with the initial term loan payment schedule), and to receive from the respective counterparty, interest payments based on the applicable notional amounts and 1 month USD LIBOR, with no exchanges of notional amounts. At initiation, the interest rate swap effectively fixed the interest rate on </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the amortizing balance of the Company&#8217;s term debt, exclusive of the credit spread on the debt. As of December 31, 2018, the interest rate swap is treated as a cash flow hedge and its fair value of a </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> liability is included in current and noncurrent liabilities on the consolidated balance sheets. See Note 2 - Summary of Significant Accounting Policies and Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes Derivative Liability</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company issued Convertible Notes with features that were either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. As required by the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Accounting for Derivative Financial Instruments and Hedging Activities </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC, in certain instances, these instruments were required to be carried as derivative liabilities, at fair value, in the financial statements. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the derivative liability was primarily determined by fluctuations in the Company's stock price. In addition, changes in the Company's credit risk profile impacted the fair value determination. These fluctuations resulted in a current period gain that was presented on the Company's consolidated statements of operations as gain on derivative liability in 2017 and 2016 related to its Convertible Notes.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791086480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 1</font><font style="font-family:inherit;font-size:10pt;">&#8212;Quoted prices in active markets for identical assets or liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 2</font><font style="font-family:inherit;font-size:10pt;">&#8212;Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Level 3</font><font style="font-family:inherit;font-size:10pt;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Items Measured at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: deferred compensation liability included in other long-term liabilities, interest rate swap agreement included in other current and noncurrent liabilities, Convertible Notes derivative liability included in long-term debt and capital lease obligations, and contingent consideration liabilities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred compensation</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation liability. The Company&#8217;s deferred compensation liabilities are measured using publicly available indices that define the liability amounts, as per the plan documents.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest rate swap agreement</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 2 inputs to value its interest rate swap agreement. See Note 8 - Debt and Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible notes derivative liability</font><font style="font-family:inherit;font-size:10pt;">&#8212;The Company utilized Level 3 inputs to value its Convertible Notes derivative liability. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent consideration liabilities</font><font style="font-family:inherit;font-size:10pt;">&#8212;Potential earnout payments related to the acquisition of Mediscan and USR are contingent upon meeting certain performance requirements through 2019. The long-term portion of these liabilities has been included in contingent consideration, and the short-term portion is included in other current liabilities on the consolidated balance sheets. The Company utilized Level 3 inputs to value these contingent consideration liabilities as significant unobservable inputs were used in the calculation of their fair value. Both of the Mediscan contingent consideration liabilities have been measured at fair value using a discounted cash flow model in a Monte Carlo simulation setting, utilizing significant unobservable inputs, including the expected volatility of the acquisitions' gross profits and an estimated discount rate commensurate with the risks of the expected gross profit stream. In the third quarter of 2017, the Company determined that one of the contingent consideration earnouts related to the Mediscan acquisition would not be achieved for 2017 and, as a result, the entire earnout was reversed. The contingent consideration related to the Company's acquisition of USR was recorded as a liability and measured at fair value using a discounted cash flow model utilizing significant unobservable inputs, including the probability of achieving each of the potential milestones and an estimated discount rate commensurate with the risks of the expected cash flows attributable to the milestones. In the third quarter of 2018, the Company determined that the contingent consideration earnout related to the USR acquisition would not be achieved for 2018 and 2019 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of contingent consideration and the associated liabilities will be adjusted to fair value at each reporting date until actual settlement occurs, with the changes in fair value and related accretion reflected as acquisition-related contingent consideration on the consolidated statements of operations. Significant increases (decreases) in the volatility or in any of the probabilities of success, or decreases (increases) in the discount rate would result in a significantly higher (lower) fair value, respectively, and commensurate changes to these liabilities. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The opening balances of contingent consideration and Convertible Notes derivative liabilities are reconciled to the closing balances for fair value measurements of these liabilities categorized within Level 3 of the fair value hierarchy as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments/Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation loss for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,698</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Items Measured at Fair Value on a Non-recurring Basis</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. During an evaluation of goodwill, trade names, and other intangible assets during the years ended December 31, 2018, 2017, and 2016, the carrying value of goodwill, trade names, and other intangible assets in the Physician Staffing reporting unit exceeded their fair values. As a result, the Company recorded impairment charges that incorporates fair value measurements based on Level 3 inputs. For further discussion on measuring the Company's non-financial assets, specifically goodwill, trade names, and customer relationships, see Note 5 - Goodwill, Trade Names, and Other Intangible Assets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Fair Value Disclosures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments not measured or recorded at fair value in the accompanying consolidated balance sheets consist of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and short and long-term debt. The estimated fair value of accounts receivable, accounts payable, and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. The estimated fair value of the Company&#8217;s debt was calculated using a discounted cash flow analysis and appropriate valuation methodologies using Level 2 inputs from available market information.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br clear="none"/>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,179</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,134</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has invested its excess cash in highly-rated overnight funds and other highly-rated liquid accounts. The Company is exposed to credit risk associated with these investments, as the cash balances typically exceed the current Federal Deposit Insurance Corporation (FDIC) limit of $250,000. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions and diversifying its counterparties.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables based on a review of specific accounts and the Company&#8217;s historical collection experience. The Company writes off specific&#160;accounts based on an ongoing review of collectability as well as past experience with the customer. The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days from the date of invoice and are considered past due based on the particular negotiated contract terms. Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784023696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Benefit Plans</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains a voluntary defined contribution 401(k) profit-sharing plan covering all eligible employees as defined in the plan documents. The plan provides for a discretionary matching contribution, which is equal to a&#160;percentage of each eligible contributing participant&#8217;s elective deferral, which the Company, at its sole discretion, determines from year to year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contributions by the Company, net of forfeitures, under this plan amounted to </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Eligible employees who elect to participate in the plan are generally vested in any existing matching contribution after three years of service with the Company.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers a non-qualified deferred compensation program to certain key employees whereby they may defer a portion of annual compensation for payment upon retirement. The program is unfunded for tax purposes and for purposes of Title I of the Employee Retirement Income Security Act of 1974. The liability for the deferred compensation is included in other long-term liabilities on the consolidated balance sheets and amounted to </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784135568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Commitments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operating Leases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has entered into non-cancelable operating lease agreements for the rental of office space and equipment. Certain of these leases include options to renew as well as rent escalation clauses and in certain cases, incentives from the landlord for rent-free months and premises reductions, and allowances for tenant improvements. The rent escalations and incentives have been reflected in the table below. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, associated with these agreements with terms of one year or more are as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,857</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating lease expense included in selling, general, and administrative expenses was approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$9.4 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$8.4</font><font style="font-family:inherit;font-size:10pt;"> million for the years ending </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sales and Other State Non-income Tax Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Non-income tax expense is included in selling, general and administrative expenses on its consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, on its consolidated balance sheets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Proceedings</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount, or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve a significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments including available insurance recoveries, which would impact its profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require it to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect its financial results. With regard to the outstanding contingencies as of December 31, 2018, the Company believes the outcome of these matters will not have a material adverse effect on its business, financial condition, results of operations or cash flows.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6703048992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">he components of the Company's (loss) income before income taxes are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,826</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,309</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,236</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The components of the Company&#8217;s income tax benefit are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(273</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(689</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,136</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,137</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,245</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,114</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,812</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,322</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Tax Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued other and prepaid expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">607</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">624</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating&#160;loss carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,952</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,729</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">189</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,415</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,661</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,585</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred Tax Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax on unrepatriated earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,571</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,471</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,655</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,114</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the 2017 Tax Act was signed into legislation which, among other changes, reduced the corporate federal income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> effective for the Company's year ended December 31, 2018. The Company recorded income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;">, primarily due to a re-measurement of its deferred tax assets and liabilities in the fourth quarter of 2017. The impact of the Global Intangible Low-Taxed Income provision, the transition tax on the deemed repatriation of deferred foreign income, and any future tax impact associated with basis differences on foreign subsidiaries were immaterial. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Securities and Exchange Commission (SEC) staff issued Staff Accounting Bulletin No. 118 (SAB 118), which provided guidance on accounting for the tax effects of the 2017 Tax Act. SAB 118 provided a measurement period that should not extend beyond one year from the enactment date for companies to complete the accounting required under the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC. In accordance with SAB 118, the Company provided a provisional amount with regard to certain foreign tax provisions in 2017. In 2018, the Company revised its estimate with regard to the 2017 Tax Act and recorded </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of tax expense.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2016, the Company determined that it could not sustain a conclusion that it was more likely than not that it would realize any of its deferred tax assets resulting from recent losses, the difficulty of forecasting future taxable income, and other factors, and as a result, the Company had a valuation allowance on its deferred tax assets, exclusive of indefinite-lived intangible deferred tax liabilities.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the year ended December 31, 2017, predominantly on the basis of a reassessment of the amount of its deferred tax assets that are more likely than not to be realized, the Company reduced its valuation allowance by </font><font style="font-family:inherit;font-size:10pt;">$45.4 million</font><font style="font-family:inherit;font-size:10pt;"> (comprised of </font><font style="font-family:inherit;font-size:10pt;">$15.7 million</font><font style="font-family:inherit;font-size:10pt;"> related to U.S. net operating losses, </font><font style="font-family:inherit;font-size:10pt;">$4.4 million</font><font style="font-family:inherit;font-size:10pt;"> related to state net operating losses, and </font><font style="font-family:inherit;font-size:10pt;">$25.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to other net deferred tax assets). The valuation allowance on a portion of state net operating losses not more likely than not realizable was not released after analysis of respective expiration periods and specific state taxable income projections.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 31, 2018, the Company continues to maintain a valuation allowance of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> on a portion of state net operating losses not more likely than not realizable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$185.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$166.1 million</font><font style="font-family:inherit;font-size:10pt;"> of federal, state, and foreign net operating loss carryforwards. The carryforwards will expire as follows: federal between </font><font style="font-family:inherit;font-size:10pt;">2032</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2037</font><font style="font-family:inherit;font-size:10pt;">, state between </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2038</font><font style="font-family:inherit;font-size:10pt;">, and foreign between </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2023</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation of income tax computed at the U.S. federal statutory rate to income tax&#160;benefit is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax at U.S. statutory rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,506</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,591</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(543</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(252</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(455</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(260</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible items (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,676</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uncertain tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,090</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Return to provision</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,011</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(831</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Includes non-deductible meals and incidentals, miscellaneous non-deductible items, and beginning in 2018, non-deductible stock-based compensation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax years 2008 and 2010 through 2017 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax. During 2018, the Company accrued </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> of India tax on earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">. India withholding taxes on a dividend of India earnings are not affected by the calculation of U.S. taxes due and continue to be accrued. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,071</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to the current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reductions based on settlements of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Tax Act federal tax rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term unrecognized tax benefits are included in other current liabilities on the consolidated balance sheets and were </font><font style="font-family:inherit;font-size:10pt;">$0.1</font><font style="font-family:inherit;font-size:10pt;"> million as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016. Long-term unrecognized tax benefits are included in other long-term liabilities on the consolidated balance sheets and were </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, respectively. See Note 7 - Balance Sheet Details. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, the Company had unrecognized tax benefits, which would affect the effective tax rate if recognized, of </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$4.9</font><font style="font-family:inherit;font-size:10pt;"> million, respectively. During </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had gross increases of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> to its current year unrecognized tax benefits, related to federal and state tax positions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. During the year ended December 31, 2017, the Company recognized a decrease in interest and penalties of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">, related to statute expirations. The Company has accrued </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$0.2</font><font style="font-family:inherit;font-size:10pt;"> million, and </font><font style="font-family:inherit;font-size:10pt;">$0.5</font><font style="font-family:inherit;font-size:10pt;"> million for the payment of interest and penalties at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and 2016, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784135568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders&#8217; Equity</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Repurchase Programs</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under an authorized share repurchase program, during the year ended December 31, 2018, the Company repurchased and retired </font><font style="font-family:inherit;font-size:10pt;">432,439</font><font style="font-family:inherit;font-size:10pt;"> shares of its Common Stock for </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">, at an average market price of </font><font style="font-family:inherit;font-size:10pt;">$11.54</font><font style="font-family:inherit;font-size:10pt;"> per share. During the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not repurchase any shares of its Common Stock under this program. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company has </font><font style="font-family:inherit;font-size:10pt;">510,004</font><font style="font-family:inherit;font-size:10pt;"> shares of Common Stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Amended and Restated Credit Agreement. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shares Issued</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 17, 2017, the Company issued </font><font style="font-family:inherit;font-size:10pt;">3,175,584</font><font style="font-family:inherit;font-size:10pt;"> shares to its prior Convertible Notes noteholders. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Payments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2014 Omnibus Incentive Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's 2014 Omnibus Incentive Plan (2014 Plan) provides for the issuance of stock options, stock appreciation rights, restricted stock, performance shares, and performance-based cash awards that may be granted with the intent to comply with the &#8220;performance-based compensation&#8221; exception under Section 162(m) of the Internal Revenue Code, and other stock-based awards, all as defined by the 2014 Plan, to eligible employees, consultants and non-employee Directors. On May 23, 2017, the Company's shareholders approved an amendment and restatement of its 2014 Plan (2017 Plan) which, among others, included the following modifications: (i) a </font><font style="font-family:inherit;font-size:10pt;">2,000,000</font><font style="font-family:inherit;font-size:10pt;"> share increase of the aggregate share reserve to </font><font style="font-family:inherit;font-size:10pt;">6,100,000</font><font style="font-family:inherit;font-size:10pt;"> shares, (2) extension of the 2014 Plan until May 23, 2027, and (3) re-approval of the Section 162(m) performance goals so that certain incentive awards granted to certain executive officers of the Company may qualify as exempt performance-based compensation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the 2017 Plan, the Compensation Committee of the Company&#8217;s Board of Directors (the Committee), has the discretion to determine the terms of the awards at the time of the grant provided, however, that in the case of stock options and stock appreciation rights (share options): 1) the exercise price per share of the award is not less than </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> (or, in the case of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more stockholders, the exercise price of the incentive stock options (ISOs) granted may not be less than </font><font style="font-family:inherit;font-size:10pt;">110%</font><font style="font-family:inherit;font-size:10pt;">) of the fair market value of the common stock at the time of the grant; and 2) the term of the award will be no more than </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years after the date the option is granted (or, shall not exceed </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years, in the case of a </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more stockholder). In the case of restricted stock, the purchase price may be zero to the extent permitted by applicable law.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted stock awards granted under the Company&#8217;s 2017 Plan entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. The shares vest ratably over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> year period ending on the anniversary date of the grant, and vesting is subject to the employee's continuing employment. There is no partial vesting and any unvested portion is forfeited. Pursuant to the 2017 Plan, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515,601</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(219,881</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,062</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589,120</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">365,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 31, 2018 and 2017, the Company awarded performance stock awards totaling </font><font style="font-family:inherit;font-size:10pt;">238,328</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">181,067</font><font style="font-family:inherit;font-size:10pt;">, respectively. If the minimum level of performance is attained for the </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and 2017 awards, restricted stock will be issued with a vesting date of March 31, 2021 and 2020, respectively. The level of attainment will be certified within 30 days of the vest date. During the first quarter of 2017, the Company's Compensation Committee of the Board of Directors approved a </font><font style="font-family:inherit;font-size:10pt;">48%</font><font style="font-family:inherit;font-size:10pt;"> level of attainment for the 2016 performance-based share awards, resulting in the issuance of </font><font style="font-family:inherit;font-size:10pt;">66,692</font><font style="font-family:inherit;font-size:10pt;"> performance shares that vested on December 31, 2018.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> pre-tax of total unrecognized compensation cost related to non-vested restricted stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.45 years</font><font style="font-family:inherit;font-size:10pt;">. The fair value of shares vested was approximately </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$3.7</font><font style="font-family:inherit;font-size:10pt;"> million, and </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had approximately </font><font style="font-family:inherit;font-size:10pt;">$0.3</font><font style="font-family:inherit;font-size:10pt;"> million pre-tax of total unrecognized compensation cost related to performance stock awards which may be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">1.87 years</font><font style="font-family:inherit;font-size:10pt;">, the remaining service period. The fair value of shares vested was approximately </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;"> for the years ended December&#160;31, 2018, 2017, and 2016, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the years ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company did not issue stock options or stock appreciation rights. The following table represents information about stock options and stock appreciation rights exercised in each year. </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total intrinsic value of options exercised</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The stock appreciation rights can only be settled with stock or cash, at the discretion of the Committee. The stock appreciation rights vest </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> per year over a </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> year period and expire after </font><font style="font-family:inherit;font-size:10pt;">7</font><font style="font-family:inherit;font-size:10pt;"> years. The Company&#8217;s policy is to issue new shares from its authorized but unissued balance of common stock outstanding or shares of common stock reacquired by the Company if stock appreciation rights are settled with stock.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded compensation expense for stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Due to the adoption of the 2014 Plan (previously titled the 2007 Stock Incentive Plan), no further grants have been issued under the Company&#8217;s 1999 Plans referred to below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">1999 Stock Option Plan and Equity Participation Plan</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December&#160;16, 1999, the Company&#8217;s Board of Directors approved the 1999 Stock Option Plan and Equity Participation Plan (collectively, the 1999 Plans), which was amended and restated on October&#160;25, 2001 and provided for the issuance of ISOs and non-qualified stock options to eligible employees and non-employee directors for the purchase of up to </font><font style="font-family:inherit;font-size:10pt;">4,398,001</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company&#8217;s activities with respect to all of its share option plans (issued under the 2014 Plan and the 1999 Plan) for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Option Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-<br clear="none"/>Average<br clear="none"/>Remaining<br clear="none"/>Contractual<br clear="none"/>Life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate<br clear="none"/>Intrinsic<br clear="none"/>Value (amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding, January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited/expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding and exercisable, December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.35-$5.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">51,500</font><font style="font-family:inherit;font-size:10pt;"> share options outstanding, all of which were vested at a weighted average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$4.87</font><font style="font-family:inherit;font-size:10pt;">, intrinsic value of </font><font style="font-family:inherit;font-size:10pt;">$0.1</font><font style="font-family:inherit;font-size:10pt;"> million, and a weighted average contractual life of </font><font style="font-family:inherit;font-size:10pt;">1.02</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791134272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,383</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,626</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,246</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.01</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years 2018, 2017, and 2016, no tax benefits were assumed in the weighted average share calculation due to the Company's net operating loss position.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the securities that could potentially dilute net income per share attributable to common shareholders in the future that were not included in the computation of diluted net income per share attributable to common shareholders because to do so would have been anti-dilutive for the periods presented.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783995984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Related Party Transactions</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides services to hospitals which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes services with related parties were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Accounts receivable due from these hospitals at </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> were less than </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> and approximately </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the acquisition of MSN, the Company acquired a </font><font style="font-family:inherit;font-size:10pt;">68%</font><font style="font-family:inherit;font-size:10pt;"> ownership interest in Cross Country Talent Acquisition Group, LLC (formerly InteliStaf of Oklahoma, LLC), a joint venture between the Company and a hospital system. The Company generated revenue providing staffing services to the hospital system of </font><font style="font-family:inherit;font-size:10pt;">$19.4 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;"> in 2018, 2017, and 2016, respectively. At </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and 2017, the Company had a receivable balance of </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a payable balance of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> at both periods.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to the Company's acquisition of Mediscan on October 30, 2015, Mediscan continued to operate at premises owned, in part, by the founding members of Mediscan. The Company paid </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> in 2018, </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> in 2017, and 2016 for rent for these premises. In the fourth quarter of 2018, the Company vacated the premises.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791140400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Data</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Data</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, the Company reports </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> business segments &#8211; Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Company manages and segments its business based on the services it offers to its customers as described below:&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Nurse and Allied Staffing - </font><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added workforce solutions including: temporary and permanent placement of travel and local branch-based nurse and allied professionals, MSP services, education healthcare services, and outsourcing services. Its clients include: public and private acute care and non-acute care hospitals, government facilities, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and many other healthcare providers throughout the United States. Substantially all of the results of the Advantage and AP Staffing acquisitions have been aggregated with the Company's Nurse and Allied Staffing business segment. See Note 4 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Physician Staffing -</font><font style="font-family:inherit;font-size:10pt;"> Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Human Capital Management Services -</font><font style="font-family:inherit;font-size:10pt;"> Other Human Capital Management Services includes retained and contingent search services for physicians, healthcare executives, and other healthcare professionals within the United States.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income or loss from operations before depreciation and amortization, acquisition and integration costs, acquisition-related contingent consideration, restructuring costs, impairment charges, applicant tracking system costs, and corporate expenses not specifically identified to a reporting segment. Contribution income is a financial measure used by management when assessing segment performance and is provided in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC. The Company&#8217;s management does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,610</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,365</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,614</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,589</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges (b)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;padding-left:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been centralizing administrative functions to gain efficiencies, which have been recorded in unallocated corporate overhead, which includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:37px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:13px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783903168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Data (Unaudited)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables contain selected unaudited statements of operations information for each quarter of 2018 and 2017. The following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br clear="none"/>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">210,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">204,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,907</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(118</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,343</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,642</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,539</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Diluted (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br clear="none"/>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">207,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">209,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228,488</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56,528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,480</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,718</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,044</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Excludes depreciation and amortization.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(b) The sum of the quarterly per share amounts may not equal amounts reported for year-to-date due to the effects of rounding                       and changes in the number of weighted average shares outstanding used in the calculation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following items are the most significant items that impact the comparability and presentation of our consolidated data:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018 and 2017, the Company recorded non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$22.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$14.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the goodwill and trade names of Physician Staffing. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company settled its Convertible Notes and recognized a loss on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 8 - Debt.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2018, the Company acquired AP Staffing and on July 1, 2017, the Company acquired all of the assets of Advantage. The acquisitions have been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">using the acquisition method. The results of the acquisitions' operations have been included in the consolidated statements of operations from their dates of acquisition. See Note 4 - Acquisitions. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, the Company benefited from a </font><font style="font-family:inherit;font-size:10pt;text-transform:default;">$43.3 million</font><font style="font-family:inherit;font-size:10pt;"> reversal of valuation allowance on its net deferred tax assets, offset by additional income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to the remeasurement of its deferred tax assets as a result of the 2017 Tax Act. See Note 13 - Income Taxes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded changes in the fair value of Convertible Notes derivative liability, recording a gain in the first quarter of 2017 of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 9 - Derivatives.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791042912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Schedule II</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CROSS COUNTRY HEALTHCARE, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">VALUATION AND QUALIFYING ACCOUNTS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOR THE YEARS ENDED DECEMBER&#160;31, 2018, 2017, AND 2016</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at<br clear="none"/>Beginning<br clear="none"/>of Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Charged to Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Write-Offs, net of recoveries</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other<br clear="none"/>Changes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at<br clear="none"/>End<br clear="none"/>of Period</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Allowances for Accounts Receivable</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,688</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,974</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,245</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,705</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,262</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,688</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,045</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,034</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,245</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;text-decoration:underline;">Valuation Allowance for Deferred Tax Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">113</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,189</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(43,333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(c)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Year Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55,336</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,894</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,454</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uncollectible accounts written off, net of recoveries.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Release of valuation allowances on the Company&#8217;s deferred tax assets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance on deferred tax asset related to share-based compensation.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786568800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles (U.S. GAAP), requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions are used for, but not limited to: (1) the valuation of accounts receivable; (2) goodwill, trade names, and other intangible assets; (3) other long-lived assets; (4) share-based compensation; (5) accruals for health, workers&#8217; compensation, and professional liability claims; (6) valuation of deferred tax assets; (7) purchase price allocation; (8) fair value of interest rate swap agreement; (9) legal contingencies; (10) contingent considerations; (11) income taxes; and (12) sales and other non-income tax liabilities. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. Actual results could differ from those estimates.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers all investments with original maturities of three months or less to be cash and cash equivalents. The Company invests its excess cash in highly rated overnight funds and other highly rated liquid accounts. The Company is exposed to credit risk associated with these investments. The Company minimizes its credit risk relating to these positions by monitoring the financial condition of the financial institutions involved and by primarily conducting business with large, well established financial institutions, and diversifying its counterparties. The Company does not currently anticipate nonperformance by any of its significant counterparties.</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Interest income on cash and cash equivalents of </font><font style="font-family:inherit;font-size:9.75pt;">$0.4 million</font><font style="font-family:inherit;font-size:9.75pt;"> for the year ended December 31, 2018, and </font><font style="font-family:inherit;font-size:9.75pt;">$0.1 million</font><font style="font-family:inherit;font-size:9.75pt;"> for the years ended December 31, 2017 and 2016, is included in other income, net, on the Company&#8217;s consolidated statements of operations.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable, Allowance for Doubtful Accounts, and Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Accounts receivable potentially subject the Company to concentrations of credit risk. The Company&#8217;s customers are primarily healthcare providers, and accounts receivable represent amounts due from them. The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts represents the Company&#8217;s estimate of uncollectible receivables resulting from the inability of its customers to make required payments, which results in a provision for bad debt expense. The adequacy of this allowance is determined by continually evaluating individual customer receivables, considering the customer's financial condition, credit history, and current economic conditions. The Company writes off specific</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">accounts based on an ongoing review of collectability as well as past experience with the customer. </font><font style="font-family:inherit;font-size:10pt;">In addition, the Company maintains a sales allowance for customer disputes which may arise in the ordinary course, which is recorded as contra-revenue. Historically, losses on uncollectible accounts and sales allowances have not exceeded our allowances.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s contract terms typically require payment between </font><font style="font-family:inherit;font-size:9.75pt;">15</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">60</font><font style="font-family:inherit;font-size:9.75pt;"> days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's business activity is with hospitals located throughout the United States.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PrepaidRentAndDepositsPolicyTextBlock', window );">Prepaid Rent and Deposits</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Prepaid Rent and Deposits</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company leases apartments for eligible field employees under short-term agreements (typically </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">six</font><font style="font-family:inherit;font-size:9.75pt;"> months), which generally coincide with each employee&#8217;s staffing contract. Costs relating to these leases are included in direct operating expenses on the accompanying consolidated statements of operations. As a condition of these agreements, the Company may place security deposits on the leased apartments. Deposits on field employees&#8217; apartments related to these short-term agreements are included in other current assets on the accompanying consolidated balance sheets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property and Equipment</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined on a straight-line basis over the estimated useful lives of the assets, which generally range from </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">seven</font><font style="font-family:inherit;font-size:9.75pt;"> years. Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the individual lease. On an annual basis, the Company reviews its property and equipment listings and disposes of assets that are no longer in use. </font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Certain software development costs have been capitalized in accordance with the provisions of the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other/Internal-Use Software</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). Such costs include charges for consulting services and costs for Company personnel associated with programming, coding, and testing such software. Amortization of capitalized software costs begins when the software is ready for use and is included in depreciation expense in the accompanying consolidated statements of operations. Software development costs are being amortized using the straight-line method over </font><font style="font-family:inherit;font-size:9.75pt;">three</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">five</font><font style="font-family:inherit;font-size:9.75pt;"> years.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company applies accounting in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Business Combinations</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC when it acquires control over a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded as acquisition and integration costs; noncontrolling interests, if any, are reflected at fair value at the acquisition date; restructuring costs associated with a business combination are expensed; contingent consideration is measured at fair value at the acquisition date, with changes in the fair value after the acquisition date affecting earnings; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the consolidated statements of operations of the combined entity beginning on the date of acquisition. See Note 4 - Acquisitions.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill, Trade Names, and Other Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill, Trade Names, and Other Intangible Assets</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Goodwill represents the excess of purchase price and related costs over the fair value assigned to the net tangible and identifiable intangible assets of businesses acquired. Other identifiable intangible assets with definite lives are being amortized using the straight-line method over their estimated useful lives which range from </font><font style="font-family:inherit;font-size:9.75pt;">1</font><font style="font-family:inherit;font-size:9.75pt;"> to </font><font style="font-family:inherit;font-size:9.75pt;">16</font><font style="font-family:inherit;font-size:9.75pt;"> years. Goodwill and certain intangible assets with indefinite lives are not amortized. Instead, in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC, these assets are reviewed for impairment annually at the beginning of the fourth quarter, and whenever circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">When reviewed, the Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, as a basis for determining whether it is necessary to perform the quantitative testing. If it is determined that a quantitative test is necessary or more efficient than a qualitative approach, the Company generally measures the fair value of its reporting units using a combination of income and market approaches.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">For the periods prior to the fourth quarter of 2017, the performance of the quantitative impairment test involved a two-step process. The first step required the Company to determine the fair value of each of its reporting units and compare it to the reporting unit&#8217;s carrying amount. If the reporting unit's fair value was less than its carrying amount, the Company was required to perform a second step to calculate the implied value of goodwill. The implied value was then compared to its carrying amount to calculate the impairment charge, if any. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Beginning in the fourth quarter of 2017, for its annual review on October, 1, 2017, the Company early adopted the provisions of Accounting Standards Update (ASU) 2017-04, </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. </font><font style="font-family:inherit;font-size:9.75pt;">Under ASU 2017-04, the second step of the quantitative assessment is eliminated, and, if the reporting unit&#8217;s carrying value exceeds its fair value, an impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value not to exceed the total amount of goodwill allocated to that reporting unit. Additionally, income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss is considered, if applicable.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company determines its reporting units by identifying its operating segments and any component businesses and aggregates the components businesses if they have similar economic characteristics. The Company had the following reporting units that it reviewed for impairment: 1) Nurse and Allied Staffing; 2) Physician Staffing; and 3) Search.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. However, fair values that could be realized in an actual transaction may have differed from those used to evaluate the potential impairment of goodwill.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Long-lived assets and identifiable intangible assets with definite lives are evaluated for impairment in accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Property, Plant, and Equipment</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC. In accordance with this Topic, long-lived assets and definite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Recoverability of long-lived assets is measured by a comparison of the carrying amount of the asset group to the future undiscounted net cash flow that is expected to be generated by those assets. If such assets are considered to be impaired, the impairment charge recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. </font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Any related impairment losses are recognized in earnings and included in the caption impairment charges on the consolidated statements of operations. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Discount and Debt Issuance Costs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Debt Discount and Debt Issuance Costs </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Stated discounts on proceeds, and other fees reimbursed to lender, as well as the initial value of any embedded derivative features of the Convertible Notes and Term Loans, as defined in Note 8 - Debt, are treated as a discount associated with the respective debt instrument and presented in the balance sheet as an offset to the carrying amount of the debt. Discounts are amortized to interest expense using the effective interest rate method, or a method that approximates the effective interest rate method, over the expected life of the debt.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Convertible Notes and the Term Loans were capitalized and are presented in the balance sheet as a direct deduction from the carrying amount of the debt liability. Deferred costs are amortized using the effective interest method. Deferred costs related to the Convertible Notes were written off in connection with the repayment of such Convertible Notes. See Note 8 - Debt. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred costs related to the issuance of the Company&#8217;s Revolving Credit Facilities, as defined in Note 8 - Debt, have been capitalized and included in other assets on the consolidated balance sheets, and amortized using the straight line method over the term of the related credit agreement.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to interest rate risk due to its outstanding senior secured term loan entered into on August 1, 2017 with a variable interest rate. As a result, the Company has entered into an interest rate swap agreement to effectively convert a portion of its variable interest payments to a fixed rate. The principal objective of the interest rate swap is to eliminate or reduce the variability of the cash flows in those interest payments associated with the Company&#8217;s long-term debt, thus reducing the impact of interest rate changes on future interest payment cash flows. The Company has determined that the interest rate swap qualifies as a cash flow hedge in accordance with ASC 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">. As the critical terms of the hedging instrument and the hedged forecasted transaction are the same, the Company has concluded that changes in the cash flows attributable to the risk being hedged are expected to completely offset at inception and on an ongoing basis. Changes in the fair value of an interest rate swap agreement designated as a cash flow hedge are recorded as a component of accumulated other comprehensive income (loss), net of deferred taxes, within stockholders&#8217; equity and are amortized to interest expense over the term of the related debt as the interest payments are made. Interest rate swap payments are included in net cash provided by operating activities on the Company&#8217;s consolidated statement of cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with entering into the interest rate swap agreement, the Company early adopted ASU 2017-12, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative and Hedging (Topic 815) </font><font style="font-family:inherit;font-size:10pt;">to simplify the application of hedge accounting. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates embedded conversion features within its convertible debt in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC to determine whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value. Changes in the fair value of these derivatives during each reporting period were reported in other expenses (income) on the consolidated statements of operations. The fair value at inception had been recorded as debt discount and was being amortized to interest expense over the term of the note using the effective interest method. On March 17, 2017, the Company paid in full its Convertible Notes and, as a result, derecognized the derivative liability. See Note 8 - Debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock', window );">Sales and Other State Non-income Tax Liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Sales and Other State Non-income Tax Liabilities</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company accrues sales and other state non-income tax liabilities based on the Company&#8217;s best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company&#8217;s business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityReserveEstimatePolicy', window );">Insurance Claims</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Insurance Claims</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company provides workers&#8217; compensation insurance coverage, professional liability coverage, and healthcare benefits for eligible employees. The Company records its estimate of the ultimate cost of, and reserves for, workers' compensation and professional liability benefits based on actuarial models prepared or reviewed by an independent actuary using the Company&#8217;s loss history as well as industry statistics. The healthcare insurance accrual is for estimated claims that have occurred but have not been reported and is based on the Company&#8217;s historical claim submission patterns. Furthermore, in determining its reserves, the Company includes reserves for estimated claims incurred but not reported as well as unfavorable claims development.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Other Expenses/Insurance Costs</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC previously issued authoritative accounting guidance in the area of insurance contracts and related activity thereto. This topic concluded that, under circumstances such as in the Company&#8217;s insured professional liability and workers' compensation policies, since a right of legal offset does not exist due to the fact that there are three parties to an incurred claim, the insured, the insurer, and the claimant, the related liability to the claimant should be classified separately on a gross basis with a separate related receivable from the insurer recognized as being due from insurance carriers. Accordingly, the Company&#8217;s consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;"> reflect the related short-term liabilities in accrued compensation and benefits and the related</font><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">&#160;</font><font style="font-family:inherit;font-size:9.75pt;">long-term liabilities as long-term accrued claims, and the short-term receivable portion as insurance recovery receivable and the long-term portion as non-current insurance recovery receivable. See Note 7 - Balance Sheet Details. The ultimate cost of workers&#8217; compensation, professional liability, and health insurance claims will depend on actual amounts incurred to settle those claims and may differ from the amounts reserved by the Company for those claims.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Workers&#8217; compensation benefits are provided under a partially self-insured plan. The Company has letters of credit to guarantee payments of claims. At </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the Company had outstanding approximately </font><font style="font-family:inherit;font-size:9.75pt;">$18.8 million</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">$19.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, respectively, of standby letters of credit as collateral to secure the self-insured portion of this plan.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has occurrence-based primary professional liability policies that provide the Company and each working professional in its nurse and allied healthcare business with coverage. Effective January 1, 2016, the Company has a claims-made professional liability policy for its physicians and advanced practitioners, with a </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;"> self-insured retention per claim. Prior to January 1, 2016, the Company had an occurrence-based professional liability policy for its independent contractor physicians and advanced practitioners which was insured by a wholly-owned subsidiary, Jamestown Indemnity, Ltd., a wholly-owned Cayman Island captive company (the Captive), until its voluntary liquidation in the third quarter of 2015. Beginning in March 2015, the Company's Physician subsidiary self-insured </font><font style="font-family:inherit;font-size:9.75pt;">$0.5 million</font><font style="font-family:inherit;font-size:9.75pt;"> for each of its professional liability claims. Under the terms of the Captive&#8217;s reinsurance policy there was a requirement to guarantee the payment of claims to its insured party&#8217;s primary medical malpractice insurance carrier via a letter of credit. As a result of the Captive's liquidation, the letter of credit was reduced. As of </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, the value of the letter of credit was </font><font style="font-family:inherit;font-size:9.75pt;">$1.8 million</font><font style="font-family:inherit;font-size:9.75pt;"> and </font><font style="font-family:inherit;font-size:9.75pt;">$2.0</font><font style="font-family:inherit;font-size:9.75pt;"> million, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Subject to certain limitations, the Company also has umbrella liability coverage for its working nurses and allied healthcare professionals. While this umbrella coverage does not extend to professional liability claims against its independent contractor physicians and advanced practitioners, it does cover claims brought against all of the Company&#8217;s subsidiaries for non-patient general liability.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of 2018, the Company adopted ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">. ASU 2014-09 introduces a new five-step revenue recognition model in which an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new standard also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts. See Note 3 - Revenue Recognition for additional accounting policy and related disclosures. The Company elected to adopt the standard using a modified retrospective method, which only impacts contracts not completed as of December 31, 2017.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from the Company&#8217;s services is recognized when control of the promised services are transferred to the Company&#8217;s customers, in an amount that reflects the consideration it expects to receive in exchange for the service. The Company has concluded that transfer of control of its staffing services, which represents the majority of its revenues, occurs over time as the services are provided, which is consistent with revenue recognition under the prior guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a description of the nature, amount, timing, and uncertainty of revenue and cash flows from which the Company generates revenue.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Temporary Staffing Revenue</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from temporary staffing is recognized as control of the services is transferred over time, and is based on hours worked by the Company&#8217;s field staff. The Company recognizes the majority of its revenue at the contractual amount the Company has the right to invoice for services completed to date. Generally, billing to customers occurs weekly, bi-weekly, or monthly and is aligned with the payment of services to the temporary staff, with payment terms of </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">60</font><font style="font-family:inherit;font-size:10pt;"> days. Accounts receivable includes estimated revenue for employees&#8217; and independent contractors&#8217; time worked but not yet invoiced. At December 31, 2018 and December 31, 2017, the Company's estimate of amounts that had been worked but had not been billed totaled </font><font style="font-family:inherit;font-size:10pt;">$44.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$41.8 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, and are included in accounts receivable on the consolidated balance sheets.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Service Revenue</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company offers other optional services to its customers that are transferred over time including: managed service programs (MSP) providing agency services (as further described below in Gross versus Net Policies), recruitment process outsourcing (RPO), other outsourcing services, and retained search services, which is less than </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> of its consolidated revenue for the years ended December 31, 2018, 2017, and 2016. Generally, billing and payment terms for MSP agency services is consistent with temporary staffing as the customers are similar or the same. Revenue from these services are recognized based on the contractual amount for services completed to date which best depicts the transfer of control of services.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s RPO, other outsourcing, and retained search services, revenue is generally recognized in the amount to which the entity has a right to invoice which corresponds directly with the value to the customer. The Company does not, in the ordinary course of business, offer warranties or refunds.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Gross Versus Net Policies</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company records revenue on a gross basis as a principal or on a net basis as an agent depending on the contracted arrangement, as follows:</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Managed Service Programs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has certain contracts with healthcare facilities to provide comprehensive services through its MSPs. Under these contractual arrangements, the customer&#8217;s orders are filled with either one of the Company's healthcare professionals or a third party's healthcare professionals (subcontractors).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When its healthcare professional is staffed, the Company determined that it acts as a principal in the arrangement, as it is considered the employer of record. Accordingly, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Alternatively, the Company determined that it acts as an agent in the arrangement when a subcontracted healthcare professional is staffed, as the Company does not control the services before they are transferred to the customer. Accordingly, revenue is reported on a net basis on the consolidated statements of operations. The customer is invoiced for the hours worked by the subcontracted healthcare professional multiplied by the hourly bill rate. A subcontractor liability, which is recognized as a reduction of revenue, is established in accrued expenses for the invoiced amount, net of an administrative fee, and is generally payable after the Company has received payment from its customer. The Company&#8217;s administrative fee is calculated as a percentage of the customer&#8217;s invoice and is recognized over time as the services are rendered by the subcontracted healthcare professional. The Company does not collect or recognize an upfront placement fee.</font></div><div style="line-height:174%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Physician Staffing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Physician Staffing business has contracts with its healthcare customers to provide temporary staffing services. The Company uses independent contractors for these services. The Company determined that it acts as a principal in these arrangements and, therefore, revenue is reported on a gross basis on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 3 - Revenue Recognition for the Company's revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenue.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contract Costs</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All contract fulfillment costs are expensed as incurred to direct operating expenses. With respect to FASB ASC 606, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, there were no contract assets or material contract liabilities as of December 31, 2018 and 2017.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Practical Expedients and Exemptions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Company&#8217;s contracts that have an original duration of one year or less, the Company uses the practical expedients and has elected to recognize any incremental costs of obtaining these contracts as expensed when incurred. Further, the Company does not disclose the value of unsatisfied performance obligations for: (i) contracts with an original expected length of one year or less, and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company has, from time to time, granted stock options, stock appreciation rights, performance-based stock awards, and restricted stock for a fixed number of common shares to employees. In accordance with the </font><font style="font-family:inherit;font-size:9.75pt;font-style:italic;">Compensation-Stock-Compensation</font><font style="font-family:inherit;font-size:9.75pt;"> Topic of the FASB ASC, companies may choose from alternative valuation models. The Company used the Black-Scholes method of valuing its options and stock appreciation rights. The Company has elected to recognize compensation expense on a straight-line basis over the requisite service period of the entire award. The Company values its restricted stock awards and the fair value of its performance-based stock awards by reference to its stock price on the date of grant.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company granted performance-based stock awards to certain key personnel pursuant to its 2014 Omnibus Incentive Plan, amended and restated on May 23, 2017 (2017 Plan) as described in Note 14 - Stockholders' Equity. Pursuant to the plan, the number of target shares that vest are determined based on the level of attainment of the targets.&#160;If a minimum level of performance is attained for the awards, restricted stock is issued based on the level of attainment. The Company recognizes performance-based restricted stock as compensation expense based on the most likely probability of attaining the prescribed performance and over the requisite service period beginning at its grant date and through the date the restricted stock vests.</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9.75pt;">Compensation expense related to share-based payments is included in selling, general and administrative expenses in the consolidated statements of operations, and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$3.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$4.1</font><font style="font-family:inherit;font-size:9.75pt;"> million, and </font><font style="font-family:inherit;font-size:9.75pt;">$3.4</font><font style="font-family:inherit;font-size:9.75pt;"> million, during the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively. See Note 14 </font><font style="font-family:inherit;font-size:10pt;">-</font><font style="font-family:inherit;font-size:9.75pt;"> Stockholders&#8217; Equity.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company&#8217;s advertising expense consists primarily of online advertising, internet direct marketing, print media, and promotional material. Advertising costs are expensed as incurred and totaled </font><font style="font-family:inherit;font-size:9.75pt;">$6.7 million</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">$7.6 million</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">$10.2</font><font style="font-family:inherit;font-size:9.75pt;"> million, for the years ended </font><font style="font-family:inherit;font-size:9.75pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9.75pt;">, </font><font style="font-family:inherit;font-size:9.75pt;">2017</font><font style="font-family:inherit;font-size:9.75pt;">, and </font><font style="font-family:inherit;font-size:9.75pt;">2016</font><font style="font-family:inherit;font-size:9.75pt;">, respectively.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring Costs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring Costs</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring costs on the consolidated statements of operations include on-going benefit costs for its employees, exit costs, and other costs including write-offs related to abandoned locations.</font></div><div style="line-height:120%;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Deferred Rent</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Rent</font></div><div style="line-height:120%;text-align:justify;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Deferred rent consists of free rent, rent escalation, tenant improvement allowances, and other incentives received from landlords related to the operating leases for our facilities. Rent escalation represents the difference between actual operating lease payments due and straight-line rent expense, which we record over the term of the lease. The excess is recorded as a deferred credit in the early periods of the lease, when cash payments are generally lower than straight-line rent expense, and is reduced in the later periods of the lease when payments begin to exceed the straight-line expense. Tenant allowances from landlords for tenant improvements are generally comprised of cash received from the landlord or paid on our behalf as part of the negotiated terms of the lease. These tenant improvement allowances and other leasehold incentives are recorded when realizable as deferred rent and are amortized as a reduction of periodic rent expense, over the term of the applicable lease. See Note 12 - Commitments and Contingencies.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for income taxes under the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes in its financial statements the impact of a tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains valuation allowances when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In determining whether a valuation allowance is warranted, the Company evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods, and tax strategies. The Company considers all positive and negative evidence to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. It considers cumulative losses in recent years as well as the impact of one-time events in assessing its pre-tax earnings. Assumptions regarding future taxable income require significant judgment. The Company's assumptions are consistent with estimates and plans used to manage its business, which includes restructuring and other initiatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the event that actual results differ from these estimates, or the Company adjusts these estimates in future periods for current trends or changes in its estimating assumptions, it may modify the level of the valuation allowance which could materially impact its business, financial condition and results of operations. The Company will continue to assess the realizability of its deferred tax assets. See Note 13 - Income Taxes.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Comprehensive Income (Loss)</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total comprehensive income (loss) includes net income or loss, foreign currency translation adjustments, and net change in derivative transactions, net of any related deferred taxes. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. In accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:inherit;font-size:10pt;">assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying consolidated balance sheets and was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2018 and </font><font style="font-family:inherit;font-size:10pt;">$1.2</font><font style="font-family:inherit;font-size:10pt;"> million at December&#160;31, 2017. The cumulative impact of net changes in derivative instruments included in other comprehensive loss in the consolidated balance sheets was an unrealized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> at December 31, 2018. See Note 9 - Derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax impact related to components of other comprehensive income for the period ended December 31, 2018 is reflected on the consolidated statements of comprehensive income. During the period ended December 31, 2017, </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> of income tax expense was included in the consolidated statements of operations due to the impact of a change in federal tax rate on the deferred tax asset related to foreign currency cumulative translation. See Note 13 - Income Taxes. There was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> income tax impact related to foreign currency translation adjustments for the period ended December&#160;31, 2016.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company complies with the provisions of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, which defines fair value, establishes a framework for measuring fair value under U.S. GAAP, and expands disclosures about fair value measurements. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s financial assets and liabilities required to be measured on a recurring basis were its deferred compensation liability, its interest rate swap agreements, and its contingent consideration liabilities. See Note 10 - Fair Value Measurements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with the requirements of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:10pt;"> Topic of the FASB ASC, basic earnings per share is computed by dividing net income available to common shareholders (numerator) by the weighted average number of vested unrestricted common shares outstanding during the period (denominator). Diluted earnings per share gives effect to all dilutive potential common shares outstanding during the period including stock appreciation rights and options and unvested restricted stock, as calculated utilizing the treasury stock method, and Convertible Notes using the if-converted method prior to their payment in full in the first quarter of 2017.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. Early adoption is permitted for all entities, including adoption in an interim period. The Company is currently in the process of evaluating the potential impact the adoption of this standard may have and expects to adopt this standard in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU No. 2018-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. </font><font style="font-family:inherit;font-size:10pt;">The amendments in this update modify the disclosure requirements on fair value measurements in Topic 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">, based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments in this update are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, and should be applied either prospectively or retrospectively depending on the nature of the disclosure. An entity is permitted to early adopt any removed or modified disclosures upon issuance of this update and delay adoption of the additional disclosures until their effective date. The Company is currently in the process of evaluating this standard and expects to adopt the full provisions in its first quarter of 2020.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2017, the FASB issued ASU No. 2017-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features, and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception</font><font style="font-family:inherit;font-size:10pt;">. The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception. Those amendments do not have an accounting effect. For public business entities, the amendments in Part I of this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and should be applied retrospectively to outstanding financial instruments with a down round feature by means of either a cumulative-effect adjustment or for each prior reporting period presented. Early adoption is permitted for all entities, including adoption in an interim period. The Company expects to adopt this standard in its first quarter of 2019, and does not expect this guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">, which will require, among other items, lessees to recognize most leases as assets and liabilities on the balance sheet. Qualitative and quantitative disclosures will be enhanced to better understand the amount, timing and uncertainty of cash flows arising from leases. The FASB has issued several other subsequent updates including the following: 1) ASU No. 2018-10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Codification Improvements to Topic 842, Leases</font><font style="font-family:inherit;font-size:10pt;">, which includes sixteen separate narrow-scope amendments to clarify the codification and to correct unintended application of guidance; and 2) ASU No. 2018-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842): Targeted Improvements</font><font style="font-family:inherit;font-size:10pt;">, which provides entities with relief from the costs of implementing certain aspects of the new leasing standard by allowing them to elect not to recast the comparative periods presented when transitioning to ASC 842. The new lease standard, and the subsequent ASUs that modified Topic 842, are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, with early adoption permitted.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With respect to the adoption of the new standard, as of December 31, 2018, the Company had </font><font style="font-family:inherit;font-size:10pt;">$34.6 million</font><font style="font-family:inherit;font-size:10pt;"> of undiscounted future lease payments, primarily related to real estate, that is expected to be included in its initial measurement of its lease liabilities and corresponding right of use asset, and </font><font style="font-family:inherit;font-size:10pt;">$7.2 million</font><font style="font-family:inherit;font-size:10pt;"> of accrued rent that is expected to be reclassified from liability accounts to reduce its beginning right of use asset balance.&#160;The Company does not expect the adoption of ASU 2016-02 to have a material impact on its consolidated statements of operations and statements of cash flows.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PrepaidRentAndDepositsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for prepaid rent and deposits on field employees' apartments related to short-term agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PrepaidRentAndDepositsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for sales and other state non-income tax liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SalesAndOtherStateNonIncomeTaxLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84159346&amp;loc=d3e8275-108329<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054294&amp;loc=d3e8384-108330<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating its liability as of the balance sheet date for the ultimate cost of settling reported and unreported claims incurred and claims adjustment expenses (including effects of inflation and other societal and economic factors).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=2560295<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.13(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e4975-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784190768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of restructuring costs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Reconciliations of the beginning and ending total restructuring liability balances are presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">On-Going Benefit Costs</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;font-weight:bold;">Exit Costs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">338</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Charged to restructuring costs (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">1,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">504</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(1,131</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(235</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(760</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(336</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(282</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">(255</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;background-color:#cceeff;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">390</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">441</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;">273</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9.75pt;"><font style="font-family:inherit;font-size:9.75pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) The restructuring costs on the consolidated statements of operations include direct write-offs of </font><font style="font-family:inherit;font-size:10pt;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> related to abandoned locations, as well as other costs of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787123680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of business acquisitions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is the estimated fair value of the purchase price for Advantage on July 1, 2017:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net working capital adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,438</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of assets acquired and liabilities assumed</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table is an estimate of the fair value of the assets acquired and liabilities assumed on July 1, 2017.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,396</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">392</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,900</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,055</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,395</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro forma information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma financial information approximates the consolidated results of operations of the Company as if the Advantage acquisition had occurred as of January 1, 2016, after giving effect to certain adjustments, including additional interest expense on the amount the Company borrowed on the date of the transaction, the amortization of acquired intangible assets, and the elimination of certain expenses that will not be recurring in post-acquisition periods, net of an estimated income tax impact. These adjustments include removing transaction-related expenses of approximately </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the year ended December 31, 2017. These results are not necessarily indicative of future results as they do not include incremental investments in support functions, elimination of costs for integration or operating synergies, or an estimate of any impact on interest expense resulting from the operating cash flow of the acquired businesses, among other adjustments that could be made in the future but are not factually supportable on the date of the transaction. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.83040935672514%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(unaudited, amounts in thousands except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">916,149</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">934,904</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income attributable to common shareholders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,255</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Net income per common share attributable to common shareholders - diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784021728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has determined that its revenues are generated from temporary staffing services and other services, as disaggregated in the following table. See Note 2 - Summary of Significant Accounting Policies.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the year ended December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse<br clear="none"/>And Allied<br clear="none"/>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician<br clear="none"/>Staffing Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human<br clear="none"/>Capital<br clear="none"/>Management<br clear="none"/>Services Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary Staffing Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76,979</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">782,414</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,326</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,070</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785759408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Acquired Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had the following acquired intangible assets:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets subject to amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Databases</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,314</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,909</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,758</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,524</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,612</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">319</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,183</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">878</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,487</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,305</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,068</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,092</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,976</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets not subject to amortization:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,402</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,702</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,584</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,678</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Annual Amortization Expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, estimated annual amortization expense is as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:82%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,535</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,131</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,780</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,677</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,628</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,182</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in the carrying amount of goodwill by segment are as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nurse and</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Allied Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Physician</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Staffing</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Human</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Services</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate goodwill acquired</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">347,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">410,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,375</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(283,107</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,141</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,030</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117,589</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes to aggregate goodwill in 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charge</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,223</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balances as of December 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Aggregate goodwill acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348,567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,307</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411,279</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of business</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,889</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Accumulated impairment loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(259,732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(300,330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill, net of impairment loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,835</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,418</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,060</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill acquired from the acquisition of AP Staffing. See Note 4 - Acquisitions.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791133232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's property and equipment consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3-5 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,651</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,933</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Office equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,514</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5-7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,966</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,680</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,716</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,764</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,476</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30,678</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,628</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,086</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:61px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:37px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 2 &#8211; Summary of Significant Accounting Policies.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800536640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Balance Sheet Details</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery receivable:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,623</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,891</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,874</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,497</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other non-current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,280</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,093</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance recovery for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,924</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,011</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current security deposits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,095</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current income tax receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">935</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">985</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,076</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,228</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued compensation and benefits:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries and payroll taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,342</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Bonuses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,476</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,454</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,786</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for healthcare benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for vacation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,332</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term accrued claims:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for workers&#8217; compensation claims</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,160</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrual for professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,597</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,299</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-current deferred tax liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred rent</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,039</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term unrecognized tax benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">590</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">485</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,767</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 3<br> -Paragraph i<br> -Subsection 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791256672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's long-term debt consists of the following:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Principal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt Issuance Costs</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,235</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,641</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(697</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,125</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subject to the Amended and Restated Credit Agreement, the Company pays interest on: (i) each Base Rate Loan at the Base Rate (as defined therein) plus the Applicable Margin in effect from time to time; (ii) each LIBOR Index Rate Loan at the One Month LIBOR Index Rate (as defined therein) plus the Applicable Margin in effect from time to time; and (iii) each Eurodollar Loan at the Adjusted LIBOR for the applicable Interest Period (as defined therein) in effect for such Loan plus the Applicable Margin in effect from time to time. The Applicable Margin, as of any date, is a percentage per annum determined by reference to the applicable Consolidated Net Leverage Ratio (as defined by the agreement) in effect on such date as set forth in the table below.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.9317738791423%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Consolidated Net Leverage Ratio</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Eurodollar Loans, LIBOR Index Rate Loans and Letter of Credit Fee</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Base Rate Loans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitment Fee</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less than 1.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">II</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 1.50:1.00 </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">but less than 2.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.00%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">III</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.00:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 2.50:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.25%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IV</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 2.50:1.00</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;but less than 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.50%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.35%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">V</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than or equal to 3.00:1.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.75%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.40%</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate scheduled maturities of debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the aggregate scheduled maturities of debt are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Term Loan</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Through Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,671</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,980</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65,990</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,876</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784063648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table which follows summarizes the estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Liabilities:</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 1)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 3)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The opening balances of contingent consideration and Convertible Notes derivative liabilities are reconciled to the closing balances for fair value measurements of these liabilities categorized within Level 3 of the fair value hierarchy as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Convertible Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Liability</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments/Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25,951</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation gain for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(922</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(280</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accretion expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation loss for the period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,698</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,689</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br clear="none"/>Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair<br clear="none"/>Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Level 2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,179</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,134</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784148560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future Minimum Lease Payments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, associated with these agreements with terms of one year or more are as follows:&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Years Ending December&#160;31:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,451</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,287</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,857</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,893</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800983824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of Income (Loss) Before Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of the Company's (loss) income before income taxes are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,826</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,309</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,236</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18,195</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,301</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of the Company&#8217;s income tax benefit are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">227</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(273</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">587</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">322</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(689</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,136</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,137</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,245</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,114</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,684</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(866</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33,812</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,322</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred Tax Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued other and prepaid expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,955</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for doubtful accounts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">607</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">624</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible Assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,776</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating&#160;loss carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,718</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued professional liability claims</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,952</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued workers&#8217; compensation claims</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,729</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,512</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">646</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit carryforwards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">188</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">189</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,415</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,661</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,076</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,226</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,585</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred Tax Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(52</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indefinite intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax on unrepatriated earnings</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(383</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(466</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,571</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,471</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,655</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,114</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation of income tax computed at the U.S. federal statutory rate to income tax&#160;benefit is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax at U.S. statutory rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,506</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,591</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State taxes, net of federal benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(543</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,374</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(252</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(455</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(260</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible items (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,676</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,546</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign tax expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(45,354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,379</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Uncertain tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,629</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,090</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Return to provision</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,011</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(831</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,478</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(34,501</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Includes non-deductible meals and incidentals, miscellaneous non-deductible items, and beginning in 2018, non-deductible stock-based compensation.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at January 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,071</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to the current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,054</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions based on tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">204</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reductions based on settlements of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017 Tax Act federal tax rate change</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,859</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(220</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at December&#160;31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,412</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=109238393&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794321360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Award Activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restricted Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Performance Stock Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of<br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Target <br clear="none"/>Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Grant Date<br clear="none"/>Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, January&#160;1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515,601</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">391,108</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.96</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238,328</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(219,881</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(66,692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(97,708</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64,062</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.03</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested restricted stock awards, December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">589,120</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">365,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock', window );">Stock Options and Stock Appreciation Rights Granted and Exercised</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents information about stock options and stock appreciation rights exercised in each year. </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:59%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Total intrinsic value of options exercised</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Share Option Plans Activities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company&#8217;s activities with respect to all of its share option plans (issued under the 2014 Plan and the 1999 Plan) for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Option Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted<br clear="none"/>Average<br clear="none"/>Exercise<br clear="none"/>Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-<br clear="none"/>Average<br clear="none"/>Remaining<br clear="none"/>Contractual<br clear="none"/>Life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate<br clear="none"/>Intrinsic<br clear="none"/>Value (amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding, January 1, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.16-$7.44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited/expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share options outstanding and exercisable, December 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,500</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.35-$5.21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.02</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised and the weighted average grant date fair value of options granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_IntrinsicValueOfOptionsExercisedAndWeightedAverageGrantDateFairValueOfStockOptionsGrantedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791173472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest on Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">694</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,383</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on derivative liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,581</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,805</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,951</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,626</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,545</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,132</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective of diluted shares:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">593</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,521</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares - Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,657</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,246</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.48</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.01</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.15</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table represents the securities that could potentially dilute net income per share attributable to common shareholders in the future that were not included in the computation of diluted net income per share attributable to common shareholders because to do so would have been anti-dilutive for the periods presented.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based awards</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6950103552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Information on Operating Segments and Reconciliation to Income From Operations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December&#160;31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720,302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">758,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">721,486</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,305</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,610</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98,283</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,877</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,768</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">816,484</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865,048</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">833,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contribution income:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nurse and Allied Staffing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66,365</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73,614</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physician Staffing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,755</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,256</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Human Capital Management Services</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(357</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,718</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,513</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,722</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated corporate overhead (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,589</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,780</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition and integration costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,975</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,557</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">814</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,758</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment charges (b)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,356</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,311</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) income from operations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,880</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,748</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,184</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;padding-left:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:12px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been centralizing administrative functions to gain efficiencies, which have been recorded in unallocated corporate overhead, which includes corporate compensation and benefits, and general and administrative expenses including rent and utilities, computer supplies and expenses, insurance, professional expenses, corporate-wide projects (initiatives), and public company expenses.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:37px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:13px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6783903168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Data</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables contain selected unaudited statements of operations information for each quarter of 2018 and 2017. The following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br clear="none"/>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">210,288</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">204,572</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">200,907</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,753</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,689</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,920</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(118</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,343</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,642</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,539</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income (loss) per share attributable to common shareholders - Diluted (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">First<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Second<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Third<br clear="none"/>Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fourth<br clear="none"/>Quarter</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(amounts in thousands, except per share data)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Revenue from services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">207,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">209,313</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">228,488</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">219,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gross profit (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56,528</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">60,480</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">58,303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Consolidated net (loss) income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,718</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,220</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,044</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income attributable to common shareholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,850</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,950</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Basic (b)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net (loss) income per share attributable to common shareholders - Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">________________</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) Excludes depreciation and amortization.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(b) The sum of the quarterly per share amounts may not equal amounts reported for year-to-date due to the effects of rounding                       and changes in the number of weighted average shares outstanding used in the calculation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following items are the most significant items that impact the comparability and presentation of our consolidated data:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2018 and 2017, the Company recorded non-cash impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$22.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$14.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the goodwill and trade names of Physician Staffing. See Note 5 - Goodwill, Trade Names, and Other Intangible Assets.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company settled its Convertible Notes and recognized a loss on extinguishment of debt of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 8 - Debt.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 1, 2018, the Company acquired AP Staffing and on July 1, 2017, the Company acquired all of the assets of Advantage. The acquisitions have been accounted for in accordance with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Business Combinations </font><font style="font-family:inherit;font-size:10pt;">Topic of the FASB ASC</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, </font><font style="font-family:inherit;font-size:10pt;">using the acquisition method. The results of the acquisitions' operations have been included in the consolidated statements of operations from their dates of acquisition. See Note 4 - Acquisitions. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of 2017, the Company benefited from a </font><font style="font-family:inherit;font-size:10pt;text-transform:default;">$43.3 million</font><font style="font-family:inherit;font-size:10pt;"> reversal of valuation allowance on its net deferred tax assets, offset by additional income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to the remeasurement of its deferred tax assets as a result of the 2017 Tax Act. See Note 13 - Income Taxes.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded changes in the fair value of Convertible Notes derivative liability, recording a gain in the first quarter of 2017 of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">. See Note 9 - Derivatives.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109225645&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801064624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">46 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan', window );">Outstanding standby letters of credit as collateral</a></td>
<td class="nump">18,800,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Equity compensation</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Cumulative impact of currency fluctuations</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Net change in derivative instruments</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense', window );">Income tax expense related to deferred tax asset</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax expense (benefit) related to items of other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember', window );">Occurrence-Based Professional Liability Insurance | MDA Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident', window );">Coverage for professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_ClaimsBasedLiabilityInsuranceMember', window );">Claims-Based Liability Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim', window );">Self insured retention per claim</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_ClaimsBasedLiabilityInsuranceMember', window );">Claims-Based Liability Insurance | MDA Holdings Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds', window );">Letter of credit for malpractice claims</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LeaseExpirationPeriod', window );">Short term leases period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets- useful life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LeaseExpirationPeriod', window );">Short term leases period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets- useful life</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life of assets</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of time the payments are typically required to be made from the date services are provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LeaseExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Apartments lease period for field employees under short-term agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LeaseExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Malpractice Insurance, Policy, Self Insured Retention Per Claim</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_MalpracticeInsurancePolicySelfInsuredRetentionPerClaim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of standby letters of credit issued as collateral to guarantee payments of workers compensation claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OutstandingLettersOfCreditCollateraltoGuaranteePaymentsUnderSelfInsuredPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109240241&amp;loc=d3e32022-110900<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum coverage per malpractice claim provided by the insurance arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeInsuranceMaximumCoveragePerIncident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of letters of credit and other surety bonds that are available for the future payment of malpractice claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyLettersOfCreditAndSuretyBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_OccurrenceBasedProfessionalLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ccrn_MDAHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ccrn_MDAHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_ClaimsBasedLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=ccrn_ClaimsBasedLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800461440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled contracts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.1<span></span>
</td>
<td class="nump">$ 41.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Services | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ContractualTerm', window );">Contract terms</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of time the payments are typically required to be made from the date services are provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800461296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Restructuring Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring costs (a)</a></td>
<td class="nump">$ 2,758<span></span>
</td>
<td class="nump">$ 1,026<span></span>
</td>
<td class="nump">$ 753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember', window );">Cost Optimization Project</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_RestructuringChargesWriteOffRelatedToAbandonment', window );">Direct write offs related to abandoned locations</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember', window );">Cost Optimization Project | On-Going Benefit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring costs (a)</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">522<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(1,131)<span></span>
</td>
<td class="num">(760)<span></span>
</td>
<td class="num">(282)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember', window );">Cost Optimization Project | Exit Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring costs (a)</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(235)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">$ 273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember', window );">Cost Optimization Project | Other costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring costs (a)</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_RestructuringChargesWriteOffRelatedToAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Write Off Related To Abandonment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_RestructuringChargesWriteOffRelatedToAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ccrn_CostOptimizationProjectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784171600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - ASU Adoption (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Undiscounted future lease payments</a></td>
<td class="nump">$ 34,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued rent</a></td>
<td class="num">$ (7,200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801228016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - American Personnel, Inc. (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,060<span></span>
</td>
<td class="nump">$ 117,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_AmericanPersonnelInc.Member', window );">American Personnel, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_AmericanPersonnelInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_AmericanPersonnelInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787626608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregation of Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 816,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember', window );">Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">782,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember', window );">Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">34,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse and Allied Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">720,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse and Allied Staffing Segment | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">705,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse and Allied Staffing Segment | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">14,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">82,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">76,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember', window );">Other Human Capital Management Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">13,877<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember', window );">Other Human Capital Management Services Segment | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember', window );">Other Human Capital Management Services Segment | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 13,877<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130543-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130539-203045<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801981744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Advantage RN (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 28, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,930<span></span>
</td>
<td class="nump">$ 85,977<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 62,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember', window );">Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment', window );">Net working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement', window );">Reimbursement from working capital adjustment settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Release of remaining contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities', window );">Escrow payment related to tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities', window );">Escrow payment related to post-close liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelease', window );">Release of escrow to seller</a></td>
<td class="nump">$ 7,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities', window );">Escrow deposit related to tax liabilities</a></td>
<td class="nump">$ 7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand', window );">Consideration transferred, available cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Net income since acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember', window );">Deferred Consideration Transferred | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationDeferredPeriod', window );">Period of deferred consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember', window );">Purchase Price | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Forecast | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelease', window );">Release of escrow to seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities', window );">Escrow deposit related to post close liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationDeferredPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Deferred, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationDeferredPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Working Capital Adjustment, Reimbursement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustmentReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Funded With Cash On Hand</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredPortionFundedWithCashOnHand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit Related To Post Close Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationEscrowDepositRelatedToPostCloseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit Related To Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationEscrowDepositRelatedToTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationEscrowDepositRelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit Release</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationEscrowDepositRelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses, Escrow, Portion Related To Post-Close Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToPostCloseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses, Escrow, Portion Related To Tax Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsToAcquireBusinessesEscrowPortionRelatedToTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_IncrementalTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_IncrementalTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787585808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Fair Value of Purchase Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,930<span></span>
</td>
<td class="nump">$ 85,977<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember', window );">Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="nump">$ 86,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired</a></td>
<td class="nump">2,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Total consideration</a></td>
<td class="nump">89,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember', window );">Purchase Price | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_NetWorkingCapitalAdjustmentsMember', window );">Net Working Capital Adjustments | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="num">$ (1,438)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_PurchasePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_NetWorkingCapitalAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredAxis=ccrn_NetWorkingCapitalAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787589072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 101,060<span></span>
</td>
<td class="nump">$ 117,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember', window );">Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,900<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities', window );">Accrued employee compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,055<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Employee Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedEmployeeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=108330185&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786424464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember', window );">Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 29,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be deductible</a></td>
<td class="nump">$ 43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Databases | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements | Advantage RN, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Assets acquired</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life of assets acquired</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_AdvantageRNLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800802928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems', window );"><strong>Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="num">$ (19,343)<span></span>
</td>
<td class="num">$ (118)<span></span>
</td>
<td class="nump">$ 1,824<span></span>
</td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="nump">$ 28,256<span></span>
</td>
<td class="nump">$ 7,044<span></span>
</td>
<td class="nump">$ 5,220<span></span>
</td>
<td class="num">$ (1,718)<span></span>
</td>
<td class="num">$ (15,717)<span></span>
</td>
<td class="nump">$ 38,802<span></span>
</td>
<td class="nump">$ 8,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue from services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916,149<span></span>
</td>
<td class="nump">934,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income attributable to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,255<span></span>
</td>
<td class="nump">$ 11,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net income per share attributable to common shareholders - Basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net income per share attributable to common shareholders - Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems', window );"><strong>Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802506080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">21 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2017</div></th>
<th class="th"><div>Oct. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 01, 2016</div></th>
<th class="th"><div>Apr. 01, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_USResourcesHealthcareLLCMember', window );">US Resources Healthcare, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember', window );">Mediscan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash purchase price paid at closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated', window );">Cash consideration plus working capital estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Fair value of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment', window );">Net working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationEscrowDepositRelease', window );">Release of escrow to seller</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember', window );">Medical Staffing Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Release of remaining contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2017 | US Resources Healthcare, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2017 | Mediscan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2018 | US Resources Healthcare, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2019 | US Resources Healthcare, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AcquisitionRelatedContingentConsiderationMember', window );">Acquisition-Related Contingent Consideration | US Resources Healthcare, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Release of remaining contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember', window );">Assumed Additional Contingent Purchase Price Liabilities | Mediscan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member', window );">Potential Earnout, Attainment of Specific Performance Criteria in 2016 | Mediscan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, range of outcomes, high</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember', window );">Deferred Consideration Transferred | Medical Staffing Network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationDeferredPeriod', window );">Period of deferred consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationDeferredPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Deferred, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationDeferredPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash Consideration Negotiated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredCashConsiderationNegotiated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationEscrowDepositRelease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Escrow Deposit Release</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationEscrowDepositRelease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109124213&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_USResourcesHealthcareLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_USResourcesHealthcareLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_MediscanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_MedicalStaffingNetworkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AcquisitionRelatedContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_AcquisitionRelatedContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_AssumedAdditionalContingentPurchasePriceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_PotentialEarnoutAttainmentofSpecificPerformanceCriteriain2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=ccrn_DeferredConsiderationTransferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786916064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets - Acquired Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 89,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">34,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,092<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">55,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names</a></td>
<td class="nump">20,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets not subject to amortization, net</a></td>
<td class="nump">75,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">30,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">9,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,702<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">21,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">49,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">23,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,912<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">26,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">8,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">878<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 7,183<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 6,838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6701165696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets - Estimated Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 7,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2020</a></td>
<td class="nump">7,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2021</a></td>
<td class="nump">7,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2022</a></td>
<td class="nump">6,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">6,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">19,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 55,182<span></span>
</td>
<td class="nump">$ 60,976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800731904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,060<span></span>
</td>
<td class="nump">$ 117,589<span></span>
</td>
<td class="nump">101,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="num">$ (17,700)<span></span>
</td>
<td class="num">(17,200)<span></span>
</td>
<td class="num">(5,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283,107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,223)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411,279<span></span>
</td>
<td class="nump">410,585<span></span>
</td>
<td class="nump">411,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,330<span></span>
</td>
<td class="nump">283,107<span></span>
</td>
<td class="nump">300,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,060<span></span>
</td>
<td class="nump">117,589<span></span>
</td>
<td class="nump">101,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nurse and Allied Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,567<span></span>
</td>
<td class="nump">347,873<span></span>
</td>
<td class="nump">348,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,732<span></span>
</td>
<td class="nump">259,732<span></span>
</td>
<td class="nump">259,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,835<span></span>
</td>
<td class="nump">88,141<span></span>
</td>
<td class="nump">88,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,223)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,405<span></span>
</td>
<td class="nump">43,405<span></span>
</td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,598<span></span>
</td>
<td class="nump">23,375<span></span>
</td>
<td class="nump">40,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807<span></span>
</td>
<td class="nump">20,030<span></span>
</td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other Human Capital Management Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill balances</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract', window );"><strong>Goodwill, Translation and Purchase Accounting Adjustments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,307<span></span>
</td>
<td class="nump">19,307<span></span>
</td>
<td class="nump">19,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness', window );">Sale of business, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
<td class="num">(9,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,418<span></span>
</td>
<td class="nump">$ 9,418<span></span>
</td>
<td class="nump">$ 9,418<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_GoodwillWriteOffRelatedToSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Write Off Related To Sale Of Business</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_GoodwillWriteOffRelatedToSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6803250560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill, Trade Names, and Other Intangible Assets - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,182<span></span>
</td>
<td class="nump">$ 60,976<span></span>
</td>
<td class="nump">$ 55,182<span></span>
</td>
<td class="nump">$ 60,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400<span></span>
</td>
<td class="nump">14,400<span></span>
</td>
<td class="nump">22,423<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="nump">$ 24,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="nump">17,200<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying amount</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,183<span></span>
</td>
<td class="nump">6,838<span></span>
</td>
<td class="nump">7,183<span></span>
</td>
<td class="nump">6,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets- useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,462<span></span>
</td>
<td class="nump">29,612<span></span>
</td>
<td class="nump">$ 26,462<span></span>
</td>
<td class="nump">$ 29,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangibles finite lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember', window );">Income Approach Valuation Technique | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember', window );">Income Approach Valuation Technique | Search Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember', window );">Income Approach Valuation Technique | Nurse and Allied Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=ccrn_IncomeandMarketApproachValuationTechniqueMember', window );">Income and Market Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsForecastPeriod', window );">Forecast period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember', window );">Market Approach Valuation Technique | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember', window );">Market Approach Valuation Technique | Search Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember', window );">Market Approach Valuation Technique | Nurse and Allied Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsWeightingApplied', window );">Weighted applied percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets- useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Income Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsTerminalValueGrowthRate', window );">Terminal value growth rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Market Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA', window );">Ratio of total enterprise value by EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets- useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Income Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsTerminalValueGrowthRate', window );">Terminal value growth rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Market Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA', window );">Ratio of total enterprise value by EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangibles indefinite lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount Rate | Income Approach Valuation Technique | Customer relationships | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillImpairmentTestMeasurementInput', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount Rate | Minimum | Income Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillImpairmentTestMeasurementInput', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount Rate | Maximum | Income Approach Valuation Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems', window );"><strong>Goodwill and Intangible Assets Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_GoodwillImpairmentTestMeasurementInput', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueInputsForecastPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Inputs, Forecast Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueInputsForecastPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Inputs, Ratio of Total Enterprise Value by EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueInputsRatioofTotalEnterpriseValuebyEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueInputsTerminalValueGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Inputs, Terminal Value Growth Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueInputsTerminalValueGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueInputsWeightingApplied">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Inputs, Weighting Applied</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueInputsWeightingApplied</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Intangible Assets Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_GoodwillAndIntangibleAssetsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_GoodwillImpairmentTestMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Impairment Test, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_GoodwillImpairmentTestMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_SearchReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_SearchReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ccrn_IncomeandMarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ccrn_IncomeandMarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802113776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 47,104<span></span>
</td>
<td class="nump">$ 44,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(33,476)<span></span>
</td>
<td class="num">(30,678)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation and amortization</a></td>
<td class="nump">13,628<span></span>
</td>
<td class="nump">14,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">6,257<span></span>
</td>
<td class="nump">6,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">26,651<span></span>
</td>
<td class="nump">24,933<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">1,514<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">4,966<span></span>
</td>
<td class="nump">4,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 7,716<span></span>
</td>
<td class="nump">$ 7,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800676224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_InsuranceRecoveryForWorkersCompensationCurrent', window );">Insurance recovery for workers&#8217; compensation</a></td>
<td class="nump">$ 2,295<span></span>
</td>
<td class="nump">$ 1,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceReceivableForMalpracticeCurrent', window );">Insurance recovery for professional liability</a></td>
<td class="nump">1,891<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance recovery receivable</a></td>
<td class="nump">4,186<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent', window );">Insurance recovery for workers&#8217; compensation claims</a></td>
<td class="nump">5,280<span></span>
</td>
<td class="nump">6,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceReceivableForMalpracticeNoncurrent', window );">Insurance recovery for professional liability claims</a></td>
<td class="nump">9,924<span></span>
</td>
<td class="nump">10,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Non-current security deposits</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Non-current income tax receivable</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Deferred compensation assets</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Net debt issuance costs</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">985<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">18,076<span></span>
</td>
<td class="nump">19,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Salaries and payroll taxes</a></td>
<td class="nump">15,884<span></span>
</td>
<td class="nump">16,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Bonuses</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrual for workers&#8217; compensation claims</a></td>
<td class="nump">6,454<span></span>
</td>
<td class="nump">5,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent', window );">Accrual for professional liability claims</a></td>
<td class="nump">2,786<span></span>
</td>
<td class="nump">2,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent', window );">Accrual for healthcare benefits</a></td>
<td class="nump">5,158<span></span>
</td>
<td class="nump">5,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrual for vacation</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">33,332<span></span>
</td>
<td class="nump">34,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Accrual for workers&#8217; compensation claims</a></td>
<td class="nump">12,997<span></span>
</td>
<td class="nump">13,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent', window );">Accrual for professional liability claims</a></td>
<td class="nump">16,302<span></span>
</td>
<td class="nump">15,597<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Long-term accrued claims</a></td>
<td class="nump">29,299<span></span>
</td>
<td class="nump">28,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Non-current deferred tax liabilities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation</a></td>
<td class="nump">1,725<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
<td class="nump">6,039<span></span>
</td>
<td class="nump">6,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Long-term unrecognized tax benefits</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OtherLiabilitiesMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">318<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 8,767<span></span>
</td>
<td class="nump">$ 9,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_InsuranceRecoveryForWorkersCompensationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of the amount receivable from insurance for recovery for workers compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_InsuranceRecoveryForWorkersCompensationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The long term portion of the amount receivable from insurance for recovery for workers compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_InsuranceRecoveryForWorkersCompensationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OtherLiabilitiesMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Miscellaneous, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OtherLiabilitiesMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902458&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31958-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceReceivableForMalpracticeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of the amount receivable from insurance and similar arrangements for reimbursement and payment of malpractice claims and litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceReceivableForMalpracticeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceReceivableForMalpracticeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of the receivable from insurance and similar arrangements for reimbursement and payment of malpractice claims and litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceReceivableForMalpracticeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99382578&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=99382578&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the current portion of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscountedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the noncurrent portion of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscountedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785821328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Long- Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">$ (5,235)<span></span>
</td>
<td class="num">$ (6,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">78,641<span></span>
</td>
<td class="nump">93,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(697)<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Senior Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">83,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Senior Debt | Term Loan, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Term Loan, interest of 4.80% and 3.61% at December 31, 2018 and 2017, respectively</a></td>
<td class="nump">83,876<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">$ (697)<span></span>
</td>
<td class="num">$ (866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">3.61%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6803056752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Amendment And Restatement Of Senior Credit Facility (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 01, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>financial_covenant</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 62,000,000<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308,000<span></span>
</td>
<td class="nump">$ 901,000<span></span>
</td>
<td class="nump">$ 1,182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans', window );">Sub facility for swingline loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit', window );">Line of credit, subfacility for standby letters of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault', window );">Interest rate increase (decrease) (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Quarterly commitment fee on the average daily unused portion (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_NumberofFinancialCovenants', window );">Number of financial covenants | financial_covenant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio', window );">Consolidated fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | Fiscal Quarters Ending September 30, 2018 through June 30, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | Fiscal Quarter Ending September 30, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | Fiscal Quarter Ending December 31, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember', window );">Amended And Restated Credit Agreement | Each Fiscal Quarter Ending Thereafter | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember', window );">First Amendment, Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember', window );">First Amendment, Amended And Restated Credit Agreement | Fiscal Quarters Ending September 30, 2018 through June 30, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember', window );">First Amendment, Amended And Restated Credit Agreement | Fiscal Quarter Ending September 30, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember', window );">First Amendment, Amended And Restated Credit Agreement | Fiscal Quarter Ending December 31, 2019 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember', window );">First Amendment, Amended And Restated Credit Agreement | Each Fiscal Quarter Ending Thereafter | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio', window );">Consolidated total leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilityAdditionalCapacity', window );">Additional capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentForDebtPrepayment', window );">Payment for debt prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amended And Restated Credit Agreement | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit | Amended And Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Consolidated Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantConsolidatedFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantConsolidatedTotalLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>calculated as total Indebtedness, as defined divided by Adjusted EBITDA as defined</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantConsolidatedTotalLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Interest Rate, Increase (Decrease) in Event of Default</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentInterestRateIncreaseDecreaseinEventofDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilityAdditionalCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Additional Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilityAdditionalCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Sub Facility For Swingline Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit, subfacility for standby letters of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_NumberofFinancialCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Financial Covenants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_NumberofFinancialCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentForDebtPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment For Debt Prepayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentForDebtPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_AmendedAndRestatedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuartersEndingSeptember302018throughJune302019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuarterEndingSeptember302019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuarterEndingSeptember302019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuarterEndingDecember312019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FiscalQuarterEndingDecember312019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_EachFiscalQuarterEndingThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_EachFiscalQuarterEndingThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_FirstAmendmentAmendedAndRestatedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785665472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Debt Maturities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 78,641<span></span>
</td>
<td class="nump">$ 93,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2019</a></td>
<td class="nump">5,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2020</a></td>
<td class="nump">5,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2021</a></td>
<td class="nump">6,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2022</a></td>
<td class="nump">65,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 83,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6793016416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Consolidated Net Leverage Ratio (Details) - Credit Agreement<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 05, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 | Eurodollar Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 | LIBOR Index Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 | Letter of Credit Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member', window );">Covenant Term 1 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | Eurodollar Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | LIBOR Index Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | Letter of Credit Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member', window );">Covenant Term 2 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Eurodollar Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | LIBOR Index Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Letter of Credit Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | Eurodollar Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | LIBOR Index Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | Letter of Credit Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member', window );">Covenant Term 4 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 | Eurodollar Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 | LIBOR Index Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 | Letter of Credit Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member', window );">Covenant Term 5 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ConsolidatedNetLeverageRatio', window );">Consolidated Net Leverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ConsolidatedNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidated Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ConsolidatedNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=ccrn_LetterofCreditFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=ccrn_LetterofCreditFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800214944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - 2016 Senior Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 05, 2017</div></th>
<th class="th"><div>Jun. 22, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentPrepaymentPenalty', window );">Prepayment penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
<td class="nump">$ 4,969,000<span></span>
</td>
<td class="nump">$ 1,568,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_SecondLienTermLoanMember', window );">Second Lien Term Loan, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Senior Debt | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember', window );">Subordinated Debt | Second Lien Term Loan, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan | First Eight Installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal', window );">Periodic payment, percentage of principal</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan | Remaining Installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal', window );">Periodic payment, percentage of principal</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Incremental Term Loan | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans', window );">Sub facility for swingline loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit', window );">Line of credit, subfacility for standby letters of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Credit Agreement | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Credit Agreement | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member', window );">Covenant Term 3 | Credit Agreement | Base Rate Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percentage Of Principal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentPeriodicPaymentPercentageOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentPrepaymentPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentPrepaymentPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Sub Facility For Swingline Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubFacilityForSwinglineLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit, subfacility for standby letters of credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilitySubLimitForLettersOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_SecondLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_SecondLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_IncrementalTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_IncrementalTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FirstEightInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_FirstEightInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_RemainingInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=ccrn_RemainingInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtCovenantTermsAxis=ccrn_CovenantTerm3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6802142512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Private Placement of Convertible Notes Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 17, 2017 </div>
<div>USD ($) </div>
<div>day </div>
<div>instrument </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,124,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 30,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
<td class="nump">$ 4,969,000<span></span>
</td>
<td class="nump">$ 1,568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt', window );">Payment of debt and extinguishment fees</a></td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of debt</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Extinguishment fees</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Non-cash write off related to settlement of convertible notes</a></td>
<td class="nump">$ 46,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price (in usd per share) | $ / shares</a></td>
<td class="nump">$ 7.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt instrument, convertible, number of equity instruments | instrument</a></td>
<td class="nump">3,521,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate', window );">Debt Instrument, convertible, threshold period following issuance date (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument, convertible, threshold percentage of stock price trigger</a></td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument, convertible, threshold trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument, convertible, threshold consecutive trading days | d</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">3,175,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember', window );">8% Convertible Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Original debt amount in debt conversion</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember', window );">Convertible Note Derivative Liability | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Original debt amount in debt conversion</a></td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible,Threshold Period Following Issuance Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentConvertibleThresholdPeriodFollowingIssuanceDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Debt Extinguishment Costs And Repayment Of Long Term Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsForDebtExtinguishmentCostsAndRepaymentOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A8ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_ConvertibleNoteDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790724560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.627%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember', window );">Senior Debt | Term Loan, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Debt fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800317712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration liabilities</a></td>
<td class="nump">$ 7,689<span></span>
</td>
<td class="nump">$ 5,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember', window );">Deferred compensation | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Deferred compensation</a></td>
<td class="nump">1,725<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swaps | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Interest rate swaps</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785818528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember', window );">Contingent Purchase Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 5,368<span></span>
</td>
<td class="nump">$ 5,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Settlements</a></td>
<td class="num">(280)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense', window );">Accretion expense</a></td>
<td class="nump">903<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Valuation gain (loss) for the period</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="num">(922)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">7,689<span></span>
</td>
<td class="nump">5,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember', window );">Convertible Notes Derivative Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25,951)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense', window );">Accretion expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Valuation gain (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Accretion Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_ContingentConsiderationLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6701228416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Instruments that were not Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Amount</a></td>
<td class="nump">$ 78,641<span></span>
</td>
<td class="nump">$ 93,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Level 2 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Amount</a></td>
<td class="nump">83,179<span></span>
</td>
<td class="nump">99,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember', window );">Term Loan, net | Level 2 | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 81,800<span></span>
</td>
<td class="nump">$ 100,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785932240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">15 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">60 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold Period, Past Due for Payment of Services Provided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ThresholdPeriodPastDueforPaymentofServicesProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6701129872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Company contribution net of forfeitures</a></td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">$ 1,725<span></span>
</td>
<td class="nump">$ 1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6949546704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Future Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 7,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">6,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">4,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="nump">4,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
<td class="nump">5,893<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 34,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791236864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease expense</a></td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785564960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income (Loss) Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (18,619)<span></span>
</td>
<td class="nump">$ 3,826<span></span>
</td>
<td class="nump">$ 3,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">424<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">1,236<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(Loss) income before income taxes</a></td>
<td class="num">$ (18,195)<span></span>
</td>
<td class="nump">$ 4,301<span></span>
</td>
<td class="nump">$ 4,545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784111168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="num">$ (555)<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">620<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">932<span></span>
</td>
<td class="num">(689)<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(2,137)<span></span>
</td>
<td class="num">(23,245)<span></span>
</td>
<td class="num">(4,114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(1,277)<span></span>
</td>
<td class="num">(10,684)<span></span>
</td>
<td class="num">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="num">(342)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="num">(3,410)<span></span>
</td>
<td class="num">(33,812)<span></span>
</td>
<td class="num">(5,322)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (2,478)<span></span>
</td>
<td class="num">$ (34,501)<span></span>
</td>
<td class="num">$ (4,186)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786171360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred Tax Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses', window );">Accrued other and prepaid expenses</a></td>
<td class="nump">$ 2,734<span></span>
</td>
<td class="nump">$ 2,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible Assets</a></td>
<td class="nump">11,300<span></span>
</td>
<td class="nump">7,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">15,717<span></span>
</td>
<td class="nump">14,718<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Accrued professional liability claims</a></td>
<td class="nump">1,952<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits', window );">Accrued workers&#8217; compensation claims</a></td>
<td class="nump">2,729<span></span>
</td>
<td class="nump">2,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">646<span></span>
</td>
<td class="nump">734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Credit carryforwards</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">36,415<span></span>
</td>
<td class="nump">31,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(1,189)<span></span>
</td>
<td class="num">(1,076)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">35,226<span></span>
</td>
<td class="nump">30,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred Tax Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Indefinite intangibles</a></td>
<td class="num">(11,136)<span></span>
</td>
<td class="num">(9,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Tax on unrepatriated earnings</a></td>
<td class="num">(383)<span></span>
</td>
<td class="num">(466)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(11,571)<span></span>
</td>
<td class="num">(10,471)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DeferredTaxAssetsLiabilities', window );">Net deferred taxes</a></td>
<td class="nump">$ 23,655<span></span>
</td>
<td class="nump">$ 20,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Accrued Other Liabilities and Prepaid Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DeferredTaxAssetsAccruedOtherLiabilitiesandPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DeferredTaxAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets (Liabilities)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DeferredTaxAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiaries and other recognized entities not within the country of domicile of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801511648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Provision income tax expense related to deferred tax asset</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 8,011<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense', window );">Income tax expense related to deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reduction in valuation allowance</a></td>
<td class="nump">43,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal, state and foreign net operating loss carryforwards</a></td>
<td class="nump">166,100<span></span>
</td>
<td class="nump">185,100<span></span>
</td>
<td class="nump">166,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred liabilities on undistributed foreign earnings</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">3,807<span></span>
</td>
<td class="nump">5,412<span></span>
</td>
<td class="nump">3,807<span></span>
</td>
<td class="nump">5,180<span></span>
</td>
<td class="nump">$ 4,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits, which would affect the effective tax rate</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">5,600<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases', window );">Gross increases in current year unrecognized tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Increase (decrease) in recognized interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefit accrued interest and penalties</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">India</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred liabilities on undistributed foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_RepatriationOfForeignEarningsAmount', window );">Repatriated amount of foreign earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_NetOperatingLossesMember', window );">Net Operating Losses | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reduction in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_NetOperatingLossesMember', window );">Net Operating Losses | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reduction in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_OtherNetDeferredTaxAssetsMember', window );">Other Net Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reduction in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_RepatriationOfForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repatriated amount of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_RepatriationOfForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of increases in unrecognized tax benefits related to federal and state tax issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_UnrecognizedTaxBenefitsPeriodGrossIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiaries and other recognized entities not within the country of domicile of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_NetOperatingLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_NetOperatingLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_OtherNetDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=ccrn_OtherNetDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6789736592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Tax at U.S. statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,821)<span></span>
</td>
<td class="nump">$ 1,506<span></span>
</td>
<td class="nump">$ 1,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="num">(1,374)<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(455)<span></span>
</td>
<td class="num">(260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">2,676<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,354)<span></span>
</td>
<td class="num">(8,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">1,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount', window );">Return to provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(458)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Federal rate change</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,011<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="num">(831)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,478)<span></span>
</td>
<td class="num">$ (34,501)<span></span>
</td>
<td class="num">$ (4,186)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return To Provision, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786168640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 3,807<span></span>
</td>
<td class="nump">$ 5,180<span></span>
</td>
<td class="nump">$ 4,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">1,401<span></span>
</td>
<td class="nump">1,145<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions based on settlements of tax positions related to prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(439)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange', window );">2017 Tax Act federal tax rate change</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,859)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 5,412<span></span>
</td>
<td class="nump">$ 3,807<span></span>
</td>
<td class="nump">$ 5,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of increases ( decreases) in unrecognized tax benefits resulting from other items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromOtherDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Reduction Resulting From Federal Tax Rate Change</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_UnrecognizedTaxBenefitsReductionResultingFromFederalTaxRateChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785608496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchase and retirement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock left remaining to repurchase under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchase and retirement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Stock repurchase and retirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_StockRepurchasedDuringPeriodPricePerShare', window );">Stock repurchase and retirement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares converted (in shares)</a></td>
<td class="nump">3,175,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_StockRepurchasedDuringPeriodPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchased During Period, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_StockRepurchasedDuringPeriodPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787860592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - 2014 Omnibus Incentive Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>May 23, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of the fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod', window );">Stock expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=ccrn_TenPercentOrMoreStockholdersMember', window );">Ten Percent Or More Stockholders | Minimum | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Exercise price percentage of the fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=ccrn_TenPercentOrMoreStockholdersMember', window );">Ten Percent Or More Stockholders | Maximum | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod', window );">Stock expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Pretax of total unrecognized compensation cost related to non-vested restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Pretax total unrecognized compensation cost related to share options- period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 5 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Pretax of total unrecognized compensation cost related to non-vested restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Pretax total unrecognized compensation cost related to share options- period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards | Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued (in shares)</a></td>
<td class="nump">238,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,067<span></span>
</td>
<td class="nump">66,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage', window );">Percentage of performance attained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights | 2007 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod', window );">Stock expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested', window );">Stock vesting percentage per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options expiration period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award stock award and option vesting rate per year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfSharesVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Level of Performance Attained, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SharebasedCompensationArrangementbySharebasedPaymentAwardLevelofPerformanceAttainedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share instruments newly issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=ccrn_TenPercentOrMoreStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=ccrn_TenPercentOrMoreStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_IncentiveCompensationPlan2007Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_IncentiveCompensationPlan2007Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786550160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Restricted Stock Award Activity and Performance Stock Awards (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (in shares) | shares</a></td>
<td class="nump">515,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">391,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(219,881)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(97,708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (in shares) | shares</a></td>
<td class="nump">589,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 13.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">10.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">12.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">13.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (in shares) | shares</a></td>
<td class="nump">257,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">238,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(66,692)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(64,062)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (in shares) | shares</a></td>
<td class="nump">365,149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 13.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">11.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">11.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">13.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 12.35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6791255152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options and Stock Appreciation Rights Granted and Exercised (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">$ 516<span></span>
</td>
<td class="nump">$ 1,323<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784208576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - 1999 Stock Option Plan and Equity Participation Plan (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Oct. 25, 2001</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share options outstanding (in shares)</a></td>
<td class="nump">51,500<span></span>
</td>
<td class="nump">94,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Shares options outstanding vested or expected to vest -weighted average exercise price (usd per share)</a></td>
<td class="nump">$ 4.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Shares options outstanding vested or expected to vest ,intrinsic value</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Shares options outstanding vested or expected to vest -weighted average contractual life</a></td>
<td class="text">1 year 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_StockOptionAndEquityParticipationPlan1999Member', window );">The 1999 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of common stock shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,398,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_StockOptionAndEquityParticipationPlan1999Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_StockOptionAndEquityParticipationPlan1999Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786702688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Company's Share Option Plans Activities (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share options outstanding at beginning of year (in shares) | shares</a></td>
<td class="nump">94,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(40,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited/expired (in shares) | shares</a></td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share options outstanding at end of year (in shares) | shares</a></td>
<td class="nump">51,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share options outstanding at beginning of year, weighted average exercise price (usd per share)</a></td>
<td class="nump">$ 5.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, weighted average exercise price (usd per share)</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, weighted average exercise price (usd per share)</a></td>
<td class="nump">5.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited/expired, weighted average exercise price (usd per share)</a></td>
<td class="nump">7.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share options outstanding at end of year, weighted average exercise price (usd per share)</a></td>
<td class="nump">$ 4.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share options outstanding at end of year, weighted-average remaining contractual life</a></td>
<td class="text">1 year 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share options outstanding at end of year | $</a></td>
<td class="nump">$ 127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeOneMember', window );">Exercise Price Range One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise Price, Lower Limit (usd per share)</a></td>
<td class="nump">$ 4.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Upper Limit (usd pre share)</a></td>
<td class="nump">7.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeTwoMember', window );">Exercise Price Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Upper Limit (usd pre share)</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeThreeMember', window );">Exercise Price Range Three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise Price, Lower Limit (usd per share)</a></td>
<td class="nump">4.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Upper Limit (usd pre share)</a></td>
<td class="nump">7.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFourMember', window );">Exercise Price Range Four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Upper Limit (usd pre share)</a></td>
<td class="nump">7.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFiveMember', window );">Exercise Price Range Five</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise Price, Lower Limit (usd per share)</a></td>
<td class="nump">4.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price, Upper Limit (usd pre share)</a></td>
<td class="nump">$ 5.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ccrn_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6787480128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (loss) income attributable to common shareholders - Basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,951)<span></span>
</td>
<td class="nump">$ 37,513<span></span>
</td>
<td class="nump">$ 7,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Interest on Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="nump">3,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,600)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,581)<span></span>
</td>
<td class="num">(5,805)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net (loss) income attributable to common shareholders - Diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16,951)<span></span>
</td>
<td class="nump">$ 36,626<span></span>
</td>
<td class="nump">$ 5,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares - Basic (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,657<span></span>
</td>
<td class="nump">35,018<span></span>
</td>
<td class="nump">32,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effective of diluted shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share-based awards (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="nump">593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible Notes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">723<span></span>
</td>
<td class="nump">3,521<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares - Diluted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,657<span></span>
</td>
<td class="nump">36,166<span></span>
</td>
<td class="nump">36,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net (loss) income per share attributable to common shareholders - Basic (usd per share)</a></td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net (loss) income per share attributable to common shareholders - Diluted (usd per share)</a></td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1930-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The after-tax amount of interest recognized in the period associated with any convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6701114864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Antidilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember', window );">Share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ConvertibleNotesandSharebasedPaymentAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785624608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Account receivable due from related parties</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_JointVenturePercentOwnership', window );">Percent ownership in joint venture unit</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromJointVenturesCurrent', window );">Receivable balance with joint venture</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to joint venture</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent expense</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_JointVenturePercentOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Percent Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_JointVenturePercentOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromJointVenturesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amounts due from an entity in which the reporting entity shares joint control with another party or group, due within 1 year (or 1 business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39599-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromJointVenturesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873854&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6784117328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786822528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Data - Operating Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,907<span></span>
</td>
<td class="nump">$ 200,717<span></span>
</td>
<td class="nump">$ 204,572<span></span>
</td>
<td class="nump">$ 210,288<span></span>
</td>
<td class="nump">$ 219,674<span></span>
</td>
<td class="nump">$ 228,488<span></span>
</td>
<td class="nump">$ 209,313<span></span>
</td>
<td class="nump">$ 207,573<span></span>
</td>
<td class="nump">$ 816,484<span></span>
</td>
<td class="nump">$ 865,048<span></span>
</td>
<td class="nump">$ 833,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses', window );">Contribution income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,718<span></span>
</td>
<td class="nump">78,513<span></span>
</td>
<td class="nump">79,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SegmentReportingUnallocatedCorporateExpenses', window );">Unallocated corporate overhead</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,589<span></span>
</td>
<td class="nump">39,190<span></span>
</td>
<td class="nump">38,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,780<span></span>
</td>
<td class="nump">10,174<span></span>
</td>
<td class="nump">9,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition and integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense', window );">Acquisition-related contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,557<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,423<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
<td class="nump">24,311<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">(Loss) income from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,880)<span></span>
</td>
<td class="nump">11,748<span></span>
</td>
<td class="nump">6,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nurse and Allied Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">720,302<span></span>
</td>
<td class="nump">758,267<span></span>
</td>
<td class="nump">721,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses', window );">Contribution income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,365<span></span>
</td>
<td class="nump">73,614<span></span>
</td>
<td class="nump">71,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Physician Staffing Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,305<span></span>
</td>
<td class="nump">93,610<span></span>
</td>
<td class="nump">98,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses', window );">Contribution income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,755<span></span>
</td>
<td class="nump">5,256<span></span>
</td>
<td class="nump">8,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other Human Capital Management Services Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,877<span></span>
</td>
<td class="nump">13,171<span></span>
</td>
<td class="nump">13,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses', window );">Contribution income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 598<span></span>
</td>
<td class="num">$ (357)<span></span>
</td>
<td class="num">$ (535)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationArrangementsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationArrangementsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Before Depreciation Amortization Acquisition and Integration Cost Contingent Consideration Restructuring Costs Impairment Charges And Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingIncomeLossBeforeDepreciationAmortizationAcquisitionandIntegrationCostContingentConsiderationRestructuringCostsImpairmentChargesAndCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SegmentReportingUnallocatedCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Unallocated Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SegmentReportingUnallocatedCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=84229725&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_OtherHumanCapitalManagementServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790144208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Financial Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 17, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue from services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,907<span></span>
</td>
<td class="nump">$ 200,717<span></span>
</td>
<td class="nump">$ 204,572<span></span>
</td>
<td class="nump">$ 210,288<span></span>
</td>
<td class="nump">$ 219,674<span></span>
</td>
<td class="nump">$ 228,488<span></span>
</td>
<td class="nump">$ 209,313<span></span>
</td>
<td class="nump">$ 207,573<span></span>
</td>
<td class="nump">$ 816,484<span></span>
</td>
<td class="nump">$ 865,048<span></span>
</td>
<td class="nump">$ 833,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,559<span></span>
</td>
<td class="nump">51,562<span></span>
</td>
<td class="nump">53,689<span></span>
</td>
<td class="nump">53,753<span></span>
</td>
<td class="nump">58,303<span></span>
</td>
<td class="nump">60,480<span></span>
</td>
<td class="nump">56,528<span></span>
</td>
<td class="nump">53,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Consolidated net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,343)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
<td class="nump">28,256<span></span>
</td>
<td class="nump">7,044<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
<td class="num">(1,718)<span></span>
</td>
<td class="num">(15,717)<span></span>
</td>
<td class="nump">38,802<span></span>
</td>
<td class="nump">8,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,691)<span></span>
</td>
<td class="num">$ (441)<span></span>
</td>
<td class="nump">$ 1,539<span></span>
</td>
<td class="nump">$ 1,642<span></span>
</td>
<td class="nump">$ 27,950<span></span>
</td>
<td class="nump">$ 6,723<span></span>
</td>
<td class="nump">$ 4,850<span></span>
</td>
<td class="num">$ (2,010)<span></span>
</td>
<td class="num">$ (16,951)<span></span>
</td>
<td class="nump">$ 37,513<span></span>
</td>
<td class="nump">$ 7,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share attributable to common shareholders - Basic (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (0.06)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.07<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share attributable to common shareholders - Diluted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,423<span></span>
</td>
<td class="nump">$ 14,356<span></span>
</td>
<td class="nump">$ 24,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">4,969<span></span>
</td>
<td class="nump">1,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reduction in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Income tax expense related to deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,011<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain on derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,600)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,581)<span></span>
</td>
<td class="num">$ (5,805)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114001942&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6800164736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember', window );">Allowances for Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 3,688<span></span>
</td>
<td class="nump">$ 3,245<span></span>
</td>
<td class="nump">$ 4,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Operations</a></td>
<td class="nump">5,974<span></span>
</td>
<td class="nump">4,705<span></span>
</td>
<td class="nump">4,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Write-Offs, net of recoveries</a></td>
<td class="num">(5,957)<span></span>
</td>
<td class="num">(4,262)<span></span>
</td>
<td class="num">(4,834)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Other Changes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">3,705<span></span>
</td>
<td class="nump">3,688<span></span>
</td>
<td class="nump">3,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Valuation Allowance for Deferred Tax Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Period</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">46,454<span></span>
</td>
<td class="nump">55,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Operations</a></td>
<td class="nump">113<span></span>
</td>
<td class="num">(3,007)<span></span>
</td>
<td class="num">(8,894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Write-Offs, net of recoveries</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(43,333)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Other Changes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 1,189<span></span>
</td>
<td class="nump">$ 1,076<span></span>
</td>
<td class="nump">$ 46,454<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>109
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_O"["5NOS=[\8^.K8-?"KW_1?0%02P,$%     @ E9I<3IE<G",0!@  G"<
M !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T
M$W-I=MNTF83M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY
M\^XN8NB&B)3R>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2
MP]R"BPA+>!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA
M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M
M&N#C\7@XMLO2BW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_K
MFVB<"HU;3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K
M>A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T
M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)
MI#-ZG7TZSFN4?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R
M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M1D\#"A>IN[GJ<WM2V8%D_7@(H^E/4/T!4$L#!!0    ( )6:7$[5J]*@G 0
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M8Z,2>V5>F7YO^SM#WU#R--R'@O%2MOH/4$L#!!0    ( )::7$XNJZUO0@4
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M#<+W[NS08C-+)348+ZTA#NJ<WF^/IWV,3P%/$@:_.)-8R<7:YVA\KG*ZB8)
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M1UCJ>4/)4OQGN(+"\* $<U1&N;B2:G3>Z(4%I6CQ/.^RC_LTWV3I ML'\ 7
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MMA@*:A^.'_!LIS&;#&_Z^0>QY1L7OP%02P,$%     @ EII<3L8UML>U 0
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M0>7#<8]G.X[9:'C333^(S=\X_PU02P,$%     @ EII<3K&V-&VS 0  T@,
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M_FRF,9L,A_W\@]CRC8O?4$L#!!0    ( )::7$X*?I]UM $  -(#   9
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M>P2%8TY3^NIXE$WK@H,562\:^ GN5W\RWF*+2B4U=%9B1PS4.;U-#\=]P$?
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M"=/(SI(S.O^RL?\UH@,O97?E1ZCU'VPQ%-0N'#_YLYG&;#(<]O,/8LLW+OX
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MOFSL?VV,!Y22W.$(M?C!%D-![</Q+9[M-&:3X4T__R"V?./B-U!+ P04
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MC.]V=TP+:6B9)]_9ECD.7DD#9TO<H+6P/T^@<"SHGKXZGF3;^>A@9=Z+%KZ
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M[FG1\(.VMZ6YE\/<.2RTZ,>9.ID&^\U?4$L#!!0    ( )::7$XQ3_O5M@$
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M'+MI9%MJ6DV;U$I1IVV?B7U^4<%X@./VWQ>PZWDI7PQW//<\=_B.=)3J53<
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M971S+W-H965T,S N>&UL;5/;;IPP$/T5RQ\0@Y?<5H"4312U4BNM4C5]]L(
M5GPAMEF2OX]M"*4I+[9G/.?,F?$X'[5YL1V 0V]2*%O@SKE^3XBM.I#,7N@>
ME+]IM)',>=.TQ/8&6!U!4A":)%=$,JYPF4??T92Y'IS@"HX&V4%*9MX/(/18
MX!1_.IYXV[G@(&7>LQ9^@?O='XVWR,)2<PG*<JV0@:; =^G^D(7X&/#,8;2K
M,PJ5G+1^"<;WNL!)$ 0"*A<8F-_.< ]"!"(OXW7FQ$O* %R?/]D?8^V^EA.S
M<*_%'UZ[KL W&-70L$&X)SU^@[F>2XSFXG_ &80/#TI\CDH+&U=4#=9I.;-X
M*9*]33M7<1^GF^QZAFT#Z R@"^ FYB%3HJC\@3E6YD:/R$R][UEXXG1/?6^J
MX(RMB'=>O/7><TEODYR< ]$<<YABZ"HF72*(9U]2T*T4!_H?G&[#=YL*=Q&^
M6V>_O=HFR#8)LDB0_5-B^J7$K9BO*LFJIQ),&Z?)HDH/*D[RRKL,[!V-;_(W
M?)KVG\RT7%ETTLZ_;.Q_H[4#+R6Y\"/4^0^V& (:%X[7_FRF,9L,I_OY!Y'E
M&Y<?4$L#!!0    ( )::7$ZVL[2<T0$  )P$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;&U4[V[;(!!_%<0#E(0D;A+9EII.U29M4M1IVV=BGVU4
M,"[@N'O[ 78\+^.+X8[?GSL,I(/2;Z8!L.A#BM9DN+&V.Q)BB@8D,P^J@]:M
M5$I+9EVH:V(Z#:P,)"D(7:T2(AEO<9Z&W%GGJ>JMX"V<-3*]E$S_/H%00X;7
M^)9XY75C?8+D:<=J^ [V1W?6+B*S2LDEM(:K%FFH,ORT/IX2CP^ GQP&LY@C
MW\E%J3<??"DSO/(%@8#">@7FABL\@Q!>R)7Q/FGBV=(3E_.;^DOHW?5R80:>
ME?C%2]MD>(]1"17KA7U5PV>8^MEA-#7_%:X@'-Q7XCP*)4SXHJ(W5LE)Q94B
MV<<X\C:,P[B2W&AQ IT(=";L X&,1J'R3\RR/-5J0'K<^X[Y7[P^4K<WA4^&
MK0AKKGCCLM><'C8IN7JA"7,:,72!6<\(XM1G"QJS.-'_Z#1.WT0KW 3Z9NE^
M.,0%ME&!;1#8_M/B]J[%&&87-]E%3781@>3.)(9YC)LD49,D(K"_,XEA[K>+
M+$Z'!%V'>V%0H?HVW,E%=KYZ3S2<KK_P\=Y^8[KFK4$79=T9#2>I4LJ"*V7U
MX!INW%,Q!P(JZZ>/;J['"S,&5G736T#F!RG_ U!+ P04    " "6FEQ.-ZHT
M#[4!  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6QU4]MNG# 0
M_17+'Q"#(4VT J1LHJJ54FF5*NFS%P:PX@NUS9+^?6U#*$WIB^T9GW/FXG$Q
M:?-J>P"'WJ10ML2]<\.!$%OW()F]T@,H?]-J(YGSINF('0RP)I*D(#1)/A')
MN,)5$7TG4Q5Z=((K.!ED1RF9^74$H:<2I_C=\<2[W@4'J8J!=? =W/-P,MXB
MJTK#)2C+M4(&VA+?I8=C'O 1\,)ALILS"I6<M7X-QM>FQ$E(" 34+B@POUW@
M'H0(0CZ-GXLF7D,&XO;\KOXYUNYK.3,+]UK\X(WK2WR+40,M&X5[TM,76.JY
MQF@I_A$N(#P\9.)CU%K8N*)ZM$[+1<6G(MG;O',5]VF^R=.%MD^@"X&NA-L8
MA\R!8N8/S+&J,'I"9N[]P,(3IP?J>U,'9VQ%O//)6^^]5%F2%.02A!;,<<;0
M#29=$<2KKR'H7H@C_8=.]^G9;H99I&=;>O(?@7Q7((\"^5\"Z8<2]S#9AR!D
MTU,)IHO39%&M1Q4G>>-=!_:.QC?Y Y^G_1LS'5<6G;7S+QO[WVKMP*>27/D1
MZOT'6PT!K0O'&W\V\YC-AM/#\H/(^HVKWU!+ P04    " "6FEQ.-RJE-;8!
M  #2 P  &0   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6QM4]MNG# 0_17+
M'Q"S+)M&*T#*IHI2J956J=H^>V$ *[Y0VRSIWW=L"*$I+[9G?,Z9B\?Y:.R+
MZP \>552NX)VWO='QES5@>+NQO2@\:8Q5G&/IFV9ZRWP.I*49&F2W#+%A:9E
M'GUG6^9F\%)H.%OB!J6X_7,":<:"[NB;XUFTG0\.5N8];^$[^!_]V:+%%I5:
M*-!.&$TL- 6]WQU/6<!'P$\!HUN=2:CD8LQ+,+[4!4U"0B"A\D&!XW:%!Y R
M"&$:OV=-NH0,Q/7Y3?TQUHZU7+B#!R-_B=IW!;VCI(:&#](_F_$)YGH.E,S%
M?X4K2(2'3#!&9:2+*ZD&YXV:53 5Q5^G7>BXC]--=IAIVX1T)J0+X2[&85.@
MF/EG[GF96S,2._6^Y^&)=\<4>U,%9VQ%O,/D'7JOY3[9Y>P:A&;,:<*D*\P[
M@J'Z$B+="G%*_Z.GV_3]9H;[2-^OZ<EA6R#;%,BB0/:/0/:AQ"W,[8<@;-53
M!;:-T^1(908=)WGE70;V/HUO\@Z?IOT;MZW0CER,QY>-_6^,\8"I)#<X0AU^
ML,60T/AP_(1G.XW99'C3SS^(+=^X_ M02P,$%     @ EII<3K,A^!#$ 0
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MXM17"QJS.-%W=!JGI]$,TT!/M_3D$!?81P7V06#_7XGI38DQS#YNDD5-LHA
M=F,2P]S?F)#-Q4G0;7BR!E5J[$.[;*)K5SS0</'_X'-+?6.ZY;U!%V7=\PF7
MW"AEP:62W+E<.M?%ZT) 8_WT@YOK^2W/"ZN&I4W)^J\H_P)02P,$%     @
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MKXFYRVGT)T.+?MYJ>%FM^5]02P,$%     @ EII<3D^H<A33 0  G 0  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL=53KCIP@%'X5P@,LBC-V.E&3
MG=TT;=(FDVVZ_<WH\9(%L8#C]NT+Z%H[9?\(Y_!=SD$@FZ1ZT2V 0:^"]SK'
MK3'#D1!=MB"8OI,#]':EEDHP8T/5$#TH8)4G"4YH%*5$L*['1>9S9U5D<C2\
MZ^&LD!Z%8.KW";B<<ASCM\13U[3&)4B1#:R![V!^#&=E([*J5)V 7G>R1PKJ
M'-_'QU/J\![PW,&D-W/D.KE(^>*"+U6.(U<0<"B-4V!VN,(#<.Z$;!F_%DV\
M6CKB=OZF_LGW;GNY, T/DO_L*M/F^(!1!34;N7F2TV=8^MECM#3_%:[ +=Q5
M8CU*R;7_HG+41HI%Q98BV.L\=KT?IWDE31=:F$ 7 ET)!^]#9B-?^2,SK,B4
MG)":]WY@[A?'1VKWIG1)OQ5^S1:O;?9:)/20D:L36C"G&4,WF'A%$*N^6M"0
MQ8G^1Z=A>A*L,/'T9$NG:5A@%Q38>8'=/RU^O&DQ@$FBL,D^:+(/",0W)B',
M.UN1!DW2@$!R8Q+"[&Y,R.9T"%"-OQ<:E7+L_9W<9->K=T_]Z?H+G^_M-Z::
MKM?H(HT]H_XDU5(:L*5$=[;AUCX5:\"A-F[ZP<[5?&'FP,AA>0O(^B 5?P!0
M2P,$%     @ EII<3K;17M[! 0  -P0  !D   !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL;51A;]L@$/TKB!]0$ARW761;:CI-G;1)4:>UGXE]ME'!N(#C
M[M\/L.-Z&5\"=W[OW3O@DHU*OYD6P*(/*3J3X];:?D^(*5N0S-RH'CKWI59:
M,NM"W1#3:V!5($E!Z&9S2R3C'2ZRD#OJ(E.#%;R#HT9FD)+I/P<0:LSQ%E\2
MS[QIK4^0(NM9 [_ _NZ/VD5D4:FXA,YPU2$-=8X?MOM#ZO$!\,)A-*L]\IV<
ME'KSP?<JQQMO" 24UBLPMYSA$83P0L[&^ZR)EY*>N-Y?U+^%WETO)V;@48E7
M7MDVQ_<855"S0=AG-3[!W$^*T=S\#SB#<'#OQ-4HE3#A%Y6#L4K.*LZ*9!_3
MRKNPCK/^A18GT)E KPAD*A2<?V66%9E6(]+3V??,7_%V3]W9E#X9CB)\<^:-
MRYZ+)$DS<O9",^8P8>@*LUT0Q*DO)6BLQ('^1Z=Q>A)UF 1ZLJ;3+W&!751@
M%P1V_[1X>]5B#',7+Y)&BZ01@?NK(C',=2=D=7$2=!.>K$&E&KHP+JOL,A4/
M-%S\)WP:J9],-[PSZ*2L>S[ADFNE+#@KFQOGI753O 0":NNW=VZOI[<\!5;U
M\YB2Y;^B^ M02P,$%     @ EII<3M;OE0>W 0  T@,  !D   !X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL;5/;;IPP$/T5RQ\0@R%-L@*D;*JJE1IIE:KM
MLQ<&L.(+M<V2_'UL0RA->;$]XSEGSHS'Q:3-L^T!''J10MD2]\X-!T)LW8-D
M]DH/H/Q-JXUDSINF(W8PP)H(DH+0)/E$).,*5T7TG4Q5Z-$)KN!DD!VE9.;U
M"$)/)4[QN^.)=[T+#E(5 ^O@![B?P\EXBZPL#9>@+-<*&6A+?)\>CGF(CP&_
M.$QV<T:ADK/6S\'XUI0X"8) 0.T" _/;!1Y B$#D9?Q9./&:,@"WYW?V+[%V
M7\N967C0XC=O7%_B6XP::-DHW).>OL)2SS5&2_'?X0+"AP<E/D>MA8TKJD?K
MM%Q8O!3)7N:=J[A/\\W-W0+;!] %0%? ;<Q#YD11^6?F6%48/2$S]WY@X8G3
M _6]J8,SMB+>>?'6>R]5EB<%N02B)>8XQ]!-3+I&$,^^IJ![*8[T/SC=AV>[
M"K,(S[;P['J?(-\ER"-!_D^)Z8<2]V(^JB2;GDHP79PFBVH]JCC)&^\ZL/<T
MOLG?\'G:'YGIN++HK)U_V=C_5FL'7DIRY4>H]Q]L-02T+AQO_-G,8S8;3@_+
M#R+K-Z[> %!+ P04    " "6FEQ.?'G'Z[@!  #2 P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6QM4]MNW" 0_17$!X1=[+3;E6TIFRAJI59:I6K[
MS-KCBP*,"WB=_GT!.ZZ;^ 68X9PS%X9L1/-L6P!'7I34-J>M<_V1,5NVH(2]
MP1ZTOZG1*.&\:1IF>P.BBB0E&=_M/C E.DV++/K.ILAP<++3<#;$#DH)\^<$
M$L><[NFKXZEK6A<<K,AZT<!W<#_ZL_$66U2J3H&V'6IBH,[IW?YX2@,^ GYV
M,-K5F81*+HC/P?A2Y707$@()I0L*PF]7N <I@Y!/X_>L29>0@;@^OZH_QMI]
M+1=AX1[EKZYR;4X/E%10BT&Z)QP_PUS/+25S\5_A"M+#0R8^1HG2QI64@W6H
M9A6?BA(OT][IN(_3S6TZT[8)?";PA7"(<=@4*&;^()PH,H,C,5/O>Q&>>'_D
MOC=E<,96Q#N?O/7>:Y&D2<:N06C&G"8,7V'V"X)Y]24$WPIQXN_H?)N>;&:8
M1'JRIB>';8%T4R"- NE_):9O2GR/X<FG-T'8JJ<*3!.GR9(2!QTG>>5=!O:.
MQS?Y!Y^F_9LP3:<MN:#S+QO[7R,Z\*GL;OP(M?Z#+8:$VH7C1W\VTYA-AL-^
M_D%L^<;%7U!+ P04    " "6FEQ.$\\Z9,T#  !!$P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6R56.UNVC 4?94H#]#$=N*$"I *=-JD3:HZ;?N=
M@H&H2<P2 ]W;+U^EQ#Z&P@^2F'/O/;[VN29W?)3E:[450CEO>594$W>KU.[>
M\ZKE5N1)=2=WHJA_6<LR3U3]6&Z\:E>*9-4:Y9E'?9][>9(6[G3<CCV5T['<
MJRPMQ%/I5/L\3\I_,Y')X\0E[OO <[K9JF; FXYWR4;\%.K7[JFLG[R3EU6:
MBZ)*9>&48CUQ'\C](XL;@Q;Q.Q7'ZNS>::;R(N5K\_!M-7']AI'(Q%(U+I+Z
M<A!SD66-IYK'W]ZI>XK9&)[?OWO_TDZ^GLQ+4HFYS/ZD*[6=N+'KK,0ZV6?J
M61Z_BGY"H>OTL_\N#B*KX0V3.L929E7[[2SWE9)Y[Z6FDB=OW34MVNNQ]_]N
MA@UH;T!/!H1?-&"] ?LP""X:!+U!\%F#L#<(-4I>-_<VF8M$)=-Q*8].V>V'
M7=)L.W(?ULNU; ;;U6E_J_-9U:.'*0O"L7=H'/6868>A9Q@R1#R:"!;P$\:K
M&9QH4$1C1@T'=!AB;B*8QG-A0F)?(WHISH F@]EBK3D;S#/"#@+H(&@=! ,'
ML9;N#L-;3-%B K_Y: DQ803 %E=A ]8A9!T"UB.-=8<)S^/$,>(-@",.@(^A
MR5SW..#.(7=N<"?ZQIEQ@Q)#C.8F+H Y!_Z""\0C2#PRDQYJ@6:1$8A'B+B)
MB] $%R:.^/0"\Q@RCP%SK6+,8C,20\P!CJ+-<MW?@/@($A\!XEH=FHV,0)#/
M5=B #O%Q<?8!(:979Q\L&L@DP%VD9#DO"* 4:-NH!YU+UQ8%'@</A((HH<4%
M+M7DAEI-<+$FH%J'7%OH'G2>UO!26G&%):#$AC:VN- 1?L.$<<DAJ.;HQQ,Q
MBT2(%' =-Z2$:PE!Q61D<8%534:?3PS%0J1 B%POQCUH>& A)0)@IT3CW\IU
MCT/V6+,4:)83BPLL2$IOR"$6)&6 A5Y=(8A9XF#54J!:'NAQ$,A28"B6+ 62
MY5R/@T"VO&%=4_,?#..Z*"'((A.*Q4^!^"/;1L-BI?$-NP2+E8(SV,PJ EGB
M,*QH!A0=633!L*P8^?QL&985 ^><H0D$BFRO+9;W%B0K71,(%%FTQ[#V&)*5
MOGH(% 66.%A[#,E*UP0"11:-,ZP]!F0565YL&985BV[8)5A6#)R!9E8!*-+C
M>&=M@5R4F[9'4SE+N2]4\UI\-GKJ SW0IJV@C<_(_:+KYGRXZ9I+/Y)RDQ:5
M\R*5DGG;6EA+J43-T;^K5V0KDM7I(1-KU=Q&]7W9-76Z!R5W?</*.W7-IO\!
M4$L#!!0    ( )::7$XH1W:&E (  !4*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;)56;:^:,!C]*X0?()1W#9+XMFS)EIB[W.USQ:KD F5MU;M_
MO[8@"CXX_2)M/>?TG):'-CY3]L$/A CCL\A+/C4/0E03R^+I@128CVA%2OG/
MCK(""]EE>XM7C."M)A6YY=AV8!4X*\TDUF-KEL3T*/*L)&MF\&-18/9W3G)Z
MGIK(O R\9?N#4 -6$E=X3WX2\5ZMF>Q9K<HV*TC),UH:C.RFY@Q-5FBL"!KQ
M*R-G?M,V5)0-I1^J\VT[-6WEB.0D%4H"R\>)+$B>*R7IXT\C:K9S*N)M^Z+^
M18>783:8DP7-?V=;<9B:D6ELR0X?<_%&SU])$\@WC2;]=W(BN80K)W*.E.9<
M_QKID0M:-"K22H$_ZV=6ZN>YT;_08(+3$)R6(.=^1' ;@GLE! \)7D/PK@3O
M(<%O"'Z/8-79]6(NL<!)S.C98/7[4&'UVJ&)+[<K58-Z=_1_<CVY'#TE;AC%
MUDD)-9AYC7$ZF'$7L[C'H!9A20>M#0>R,7?NIXCLWA3W&*>+6 (J?A>RNH?<
MS-,QZH+KY6J^VS$ZD-0#!3PMX'4$>CD6-6:L,:7&>-X(]<("(#2*8"L^:,4'
MK+BP0  *!,\O1@@*A( #K[<8$*:WJ\LG,*O'F([9"#0;W0L$ VG'H,#X^>5"
M-ERM-N"A__: H(%]10-?!00L5C @ 5;T##DOI(5K#;G_3SL'04-IX9)$0$V&
M0U;A4D+^"VGA8D+!,WL+@$)G8!ZXYA!4".& !%P)*'HA+5P+:/S,W@*@N[36
MS5%7$+;7]PYNI/18"O6EOQEM[S8S1QV5O?&%NO/H(_0J4U^8?F"VSTIN;*B0
M![$^+G>4"B(]VB.Y\P=Y1VL[.=D)U0QEF]47E;HC:-5<PJSV)IC\ U!+ P04
M    " "6FEQ.EQT1$2P#  !/#0  &0   'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6R55VUOFS 0_BN([RM^ 4.J)%*3:-JD3:HZ;?M,$R=!!<RPDW3_?K:A
ME-A'E7T)V'GN\7/GN\.>7T3[(H^<J^"U*FNY"(]*-?=1)+='7N7R3C2\UO_L
M15OE2@_;0R2;EN<[:U25$4&(155>U.%R;N<>V^5<G%19U/RQ#>2IJO+V[XJ7
MXK((<?@V\50<CLI,1,MYDQ_X#ZY^-H^M'D4#RZZH>"T+40<MWR_"!WR_(<08
M6,2O@E_DZ#TPKCP+\6(&7W>+$!E%O.1;92AR_3CS-2]+PZ1U_.E)PV%-8SA^
M?V/_;)W7SCSGDJ]%^;O8J>,BS,)@Q_?YJ51/XO*%]PXE8=![_XV?>:GA1HE>
M8RM*:7^#[4DJ4?4L6DJ5OW;/HK;/2\__9@8;D-Z # :8?6A >P/Z;A!_:!#W
M!K%C$'6NV-AL<I4OYZVX!&VWO4UNL@C?QSKZ6S-I@VW_T^&1>O:\I%DVC\Z&
MJ,>L.@P98?" B#3[L 2!EE@1SYQ<+[#V$32YAFQ\2(9@$13TDUI[>N7G#":(
M08+8$L1C@AER M5AF,74G:=IXD1S[8,P(LQQUP>E"87E)J#<!) [L6L,)&"W
M!RP%"5) @;/QJPZ3C-R,T<2V9N B&;#(1)QF(,'L=C<Q@BL( 1IBMX20YVF6
M.HD!8"AQZP  Q?&$WHF*QS=D<@\:+X,90JYB'Y40XBH&0&QBCS#801XP 20G
MKF3BK?,)8XI=S0 L9<@5#:!(1B94PRT'4T U<U53/SH)<S7[(#=[-@!FG#W7
M@N$6AZ$>ETY0P&T')_]13W#CP>R6>F) &7A;[8-(2MVX^2!*LPG%<*?#4*OS
M*LKO=3B+7<4^*$&QJQA@FDUT30RW30SU3:^@,J &W _S&D)1ZG[/0*YD*CWA
M5HUGM]33S-].=R_6/8A]E#T; #3.GNN##_QI(-"G82*W"-RM";Z]H C</0G4
M/=WT[$'L*O/<I(I&I\J*MP=[8I?!5IQJ90YGH]GA5O!@+P7._$K?%KJS_3M-
M=]7XGK>'HI;!LU#ZS&M/IGLA%-<:T9W>U:.^W0R#DN^5>4WU>]L=\;N!$DU_
M?8F&.]3R'U!+ P04    " "6FEQ.8=8H;,(!  !%!   &0   'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6R-E,ENVS 0AE^%X+VA3"VI#4E G:)H@18P4J0]
MT]+($L)%)6DK??N2E"PX"0^]B)SAS#?S<U$Y*?UL>@"+7@27IL*]M>..$-/T
M()BY4R-(M](I+9AUICX1,VI@;4@2G- D*8A@@\1U&7P'79?J;/D@X:"1.0O!
M]-\]<#55>(.OCL?AU%OO('4YLA/\!/LT'K2SR$II!P'2#$HB#5V%/VUV^\+'
MAX!? TSF9HZ\DJ-2S][XUE8X\0T!A\9Z G/#!1Z <P]R;?Q9F'@MZ1-OYU?Z
MEZ#=:3DR P^*_QY:VU?X(T8M=.S,[:.:OL*B)\=H$?\=+L!=N._$U6@4-^&+
MFK.Q2BP4UXI@+_,XR#!."_^:%D^@2P)=$^BL92X4.O_,+*M+K2:DY[T?F3_B
MS8ZZO6F\,VQ%6'/-&^>]U.EV6Y*+!RTQ^SF&WL1D2;+&$,=?B]!H$1H Z2O
M)@Y(HX T +)7 /JFRSFF"#%R5I+EVSQ>)HN6R2)ETC@@CP+R_Q=:1 %%I(/L
MC=#BG= /]_3=@9";&^ ?V ^F3X,TZ*BLNTSAR#NE+#AB<N?Z[MV;7@T.G?73
M>S?7\\V>#:O&Y=&2]<]1_P-02P,$%     @ EII<3K=K$AY) @  K0<  !D
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M*1,P?F,"[E6^/5V4:M?UIXDY;\8O ^-%IP_35X_H].EE]0=02P,$%     @
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M_<C)CHG7F+]7S76U^6#TJ*[B7OO_P.P_4$L#!!0    ( )::7$Z.FYRLSP,
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MF)KC=GP%-9YH=;*OUZ+I'=_V?U!+ P04    " "6FEQ.,"/JJ& #  !0#P
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M^XYW.&7@ Y0!G#(PA3+@XB-)9&HOB:N2TE?^@#,&IC &7'C0V$$,HDI\AP?
M 0-3 #.(QD=;21.K7E:(JCL VYY=59PPVW0TNJET=\WO6;W/JR9XT:VY]/17
MDYW6K3(9R8.9_\%<;V^-0NW:[E6:]_IZQ[LV6GT<[J_1[1*]^ =02P,$%
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MX^ZZ'C^]CC=M=3*?E8/+M^W-_U!+ P04    " "6FEQ.Y'OW#@$%  !\'0
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MHS+51-=%_S;U#<7;X=U%X^-?_ -02P,$%     @ EII<3JWGBHI_!   \!@
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MPX>:M:V1@1'K"_(CAII'I)%#S9.M(6G$^HHT1EW/*!9=-7ZSMM<%YG"!>>=
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M"(DV75:]]J;+P9UT/)$!:*1C?R$Q#7+"IDMB&B28#M;SC18-M^>W'T(Q.!*
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M",EC"365#[R%1O\Y<U%3I8?B@F0K@)YL4,T0"8(8U;1J_"*W<WM1Y/RJ6-7
M7GCR6M=4_-T"X]W&Q_[[Q'-U*9690$7>T@O\!/6KW0L]0B/+J:JAD15O/ 'G
MC?^(USML RSBI8).3OJ>2>7 ^:L9?#MM_, X @9'92BH;FZP \8,D_;Q9R#U
M1TT3..V_LW^QR>MD#E3"CK/?U4F5&S_UO1.<Z96I9]Y]A2&AR/>&[+_##9B&
M&R=:X\B9M%_O>)6*UP.+ME+3M[ZM&MMV_9\H'<+< 60((&, 7OTW(!P"PED
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M3;: G#E7H"F#!VVYU&_*.&!P5J:;Z+[H"VL_4+P='@TTOES%/U!+ P04
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M;W<4J2NWQ+]68F D8,%2)3 +,B)+2<R"1#'IK@&MD.BJ 8TGY+'H=C+$MQ)
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M352?]]=U/Y"L'9XB-+Z'V3]02P,$%     @ EII<3FQD(H>V @  $ H  !D
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M1FK.^YO?+R1KAT<-C2]K^A]02P,$%     @ EII<3OY@X:0" @  Q04  !D
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MG@RF-9BG3>C-?XO6'M88T:+T>\QNAK&IH]GWIL K,TO"R5G?2MVVF7<:U^=
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MPZ"/_JLZJ<+*'8E=8ZV+IOT,UL?&Z++W8E'*[*U[YE7[//?^W\UP ]8;L,'
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M>)*#:H5UP[J7<A"JFGBACO.H7DGF02WVPWB;J_MNZLNGP2!/YITCFE]\UO\
M4$L#!!0    ( )::7$Z#B$H$\ $  -L$   9    >&PO=V]R:W-H965T<R]S
M:&5E=#@S+GAM;'U4VVZC,!#]%>0/J+F%9B- :A*MNM*N%'6UW6<'AHMJ8VH[
MH?OW:QM"":"^8,_XG#,7/(X[+MYD!:"<#T8;F:!*J7:'L<PJ8$0^\!8:?5)P
MP8C2IBBQ; 60W)(8Q;[K1IB1ND%I;'TGD<;\HFC=P$DX\L(8$?_V0'F7( _=
M'"]U62GCP&G<DA)^@_K3GH2V\*B2UPP:6?/&$5 DZ,G;'4.#MX#7&CHYV3NF
MDC/G;\;XD2?(-0D!A4P9!:*7*QR 4B.DTW@?--$8TA"G^YOZ=UN[KN5,)!PX
M_5OGJDK0%CDY%.1"U0OOGF&H9X.<H?B?< 6JX283'2/C5-JODUVDXFQ0T:DP
M\M&O=6/7;M"_T=8)_D#P1X(7?4D(!D+P20B_)(0#(9P1<%^*[<V1*)+&@G>.
MZ/]N2\PE\G:A[GYFG+;9]DRW1VKO-=U^BV)\-4(#9M]C_ G&&Q%8JX\A_+40
M>W]!]^\#'):(8',/.2XA6W<]B6"USL#R@VD2?K0N$*X*A%8@O&O4XZQ1/2:R
MF*8/$H2S6I>8C3=K^'&)\0(_F&6+)[^8@2CM^$@GXY=&F4Y-O..$/OGFBLS\
M>SVY_:!]RO1C_XN(LFZD<^9*7T![30K.%>@<W0<]2Y5^:4:#0J',]E'O13]O
MO:%X.SPE>'S/TO]02P,$%     @ EII<3E?R]JP^ @  P@8  !D   !X;"]W
M;W)K<VAE971S+W-H965T.#0N>&ULC57;CILP$/T5Q ?$7$P"$2!M$E6MU$K1
M5MT^.V02T!I,;2=L_[ZV(2PAWE5?L#V<RXPQX[1C_%64 -)YJVDC,K>4LETC
M)(H2:B(6K(5&O3DQ7A.IEOR,1,N!' VIIBCPO"6J2=6X>6IB>YZG[")IU<">
M.^)2UX3_W0!E7>;Z[BWP7)U+J0,H3UMRAI\@?[5[KE9H5#E6-32B8HW#X92Y
M3_YZYWN:8! O%71B,G=T*0?&7O7BVS%S/9T14"BDEB!JN,(6*-5**H\_@Z@[
M>FKB='Y3_V**5\4<B( MH[^KHRPS-W:=(YS(A<IGUGV%H:#(=8;JO\,5J(+K
M3)1'P:@P3Z>X",GJ046E4I.W?JP:,W:#_HUF)P0#(1@)_O)30C@0PG<"_I2
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M"B2?6+=DLB8H=8Q=L$FFR4"SR=)!*-^)8<<IZ#@%'!O3K %,=&<_*"_0QO<
M"63N?&^2&=])C,3T(.,WN;/*Z$X90H ;WW2#H(D"T\X'J%L[8,E:(1^P<T\"
M+CCH/RH.@DL. FI.-"G.4-&9Y 0"&4K;#T"=8W=TL%2$G?6AS:T#O=1"U>?1
MZ' Q6/GJ8#+&U^K"H ^L=YGNMO$#LW-1<VM/A3SV].%THE00Z=%S9$G*Y05G
MZ)3D)%1S)MNL.^6[CJ!-?X-QAVM4]@]02P,$%     @ EII<3K_F73Z] 0
MT@,  !D   !X;"]W;W)K<VAE971S+W-H965T.#DN>&UL;5/;;IPP$/T5RQ\0
M[QK(905(V515*[72*E6;9R\,%\47:ILE^?OX0BA)>;$]XS-GSHS'^:3TL^D
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M\P'H :%D*&L!O0;]&T\<4%"@$DIFJ04PVB=B&9/ID>&4%=K@GN'\06)U(/:
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M[!PN%:SL_=UC SIF5KI.3TTKL%0/&&E#2V:'S%?FW1XT&_4N)O![=LNZB+8
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MYNX&9/9C#G/6GC$?"?C.$S&I?EI-+XTH#\>%WI<X=A2U>3UT:1JY"7 0NAY
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M3/\VQ>M3]20+/KTTH143J<TX:E^IHS;ISR"D,=#BKM'_A4Y%22G+@DP@GP1
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MK;H_L"%-59;YMJ,7PUK<UMEN1_ZY5;5V?KI68AK(O*TK#[PHBLRQR^WVAP=
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MZZ]1QO3XPDMGDM[+8;$&1)Y26%0R2C$L7KZU\"86I9Z@'['FSAF&U%LFDMW
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MZRZ]BJ1>8,0#V6:EX!J9,-H8Y/M;1<@Q D]=\\?)RZS->O**R0325QZW7\Q
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MJ9CGJA08X#-SQ41B3M=A8J5F)T7NLB^4L8,/C",^*F;=F+V*Y9W2 R+L4S;
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M! >E']14;BS4[JBN.= !7=;T@ _)^87!7'4>'_%;7@@7:'UU+^!8>I^!;H-
MH?S8N5?)<1SH,Y;X(3-\]'NX$BM:G)LAVGP)&HY)10$@6]TY?+8@K2Q.3<?>
ML/J\"7ATFHK5NK@NR#V/6SAK1Q?S^50T:$WXDN8\_!2#<)%?,<PL"\.K/>(T
M^N2K'>:X,E\/T7,#-$^5-QBM"D&?2NL0-]&< FKC ;Q4729-(A!4+-+4OO%<
M)5YRYS;6313T.\Q-F9R/_HC$/)[A+QSV(EEW6Z%PSK=E L-7Y(TI_G0 &$P/
M-_EC)=3EMU!7VD#RPTTJ$NC5P!QD.=T<E*NZN9@"!EQ]*3<55#&Z 2;P*%B!
M_@D:+Q);3?;N^_W-%O;/E4R(\A7]8:=8(^3UA&/)"_/]*X5O^Y&K7+V1 *N4
ML1-3$*!]'03)OK:R\PG'/YZ:\=6"Q4Q" *PP;0VF\TO]*E<;V A:R!7\S"4Q
M2>[EQ>R/C"7IW;A]!W(R^Z-^'2^\HC+W\#A\\YJ+$<86%2:D&5"('X[H 78L
MN/!5J9%]9!?Q.V[PYTA!H4T(!4RGE>HHAVWSX0@U63T<G$E9N'FTH%>9(%*L
M$9 ,#FJ4%>N"52(-$S3HHOE=*@2YDL42P] 5CA$97R^TCX$7#??^%R22LP]\
MB%YQ[IBC0&'M)[]\>/7JE]/A:PO726MW#-Q< VF% MYV0.#QE:TI5JD3]$:3
MP/$9"+E(9PA65962,.'6I3(K0J(R8<T85<%2;&F<^](&4<DV!CGS.6^^?)J:
MG@/9/8C/:6O)?*>8#R;W@+T2JYR>P\&BZGUW)*0;DKI!:>.SYC.92Q!3WR2J
M)X0*C($%T5H"MX4FVIJ$%:W;A%%>-U2Y"=^MLU*#!ZV!M-LXY<C@;CJTL&$;
M-)T^PM<5)0(=CS3_>X3W\)92CQ2HX5R= )$@3?F5IBD//952%9(V?/@X7_UW
M)#/TI41;[.S F1]Y['_E%,^WE&SN0=V'LKJAVSV>!9-[?28)J<FS9)Y.9@OZ
M>3&=^(>;:M,^X$;[9R?S=#X;H\O]<CI-WF/61VX:G9TMY,%Q.AM?P+_3Q276
ME +F@HM/2!K%%_R],0]#:_,Y_#M?CI*W'@O9XCFCBX8=ZHMT>C%*+A;I>'21
M7%RDB_D%O(0RC/$NK<W%Q^05W'O3:7JQ('3WZ8@<WJ<<\<$.V_%%.EK.>[U$
M)FB&9,7Q#U\3.M,!B)2XMVN,>X/]!>Z\[:)(!@]]%-W#1X<<0)1,ONRVSQL0
M^O)_^0,Q,Q"6__#GH8( @Q$<>G)1'_N<UX\F\_]YW]=4CPNK6/I*(4%Z/3KF
M)I?D[845GPXU$52X]&%>XW1Y.<9_%Q0.DHZ7A+N?7EPNQ+E-RF( 0O!-PQ0X
MK&?)+)TL1W0\1I=?.UIIY#*]G,!Q&*6C\9@#361\#>:.XH- L0B'"X\N)S"[
M$:R/?<XDBAK<!:QI ,]>7'@\[!#(@/7S"SBKZDK%6)TU@@YA^2 .:B4=Y7(Z
M@ZYG'%@S6LS9%S^9>*R$08B$Y^@+9J0Z0I3-'NL*#4.$WPW-S-(E!9>,YW!T
M)\F/54GE[L9T!B?I:+[@/EC).F9/@%'-+F!?+F?AJX<W89(NEMCA?#D-WC)0
M @[U89:.9TO\=S0+GOV<B84?&!P0X"0=CREF9YI.IQ,.WIDLQLE;Y^A2^ D>
MP_.OG2FLVB2]O%PP?QK/1U\Q7USOT037?T8-3& _+S&N9;),%S,]+=XG9V)<
MGP?$%P GVTC89PD?8UBD?@(<IXO)#'<:]C@L$@&':7J)D5&+F5FM80SOV24P
M?0?$,06F-:4Z(#"5.?OX)XMYS#L17:OOLZ\.KOO.^B[I^!Q[40^$UGUPE4EI
M/&_T,')EE,/?#D9.PMC>$BZ92V^&P5V<+T6QGI[/QW]$0_UP/<S0 8?+BV&0
MR Q.YI<+OB9'(X(7@H^6<[Q#Z?)54E&X\Q-@FM,@MH:WVG_P-EQ/#-],YU0R
MQ75U"11/Y5.DIRM3(.ZC%HB[SDN$,H_ W# &/ 1>BY#1:876[.L&*96:=JJ6
M-*YV*0,6=^5R43ATG7P>DXED?IWTCC!^]33EU!0!B1,GNF0PLM0OEY<+SEE1
MN07*14,T<P<'))/%C(')>!8DKE@P.P=9QQZ_D86V<V-V]',JZL2S<= D*"W5
MEO 'I.*(Z]XU\=$]$FT'2%IM=<L@]BZRHM-Q&GP<-@'LYI0UJR<[4Z6KX?+B
M;IA4U!./*-48P>4 Q?0^80*0H!$"\'=VZV?1FLJZ3.VG#9IP=H6/8' 7*^8"
MM? *^FQRV+R:W3$T6)X*)7CG7"T%MF5NTX59!:0R*V*$M-:G9_997SJCS!\.
M[!-9$5 O4[AW4/^S1X^-:(MPQ!91HN_>LT8(M>3]56?::6AZK% D<%;SPAFI
M-GENXE1*H^<%X 8FMH)+M-))40-"SWDH<L$"!>U2A"LU7N=?6B8>:,BRA\DD
MI*V#YY?SDSR1:2HK;5N>J9J)!U9'*:L98*5K:HFUV/KY,2?P',"'B(K=RI5?
M\7OV],FH:E^ZG8KK8@5EBBOP65:.67 5@[([B.B0S"P[H=/-%5DI6=$D;_DA
M,X3H%T%S(@="34C]2+^=!TTC\NBYB %<>H>$SKJ@ X)"7)C7T\#A!.DT2,#J
M[&A$O^<@I/:<B0[#"G+(8+'$Y$3X* T6V!/,&W:^X<1R0@55 )V)AC5(S73V
MCJ<Z5J)67FX3=H%XN&E$'?N24')]O7--J7I0W!$M3:6CK<KN$>F>-8S77]WE
MZSVFE"H^<<J JL+%.0N>,3)M.$[3GQ%/MAU''_?$@5QJ=9![RM;81H^23UPZ
MZI!VZ_V2O9,*/6/R'R*;%A*5U*G5S&7LB3EZR*&"BU'"9E9;.CB(]@-3Y> :
M3(B$5W8%@D744J$&#CR,67"1L"P;.AY@.]%J<D*5J[;Y_5U5%BO]% M8WK=4
MLJK<%!QO4M*KT,1IE'C5:%V0M1GPP2M4B-FQGJ)>[7=X6%:Y+6A("X+QM5PL
M3&\I/HU4MJ:ARO,PA771:.T>XA<"*F: DS"PIT&+3NB1.M1'?(UJ4R0IANEK
M3^4_^C/B"5F(7NS@U&@<8^^/^)"T+6$/P[D%DD3 @C E$<S2^4*2".;I)6<.
M3)(YZ+&7DD6@PK$F)HGX?>UOC:,/0'CL@#),#27,!\%B['3$L"('^V>9I;%U
MUG]ZPGF)$KP##10@(5(RO#AQM5#8+^3_3'SUJLZY^H%+MU.W;]_\^/XC,)QU
M_J7;^WNXFG[!4+#N8__4X> *PI!T3*_V-7HM\+JPH[FBE'OHCP?CBC/[OM3S
MEHA[I'>09B0HB6(E)NKEVP8O DO\BB9Y4]05^08* HK.:T0W1G"W>TK0+_>[
MR)4?E J/YO?"INNB">EM+JB#'U'1#^8KY].E4-F)D[P,\^:RS816@(O1WJG;
ME=. Z!8^ITZV3_8=;1KB1/21%LL);TD0QP52WICGT0EH3'$[^OH-J[@4FS4^
MGXV>C\^QIN@Y^C9'\B\Z,-^\27XB<&Z)XZK(WHX2567>0[0O'[@^@8_X<_SM
MC^C<'F%[TQ&V=Z!!_V+<X,PUB(,:T[_2X%\.M=<_P*D9X(P&..,!0JL'FK.O
M+6@8O$X7\/)AAMTC9)'?^BG1]J:J<\_A\(IG-Y@;4LQ3Z-CQI$PL&+Y,[Q5A
MJF+I!7.4:VB;"@Z>^2QF C@ V7[;LF#;)S=^A< 2W^THB1C)&'4GAY$HIV&=
M(3#?OB3ESI2=.THSB,KT=3F1 _#DK1_*)WHJI/<7\M9/>Z.O8YM,N!_-0W;/
M.BOF$W AKR_W;,.#CS=;+$GF*TRW\88VUM-*6@HV@9>_Q?'/74@U)Z-/M&:/
M\_Q<$FI_77S64F?'ZXT85$EX]^S6S<B5(EYFK< K@8Z^E.0&Q4 .)$-W U84
M_:I.25GMZ=D5W'.M!MII@^X&E_N"04TB,V"D]PWTY.*&[FLU[.94#UXN>2S%
MU?P@MZLI.JY)D/C5YU,;7@J?P =47JX@-[FJ!G)/?X:&&LDZZX%HX.A$?9U0
M7UP6[S]CP:2RGS_HODJZ#%2_P&J)&!AVIG][[&:'C667$0]?^7N]OV]7CV(-
MA!L/NEL]\@D1_%61AC-WU?)2)FQ$:.MJZV+K-L ,Y&14-QPEQ_:A>---8*?_
MK+^:LF<GG4HN+C'E6XTH6,_%Q]JYD3#)>1B^0!9@(=E) W5'$E')R\EYU%11
M=IMZ77S!,7)$Z8OJR19-$2"I T[RXP:!;;8V\@2ORX0NPJ<4%>6"R(4*21<H
M0G2TG@7JW3XA7A_,UKUKNOA>!YDQ+!!&=GLK^4GTP:F:"X[;?#9SA(BIN#$4
M=Z@E05?H5-Q0>++PC)2+,S+V4^!S.1F?<M0?9Z&0551CCCKU;_U*H1QHZ4
M 7'*V#0)ZL $05(0ZM>\J.B$Q ?"U\(4,RL6&.11U+ Y9T@T#55%T; 9LNYB
MBAR<4. "04T6CS@7%5N$._MW015>K[$V*_+IC5QG."YY0,1C,=]Q18;&FQK7
MF/I\ZO\4R]#31XX%<!+W%C,F<XT<G.#?S_%OT99,8? . -4RT2P"FT-RF7+3
M=(*>^Z9'(^TJ:%HDC$[CVLPD&N%HU#O"@=RC2\V>*/1L#;;0,)O@9"J.;1+4
M-KS38$<Q.)PW\-\1\I3H^8.S<IDLXD/<;!IOF,<*/V++U";#:%D*&-)S]P["
M>$4,(#8W%!&2/M9JS7-7M%,,N89<?:ED!QG9A9LJJS(J+V%!DZ*0ANB,'O:+
M]'0?5%I:N])VT%SD"XYR'IWFXB.];ROL=XTX><6]O4DSQU%!M/Z[HP:M5$M@
MG:C<]*CGB,T16,"ENG43"_U'J!T6">PK]18&+8(;#]-S6/TW4%J=P'H0*PG5
M$:VHV\>SZ@%).ZAVJ 'Z%!HC#7)FT1E5K<8=<V$S3L1WZ)I;W(N:,"NZ9^?8
M2QAIX-G$9H=T/'B$RHSN/4X7-^7EABZ%0^$>LH-]T1R%"SBZ=QA,A[UQBG^F
M?NF#-WO#K<BD/-;B2:^GY%2GZCP6&\9:YQMO&[F:@R)J)QT/\_"1A)?9-1M[
MJ[_.Q1RYE@\NVRG[-!Q#8M<)Y0J2P3B7*CIN82?C<\G;><(1O?YO[8C^8)S0
M^-H@67G7L:\>%P0R]!$]%YH7(M,C3;S[C"T.?<SXV=3N^37'<[\%A3*R"D6N
M95LJCRX;ZUL.(R*@TYS#C;W7)BI9JN525+ESR],WFJ@R7_X%!3JXQN]VSCAT
MTR;]D,R]L-R<O5D.M51UJCR,S="%&?8'PJ?QQ8C>I?RLVE#2YK[T:$^EQ@JZ
MP'+&@0QN6>OI/[3^OB3F[.F '%UEKW#(W=KOO@WHT4ON=,%&X"V^"&) #4WN
M-KAK^X)&V13]!H&* T.9K6EAXB@$ A,CQ"A]7_D1GP9U5M_6("6A'Y!-M3CD
MV)C-1NM>>W8JMEU\+;9@,W]@JV]H-<0K$&3_U%4$.V(W2BS-ZJ;IB=YO (XA
M9/8TY>M]^:G><V+\6Y+XV)@;ZGI7M[+!>)8IK!'HU4<Z1/B\AS:5CVS_8+O!
M( $K=RDV[$;EK ;C)W8^7G;L#D0(]'?-*>Y/APE(@ ##=74Q>FE)R<Y =B?S
M+LBK@G,3NCQ]/(#<*B=6??1 TH8E47J@]\J?NH/$N=V4KQ0,V_HXEI3NA;&$
MF'<BF]49A'S>OU;:G4?XM)W]\-\F4H+E2'N"!IC'5YYJHD'F!R9/MJ?-^,CC
M>\P0SE$!!'6/JVRAT3J$L@B,IAS=Z,3R0!*/>'+<JJ\\:0)I<, #7YX*"6O?
M)3ZF=5:B&N?:C'Q]ZD0OQ?0]QPZ<)GV@UY"Q-:CSFA>T^R#,B9!D(QCTE9E\
M24MZPNU&*WU*]QR[.?#0=GDKT1]N(NEO?6T,ZMSN7(8MXHV<'S6M:3H6K$>!
MIB<#F 6>!]XK"6\@#(U&H[%(FYQ]'S.8 #;>RQ\G3H@.(GHB!.E M%+Y*)3!
MJ%(Q^4=ZY2J.("2Q7:JM^U!)E$,^!_7'#]1T\"G$IP+7@B@5'L576!:'JP0P
M8Z:>6GSF3D(^AOKD*(+:P2>")>)@&%Z64X$14E^3T0FQ-H&%)#@]($DZ[ 0!
M3(CCK!!(387-#"^E:)%9EG"MV/@P"ZL/5'U&I1,84Y*TOWE/Y;$N0@N3HJD1
M*&Q<MOUK=D^Q5 Y,1VG-NQX.B<"DR3I9UEY*8G<@P!4#@?(:RRBMA1K(:DSR
M1A1@R'>'9V<+]?[&-$2B@^4]$I)2!58D/>YDYD#5P @NQ+S]:1<R<2>>/>4K
M/UQ?%6-Q/A[Y@F"$*S1-9Y-Q.I[,!_@'W(M"U^CYY>R^;D07QZ6$]A:^ZC@^
MKR5#)D;&VX$-GC,I7\A(.&>=NI@\H9.__/7JPZFI;Z9Q_78M' [?>.+E%_B_
M["X0ESF J3QRN WL)/Y!N!N$MB&!0/WT<#JTWT-1#-#%DF(.7/1.VB]1"I_V
M(M,@90V;-Y@H)_#OOJ1($#Q(!3E7%<%^G9(*315_"-* FJ<*0MT(9^M&CEU=
M=-:=[9O]^]#LP%9C1N4V.CG=!!_GG!_^"M/XVGK/+ 2/]L_YFH /KORU<522
MD.G-1X&16':- 0MO5!;XIG"'S LQ#.!6F@ %K088!"JPT&BJ5KNGHFCW=Y4S
MV5F$)^(W%*.+QJ>R9;R?*HSHZ@N7"<>KP2M!H3D?R+(A=VMM;*46\I)@7FJN
MSTVQ-O/)PA"^XFLPC\8]P]A9#C=G<>0FAZTD-HUU+"Z6IFPQB)DU]E5QP*:3
MK+KF2Y5--&ST-%63DQ:5<8QM8/ F#\L%.0?& Q-@%TV!:5*J/22_7K]D;4'(
MH"2[H( ,PPK%+P,7;IT+4HNK]&R7HR7@&[PEW0=AJ!@AY=P5;M%5;QHP]#OO
M2*H.U,_N63'Y-7#'9[Z.*SP[:)X?G$+1A&X:7ZH3=NU6<JO0[1I('1E*F1Z'
MTMC:0PG5^9K*M74]!<5 OJ:>R=>56J!NCZB#TF63AL^]=7.S*J!H##VW M*7
M)+$H]!H552K(L([1&%1?:+-A:"X.^8G@+U,)\]W=5.M'@2#!MU9;ELC8N5\U
M2'?&%GE7,1P2,5K&,>3H(<3LNR'IFT50K7$ED:;VS!$%N<@Y31CP:XO7MED=
M6XWYR?M@H P=THE<='3OEBO)/Z)ZA+Y5P;WW07TWC+]6,.WVR/D<!-8:XDU5
M!?/!#%X4_CK-DX6?>/^[%FJG"/VG\(<^A<30^)+BXV[DDNA*^[WZ#!O>U(@;
MQB7W1?;YM-R&!#>2R2(8W@ALWZ";,/M!NF3HKFWNT0\C%46'DG$NVB=&+;0C
MLI!ZF<^#9?'OEA,@/'9JJ--\;;%Q+*E.5INR?QD96GZAZ;SSV#/=M33$XLP
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MWP9EL<@NT/>?*VQ30P$C@FZ^"X"7)=S%XF.&2)@<5]$P+*1WII)=0K,XM.,
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M#==#M*UAJRNNL\(9Y</V ,W<<*&%+OX5CR0TR='Z&7N5&P/(;3YT.03EVF%
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MRR?]OKEXW'ISBQ(N:7-M+1&_8CC,1]-9-ICEQ:R7#:;YL-?S41'KYSI 4TX
M$Z1GAG&8F1>G?<^N$CWJL^$,4 )FDY%IHW[\.$U[/Q^9G@Z'9J*&%$'L7P$
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MN&T\*U(4]PKSPS"EZ,.)M.L60[[A:8T,K*Y.7#:(-X[X*7#-4G=#CM#R6\5
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M7Y?.C #?<\L:6>LB=-(>E[5/6EA,Z\QUQ4S!W=4A/,&J#R7=/$;:C=8NBPF
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MKU:]\.R8YX')\0Y0I$B9KNNF+F<!P6JP%:'!F(_IAKF7 '+9G4ZM#K04"CZ
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MT6X0W28]/<#,ZM>KRDI=]LJ+B=WMAN<>/&&4N,[O05D09H/@*Q2PGGF+6GO
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MYH;XXE#^7F:=U5G](-'#Y=(FR\V7_5U\U& L.BNO(-A!?(7M8UX"07"LJ1^
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M<7W6J#IXR1ZI2+F8_R@U0O*#D80/<]JM4#OX$K,/]YN5$4J I1/&Q2P&P,@
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M=.?Z<+,7)J+S8>\LMR%D1@^^\(E+WT(*!;J:<&[)D?56G'-()WFYWAXH3.>
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MD&PP'^3#@@,D\VF!-R<X(>&7M^%0OH!V#"=3[&@'MEBOH-]-6Z:FKD#>5Q>
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MP-."Y;+='"(V*70WFY%YVICKMT\::/WBG;4$)UW;^O&O\T7<MJ>FPTLB:G!
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M\Q=CM [ND28VZ\:F-QS*(<7UD0WVG)M&6XP"OX)'DRUG=K-3^:-E/UX]DSC
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M2D/C7I.Z$V]69!!P@!LCC/Y25?O_]7\!4$L#!!0    ( )::7$Z98)-N=P(
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M%1Z,ZE6SFB+$C?T58EKP<NKWFJ_&Z2]02P,$%     @ EII<3C.!@<T$!P
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M;5,44UNV5!>:NW)_CN<_!'_^#U!+ P04    " "6FEQ.[\T8:\,"  "Y-@
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MVP.]/5_O /0.?+T#T#OP]0Y [\#7.P"] U_O /0."[RK1"\K^7H'H'?@ZQV
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M+MG</N_^3[FM^B?"3"O*TV]02P,$%     @ EII<3O& UI=( @   C4  !,
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M+GAM;%!+ 0(4 Q0    ( )6:7$Y4$S(0[P   "L"   1              "
M 9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )6:7$Z97)PC$ 8
M )PG   3              "  ;<"  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ E9I<3NQQ+IW, @  -PL  !@              ( !^ @  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )6:7$Y(^=A/<P0
M *$5   8              "  ?H+  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    " "5FEQ.+Z6*.0X"   5!@  &               @ &C
M$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ E9I<3M6K
MTJ"<!   I14  !@              ( !YQ(  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( )::7$YUD\!T.P,  * -   8
M  "  ;D7  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "6
MFEQ.+JNM;T(%   3&P  &               @ $J&P  >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ EII<3H1L";+;!0  Y!X  !@
M         ( !HB   'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( )::7$XW@+8FL0$  -(#   8              "  ;,F  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "6FEQ.Q=8Q^+4!  #2 P
M&               @ &:*   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ EII<3F7%[GZT 0  T@,  !D              ( !A2H  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "6FEQ.4G)69+4!
M  #2 P  &0              @ %P+   >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( )::7$ZUU7'6M@$  -(#   9              "
M 5PN  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ EII<
M3D49E]VS 0  T@,  !D              ( !23   'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    " "6FEQ.YH^4:K4!  #2 P  &0
M        @ $S,@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( )::7$[&-;;'M0$  -(#   9              "  1\T  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ EII<3K&V-&VS 0  T@,
M !D              ( !"S8  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    " "6FEQ."GZ?=;0!  #2 P  &0              @ 'U-P
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( )::7$Y[H-16
MM0$  -(#   9              "  > Y  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ EII<3C*:>FZT 0  T@,  !D
M ( !S#L  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "6
MFEQ.%^TI#;0!  #2 P  &0              @ &W/0  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )::7$XW\83YM $  -(#   9
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M970R-2YX;6Q02P$"% ,4    " "6FEQ.0T##E+,!  #2 P  &0
M    @ $[20  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M )::7$Z+M,]"R (  .0+   9              "  25+  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ EII<3C%/^]6V 0  T@,  !D
M             ( !)$X  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    " "6FEQ.>4AQV-0!  "<!   &0              @ $14   >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( )::7$YEC28[M@$
M -(#   9              "  1Q2  !X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ EII<3K:SM)S1 0  G 0  !D              ( !
M"50  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " "6FEQ.
M-ZHT#[4!  #2 P  &0              @ $15@  >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( )::7$XW*J4UM@$  -(#   9
M      "  ?U7  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ EII<3K,A^!#$ 0  -P0  !D              ( !ZED  'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "6FEQ.LL\VJ- !  "<!
M&0              @ 'E6P  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    ( )::7$XLD =FM@$  -(#   9              "  >Q=  !X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ EII<3D$_JI;J
M 0  9@4  !D              ( !V5\  'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    " "6FEQ.3ZAR%-,!  "<!   &0
M@ 'Z80  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( )::
M7$ZVT5[>P0$  #<$   9              "  01D  !X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ EII<3M;OE0>W 0  T@,  !D
M         ( !_&4  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
M    " "6FEQ.?'G'Z[@!  #2 P  &0              @ 'J9P  >&PO=V]R
M:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( )::7$X3SSIDS0,  $$3
M   9              "  =EI  !X;"]W;W)K<VAE971S+W-H965T-#(N>&UL
M4$L! A0#%     @ EII<3BA'=H:4 @  %0H  !D              ( !W6T
M 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " "6FEQ.EQT1
M$2P#  !/#0  &0              @ &H<   >&PO=V]R:W-H965T<R]S:&5E
M=#0T+GAM;%!+ 0(4 Q0    ( )::7$YAUBALP@$  $4$   9
M  "  0MT  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @
MEII<3K=K$AY) @  K0<  !D              ( !!'8  'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"% ,4    " "6FEQ.Y2IZ31(#   ;#@  &0
M            @ &$>   >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4
M Q0    ( )::7$ZU0PS0D ,  (81   9              "  <U[  !X;"]W
M;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ EII<3I!R5_5> @
M-@@  !D              ( !E'\  'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6Q02P$"% ,4    " "6FEQ.!P$O[YX"  "'"0  &0              @ $I
M@@  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( )::7$XB
M<]]&R (  !8,   9              "  ?Z$  !X;"]W;W)K<VAE971S+W-H
M965T-3$N>&UL4$L! A0#%     @ EII<3H4_$>0< P  &PP  !D
M     ( !_8<  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )::7$[D>_<. 04  'P=   9              "
M <.:  !X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ EII<
M3H]@ !K8 P  &A0  !D              ( !^Y\  'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6Q02P$"% ,4    " "6FEQ.Y*CL,LT#  "K$0  &0
M        @ $*I   >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0
M   ( )::7$[WVJ?S40(   @(   9              "  0ZH  !X;"]W;W)K
M<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ EII<3JWGBHI_!   \!@
M !D              ( !EJH  'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q0
M2P$"% ,4    " "6FEQ.+C]#SBP"  #%!@  &0              @ %,KP
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( )::7$Y@0P/(
M&04  #@B   9              "  :^Q  !X;"]W;W)K<VAE971S+W-H965T
M-C,N>&UL4$L! A0#%     @ EII<3M[NLP+) P  .!0  !D
M ( !_[8  'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " "6
MFEQ.[0UYE)4#  ">$   &0              @ '_N@  >&PO=V]R:W-H965T
M<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( )::7$X^:O!+] $  * %   9
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M  !X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ EII<3O(
M+I+B 0  ^@0  !D              ( !AL@  'AL+W=O<FMS:&5E=',O<VAE
M970W,"YX;6Q02P$"% ,4    " "6FEQ.2P5D[ 0"  !E!0  &0
M    @ &?R@  >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (
M )::7$[^8.&D @(  ,4%   9              "  =K,  !X;"]W;W)K<VAE
M971S+W-H965T-S(N>&UL4$L! A0#%     @ EII<3C_L6^[R 0  Z 0  !D
M             ( !$\\  'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"
M% ,4    " "6FEQ.$=@&@3$"   ^!@  &0              @ $\T0  >&PO
M=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( )::7$X6C>9!X0(
M +4*   9              "  :33  !X;"]W;W)K<VAE971S+W-H965T-S4N
M>&UL4$L! A0#%     @ EII<3NOB1-TN P  ]@P  !D              ( !
MO-8  'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " "6FEQ.
M3L^,I0H$  !%%   &0              @ $AV@  >&PO=V]R:W-H965T<R]S
M:&5E=#<W+GAM;%!+ 0(4 Q0    ( )::7$X.3S*<( ,  &@,   9
M      "  6+>  !X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%
M  @ EII<3L!KY2.2 @  [ @  !D              ( !N>$  'AL+W=O<FMS
M:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " "6FEQ.T+#Y;T "  !J!P
M&0              @ &"Y   >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+
M 0(4 Q0    ( )::7$XX1[\MFP,  !02   9              "  ?GF  !X
M;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ EII<3K.$OP<M
M P  ! T  !D              ( !R^H  'AL+W=O<FMS:&5E=',O<VAE970X
M,BYX;6Q02P$"% ,4    " "6FEQ.@XA*!/ !  #;!   &0
M@ $O[@  >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( )::
M7$Y7\O:L/@(  ,(&   9              "  5;P  !X;"]W;W)K<VAE971S
M+W-H965T.#0N>&UL4$L! A0#%     @ EII<3E(P6\\T P  =0X  !D
M         ( !R_(  'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"% ,4
M    " "6FEQ..^K%(\$#   J$0  &0              @ $V]@  >&PO=V]R
M:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( )::7$YGNABB] $  !D%
M   9              "  2[Z  !X;"]W;W)K<VAE971S+W-H965T.#<N>&UL
M4$L! A0#%     @ EII<3I$D#D>6 @  4@D  !D              ( !6?P
M 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    " "6FEQ.O^9=
M/KT!  #2 P  &0              @ $F_P  >&PO=V]R:W-H965T<R]S:&5E
M=#@Y+GAM;%!+ 0(4 Q0    ( )::7$Y70QG/:P0  $H5   9
M  "  1H! 0!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @
MEII<3DZRA\:E!   T!8  !D              ( !O 4! 'AL+W=O<FMS:&5E
M=',O<VAE970Y,2YX;6Q02P$"% ,4    " "6FEQ. W<L P$#  #B"P  &0
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9>&UL4$L%!@    !E &4 M1L  )+X 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>368</ContextCount>
  <ElementCount>468</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>117</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/OrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2133100 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2139100 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2141100 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2143100 - Disclosure - Segment Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentData</Role>
      <ShortName>Segment Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2144100 - Disclosure - Quarterly Financial Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited</Role>
      <ShortName>Quarterly Financial Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2145100 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2302302 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/Acquisitions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/RevenueRecognition</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/PropertyAndEquipment</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/BalanceSheetDetails</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/Debt</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/FairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2333301 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/StockholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2339301 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/EarningsPerShare</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2343301 - Disclosure - Segment Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataTables</Role>
      <ShortName>Segment Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SegmentData</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2344301 - Disclosure - Quarterly Financial Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnaudited</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2402404 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2402405 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Restructuring Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesReconciliationOfRestructuringLiabilitiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Restructuring Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2402406 - Disclosure - Summary of Significant Accounting Policies - ASU Adoption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SummaryOfSignificantAccountingPoliciesAsuAdoptionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - ASU Adoption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Acquisitions - American Personnel, Inc. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsAmericanPersonnelIncDetails</Role>
      <ShortName>Acquisitions - American Personnel, Inc. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RevenueRecognitionDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenue Recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Acquisitions - Advantage RN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsAdvantageRnDetails</Role>
      <ShortName>Acquisitions - Advantage RN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Acquisitions - Fair Value of Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsFairValueOfPurchasePriceDetails</Role>
      <ShortName>Acquisitions - Fair Value of Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2403405 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2403406 - Disclosure - Acquisitions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsAdditionalInformationDetails</Role>
      <ShortName>Acquisitions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2403407 - Disclosure - Acquisitions - Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsProFormaDetails</Role>
      <ShortName>Acquisitions - Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2403408 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Acquired Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsAcquiredIntangibleAssetsDetails</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets - Acquired Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Estimated Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsEstimatedAnnualAmortizationExpenseDetails</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets - Estimated Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsChangesInCarryingAmountOfGoodwillBySegmentDetails</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2405405 - Disclosure - Goodwill, Trade Names, and Other Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill, Trade Names, and Other Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/GoodwillTradeNamesAndOtherIntangibleAssetsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Balance Sheet Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsDetails</Role>
      <ShortName>Balance Sheet Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/BalanceSheetDetailsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Debt - Long- Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtLongTermDebtDetails</Role>
      <ShortName>Debt - Long- Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Debt - Amendment And Restatement Of Senior Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtAmendmentAndRestatementOfSeniorCreditFacilityDetails</Role>
      <ShortName>Debt - Amendment And Restatement Of Senior Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Debt - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtDebtMaturitiesDetails</Role>
      <ShortName>Debt - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Debt - Consolidated Net Leverage Ratio (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtConsolidatedNetLeverageRatioDetails</Role>
      <ShortName>Debt - Consolidated Net Leverage Ratio (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2408406 - Disclosure - Debt - 2016 Senior Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Debt2016SeniorCreditFacilitiesDetails</Role>
      <ShortName>Debt - 2016 Senior Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2408407 - Disclosure - Debt - Private Placement of Convertible Notes Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DebtPrivatePlacementOfConvertibleNotesNarrativeDetails</Role>
      <ShortName>Debt - Private Placement of Convertible Notes Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2409401 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Fair Value Measurements - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsEstimatedFairValuesAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Estimated Fair values Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Fair Value Measurements - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsScheduleOfReconciliationOfOpeningAndClosingBalancesForFairValueMeasurementsCategorizedWithinLevel3Details</Role>
      <ShortName>Fair Value Measurements - Schedule of reconciliation of opening and closing balances for fair value measurements categorized within Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Fair Value Measurements - Financial Instruments that were not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsFinancialInstrumentsThatWereNotMeasuredAtFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Instruments that were not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2411401 - Disclosure - Employee Benefit Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EmployeeBenefitPlansNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CommitmentsAndContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Income Taxes - Components of Income (Loss) Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income (Loss) Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Income Taxes - Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesComponentsOfIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Income Taxes - Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfIncomeTaxComputedAtUSFederalStatutoryRateToIncomeTaxBenefitExpenseDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax Computed At U. S. Federal Statutory Rate to Income Tax (Benefit) Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/IncomeTaxesReconciliationOfBeginningAndEndingBalanceOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2433402 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2433403 - Disclosure - Stockholders' Equity - 2014 Omnibus Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquity2014OmnibusIncentivePlanDetails</Role>
      <ShortName>Stockholders' Equity - 2014 Omnibus Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2433404 - Disclosure - Stockholders' Equity - Summary of Restricted Stock Award Activity and Performance Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfRestrictedStockAwardActivityAndPerformanceStockAwardsDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Restricted Stock Award Activity and Performance Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2433405 - Disclosure - Stockholders' Equity - Stock Options and Stock Appreciation Rights Granted and Exercised (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquityStockOptionsAndStockAppreciationRightsGrantedAndExercisedDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options and Stock Appreciation Rights Granted and Exercised (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2433406 - Disclosure - Stockholders' Equity - 1999 Stock Option Plan and Equity Participation Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquity1999StockOptionPlanAndEquityParticipationPlanDetails</Role>
      <ShortName>Stockholders' Equity - 1999 Stock Option Plan and Equity Participation Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2433407 - Disclosure - Stockholders' Equity - Summary of Company's Share Option Plans Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/StockholdersEquitySummaryOfCompanysShareOptionPlansActivitiesDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Company's Share Option Plans Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2439402 - Disclosure - Earnings Per Share - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShareComponentsOfNumeratorAndDenominatorForComputationOfBasicAndDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2439403 - Disclosure - Earnings Per Share - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EarningsPerShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Earnings Per Share - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2441401 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/RelatedPartyTransactions</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2443402 - Disclosure - Segment Data - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataAdditionalInformationDetails</Role>
      <ShortName>Segment Data - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2443403 - Disclosure - Segment Data - Operating Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SegmentDataOperatingSegmentsDetails</Role>
      <ShortName>Segment Data - Operating Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2444402 - Disclosure - Quarterly Financial Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedDetails</Role>
      <ShortName>Quarterly Financial Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/QuarterlyFinancialDataUnauditedTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="ccrn-20181231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2445401 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/ScheduleIiValuationAndQualifyingAccounts</ParentRole>
      <Position>92</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ccrn-20181231.xml</File>
    <File>ccrn-20181231.xsd</File>
    <File>ccrn-20181231_cal.xml</File>
    <File>ccrn-20181231_def.xml</File>
    <File>ccrn-20181231_lab.xml</File>
    <File>ccrn-20181231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/invest/2013-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0001628280-19-002315-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-19-002315-xbrl.zip
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M]A9B.>*$V,Y!)*!(.]R1U @)LI<6E_P$8Y+7CE3HFBAMP<RN$'HPEI..[Z,
MNQ1[CNLJK#$+K(3#5&/JXIHAM2O\? P'+[9^$'AE4[/E,S@SO=>[:/"0_Q0!
M3", 8:)G]"",GY?;(G>]IZ@_M@Y#T]MS#9#TO\91=CWMF5;A*_O^H0?J;5J)
M]74Z=T6M75]II87#7#!3#&,:NZJX[P4^) ^6U_;>#A-31'[*[9WT87KR6%[1
M':X\W-P;4VD0Z#[\ Z#W),?<E:;$1^!Q7@UI-?67*H/U[:!-H9_ZN)-C!=M]
MSHL>TBPRT4L&JYL4GG^VZ3O_,_GSK#YPF-@3R.AQ8LIH6SF]^43=8B$;]\!\
MM$(+Q@UGQP>3:DZV2][4K&V^L;7&71NJ'5O"FAC)/8Y<L,H(+LM#$L9K72:D
M(PF9,=(QX^*D"7;,\3\L@#U<7VC*D.]I[ 2<E)U)N,]JT6.)':?CF;/AF;?'
M/ .ML %& ;_&  M);C0JBQ%B3&H&TA6GO..?<^&?30.\7!.7(@HZG =(Z8 2
M59C33 OJU\2-(J+CEGURRXIKK6[@VQXB ?&< /[ET*#,*&/P0U#O J$XIAW!
M]DZP8S8I8,LRJC!8$ZYOJ%$>-5.>H4+5$D,E%=4+]\=,CHYG#F%2V,H 8$0P
MS+%R/4<9BLJ20:[#9*UB TR0'?^<"_]L?&8L78X=@@E8HBHP6H"+4IH41OCU
M/E>$BXY;]L@M*RI(:..Z>5DCEP?,^(A+,6L7*'DM;T=BB55'L+T3[)A-"M]W
M'60[=4@<&$0#')!"(S!/*%S+4A*"=G[#^?#,VTT*X0;&0R!O*-,4(P^$2I$8
M01U!=/T@UNE$SMFPSZ86A9822>$2WS?<TU0PP]DTC8\'M3@ZD_SDA,U");:/
M\; 7#09A$J7CX;9)53Z7-OG88P20!KN,4^&4=S(-$;4C>EKM?+SFBMX.P;+\
MJ8 RGPB%=!!P7U(=&%$T[A'<;RA62.<LDTTA&(^&HS OS+MPRJG3@<U]RL+!
M*/V/<9B% $)4U&\<_I$ $U2.]C[#%U;3J7K<J#4)/,JUK9:!7==UW*#(4*12
M85H[L\7.7%'&':[[,+A8I/A<E]P @-<N =N".@[2KFLK4"/7$^ Z8%K+F,-*
M[1L7Q: @S>P!ZZSH96,[I"^[.X]]4][3'%(=PI!6OBL0<8D!]H'%VJ0 R8TM
M9%ICL/G6PVWP;X4@=I0(HD)*'[P@L#+ !?)<"AN1,L\@Y'/%>5M>V(8(&A8C
M_!]6A8".><K5@]46.:C%M)L'"\_7 IX]5<UN000W6GE8HX#ZA+B:$ZG+C'E;
M@+B>L"H:$+$5G#5D?4V+9KJE(1$-)RV+/UM5;57NNBWD*Y6)=]5@N(HS>[.;
M$P<KZBOM8N%15B@IY@<^J3E#DC?A[$W@;H^\):WA]XPV%[M,8"&9AZD$@TZ[
MID";),K(VD$E9F_#6TN+^&E=2S )33J^'SV,!VXOOPQKZ^'F1H1KB\#;/)[-
M<T \#QMB)!($>$,ZE'!17*<+/,3K^5@,50OW;K:XG<&TXA#*MA-T*"6V0X2M
MNXQ ,Q=WE! *4,TJ8Q+Q=X=I513,U[9#'A+(7D50BB$<E!GIKB;UE"]'OIU.
M5A2.LHD'<O-@*X_&CXD?9K:<^7!Y0=B%^]>VOO!X])1FB\F9Q4NU?5?65$*D
MNB69PBC0RG$<H;@4!#%=G 9S,,/KCM;<AEP#F K@57=IXA_5[@JY]X"Z-&FU
M)*I8F'NAM=ZJ956&HYN74?Q<N'= JW]%O96*$'E:<^X;*L%& IN)<L<+,(@F
MZ3(6U'PG-H^*S<";XJ7PE2L%JD+@FEYN ;TY'<W>M2 2.QYSP&E&+@-WH\QJ
M-*ZNL3A5<T!MLK8= ;1"#@$<"EE7"=0OLC4<P-<M .+2K]=XI@YVWA>@%4+(
MQUY . H\W_4=["G,RZB8+7)E:J%X*WR=MP($[!GE:;+5.T5NEMF[)GD<YW4V
MI%"Z[O<PZ]_D[1B&N[IB,]W*=O=^"I\K1OS-<Q+?CX?V0>VRBZM<8S"8IBS0
M$CB&8*\\O7"$1FJNU/.N83UI)$['?HU'-L?Z&KSF;W%_' ZJ[E-27K#*/H)$
MOQNEO3]M=QQPK&ND "N.8,-L'(,33K3AO+@ [FM?2=L&EY\/)4KLY9-K7E>.
M*%L4I0PPWMIB?<,[]_9N):5 H\.BXF]1%0([#*2 K'<] F$N-:=6<5/&M(-8
M6<8;NSZW78_D\6*]VOTD'S'\!^C.-8H]OA/:6R^622 "D:XVQN;L4@_AHHI-
M@&V%F^65'7>.OGG"W"]Y\_WK;$CUS;;_UR!]@ ^ 2?MLS59W- K!P:I\LTEA
MXR\KB51YYV3-VRB YGNE#/M@#PBCN /V*^P#59Y+4D4-:BZ-S525#/M"UHPD
MED=!1X^SWI-]D9G8K/F&^IS%/7NE-?_,^@5/?7" 1Z]VT6DR/6J9!8">G],D
M_^K*6DP8N>#:88DI4CY'P+C2"XS@X.K9RZ[S]D>Y3G#-\2^<E4A<%[PI0L!W
MT>/<3_I[>C]T>_; !! >)T4_BL4>*E./9T4ES%;;'JQ$>[F'8!^</GL3 Z L
MN,1(A6H5 4C5#'[K:O<(=H-U.1_D]'WD4LR):R07G%//MD3!GA]0[+/Z;<3]
M@#W?8.]S.!R9L3V/*S94^E >(>=.=7^)+EC_TC9FBKF^"+AC?$S!P<>\K,F#
M'084__VS0*8$=>,5'@BXEOO>A$EC'!V B45<K,&3<\J*ZP@)F7<[X3L [H\$
MU&KZF,3_DY/9BY+H(1X-R[9_P[+OWQ#<W_' .B!!EC[GL0\3]<>3.@(;>ZT:
M=BMRB?$](XV'A7#+6K\*&:>>GE0R[$Y6NV_85S4QHDQKX7D!LL5_L">Q+@)M
MQC,^J3FX5_GUL9/"P*JP'$::^#YQA60(L[R20='@S7<,KHGJ@\(^V4+_D:7#
MV8LWELKVM,!HQ1SA(>,%/& !*2N?.)S7HC)X[L1E@Y6M@N:VA'L.)4%D4QP&
MA92?"/V-][!@@GO8* >(Y[F@>S J>PYRW-"];@5TZZ]TGS"OV+N<@W&!/0WZ
M5B**K&.@RTZ>&BA>/\CFSDJZ'@?D*_:L*S'VE._XGFTIJXEA7)0=)L$VK]D9
M.X6Y'\6_37LY!X/PL7WYLP6[@@&E0*2"=6!\;I/0BAB2Y5?GY]\? ,KH+[_6
M7EY^L:B6-.GQ_%]1:+MOUUH>-W^<R\ 'I CN^Y@QC"5798D@)BA1(-6O,+FB
M>/+YMB^5*S%I+S],GPPHFQCWQDL$4Z45$Z,.V+_2Q<H(,)>D\:=X, 'Z^??@
MOR:K:/U*\S+L.M==!-/<4;Y/;0HYE91XQBG.((@(P+_+&T*JIF5,O[*XB,GZ
MUB>))Q10@R&PI!@XD)A[3B&2"94L4),E5*G2^*7%95A'>(VO!Y1S(90#*,!N
M0'R)>(D BHUPK&%^]9_SW[6O+C_G)R/K#,*OF2U;WH]^_&?TNL9W@?BV/T\@
M H]@@H3@905_<)2D :A!/&$,+(KHY.N-7UI8QLSYG/CZE02=6I$,YPL.HOOY
MWK4+16>(<)EAQ%/V.!5+!P@TI0QXJA71,LP_]_/O5&!@:BGFEKQD50OKGVRW
M:4C=NMSKL3&XS9[0( N5IEJZ >.ZW-;<Y>3GW_\K&LZMJ?%+\ZOQGZ/L$9Y-
MVG19?S],UB&MYIAK$3C<<&:,M!8'<<&@E)0J%[R&.0&WY%/SJPGB091I8/3'
M-%MG%90@V%8< Y]), @<Y-.R&CXE& .#N;U>-+ 9E> 7Y6^OKFCN<_,K^3R^
M'\2]8)"&C?F%<PR%JNPDM:/ >X+-ACT#2EI14ZZ(*5W+W* .)Y((-L?_E8_/
MK^HV>HR'(YMH9J-9:R#(4(F!2JZ'N7)@:<:=(8@R(W[^7=_>W-W]I&_^^/3U
M]K]^^IOO?OCZ-^W>^C]=?]+5-<U_>GY9=T_18+ ^[_C8M_>#B7(Y8@$8+M)5
MEG<,!WTE MS .]4O+'P;:#!H+H39^'%[!45YAF@##KSC:64(RQDW[S:B6-/'
MJY^8__H_TL$X&879A)76^3[R?%][BL&V89IR QLW*'<QT@* _Y16/[[PA?G/
M_Q.P\I])^CVY WL\3:+^]7 XCK*U%!)L5&-<9!!8"V!9<EPN@QA-O<5EM'RI
M7,[7++22[N[U^3X=K"/+P&QSB90V>@(V@JV4)DK-(,$[ [[4MY\F"YA[M_U@
MG'R+AJ/?9BTU/J5Y9O6@*;]ALE^K99+*6956\/'PSX4*]*,(9'A>N_[N>_BR
M,ETK<#P_D(Q1)!RB90"<90N82>E[U-2NP[)IAND*4"RTQ9I^*Y,_/H>OMEF'
M6^: ]/*^VY4\I*U*FFK'Q6!=^P3<"@^!0'++/E+@9SFFGJ6'N#.YD;GM^G8+
MV[*4;P_THTWV!6?813J /WD%KTL/^WX]\0),,K9SV&ZC7A3G?58^1:.M:(2Y
M (/54'  P8>@S#&\T"T2-G ]DQ+;5IZT$9"FQ6R_Z&7(Q\0#<X#XGJ,%15@'
MOELV8_69JM\8P$)@HG:TZ$J!T;6:RL_%MD%MD@!TN<P/?HSGD2).%"C.>'U3
M%UMZW=6\;>7+$MX1I8[G&BJHAQ3800I,;"_0')P/V[^ZUI =OVWE=@MX:3(>
M;BMZL*UM3Q H(W!2& K\TD>DPE8#JY^=B)KDJ:]ABT4N8V/E<0\V'@(SDRG'
ME9ZO<-G_&ZRJ^MYC4FRUR%N;USQY"F)FQ2V7V;%H_U_CX:C,E/X4?2]H:,_)
MLC2!/_:BV96IZ:SIH#OKJH19?_C'2Q\H;>-OB*S0>@H3F\?&%(@88#-/2&4O
MWJ' <32A;BTH<R5)G=&6@=R G;MP$&;;ZC@EA$'@KW#8S*#N7"QDF1ZLP!JI
MGU8)RDC3@A=6L<TZE_$:4LS57"%'44RY0RDOVST0Y7M>/7[+E:KIJ_76^8^P
M-[F'M@T^ 9%@0&N0[<SQM<,0=@M\<B0=48M'@D?6N'$7%K'-,I>ATY[Q&,(I
M-5Z@'/""R+34H "E5 ^;<MF(S>7+'#^/<QE9O0((?Q[D7=+L9>C*=4#8DB]1
M!G[>(,Q9WAZVO]234E?AW\&NKZ50'O485[Y FA: (=#[7KUP*0C.FF;=R;H/
M@XME1'8U4K U !W$P50)CAQ9X,(#G[)^K8\V".A]XB(W&*T'FT5/43+,_8_R
M\FB949TS5F]2)'W2QFXFU\'DN7GX&O[8S(A!A-J[]$S:P(S!PO7=(O)'>0!S
M:S(:-\CH78-P< PM,Y8XMF?!A'/F2^53X4K%;%9VP'Q,F:Y9'U=Y\:OCP]#Z
M_#%W&]8$@4;@]\'&L;%Z@E$1E[;9W+1V%'Z%P3[?!OJ]0+9,(#"-I +;UV6&
M(]?%C!6IHT38'G U\_T*,U%3]MM#EM\?ZB_I9#GIM1SUW6]1%CY&?PRCA_'@
M0_PP']7;U86I2J*2IUU,P;2F*F"&@"E4GJ0%S&5!F=R\"TB.&"/[ZC5:94"/
MF4 XA!M[-@NNHP[*+H2>2SI,KX-I$XY"FQK9D!E.F1N !C<RX C;Q@N\T/=@
M8\+6[["[&KO6T[)9J:-H>@NZCFC#N*?!72(^#R3CX'H[=&KD4Z=,P>_PW(YG
M&\".[*E)';NNLO$D>SJ.B>-C#99[<3XC'8\J[R38&-2PB7KK8A<$9]P+;;K_
M,$V2: ":])<Z7@ 3S%"?,QE02CS)1>!S'^QZQVCEDKWA9=IXY7,8PRN*8D25
MT]T-[2M&A8,]'E#F8; P7*5I>97"L'H3*FHKJBR8(2N7]%8 EOI5V#7,(<HH
MA17R;2FNTL</ L3J-_P014R]"8!I).MKVC*U.:O^-IJP6U2DFTXR)VXG"4!V
M0-[_?.-,,X09Q9[G.)@K3GT1.(26)V7$XW424NDLP+]?B(X!>QM>(&A9V:HZ
MY+XCC&\45YX,-,A';HJX&-:,U_-V+XP2*[('?:4]S,#%I8ZA''N!%@4?8T=B
M4<M[94BAB\/>0?C851P9USB(2D9] C31TWPT[-:[+5X8)5;E@AKC<D8-!9H)
ML!&H*K-@[4UT63O=HESRB\/>0?A8^HP1[=CJ*L;!CE$!]LN8:\!I/>;ZOI3(
M:Q:!9?K8>MNIP1*8JWF%N:9,*>,(L(4$H=HMBP. )X1JN5T8U8*IM45LNL05
M]] D<<%: 0]8N5Q12HU#V+0P.W?JA8/$SE>XXG*"<%1@>XAX5!LG<*C$ >@B
MS*2]5DGJU6ORL]X-5EB6)VB^ +LMZ3WI(VGKQW'M^Q[WP0\NHHG4XZ9>0X[6
ML@'66M<N(%G!(1@8Q&&!#@+#"<$!<LJ(+W4Q%C5(6"T[X&"0K. D0C'&CI#,
ME4 8+('MI>4D0@)?2[=VKD=KO+X5)'G!G:!>E&>6+;'582JUC7V9PZG47 '3
M,Q"K120@\ "T.C1*U:!9>VT[!&IIUH1+7:*50()+S_6)\HH8*%'( 6.G!E19
MUNGM0%6.ZF[*]G!%'=6-7<! $Z1$0(W0DCN.#QNHJ!9KM')DS?&P-7WFP5BR
MFNU7O<+@EUQ[E' B$6QL3;1M&%T4SR"NIC7D"XX/L.@5UIW12!OJ8=_Q S"1
MP3'A7ADU!Y51R]%@B\&&K1:]&"M:669R-V' MB-))J56%!2X9[0/JB=P;(XN
M$Z!HJ->0L+ HUY;"-H>%9!3WX\'89I[>1;UQEB<Q^C]Z@W$_ZMM+458@CD?%
MJ\K26^5]^[9Z8@LQ@3=^Q7MM?D&U'M>T(.6G=!39*^7-5156U1 W;L!\*DP@
M$,9!P#SI%)W.A%1JSJ(M+X-4\;X+;!Z //)4R4-<-Q!,$RF,P[$R!)>W&6!K
M@/O70!Z,%^3#B=!HL3;-Z="(^H)*X?B"BP!L32[0-.(M\5Q2TO0^E:1[IE':
MB^U1O0Z'3P$8%'^+^H]@-.2'^_"-_PCCQ#YV'T91MG$"B1 V']BG+M..P<8@
M-Z!@AOHH\,"*TS6'YJKF%&ZVNCG \KH8BV7A:P<T1>]MBG9=4K^*!P-[$/N<
M<'"*P0N5CIIFIPNCO'H)%%9+I&F$9D-XU['G;#%F%6A#?.5Q85,J2>G(N\*O
MMR^#I6*\IZ7*W+!84F&%NR[BQ@0,2\=3GH8U!QY'FKE:^O68 ZMYGKM<ZE*L
M"D<KS3SAN()YUC/SRYKS3/.&Z^FY<-C/4M5RK#H!ML7DB&(.8E[ ,2]:OMO[
MY& #U!B [ ^KJPHX"NP'P@D"(L!E F>#ELG H/&TJ/F%L%1"MUGJ&M<CYNYU
MP,H=HS!SD:0::UO7O-CN2/&&(+:00LGZPM9:R#(?DS+%/1((#3X_<1$2/O6G
M-Y?<>AB P0(7;\6T+&0K1Q[HHMT &0&HP2Y6'BFO,PCX8SW  JZE:D1,DU>[
M?%E++T%YAED?%H.##90( NX4NU.ZTJNWQ\$.[ V^WK(:#OPGX>;R'MTPORW8
MO\GLO_,+/'FIM++"W.1I36WQ+^RF-Z+HJJ*XEN86?(SZ]MI^0T6W^3O?+E&2
M2]\'\K@!""FP),L+8<3WD&JR49BC))[A8C<@KT#BYRP-;/6WFCD7@F9>1^M5
M"]D%D@'=$68:C#-;Q(ZP\E9!GC#=5HD-_4+Y4KB7KG*W$-8UT!R$U)6(^I@S
MY3&0!Y26=UHIF)Y$M4&(?\'BX! ::^ V%>M:3D5)E'8"%^0(*%J7^ Z(WI**
MRE.M,$Y*0VZ_SEU#N9R2'J<(9+GOF0 XUJ$>G98- 7-(X79*(F>?4!85"/.B
M@T7T&'[^CS3M?X\' QLP[HWR2C-%Q2<;=*D[>-?[[8* '>V & .+5OH8N>"/
ME(FG@0]F1#V$5@N,[Q3T%3@=EB3Y5%;XL\[.YB8]6$6*,L]>,[5)2F"<N&5C
MJH#4VSIA3!V\"NCFM>T(H%4=$5RPCCDA2FG-P9@&,(J3/,RQCVO'W P1SO<+
MT&WT+4JVR*"26DJ-!/&P#WX6DX$@93$DJ6B]N8-#K5F^-BS%LMX,Q0J"!%@[
MOK#M#,!O"&SRFS>MJA1H42.(@\$"='8!A4Z?[^-DL9%<<2=WNQ,-T/A* 7\Y
MQ"#?P2 A5.$!<^SI>N'.A7MCZZ]L5_"L\CU-H#G8M,;V(T<TH 9/Z_;#[J^U
MF<".;-XLAX9H#_*?4>,QABDQE.' <ZDL2] (W^--#DB+^#\<+E8="DE;+29P
M!' JEQ(C#['I+3:OWFR,M8CV0P.T@XSH%AK[/K79D-+A+@E\L -=E]K\:*OE
MN71JPF@QYK@SC.AJR\K\3MND:"]N3\+/@=[@597&PM'HGVGVISW/FR0'51*(
M%O+TW[:=YLZPJ<)&>V!/@:-NBX5BMSR1I!1HT'"1C*Z4EJUH.R9TS]E\.\7O
M7"S.$P[3OO7'7>%CZ1KFE_C%!M6"L47MG Z_:_*OY^G 0THXQA&^=D XN$4=
M$\,(N,I'BM_=72IIXSM0BA0KL$D95L1'KN=@$*$"K!^;X%=3*NNHR5VCI3&D
MY";],J:TSY#9?*T/Z1D'="Y&4DA.'&XUS\2F4!3[]:RQQ:R]'0*]&I=-[90K
M/1>&D]JNU\G$0;UY:)E2UG5ZK7.GR#MFTC79TR*Y%P[*@S108]]!C:U .7$,
M!MWC.,8(P@/AN1XMW/B J7K2T=7B$<6!<',,Y !;V@IC$!A[4%"(,ZV)BT'9
M$\^G)N"T=/RPY]'Z37)^F82H'&>N1X4_[FZC80I*,!K^+0H'HZ=>F$7U*Y<M
MJ_!>Y_OR-MFOC1-7[3NBE.<)2;@(&%(2N[C, 3*(L=HY=KT@Q,G0.V\&<?-P
M,Q[94- PSYG_6_SX5#]9$I5:4QOHDXUI""+^&83]]"K ;-Z<L51MP;["&?:U
M8H1Y&IG 95HB/^#V<H(GB/%D4-N\NZ%E&V(/23)YJB233!!BD*,=7V)[6(5%
M>8=!F 9Y>SXD4Z=*,D$#4'J:^$[@>(@3:R06!ZK@.[OUY/5S(-EUQ=[>J;$-
M:L83V@!"F6;81WP:[A*^QQ;/,7_^7:[GF9PY.C?=!9_3$0R)PX$]"TS'HTE_
MM:)AT0M0YB'N5=JO:=ML-XMAB%6'J\)SW.>.X(%Q NU18?LO%#:$O=_AU&\J
M[\9D["BX-@4;VB_.'Z+:R[D>D2R0$@6><J>]5BCS5#VK\WPH*#8)O"PWX=MM
M;*-QX-L"M8Q26YC+ET5,RG<1PO5V[QUVW^X@[7.[V$1*:;MD4N2B0/NN$F4=
M.8UTO;<Y/AN5=:($5:MVJ%*.!KO#N-S1.K MX\K"1)2X;HV@:T9'.X+NBZ#.
M"H(&#'O4%<K%6FJBN9)%4RCL8Z+K#=/P,8K<:?"C[CNQ+^3MP=A-"5:V*&T+
M9:\R$PWQA"ML^7.7@T840I8E60+%4?T(8GN:3#&W<\17XPQ!&&<YB;W7Z1__
M%L,[P*M\S5L:S]V(G(ZY3E[&HV$^@*XJ.F$8#BAW4$"QXS+M ^H*G#'">"T\
MQZE8YS3VL#A;V]'?*%!-$0D",*>P*X1 #NQK4_B-B 6J?H5\\=[H26'FV$(@
MCM!<.!YSN&'(2.4JAY7-.8PC:R=D<KT3LO?#_@'VLA\XQF42>R#L!%+<(>7=
M%KN;96TO2Z&:$^K>"6<3<X&X+UD\V.M1(#7*94)JU[9:DX'D7GDD$6BFZGKB
MR';V;A*>#ZR<F6=\8$J?.<*AAFIP:,H-S0*_7D"Z+8GZ<#A?UBQDV8TEPVTI
M%4DH_!<9)W"5I\JK0<!?-6^<(_5FE=K<Y6/'0"^[#V4KQ'!&L ="Q\'@TMB6
MT 70MF]73?8P]&;9LS;095+P=9+;^O:G\L;"3693MF\>BHJGT5T,GD!E#]DV
MH6YO- X'ASTE%]2XPJ,!]CVM788XHD6U$8.X@^L5DM3J_;(3-&R.ZB(5^_AP
M[#C&8RYL5F:DZTF% E'H2RX=HVJIB&R=DX&W(6 %=F^G[9>O^]:U?8C#:2&2
MLF:OFU0[J)666?TFZ!ZNS<QUUW8<4*SV\HCVA+&%5YA;EF)6LBX%'3R)2BY%
M[AOAWQ=V;:F!HF?)MW!@_?1#8MHA&@5<@$Z56#H^(4H6M[ND]*2NQY84I7M#
M=!T5>T-ZT>(J'YEWE#@DTIE-;?0<W_6-HMQW&"YM;2D#7O>;J4/VA_,:)@Z"
M\UG!L(.RNXV%>UPBSVCN&H](0::%,9R U-MY,>J(P^"^@I$]4Z#Z8+Z9YD$W
M 04UZ2M-N F,"Q;(-)5/NJ[@M6M/:\2.]H>8PU'DX,*("(?Y6A/'#_).V<CB
MOZ #55Z-#GL718O(V!?N%XNQY1_[^A1.+](>D@J@>3DU!"L9.(1IEQM3GO$H
M@>L]TXCCK#8G]X>:?=&D\LLAL:_ N:9N7OW#",Z$AU1I!0FCZO8F02WW>W>,
M@WVA^5.T]UOP<V5A:,"E!WP,_A+")&]N59KSKO9K]HYRJ+,__ +P^\+K>@T4
M]XQMSU784U2X&GF!\+GO3:/?RF_HX4OW:-&OU9DQ-_O+IC%9^EQ!P5X:L+4*
M >ZX ?%1X"@A'6:X5M/+65*N=H66P%$#-\F=G8JGXXYTF&6O<?+84$R^R.9J
MMZ4\'TF7.9YDBE&,A,.+I0<.]E5=AS/>L/15:]H!$&)9522DN<^0X$A@XPOC
M"*(+(*@1?L,E,$'1NT"QM.24X $-$/<Y#L"GT($NJ[X+*B2N-^+EG,IW@6)I
M1%9S3V+F^P$E7-G2-F7E2&D#T?4JRP)A9Q]03)H)7">]+ J'D8DF_]ZXQ@*3
M.@ ?0QD3$%@G5521@K>0+TE- V&%Y3I4:5[>[L!:46I!VQWCNU3;:Q4(,X\$
MY7U2XI*&"LT..@:H5I08$,* XZ$I#HSO:2\P1A=%<WP&=G&]BJ<M0+L;L-+G
MYWARA]U.+X\0>HOFZ$P*S#@,J* \W^,$<]_62'#*ECZ22A4L<MA//X;Q;TD\
M^.O/HVP<_?S3KULO0\TM@P"2/!]4@?0\*K'C(Z&FD5/B+6[<E<LHNH)5&X ,
M;Z-AE'T#'9=FP7@TSJ+\-FC2:PH?D(_A*Z%3;6WM %MV>Z:B;YZ3^'X\M ]6
ME8H+&.@UQK7V2>#Z6)% E0V4;:_[JF@M2\6)Q=/7C6%J0<CG,+O)\LJM_5R2
ME<6K5BJ+>9 X,Y)1[O)  #0TH*JL_2(-=LC"24VUA!A A1O!:EO9FP%1RP!!
MW!/4>#Z(%]<@J;CQ2_8WFCOT2 "9$,3>%^X]83EERP]I\CB*LF<3W8^F!]>5
M(^ZR'+-]OHI+?:9<YOJ*B,!(7WI&!&633A-@1/:/B0E'N^/14YI9FWU3GO2Q
M"5SJ(M#ZTN>*$UKZ#QH$&VW89D4*<<M&6US/ULM>RH&.+UTP5:0 ]\>G',Q@
MIPSM!EPI=[_+;BB;N1K3+@V4IK97$W:U ?/$\<NP@Z\"A1J6;#L1*(S4DA77
MRUFNO=JE" Z0E*"5D>MIC7T1,+#*RRVNC&Q>K2!<..1MJ[T9CX:C,.F#$MP0
MP5CXQMB&Q%* <^%JS,I*=-)(P1N+BZY&<&4]VZ][*:H5RS,HL6L[EBK/EMDO
MFIQH8(RY>A@;H'KUNK?P=X3F*@!&")"F@GN&4EER!0N$U]! KV6[U1V"E>M:
MYL$05P: PH"B0$CC._#G<ETV<ZMN&F^RKL7>\V7?^8W]$B6H \I?>0YCGBV7
MZI9A7R09=VJQ&NDLQAS:%[/UFE<Y'9PH1[F!3WQ?4V68 $:=K-D%.5;+?*"2
M+^0H[6/1*WP*A2C'E I*'*Q50#A%Q1TR<-5]TU!)0!*VZU7#WP9CN_T^VZ8P
M:>*.1AD8OR,;3/N:YBW DU&6#@8PI*RYLC%+V?QU(P,/7'?A* R; !7G:D@'
MOEMC*24<N2Z<VP!P4-RL8MU >I)@U]>><:GTF>0E%RCJ"%)C7:46PP GC)Q5
M;K<) D5\J07SP1P12I2^"')!DM<DYI4-^M3$YOZP \X8C)C$H^/AGV $VQ_"
MQZBA],E"UZ/:9._5 W_ZZ3G,_IRS]>_"@?4%\Y0K6'D]V77Q-35OX7.6VIJ[
MM:&KW 9K<R#A@/SW[/$'<C#PICT4=[6'Z%QO@22O7IY[#+R*^W8$;8](>7J(
M#(BGL;+6-+C6 O-)1P0.=HGOFKE0WR$1J4X.D;9N:2 Q(;XK06D:GV '$$F)
MP<S'5.T0D<,\T%4T>=R\@JYQ79<)QPM\SJ6M#21UD9,/WHI3OVP#7B)=/ !9
M6,-FZUNE=K 7,.4B*JGBFC.PX NUPXROZCUN%*>+53G>MKX5DA\)ZA/M>UA@
MXFJ'@<E<%(5F- #GM(X_AXI%R;]D?=/^2?[#0]0;W22WD;U,&?7+#.)22:P6
M0/OLH4QM+T9?*L<-I(UEV< Z_%,;[F'IU:LS<CI_2+T!G.^+GL7WK\K4<I1&
ME)& "*$=8WS8:!.\@+W/O=K!Z-7.$)/G P613=X?P-."N4!01@_QYI9Q(*6M
M&B>DAU'@@?E'3-%I*# 4X_HI*5FP_9:OYTU+7R%!P-(RB M!$?BS&!R6H(S)
M$:,TK1<@Y'R1!/M;^ZHF\3YR):5$<&O*(..@4KI0K< 6K_= >.O*TRR*'Y.W
M,XS%-M/@AALI',-\@EAI$2/-ZMFBE)#&I;>LYTU+7]6R@/C4UNKBQ"%.'HT/
M"E[WE8M1[0H(IL[!EKZ"7QBXZ-)W M]AS$>VB1G'Y3&/RU7]!%V\=>D33^7M
M_.(9+3T>*,<!^Q,K'TMDRG[>Q/?JE>\Q%4U+;UG/6U:^@ET4XTA[G@3^((HS
MY$RO*U,D9/U6X]7B[<_]K7P%MU G0+8%M-222D,$ 9%2GNPS(FK2Q:&->W3]
MA><JUB8[I;U=*"7/$5(*4*@D$,H-@/G-_V/ORYK<.G)T_\M]5T<BD>O+1.0Z
M[0[9<MOJ>V.>)N@J2N),J:@AJV1K?OU%LDZR2.8A#]=:9/=,M^5:* ")Q);
MA[I$*)#"-[&A-+U.:3=59V!C0($0O92JK'R*BF>9I5@N'#1H18O,SG6OF;\X
M'P/JY'E*C#LN@?()N@,^(W3J! BIZ015G)W&1GE2?'AAG#],+9:WQM*!.[^;
MW2\VO2XP2/MP=A?/F&=[Q5R?((0HHL]1)ND$VN1=9\D@)#K:)J,2:O,A;5^^
M#I+%ZI/1/A+9+QQ>*?8/Y<12D4@4BQ@R\ZS8F@ZYA<L4,$+?PPQH*8TX0#)K
M7&Z7S[O9Y..$4ISRU?V5I/STRB$\MDJ:L+%V>*/4<$;M"M85UP>!$F+))5(V
M47='!\=%N_*S>:8=E,13B6U#:'$\FWQ=9#K+0>/+B1&R2HJD:*R0 1RGM+T^
M<968M;&Y?."2[B'&1Q&4?7OS7[_,QJ/K=[?_=S1;= 3_0M=MZWH&6:$ RM_Y
M=7P[NKU[3X)86WS]^&7<D-O6 YB-*==W'V?CQ47?^*U5PM8D3>0OOCA83>3>
M>Q4R"$C1NA""S'4],<4<H;\(!JL+_O:5VW<KZW0_FUY/;VY&LT%I:Y9#))^C
MA \H/<>ZR%9)(=9P]E>DS?^2]HJTR<!<3V\73RB_C6[_^]V'#V/ZH/)C;W_P
M[WX9/@+!I;10P#;+_M6 %(6*H)5.2(EC?K%',"3.1=]G^1(%9'0*;Z<-7E&O
M:5[\[I9?.-FZ<%[F'DFV)&UOA.5NB?81(-F7:UU>DK#W-R^,\EO'$%2((0H;
M0(HZ<AJR6@-2_$NW+V1?-(< .@,D&2TKS\S<DWTQR:CDXUJ-Y-G/8/7A[A +
M#Y>Q\(O?>3N^(\E//SS\;A[WV)C5?G!;@D)>]J!+X2U&K5"0N!ES :)AL,7"
MZ+_$?;@QITC<9<L-%[Y4C2FGZ9;3)58 /_M%S?X2]7ZF?%6K#8LVY>1!@L(0
M3#!Z66A-)-*_M/K\9GQ5_@J]]-K;K"&[J!?=[@NK8B(%\+C%B+\N^?.78\1Y
ML%9$Q7T463%5]AW+A;A3,CZN;7Q;]9F;F?Z?4=R'&G&(R#0FY8%GC9H2T;KJ
M6V0OW18C#G\)^E 3KI%,N"$)ES8WP03GK)O(3+@!N?"73E_ A/O@??8!,S-6
M,D^AH$@+FQ*\,*B^"_E?J-)RC G7%C!+E;3A/(!#3_\MXH:"X!_2BTH]7YBX
M#X[#/4.RXIY#643/G'.^!H<A<KZE;_%YBBHO5-3[&G&;$D1NR^.7\Q@+9'1M
M2\I:Q"V]MG]I];F,N,X6=(YH"D1#]#+D!R,.!4(XPI9HY77)7[P<(\[(K%CF
MK P&N!(A)0$+<:N4=88MEH7+U^0S+R3N0XVX2H$5N")G-.,JHR4'6L-#KMTV
M(_Z78A]LPYWF1D6*P%DREE..8[L-AY"YL'*;#?E+J<]DPQW7D%5I*46P#%Q4
M9-"+49&0953;"N*O2O[RY=AP"4HNNDHUD"T/W ?G%N)V4:*SV]3]596N+B3N
M0VVXMU9D$QR@"XH'BL15W2RHN5V;1'VU5<(+BWI?(RZ2#:"45-Q)!$.Y3U>V
M@L1)_%M$_9=6G\N(9V4HWDZ:0D.A'!: #+NP*I:\J.-;'O*?7_Z5^<YXCJX6
M+6L;PT)?IS=?)[<?UW]FS\-P]*_7"W#(7\;S!8+-\[2U2 HC#:5)@D>4QAKC
M*\JQ 2W,MLZB\WK9BGWWT%RW>WW;-H$>\KY?O_GK^'8RG95OO?OM9O)Q,8\Y
M-/0E)?@04^E, 4.A",@@EQ,!*K5(Z2V6SB[FCQ>2>4%""H%9X5B,4C'C?"+)
MV%K_B,:U@Y-HM#J'C![[1!_;-Q=+TM:O^A/ 74FOR9D+#2ED9KT7P7?3.M(9
MRS:F=1[AKO3?8+L8MK.WETQ^6MS@=Q\>NKX??V2^1Z/O.65C50!,,:&Q(MAH
MG:B(IA$*1-B*;"9+(@N4#P?@:@_I;&5T+S&]_S0;SS]-;Q9;N<97]Z5M^?UL
M5$ :XNC;_/(C!QMUV\1L$CE$YD$S*:TU4 &\-"5'*](JLW;[:,\0AX>)Z7%\
M_=V'!URVHI+O9Y./'S<@^R\O+"<CW;.L+8_%M6EFH XB.)M-7WT$_K:][G<P
MNX=);D7F3RPG:;S+& -Y,2489=J6UQP$>#*KSUS7HV]EU. 0$:WPM5T@1,=X
MFS-;W91[3K8%6&$5A:2.<]0R:)Y412&6,C139=TV6PIYMK'_R,7!G'9XY^[^
M(YPK7MR!4A<S"SZ4=?;.EJ$ES;3/AJG(#1/8N&0.KXSU@ULZ=Q@189@-R! A
M<N&C,]$562W JVUHH**6,=XE9?74':\[6E7)>.0(,7KI66#<\P[2%W*@0*^9
M!11GDDZWO/7BZYTWVQ-6/O+'\6A^_R#@1:*S7I28WY&\[L@M+']C^8<XF5_=
M3,OOGN$XUG'-1/2*15DRN)!!)6\[7%7N8NJ9:&=L<T7W%D$?=19G7L_[NLY"
M82I="]G0(4 4()7JQD.C3SXT.&H&-C=,'GP4%1.LI-@/4+B/\<F+RZ0W[(@U
MV3K'4YFFS2)QG?3RE1S7$(%7:@^HMG:5[9+%N23XS&GV!J:R52J@X@:]-06!
M5B[7MB5TN 4<C;S;,TGP"?)N;X(PPI,L?-D57):=UU&Y'!UL:;TPIPND+G+^
M7";:UW?JAIO1?#[Y,!E?'[+^>'6D-3FID]0E7^:4(@>1//E@)UVBS##'ULBW
M)OY ^B[,W#H&:0[)N&@Y"IM3T$+5\2/FN&[PI4 H_:*8VX6WB\)%U#'+P'(4
ML2R8Z0JLG*R=;EP":"Y?-'.K:LE4MJQ@%1F$+&2.S'8#Z]+H'!L$+-"75LNR
M+Z%G+^^@#@:C"O9=5$8Z%@-94FM]UE: * ]'S04;X.&1C%,(WJ57@$89*[T!
M7M0KTHT7#P1C:;QI,EFQ 9!\.-4=TM2Y0(&B# &U$-+S;"P([6+MKU#@?0-G
M1+G[!JKJ?H2=@Y4A'$,E#5" QY/US-+!1*P+. 3EV2U*$#DFT7_++\_+ -!+
M+E#P9?DNLQEY5K* "'6\F,Q:4#L.V&^-CV!E<EM6BRPP$S=7\0U[$= 6!1JG
M2GF926'KKL(""=<"FQNU^>+02\2Q=+Z8MQBM*!<1##B$7)94I>4^6>11MQLT
M+RF770;-F;#85R.Y!%8V]7"IJJ/D1K8(0W:+VIV'SA=S?F0-8R8K+SD7) G'
MR1MUYP>J9^?[N>2R=+D'WT0KM:3+I[@%6=[\8]3=@P48D]O7/VNVV,)MY)Q(
M^\YP+2CGP 22>1(<R+\N1^$96-5 \%@\!^T/D'SG\JRIU/(3B=R(:'-&CW7G
M$(^&8N?&A*/@_4SLI.L<G PY5N=53-'YY#PK8PMHJTUG9=U5"QRX1?<OSLB
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MN#/FF)E)#A(#=)&7/6&YC@P'9ILS5DKO?^^W$WDBF]/[0Q?')!D=$V4>EF%
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M[E%(G=%5Z LGN&Z+^%+L92).X(V^\/#,\W%,7SQ"%W4L;<PZ1L]!12F-CO7
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MO#-(V\/3S")5W^M<U^8*LX\>*9N,-B$/P(P$I,Q2+Q[#??M>V0QH-#0<3.+
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MZPS(5"1F@G992&[)'?#J]Z4H3X(M1NKFN/N19%Z$TUWGZ3)BL@'+&UZFG"%
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ML3QSP+MZXP6*!G$01#:]&&LB U*ADT08RUINJEZ1WO2 =W #Q4+',<2B ;&
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MI3MM+8NM,$I&C][007=ZR4,R*3%2;L83+X679U:^;[)T./#2^X?A^#&%ZT#
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M-YE+V6SHN^FZC!=4KDH:%F'[$FF<4"W\\96H>(5&BWL<>X+6+'V3^9M'&QJ
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M*1%5QY47: C>IGY*1-![*3J)LA(VJB(8J*\U#Q@@B"K]2!\4SEL+:;\+GZ
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M@9:'Y]!?\/SEJC#I&J&T/<^5XU57?$V=\*_R :/I+=:%^9;Y=G>^_3)]CB
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M)8<=4)+FZGA82;*29"79!%YE)=G4W!$K25:2K"0;P:NL) UZDNV^?34T5\O
M6G+#+.6/!-13>?UZ+*M-4*J*L%9W(L3&4-$7&7Z=BE#NT'7ZZN/'N^['0>=3
M]^JVW_TTZK<^*ACRJ^'P9G!]K(!6ZB->OAZ#/*6@]05K.)"&:]=[PYD<78?I
MUP_O<S5DH^ZGD:'YU0CCN,%2[C*Q:@1'FZ"-'81752_%AF[1E)!W(T(83F*%
MLPL+XJ+](!1>#38L'H7KI=#+\,TL\-7-&EK8NO"3&4*K!>';M,.+8EV$-03U
M+!ZD!9<@5@D,#%OO89M2'R$(0Y?0FHM/+:.Y:^!&?*9&:[P 5RD@T')X'W:P
M]FCP%7-[(.A'A7M(D.F>!Q.$RQ&#<![$L,P(XK_-RQ50,7ZI.EU@8VOIJ YK
M%AE%C1XWURTB?)RIGG)APG0W@<J!Y7(TX#,,S%/-S C*,:0^5L_Z36EG;'SB
M,OYB#O/H3MYIA%)XHN[Y.@\1$5^A\;IA!I.>03JF76#"*$;@\S!6*X5(D-NV
MI'A!R:^S!]M8@KO1X.KV[GK4N?IX=W=]<W=UW6F3)6C#]:.K3\=J"=0VV3*L
MH$7-@"=!J#55!AJ>Z:E,!HE#"C)":*KI/4F<00ZKYMNH%NB&E6+T?F<-O@%=
M2S%#8R$'->Y7JV400;!C!$&P?V HM=9A7\^3/Y/)<^7V:Q$@V@RB]P\$S[LK
M@>?E1.VV[1V"9V;&79B1$7$JN',;",?F,5OC<MG,;"\PF[$-*68V9K:7F&WC
MPR3'7C[;7-9\V0,T2<77L.!H-T)EMU6B?]F6_([=5PKYP;&(1;V@8*?E]/V2
MIIC6IX1V5(W[47V-D\^&\4_CZ,/\P_S#_%,3?6KTMMK';^YDK!NM9CNA"WUH
MJS9#WUD?<5/ED!+<>!P/1G$IWG?1[MNC7GMO-,DEK3XJ&6>9C?UTCA4;Y$NP
M)CHJ3=0=V+UVMW:2-&7Q\3XN-6=5PZKF ,>K[9$YS*W&K_UK-<WKDX_''XY]
M3KM60\2U5 "Y2T+@Y !9:H"?;<KBUVVJV2*?L%ST1\:.%;$\L#P<O3QT[>[0
M6)1W*A+!J? UQ/V;<'WTN\9PQ:.@\S.>*^Y=SXV?ZQ"I0Y4B'(5/=O+1#N=5
M]F"U7JI$.QT1O&C;O:&Y[977THVW7UAV678WE=V>/:P+7XQEE[.,QHH^]#'T
M>CC5%-C.,2";[ ]3YT 4:WX!R::$VTH;'@7S&7-SV)MA_<;ZS52^LF_WS;6C
M>1D9[!C8B#< 6(&Q CL2!=:S>U=[!,D^!BYZK?XZM7.B&N*H@WA&!]=\FQ]G
MWB-!CXV(C2$<<R)S8C,(QYQXSIS()^@_W.:PC'R&OL&'"4XLDF7^8?YA_FF2
M63N7PL'_6\0!+X-M;W]8_@Q+"+L]N]_CLU)G$/ T1]&?E709!-YDZ6+I8NDJ
M2%?';G?--5$^=>GB"KSXPQWU:\$C)L$D:TNA_$7.F7#,RS%O,^C#_,/\T\2<
M"6UT'+4!I&98[^Y%A&F3)Q&.:T&W.!T?DX]8<AC'85RM(G;5,5>^QJ+%HL6B
ME=>&CAAP<7_ID>/W#O<"?7;@9G#'X2.^0*.F,$S=]HS-UAG+U:!CSGJQ/+$\
MG;L\=>U>9V]0-:<B45R!]9H*K.V1*W84SZJC:B;#N,W/O>U=JLU6<.U,U;,X
M&<CYE[T;WC.6[+[=[N\1FH EFR6;)7M/DMVY8LENL =_>*ENSMG*YA><-(I6
MS%?,5\Q7S%='0:MCA[K9+USK7(8JMW6(;KWUH((U?5M_?XA@)]'Z[J)U>67N
MP-FK27;:F-9'I"<;ES-@5<>J[G7D:E^V&K#MT13FX?PGZ[(&L2/KLJW(U;HT
M6 1_]KJ,,[Z<06F,_F>^8KYBOF*^:@JM..-;9\;W*%IU-=W_X^"!<[Z<\^4\
M":LZ5G5+.=_]M2)L//-PSI=U68/8D779ECG?-N=\Z\CY_D@Q6M7U>QM8@6B>
MZ\MW.OQO=UH_?"A0\9])%+N3YT-HLPU':'R=/P6A%4^E]0SDC*Q.JSVT\=\#
MVQ+^&/_JVY8?6+'X;MU+7T[<.+*>),;?493,Y!@"<[K_:?'HH8K203*<Q!.Q
M"Z'Y.*% ':^^"6; UL]_BBP?0OP HGJXQ'^P,-:WYD'DX@V7C5W2&EG0^ )_
M W)/ @]L-1)8I4M".0]E)'U82UR-2#H)W.Y*_"ABT#J)-X9EB.$*5WC>LX9F
MI<7:*1&CF622Q G<02\A)O(#>J"7C'-.@OOG\#1BF0(J[,[OOI>.2"+Z>1Q8
M46 ]T?2FP*CPF_2!T6/W';T&@6@G6B#@)6XP!FY4E))C(^SHX*/"E0M<>$K)
M)<$T)3W%]<';4I^+K_&#<":\DKEMXS79@Q6%'.EY^IJ_O&F]H<]@7YST<P5K
M?7-GP!:_R"?KMV FEAR]F0@?7%\-4B1QD'ZAO$KZYLD=Q]/WH_[EU:C=Z0Q;
M ] NO:NK'U(C"3;.$_-(OD__6!*'?!;%!&EF&T>5R=_-4ZQJ@+W!#R\;WTH7
M0-W?[KSR_M?=_MJW\^@WO_U(][,/'J-EPQTV&^IC24F/=B,7WD:?E',$L_/&
MZCG_ ,_!NO/1ZMU*1\[N99A3M-NV=_"RF1-WX<1#@,YLOWNYN0.Q)06KN;-C
ML$D*,QLSVTO,9JQLF)F-F>TE9MOXF/^Q%V8TES5?=/\.!/AKTN]3E0!B!K.(
M=?XC2"+ACZ.-M[:/Q+EK;'N$_6\)-68OHSNH":JS@E!-X96=LK+L7!BCSVE+
M5-M@WTB6*)8HEJC:8=I/6+(VVEVO^OO//R;1NP<AYN_O1.@#:T1?9$A>UC>8
M[D<O</[XZW_^QY_3BSX)-_Q?X27RX_-'X0G?D5^G4L9_ ^=\#C=G]P I?:37
M;W+RES>?;C&!]/>K?WR[?6.Y8_A"./&[]O55[Z;=N[[NMF_O;@?#7GMT>SVZ
MNVUW6K>MF]OVF[\NT'^+7:BJY=O[)JLCPO 9]UA3IQ\WT&44NS.!^Y<3(*7U
MB+3$7<W")G@F!X,/D17!\-P)<#:,8>+Z0'%7>! ^1'&8S/2&;7'S="9%E(3H
M'<?%-]#>:*3W?5]HI<D[E^MW+MNMEKF]RG;?R&9E=WC0[;HCWRWDR?/DCV#R
MJS1!]H274KRF_.L#^DFORC,.CFR;N8:$=^7NLL4;?,QP^V:XC3?Y5JF]C4\4
MG^7.UHV./E9%EM<4E+#0FQ=Z9L<*=L3$P2I6I(0"<R)S(BM&9L=S8T=CBI'+
M4^KBVW:/ZU.X/F6STW-9BOXG5]R['AVB6I]N/RJ8I(,+9<-XJ7'T8?YA_F'^
M8?YA_FD@?8[=1:_)<ZH.C"Y^DH_2LSK;(']M?MCA0!Y[75531JO,3AV*Y(@D
MKEGZBR6,)8PEC"6,)8PEC"6,)>RD)<Q -KMUQ$&9*F.7X<SZ*1"^C7!;QEBG
M0<=8CAAD\YC.]@R[=GLPVAMIFL(,=5MY-N:L:5C3E#5-VQZV6JQI6-.PIF%-
M4Z>F&8WL=O>*-0UK&M8TK&EJQ1IIM>P>.S6'0$78%/"@$B3AUHT<+\#S^-$V
MR BM3N_Z>C08WG8'HYO6\+9U=7.CD!% C_2.%QF!/E860%M$+NMG!5Y N 9K
MUWC=X _.@(?$G%@:V"Y+1)>_=V,8I[-VC0C1HL#DKWT[O<OZ%LQ=)\7$^'3]
M]:-U_?7&&LL)$#,J@5JH;@7RNS,5_H.TYJ'KI,T$"-+_'CL;.-)]1+B-((3A
M8I<*;# 16G/ACJG[1"C\:"+A1\O3);O/U@5<*;^[L7KDV[03 7SR'7<N/'S
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M1T$>4?40\\&-Y;UZNB/FR-7@0 OTRB$8>*!)1JI]'^8>@##X<O@S N<J+-.
M7:IZK-%M%>>9MDT%4;*2&);SW\!%J6.5VJI FQ7LV_B"/*@@K4HXU]^($HIV
M+1/+)$)IG"? C@ZX0^)1@ NG#.B8_#0RA2K")V.7\[L^D&RC,SB7NA.?!_[8
M.' 4 ";S:PW\^GF-@ML#VXXUVW8JV7:=]KVTODJE0*VA]<ZZ314C?3.B;U*M
M>H:<LY]T0=&4^2M-V1[9J%O)1IM9W$OK5]_Z&9-G%C;!5:UP"VB]*I$(UI@"
MO.KG @.2 D/?)$J\V,8W22< MQ\'B4^K?'4#E_P4E-O-!EZ0:>[\DC;/M8!F
M?I!@BO=9)=%#Z5%&08=^P@'?5C4\QMCO9SEV(TQ H!;[_>MO9%D+?EPR#S#%
M*JE=L@-\)X 7P5).$$?9=V3J*Z=@T6&0/$R1C4?*O.=.)(:N^J4PCDB6[/E4
M1*HY;M$!7>5.VCJ^Q:;/\-#RX]UHC8=<?&60MO_U"09(95W4'AP\%V8<E1R4
MEX5>S6H3'QB%M1B55^:V,:R@7'3:I[C0VEK1$.+%8LK[(\PU#>>S9=UH.'EO
MXA7XWLK#$A8^%!TF=,U$-+6PK,&:!6/I47[5^AG>!A03H1=@)BT=+@18. A;
MTQ"?]<+T;;V(>*G:A)E+!U_[&. SR7=+,Q<Y0T=_LAY":ND=!M0Y'/D$]R R
M5/1T LJV8_MF<"\3^O#D OGP@:$;_1&E3\]>7'PP"&HHQ>S2^JR6)IZZX=CZ
M5R)"8$6\<UF-CR5R*2@FG9@!I9:^8N42:5%>$N%<9@NRK+:D,/MXCS29NC+=
MEL+!5-@(FAV\&=@LU1E/ M\%U@783C'_RK$M#"EOL+Z@7U"EJ,<ZN"\U5F,H
M.."XW;,ST^W,3[".]^D08)2*7OBCA#_3A<DZDEN@BH&' E\:9:EL-M%28W':
MD,M>NI;1ANL9;1,.6UQ-L@.;\M:02((:?SV3Y6M>9K/,H;X"]_FZ(,SGYS_7
MDOTJYWI7LD)J4D44!8Y+W% T$4\NN)^X^F/T^!2K%/?*8R4YH20[#(*$!A4D
M$004T]()"!%: 4_EL ('+#((928@:HN==E2*3X4QI:PI'">46O5,/"5 HJ1N
MWJ67KIQCE<F/8OB/\EYP/WJNKP69^UI0*: ]0LQY1=;%6.H_LWW[HDT*U29\
M9IUR14,^QP2WGAP9P=SATNQ1UD7V@NRI9;VB1%")E;*U!8WG/5M38"A0"1>@
M363XMD!$&V]"A0.^O_><YND*2BHEO9+]LE]VN5SQP3'";F*H5+NJC]!]4H 7
M9C,14AZ-%.66S5L6<]BTMD6A79NXWD>7EJ:M[+X0-TT6G'%/',,]<89&6N+T
M#MP2Y["O/W!CE/U._DB 1QMWSH"1F=?9B;1SA<4=4ICS#LIYKVZ5LI[$S8&*
MV>_! V-8S2^V^6%\\",RTX= N6SOA'+)&*ML?!FC]W@P>H\>#VJS,K8F'6QN
M/$S9_DX\O\BD1W$4VAYT>H<G65.X9Z=<+,-('BE*0^/9D979ELKLJK]Q;,_*
MC./+AG518!C<)BS\7AP!MO<L%F<H%IP-6$/<Y4-"ZXLHV'UF]]DDN3I[1%]L
M/.]P)J"AII!5&:NR;4Z*'9YP3>$AS@?4E@_H\GXS[S?O/7!F_N$(<RMR[G12
MF_TT]M/J\M,&=G^XOS9&C><>#CH;ZG6P,F-E]B*Y>G:W;^Q0 RNSK;L-\ GY
M#8_F!G/INW0LEM!?HA?/R6\$[93"U"'RA>^X7@ZO@'CVI?<ADD+AR.^LB(%?
M"9?CB%@^!"'!T> 9>M?/4&GT>>%*='81I4>/]W'XEX^C[O,XZM5ASX.^]D3G
M41]''?%QU"/P:!N6)]KSH;]"KN.F:- X$<D,9HK!RDY1K2E*9C<^Y+R6'7\R
MG\)EGF.>>^%@?18%_K02A_A$S]8WEU7Y^/PIF^$T-X$9@N;P7#,\P$;3BOF*
M^>JHRAV.O=IA$?:G?TAA;?QVC;G-OM/8R^NWEIO=F:9(4]8>[^.Z@Q-Q"QK/
M;:QI2J=N!G:ON]P<EE5-75%;^^@=FR^ZU<V/7S.$^6UR?J=[\/:B,VR95KWY
M\M>G58QSR#;'$1H>EQ[<0)^RN/3L46^Y#SU+S&$B[N.W3-=9TQ)L^N-'L@XY
M.U3^VKP C@S"%9VZX\<QYAY,V.F(5ATG@$]=Q#BVBC]@(QM5^/R G3^Q4IG:
M6L$-P;@6D:NA<."P7N6H8RZ=L2%Q3MOEY""-Q6VUN+7MWM!8#,<"5W.,=_0&
M<N=F*N?IAYH]%'CJ'N@1R=@1F\"3$2X.\CC(>\T&6AW2=71"Q)MF'(_QIMDA
M;4Y3!. @IH6WQMBUJ]H:X_)+CIJ:9*A.1[0X:N*HZ75;8UX01;PUMDN#JOZH
M)H2P9>HTA6WJMFYLQ,Y8HFH'>C]=N>)-KLTWN?8'Z\@G?EY%OI,X$L2HR!P>
M-\2S8&7&RJSA'MHYJC3&1C8\6/41+W_OQO!X1WVSA'CU.9:SR/I9 1:/+1%;
MGQ!X^'\)>!C1DJU? O]=*)TD#$$BK8\B<M=O,V\XV7\F4>Q.G@]A$0[%.PA5
M?1/,0$*?_Q19P#OO)JXO?,<5GB6B2,:1;46),T68YX<@&#^YGF=;<2C&TO+%
M3,+/00R/MUP_%OX# 36F]R&J]3P,YJ!?GNF#_%?BSK$HP"80ZUEAA0O0TD]3
MB5!3$JYP([@/'CT&_10'(>)0NS!6-\2'T"-3,&Q05HO/"7SO63T,GY'?YDQ%
M^$#/QAL??"#(^-*Z38B7X%+YF.7@X'TK)HWO7C%Q:ZP>A7F[9Q#)R)(^CFXI
MWE&E?>I9")UB*R!O$8;/>+^>Q4Y#(+ N:7V9/D<NK*5O?8W%9()/#>4\"!&T
MU4I\-[;D=U#:.#JXW"T"AD>7UC50'ZZ/$B]60].,DA-\B:H17 >KX/IP ;Q'
M((SY*A#R>Q'!(X(<9=SUYTD,[_V$R.5)2%,;NY&31!$MAJ_O3XG[(M_.I>-.
MT+0!(ZPA(KP ;!R\+)0>K7LT=>=XOU2@HU;/>F?]+;O_&]W_2W[_KS32S_DB
M7-, +JU&2ORI60M%_8*%N 66\0+D,R-&P?P"--LB?,KDR/6C.$R4L/I!G.OK
M(%RE<[7>$8ZC9!-%%5L=8'(/E,$X;4]@15.)>HK:($0Q-4<0T52)(_Z!I@(>
MB>^VZ7&$00AOE? UR%CAR[EX)NQ^,@>.$R;P&KW]KP4TFH+*H[^\ #UZ&<ZL
ML;R/+RTT?Q*,_HP&5S0>D\W>2B_(5W3Q_9:8@P7\3L_7*C;3[PI8$:R%3'LX
MT#C5\'P1 ZGS1@V%M5@_ZH)BS**"P8>(YFL]"6SSX#F)1W<FU#%"D)+%L4A-
M?(R.85[" ^L1*;KB-.:AB]/(S>-,QM-@#,[_ _:/4$]3RKRCE;DU"8.9)1Z%
MZ]$:S43XAT3[,,%^#/B0RT8*P;$HR<R'6^ JM6K;\D@$PR.#"6.85*H!LNY/
MZ)J5%$)9":!/QEU!&M@5I-TWTA:D.SQL9XS#-N8X<%L0GCQ/?A^O7Z4)LB?4
M471<E=@_8 *Q7H3PPY8)[ >Z7F4\<D*:WNKEW2-FN$T8;N,#M*O4'O>H6$?W
M&QU]K J;KBDH8:$W+_3,CA7LB,G 5:Q(.4+F1.9$5HS,CN?&CL84X['7M3:7
M;]N]AIZ1XLY232N@SG?J"GT)UZ?;CZH#T,&%LF&\U#CZ,/\P_S#_,/\P_S20
M/L?NHM=95K84&%WHLI5MX(G.%M7 Z/&64S]%<$02URS]Q1+&$L82QA+&$L82
MQA+&$G;2$F8@F]TZXJ!,E;'CN8>? N';EB^-[8G6<GZ^*23;WS'Y8SH-/^S:
M[<'^L#V:P@QU6WDVYJQI6-.4-4W;'K:, ;NSIF%-PYJ&-4W5?:.1W>Y>L:9A
M3<.:AC5-K?C)K9;=8Z>F'KBPO0ULW;GZ ZB<!N/'W 0^EK:&&>+3;V[T1S-H
M:WKA]P0D9DT%%O4^R@BA)]PX(I2I*%+@(JYO36%(WO.[D* IT"#Z.$9KDOCC
MJ !K5;K,<_^5N.,,?T6!H*0O=/$5\P#QI.+ <D(Y=F,KA'5$+*C <>D)3VX\
MS=!4<' SC2X3:=PM&)R&IX%OGN<:.$HA9*E+DC!$K*M/$E2:\*Q;">^$-WWV
MHR0D6)L;#7N%K'3QZ?;SS5L8^,PE@)O_ZO1:-FB\\M!GK@\7_!M>B80J#EVA
M42'65:"'36]#?"KK'FX,?#<.,C"L'*_#"?RQFS)S^2>$\G#C1#T#B!!XCXC>
M 12'!\Y#=R9"6&=Z0N+0N^\1U077CJCG(<:7;3U)ST-P$=!R;C1%>)'J-^"#
M@1]E&+D3 B>A*1+23#@7(98K-Q3^I;%:;4G6'J2/O BK-@ZDPFD*$3PIE!;!
MA,3$J;@2P(;N R&R+7(:+CYXI4$XPT72O^0P>&HA"_PFXG=*N$K"*!#NA:0
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M^\\_)M&[!R'F[_$4&ITV*R#U?0-U^=$+G#_^^I__\>>E"POG6U)8V%_]WU(
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M/%"P*U@_[CTS)V1A//I#6!'^'>YKL&NX"VY6+)"_EEM6$,/:+U%P*S7>;)C
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M$/J0 !:9ZS#WY#*?,P'9A:>G44+ A5@D6R !1^J?XTHD$P?3R0M%MI<II ,
MYA&F>";N0S!-P5 ^5X&4^&8A%CEA<@,&V,.\M6C!O]#@3%0"#P A4\#./\Y0
MMJG%P\E\Q&@"*),(@16(+P<#MNIK4\ IRO'8L:624^1+$*!7OEF].'OG"&P_
M3QIP,#5<,[BN^+KD34  Q2(Y^WIAW66@=HF/%N<%< HFK735QHH 13Y2PU?/
M1(TVXX[TZI!C1F+"W;&TBGD0I?,"@]1'>P:'#^L6+B]<*%YG\!Q_RYLF@$QY
M3L<99"LN"9BJ(C#\>$X'R;5)@QE\BA[%?U,F"=(:GS@^M32.M;":*QF0SV8
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M!5]1X I/2O9WO3@(E7T 2(I&>SZ,E&S'*F,]C38UV$UV4NL?W),!&(5F2\?
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MT_H\:N9,SGQUJ2>\"_\<A!-G-B]8GGH@Q1VP$/<:L9X=AK+#Q;]F-SOY8U,
M+Y@4AG]+3W1)?YE;<WLM,2)#90#*\D@"\^J]% 6MO %%A<\UZ*5L@PEW&60W
MJ+38P7P-"KZ"#%AYR*)9Q9=\.[%9SN92Q2'>:EKZBCF_KL5^C$M]H*JYO\J#
M<&F5HD^9/U7!*=5M">1]E_.F)ZG<@"&"AXF63PYES0&P]D681)"3C0M;%M>6
M1WSD"B4E,%#U7:FC<Q</@4AJDDIA4J=<$Z-N6#@/*??3Q2A21?:R\YEI5=R_
MF<UY?VC@BK^96<PBZ=DYRHU+!@VF*J5:1DU!0V)DH*!V1AC+?4RK:>5>F^Z
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M4C7(HFT_=G_;K;M.N64VC=9 6U['L6RF5@\,*F=/$08<#08T.T:WKZVW!F$
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M-[9%R&PQ"X3E\,CQ/<8]F_&I#P+Q7_E#HYKC'[UG]Q/!PGC*_#&+X..?JC6
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MP/D2X8(D90QB.^$LQH52?(LI,0 OH4C-(&D;\0"9+@Y"D?*W$\[-,)@O<F3
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M80UA#6%-V7:-:70&VAKY57[U=\6:W8.']?>GENL&;>/&O]68M^2@M'Y1&K3
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M).XN13"31N'SF+F$A(G@;C2Q4'^-N>6XCA1A@(<DP"BU4R F A3I8T[A19/
MCQ\F4N.#\@4'[_<TM!@NJ+PY0X1& 74*4"IWUY4B'2LO28Y/. I=/;'0VAS\
ML-S88;1C0"-I04H$XG"M$ZBVY:]>>Q;&HYP/^?Y$M&B9@_UWNG7W M%1\4G[
M"\/7^?#0<J\F)CEU 9Q2_;B -'!U:O(!*R5-R)(80J""IPB"*A2!&NT![<J<
M,@X$&(=)4_LB.J[R'F$&D>)J?+;J<8=MRDZ$@?:MS2Y<X V/IW[_NFR3JJQE
MGE'[4YSEY!\>L [+)B[#HKF4V>2%4.U(@+$O\+?GE_:ZYE;8>IPY5\H;\:6T
M\;)=8"?,8F&9=[8J6+P>>::Q&SDS;.20WH?/ KL3W386R!CN!2M +7,=/D*%
M\YQS;8OA;VSQ:L=6NE>2$,3 "\$WXB/7"2=9R"? ;I.XS^=A?\ET2MD<T\T5
M)![&[> >&W@&O,- ,A4;BWGX?&Z6IVU0^3@2!3] *M5D+W'ND4K?,!^U*%C6
M!86W_'H)7]RU8K6=KE!/!%@'&9@XU7\KM6?J 23CSY'Q]6W$ %WQ8,/57NTM
M8-8;[L J^S]Y/](YG@%5,"CB<DM)'LRU%J[!&_9@UB(BVY&J)/3C8BT/-?/@
MTOWMO%6XH+QS(;BY8?A*H\0B@\0HCR^$['/]1E??O)%)$!8 7O9KE)HBD!A,
MNKZ*@UTK!:EH]V?M.XN--T?/V0++2 SVW.1NTK8SABO%N8K+1?Q; G_B6[)K
M('%[ITUR6M17PREI@B(L8QA5TV.N"X43<]C-<)2-8Q=]YJD"US!*F5O:0M*0
M )R,4Y-3Q013% /83HVF!ONWRAN2&VQXZ>W%W26[N+O"_-'#)K)JVCR4RH ]
MX;\\?TY 'H8BDG$#W-<-')XC;FJF8EQD=6+A(-VQV"'#D!C[1?[XC,N )SG8
M#3"J[:2J';Z""2+U\-8SJ329][6+,3?^DBR&1VFW^X'SX,CTY#A)I$3;QTN:
M3:(#)^/_T:*II[(+TS43Q35#8S.7#IQW%)X1I0)I9DGY"Q-K2Z9]RXR?0FQ1
M2F.&<2I=/$&Y!KM5>[C&:D<]2506N0T1>%'LA3#-4*8@ S:.L9$UI@?XX&<^
M*'L/C9$/[,QYOV@PY\FE<DWA(:[P'N!O*ZF&M#AS"@]"0R=QA*-5&?%)BM7B
MMI 3K9E6E<P)R5,UR=_A[-)+YX]>/DN4/WAT9TV$';OBT_C"BQS;<6-TQN\$
M\)%$_)O$0%2GF::S.)*,\&E\PP/DR?"S".XFH&TW.:ET->Q?M@<W-S>]WO#B
MLC=H7G6OY$DE\_;"O.V;=3VIM"+E535[7TA]#C/R*L"Q_-@%D?-QG]Z141>Y
M$$+&:D"FP0! YF4A$AK$( J<4:R>C$F _G0*V"3_./%=N8N01/O&,2;6JI<D
M.C\J9 HI1R];5A15]6I[^W>/A,7C4/[9]L$384]R>A)591(8;I.>IZR6N3?P
M$@>/D"24 BG5(:1O]-#*/:5P2C>+J3C28Y??\Z_Q$!O=PB%3&8?)'JPH9 G7
M3:[YZ5WSG?P>SKB5?M^<O:<\ )!5@^1QY*<_J(/6\A?5C'O8:W2&9JLU:/;!
M+NMV.M^E!S@Q3,5GH?B0?E@2A_DL\H7:LD.=PY75]=8O]:8&V.WOV&W\L,W2
M=WT[C9XZQ9==MB ;[J!FC>*'VY%KF/I02V>#_X.VYTTAZVY.4?!BUR4J<6+)
MQ5Y/LN<KVL@;$).8C9AM)V;35G*)F(V8[2UF6[M=0MT+1%>7-=\T_W02\4!V
MG[SM .VMCZL0N0SE);O$_(D'MK;FU:542:M,D:YVO[TW0E6%5[8+5Y-Q01*U
MUF%P?2X1211)%$E4*4UX3T6R-)2%U+_3NGH?]S)):[VP_HR=4.[_AI?/N6^;
M[-0.;ZYZ@VZ[>=V\[K7-3KO7Z5^HFI*]0>_FXJ;TG=KR=F8=M1<[K[PQYDXP
M3X:06Y)Q8$W %L8\VR29X,)^Y$DVNL?^$;O/+*F1L=WY/MJM3#:$FDU]^Y,=
M+?N3_=YA=^AHBZT.]D0VW'8)7>PJ%-X[5'BE0O&],NV3SP5-<TA[O_*]SJG3
M??Z^P<  .[MTDE1E\37:\556<V62$$MYX E7M($M/L-$<\;M/^)05F[:)-Y[
MT*VO@W9X/3.-3KND^-3+Y)GS4GD(I9W=R#S00,0KK'1;J.E<BI@>:!NP!*W8
M,[H]?2U*22L>O5:4$L8MV9K +D.X:B=#+6/0UK:I695E/HBDK(>K9NUE2'8Q
MWUI-[7]GIMZ=KJC'FD9[86BTA]2MMX9[:>OO=JW>+<.=-I@!.+Z?QA_E:;=[
M_NU&':J]%)X8.]$]CG&333.S>]F[,;N#Z][51;?9Z5Y==0?)IEGSLMWM[_-X
M(_KUSOA9^SZ:E=%MH2SA0E4F>7XPXM_82!%3%F;8M2KF:QN#M=LC*V$#S&SI
M.:%WV!VP Q^1._#M-'G:^]RC3M]I[],TJQT WL=)AQ,[85A=9GQK(_Y4S^'0
M"4-B-CIA2,QV?,Q&)PP/SIIO6X!TQ)"L.[73AA7JO.CUR$]=DBRK8?M6C'NJ
M"U/$/\0_Q#]ZZ4-;XJ]5G16X$^X>4A8KG[U$"=WY^SKZ"@E4?>'QOC*/.Y/G
M1C!#,/-"!GNWJR_?Y2V"''?B.L$0P1#!T)9)QBUM.P657_E=S9W=8X?U]Z?N
ML _9-I[[T:7G]UK:3GU697'+]@=(WQZQ/)RU])7@([N5Q.7(Q:4[T&9X587Q
M#V)?G4P@VP\$/+@,V3F>8\>MWI"\&8J:5$<M'8]HF6T2+1(M$JTR:I>WJ%+&
M_F)PM;<$Y2G_4B2JA/3E]0]4[UOJAFU]4O<&X4[B5'GUA+#&NNVD)/&L-]!G
M6Y91RJT6\DMA1Q+4LGU PVRO?=:'E.9A0YZUMW.OQ5@$@;"W.JAR.MYC"5U8
MCMV)K)& U5@UDH21A)&$D821A%7&<CRV/?&-#W<=;S[)60N<,^U5/R@!BY31
MT0I,VVAUM)W!(8DAB3EVB>D8IMDA@=E$8"BG\1"'28[',SHSC5:__"-:IR&,
M%)6@J,1&LM<T>@-M"H^$CX2/A&]MX1OT]&TUG[;D4:BPW.,SQ]9<4Y_&>X,R
M56$.O(]2'RNBP8Y-FDQ]M;A)GDB>3EZ>SMJ=O27NDWU8!W?M* _;')$GUS8Z
MIK9:.3O3[;AEN49B>[PZ]9ADMVT,S/T=E"/A)>$EX=4EO%U#Y]%RDMUR@ZRU
MMY4_+C4;+H?W-'6?KPK9]M='OCRBE)+/VNEK:YFX-FF.&Z2JAT>5LR,(APB'
M%L*-1K=I$A 1$!$0$1 =$(@ZACDHJ?K"R>)0SFO[/N(P_Y77K_C\X_=Q>/[
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M!D)EUZQ%R0U57!9*!:KDLC0;G:TB'9N==_WQ^S@\?^!\]N'.F@@[=L6G,7;
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M[6>#*H:19@ABK8R1;1Z)4F-J=[Y_':-6(F4ZISUOMX[[>IK\F4R^)GN6I9H
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M8U*Z)RP25M.P^MHB_202)!+U%XF.T>IH<^9()$@DRDTMU2\![;;1UM?CBB2
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M^?. 1-R2,?N[42Z_[8)/8%YQQ%P?M'V01-QWHK>ELN3)X.0:N1X#IXS&[ \
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MYMUV#5.?H%1E=4G5Z!24;;:#SU#5=(RNQO@RJ9I*[&J5+%)-TCU2<CI=:OE
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M;OL\XS1N_Y6X63WC,2P[*!X!!LYH%(J13(;-#9Q4\_TC6J]CEW0S#%$(]EL
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MJF.M. )E/+D8D0YQNTZ)F(IDJZ$6YB\E)\08U8RGBD_GD6(M5 LSKB[0;)K
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MH8>Q8#?!!-[^S,8\8H]"^,!U?AS"8/^#^5[<F;B^&\48HODJV##Q;1FK87'
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MM]BGB>\^)A'+]39#Q0VP!38!^DD9?$DO"1;[GR"/5M/ F[OL0OY_O.$M VD
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M;TWY,W)C)#E7!3JD\$;@!\.J&AO&,N2R8N4#S)_B:F'A'_5HX+A92HVRA^(
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M6MV[[JUE]9I6_\-MP^S>-0;PAVDU!Q_:O?Z;GQ=@KTB35ZI7K]*$!^T\L52
MZEZ69W^6A5-G%&0S$K*,ACJTP'G5Q%<?\?*LU\?J-?A==4GXD+;%.4]*]Z^Z
M[=T&6+P3.Q!,0S'E(<_Z_8#$R_P:U7#(];EONX";LH6&A!.LF087#8-P@FTZ
M9 N"WWU,DF+W>%'$1L('X/6\9\;!U)U**)X)"&@Z>.04&Q%=_'YU?\5^&0P^
MOS58*&3WJH@!$ !JX[NPI<&$_SEK@:1::? H2B99PXTQ*M;A4#9 @-G 9()0
MOK%8X4UL,"WY9-M6=@<.U _@A5=S<KY^'&@0))%J'6+(MEYP.VB;B21,'+QC
M%^9;.1+4HCFU4[I@9R-;N%_1>G[/+JRW;!0$SA/H-;"&0NX(YG- 2J7A ME+
M"=0R]U6C$1B'B".XK_DV_=$+T#UUL=E*_F/KK;);+E5SJ6(G*OBU_1;'$H**
M5#U)QH)[\=A@3T'X)ZB7_&1H]_W<G4;6-V4HH@@^2PW+'UT/6</VN#O!5W?>
MSL_:R=LX\6^S 7;?SKJ@*',(>"BPLQ'VWB[TOW(QNH*-]D+L>A4]\2GCHU#(
MY83K^V^9)T8P(-1AL)["1UB&'\S&V]EWL>0,%U2H?(_\'18*6#28"!P?WH)S
MO#!A52+NI6NOZ(Q-76:7YE-WD6\&2$Z8(]A.22B;R"AZ9#UI1 B6(;[(2YQB
MDR_5C$WQI&P9]Z<?//G%FZ4I$R+[SO@1URR]!!Z92.IF7)C)!(Y)&D'P]L3#
MAHA!XCG,<4%\0O6N>!Q$!7&CSBZE:;$;'HWE:LH_T'P#QL9%/TN2ZU-GF>.8
MB74D73+71S=,"9746$'HCER$*^#S)%3==&2W.P 0-H&GCR/LM0CB'JEF<[(W
MJ%PP^8>8+=A</\CT39'LP2.^V7B_O 'TT!@H 4HQ5,VHP#GQD31LF/A.$53F
M+O-<>%&N/Q??A:^8!I%JB&>#S+L@[6[T)X)J@(T>LZ:.\&"0ZP(5YA\T<7W0
M5-AT"(==?% H/"[5MFH-B- <1&[:I? 9*>7&0,NTS^!,L0+Y';?80W#V$P!B
M[,:)>@8,*?"^IIVZX($ _-C_R),+Z"2V?/<C=C)$2LJY>#P<"=!,PI, "#K3
MC<9S6KWX!J6A@"N!%4 D\'&N@CY4'U-L,B86J.$$0 @$3HFC?HR&C)_V(A.(
M^5,1HODC0?T1?WS.NRX5C(6%5Y0CUWH$IP:R_3'3]JF^!<Y:*Y%[.OC%UW[7
MN&IE 09-CUS56&LI.T>QK;Y)F&5.(EHSBZZ<!/S1,1"K4EL'3:+<B,6U-)@O
M8B/K8;JJY=F<]5ZPV6&=@VEFNI&Q<@YA=AKL\6S60>:M?LF]58,-L(&A5(4(
M";=!\A@/$R\+B:7Z]R:0;8%G888;96-\ 1N#Q'9'#!XL!P_ .HNQ_;*,OD3)
MX[^SN$AFVZ"=6%P+U<QS9O"M;VYN XD!K$,5ZYC9:2I28*LO9?_4,%WT%<$-
M]$71]X7I9@$:![SYU/<4DWE#;!9(RDVR-$K$9/?"&'^5KYJ K3F2CO"B 8LV
MI3+7T/1+?Q%Y.$(9W@4SEL>7RH*>L[CY'),[&9,79IA.:WW;SLRIEAU>_:R3
MK:))1IXH=<UQ(!E-0$EF 974R)RM1!8?2ZGBL&D:\\]ZX6:>/FA<KI8'HS1R
M$H\<S&+Q&&=MR-.).O H;C\KL]V-"C.'#XX D@,A58]Y%41)Y )E%$7S&BQ_
M8 ,,-&0C+4[1R%VSS&O(KOI'M,J!,+)%@]' &CTKWDI-<R;@NF#BVK/K%XSY
M)Y ?Z=L-&;9)1>-\?Q-H-3R^ !B["7C.7GD_> [@Z8\"I!PV8A=/*F0K>2GC
M$AXIWPC^G?)(K6_H"ES"S!?,27ZE9R/L(XS,R9:K"#?8:B:&_P$?9<&S.4G*
M&<1QHVF""Z7X=L)A'J$K?5;5Z#YT@#5"9+HDC$3&WZX$%TR>QDAGNM-W":01
M?@(<_5^293 G _M%>T$4(2OX"_*7DQD9:V&4:;=ZA![TY@6^"$90N$"+V5F*
MRZ3=_"AF\/2FWPX9SUET!^2&+D,T A1\GJHESK5#"H/L4<1/0OBZ_"BSK<M[
MVJ^_=_%1G7UR&N;&Y/#G:*9UG%1588!&QN)1H8<B!V^I; !=4'WG\"0[F<N^
M[8D'OJTO1D&LHE#S2Z8@>L+_#<(9/V<AHG2I00WD 9^TU[4,=4GP&@?1%&W4
MB,FM =E-/@R2T3A(E*$SMQ5UQ7X+&#QJY,T@+Q/WM,W[)(!)Q6, 5K/Q_<)(
MYIANE37SR#T)95QGR*&4_)JYE=886D O7].C# RXIM"],KQ0%_H:E22NWD5?
M+I6TVZ-6&""[:"-9:N3(WO%GW$AW'7".T;OQ,1PF8^6[[^AL,4/]&RA@-:"U
MQ!'/T]U(D$D!+Y=&T] 5GL/$9.H%SP*N2T!$0Q:-@S"^1(R?[<5&[&*FH36Q
MC=RGJ9XRCMQON@:E]J#>9H;NS!6V \R?<%)C7G#X,5N%.7T5Q7PXE#YOJGJO
M8&DCJ;\6MW2RI0[%7(S6 5,*-'8:884;4D\QRE3]7+K$9C%:-D!78'%W",8P
M8Y=%#P(<>(^#DHV$G4ASP4GE*AN&'+Y3X-2K7/3PD@5.+:8R%)A;4D5MI*D!
MK6;E11JI.';FC:I<AM?)D]D-T5C ]12X+A&3D??0*08\QDWV*2[C6=);CX:8
M(ZC(""K%0LJ\3'2V 6<,M7<.,I!,$B5:#@;)<%<:!%^*:/YI(;:$@0YX7,AQ
M7I<X1W0QX!K<-)>B-4N722*!D3A,=HHR\UV)X3)TAMP?I<'&$]=#:$7K&I;*
M36:_(LIBMC%S)QA)+ !BOK!I7H-<!(F?\+=:$S=<M6:8BZVNECB;+E\A@"BA
M_8I]DI$O[F.P4;'"O))0L3 5_)VNYE#/C5"'16DZ0(1I$Y)A4LQ6B80AAGID
M^IS<G<21[F&ATLX]WGD#J\&!EE$PC)\4NWP57J"6Q98FB8RQ/6*DQN;2O8=G
M2/6**C1T^%SL,@]CY_*N*: [IT^RI(,TR3*Z_"7-R)0,] G5_@\R)\'GWB6F
M)-^GT],E=@\!V,S9#._RN'@AU?P>3YWPT(G8=0#_L(N[P?WUV]57W 2.S$N1
M:'LQN+]Y>\7N$T!'M0!9&J(]QN2:-)T0*)SN16"RHFNGJ8_J#KPB$S^0MRCP
M?>$MY1W!6HU"/IG(LS%VD)Z1@8?$(E)/QC%DG '6X01 P_W/+!NYP XY_Z@!
M/(H1QI6?QD)96_G/,B;,G6<YQ"12H:N%](.B*LK,VBS4O(M5>[^>M_';1R&W
MEM3D) !F>Q_S6FXBXG&08NAI:Z@AZ&N]"NHLC;J#&-'76306Y/T1@$CR?-4F
M<^B$"_T!%SZ=>IB&6C@KL48#EJ;O-EMI+0H-5!4#-:3PVP73RTZ/?\AP1> I
M$.3Y5L 5RP=G%P8GX74^H@]VW.R@0+JK/5-+\CTJ@[4 T*D*D)N(>?Z\2M2?
M[2X6;Y4Z!5XY2E-:Y*/>8W)H.GY/K9]*6@1SU1UBGJ@AWQ:*(6X^*F>I<*B!
MQZD"FKT'%<][W,:/P\3&3&6ID^2P%U3MC%1% LW-[OW:<P^H'R=@:R?AIH,R
MU%O!8/!'(C]F4[QO&*>>P.*MZ7D=&5'BH8]6N=J3R Z]++B#7"55I-G463[Q
MW%F0[(C/;$+PZ:MX5MI^<1"YC[+\$%_D49R4(YV4A692*;,G5C)C?H9I_J#0
MOQ-GE'I+,F<#U\..TWOP:<,$EC9-,<<Z&#-/-AU#_K[4>AH7#\>HB_'@1N$!
M\!H@!@QXZ,JMJJ7S0H:R@Q25,W-DYJ,52".%*J6)[Q1/N2S0:':/9$] S32@
MEK]92<W\0&:37'HZ'K 2:M\QWV.<'0_[QR*="P>RC-3<PXD5DGVDEY?$+EJ4
MZ8X@)A7,3B>!P6H+)PG3)\;"'OON7PEN)7[,EF3N#,W\Z9G%HVJSE9>'PQ0O
M%D_8*#\VRX7*T283IU4'U=2I'?7^-+$G &++109-XH;2^,Q]Z25J%P0MW7)3
MF^9X6,\388&E1&:RSMO)\!L,S(U%>L1LZ1V*&S(*K6-E$?VC8$,O15:73NVM
ML[YG\H^2"!<BUX/_+QT$R=EI/#;;TBY  5CN0K#? OBAQ2[!=<I_*26OXR#F
MVB_YXC[(HX._S8X.2K>5S;Q:-I#K=9:FLQX#+H\*+&0 SI35XIE&:51X:5($
M*O)5VF@./5.U-(^B+V([OG<F9@645@SPRLU2L3M"R7@:6=W5BUT;^ON:YWKI
MC\KN4U>B)']7VX9Y%HZ="T?9:8AMS5JZ_HK5Q)2V?"U!N_E1++AC'-SG>#G&
M5JKS861[CZEFE*8Y1I)33Z*@3E7L&4^"*7.XH%Q2>S1(0B#57PG'J+>"6_1M
M!$J![89V,L$J,1A$4S:SLD6>I#*724B>^Z> %\A<))7J["2V6&&G\O1$+[X]
M@56%P8#)IU*#>1@^IU(*%L49Y2;J'N#_HE^:<<-B32*%\:H $(+$T TCY3<
MY@,+@/T*MLE77#@[#E2B=N[0(%LH&(ZEV[5J[25O;+#R<+\ZHHHWKF  0_JM
MZ>Z93%TO&/SSX_ %:BRTAF&P:<J\' +,!PTJ-:$T;BNM875?P5%3>RC+-\P_
M/DNZ$\,A5DKQ8S5Z/D<X/@5+G-OC><K/MO)29S5:0217Y>,7R!2EJHK/><8R
MN5&>)91' 'CX)_I^Z7O/,J\WZ['3.$"JT5VZ\8>YZ8&#VW8N?A.L %-<*4R%
M,[(;\L.W*?;.,5P!M!7OY2>,6?P4@ (24^7E1:F?HH17?I^?HU@X,C.3W65V
MDQDX:]A.;9? 8]"WB;/9S5\UG]F\@-^9TSE_"QZ4F(WAB;\* L7IX.6S><Y$
MG6."38 9\$@)/"?$/5ONW"M'<H+126<V[\R'5$2<__E)(:2?35Z^:,7(5KXF
M6SVU%Y5%SC0D"AZ2O:]S^R!SY=>PM+0S)*OX*JR@3G7X[!-HCD>T)-*SM/.K
M"**/QH@33..47>>W15=N OX^E2[PQ>#^][?RF9>-EHYDU9TL.W:A;+)FN_'V
M';N7#*3.Y^-L'E!TD3;YC1]SSMCKT$IQD7Z7.8M C1DQI#=3D(-5"*/TO.11
MK," 17Y\=&ZDT2?Y=5,I5]*B#I:H[(697./3EL4A._$R\J4+EJ5)I^+T^)SZ
M5#(>LB!KV6M>&5P!6:0E$J0WJC2-(,83=^J!!1#(HI&9Q\KCA5=<L4%Z0$B=
MQ2E4S1$R&IP>/9" "U\Z0A9_0$\F?T<:QEF<5["*WFI?05D)&4_-PLLSJN*9
M(*3I[%B# AS<B['1/][=##@&[!3WDW*E%:W43< K:1P@+XHQR_2,1!:PQK"J
M+*<RF8*A@3Q6B"O@CZ-1*-31RS0(IZZ+BA<JD7A6>1X1R N>#ID=W0/.!CL9
MI@6VI;UP?@\+@"K\Q!-7ZN#;_$0DM^%QS]6NVSMFOF6_X:$Q.=Z!)_74?9H=
M^YY9;]GG\7,$IBC(V^QKO+;YEMT#T-KC>C'!/V<%U&95<,;Y4;CB@4"Y@BB^
M7SFLB0H'2>M*[1TI'R1V)XN&3[36X@D+FPA7[+^")W2 C;E;Y8*I*/8CRFTA
MW<?/PNMQR/T(3__(B'_*.2K6CBL\JU65I-5OT@.H:J#Y*>B%B'ANLU3&S?QU
ML5+;)M&]=0&ZC 9+T8M#QW2R+%&#??:X]$)?3+_5&=/!2-:*R0+$R\N-Y=IX
M*B-0O+RE\6)P*(_S8-IE+ M'%?9%YX,_F-QH9WRZJ,J0TU'I2K&P,8"ZGPHB
MSW/%G5\RRN:'ZI=9HK@=CA6>4D?&C69;8VO,$/D A@7?I[DWJW9W$UCY*$M4
MP(!^OEN;JK HW1A6@ 8\H,(=L1J#@KML@PW\0IDZ5^#.PLE,=;OBT"QZM6Q*
M%NQ(-]K8C)S+L9XS*I=WT[/1UHH_!C*A6.W0+%B*(L.!&>'\/(<AW=U>V,'D
M*DBX1/W\E,BF&8;9/F6;7;+MM_AJNYMYBR4J;E/!28_5P3<?HRB1^*[.--$.
MYL[L?J^.;638)/E2QL= K(L%9X="EB=Q)X]H2TN,\?!<;F@4*TZHG -7VEZS
ML#4&+":/PG'D*9#0_9I&QP467YR=V[C!G)U0>7W(ZTJD'O!HP*\!E[7\(J6I
ME8!)>>B!/"!+J-2J&,S).$W7RN>TJAPBIB<@V.(X9!D4+!H8)I/L\&:ZFSN3
MY+DS6_+YJ J&B/8ISJ]!2GSZ5<[":<9:OHF*@;&LM%V68#';6%6^L0QKSE6[
M55NL,GV#9_NM*OJ.\>MO:0;*1D_(C]1DNB<KD9^/O;*L6[MTS]NL\+$].XDY
MV^1W,TQ[41Q4="P3"=5CHI@FGQ5JV("!LQ.>:; %STIF:4PO\/*LPC,>XIJ;
MT#QKO\C&BO^6GK! DF42R/EB41_P\&15'U6.W!=J @7QSHJ !*FIM/2L@E+-
M0$3/81]B]EV8?;GDQA>!6S?(1&FYN#MNI[F!KZB"U0>*%@TTI=CF#^V^<$XW
MK6KV0OX+6Y7_,G>V+4_]41/*3Q97SCXKG><TFUN;VY.Y^3$[5/4QU_W5S84[
MG/CO/]AB '>^2/6\$2(K[6$%H71[L-C!&I07[@C+4_]X+PJ1!RJ/R:Z**D83
MH-0.DA'0.]LFRY+AOV*%_#1\-GMC6G] I:8N9W7,/9K[+[88D$''3*^I>M6H
M7F0Z;I@G&,"DED>25>G#1W V=+_!*]7H'N1&GFR0 6P9R/J-R*JS;-[%\;@J
MHSS;A%()O7GBD'IW'NA0FCW/$9>&01"M&MDJBWD51,O0B5P;1P)O/$XB-8 ,
M&]'SM>/EA@U9A RM#A4@61Q%8:B+>P++:2=KR"-S2H8JF1S#.'G(92R<D5@5
M&,5#*3VSO=>^Z!I$6@ @9<_]%PP$:+7OV])J.H-T&P9+VF.L7U5(2Y=^K%ZU
MZ.ID/ZG I@ :23U=B,!+SPKU',=JS8M2@P5%E4Y5D?WY(R$%?N-Q'+J/B6P2
MF"=#R"*=,K,T'4-V8B4+A&'HS8/5]IXS?XO+*N!BFI_$F:^,*+.=KMC-VJ,I
MTB5]6;@=@0FX,U=RD7&R,%!^-JBP0Z;ZNN1E#](2(?!S*,;@WRDS6&Y_7F!0
MZ:VL?[W8%P5-'.1'/#@=!_:?:9^O8O42(7M^Y0;_RS[EB]:(-.MS[WT)"T*L
MU>8(#*TOD6SNJJ)QE4<XTZJP,H@YVV%,*[NYLT#8YH6_U<G@'!LJJ0)KI:\_
M2A_JWXE?<**D+DP/L07KX#47F)>R4_($"],Z *H6037+,0$\?ZNGTFF,]015
MJHJ*<*M$@4S?I^"0)]\47,R^=$YR[">NU6IE9EN?T2S0J PR5>\X"S2FB*HZ
M@,S" 6D 4/<FZ;',@#5';5<F(<OPS'J281F7=*/^T1TFH<KQR<-$8#TN14X7
M3N/*.%-!.N=/Y[ZHI%5VOE.@E*.R>63.Y2SU0.60JM!0W@ N]^_SJF472NN^
MW7+GY6'A:$[1^,#L%!EF*-H"DIN<XI8%YD,NGI[96$EC'[K-8FF??/9/3%=A
MF"VXG#,HJQ.Z:&YC#E0<K0XPIBGCF8N$&XKY;I<* >9K60@$+D?2*@D9=<&W
M3:,9]WE#.K7O)S=S8"'RMG0/_!O[=7:DMK+1C>KODQ6UC6R5"(1?[ <H0>2%
MKH#SE9)7&;R/$@X*K0+2DE:/TF>:]5949YAE-8!9DZK525QII8(0W(\X-U3
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MB0.AFG#"XXVR*P.[NBI 87U9Y=?!*5^OA%+SD6J&"24A61- ?<G%O1E+,9N
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M-:]]!G!32XV\E[W]U;-T2T03Q_!QVHWZU;>&$,K+35&N-X-CXRV<E&-[+M@
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MR^.L:XSE.TO]<;"S C)D,4VDND])([1HM(I0[/LUEBZ=;J#T  RT--?-Q%8
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M$=7YV?*(^3W7&9WEN,?TT 4KJK:RHUVA"&=%/5#&6,/9BX)NI]6M=5[V:A-
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MDLW&M-N;W-.:CCE:V%>I_^ROE92VO]%V3!9+*7[CB.I3O\[@$7.;B)I+OT_
M1Z&%I(X_Y%A(W/?[VSS])W%N+)\=*^#''QU"CEXMRT?46ZT0W_C?-$5T(_1%
MM-LQ7?1MU0_K;R!NI.5"ZTD=C\BS'K]M_]LLNO6_B> *WE@X(:PM"Z_FL@L:
M?/>-$UM_A1.<P /B3J MV),UPEQ/1,"GJZ/W3V9!M9@I-*K4CO1BH]HR%+HE
M:#(T)W^?68RK>*%72_,56BOSSZ-FG  XS9P R,*ZBQ,!85^+G;\()NP)78R8
MJW*MRG"5HVU>G3_)FC#8]LCXL9$M;2LD_HID0MM]X?4=MJX_"5ZU-?,B_DG6
M5$%IM&'.?/+5"IOLIL<M!4Q#J6.UM@I-(#U%L(\)=#S)+(7)]W#LI1S\R;'Z
M+STZE\?[Q_#7*\A) )+GB77TZMGP%5FZ:.H$Z=.P4N@BTO,)^[B(]''F'88Z
M?[2T+*BI#7S?PY+R&BVTF73"MY_-9&Q'>[6-')AJI7G[M&#>5PC_U1E<_M()
MX2]'C\+YA-9K0N<,'@4/*&4^]_H9/,*N_\UC-%->$MGR\X%REOA VX-M<_KO
M_L?DIY=O\6J&^8%%T0I_/C"\)ZX+2@Y)"D^U0:0'[?_&F;?^?/ XXR[Y1"1>
M'5A2<?_Y@#)*O=4GAZT0H=?J!0AU8/D%UY@3YDQU0<?CP?'KHSV$@3MZA59H
ML$=?,0^&@>%J!"J(@WVJ"1GWKM9"T9U[U1?0 H_O;FXN$O)EOVNA$.JUH]<I
M8%370'#L$-E?<*RK)N0J7;R5HG)P7R/,A6H(N]?4?I,2SU"DA2()X:T4'-'F
MMVTO&GG<7B*!1TH@O/.]HAV!:Q!X-G5$XI][@E LX"*Y&7P14I7?<1[A;2@C
M33B4>>]:503UGX12- Y\D0SZA)0O1O^1B+*BIZN5D]V1GQRB.!:!K+M:@'4
MNGARM&/,7R"QW'EWAQ=,$J2/;^^M"C.UZM:Q8E2%Q'R3U$SP?1,EMO:MSV$T
ME[J#5M!55+']WB'&]1V6WQC_0UGI!5H3B=R^\Q]/2/]RD[UU8*;6.GMI6&%C
M3%8SCPO<O/:2I)]0E0Z>?1]-CN 6>$:O/(BKX%M+X&V&] NB55R5F=I+,[VL
MA*#/.7RRP?]$HW\7GEE/Y8F\)',:")NSATN\9BJ+"E*H*1LQ(>$+7_%XS:"=
MO8@\B_$0JK(,Z.M-:&>*'NOH)57].>RE(85@9.PV.<5?E/\81U>Z7CNP'W9.
M4.H#1VCG?L8@&0H_I5S.5AINIFV]+#>8O' 168ES91B1;)MK*A18JK'=)+-<
MT></&&&(8"YQH+NK* 0^%\AA"@=J1K*8RU2';^UQ;)*@$D;9HU\$0@*FLJ5;
M@926V$/N%/-57(+=QRU,W1.3NY>*WKU>@L^'I6SY]DU0)6>RE2?46TQGX Q&
M: .U_2U_1J'+U&NC\$+"5MI5<('HB+/_8%LF)347:J-8]Y@J5P1=K)<4)NM5
MNT4XR1?AY(6(<)HOPND+$>%MO@AO7X@([_)%>-=F$4SK/:U;W8G8OL0S&:HX
M'I1=D4?L7*BQ8H'A=2J JU#O68*Z0D&G3"(W,T;=JT:[(M8XZ]!Q1'SU(N_E
M\Z]1E)=G=V(]_W4[.IC*TE3[*S\E" .RZ9)C <<!_ 6R*^:Z[ &4I_):R.@N
ME:W%!:Q#Y/GB]QP]7%.)%><2OM%Q355*C>#+(?Z_A X4E)+!=R"0Y\IL)>Q)
MH9(A*"M0<L(QX(;%]]$B=A""C_Q&E#N!F_8)A;/F;K;8)6NV3%R.UR&_%+EP
M\T.F;!G%6C=79O!1P3(G6\%,>,9N'6.)]D4T6W:S%TGRA"LHW0:7G/R^C'KL
M8?^SI;%Y1)4M:Y,D3K"X(9+"5J+0UOGNE% 9,[<%95HF6KYI,UM[G/!?!%]7
MDWH^-;KTJA]4CD3?KTYU53Q1##5 ]O**"!NYP17;_@?<ILIB,9JKOW?[<_GB
MS]^A!_,YAO.PVP^?0E2PN^-^C*7'Z92-.+LG$+SZWZ>/Q*U%XN6,4N&E!7H[
MVAA6;Z^4T GHS67:-U)E,,R\I#V;R[P$H8:T$*AXD9<@$N0OA4+M%GH18CVP
M0J%B1=HH$I$PI2Z28B0?/[_SOT*$PT6PRG.O/2FN&,<V$G)WLVI1H18DR D6
M]<02F^O)I@'DNFNN[$<7F&T&Y]?3RWZ.<.5J/MV$515I8=:&J)Q//U+M/\CE
M.#;_4;KT<^>]"4:_8;@V"&X^7J]=@O/,,:-8:P2YQ0@.,<';!R*77RF;"<SO
M@;G W!(QDNUQKK]3+$B4'6P@/\)Z2\SN7K.G;^;EA&97<*(*WZA0"PZ&7-/@
MC)7_Y!H2C@6)]L3<$*H[89295:[=ND3EBG A]0D9O3R]W\F:JI7;-P1K20;@
M&&"&#+FNWF:9(6U^F38*E<HH+[&M^3WMG1SWSI+RE2W^(D2=X+7TF3\N)6M>
M^98+*[*X_RB7BK7%\A\>Q87B[TNA?0KYC3'G0;&E??&N\]V>#$XY\;UKM<YY
MEY) 'W'>2^:P1NDURN4&(B%OAI_L'%7(]_5JK8(8>#=58TPLCM%Q2U+*PM(U
M,A%LDQ5RZRZ4AYQ^XZJ)X7P>;=R>(%?]'>[=30I67/S%[,F-;OZ-+]3 +8XG
MQ\<?=KU6N:+M<T_^+">BSBWB?V )5YTR9"^C#ZI,L;VDY$\/I\3=LUHK1?=[
MG+^[]88AFA(RM\#S3W=$.[XA(;K'?'/%.!ST4H-FW 8O5'H4.SBV=ZV6K>3L
M*_Z=RA4K:6"G8GN5 $.8(+9.G8?SX.[BZ$)B-93Z4PKJI[]-2=];#)M!HH1[
M.(_?P!S<:ZR'V2E^E.>N>K=5W?=JKD;WDB&9VCWL'XQ0^;MZI$;F8'_%\($J
M.UF2=:B2@C)/.'M3QCYN8!/,X'%-?&EWIT+S7K9PC_\-EBH98',_:;]*KA3D
MOWY^-PU!^C#D#-G^[-3V>@BT5L^V^V!*EVY;#&64=^+-PI_*V4Y@7YJKBL&
M*DR2%]1[:3JX(2OU-^.^N8JP1($&\FNU3?[<[GM[V?_"7$CDX;L=NWTWY]WS
M=]Q;Y*Y!&F+C*&30EW-M)MB=ZT?8&6,)8;_VGOI87B16U=HM"S7R,54&8B-W
M(M%\KL"[P_)!!5$);,UEVI<2 ,/"3N8!J:?M8URI-OK0VPT3(GDOD>%]*X7)
MN[$B+59QR>=W)7<>L,+F5X2JGDC@5BA_CWHT^AE+5'<)*C;%"\R;1P@N#5'1
M?M^%5<JP?R>P,9=IG]D-;3_AL[$^6CU2<& A=.!5="*[6M46JL#_Y!7,6R4$
MS'CQ_/TJ<FG^=!0XMG,\9QQ?XNT7>_HKN,/%/PP:NR81Z5EFO.#!O29"YIS7
MWKF=5^]YV4[=^N>;X+-%%XROF:J DSN$6\[CRUD5UUNJ88:&XR6<.@IW:()&
MI^BQE]RFNT?YUBV>:-Z_>"M$@W'M%E'DWZ\SP?Q>!96)@7"?"BWHMXG=\;<J
MO,***XJ9)](S=N6+OYB,2(NDHI?4-OH,6(W%6CB& ,\&*VVC/7H2((0D-)%E
M7S 75K$X<B7[S4-ZMA('1Z[$5^J .%$Z!Z-C)&JC)-MFUY'F KZO&(<37-MS
M6Z$:#.];-_(DA1(!UX-'&'+5F+STSURJT57O(PI$&<YO&%W  A$43@A>E4;[
ME3-EP6U,X<(N%OXM5\&5>:7N4&N*V%](7=F7JM4GTSH5Y0X@H^5&$!48T^R\
M,O]U^\;"$=,3?,@=($Z9)_M2JF:@#IM/UBKZGQ-[M/UFWP5LG>!$%3DY[KU/
MB-T(J;^6BCXTIZ(V[]&H(]?'YE3T\2^JHK/F5-2"C8A;E?CGC<>P^YDZP=V3
M_H>Q-JF5_;*%6[$N'QV[5!A<,F\FYYX;?$$%#EKK+*,/]U\ /MLA=-]:;;N^
M-M_XXU\62!ASYJOV]=\Q!K)ZEBQOB[NYR//W-PCF)0\_,@8'R\B"@@^!I<W=
M,\;EBK;-_F*2QF<;_>G%U*[/_DQU*D;CR6"%>JW5 6QJA13.G]* $R5WC$9'
MQF.A=X[#K5'_.7UP;@>>V$OL>+#1-W'B2,EXE7_^:&<#>$T:S[\E/%\[&"D_
MK+H]9&ET\57)LNO<3 7:YZTG< 3/N2&89F^<-;Q_?C\]P0MX$-.U&DR8[7\S
M*V<19\\Z[?5:<.>K7J*,;W6-W=Y_OMD6B5\+&^WTS-Y*^ 1T6W 0N[)4\<NX
M= GQNQKZ<'UU&0@_]SGA[77".3+--MDW#L,%BBZ;QU(J/^/",6EW%/>$C3R3
M$O,=K>DCE*E#8Z5+MVZ]L_ACFZ5D? F1P';SNXIJ!G]Z1&Y&2 TJ<&&?=H#*
MT??.SA*3$OM7:\% "SRK(3-(09U+'??[#E[GH^JG[JT[0I:L4*.G:A*UI5-1
M^H6G9P[^P6:B;\,^"^6$" UNC$HNV4:Q?>+B@P;HM"W<R#7^*5Y!K,0WX=1]
M]C)Q<;'VA<133,/C'_Q6)?3:EN$^5LQ3TI4HV48!LR+]%L;WB9MP1TC(2P]V
M7 7Q )N'YJ1G!)UM6%:I9@M/RWR=C+%@RHMB\27ZQ'7JD[J%I9X?RJ^41U\#
M4A[O'%,\)U*$M_R*\)I?H23Q7(@$KCA;Z2F52^QXMLXM(GD;(M:ZA=0B=?G6
M_!M\^#P2MD I.55>G.CC$+@=3*\P[)MT@P'6'V\+%+(7H6<?C_UOJ0M[B5?H
MUQ_^'U!+ P04    " "6FEQ.$X>.N 0W   H:P( %0   &-C<FXM,C Q.#$R
M,S%?8V%L+GAM;.U]6W,;.9+N^_Z*/KW/F,;]LK&S&_*MCR.Z6UK;O;/[5(&K
M5#L4Z5,DW=;^^I,@*5FV)++(JD*5W#,Q+4MD 95(?,@;$HE__??/U[,?/L5F
M62_F?_V1_ 7_^$.<^T6HYY=__?'W]^CL_<NW;W_\]W_[IW_]/PC]UXMWO_SP
M:N'7UW&^^N%E$^TJAA_^J%=7/_PMQ.7??TC-XOJ'ORV:O]>?+$+;1C]L?IG5
M\[__2_[A[#+^\'E9_\O27\5K^\O"V]7FW5>KU<=_^>FG/_[XXR^?73/[RZ*Y
M_(EBS'ZZ:_7D$_DO=/L8RA\A0A$C?_F\##_^ ".<+S?O;O&2V\<_/WC^#[9Y
MFAAC?MI\>_?HLG[L0>B6_/1?O_[R?C-.5,^7*SOW\<=_^Z<??MBRHUG,XKN8
M?LC__O[N[5>=^&:Q7/K%>KYJ;JZBG:VNO&WB7_SB^J?\^$]G_O^MZV6=6;<$
M0C;]734Q_?5'[YLY\(!H0K<<^.?'GEW=?(Q__7%97W^<P9A_ZI^HLQ VO]C9
MVWE:-->;67X55[:>'45PFWX*#.:3G:_L97QWVA">:CT\X=>QJ;V=7\ *7\SG
M$9CH3QG!X6Z&'\IR&5?+S2=-#&?S\$MM73V#+V/^#F12.&5D1_<Z^$#?V+KY
M3SM;Q_-TL6[\%4BE"^!^/&%T+;L:?$B_V::!A?OIE#$\U79PHB^:Q9LL<$Z@
M^8FF@Y/\P;I9/(K2KUL,0N +.\N*[_U5C*N6O-S3I!2)IU,Z$L'MYOY@PT'(
M?;FXOJY7V6I<@HA]N9BOP+X$.[,^3'"+IJ5)?K->K9OX:SVOK]?7O\0L5.W-
MYLF6H.FC[]*#/E:$G]!5Z2&U6S&M.QB(_/ER,:M#]K3NK]T69!]H6);<"WAL
MOKJ**S C9R?3_F@O@P_D_0I^;@!PGE[:Y=6;V>*/H_B_MX.RY"^N/S;Q*LZ7
ML/S B%]<QY,'\G1718=T_C$VMI4?W+Z'H@-XOUKXOU\M9@&<J]=@F:UN3AW(
MTST-,J!7T:T.D7K_F<&(@#?*]W%>+YJ7X,35JS?6[URXELKJJ$X&&P9XV?.0
MIQ+TS+NXO)U8F->'9-T<,;(N_0XVV/L8_BVN?HF?8!%>QG=Y(1XQMB.Z&6PH
M^;]?+=AMQT)N;\/!R/UE,;_\$)OK+06MB=W3;#!2+YKZ$\SLQ<SZ'61AOF&&
M5S487K\M5L>;I=UZ'6R@[4S1AT\.1-"&03#\%A0]>'1HDKH$EH_L9IBA[/9/
M0!B_!E]B=7/O_0?I;]%V$*)?VV8.;L_R(C;OK^";0X0^]7P1XLZ -:&>K?,\
MOX_^.+E\4F=%AI4-[L5\:^G]!C  ";5H  FOXGQQ7<_S7V] F\-3Z]4&$>?I
MA5W6/C^2!Q##MSV>R)+!"2G"SG8B=W^K80B%WA8W,;Z(\YCJ%:BIPZ[-OC;%
MB#Q6%Q_3QR"#N-L>^37:Y;K9NE&'J-[;J!R9KY>K^CI;O7??WNYE?;6'M6L2
MSN?OLO!J ,MY+;:5A@5>78YE;T VS7V=-?YRU6P4Z?+#E5W]+3;9[+NE]VQU
MU[H+ESJ_K1QCCEVX1W52;A@YTR*L9_$\ > 6\^S/[M3/^<>8I7B.W\X6RPT0
M-U'%)>BI1[MZ"?"^7#3U_\;PMWIU5<^S8SEC7?A3G+IRC&^G2ELT'83DGQ>+
M\$<]FWUH;(B_V>N8Y=3YZBHV;^<K.[_,7M]6?AT:P?$]C3R@V[R&;S]OB>/>
M7S0R.UY>P9]Q^7;^$F3535YRU[G;\W3;Q8N;]_$RX[)W!IW\ZI%9=J?KS^;S
MM9T!U<VJ_M^-X'K]&>36LJW.&/"5([/H6.W9O>>1!]Q.W)_:WR"#V^Y/?;"?
M#]/]R*-#DW3?H=Y^_ NT?1'3HHGW'FN)K\X=EQ\N?+Q;VCM?L(^A'NITZ&$>
M*Q=:-!V:Y&\MTQ?QLI[O;-/7\_#%-#U/O\\;>/ARGHU0:+MC\0D8[?V=I9ET
M]]4VXI5=NM_?OXDA-G:6=V?7JT5S\PX4VH?%W:,[TH]3H25I&)J)[VN8QI1S
MBE?W5^ZKF&+3;&;WL9#"\8SJY3U#,Z.=0GVRP2#DG3>7=KXSNX YF\C->;IH
MXA(XV&JSHGT/@PS@HEE\C,WJ)HL1<$X^9MOZ$,G[VA0CLB7(6S0M1G([ !]N
M.0C!_[&VS2HVLYN[B-PKN[*_S^TZU" I#U'=LOD8I+=$RG&]C#&0=O@YJI-!
MAO$NSK)C>@%TW(!?,U]:WRKS[%"[HL2V1$W+Y@.1_BG.U_'=UMIKHVR>;E&(
MP%?UTEY>-O%R9Y'MGFC-[-/Z*S2X=NOS4+M!B+T-J[^M<VSYUM@ 43&KTR;.
MYC>-#Q)_;#^C#J8EJD[L;IBA[:*;(+$/DOWPT:%)ZI)4=&0W0P]EE\T\O]Q]
MUAHL[;L8>@CMQ,V3#88A[^@L[<+9V ]?EX^J;SX]_YAQF/,K=J;WZB:K]=K7
M'^WM-VU1TNM;"C$"1L#/K^>U6R_!B0;,U)]BIS&W[+#0\(X--+;OH=  [L$G
M!V(V?YY]_-A$OXUOO:LOKU;+G\$(W>P*A=>?8^/K96L':+@WEF+0^OK:-C?;
M0S=V?K/<Y*)]67#+,[#-/QT3(NOS':69D,\P-+7?''[)\_:';<*.N!Q;N(C-
M1O?F4V-WW_? ESY>6XA5+17H@7;#$'O+SGN1V9T="@;'Q6)6MSD5?%PO(P[D
M;+D^"XN/QYB3'?L=<;!'*Z).O8XXT'YA.B&X?KNOM)%Y:Y^/*,TOC]^(&?2E
MH[+I0;BF7X8<Z'[$H;=4+2?T]>2@O)WY]6P#CE_@[]WCF>;.);.V[XR?5W$>
M<BQ_V+>V#P^4HVA_::IB=+0M,%6,H!/K0MW1EZF[I6^V\%^MEQU-FPITR2[=
MIE[<>HDNK?WX4UY'/\79:GG[R69E(4QV!>W^>?=Q]6*]K.=QF3-?7#YUD]V6
MN_2(MR%[I:FV#U(T'QW+;_%NGW-F79S]]4>@N1KH314AFB=%'(K.2,2XU4AY
M+9'GS#J!#5<V?<W662X3N&AVL_Y\^'KODT+\O?=)Y3T)6G&"L$OP(P''@[,!
M22V,#4'(@'$;/M];7V>-_V'1@,?PUQ_)CS_\$;.?_-<?$;GMQC;^P;K[NM+B
M[HF?EEE%Y"Y1O8K7M^US!<D)@6\QU8D"+CZ[Q?!RW>3R+?>_V&U 7-B;W$>A
M)7*0CBJYR!AQ"44F+5*<"41C]/ GY<9)CXU1O2R<9[)N3L;J@.MGB%D\O*H>
MFKKYDU,'9A\;V.VQR/VZH\1K*PF6C%$6(ZXH1AI'BK@5%ED3 XV2!6KLZ>N
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MB'$30#2JD#Q6.MI6>F88CMPG]0VLN7NSN(<!>UI5WON *:"4^*"1DYBAR(0
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M[O7&'V]0<>&E22:B8+5&5.N<NA8Y(HJ"K>?!,TT=,@'+G!,N9>7TQ<%BE6<
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M,8^<SWG;EF%$$V%2"I(,[B*8Z'>.J9YX.KZ4^E(BX6%UA)/DUKX.*T,\$SP
M7XA." L"*Q L@1Q%]9A@H5V7"_#(=Q6)+L;BJ8BV4Y'W9"^5Q<P$!JXL#TXC
MBY4$?Y9L/-LL\WW4N,M>_'<1T"[#UU(8>X)9;^>?XK)KML<CG5142R$BXXC#
MP/,EIPEYP1,2(6)C<,!@L$Y]7W;L;(]^^%HPV\/'&)9O@(^OZ@WE^2:K\W1[
M^#9N$W?S2+??Q[ ':Z=T5Q'%O30@U(,+#BDB'#+86L1)\MA2F4CH$*\:-8.D
M,Q@>9I"4X&\Q].UN2ONP./.P5IOXR#!VW^Q%W1'=5!K;?!)8(:*)1S(&BA@W
ML.Z#"L /I:/M4,E[7$^A=[@-R]C2,'NS:.XOH(LF?JH7Z^5F!,OZ0/"T?2>5
MEUXPYR(2B1%$ ^'9JN H:*V,QRPITL^],M\1Q 9AZVAR[,D;$8Z18D]V4LF@
M3<H5+5@,$3'I*$K>!C"4\TV2$LLD.YROYM\EP 9AZ\B.P%U"5Q='X)%.*F $
M49%RA"68Q%CB@"PU&$5.I5<Z7P7>(49;)K QMB/0#U_'< 3>+I?KG.MUGNX7
M!VMI]C_>N))@'1!L)')),%BXDB E7<B[JBEJH<!"Z* 31S7R.T_T'B._-VZ6
M.T/Y<2=P6Z/GJ2:53Y9$Q242AF+DF1.(@6A&5H48X?6)MCN*,T53O6_0],C$
M,:#R<@%JOUGE.T2.0,LWK:HH;938.:2%,; V.-B*TFA$P26Q&(/%B/O)#/_.
M -.=CV.HJ5^R*PK$@_.Y-[GWR3:5"R((;P52@8-'D>"'%-PB1SEC22HA=8?[
MVT8-J ^IE+HR<11=U!(L3[:IF C6*ITSE1T!SU,+A//.5.28P6I)(%\[6##B
MNQ4N7;E8VHG?YOW=&EZ'3BKM:55)ZWT@%KQ( GQ3.F>A&N E-1I3F[AQH8,Z
M&C?ENW?YTBL?Q\',U_FCQR'GD;85Q=S"P D2RE%$&;4H,!I0P)K"<J$^= GS
MJ.\8/_UP<X3X- C.=>.O[#)FJZQ-^:O#C:O K:'2*!AJ/K&5SXAJRD!#!V.%
MM)@[U@%'XR:$#X6C7MDYAG5\;R";U(?C8H5']E0Q'55B^1X"$-1(*T6!V]:B
MY*AW*F@;? =+>M0<\B$MZ6%86PINKU.*?G6>7G^&53*_C._L*I[/'X^[[L':
M,=U4$=:<R1: E@I6(' :P7\289RB9#CE"S&F[K(5BTP/S-E1*R=]5:GH8<FY
MKRDM6;/H(2TMZA#N:57Y)+$(S""#I0('&RMDI<O^=K*2:X*Q:75RM/AX>RY.
MW?.;*ARE"E0R)"-.R+O \_D=^--K'UUT4H<.YYX*U3;J"S</B\>.S.M_U#L:
M!37#S^YS+(K4IK#IHPS;EO3;@ZR./5?"2"XL^"&;DHD&XWQ 0PHP$5T*P1'2
MJ2!MH93="<&Q_'Q, <,O8EHT<;^)TJI]E0+FFBF"E(T&O!5M4>! C-$T)<6\
MI7'R2K4H!H[ 7Q<NCXTR\'!AXN;;.P;]S8?&SI?6[XJ9;?[:3?;=%6)WH^U7
ML Y#2*4U"2Y*CD14$FE/P5_WFW-+W&%G:/*\0XQM?-R?B+V6Z)[,I(R]3#*K
MOU2Z6?['VL[J=+,YE/E_8[B,G25UN\XKKFU*G@1$@F'(8>I18#(AF1R-/ B;
MR.1OR!P/SH,R>@H0?1?]S"Z7=:K]-^LR1S7/SE^^O5^PJ3-H3WU=1;QAGE'P
M*%C*9YAM0$XJ S:AS&<5DM2R@S52*"%H7!P7Y/T4D'TZ2/.8P8$-2AJ!F#<>
M64TQ(I[E(ZM&J0#^J](=CN@6REB<JOE[&H.G *K'S)MO#9K3@=>R]PI3)S#;
M[ELF%)+2B#"M\FY2%,%K$>GD[\CJ%1]'8&\X'D\!GWMME8%LS<PM*B5FV$KD
MM+1(YVP,&KA&(#>L"RXEUZ5"[_A6YI"('("Y4X#BD>9&,9MR8]$8KKVW#G'%
MP<2B 9:Y(PG%*(60P5+*.SA%$[ FA\1K$7X7/(_W960=MS6/[JM*PD:,:81%
M3212SL,4N9QV[0-1Q D67(=,Y$)6YE [ER78.9G$AUT]&_AVM'R'K_C=%N:5
M)3A&2SA*/#CH$AR%0/*-%<HYP04&:=.JTLP_]H1[S'X[=7Z>XX[N/=,>6+&]
M 'X-4N'+BMI&,N[*V,?EMW?-G<W#U[UL[\#[-:ZN<AY7/L9^?2#UK2 5H$U!
M>@9)D; <IL%[CC"WF3=4,>IA6DR'2W?*@/14:#VL#C9AMA<SPV^+H;62WX\\
M70FO#18JWSN$.5(&O%TF _P0SLC@$Q==:NF4@=1DL?"M;=T+_\L=O?L4Y^N]
M*>:WCU2<B60X=LARE:^8IL ?PBBRE(.JT4F:+N5R"L6ENL[.@P-T)S.GU!1O
M3M7D^BG;JM;[IOK;1RNM*?,^!22$38AQ'1$#$8X,X8QA10/U9O(>3-]SW@.7
M2LW]J[K)B>6W##ATU.VQQRL6%'.2."039L@S</=T$ EIHXVSB>O0J7INH<RU
M+E/V[:TW_7"I% ;>QXT;_7.< \&S7+XW7-?S>KEJ-A&<P_<,M.N@DH9YGH\]
M1)DL,EX+)*T4X*C;7+Q022>>089CCS@9C&\%4ZZW%\Z]>7CAW'Z'^\EFE:+8
M4)*3/ -EN^J#6F;^2I)L$IY^>TO\B;'9YX*2GKE53+,\^^MG"YTAZU7S/.]+
M9F^KDKY<7+MZOIV/+W4CW\59#IL>LE':=U+QA(W#Q""BC$;1&H\B X?.4VX]
MV'GYN]/Q4^8VR%[Q,RCORKFLH$'7?K5NLO%U\-J^QQZO(N;>PGH 1XU3I,%
M0U2!XA7,<.5]8 9W"(C(YX>,GKA4"@/_N+QQ(!P4O*+QB2NH'Y%1VV#?Y:9"
MR'Q9AUW [ZQI\F'I3<CN:2^F>Z=53!QSG;(>C0X1#?:8$U1O;U(.,@G6Y>R6
M?CXH&867Y7::ME'BPP[Q-T]65DC'N%-(*.MRK6N/5(X":":EYL824*:3CY(]
ME_AZ=^:7<Y&>[SW591SIYX*YYWS/]7.^P[B,B_Y<4/B<[T"^O61U\?5>3/M+
M;A]O6'$2C4PZH,A-CKA'O5V!5"7B5> AR0Y2L(R+_USPU_M4E,TA L;M2'T1
MYS'MK2[[1(O**.=L% I,#,T1#];  @.S0Q(<!:P];NCT]T-[3<[I@T?3R27;
MEX?Z&AY?W71*$CO<?>44N-I>$62CBSF1-B'!,?AFBE/'N4I>=HAYEZNEWU..
MXD@\G4SB\*:2Y=5B!K.WW,KT)Q*(=]3V2=-]X[#,VV#=RO=Q7B^:;17J-];O
M+O]\%5>VGCV5/3T0.6<P"2%/!*C7'"#=30O,RD,:;T:A\#YL8-']$C_!LMC4
M#ZP7HQ"4__O5YC#RX5D;7N"WO-CDJWLX- [>8F<1Y\$C+:1 R1F'/(TA>>V9
M4*W2788?T1<^WR_C?M'4<U]_M+.W\]^ U1_^B+-/\5>0B5?[XN.=^JV$=\QP
MXQ$)H/?![9 H84R1!1O"A*AL[%)5MDR*T.D@6(S+RE+6TU'C^N]HFP]_+/I"
MW*Z[2C#)N) &^6ROLD < A6^V>KVCI.LY_NQCKX[H)W.P>GB"]Z^+W1P6H>5
MYT(Q!\PA>?'ID"(PQQGDI,$L"; <99IZ8'5$C)W(P\FB[,UBW?0)LMQ?KN$<
M;#[I'0.6R#E*D'94(Q55!"$OC5$=#J*5"9N.A[$363A=B-6?>I5CN;]*&Z#.
M&XJ2E@E1'<&:$,PCSG3BEO$(2W/JD=$1(78:"XO'#?* [@]N%*?O8K,3%B]F
MUN\<Y'L7U?VV6,7E;[;9)CV?[A$^D2YR[V:&)RZ4V3CONXD^>-=EYSYS^B57
MB5FDL(^ 4 OZ+X$IOTEPB%Q1W>ZXQ%#)<\_EVL]AO;["\_S\+P%]SC=H#>O7
MC0NE8>_3*JC%/N0 ?E'%=5?#9I27GH6PR;K.%D=:-->[I/[2ZGOAU[L(]W:S
MY!XQY:AX;9LYX#9?K?/^"KX9[\UGP(10S]9YBMY'WRJ.78"L7(1G,=^N\]]@
MPIHL^V#.7L7YXCHG82[ *=I4=%JO-B\_3R_LLO;YD3R:&+[M<>S0_-\V CF&
ML^V.!0S*Q0:$V);:#8G+\_5JN;+S?*W 'NUR9$\5)3[R1!-B1GDD/:9(2R:0
M\H83+BV&_X]GH#TQF@?#V$SO\5QYO)^*AF"LT01%(4PNNTU0(IXB'IPR21&K
M8H>85YD _J X6)3E;L&,B&;CLMG9R^W-B9L1?+VGOOD,1A+#SMBXG]>]/Q^B
M8^=5%-3%Q!(*$LRC0*A!VDF+N":&)A&,ZJF"VG>"RU%8/BFP;B,/RXT*S&;E
M%R7>%:E/]UP%321C=I-09_+)AH"\833GOR4GO=&&="@G76;+8'(P[97?Q5V:
M;^VMTN[-Z^N/L\5-O,W*NYC9)VL/%GI[RQC@ -2\L77SGW:VCK]&NUPW7RNN
MD5[_>KFJKW/:SMVWR\W9NQPG^*6V;I?WM&L2SN?O,OR;G4U1WB-Y=!"[:W"S
M"YN/CVX^^W!E5W^+38[[WA)_MKIK/0VZ)P;%]_XJAO4LGB>8Y,4\YY/MG+CS
MCS%+D7P+[&RQW$P^+"4?<YSIT:Y> J0N%TW]OS'\K5Y=U?.<$C9CTQAG:1GX
M\V(1_JAGLP^-#?$W>QWSXMIDL;\%U3._S-L3VT4W19HV)_.;?+/UUY^/[;E_
M2\]O<?7Z\^[VO]O1[3\\>;!Y91,FE"J&HHX122$\"M9F"\,9">H],-4JSV<H
M#@30:G.PIWX!&1*^3.7>83_1IB+,46.21]1@@:A68,Q@L&T\#E@Q:I.EK4KL
MCEN<L>])?6 Q]L>^4O[*FR_T/L*?/5C9W[ *S 5/L4?""XVDBQ(%)23"UD=I
MC4IT^G=^#0Z8WGDX =3\W.PO_7JH::4L-R$IB5@^&BB=M4CGRF,TFAR#"IKA
MR5?P['-BVV/F5/Y- #5GWJ^OUYO2/BV+<QW?6>4-52:'B1*5%"7",5+22"2B
MYU@IS3CK$$ N=&QI'&CUQ]+B08[VQNS+JQQA7+Z=OP37:W,#SG7N]CS==O'B
MYGV\S%Y"<5>E_2#N?/:S^7QM9_=G:W<&<FS;?.HF1WGA]W".CC@5TZWCBE,6
M\QV**'$6D,EG\H7*B1@D"$&IH]9._J[AD63B(-R=@C)^.+##1V5.ZJ^BVAN2
MF$-,X8BBD@EQ8@R2)G(BI;7.3_[2MLF@[W2F3AAT!\[/G-ACE90RDE,-G %3
M&68APIKD BEC,95!"ZXZB+TRNV'3 MZ);)TN] X<JCFMPTH1<,%BKOT5;0*S
M&>9':>G 8LY%)Y*CFG2HZEGF5,VD@'<B5R>,N_TG;4[KL-)!"NI20"D?%A'$
M :4X2.0,]MP:GHSL</RYS%&;:>'N-*Y.$W=G:16;WL'W5:\5SB7F8(K (C$:
MV>0Q4LE[% ,UTD:3#.EP%*-,/>/)(+ K:R<<AAEOX[L]C:5WB>^551OEI?=S
MN[^4.WI0\FWLT-(_+F(\]2+&R<S'*_AEN=J;-MZAURK*9 )G$10VJ&G%14!.
M,HY,#%P9BHUPD[]==;+XZGXS9H=YFDZ!O@>C>@-_UI?[=K-.[[2R/"J>+YM.
MC#BDL?/(<FX1XY)'$WQP;/+IY]\QHD^?IN(FVEY]_Z"&YC1T_90*I@XSSI?K
MIH&).'ZX^QM6FL@8G!<(Y*Q#A#"/E(\T9\GK$(00C/#GH0D[SNBW-V?VS;92
MBFE'^)N8K[:8G8"4IUI6SBB1DG'($I*C:TZ@2#!'$5,I@W,N==FE*72[9H_3
M^CAB>F1?8<ALBKGFG'Z8M5. L[]]Q0.3PAN!@F4!>>;S!:32(67 K*-:V&3Z
MR;MYUO#IG8FEY<[6T#E%[CS1LH*E(:ST'J4H(B(Z$11-RBE&6O,@M%-=5%2A
M>SB'ESO]L:_<K3,I-IMC \<:-0=:5E%;8UW*5Y"&7+T[$)0<+!-I6(I),DI-
M!\B4](;ZM6KZYUMIK.S4Z^F0V=]!)06.TNN$",<&N!L)(E0FI#0WV"1-HYR\
M/=SK+#^!H-[96!I(7RG:T^'4IIN*8&NQL1Y)[#AR06N0[,PAKX5C"2>7\&1K
M1I4$U4#,+"ZCMJJX@XS:VT&E.?:66XJ(X!0E&R@RAGK$,0'KT'#'S.0O)B\B
MH_IFXYBQN/'V0^\1\>VAWQ?QLI[OCOV^WI61V9SZ/4^_SQMX^'*>S_="VQW3
MRY\&WT/]W5?;:E3Y]/?O[W>*+8NB-2R9FW<@DCXL[A[=C6,B2?1_ENCG'=5?
M3^$3@SE;?3N)7]K#;+;A3A_OJ;A,@46ND&/*(!:$ [<]Y$KCP8NHM9-J\J6J
MAO!"QN9RV3W"!^-\W,HY5/7GF)XJPI4V,CCD: B@T&A")@%CM!?**RXL_'_J
M!F=!Y/7(QY&Q]>U^:-N[*T_IKDJ1$97OYL"*"B0"F%))6(DB4TQ(F"=I^[%#
MA[],N@C,^N;FR%C[;9&MG+7?U$X_&6*/]5(%[YWS(2%FP040'/@.7"?(<::H
M(9(3T:HR^?AW]18!5D\\'!E/W[IK6;N_JA/X<G&^JNW^2BTG]5A%HS'/=1HP
M,1@)X0/\!A.B10 /T,<HN^2!E;R3MPC.!N#GR)C;'O9^.[\-&< #V]3>7!%J
M.Y^SV>*/[-(>#[\C.J\X9DY3+A"UPL,:Q0)Q+04BQ*<07:#&=$!BF;3X@D@<
MEK4C@W(3D<A)99<1/CS%,?BVAXJ!"R5PXN :20L:@21$O!<H!B&!(8HHVR$]
M4'UO\.J!?X<Q],0U,:]!GOH<Z/M*S'Y-W[NX6C?S#XN+9O&ISG5'MS4J'@%*
MURZKEZ\-Q5K)UZ]>O1)G].7KU^SLQ9LWFKW0+PA5'>X0U\_/P"_,S8DHQ]=S
MZU<;&7M:^.SQ?BJGK4Q2)12$PB@XK1%3"5:7D-IK*J/S':K)F>]-)O7&Q9%1
MM3E)=1;^9]WV",W!'BKEM4Y9)N,8' J4>V2<!D]:<AFLP 3[+H%6_+U!J0<&
MCKD5]AY\D#K5WN9[@[YDJ#^P!;^N3]S[?6X/WG?O94]IXGUM*BUA8DF""> 1
M(R-X0,$SC:R)@8;$M"1ZO#V8!Z3O+]/TV.,55](QJ2PB-D@4'>/(8^*0,,(I
MP4&6V58C'.T>MO[F[XD]ZX[L*IWJ<$?NH8*/CS>H@B%@68-'E@A+R'AMD$\N
M(1:2(R$02[J$D,NF6YT^=8>P<"JO3O9!'HI2^'@=MZ>@[T'>SL-%$S_:.NR4
M5GO!U[K'BLK@,(\1.98\D@&# E1:;)=5U,%RW>'*BI$P<L*4+L9BYVA"!7ZY
M_6Q'_KNXC,VGS8G\S8CM;'D7Z,D7&B[6;I76,_@N6Q)'":3.+ZMXB-(Z19 0
M8*DY@BDB$J:4\(2YIUQQ-_E=UQZ!.BE.CZ<8=]4D-B=3'R_EWTI=/MU-!8X!
M+&,;D,%2(.$)1TD%C&A*S'L>DNP2.RZ;#S@D[OKEX6B(VATSGE_F$\B;(K5I
MT?QAFW 4H)[NI=)*!;!>@1@K0]Z$3HA$!HO-D7Q_.2=8Q=/Q5&;WM02>>F7A
MA)1L=JKAW^W$S<-MZN:7R]CN/Y!O[NVF9H]^746T<DY)\+%\B,ASX&XP,1?=
MDE%9R1B.':KGE=FV'4?1EN#UF$A^"7_7JY.%XN,]5)9I9R1EX-CC@!RF'@66
M0ZZ:)R<MC]:W*J\SYN9L(;SUP[[Q=&OVGXY2H[E!A;TGS-.$I(-A.L4)XHG"
M&Q6CPJNHB.RP459F>[6(QCR16]-7CD<#Y[B>*RQ,M,0+Y"P1X+5SAUAR8*G"
M7!BF?**B0Q!$?S<(&YRMTX?B-S=:=@R"M'Q)90-(\GQ,2R1&D2+.P6\ZY -Z
M3$>%)>4=ZGJ6V<V=%$![X/!H6#TJ>ZY-#E<P-BGI&;(R5\MR3"$25$ \&A>U
M5]BF?FX(&#(39?B-@EXX-UKYA_W[IVV:5<);6 HLYSOG^KN"*J1C9,AK)H)-
M7L!2F2Q.RNPP]L2W$63+/8(OFL7'V*QN\G7-N>A?+O/W,><RM),S;7JJ> QY
M8\P 4;!R?%0<.*XB"L$;AST)DG8(@XU4"N+D27]:] S$S'$!MB=6?%H8_[2^
M*TZ=)#GRPGF2*"3.D: .(^(T=R12#2;!<]E3*@3"8=D[+BQ_GX=ZN6IJEX^K
M[XYCO+9-/H)_/ [W=5:I%)BVE"-JJ4#@!G'$I9+(:H:U5E33+C'6D8I,# N\
MGODY9HI=Z<KVY\VEG>_N-L@^D%W6R_-TT<0E*(_-I^5HN55BCYD5X[Q][#(3
M3ZKU_2F ^YI5B2D;L,;(*W!^(JPWY W+]]4:1Z1UGM-6-]$4'O&A/+?]#2NE
MI:1))9 "TB(1I$;.:IOK-RHPX;5R<?(WJ/<WK8N!>5=*5]^[%_=5_-A$OTVS
MAM]G<2?1[E_><HKSTM<K*FRQ]CF)G!#'4%36(Y:\0<Q2YJ4*QG4I'E4HDC(8
M!$=D<W%U_YBF*:WW_V-MFU5L9C=OZKF= [=GK^S*_CZWZP ("),AI'C9J@/T
ME)ZG=W&S)BZ J)L/C9TOK<]=3H""XC/S+GZ*\_7FO-_EO"YKFCY\]ZMZ:2\O
MFWBY/=B3=D],@"NE(?K>7\6PGL6W]9<H^#S .IK5:7.-^S<YP=.AJ/ADW=Y?
M#Q)EE)>>A;"!2"ZVE!;-]4['CL>%NTR^W6>C7V%V1]"7NV;V&(>//%T)KPW.
M1T*%P1QL9*41DP%^"+ \@D]<V%;QFY8G1G:,>Q<_9NMH?@F::K;I,*>4-? A
M_';HC,@Q?50V.1E]3(@P(9#TRB%'G$>$*TM"<-J1?DZ%#&G'=IZX13GVE0M\
M'K:[]X8Z#S>O8'">>)=Y+!WBG@6$J69(26")5)JI+@E]A9R@OL S,.=*X>;%
M>EG/XS)?6N7 9MX0[\&O6=;;@@RS[4)8[MVP:=])Q1,V#A/P\/)MJ]$:CR+C
M#'G*K0=NY^]Z"9 _)PP-RK]22'H7EZMF[5?K!ACS\LHVEWL3$AY[O(J8>PMK
M G'"*=+.)D3S*3O!#%?>!V9P/Q>\/R=T],2I8F&]O$?X]OJCK9NL6 \CX?$&
M%1=>FF0B"E9K1+6&L<K( ?@49*DW*J0.22GB>6*A-UZ=?,CYD1%M[VV\KPCO
M*[][DLQN]I;C97-W4.*N7E3^;5F'W5607T,^"[X'8P85V]I$GC+-E9$F4J[!
MB-0\(4FB0YA3LK4I8ZY6(CN8Y&6.2?1JD7]GLW7R2GO$*GAB,&=-DZL<;7SP
MITO*=N^TBHECKE.V7F'@1 N&G*!ZY__()%B7Y"[UO&3R*/PLOM]Q+]Y3/#:Y
M6OB_7RUFP,'E]D;B,=]-C#&;3\\_;C:Q9G:^VP-:W>3X>NWKC_;VF_)AN0?T
M@D#AY]?SVJV7 /1<:O93G AIX]W*\I"6>U.:)?[FS[./7Q3-NRR0EC_#VLU7
MG<"$?XZ-KY<C;&X]0GN6>,W-><J'(>S\9GLB]0L^EV>YXF*+.EYEJ=WHWCJ7
MX]MR.Y]WW%&:MU4O8K,);P-HOWP_A0$4EW^W#+M7NFVW^P'ZY6(QJ^_7N9T*
M/6?+]5E8?!QG<Z(5A2.*GU;T375FO[T)ZBL;NG7-P!')?[ -/$U"#\J9G>F7
M?SB[C/_V3_\?4$L#!!0    ( )::7$XZ6:_:,)   $$X!P 5    8V-R;BTR
M,#$X,3(S,5]D968N>&UL[+UK=QLYDB;\?7]%;>WGZL+],F=Z]^#:[?>X+(WM
MGM[]E"=-IB1.44Q-DK3+\^M?@&12%_.2S+M4,SU594L)).*))X% (!#QK__G
MC_OY3U^S8CG+%W_]&?X%_/Q3MICDT]GB]J\__^/3+^J3>??NY__SO__'O_[/
M7W[YO_KC^Y]L/EG?9XO53Z;(TE4V_>G;;'7WTS^GV?+WGVZ*_/ZG?^;%[[.O
MZ2^_;!O]M/G#?+;X_5_BO[ZDR^RG/Y:S?UE.[K+[]'T^25>;=]^M5@__\NNO
MW[Y]^\L?7XKY7_+B]E<$ /YUW^KH$_%OOY2/_1)_] M$OV#XES^6TY]_"A(N
MEIMW5WA)^7C\[72U;_#T8?KK]I?[1W_H^AO>/ NEE+]N?KM_=#D[]&#H%/[Z
M?W][_VD#R2^SQ7*5+B;9S__[?_STTQ:Y(I]G'[.;G^)___'QW;-.)D6^7$[R
M]6)5?+_+TOGJ;I(6V5\F^?VO\?%?U>0_U[/E+**\# /9]'=79#=__7DR*18!
M+B@@VH+UOPX]N_K^D/WUY^7L_F$>X/FU_4&IZ73SAW3^;G&3%_<;0MALE<[F
M%PVX2C\]"/,U7:S2V^QC/1&.M>Y^X/=9,9NDB^LP&>2+119 G-21X'PWW8NR
M7&:KY>8G1395B^G[6?IE-@^_S.+OPO0UK2/9Q;UV+JA/9\6_I_-U=G5SO2XF
M=V$"NP[H9S6DJ]A5YR)]2(LB?+A?Z\APK&WG@[XN<A\GG!IC/M*T\R%_3K_,
MLXM&^KQ%)P/4Z3PN?)_NLFQ5$<L33?H:8OV1#C3@:KH_V["3X9K\_GZVB@;F
M,DRQ)E^L@BD:3-+9^0%7:-KWD/UZM2ZRWV:+V?WZ_GT6)]7T^^;)BJ1IH^^^
MA;YT"J_15=\B5?MB*G?0T? 7RWP^F\9-V=-OM\*PSS3L=[C7X;'%ZBY;!3-R
M7GOL!WOI7)!/J_#O#0&N;DRZO//S_-M%^)_LH-_AY_</17:7+9;A\PM&?'Z?
MU1;D>%>]BG3UD!5II7UP]1YZ%>#3*I_\?I?/IV%SY8)EMOI>5Y#C/74BD,V^
MK,X-]>DSG0TBO)%]RA:SO#!A$S=;^72RV\)57*PNZJ0S,<(N>S&-J@SKS,=L
M62HVZ/7'87V_0+(F_78F[%,.?\A6[[.OX2.\S3[&#_$"V2[HIC-1XC^_I<%N
MNY1R)QMV-MSW^>+V<U;<;T=0>; GFG4VU.MB]C5H]GJ>3G:4#?H.&E[-@N'U
M(5]=;I8VZ[4S0:N9HC\^V=& -@ %\2N,Z(='NQY2$\?RA=UT(\KNJ"5,QB[L
M)5;?G[S_[/@KM.UDT"XM%F';L[S.BD]WX3?G!GKL^5X&IP(TT]E\'?7\*9M<
M-B_7ZJP7L:+!G2^VEMZ'0(,P0^5%8(+-%OG];!'_YL-J'IY:KS:,N+K1Z7(V
MB8]$ ;+IRQYK0M+Y0'J!L]J4>[I5-P,-O>7?LTQGB^QFM@K+U/FMS:DVO0WR
MTK7XDCXZ$6)_//);EB[7Q78;=6[4)QOU-TRW7,WNH]6[_VUYEO7L#&O79'JU
M^!@GKR)P.7Z+56?#'E[='V0^S$V+R2RN^,M5L5E(EY_OTM4_LR*:?>5XU6K?
MN@E*C=_6'S"7?K@7==*?&#'28KJ>9U<W@7#Y(NYG=\O/U4,69_'HOYWGRPT1
M-U[%95BG#G9E KUO\V+V7]GTG[/5W6P1-Y9SW 2?WD?7'_#5EM(*33L9\M_R
M?/IM-I]_+M)I]B&]S^(\=;6ZRXIWBU6ZN(V[ONW\=4Z"RWL:6* RKN'ESROR
MN/47#0R'N0M_S9;O%B;,5=_C)W<?N[VZ*;O0WS]EMY&7K0-4^]4#0[9?Z]5B
ML4[G8=3%:O9?FXG+_1'FK675-:/#5PX,T:6K9_.>!Q:XVG1?M[].A-N>3WU.
M_S@_[@./=CVDIQOJ[8_?A[8ZN\F+[,EC%?G5N./^Q0T_WGW:N[U@&Z*>Z[1K
M,2^=%RHT[7K(+RU3G=W.%CO;U"VFCZ;IU<T_%D5X^'81C=#0=@=Q#8ZV_LZ^
M0=K_:NOQBENZ?WSRV30KTGD\G5VO\N+[Q["@?<[WC^Z&?MD2VN<8N@;QTRRH
M\2;&%*^>?KDVN\F*8J/=0RZ%RX%JY3U=@U%M03W:H)/A716WZ6)G=@5P-IZ;
MJYOK(EL&!"L=5E3OH1,!KHO\(2M6W^,T$C8G#]&V/C?D4VUZ&V1%DE=HVMN0
MJQ'X?,M.!OQOZ[189<7\^]XC9]-5^H]%NI[.PDQY;M05FP\Q](I,N:R7(02I
MQI^+.NE$C(_9/&Y,K\,XOH=]S6*93BI%GIUKU^M@*[*F8O..AOXU6ZRSCUMK
MK\IB<[Q%3P.TLV5Z>UMDMSN+;/=$9;#K]=>3<-6^SW/M.AELZ59_-XN^Y=+8
M"%/%?':S\;---HW/#O[2?@85IB*K:G;7C6@[[V:8L<\.^\='NQY2DZ"B"[OI
M6I1=-//B=O>SRF2IWD77(E2;;HXVZ&9X%T=I]QR-_>/KXE7US4^O'B(/8WS%
MSO1>?8_+^FPR>TC+WU1E2:MOZ0F(( &YNE_,OJR781,=.#/[FC62N6*'/8EW
MJ:.Q>@\]"?"$/M$1L_FK>G@HLLG6O_5Q=GNW6OXM&*&;4Z&I^R,K)K-EY0U0
M=V_L"Z#U_7U:?-]>NDD7WY>;6+3'#VZI@FW^]1(769OOZ!N$>(>AF$TVEU^B
MWKZEQ70WN.A;N,Z*S=H;;XWM?]\"+FV\MB>H*BZ@9]IU,]@2SB>>V9T=&@R.
MZWP^JW(K^+)>!A1$+==JFC]<8DXV['= 82]>B!KU.J"@[=)T1'1]>:ZTF?/6
MDWA%:7%[^4%,IR\=%*8?W#7M G*F^P%%K[BTU.CKJ%!I,2GEVOWQJ6C[+%ZS
MQ>K7Z>S^U]TSOZ;S%Q?-C^0)*U-_Q1QC=#/Z)RW;'E3X<[PQG2]^F68WZ7J^
MJCG$H_UT..#\/ITMFH_W63>M#W?3^R_WV?V7K*@[UD-]M#W0N]!?,5E_R7[9
M0U-SN"=Z.CKH0)K9=F9Y'_ZZ>SJ.JW$2NNTKLS]6V6(:3\<Z?6EU?]M^0'$X
MY8#F^>00Y!NX;]+EEPWFZ^4OMVGZ\&N<WW[-YJME^9/-C/<+@+N<A/]K]^-$
MKY>S1;9</AEHD#=[M\KN]X.:IU^R^5]_#@-(JC1+M!-  P",1\8Y#YTR6'MB
M-''*2Z"?"SN/^1?S8@=^M](^AK4?$&"IOS_YVV:Z/X' I5TE4B&%$36:4^B%
M<TP;ND7%"N@)K8+*(RE5,?DI+\)FZ*\_P[+E[FN]:+&)^3*[4&W>*UI!L/"#
MS53S+Y-YOLRF?_TY6&79XP_SQ2I\56Z^">0/L\S6'=L+Z7Q46?8^[ E^B#C7
MWW]+_R,OS#P-@/PQ._7%7=!+HB 0A$%"#,#(0$V8=AOPJ-9*8=(CU4[,]S]2
MKSN6Y'V!N6'BL*1Z''\,9+;/+)C+B'6HIT12@@3E@BB"I0<065?B86#X:W+0
MQNN49$?MRQ\IUHGFJ[.K143_FVG#,.R9E&^#8,,0Z_&NQ6_/-B\'F//RT40*
M@+%"7$+GF</*&N@W$C%$/&6J3VH<VH!=Q(MF.LM;A:HOY9OU<I7?9\4F<"NN
M[G>SA_,\.-$JH<@PZPG6S,E@I0*)T$Y.+H47]6<+]-HIT1YJ?;$CADG$7/CG
M&?'BR<0 Y;%'7 E&N$?. &^W\B@).!"U68!?.PN:(=67YC_D\>+ 0[;*U&V1
M;:]=GR7!\48)H\8AR;D)LYW6$FF%S59*JPU@N#8?R&OG0VN@]46- WO",WOF
M(RT2QPP"@BE-"/8Z_"GL&G?;1HDHK$^*RY>*<>Z/VP%N2&)LK_B?WY.<;9LP
M8"@*('I.E1(JX"A *3-0E(U[O]M8DQ68T09>?PZNC'+'.CZ*7$J-'X]TXT^2
MQU(V']Z_-T>MB*//)F& !E)M'0@#HQ)R*\AV'0S_"-^K.JL9#RUBG[>+3K_N
MJODA\ZG,^P)/?.-5FB=!8(X%9M!A8I6V85G=;IH"LHKR7AU3M7G1_%"G ZSZ
M8DDYOA/&]C^S&%:;3=4V2?,_EMG->OY^=G/J4+!)MPGGR'((6##,E#'2:Z;E
M%BFBK1+U3VTZ<V!TPJH>,1S0Z'A6X4K-Y[LBA&4>FICG8+*Y)OJ'#2;_9)/M
M>9N%Z3(#I?Y[$@V@<@H!+9@-GZRS0F]W@91S3:@?GRNE$SX."6K?!#7Y_9>8
M$[<T&[;B[B[7FGRYJK+;/M])HI D,NQ$M;,&$^FI%3N?A122B?KN^\Z\,IU2
MJW7$'GGSK[^^ "N,^O=NHYQ.UX]\Y;%-'G "">(*6 T\QL )C(DF"$B F:SD
M7WY[L4W&4(LAHHXI@43XBS!JBXI0PAK8HT%</[:ILFJ;QC9=AM:H8YOV!7T^
M3;)%6LSR,Q[9@\\G81O ,-;88&MXF,^H\F@'B':>US^T&5N\4F7-OZ18"[#U
M94N40_S'8AG,H-G-+)N>]:P=;9-XCP5DR!DO&6+.2&AQ*2-!1HS;^]I0;S],
M-.VB]#89,4H?ZUB(,"P!?%YDDW2Y.GN@>[A!@IRU0@CGO? $"Q_DTZ5T5LGZ
MYW:=^=U:T-01W3>"IK9+_<".)18UFTUW10DWN9>VV0J/6 )UNDF"-,09 ZP)
MWPA@&G .=M(9BIA],P>VEQH(/:#9!U>.+@?U.DJ<Y)13Y)GF DML .1\+R'A
M?IQ60[?*K,F81HB^1>Z,RKYXS91IB2K/G+&G#WD//)HX&+UW"-L@N$)*2*QL
M.4H25M3QV!1=JR%O%:F^;,M8Z7.UJ_3Y.;SYC /BT..)54Y(K@%25 LD"772
M[22SDMOZY[F7GW2,R[QH$;6A^'!VIWFX0:*%9%!*9YT)YCBU+!CJI70:>3U.
M$Z(=A9W1?B.$WAH/1F4.C$G]+2WOL8KS^SQ=G%[9GS^5$,"(PDYX((U6D!FA
M8#DVS^B(%O6V0,[; J.W*QY!T,=B@V=6[1\?3H!2G'NGE"?*&L$9=Z7#PUK8
MP$R__ AYG&MV8\R&84*EFZ3'FB300^LMTIHYZ[WVADI:2J@0E.->M9NH[*3V
M&R/T%KDPRI5[#!1H:>4V80\Z6^TO%YU>P \^G&C$&/7($JZDPI1CA,N]JV,,
MF_&MX\U!SUM&I;;^WBTFV[JGZ;R:$7:T04)M&"0+XV7<(VJ)I_O##J<$Z--_
M/X@>VT*FM]O9^2;U71;K4#UQ+NGO%3PL9]LF7D ,.2("6V4$%)JKTJ)QG"-7
MFPWTC9AN;4,X,&TJ;;_/MDT@5I)3*3T.TH;O)DQUY9?G(()FW+9=BSJMQI;&
MR/TY6#-**W#,9&G)NBB+&AX[O3AM:E1K'4QGX8"G5%@J +5 Q@PH6UD\5K3^
M2M.9_=BB?O*N\7I]%_^YYMB&W1/D4D$3S2U0;J4\);3^O0/V1BR/=H![&Y>Y
M/1<: B"MDX(:3(& Y3&Y-YK2<=L;C35Y\:WN>GC].;@R2BMC?!1IR;9H?/$_
M# @H[Q5 S#D7A%:T/';QT#7((C7@Q?_*V)^]^'\9.GU]X-?I]TT.H\_Y3O 2
MDFSY(5M=W9AT>5?>+3[QK5_238(Q(#H82L@S9H30WA%37AERP/5Z.-S"/<:Z
M-Z ZQ&S &[#';.53Z2,NZ28Q%$,KJ ]3K.3:0BB4+)$P@-=GSS 7_NNRIT/,
M^H@_#0S_9U[\'C9M)GV8K=*YFO['>KEZ6HV]05#JB=X38%GX?HRD''GB/1.H
M-/(E $C6Y\\P%_0OY<]P4 Y,JX_9[/[+NEAFW7/LV:L2Z(%"@.)@1$#$G<<&
M[S44?]!CS,4K)UP37(==$@]YI\JR5]\O7AE/]I8H)XW@FG% #8?!>(V*V>("
M'43U=U67'Q2-;X%L$[K.)K32[WB=%;/\D-E=HY?$"\2 MQY82KRB0JE'V2"A
M]5WZEWOQ1CL--8)L?#.,*L*T>KM-4FONXA_?+;89=6()V-/?PN7V>NLC2)S$
M1EH%N?&"$T&1<7O\PU:H?@ $?Q64'3?<]:\>'=_WNF5 ^]MU7L21[3+Y?,X_
MIW\\*1%Y;#ILV&W"A"' .@.4T1QPRZSCI?0&-[C.(EX%V0; L#\&7>?+E8E9
M8+K@T:'.$RF5 081YSSBQLJP/W(E$CK\7VTVR3?,IA:0;-,FVP[29@]Y@",,
M,DN7A_(_7=(\T1Y#)KGR H1YEBIM2?F%(&IA@[-U\'J(T0U87:K^DH6H9G<)
ME(IBI:@&P"*('39E<(I$7H(&IV&OPR_>(WC=4^62%:=1IXFU!$!MA.?2(*2"
MH889)L;%Z&8+&T0)P]?A$.\=PC[\F+N5T:]CTL=_SE9W\3#H:O'W=%';'5"M
M]T0C3PR0P?P''E!(F"OO34CD D#UZ?0V_>/M8=G;D6^13[)LNO0!R'?+Y3I=
M3+*KFWB5\O/N*N6I@]ZSC1,-.&3  D8PY\Q9CB'=3\6L0;@8?!T.[\Z@&M#!
M%&3QL?CVDQK<'[.OV6(=)"HC)C[-@H!/$+1AQE63U3J=G^!3Z^]*%#=.> JA
M<8PQBJQ\@JF'#=;#5^__[A79<;'5I<5BMKA=7A7O\^6R%])>_LK$!!$E1Y(A
M:B@1A >S=K]@0-U@\7T=3OJ1 ?Q(X?X3@M]GQ6R2+JZS8IDO%MG\W6+R%C.#
M&XZ]I@X[:((-C@)7B';4<2(MXKH:X[N1=M#,X$A8@*'2BAD'(0; V"TJADG=
MZPV,^IG!*ZNV<6;PB]!*QYP9O+U+&QJ%&5;$0 A#&(_>,L9VH' '&B3_'%UV
M\*K:KWAIXS+@WD8@/H]5;87C3@19)53(8;^3V6HL1IXOO+$F+X[(KX?7GX,K
MPW"DYJ6-X2C2DD_QD)WXES-W-XXW2:SR$B/#G- 2AE%J!$$8M1060^%EGR5)
M6KO"45D3>2<@O>58?"I!K(D)G=-,&X"!<FH+;?BA?25T:6ZQ=HA97^SIHP H
MUTA*%,_SK47>8NJMBY(;HXV!\K65:JS+E@ZPZHLE3:I,GF!/H^*5 0PH0 !)
M$V40< &@B)1@E$I%7MU]CKJLZA'#OMA65H8\P9SRD818C01ARB&JI8;.AG4X
M2B"5XD&D^D5.ACESJLN"FG@,:*-T6S$3&\.44%H12[P!W&D447#&8H ;7# ?
MYBBH1?ND'<2&=) _6S#58OHDH"/\;GV?3=^BO]P3"0PQD!BLK ^&@:$HUC?%
M6B(KJB7P?7O^<N<@QC'7CO#<>>0@D'*'"@00\MK?>:^5-*NJMJF__#*T_B3^
M<HP<4Y118.)%>^TI%JP$A6K]=OSEE;5?T5]^&7!OPP=*$:.<:<$-1(IS0X/U
M7'ZJP9(>>5+%QIJ\V!E:#Z\_!U=>E;]\.(JTY2]OFN0(:2=4F$##4&W8)X=A
M0EV.DP/::Z&SMCSDE;$_F^3H,G0&W'9^S";Y[6+V7]GTW308*[.;6?J#%^[@
MIF*3E6<Q=>&1K^D\7F^Z;*O:XHL3##$TPC*)J0]?I,2<\!)M)OWKX&)S WA4
M*+]*3J^+(M9-V#P9>LF"[*%E;\P^\OK$*1XF($L@18AR8@1 =H<\-E#6Y_=
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MTM<D/EB[V"M%O4(*!4-%TC+H*-@OLL%Z_>K/(0;$N2_&_C9;Y,63=/8EI#Z
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MJI-:;X3.6]+_J%;DL:A]&'5_S+[F\Z^QSN.S,5>X;GNB7<(0)L%X\<( XQS
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M7#-D]U(YA-"XS>;Z2CJA[4;(O!6]C])$'E+=PZC9K8M\FL_G:7'63_GRT81
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MEYA9U,& @B)&[:7'3O#ZGUOK.YQ6]-9 ]F'\8LVR4C CI<$: >2Q DXCNC_
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M@[6>U?]6#M8D4IH(!#GBACI'&(_'4-NE5;(&>>7Z/EBKK+ +#M8N ^>U9),
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M48)/=VF1+=\ME^ML>BZ!>/6.$J.-4H8(0X5FR%#H(2W10(".WB_8#E$Z VR
M;>!U6EP5V_B1?T_GZYC&>B-!M8WAL=:)8@11XR3 1@@C.($"EW);Q4>8-KQM
MHK2/4NUC@^M=R@R_O<KE_EC-%K?KV?)N$RT<P\S48KK/K'%U<R9:LW&?"6%2
M.\V4(I(1$:2U2I9R$R_JGR/U'NMW*3OZQJZO&>5I7I:*P;['FB184,J-8&'9
MY0I#3@0N,86(J1&FP&E[[F@)FKZ4?[T?[!$ZGV#!V;8)#W.D")PW--A?P:ZW
M6.]EUJ#!9:S.$N&T38>V,1K&2KTJ9K>S13J//]T:U]4-TP-M$QT#X:5DTC##
MB13"\=(RAQXW2,[!7PLOVL:H+U[\+8"U?)\OE]GR:O&<SEN*G^#%V;:)X-18
M1P7UQF@:Q$:,ES)#@>HG?A2OA1=M8S2:7>VET\;Q+A*%D-2<6(6Q\4%^P8@K
M$9#"U=_)RM?"DHZ@&N@FZ:/G[E&FZV(VN:!\VHD^$APST5M)&9&6,AR 5N4^
M'L5RD/4]9. U\:4+L 8GS(=U!/+J9GM8_/A(]5#W*ITEAE!"G$-0QY($7'(J
M2MR1HJ)!*/PK];)V@%IM%\G1D<5DR,N[?!YO5\WRJ<_G\_Q;6%"C@R_>TK/I
MZI"OK'FG"8,.$$#B>96DV$MNJ=M+;G&#*6?TSM;>T1M\#GHJT^X2W]7-UGD8
MY]3/P;:_/7FBU[#GA&H7,^=ZHKT$2@M)O"KQ(LHW8-NK\=CV"^%X*/>Y2*?A
M\['I]UHKWJ%^$NRQ4,YJ&?Z+(6204%MBX8)2ZM-I]"[>/@ ;#WEBW>5LLHZQ
M\4_$J65TG^LS,5H[28CP%$BOO55"L1(C!)ND8WTUGN&^P'NK603"1Z:A#V"C
M@($(1D$ 93]' ]4@;OG5>),[0VN - *;^,YCJ0%V8VGUE>4]H$'>J:;337>Q
MXL%-7MQOTG$.GQ[A\6Y4E=0(/SR=<.XYA$H[*[!%VF"C$0;>@WBITE7+_-*U
M;.=3(CQ[,A%8A T( DY#1>WFMJC8R404 WW>CSB3#J&!/GZ86)I@,.HT"&U$
MU$/)I0@S<PQ'#6 H+O@>#F%,GTDE+XRHKZG6*M'TEX'RVJ*HH8A+)H<\?$8"
M 0R#E#OI E;\-4;35U98M7#J>@B]-1X,H_\ZT?0]JW\8M;>?2%Y$?[,G0&.&
M# ,"(,Y*.;TGO284;A197UEA%R22OPR<87:FEV<^TIY;:36%89]$*9*(>%Q*
M)52OH=*#+/>-(1E&T<TRW81M,8E5SI1C!B-G@7!N)R$33N)Q+_A-5%8UY4T]
MA-XB%T:YZ(^! BT=Z=9*(D^TM4!!*SEA"B(G +'EV*@P]6./^\]P5!GF$TGD
M+X.COZ^T7*(>!?\X6_Y^=I$^WBSARDME8GT$ 0"D@D/H2TD1I/7O/G9^W[VM
MY;HU</JG@<D7FQJCE?9HIYHEAD,=#%P'L!6> QH^E-(698Y1/?8%O TE'F5&
M:WB]98:,=%D?&S&&(<2STZYOZ</93?WA!HE&W@ODO*.*08&)!KR$C',N>W7H
M5#43VE!6W@$Z_4\&?O9'C'-^''NEN>"'5HF%4IH@*#>"0*"#?2Q+RY@32!K$
M3'7/@C:/>YHB<QD#EMGD+[?YUP#!U_"ZJ'^\^W/4/'ZB^>U/GPST0[X]/CV:
M*>%,BX3'F*Y@4VMKO'6> :!*>U@PY^I;B1V&9#;7>+NH].F\+R]./L8TZ"PM
M9HO;2Z: RSI*HMDM$"76DECFP3((P X-Z2"IOS9T&$C9WJS0*5C]+Q5EOM=9
M5C6J8?]\(ABT!GLIB-*0&.LMCY<A,%(DV%FZOB^APQ#(+I:'^ICT'5&43[9N
MK\74+5:;BPC[,)O>XGU<6BS"I[)\F8BC]Q>K ,%T-M]$$G[*)NMBH\&APXT.
MC\K],9FOPP!\H'3,]KA>;91V=?-2J/<58I3:>D4"D25>&X*HHLA+K:4%VFN'
MJ0$4V4HK04<GG).[;+J>9U<W#84]%Q?5[HL2JP"AQGO$&3!$L6!=^"VBV@/$
M^ZSQ>3*LJG\*O3QO'1+W48=R-<1#?S_<P1G?<X=O38RQP$)$PN:'<R 8X4Z7
MRN'"]UEZZ2+7]5 <S<>JFK[,V\,#KG3:>:YI@KV@C#.JO( ZR&Q$,!IW$Q9#
MC(W;@3X*+E3B9V/(_PQD&Z4O_DURK*4S^Y?E==+%="/TES08$;LT2.I;6DS/
M5#"ZM)^$,2FE1T8+[+A0/AA;JI1/8S?"RD;MJ>Q$X9NV@1MVTJG\C9W-I-M*
M_XF5@B,-&)0,.VBA(L#LL(/ @1&FW1U\7S,$\#U[H5Z.^;%,R=7-A_5]5D06
MJ,749HO\?K:(?_-Y\4QLG2YGD_A(1"J;ONSQM ^G>\]2S[?VW/W#//^>93I;
MA/Y6U_-T,>S+*Y8V;G\P/IT5FPRTOV7I<EUDS[+<#/-VMUS-[N.UT_UOEVJY
MS#8I4)\XCG=-IE>+C_&KCX<)D>2#NR/WHZXXZ/# AWQ1/).ABD^RU?<D$EHK
M:5B?#?,8,Z.5,5N?/B(<@4H'U^/%\YQ/LK5W)!@;;(D*RPD$AL;:CV)W>H6
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M&VLA@@9ZY0S%QA*N>0D0#);EZ/T8O3/EHC37E\$[QMPLKR_IKS+4"!9L)$6
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MV SISSA<7:8O7KUE"'>.6=8U9)Z4W]I4'?L6IWPB@.#0D&!PW,2QQEI)!#E
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M=556A@'E%+!<(" 9H18!;2OJF&R1==M/R]"!!*83L#)P'[=J!\J,MU!2"@6
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M91Y322H^:,7?4US=>UE);9EX^8MISZ@7H5*;<]I.5H6?3!>;P)%LW SGS#1
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MEQM9&#M'Z=?B]R?S6Y3S^./5-JSKT\+\2*+^8?[TB>G\:GH_*S[62%%J_>Z
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M&?/R)=JL\W618DQNM]\<.XS$E-&"3O4;TF2^3)?__E@C>.3PH$ (])(1R"P
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M.M^@\H&]FM/.1]X_]J_[OFWOR11?<W80:=A+@E18G=1+?,(>CO"#&("H1Q)
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M<YD( .R)**\6 )JU=\#<*6^==<_PW/: A8M4:P@ G^XNSKV8\CZG_0@P8_\
MN;W,.[YV,N">O=*U,+-7I%=KH,P07[TNOJRSK9M/;@'N7T;Z7,+U?^Z+*C\#
MH?_)9I4$:9"X'B9^A'T/QQA'40\!H\3S),HB*+4OL?TO42&AA5,7[3/)-VV]
M;-K9V]6$K <J*,%*0\ IO;/3+B>YPR-R36GU<"XJ+7R-?#U**T#D-875$0]#
ME%6+:Z>*JH\_425-R^I8WS]4^=>BW-='JK&B&3."* D3G'HH!J[O' !X7D0F
MZ*@"Z[.KZ)OA*?HZ;YIM+O&VITKNQ01T+KZGR2>K9O?3L_SU9VN :AUA748[
M7^>00SD5!L(LW53IV 755,Z==/9)83SF5?/T@;;C!NXV[%+R8_L$._1C:"=I
M!+PH89MC8>@.CUGAV(N1V'E3A8;UGSFEW[]O7\VEJ<YCC[,]NY,/("<FG!-8
METPW-=.M+-D<<-Y8+=*;EG;R*NWSI)H7211)-*='PBRY5.G8:TFF*N[4[U*M
ML(=#&/LNI3)R;,Q*9@^K!1B3(%&PKR]C=JY]_7VW'S+KMM3KG*O>CE)*M_9M
M*%/WGI3L.7&'P@RUU.&8]!Z3('<3U7)\6>#<)E<:1I[KN3X"#HH3'R(XR#8)
MO$3HLKL&\S/OZ=\-4%6+YZ003!+1N=A7*J8C:(/W]*\0*ZZO*J)DM,XJ<9!/
M;]5Q*;.G/[S3\_[N7;G[\CFO'MK2;39!,0%LW0!#X+L)(-YP8XO0KX5>AE)@
M;M;]>H;*>E=FNPD[];*TBN_+S\#HE%WX\1VH\LYB -\TC-WY:T*^3AGG]OI$
MOLU0/94.7=DZ5\(5KZI]S!_[Z?^I.=N##B%![--I?N*0B,3#PWJ$V*XOL9DC
M;6N>K9L/54%'E,=L:PTP66E665V3)Y9/S?22*:5A!TA+Z]8E<JZHU60^S="H
MZ6Z4BMN9O!ZADDZJJZ:XW>9=95S?=](TQ8Z=1 "&3AQ$_F Q0K$]49)$S<VC
M2D>HK-_+)N\O^'2HY25)F%MQ5=+"IP)A.F9T66DZ88A3G61Y-4^@I#VYHE'3
MV)&9#+YC)W*HX2K?%-2>30C ?AB'46*S8SA>.%SD(8F3"MW,EK>B>>J7E%55
M?J.S[S9%JO*OY?8K6\A9M^BLNVPM\;#2!$[%)X#ZZ)PR[VM1M1K5XEINLO>,
M'LXYGARE9JB2 C^NS.BF,",UD7MF#Q'7I1-$C!' P Z]-(R'6KLI"J)$[(B)
MO!WM)TJ.AWEEJC2!5XF)G'I"5<SDEE2EB_3PSN6D*#5#E13X<6TV-X$9T9-P
MW=LFP\I6]_@YB@(<)B$,XMC!"/F0),,$,G4\QYUP7%C&W#S3.8;+*H;E78DG
M B8QRIDGZ69QVCFV_G6DPR(YNLJBUD-K9RCB.*4VA5@SE$F))Q?.H4UG1TZ=
MGK_&U-D-21*%& 4)L),8N(E+TF$KD7[ARZR"3S<ZCU*=O$EVEXN>DE# KHQ>
M:6-TBFJU5Q5:U3I]ZJW_=EN!M_M5!GE)-3M#(+>F32'?1&6;Y,]5?9O.E,0-
M+IK^]:?NV4+9PT.Y^]24ZW^N(C],G- )4SM.4I#X@9T,51!2UW63:3>W9*W.
MHW,M%CI;'#"V9^&KO"FJ7/X.PA2NQ41/-[_3;V@=X'6K[PR@U2)<[%[6!<8X
M9$X!W6;IG J'+M^_4L.5S*K\$8BV3N&9 V,KV[6)[841\0C-+[&31/YP^ROU
MDT1ZK5Z%;<TK^"TN^?5Y)>R*K]K/3>R4M?R?CD7PY[Z6ZKDSK\NM\G/0R;GV
MKS(PANBC+N^N[!.H9U']I8*5&X1^%/E!G*( D2!R S0""!%045I5QJR07DZX
M@O73?CB_?EQD=<X[!:]'@$]8%R)?3%,E[A"8>G'@BI1J"(49*JK#,>D+ H+<
M\6HGN;O+U\W[._)]W3ZO^9%.1-_OVM(LNPW[#[L_^S7;,F5?^0Y";I@F-KN2
MD&#H!TY_BA?;/@BQ2,JIU+#F?+/#RB: >8_6JC)VFJU_D91."9F\BFFF6N;Y
M5',QTL5T\\#W -1B2!G/K9RR18[VBR.X\PJG")%7I%-+/,P03SVNE3.T9S$!
M/6_L0UX5Y>;TU8$5CDE $^ T#DCL@M .4&H/$!S 'F[F3S^5&M:<@'9/-[/+
M_^NA_[9?Y!S]=P;6^<1S,<+%Q/.B0MY8'5;KS(,I\ZJG")-7U%-+0,Q03SVN
ME3,T:!7J"6E27%5/-/_]CVR[SU>VG1*?1 " B&((H0,Q&FR'<0)7CRWF3TU6
M-5/$4]2N2"<^A2C>GT\5T\H:ZS;_4NQV; I)DZ6G/!-<%55$_Q3]U,FY,N',
MV#R^0VFU,$W0RQ/FA(52EGF3%5+:)RYIG,:86DT,213! ((P)"B(HYC^-QEL
MQRE"O2:2'>?1:#56Q15Q *A&#W/V]/,K2O@#=U%>^G^D+LKMDU07%6.,MXM^
MVC\^=D5QLRT#D&[+;V]W=V7UD+'*G&,Q#]M!?HP(2OPX88\B1;8-QJ0)0:$%
M,U4V-:^5'<.T-D6]WI9U_Q[#>JAE1">"(^Z_BF4LRICGRUF6(%TL:WG&=ZN-
M#*-U!'*QLD2<Y%U11=7TFZ&+RKTJ]39:T9> J6KD=?,A*S:_Y\TJ"4B"Z*>E
MV $I )YOVUTA.<_V(R\6?'Q=[+,U:]T QWJD>$1?\Q5DB4^O=!(DIDLC-PS*
M#5O(W^XW;/Z$LL>"-LSBOW*V$M7]THT!#TZ>4'=%E61)-D-]I-&_>%)W"@L"
M[XJ7#_GG['M>,T,K!Q,0VR%PD@!Y49PX2=R?,L9.%#NB;X<+?;9V-6%PK(;A
MD5(40:9X%44?2:**TO+30FE59?9GO(^)N*H/<I29H@^2Z%\^N3V!!>Z9V'U6
MY??EEI)2LVE@\T3GA.TWDZS.-V-Y\/Q[DVS9X5TW2*(H 2!@.0ZF\\(D22$@
M.$A"B.,T%)J2J3:N>V[&CB_W>/^'U2$6G'XIIYMS'K8DTX(3LB.H \GM>E7[
M@S>W#*\U'J_]DT&V6LQSS\X$*;TV3=,5'3,449][IQ,WO3QR:VJ3->WT\?U=
M)^)LF:U\>*38\EU=?,W[[P[S2,?UD1O%H9?8@.9^F+V"2 (,4A@2$G&7AU9M
M5F,7'Y#V=X(.$*T^25ELR46,PVM]6E,T#.G2NKP[[=%:612X6G17-._*NEZE
M89R2*([]%)(H"@,"(S(8 !@X@K>&>#]6<V*#REU=;HM-^V(=>_WSIRU%];-5
MM.S.?D>E9^5*[Y*@SHR.(P/\Y:41.=]YFWM[_>1,+V,FD_RNK-BLY$-9M8NA
M35,5M_LFN]WFG\L/=*C=-6-O#&R0V"1.$T*@AYT$I(XSP'/LF(ATEME :>YJ
MW56P];-![UEON[%N6W?Z?[+U#,$]GOGBQY>8&!DZL8REB]K95.4GYL;/8]2H
M*S=6[XQU[ U[@JWS9['L1E4@K@CS[+$V0];G=[M<N(^I&5)2"JSXLD/[BH)8
M/WVNLEW-+M%1D+M-^Z]MM^>V^<>^;E@BR./,"H'0ABY"8900WW,3!&VO=R*E
MB:"]^II7M^74H6<A\"(J=^PGM]C]L:OR?H/IKG/16O<^6LW!K6'8^I(5EQ_9
M_2%:P[1A[ =H!LH'N]YG:W#:.O*Z7:P[\MLZ."XR2IHQ-.H)KL0 NG K,WN8
M79H<SL%X:9C*9H$XKXJO%.K7O/[W/1TJ[MB!05C_6[[YDA_2C5604AA)Z 4(
M.XZ'_!!ZT0",(*)L_J<(CN:9W]&PR@9.=ANS& YY=-=ARUV;@PG>Y9HC4-,G
M>@O$2/FH=^2#=7#"RFJK<^-X>#-C^.)G7G).ISBL9@\S.AP6F,=IX5K%</ Q
M7V^SNB[NBO7)^,4*V\#WZ.W[W1'X U00^W$"*4800^0[F#B^/4!U_4BF"O0B
M.+E4:7*QPE/X5C;B9VGS.)CDWQ^IYY>7[0V*[_1Q9=F8ZAII7H3ZX%978(PY
MQC*((]?,''UDXR,Y'FEO#N:/4/HI$!BS9HJ'TJVME>W8A$1>$B8P 7%H$R<9
M)U1V0@*1,A-J+ I-3<3K2YBR*?4Z\PIWG)22KG$[R1PMGRK.XM2;K[82/LEL
MW0@R]IH>KM?5[JIA:M(9]X2BQ($P(@B!V"6I'Q([ZF<4D1T'*=<U3+469]FD
MO]H_&5R>C5R=M%\7P^485RZ&)I"]*=?[]DX@2V,,)/T9OB7(/QF.&!/M(..X
M_1 CQ,V9(48/M\L.,9I\*G6V1G4I][D-D=,M$#;X.:&-'()30&PZ*XA(F+ A
MKT.6(.BJVDA0A4?S\'2XZ4;3Q%U^5S16E6_;PYM->7W/_K!DI'"705D8IV?W
M2T1PIMWU,[OI1LT..*F7G#NH#JSY,POE'@O,._2PK7WKF4%R;1@0'$+'#0G$
MT$_MR!T@1<B&LVPZ\P!9=)#8F[89S14ZS=O0JJ.VP :T42/":V3KV',6B:'Y
M8X Z5U7M,XOSN\ .,P/I>= A/HQ"Y"08!Q0F >/09"?>LGO+/ CGV54^&B?Z
MC>/C<:+Z0?:<N2(^^VZSLBB;M<]LU" C'I)YMI9%8F_^0*33>7W;R>(Q4#%8
M,:MQ8CM.Y) $X22&#K0=,JRE.=AQA![*FFI+\^9Q5U"(:D3YVBZRPBUC+HZG
MZ[UJ>G7LC)@CQ?+:*L*S^6(IY(V ^HFSI$+.?L^;]W>O7$&P[=AQ ?(@3 E.
M(BJW>!!9)W%MHDKN5&!9_BP-J[!0WK&46YT@*HG2=,&<.T#*!?7W+C8_S 4U
M3M(E=5EE.,W7;:7>"NBZ>I:YWTIX"6@ 0__559P]B^IWRC9;(2ZW]-._#+5,
M5W;@0&('L0N\((A3[*91,* $B8V$'NB:&9OF<0%='A$$'YV9.V9\HX+)X1(;
M);C'A]&OBR/%<]_&>LTSOZVA-C)7AI*EVH 90\MBWI^^[+%H% 1>'3^,@'PX
M  H@'?7:V\Z^%SK0P0..U %"E?#56]>\G?LNK^N_MNK3'\'/3J1F]UQJQI7Y
M8F?5^]NZV!19)5BM5D.(^,:29:,C-EJPD#P;(\P<!(0IO2+S^L)CAI!K]._E
M^^5:F50P#UCYKN/#-'5C H+("4$"\+CB!&'@*,KI7[6S7'[^0FOI-Q]HME<?
MU1M6EL._SO?D?%PIU9IR:Q/67*Y0*)<$<Q-OA@XJ\80_.15DA[L<]_H^W^RW
M^?N[MA1X6T">H: 0VCW$CU16JV+=Y)NVOC_<;4Z^\\>N:.K^69VGSZTZCQ7$
M$S?&%*CGI:X+DIAXKIUT%<33P$]3H?=4%@6J.7W]M']XH/DGZ]X'T%:+VH+?
MLFHSO%LD^J#"HL'E4^(?)JYB4CZXQ6)Z_#;#L6LW+Z/-JL.]^&;KX=@$K#];
M)ZWEWG;0&+$K(X<1#<6,H<<,*DZKT1L!BO^"+YTT5 4=:-?M6Z[O[]X_,I0U
M^9Y7ZX)BIP#_GA=?[BD\^#6OLB_YWZILU^"LR=.LJ/J_:I'W?]K^/-^<0'?"
MP/61X_DX@CCUH>>'_3,::4C=XJKS9A1@W8-AJWD]PNYMFVX@?*2IT;KH3N)]
M9'[65N] ^ULC#P(78$VAE.>RLBE8]8V9HX=6"]9Z?S<V@]%+B[II#7Y:O:-=
M.["8JQ;S]?#WSQO3T%RZ 93K=22#VXS G6M3,(NT';DKVQ30?IM5)X]#-_=L
MFLP>,2[&-O:U;2/TAV7?.O*QC3$Y87_R;6AG6=_.OK3MC+T$8MVQ=O;B,[[T
M+6RSK]AJ)ON0[B7Z7R;>#)\I@F?R+R,;D 'WTHVCI#2XPT]:E$A.4\EC7!<2
M1IOX-G0P!#$)XQ#&+J+_WP-#?B3V$J-^./,M,+0N]".B]8'^5LWS*/)B89):
M1%@Z0H)+!1>7!YYE+S?&K@!(T,T_S]<92R-G\UH=OCYGU\\U[P@P#D)XS./J
ML11+0EP<VR@ER'.].$0I2&%K$F'HQ(1W#VB2#7UR<#2!.0*VV+-(UUBZTHN5
MD&M&_U3C2JFA\<EF5:-Q6-=Y4]-D\%V1W1;;-@?X+<\8FLW[W<><5<FA\QBJ
M"T5]TN\A\GS']Q*2TM0O :X31_: ,75<()=@S8%LOER+U$WQT%X6/G3JFOT@
M+7;9;EW0^6CG9SOC//+4&EQE-\<R:W37:OV5S=)F";MHPF9:Q.6W>0XQON$)
MZTE0#4KJ%(2$*[^;,_1F#"4+^7XQZYL_ L()( ^@$4N$[!@&&" O#4A,Z#\I
MB Y+DD <BPQ*>A!H'GR.->B2\%3/A>?&^F-7WM9Y];75G[>[QWW#Q(FV:/K7
M[31 ;,#1%#K!I'ZQJ,EF^Y<#9MI((<4QSUQ!2\S,4'[-/EZ:76AD5%C)DZ<D
MHVU_G7^ZS_/F;U6Y?Z08#N:#*$VC)/0\&T<N>[@[ O%@'L1$Z+28,J.:]1IE
M5=56*8,/Y7[79XP7IPV?BB^[MKK'KCF:0KS=T6GCOBLZ=)\UUK>\RJU=V1PT
MA'[S\$F28CXY>H+Z/6?@Y"7[]LGJ85HM3FL :HY(OT(DCRZKBH5A4JS,K4OJ
MJY8W7L'MS@U_SKX?EI8.)@G-R&V0I"")'">) B>(@M8D3!([2)"(R$XRI%E8
M^\/S;?D=,<6;1A^?RLW&G.@!G(&THZ5GOG,R6C3L&DU7=$L)NV9HE1I72@VM
M3TR3/G9%$S]D57/\LN]AR=NV(R?P(C=)O0B&H1>EL==M(^'( 0'O1O!D._HZ
M5P_-:K$=/PF^W-[.:VQ=Z6/*B#:CGZESI]34(-7TMW,]/G4"VXL=%Z9TO@=\
MDL0D&!!XV!%ZB%JE7<T9PN7^*)8O**5ZFLKI9EF9X!F170BP*"&$4V)AMB9.
M\HQ3'J>S)SQ;>K[D/7Z;=+6;D^Z5 -BD.:4]VWYJLF9/H_-T^'OJR"H%7IS"
MP(UQ /PPML,D EYHVP $21SX0L<.YT6F66W9G")KK#]^^?2+50\(V\<4)&=G
M\X1+<#IG7*3$%)O<W>7LE-=X]YQ%C6$ZV0]J%Q0['ZS1B=._N>G7-!>:,JH(
M!<\<<]:0FS$P+.3[I5GL A&8.+@P##G;;*>!W(Z_D]>KQ/&!'Z$P2!'!"$(7
M>*A'@3P2"CWEIMJV[F-3#!>K^LIJZ/<U8.]ZC>F?Z%$R4LAS/VDLF(5V/6I_
M8W6Q:0\S,?A'O\^"99#,7V)97,@GQ\MHJ9[N'9\8*V)QHMS^5NS*JFB>AC)1
MW:_UX\,*I4X4$1\Y3H1AC$,[0>D Q4%1*/$4CA8<7$(P^<&;DW)LQ6OEV&:,
MPR3]G8%[S2)\H5#>:9DH@]3X*N?BDJPFA$;KLB(7^<19)9\3%9JV[4V^V=..
M<+L=$6 <A*$?>E'B>SZ,X]BSR8" )*'0NK1*NYH388KIS0&4533Y@^P.M@J2
M)ZFN=GXUBNU1#'KD1HGK.6K%-752@(R6TFF>\2FH O8F"F?_%/&SM0Q<T&;.
MZD$6V7;ET#0[=9#G 3<$( K<@'@#&AS8@0(1G8Q!]YGX_L'PHT<<E>CI=.XG
M:>NLM.O2V2$VI[]W[(A1LOL:Z^(2K"R.1LNQ.B_YI%DQJQ-E&MW3[I&_W>&<
M JA8%97OW8TK=DRT>ZMQNRV_L:.B*VJ;V&X<V8[OVV'LP##%(S _5K&%J!*.
M9O$>$5G9 $E--JPT)).$?*EHZ-+TSA_VM,+@4?N[_9780T!'KXP2>(%HB&N]
MCE ;+?M:'.8; ?1Q/7$PH-] )1V$*#KZS;Q>Q="E<X0H=!+H^8$'$<1Q;QW'
M2(GB"]O4+.M_4-:K)BNZK/RQK N)DW?*^)TDWUJIU:71[ <'U$]&*? IH>(R
M*QT2H[54WBL^P9S(&E?1Y;&%/DO,G^/XF#?[:O>Y_%"57XN:Z73;-E<$@2!Q
M$E8%&@&7  ]%P\(*1@%T!#;JM&.99[.N0\<> 'D<\ D4LM4:B^N2:@;_FC6V
MC\[GTAK1OZJS,T=)H(2P*=&2*PNL-VI\)7PG,'AF")PM* :4VIW%S7+FQJYT
M88GLLG5;G;<[S4A"WTN!C5.;(!BA-'6<83Z#PR"&JZ]Y=5LJ6D42M"W2V8]A
M\J_W]Z<&V>%R:]V"5+IB),JUDL4AC23K7P?JP9MY-/P\P_)K.Y*1,GKJ,=4W
ML16;20Q.%-3V)7JX^<>^;EB64:]< "#V AL1)W5]&"<V',[!X(0 H3J7JFQJ
M7IQI\2B13'$V)XFE5B)UR60+VCI";90ZGE(JKHO203%:$>6]XM/"B:SI*+-X
M7":PK1)XNGQ$O[]R4R>.40I &">AG]@A<9PD!=@!"0Y!)"27LX/3?1!%O-8?
M1W'&OM(4YQ-&RP6>3]F-CKG8$+!0N!<O^<@3EBO#R&(MP(SQ9CGW)]20U! '
MB?*2 ] GM,WJ&GXOZA7"V'$=Y*20H,!#V(^2:+#IQ%XD65-2PI+FL65$9+60
MK#\9*-DQ08Y*08'7SJ*86@L2J+MFXTMN>"1S$J>&Z=\T7RZ79)S,T *Y]2EJ
M7#YDQ6X%48#BD/@8^C8)4N)A&W>XD4OL6*YB[F)H9\N^6=76%]V] [E<%BT;
MXMG3ZAFB*YMG2P76]'SY/-_S)- 38VW8B+(\'_I2;"61XCK",YX1:NA7=<'V
MVAB T?QO^<-M7JV2@*W5.Q@ -PZ3*$P@\'K+GA,ZD/O9<T7V-(\N!Y36!_HK
M]UF='T_Z!0Y\J.*7XP3. M2*2?L1J\\0'JG\GQU(D1>\53$L<'IF :;E#LJH
M8)SO. P?)9=.OB@FU(!#+JH]*O4U/[%Y$,ZKXFO&]L+&-RL.3U;4SX:^%@6=
M<<40A&$" N#X)"9I[ XH?"\4FM6HMJU_%/F:5]VE\]_+)J^M@P.''B@V1U%.
M/]^,8TGFQ0:9(XK//:I2/U^]%U4_-?,)03:OS YTQ<6,7%^;=^4\K7NQ%:9W
MQ2Y_RTJ-K$(/>#$ Q$%^[($D#5*0]%!]V\?.0HM*_ !_T%U<YJ#5>KC<(I1
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MI"G%_ACSJ'=YCUHZC5,6%.&L;HEX3$CRCN#>6,\ 6\-)(?):,'0G?9R4\N6
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M/"G5-RP!.?\MWQ3U.AM/* 6>XZ=I .(P"5,  0S' 2-$'M>46.9S-<OU@$9
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MB?I:T8\\6&ID1<DHJCMJO,/KA^RIQ?.Y[ _:#.[D=?LL^PHYGNV&+@XPQG:
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M9HT4<SG]^J$U_9RK7B_\/6_^WJUUH6ZI"V[^L:\;-IM?^7:($; 3QTYPFN(
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M9YPOE^3( D.JZO3$5'?@+_"2"',_#&D2!3 2 Q7D];;\.-3:L6EF86(U,CR
M;,B>F@RY)VZ<_,QTB/A%6J[HSC@:EZ$W(WTH;38L[26?AW+?#,:Z'>LQ$=^,
M8.#'2/R2,3\B06<'PI1J;171_[IC76D!M=,0>E)B0)3R"IA#CO0DY)R>F0ZH
M/*/C^B*6(77+D(T1^)\O2(UB0E4NR'9;R$6O]>[#NMB^V=/UUZ)>[_H[!GG
M,(VRE 8D)1'UJ3_8C),LT9&.<98<R\@)')#H?GNS!QT^/5$92:>:P$S'I)[8
M/"6Q&$B<27JN$G5%ANP0O Q)LN1+Z:():DK5Z7WQ9E%(UE.'_(M<*9)7Q&_*
MA[RS'W(8^DG(*0X)]B$-8N@/]D69I25;UJRZEK 3T&XQ]K-\'Q,\ @S>EE5E
M\*ZE1>X5-6X6VC7U[CU] TA='XK;8]T\V%:70OD.S5!M'L%39>V:^%EG?B%"
M:-^OIZ+HB#E5@?R8UV)<F6^S]6%?[.^KSI@\?1!D49KX!"/BTR2+LMY8&""H
MHX:&)AQ+WR_GVL?RNV)3U+^"'BOHP>I)GBF;:OHV 9%Z8O:,K9DD[&5BKNC5
M2":7(4YCG2BMMBX]V7DG7)1/8)0[\8?N^W,[G<F(14%&_"C$":4D"1CW^B4^
M7XQEM5YZ'&7(L00]Q@:&TTMB#/3I>%L5VV)]N'PBQP&O:C(T&:5Z8G2)S7DD
MZ1I)5X3)"K?+D"<[KI0.VI[AUH"WPTEYSF(>>F$@OBM*,,()@E%O2/Q/Z_4<
M@\]/MW7HK>E5)2:D::[[N^%+3W,TJ7*[U/]6X<Z.$>PM0U7&.'!I)=^4"_4W
MN#:'?%WE+&___6;_?-_C1Z%HO#S\OCYL5UF<931)6  I]A'GL4]@CX+Y5&OP
M9=NV8^WIX8)?>L"_-N70BSN&)6[0 =?4)^LA41.O.:.AIVP. N'HM3 M1J](
MHZO8+$,WG7GW[.$QERPJUVQ?UJ)MOS_65;W>;T6EN()I&$=(?M[CH1]3S"CI
M[* X9.GJ:WXHRJW("0?% ^GZ-G1ZZU,XRATWS>^+_;Z]ATS\AXWHP:+?5@W8
M7S6+.'T6%6LXI]1IEG -EAMPAF;B^NTI&=?*-V/BEJ%"(_ _+=Y&,J$^^GNJ
M7D+A=D=I\4-Y:([^GBWF?"Y?'J"N_#3P0Y@2 G&4!E[0'##KP 4PC0WD9QI@
M\VB6[F!SFABI#E 7%QC=0>WS&D_>7-PY 3HOGJUB7IB FWHT;(/]JR/H2<.[
M$-V>V.EG(_49.-?*$&^JZIAOV5'>\?:AE<$F037_\?W7YJZW['M^V!15OEVQ
M.*(\\GP_#H(P1C2A7MH#R0BE>H^..0"@(RY&+X_U4.1QX*8V!66+<42UZB .
M&HH_7P ,ZMW?;L70[,F;L>1P$'^NG<V\_0'._]R']8_FQT0.V42I_+6['[/W
MIY)3 ZW3,ZB]%O.O*;N;,"Y(Q1TY^))BN^32CCK+?Z:RB9_WA%5"PC1 *.:>
M/'0>8C_$_2$+Q$)/\U2X??N.YV#_)G*E+."$-,NT>2@V<HM,U1P'D+>VB#+_
MKCP\-',+W4^E+CB3;L,@V=!N]_$Q*,U!"Q>T>#O=O0']1,8E@;\![_+F^@U>
M'N[RHCX>IKY_T(!K8[D>%[F?0:]'>J@EV#;8'*G8S>7*%X $$?(80IZ?9CXB
M,41Q/!3V6>R%%@1[C/F%ZK45C1X5EE$2/55$["ET][K(3R?05YC6UV<;85NT
M/%MQ4$V=[7%II9Q^E__>_*=J19(X8E[J!1GA&-,@Y$'8&0_"B-D09%V3KC=-
M-7! T79\H;>B:^^_Y8>ZD+.C[\HZ=U4?:[!NH21V0[C]*EC@;/_$,B3T"7FF
M9:T^^XN62F.G=(I74\YLU*LGVXGG1XG<0I:&E&'J>S[MM]$'#!.MXX5V+,XO
MB/8*4 V>Q]><;BBV7F8N3 $?4V=8-^I3OVC],_5)HSHT94S]+HA_'*M:K@Y4
MG\L+)[P;*;A]6J%^S/_C6%1%G7_*#]^*3=Z"_IAOROM]\Y4&_RJ3$\$\@"S&
M/$9A0IB/>MAQZFN5DK.#=:RYW7Y,\^?B9B=(^3:+GRB0>LI^YIK<5/'D?@QP
MNA_CVD3"X"7HW.R2 SAS=.IK-=Q&[$I"64QC648N6@X=S^X'60HP_?K_8_Y5
M].<O$MCP%,@+8Y%5@,,LB5@4!E$<1C!!+!Z&(#&&R6J?W\L3Z9\U1P.V["OI
MVO BUA.HFM7K8<#<3%.?/0$Q;J+$6BPTA@J3\C]BQ'"&LR&]0_KR+,H,XP9%
M'E\;/M@.QS*4VXUK+PTFW/!G5U%;3?<0BE&2$!YA!K%'4Q+V9WZ#(.'N!%7-
M_"+TU(6&*K)O4T(M,NY>01NP2Q30UZIE%['XF>13TS,C]31A3_DNW_92H^);
MGMW=Y9M:/C[]^&*7=WG]_N[S^CM<H8"AB 9(FD,)ARR*^@T<012F6O<8V+3K
M>)KD!/6WO,$*UL/0 _S65I[=L-I\*L5J'-1D=*X0Z,GH"25H88)R__S>K6$S
MA$ [\=W#ZBQ>D5$7L5B&C#KQ[.E-QL[84Y712Y?QR;LP>7G(B_L]/1X.^7[S
MX_-A+11BTST#VOQNUSX*.JA*CW859-#'&>(>\6-1+U.*63\%$49([U[UF2 Z
M%N<..=ATT$%]0GNFT\U]I%(?ZO5WW97$N6*KIN(_05CU!+^]6/;QE;*M2^ 7
MZ=2O-Z />N\8./.LJ;+/? /DK!',E23<!.E*/IFY52PC]<Q-0KFHGFHOH=%U
M]87ORM__+=_>YW\6>5;^D-P)]?Z8;W;KJBKNBDW_SK6$R./41YR0D!.?^!@F
M..SOH@VS$&O=\3\I,,?)2\J1&/CM[W.Y4/=%H)9S O4I^*[2EOT(CD]6LP;/
M>HJ2W@#I#FC\N0'2H^&_KJ5;X*E?;>I:4F[2C8EA1G(6^N7G(7>N:V0?Q_RK
MYIR_%/ORT)S6;T_@]Y="<<$H*ZKVR+X\!7KIR/Z_M6?^5Q#)DT4!35 (8Q0&
M7I"D0TKT_,!@EG\R;-,L 9Q#EOM&]H\OXVCFM-H;%/22SG0A5$LXRPJ;S8N*
M;T#O"Y"* QYY<^5^%=!Y-&V2L16'*PEF\E O([E,[W8Y<Q?32RH?#N5=4<N$
MMD(LB$D4A="G/J4\#L*H?VTU)$F&]>Y1T?BPCC@8W8\B!Q*_[&1M*082,JM/
MV[M/5%SIGP9\+:.'F0 O1[>5L3=8RCX49YRR"$8TC2+(2;]_._3CD'=7R&7[
MK>(V!VT+.JW^,1CU'<P-$JVK*Q=X*:,JD<OH#B/POWHIHQX3$U_*&$4)Y1XF
MF>=YB9>D#+-^Y2B,18?6[E'3P)J\&_Z_&_S&A&DAG7QBI]W<X*?'N?H;:)+$
M8E<T,R+O[_ZZ/[1;Q_\SEY,C:;[/1;*OLN\=8O)0'O=U]2$_R#5I\8//9?9]
M_2"7I\4?_YC7Q\.^.K_DVF<QBT@JH!.&HA1A&'*",Q:R+",TT'Q-;6:PCJ?0
M'_LGI\K//92SJ:#W45Y UU]*VKD)3G[*(7/O:?/7.E]'O1LP._O*3\7]1*U$
M;_ID,0W$T5-V;@-W)2\NILTL(V,NAXYG#_4M!9A6EKT <T62 $64)#P.,Q*)
M5!XD06>->S&!^E>CFUK2+ZQ-[CKOAK;K&ORO]?ZX/OP <%J)N4#/%6482^@R
M.O1H+TJ[S<Q*]^G?6ZD^YM5Q)^^!D].T[;:3NMUM+O[TA[)JSD%6*T@])*>H
M$C^D7NQ[F<?#'ASQ0J93BDX$R7'!V9\TK4"[Y5NNGXEBX&N/#QSR]I%@42[4
M7_)N8V(-?N1KS;6TJ4*H5B(N,'IZA>"5LF]XO6IPHEU3Z]SH3\/+OS1XL@@1
MUF1?7[-=A7?1$N_,:;6,X)9S)PGD@P!U> $:)0A3%,$40182%&6,^3VT($38
M6?HP!;2@Y/%5NM"D#<V-?]-$SD'6F")HSG-&X\3/EC$N,&\K7XP-[$^8+4:[
M/"97V.%[9*;H]X&H04M#Y*,0$2\(0HQPXI$8M="XR&XLZ[?LC<H5=B$9[-33
MG=O>'C=/TD65U_4N;^][:O>%3Y,]+$=S5/:8(8RVL\>P=^_GRAY:S.MG#S>!
M773V<.2R6O9PR?=KV6.S.>POX1J$[Q$NGHL0K7=R$EJH'&W.S:QXS%'H)9#P
MA/L^S7B2XAY4G&"NEC<F N,\8XC>'#>R038UN&LA-CGB(+[5'3522P=3A>=Z
M(EA27&RG@ '_60Z0'H#.A7:-4<:-+C!NVW)SE%5(^WK 3Q2_1\ 7%<<GB5QR
MUZ1GZ'?)V0Z;+Z3EB<,T;T*>VMEREJXP/@D/0\N7JX3F/!D;1B@K$E!,0Q9F
M1(PL4^2%?CI4!S#F@<I4WX1P'$_T-7#&*[;M&)AGVQGIMSYE5X%?!B]^?:K:
M[=G>DRO+"^+XU#MC,,W2[^<O.;@_E%4%ULWN%#GU49RB";:G<!9[<#QO K+Z
MO>W\E@^>G8^VRR;619T_5']RDY;UF-9,S8["N-ST[,IAA13ME.NQ>Z(2ZD7<
MQUZ08,%T&N 4T:$H8(3JGDPPM3/!48.S_5 B$OG#K>C Z*?=$:5*Z**GL-2]
M4-P1I<>*\HTVHL6M97]]VW1??I0O)OZEV!</QX?NQ?**'?-NG7V%(\))F@:0
M>! BG&0\#5(NK]X, Y]$6J\Z6S;MN'85K1YK7C5CF5JUU8$96=4K20>@H$5Z
M UJLH ,+>K2 M2\Q?:_!Y]_SW3?Q)\I]_67BN7\]7J^HGJ, +4,,73GW]-H6
MEQQ:ELXW^\^_E_]7+CFN,/43+I @QJ,PXQSY'NMPA!@SK7VC]JT[%U#?<R*@
M.@1;U5!'W#J2T1NIHW(@*$"#_WMU"7Q. 3V1.EY##0+T4\FHB7]F2FK,I'TQ
M%6TR[Y#P* KC$"$?QH%'PHB&7H_$2UGJ1D[5[;L7U,M#O.E(MBVI;OAU+JH2
M]K)E=2#6BK#JA^EGDU8##XW%U91-Z_+*19=H@;!8[F>):093+/[?PW+*H0,"
MHU3O>EK[YMV+J^](7#4HMJRM;MAU+:T2]:*5=:#5AK#JQ^@GTU4#!TUEU91+
M^ZI:?.OD/4$8^CA)$6%Q1#*/\)3V0&@6N:E9U<V[5U7D2E75*;:MJD[8=:ZJ
M\GKN1:MJ3ZL55=6.T<^FJOH.&JNJ(9>65?7SE_R0-U?&KU@4^#Z*TS .(/5Y
M"GT6=CA2A",7I:J&=<>:>D+B1%EU:+8JK(X8=JJK"K&84U1/\,9KJD%X?BI)
M-?'/3%&-F;0LJ"MA)V(X"JA/_)1'(4*D+Y)3CG"XJLMZO;,JHZ_:U!+/ 9ZZ
M>,J_XD0W7V?3JEI:)=+A0OXB=7&\&BK3_U-IH+I79LJGR9K2OGW6;:7M_[W>
M;[-]W=R5>E<>'MKW6FZK^K#>U"L:90QG*8]1BGR8T)@SGQ /QK&\'I6^=I^#
M?8/N>FD/#YSA!"U0<(84_+W'JGBIIP/2-;9RST:^V8YMBT%0VX"MP\^E?=9.
M.%[ =FHW?I6N6Z>:%F[S8C#_6?R-5<C#,$@1C'F,?0(SGH9)^WGBH9AZ*F-D
M[8\Z'OH.W4F"49,K?5ZNIP"GE!@J_%4V7JBSJK[0JO+-G^[+;_]=.-766.(7
M3TNKIPZ_H!K&G,PK"N:PRY%M0;U+$_'MK?P^WZWO5['<>R/^0;,X"H(D)H$/
M^^\G84Q4^[3>5QUWZ@$,D&C4>[4F-:]W:W>LZ/5K14)L=.Q'+E_HV6:TS-^U
M#7&78QN$?K[^T!\"8NLZ7_F(9SQ+@RR,(<0$<^)EO9TTQ$KO'IA_?:H,WEWN
M(V !B4L_F6N2II[5W?%EF-Y5J;*9Z1^1\$K*-R-L?H$8B?^%(F ,$SJ"P8MJ
ML][)-3DN?E*M4(P2GW%A@WE1[!%$4=A9@C3)E$YIC?G^5*+1XFI6L4&#3%\V
MM*E3%PZ7K!E*ASIA-L7C"1&OR(<I;<L1$&,/7I"0<6SHBT@K69TM&*<!2K#O
M0Z%<!(6,![VM($J4EM7'69A82+K,.DI*M C4%1-7W(V3$R7:[ O*&1E*DF)"
MWM)$Q<B'B[)BSHB*L'P^K.7+.9]^/-R6NQ7B-. 9\D,2^5F0P#CDJ/]^F&&J
M*B9Z7W6]]Z8% UHTZI*A2<WK,N&.%3UI4"3$AA@\<OF" )C1,G^G-\1=CFT0
MZIV[7<?XF-_+M\S7^_K=^B%?I5Z& ^)Y-* IYEP8\>/>C!=D2+6/&WW<<5?O
M5NE.H(!$I=[ES0A[O><[YTI/ #1ILB$$+S%P00]&D36_+(R#7UIJ-+HB046]
M<5COWNRW^??_G?]8)2&EU(^2,$BY1Z,X#I'?VXF@IUP)F'U]&IGH4($&%A"X
M=(5"FS15I7#)EY%4J%-E3RR>D'!5+4P)6XI<&.-_IA?CF% 1C.["EM.D1S]W
MZF5>C"".D/B\L <AI:0SY0<L4[I'=90!Q[+1OZEV/D&GOQ9B3M_KZC$)<WH"
M8D2:#1&YQ,4%'1E-W?Q2,MZ%TF)3TJU _CW?[?[WOOQ]_RE?5^4^W[ZIJF-^
M6,782U' DI2&C* @]@CN]V?X'F/*JC+.RC05B43WVS\E/-#C RU W=+$F$W5
M$F4*(HU*%0,.[=4L%UBY6KN,97)^X;'DQ[-:Q@XSZA+TZ8LP2,N'K^O]CQ4.
M$AR%$681)SY*$"2(2B-,GIH4M9.>[FA]>AJQ:2"!#I.NONA1I2HJSE@R4A(U
M@NR)Q[GW5Q7#B*:ER(09^&?:,((##4%X6.]VZ;$J]GE5K5)1Z@2,B$%4DF1"
M:K#GL49V<.R%,=6L1/2^/9$D2$R@!Z6M"7IL*8N",Z+,5$&-(XNR<.[_=5TP
M8FHQPF"&_KDRC&!!71JRA_QP7^SO_WPH?Z^_]$(41S! OI^$. @Q]F,OSMKI
M61P*TZFF1)C9F$8J>FR@!6=:1QC2J*H=[ADTTA!=\NR)R8N$7!65<10N15Q&
M>O%,9&RPHK$ZTT[&?,R_E@=Y8O=3O:Z/U<H+D1<QSB@4ZA:G0MG2?CN(#QE2
MNJ=JM)&)UFJZ:<0!'6CA:2_9&#*IO'+CGD2S!1Q=_BRNX[Q(R?7EG'$L+D5T
MQKKQ?'''!B_JLO.W<G?<U^O##U[L1,]=(1ZQA'&.4H0@YRDBPPX5WP\]S>I&
M]^O3",V "K2P= 5&FS-597%)EY&D*#-E3TJ><'!50TSY6HIX&.-_IAKCF%"7
MB^;S=%WG]^7AQRH*DU ($?$I9S&-,YYEO+?"(?3UQ$+OV]-(18,)]*!TA4*3
M+569<$>4D4@H<F1/(A[Y?U4@S)A:BCP8HG\F#F-8T!C E \/Y?Y376[^^>G+
M6C2;]\>ZDE=MB")FQ83LP#A$*8<4>G)7N]^O*"-.U%[<L61JHL%, Q$T&&]
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MS/>U^%55;)LJL=R3PT$TQF:FN^I5$H>9AQ+?"WV,/9^B,.2X Q3C""N5;1/
M<"QH9/,?1Q$SB>ZW0[Y;U_D6; ;T\I<G^!H/2SD.S74I7%A4](2RQPW.@-^
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M!#'D*=1:DM#XK..5"+G+K-P5VV8[C<C:X)?=V=+$Y/OR.U:N] H#ZI;1$4R
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M+(2:67"\'/I<6H2JMSJB(C+@-]"X 7XY5MO37[T\DVB3>S41<D^[GACU>(
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MU[)SMJ(A_G-(UP3_C<_9RD5BD3MF/A9_I&7W5?:0U1L""24NC.PH8LU O[T
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M;7N?[@[[]/,M/E19GE85VO[SD%59BP;_//O3M_1'C1OV_[$A@,4@"CPOPBB
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M$5F_)<WP(:NSD3V\1K3G%79&)&<*E^M0FDD>%/I:EKJN;"(W]"G@VZL()8A
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M976>+;[/=EI@Y';ASM0(5KM'=R[_W][!.VLD]&:AX86$SR5_[44(+FEZ0Q3
MR(<>\=S0#4!TG%.F  L-+Q<':3@G\4-$6??PTBQIR408=6:GA2-H,$D=WY<I
M2HO[]LZSE7R@)B<M@VWC/>4NDS0HI3#C<1&^A.QPT\2( ^7/]]P,%Q-%O@T]
M%KH8N(%GTS@($'^<VP6,1 X"@=0E9&HF#&>1<U06AR5Y&YDB;V+"/P-E<K+]
M@JVE+B-[E9@1F9S(Y#I$;JH3SR\CT\&)T*++U[3Q</<Q2_-G%^ZPT/;B1L.H
M[=D.\Z,8@+"WA7P[$KIK=9H%T_+2XK(XL--M4%=6GLK<:J!.G\#:QBS,2:K,
M:Z2IW$:F3IS$8L(L!*HM#R@2*3;7?\GO2[/WDWE:P7S\=!\*G2U'KL:CA[+8
M%?M]4O9F7.!BZKHVA([M$.S8OH=[,QCZ$96[24#ZXV7:O](U 2=$\U8GSYD8
MJ4N425M'1:(.O]#4>"2J$):554VSN_OZ0U[5R7[?'H,8["&;DA#&S \Q/\X0
M,3ON[1$8.DRX$IEDQ7 UTF*S6G#6.3J)E#J-1(%Z9#;^Y&J22]2IE"73.)0H
M36;C4JT\4>=4K$(9<_]2E:*%LA54*GK\*'0W)@FY_I+R2_?;M]%>F(M"@B(<
M!YC8.'2<,$3QT9Q#D=#E^).-&%]S[Z&I2O4D @64>B[NY(3Z==I49'H2?Q(J
M/1>/:B*MRJ>81(_X?DFA=="U H'6XD:AN1E)R#.?,>26RK9-79=I?TG$=9HG
M^_KGAOK8@RP,'2]D3F3[D+EV;S(.&S#"$CW5D&&9/@&R'CM$$A(SF40!F9Z3
M/SFI;A<03M#X^N^1R^OYN920[#DY59/M*=R*2?<;'%R2;UW4K4#"M;E2&&A:
MZE*>EEFQR[;7@]VF@36M[R[]?'M=9ODV>TSV&P@@A#%FOA="#\6NZ\>1XQ(4
M4I^"0.)R0@.V30M^CW&X%>FJT?T!)M^9\C@ 5=<N+1&03PUSDS\U6PR!N!X"
M<8)L?;ZUKE<2"/6\,G= =*6:R8%1RD "; DF)9V\KR]/:?5N)'7I9U'\H>AB
M^P_T^%BFVZS;*LRGK:JOZ,O7?D 4$. CB% 0N';L  1]0KLL"N-F/.3*/1H]
MU9KI30@<H'6.T.H@RCXE/9G5\9RT#*&2>Q,N<6G]TN"K_K+4AJBW*!O;&Z6-
M[G4L2FKTY\4#U7J9$M6S;UF];V3S0[[+OF>[0[)O'\9&U".^[\:QCT#@Q]2C
M03C8LDDH]*[0- N&=:L%Q4OJ$ZRW7G;729^86)EG3DZ@%$@SHDBO\C*B0M-X
M7(?R3/2AT-FR)BH,/\7;7L[1J%QUGSU^*VA>9_7/_BEL&",;Q&' 7TR,7!L[
MK"G-.Q34#SVI9PIUVS:^+G="QJ^3ZK"]_?3[/+PKBM:,E,LNYZFQ/8^FC=,F
MHW:: K!2'=3EW5L*J95%H;G3;VG>CVP_E[\59=J6B/?%OF%X6'QSXI"2@'@V
M)11'B-K0C0>KS?^)\%RI!ENF*[8T'^9ZK,^EQ4%:YR@E9N)T$"LP!3HSIY*U
MW!MTJNQJT,&KQ(SFS/RJS6!.YUELPO)M,BY-4&JD<043DCJ]*<PT-LDGOIOF
M]"EY2-L*W?&8'7N4>!%#'O ]QW5(;X*YT/:EGO"6^6#3"U_-GRP.1FD0+D>1
M6!EKC!TYF18FQLS+Y6<DC%2<2ERMHYQ4@_[\97%U_V55H*\V$?(9AI'CQ8
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MN;*XCA@:7R&G_SQD]<_3XTLO:HV_M6X/ZR^MXRS)RK_Q(S:;D'@LB'Q* (L
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MCGP4A._TS:\8RCVNRD-=?#YRE/Q(33^969.BV=4Y_W1;WXU_"=WPM=V-2P&
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M6[<2,W'XZ;I5A:+3B.VANPE_T(==IP_-UVV=]\B=G]L;7W:ZQ%LP*JHE6WU
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M+8M_M8N23%R:ZKK8M]^@<O^!(1BN0WE_E17EMMP5V^N/[).NRKP_EH-!3&+
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MN!85*Z^,N.>JEU?FPJ-R9MRCW[*O_OIOPR?L7QSW7__M_P!02P,$%     @
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M-5\\? H+VI?Y_M'=T*LMH5V.H6T0/T^"&J]C3/'JZ9=K\^M\L=AH]ZTMA>I
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M^3C/KY8^ /EAN5R/9N/\XCK>0_VRNX=Z*/#A:.-, PX9L( 1S#ESEF-(]TL
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M)-W=43',^J3,' ,\^&^5S)UJH@N;X4".K 9LA@.]9P0P:R30$.B8+YFJQPU
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M=P5\5Q;J4R'RR;=H5 <Q?AM-[R,PDW'^/ONJ=I%!YS26 5U#C3 $!:,,[A"
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M7 <9Q!9HY +0 "LI@+$<[+]3"),JM"3MZY\^&UO10,?6WC]&XR,108<;9$A
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MR&_SX*Y^RS_,QO.[_.-\&<->+ZZ_C+X?#HZHTE,FI=74<6N<@092PZ#80XV
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MZFZUWNIWB]Z7T??=]72=S_+K@S&L1UIFT$/'.+5(2">()1@(5<@+)4^Y4S3
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M*#@)#S"R0B\9)A8S0W 4&@L/+6/%%@AA5*<<J _T\FDG5&Q/!9WF>GNG$GI
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MD"Q)./:S$?8IO\KO-JF=MQES*NV=OM4XTT%B3;SF6B/EN!84%!:\H2 I1'6
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M4@)5SQIEL>5*&82#3625PD0 6T@E!3I#FM36Z_&L4=7 [(<B];)&$>J@18H
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M?7+;#]J^4$OVQ(C@F+)8D>C7, ^MB\9C=&IV,FH,S6 M(487!E*9#"?#_G.
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M,1$BI<AIZ_:@&<9 3JI)UO7(%=.I#:#'X'GZ)V^DH9/Y;(9 (. .4:RICL:
MEDH=0L.,8BC'G\PZ +E>HG6#?/:QVM-K?2I6Z]?%,"X=IYT?'0#FJ?L\ !IY
M;9BFQ)9G1,9@EF//U^X[<]TLZ@[UQ@SR\1U2:&FQ_:FK3\7RZW0^F6W_Z+?E
MXL_UEU1"Y12#JHT.WD. ,6>6:\2X!EBY<AVV6MN<@+C:_6AN@$&=H-X6@_QB
M6=Q-5NN3?4$O#PI:2VJ] ,AQ9*,E2+ O<THMDED%[U.=GU^=,%EHM\63#TDS
MBX=/J2ZKFT>0ORVGJV+[P.<?3O_^R:J*Y*DP4U!&89E$HDA*0@G'K+PXLQ*
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M+SC7@A*,M"$0>NH=M=)SR1EVE;ZM;F0UF^5R&S1S5!/':%L!BN:3!D.\!1A
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M:D7U'HEHR&9Y""-L:M$S4=L#?C *-BIF6V.6H( 0C)+H*T7?"2#BM$5['+C
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MLO(K1UB$M4LRM8?RX%[CF^F\^'U=?&UT6'$8'+B3FBD5UV0H%63(,Z@.WQ"
M.7VNQ[X1#G=6T13^P4EWJ8+:^8%!:$0(4L0JPRPFU@!"2VF)QK]D&$8#+E2E
M61/0^Z*8NKO;?-W,4KJT+:+F[G8QX/'WLV(?@Z:^+I;K?7Q:DSHR;?V((&S4
MAH7 ,2^!M QX7>XV#EG?CR<Z5'V##HD[D((&7T7/5W4[-RPH9J.E@XSWT0.7
MT=K%C!\DA:K?[;K?-H=#K*#U(1^<7/]8%0^;V9OIP[GHJ JC0]PR4GL,I;2$
MSE- "0.EW-*!G+9Y5^O/=DBUQLB/)%9RX)(*W89*6FPD=T0Q#+'%'CO&]QY
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M06/DO,264RY8M1H4:75>H4 M0*0U6@ZL'7VL$9-V:&A@S!IA*+,J6I&((TZ
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MHEJCC"6$Q07#S3H5I[!6D-/X_9KML;OLAK##[N97LS^GG6R%9CS%?%/LI-)
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ME5P0O90B Y&_+W,X"89/D[M#K1:>/A8\Y899+@$'S+@H*0FTU4JB_79F0!H
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M/8X)48HBP0AP D(BE?,:X&K>C&4UNSB9PE*C %-CGK2)I>G/HR73XY@ B>!
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MK)G5KJ($U8!D%0LY 30<R[^R(\(.(D;2 E8"=14?=,RA]'ID, ;KU,+6 "4
MLH!K49&01DOAS#K0]7X\95.\+X2EWGPOJ%*K&>N;8P**FT@!Y@V&J7$305I5
MNXAIQ[.\C.-#56L<?Z/+:AOT[<V9>'=_6_XJBJ]%*BR[KT'F@1$A;CC.E* X
MG:4&$$LQW:Y/F:RHE_'AIP4^OW0=MD+7Q@I/"E582=+]*LZ+QX*2A!F@O0>I
M43LR/JI[U>P(DUGNNW/F>@O$[+6&U+,U'Y01NX8$;Q1&(!H#45\3EA"$L,&
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M?;(H_O?_^&]02P$"% ,4    " "6FEQ.%SFK#D"! @">-"8 $0
M    @ $     8V-R;BTR,#$X,3(S,2YX;6Q02P$"% ,4    " "6FEQ.>JO"
M=B <  !V. $ $0              @ %O@0( 8V-R;BTR,#$X,3(S,2YX<V10
M2P$"% ,4    " "6FEQ.$X>.N 0W   H:P( %0              @ &^G0(
M8V-R;BTR,#$X,3(S,5]C86PN>&UL4$L! A0#%     @ EII<3CI9K]HPD
M03@' !4              ( !]=0" &-C<FXM,C Q.#$R,S%?9&5F+GAM;%!+
M 0(4 Q0    ( )::7$X5(P3:?4<! /AU$0 5              "  5AE P!C
M8W)N+3(P,3@Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "6FEQ.)J_ASV_8  #*
M 0L %0              @ $(K00 8V-R;BTR,#$X,3(S,5]P<F4N>&UL4$L%
3!@     &  8 B@$  *J%!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
